data_2kmn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kmn _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.863 HG12 ' HA ' ' A' ' 37' ' ' THR . 25.5 m . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.672 0.273 . . . . 0.0 111.327 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.867 HD11 ' HB ' ' A' ' 51' ' ' VAL . 2.0 pt? -80.46 -147.47 0.05 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.511 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 51.7 tt0 -98.58 104.76 16.83 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.938 0.399 . . . . 0.0 110.889 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.454 HG23 HG23 ' A' ' 37' ' ' THR . 40.4 t -88.36 126.38 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-O 121.496 0.665 . . . . 0.0 112.152 -178.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 1.061 ' HB2' HD23 ' A' ' 13' ' ' LEU . 50.2 mt -85.86 144.97 27.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.22 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 53.6 m-70 -123.01 144.05 49.52 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -178.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.861 ' CD1' HD12 ' A' ' 13' ' ' LEU . 49.3 mm -65.8 132.67 94.85 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.787 177.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -77.31 143.74 75.76 Favored 'Cis proline' 0 C--N 1.35 0.641 0 C-N-CA 124.553 -1.019 . . . . 0.0 111.778 -0.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 1.016 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.7 t70 -162.51 126.79 3.11 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.478 ' HG2' ' N ' ' A' ' 12' ' ' ARG . 0.6 OUTLIER -57.9 -45.85 85.84 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.754 -178.444 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.696 ' HB2' HD11 ' A' ' 6' ' ' LEU . 21.4 mtt-85 -59.89 -26.83 66.2 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 1.061 HD23 ' HB2' ' A' ' 6' ' ' LEU . 10.6 mt -77.66 -30.56 52.14 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 120.964 1.711 . . . . 0.0 108.586 177.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.589 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 15.0 mmm180 -95.11 8.62 42.43 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.072 -1.422 . . . . 0.0 109.059 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -90.17 147.67 23.44 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.7 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 90.4 t -81.93 128.83 38.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.769 ' HB2' ' HG3' ' A' ' 56' ' ' ARG . . . -90.28 145.4 25.01 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.846 ' HD3' ' HD2' ' A' ' 19' ' ' PRO . 8.0 tmtt? -107.11 131.42 21.71 Favored Pre-proline 0 C--N 1.318 -0.768 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.846 ' HD2' ' HD3' ' A' ' 18' ' ' LYS . 54.1 Cg_endo -81.56 114.44 2.7 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.774 1.649 . . . . 0.0 110.333 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.63 HG12 ' N ' ' A' ' 21' ' ' GLU . 19.4 t -68.97 144.88 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 CA-C-O 122.692 1.234 . . . . 0.0 113.342 -175.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.63 ' N ' HG12 ' A' ' 20' ' ' VAL . 52.8 mt-10 -63.31 -21.26 66.15 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 112.861 -1.972 . . . . 0.0 112.986 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -157.84 144.51 17.82 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.166 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.793 HG23 HD13 ' A' ' 111' ' ' LEU . 3.2 t -79.64 106.85 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -178.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.892 HD21 HD12 ' A' ' 27' ' ' ILE . 56.1 m-80 -92.61 153.22 19.13 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.802 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.724 ' HB2' HH12 ' A' ' 29' ' ' ARG . . . -54.14 -24.19 16.93 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.241 0.543 . . . . 0.0 110.782 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.87 ' HG3' HD13 ' A' ' 27' ' ' ILE . 13.9 pt-20 -75.15 -42.19 56.66 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 177.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.892 HD12 HD21 ' A' ' 24' ' ' ASN . 2.0 mp -65.19 -35.72 76.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.748 177.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -66.32 -40.57 90.03 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 122.349 -0.22 . . . . 0.0 110.493 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.724 HH12 ' HB2' ' A' ' 25' ' ' ALA . 67.9 mtt85 -62.83 -38.69 91.77 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.919 HG23 HD12 ' A' ' 57' ' ' ILE . 1.6 mp -56.07 -49.97 72.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.927 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.81 ' CG1' HG23 ' A' ' 71' ' ' VAL . 36.7 t -67.25 -43.14 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.924 0.392 . . . . 0.0 111.17 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.807 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -55.45 -41.11 72.42 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.067 -179.103 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.519 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 1.3 m-20 -76.37 -30.22 57.46 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.318 176.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.783 ' HG3' ' O ' ' A' ' 30' ' ' ILE . 32.5 mtm -60.74 -44.59 96.49 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 120.55 -0.46 . . . . 0.0 109.95 -178.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.807 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 10.6 p90 -70.17 -46.19 65.15 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.549 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 29.7 mm-40 -51.86 -40.99 61.51 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 121.634 0.731 . . . . 0.0 109.411 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.863 ' HA ' HG12 ' A' ' 2' ' ' VAL . 91.6 m -70.43 -61.84 1.62 Allowed 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 118.479 -1.288 . . . . 0.0 108.411 177.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.918 ' HE3' ' HB2' ' A' ' 61' ' ' ASP . 2.1 ttp -46.16 -41.06 12.08 Favored 'General case' 0 CA--C 1.46 -2.483 0 C-N-CA 124.346 1.058 . . . . 0.0 110.775 -171.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.713 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 45.8 m-85 -70.07 -42.61 72.59 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.751 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.469 ' HB1' ' CG1' ' A' ' 2' ' ' VAL . . . -61.26 -24.33 66.31 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.436 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.964 ' HG2' HD13 ' A' ' 91' ' ' LEU . 16.5 tp10 -89.11 -11.24 44.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.466 177.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 63.8 25.41 14.09 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.048 -176.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.35 144.53 25.84 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.819 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 1.014 HG21 HG23 ' A' ' 62' ' ' VAL . 51.6 mt -79.92 0.73 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 117.823 0.811 . . . . 0.0 112.062 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.51 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 178.03 140.34 3.77 Favored Glycine 0 CA--C 1.517 0.198 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.957 HD13 ' HG ' ' A' ' 91' ' ' LEU . 7.0 tp -127.4 135.22 50.17 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.855 1.327 . . . . 0.0 109.66 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.47 133.3 49.57 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 122.033 -0.417 . . . . 0.0 111.621 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.64 ' HA ' ' SD ' ' A' ' 34' ' ' MET . . . -26.82 -57.24 0.09 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 116.113 1.894 . . . . 0.0 116.113 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 1.029 HG22 ' HA ' ' A' ' 137' ' ' LEU . 70.1 p -54.44 -34.87 62.25 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 121.969 0.89 . . . . 0.0 112.199 -178.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.702 ' NE2' HD22 ' A' ' 91' ' ' LEU . 57.4 mt-30 -62.14 -40.0 94.49 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.547 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.867 ' HB ' HD11 ' A' ' 3' ' ' LEU . 1.7 m -93.41 18.35 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.829 ' OD2' HD21 ' A' ' 6' ' ' LEU . 6.6 t0 80.13 25.51 0.35 Allowed 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 176.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.819 HD11 ' O ' ' A' ' 55' ' ' GLN . 1.0 OUTLIER -119.18 107.42 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 118.759 -1.176 . . . . 0.0 111.004 178.056 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -75.91 60.58 1.38 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 122.18 0.99 . . . . 0.0 110.642 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.819 ' O ' HD11 ' A' ' 53' ' ' ILE . 88.5 mt-30 -147.19 131.64 17.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.945 -1.479 . . . . 0.0 107.058 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.859 ' HG2' HD11 ' A' ' 137' ' ' LEU . 75.9 mtp180 -64.67 75.63 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.919 HD12 HG23 ' A' ' 30' ' ' ILE . 23.0 mt -117.25 125.06 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.866 HG23 HD21 ' A' ' 137' ' ' LEU . 1.8 pp -122.65 142.45 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 120.119 -0.632 . . . . 0.0 112.254 -177.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.524 HG13 ' O ' ' A' ' 46' ' ' LEU . 2.5 p -127.79 132.53 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 1.055 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 1.8 mt -114.65 154.89 15.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.898 0.856 . . . . 0.0 111.985 -177.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.918 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 14.9 t70 -145.12 31.86 1.12 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 113.986 -1.461 . . . . 0.0 110.068 -177.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 1.014 HG23 HG21 ' A' ' 44' ' ' ILE . 48.1 t . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.652 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.2 ttt85 . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.912 0.387 . . . . 0.0 111.389 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 1.055 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 55.3 mt -103.37 133.27 48.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.804 0.335 . . . . 0.0 111.678 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.92 HG22 ' HB2' ' A' ' 113' ' ' ARG . 7.1 p -135.86 133.89 51.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.187 177.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.843 ' HB2' ' CD1' ' A' ' 58' ' ' ILE . 1.7 mm? -140.55 141.82 35.21 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 1.024 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.6 mp -120.18 132.92 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.692 ' OD1' ' HA ' ' A' ' 19' ' ' PRO . 59.7 m-20 53.7 37.68 0.44 Allowed Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.838 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 95.0 Cg_exo -57.1 148.29 70.11 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 123.011 2.474 . . . . 0.0 114.129 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.462 ' O ' ' HB ' ' A' ' 108' ' ' ILE . 11.6 pt-20 -135.85 144.61 45.73 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 1.021 ' HB2' ' HE2' ' A' ' 134' ' ' MET . 44.5 tp -80.04 138.03 36.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.319 0.58 . . . . 0.0 111.98 -178.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.9 ' CD2' ' HG3' ' A' ' 109' ' ' ARG . 2.8 mm? -112.99 -39.33 4.25 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.971 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.601 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 85.2 tt0 -160.02 145.37 15.22 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 121.269 0.557 . . . . 0.0 111.695 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.948 ' HA ' HG11 ' A' ' 106' ' ' VAL . 10.8 ptpp? -138.52 149.58 45.51 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.482 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.1 p -159.02 149.21 19.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.801 0.334 . . . . 0.0 111.444 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.609 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 76.83 149.55 3.19 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.783 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -117.64 113.68 22.27 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.884 0.849 . . . . 0.0 112.406 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.714 HG21 ' HG2' ' A' ' 104' ' ' GLU . 1.7 p -112.08 160.37 17.59 Favored 'General case' 0 CA--C 1.485 -1.52 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.716 ' O ' HD11 ' A' ' 86' ' ' ILE . . . -151.28 118.68 0.93 Allowed Glycine 0 C--N 1.311 -0.852 0 CA-C-N 112.392 -2.186 . . . . 0.0 110.509 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.716 HD11 ' O ' ' A' ' 85' ' ' GLY . 47.8 mm -147.76 139.92 18.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-N 117.383 0.592 . . . . 0.0 111.183 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 50.5 mt-10 -71.19 137.32 48.63 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 123.322 1.534 . . . . 0.0 111.833 -176.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.712 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 42.3 mt-10 -155.15 161.68 41.17 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 112.477 -2.147 . . . . 0.0 111.91 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.789 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -121.43 164.3 14.65 Favored Glycine 0 CA--C 1.5 -0.853 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 5.7 m -118.59 139.02 52.15 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.264 0.554 . . . . 0.0 111.854 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.964 HD13 ' HG2' ' A' ' 41' ' ' GLU . 2.4 mm? -49.64 -26.83 3.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.433 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.843 ' CB ' HG12 ' A' ' 8' ' ' ILE . 57.4 m -78.82 -36.52 42.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.43 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.778 HD12 ' CB ' ' A' ' 8' ' ' ILE . 43.6 mm . . . . . 0 N--CA 1.45 -0.425 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.392 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.789 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 18.8 mtm105 . . . . . 0 N--CA 1.462 0.164 0 CA-C-O 121.794 0.807 . . . . 0.0 111.817 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -134.48 153.42 51.94 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 114.433 -1.258 . . . . 0.0 109.82 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.667 HD21 ' HA3' ' A' ' 85' ' ' GLY . 6.9 tt -76.12 115.99 16.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.652 0.739 . . . . 0.0 111.146 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.907 HG13 HH21 ' A' ' 102' ' ' ARG . 17.3 t -111.0 136.09 20.81 Favored Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.665 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.83 ' HD2' HG12 ' A' ' 100' ' ' VAL . 91.8 Cg_endo -84.23 126.37 3.71 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 122.725 2.283 . . . . 0.0 112.655 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.907 HH21 HG13 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -145.6 166.76 24.8 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.102 0.961 . . . . 0.0 109.004 178.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.609 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -67.9 154.07 42.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 118.599 0.636 . . . . 0.0 110.473 -178.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.714 ' HG2' HG21 ' A' ' 84' ' ' THR . 2.7 tm-20 -73.48 -41.26 63.36 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.393 -175.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.788 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 56.6 mttp -139.24 140.43 37.7 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.479 0.657 . . . . 0.0 109.433 177.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.948 HG11 ' HA ' ' A' ' 80' ' ' LYS . 26.1 m -150.14 136.37 12.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.455 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.978 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 46.5 mmtt -107.47 127.49 53.65 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.699 ' HA ' ' CD2' ' A' ' 78' ' ' LEU . 1.5 pp -135.09 156.54 39.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -176.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.9 ' HG3' ' CD2' ' A' ' 78' ' ' LEU . 92.7 mtt180 -103.3 138.17 40.43 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.502 -178.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.766 ' HB2' ' HB3' ' A' ' 72' ' ' LEU . . . -160.66 170.13 21.44 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.856 -176.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 1.024 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.6 pp -118.76 151.9 37.18 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 176.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.661 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 17.0 t70 -84.7 162.87 19.51 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.668 -176.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.92 ' HB2' HG22 ' A' ' 71' ' ' VAL . 50.7 ttp85 -53.5 -17.71 2.23 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.816 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -79.0 -28.81 43.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.819 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.636 ' HA2' HG23 ' A' ' 23' ' ' VAL . . . 109.33 35.49 2.28 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.475 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -128.77 102.8 19.44 Favored Pre-proline 0 C--O 1.236 0.376 0 CA-C-N 116.971 0.386 . . . . 0.0 110.891 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.7 Cg_exo -72.8 115.64 4.42 Favored 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 121.83 1.687 . . . . 0.0 115.696 -177.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.661 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 12.3 p90 -129.52 167.06 18.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.562 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.735 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 6.2 mp0 -107.35 130.3 54.81 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.911 HD22 ' O ' ' A' ' 120' ' ' LEU . 0.2 OUTLIER -127.31 141.45 51.7 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 121.785 0.802 . . . . 0.0 111.703 -178.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.978 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 11.4 pt-20 -94.13 123.69 37.67 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.998 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.867 ' O ' ' HB3' ' A' ' 127' ' ' ALA . . . -115.67 135.19 54.3 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.586 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.788 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.2 m-20 -126.94 163.12 24.37 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.761 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 50.55 -139.46 21.94 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 120.218 1.372 . . . . 0.0 115.726 177.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.792 HD21 HG11 ' A' ' 62' ' ' VAL . 25.6 tp -54.69 -30.3 55.32 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.38 -0.91 . . . . 0.0 111.643 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.742 HD21 ' CD1' ' A' ' 70' ' ' LEU . 0.5 OUTLIER -71.38 -53.32 14.49 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.56 0.695 . . . . 0.0 109.286 179.451 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.867 ' HB3' ' O ' ' A' ' 122' ' ' ALA . . . -59.46 -39.77 84.71 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.332 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.786 HG21 ' HG3' ' A' ' 102' ' ' ARG . 45.9 mm -67.0 -54.51 23.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.347 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.804 ' HG ' HG21 ' A' ' 62' ' ' VAL . 73.0 m -60.61 -50.44 73.51 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.614 HG23 ' N ' ' A' ' 131' ' ' GLN . 21.2 tt -58.61 -44.59 89.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.697 0.284 . . . . 0.0 110.961 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.652 ' HG2' ' O ' ' A' ' 127' ' ' ALA . 22.7 pt20 -65.84 -37.65 86.79 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -60.15 -47.12 87.27 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.548 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.829 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 3.0 mm-40 -60.1 -38.03 81.77 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 1.021 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 72.4 mtp -58.07 -45.01 87.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 122.344 1.069 . . . . 0.0 109.183 177.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.903 ' O ' HG12 ' A' ' 138' ' ' VAL . 57.0 m-20 -67.76 -48.73 65.56 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.0 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.678 ' CE1' ' HG2' ' A' ' 50' ' ' GLN . 6.4 t-80 -57.71 -52.87 63.66 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.393 0.616 . . . . 0.0 111.648 -178.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 1.029 ' HA ' HG22 ' A' ' 49' ' ' THR . 0.2 OUTLIER -64.95 -28.8 69.77 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 119.822 -0.751 . . . . 0.0 111.762 -179.291 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.903 HG12 ' O ' ' A' ' 135' ' ' ASP . 11.5 p -81.47 24.16 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 122.08 0.943 . . . . 0.0 109.364 175.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.589 ' O ' ' HA ' ' A' ' 14' ' ' ARG . . . 68.41 -3.63 5.82 Favored Glycine 0 CA--C 1.484 -1.886 0 CA-C-N 113.769 -1.56 . . . . 0.0 113.217 175.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.889 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 11.4 ptmt . . . . . 0 N--CA 1.408 -2.552 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.802 ' CG1' HG21 ' A' ' 37' ' ' THR . 40.5 t . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.61 0.243 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.999 HD22 HG13 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -79.1 -143.43 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.34 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -107.31 104.49 14.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 118.174 0.443 . . . . 0.0 110.363 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.1 t -87.77 125.11 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 121.557 0.694 . . . . 0.0 111.967 -178.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.988 ' HB2' HD21 ' A' ' 13' ' ' LEU . 20.9 mt -87.63 138.68 31.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.07 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 32.7 m-70 -111.69 149.39 31.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.172 0.511 . . . . 0.0 111.91 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.788 HG12 ' CB ' ' A' ' 92' ' ' SER . 47.1 mm -57.21 145.41 66.48 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.392 178.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.522 ' CA ' HG22 ' A' ' 8' ' ' ILE . 72.7 Cg_endo -92.68 52.48 1.0 Allowed 'Cis proline' 0 C--N 1.353 0.808 0 C-N-CA 124.597 -1.001 . . . . 0.0 112.872 0.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.998 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 9.4 t0 -53.81 134.45 42.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.972 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -59.23 -45.22 91.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.425 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.712 ' HB2' HD12 ' A' ' 6' ' ' LEU . 28.2 mtt-85 -59.29 -23.78 62.71 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.998 ' HG ' ' HB3' ' A' ' 10' ' ' ASP . 11.2 mt -73.48 -33.06 64.64 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 119.661 1.119 . . . . 0.0 108.393 178.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.678 ' C ' ' HA3' ' A' ' 139' ' ' GLY . 15.0 mmm180 -98.34 11.19 38.81 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.784 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.521 ' HB2' ' HA ' ' A' ' 12' ' ' ARG . 62.3 tttp -87.06 148.05 25.43 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.217 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.702 HG13 HG23 ' A' ' 138' ' ' VAL . 48.9 t -82.41 118.65 30.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.777 ' HB2' ' HG2' ' A' ' 56' ' ' ARG . . . -78.08 146.5 35.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.272 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -103.83 127.99 28.22 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.616 ' HD3' ' CD ' ' A' ' 56' ' ' ARG . 64.4 Cg_endo -78.24 115.51 3.73 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.206 1.937 . . . . 0.0 110.984 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.645 HG13 ' N ' ' A' ' 21' ' ' GLU . 21.7 t -68.32 144.27 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 CA-C-O 122.717 1.246 . . . . 0.0 113.28 -175.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.645 ' N ' HG13 ' A' ' 20' ' ' VAL . 96.5 mt-10 -67.79 -26.52 66.13 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 112.731 -2.031 . . . . 0.0 112.203 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.545 ' O ' HG11 ' A' ' 20' ' ' VAL . 42.4 tt0 -154.47 145.17 22.39 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.168 -178.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.959 HG22 ' HA2' ' A' ' 115' ' ' GLY . 4.6 t -79.6 103.8 6.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -178.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 1.012 ' HB2' HD13 ' A' ' 27' ' ' ILE . 1.9 m120 -93.19 155.6 17.35 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.701 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.7 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -56.17 -25.92 48.6 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.278 0.561 . . . . 0.0 110.88 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.473 ' HA ' ' OE1' ' A' ' 26' ' ' GLU . 4.2 mm-40 -75.29 -40.45 58.62 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 1.012 HD13 ' HB2' ' A' ' 24' ' ' ASN . 1.8 mp -66.76 -35.01 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 113.86 -1.518 . . . . 0.0 110.238 178.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -70.39 -38.88 74.75 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 122.208 -0.307 . . . . 0.0 110.715 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.7 ' HG3' ' O ' ' A' ' 25' ' ' ALA . 39.8 mtp85 -64.05 -39.0 93.12 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.785 ' O ' ' HG3' ' A' ' 34' ' ' MET . 3.0 mt -56.88 -49.16 79.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.771 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.818 HG13 HG21 ' A' ' 71' ' ' VAL . 9.6 t -67.36 -41.13 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 CA-C-O 121.004 0.43 . . . . 0.0 110.815 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.808 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 21.1 m-20 -54.74 -43.53 72.77 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.351 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.526 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 19.1 m-20 -76.4 -29.3 57.03 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.546 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.83 ' HE1' ' O ' ' A' ' 57' ' ' ILE . 85.0 mtp -59.87 -46.07 90.46 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.247 -178.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.808 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 13.2 p90 -69.9 -45.24 68.04 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 176.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.764 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 40.3 mt-10 -52.37 -38.52 59.05 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 121.707 0.765 . . . . 0.0 109.291 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.811 ' OG1' HD21 ' A' ' 3' ' ' LEU . 88.6 m -70.35 -61.72 1.66 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.273 -1.331 . . . . 0.0 107.833 177.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 1.015 ' HE3' ' HB2' ' A' ' 61' ' ' ASP . 2.8 ttp -45.77 -40.78 10.01 Favored 'General case' 0 CA--C 1.46 -2.488 0 C-N-CA 124.321 1.048 . . . . 0.0 110.059 -171.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.672 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 18.6 m-85 -70.1 -43.09 71.77 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.097 178.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 37' ' ' THR . . . -60.85 -25.17 66.45 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.75 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 1.051 ' HG2' HD12 ' A' ' 91' ' ' LEU . 17.0 tp10 -88.76 -11.46 44.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.645 -1.161 . . . . 0.0 108.469 176.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 64.31 26.41 13.65 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.943 -176.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.31 142.67 23.21 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 113.947 -1.479 . . . . 0.0 111.276 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.988 HG23 HG22 ' A' ' 62' ' ' VAL . 42.6 mm -79.33 -0.95 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 117.293 0.547 . . . . 0.0 112.208 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.471 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 179.0 135.27 2.32 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 118.928 -0.929 . . . . 0.0 111.437 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.995 HD12 ' HG ' ' A' ' 91' ' ' LEU . 4.5 tp -125.17 133.96 52.59 Favored 'General case' 0 C--N 1.354 0.783 0 CA-C-N 119.332 1.566 . . . . 0.0 111.64 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.527 ' HB3' ' OE1' ' A' ' 133' ' ' GLU . . . -99.83 131.36 45.85 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 122.184 0.194 . . . . 0.0 111.151 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.697 ' O ' HG21 ' A' ' 51' ' ' VAL . . . -30.38 -54.87 0.19 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.654 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 82.7 p -53.1 -36.21 60.49 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.482 0.658 . . . . 0.0 111.829 -178.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.727 ' HB2' HD11 ' A' ' 46' ' ' LEU . 86.0 mt-30 -63.85 -42.26 97.61 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.998 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.999 HG13 HD22 ' A' ' 3' ' ' LEU . 0.8 OUTLIER -83.49 16.6 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.932 ' HA ' HD13 ' A' ' 6' ' ' LEU . 37.8 t70 73.79 29.86 1.42 Allowed 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 177.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.826 HD11 ' O ' ' A' ' 55' ' ' GLN . 1.0 OUTLIER -121.25 109.51 25.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 C-N-CA 119.179 -1.009 . . . . 0.0 110.609 177.303 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 21.6 p-80 -76.47 63.6 2.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.378 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.826 ' O ' HD11 ' A' ' 53' ' ' ILE . 88.9 mt-30 -153.94 132.47 12.12 Favored 'General case' 0 C--O 1.219 -0.512 0 CA-C-N 114.194 -1.366 . . . . 0.0 107.875 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.777 ' HG2' ' HB2' ' A' ' 17' ' ' ALA . 74.7 mtp180 -63.01 69.03 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -177.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.83 ' O ' ' HE1' ' A' ' 34' ' ' MET . 8.1 mm -111.81 123.06 67.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.987 HD12 ' HB2' ' A' ' 72' ' ' LEU . 2.0 pp -128.24 144.36 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 119.698 -0.801 . . . . 0.0 112.977 -177.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.566 HG22 ' H ' ' A' ' 46' ' ' LEU . 33.2 m -127.47 137.64 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.676 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.983 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 2.2 mt -115.59 151.03 17.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.57 0.7 . . . . 0.0 110.972 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 1.015 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 34.6 t70 -135.2 24.1 3.52 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.858 -178.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.988 HG22 HG23 ' A' ' 44' ' ' ILE . 23.5 t . . . . . 0 N--CA 1.466 0.349 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.46 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.614 ' HD3' ' O ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.793 0 CA-C-O 121.241 0.544 . . . . 0.0 110.528 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.983 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 7.9 mp -111.52 137.64 49.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.027 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.888 HG23 ' HB2' ' A' ' 113' ' ' ARG . 9.0 p -133.08 132.87 58.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.73 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.987 ' HB2' HD12 ' A' ' 58' ' ' ILE . 3.3 mm? -141.86 143.04 33.16 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 177.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.994 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.9 mp -121.03 136.21 58.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.761 0.315 . . . . 0.0 110.588 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.749 HD22 HD21 ' A' ' 111' ' ' LEU . 13.4 p30 45.49 40.23 0.6 Allowed Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 113.826 1.046 . . . . 0.0 113.826 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.777 ' HG3' ' HB2' ' A' ' 110' ' ' ALA . 99.2 Cg_exo -56.56 150.96 48.97 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.831 2.354 . . . . 0.0 113.151 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -135.63 143.79 45.73 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 1.048 ' HB2' ' HE2' ' A' ' 134' ' ' MET . 1.5 tt -80.57 133.69 35.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.274 0.559 . . . . 0.0 111.723 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.908 HD22 ' HE ' ' A' ' 109' ' ' ARG . 4.8 mp -108.54 -44.78 4.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.207 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.598 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 5.2 tp10 -152.25 146.95 25.81 Favored 'General case' 0 N--CA 1.46 0.065 0 CA-C-O 121.095 0.474 . . . . 0.0 111.325 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.974 ' HD2' HD13 ' A' ' 77' ' ' LEU . 10.9 ptmm? -147.67 145.12 28.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.349 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.3 t -160.14 151.78 19.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.463 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.736 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 80.85 160.42 23.86 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.492 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -137.1 113.37 9.95 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.954 0.883 . . . . 0.0 113.065 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.627 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.5 p -105.59 161.59 14.24 Favored 'General case' 0 CA--C 1.487 -1.468 0 CA-C-N 114.061 -1.427 . . . . 0.0 114.761 178.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.729 ' O ' HD11 ' A' ' 86' ' ' ILE . . . -146.03 114.81 0.77 Allowed Glycine 0 C--N 1.309 -0.928 0 CA-C-N 112.818 -1.992 . . . . 0.0 110.396 177.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.729 HD11 ' O ' ' A' ' 85' ' ' GLY . 49.3 mm -146.9 137.86 18.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-N 117.368 0.584 . . . . 0.0 111.206 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.495 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 50.4 mt-10 -71.41 137.23 48.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 123.193 1.473 . . . . 0.0 112.066 -176.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.67 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 40.8 mt-10 -154.76 161.62 41.44 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 112.196 -2.275 . . . . 0.0 111.079 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.67 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -120.32 163.84 13.98 Favored Glycine 0 CA--C 1.499 -0.937 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 13.1 m -117.86 140.88 49.08 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 117.729 0.765 . . . . 0.0 111.101 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 1.051 HD12 ' HG2' ' A' ' 41' ' ' GLU . 2.2 mm? -47.47 -26.65 1.44 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.971 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.788 ' CB ' HG12 ' A' ' 8' ' ' ILE . 54.1 m -79.36 -35.69 40.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.924 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 59.0 mt . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.648 -179.861 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.67 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 15.6 mtt85 . . . . . 0 N--CA 1.463 0.195 0 CA-C-O 121.649 0.737 . . . . 0.0 111.722 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -134.73 155.86 49.82 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 114.581 -1.191 . . . . 0.0 109.479 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.604 ' HG ' ' N ' ' A' ' 86' ' ' ILE . 7.6 tt -76.38 113.8 14.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.666 0.746 . . . . 0.0 111.813 -178.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.801 ' HB ' ' CZ ' ' A' ' 102' ' ' ARG . 40.3 t -104.29 132.25 21.15 Favored Pre-proline 0 N--CA 1.47 0.572 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.939 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.627 ' HA ' ' O ' ' A' ' 84' ' ' THR . 92.2 Cg_endo -84.26 127.45 3.95 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.596 2.197 . . . . 0.0 112.496 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.85 ' HB2' ' OE1' ' A' ' 131' ' ' GLN . 0.0 OUTLIER -144.39 166.98 23.57 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.54 0.736 . . . . 0.0 109.357 178.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.736 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.69 155.62 39.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 118.307 0.503 . . . . 0.0 110.301 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -73.12 -41.32 64.12 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.19 -176.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.822 ' HZ2' ' HB3' ' A' ' 123' ' ' ASP . 66.8 mttm -139.67 140.5 36.9 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.467 0.651 . . . . 0.0 109.505 177.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.742 HG13 ' HA ' ' A' ' 80' ' ' LYS . 30.6 m -147.5 136.95 16.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.186 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 1.057 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 52.1 mmtt -107.58 126.02 52.03 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.853 ' CD1' HD11 ' A' ' 130' ' ' ILE . 1.7 pp -136.34 151.3 28.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -176.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.908 ' HE ' HD22 ' A' ' 78' ' ' LEU . 94.4 mtt180 -102.17 138.89 38.51 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.865 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.777 ' HB2' ' HG3' ' A' ' 75' ' ' PRO . . . -159.98 168.73 25.0 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.866 -177.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.994 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.4 pp -116.42 151.58 35.71 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.567 ' O ' HD12 ' A' ' 111' ' ' LEU . 17.9 t70 -85.96 164.48 17.39 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.873 -176.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.888 ' HB2' HG23 ' A' ' 71' ' ' VAL . 48.0 ttp180 -52.01 -20.36 2.36 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.016 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -79.12 -25.67 42.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.526 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.959 ' HA2' HG22 ' A' ' 23' ' ' VAL . . . 105.91 36.28 2.8 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.223 -0.989 . . . . 0.0 113.525 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -128.64 102.82 19.77 Favored Pre-proline 0 C--O 1.237 0.403 0 CA-C-N 116.736 0.268 . . . . 0.0 110.737 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.563 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 32.1 Cg_exo -72.89 115.12 4.23 Favored 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 121.748 1.632 . . . . 0.0 115.389 -177.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.411 ' N ' ' O ' ' A' ' 110' ' ' ALA . 0.4 OUTLIER -126.32 167.05 16.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.422 -178.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.639 ' CG ' ' HG2' ' A' ' 109' ' ' ARG . 3.1 mp0 -107.33 130.18 54.81 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.784 HD12 ' CD1' ' A' ' 130' ' ' ILE . 4.4 pp -126.6 133.62 51.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.342 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 1.057 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 15.5 pt-20 -96.32 123.9 40.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.984 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.988 ' HB3' HD21 ' A' ' 126' ' ' LEU . . . -116.63 136.47 52.94 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.822 ' HB3' ' HZ2' ' A' ' 105' ' ' LYS . 41.6 m-20 -127.15 162.71 25.47 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.761 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 51.58 -138.67 28.49 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 120.539 1.518 . . . . 0.0 115.271 177.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.527 ' H ' ' CD2' ' A' ' 125' ' ' LEU . 2.6 mm? -53.37 -32.4 49.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.899 -0.651 . . . . 0.0 111.401 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.988 HD21 ' HB3' ' A' ' 122' ' ' ALA . 0.6 OUTLIER -70.77 -52.64 19.38 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.847 0.832 . . . . 0.0 109.487 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.903 ' HB3' ' O ' ' A' ' 122' ' ' ALA . . . -59.73 -39.5 84.95 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.551 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.761 HG12 ' O ' ' A' ' 124' ' ' GLY . 46.5 mm -68.97 -56.04 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -178.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.513 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 29.7 p -58.15 -49.93 75.29 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.853 HD11 ' CD1' ' A' ' 108' ' ' ILE . 19.1 tt -59.34 -44.19 91.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.179 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.85 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.0 pt20 -67.79 -39.76 84.01 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.39 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.648 ' HA ' ' OD1' ' A' ' 135' ' ' ASP . 69.0 t60 -57.04 -47.37 81.1 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.568 0.699 . . . . 0.0 109.869 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.904 ' O ' HD21 ' A' ' 137' ' ' LEU . 48.0 mm-40 -61.35 -39.6 91.2 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.272 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 1.048 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 74.6 mtp -58.43 -49.66 76.51 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.476 0.655 . . . . 0.0 111.005 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.908 ' O ' HG13 ' A' ' 138' ' ' VAL . 5.6 p-10 -65.78 -45.03 83.99 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.756 178.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.44 ' CE1' ' CG ' ' A' ' 50' ' ' GLN . 9.0 t-80 -55.94 -52.53 63.82 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 121.466 -0.771 . . . . 0.0 111.17 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.904 HD21 ' O ' ' A' ' 133' ' ' GLU . 1.3 pp -59.17 -30.97 68.57 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.2 -178.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.935 HG12 ' HG2' ' A' ' 140' ' ' LYS . 12.7 p -86.07 22.76 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-O 122.264 1.03 . . . . 0.0 109.268 176.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.678 ' HA3' ' C ' ' A' ' 14' ' ' ARG . . . 55.6 37.85 69.22 Favored Glycine 0 CA--C 1.484 -1.9 0 CA-C-N 113.493 -1.685 . . . . 0.0 112.415 176.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.935 ' HG2' HG12 ' A' ' 138' ' ' VAL . 3.7 ptmt . . . . . 0 N--CA 1.421 -1.91 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.754 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.854 HG11 HG21 ' A' ' 37' ' ' THR . 41.9 t . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.613 0.244 . . . . 0.0 110.523 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 1.009 HD11 ' HB ' ' A' ' 51' ' ' VAL . 1.9 pt? -83.1 -148.76 0.09 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.262 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -102.28 106.34 17.13 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.994 0.426 . . . . 0.0 110.831 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.517 HG11 HD13 ' A' ' 91' ' ' LEU . 45.2 t -88.84 127.63 41.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.372 0.606 . . . . 0.0 111.539 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.883 HD13 ' HA ' ' A' ' 52' ' ' ASP . 24.9 mt -83.9 142.7 30.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.805 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.441 ' N ' ' CD2' ' A' ' 7' ' ' HIS . 5.0 m170 -114.08 145.43 41.62 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.075 0.464 . . . . 0.0 111.911 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.79 HD12 ' CD1' ' A' ' 13' ' ' LEU . 2.9 mp -55.8 146.95 44.61 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.883 178.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.404 ' HA ' ' CG2' ' A' ' 8' ' ' ILE . 74.8 Cg_endo -93.17 52.13 1.06 Allowed 'Cis proline' 0 C--N 1.354 0.838 0 C-N-CA 124.38 -1.092 . . . . 0.0 113.47 0.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.56 133.74 50.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.914 0.388 . . . . 0.0 110.853 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -58.8 -41.09 85.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.59 -179.149 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.631 ' HB2' HD12 ' A' ' 6' ' ' LEU . 42.8 mtt180 -58.18 -25.03 61.05 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.846 HD23 ' HB2' ' A' ' 6' ' ' LEU . 11.3 mt -75.6 -33.14 60.54 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 120.378 1.445 . . . . 0.0 108.425 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.585 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 20.6 mmm-85 -93.29 8.76 39.04 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 113.762 -1.563 . . . . 0.0 109.297 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.427 ' CB ' ' HA ' ' A' ' 12' ' ' ARG . 63.7 tttm -90.36 148.94 22.51 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.748 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.761 HG13 HG21 ' A' ' 138' ' ' VAL . 58.7 t -83.4 124.21 39.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.998 0.428 . . . . 0.0 109.871 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.751 ' HB2' ' CG ' ' A' ' 56' ' ' ARG . . . -80.8 148.53 29.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.002 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -109.07 130.74 22.37 Favored Pre-proline 0 C--N 1.327 -0.405 0 C-N-CA 121.165 -0.214 . . . . 0.0 110.634 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.881 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 60.8 Cg_endo -79.62 113.89 3.15 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 121.99 1.794 . . . . 0.0 110.821 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.631 HG11 ' N ' ' A' ' 21' ' ' GLU . 16.7 t -68.56 144.92 13.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 122.629 1.204 . . . . 0.0 113.558 -175.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.631 ' N ' HG11 ' A' ' 20' ' ' VAL . 69.9 mm-40 -61.54 -27.38 68.57 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 113.143 -1.844 . . . . 0.0 112.349 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -156.76 151.77 26.13 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.789 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.671 HG22 ' HA2' ' A' ' 115' ' ' GLY . 3.2 t -80.38 103.65 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -178.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 1.109 ' H ' HD13 ' A' ' 27' ' ' ILE . 2.2 m120 -85.7 153.26 22.46 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.167 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.569 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -54.69 -31.95 58.72 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.44 0.638 . . . . 0.0 110.085 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.532 ' HG2' ' NH2' ' A' ' 29' ' ' ARG . 49.7 mt-10 -71.52 -38.05 71.13 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 1.109 HD13 ' H ' ' A' ' 24' ' ' ASN . 68.5 mt -65.86 -38.79 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 113.964 -1.471 . . . . 0.0 110.494 178.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.641 ' CD ' HG11 ' A' ' 23' ' ' VAL . 13.6 mm-40 -66.94 -40.57 87.62 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.746 -0.206 . . . . 0.0 110.976 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.569 ' HG3' ' O ' ' A' ' 25' ' ' ALA . 83.9 mtm180 -63.88 -38.65 91.88 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.822 ' O ' ' HG3' ' A' ' 34' ' ' MET . 5.0 mt -56.28 -50.77 69.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.496 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.63 HG11 ' CG2' ' A' ' 71' ' ' VAL . 13.7 t -66.19 -41.47 89.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.95 0.405 . . . . 0.0 111.39 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.887 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -56.59 -42.56 78.9 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -179.26 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.492 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 14.8 m-20 -76.29 -30.15 57.66 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.768 176.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.822 ' HG3' ' O ' ' A' ' 30' ' ' ILE . 23.0 mtm -60.26 -46.84 88.4 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.297 -177.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.887 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 9.6 p90 -69.58 -43.67 72.36 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.607 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 56.1 mm-40 -52.97 -42.03 65.12 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.854 HG21 HG11 ' A' ' 2' ' ' VAL . 98.9 m -69.51 -61.72 1.67 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 118.722 -1.191 . . . . 0.0 108.104 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 1.006 ' HE3' ' HB2' ' A' ' 61' ' ' ASP . 1.7 ttp -46.38 -40.58 12.26 Favored 'General case' 0 CA--C 1.468 -2.202 0 C-N-CA 124.057 0.943 . . . . 0.0 110.18 -171.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.743 ' OH ' ' HA ' ' A' ' 69' ' ' ARG . 45.2 m-85 -69.95 -41.5 74.47 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.023 177.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 37' ' ' THR . . . -61.93 -23.09 66.14 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.008 -0.997 . . . . 0.0 109.561 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 1.055 ' HG2' HD12 ' A' ' 91' ' ' LEU . 13.8 tp10 -90.16 -11.62 40.61 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.177 -1.374 . . . . 0.0 108.267 177.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 63.68 28.75 15.03 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.762 -176.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.78 141.83 19.7 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 113.683 -1.599 . . . . 0.0 110.691 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.798 HG22 ' O ' ' A' ' 61' ' ' ASP . 47.2 mt -79.43 2.18 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 117.859 0.829 . . . . 0.0 111.919 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.494 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 177.25 133.57 1.85 Allowed Glycine 0 CA--C 1.523 0.539 0 CA-C-O 119.06 -0.856 . . . . 0.0 112.043 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 1.081 HD13 ' HG ' ' A' ' 91' ' ' LEU . 8.8 tt -126.62 135.36 51.11 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 119.116 1.458 . . . . 0.0 110.967 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.594 ' O ' HD21 ' A' ' 46' ' ' LEU . . . -97.99 134.6 40.87 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.727 ' HA ' ' SD ' ' A' ' 34' ' ' MET . . . -31.01 -55.05 0.22 Allowed 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.962 1.468 . . . . 0.0 114.962 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.514 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 81.3 p -53.09 -36.26 60.5 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.523 0.677 . . . . 0.0 112.361 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.647 ' NE2' ' HB3' ' A' ' 90' ' ' CYS . 47.1 mt-30 -63.93 -40.77 97.24 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.486 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 1.009 ' HB ' HD11 ' A' ' 3' ' ' LEU . 1.2 m -85.63 17.3 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.607 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.883 ' HA ' HD13 ' A' ' 6' ' ' LEU . 50.8 t0 77.89 26.6 0.61 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 176.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.829 HD11 ' O ' ' A' ' 55' ' ' GLN . 1.0 OUTLIER -121.35 109.84 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 C-N-CA 118.985 -1.086 . . . . 0.0 111.243 177.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.479 ' HD2' ' CZ ' ' A' ' 12' ' ' ARG . 6.8 p80 -76.46 59.47 1.47 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.791 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.829 ' O ' HD11 ' A' ' 53' ' ' ILE . 7.1 mp0 -148.75 134.05 18.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.449 -1.251 . . . . 0.0 108.075 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.881 ' HD2' ' HD3' ' A' ' 19' ' ' PRO . 68.0 mtt-85 -63.13 68.65 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -177.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.653 HG13 HD12 ' A' ' 53' ' ' ILE . 7.4 mm -112.77 122.84 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.993 HD13 ' HB2' ' A' ' 72' ' ' LEU . 2.2 pp -126.24 148.03 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -177.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.554 HG22 ' H ' ' A' ' 46' ' ' LEU . 32.6 m -129.06 138.49 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.212 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 1.088 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 10.9 mm -115.77 151.95 17.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-O 121.483 0.659 . . . . 0.0 109.859 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 1.006 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 10.0 t70 -139.78 43.31 1.97 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.821 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.89 HG21 ' CG2' ' A' ' 60' ' ' ILE . 13.9 t . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.129 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.743 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 71.7 ttt180 . . . . . 0 N--CA 1.472 0.633 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 1.088 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 9.4 mp -108.56 137.1 47.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.695 0.283 . . . . 0.0 111.656 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.774 HG21 ' HB2' ' A' ' 113' ' ' ARG . 14.6 p -135.57 135.96 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.993 ' HB2' HD13 ' A' ' 58' ' ' ILE . 3.0 mm? -143.91 147.29 33.79 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.539 -0.171 . . . . 0.0 110.539 177.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 1.068 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.7 mp -122.11 136.5 58.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.564 0.221 . . . . 0.0 110.419 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.694 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 8.2 m120 50.38 37.98 0.47 Allowed Pre-proline 0 CA--C 1.55 0.96 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.852 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 79.6 Cg_exo -58.23 147.48 83.92 Favored 'Trans proline' 0 N--CA 1.486 1.085 0 C-N-CA 123.137 2.558 . . . . 0.0 114.844 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.431 ' O ' ' HB ' ' A' ' 108' ' ' ILE . 11.8 pt-20 -136.37 140.51 43.3 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 1.079 ' HB2' ' HE2' ' A' ' 134' ' ' MET . 1.7 tt -81.95 134.51 35.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.177 0.513 . . . . 0.0 111.267 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.859 HD22 ' CG ' ' A' ' 109' ' ' ARG . 5.9 mp -109.57 -43.76 4.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.13 -178.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 39.3 tt0 -147.54 149.73 33.17 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.05 0.452 . . . . 0.0 111.611 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 1.04 ' HE3' HD12 ' A' ' 77' ' ' LEU . 9.2 ptpp? -147.6 143.86 28.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.83 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.6 p -155.4 147.22 23.28 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.786 0.327 . . . . 0.0 111.257 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.721 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 81.22 147.82 5.79 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.114 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -115.57 114.29 24.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.724 0.773 . . . . 0.0 112.542 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.737 ' HG1' HD12 ' A' ' 128' ' ' ILE . 1.7 p -116.51 161.14 19.59 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 115.505 1.669 . . . . 0.0 115.505 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.807 ' HA3' HD22 ' A' ' 99' ' ' LEU . . . -150.09 119.17 1.0 Allowed Glycine 0 C--N 1.312 -0.764 0 CA-C-N 112.363 -2.198 . . . . 0.0 111.499 178.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.726 HD11 ' O ' ' A' ' 85' ' ' GLY . 49.5 mm -146.45 136.44 17.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 117.278 0.539 . . . . 0.0 111.373 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.558 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 50.2 mt-10 -72.47 141.23 48.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 122.841 1.305 . . . . 0.0 112.657 -176.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.595 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 55.2 mt-10 -153.71 163.97 39.1 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 112.713 -2.039 . . . . 0.0 111.538 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.729 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -120.36 168.59 13.88 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.704 ' HB2' ' CG1' ' A' ' 93' ' ' ILE . 90.3 m -114.12 140.02 48.84 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.215 -0.594 . . . . 0.0 112.03 -177.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 1.081 ' HG ' HD13 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -53.87 -16.65 1.91 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.845 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.834 ' CB ' HD11 ' A' ' 13' ' ' LEU . 22.0 m -102.96 -31.55 10.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.507 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.704 ' CG1' ' HB2' ' A' ' 90' ' ' CYS . 48.0 mt . . . . . 0 CA--C 1.534 0.347 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.332 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.729 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 55.5 mtm-85 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 121.109 0.481 . . . . 0.0 109.931 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -125.06 146.03 49.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.054 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.807 HD22 ' HA3' ' A' ' 85' ' ' GLY . 7.3 tt -76.1 113.69 13.91 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.847 0.832 . . . . 0.0 110.779 -178.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.781 ' CG1' HH21 ' A' ' 102' ' ' ARG . 48.8 t -101.82 128.79 27.96 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.706 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.732 ' HA ' ' O ' ' A' ' 84' ' ' THR . 87.6 Cg_endo -83.0 126.13 4.32 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.163 1.908 . . . . 0.0 111.57 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.913 HH11 HG23 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -144.11 166.71 24.23 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.378 179.432 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.721 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.05 155.09 40.28 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.881 0.372 . . . . 0.0 110.461 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.419 ' OE1' HG21 ' A' ' 84' ' ' THR . 16.7 tp10 -72.26 -40.89 67.33 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.475 -175.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 1.01 ' HZ1' ' HB3' ' A' ' 123' ' ' ASP . 67.1 mttm -140.42 140.22 35.41 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.395 0.617 . . . . 0.0 109.507 176.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.976 HG11 ' HA ' ' A' ' 80' ' ' LYS . 25.3 m -150.42 141.37 16.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.417 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.933 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 23.7 mmtp -108.0 126.48 52.77 Favored 'General case' 0 C--O 1.227 -0.093 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.845 HG23 ' HA ' ' A' ' 77' ' ' LEU . 1.8 pp -135.36 152.9 32.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -176.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.859 ' CG ' HD22 ' A' ' 78' ' ' LEU . 44.2 mtm180 -103.45 140.73 37.09 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.926 0.87 . . . . 0.0 111.507 -178.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.654 ' HB2' ' HB3' ' A' ' 72' ' ' LEU . . . -161.14 169.51 22.18 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.483 -177.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 1.068 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 1.9 pp -116.64 149.76 39.22 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 176.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.791 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 23.1 t70 -84.41 163.66 19.36 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.587 -176.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.774 ' HB2' HG21 ' A' ' 71' ' ' VAL . 14.5 ttp-105 -53.48 -17.24 1.85 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.865 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -79.13 -28.35 42.9 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.948 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.671 ' HA2' HG22 ' A' ' 23' ' ' VAL . . . 107.63 35.8 2.55 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.622 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -128.82 103.25 19.1 Favored Pre-proline 0 C--O 1.237 0.43 0 CA-C-N 116.699 0.25 . . . . 0.0 110.705 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.578 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 32.7 Cg_exo -71.99 114.51 3.99 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 121.34 1.36 . . . . 0.0 114.619 -177.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.791 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 10.2 p90 -127.16 168.6 14.45 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.484 -178.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.654 ' HG2' ' HD2' ' A' ' 109' ' ' ARG . 29.8 mt-10 -107.03 129.72 54.76 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.686 HD22 HD12 ' A' ' 72' ' ' LEU . 4.3 pp -123.45 132.63 53.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.434 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.933 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 9.0 pm0 -92.54 123.38 35.8 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.54 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 1.052 ' HB3' HD23 ' A' ' 126' ' ' LEU . . . -117.05 133.54 55.87 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 120.47 -0.492 . . . . 0.0 112.134 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 1.01 ' HB3' ' HZ1' ' A' ' 105' ' ' LYS . 29.4 m-20 -127.81 160.73 30.86 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.64 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 54.9 -138.09 42.7 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 120.952 1.705 . . . . 0.0 114.779 177.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.568 ' H ' HD12 ' A' ' 125' ' ' LEU . 4.7 mp -54.24 -32.29 55.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.2 -0.5 . . . . 0.0 111.333 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 1.052 HD23 ' HB3' ' A' ' 122' ' ' ALA . 0.6 OUTLIER -70.72 -51.79 25.15 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.394 0.616 . . . . 0.0 109.676 179.707 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.737 ' O ' ' HG3' ' A' ' 131' ' ' GLN . . . -61.67 -46.76 88.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.949 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.913 HG23 HH11 ' A' ' 102' ' ' ARG . 47.3 mm -64.43 -55.67 20.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -177.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 78.0 m -58.56 -48.08 82.1 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.817 HD11 ' CD1' ' A' ' 108' ' ' ILE . 20.2 tt -59.35 -41.86 85.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.157 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.825 ' CG ' HG21 ' A' ' 106' ' ' VAL . 70.5 mt-30 -64.86 -38.51 91.22 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.761 0.315 . . . . 0.0 110.185 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.743 ' HA ' ' OD2' ' A' ' 135' ' ' ASP . 79.6 t60 -58.7 -45.54 89.27 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.295 0.569 . . . . 0.0 110.401 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.909 ' O ' HD21 ' A' ' 137' ' ' LEU . 4.5 mm-40 -60.72 -43.2 98.15 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.732 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 1.079 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 70.2 mtp -57.85 -48.55 79.47 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.374 0.607 . . . . 0.0 110.934 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.826 ' O ' HG12 ' A' ' 138' ' ' VAL . 2.5 p30 -65.14 -46.32 81.4 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.114 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.463 ' CE1' ' HG2' ' A' ' 50' ' ' GLN . 11.7 t-80 -58.95 -51.69 68.95 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 121.698 -0.626 . . . . 0.0 111.527 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.909 HD21 ' O ' ' A' ' 133' ' ' GLU . 1.4 pp -60.12 -31.42 70.04 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.952 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.953 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 14.2 p -82.98 25.49 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-O 122.487 1.136 . . . . 0.0 109.825 177.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.633 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 60.13 6.49 5.64 Favored Glycine 0 CA--C 1.487 -1.682 0 CA-C-N 113.082 -1.872 . . . . 0.0 113.382 176.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.953 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 14.3 ptmt . . . . . 0 N--CA 1.413 -2.297 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.702 HG11 ' HA ' ' A' ' 37' ' ' THR . 30.9 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.649 0.262 . . . . 0.0 110.987 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.715 ' H ' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -85.28 -172.8 4.35 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.605 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.682 ' NE2' ' H ' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -79.88 111.09 15.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.28 0.562 . . . . 0.0 110.993 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.0 t -89.52 131.4 36.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.975 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.992 ' HB2' HD21 ' A' ' 13' ' ' LEU . 30.5 mt -86.81 147.5 25.8 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.556 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.478 ' HA ' ' CA ' ' A' ' 92' ' ' SER . 3.2 m80 -122.74 144.34 49.23 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.637 ' CD1' HD12 ' A' ' 13' ' ' LEU . 35.5 mm -67.44 135.88 93.17 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.526 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -78.92 144.5 73.88 Favored 'Cis proline' 0 C--N 1.352 0.736 0 C-N-CA 124.614 -0.994 . . . . 0.0 111.551 -0.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 1.027 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 9.1 t0 -164.0 129.14 2.87 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.404 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.471 ' HG2' ' N ' ' A' ' 12' ' ' ARG . 0.6 OUTLIER -58.08 -45.43 87.15 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.526 -178.769 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.551 ' HB2' HD11 ' A' ' 6' ' ' LEU . 23.2 mmt-85 -58.29 -28.41 64.97 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 1.027 ' HG ' ' HB3' ' A' ' 10' ' ' ASP . 9.7 mt -77.4 -32.13 54.59 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 120.613 1.551 . . . . 0.0 108.306 177.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.459 ' C ' ' HA3' ' A' ' 139' ' ' GLY . 14.6 mmm180 -93.38 11.76 27.19 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 114.105 -1.407 . . . . 0.0 109.13 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.434 ' HB2' ' HA ' ' A' ' 12' ' ' ARG . 59.5 tptt -89.86 147.93 23.47 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.678 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.65 HG13 HG21 ' A' ' 138' ' ' VAL . 74.6 t -82.56 128.9 38.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.756 ' HB2' ' CG ' ' A' ' 56' ' ' ARG . . . -86.97 142.63 27.82 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.77 ' HB2' ' HZ2' ' A' ' 18' ' ' LYS . 4.7 ttmp? -105.57 129.8 24.09 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.877 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 56.8 Cg_endo -81.45 112.94 2.54 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 121.653 1.568 . . . . 0.0 110.812 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.615 HG11 ' N ' ' A' ' 21' ' ' GLU . 15.9 t -69.66 144.66 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 CA-C-O 122.552 1.168 . . . . 0.0 113.213 -175.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.615 ' N ' HG11 ' A' ' 20' ' ' VAL . 69.9 mm-40 -61.07 -23.41 65.45 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 113.019 -1.9 . . . . 0.0 112.438 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -161.18 139.85 9.89 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.183 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.794 HG23 HD11 ' A' ' 111' ' ' LEU . 2.6 t -79.43 118.88 27.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.856 ' H ' HD11 ' A' ' 27' ' ' ILE . 50.3 m-80 -104.27 -176.66 3.14 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.894 -0.504 . . . . 0.0 110.655 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.675 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -68.79 -25.41 64.69 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.456 0.646 . . . . 0.0 110.48 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.463 ' HA ' ' OE1' ' A' ' 26' ' ' GLU . 4.3 mm-40 -75.12 -43.19 54.15 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.856 HD11 ' H ' ' A' ' 24' ' ' ASN . 54.2 mt -65.04 -40.1 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 114.086 -1.416 . . . . 0.0 110.695 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.824 ' HG2' ' O ' ' A' ' 24' ' ' ASN . 1.6 mm100 -64.96 -40.8 95.56 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 122.431 -0.168 . . . . 0.0 111.064 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.675 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 26.5 mmm180 -61.86 -38.73 89.36 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.785 ' O ' ' HG3' ' A' ' 34' ' ' MET . 4.2 mt -57.76 -49.22 81.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.829 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.734 ' CG1' HG23 ' A' ' 71' ' ' VAL . 25.3 t -67.97 -41.72 84.88 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 CA-C-O 120.919 0.39 . . . . 0.0 111.339 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.84 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 27.9 m-20 -53.74 -45.97 70.72 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.121 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.453 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 3.0 p30 -74.57 -29.63 61.42 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.137 176.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.876 ' HG2' HG22 ' A' ' 51' ' ' VAL . 82.6 mtp -61.12 -46.93 88.57 Favored 'General case' 0 C--N 1.346 0.434 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.851 -178.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.84 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 22.5 p90 -70.82 -47.85 57.24 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.627 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 30.4 mm-40 -50.83 -41.59 57.69 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.702 ' HA ' HG11 ' A' ' 2' ' ' VAL . 48.4 m -70.34 -60.28 2.37 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.201 -1.363 . . . . 0.0 108.907 177.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.949 ' HE3' ' HB2' ' A' ' 61' ' ' ASP . 1.2 ttp -47.13 -39.72 14.08 Favored 'General case' 0 CA--C 1.464 -2.33 0 C-N-CA 124.046 0.939 . . . . 0.0 110.401 -171.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.656 ' OH ' ' HA ' ' A' ' 69' ' ' ARG . 68.2 m-85 -70.72 -42.1 71.02 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.146 177.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.593 ' HB1' HG11 ' A' ' 2' ' ' VAL . . . -60.95 -25.28 66.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.371 -0.831 . . . . 0.0 108.987 178.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 1.042 ' HG2' HD11 ' A' ' 91' ' ' LEU . 11.4 tp10 -87.02 -10.72 52.4 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 114.303 -1.317 . . . . 0.0 108.669 176.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 63.76 23.62 13.52 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.21 -176.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.6 140.79 23.88 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.324 177.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 1.02 HG22 HG22 ' A' ' 62' ' ' VAL . 43.2 mm -78.67 -0.8 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 117.464 0.632 . . . . 0.0 111.756 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.52 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 177.91 136.05 2.42 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 118.68 -1.067 . . . . 0.0 110.872 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.97 HD22 HG13 ' A' ' 51' ' ' VAL . 8.9 tt -127.98 135.37 49.83 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-N 119.714 1.757 . . . . 0.0 111.03 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.567 ' O ' HD23 ' A' ' 46' ' ' LEU . . . -97.43 134.16 41.06 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.741 ' O ' HG23 ' A' ' 51' ' ' VAL . . . -31.11 -53.68 0.21 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 137' ' ' LEU . 57.0 p -53.36 -35.32 60.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.77 0.795 . . . . 0.0 111.268 -178.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.743 ' NE2' HD23 ' A' ' 91' ' ' LEU . 74.8 mt-30 -64.22 -41.84 96.85 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.175 -1.375 . . . . 0.0 109.813 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.97 HG13 HD22 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -84.8 16.27 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-O 121.195 0.521 . . . . 0.0 112.132 179.763 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.956 ' HA ' HD12 ' A' ' 6' ' ' LEU . 50.5 t0 75.36 30.04 0.87 Allowed 'General case' 0 C--O 1.233 0.185 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 176.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.818 HD11 ' O ' ' A' ' 55' ' ' GLN . 1.1 pp -123.54 111.41 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 C-N-CA 119.228 -0.989 . . . . 0.0 110.898 177.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.9 p-80 -76.3 62.68 1.82 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.992 0.901 . . . . 0.0 110.586 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.818 ' O ' HD11 ' A' ' 53' ' ' ILE . 89.6 mt-30 -151.94 134.83 15.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.25 -1.341 . . . . 0.0 107.691 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.877 ' HD2' ' HD3' ' A' ' 19' ' ' PRO . 65.0 mtt-85 -64.26 70.74 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.803 ' O ' ' HE1' ' A' ' 34' ' ' MET . 9.1 mm -112.09 122.74 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 1.101 HD12 ' HB2' ' A' ' 72' ' ' LEU . 1.8 pp -126.17 144.34 36.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 119.836 -0.746 . . . . 0.0 112.913 -177.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.673 HG23 ' H ' ' A' ' 46' ' ' LEU . 33.5 m -127.22 137.12 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 1.023 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 6.1 mm -114.73 149.99 16.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.748 0.785 . . . . 0.0 109.555 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.949 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 58.5 t0 -137.35 27.84 2.81 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.442 -178.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 1.02 HG22 HG22 ' A' ' 44' ' ' ILE . 28.7 t . . . . . 0 C--N 1.332 -0.164 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.253 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.656 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 32.2 ttm180 . . . . . 0 N--CA 1.462 0.174 0 CA-C-O 120.638 0.256 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 1.023 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 61.2 mt -102.48 132.35 48.58 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-O 120.834 0.349 . . . . 0.0 111.557 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.838 ' O ' HD12 ' A' ' 72' ' ' LEU . 8.6 p -135.03 134.22 53.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.544 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 1.101 ' HB2' HD12 ' A' ' 58' ' ' ILE . 10.4 mp -140.6 142.45 35.05 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 1.024 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.7 mp -119.97 133.04 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-O 120.678 0.275 . . . . 0.0 110.413 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.727 ' OD1' ' HA ' ' A' ' 19' ' ' PRO . 66.8 m-20 54.2 37.14 0.39 Allowed Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.924 ' HG2' HG12 ' A' ' 58' ' ' ILE . 97.0 Cg_exo -56.65 150.17 54.43 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 C-N-CA 123.032 2.488 . . . . 0.0 114.016 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.642 ' OE2' ' HD2' ' A' ' 109' ' ' ARG . 23.0 pt-20 -138.45 143.12 39.51 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.864 HD23 ' N ' ' A' ' 78' ' ' LEU . 1.6 tt -80.24 135.19 36.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.434 0.635 . . . . 0.0 111.958 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.864 ' N ' HD23 ' A' ' 77' ' ' LEU . 5.2 mp -109.75 -40.4 4.82 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.283 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 85.2 tt0 -156.05 154.62 31.29 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.277 0.561 . . . . 0.0 111.802 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.842 ' CB ' HG12 ' A' ' 106' ' ' VAL . 9.1 ptpp? -147.56 151.07 35.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.231 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 46.4 t -160.33 147.07 15.77 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.697 0.284 . . . . 0.0 111.318 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.642 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 75.16 161.71 9.42 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.571 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -135.76 113.29 10.8 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.867 0.841 . . . . 0.0 112.972 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.763 ' HB ' HH12 ' A' ' 102' ' ' ARG . 1.6 p -105.68 162.37 13.58 Favored 'General case' 0 CA--C 1.489 -1.402 0 N-CA-C 115.011 1.486 . . . . 0.0 115.011 178.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.701 ' O ' HD11 ' A' ' 86' ' ' ILE . . . -148.98 118.47 0.96 Allowed Glycine 0 C--N 1.314 -0.677 0 CA-C-N 113.035 -1.893 . . . . 0.0 110.866 178.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.719 ' HB ' ' NH2' ' A' ' 102' ' ' ARG . 47.2 mm -148.19 140.28 18.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 117.472 0.636 . . . . 0.0 111.602 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 55.7 mp0 -71.24 135.37 47.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 123.365 1.555 . . . . 0.0 112.368 -176.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.692 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 80.2 mt-10 -152.26 161.34 42.76 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 112.324 -2.216 . . . . 0.0 112.039 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.766 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -121.16 164.13 14.46 Favored Glycine 0 CA--C 1.501 -0.811 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.444 ' HB2' HD11 ' A' ' 93' ' ' ILE . 22.4 m -113.39 141.23 47.31 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.594 0.712 . . . . 0.0 112.656 -177.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 1.042 HD11 ' HG2' ' A' ' 41' ' ' GLU . 2.2 mm? -50.27 -26.98 5.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.818 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.653 ' HB3' ' CD1' ' A' ' 13' ' ' LEU . 61.2 m -85.3 -31.59 22.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.299 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.444 HD11 ' HB2' ' A' ' 90' ' ' CYS . 58.7 mt . . . . . 0 N--CA 1.448 -0.537 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.188 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.766 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 52.7 mtm-85 . . . . . 0 N--CA 1.465 0.283 0 CA-C-O 121.787 0.803 . . . . 0.0 112.282 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -133.88 154.73 50.85 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.423 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.603 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.8 tt -76.56 112.27 12.93 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.85 0.834 . . . . 0.0 112.181 -177.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.667 HG22 ' HD2' ' A' ' 101' ' ' PRO . 11.1 p -99.86 133.12 21.91 Favored Pre-proline 0 N--CA 1.469 0.477 0 CA-C-N 114.593 -1.185 . . . . 0.0 112.372 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.667 ' HD2' HG22 ' A' ' 100' ' ' VAL . 96.6 Cg_endo -87.22 126.45 2.34 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 122.635 2.224 . . . . 0.0 112.485 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.81 ' CZ ' HG23 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -145.53 167.71 22.36 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.001 0.92 . . . . 0.0 110.259 179.83 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.642 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.44 155.85 39.04 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.804 0.335 . . . . 0.0 110.15 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -73.35 -42.0 62.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.936 -176.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.669 ' HB3' ' OD1' ' A' ' 123' ' ' ASP . 59.7 mttp -140.63 141.04 35.13 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.376 0.607 . . . . 0.0 110.155 177.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.842 HG12 ' CB ' ' A' ' 80' ' ' LYS . 22.4 m -149.25 138.84 15.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.346 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.966 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 20.1 mmtp -108.21 126.46 52.83 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.789 ' HA ' ' CD1' ' A' ' 78' ' ' LEU . 1.4 pp -135.89 154.75 34.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -176.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.833 ' HG3' ' CD1' ' A' ' 78' ' ' LEU . 92.6 mtt180 -101.41 137.98 39.03 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.319 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.728 ' HB2' ' HG3' ' A' ' 75' ' ' PRO . . . -159.34 169.36 24.18 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.504 -1.225 . . . . 0.0 111.093 -177.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 1.024 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.7 pp -118.94 154.75 32.5 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 177.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.59 ' O ' HD12 ' A' ' 111' ' ' LEU . 19.5 t70 -89.09 162.59 15.89 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.197 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.657 ' H ' HG13 ' A' ' 71' ' ' VAL . 13.1 ttp-105 -54.44 -15.32 1.62 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.832 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -78.95 -29.48 44.01 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.727 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 109.23 34.1 2.6 Favored Glycine 0 C--N 1.34 0.797 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.886 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -128.72 102.86 19.54 Favored Pre-proline 0 C--O 1.237 0.432 0 CA-C-N 116.764 0.282 . . . . 0.0 111.166 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.59 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 33.1 Cg_exo -73.26 116.81 4.84 Favored 'Trans proline' 0 C--N 1.36 1.169 0 C-N-CA 122.015 1.81 . . . . 0.0 115.094 -178.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.545 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 12.6 p90 -128.4 166.48 18.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.568 -178.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.778 ' HG2' ' HG2' ' A' ' 109' ' ' ARG . 22.4 mt-10 -107.73 131.96 53.88 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.873 HD21 ' O ' ' A' ' 120' ' ' LEU . 0.3 OUTLIER -129.64 141.84 50.85 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.663 0.744 . . . . 0.0 111.742 -179.465 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.966 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 11.3 pt-20 -95.19 123.43 38.69 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.536 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.808 ' CB ' HD13 ' A' ' 126' ' ' LEU . . . -115.82 134.87 54.56 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.958 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.734 ' CA ' ' HB3' ' A' ' 127' ' ' ALA . 37.7 m-20 -126.44 162.22 26.1 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.773 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 48.4 -132.9 20.48 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-N 119.85 1.205 . . . . 0.0 115.705 177.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.42 ' HA ' HD22 ' A' ' 125' ' ' LEU . 80.9 mt -54.7 -35.74 63.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.74 -0.73 . . . . 0.0 111.774 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.808 HD13 ' CB ' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -70.72 -52.03 23.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.799 0.809 . . . . 0.0 109.225 179.854 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.734 ' HB3' ' CA ' ' A' ' 123' ' ' ASP . . . -58.65 -40.25 82.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.346 -1.297 . . . . 0.0 111.691 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.81 HG23 ' CZ ' ' A' ' 102' ' ' ARG . 50.8 mm -68.41 -55.89 14.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.879 -178.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.764 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 29.4 p -57.88 -50.48 73.17 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.615 HG21 ' N ' ' A' ' 131' ' ' GLN . 19.4 tt -59.04 -43.69 89.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.957 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.795 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 21.9 pt20 -68.41 -40.04 81.41 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.627 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -59.27 -47.44 85.34 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.077 0.465 . . . . 0.0 109.776 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.899 ' O ' HD22 ' A' ' 137' ' ' LEU . 3.5 mm-40 -58.63 -42.68 88.83 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.512 -179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.918 ' HA ' HD21 ' A' ' 137' ' ' LEU . 30.2 mtm -57.21 -47.3 81.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.634 0.73 . . . . 0.0 110.16 178.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.873 ' O ' HG13 ' A' ' 138' ' ' VAL . 31.9 m-20 -62.77 -48.31 79.71 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.095 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.524 ' CE1' ' HG2' ' A' ' 50' ' ' GLN . 8.4 t-80 -58.16 -52.93 63.52 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.271 0.557 . . . . 0.0 111.376 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.918 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.6 pp -58.67 -31.52 68.26 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.701 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.926 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 12.9 p -85.54 25.09 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-O 122.187 0.994 . . . . 0.0 109.83 176.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 55.91 30.67 57.41 Favored Glycine 0 CA--C 1.485 -1.843 0 CA-C-N 113.578 -1.646 . . . . 0.0 112.942 176.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.926 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 5.8 ptmt . . . . . 0 N--CA 1.424 -1.763 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.303 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.765 HG12 HG21 ' A' ' 37' ' ' THR . 40.1 t . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.497 0.189 . . . . 0.0 110.597 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.762 HD21 ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -87.93 -174.15 4.58 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.752 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.603 ' N ' HD22 ' A' ' 3' ' ' LEU . 8.4 tt0 -80.52 109.84 15.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.035 0.445 . . . . 0.0 111.073 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.506 HG22 HG23 ' A' ' 37' ' ' THR . 36.2 t -89.47 131.64 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.783 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.946 ' HB2' HD22 ' A' ' 13' ' ' LEU . 45.3 mt -84.06 142.68 30.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.862 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 5.1 m170 -119.14 145.51 45.91 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.207 0.527 . . . . 0.0 112.044 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.749 HG12 ' HB3' ' A' ' 92' ' ' SER . 51.2 mm -54.19 146.03 32.72 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.827 178.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.62 ' CA ' HG23 ' A' ' 8' ' ' ILE . 64.8 Cg_endo -91.86 50.2 1.12 Allowed 'Cis proline' 0 C--N 1.355 0.898 0 C-N-CA 124.644 -0.982 . . . . 0.0 113.123 0.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.856 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 9.7 t70 -53.56 131.48 38.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.799 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -59.17 -41.71 89.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.423 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.646 ' HB2' HD11 ' A' ' 6' ' ' LEU . 10.5 mtt85 -60.19 -23.55 64.08 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.946 HD22 ' HB2' ' A' ' 6' ' ' LEU . 9.8 mt -76.31 -31.73 58.35 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 120.413 1.46 . . . . 0.0 108.134 177.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.553 ' HD2' ' O ' ' A' ' 139' ' ' GLY . 24.0 mmm-85 -91.58 1.7 56.96 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 113.93 -1.486 . . . . 0.0 109.09 178.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.54 ' HD3' ' HB3' ' A' ' 54' ' ' HIS . 62.6 tttp -83.97 150.56 25.57 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.126 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 138' ' ' VAL . 84.3 t -82.89 136.22 23.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.179 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.767 ' C ' ' HG3' ' A' ' 56' ' ' ARG . . . -90.7 139.96 30.23 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -104.81 129.28 25.17 Favored Pre-proline 0 C--N 1.323 -0.58 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.546 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.917 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 68.3 Cg_endo -77.5 114.67 3.75 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 121.824 1.682 . . . . 0.0 110.197 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.627 HG11 ' N ' ' A' ' 21' ' ' GLU . 17.3 t -70.09 144.83 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 122.488 1.137 . . . . 0.0 113.285 -176.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.627 ' N ' HG11 ' A' ' 20' ' ' VAL . 56.1 mt-10 -62.44 -25.59 68.05 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 113.322 -1.763 . . . . 0.0 112.103 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.407 ' O ' HG12 ' A' ' 20' ' ' VAL . 88.9 tt0 -159.29 143.9 15.44 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.537 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.865 HG21 HD12 ' A' ' 111' ' ' LEU . 2.9 t -79.26 107.2 11.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -178.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 1.012 HD21 HD12 ' A' ' 27' ' ' ILE . 64.1 m-80 -87.87 153.04 21.63 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.455 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.797 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -54.44 -26.99 34.06 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 121.078 0.466 . . . . 0.0 110.64 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -72.47 -40.39 66.98 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 177.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 1.012 HD12 HD21 ' A' ' 24' ' ' ASN . 62.9 mt -62.92 -47.59 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.038 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -57.89 -39.86 78.9 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.916 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.797 ' HG3' ' O ' ' A' ' 25' ' ' ALA . 19.7 mtm105 -59.62 -40.36 87.29 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.806 ' O ' ' HG3' ' A' ' 34' ' ' MET . 4.3 mt -58.6 -49.78 81.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.624 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.789 HG13 ' CG2' ' A' ' 71' ' ' VAL . 5.0 t -67.22 -42.34 87.81 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-O 120.746 0.308 . . . . 0.0 111.619 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.851 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -54.35 -43.08 70.97 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.641 -179.604 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.543 ' HB3' HD12 ' A' ' 3' ' ' LEU . 53.6 m-20 -74.96 -30.95 61.35 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.613 176.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.806 ' HG3' ' O ' ' A' ' 30' ' ' ILE . 79.8 mtp -60.08 -47.76 84.54 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.162 -177.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.851 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 15.6 p90 -68.97 -43.54 74.77 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.787 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 31.9 mt-10 -51.41 -43.56 61.99 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.765 HG21 HG12 ' A' ' 2' ' ' VAL . 97.3 m -70.98 -61.91 1.59 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 118.876 -1.13 . . . . 0.0 109.092 177.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 1.076 ' HE3' ' HB2' ' A' ' 61' ' ' ASP . 1.8 ttp -45.51 -44.74 12.8 Favored 'General case' 0 CA--C 1.458 -2.576 0 C-N-CA 123.618 0.767 . . . . 0.0 109.978 -170.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.868 ' HH ' ' HA ' ' A' ' 69' ' ' ARG . 58.9 m-85 -70.26 -40.63 74.26 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.197 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.39 -27.32 67.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.863 0.839 . . . . 0.0 108.764 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.82 ' HG2' ' CD2' ' A' ' 91' ' ' LEU . 10.5 tp10 -85.49 -10.48 56.0 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.19 177.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 63.44 29.46 15.5 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.892 -176.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.69 143.29 20.64 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.865 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.786 HG23 ' O ' ' A' ' 61' ' ' ASP . 56.7 mt -78.77 -0.96 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 117.976 0.888 . . . . 0.0 112.065 -178.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.529 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 176.49 135.3 2.13 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-O 119.26 -0.744 . . . . 0.0 112.54 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.856 HD11 HD11 ' A' ' 91' ' ' LEU . 3.2 tp -125.22 133.56 52.68 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 118.618 1.209 . . . . 0.0 111.001 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -97.4 132.89 42.69 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 111.421 0.156 . . . . 0.0 111.421 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.772 ' O ' HG22 ' A' ' 51' ' ' VAL . . . -34.56 -52.51 0.51 Allowed 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.549 HG22 ' O ' ' A' ' 137' ' ' LEU . 59.9 p -53.67 -37.27 63.03 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.898 0.856 . . . . 0.0 110.656 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.675 ' HB2' HD13 ' A' ' 46' ' ' LEU . 73.8 mt-30 -66.93 -38.36 86.04 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.006 -1.452 . . . . 0.0 109.854 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.815 ' CG1' HD21 ' A' ' 46' ' ' LEU . 0.8 OUTLIER -83.8 11.62 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 179.113 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.911 ' HA ' HD12 ' A' ' 6' ' ' LEU . 54.6 t0 79.35 31.52 0.27 Allowed 'General case' 0 N--CA 1.46 0.06 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 176.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.824 HD11 ' O ' ' A' ' 55' ' ' GLN . 1.2 pp -128.28 114.02 32.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.605 177.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.54 ' HB3' ' HD3' ' A' ' 15' ' ' LYS . 6.0 p80 -76.23 65.37 2.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.923 0.868 . . . . 0.0 110.587 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.824 ' O ' HD11 ' A' ' 53' ' ' ILE . 88.5 mt-30 -155.77 134.84 12.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.676 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.917 ' HD2' ' HD3' ' A' ' 19' ' ' PRO . 99.0 mtt180 -62.74 69.06 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -178.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.781 ' O ' ' HE1' ' A' ' 34' ' ' MET . 8.4 mm -113.76 122.3 67.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.919 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 2.4 pp -131.31 146.89 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -177.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.9 m -127.83 138.69 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.266 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.828 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 2.2 mt -115.98 144.12 24.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 122.332 1.063 . . . . 0.0 112.233 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 1.076 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 52.4 t0 -122.78 50.07 1.56 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 113.506 -1.679 . . . . 0.0 107.666 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.656 ' HB ' HD21 ' A' ' 126' ' ' LEU . 24.6 t . . . . . 0 N--CA 1.444 -0.745 0 CA-C-N 112.243 -2.253 . . . . 0.0 105.869 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.868 ' HA ' ' HH ' ' A' ' 39' ' ' TYR . 34.6 ttm180 . . . . . 0 CA--C 1.536 0.42 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.828 ' CB ' ' HB ' ' A' ' 60' ' ' ILE . 8.8 mp -100.45 129.46 46.42 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.881 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.8 HG23 ' HB2' ' A' ' 113' ' ' ARG . 13.4 p -133.87 131.32 56.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.211 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.919 ' HB2' ' CD1' ' A' ' 58' ' ' ILE . 2.9 mm? -141.75 143.91 33.74 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.398 177.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 1.044 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.6 mp -122.31 135.87 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 O-C-N 122.168 -0.332 . . . . 0.0 110.441 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.685 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 8.0 m120 52.34 37.14 0.4 Allowed Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.844 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 97.4 Cg_exo -56.46 150.93 48.37 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 122.949 2.433 . . . . 0.0 114.091 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.541 ' HG3' HD21 ' A' ' 78' ' ' LEU . 11.9 pt-20 -138.72 145.57 40.46 Favored 'General case' 0 C--N 1.335 -0.055 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.855 ' N ' ' HE2' ' A' ' 134' ' ' MET . 9.5 tp -80.69 138.07 36.34 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.111 0.481 . . . . 0.0 110.901 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.883 ' CD2' ' HG3' ' A' ' 109' ' ' ARG . 3.0 mm? -114.27 -36.17 4.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.243 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.465 ' O ' ' HB ' ' A' ' 106' ' ' VAL . 16.5 tp10 -160.9 147.6 15.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.055 0.455 . . . . 0.0 111.86 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.965 ' HA ' HG11 ' A' ' 106' ' ' VAL . 19.6 ptpt -140.48 150.22 43.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.91 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.6 p -157.73 147.61 20.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.779 0.324 . . . . 0.0 111.243 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.745 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 73.46 165.27 10.08 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.791 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -139.79 113.16 8.38 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.689 0.757 . . . . 0.0 112.697 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.663 ' HB ' HH12 ' A' ' 102' ' ' ARG . 1.4 p -102.26 160.18 14.75 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.738 ' O ' HD11 ' A' ' 86' ' ' ILE . . . -139.82 104.73 0.43 Allowed Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 113.077 -1.874 . . . . 0.0 111.856 178.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.796 ' HB ' ' NH2' ' A' ' 102' ' ' ARG . 49.8 mm -147.1 140.32 19.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.595 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 92.5 mt-10 -74.01 143.81 45.4 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 122.589 1.185 . . . . 0.0 112.619 -178.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.552 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 10.1 mp0 -151.1 169.68 21.26 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 113.192 -1.822 . . . . 0.0 108.608 177.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.737 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -118.77 165.29 12.96 Favored Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 119.322 -1.418 . . . . 0.0 109.92 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 19.9 m -119.07 130.65 55.73 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.856 HD11 HD11 ' A' ' 46' ' ' LEU . 13.4 mt -57.5 -13.32 3.52 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.784 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.838 ' HB3' HD11 ' A' ' 13' ' ' LEU . 58.0 m -83.26 -37.2 23.83 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.656 ' CD1' HG13 ' A' ' 8' ' ' ILE . 48.4 mm . . . . . 0 CA--C 1.534 0.339 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.557 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.737 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 40.9 mtm-85 . . . . . 0 N--CA 1.463 0.186 0 CA-C-O 121.627 0.727 . . . . 0.0 111.493 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -132.11 151.0 52.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.13 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.62 ' HG ' ' N ' ' A' ' 86' ' ' ILE . 6.9 tt -75.58 135.73 40.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.808 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.76 HG23 ' HD2' ' A' ' 101' ' ' PRO . 13.6 p -130.09 140.29 38.2 Favored Pre-proline 0 C--O 1.232 0.181 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.393 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.76 ' HD2' HG23 ' A' ' 100' ' ' VAL . 97.1 Cg_endo -88.16 122.7 1.57 Allowed 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.377 1.385 . . . . 0.0 113.552 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.796 ' NH2' ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -142.74 165.45 27.36 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 113.545 -1.661 . . . . 0.0 110.783 178.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.745 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.74 154.04 42.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.9 0.381 . . . . 0.0 110.377 -178.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.408 ' OE1' ' HA ' ' A' ' 104' ' ' GLU . 5.1 tp10 -73.06 -42.03 63.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.66 -176.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.771 ' HG2' ' HB3' ' A' ' 123' ' ' ASP . 4.7 mtpm? -139.5 138.32 36.26 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.489 0.661 . . . . 0.0 109.674 177.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.965 HG11 ' HA ' ' A' ' 80' ' ' LYS . 25.1 m -147.02 141.63 20.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.736 -1.12 . . . . 0.0 112.122 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.942 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 31.9 mmtm -107.2 126.04 51.88 Favored 'General case' 0 N--CA 1.461 0.101 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.928 HD11 HD11 ' A' ' 130' ' ' ILE . 2.0 pp -129.61 161.82 38.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.883 ' HG3' ' CD2' ' A' ' 78' ' ' LEU . 45.4 mtm180 -113.24 138.17 50.4 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-O 120.843 0.354 . . . . 0.0 110.083 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.722 ' HB2' ' HB3' ' A' ' 72' ' ' LEU . . . -156.44 167.89 29.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.658 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 1.044 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.2 pp -114.03 151.66 32.13 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.582 ' O ' HD13 ' A' ' 111' ' ' LEU . 10.7 t70 -87.9 164.37 15.89 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.692 -177.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.8 ' HB2' HG23 ' A' ' 71' ' ' VAL . 49.1 ttp180 -51.66 -21.36 2.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.311 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.55 -21.75 44.75 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.908 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.5 37.27 3.31 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.992 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -128.64 102.82 19.78 Favored Pre-proline 0 C--O 1.238 0.457 0 CA-C-N 117.054 0.427 . . . . 0.0 110.708 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.565 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 32.2 Cg_exo -73.18 114.16 3.97 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 121.616 1.544 . . . . 0.0 114.959 -177.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.407 ' CE2' ' HB2' ' A' ' 112' ' ' ASP . 0.4 OUTLIER -125.58 169.56 12.35 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.417 -178.52 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.698 ' HG2' ' HD2' ' A' ' 109' ' ' ARG . 34.9 mt-10 -106.75 129.4 54.63 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.02 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.839 ' HG ' HD13 ' A' ' 108' ' ' ILE . 4.1 pp -123.39 133.01 54.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.848 -178.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.942 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 15.4 pt-20 -92.48 124.37 36.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.673 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 1.021 ' HB3' HD12 ' A' ' 126' ' ' LEU . . . -116.39 134.59 54.7 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.771 ' HB3' ' HG2' ' A' ' 105' ' ' LYS . 25.2 m-20 -126.81 164.54 21.14 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.602 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 46.78 -134.56 11.13 Favored Glycine 0 C--N 1.347 1.188 0 CA-C-N 120.722 1.601 . . . . 0.0 116.44 177.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.791 ' H ' HD12 ' A' ' 125' ' ' LEU . 4.8 mp -54.64 -33.99 61.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.431 -0.884 . . . . 0.0 111.619 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 1.021 HD12 ' HB3' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -70.95 -53.35 15.24 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.239 -0.584 . . . . 0.0 109.796 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.785 ' O ' ' HG3' ' A' ' 131' ' ' GLN . . . -59.44 -47.12 86.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.93 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.701 HD12 ' HG2' ' A' ' 102' ' ' ARG . 49.9 mm -61.28 -55.69 22.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.084 -178.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.714 ' HG ' HG21 ' A' ' 44' ' ' ILE . 82.2 m -57.45 -50.89 71.55 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.928 HD11 HD11 ' A' ' 108' ' ' ILE . 18.7 tt -59.0 -41.35 82.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.826 -0.17 . . . . 0.0 111.413 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.865 ' CG ' HG21 ' A' ' 106' ' ' VAL . 66.0 mt-30 -65.99 -40.83 91.51 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -56.08 -47.74 77.42 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.882 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.841 ' O ' HD21 ' A' ' 137' ' ' LEU . 3.7 mm-40 -58.71 -46.08 88.11 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.098 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.921 ' HA ' HD23 ' A' ' 137' ' ' LEU . 1.9 mmm -55.68 -47.54 76.59 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.466 0.65 . . . . 0.0 110.037 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.839 ' O ' HG11 ' A' ' 138' ' ' VAL . 31.3 m-20 -61.6 -49.24 77.39 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.205 178.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.457 ' CE1' ' HG2' ' A' ' 50' ' ' GLN . 10.3 t-80 -59.25 -50.76 72.79 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 121.768 -0.583 . . . . 0.0 111.171 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.921 HD23 ' HA ' ' A' ' 134' ' ' MET . 1.6 pp -58.27 -31.27 67.29 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.726 -178.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.839 HG11 ' O ' ' A' ' 135' ' ' ASP . 13.8 p -83.04 20.5 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-O 122.803 1.287 . . . . 0.0 108.755 175.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.754 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 65.84 7.3 35.13 Favored Glycine 0 CA--C 1.494 -1.278 0 CA-C-N 112.501 -2.136 . . . . 0.0 112.843 176.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.822 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 4.6 ptmt . . . . . 0 N--CA 1.429 -1.492 0 C-N-CA 119.53 -0.868 . . . . 0.0 108.716 179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.827 ' CG1' ' HA ' ' A' ' 37' ' ' THR . 28.3 m . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.371 0.129 . . . . 0.0 110.783 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.843 HD22 ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -79.01 -159.3 0.18 Allowed 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.108 179.858 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.736 ' N ' HD23 ' A' ' 3' ' ' LEU . 2.2 tp-100 -88.31 105.58 17.66 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.254 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.463 HG21 HG23 ' A' ' 37' ' ' THR . 46.4 t -88.33 127.0 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 121.333 0.587 . . . . 0.0 111.483 -179.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 1.035 ' HB2' HD21 ' A' ' 13' ' ' LEU . 24.4 mt -88.08 144.29 26.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.222 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 4.3 m80 -120.85 145.99 47.04 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.948 ' CD1' HD12 ' A' ' 13' ' ' LEU . 44.5 mm -69.29 135.79 88.94 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.674 178.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.435 ' HA ' HG22 ' A' ' 8' ' ' ILE . 74.1 Cg_endo -76.48 141.74 70.95 Favored 'Cis proline' 0 C--N 1.352 0.729 0 C-N-CA 124.145 -1.19 . . . . 0.0 112.031 -0.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.968 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 8.4 t0 -163.39 125.18 2.47 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.271 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.419 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 23.7 pt-20 -57.53 -46.23 84.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.74 -178.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.684 ' CZ ' ' HD2' ' A' ' 54' ' ' HIS . 14.8 mmt85 -56.21 -30.1 61.83 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 1.035 HD21 ' HB2' ' A' ' 6' ' ' LEU . 11.5 mt -75.78 -33.29 60.17 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 120.098 1.317 . . . . 0.0 109.054 178.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.642 ' C ' ' HA3' ' A' ' 139' ' ' GLY . 26.6 mmt-85 -96.21 13.29 27.91 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.299 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.572 ' HZ1' ' HE ' ' A' ' 12' ' ' ARG . 88.4 tttt -91.65 149.93 21.4 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.128 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.526 ' HA ' ' HA ' ' A' ' 138' ' ' VAL . 49.5 t -82.95 122.13 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.801 ' HB2' ' CG ' ' A' ' 56' ' ' ARG . . . -80.02 145.57 32.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.856 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.589 ' HB3' HE22 ' A' ' 55' ' ' GLN . 83.4 tttt -101.81 134.22 20.28 Favored Pre-proline 0 C--N 1.326 -0.442 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.788 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -77.36 115.52 3.94 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.365 2.044 . . . . 0.0 111.261 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.653 HG11 ' O ' ' A' ' 22' ' ' GLU . 24.9 t -68.94 144.98 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 122.526 1.155 . . . . 0.0 113.022 -176.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.638 ' N ' HG13 ' A' ' 20' ' ' VAL . 4.3 mm-40 -67.45 -29.24 68.65 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 113.303 -1.771 . . . . 0.0 111.734 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.653 ' O ' HG11 ' A' ' 20' ' ' VAL . 16.9 tp10 -156.57 154.17 29.81 Favored 'General case' 0 CA--C 1.527 0.063 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.178 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.966 HG21 ' HA2' ' A' ' 115' ' ' GLY . 6.3 t -80.07 102.38 5.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -178.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 1.024 ' HB2' HD12 ' A' ' 27' ' ' ILE . 62.3 m-80 -89.04 151.16 22.42 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.569 -177.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.404 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -55.48 -28.21 53.12 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.508 0.67 . . . . 0.0 110.534 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.956 ' HG3' HD13 ' A' ' 27' ' ' ILE . 21.7 pt-20 -74.02 -36.92 64.48 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 177.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 1.024 HD12 ' HB2' ' A' ' 24' ' ' ASN . 1.7 mp -67.46 -38.79 81.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.952 177.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -65.78 -40.29 91.84 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 122.401 -0.187 . . . . 0.0 110.938 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.444 HH11 ' HG2' ' A' ' 29' ' ' ARG . 47.7 mmt-85 -64.94 -38.41 90.89 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.784 ' O ' ' HG3' ' A' ' 34' ' ' MET . 4.7 mt -55.39 -50.47 65.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.177 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.926 ' CG1' HG21 ' A' ' 71' ' ' VAL . 19.2 t -66.87 -40.4 85.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-O 121.218 0.533 . . . . 0.0 110.408 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.82 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 71.1 m-20 -53.06 -46.08 68.39 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.072 -178.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.691 ' HB3' HD13 ' A' ' 3' ' ' LEU . 1.5 m-20 -75.13 -29.25 60.46 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.07 176.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.784 ' HG3' ' O ' ' A' ' 30' ' ' ILE . 83.2 mtp -59.46 -46.63 88.22 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.171 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.82 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 13.9 p90 -70.2 -44.18 69.2 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.747 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 85.9 mt-10 -51.61 -44.48 62.9 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.622 0.725 . . . . 0.0 109.376 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.827 ' HA ' ' CG1' ' A' ' 2' ' ' VAL . 96.7 m -70.5 -61.35 1.8 Allowed 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 118.592 -1.243 . . . . 0.0 108.709 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 1.028 ' HE3' ' HB2' ' A' ' 61' ' ' ASP . 2.0 ttp -45.68 -41.5 10.52 Favored 'General case' 0 CA--C 1.463 -2.393 0 C-N-CA 123.878 0.871 . . . . 0.0 110.133 -171.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.697 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 55.9 m-85 -70.4 -42.13 72.08 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.083 177.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.424 ' HB1' HG11 ' A' ' 2' ' ' VAL . . . -61.16 -24.47 66.32 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.491 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.971 ' HG2' HD13 ' A' ' 91' ' ' LEU . 11.9 tp10 -88.81 -11.56 44.49 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.482 177.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 64.83 26.54 12.94 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 122.047 0.927 . . . . 0.0 109.927 -176.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.48 141.58 22.16 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 113.76 -1.564 . . . . 0.0 110.67 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.999 HG23 HG23 ' A' ' 62' ' ' VAL . 53.1 mt -80.0 0.68 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 117.643 0.722 . . . . 0.0 112.266 -178.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.479 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 178.09 135.54 2.31 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-O 119.022 -0.877 . . . . 0.0 111.926 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 1.022 HD12 ' HG ' ' A' ' 91' ' ' LEU . 5.4 tp -125.68 134.24 51.9 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-N 118.993 1.397 . . . . 0.0 111.56 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -98.9 132.33 44.31 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.734 ' O ' HG23 ' A' ' 51' ' ' VAL . . . -29.85 -54.59 0.16 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.575 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 58.4 p -53.97 -36.64 63.1 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.698 0.761 . . . . 0.0 111.81 -178.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.672 ' NE2' HD22 ' A' ' 91' ' ' LEU . 85.5 mt-30 -64.51 -40.62 95.97 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.627 -1.169 . . . . 0.0 110.028 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.857 ' CG1' HD23 ' A' ' 46' ' ' LEU . 0.8 OUTLIER -84.36 17.37 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 112.665 0.616 . . . . 0.0 112.665 -179.84 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.848 ' HA ' HD12 ' A' ' 6' ' ' LEU . 11.1 t0 77.51 26.86 0.65 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 176.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.822 HD11 ' O ' ' A' ' 55' ' ' GLN . 1.0 OUTLIER -124.13 110.7 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 C-N-CA 118.915 -1.114 . . . . 0.0 111.77 178.644 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.684 ' HD2' ' CZ ' ' A' ' 12' ' ' ARG . 6.9 p80 -76.48 60.5 1.61 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.611 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.822 ' O ' HD11 ' A' ' 53' ' ' ILE . 2.5 mm100 -149.67 134.18 17.53 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 114.342 -1.299 . . . . 0.0 107.788 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.801 ' CG ' ' HB2' ' A' ' 17' ' ' ALA . 75.7 mtp180 -64.11 68.62 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -177.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.686 HG13 HD12 ' A' ' 53' ' ' ILE . 8.5 mm -110.49 122.16 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.905 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 1.5 pp -121.95 140.73 44.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.0 -0.68 . . . . 0.0 112.285 -178.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.477 HG11 ' O ' ' A' ' 46' ' ' LEU . 1.5 p -125.16 134.5 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 1.034 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 9.1 mm -114.36 155.27 15.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.616 0.722 . . . . 0.0 110.921 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 1.028 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 31.9 t70 -142.57 28.56 1.62 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.659 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.999 HG23 HG23 ' A' ' 44' ' ' ILE . 39.3 t . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.81 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.534 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 40.7 ttm-85 . . . . . 0 N--CA 1.465 0.292 0 CA-C-O 120.743 0.306 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 1.034 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 47.8 mt -103.72 134.38 47.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.915 0.388 . . . . 0.0 111.716 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.926 HG21 ' CG1' ' A' ' 31' ' ' VAL . 6.3 p -134.88 135.9 52.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.308 178.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.905 ' HB2' ' CD1' ' A' ' 58' ' ' ILE . 3.0 mm? -141.63 142.12 33.42 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 177.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 1.004 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.6 mp -121.71 135.05 63.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.702 0.286 . . . . 0.0 110.336 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.694 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 7.3 m120 54.48 34.86 0.26 Allowed Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.87 ' HG2' HG12 ' A' ' 58' ' ' ILE . 89.3 Cg_exo -56.39 146.8 71.58 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.766 2.311 . . . . 0.0 113.707 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -138.0 145.51 41.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.797 ' HB2' ' HE3' ' A' ' 134' ' ' MET . 29.8 tp -79.12 138.2 37.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.424 0.63 . . . . 0.0 112.084 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.849 ' CD2' ' HG3' ' A' ' 109' ' ' ARG . 2.7 mm? -112.77 -43.55 3.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.474 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.556 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 39.2 tt0 -157.21 147.81 21.31 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.211 0.529 . . . . 0.0 111.949 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.88 ' HA ' HG12 ' A' ' 106' ' ' VAL . 19.3 ptpt -143.08 146.01 33.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.34 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.0 t -157.07 149.81 23.47 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.352 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.734 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 78.11 156.12 8.52 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.718 -0.754 . . . . 0.0 111.499 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -131.3 113.22 13.53 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.965 0.888 . . . . 0.0 112.632 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.777 ' HB ' HH12 ' A' ' 102' ' ' ARG . 1.5 p -105.98 161.9 14.06 Favored 'General case' 0 CA--C 1.487 -1.447 0 CA-C-N 114.016 -1.447 . . . . 0.0 114.894 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.81 ' HA3' HD23 ' A' ' 99' ' ' LEU . . . -149.22 118.05 0.92 Allowed Glycine 0 C--N 1.314 -0.674 0 CA-C-N 113.103 -1.862 . . . . 0.0 111.047 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.71 ' N ' ' HG ' ' A' ' 99' ' ' LEU . 32.5 mt -148.79 140.45 17.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 117.432 0.616 . . . . 0.0 111.84 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 55.8 mt-10 -71.14 139.18 50.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 123.135 1.445 . . . . 0.0 112.104 -176.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.591 ' HA ' ' HD2' ' A' ' 97' ' ' ARG . 84.1 mt-10 -157.5 162.44 38.88 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 112.543 -2.117 . . . . 0.0 111.774 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.744 ' N ' ' HG2' ' A' ' 97' ' ' ARG . . . -120.94 162.97 14.53 Favored Glycine 0 CA--C 1.5 -0.905 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 11.2 m -116.28 139.38 50.44 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 117.564 0.682 . . . . 0.0 110.763 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 1.022 ' HG ' HD12 ' A' ' 46' ' ' LEU . 2.5 mm? -47.25 -20.58 0.2 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.501 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.865 ' CB ' HG12 ' A' ' 8' ' ' ILE . 31.5 m -86.53 -41.82 14.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.537 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.942 HD12 ' HB ' ' A' ' 8' ' ' ILE . 44.0 mm . . . . . 0 CA--C 1.539 0.553 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.199 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.744 ' HG2' ' N ' ' A' ' 89' ' ' GLY . 74.9 mtm180 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 121.36 0.6 . . . . 0.0 110.375 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -125.1 147.31 49.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.414 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.81 HD23 ' HA3' ' A' ' 85' ' ' GLY . 7.7 tt -75.26 111.94 11.03 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.707 0.765 . . . . 0.0 110.512 -178.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.63 HG22 ' HD2' ' A' ' 101' ' ' PRO . 12.2 p -97.93 133.05 23.67 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.93 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.63 ' HD2' HG22 ' A' ' 100' ' ' VAL . 95.6 Cg_endo -88.29 125.71 1.86 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.391 2.061 . . . . 0.0 112.227 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.946 ' HG3' HG21 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -144.4 166.77 24.16 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.798 0.839 . . . . 0.0 109.653 179.84 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.734 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.29 154.62 41.39 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.883 0.373 . . . . 0.0 110.1 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -73.06 -40.56 64.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.72 -176.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.754 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 89.3 mttt -139.82 140.34 36.57 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.34 0.59 . . . . 0.0 109.481 177.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.88 HG12 ' HA ' ' A' ' 80' ' ' LYS . 30.3 m -149.03 140.17 17.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.07 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.936 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 23.4 mmtp -107.63 126.42 52.55 Favored 'General case' 0 N--CA 1.461 0.091 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.857 HD11 HD11 ' A' ' 130' ' ' ILE . 1.7 pp -135.4 151.05 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -176.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.849 ' HG3' ' CD2' ' A' ' 78' ' ' LEU . 91.8 mtt180 -102.36 137.54 40.47 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.205 -178.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.708 ' HB2' ' HG3' ' A' ' 75' ' ' PRO . . . -160.64 169.01 23.73 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.908 -177.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 1.004 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.4 pp -116.39 151.64 35.54 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.716 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 18.9 t70 -83.66 165.4 18.99 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -176.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.832 ' HB2' HG13 ' A' ' 71' ' ' VAL . 52.9 ttp180 -52.2 -20.95 2.92 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.58 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -79.37 -25.85 42.14 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.699 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.966 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 106.31 36.57 2.65 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.712 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -128.44 102.6 20.48 Favored Pre-proline 0 C--O 1.236 0.377 0 CA-C-N 117.067 0.433 . . . . 0.0 110.731 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.568 ' HA ' ' CA ' ' A' ' 111' ' ' LEU . 34.2 Cg_exo -71.92 114.98 4.13 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 121.777 1.651 . . . . 0.0 115.596 -177.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.716 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 12.1 p90 -128.06 168.08 15.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.574 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.527 ' CG ' ' HG2' ' A' ' 109' ' ' ARG . 27.7 mp0 -107.35 130.28 54.81 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.691 HD23 HD12 ' A' ' 72' ' ' LEU . 4.3 pp -126.33 133.73 51.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.566 -178.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.936 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 11.5 pt-20 -93.04 123.8 36.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.629 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.992 ' HB3' HD13 ' A' ' 126' ' ' LEU . . . -116.83 134.97 54.13 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.754 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.2 m-20 -127.04 162.49 25.91 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.647 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 51.83 -136.35 33.34 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 120.293 1.406 . . . . 0.0 115.426 177.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 74.4 mt -54.84 -33.8 62.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.719 -0.741 . . . . 0.0 111.706 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.992 HD13 ' HB3' ' A' ' 122' ' ' ALA . 0.3 OUTLIER -71.47 -51.6 22.87 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.851 0.834 . . . . 0.0 109.15 179.619 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.754 ' HB3' ' CA ' ' A' ' 123' ' ' ASP . . . -58.82 -43.0 90.53 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.258 -1.337 . . . . 0.0 111.91 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.946 HG21 ' HG3' ' A' ' 102' ' ' ARG . 50.3 mm -67.96 -55.72 15.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.769 ' HG ' HG21 ' A' ' 62' ' ' VAL . 84.2 m -58.73 -50.67 73.06 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.857 HD11 HD11 ' A' ' 108' ' ' ILE . 20.4 tt -58.24 -43.84 86.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.13 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.757 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.4 pt20 -67.73 -37.9 82.83 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.083 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.577 ' NE2' ' HD2' ' A' ' 136' ' ' HIS . 3.8 t-160 -58.88 -47.4 85.06 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.864 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.6 mm-40 -59.61 -42.43 92.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.083 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.932 ' HA ' HD22 ' A' ' 137' ' ' LEU . 30.1 mtm -57.33 -47.48 81.44 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.832 0.825 . . . . 0.0 109.902 178.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.901 ' O ' HG11 ' A' ' 138' ' ' VAL . 57.8 m-20 -62.51 -47.59 83.28 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.197 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.577 ' HD2' ' NE2' ' A' ' 132' ' ' HIS . 6.2 t-80 -59.45 -52.96 63.37 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.123 0.487 . . . . 0.0 111.557 -178.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.932 HD22 ' HA ' ' A' ' 134' ' ' MET . 1.5 pp -57.93 -31.47 66.84 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.308 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 1.029 HG13 ' HG2' ' A' ' 140' ' ' LYS . 14.7 p -86.86 22.78 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-O 122.356 1.074 . . . . 0.0 109.359 176.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.642 ' HA3' ' C ' ' A' ' 14' ' ' ARG . . . 53.28 38.45 56.99 Favored Glycine 0 CA--C 1.481 -2.041 0 CA-C-N 113.331 -1.759 . . . . 0.0 112.17 176.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 1.029 ' HG2' HG13 ' A' ' 138' ' ' VAL . 2.4 ptmt . . . . . 0 N--CA 1.42 -1.935 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.83 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.887 HG13 ' HA ' ' A' ' 37' ' ' THR . 27.1 m . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.787 0.327 . . . . 0.0 111.388 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.994 HD11 ' HB ' ' A' ' 51' ' ' VAL . 1.1 pt? -79.68 -158.69 0.17 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.53 ' HG3' ' HB3' ' A' ' 52' ' ' ASP . 23.4 pt20 -88.66 104.43 16.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.882 0.372 . . . . 0.0 111.88 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.503 HG13 ' CD1' ' A' ' 91' ' ' LEU . 49.1 t -89.38 131.66 36.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-O 121.251 0.548 . . . . 0.0 111.953 -178.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 1.0 ' HB2' HD21 ' A' ' 13' ' ' LEU . 22.6 mt -91.08 140.11 30.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.998 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.612 ' HA ' ' CA ' ' A' ' 92' ' ' SER . 37.1 m-70 -112.53 140.6 47.15 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.743 HG12 ' HB2' ' A' ' 92' ' ' SER . 37.1 mm -61.81 132.88 93.51 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.81 176.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -79.89 148.25 78.78 Favored 'Cis proline' 0 C--N 1.352 0.719 0 C-N-CA 124.795 -0.919 . . . . 0.0 111.67 -0.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 1.033 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 9.0 t0 -165.1 131.09 2.73 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.403 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.413 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 23.8 pt-20 -58.45 -45.8 87.85 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.774 0.321 . . . . 0.0 110.643 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.658 ' O ' ' HB ' ' A' ' 49' ' ' THR . 14.7 mmt85 -59.67 -26.44 65.55 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 1.033 ' HG ' ' HB3' ' A' ' 10' ' ' ASP . 9.9 mt -77.42 -31.43 54.02 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 120.736 1.607 . . . . 0.0 108.39 177.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.672 ' C ' ' HA3' ' A' ' 139' ' ' GLY . 25.2 mmm-85 -94.46 10.43 34.52 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.108 -1.406 . . . . 0.0 109.173 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.714 ' HZ2' ' HB2' ' A' ' 54' ' ' HIS . 64.2 tttm -84.64 141.2 30.8 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.196 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.614 ' CG1' HG23 ' A' ' 138' ' ' VAL . 61.8 t -84.22 94.95 3.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.201 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.677 ' HB2' ' HG3' ' A' ' 56' ' ' ARG . . . -57.71 145.12 35.54 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.887 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -104.42 134.77 19.51 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.596 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.633 ' HD3' ' HD3' ' A' ' 56' ' ' ARG . 58.8 Cg_endo -80.26 115.74 3.24 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.235 1.957 . . . . 0.0 110.384 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.62 HG13 ' N ' ' A' ' 21' ' ' GLU . 16.4 t -69.23 144.3 14.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 122.476 1.131 . . . . 0.0 113.177 -175.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.62 ' N ' HG13 ' A' ' 20' ' ' VAL . 69.8 mm-40 -62.48 -23.59 66.99 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 113.197 -1.82 . . . . 0.0 112.57 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -160.03 148.0 16.82 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 121.034 -0.267 . . . . 0.0 110.744 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.941 HG21 ' HA2' ' A' ' 115' ' ' GLY . 3.0 t -82.44 105.83 12.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.868 HD21 HD13 ' A' ' 27' ' ' ILE . 64.8 m-80 -89.23 157.85 18.09 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.988 -178.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.522 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -54.53 -31.48 56.38 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.509 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -71.28 -37.57 71.87 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 177.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.868 HD13 HD21 ' A' ' 24' ' ' ASN . 63.4 mt -64.25 -47.15 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.143 178.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.415 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 51.0 mt-30 -57.65 -39.86 78.0 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.027 0.441 . . . . 0.0 110.733 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.522 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 38.9 mmt180 -60.99 -40.09 92.15 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.543 0.687 . . . . 0.0 109.159 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.819 ' O ' ' HG3' ' A' ' 34' ' ' MET . 4.6 mt -58.62 -49.66 81.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.879 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.599 ' CG1' HG21 ' A' ' 71' ' ' VAL . 17.9 t -68.47 -41.32 83.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.916 0.388 . . . . 0.0 111.422 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.831 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 47.8 m-20 -53.24 -46.11 69.01 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.588 0.709 . . . . 0.0 111.53 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.545 ' HB3' HD21 ' A' ' 3' ' ' LEU . 1.4 m-20 -74.71 -30.21 61.46 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.661 176.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.819 ' HG3' ' O ' ' A' ' 30' ' ' ILE . 87.3 mtp -59.61 -47.0 87.29 Favored 'General case' 0 C--N 1.345 0.378 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.723 -177.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.831 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 17.4 p90 -69.54 -44.38 71.05 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.745 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 77.9 mt-10 -51.65 -42.64 62.23 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.887 ' HA ' HG13 ' A' ' 2' ' ' VAL . 76.8 m -69.33 -60.42 2.35 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 118.79 -1.164 . . . . 0.0 108.487 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 1.123 ' HE3' ' HB2' ' A' ' 61' ' ' ASP . 3.2 ttp -46.24 -43.33 15.38 Favored 'General case' 0 CA--C 1.463 -2.385 0 C-N-CA 123.749 0.819 . . . . 0.0 109.869 -170.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.693 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 58.9 m-85 -68.96 -42.02 77.21 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.878 178.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.496 ' HB1' ' CG1' ' A' ' 2' ' ' VAL . . . -60.14 -28.9 68.27 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.626 0.727 . . . . 0.0 109.045 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 1.065 ' HG2' HD22 ' A' ' 91' ' ' LEU . 3.2 tp10 -83.95 -10.15 58.16 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 114.392 -1.276 . . . . 0.0 108.835 177.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 62.41 25.42 15.16 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.916 -176.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.96 140.61 22.53 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.187 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 1.009 HG22 HG21 ' A' ' 62' ' ' VAL . 38.5 mt -79.2 0.42 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 117.829 0.815 . . . . 0.0 111.93 -178.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.479 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . -179.75 133.5 2.04 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-O 119.215 -0.77 . . . . 0.0 112.066 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.98 ' HB2' ' HG3' ' A' ' 38' ' ' MET . 9.2 tp -125.31 135.37 52.42 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-N 119.531 1.665 . . . . 0.0 111.712 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -101.45 130.63 47.73 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.689 ' O ' HG22 ' A' ' 51' ' ' VAL . . . -29.31 -56.16 0.15 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 115.902 1.815 . . . . 0.0 115.902 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.658 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 77.2 p -53.82 -34.73 60.11 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.725 0.774 . . . . 0.0 111.378 -178.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.487 ' NE2' ' HB3' ' A' ' 90' ' ' CYS . 37.2 mt-30 -65.34 -38.52 90.34 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.168 -1.378 . . . . 0.0 109.843 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.994 ' HB ' HD11 ' A' ' 3' ' ' LEU . 1.6 m -89.1 13.42 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 121.013 0.435 . . . . 0.0 111.752 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.954 ' HA ' HD13 ' A' ' 6' ' ' LEU . 38.2 t70 77.13 35.27 0.36 Allowed 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 176.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.808 HD13 ' HB2' ' A' ' 55' ' ' GLN . 1.2 pp -125.81 110.87 25.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 119.495 -0.882 . . . . 0.0 109.706 176.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.714 ' HB2' ' HZ2' ' A' ' 15' ' ' LYS . 23.4 p-80 -75.99 64.76 1.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 122.098 0.952 . . . . 0.0 110.145 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.808 ' HB2' HD13 ' A' ' 53' ' ' ILE . 89.3 mt-30 -153.97 131.83 11.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.934 -1.485 . . . . 0.0 108.146 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.677 ' HG3' ' HB2' ' A' ' 17' ' ' ALA . 60.1 mtp85 -62.81 74.55 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 -178.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.729 ' O ' ' HE1' ' A' ' 34' ' ' MET . 29.7 mm -116.56 124.2 72.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 1.014 HD12 ' HB2' ' A' ' 72' ' ' LEU . 1.9 pp -127.67 145.51 34.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -177.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.683 HG21 ' H ' ' A' ' 46' ' ' LEU . 33.7 m -127.44 136.33 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.123 179.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.954 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 1.3 mt -116.44 147.92 19.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.785 0.803 . . . . 0.0 110.698 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 1.123 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 33.2 t70 -136.07 30.23 3.04 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.217 -178.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 1.009 HG21 HG22 ' A' ' 44' ' ' ILE . 24.4 t . . . . . 0 N--CA 1.462 0.147 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.16 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.62 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 72.9 ttt180 . . . . . 0 N--CA 1.466 0.358 0 CA-C-O 120.798 0.332 . . . . 0.0 111.401 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.954 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 65.0 mt -104.28 133.1 49.77 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.637 HG13 ' H ' ' A' ' 113' ' ' ARG . 14.5 p -135.01 134.38 53.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.291 177.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 1.014 ' HB2' HD12 ' A' ' 58' ' ' ILE . 3.0 mm? -140.01 141.73 36.3 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 177.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.991 HG13 HD11 ' A' ' 111' ' ' LEU . 3.5 mm -120.43 134.32 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 121.232 0.539 . . . . 0.0 111.548 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.682 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 6.7 m120 51.36 38.68 0.54 Allowed Pre-proline 0 C--N 1.317 -0.807 0 CA-C-N 115.217 -0.902 . . . . 0.0 112.323 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.746 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 84.5 Cg_exo -54.92 149.78 40.7 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.974 2.449 . . . . 0.0 114.104 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.458 ' HG3' HD13 ' A' ' 78' ' ' LEU . 15.7 pt-20 -135.79 142.36 44.89 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 1.028 ' HB2' ' HE2' ' A' ' 134' ' ' MET . 1.7 tt -81.79 134.21 35.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.643 0.735 . . . . 0.0 111.806 -178.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.873 ' N ' HD22 ' A' ' 77' ' ' LEU . 6.7 mp -110.74 -37.51 5.41 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.691 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.543 ' C ' ' HE2' ' A' ' 80' ' ' LYS . 85.2 tt0 -160.28 153.71 22.19 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.186 0.517 . . . . 0.0 111.782 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.99 ' HZ2' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -148.03 151.7 36.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.378 179.125 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.7 m -160.46 141.55 12.06 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.578 0.228 . . . . 0.0 110.984 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.769 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 80.35 168.33 38.0 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.235 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -146.26 113.73 6.33 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.672 0.749 . . . . 0.0 112.926 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.823 ' HG1' HD11 ' A' ' 128' ' ' ILE . 1.5 p -99.54 160.91 13.94 Favored 'General case' 0 CA--C 1.49 -1.331 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.764 ' O ' HD11 ' A' ' 86' ' ' ILE . . . -134.44 100.51 0.38 Allowed Glycine 0 C--N 1.317 -0.475 0 CA-C-N 113.064 -1.88 . . . . 0.0 111.132 178.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.764 HD11 ' O ' ' A' ' 85' ' ' GLY . 39.5 mm -143.73 135.51 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -178.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.601 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 49.0 mt-10 -72.96 143.89 47.48 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 122.389 1.09 . . . . 0.0 112.499 -178.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.558 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 50.4 mt-10 -154.16 166.15 34.0 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 113.619 -1.628 . . . . 0.0 109.053 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.754 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -119.87 159.61 14.89 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 119.304 -1.427 . . . . 0.0 109.623 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.735 ' HB2' HG13 ' A' ' 93' ' ' ILE . 69.2 m -111.71 138.83 47.76 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.552 -177.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 1.065 HD22 ' HG2' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -50.04 -32.36 15.24 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.535 0.683 . . . . 0.0 110.0 -179.636 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.743 ' HB2' HG12 ' A' ' 8' ' ' ILE . 11.4 m -77.78 -27.14 50.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.7 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.735 HG13 ' HB2' ' A' ' 90' ' ' CYS . 48.5 mt . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.617 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.754 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 81.1 mtm180 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 121.652 0.739 . . . . 0.0 111.377 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.84 148.28 49.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.874 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.612 ' HG ' ' N ' ' A' ' 86' ' ' ILE . 6.9 tt -75.23 135.73 40.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.208 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.796 HG11 ' NH1' ' A' ' 102' ' ' ARG . 55.8 t -131.97 131.49 22.61 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.173 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.517 ' HA ' ' O ' ' A' ' 84' ' ' THR . 74.3 Cg_endo -78.24 125.43 7.1 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.692 1.595 . . . . 0.0 113.137 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.949 ' HG2' HD13 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -141.42 165.51 27.31 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.413 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.769 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -69.38 154.75 41.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.727 0.299 . . . . 0.0 110.513 -178.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -73.41 -43.33 60.68 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.243 -176.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.772 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 84.2 mttt -139.47 138.19 36.19 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.416 0.627 . . . . 0.0 109.624 176.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.921 HG11 ' HA ' ' A' ' 80' ' ' LYS . 28.3 m -144.52 140.38 23.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.991 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 1.07 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 23.6 mmtp -107.99 125.92 52.1 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.714 ' CD1' HD11 ' A' ' 130' ' ' ILE . 1.9 pp -132.0 161.36 41.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -177.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.857 ' HG3' ' CD1' ' A' ' 78' ' ' LEU . 92.2 mtt180 -109.58 137.53 47.28 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.782 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.579 ' HB2' ' HB3' ' A' ' 72' ' ' LEU . . . -155.1 166.5 33.38 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.655 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.991 HD11 HG13 ' A' ' 73' ' ' ILE . 2.0 pp -116.46 150.47 37.81 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.538 ' O ' HD13 ' A' ' 111' ' ' LEU . 22.0 t70 -84.0 171.33 13.06 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.579 -175.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.778 ' HD2' ' OD1' ' A' ' 32' ' ' ASP . 50.8 ttp180 -54.49 -23.43 16.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.798 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.52 -14.41 58.89 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.873 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.941 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 93.15 40.09 4.94 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.02 -1.086 . . . . 0.0 114.593 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -128.11 102.49 21.49 Favored Pre-proline 0 N--CA 1.469 0.479 0 CA-C-N 117.59 0.695 . . . . 0.0 110.389 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.611 ' HG3' HD22 ' A' ' 111' ' ' LEU . 32.3 Cg_exo -73.56 115.23 4.26 Favored 'Trans proline' 0 C--N 1.359 1.108 0 N-CA-C 116.249 1.596 . . . . 0.0 116.249 -177.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.64 168.95 13.01 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.739 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.689 ' HG2' ' HG2' ' A' ' 109' ' ' ARG . 36.1 mt-10 -107.6 130.03 54.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.008 0.432 . . . . 0.0 110.278 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.733 HD12 ' CD1' ' A' ' 130' ' ' ILE . 4.1 pp -126.71 134.27 50.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.804 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 1.07 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 15.5 pt-20 -96.79 124.35 40.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.004 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.897 ' HB3' HD23 ' A' ' 126' ' ' LEU . . . -116.71 135.79 53.49 Favored 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.772 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.3 m-20 -125.99 164.71 20.24 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.708 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 45.14 -132.53 8.26 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 120.627 1.558 . . . . 0.0 116.194 177.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.756 HD11 ' H ' ' A' ' 125' ' ' LEU . 5.0 mp -54.09 -35.83 62.53 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.739 -0.731 . . . . 0.0 111.361 -178.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.897 HD23 ' HB3' ' A' ' 122' ' ' ALA . 0.6 OUTLIER -70.44 -53.02 18.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.581 0.705 . . . . 0.0 109.655 179.721 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.751 ' HB3' ' CA ' ' A' ' 123' ' ' ASP . . . -58.46 -41.09 84.38 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.884 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.949 HD13 ' HG2' ' A' ' 102' ' ' ARG . 51.0 mm -68.8 -54.87 18.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.522 -178.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.478 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 31.4 p -57.77 -50.33 73.61 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.733 ' CD1' HD12 ' A' ' 120' ' ' LEU . 20.6 tt -60.07 -43.9 93.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.609 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.856 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 23.3 pt20 -66.97 -37.42 84.21 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.231 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.637 ' HA ' ' OD1' ' A' ' 135' ' ' ASP . 8.5 t-160 -56.04 -47.11 78.48 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.692 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 3.8 mm-40 -60.68 -43.03 98.21 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.711 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 1.028 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 76.2 mtp -61.0 -49.49 77.24 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.453 0.569 . . . . 0.0 111.66 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.876 ' O ' HG13 ' A' ' 138' ' ' VAL . 6.6 p-10 -65.18 -45.85 83.19 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.552 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.466 ' HD2' ' NE2' ' A' ' 132' ' ' HIS . 18.3 t-80 -59.67 -52.34 65.93 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 121.9 -0.5 . . . . 0.0 112.035 -178.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.897 HD21 HG22 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -62.51 -29.41 70.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.656 -177.206 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.946 HG12 ' HG2' ' A' ' 140' ' ' LYS . 8.4 p -81.15 21.56 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 CA-C-O 123.067 1.413 . . . . 0.0 107.816 173.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.774 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 56.16 24.7 44.93 Favored Glycine 0 CA--C 1.487 -1.7 0 CA-C-N 111.934 -2.394 . . . . 0.0 112.587 176.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.946 ' HG2' HG12 ' A' ' 138' ' ' VAL . 6.2 ptmt . . . . . 0 N--CA 1.427 -1.576 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.435 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.408 HG12 ' CB ' ' A' ' 40' ' ' ALA . 21.7 m . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.121 0.486 . . . . 0.0 111.771 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.85 HD22 ' HB ' ' A' ' 51' ' ' VAL . 61.5 tp -77.45 162.37 27.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.374 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -78.82 106.48 10.86 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.251 0.548 . . . . 0.0 110.282 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.567 ' CG2' HG23 ' A' ' 37' ' ' THR . 33.4 t -89.93 131.69 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.788 -178.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.914 HD11 ' HA ' ' A' ' 52' ' ' ASP . 39.1 mt -89.49 149.35 22.95 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.135 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.559 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 1.9 m80 -124.37 149.79 46.26 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.655 HD12 ' CB ' ' A' ' 92' ' ' SER . 2.9 mp -55.81 145.54 51.71 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.835 178.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -92.35 51.19 1.06 Allowed 'Cis proline' 0 C--N 1.355 0.916 0 C-N-CA 124.572 -1.012 . . . . 0.0 112.915 0.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.691 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 9.9 t70 -55.65 130.86 44.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.896 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -59.17 -40.13 84.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.016 0.436 . . . . 0.0 111.139 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.686 ' HB2' HD13 ' A' ' 6' ' ' LEU . 19.0 mmt-85 -57.65 -26.07 61.09 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.645 0.979 . . . . 0.0 113.645 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.691 ' HG ' ' HB3' ' A' ' 10' ' ' ASP . 8.8 mt -76.21 -33.24 59.26 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 120.61 1.55 . . . . 0.0 108.434 177.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.417 ' C ' ' HA3' ' A' ' 139' ' ' GLY . 32.1 mmt180 -91.82 7.99 39.28 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.631 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.757 ' HZ2' ' CG ' ' A' ' 54' ' ' HIS . 87.8 tttt -88.3 148.39 24.33 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.089 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.677 HG13 HG21 ' A' ' 138' ' ' VAL . 97.1 t -82.68 128.79 38.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.765 ' HB2' ' CG ' ' A' ' 56' ' ' ARG . . . -86.24 143.57 27.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.394 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.814 ' HD3' ' HD2' ' A' ' 19' ' ' PRO . 7.6 tmtt? -106.33 130.16 23.39 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.913 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 60.9 Cg_endo -78.14 116.47 3.93 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.342 2.028 . . . . 0.0 111.26 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.632 HG11 ' N ' ' A' ' 21' ' ' GLU . 19.3 t -67.08 144.7 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-O 122.803 1.287 . . . . 0.0 113.14 -175.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.632 ' N ' HG11 ' A' ' 20' ' ' VAL . 97.9 mt-10 -62.96 -24.51 67.92 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 112.57 -2.105 . . . . 0.0 112.68 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -161.01 143.52 12.54 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.975 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.823 HG23 HD23 ' A' ' 111' ' ' LEU . 3.3 t -79.55 107.7 12.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 1.034 ' H ' HD11 ' A' ' 27' ' ' ILE . 57.4 m-80 -98.06 158.51 15.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.686 -178.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.722 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -55.72 -23.82 31.21 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.215 0.531 . . . . 0.0 110.678 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.469 ' HA ' ' OE1' ' A' ' 26' ' ' GLU . 4.3 mm-40 -74.05 -41.83 61.18 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 176.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 1.034 HD11 ' H ' ' A' ' 24' ' ' ASN . 69.0 mt -64.01 -48.24 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.245 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -57.15 -40.06 76.48 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.722 ' HG3' ' O ' ' A' ' 25' ' ' ALA . 99.3 mtt180 -61.76 -39.8 92.93 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.771 HG22 HD11 ' A' ' 53' ' ' ILE . 4.1 mt -56.91 -50.01 77.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 114.832 -1.076 . . . . 0.0 112.075 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.827 HG11 ' CG2' ' A' ' 71' ' ' VAL . 10.5 t -68.58 -42.16 83.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 120.842 0.353 . . . . 0.0 111.432 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.776 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -55.76 -39.48 71.26 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.33 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.509 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 31.6 m-20 -76.07 -30.45 58.35 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.985 175.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.714 ' HG3' ' O ' ' A' ' 30' ' ' ILE . 15.2 mtm -60.58 -46.66 89.42 Favored 'General case' 0 C--N 1.347 0.465 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.44 -177.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.776 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 14.0 p90 -69.05 -46.43 67.91 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.542 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 27.2 mm-40 -51.05 -38.57 52.31 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.567 HG23 ' CG2' ' A' ' 5' ' ' VAL . 57.5 m -69.83 -62.31 1.44 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 118.725 -1.19 . . . . 0.0 108.272 177.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.987 ' HE3' ' HB2' ' A' ' 61' ' ' ASP . 2.9 ttp -46.58 -44.25 17.9 Favored 'General case' 0 CA--C 1.458 -2.578 0 C-N-CA 124.016 0.926 . . . . 0.0 110.412 -170.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.708 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 70.0 m-85 -67.67 -41.73 83.24 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.794 178.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.408 ' CB ' HG12 ' A' ' 2' ' ' VAL . . . -60.38 -26.67 66.82 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.773 0.796 . . . . 0.0 109.038 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 1.121 ' HG2' HD11 ' A' ' 91' ' ' LEU . 2.6 tp10 -86.74 -10.89 52.63 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 114.361 -1.29 . . . . 0.0 109.155 177.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 63.94 26.6 14.22 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.107 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.56 144.49 25.54 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.111 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 1.033 HG21 HG23 ' A' ' 62' ' ' VAL . 46.0 mm -79.25 -3.93 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 117.631 0.715 . . . . 0.0 112.141 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.523 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 179.19 137.9 3.07 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-O 119.109 -0.828 . . . . 0.0 111.302 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 1.022 HD12 ' HG ' ' A' ' 91' ' ' LEU . 2.3 tp -124.39 135.22 53.12 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.285 1.542 . . . . 0.0 110.828 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -103.68 130.62 51.18 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 122.085 -0.384 . . . . 0.0 111.299 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.577 ' O ' HG21 ' A' ' 51' ' ' VAL . . . -28.51 -57.99 0.13 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 116.647 2.092 . . . . 0.0 116.647 -177.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 74.9 p -53.42 -34.69 58.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 122.098 0.951 . . . . 0.0 111.478 -177.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.67 ' HB2' HD11 ' A' ' 46' ' ' LEU . 23.2 mt-30 -63.56 -38.47 91.26 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 113.929 -1.487 . . . . 0.0 110.686 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.85 ' HB ' HD22 ' A' ' 3' ' ' LEU . 1.5 m -92.52 19.44 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.914 ' HA ' HD11 ' A' ' 6' ' ' LEU . 37.5 t70 78.25 25.99 0.58 Allowed 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 176.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.82 HD13 ' HB ' ' A' ' 57' ' ' ILE . 11.9 pt -120.36 108.56 23.38 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.131 177.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.757 ' CG ' ' HZ2' ' A' ' 15' ' ' LYS . 7.8 p80 -75.41 51.2 0.56 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-O 122.16 0.981 . . . . 0.0 109.905 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.533 ' O ' HG12 ' A' ' 57' ' ' ILE . 83.2 mt-30 -139.01 132.52 30.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 113.892 -1.504 . . . . 0.0 107.716 178.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.913 ' HD2' ' HD3' ' A' ' 19' ' ' PRO . 96.0 mtt180 -61.79 72.52 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -178.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.82 ' HB ' HD13 ' A' ' 53' ' ' ILE . 10.3 mm -116.35 122.75 70.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.944 HD12 ' HB2' ' A' ' 72' ' ' LEU . 1.8 pp -127.0 145.4 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 -177.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.641 HG22 ' H ' ' A' ' 46' ' ' LEU . 33.9 m -128.71 134.95 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.362 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 1.058 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 1.6 mt -116.54 145.45 22.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.504 0.669 . . . . 0.0 110.344 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.987 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 28.0 t70 -124.69 16.29 8.75 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.391 -178.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 1.033 HG23 HG21 ' A' ' 44' ' ' ILE . 29.8 t . . . . . 0 C--N 1.332 -0.155 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.598 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.552 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 35.5 ttt85 . . . . . 0 N--CA 1.465 0.319 0 CA-C-O 120.847 0.356 . . . . 0.0 110.83 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 1.058 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 63.8 mt -102.69 135.16 44.84 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.827 ' CG2' HG11 ' A' ' 31' ' ' VAL . 12.5 p -134.74 130.5 52.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.083 178.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.944 ' HB2' HD12 ' A' ' 58' ' ' ILE . 90.6 mt -141.37 142.2 33.78 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.59 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 1.021 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.6 mp -121.27 134.87 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-O 120.652 0.263 . . . . 0.0 110.901 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.686 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 7.2 m120 57.02 37.56 0.38 Allowed Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.89 ' HG2' HG12 ' A' ' 58' ' ' ILE . 88.4 Cg_exo -56.59 145.72 79.48 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 122.838 2.359 . . . . 0.0 114.101 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.468 ' CG ' ' HB2' ' A' ' 109' ' ' ARG . 15.2 pt-20 -136.89 142.22 42.75 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.955 HD22 ' HZ2' ' A' ' 80' ' ' LYS . 1.7 tt -81.84 133.27 35.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.375 0.607 . . . . 0.0 111.753 -178.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.995 HD23 ' HE ' ' A' ' 109' ' ' ARG . 4.8 mp -108.82 -39.14 5.43 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.997 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.486 ' O ' HD23 ' A' ' 77' ' ' LEU . 42.4 tt0 -156.36 152.83 28.06 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 121.192 0.52 . . . . 0.0 111.764 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.955 ' HZ2' HD22 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -147.28 149.81 33.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.936 179.385 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.3 p -160.07 152.94 21.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.79 0.329 . . . . 0.0 111.571 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.676 ' C ' ' HG3' ' A' ' 104' ' ' GLU . . . 73.63 146.33 0.92 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.749 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.98 112.62 24.58 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 121.631 0.729 . . . . 0.0 111.229 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 1.045 HG21 ' HG2' ' A' ' 104' ' ' GLU . 1.6 p -114.81 160.94 18.86 Favored 'General case' 0 CA--C 1.484 -1.595 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.759 ' HA3' HD22 ' A' ' 99' ' ' LEU . . . -155.83 123.26 1.3 Allowed Glycine 0 C--N 1.311 -0.855 0 CA-C-N 113.01 -1.904 . . . . 0.0 110.95 178.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.449 ' N ' ' HG ' ' A' ' 99' ' ' LEU . 34.4 mt -147.34 139.18 18.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-N 117.643 0.722 . . . . 0.0 111.834 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 56.1 mt-10 -71.23 135.15 47.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 123.538 1.637 . . . . 0.0 112.349 -176.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.699 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 41.0 mt-10 -154.24 166.61 32.61 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 112.132 -2.304 . . . . 0.0 111.425 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.778 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -120.73 163.3 14.32 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.734 ' HB2' ' CG1' ' A' ' 93' ' ' ILE . 65.1 m -109.64 137.42 47.49 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.865 0.364 . . . . 0.0 110.926 -177.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 1.121 HD11 ' HG2' ' A' ' 41' ' ' GLU . 3.1 mm? -51.53 -38.66 55.24 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.73 0.776 . . . . 0.0 109.719 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.655 ' CB ' HD12 ' A' ' 8' ' ' ILE . 22.8 m -77.12 -26.66 53.45 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.59 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.734 ' CG1' ' HB2' ' A' ' 90' ' ' CYS . 53.1 mt . . . . . 0 CA--C 1.533 0.293 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.778 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 18.4 mtm105 . . . . . 0 N--CA 1.464 0.248 0 CA-C-O 121.852 0.834 . . . . 0.0 111.638 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 87' ' ' GLU . . . -135.15 155.55 50.51 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.273 -1.33 . . . . 0.0 109.22 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.759 HD22 ' HA3' ' A' ' 85' ' ' GLY . 7.5 tt -76.52 110.86 11.42 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.828 0.823 . . . . 0.0 111.532 -177.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.794 ' HB ' ' CZ ' ' A' ' 102' ' ' ARG . 40.3 t -98.4 126.16 40.53 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 114.415 -1.266 . . . . 0.0 112.021 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 84' ' ' THR . 81.7 Cg_endo -78.84 126.55 7.31 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.318 2.012 . . . . 0.0 112.277 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.857 ' HB2' ' OE1' ' A' ' 131' ' ' GLN . 0.0 OUTLIER -145.03 166.77 24.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.637 179.011 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.59 154.94 40.95 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.208 0.527 . . . . 0.0 110.283 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 1.045 ' HG2' HG21 ' A' ' 84' ' ' THR . 50.0 mt-10 -73.61 -42.19 61.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.645 -176.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 1.042 ' HZ1' ' HB3' ' A' ' 123' ' ' ASP . 66.5 mttm -140.41 139.62 35.3 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.801 HG13 ' CB ' ' A' ' 80' ' ' LYS . 28.7 m -149.98 141.63 17.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.437 -178.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.671 ' CE ' ' HB3' ' A' ' 121' ' ' GLU . 0.4 OUTLIER -107.65 125.15 51.0 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.46 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.736 ' HA ' ' CD1' ' A' ' 78' ' ' LEU . 1.4 pp -135.42 151.8 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -176.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.995 ' HE ' HD23 ' A' ' 78' ' ' LEU . 94.2 mtt180 -100.81 138.54 37.73 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 122.214 1.007 . . . . 0.0 111.128 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.707 ' HB2' ' HB3' ' A' ' 72' ' ' LEU . . . -158.8 169.35 24.57 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.759 -176.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 1.021 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.9 pp -120.27 154.78 34.46 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.587 ' O ' HD13 ' A' ' 111' ' ' LEU . 25.1 t70 -88.15 164.43 15.69 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.443 0.64 . . . . 0.0 111.991 -176.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.806 ' HB2' HG12 ' A' ' 71' ' ' VAL . 24.6 ttm180 -52.62 -20.29 2.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.055 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -81.88 -22.22 37.0 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.03 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.635 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 105.11 35.86 3.06 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 119.893 -1.146 . . . . 0.0 113.857 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -128.62 102.4 20.16 Favored Pre-proline 0 C--O 1.235 0.325 0 CA-C-N 117.344 0.572 . . . . 0.0 111.185 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.58 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 36.4 Cg_exo -74.03 116.72 4.75 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 121.914 1.743 . . . . 0.0 115.715 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.427 ' N ' ' O ' ' A' ' 110' ' ' ALA . 0.5 OUTLIER -129.04 165.78 20.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.418 -179.278 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.819 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 5.8 mp0 -107.72 135.19 49.56 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.877 ' O ' HD23 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -132.39 142.26 49.22 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.679 0.752 . . . . 0.0 111.911 -179.137 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.671 ' HB3' ' CE ' ' A' ' 107' ' ' LYS . 15.2 pt-20 -94.13 123.44 37.51 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.877 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.871 ' CB ' ' HG ' ' A' ' 126' ' ' LEU . . . -115.85 134.47 54.96 Favored 'General case' 0 C--O 1.22 -0.489 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.572 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 1.042 ' HB3' ' HZ1' ' A' ' 105' ' ' LYS . 38.7 m-20 -127.04 162.19 26.64 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.758 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 48.42 -134.77 19.25 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 120.436 1.471 . . . . 0.0 115.491 177.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.913 ' H ' HD21 ' A' ' 125' ' ' LEU . 2.6 mm? -53.84 -35.17 61.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.052 -0.574 . . . . 0.0 111.34 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.871 ' HG ' ' CB ' ' A' ' 122' ' ' ALA . 3.7 tp -70.22 -52.34 23.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.372 0.606 . . . . 0.0 109.81 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.719 ' HB3' ' CA ' ' A' ' 123' ' ' ASP . . . -58.93 -42.94 90.91 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.328 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.758 HG12 ' O ' ' A' ' 124' ' ' GLY . 47.1 mm -67.17 -56.11 14.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 31.4 p -56.47 -50.21 72.4 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.619 HG21 ' N ' ' A' ' 131' ' ' GLN . 19.1 tt -58.91 -44.24 90.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.155 -178.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.857 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 23.1 pt20 -68.16 -37.77 81.38 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.071 178.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.72 ' HA ' ' OD2' ' A' ' 135' ' ' ASP . 10.9 t-160 -56.58 -50.0 73.23 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.57 0.7 . . . . 0.0 110.105 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.934 ' O ' HD22 ' A' ' 137' ' ' LEU . 3.2 mm-40 -60.1 -42.24 94.27 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.576 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.875 ' HA ' HD21 ' A' ' 137' ' ' LEU . 74.2 mtp -57.18 -48.74 77.99 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.279 0.562 . . . . 0.0 111.059 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.89 ' O ' HG13 ' A' ' 138' ' ' VAL . 3.3 p30 -66.38 -46.53 76.35 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.416 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.608 ' CE1' ' HG2' ' A' ' 50' ' ' GLN . 10.7 t-80 -56.12 -51.46 67.84 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.489 0.661 . . . . 0.0 110.768 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.934 HD22 ' O ' ' A' ' 133' ' ' GLU . 1.2 pp -61.35 -30.16 70.35 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.955 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.946 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 14.6 p -86.58 25.94 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-O 122.292 1.044 . . . . 0.0 109.549 176.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.598 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 59.32 15.31 30.43 Favored Glycine 0 CA--C 1.49 -1.511 0 CA-C-N 113.395 -1.73 . . . . 0.0 113.359 176.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.946 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 9.9 ptmt . . . . . 0 N--CA 1.424 -1.746 0 C-N-CA 119.617 -0.833 . . . . 0.0 108.932 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.532 ' CG1' HG21 ' A' ' 37' ' ' THR . 43.2 t . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.952 0.406 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.852 HD21 ' HB ' ' A' ' 51' ' ' VAL . 58.5 tp -77.11 165.74 24.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.404 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -78.82 107.11 11.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.084 0.469 . . . . 0.0 110.271 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.55 ' CG2' HG23 ' A' ' 37' ' ' THR . 39.0 t -89.69 131.58 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.652 -178.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 1.029 ' HB2' HD22 ' A' ' 13' ' ' LEU . 16.7 mt -93.52 141.33 28.59 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.497 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 35.2 m-70 -117.92 145.29 44.77 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.873 HG12 ' CB ' ' A' ' 92' ' ' SER . 49.8 mm -61.0 133.56 92.58 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.229 177.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.66 145.35 69.87 Favored 'Cis proline' 0 C--N 1.353 0.779 0 C-N-CA 124.51 -1.037 . . . . 0.0 111.951 -0.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.968 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 8.8 t70 -165.04 127.1 2.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.402 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 16.1 pt-20 -58.44 -45.79 87.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.658 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.578 ' HB2' HD13 ' A' ' 6' ' ' LEU . 15.1 mmt85 -56.59 -27.97 59.21 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 1.029 HD22 ' HB2' ' A' ' 6' ' ' LEU . 10.0 mt -77.01 -35.09 57.3 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 120.585 1.539 . . . . 0.0 107.972 177.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.76 ' NH1' ' HB3' ' A' ' 14' ' ' ARG . 2.1 mmm180 -89.2 11.18 19.48 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.802 -1.545 . . . . 0.0 109.395 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.719 ' HD3' ' HB3' ' A' ' 54' ' ' HIS . 59.5 tttp -85.6 137.71 32.67 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.568 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.674 ' CG1' HG23 ' A' ' 138' ' ' VAL . 58.4 t -84.1 94.4 3.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.237 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.597 ' HB2' ' CG ' ' A' ' 56' ' ' ARG . . . -54.0 148.31 10.95 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -106.43 132.73 20.66 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.798 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.651 ' HD3' ' CD ' ' A' ' 56' ' ' ARG . 66.1 Cg_endo -78.2 114.72 3.61 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.174 1.916 . . . . 0.0 110.684 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.621 HG12 ' N ' ' A' ' 21' ' ' GLU . 17.8 t -69.14 144.4 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-O 122.521 1.153 . . . . 0.0 113.126 -175.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.621 ' N ' HG12 ' A' ' 20' ' ' VAL . 97.1 mt-10 -63.47 -24.55 67.87 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 113.311 -1.768 . . . . 0.0 111.867 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.49 ' O ' HG13 ' A' ' 20' ' ' VAL . 42.4 tt0 -161.16 140.71 10.51 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.864 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.829 HG22 HD11 ' A' ' 111' ' ' LEU . 2.8 t -78.96 110.95 15.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 1.03 ' H ' HD13 ' A' ' 27' ' ' ILE . 60.8 m-80 -92.98 163.3 13.72 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.613 0.244 . . . . 0.0 110.995 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.586 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -56.04 -30.67 62.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.993 0.425 . . . . 0.0 110.819 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.572 ' O ' HD12 ' A' ' 30' ' ' ILE . 55.7 mt-10 -71.72 -40.07 69.71 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 1.03 HD13 ' H ' ' A' ' 24' ' ' ASN . 58.3 mt -62.7 -46.64 95.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.911 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.551 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 13.1 mt-30 -57.92 -39.23 77.49 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.597 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.586 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 41.0 mmt-85 -60.16 -40.98 91.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.864 0.84 . . . . 0.0 108.987 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.807 ' O ' ' HG3' ' A' ' 34' ' ' MET . 1.6 mp -58.89 -48.61 85.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 114.455 -1.248 . . . . 0.0 112.119 179.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.769 HG11 ' CG2' ' A' ' 71' ' ' VAL . 6.5 t -68.33 -41.81 83.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-O 120.845 0.355 . . . . 0.0 111.448 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.846 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -55.27 -42.36 73.48 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.526 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.515 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 56.8 m-20 -75.95 -30.18 58.58 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.632 176.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.826 ' HG2' HG23 ' A' ' 51' ' ' VAL . 83.7 mtp -59.86 -47.09 87.15 Favored 'General case' 0 C--N 1.347 0.473 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.531 -177.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.846 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 14.4 p90 -69.49 -44.28 71.44 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.776 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 76.6 mt-10 -51.78 -40.66 60.72 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.55 HG23 ' CG2' ' A' ' 5' ' ' VAL . 41.8 m -68.84 -61.92 1.6 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.576 -1.193 . . . . 0.0 107.864 178.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.944 ' HE3' ' HB2' ' A' ' 61' ' ' ASP . 2.8 ttp -46.11 -41.72 12.76 Favored 'General case' 0 CA--C 1.458 -2.581 0 C-N-CA 124.103 0.961 . . . . 0.0 110.21 -170.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.713 ' OH ' ' HA ' ' A' ' 69' ' ' ARG . 48.2 m-85 -69.22 -41.79 76.58 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.328 178.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.483 ' CB ' HG22 ' A' ' 2' ' ' VAL . . . -61.0 -27.45 68.32 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.611 0.72 . . . . 0.0 109.139 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.984 ' HG2' HD12 ' A' ' 91' ' ' LEU . 10.5 tp10 -85.53 -10.69 55.64 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.795 176.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 62.21 28.62 17.15 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.859 0.838 . . . . 0.0 109.95 -176.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -83.43 143.41 21.76 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 114.0 -1.455 . . . . 0.0 111.122 178.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 1.026 HG21 HG22 ' A' ' 62' ' ' VAL . 47.7 mt -78.98 -2.54 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 117.709 0.754 . . . . 0.0 111.976 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.466 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 179.83 133.59 2.03 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-O 119.102 -0.832 . . . . 0.0 111.606 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 1.025 HD12 ' HG ' ' A' ' 91' ' ' LEU . 4.1 tp -124.56 134.55 52.94 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 119.063 1.432 . . . . 0.0 111.329 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -101.06 129.69 46.97 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.644 ' O ' HG21 ' A' ' 51' ' ' VAL . . . -27.21 -56.82 0.09 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 116.099 1.889 . . . . 0.0 116.099 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.669 HG23 ' O ' ' A' ' 137' ' ' LEU . 70.1 p -53.54 -34.38 58.01 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.8 0.81 . . . . 0.0 111.727 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.794 ' NE2' HD23 ' A' ' 91' ' ' LEU . 85.1 mt-30 -64.56 -40.9 96.4 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.347 -1.297 . . . . 0.0 109.947 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.852 ' HB ' HD21 ' A' ' 3' ' ' LEU . 1.0 OUTLIER -87.86 15.73 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.98 ' HA ' HD11 ' A' ' 6' ' ' LEU . 38.2 t70 77.51 33.06 0.41 Allowed 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 176.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.808 HD11 ' O ' ' A' ' 55' ' ' GLN . 1.1 pp -125.93 110.45 23.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 119.155 -1.018 . . . . 0.0 110.301 177.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.719 ' HB3' ' HD3' ' A' ' 15' ' ' LYS . 0.5 OUTLIER -75.91 63.53 1.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.472 -179.109 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.808 ' O ' HD11 ' A' ' 53' ' ' ILE . 69.1 mt-30 -154.53 133.85 12.58 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 114.196 -1.365 . . . . 0.0 108.535 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.784 ' HA ' HD11 ' A' ' 137' ' ' LEU . 54.3 mtp85 -64.37 72.46 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -177.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.784 ' O ' ' HE1' ' A' ' 34' ' ' MET . 7.1 mm -115.27 125.03 72.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.914 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 2.1 pp -131.28 147.77 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.578 HG22 ' H ' ' A' ' 46' ' ' LEU . 33.4 m -127.72 139.74 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.485 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.994 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 7.4 mm -115.11 151.41 16.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.692 0.758 . . . . 0.0 110.033 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.944 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 10.7 t70 -138.99 39.88 2.14 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.079 -178.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 1.026 HG22 HG21 ' A' ' 44' ' ' ILE . 33.1 t . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.359 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.713 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 72.9 ttt180 . . . . . 0 N--CA 1.467 0.413 0 CA-C-O 120.5 0.191 . . . . 0.0 111.413 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.994 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 6.1 mp -102.47 132.54 48.44 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.911 HG23 ' HB2' ' A' ' 113' ' ' ARG . 9.6 p -133.91 131.05 56.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.367 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.914 ' HB2' ' CD1' ' A' ' 58' ' ' ILE . 93.5 mt -141.16 139.04 33.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.924 -0.125 . . . . 0.0 110.999 178.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.992 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.7 mp -119.53 135.71 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-O 120.595 0.236 . . . . 0.0 110.944 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.688 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 8.1 m120 55.17 34.68 0.25 Allowed Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.822 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 88.8 Cg_exo -55.91 148.02 59.46 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.649 2.233 . . . . 0.0 113.482 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.426 ' HG3' HD13 ' A' ' 78' ' ' LEU . 15.6 pt-20 -136.93 143.28 42.82 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 1.022 HD11 ' HZ1' ' A' ' 80' ' ' LYS . 1.7 tt -80.47 135.04 36.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.782 0.801 . . . . 0.0 111.544 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.877 ' N ' HD21 ' A' ' 77' ' ' LEU . 7.3 mp -110.45 -40.2 4.7 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.335 -1.302 . . . . 0.0 112.062 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.526 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 42.2 tt0 -160.34 154.0 22.5 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.179 0.514 . . . . 0.0 111.538 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 1.022 ' HZ1' HD11 ' A' ' 77' ' ' LEU . 9.6 ptpp? -147.83 150.63 34.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.212 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.5 t -160.58 144.65 13.9 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.548 0.213 . . . . 0.0 110.958 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.774 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 81.24 169.85 42.6 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.85 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 102' ' ' ARG . 87.9 tt0 -147.38 113.6 5.88 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 117.788 0.794 . . . . 0.0 113.116 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.604 ' HG1' HD12 ' A' ' 128' ' ' ILE . 1.4 p -98.72 159.9 14.63 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.646 ' CA ' HD22 ' A' ' 99' ' ' LEU . . . -137.87 103.02 0.4 Allowed Glycine 0 C--N 1.317 -0.528 0 CA-C-N 113.193 -1.821 . . . . 0.0 112.1 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.695 ' HB ' ' NH2' ' A' ' 102' ' ' ARG . 21.2 mt -147.07 138.92 18.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 56.3 mt-10 -71.09 143.47 50.63 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 122.682 1.229 . . . . 0.0 112.211 -178.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.633 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 93.3 mt-10 -157.8 161.45 38.41 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.581 -1.645 . . . . 0.0 109.754 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.855 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -120.24 159.11 15.24 Favored Glycine 0 CA--C 1.501 -0.809 0 C-N-CA 119.44 -1.362 . . . . 0.0 110.184 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 16.4 m -112.9 138.35 49.89 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.61 0.719 . . . . 0.0 112.207 -177.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 1.025 ' HG ' HD12 ' A' ' 46' ' ' LEU . 2.3 mm? -48.96 -23.37 1.1 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.375 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.873 ' CB ' HG12 ' A' ' 8' ' ' ILE . 52.7 m -83.89 -34.98 24.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.158 0.504 . . . . 0.0 110.566 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.576 HD13 ' HB ' ' A' ' 8' ' ' ILE . 45.2 mm . . . . . 0 N--CA 1.45 -0.462 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.418 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.855 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 18.2 mtm105 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 121.759 0.79 . . . . 0.0 111.87 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.463 ' C ' ' HA ' ' A' ' 87' ' ' GLU . . . -134.53 154.28 51.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.353 -1.294 . . . . 0.0 109.993 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.707 HD23 ' N ' ' A' ' 100' ' ' VAL . 6.5 tt -74.9 136.29 41.45 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.707 ' N ' HD23 ' A' ' 99' ' ' LEU . 21.0 t -133.46 137.9 30.07 Favored Pre-proline 0 N--CA 1.454 -0.237 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.529 -178.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.693 ' HD2' HG13 ' A' ' 100' ' ' VAL . 90.5 Cg_endo -85.66 125.31 2.82 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 121.704 1.603 . . . . 0.0 113.574 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.774 ' HG3' HG23 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -142.05 166.29 25.11 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 113.627 -1.624 . . . . 0.0 110.684 178.643 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.774 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.47 156.05 38.7 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 120.649 0.261 . . . . 0.0 110.519 -178.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -73.2 -44.55 59.55 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.505 -176.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.805 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 81.4 mttt -139.61 138.14 35.91 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 121.658 0.742 . . . . 0.0 109.694 177.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.852 HG12 ' CB ' ' A' ' 80' ' ' LYS . 33.8 m -139.85 138.23 38.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.939 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 1.08 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 53.2 mmtt -107.5 125.72 51.62 Favored 'General case' 0 C--O 1.224 -0.27 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.777 ' CD1' HD11 ' A' ' 130' ' ' ILE . 1.8 pp -131.23 162.97 38.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -177.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.868 ' CG ' HD22 ' A' ' 78' ' ' LEU . 94.9 mtt180 -112.05 139.01 47.92 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.998 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.701 ' HB2' ' HG3' ' A' ' 75' ' ' PRO . . . -158.06 167.3 30.25 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 120.729 0.3 . . . . 0.0 111.095 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.992 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.4 pp -115.48 153.97 30.17 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 177.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.571 ' O ' HD12 ' A' ' 111' ' ' LEU . 10.3 t70 -90.77 163.27 14.52 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.581 -177.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.911 ' HB2' HG23 ' A' ' 71' ' ' VAL . 46.3 ttp180 -51.6 -19.21 1.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.101 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -78.99 -26.67 43.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.532 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.35 35.0 2.77 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.132 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.686 ' HB3' ' HZ3' ' A' ' 116' ' ' LYS . 6.6 mtpm? -128.76 102.83 19.47 Favored Pre-proline 0 C--O 1.238 0.488 0 CA-C-N 116.799 0.3 . . . . 0.0 111.167 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 34.2 Cg_exo -74.14 116.56 4.68 Favored 'Trans proline' 0 C--N 1.36 1.164 0 C-N-CA 122.009 1.806 . . . . 0.0 114.903 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.0 167.92 14.65 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.32 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.708 ' HG2' ' HG2' ' A' ' 109' ' ' ARG . 78.9 mt-10 -107.68 129.99 54.97 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.953 0.406 . . . . 0.0 109.974 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.71 ' CD2' HD13 ' A' ' 72' ' ' LEU . 4.1 pp -127.19 132.91 50.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.347 0.594 . . . . 0.0 112.084 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 1.08 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 23.0 pt-20 -92.0 125.63 36.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.527 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.848 ' O ' ' HB3' ' A' ' 127' ' ' ALA . . . -116.08 135.56 53.83 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.805 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.1 m-20 -126.82 163.62 23.18 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.754 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 46.92 -135.5 10.78 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-N 119.787 1.176 . . . . 0.0 115.811 177.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.717 ' H ' HD21 ' A' ' 125' ' ' LEU . 1.6 pt? -54.73 -32.57 59.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.563 -0.819 . . . . 0.0 111.674 -178.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.651 HD11 ' C ' ' A' ' 126' ' ' LEU . 0.5 OUTLIER -70.89 -53.9 13.42 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.743 179.88 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.848 ' HB3' ' O ' ' A' ' 122' ' ' ALA . . . -58.92 -42.87 90.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.492 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.774 HG23 ' HG3' ' A' ' 102' ' ' ARG . 49.7 mm -62.52 -55.05 26.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.43 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.686 ' HG ' ' CG2' ' A' ' 62' ' ' VAL . 30.4 p -60.47 -51.57 68.92 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.777 HD11 ' CD1' ' A' ' 108' ' ' ILE . 20.8 tt -60.08 -42.06 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 111.445 0.165 . . . . 0.0 111.445 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.675 ' HG2' ' O ' ' A' ' 127' ' ' ALA . 20.9 pt20 -67.24 -41.68 85.23 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -57.83 -44.8 86.7 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.672 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.842 ' O ' HD21 ' A' ' 137' ' ' LEU . 3.8 mm-40 -60.45 -45.37 93.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 118.902 -0.57 . . . . 0.0 111.814 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.921 ' HA ' HD23 ' A' ' 137' ' ' LEU . 36.9 mtm -56.7 -47.69 79.36 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 119.06 0.845 . . . . 0.0 109.913 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.857 ' O ' HG12 ' A' ' 138' ' ' VAL . 30.9 m-20 -61.83 -49.17 77.37 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.98 178.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.44 ' CE1' ' CG ' ' A' ' 50' ' ' GLN . 12.2 t-80 -56.27 -51.81 66.79 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 121.739 -0.601 . . . . 0.0 110.908 -179.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.921 HD23 ' HA ' ' A' ' 134' ' ' MET . 1.3 pp -60.4 -30.93 69.91 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.481 -0.782 . . . . 0.0 111.775 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.857 HG12 ' O ' ' A' ' 135' ' ' ASP . 14.9 p -80.49 21.05 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 CA-C-O 123.208 1.48 . . . . 0.0 108.947 175.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.841 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 69.27 -2.37 9.98 Favored Glycine 0 CA--C 1.492 -1.377 0 CA-C-N 111.723 -2.49 . . . . 0.0 112.452 176.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.744 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 1.3 ptmt . . . . . 0 N--CA 1.428 -1.525 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.749 HG12 ' HA ' ' A' ' 37' ' ' THR . 31.5 m . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.779 0.324 . . . . 0.0 111.378 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 1.034 HD23 HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -79.09 -141.25 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -112.2 106.83 15.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.953 0.406 . . . . 0.0 110.617 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.733 HG11 HD11 ' A' ' 91' ' ' LEU . 48.2 t -89.19 126.23 42.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.518 0.675 . . . . 0.0 111.47 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.993 ' HB2' HD23 ' A' ' 13' ' ' LEU . 23.1 mt -83.49 141.99 31.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.603 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.772 ' HA ' ' HB3' ' A' ' 92' ' ' SER . 1.7 m80 -111.48 145.48 38.94 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.959 HD12 HD12 ' A' ' 13' ' ' LEU . 42.5 mm -57.77 145.41 70.77 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.279 178.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.427 ' CA ' HG23 ' A' ' 8' ' ' ILE . 73.8 Cg_endo -92.14 51.68 1.02 Allowed 'Cis proline' 0 C--N 1.353 0.81 0 C-N-CA 124.442 -1.066 . . . . 0.0 112.942 0.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.877 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 9.4 t0 -52.72 134.64 36.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.951 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -58.62 -44.75 90.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.514 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.665 ' HB2' HD11 ' A' ' 6' ' ' LEU . 11.3 mtt85 -58.91 -24.19 62.1 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 1.013 HD11 ' HG ' ' A' ' 92' ' ' SER . 11.6 mt -75.42 -33.13 60.92 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 120.205 1.366 . . . . 0.0 108.3 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 22.8 mmt180 -92.11 8.02 39.79 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 113.841 -1.527 . . . . 0.0 109.397 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.42 ' HD3' ' HB3' ' A' ' 54' ' ' HIS . 88.5 tttt -89.86 148.96 22.86 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.186 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 66.8 t -83.67 126.23 40.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.091 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.802 ' HB2' ' CG ' ' A' ' 56' ' ' ARG . . . -83.53 147.8 27.57 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.297 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.732 ' HD3' ' CD ' ' A' ' 19' ' ' PRO . 5.7 tmtm? -110.48 132.31 21.61 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.79 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 63.6 Cg_endo -77.62 116.14 4.0 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.378 2.052 . . . . 0.0 111.732 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.624 HG12 ' N ' ' A' ' 21' ' ' GLU . 22.0 t -68.01 144.95 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 CA-C-O 122.869 1.319 . . . . 0.0 113.087 -175.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.624 ' N ' HG12 ' A' ' 20' ' ' VAL . 55.6 mt-10 -63.73 -29.4 70.62 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 112.893 -1.958 . . . . 0.0 111.897 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.509 ' O ' HG13 ' A' ' 20' ' ' VAL . 88.8 tt0 -157.11 145.05 19.19 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.8 -178.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.76 HG21 HD13 ' A' ' 111' ' ' LEU . 3.5 t -79.41 105.18 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.814 ' HB2' HG13 ' A' ' 27' ' ' ILE . 2.1 m120 -87.05 153.08 21.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.908 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.456 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -54.57 -30.23 53.69 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.452 0.644 . . . . 0.0 110.207 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -72.82 -37.63 67.42 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.814 HG13 ' HB2' ' A' ' 24' ' ' ASN . 67.7 mt -67.0 -36.36 76.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.355 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -68.33 -39.49 81.92 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.372 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 40.1 mmt180 -64.09 -38.86 92.6 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.768 ' CG2' HD11 ' A' ' 53' ' ' ILE . 2.9 mt -55.7 -49.19 75.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.614 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.645 ' CG1' HG22 ' A' ' 71' ' ' VAL . 19.8 t -66.33 -40.97 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 121.135 0.493 . . . . 0.0 110.941 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.841 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 26.5 m-20 -53.84 -46.27 71.17 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.575 -178.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.504 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 1.5 m-20 -74.54 -30.11 61.63 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.907 176.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.765 ' HG3' ' O ' ' A' ' 30' ' ' ILE . 85.2 mtp -60.21 -46.31 90.18 Favored 'General case' 0 C--N 1.345 0.408 0 C-N-CA 120.566 -0.454 . . . . 0.0 109.841 -176.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.841 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 11.9 p90 -69.79 -44.76 69.41 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.609 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 31.8 mm-40 -53.34 -39.23 63.96 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.799 ' OG1' HD22 ' A' ' 3' ' ' LEU . 76.9 m -70.51 -60.4 2.28 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 118.28 -1.368 . . . . 0.0 108.613 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 1.032 ' HE3' ' HB2' ' A' ' 61' ' ' ASP . 2.6 ttp -46.76 -41.03 14.61 Favored 'General case' 0 CA--C 1.463 -2.378 0 C-N-CA 124.101 0.96 . . . . 0.0 109.958 -172.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.702 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 60.5 m-85 -70.32 -42.06 72.43 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.312 177.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 37' ' ' THR . . . -61.07 -24.86 66.53 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.577 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 1.047 ' HG2' HD21 ' A' ' 91' ' ' LEU . 3.1 tp10 -88.94 -11.19 45.14 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 114.345 -1.298 . . . . 0.0 108.337 177.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 64.11 26.68 14.0 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.7 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.87 142.52 23.5 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 113.89 -1.504 . . . . 0.0 110.596 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 1.0 HG23 HG21 ' A' ' 62' ' ' VAL . 46.1 mm -79.52 1.2 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 117.611 0.706 . . . . 0.0 111.997 -178.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.523 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 176.38 137.86 2.73 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 118.838 -0.979 . . . . 0.0 111.371 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.908 HD23 ' CG1' ' A' ' 51' ' ' VAL . 10.7 tp -126.38 134.54 51.02 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-N 119.505 1.653 . . . . 0.0 111.265 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -98.83 132.15 44.4 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.766 ' O ' HG23 ' A' ' 51' ' ' VAL . . . -31.22 -54.88 0.23 Allowed 'General case' 0 C--N 1.343 0.285 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.558 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 80.6 p -52.86 -36.07 58.53 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.891 0.853 . . . . 0.0 111.031 -177.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 44.1 mt-30 -65.84 -40.56 91.88 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.328 -1.306 . . . . 0.0 110.202 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 1.034 HG13 HD23 ' A' ' 3' ' ' LEU . 1.0 OUTLIER -83.81 16.08 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 179.558 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.905 ' HA ' HD12 ' A' ' 6' ' ' LEU . 36.1 t70 76.93 27.67 0.7 Allowed 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 177.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.837 HD13 ' HB ' ' A' ' 57' ' ' ILE . 13.4 pt -122.26 110.94 28.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 C-N-CA 119.036 -1.066 . . . . 0.0 111.386 177.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.42 ' HB3' ' HD3' ' A' ' 15' ' ' LYS . 7.4 p80 -76.33 52.11 0.74 Allowed 'General case' 0 N--CA 1.46 0.075 0 CA-C-O 122.241 1.019 . . . . 0.0 109.767 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.43 ' O ' HG12 ' A' ' 57' ' ' ILE . 25.7 mt-30 -140.6 132.31 27.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 113.817 -1.538 . . . . 0.0 107.752 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.861 ' HG2' ' CD1' ' A' ' 137' ' ' LEU . 99.1 mtt180 -61.78 68.1 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -178.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.837 ' HB ' HD13 ' A' ' 53' ' ' ILE . 10.9 mm -111.88 121.65 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.898 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 2.2 pp -129.69 145.74 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -177.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.532 HG21 ' H ' ' A' ' 46' ' ' LEU . 32.6 m -126.0 139.88 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.293 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 1.011 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 11.9 mm -115.45 151.88 17.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.688 0.756 . . . . 0.0 110.154 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 1.032 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 34.9 t70 -141.82 37.78 1.63 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.391 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 1.0 HG21 HG23 ' A' ' 44' ' ' ILE . 38.8 t . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.378 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.698 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.497 0 CA-C-O 120.76 0.314 . . . . 0.0 111.671 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 1.011 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 4.0 mm? -103.84 132.64 49.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.937 0.399 . . . . 0.0 111.817 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.717 HG21 ' HB2' ' A' ' 113' ' ' ARG . 12.3 p -134.58 134.46 54.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.226 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.898 ' HB2' ' CD1' ' A' ' 58' ' ' ILE . 3.0 mm? -142.14 146.55 35.47 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.531 -0.174 . . . . 0.0 110.531 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.993 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.8 mp -122.92 136.44 59.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.732 0.301 . . . . 0.0 110.595 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.693 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 6.9 m120 51.65 37.62 0.44 Allowed Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.857 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 91.1 Cg_exo -57.51 148.26 73.7 Favored 'Trans proline' 0 N--CA 1.488 1.152 0 C-N-CA 123.046 2.497 . . . . 0.0 114.302 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -137.49 142.95 41.5 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.735 ' N ' ' HE2' ' A' ' 134' ' ' MET . 10.2 tp -80.28 136.84 36.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.109 0.481 . . . . 0.0 111.015 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.821 ' CD2' ' HG3' ' A' ' 109' ' ' ARG . 2.7 mm? -109.94 -44.48 3.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.068 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.537 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 17.2 tp10 -153.34 144.18 22.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.05 0.452 . . . . 0.0 111.932 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.967 ' HA ' HG13 ' A' ' 106' ' ' VAL . 19.3 ptpt -138.14 142.53 40.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.347 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.1 p -151.75 150.49 30.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.854 0.359 . . . . 0.0 111.052 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.614 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 76.91 143.72 1.64 Allowed Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.524 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -109.87 113.8 26.84 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.81 0.814 . . . . 0.0 111.896 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.992 ' HG1' HD11 ' A' ' 128' ' ' ILE . 1.7 p -117.21 160.99 20.2 Favored 'General case' 0 CA--C 1.487 -1.447 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.737 ' CA ' HD21 ' A' ' 99' ' ' LEU . . . -154.03 124.06 1.5 Allowed Glycine 0 C--N 1.314 -0.69 0 CA-C-N 112.536 -2.12 . . . . 0.0 111.228 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.728 HD11 ' O ' ' A' ' 85' ' ' GLY . 48.8 mm -147.07 137.52 17.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 117.507 0.653 . . . . 0.0 111.46 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 56.0 mt-10 -71.38 139.78 49.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 123.21 1.481 . . . . 0.0 112.606 -176.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.619 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 40.6 mt-10 -155.78 166.25 34.05 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 112.376 -2.193 . . . . 0.0 111.901 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.745 ' N ' ' HG2' ' A' ' 97' ' ' ARG . . . -120.88 168.27 14.04 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 87.3 m -113.46 142.74 45.55 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.34 0.57 . . . . 0.0 111.041 -177.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 1.047 HD21 ' HG2' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -53.36 -15.54 1.05 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.511 -179.417 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 1.013 ' HG ' HD11 ' A' ' 13' ' ' LEU . 4.3 m -100.77 -33.48 10.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.2 0.524 . . . . 0.0 110.471 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.542 ' CG1' HG13 ' A' ' 8' ' ' ILE . 57.4 mt . . . . . 0 CA--C 1.533 0.32 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.586 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.745 ' HG2' ' N ' ' A' ' 89' ' ' GLY . 84.7 mtm180 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 121.142 0.496 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -125.73 148.93 48.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.796 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.737 HD21 ' CA ' ' A' ' 85' ' ' GLY . 7.4 tt -76.08 113.61 13.8 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.979 0.895 . . . . 0.0 111.208 -177.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.906 HG13 ' NE ' ' A' ' 102' ' ' ARG . 14.0 p -103.7 129.21 25.77 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 114.572 -1.194 . . . . 0.0 111.575 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.616 ' HA ' ' O ' ' A' ' 84' ' ' THR . 87.8 Cg_endo -83.55 126.61 4.15 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 122.67 2.247 . . . . 0.0 113.844 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 1.048 ' HG2' HD13 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -143.63 166.96 23.41 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.595 1.158 . . . . 0.0 109.288 179.381 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.646 ' O ' HD12 ' A' ' 128' ' ' ILE . . . -68.18 155.33 39.86 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.914 0.388 . . . . 0.0 110.302 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -73.25 -40.37 64.69 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.483 -175.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.72 ' HB3' ' OD1' ' A' ' 123' ' ' ASP . 96.0 mttt -140.03 140.91 36.3 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 176.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.967 HG13 ' HA ' ' A' ' 80' ' ' LYS . 19.4 m -152.94 141.54 14.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.836 -1.075 . . . . 0.0 112.58 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.891 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 31.9 mmtm -107.52 127.03 53.26 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.88 HD11 HD11 ' A' ' 130' ' ' ILE . 1.8 pp -134.57 150.95 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -176.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.821 ' HG3' ' CD2' ' A' ' 78' ' ' LEU . 43.7 mtm180 -103.42 140.5 37.38 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-O 122.277 1.037 . . . . 0.0 111.602 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.691 ' HB2' ' HB3' ' A' ' 72' ' ' LEU . . . -160.54 168.73 24.41 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.779 -176.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.993 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.3 pp -116.15 151.21 36.1 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.766 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 20.5 t70 -85.53 163.84 18.15 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.742 -176.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.717 ' HB2' HG21 ' A' ' 71' ' ' VAL . 13.2 ttp-105 -52.71 -19.29 2.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.046 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -79.41 -26.12 41.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.434 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.588 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 106.77 35.99 2.68 Favored Glycine 0 C--N 1.34 0.792 0 C-N-CA 120.168 -1.015 . . . . 0.0 113.545 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -128.57 102.93 19.87 Favored Pre-proline 0 C--O 1.238 0.5 0 CA-C-N 116.859 0.33 . . . . 0.0 110.694 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.581 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 32.1 Cg_exo -72.67 115.2 4.25 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 121.307 1.338 . . . . 0.0 114.563 -177.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.766 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 10.4 p90 -127.15 168.75 14.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.551 -178.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 109' ' ' ARG . 3.0 mp0 -107.1 130.11 54.73 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.694 HD21 HD12 ' A' ' 72' ' ' LEU . 4.3 pp -122.81 132.56 54.26 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.416 -178.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.891 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 15.3 pt-20 -92.17 123.97 35.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.789 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 1.057 ' HB3' HD12 ' A' ' 126' ' ' LEU . . . -118.58 133.64 55.71 Favored 'General case' 0 C--O 1.22 -0.472 0 C-N-CA 120.456 -0.498 . . . . 0.0 112.13 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.72 ' OD1' ' HB3' ' A' ' 105' ' ' LYS . 31.5 m-20 -127.38 161.54 28.43 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.55 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 55.1 -140.59 38.86 Favored Glycine 0 C--N 1.346 1.109 0 C-N-CA 118.94 -1.6 . . . . 0.0 115.145 177.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.525 ' H ' ' CD1' ' A' ' 125' ' ' LEU . 4.6 mp -54.9 -30.69 58.86 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.831 -0.684 . . . . 0.0 111.62 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 1.057 HD12 ' HB3' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -71.22 -51.77 22.79 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.677 0.751 . . . . 0.0 109.209 179.607 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.75 ' O ' ' HG3' ' A' ' 131' ' ' GLN . . . -60.22 -47.01 87.77 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.767 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 1.048 HD13 ' HG2' ' A' ' 102' ' ' ARG . 46.9 mm -63.69 -55.01 25.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -177.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.657 ' HG ' HG22 ' A' ' 62' ' ' VAL . 81.8 m -58.19 -48.61 79.79 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.88 HD11 HD11 ' A' ' 108' ' ' ILE . 20.0 tt -59.01 -40.93 81.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.854 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.776 ' CD ' HG22 ' A' ' 106' ' ' VAL . 69.2 mt-30 -67.59 -40.76 84.81 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.463 ' HD1' ' NH2' ' A' ' 102' ' ' ARG . 79.7 t60 -57.72 -45.87 85.16 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.021 0.439 . . . . 0.0 110.026 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.894 ' O ' HD21 ' A' ' 137' ' ' LEU . 4.2 mm-40 -59.99 -42.57 94.48 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.227 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.908 ' HA ' HD23 ' A' ' 137' ' ' LEU . 3.0 mmm -56.83 -47.55 80.06 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.772 0.796 . . . . 0.0 109.999 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.861 ' O ' HG13 ' A' ' 138' ' ' VAL . 32.3 m-20 -65.4 -48.37 73.07 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.701 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.464 ' HA ' ' O ' ' A' ' 140' ' ' LYS . 16.2 t-80 -57.38 -50.77 71.93 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.722 -0.611 . . . . 0.0 111.051 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.908 HD23 ' HA ' ' A' ' 134' ' ' MET . 1.6 pp -60.7 -30.7 70.11 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.812 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.892 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 11.9 p -84.19 24.83 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-O 122.412 1.101 . . . . 0.0 109.957 177.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 66.76 3.03 19.45 Favored Glycine 0 CA--C 1.487 -1.673 0 CA-C-N 113.423 -1.717 . . . . 0.0 113.262 176.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.892 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 9.4 ptmt . . . . . 0 N--CA 1.416 -2.131 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.713 ' CG1' HG21 ' A' ' 37' ' ' THR . 37.2 t . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.631 0.253 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.844 HD13 ' O ' ' A' ' 51' ' ' VAL . 3.4 pp -78.75 -175.97 4.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.746 0.308 . . . . 0.0 110.548 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.768 ' N ' HD11 ' A' ' 3' ' ' LEU . 52.2 tt0 -83.25 107.62 15.91 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.817 0.341 . . . . 0.0 110.643 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.463 HG23 HG23 ' A' ' 37' ' ' THR . 39.1 t -89.56 131.5 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 121.229 0.538 . . . . 0.0 112.235 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 1.053 ' HB2' HD22 ' A' ' 13' ' ' LEU . 14.7 mt -88.31 140.25 29.67 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.931 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.605 ' HB3' ' O ' ' A' ' 92' ' ' SER . 41.4 m-70 -116.71 144.33 44.56 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.795 ' CD1' HD11 ' A' ' 13' ' ' LEU . 43.5 mm -62.95 135.56 96.2 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.999 177.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.45 ' HA ' HG21 ' A' ' 8' ' ' ILE . 84.2 Cg_endo -80.2 145.5 71.87 Favored 'Cis proline' 0 C--N 1.354 0.818 0 C-N-CA 124.387 -1.089 . . . . 0.0 112.006 -0.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.974 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 8.9 t70 -165.88 128.44 2.02 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.426 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.434 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 24.1 pt-20 -58.19 -46.0 86.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.592 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.568 ' O ' ' HB ' ' A' ' 49' ' ' THR . 20.2 mmt-85 -56.09 -28.73 58.9 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 1.053 HD22 ' HB2' ' A' ' 6' ' ' LEU . 10.1 mt -76.72 -34.27 58.13 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 120.339 1.427 . . . . 0.0 108.786 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.807 ' NH1' ' HB3' ' A' ' 14' ' ' ARG . 1.7 mmm180 -91.99 11.1 26.28 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.029 178.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.827 ' HD3' ' N ' ' A' ' 16' ' ' VAL . 11.2 tmtt? -84.3 139.37 32.36 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.482 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.959 HG12 HG23 ' A' ' 138' ' ' VAL . 46.0 t -84.29 93.93 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.79 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.645 ' HB2' ' CG ' ' A' ' 56' ' ' ARG . . . -53.88 147.85 11.38 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.337 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -104.25 131.24 22.1 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.746 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.545 ' HD3' ' HD3' ' A' ' 56' ' ' ARG . 69.2 Cg_endo -77.52 114.67 3.75 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.097 1.864 . . . . 0.0 110.56 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.638 HG13 ' N ' ' A' ' 21' ' ' GLU . 19.7 t -69.36 144.57 13.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 122.624 1.202 . . . . 0.0 113.313 -175.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.638 ' N ' HG13 ' A' ' 20' ' ' VAL . 55.1 mt-10 -66.12 -24.68 66.72 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 113.266 -1.788 . . . . 0.0 111.915 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.553 ' O ' HG11 ' A' ' 20' ' ' VAL . 88.7 tt0 -160.96 141.0 10.98 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.658 0.266 . . . . 0.0 110.734 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.868 ' CG2' HD22 ' A' ' 111' ' ' LEU . 2.8 t -79.18 109.82 14.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 1.058 ' H ' HD11 ' A' ' 27' ' ' ILE . 60.1 m-80 -92.07 164.55 13.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.52 0.2 . . . . 0.0 110.94 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.708 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -56.22 -30.72 62.72 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.176 0.513 . . . . 0.0 110.762 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -71.52 -39.6 70.64 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 177.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 1.058 HD11 ' H ' ' A' ' 24' ' ' ASN . 59.6 mt -63.26 -47.24 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.132 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.506 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 11.5 mt-30 -57.83 -39.25 77.2 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-O 120.896 0.379 . . . . 0.0 110.701 178.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.708 ' HG3' ' O ' ' A' ' 25' ' ' ALA . 99.6 mtt180 -60.3 -39.86 88.44 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.812 ' O ' ' HG3' ' A' ' 34' ' ' MET . 3.3 mt -60.06 -48.54 87.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 114.641 -1.163 . . . . 0.0 112.108 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.717 HG12 ' CG2' ' A' ' 71' ' ' VAL . 12.5 t -68.49 -42.63 83.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-O 120.862 0.363 . . . . 0.0 111.378 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.837 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -55.17 -42.02 72.61 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.516 -179.705 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.488 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 23.4 m-20 -75.23 -30.3 60.52 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.348 175.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.812 ' HG3' ' O ' ' A' ' 30' ' ' ILE . 86.5 mtp -60.54 -46.83 88.73 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.857 -177.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.837 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 14.1 p90 -69.38 -44.43 71.52 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.772 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 34.0 mt-10 -51.36 -42.1 61.09 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.713 HG21 ' CG1' ' A' ' 2' ' ' VAL . 73.7 m -69.3 -62.08 1.53 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.493 -1.23 . . . . 0.0 108.236 178.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 1.042 ' HE3' ' HB2' ' A' ' 61' ' ' ASP . 3.4 ttp -45.91 -42.53 12.86 Favored 'General case' 0 CA--C 1.454 -2.739 0 C-N-CA 124.183 0.993 . . . . 0.0 110.563 -170.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.681 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 50.2 m-85 -69.42 -41.58 76.18 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.569 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.608 ' CB ' HG21 ' A' ' 2' ' ' VAL . . . -60.8 -28.69 68.96 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.796 0.807 . . . . 0.0 109.003 178.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 1.064 ' HG2' HD13 ' A' ' 91' ' ' LEU . 11.0 tp10 -84.33 -10.11 57.88 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 114.248 -1.342 . . . . 0.0 108.788 177.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 61.57 26.12 15.89 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 121.914 0.864 . . . . 0.0 109.987 -176.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.73 142.21 23.37 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 113.993 -1.458 . . . . 0.0 110.757 178.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.992 HG23 HG22 ' A' ' 62' ' ' VAL . 49.2 mt -78.57 -2.54 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 117.702 0.751 . . . . 0.0 111.925 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.487 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . -179.28 133.33 2.04 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-O 119.114 -0.826 . . . . 0.0 111.794 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.993 HD12 ' HG ' ' A' ' 91' ' ' LEU . 5.8 tp -124.45 133.99 53.2 Favored 'General case' 0 C--N 1.351 0.632 0 CA-C-N 119.085 1.442 . . . . 0.0 111.278 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -100.44 129.27 46.38 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.218 0.207 . . . . 0.0 111.236 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.62 ' CB ' HD11 ' A' ' 53' ' ' ILE . . . -27.06 -55.74 0.08 Allowed 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 116.126 1.898 . . . . 0.0 116.126 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.686 HG21 ' O ' ' A' ' 137' ' ' LEU . 66.2 p -53.29 -33.87 55.02 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.882 0.848 . . . . 0.0 112.032 -178.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.842 ' NE2' HD23 ' A' ' 91' ' ' LEU . 82.4 mt-30 -63.93 -42.68 97.3 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.15 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.844 ' O ' HD13 ' A' ' 3' ' ' LEU . 0.9 OUTLIER -86.9 16.2 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.969 ' HA ' HD11 ' A' ' 6' ' ' LEU . 53.6 t0 77.43 34.05 0.38 Allowed 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 176.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.824 HD11 ' O ' ' A' ' 55' ' ' GLN . 1.0 OUTLIER -125.39 109.18 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.302 177.08 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -75.74 63.34 1.61 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.206 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.824 ' O ' HD11 ' A' ' 53' ' ' ILE . 88.9 mt-30 -153.96 134.0 13.19 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 114.156 -1.384 . . . . 0.0 108.425 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.724 ' HG2' ' CD1' ' A' ' 137' ' ' LEU . 77.4 mtp180 -65.13 72.38 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -177.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.801 ' O ' ' HE1' ' A' ' 34' ' ' MET . 6.7 mm -114.84 124.93 71.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 1.05 HD13 ' HB2' ' A' ' 72' ' ' LEU . 2.2 pp -131.41 147.26 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.546 HG22 ' H ' ' A' ' 46' ' ' LEU . 34.1 m -128.84 138.15 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.709 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.938 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 2.2 mt -116.92 142.92 28.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.835 0.826 . . . . 0.0 110.821 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 1.042 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 11.4 t70 -124.87 25.86 7.24 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.18 -1.373 . . . . 0.0 110.294 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.992 HG22 HG23 ' A' ' 44' ' ' ILE . 21.9 t . . . . . 0 N--CA 1.465 0.322 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.57 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.661 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 32.8 ttm180 . . . . . 0 N--CA 1.467 0.402 0 CA-C-O 120.81 0.338 . . . . 0.0 111.35 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.938 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 67.2 mt -100.72 132.42 46.12 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.867 HG22 ' HB2' ' A' ' 113' ' ' ARG . 9.9 p -134.38 130.09 53.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.106 178.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 1.05 ' HB2' HD13 ' A' ' 58' ' ' ILE . 2.8 mm? -141.07 139.54 34.07 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.505 -0.183 . . . . 0.0 110.505 178.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 1.007 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.7 mp -118.79 134.99 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 110.345 -0.243 . . . . 0.0 110.345 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.685 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 8.6 m120 54.04 35.56 0.29 Allowed Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.811 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 95.2 Cg_exo -55.83 150.1 47.38 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.72 2.28 . . . . 0.0 113.639 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.62 ' CD ' HH21 ' A' ' 109' ' ' ARG . 15.6 pt-20 -136.74 144.22 43.72 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 1.024 ' HB2' ' HE2' ' A' ' 134' ' ' MET . 1.4 tt -81.82 136.28 35.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.534 0.683 . . . . 0.0 111.215 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.886 ' N ' HD21 ' A' ' 77' ' ' LEU . 7.5 mp -116.61 -37.81 3.62 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.308 -178.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 5.2 tp10 -155.36 146.85 22.96 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.107 0.479 . . . . 0.0 111.13 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.717 ' HA ' HG11 ' A' ' 106' ' ' VAL . 12.8 ptmt -148.4 147.38 29.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.258 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 52.8 m -160.56 145.4 14.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.675 0.274 . . . . 0.0 111.303 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.814 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 84.76 169.75 46.22 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.175 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -146.97 113.53 6.0 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.642 ' HG1' HD12 ' A' ' 128' ' ' ILE . 1.5 p -101.94 159.87 14.98 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 115.132 1.531 . . . . 0.0 115.132 178.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.769 ' O ' HD11 ' A' ' 86' ' ' ILE . . . -137.12 102.61 0.39 Allowed Glycine 0 C--N 1.316 -0.532 0 CA-C-N 112.856 -1.974 . . . . 0.0 111.589 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.769 HD11 ' O ' ' A' ' 85' ' ' GLY . 39.8 mm -145.54 136.97 19.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 56.3 mt-10 -71.31 144.36 49.98 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 122.476 1.131 . . . . 0.0 111.779 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.618 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 55.0 mt-10 -158.06 162.06 38.06 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 113.933 -1.485 . . . . 0.0 109.618 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.885 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -119.96 158.01 15.44 Favored Glycine 0 CA--C 1.499 -0.942 0 C-N-CA 119.271 -1.442 . . . . 0.0 110.15 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 20.5 m -111.88 137.3 50.04 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.564 0.697 . . . . 0.0 111.893 -177.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 1.064 HD13 ' HG2' ' A' ' 41' ' ' GLU . 2.3 mm? -48.35 -23.03 0.79 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.591 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.701 ' CB ' HG12 ' A' ' 8' ' ' ILE . 48.7 m -84.25 -34.05 23.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.649 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.6 mt . . . . . 0 N--CA 1.45 -0.442 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.758 -179.811 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.885 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 18.5 mtm105 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.851 0.834 . . . . 0.0 111.903 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.418 ' C ' ' HA ' ' A' ' 87' ' ' GLU . . . -134.47 153.45 51.92 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.249 -1.341 . . . . 0.0 109.624 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.752 ' HG ' ' N ' ' A' ' 86' ' ' ILE . 6.8 tt -75.16 136.33 41.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.458 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.818 ' HB ' ' CZ ' ' A' ' 102' ' ' ARG . 89.7 t -130.14 132.92 24.39 Favored Pre-proline 0 CA--C 1.53 0.177 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 84' ' ' THR . 2.1 Cg_endo -81.3 124.1 4.67 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.693 1.595 . . . . 0.0 112.7 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.863 ' HB2' ' OE1' ' A' ' 131' ' ' GLN . 0.0 OUTLIER -142.15 166.4 24.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.765 179.112 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.814 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.67 156.22 38.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.666 0.269 . . . . 0.0 110.286 -178.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -72.82 -43.96 62.06 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.422 -176.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.715 ' HB3' ' OD1' ' A' ' 123' ' ' ASP . 56.6 mttp -139.44 138.24 36.29 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.72 0.771 . . . . 0.0 109.611 176.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.717 HG11 ' HA ' ' A' ' 80' ' ' LYS . 28.4 m -140.05 138.6 37.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.043 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 1.048 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 32.9 mmtm -107.22 125.27 50.9 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.906 HD13 ' CG ' ' A' ' 120' ' ' LEU . 2.1 pp -128.37 161.46 36.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -177.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.818 ' HG3' ' CD1' ' A' ' 78' ' ' LEU . 68.0 mtm180 -114.28 140.15 48.83 Favored 'General case' 0 N--CA 1.461 0.104 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.77 ' HB2' ' HG3' ' A' ' 75' ' ' PRO . . . -159.58 168.29 26.46 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.966 -178.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 1.007 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.5 pp -113.59 152.99 29.58 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.572 ' O ' HD11 ' A' ' 111' ' ' LEU . 11.2 t70 -90.79 164.37 14.11 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 119.716 -0.793 . . . . 0.0 111.42 -177.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.867 ' HB2' HG22 ' A' ' 71' ' ' VAL . 15.1 ttm105 -51.57 -19.2 1.38 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.237 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.24 -26.56 42.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.602 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 106.81 34.63 2.98 Favored Glycine 0 C--N 1.337 0.619 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.948 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 1.061 ' HZ1' ' HB2' ' A' ' 116' ' ' LYS . 9.7 mtmp? -128.63 103.17 19.62 Favored Pre-proline 0 C--O 1.237 0.416 0 C-N-CA 121.228 -0.189 . . . . 0.0 111.236 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.584 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.4 Cg_exo -72.84 116.06 4.58 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 121.799 1.666 . . . . 0.0 114.802 -178.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.474 ' HE1' HD13 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -126.45 168.62 13.97 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.372 -179.626 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.676 ' HG2' ' CG ' ' A' ' 109' ' ' ARG . 80.2 mt-10 -107.52 129.64 54.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.121 0.486 . . . . 0.0 110.16 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.906 ' CG ' HD13 ' A' ' 108' ' ' ILE . 4.2 pp -123.08 129.04 50.95 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.752 -178.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 1.048 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 9.3 pm0 -92.76 124.36 36.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.27 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.934 ' HB3' HD12 ' A' ' 126' ' ' LEU . . . -116.35 137.18 52.36 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.715 ' OD1' ' HB3' ' A' ' 105' ' ' LYS . 34.3 m-20 -126.96 163.8 22.88 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.798 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 47.5 -135.47 13.62 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 119.996 1.271 . . . . 0.0 115.864 177.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.0 mt -54.66 -32.73 59.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.654 -0.773 . . . . 0.0 111.667 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.934 HD12 ' HB3' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -71.31 -54.01 12.29 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.842 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.868 ' HB3' ' O ' ' A' ' 122' ' ' ALA . . . -58.85 -42.98 90.62 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.469 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.798 HG12 ' O ' ' A' ' 124' ' ' GLY . 49.2 mm -62.17 -54.47 33.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.559 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.873 ' HG ' HG23 ' A' ' 62' ' ' VAL . 73.4 m -60.12 -50.72 72.59 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.832 ' CD1' HG12 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -58.88 -44.1 89.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 121.201 -0.199 . . . . 0.0 110.567 -179.674 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.863 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.9 pt20 -67.72 -38.35 83.48 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.735 ' HA ' ' OD2' ' A' ' 135' ' ' ASP . 68.7 t60 -59.22 -46.1 89.35 Favored 'General case' 0 C--O 1.226 -0.16 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.86 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.9 mm-40 -59.67 -45.02 93.33 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.271 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 1.024 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 72.6 mtp -56.84 -48.51 77.9 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 118.913 0.779 . . . . 0.0 110.865 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.872 ' O ' HG13 ' A' ' 138' ' ' VAL . 2.4 p30 -63.35 -46.68 85.42 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.37 178.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.454 ' CE1' ' CG ' ' A' ' 50' ' ' GLN . 7.8 t-80 -58.03 -52.6 64.86 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.814 -0.554 . . . . 0.0 111.476 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.912 HD22 ' HA ' ' A' ' 134' ' ' MET . 1.5 pp -59.21 -32.68 70.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.553 -177.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.959 HG23 HG12 ' A' ' 16' ' ' VAL . 10.3 p -80.09 19.02 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 CA-C-O 123.101 1.429 . . . . 0.0 108.856 175.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.804 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 61.5 20.52 59.12 Favored Glycine 0 CA--C 1.489 -1.537 0 CA-C-N 111.779 -2.464 . . . . 0.0 112.313 176.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.916 ' HG2' HG12 ' A' ' 138' ' ' VAL . 7.2 ptmt . . . . . 0 N--CA 1.424 -1.739 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.046 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.931 HG13 ' HA ' ' A' ' 37' ' ' THR . 27.9 m . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.571 0.224 . . . . 0.0 110.963 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.876 HD11 ' OG1' ' A' ' 37' ' ' THR . 0.0 OUTLIER -85.71 -170.15 2.97 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.595 179.88 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.683 ' N ' HD22 ' A' ' 3' ' ' LEU . 70.9 tp60 -84.52 108.4 17.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.736 0.303 . . . . 0.0 110.798 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.656 HG12 ' O ' ' A' ' 50' ' ' GLN . 43.0 t -89.79 131.82 36.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.25 0.548 . . . . 0.0 111.767 -179.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 1.026 ' HB2' HD23 ' A' ' 13' ' ' LEU . 21.5 mt -85.03 141.73 30.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.071 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 2.8 m80 -119.77 144.35 47.33 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.739 HG12 ' HB3' ' A' ' 92' ' ' SER . 50.7 mm -60.71 134.28 92.02 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.29 177.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -83.02 138.88 35.56 Favored 'Cis proline' 0 C--N 1.352 0.739 0 C-N-CA 124.48 -1.05 . . . . 0.0 111.896 -0.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.67 ' HB2' HD12 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -155.86 128.99 8.11 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.562 179.672 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -58.46 -44.71 89.36 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.517 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.557 ' HB2' HD12 ' A' ' 6' ' ' LEU . 24.1 mtt180 -60.5 -24.86 65.63 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 1.026 HD23 ' HB2' ' A' ' 6' ' ' LEU . 10.3 mt -78.41 -31.03 48.03 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 120.892 1.678 . . . . 0.0 107.617 176.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.599 ' C ' ' HA3' ' A' ' 139' ' ' GLY . 15.7 mmm180 -91.8 8.77 35.59 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 113.767 -1.56 . . . . 0.0 109.12 178.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.55 ' HD3' ' HB3' ' A' ' 54' ' ' HIS . 60.2 tttp -88.19 143.5 27.01 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.08 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 138' ' ' VAL . 56.4 t -83.99 100.24 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.029 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.673 ' C ' ' HG3' ' A' ' 56' ' ' ARG . . . -58.74 143.78 45.85 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.944 0.402 . . . . 0.0 111.44 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.698 ' HD3' ' N ' ' A' ' 19' ' ' PRO . 1.7 tmtp? -108.94 132.47 21.16 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.183 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.922 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 56.4 Cg_endo -80.35 115.7 3.21 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.29 1.994 . . . . 0.0 111.057 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.599 HG11 ' N ' ' A' ' 21' ' ' GLU . 17.1 t -70.14 144.42 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-O 122.497 1.142 . . . . 0.0 112.665 -176.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.599 ' N ' HG11 ' A' ' 20' ' ' VAL . 8.7 mp0 -60.4 -22.95 63.95 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 113.29 -1.777 . . . . 0.0 112.29 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -161.17 140.31 10.22 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 120.801 0.334 . . . . 0.0 111.157 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.912 HG21 HD13 ' A' ' 111' ' ' LEU . 2.7 t -83.02 117.99 29.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.138 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.891 ' O ' ' HG3' ' A' ' 28' ' ' GLN . 9.8 p30 -105.76 -168.66 1.47 Allowed 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 122.295 -0.253 . . . . 0.0 110.353 -178.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.651 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -73.31 -25.83 60.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.779 0.323 . . . . 0.0 111.434 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.574 ' HB2' ' OD1' ' A' ' 24' ' ' ASN . 4.6 mm-40 -72.89 -40.21 65.74 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.537 HD12 ' HA ' ' A' ' 23' ' ' VAL . 50.8 mt -65.78 -46.04 89.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.166 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.891 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 45.5 mt-30 -57.09 -40.28 76.69 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.705 0.288 . . . . 0.0 110.444 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.651 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 39.4 mmt180 -61.52 -41.16 96.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.654 0.74 . . . . 0.0 109.074 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.813 ' O ' ' HG3' ' A' ' 34' ' ' MET . 4.8 mt -59.72 -50.12 81.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.742 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.676 HG12 ' CG2' ' A' ' 71' ' ' VAL . 10.8 t -67.87 -43.8 85.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-O 120.843 0.354 . . . . 0.0 111.723 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.823 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 26.0 m-20 -54.37 -41.8 69.58 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.404 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.644 ' CB ' HD12 ' A' ' 3' ' ' LEU . 55.9 m-20 -74.39 -31.17 62.25 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.077 176.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.813 ' HG3' ' O ' ' A' ' 30' ' ' ILE . 85.1 mtp -60.3 -47.1 87.47 Favored 'General case' 0 C--N 1.346 0.453 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.869 -177.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.823 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 15.9 p90 -69.35 -44.51 71.45 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' A' ' 32' ' ' ASP . 3.3 mm-40 -51.22 -43.79 61.5 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.931 ' HA ' HG13 ' A' ' 2' ' ' VAL . 96.6 m -70.06 -59.98 2.57 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 118.723 -1.191 . . . . 0.0 109.267 177.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 1.008 ' HE3' ' HB2' ' A' ' 61' ' ' ASP . 3.7 ttp -46.32 -42.5 14.81 Favored 'General case' 0 CA--C 1.461 -2.45 0 C-N-CA 123.42 0.688 . . . . 0.0 109.646 -170.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.747 ' OH ' ' HA ' ' A' ' 69' ' ' ARG . 60.4 m-85 -69.56 -42.35 74.68 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.593 178.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.566 ' HB1' HG13 ' A' ' 2' ' ' VAL . . . -59.84 -28.4 67.47 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.912 ' HG2' HD23 ' A' ' 91' ' ' LEU . 17.6 tp10 -84.9 -10.81 56.73 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.708 177.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 63.87 24.2 13.63 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.952 -176.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.1 142.18 26.0 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 114.143 -1.39 . . . . 0.0 110.595 177.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.981 HG21 HG23 ' A' ' 62' ' ' VAL . 44.2 mm -78.77 -2.18 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 117.566 0.683 . . . . 0.0 112.195 -178.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.511 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 179.36 135.5 2.41 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-O 118.88 -0.956 . . . . 0.0 111.769 -178.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.967 ' HB2' ' HG3' ' A' ' 38' ' ' MET . 9.1 tp -125.85 135.16 51.64 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.437 1.619 . . . . 0.0 111.743 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.502 ' HB3' HE21 ' A' ' 50' ' ' GLN . . . -99.5 129.97 45.72 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.817 ' O ' HG21 ' A' ' 51' ' ' VAL . . . -30.72 -54.51 0.2 Allowed 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.73 HG21 ' O ' ' A' ' 137' ' ' LEU . 66.6 p -53.53 -35.41 60.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.775 0.798 . . . . 0.0 111.364 -178.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.656 ' O ' HG12 ' A' ' 5' ' ' VAL . 55.8 mt-30 -66.35 -37.36 85.16 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.078 179.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.898 ' CG1' HD23 ' A' ' 46' ' ' LEU . 1.1 m -86.4 12.13 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.926 ' HA ' HD13 ' A' ' 6' ' ' LEU . 55.3 t0 78.96 32.37 0.28 Allowed 'General case' 0 C--O 1.23 0.059 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 176.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.793 HD11 ' O ' ' A' ' 55' ' ' GLN . 1.2 pp -127.31 111.75 26.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.065 177.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.55 ' HB3' ' HD3' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -76.23 65.05 2.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.089 0.947 . . . . 0.0 110.466 -179.034 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.793 ' O ' HD11 ' A' ' 53' ' ' ILE . 28.3 mt-30 -154.88 134.54 12.75 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 114.169 -1.378 . . . . 0.0 108.527 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.922 ' HD2' ' HD3' ' A' ' 19' ' ' PRO . 77.8 mtt-85 -63.34 70.82 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -177.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.727 HG23 ' SD ' ' A' ' 34' ' ' MET . 8.7 mm -112.9 122.74 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.919 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 1.7 pp -128.61 146.03 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 119.635 -0.826 . . . . 0.0 113.177 -177.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.708 HG23 ' H ' ' A' ' 46' ' ' LEU . 33.8 m -128.05 138.75 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.96 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.947 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 12.1 mm -116.13 150.57 18.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.642 0.734 . . . . 0.0 109.859 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 1.008 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 28.9 t70 -132.7 21.72 4.25 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.508 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.981 HG23 HG21 ' A' ' 44' ' ' ILE . 32.6 t . . . . . 0 N--CA 1.464 0.226 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.328 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.747 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 78.8 ttt180 . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.947 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 44.0 mt -104.73 133.55 49.37 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -178.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.8 ' C ' HD11 ' A' ' 72' ' ' LEU . 14.4 p -135.07 133.15 53.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.56 177.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 1.023 HD21 HD23 ' A' ' 120' ' ' LEU . 10.4 mp -138.96 139.79 38.05 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.996 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 2.6 mm -118.86 132.49 68.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.102 0.477 . . . . 0.0 111.197 -178.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.698 ' OD1' ' HA ' ' A' ' 19' ' ' PRO . 68.4 m-20 50.7 38.0 0.47 Allowed Pre-proline 0 CA--C 1.547 0.843 0 CA-C-N 115.003 -0.999 . . . . 0.0 113.075 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.763 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 96.2 Cg_exo -55.85 152.33 36.26 Favored 'Trans proline' 0 N--CA 1.487 1.135 0 C-N-CA 123.027 2.485 . . . . 0.0 114.156 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.432 ' HG3' HD13 ' A' ' 78' ' ' LEU . 15.7 pt-20 -137.14 143.25 42.37 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 1.073 ' HB2' ' HE2' ' A' ' 134' ' ' MET . 1.8 tt -81.14 135.44 35.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.711 0.767 . . . . 0.0 111.609 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.904 ' N ' HD22 ' A' ' 77' ' ' LEU . 6.9 mp -111.99 -37.3 5.13 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.045 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 37.6 tt0 -161.0 156.09 24.23 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 121.271 0.557 . . . . 0.0 112.004 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.803 ' CB ' HG12 ' A' ' 106' ' ' VAL . 18.3 ptpt -148.07 153.14 38.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.06 178.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.6 p -159.62 146.38 16.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.852 0.358 . . . . 0.0 111.24 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.741 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 69.73 173.22 10.59 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.843 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.676 ' N ' ' HG3' ' A' ' 104' ' ' GLU . 56.1 mt-10 -146.62 113.89 6.26 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.541 ' OG1' HD11 ' A' ' 128' ' ' ILE . 1.5 p -96.03 159.89 14.73 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 178.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.764 ' O ' HD11 ' A' ' 86' ' ' ILE . . . -135.63 100.81 0.36 Allowed Glycine 0 C--N 1.319 -0.406 0 CA-C-N 113.452 -1.704 . . . . 0.0 111.878 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.764 HD11 ' O ' ' A' ' 85' ' ' GLY . 39.6 mm -145.15 136.94 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -178.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.602 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 47.6 mt-10 -73.35 143.41 46.88 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 122.845 1.307 . . . . 0.0 112.968 -177.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.604 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 95.2 mt-10 -154.96 166.27 34.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 113.502 -1.681 . . . . 0.0 109.515 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.784 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -119.86 165.31 13.5 Favored Glycine 0 CA--C 1.498 -0.993 0 C-N-CA 119.339 -1.41 . . . . 0.0 110.225 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 1.035 ' HB2' HD11 ' A' ' 93' ' ' ILE . 95.3 m -118.2 140.22 50.12 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.879 -176.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.912 HD23 ' HG2' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -56.9 -23.43 44.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.627 178.741 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.739 ' HB3' HG12 ' A' ' 8' ' ' ILE . 58.7 m -79.45 -38.51 34.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.407 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 1.035 HD11 ' HB2' ' A' ' 90' ' ' CYS . 2.6 mp . . . . . 0 CA--C 1.535 0.367 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.397 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.784 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 45.8 mtm-85 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.757 0.789 . . . . 0.0 111.437 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 87' ' ' GLU . . . -134.62 153.92 51.75 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.113 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.676 ' C ' HD22 ' A' ' 99' ' ' LEU . 6.6 tt -75.13 136.95 41.07 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.892 ' HB ' ' CZ ' ' A' ' 102' ' ' ARG . 21.9 t -132.04 134.23 24.91 Favored Pre-proline 0 C--N 1.339 0.138 0 C-N-CA 120.461 -0.495 . . . . 0.0 110.986 -178.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -79.75 123.14 5.17 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 121.409 1.406 . . . . 0.0 112.321 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.892 ' CZ ' ' HB ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -144.08 165.75 26.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.653 178.455 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.741 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.72 154.02 42.71 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.014 0.435 . . . . 0.0 109.96 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.676 ' HG3' ' N ' ' A' ' 83' ' ' GLU . 46.8 mt-10 -73.95 -42.29 60.73 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.336 -176.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.652 ' HG2' ' HB3' ' A' ' 123' ' ' ASP . 93.6 mttt -139.79 137.98 35.46 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.683 0.754 . . . . 0.0 109.677 176.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.803 HG12 ' CB ' ' A' ' 80' ' ' LYS . 28.9 m -141.44 142.04 29.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.754 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.989 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 23.6 mmtp -108.13 125.67 51.87 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.73 ' CD1' HD11 ' A' ' 130' ' ' ILE . 1.9 pp -130.71 161.75 40.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -177.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.893 ' CG ' HD21 ' A' ' 78' ' ' LEU . 93.7 mtt180 -111.0 138.34 47.52 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.728 ' HB2' ' HG3' ' A' ' 75' ' ' PRO . . . -155.23 166.34 33.87 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.828 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.996 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.2 pp -117.27 152.01 35.74 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.595 ' OD1' HG12 ' A' ' 71' ' ' VAL . 20.0 t70 -85.25 168.78 14.42 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 119.326 -0.95 . . . . 0.0 112.404 -176.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.767 ' HB2' HG23 ' A' ' 71' ' ' VAL . 46.5 ttp85 -54.87 -20.26 8.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.689 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -79.71 -19.4 48.96 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.523 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.548 ' HA2' HD13 ' A' ' 111' ' ' LEU . . . 98.83 39.13 3.68 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.156 -1.021 . . . . 0.0 114.141 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.674 ' HB3' ' NZ ' ' A' ' 116' ' ' LYS . 2.2 mmmp? -128.28 102.21 21.27 Favored Pre-proline 0 N--CA 1.467 0.397 0 CA-C-N 117.516 0.658 . . . . 0.0 110.82 178.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.568 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.8 Cg_exo -74.58 115.56 4.34 Favored 'Trans proline' 0 C--N 1.361 1.188 0 C-N-CA 121.733 1.622 . . . . 0.0 116.061 -177.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -125.42 168.49 13.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.043 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.728 ' HG2' ' HG2' ' A' ' 109' ' ' ARG . 35.2 mt-10 -108.09 130.63 55.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.972 0.415 . . . . 0.0 110.305 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 1.023 HD23 HD21 ' A' ' 72' ' ' LEU . 4.1 pp -128.48 135.72 49.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.222 0.534 . . . . 0.0 112.092 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.989 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 11.7 pt-20 -95.5 125.63 40.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.974 178.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.889 ' CB ' HD13 ' A' ' 126' ' ' LEU . . . -116.55 135.72 53.58 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.704 ' CA ' ' HB3' ' A' ' 127' ' ' ALA . 24.0 m-20 -125.84 165.04 19.42 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.765 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 46.81 -136.79 9.57 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 120.125 1.329 . . . . 0.0 116.261 176.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.745 HD11 ' CG1' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -54.76 -32.79 60.46 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.319 -0.941 . . . . 0.0 111.341 -178.387 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.889 HD13 ' CB ' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -71.46 -52.64 17.35 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 121.626 0.727 . . . . 0.0 109.455 179.536 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.704 ' HB3' ' CA ' ' A' ' 123' ' ' ASP . . . -58.24 -40.77 82.62 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.58 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.856 HD13 ' HG2' ' A' ' 102' ' ' ARG . 49.7 mm -68.6 -54.42 21.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.437 -179.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.722 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 31.9 p -57.67 -50.92 71.6 Favored 'General case' 0 C--N 1.334 -0.089 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.73 HD11 ' CD1' ' A' ' 108' ' ' ILE . 20.7 tt -60.55 -44.0 95.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.41 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.825 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 21.5 pt20 -67.85 -38.33 83.03 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.226 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.742 ' HA ' ' OD2' ' A' ' 135' ' ' ASP . 7.8 t-160 -58.45 -46.93 85.57 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.876 ' O ' HD23 ' A' ' 137' ' ' LEU . 4.1 mm-40 -59.42 -44.42 92.86 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.802 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 1.073 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 75.2 mtp -57.01 -48.84 77.52 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 118.411 0.551 . . . . 0.0 110.969 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.811 ' O ' HG11 ' A' ' 138' ' ' VAL . 2.6 p30 -64.24 -47.26 80.34 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.474 -0.49 . . . . 0.0 109.785 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.451 ' CE1' ' CG ' ' A' ' 50' ' ' GLN . 20.6 t-80 -56.47 -51.79 67.15 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 121.589 -0.694 . . . . 0.0 110.94 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.887 HD22 ' HA ' ' A' ' 134' ' ' MET . 1.3 pp -60.6 -31.31 70.47 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 119.895 -0.722 . . . . 0.0 112.053 -177.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.811 HG11 ' O ' ' A' ' 135' ' ' ASP . 14.7 p -80.6 23.09 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-O 122.966 1.365 . . . . 0.0 109.815 176.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.862 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 64.45 6.34 21.21 Favored Glycine 0 CA--C 1.491 -1.426 0 CA-C-N 112.482 -2.144 . . . . 0.0 112.896 176.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.796 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 4.5 ptmt . . . . . 0 N--CA 1.43 -1.44 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.443 HG11 ' CB ' ' A' ' 40' ' ' ALA . 20.1 m . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.026 0.441 . . . . 0.0 111.662 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.924 HD21 ' HB ' ' A' ' 51' ' ' VAL . 58.6 tp -77.82 158.08 29.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.284 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -78.56 106.07 10.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.127 0.489 . . . . 0.0 109.946 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.772 HG12 ' O ' ' A' ' 50' ' ' GLN . 37.3 t -90.51 131.98 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.668 -178.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.916 HD13 ' HA ' ' A' ' 52' ' ' ASP . 29.6 mt -83.49 140.79 32.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.951 179.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 19.5 m-70 -111.18 142.93 42.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.202 0.525 . . . . 0.0 112.33 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.865 HD12 HD12 ' A' ' 13' ' ' LEU . 49.6 mm -50.87 144.81 12.8 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.799 178.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.48 ' CA ' HG23 ' A' ' 8' ' ' ILE . 79.1 Cg_endo -98.18 55.48 1.04 Allowed 'Cis proline' 0 C--N 1.354 0.837 0 C-N-CA 124.844 -0.898 . . . . 0.0 113.159 0.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.573 ' OD2' ' HB3' ' A' ' 6' ' ' LEU . 66.8 m-20 -55.11 140.89 36.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.375 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 23.9 pt-20 -58.84 -45.54 89.81 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.656 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.751 HH21 HG21 ' A' ' 49' ' ' THR . 0.0 OUTLIER -56.8 -24.91 54.07 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 179.711 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.865 HD12 HD12 ' A' ' 8' ' ' ILE . 8.2 mt -76.77 -32.87 58.01 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 121.193 1.815 . . . . 0.0 108.509 178.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.55 ' HG2' HH11 ' A' ' 14' ' ' ARG . 24.3 mmt-85 -94.76 5.89 50.54 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 114.159 -1.382 . . . . 0.0 109.716 178.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.75 ' HD3' ' NH1' ' A' ' 12' ' ' ARG . 75.7 tttt -93.13 155.74 17.29 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.811 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 138' ' ' VAL . 64.3 t -82.5 136.17 23.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.293 0.568 . . . . 0.0 111.335 -178.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.734 ' HB2' ' HG2' ' A' ' 56' ' ' ARG . . . -87.18 141.13 28.88 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.67 ' HD3' ' N ' ' A' ' 19' ' ' PRO . 1.9 tmtp? -102.42 127.92 29.41 Favored Pre-proline 0 C--N 1.324 -0.503 0 C-N-CA 120.717 -0.393 . . . . 0.0 109.976 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.731 ' HB3' ' HD3' ' A' ' 56' ' ' ARG . 61.9 Cg_endo -78.81 115.02 3.52 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.14 1.893 . . . . 0.0 111.151 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.646 HG11 ' N ' ' A' ' 21' ' ' GLU . 19.8 t -70.07 145.0 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 CA-C-O 122.569 1.176 . . . . 0.0 113.232 -176.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.646 ' N ' HG11 ' A' ' 20' ' ' VAL . 51.6 mt-10 -65.93 -22.59 66.5 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 113.189 -1.823 . . . . 0.0 112.636 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.409 ' O ' HG12 ' A' ' 20' ' ' VAL . 5.0 tp10 -159.55 151.38 20.45 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.199 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.835 HG21 ' HA2' ' A' ' 115' ' ' GLY . 4.4 t -80.1 101.71 5.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 1.066 ' HB2' HD12 ' A' ' 27' ' ' ILE . 59.9 m-80 -91.53 160.33 15.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.933 -177.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.524 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -56.39 -32.97 65.3 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.494 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -71.78 -37.45 70.45 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 1.066 HD12 ' HB2' ' A' ' 24' ' ' ASN . 1.7 mp -64.24 -47.93 87.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.084 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.573 ' CD ' HG13 ' A' ' 23' ' ' VAL . 11.0 mm-40 -57.94 -40.51 80.68 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.788 0.328 . . . . 0.0 111.096 178.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.524 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 39.3 mmt180 -61.16 -41.3 96.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.808 0.813 . . . . 0.0 109.315 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.763 ' O ' ' HG3' ' A' ' 34' ' ' MET . 6.9 mt -59.37 -50.58 79.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 114.486 -1.233 . . . . 0.0 112.322 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.683 HG13 ' CG2' ' A' ' 71' ' ' VAL . 9.4 t -67.04 -42.15 88.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-O 120.846 0.355 . . . . 0.0 111.66 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.88 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -56.24 -42.44 77.35 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.96 -179.37 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.625 ' HB3' ' HB2' ' A' ' 3' ' ' LEU . 1.4 m-20 -75.07 -30.73 61.04 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.157 176.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.764 ' HE1' ' O ' ' A' ' 57' ' ' ILE . 79.3 mtp -60.58 -47.84 84.4 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.007 -177.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.88 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 15.9 p90 -69.02 -43.76 74.13 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.61 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 52.9 mm-40 -52.43 -41.05 62.91 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.747 HG23 ' CG2' ' A' ' 5' ' ' VAL . 31.0 m -69.98 -62.16 1.49 Allowed 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 118.792 -1.163 . . . . 0.0 108.757 177.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.923 ' HE3' ' HB2' ' A' ' 61' ' ' ASP . 1.4 ttp -46.3 -42.63 14.89 Favored 'General case' 0 CA--C 1.46 -2.496 0 C-N-CA 123.611 0.764 . . . . 0.0 110.016 -170.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.82 ' HH ' ' HA ' ' A' ' 69' ' ' ARG . 66.7 m-85 -69.29 -41.65 76.51 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.389 178.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.443 ' CB ' HG11 ' A' ' 2' ' ' VAL . . . -60.06 -28.49 67.83 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 1.053 ' HG2' HD23 ' A' ' 91' ' ' LEU . 3.0 tp10 -84.62 -10.38 57.41 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.977 177.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 63.37 25.59 14.66 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.953 -176.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.43 142.73 24.15 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.856 177.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.938 ' CG2' HG21 ' A' ' 62' ' ' VAL . 46.1 mm -78.99 -1.71 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 117.576 0.688 . . . . 0.0 112.254 -178.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.468 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 179.12 135.94 2.5 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 118.948 -0.918 . . . . 0.0 112.024 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.878 ' HB2' ' HG3' ' A' ' 38' ' ' MET . 6.9 tp -126.82 134.54 50.52 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.359 1.58 . . . . 0.0 112.295 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.558 ' HB3' ' OE1' ' A' ' 133' ' ' GLU . . . -97.8 131.1 44.6 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 122.386 0.274 . . . . 0.0 111.39 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.808 ' O ' HG22 ' A' ' 51' ' ' VAL . . . -33.73 -54.12 0.45 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -178.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.751 HG21 HH21 ' A' ' 12' ' ' ARG . 81.8 p -52.84 -35.77 57.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.722 0.772 . . . . 0.0 111.176 -178.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.772 ' O ' HG12 ' A' ' 5' ' ' VAL . 53.4 mt-30 -66.85 -36.76 83.07 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.023 178.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.924 ' HB ' HD21 ' A' ' 3' ' ' LEU . 1.3 m -87.21 13.49 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.916 ' HA ' HD13 ' A' ' 6' ' ' LEU . 54.5 t0 77.75 32.4 0.4 Allowed 'General case' 0 C--O 1.23 0.075 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 176.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.816 HD11 ' O ' ' A' ' 55' ' ' GLN . 1.2 pp -127.11 112.76 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.201 177.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.72 ' HA ' ' NH2' ' A' ' 12' ' ' ARG . 0.4 OUTLIER -76.0 67.02 2.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.862 0.839 . . . . 0.0 110.517 -179.439 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.816 ' O ' HD11 ' A' ' 53' ' ' ILE . 89.2 mt-30 -157.59 134.05 9.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.691 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.768 ' HA ' HD11 ' A' ' 137' ' ' LEU . 52.2 mtp85 -62.84 70.69 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -178.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.764 ' O ' ' HE1' ' A' ' 34' ' ' MET . 8.5 mm -113.16 122.35 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.897 HD12 ' HB2' ' A' ' 72' ' ' LEU . 2.1 pp -129.02 146.37 34.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.877 -178.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.66 HG22 ' H ' ' A' ' 46' ' ' LEU . 33.3 m -127.82 138.6 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.652 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 1.033 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 12.1 mm -115.1 149.23 17.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.617 0.722 . . . . 0.0 109.301 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.923 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 57.0 t0 -134.2 30.58 3.59 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.767 -178.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.938 HG21 ' CG2' ' A' ' 44' ' ' ILE . 30.4 t . . . . . 0 N--CA 1.463 0.185 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.877 179.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.82 ' HA ' ' HH ' ' A' ' 39' ' ' TYR . 73.8 ttt180 . . . . . 0 N--CA 1.465 0.299 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 1.033 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 4.0 mm? -103.89 133.11 49.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.786 0.327 . . . . 0.0 111.473 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.808 HG21 ' HB2' ' A' ' 113' ' ' ARG . 10.6 p -135.38 133.3 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.593 178.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.897 ' HB2' HD12 ' A' ' 58' ' ' ILE . 1.5 mm? -140.71 142.2 34.86 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 177.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 1.039 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.7 mp -121.14 135.22 62.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 117.987 0.358 . . . . 0.0 110.679 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.692 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 7.9 m120 54.46 37.07 0.38 Allowed Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.857 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 99.5 Cg_exo -56.71 148.63 64.25 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 123.058 2.505 . . . . 0.0 114.408 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.505 ' O ' ' HB ' ' A' ' 108' ' ' ILE . 15.8 pt-20 -139.61 143.04 37.07 Favored 'General case' 0 C--O 1.23 0.079 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.731 ' HB2' ' HE3' ' A' ' 134' ' ' MET . 8.5 tp -80.07 138.02 36.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.443 0.639 . . . . 0.0 111.43 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 1.055 HD21 ' HE ' ' A' ' 109' ' ' ARG . 6.8 mp -113.13 -36.91 4.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.181 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 41.4 tt0 -159.0 149.55 19.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.208 0.528 . . . . 0.0 111.42 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.886 ' HA ' HG11 ' A' ' 106' ' ' VAL . 12.5 ptmt -146.47 149.59 33.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.282 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 81.2 p -158.58 145.04 17.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.526 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.764 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 79.12 154.74 8.48 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.117 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 -127.36 113.82 16.75 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.783 0.801 . . . . 0.0 112.316 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.632 ' OG1' HD11 ' A' ' 128' ' ' ILE . 1.5 p -106.44 160.89 15.06 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 115.645 1.721 . . . . 0.0 115.645 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.689 ' CA ' HD22 ' A' ' 99' ' ' LEU . . . -140.39 105.92 0.46 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 113.046 -1.888 . . . . 0.0 111.584 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.682 ' N ' ' HG ' ' A' ' 99' ' ' LEU . 20.4 mt -144.99 135.45 19.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -178.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.599 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 52.8 mt-10 -72.73 143.28 48.07 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 122.818 1.294 . . . . 0.0 113.37 -177.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.586 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 55.6 mt-10 -156.54 168.64 26.77 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 113.301 -1.772 . . . . 0.0 109.289 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.668 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -120.06 165.97 13.58 Favored Glycine 0 CA--C 1.5 -0.867 0 C-N-CA 119.421 -1.371 . . . . 0.0 110.628 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.544 ' HB2' HG13 ' A' ' 93' ' ' ILE . 63.0 m -115.71 137.65 51.87 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.921 -177.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 1.053 HD23 ' HG2' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -50.89 -33.27 23.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.65 0.738 . . . . 0.0 109.403 179.647 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.638 ' HB3' ' CD1' ' A' ' 13' ' ' LEU . 60.1 m -76.92 -30.56 56.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.829 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.544 HG13 ' HB2' ' A' ' 90' ' ' CYS . 57.7 mt . . . . . 0 C--N 1.327 -0.382 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.668 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 42.9 mtm-85 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 121.67 0.748 . . . . 0.0 111.659 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -134.2 153.94 51.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.839 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.689 HD22 ' CA ' ' A' ' 85' ' ' GLY . 6.9 tt -75.53 135.95 40.59 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.875 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.806 HG12 ' NH1' ' A' ' 102' ' ' ARG . 60.2 t -130.38 134.64 26.32 Favored Pre-proline 0 N--CA 1.454 -0.265 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.604 ' HD2' HG11 ' A' ' 100' ' ' VAL . 88.2 Cg_endo -82.71 124.12 3.91 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.395 1.397 . . . . 0.0 113.721 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 1.031 ' HG2' HD13 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -141.99 164.95 28.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 113.914 -1.494 . . . . 0.0 110.22 179.204 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.764 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.86 154.85 41.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.809 0.338 . . . . 0.0 110.913 -178.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.495 ' OE1' ' HA ' ' A' ' 104' ' ' GLU . 28.2 tp10 -72.66 -43.93 62.51 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.283 -176.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.762 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 55.8 mttm -139.13 138.36 36.94 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.463 0.649 . . . . 0.0 109.495 176.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.906 HG23 ' CG ' ' A' ' 131' ' ' GLN . 25.8 m -147.49 140.43 19.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.614 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.878 ' HD2' ' CB ' ' A' ' 121' ' ' GLU . 51.3 mmtt -107.41 125.37 51.13 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.676 ' CG2' HD12 ' A' ' 77' ' ' LEU . 1.4 pp -129.95 160.75 40.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 1.055 ' HE ' HD21 ' A' ' 78' ' ' LEU . 92.7 mtt180 -107.51 135.01 49.69 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-O 121.142 0.496 . . . . 0.0 110.326 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.756 ' HB2' ' HB3' ' A' ' 72' ' ' LEU . . . -155.75 167.5 30.2 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.184 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 1.039 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.3 pp -115.54 151.69 34.4 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.583 ' O ' HD12 ' A' ' 111' ' ' LEU . 19.8 t70 -86.67 163.46 17.36 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.604 -176.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.808 ' HB2' HG21 ' A' ' 71' ' ' VAL . 14.4 ttp-105 -54.75 -16.44 2.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.77 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.37 -25.7 42.14 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.975 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.835 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 105.91 35.51 2.97 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.573 -0.822 . . . . 0.0 113.837 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -128.92 102.98 18.93 Favored Pre-proline 0 C--O 1.238 0.485 0 CA-C-N 116.967 0.383 . . . . 0.0 111.139 178.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.562 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 32.5 Cg_exo -73.23 114.76 4.12 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 121.653 1.569 . . . . 0.0 114.994 -177.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -129.6 168.93 15.69 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.908 -178.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.832 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 6.2 mp0 -106.63 130.11 54.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.91 0.386 . . . . 0.0 109.981 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.873 HD21 ' O ' ' A' ' 120' ' ' LEU . 0.2 OUTLIER -124.45 141.78 51.82 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.881 0.848 . . . . 0.0 112.017 -178.57 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.878 ' CB ' ' HD2' ' A' ' 107' ' ' LYS . 15.3 pt-20 -94.84 123.33 38.24 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.998 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.637 ' HB3' HD22 ' A' ' 126' ' ' LEU . . . -116.52 134.17 55.16 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.453 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.762 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.2 m-20 -126.76 163.62 23.14 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.734 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 45.89 -133.75 9.61 Favored Glycine 0 C--N 1.348 1.198 0 CA-C-N 120.832 1.651 . . . . 0.0 116.224 176.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.0 mt -53.38 -35.06 59.91 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.444 -0.878 . . . . 0.0 111.444 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.637 HD22 ' HB3' ' A' ' 122' ' ' ALA . 0.6 OUTLIER -70.68 -53.67 14.81 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.311 0.577 . . . . 0.0 110.116 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.734 ' O ' ' HG3' ' A' ' 131' ' ' GLN . . . -59.0 -42.95 91.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.699 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 1.031 HD13 ' HG2' ' A' ' 102' ' ' ARG . 49.5 mm -64.72 -55.47 20.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.366 -178.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.651 ' HG ' HG23 ' A' ' 62' ' ' VAL . 28.9 p -57.76 -49.71 75.69 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -178.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.6 HD12 HG12 ' A' ' 108' ' ' ILE . 19.3 tt -59.26 -42.42 87.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.906 ' CG ' HG23 ' A' ' 106' ' ' VAL . 66.5 mt-30 -65.79 -40.57 92.07 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 178.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.652 ' HA ' ' OD2' ' A' ' 135' ' ' ASP . 74.1 t60 -56.0 -49.2 74.3 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.524 0.678 . . . . 0.0 110.219 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.856 ' O ' HD21 ' A' ' 137' ' ' LEU . 24.0 mm-40 -60.7 -42.44 97.18 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.083 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.916 ' HA ' HD23 ' A' ' 137' ' ' LEU . 35.5 mtm -58.16 -49.62 76.36 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.351 0.978 . . . . 0.0 110.968 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.871 ' O ' HG12 ' A' ' 138' ' ' VAL . 4.1 p30 -63.0 -46.09 89.31 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.681 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.452 ' CE1' ' CG ' ' A' ' 50' ' ' GLN . 11.7 t-80 -56.76 -51.57 68.38 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 121.78 -0.575 . . . . 0.0 111.039 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.916 HD23 ' HA ' ' A' ' 134' ' ' MET . 1.2 pp -59.76 -30.72 69.05 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.799 -177.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.871 HG12 ' O ' ' A' ' 135' ' ' ASP . 10.7 p -83.11 20.48 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-O 123.083 1.42 . . . . 0.0 108.22 174.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.781 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 60.36 17.49 46.99 Favored Glycine 0 CA--C 1.491 -1.455 0 CA-C-N 112.106 -2.316 . . . . 0.0 112.553 176.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.929 ' HB2' ' HZ3' ' A' ' 140' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.431 -1.424 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.511 ' CG1' HG21 ' A' ' 37' ' ' THR . 42.2 t . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.926 0.393 . . . . 0.0 111.276 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.836 ' CD2' ' HB ' ' A' ' 51' ' ' VAL . 58.4 tp -77.39 161.74 27.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.335 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 71.0 tp60 -78.44 106.67 10.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.03 0.443 . . . . 0.0 110.03 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.781 HG12 ' O ' ' A' ' 50' ' ' GLN . 39.5 t -90.08 131.94 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.647 -178.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 1.029 ' HB2' HD23 ' A' ' 13' ' ' LEU . 25.5 mt -85.01 140.73 30.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.479 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 39.2 m-70 -115.79 141.78 47.63 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -178.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.647 HD12 HD13 ' A' ' 13' ' ' LEU . 41.4 mm -62.77 134.5 95.48 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.889 177.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.3 144.81 78.83 Favored 'Cis proline' 0 C--N 1.352 0.754 0 C-N-CA 124.615 -0.994 . . . . 0.0 111.815 -0.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.949 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.6 t70 -164.56 126.46 2.23 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.505 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.533 ' HG2' ' N ' ' A' ' 12' ' ' ARG . 10.5 pm0 -58.28 -45.49 87.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.551 -178.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.678 ' HD3' ' HE3' ' A' ' 15' ' ' LYS . 14.2 mmt-85 -58.13 -27.63 63.92 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 1.029 HD23 ' HB2' ' A' ' 6' ' ' LEU . 9.6 mt -77.58 -31.3 53.0 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 120.814 1.643 . . . . 0.0 108.86 177.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.607 ' C ' ' HA3' ' A' ' 139' ' ' GLY . 13.5 mmt85 -95.54 10.0 38.14 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 114.147 -1.388 . . . . 0.0 109.308 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 1.105 ' HZ1' ' HB2' ' A' ' 54' ' ' HIS . 20.4 ttpp -92.05 146.49 23.69 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.204 -179.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.894 HG13 HG23 ' A' ' 138' ' ' VAL . 44.5 t -84.15 95.26 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.535 -178.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.549 ' C ' ' HG3' ' A' ' 56' ' ' ARG . . . -54.8 148.24 13.42 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-O 121.053 0.454 . . . . 0.0 111.868 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.406 ' HB3' ' OE1' ' A' ' 55' ' ' GLN . 54.2 tttp -103.21 129.42 25.58 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.902 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.66 ' HD3' ' HD3' ' A' ' 56' ' ' ARG . 60.1 Cg_endo -79.64 116.48 3.52 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.428 2.085 . . . . 0.0 110.506 179.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.637 HG11 ' N ' ' A' ' 21' ' ' GLU . 20.9 t -71.27 144.71 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-O 122.552 1.168 . . . . 0.0 113.143 -176.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.637 ' N ' HG11 ' A' ' 20' ' ' VAL . 96.8 mt-10 -69.15 -21.13 64.02 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 113.121 -1.854 . . . . 0.0 112.329 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.551 ' O ' HG12 ' A' ' 20' ' ' VAL . 88.7 tt0 -159.25 142.03 14.16 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 121.157 -0.217 . . . . 0.0 110.566 -179.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.949 HG23 HD12 ' A' ' 111' ' ' LEU . 2.8 t -80.51 106.01 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 -178.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 1.004 HD21 HD12 ' A' ' 27' ' ' ILE . 64.5 m-80 -89.34 159.05 17.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.692 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.55 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -54.17 -30.54 49.83 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.024 0.44 . . . . 0.0 110.69 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -71.81 -39.66 69.7 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 1.004 HD12 HD21 ' A' ' 24' ' ' ASN . 60.6 mt -63.56 -47.6 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.297 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.499 ' HG2' HG12 ' A' ' 23' ' ' VAL . 11.6 mt-30 -57.85 -40.34 79.87 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.77 0.319 . . . . 0.0 110.627 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.55 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 40.0 mmt-85 -59.84 -40.45 88.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.811 0.815 . . . . 0.0 108.866 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.769 ' O ' ' HG3' ' A' ' 34' ' ' MET . 4.4 mt -59.64 -49.48 83.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 114.419 -1.264 . . . . 0.0 111.846 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.767 HG23 HG21 ' A' ' 57' ' ' ILE . 18.7 t -66.82 -42.21 88.86 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-O 120.839 0.352 . . . . 0.0 111.395 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.845 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -55.32 -43.91 75.32 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.997 -179.321 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.606 ' HB3' ' HB2' ' A' ' 3' ' ' LEU . 31.9 m-20 -75.29 -30.83 60.5 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.355 176.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.791 ' HG2' HG23 ' A' ' 51' ' ' VAL . 79.2 mtp -59.55 -47.22 86.38 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.566 -177.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.845 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 13.6 p90 -69.05 -43.99 73.54 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 177.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.758 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 81.7 mt-10 -51.85 -40.31 60.35 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.657 HG23 ' CG2' ' A' ' 5' ' ' VAL . 37.2 m -69.8 -61.45 1.77 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 119.042 -1.063 . . . . 0.0 108.638 177.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 1.0 ' HE3' ' HB2' ' A' ' 61' ' ' ASP . 3.3 ttp -46.22 -43.81 15.72 Favored 'General case' 0 CA--C 1.459 -2.528 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.861 -170.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.706 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 70.2 m-85 -69.63 -41.62 75.41 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.635 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.491 ' CB ' HG22 ' A' ' 2' ' ' VAL . . . -60.23 -28.62 68.16 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 178.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 1.071 ' HG2' HD22 ' A' ' 91' ' ' LEU . 3.2 tp10 -84.72 -10.06 57.62 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 114.407 -1.269 . . . . 0.0 108.876 177.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 62.01 26.05 15.68 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.824 -176.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.89 143.13 25.1 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.373 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.977 HG23 HG23 ' A' ' 62' ' ' VAL . 40.6 mt -78.99 -0.78 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 117.941 0.87 . . . . 0.0 112.008 -178.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.524 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 179.33 135.3 2.36 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 118.972 -0.904 . . . . 0.0 112.005 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.91 ' HB2' ' HG3' ' A' ' 38' ' ' MET . 9.0 tp -126.51 135.43 51.31 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.535 1.667 . . . . 0.0 112.084 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -99.68 130.73 45.93 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.776 ' O ' HG21 ' A' ' 51' ' ' VAL . . . -29.7 -56.15 0.16 Allowed 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.736 HG21 ' O ' ' A' ' 137' ' ' LEU . 75.7 p -53.16 -35.02 59.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.964 0.888 . . . . 0.0 111.167 -178.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.781 ' O ' HG12 ' A' ' 5' ' ' VAL . 36.6 mt-30 -66.1 -38.08 87.36 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.174 -1.375 . . . . 0.0 110.358 179.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.906 ' CG1' HD22 ' A' ' 46' ' ' LEU . 1.4 m -87.61 15.29 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.905 ' HA ' HD11 ' A' ' 6' ' ' LEU . 56.0 t0 76.53 32.89 0.54 Allowed 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 176.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.804 HD11 ' O ' ' A' ' 55' ' ' GLN . 1.2 pp -126.91 111.12 24.77 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.404 177.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 1.105 ' HB2' ' HZ1' ' A' ' 15' ' ' LYS . 0.5 OUTLIER -75.6 64.89 1.73 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.942 0.877 . . . . 0.0 110.59 -179.207 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.804 ' O ' HD11 ' A' ' 53' ' ' ILE . 11.8 mm100 -155.48 134.8 12.36 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 114.359 -1.291 . . . . 0.0 108.385 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.712 ' HG2' ' CD1' ' A' ' 137' ' ' LEU . 77.1 mtp180 -65.37 72.4 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -177.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.767 HG21 HG23 ' A' ' 31' ' ' VAL . 7.4 mm -113.52 122.99 68.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 1.026 HD12 ' HB2' ' A' ' 72' ' ' LEU . 1.9 pp -127.11 145.52 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -177.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.663 HG22 ' H ' ' A' ' 46' ' ' LEU . 32.8 m -127.48 138.41 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.369 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 1.035 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 13.5 mm -115.88 152.69 17.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.571 0.701 . . . . 0.0 110.58 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 1.0 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 36.6 t70 -146.11 34.12 1.0 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.417 -178.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.977 HG23 HG23 ' A' ' 44' ' ' ILE . 38.8 t . . . . . 0 N--CA 1.465 0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.289 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.598 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 76.0 ttt180 . . . . . 0 N--CA 1.462 0.143 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 1.035 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 40.8 mt -104.91 133.48 49.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.455 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.803 HG23 ' HB2' ' A' ' 113' ' ' ARG . 9.9 p -134.82 133.02 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.023 178.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 1.026 ' HB2' HD12 ' A' ' 58' ' ' ILE . 87.3 mt -141.85 141.95 33.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.907 -0.133 . . . . 0.0 111.252 178.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 1.038 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.9 mp -118.24 134.09 62.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 110.418 -0.215 . . . . 0.0 110.418 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.657 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 15.4 p30 46.32 40.75 0.71 Allowed Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.808 ' HG3' ' HB2' ' A' ' 110' ' ' ALA . 92.5 Cg_exo -56.79 155.43 27.26 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.987 2.458 . . . . 0.0 113.247 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.441 ' HG3' HD11 ' A' ' 78' ' ' LEU . 11.7 pt-20 -137.78 143.75 41.25 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 1.047 ' HB2' ' HE2' ' A' ' 134' ' ' MET . 1.8 tt -81.3 133.93 35.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.609 0.719 . . . . 0.0 111.506 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.901 HD22 ' CG ' ' A' ' 109' ' ' ARG . 6.8 mp -109.3 -38.83 5.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.541 -1.208 . . . . 0.0 111.905 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 42.7 tt0 -160.28 155.66 25.16 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.264 0.554 . . . . 0.0 112.056 -179.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.852 ' CB ' HG12 ' A' ' 106' ' ' VAL . 18.7 ptpt -148.25 151.53 35.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.451 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.403 ' HG ' ' C ' ' A' ' 80' ' ' LYS . 53.2 m -160.08 143.46 13.94 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.679 0.276 . . . . 0.0 111.193 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.739 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 81.98 159.72 25.28 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.556 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -130.67 114.0 14.87 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.531 0.682 . . . . 0.0 112.617 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.5 p -107.76 159.31 16.59 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 179.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.768 ' O ' HD11 ' A' ' 86' ' ' ILE . . . -140.06 103.44 0.37 Allowed Glycine 0 C--N 1.318 -0.461 0 CA-C-N 113.039 -1.891 . . . . 0.0 111.63 178.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.768 HD11 ' O ' ' A' ' 85' ' ' GLY . 40.7 mm -144.67 135.86 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -178.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.601 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 48.8 mt-10 -72.27 143.68 48.66 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 122.577 1.18 . . . . 0.0 112.736 -178.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.596 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 50.3 mt-10 -155.61 164.16 39.0 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 113.727 -1.579 . . . . 0.0 109.482 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.763 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -118.68 163.29 13.16 Favored Glycine 0 CA--C 1.498 -1.016 0 C-N-CA 119.258 -1.449 . . . . 0.0 110.235 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.535 ' HB2' HG13 ' A' ' 93' ' ' ILE . 71.8 m -111.71 137.8 49.12 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.886 -177.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 1.071 HD22 ' HG2' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -50.01 -33.51 18.29 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.678 0.752 . . . . 0.0 109.891 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.605 ' HB3' ' CD1' ' A' ' 13' ' ' LEU . 29.2 m -77.55 -29.98 52.48 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.801 -179.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.535 HG13 ' HB2' ' A' ' 90' ' ' CYS . 59.9 mt . . . . . 0 C--N 1.327 -0.377 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.763 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 77.7 mtm180 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 121.729 0.776 . . . . 0.0 111.652 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -129.63 149.68 51.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.651 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.616 ' HG ' ' N ' ' A' ' 86' ' ' ILE . 6.9 tt -75.07 135.39 41.22 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.685 0.279 . . . . 0.0 110.462 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.791 HG12 ' NH1' ' A' ' 102' ' ' ARG . 57.6 t -130.25 130.61 23.07 Favored Pre-proline 0 N--CA 1.453 -0.31 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 84' ' ' THR . 5.8 Cg_exo -77.95 123.85 6.47 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 121.741 1.628 . . . . 0.0 112.587 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.92 ' HB3' HH11 ' A' ' 102' ' ' ARG . 0.0 OUTLIER -142.75 165.28 27.8 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.085 -1.416 . . . . 0.0 110.4 179.39 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.739 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.64 154.94 40.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.721 0.296 . . . . 0.0 110.656 -178.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.407 ' OE1' HG21 ' A' ' 84' ' ' THR . 16.6 tp10 -72.77 -43.08 63.29 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.231 -176.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.789 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 82.3 mttt -139.6 138.27 36.04 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.48 0.657 . . . . 0.0 109.621 176.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.852 HG12 ' CB ' ' A' ' 80' ' ' LYS . 27.4 m -142.51 141.49 27.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.852 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.954 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 52.8 mmtt -107.73 125.77 51.8 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.841 HD11 HD11 ' A' ' 130' ' ' ILE . 2.0 pp -130.86 160.1 42.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -177.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.901 ' CG ' HD22 ' A' ' 78' ' ' LEU . 95.4 mtt180 -109.84 137.8 47.12 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.808 ' HB2' ' HG3' ' A' ' 75' ' ' PRO . . . -156.94 167.49 30.31 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.761 -0.2 . . . . 0.0 111.108 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 1.038 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.0 pp -113.9 151.86 31.61 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.574 ' O ' HD13 ' A' ' 111' ' ' LEU . 9.4 t70 -89.06 162.7 15.86 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.503 -177.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.803 ' HB2' HG23 ' A' ' 71' ' ' VAL . 48.4 ttp85 -52.75 -18.6 1.92 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.235 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -79.25 -25.06 42.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.343 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.435 ' HA2' HG23 ' A' ' 23' ' ' VAL . . . 105.92 35.85 2.89 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.698 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -128.79 102.93 19.3 Favored Pre-proline 0 C--O 1.237 0.423 0 CA-C-N 116.986 0.393 . . . . 0.0 111.248 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.576 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.6 Cg_exo -73.54 114.84 4.14 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 121.703 1.602 . . . . 0.0 114.729 -177.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.18 168.75 13.62 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.683 -178.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.84 ' HG2' ' HG2' ' A' ' 109' ' ' ARG . 33.2 mt-10 -107.39 130.06 54.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.051 0.453 . . . . 0.0 110.132 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.881 HD22 HD12 ' A' ' 72' ' ' LEU . 4.1 pp -127.48 134.72 49.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.97 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.954 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 11.5 pt-20 -93.53 125.11 37.96 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.843 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.812 ' HB3' HD11 ' A' ' 126' ' ' LEU . . . -116.19 135.43 53.92 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.789 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.1 m-20 -126.31 164.49 20.92 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.751 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 47.16 -135.3 11.95 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 120.187 1.358 . . . . 0.0 116.302 176.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 125' ' ' LEU . 87.2 mt -54.04 -33.74 58.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.493 -0.854 . . . . 0.0 111.721 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.812 HD11 ' HB3' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -71.26 -53.46 14.24 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.762 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.676 ' O ' ' HG2' ' A' ' 131' ' ' GLN . . . -59.3 -46.19 89.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.876 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.751 HG12 ' O ' ' A' ' 124' ' ' GLY . 47.3 mm -61.54 -56.02 20.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.095 -178.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.671 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 73.5 m -60.0 -51.22 70.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.841 HD11 HD11 ' A' ' 108' ' ' ILE . 20.3 tt -59.11 -42.07 85.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 121.21 -0.196 . . . . 0.0 111.004 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.841 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.4 pt20 -67.81 -37.77 82.42 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -59.52 -44.94 93.04 Favored 'General case' 0 CA--C 1.521 -0.146 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.859 ' O ' HD21 ' A' ' 137' ' ' LEU . 4.2 mm-40 -59.3 -44.53 92.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.173 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 1.047 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 74.3 mtp -57.42 -48.32 79.42 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.544 0.687 . . . . 0.0 110.28 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.857 ' O ' HG12 ' A' ' 138' ' ' VAL . 30.5 m-20 -61.32 -48.63 80.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.157 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.438 ' CE1' ' HG2' ' A' ' 50' ' ' GLN . 21.4 t-80 -59.99 -51.43 69.71 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.861 0.362 . . . . 0.0 111.65 -178.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.906 HD23 ' HA ' ' A' ' 134' ' ' MET . 1.4 pp -58.76 -32.98 69.77 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.481 -177.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.959 HG11 ' HG2' ' A' ' 140' ' ' LYS . 8.2 p -82.07 20.56 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-O 123.085 1.421 . . . . 0.0 108.854 175.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.826 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 59.44 14.66 28.43 Favored Glycine 0 CA--C 1.49 -1.474 0 CA-C-N 112.178 -2.283 . . . . 0.0 112.622 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.959 ' HG2' HG11 ' A' ' 138' ' ' VAL . 8.5 ptmt . . . . . 0 N--CA 1.426 -1.65 0 C-N-CA 119.466 -0.893 . . . . 0.0 108.816 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.587 HG13 ' HA ' ' A' ' 37' ' ' THR . 30.5 m . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.848 0.356 . . . . 0.0 111.428 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.824 HD13 ' O ' ' A' ' 51' ' ' VAL . 3.0 pp -79.63 -172.4 3.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.565 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.757 ' N ' HD11 ' A' ' 3' ' ' LEU . 40.8 tt0 -82.37 108.98 16.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.782 0.325 . . . . 0.0 110.454 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.9 t -88.42 129.85 38.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.385 0.612 . . . . 0.0 112.03 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.961 HD12 ' HA ' ' A' ' 52' ' ' ASP . 23.7 mt -88.15 147.39 24.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.655 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.436 ' HA ' ' O ' ' A' ' 92' ' ' SER . 47.5 m-70 -128.19 146.06 50.84 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.782 HD12 ' CD1' ' A' ' 13' ' ' LEU . 3.3 mp -64.22 135.23 96.24 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.205 177.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.39 140.83 58.48 Favored 'Cis proline' 0 C--N 1.352 0.741 0 C-N-CA 124.253 -1.145 . . . . 0.0 111.804 -0.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.875 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.7 t70 -160.85 125.17 3.56 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.475 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.553 ' HG2' ' N ' ' A' ' 12' ' ' ARG . 2.7 pm0 -57.8 -43.81 85.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.418 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.643 ' HE ' ' HE3' ' A' ' 15' ' ' LYS . 15.5 mmt85 -55.99 -30.05 61.2 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.934 HD12 ' HB3' ' A' ' 92' ' ' SER . 9.8 mt -77.1 -32.7 56.79 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 120.891 1.678 . . . . 0.0 108.661 177.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -91.66 8.83 34.98 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 113.998 -1.455 . . . . 0.0 109.165 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.643 ' HE3' ' HE ' ' A' ' 12' ' ' ARG . 24.9 ttmm -91.26 148.05 22.62 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.05 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.64 HG13 HG23 ' A' ' 138' ' ' VAL . 85.5 t -82.78 129.83 36.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.789 ' HB2' ' HG3' ' A' ' 56' ' ' ARG . . . -90.45 144.31 25.92 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.384 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.755 ' HD3' ' CD ' ' A' ' 19' ' ' PRO . 2.0 tmtp? -106.35 133.14 20.37 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.755 ' CD ' ' HD3' ' A' ' 18' ' ' LYS . 45.7 Cg_endo -82.09 114.71 2.57 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 121.934 1.756 . . . . 0.0 110.73 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.607 HG13 ' N ' ' A' ' 21' ' ' GLU . 16.0 t -67.68 144.33 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 CA-C-O 122.574 1.178 . . . . 0.0 113.247 -175.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.607 ' N ' HG13 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -63.82 -23.45 67.36 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 112.924 -1.944 . . . . 0.0 112.639 -179.298 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -158.67 144.51 16.72 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.13 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.907 ' CG2' HD21 ' A' ' 111' ' ' LEU . 3.1 t -81.45 107.4 13.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -178.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.981 ' HB2' HD12 ' A' ' 27' ' ' ILE . 55.0 m-80 -95.38 157.79 15.74 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.769 -178.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.516 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -55.18 -24.22 25.73 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.282 0.563 . . . . 0.0 110.808 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.488 ' O ' HD12 ' A' ' 30' ' ' ILE . 70.8 mm-40 -74.45 -44.92 49.52 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 177.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.981 HD12 ' HB2' ' A' ' 24' ' ' ASN . 2.0 mp -64.72 -34.34 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 113.793 -1.548 . . . . 0.0 110.153 178.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.507 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 75.0 mt-30 -68.16 -40.59 82.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 122.297 -0.252 . . . . 0.0 110.713 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 40.3 mmt180 -61.44 -39.3 90.33 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.85 ' CG2' HD11 ' A' ' 53' ' ' ILE . 1.6 mp -57.75 -48.53 83.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.087 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.575 ' CG1' HG23 ' A' ' 71' ' ' VAL . 27.6 t -68.11 -42.26 84.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.97 0.414 . . . . 0.0 111.156 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.831 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -56.39 -42.19 77.5 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.058 -179.254 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.491 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 17.5 m-20 -75.78 -30.11 58.98 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.261 176.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.817 ' HE1' ' O ' ' A' ' 57' ' ' ILE . 87.6 mtp -60.92 -46.27 91.33 Favored 'General case' 0 C--N 1.345 0.395 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.516 -177.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.831 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 13.5 p90 -69.59 -45.91 67.53 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.583 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 29.4 mm-40 -52.51 -38.44 59.61 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.587 ' HA ' HG13 ' A' ' 2' ' ' VAL . 61.6 m -69.9 -62.23 1.47 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.487 -1.233 . . . . 0.0 107.857 178.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 1.015 ' HE3' ' HB2' ' A' ' 61' ' ' ASP . 3.7 ttp -46.65 -41.85 15.43 Favored 'General case' 0 CA--C 1.461 -2.472 0 C-N-CA 124.042 0.937 . . . . 0.0 110.72 -171.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.704 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 70.9 m-85 -70.48 -42.32 71.55 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.38 178.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.549 ' HB1' HG13 ' A' ' 2' ' ' VAL . . . -61.4 -24.31 66.42 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.358 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 1.091 ' HG2' HD12 ' A' ' 91' ' ' LEU . 3.1 tp10 -89.05 -10.7 46.49 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 114.47 -1.241 . . . . 0.0 108.566 177.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 62.96 26.7 15.65 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.818 -176.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.97 145.17 26.91 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.974 178.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.987 HG21 HG23 ' A' ' 62' ' ' VAL . 44.1 mm -79.3 -1.56 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 117.418 0.609 . . . . 0.0 112.028 -178.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.525 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 177.54 142.06 4.38 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -178.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.959 HD11 ' HG ' ' A' ' 91' ' ' LEU . 4.7 tp -126.21 135.63 51.85 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.528 1.664 . . . . 0.0 110.479 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -105.9 132.2 52.29 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.526 ' HB1' ' CG1' ' A' ' 53' ' ' ILE . . . -28.73 -56.76 0.13 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 -178.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 1.008 HG22 ' HA ' ' A' ' 137' ' ' LEU . 67.6 p -53.17 -34.64 57.78 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 121.953 0.883 . . . . 0.0 111.164 -178.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.718 ' HB2' HD13 ' A' ' 46' ' ' LEU . 50.3 mt-30 -63.94 -43.83 94.67 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.25 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.824 ' O ' HD13 ' A' ' 3' ' ' LEU . 1.0 OUTLIER -86.76 15.07 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.961 ' HA ' HD12 ' A' ' 6' ' ' LEU . 36.5 t70 78.29 27.87 0.5 Allowed 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 176.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.937 HD13 ' HB ' ' A' ' 57' ' ' ILE . 10.7 pt -119.36 109.83 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 C-N-CA 119.045 -1.062 . . . . 0.0 110.858 177.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.578 ' HB3' ' HD2' ' A' ' 15' ' ' LYS . 25.2 p-80 -75.84 49.18 0.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 122.063 0.935 . . . . 0.0 109.946 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.456 ' H ' ' C ' ' A' ' 53' ' ' ILE . 27.9 mt-30 -136.48 130.62 32.83 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.789 ' HG3' ' HB2' ' A' ' 17' ' ' ALA . 60.3 mtp85 -62.46 75.14 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.937 ' HB ' HD13 ' A' ' 53' ' ' ILE . 15.0 mt -119.83 124.62 73.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 1.038 HD11 ' HG2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -131.57 148.5 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -178.069 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.568 ' CG2' ' HB3' ' A' ' 46' ' ' LEU . 32.8 m -124.34 138.85 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 1.02 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 6.1 mm -113.57 150.86 15.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-O 121.739 0.781 . . . . 0.0 110.137 -179.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 1.015 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 36.1 t70 -140.16 27.6 2.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.895 -177.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.987 HG23 HG21 ' A' ' 44' ' ' ILE . 41.1 t . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.219 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.615 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 34.3 ttp85 . . . . . 0 N--CA 1.465 0.314 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 1.02 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 62.0 mt -106.79 135.43 48.34 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-O 120.692 0.282 . . . . 0.0 111.431 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.836 HG22 ' HB2' ' A' ' 113' ' ' ARG . 12.7 p -134.94 135.16 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.25 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.944 ' HB2' HD12 ' A' ' 58' ' ' ILE . 3.2 mm? -141.63 144.35 34.13 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 177.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.967 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.5 mp -124.33 135.78 62.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.9 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.69 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 6.1 m120 49.57 35.48 0.28 Allowed Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 178.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 1.038 ' HG2' HD11 ' A' ' 58' ' ' ILE . 80.2 Cg_exo -60.91 157.18 39.72 Favored 'Trans proline' 0 N--CA 1.485 1.02 0 C-N-CA 122.809 2.34 . . . . 0.0 114.761 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -138.05 141.78 40.33 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 1.022 HD12 ' HE3' ' A' ' 80' ' ' LYS . 1.5 tt -80.23 131.64 35.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.151 0.5 . . . . 0.0 111.369 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.795 ' CD2' ' HG3' ' A' ' 109' ' ' ARG . 2.7 mm? -104.24 -39.06 6.64 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.872 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.62 ' O ' HD21 ' A' ' 77' ' ' LEU . 40.0 tp10 -152.68 152.01 31.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.138 0.495 . . . . 0.0 111.521 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 1.022 ' HE3' HD12 ' A' ' 77' ' ' LEU . 9.2 ptpp? -147.67 148.48 31.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.437 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.8 m -158.58 147.8 19.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.254 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.647 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 73.23 158.67 4.93 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.495 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -133.92 114.38 13.22 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 122.292 1.044 . . . . 0.0 113.356 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.63 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.7 p -103.73 162.11 13.36 Favored 'General case' 0 CA--C 1.488 -1.435 0 CA-C-N 113.244 -1.798 . . . . 0.0 115.232 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.718 ' O ' HD11 ' A' ' 86' ' ' ILE . . . -148.29 117.9 0.93 Allowed Glycine 0 C--N 1.314 -0.66 0 CA-C-N 112.54 -2.118 . . . . 0.0 110.418 177.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.718 HD11 ' O ' ' A' ' 85' ' ' GLY . 48.3 mm -147.04 138.47 18.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 117.297 0.549 . . . . 0.0 111.284 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 56.3 mt-10 -72.26 139.0 47.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 123.297 1.523 . . . . 0.0 111.613 -176.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.723 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 47.2 mt-10 -155.92 161.42 40.55 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 112.693 -2.049 . . . . 0.0 111.392 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.803 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -120.15 165.51 13.64 Favored Glycine 0 CA--C 1.496 -1.127 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.514 ' HB2' HD11 ' A' ' 93' ' ' ILE . 20.5 m -114.92 137.08 52.39 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.512 0.672 . . . . 0.0 112.331 -177.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 1.091 HD12 ' HG2' ' A' ' 41' ' ' GLU . 2.3 mm? -46.77 -40.35 13.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.453 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.934 ' HB3' HD12 ' A' ' 13' ' ' LEU . 51.0 m -78.18 -27.51 47.97 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.091 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.535 HG13 HD13 ' A' ' 8' ' ' ILE . 54.4 mt . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.803 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 47.9 mtm-85 . . . . . 0 C--O 1.233 0.21 0 CA-C-O 121.837 0.827 . . . . 0.0 111.892 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -135.74 153.68 51.49 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.492 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.577 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.3 tt -76.34 114.23 14.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.61 0.719 . . . . 0.0 111.752 -178.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.902 HG11 ' NE ' ' A' ' 102' ' ' ARG . 13.7 p -106.56 129.66 24.11 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 114.931 -1.031 . . . . 0.0 112.181 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.63 ' HA ' ' O ' ' A' ' 84' ' ' THR . 1.1 Cg_endo -84.22 127.09 3.88 Favored 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 123.56 2.84 . . . . 0.0 113.921 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.902 ' NE ' HG11 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -143.82 167.61 21.91 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.512 1.125 . . . . 0.0 109.471 179.12 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.36 155.33 40.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 118.357 0.526 . . . . 0.0 109.969 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -73.63 -41.94 62.11 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.972 -175.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.699 ' O ' HG12 ' A' ' 106' ' ' VAL . 61.3 mttp -140.04 140.54 36.19 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.381 0.61 . . . . 0.0 109.573 177.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.85 HG22 ' CG ' ' A' ' 131' ' ' GLN . 22.5 m -151.36 140.2 14.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.598 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.954 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 52.8 mmtt -107.34 126.34 52.33 Favored 'General case' 0 CA--C 1.524 -0.026 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.872 HG23 ' HA ' ' A' ' 77' ' ' LEU . 1.7 pp -135.72 154.06 33.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -176.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.795 ' HG3' ' CD2' ' A' ' 78' ' ' LEU . 50.1 mtm180 -103.07 139.53 38.48 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.532 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.905 ' HB2' ' HG3' ' A' ' 75' ' ' PRO . . . -160.45 169.73 22.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.642 -176.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.967 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.3 pp -118.26 151.44 37.66 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.64 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 8.5 t70 -87.64 161.44 17.68 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.257 -176.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.836 ' HB2' HG22 ' A' ' 71' ' ' VAL . 52.0 ttp85 -52.74 -17.28 1.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.099 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.56 -29.32 46.21 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.799 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.509 ' HA2' HG22 ' A' ' 23' ' ' VAL . . . 109.2 35.58 2.29 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.45 -0.881 . . . . 0.0 113.24 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -128.79 102.99 19.26 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 121.177 -0.209 . . . . 0.0 110.972 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.589 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.3 Cg_exo -73.76 115.1 4.21 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 121.553 1.502 . . . . 0.0 114.757 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.64 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 11.0 p90 -127.38 169.01 14.05 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.442 -177.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.638 ' HG2' ' CG ' ' A' ' 109' ' ' ARG . 31.1 mt-10 -106.65 129.9 54.48 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.707 HD22 HD12 ' A' ' 72' ' ' LEU . 4.3 pp -125.72 134.66 51.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.476 -178.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.954 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 15.3 pt-20 -92.99 123.88 36.56 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.636 178.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.949 ' HB3' HD13 ' A' ' 126' ' ' LEU . . . -117.71 134.01 55.34 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.696 ' CA ' ' HB3' ' A' ' 127' ' ' ALA . 22.9 m-20 -126.96 162.86 24.97 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.747 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 50.92 -136.68 28.97 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 120.265 1.393 . . . . 0.0 115.658 177.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.964 ' H ' HD13 ' A' ' 125' ' ' LEU . 4.7 mp -55.23 -33.24 62.94 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.684 -0.758 . . . . 0.0 111.706 -178.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.949 HD13 ' HB3' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -71.03 -52.12 21.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.866 0.841 . . . . 0.0 109.203 179.692 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.732 ' O ' ' HG3' ' A' ' 131' ' ' GLN . . . -59.01 -41.23 87.2 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.194 -1.366 . . . . 0.0 111.703 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.747 HG12 ' O ' ' A' ' 124' ' ' GLY . 50.5 mm -68.43 -54.99 17.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.626 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 30.4 p -58.13 -47.73 82.39 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.844 HD11 ' CD1' ' A' ' 108' ' ' ILE . 19.5 tt -59.05 -44.03 90.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.867 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.85 ' CG ' HG22 ' A' ' 106' ' ' VAL . 69.5 mt-30 -64.72 -44.94 88.57 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 178.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 76.0 t60 -56.44 -47.75 78.45 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.243 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.795 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 3.3 mm-40 -60.23 -38.86 84.7 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 110.552 -0.166 . . . . 0.0 110.552 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.851 ' HE3' ' HB2' ' A' ' 77' ' ' LEU . 28.4 mtm -58.77 -45.66 89.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 122.338 1.066 . . . . 0.0 109.384 177.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.919 ' O ' HG11 ' A' ' 138' ' ' VAL . 0.9 OUTLIER -66.58 -48.55 69.25 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.999 179.394 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.651 ' CE1' ' HG2' ' A' ' 50' ' ' GLN . 7.8 t-80 -57.15 -53.0 63.06 Favored 'General case' 0 C--N 1.32 -0.712 0 O-C-N 121.512 -0.742 . . . . 0.0 111.491 -178.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 1.008 ' HA ' HG22 ' A' ' 49' ' ' THR . 0.2 OUTLIER -65.17 -27.85 69.0 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 119.908 -0.717 . . . . 0.0 111.903 -179.449 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.919 HG11 ' O ' ' A' ' 135' ' ' ASP . 10.9 p -81.16 23.62 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-O 122.056 0.932 . . . . 0.0 109.211 175.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.526 ' H ' ' C ' ' A' ' 137' ' ' LEU . . . 67.94 3.67 30.44 Favored Glycine 0 CA--C 1.486 -1.752 0 CA-C-N 113.793 -1.549 . . . . 0.0 113.245 175.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.89 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 10.4 ptmt . . . . . 0 N--CA 1.417 -2.106 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.591 HG12 ' HB1' ' A' ' 40' ' ' ALA . 30.9 m . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.733 0.301 . . . . 0.0 111.643 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.968 HD13 ' HB ' ' A' ' 51' ' ' VAL . 3.1 pp -79.03 -179.09 6.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.246 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.614 ' N ' HD11 ' A' ' 3' ' ' LEU . 2.2 tp-100 -80.63 108.8 14.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.753 0.311 . . . . 0.0 110.883 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.589 ' CG2' HG23 ' A' ' 37' ' ' THR . 46.6 t -89.21 131.64 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-O 121.216 0.531 . . . . 0.0 111.366 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.952 HD12 ' HA ' ' A' ' 52' ' ' ASP . 26.1 mt -85.21 143.22 28.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.463 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 26.0 m-70 -116.64 144.11 44.8 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.507 0.67 . . . . 0.0 112.63 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.633 HD12 ' CD1' ' A' ' 13' ' ' LEU . 42.8 mm -53.45 144.04 33.86 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.707 178.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.485 ' CA ' HG23 ' A' ' 8' ' ' ILE . 64.3 Cg_endo -93.49 54.12 0.94 Allowed 'Cis proline' 0 C--N 1.356 0.933 0 C-N-CA 124.727 -0.947 . . . . 0.0 113.036 0.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.922 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 9.8 t70 -55.32 134.55 50.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.037 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.423 ' HG2' ' N ' ' A' ' 12' ' ' ARG . 0.7 OUTLIER -59.65 -42.76 93.52 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.961 0.41 . . . . 0.0 111.213 -179.495 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.684 ' HB2' HD11 ' A' ' 6' ' ' LEU . 14.0 mmt85 -59.19 -23.53 62.32 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.922 ' HG ' ' HB3' ' A' ' 10' ' ' ASP . 9.2 mt -76.22 -32.7 59.07 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 120.172 1.351 . . . . 0.0 107.692 177.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 16.3 mmm180 -90.86 3.17 55.23 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 113.857 -1.52 . . . . 0.0 109.554 178.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.839 ' HE2' ' HD1' ' A' ' 54' ' ' HIS . 62.3 tttp -82.09 146.88 29.4 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.671 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.51 HG13 HG23 ' A' ' 138' ' ' VAL . 96.4 t -82.14 135.4 25.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.756 ' HB2' ' HG2' ' A' ' 56' ' ' ARG . . . -91.4 139.68 30.48 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -103.21 130.57 23.37 Favored Pre-proline 0 C--N 1.322 -0.612 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.316 178.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.478 ' HD3' ' CD ' ' A' ' 56' ' ' ARG . 67.9 Cg_endo -77.11 114.75 3.85 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.032 1.821 . . . . 0.0 110.454 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.623 HG13 ' N ' ' A' ' 21' ' ' GLU . 17.4 t -68.98 144.51 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-O 122.426 1.108 . . . . 0.0 113.308 -176.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.623 ' N ' HG13 ' A' ' 20' ' ' VAL . 69.6 mm-40 -63.65 -24.35 67.75 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 113.443 -1.708 . . . . 0.0 112.073 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.432 ' O ' HG11 ' A' ' 20' ' ' VAL . 88.8 tt0 -161.03 143.46 12.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.875 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.874 HG23 HD13 ' A' ' 111' ' ' LEU . 3.2 t -78.88 107.24 11.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.894 ' HB2' HD13 ' A' ' 27' ' ' ILE . 56.2 m-80 -91.36 159.9 15.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.317 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.588 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -56.81 -29.14 62.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.927 0.394 . . . . 0.0 110.941 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 1.039 ' HG2' HH22 ' A' ' 29' ' ' ARG . 94.7 mt-10 -71.88 -42.83 66.35 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.894 HD13 ' HB2' ' A' ' 24' ' ' ASN . 1.8 mp -62.28 -45.93 97.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.791 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.655 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 54.5 mt-30 -57.38 -40.22 77.7 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.501 178.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 1.039 HH22 ' HG2' ' A' ' 26' ' ' GLU . 75.9 mtm-85 -61.76 -38.83 89.46 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.908 HG22 HD11 ' A' ' 57' ' ' ILE . 1.6 mp -58.77 -49.12 83.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.056 178.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.698 HG13 ' CG2' ' A' ' 71' ' ' VAL . 5.3 t -65.97 -42.19 91.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.527 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.837 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 21.5 m-20 -54.43 -45.04 72.93 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.838 -179.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.484 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 54.4 m-20 -74.88 -30.72 61.39 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.64 176.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.796 ' HG2' HG23 ' A' ' 51' ' ' VAL . 79.7 mtp -59.88 -47.18 86.81 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.543 -177.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.837 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 14.4 p90 -69.31 -43.85 72.93 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.759 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 75.0 mt-10 -51.91 -41.89 62.34 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.589 HG23 ' CG2' ' A' ' 5' ' ' VAL . 57.2 m -68.51 -60.27 2.55 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 119.105 -1.038 . . . . 0.0 108.608 178.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 1.05 ' HE3' ' HB2' ' A' ' 61' ' ' ASP . 3.6 ttp -47.12 -42.42 19.16 Favored 'General case' 0 CA--C 1.466 -2.262 0 O-C-N 124.118 0.886 . . . . 0.0 109.729 -170.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.713 ' OH ' ' HA ' ' A' ' 69' ' ' ARG . 68.6 m-85 -69.32 -42.37 75.47 Favored 'General case' 0 C--N 1.285 -2.233 0 O-C-N 124.101 0.876 . . . . 0.0 110.578 178.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.591 ' HB1' HG12 ' A' ' 2' ' ' VAL . . . -60.09 -28.86 68.17 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.925 ' HG2' HD22 ' A' ' 91' ' ' LEU . 3.1 tp10 -84.1 -10.79 57.53 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.484 -1.234 . . . . 0.0 108.777 177.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 62.8 25.1 14.92 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.74 -176.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.73 145.17 29.79 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 114.142 -1.39 . . . . 0.0 110.524 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 1.02 HG21 HG22 ' A' ' 62' ' ' VAL . 46.0 mm -77.96 -2.5 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 117.621 0.711 . . . . 0.0 111.687 -178.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.621 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 176.29 138.34 2.85 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-O 119.045 -0.864 . . . . 0.0 111.552 -178.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.941 HD12 ' HG ' ' A' ' 91' ' ' LEU . 9.2 tp -125.6 135.03 51.75 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 118.821 1.311 . . . . 0.0 110.744 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -103.87 132.75 49.82 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.646 0.26 . . . . 0.0 111.553 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.704 ' HB3' ' O ' ' A' ' 57' ' ' ILE . . . -30.72 -56.14 0.21 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -177.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.682 ' CG2' ' HA ' ' A' ' 137' ' ' LEU . 42.9 p -52.92 -35.38 58.32 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 122.168 0.985 . . . . 0.0 110.876 -178.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.552 ' HG2' ' CE1' ' A' ' 136' ' ' HIS . 15.8 mt-30 -64.58 -39.44 93.75 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.666 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.968 ' HB ' HD13 ' A' ' 3' ' ' LEU . 1.7 m -88.25 14.76 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.952 ' HA ' HD12 ' A' ' 6' ' ' LEU . 37.5 t70 79.11 31.45 0.29 Allowed 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 176.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.968 HD12 HD11 ' A' ' 57' ' ' ILE . 1.2 pp -126.45 111.22 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.446 177.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.839 ' HD1' ' HE2' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -75.55 64.17 1.61 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.976 0.893 . . . . 0.0 110.518 -179.278 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.802 ' O ' HD11 ' A' ' 53' ' ' ILE . 88.0 mt-30 -153.54 135.21 14.44 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.444 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.756 ' HG2' ' HB2' ' A' ' 17' ' ' ALA . 75.2 mtp180 -64.66 69.04 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -178.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.968 HD11 HD12 ' A' ' 53' ' ' ILE . 7.2 mt -112.14 123.26 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.797 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -130.72 147.4 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-O 121.811 0.815 . . . . 0.0 112.783 -178.253 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.601 HG22 ' H ' ' A' ' 46' ' ' LEU . 34.0 m -129.08 137.96 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.44 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.907 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 1.8 mt -116.81 149.3 19.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.718 0.77 . . . . 0.0 111.262 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 1.05 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 33.8 t70 -136.84 31.95 2.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.449 -1.251 . . . . 0.0 110.35 -178.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 1.02 HG22 HG21 ' A' ' 44' ' ' ILE . 24.0 t . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.953 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.713 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 40.1 ttm-85 . . . . . 0 N--CA 1.465 0.317 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.907 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 3.7 mm? -103.32 132.29 49.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.913 0.387 . . . . 0.0 111.872 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.941 HG21 ' HB2' ' A' ' 113' ' ' ARG . 11.5 p -134.33 130.95 54.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.981 178.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.851 HD22 HD22 ' A' ' 120' ' ' LEU . 10.5 mp -139.88 140.02 36.38 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.938 -0.119 . . . . 0.0 111.019 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.984 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.6 mp -119.93 134.47 63.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.678 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 8.2 m120 54.43 35.93 0.31 Allowed Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.73 ' HG2' HG22 ' A' ' 58' ' ' ILE . 91.1 Cg_exo -55.3 148.56 50.14 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.752 2.301 . . . . 0.0 113.607 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.676 ' HG3' HD23 ' A' ' 78' ' ' LEU . 15.7 pt-20 -135.83 144.25 45.58 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.894 HD21 ' N ' ' A' ' 78' ' ' LEU . 1.8 tt -83.49 135.18 34.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.385 0.612 . . . . 0.0 111.02 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.97 HD21 ' HG3' ' A' ' 109' ' ' ARG . 3.3 mm? -116.76 -31.95 5.3 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.65 -178.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 36.6 tt0 -160.33 151.81 19.6 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.17 0.51 . . . . 0.0 111.854 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.814 ' CB ' HG13 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -148.39 151.78 35.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.088 178.792 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 81.0 p -160.36 145.2 14.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.73 0.3 . . . . 0.0 111.5 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.8 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 75.52 169.89 27.13 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.43 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 102' ' ' ARG . 52.3 mm-40 -146.78 114.71 6.52 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.801 0.81 . . . . 0.0 113.152 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.599 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.4 p -97.03 160.1 14.53 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 178.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.735 ' O ' HD11 ' A' ' 86' ' ' ILE . . . -137.99 100.53 0.31 Allowed Glycine 0 CA--C 1.522 0.52 0 CA-C-N 113.186 -1.825 . . . . 0.0 111.394 178.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.777 ' N ' HH12 ' A' ' 102' ' ' ARG . 47.7 mm -147.75 141.14 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.578 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 55.4 mt-10 -72.72 143.21 48.11 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 122.359 1.076 . . . . 0.0 112.437 -177.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.616 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 54.6 mt-10 -155.77 162.78 40.45 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.157 -1.383 . . . . 0.0 109.768 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.781 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -120.23 160.49 14.83 Favored Glycine 0 CA--C 1.5 -0.857 0 C-N-CA 119.456 -1.355 . . . . 0.0 111.223 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.608 ' HB2' HG13 ' A' ' 93' ' ' ILE . 57.1 m -110.16 139.68 45.05 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.691 0.281 . . . . 0.0 110.668 -177.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.941 ' HG ' HD12 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -52.43 -31.25 33.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.494 0.664 . . . . 0.0 109.855 179.72 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.594 ' HB3' ' CD1' ' A' ' 13' ' ' LEU . 49.8 m -77.74 -29.44 51.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.711 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.608 HG13 ' HB2' ' A' ' 90' ' ' CYS . 58.0 mt . . . . . 0 C--N 1.327 -0.398 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.781 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 20.0 mtm105 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.497 0.665 . . . . 0.0 111.384 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.419 ' C ' ' HA ' ' A' ' 87' ' ' GLU . . . -133.01 150.46 52.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.133 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.728 ' HG ' ' N ' ' A' ' 86' ' ' ILE . 6.7 tt -75.43 135.57 40.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.317 -179.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.574 HG11 ' CD ' ' A' ' 101' ' ' PRO . 46.1 t -136.94 138.58 26.27 Favored Pre-proline 0 N--CA 1.464 0.243 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.684 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 84' ' ' THR . 3.4 Cg_exo -80.49 125.48 5.67 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.408 2.072 . . . . 0.0 113.424 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 1.037 ' HE ' HG21 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -143.79 166.07 25.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.066 -1.424 . . . . 0.0 109.988 177.936 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.8 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.24 153.06 44.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.962 0.346 . . . . 0.0 110.583 -178.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.417 ' OE1' ' HA ' ' A' ' 104' ' ' GLU . 5.1 tp10 -74.29 -41.97 60.33 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.638 -176.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.806 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 48.6 mttp -139.8 137.93 35.42 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.61 0.719 . . . . 0.0 109.634 177.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.814 HG13 ' CB ' ' A' ' 80' ' ' LYS . 32.0 m -142.9 143.16 25.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.046 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.963 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 31.8 mmtm -107.48 125.58 51.43 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.84 HD13 ' HG ' ' A' ' 120' ' ' LEU . 2.1 pp -128.79 162.09 36.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -177.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.97 ' HG3' HD21 ' A' ' 78' ' ' LEU . 26.6 mtt-85 -116.03 139.4 50.31 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.624 ' CB ' HD23 ' A' ' 72' ' ' LEU . . . -158.98 168.26 27.23 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.671 0.272 . . . . 0.0 111.449 -178.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.984 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.1 pp -113.87 152.32 30.9 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.586 ' O ' HD11 ' A' ' 111' ' ' LEU . 15.7 t70 -88.58 162.75 16.2 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.021 -0.672 . . . . 0.0 111.569 -177.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.941 ' HB2' HG21 ' A' ' 71' ' ' VAL . 46.2 ttp180 -52.67 -18.91 2.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.969 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -78.96 -25.59 43.53 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.438 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 106.44 35.61 2.83 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.518 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -128.74 102.79 19.54 Favored Pre-proline 0 C--O 1.238 0.479 0 CA-C-N 117.036 0.418 . . . . 0.0 111.178 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.581 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.9 Cg_exo -73.28 115.27 4.28 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 121.838 1.692 . . . . 0.0 114.975 -177.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -124.52 168.43 13.1 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.712 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.509 ' HG2' ' HD3' ' A' ' 109' ' ' ARG . 23.0 mt-10 -107.79 131.61 54.28 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.851 HD22 HD22 ' A' ' 72' ' ' LEU . 3.9 pp -131.57 133.91 45.51 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.963 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 15.5 pt-20 -94.15 125.52 38.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.766 178.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.993 ' HB3' HD13 ' A' ' 126' ' ' LEU . . . -116.96 136.01 53.27 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.806 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.1 m-20 -126.3 164.44 21.03 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.683 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 45.55 -130.5 9.36 Favored Glycine 0 C--N 1.346 1.118 0 N-CA-C 116.431 1.332 . . . . 0.0 116.431 176.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.572 ' HB3' HG11 ' A' ' 62' ' ' VAL . 86.6 mt -55.18 -36.49 65.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.692 -0.754 . . . . 0.0 111.703 -178.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.993 HD13 ' HB3' ' A' ' 122' ' ' ALA . 0.3 OUTLIER -71.31 -52.9 16.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.471 0.653 . . . . 0.0 109.884 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.681 ' HB3' ' CA ' ' A' ' 123' ' ' ASP . . . -58.39 -46.01 87.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.913 -1.039 . . . . 0.0 112.163 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 1.037 HG21 ' HE ' ' A' ' 102' ' ' ARG . 49.3 mm -63.76 -56.04 19.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.807 0.336 . . . . 0.0 111.107 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.653 ' SG ' HG23 ' A' ' 62' ' ' VAL . 74.6 m -60.92 -50.53 73.04 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.812 HD11 HD11 ' A' ' 108' ' ' ILE . 20.3 tt -58.77 -43.73 88.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.328 -178.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.664 ' HG2' ' O ' ' A' ' 127' ' ' ALA . 22.9 pt20 -65.68 -37.63 87.04 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -56.65 -48.87 76.61 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.281 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.803 ' O ' HD22 ' A' ' 137' ' ' LEU . 2.8 mm-40 -60.93 -45.86 92.99 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 119.09 -0.481 . . . . 0.0 111.217 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.931 ' HA ' HD21 ' A' ' 137' ' ' LEU . 75.2 mtp -55.55 -47.78 75.8 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 118.965 0.802 . . . . 0.0 109.893 179.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.854 ' O ' HG11 ' A' ' 138' ' ' VAL . 1.1 m-20 -62.02 -48.49 80.05 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.376 178.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.552 ' CE1' ' HG2' ' A' ' 50' ' ' GLN . 10.4 t-80 -57.31 -49.99 74.34 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.294 0.569 . . . . 0.0 110.82 -178.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.931 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.5 pp -60.58 -30.51 69.86 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.032 -178.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.854 HG11 ' O ' ' A' ' 135' ' ' ASP . 12.9 p -81.78 22.18 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 CA-C-O 122.726 1.251 . . . . 0.0 109.051 175.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.589 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 70.85 -3.19 13.5 Favored Glycine 0 CA--C 1.494 -1.256 0 CA-C-N 112.629 -2.078 . . . . 0.0 113.035 176.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.728 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 1.6 ptmt . . . . . 0 N--CA 1.433 -1.305 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.649 ' CG1' ' HA ' ' A' ' 37' ' ' THR . 30.8 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.875 0.369 . . . . 0.0 111.417 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.824 ' CD2' ' HB ' ' A' ' 51' ' ' VAL . 3.0 pp -79.87 -169.51 2.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.696 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.715 ' N ' HD12 ' A' ' 3' ' ' LEU . 4.0 tp-100 -84.64 111.72 19.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.859 0.361 . . . . 0.0 110.053 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.7 t -88.51 127.79 41.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.371 0.605 . . . . 0.0 111.828 -178.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.972 HD13 ' HA ' ' A' ' 52' ' ' ASP . 23.1 mt -87.14 142.69 27.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.361 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.554 ' HA ' ' HB3' ' A' ' 92' ' ' SER . 34.7 m-70 -116.16 147.06 41.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.245 0.545 . . . . 0.0 111.992 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.98 HD12 HD11 ' A' ' 13' ' ' LEU . 38.4 mm -58.27 147.0 68.91 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.358 178.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.537 ' CA ' HG21 ' A' ' 8' ' ' ILE . 78.2 Cg_endo -93.22 52.38 1.04 Allowed 'Cis proline' 0 C--N 1.354 0.854 0 C-N-CA 124.504 -1.04 . . . . 0.0 113.02 0.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.841 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.7 t70 -55.15 136.04 48.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.083 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -58.88 -44.3 91.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.377 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.628 ' HB2' HD12 ' A' ' 6' ' ' LEU . 14.9 mmt85 -57.44 -25.63 59.94 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.98 HD11 HD12 ' A' ' 8' ' ' ILE . 11.2 mt -74.82 -32.71 62.03 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 119.828 1.195 . . . . 0.0 109.025 178.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.479 ' HG3' HH11 ' A' ' 14' ' ' ARG . 13.6 mmt85 -95.23 6.94 47.66 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.227 -1.352 . . . . 0.0 109.605 178.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.689 ' HD3' ' HB3' ' A' ' 54' ' ' HIS . 88.6 tttt -82.78 147.93 28.11 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.53 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.4 t -82.48 127.89 39.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.787 ' HB2' ' HG3' ' A' ' 56' ' ' ARG . . . -91.36 140.53 29.69 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.218 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -105.01 136.88 19.1 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.418 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.446 ' HA ' ' ND2' ' A' ' 74' ' ' ASN . 51.8 Cg_endo -82.13 113.97 2.47 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 121.656 1.571 . . . . 0.0 110.279 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.619 HG12 ' N ' ' A' ' 21' ' ' GLU . 16.7 t -68.11 144.68 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 CA-C-O 122.852 1.31 . . . . 0.0 113.271 -175.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.619 ' N ' HG12 ' A' ' 20' ' ' VAL . 52.0 mt-10 -60.33 -27.9 67.72 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 112.775 -2.011 . . . . 0.0 112.232 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -156.95 144.28 18.84 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.885 -178.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.957 HG22 HD11 ' A' ' 111' ' ' LEU . 3.2 t -80.11 106.51 11.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -178.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.999 ' HB2' HD12 ' A' ' 27' ' ' ILE . 59.4 m-80 -91.43 153.66 19.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.048 -178.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.692 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -54.79 -25.38 27.76 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.272 0.558 . . . . 0.0 110.819 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.473 ' O ' HD12 ' A' ' 30' ' ' ILE . 55.2 mt-10 -74.28 -42.64 59.26 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 177.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.999 HD12 ' HB2' ' A' ' 24' ' ' ASN . 1.9 mp -66.46 -34.63 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.101 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -68.32 -39.3 82.0 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.779 -0.192 . . . . 0.0 110.549 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.692 ' HG3' ' O ' ' A' ' 25' ' ' ALA . 99.1 mtt180 -63.7 -39.12 93.53 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.824 ' O ' ' HG3' ' A' ' 34' ' ' MET . 1.6 mp -56.0 -48.47 78.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.826 178.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.717 HG23 ' CG2' ' A' ' 57' ' ' ILE . 15.0 t -67.14 -40.1 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.463 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.802 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 48.3 m-20 -52.85 -47.6 67.65 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.937 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.53 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 14.1 m-20 -74.44 -28.91 61.26 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.807 176.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.869 ' HG2' HG22 ' A' ' 51' ' ' VAL . 86.9 mtp -59.62 -47.04 87.16 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.169 -177.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.802 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 19.8 p90 -70.33 -46.17 64.73 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 176.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.633 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 3.8 mm-40 -52.25 -39.54 60.48 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.635 0.731 . . . . 0.0 109.182 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.649 ' HA ' ' CG1' ' A' ' 2' ' ' VAL . 76.5 m -69.14 -61.17 1.9 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.273 -1.33 . . . . 0.0 107.992 178.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.914 ' HE3' ' HB2' ' A' ' 61' ' ' ASP . 3.6 ttp -46.79 -41.1 14.87 Favored 'General case' 0 CA--C 1.46 -2.482 0 C-N-CA 124.535 1.134 . . . . 0.0 110.501 -172.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.755 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 60.3 m-85 -69.11 -42.79 75.62 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.097 178.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.6 ' HB1' HG13 ' A' ' 2' ' ' VAL . . . -61.62 -24.77 66.93 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.566 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 1.037 ' HG2' HD13 ' A' ' 91' ' ' LEU . 11.1 tp10 -87.97 -11.71 46.65 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.407 -1.269 . . . . 0.0 108.368 176.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 63.34 27.4 15.35 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-O 122.019 0.914 . . . . 0.0 109.855 -176.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.02 145.31 26.97 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 113.781 -1.554 . . . . 0.0 110.799 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.795 ' CG2' HG23 ' A' ' 62' ' ' VAL . 45.5 mm -79.34 -0.41 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 117.497 0.648 . . . . 0.0 111.931 -178.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.533 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 175.39 140.03 3.26 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 1.006 HD11 ' HG ' ' A' ' 91' ' ' LEU . 3.9 tp -124.45 136.74 54.27 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.396 1.598 . . . . 0.0 110.821 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.41 131.72 51.46 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.416 0.15 . . . . 0.0 111.165 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.659 ' HB1' ' CD1' ' A' ' 53' ' ' ILE . . . -31.06 -55.81 0.23 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 115.802 1.779 . . . . 0.0 115.802 -177.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.777 ' CG2' ' HA ' ' A' ' 137' ' ' LEU . 69.3 p -53.17 -35.39 59.75 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.665 0.745 . . . . 0.0 111.631 -177.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.733 ' HB2' HD13 ' A' ' 46' ' ' LEU . 64.6 mt-30 -64.02 -43.43 95.65 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.405 -1.271 . . . . 0.0 110.127 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.869 HG22 ' HG2' ' A' ' 34' ' ' MET . 0.8 OUTLIER -83.16 15.49 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.972 ' HA ' HD13 ' A' ' 6' ' ' LEU . 36.9 t70 77.29 28.65 0.6 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 176.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.81 HD11 ' O ' ' A' ' 55' ' ' GLN . 1.1 pp -122.73 110.78 27.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.982 177.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.689 ' HB3' ' HD3' ' A' ' 15' ' ' LYS . 21.5 p-80 -76.51 62.65 1.92 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 122.102 0.953 . . . . 0.0 110.376 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.81 ' O ' HD11 ' A' ' 53' ' ' ILE . 89.4 mt-30 -151.37 133.19 14.97 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.066 -1.425 . . . . 0.0 107.468 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.854 HH21 HG21 ' A' ' 138' ' ' VAL . 98.8 mtt180 -65.02 70.99 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -177.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.798 ' O ' ' HE1' ' A' ' 34' ' ' MET . 30.6 mm -113.95 124.33 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.925 HD12 ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -128.62 148.58 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -177.673 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.714 HG21 ' H ' ' A' ' 46' ' ' LEU . 30.8 m -129.29 140.35 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.71 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 1.107 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 9.5 mm -115.5 153.84 17.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.337 0.589 . . . . 0.0 109.882 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.914 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 38.5 t70 -145.29 39.84 1.2 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.62 -178.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.795 HG23 ' CG2' ' A' ' 44' ' ' ILE . 57.4 t . . . . . 0 C--N 1.325 -0.472 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.626 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 1.107 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 3.5 mm? -108.08 139.66 42.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.076 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.805 HG22 ' HB2' ' A' ' 113' ' ' ARG . 12.9 p -133.09 135.7 56.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.583 177.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.925 ' HB2' HD12 ' A' ' 58' ' ' ILE . 94.7 mt -140.86 140.88 34.67 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 178.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 1.023 HG13 HD13 ' A' ' 111' ' ' LEU . 3.3 mm -121.79 136.57 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-O 121.233 0.54 . . . . 0.0 111.013 -179.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.677 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 7.2 m120 49.0 38.69 0.52 Allowed Pre-proline 0 C--N 1.313 -0.996 0 CA-C-N 115.096 -0.957 . . . . 0.0 112.839 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.793 ' HG2' HG22 ' A' ' 58' ' ' ILE . 99.5 Cg_exo -56.42 145.67 77.89 Favored 'Trans proline' 0 N--CA 1.484 0.943 0 C-N-CA 122.958 2.439 . . . . 0.0 114.144 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.542 ' HG3' HD22 ' A' ' 78' ' ' LEU . 11.7 pt-20 -133.11 143.18 49.12 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 1.04 ' HB2' ' HE2' ' A' ' 134' ' ' MET . 1.7 tt -82.95 135.71 34.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.282 0.563 . . . . 0.0 111.39 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.86 ' N ' HD21 ' A' ' 77' ' ' LEU . 2.9 mm? -115.74 -40.59 3.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.84 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 87.4 tt0 -152.84 150.59 29.49 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.21 0.529 . . . . 0.0 111.511 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.848 ' HA ' HG11 ' A' ' 106' ' ' VAL . 9.2 ptpp? -147.18 147.4 30.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.267 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.1 t -158.22 147.99 19.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.673 0.273 . . . . 0.0 111.384 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.696 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 76.85 160.29 10.78 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.41 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -136.3 113.42 10.54 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.948 0.88 . . . . 0.0 112.736 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.728 ' HB ' HH12 ' A' ' 102' ' ' ARG . 1.7 p -105.24 161.88 13.9 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.74 ' HA3' HD22 ' A' ' 99' ' ' LEU . . . -147.45 116.86 0.87 Allowed Glycine 0 C--N 1.313 -0.701 0 CA-C-N 112.694 -2.048 . . . . 0.0 110.989 178.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.724 ' HB ' ' NH2' ' A' ' 102' ' ' ARG . 47.9 mm -147.79 139.21 18.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 117.306 0.553 . . . . 0.0 111.414 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 50.4 mt-10 -71.78 139.03 48.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 122.83 1.3 . . . . 0.0 112.019 -177.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.588 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 39.6 mt-10 -154.95 163.48 40.24 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 112.753 -2.021 . . . . 0.0 111.567 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.599 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -121.49 165.62 14.44 Favored Glycine 0 CA--C 1.503 -0.714 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 13.1 m -116.21 140.76 48.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.898 0.849 . . . . 0.0 111.662 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 1.037 HD13 ' HG2' ' A' ' 41' ' ' GLU . 2.4 mm? -48.62 -17.31 0.16 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.224 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.723 ' CB ' HD13 ' A' ' 13' ' ' LEU . 21.1 m -98.36 -34.39 10.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.255 0.55 . . . . 0.0 110.255 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.463 HD13 HG23 ' A' ' 93' ' ' ILE . 58.4 mt . . . . . 0 CA--C 1.535 0.395 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.546 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.599 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 13.7 mtt85 . . . . . 0 CA--C 1.528 0.134 0 CA-C-O 121.03 0.443 . . . . 0.0 109.927 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.2 150.52 48.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.252 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.74 HD22 ' HA3' ' A' ' 85' ' ' GLY . 7.3 tt -76.02 113.92 14.07 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.727 0.775 . . . . 0.0 110.792 -178.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.657 HG12 ' HD2' ' A' ' 101' ' ' PRO . 23.4 t -103.57 133.7 20.14 Favored Pre-proline 0 N--CA 1.469 0.492 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.991 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.657 ' HD2' HG12 ' A' ' 100' ' ' VAL . 98.6 Cg_endo -87.58 126.36 2.2 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.524 2.15 . . . . 0.0 112.675 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.786 ' HG3' HG22 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -144.65 166.76 24.29 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.149 0.98 . . . . 0.0 109.764 179.438 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.696 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.41 155.3 40.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.852 0.358 . . . . 0.0 110.172 -179.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -72.67 -41.78 65.02 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.592 -175.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.759 ' HG2' ' HB3' ' A' ' 123' ' ' ASP . 95.4 mttt -140.61 140.17 35.03 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.49 0.662 . . . . 0.0 109.495 176.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.848 HG11 ' HA ' ' A' ' 80' ' ' LYS . 32.8 m -145.57 142.22 22.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.166 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.781 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 5.1 mmmt -107.43 126.22 52.22 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.839 HD11 HD11 ' A' ' 130' ' ' ILE . 1.8 pp -134.36 151.0 31.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -177.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 1.006 ' HE ' ' HG2' ' A' ' 119' ' ' GLU . 53.5 mtp180 -102.62 139.71 37.85 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.424 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.648 ' HB3' HD22 ' A' ' 72' ' ' LEU . . . -160.18 168.5 25.3 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.237 -176.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 1.023 HD13 HG13 ' A' ' 73' ' ' ILE . 2.0 pp -122.59 149.0 44.57 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.515 ' O ' HD12 ' A' ' 111' ' ' LEU . 13.5 t70 -81.67 169.11 17.4 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -175.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.805 ' HB2' HG22 ' A' ' 71' ' ' VAL . 43.2 ttp180 -50.93 -23.6 2.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.982 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -79.77 -21.45 44.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.158 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.816 ' HA2' HG22 ' A' ' 23' ' ' VAL . . . 101.37 38.74 3.19 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.151 -1.023 . . . . 0.0 113.983 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.927 ' HA ' ' HE3' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -127.13 102.24 24.5 Favored Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 117.188 0.494 . . . . 0.0 110.184 178.532 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.635 ' HG3' HD22 ' A' ' 111' ' ' LEU . 32.8 Cg_exo -74.63 115.41 4.29 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 121.643 1.562 . . . . 0.0 116.107 -177.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.444 ' N ' ' O ' ' A' ' 110' ' ' ALA . 0.4 OUTLIER -125.71 168.57 13.58 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.01 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 1.006 ' HG2' ' HE ' ' A' ' 109' ' ' ARG . 21.3 mt-10 -107.41 137.11 46.06 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.729 ' O ' HD11 ' A' ' 120' ' ' LEU . 4.3 pp -135.57 133.39 38.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.081 0.467 . . . . 0.0 111.841 -178.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.781 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 0.7 OUTLIER -95.5 123.71 39.17 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.767 178.706 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 1.029 ' HB3' HD13 ' A' ' 126' ' ' LEU . . . -116.45 135.13 54.1 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.759 ' HB3' ' HG2' ' A' ' 105' ' ' LYS . 16.9 m-20 -126.43 163.22 23.79 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.677 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 52.89 -139.02 33.47 Favored Glycine 0 C--N 1.346 1.101 0 C-N-CA 119.344 -1.408 . . . . 0.0 115.344 177.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.421 ' HA ' HD21 ' A' ' 125' ' ' LEU . 78.2 mt -54.38 -32.3 56.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.601 -0.8 . . . . 0.0 111.601 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 1.029 HD13 ' HB3' ' A' ' 122' ' ' ALA . 0.3 OUTLIER -71.42 -51.97 21.04 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.904 0.859 . . . . 0.0 109.308 179.523 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.719 ' HB3' ' CA ' ' A' ' 123' ' ' ASP . . . -58.58 -41.93 86.84 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.162 -1.381 . . . . 0.0 111.648 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.786 HG22 ' HG3' ' A' ' 102' ' ' ARG . 50.8 mm -67.45 -54.83 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -178.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.598 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 32.1 p -60.7 -49.07 79.0 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.839 HD11 HD11 ' A' ' 108' ' ' ILE . 19.8 tt -59.2 -46.51 92.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.386 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.701 ' HG2' ' O ' ' A' ' 127' ' ' ALA . 21.3 pt20 -65.71 -38.19 88.52 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.337 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -59.27 -46.4 88.63 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.549 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.785 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 3.3 mm-40 -60.81 -38.37 85.17 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 1.04 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 75.8 mtp -58.22 -45.18 88.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 122.271 1.034 . . . . 0.0 109.422 177.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.919 ' O ' HG13 ' A' ' 138' ' ' VAL . 0.9 OUTLIER -68.14 -47.97 66.65 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.716 179.215 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.637 ' CE1' ' HG2' ' A' ' 50' ' ' GLN . 6.5 t-80 -57.98 -52.75 64.21 Favored 'General case' 0 C--N 1.317 -0.813 0 O-C-N 121.672 -0.642 . . . . 0.0 111.483 -178.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.815 HD11 ' HG2' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -65.41 -28.5 69.3 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.511 -179.506 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.919 HG13 ' O ' ' A' ' 135' ' ' ASP . 11.3 p -81.1 23.39 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-O 122.294 1.045 . . . . 0.0 109.218 175.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.536 ' H ' ' C ' ' A' ' 137' ' ' LEU . . . 67.49 -0.93 7.91 Favored Glycine 0 CA--C 1.485 -1.813 0 CA-C-N 113.532 -1.667 . . . . 0.0 113.144 175.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.909 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 11.2 ptmt . . . . . 0 N--CA 1.409 -2.479 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 178.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.494 HG13 ' HB1' ' A' ' 40' ' ' ALA . 31.1 m . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.847 0.356 . . . . 0.0 111.365 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.846 HD12 ' O ' ' A' ' 51' ' ' VAL . 2.4 pp -79.53 -161.81 0.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.599 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.821 ' N ' HD13 ' A' ' 3' ' ' LEU . 2.2 tp-100 -94.66 108.17 20.16 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.925 0.393 . . . . 0.0 110.446 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.419 ' CG2' HG23 ' A' ' 37' ' ' THR . 40.9 t -88.59 129.37 39.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.4 0.619 . . . . 0.0 112.067 -178.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 1.063 ' HB2' HD23 ' A' ' 13' ' ' LEU . 21.5 mt -87.88 143.18 27.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.021 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 51.9 m-70 -120.78 145.73 47.25 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.822 HG12 ' CB ' ' A' ' 92' ' ' SER . 46.2 mm -66.05 134.41 94.93 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.676 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.8 141.36 66.57 Favored 'Cis proline' 0 C--N 1.351 0.685 0 C-N-CA 124.195 -1.169 . . . . 0.0 112.016 -0.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.982 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.7 t70 -161.24 126.28 3.6 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 12.0 pt-20 -58.21 -46.06 86.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.982 -178.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.544 ' O ' ' HB ' ' A' ' 49' ' ' THR . 25.1 mtt-85 -59.3 -26.16 64.74 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 1.063 HD23 ' HB2' ' A' ' 6' ' ' LEU . 10.7 mt -76.64 -33.38 58.35 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 120.284 1.402 . . . . 0.0 108.139 177.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.565 ' C ' ' HA3' ' A' ' 139' ' ' GLY . 14.1 mmt85 -94.11 11.01 31.47 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 113.854 -1.521 . . . . 0.0 109.303 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -92.76 150.67 20.5 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.283 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.525 HG12 HG22 ' A' ' 138' ' ' VAL . 61.8 t -83.47 124.06 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.819 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.767 ' HB2' ' CG ' ' A' ' 56' ' ' ARG . . . -80.99 147.45 30.21 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.634 ' HD3' ' N ' ' A' ' 19' ' ' PRO . 2.2 tmtp? -109.9 127.98 26.17 Favored Pre-proline 0 C--N 1.325 -0.486 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.217 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 1.027 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 65.6 Cg_endo -77.7 113.93 3.57 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 121.998 1.799 . . . . 0.0 110.815 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.617 HG12 ' N ' ' A' ' 21' ' ' GLU . 18.0 t -68.45 144.46 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-O 122.609 1.195 . . . . 0.0 113.29 -175.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.617 ' N ' HG12 ' A' ' 20' ' ' VAL . 46.5 mm-40 -60.76 -27.97 68.36 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 112.97 -1.923 . . . . 0.0 111.995 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -157.79 143.02 16.88 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.242 -178.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.863 HG21 HD12 ' A' ' 111' ' ' LEU . 3.2 t -79.75 108.46 13.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.998 ' HB2' HD12 ' A' ' 27' ' ' ILE . 54.6 m-80 -93.32 173.51 7.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.813 -179.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.605 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -65.75 -28.54 69.11 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.376 0.607 . . . . 0.0 110.859 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.46 ' HA ' ' OE1' ' A' ' 26' ' ' GLU . 4.3 mm-40 -73.92 -39.72 63.61 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.998 HD12 ' HB2' ' A' ' 24' ' ' ASN . 1.9 mp -66.91 -37.49 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.166 178.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.804 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 16.9 mt-30 -66.18 -40.46 90.48 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.233 -0.292 . . . . 0.0 110.719 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 14.0 mmp_? -63.33 -39.58 94.93 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.876 HG21 HD12 ' A' ' 57' ' ' ILE . 4.8 mt -55.34 -50.17 67.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.381 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.618 ' CG1' HG23 ' A' ' 71' ' ' VAL . 15.9 t -65.25 -41.62 91.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.072 0.463 . . . . 0.0 111.045 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.829 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 27.3 m-20 -54.97 -43.58 73.64 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.475 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.522 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 1.4 m-20 -75.81 -29.77 58.79 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.923 176.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.792 ' HG3' ' O ' ' A' ' 30' ' ' ILE . 22.0 mtm -60.14 -46.69 88.82 Favored 'General case' 0 C--N 1.347 0.467 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.534 -177.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.829 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 14.9 p90 -69.87 -45.45 67.68 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.61 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 3.8 mm-40 -52.65 -39.38 61.76 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.719 0.771 . . . . 0.0 108.996 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.468 ' OG1' ' HG ' ' A' ' 3' ' ' LEU . 61.8 m -70.06 -61.78 1.64 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.455 -1.248 . . . . 0.0 107.642 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.859 ' HG3' ' HB2' ' A' ' 46' ' ' LEU . 1.0 OUTLIER -46.52 -41.11 13.7 Favored 'General case' 0 CA--C 1.462 -2.416 0 C-N-CA 123.958 0.903 . . . . 0.0 110.431 -170.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.696 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 58.5 m-85 -70.37 -42.43 71.79 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.281 178.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.494 ' HB1' HG13 ' A' ' 2' ' ' VAL . . . -61.05 -24.61 66.33 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.416 178.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.98 ' HG2' HD13 ' A' ' 91' ' ' LEU . 11.7 tp10 -88.89 -11.4 44.7 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.475 177.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 65.43 23.93 11.95 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.042 -176.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.07 141.89 24.66 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 114.027 -1.442 . . . . 0.0 110.372 177.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 1.022 HG23 HG23 ' A' ' 62' ' ' VAL . 46.3 mt -81.33 1.41 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 117.648 0.724 . . . . 0.0 112.638 -178.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.407 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 178.73 133.78 1.98 Allowed Glycine 0 CA--C 1.528 0.867 0 CA-C-O 118.913 -0.937 . . . . 0.0 111.409 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 1.031 HD13 ' HG ' ' A' ' 91' ' ' LEU . 4.9 tp -126.02 134.33 51.48 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.15 1.475 . . . . 0.0 112.161 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -98.3 131.88 44.25 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.292 0.237 . . . . 0.0 111.448 178.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.733 ' HA ' ' SD ' ' A' ' 34' ' ' MET . . . -30.01 -55.64 0.18 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 137' ' ' LEU . 67.3 p -53.25 -36.01 60.63 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.462 0.648 . . . . 0.0 112.039 -177.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.818 ' NE2' HD21 ' A' ' 91' ' ' LEU . 85.8 mt-30 -63.83 -41.92 97.73 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.231 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.846 ' O ' HD12 ' A' ' 3' ' ' LEU . 1.0 OUTLIER -83.74 16.49 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.447 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.925 ' HA ' HD13 ' A' ' 6' ' ' LEU . 50.5 t0 77.37 28.29 0.61 Allowed 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 176.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 1.103 HD12 HD13 ' A' ' 57' ' ' ILE . 1.0 OUTLIER -122.23 110.7 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 119.204 -0.999 . . . . 0.0 111.247 177.883 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -76.76 63.19 2.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.493 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.812 ' O ' HD11 ' A' ' 53' ' ' ILE . 94.7 mm-40 -152.96 134.33 14.31 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.237 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 1.027 ' HD2' ' HD3' ' A' ' 19' ' ' PRO . 98.8 mtt180 -64.5 66.72 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -177.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 1.103 HD13 HD12 ' A' ' 53' ' ' ILE . 6.2 mt -111.1 123.22 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.872 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 1.8 pp -128.32 146.37 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 119.665 -0.814 . . . . 0.0 113.12 -177.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.555 HG21 ' H ' ' A' ' 46' ' ' LEU . 30.5 m -126.24 139.11 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.7 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 1.094 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 7.9 mm -116.16 153.39 17.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.55 0.69 . . . . 0.0 110.392 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.847 ' HB3' ' C ' ' A' ' 44' ' ' ILE . 31.3 t70 -139.46 17.85 2.55 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.363 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 1.022 HG23 HG23 ' A' ' 44' ' ' ILE . 32.4 t . . . . . 0 N--CA 1.461 0.106 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.348 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.504 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 48.0 ttp180 . . . . . 0 N--CA 1.451 -0.422 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 1.094 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 56.3 mt -111.23 138.97 47.02 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.801 HG22 ' HB2' ' A' ' 113' ' ' ARG . 11.8 p -134.82 135.29 53.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.607 177.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.872 ' HB2' ' CD1' ' A' ' 58' ' ' ILE . 1.8 mm? -140.4 140.77 35.55 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 1.053 HG13 HD11 ' A' ' 111' ' ' LEU . 3.5 mm -119.51 136.03 57.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.172 0.51 . . . . 0.0 110.952 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.69 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 8.0 m120 51.57 37.6 0.44 Allowed Pre-proline 0 C--N 1.312 -1.027 0 CA-C-N 115.349 -0.842 . . . . 0.0 112.379 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.85 ' HG2' HG12 ' A' ' 58' ' ' ILE . 77.6 Cg_exo -55.08 144.5 68.96 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 122.949 2.433 . . . . 0.0 114.102 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.523 ' HG3' HD23 ' A' ' 78' ' ' LEU . 11.5 pt-20 -135.45 145.43 47.19 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 1.024 ' HB2' ' HE2' ' A' ' 134' ' ' MET . 1.5 tt -81.2 137.69 35.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.309 0.576 . . . . 0.0 111.817 -178.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.86 ' N ' HD23 ' A' ' 77' ' ' LEU . 2.9 mm? -118.9 -50.71 2.38 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.624 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 1.037 ' HB3' ' HD3' ' A' ' 107' ' ' LYS . 39.3 tp10 -140.5 146.51 38.26 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 120.883 0.373 . . . . 0.0 110.886 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.843 ' NZ ' HD21 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -147.32 145.66 29.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.098 179.492 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.3 t -159.07 156.58 29.47 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.787 0.327 . . . . 0.0 111.592 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.745 ' C ' ' HG3' ' A' ' 104' ' ' GLU . . . 67.53 159.62 1.17 Allowed Glycine 0 CA--C 1.506 -0.5 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.352 -179.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.713 ' N ' ' HG3' ' A' ' 104' ' ' GLU . 57.6 mt-10 -131.89 113.0 12.93 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 122.006 0.908 . . . . 0.0 113.002 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.723 HG21 ' HG2' ' A' ' 104' ' ' GLU . 1.5 p -103.54 161.36 13.95 Favored 'General case' 0 CA--C 1.486 -1.505 0 CA-C-N 113.812 -1.54 . . . . 0.0 114.733 178.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.725 ' CA ' HD21 ' A' ' 99' ' ' LEU . . . -149.84 118.34 0.93 Allowed Glycine 0 C--N 1.311 -0.828 0 CA-C-N 112.911 -1.949 . . . . 0.0 111.373 178.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.525 ' N ' ' HG ' ' A' ' 99' ' ' LEU . 32.4 mt -148.16 138.69 17.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 117.278 0.539 . . . . 0.0 111.733 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 95.3 mt-10 -70.82 137.98 49.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 123.072 1.415 . . . . 0.0 112.313 -176.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.726 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 46.8 mt-10 -156.42 160.43 39.6 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 112.652 -2.067 . . . . 0.0 111.351 -179.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.648 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -120.57 165.0 13.89 Favored Glycine 0 CA--C 1.501 -0.783 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 18.2 m -116.09 140.81 48.9 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 117.897 0.848 . . . . 0.0 111.995 -177.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 1.031 ' HG ' HD13 ' A' ' 46' ' ' LEU . 2.3 mm? -47.69 -26.52 1.57 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.88 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.822 ' CB ' HG12 ' A' ' 8' ' ' ILE . 49.9 m -79.77 -38.08 33.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.871 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.9 mt . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.971 -179.634 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.726 ' HA ' ' O ' ' A' ' 88' ' ' GLU . 12.9 mtt85 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 121.757 0.789 . . . . 0.0 112.115 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -134.19 153.34 51.9 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.792 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.725 HD21 ' CA ' ' A' ' 85' ' ' GLY . 7.5 tt -75.67 112.7 12.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.681 0.753 . . . . 0.0 110.757 -178.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.886 HG13 ' NH1' ' A' ' 102' ' ' ARG . 29.5 t -98.6 128.93 31.37 Favored Pre-proline 0 N--CA 1.468 0.434 0 CA-C-N 114.724 -1.126 . . . . 0.0 112.011 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 100' ' ' VAL . 1.1 Cg_endo -83.4 125.69 3.99 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.726 2.284 . . . . 0.0 112.031 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.953 ' HB3' HH11 ' A' ' 102' ' ' ARG . 0.0 OUTLIER -145.86 167.17 23.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.312 179.759 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.619 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.62 155.17 40.53 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.745 ' HG3' ' C ' ' A' ' 82' ' ' GLY . 95.1 mt-10 -72.88 -39.87 66.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.867 -175.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.678 ' HB3' ' OD1' ' A' ' 123' ' ' ASP . 59.1 mttp -139.73 140.56 36.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.263 0.554 . . . . 0.0 109.722 177.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.777 HG13 ' HA ' ' A' ' 80' ' ' LYS . 35.2 m -149.71 140.02 16.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.511 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 1.037 ' HD3' ' HB3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -108.09 127.75 54.07 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.874 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.581 HD13 HD23 ' A' ' 120' ' ' LEU . 1.5 pp -133.03 150.15 32.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -177.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.845 ' HG3' ' CD2' ' A' ' 78' ' ' LEU . 96.4 mtt180 -102.18 137.69 40.12 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.66 -178.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.494 ' CB ' ' HB3' ' A' ' 72' ' ' LEU . . . -161.57 169.7 21.22 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 114.746 -1.115 . . . . 0.0 111.023 -176.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 1.053 HD11 HG13 ' A' ' 73' ' ' ILE . 1.9 pp -119.35 149.12 42.35 Favored 'General case' 0 C--O 1.218 -0.59 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 176.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.514 ' HB2' ' CE2' ' A' ' 118' ' ' PHE . 12.8 t70 -81.75 167.8 18.72 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 119.877 -0.729 . . . . 0.0 112.642 -175.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.801 ' HB2' HG22 ' A' ' 71' ' ' VAL . 51.0 ttp180 -50.28 -22.45 1.79 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.971 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -79.4 -25.07 42.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.898 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.755 ' HA2' HD12 ' A' ' 111' ' ' LEU . . . 104.83 37.91 2.65 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.189 -1.005 . . . . 0.0 113.834 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -128.36 102.73 20.6 Favored Pre-proline 0 C--O 1.235 0.342 0 CA-C-N 117.054 0.427 . . . . 0.0 110.473 178.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.588 ' HA ' ' CA ' ' A' ' 111' ' ' LEU . 36.8 Cg_exo -71.56 114.86 4.07 Favored 'Trans proline' 0 C--N 1.358 1.075 0 N-CA-C 116.409 1.657 . . . . 0.0 116.409 -176.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.514 ' CE2' ' HB2' ' A' ' 112' ' ' ASP . 0.3 OUTLIER -127.0 160.72 30.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.731 -179.227 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.648 ' HG2' ' HG2' ' A' ' 109' ' ' ARG . 21.5 mt-10 -107.42 130.69 54.79 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.893 HD21 ' O ' ' A' ' 120' ' ' LEU . 0.2 OUTLIER -131.66 141.59 49.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.795 0.807 . . . . 0.0 111.887 -179.019 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 107' ' ' LYS . 11.4 pt-20 -97.16 125.52 41.72 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.979 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.88 ' CB ' ' HG ' ' A' ' 126' ' ' LEU . . . -115.01 135.41 54.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.839 0.352 . . . . 0.0 111.391 -179.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.801 ' CA ' ' HB3' ' A' ' 127' ' ' ALA . 31.3 m-20 -126.66 160.76 29.8 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.788 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 51.73 -138.78 28.94 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 120.645 1.566 . . . . 0.0 115.159 177.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.516 ' H ' ' CD1' ' A' ' 125' ' ' LEU . 4.9 mp -53.5 -32.96 52.61 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.225 -0.488 . . . . 0.0 111.309 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.88 ' HG ' ' CB ' ' A' ' 122' ' ' ALA . 4.0 tp -70.78 -52.17 22.36 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.649 0.738 . . . . 0.0 109.418 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.801 ' HB3' ' CA ' ' A' ' 123' ' ' ASP . . . -58.55 -42.34 87.67 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.713 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.788 HG12 ' O ' ' A' ' 124' ' ' GLY . 44.5 mm -67.85 -54.65 21.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.689 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 30.0 p -58.19 -50.2 74.36 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -178.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.644 HG22 ' N ' ' A' ' 131' ' ' GLN . 14.2 tt -59.57 -44.21 92.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.121 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.845 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.0 pt20 -68.39 -39.42 81.71 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.518 178.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -59.44 -47.24 86.24 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.067 0.461 . . . . 0.0 109.794 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.881 ' O ' HD22 ' A' ' 137' ' ' LEU . 3.7 mm-40 -59.61 -40.41 87.47 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.586 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 1.024 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 75.5 mtp -57.52 -47.64 81.43 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.838 0.828 . . . . 0.0 109.872 178.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.872 ' O ' HG11 ' A' ' 138' ' ' VAL . 31.4 m-20 -63.38 -47.13 83.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.976 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.449 ' CE1' ' CG ' ' A' ' 50' ' ' GLN . 4.6 t-80 -59.07 -53.0 63.29 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 121.103 0.478 . . . . 0.0 111.593 -178.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.899 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.7 pp -58.64 -31.76 68.43 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.518 -178.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 1.046 HG13 ' HG2' ' A' ' 140' ' ' LYS . 14.9 p -86.44 23.85 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 122.329 1.061 . . . . 0.0 109.548 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.61 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 53.85 34.94 52.05 Favored Glycine 0 CA--C 1.482 -1.969 0 CA-C-N 113.388 -1.733 . . . . 0.0 112.432 176.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 1.046 ' HG2' HG13 ' A' ' 138' ' ' VAL . 3.6 ptmt . . . . . 0 N--CA 1.423 -1.807 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.334 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.713 HG13 HG21 ' A' ' 37' ' ' THR . 38.2 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.676 0.274 . . . . 0.0 110.619 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.842 HD21 ' HB ' ' A' ' 51' ' ' VAL . 3.1 pp -79.63 -173.39 3.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.797 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.825 ' N ' HD13 ' A' ' 3' ' ' LEU . 70.9 tp60 -83.1 106.82 15.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.026 0.441 . . . . 0.0 110.59 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.431 ' CG2' HG23 ' A' ' 37' ' ' THR . 40.6 t -87.65 127.95 40.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.543 0.687 . . . . 0.0 112.201 -178.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.924 ' HB2' HD22 ' A' ' 13' ' ' LEU . 35.1 mt -85.96 138.88 31.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.193 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 28.8 m-70 -113.44 147.47 37.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.083 0.468 . . . . 0.0 112.141 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.927 HD12 HD13 ' A' ' 13' ' ' LEU . 42.9 mm -57.26 148.08 54.5 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.426 178.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.582 ' CA ' HG21 ' A' ' 8' ' ' ILE . 69.5 Cg_endo -93.49 51.84 1.1 Allowed 'Cis proline' 0 C--N 1.353 0.802 0 C-N-CA 124.707 -0.956 . . . . 0.0 112.881 0.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.893 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.7 t70 -55.66 135.78 51.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.057 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -59.37 -44.98 92.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.999 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.645 ' HB2' HD12 ' A' ' 6' ' ' LEU . 15.1 mmt85 -56.06 -25.47 45.29 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.927 HD13 HD12 ' A' ' 8' ' ' ILE . 10.7 mt -75.42 -33.86 60.96 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 119.46 1.027 . . . . 0.0 108.679 178.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.66 ' C ' ' HA3' ' A' ' 139' ' ' GLY . 14.9 mmm180 -96.23 13.01 28.88 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 114.086 -1.416 . . . . 0.0 109.442 178.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.851 ' HD3' ' N ' ' A' ' 16' ' ' VAL . 1.1 tmtp? -87.01 145.38 26.51 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.918 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.851 ' N ' ' HD3' ' A' ' 15' ' ' LYS . 49.1 t -81.86 118.95 30.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.762 ' HB2' ' CG ' ' A' ' 56' ' ' ARG . . . -78.16 150.84 33.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.824 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.774 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -114.65 133.08 22.6 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.133 178.803 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.796 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 61.2 Cg_endo -78.81 115.94 3.67 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.454 2.103 . . . . 0.0 111.43 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.599 HG13 ' N ' ' A' ' 21' ' ' GLU . 19.9 t -67.85 144.43 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 CA-C-O 122.618 1.199 . . . . 0.0 113.096 -175.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.599 ' N ' HG13 ' A' ' 20' ' ' VAL . 51.3 mt-10 -61.62 -28.22 69.21 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 113.058 -1.883 . . . . 0.0 112.111 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -156.57 145.74 20.42 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 120.746 -0.381 . . . . 0.0 111.547 -178.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.863 ' CG2' HD22 ' A' ' 111' ' ' LEU . 3.9 t -79.15 105.87 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -178.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 1.055 ' HB2' HD12 ' A' ' 27' ' ' ILE . 57.4 m-80 -93.31 153.81 18.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.779 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.815 ' HB2' HH12 ' A' ' 29' ' ' ARG . . . -54.72 -24.17 20.97 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.254 0.549 . . . . 0.0 110.711 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -74.95 -41.06 60.35 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 177.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 1.055 HD12 ' HB2' ' A' ' 24' ' ' ASN . 1.8 mp -68.08 -33.96 63.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-N 113.846 -1.524 . . . . 0.0 110.108 178.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -69.94 -40.07 75.7 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 122.354 -0.216 . . . . 0.0 110.575 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.815 HH12 ' HB2' ' A' ' 25' ' ' ALA . 67.7 mtt85 -64.26 -38.01 89.53 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.787 ' CG2' HD11 ' A' ' 53' ' ' ILE . 4.8 mt -55.46 -50.3 66.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.302 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.875 HG13 ' CG2' ' A' ' 71' ' ' VAL . 3.8 t -67.9 -40.67 83.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.02 0.438 . . . . 0.0 110.201 178.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.811 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 12.8 m-20 -55.32 -41.38 72.35 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.73 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.481 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 52.7 m-20 -76.32 -30.21 57.6 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.158 176.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.777 ' HG3' ' O ' ' A' ' 30' ' ' ILE . 85.4 mtp -60.31 -46.25 90.54 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.268 -177.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.811 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 11.0 p90 -69.57 -44.51 70.68 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.548 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 31.2 mm-40 -53.01 -39.97 63.52 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.713 HG21 HG13 ' A' ' 2' ' ' VAL . 74.7 m -71.49 -62.6 1.35 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 118.377 -1.329 . . . . 0.0 107.886 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 1.063 ' HE3' ' HB2' ' A' ' 61' ' ' ASP . 2.0 ttp -46.91 -40.4 14.04 Favored 'General case' 0 CA--C 1.467 -2.237 0 C-N-CA 124.015 0.926 . . . . 0.0 110.145 -170.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.692 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 50.6 m-85 -70.51 -42.27 71.52 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.985 177.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.609 ' CB ' HG22 ' A' ' 2' ' ' VAL . . . -61.25 -23.23 65.5 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.566 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 1.077 ' HG2' HD13 ' A' ' 91' ' ' LEU . 11.5 tp10 -90.25 -11.38 41.07 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 114.434 -1.257 . . . . 0.0 108.273 177.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 64.12 28.55 14.16 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.889 -176.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.48 143.66 21.02 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 113.678 -1.601 . . . . 0.0 111.207 178.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.813 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 45.7 mm -79.36 -1.44 4.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 117.323 0.561 . . . . 0.0 112.061 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.522 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 177.87 135.88 2.37 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-O 119.28 -0.733 . . . . 0.0 111.721 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.958 HD12 ' HG ' ' A' ' 91' ' ' LEU . 5.0 tp -125.01 133.67 52.88 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.347 1.074 . . . . 0.0 111.305 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -100.42 132.33 45.86 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.619 ' HB1' HD13 ' A' ' 53' ' ' ILE . . . -26.9 -56.5 0.09 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.637 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 70.4 p -53.34 -35.81 60.64 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.65 0.738 . . . . 0.0 111.756 -177.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.866 ' NE2' HD21 ' A' ' 91' ' ' LEU . 8.8 mt-30 -64.52 -41.57 96.31 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.59 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.85 ' CG1' HD21 ' A' ' 46' ' ' LEU . 1.1 m -85.76 18.57 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.812 ' HA ' HD13 ' A' ' 6' ' ' LEU . 8.4 t0 78.43 28.09 0.48 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 176.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.875 HD13 ' HB ' ' A' ' 57' ' ' ILE . 11.1 pt -123.05 110.35 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 118.857 -1.137 . . . . 0.0 111.783 177.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.605 ' HB2' ' NZ ' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -76.82 51.74 0.79 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 121.888 0.851 . . . . 0.0 109.531 179.206 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.518 ' O ' HG12 ' A' ' 57' ' ' ILE . 26.2 mt-30 -140.52 129.94 23.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.103 -1.408 . . . . 0.0 107.501 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.796 ' HD2' ' HD3' ' A' ' 19' ' ' PRO . 73.3 mtt-85 -59.83 68.34 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.875 ' HB ' HD13 ' A' ' 53' ' ' ILE . 11.1 mm -112.08 122.31 66.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.907 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 1.9 pp -127.82 143.46 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 119.607 -0.837 . . . . 0.0 113.174 -177.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.567 HG23 ' HB3' ' A' ' 35' ' ' PHE . 1.4 p -127.96 134.13 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.679 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 1.041 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 2.0 mt -114.93 151.94 16.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.445 0.64 . . . . 0.0 111.111 -177.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 1.063 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 11.4 t70 -129.65 25.73 5.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.614 -1.176 . . . . 0.0 110.83 -177.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.899 HG22 ' CG2' ' A' ' 60' ' ' ILE . 11.7 t . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.634 ' HG3' ' HH ' ' A' ' 39' ' ' TYR . 51.5 ttt-85 . . . . . 0 N--CA 1.456 -0.166 0 CA-C-O 120.779 0.323 . . . . 0.0 110.68 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 1.041 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 48.5 mt -112.09 138.87 48.15 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -179.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.995 HG21 ' HB2' ' A' ' 113' ' ' ARG . 8.8 p -134.03 131.23 55.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.408 177.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.907 ' HB2' ' CD1' ' A' ' 58' ' ' ILE . 89.6 mt -142.41 143.18 32.54 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 121.31 -0.156 . . . . 0.0 110.919 177.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 1.016 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.6 mp -120.68 134.39 64.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.69 0.281 . . . . 0.0 110.743 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.664 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 7.4 m120 53.72 34.78 0.26 Allowed Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.816 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 84.5 Cg_exo -55.16 146.75 57.99 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.521 2.147 . . . . 0.0 113.571 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -135.99 149.23 48.77 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 1.087 ' HB2' ' HE2' ' A' ' 134' ' ' MET . 27.9 tp -79.63 138.3 37.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.42 0.629 . . . . 0.0 112.082 -178.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.867 ' CD2' ' HG3' ' A' ' 109' ' ' ARG . 2.6 mm? -114.26 -45.35 3.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.425 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.593 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 38.2 tt0 -158.06 146.82 19.16 Favored 'General case' 0 C--O 1.23 0.035 0 CA-C-O 121.114 0.483 . . . . 0.0 111.637 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.84 ' CB ' HG11 ' A' ' 106' ' ' VAL . 19.3 ptpt -143.59 146.91 33.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.045 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.4 p -159.67 150.98 19.76 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.733 0.301 . . . . 0.0 111.291 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.721 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 79.75 159.08 16.84 Favored Glycine 0 C--N 1.335 0.472 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.414 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -134.02 113.4 12.09 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.896 0.855 . . . . 0.0 112.93 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.599 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.6 p -106.97 161.53 14.64 Favored 'General case' 0 CA--C 1.486 -1.485 0 CA-C-N 113.902 -1.499 . . . . 0.0 114.936 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.699 ' HA3' HD22 ' A' ' 99' ' ' LEU . . . -146.95 115.86 0.81 Allowed Glycine 0 C--N 1.311 -0.861 0 CA-C-N 112.671 -2.059 . . . . 0.0 110.873 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.582 ' N ' ' HG ' ' A' ' 99' ' ' LEU . 34.1 mt -147.97 139.09 17.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 117.293 0.546 . . . . 0.0 111.618 -178.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.495 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 50.5 mt-10 -71.65 138.55 48.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 123.193 1.473 . . . . 0.0 112.082 -175.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.668 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 46.0 mt-10 -157.41 162.25 39.0 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 112.672 -2.058 . . . . 0.0 111.098 -179.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.748 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -122.01 161.53 16.12 Favored Glycine 0 CA--C 1.501 -0.817 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 17.9 m -114.63 140.43 48.82 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.313 0.578 . . . . 0.0 111.344 -178.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 1.077 HD13 ' HG2' ' A' ' 41' ' ' GLU . 2.4 mm? -48.14 -22.8 0.69 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.333 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.866 ' HG ' HD12 ' A' ' 13' ' ' LEU . 54.0 m -83.28 -34.76 25.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.921 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.71 HD12 ' CG1' ' A' ' 8' ' ' ILE . 49.5 mm . . . . . 0 N--CA 1.451 -0.381 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.226 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.748 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 18.5 mtm105 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 121.637 0.732 . . . . 0.0 111.836 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -135.16 155.85 50.0 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 114.539 -1.209 . . . . 0.0 109.432 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.699 HD22 ' HA3' ' A' ' 85' ' ' GLY . 7.6 tt -76.23 115.28 15.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.419 0.628 . . . . 0.0 111.773 -178.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.804 ' HB ' ' CZ ' ' A' ' 102' ' ' ARG . 39.0 t -107.01 131.95 21.29 Favored Pre-proline 0 N--CA 1.475 0.815 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.991 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.612 ' HD2' HG13 ' A' ' 100' ' ' VAL . 85.3 Cg_endo -82.92 127.47 4.79 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.663 2.242 . . . . 0.0 112.519 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.804 ' CZ ' ' HB ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -144.68 167.26 22.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.224 179.351 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.721 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.79 155.48 40.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 118.34 0.518 . . . . 0.0 110.1 -179.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -73.38 -41.2 63.67 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.895 -175.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.669 ' HB3' ' OD1' ' A' ' 123' ' ' ASP . 95.4 mttt -139.64 140.23 36.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.249 0.547 . . . . 0.0 109.619 177.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.84 HG11 ' CB ' ' A' ' 80' ' ' LYS . 35.1 m -146.78 139.44 19.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.311 -178.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.957 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 56.1 mmtt -106.6 127.05 53.03 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.841 HD13 ' CG ' ' A' ' 120' ' ' LEU . 2.3 pp -133.83 146.81 31.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -176.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.867 ' HG3' ' CD2' ' A' ' 78' ' ' LEU . 68.7 mtm180 -103.6 139.32 39.06 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.68 -178.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.778 ' HB3' HD23 ' A' ' 72' ' ' LEU . . . -161.05 169.42 22.51 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.037 -176.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 1.016 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.5 pp -116.48 151.83 35.28 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.571 ' O ' HD12 ' A' ' 111' ' ' LEU . 16.8 t70 -85.24 163.61 18.56 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.231 0.539 . . . . 0.0 112.053 -177.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.995 ' HB2' HG21 ' A' ' 71' ' ' VAL . 13.1 ttp-105 -51.93 -20.11 2.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.076 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -79.4 -26.44 41.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.633 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.663 ' HA2' HG23 ' A' ' 23' ' ' VAL . . . 107.3 35.98 2.58 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.199 -1.001 . . . . 0.0 113.491 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -128.46 102.68 20.36 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.781 0.291 . . . . 0.0 110.804 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.588 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.9 Cg_exo -72.6 116.27 4.65 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 121.65 1.567 . . . . 0.0 115.663 -177.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.431 ' CE2' ' HB2' ' A' ' 112' ' ' ASP . 0.4 OUTLIER -126.97 165.13 20.01 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.269 -178.655 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.523 ' HG3' ' CG ' ' A' ' 109' ' ' ARG . 5.9 mp0 -107.33 130.68 54.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.028 0.442 . . . . 0.0 109.837 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.841 ' CG ' HD13 ' A' ' 108' ' ' ILE . 4.4 pp -124.53 130.94 53.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.571 -178.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.957 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 15.3 pt-20 -91.5 123.79 35.18 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.951 ' HB3' HD13 ' A' ' 126' ' ' LEU . . . -116.24 135.62 53.74 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.669 ' OD1' ' HB3' ' A' ' 105' ' ' LYS . 45.4 m-20 -127.1 161.36 28.62 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.799 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 51.68 -137.88 30.3 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 120.334 1.425 . . . . 0.0 115.279 177.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 81.1 mt -54.05 -32.28 54.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.816 -0.692 . . . . 0.0 111.737 -178.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.951 HD13 ' HB3' ' A' ' 122' ' ' ALA . 0.3 OUTLIER -71.11 -52.58 18.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.663 0.744 . . . . 0.0 109.362 179.769 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.879 ' HB3' ' O ' ' A' ' 122' ' ' ALA . . . -59.85 -40.9 90.16 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.569 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.799 HG12 ' O ' ' A' ' 124' ' ' GLY . 46.4 mm -66.01 -54.31 28.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.698 -178.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.654 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 85.5 m -60.42 -49.39 77.76 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.765 ' CD1' HG12 ' A' ' 108' ' ' ILE . 0.1 OUTLIER -59.22 -44.72 92.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.557 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.801 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.3 pt20 -67.7 -39.14 84.42 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.683 0.278 . . . . 0.0 110.282 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -59.86 -46.05 90.53 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.12 0.486 . . . . 0.0 109.88 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.876 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.5 mm-40 -60.32 -40.74 91.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.921 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 1.087 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 73.2 mtp -57.78 -48.07 80.75 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.751 0.786 . . . . 0.0 109.948 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.887 ' O ' HG13 ' A' ' 138' ' ' VAL . 30.6 m-20 -62.76 -46.75 86.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.811 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.448 ' CE1' ' CG ' ' A' ' 50' ' ' GLN . 4.7 t-80 -59.57 -52.72 64.35 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.206 0.527 . . . . 0.0 111.675 -178.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.894 HD22 ' HA ' ' A' ' 134' ' ' MET . 1.5 pp -59.18 -30.38 68.15 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.315 -178.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.932 HG12 ' HG2' ' A' ' 140' ' ' LYS . 13.4 p -86.1 22.7 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-O 122.094 0.949 . . . . 0.0 109.356 176.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.691 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 55.88 38.75 75.54 Favored Glycine 0 CA--C 1.483 -1.966 0 CA-C-N 113.678 -1.601 . . . . 0.0 112.662 176.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.932 ' HG2' HG12 ' A' ' 138' ' ' VAL . 3.4 ptmt . . . . . 0 N--CA 1.426 -1.658 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.708 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.609 HG13 ' HA ' ' A' ' 37' ' ' THR . 31.5 m . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.905 0.383 . . . . 0.0 111.481 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.799 ' CD2' ' HB ' ' A' ' 51' ' ' VAL . 3.2 pp -79.74 -165.97 0.91 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.593 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.665 ' N ' HD12 ' A' ' 3' ' ' LEU . 40.7 tt0 -89.92 109.76 20.76 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.952 0.406 . . . . 0.0 110.473 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.43 ' CG2' HG23 ' A' ' 37' ' ' THR . 43.4 t -88.66 129.84 39.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.413 0.625 . . . . 0.0 112.079 -178.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 1.04 ' HB2' HD21 ' A' ' 13' ' ' LEU . 15.3 mt -89.95 143.21 26.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.923 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 44.0 m-70 -121.77 147.93 45.3 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -179.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.948 HD12 HD13 ' A' ' 13' ' ' LEU . 50.3 mm -63.68 135.78 96.43 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.145 178.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.443 ' HA ' HG21 ' A' ' 8' ' ' ILE . 3.9 Cg_exo -80.38 142.73 61.83 Favored 'Cis proline' 0 C--N 1.351 0.708 0 C-N-CA 124.605 -0.998 . . . . 0.0 111.746 -0.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.956 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.7 t70 -163.53 126.9 2.7 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.459 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.413 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 11.9 pt-20 -58.08 -46.07 86.08 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.598 -178.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.98 ' HA ' ' HZ1' ' A' ' 15' ' ' LYS . 16.0 mmt85 -56.28 -29.05 60.65 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 1.04 HD21 ' HB2' ' A' ' 6' ' ' LEU . 10.0 mt -76.43 -34.28 58.77 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 120.068 1.303 . . . . 0.0 108.559 177.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.783 ' NH1' ' HB3' ' A' ' 14' ' ' ARG . 2.2 mmm180 -93.42 13.0 22.97 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 113.877 -1.51 . . . . 0.0 109.182 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.98 ' HZ1' ' HA ' ' A' ' 12' ' ' ARG . 4.5 ttmp? -88.66 145.65 25.54 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.207 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.705 HG12 HG21 ' A' ' 138' ' ' VAL . 59.5 t -82.43 121.49 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.771 ' HB2' ' CG ' ' A' ' 56' ' ' ARG . . . -82.13 145.82 29.92 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.411 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -107.95 128.96 24.8 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.708 ' HA ' ' OD1' ' A' ' 74' ' ' ASN . 64.0 Cg_endo -78.97 113.54 3.26 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 121.725 1.617 . . . . 0.0 110.665 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.613 HG11 ' N ' ' A' ' 21' ' ' GLU . 16.5 t -68.97 144.43 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-O 122.469 1.128 . . . . 0.0 113.132 -175.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.613 ' N ' HG11 ' A' ' 20' ' ' VAL . 97.8 mt-10 -60.49 -24.75 65.53 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 113.125 -1.852 . . . . 0.0 112.368 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -157.28 142.71 17.28 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.296 -179.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.844 HG21 HD11 ' A' ' 111' ' ' LEU . 2.9 t -80.07 108.1 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -178.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 1.064 HD21 HD12 ' A' ' 27' ' ' ILE . 63.1 m-80 -90.85 155.36 18.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.658 -178.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.664 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -55.29 -25.49 34.46 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.35 0.595 . . . . 0.0 110.49 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.403 ' OE2' HG12 ' A' ' 27' ' ' ILE . 0.6 OUTLIER -75.11 -38.99 60.92 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 177.745 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 1.064 HD12 HD21 ' A' ' 24' ' ' ASN . 57.4 mt -66.06 -35.6 75.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 114.297 -1.32 . . . . 0.0 110.168 177.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -69.38 -39.21 78.15 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.254 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 38.1 mmm-85 -61.32 -39.24 89.79 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.788 ' O ' ' HG3' ' A' ' 34' ' ' MET . 3.0 mt -58.24 -48.69 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.2 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.722 HG11 ' CG2' ' A' ' 71' ' ' VAL . 8.7 t -67.9 -41.85 85.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 120.968 0.413 . . . . 0.0 111.557 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.83 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -55.8 -42.4 75.55 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.999 -179.412 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.482 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 15.5 m-20 -75.48 -29.91 59.74 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.284 176.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.788 ' HG3' ' O ' ' A' ' 30' ' ' ILE . 83.1 mtp -60.28 -46.51 89.58 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.315 -177.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.83 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 13.4 p90 -69.7 -45.2 68.81 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.755 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 37.9 mt-10 -51.84 -40.42 60.49 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 121.762 0.791 . . . . 0.0 108.904 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.609 ' HA ' HG13 ' A' ' 2' ' ' VAL . 56.6 m -70.24 -62.23 1.47 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.33 -1.305 . . . . 0.0 108.176 178.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 1.038 ' HE3' ' HB2' ' A' ' 61' ' ' ASP . 2.8 ttp -46.31 -41.4 13.21 Favored 'General case' 0 CA--C 1.46 -2.485 0 C-N-CA 124.144 0.978 . . . . 0.0 110.364 -171.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.705 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 61.7 m-85 -70.55 -42.69 70.84 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.686 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.555 ' HB1' HG13 ' A' ' 2' ' ' VAL . . . -61.4 -24.27 66.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.841 0.829 . . . . 0.0 109.395 179.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.946 ' HG2' HD12 ' A' ' 91' ' ' LEU . 11.6 tp10 -88.74 -11.23 45.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.471 177.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 64.27 25.42 13.53 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.956 -176.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.15 142.38 26.18 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 113.839 -1.528 . . . . 0.0 110.714 177.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.922 HG22 HG22 ' A' ' 62' ' ' VAL . 44.3 mm -79.15 -2.34 5.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 117.354 0.577 . . . . 0.0 112.139 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.504 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 177.97 134.91 2.15 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 118.759 -1.023 . . . . 0.0 111.291 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 1.002 HD11 ' HG ' ' A' ' 91' ' ' LEU . 7.6 tp -124.52 134.97 52.84 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 119.29 1.545 . . . . 0.0 111.973 -179.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -100.31 130.34 46.41 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.484 0.183 . . . . 0.0 111.299 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.673 ' HB3' ' O ' ' A' ' 57' ' ' ILE . . . -28.61 -54.43 0.11 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -179.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.601 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 69.1 p -52.96 -35.45 58.94 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.458 0.647 . . . . 0.0 112.221 -177.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.765 HE22 HD22 ' A' ' 91' ' ' LEU . 34.2 mt-30 -65.22 -42.05 93.81 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.154 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.865 ' CG1' HD22 ' A' ' 46' ' ' LEU . 0.8 OUTLIER -82.42 15.69 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 179.781 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.961 ' HA ' HD11 ' A' ' 6' ' ' LEU . 35.0 t70 77.46 30.07 0.52 Allowed 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 176.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.821 HD11 ' O ' ' A' ' 55' ' ' GLN . 1.1 pp -123.74 111.37 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.318 177.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.629 ' HB3' ' HD2' ' A' ' 15' ' ' LYS . 6.8 p80 -76.68 61.65 1.86 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.677 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.821 ' O ' HD11 ' A' ' 53' ' ' ILE . 89.0 mt-30 -151.57 134.3 15.59 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 114.495 -1.229 . . . . 0.0 107.942 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.771 ' CG ' ' HB2' ' A' ' 17' ' ' ALA . 76.3 mtp180 -64.0 69.3 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -177.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.765 ' O ' ' HE1' ' A' ' 34' ' ' MET . 8.0 mm -111.27 123.47 67.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.811 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -131.43 147.39 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 121.975 0.893 . . . . 0.0 112.965 -177.779 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.65 HG21 ' H ' ' A' ' 46' ' ' LEU . 32.9 m -127.71 139.21 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.092 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.935 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 9.2 mm -114.69 150.73 16.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.646 0.736 . . . . 0.0 109.943 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 1.038 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 33.4 t70 -138.62 28.82 2.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.735 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.922 HG22 HG22 ' A' ' 44' ' ' ILE . 40.4 t . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.556 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.687 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 41.7 ttm-85 . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.935 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 8.5 mp -102.87 132.35 49.13 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.991 0.424 . . . . 0.0 111.908 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.934 HG21 ' HB2' ' A' ' 113' ' ' ARG . 9.6 p -133.14 134.33 57.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.06 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.811 ' HB2' ' CD1' ' A' ' 58' ' ' ILE . 90.6 mt -141.74 140.95 33.23 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 121.384 -0.126 . . . . 0.0 111.009 178.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.992 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.8 mp -120.2 133.65 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-O 120.838 0.351 . . . . 0.0 110.923 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.708 ' OD1' ' HA ' ' A' ' 19' ' ' PRO . 64.5 m-20 51.72 36.32 0.34 Allowed Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 113.863 1.061 . . . . 0.0 113.863 178.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.777 ' HG3' ' HB2' ' A' ' 110' ' ' ALA . 90.1 Cg_exo -55.65 149.5 48.86 Favored 'Trans proline' 0 N--CA 1.484 0.917 0 C-N-CA 122.708 2.272 . . . . 0.0 113.415 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.434 ' OE2' ' HD2' ' A' ' 109' ' ' ARG . 23.0 pt-20 -135.91 145.88 46.76 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 1.102 ' HB2' ' HE2' ' A' ' 134' ' ' MET . 30.1 tp -79.71 138.38 37.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.38 0.61 . . . . 0.0 112.278 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 1.054 HD22 ' HE ' ' A' ' 109' ' ' ARG . 5.4 mp -112.17 -44.04 3.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.632 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 38.4 tt0 -158.79 147.79 18.74 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 121.141 0.496 . . . . 0.0 111.831 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.745 ' HA ' HG13 ' A' ' 106' ' ' VAL . 19.4 ptpt -142.3 147.46 36.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.054 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.2 t -160.03 148.02 16.83 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.702 0.287 . . . . 0.0 111.221 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.737 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 82.97 163.93 34.89 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.515 -179.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -140.55 113.59 8.38 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.922 0.861 . . . . 0.0 113.106 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.626 ' HG1' HD13 ' A' ' 128' ' ' ILE . 1.6 p -106.09 161.56 14.39 Favored 'General case' 0 CA--C 1.486 -1.481 0 CA-C-N 113.999 -1.455 . . . . 0.0 114.864 178.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.433 ' C ' HG13 ' A' ' 86' ' ' ILE . . . -145.47 114.12 0.74 Allowed Glycine 0 C--N 1.312 -0.781 0 CA-C-N 112.849 -1.978 . . . . 0.0 110.653 178.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.783 ' HB ' ' NH2' ' A' ' 102' ' ' ARG . 34.0 mt -148.67 139.56 17.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-N 117.264 0.532 . . . . 0.0 111.826 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 50.4 mt-10 -72.19 138.09 47.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 123.195 1.474 . . . . 0.0 112.581 -176.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.664 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 39.1 mt-10 -155.29 160.26 40.64 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 112.358 -2.201 . . . . 0.0 111.212 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.773 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -120.12 159.56 15.04 Favored Glycine 0 CA--C 1.499 -0.911 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.996 ' HB2' HD13 ' A' ' 93' ' ' ILE . 21.8 m -114.27 139.91 49.03 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 117.688 0.744 . . . . 0.0 111.175 -177.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 1.002 ' HG ' HD11 ' A' ' 46' ' ' LEU . 2.4 mm? -49.44 -22.47 1.19 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.036 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.919 ' HB3' HD12 ' A' ' 13' ' ' LEU . 54.4 m -79.41 -38.54 34.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.277 179.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.996 HD13 ' HB2' ' A' ' 90' ' ' CYS . 3.2 mp . . . . . 0 N--CA 1.448 -0.547 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.773 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 40.2 mtt180 . . . . . 0 N--CA 1.465 0.286 0 CA-C-O 121.573 0.701 . . . . 0.0 111.613 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -135.35 155.46 50.55 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 114.691 -1.141 . . . . 0.0 109.716 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.66 ' HG ' ' N ' ' A' ' 86' ' ' ILE . 7.3 tt -76.41 114.85 15.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.439 0.638 . . . . 0.0 111.985 -178.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.73 ' HB ' HH11 ' A' ' 102' ' ' ARG . 42.6 t -104.36 132.8 20.62 Favored Pre-proline 0 N--CA 1.47 0.573 0 CA-C-N 114.931 -1.031 . . . . 0.0 112.062 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' A' ' 84' ' ' THR . 2.1 Cg_endo -84.35 125.99 3.56 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.843 2.362 . . . . 0.0 111.804 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.783 ' NH2' ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -144.61 167.51 22.36 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.56 0.744 . . . . 0.0 109.98 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.737 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.79 154.86 41.22 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.836 0.351 . . . . 0.0 110.179 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -73.77 -41.16 62.81 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.146 -176.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.776 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 91.4 mttt -139.91 141.2 36.54 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.745 HG13 ' HA ' ' A' ' 80' ' ' LYS . 29.4 m -149.06 139.0 16.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.333 -179.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 1.0 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 51.0 mmtt -107.98 126.4 52.67 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.818 ' CD1' HD11 ' A' ' 130' ' ' ILE . 1.6 pp -136.1 152.76 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -176.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 1.054 ' HE ' HD22 ' A' ' 78' ' ' LEU . 93.7 mtt180 -102.68 138.78 39.12 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.93 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.777 ' HB2' ' HG3' ' A' ' 75' ' ' PRO . . . -160.04 167.82 27.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.102 -177.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.992 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.6 pp -117.12 153.25 33.11 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.597 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 10.1 t70 -88.2 162.97 16.38 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.519 -177.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.934 ' HB2' HG21 ' A' ' 71' ' ' VAL . 50.1 ttp85 -51.39 -19.04 1.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.251 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -79.1 -27.67 42.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.381 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.43 35.92 2.37 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.348 -0.93 . . . . 0.0 113.329 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -128.74 102.88 19.47 Favored Pre-proline 0 C--O 1.237 0.406 0 CA-C-N 116.815 0.308 . . . . 0.0 110.914 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.5 Cg_exo -73.4 116.08 4.57 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 121.766 1.644 . . . . 0.0 115.145 -177.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.597 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 10.9 p90 -126.13 166.65 16.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.312 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.729 ' HG2' ' HG2' ' A' ' 109' ' ' ARG . 30.7 mt-10 -107.5 130.51 54.84 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.743 HD11 ' CD1' ' A' ' 130' ' ' ILE . 4.3 pp -127.44 133.88 49.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.591 -178.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 1.0 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 9.1 pm0 -94.45 123.66 38.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.627 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.962 ' HB3' HD22 ' A' ' 126' ' ' LEU . . . -116.82 135.11 54.0 Favored 'General case' 0 C--O 1.222 -0.364 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.817 ' CA ' ' HB3' ' A' ' 127' ' ' ALA . 1.2 m-20 -126.66 162.35 25.97 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.703 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 49.9 -134.77 26.54 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 120.418 1.463 . . . . 0.0 115.252 177.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.526 HD12 ' CG1' ' A' ' 62' ' ' VAL . 1.7 pt? -53.78 -35.46 61.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.032 -0.584 . . . . 0.0 111.462 -179.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.962 HD22 ' HB3' ' A' ' 122' ' ' ALA . 0.6 OUTLIER -70.51 -52.01 24.85 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.996 0.903 . . . . 0.0 109.281 179.563 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.817 ' HB3' ' CA ' ' A' ' 123' ' ' ASP . . . -58.45 -41.5 85.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.925 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.703 HG12 ' O ' ' A' ' 124' ' ' GLY . 50.6 mm -68.54 -54.99 17.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.816 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 29.3 p -59.03 -50.74 72.93 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.818 HD11 ' CD1' ' A' ' 108' ' ' ILE . 17.9 tt -59.65 -43.85 92.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.189 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.672 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.0 pt20 -67.73 -40.63 84.18 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.176 178.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 69.9 t60 -58.5 -45.78 88.04 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.206 0.527 . . . . 0.0 109.931 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.879 ' O ' HD21 ' A' ' 137' ' ' LEU . 3.2 mm-40 -59.81 -41.77 92.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.708 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 1.102 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 74.8 mtp -57.25 -47.83 80.38 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.736 0.779 . . . . 0.0 110.08 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.866 ' O ' HG12 ' A' ' 138' ' ' VAL . 1.4 m-20 -63.16 -47.12 84.0 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.951 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.47 ' CE1' ' CG ' ' A' ' 50' ' ' GLN . 8.7 t-80 -58.97 -53.11 62.16 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.176 0.512 . . . . 0.0 111.472 -178.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.907 HD23 ' HA ' ' A' ' 134' ' ' MET . 1.6 pp -58.65 -31.4 68.13 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.644 -178.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.963 HG11 ' HG2' ' A' ' 140' ' ' LYS . 14.5 p -85.05 24.58 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-O 122.283 1.04 . . . . 0.0 109.816 176.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 55.84 30.81 57.49 Favored Glycine 0 CA--C 1.486 -1.757 0 CA-C-N 113.48 -1.691 . . . . 0.0 112.679 176.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.963 ' HG2' HG11 ' A' ' 138' ' ' VAL . 5.8 ptmt . . . . . 0 N--CA 1.425 -1.704 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.626 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 52.4 m . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.981 0.42 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.863 HG12 ' HA ' ' A' ' 37' ' ' THR . 25.5 m -84.32 133.16 29.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.327 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.867 HD11 ' HB ' ' A' ' 51' ' ' VAL . 2.0 pt? -80.46 -147.47 0.05 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.511 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 51.7 tt0 -98.58 104.76 16.83 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.938 0.399 . . . . 0.0 110.889 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.454 HG23 HG23 ' A' ' 37' ' ' THR . 40.4 t -88.36 126.38 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-O 121.496 0.665 . . . . 0.0 112.152 -178.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 1.061 ' HB2' HD23 ' A' ' 13' ' ' LEU . 50.2 mt -85.86 144.97 27.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.22 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 53.6 m-70 -123.01 144.05 49.52 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -178.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.861 ' CD1' HD12 ' A' ' 13' ' ' LEU . 49.3 mm -65.8 132.67 94.85 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.787 177.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -77.31 143.74 75.76 Favored 'Cis proline' 0 C--N 1.35 0.641 0 C-N-CA 124.553 -1.019 . . . . 0.0 111.778 -0.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 1.016 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.7 t70 -162.51 126.79 3.11 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.478 ' HG2' ' N ' ' A' ' 12' ' ' ARG . 0.6 OUTLIER -57.9 -45.85 85.84 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.754 -178.444 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.696 ' HB2' HD11 ' A' ' 6' ' ' LEU . 21.4 mtt-85 -59.89 -26.83 66.2 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 1.061 HD23 ' HB2' ' A' ' 6' ' ' LEU . 10.6 mt -77.66 -30.56 52.14 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 120.964 1.711 . . . . 0.0 108.586 177.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.589 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 15.0 mmm180 -95.11 8.62 42.43 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.072 -1.422 . . . . 0.0 109.059 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -90.17 147.67 23.44 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.7 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 90.4 t -81.93 128.83 38.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.769 ' HB2' ' HG3' ' A' ' 56' ' ' ARG . . . -90.28 145.4 25.01 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.846 ' HD3' ' HD2' ' A' ' 19' ' ' PRO . 8.0 tmtt? -107.11 131.42 21.71 Favored Pre-proline 0 C--N 1.318 -0.768 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.846 ' HD2' ' HD3' ' A' ' 18' ' ' LYS . 54.1 Cg_endo -81.56 114.44 2.7 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.774 1.649 . . . . 0.0 110.333 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.63 HG12 ' N ' ' A' ' 21' ' ' GLU . 19.4 t -68.97 144.88 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 CA-C-O 122.692 1.234 . . . . 0.0 113.342 -175.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.63 ' N ' HG12 ' A' ' 20' ' ' VAL . 52.8 mt-10 -63.31 -21.26 66.15 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 112.861 -1.972 . . . . 0.0 112.986 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -157.84 144.51 17.82 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.166 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.793 HG23 HD13 ' A' ' 111' ' ' LEU . 3.2 t -79.64 106.85 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -178.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.892 HD21 HD12 ' A' ' 27' ' ' ILE . 56.1 m-80 -92.61 153.22 19.13 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.802 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.724 ' HB2' HH12 ' A' ' 29' ' ' ARG . . . -54.14 -24.19 16.93 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.241 0.543 . . . . 0.0 110.782 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.87 ' HG3' HD13 ' A' ' 27' ' ' ILE . 13.9 pt-20 -75.15 -42.19 56.66 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 177.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.892 HD12 HD21 ' A' ' 24' ' ' ASN . 2.0 mp -65.19 -35.72 76.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.748 177.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -66.32 -40.57 90.03 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 122.349 -0.22 . . . . 0.0 110.493 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.724 HH12 ' HB2' ' A' ' 25' ' ' ALA . 67.9 mtt85 -62.83 -38.69 91.77 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.919 HG23 HD12 ' A' ' 57' ' ' ILE . 1.6 mp -56.07 -49.97 72.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.927 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.81 ' CG1' HG23 ' A' ' 71' ' ' VAL . 36.7 t -67.25 -43.14 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.924 0.392 . . . . 0.0 111.17 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.807 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -55.45 -41.11 72.42 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.067 -179.103 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.519 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 1.3 m-20 -76.37 -30.22 57.46 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.318 176.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.783 ' HG3' ' O ' ' A' ' 30' ' ' ILE . 32.5 mtm -60.74 -44.59 96.49 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 120.55 -0.46 . . . . 0.0 109.95 -178.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.807 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 10.6 p90 -70.17 -46.19 65.15 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.549 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 29.7 mm-40 -51.86 -40.99 61.51 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 121.634 0.731 . . . . 0.0 109.411 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.863 ' HA ' HG12 ' A' ' 2' ' ' VAL . 91.6 m -70.43 -61.84 1.62 Allowed 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 118.479 -1.288 . . . . 0.0 108.411 177.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.918 ' HE3' ' HB2' ' A' ' 61' ' ' ASP . 2.1 ttp -46.16 -41.06 12.08 Favored 'General case' 0 CA--C 1.46 -2.483 0 C-N-CA 124.346 1.058 . . . . 0.0 110.775 -171.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.713 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 45.8 m-85 -70.07 -42.61 72.59 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.751 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.469 ' HB1' ' CG1' ' A' ' 2' ' ' VAL . . . -61.26 -24.33 66.31 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.436 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.964 ' HG2' HD13 ' A' ' 91' ' ' LEU . 16.5 tp10 -89.11 -11.24 44.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.466 177.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 63.8 25.41 14.09 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.048 -176.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.35 144.53 25.84 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.819 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 1.014 HG21 HG23 ' A' ' 62' ' ' VAL . 51.6 mt -79.92 0.73 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 117.823 0.811 . . . . 0.0 112.062 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.867 ' HA3' ' H92' ' A' ' 149' ' ' BB2 . . . 178.03 140.34 3.77 Favored Glycine 0 CA--C 1.517 0.198 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.957 HD13 ' HG ' ' A' ' 91' ' ' LEU . 7.0 tp -127.4 135.22 50.17 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.855 1.327 . . . . 0.0 109.66 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.47 133.3 49.57 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 122.033 -0.417 . . . . 0.0 111.621 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.64 ' HA ' ' SD ' ' A' ' 34' ' ' MET . . . -26.82 -57.24 0.09 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 116.113 1.894 . . . . 0.0 116.113 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 1.029 HG22 ' HA ' ' A' ' 137' ' ' LEU . 70.1 p -54.44 -34.87 62.25 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 121.969 0.89 . . . . 0.0 112.199 -178.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.702 ' NE2' HD22 ' A' ' 91' ' ' LEU . 57.4 mt-30 -62.14 -40.0 94.49 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.547 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.867 ' HB ' HD11 ' A' ' 3' ' ' LEU . 1.7 m -93.41 18.35 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.829 ' OD2' HD21 ' A' ' 6' ' ' LEU . 6.6 t0 80.13 25.51 0.35 Allowed 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 176.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.819 HD11 ' O ' ' A' ' 55' ' ' GLN . 1.0 OUTLIER -119.18 107.42 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 118.759 -1.176 . . . . 0.0 111.004 178.056 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -75.91 60.58 1.38 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 122.18 0.99 . . . . 0.0 110.642 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.819 ' O ' HD11 ' A' ' 53' ' ' ILE . 88.5 mt-30 -147.19 131.64 17.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.945 -1.479 . . . . 0.0 107.058 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.859 ' HG2' HD11 ' A' ' 137' ' ' LEU . 75.9 mtp180 -64.67 75.63 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.919 HD12 HG23 ' A' ' 30' ' ' ILE . 23.0 mt -117.25 125.06 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.866 HG23 HD21 ' A' ' 137' ' ' LEU . 1.8 pp -122.65 142.45 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 120.119 -0.632 . . . . 0.0 112.254 -177.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.573 ' O ' H113 ' A' ' 149' ' ' BB2 . 2.5 p -127.79 132.53 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 1.055 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 1.8 mt -114.65 154.89 15.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.898 0.856 . . . . 0.0 111.985 -177.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.918 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 14.9 t70 -145.12 31.86 1.12 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 113.986 -1.461 . . . . 0.0 110.068 -177.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 1.014 HG23 HG21 ' A' ' 44' ' ' ILE . 48.1 t -89.89 107.03 17.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.652 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.715 ' HA ' ' HG3' ' A' ' 68' ' ' GLU . 80.5 p -55.8 65.75 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -177.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 62' ' ' VAL . 88.6 tt0 -75.81 7.54 3.81 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.324 178.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.549 ' CG ' ' H ' ' A' ' 66' ' ' ARG . 0.7 OUTLIER -163.28 -139.47 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.881 179.255 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.549 ' H ' ' CG ' ' A' ' 65' ' ' ASN . 39.6 mmt180 -75.64 -58.63 3.17 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -115.48 135.5 54.04 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.715 ' HG3' ' HA ' ' A' ' 63' ' ' SER . 2.9 mp0 -79.69 129.81 34.8 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.305 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.415 ' HB2' ' O ' ' A' ' 68' ' ' GLU . 39.2 ttt85 -179.94 63.77 0.01 OUTLIER 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.912 0.387 . . . . 0.0 111.389 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 1.055 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 55.3 mt -103.37 133.27 48.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.804 0.335 . . . . 0.0 111.678 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.92 HG22 ' HB2' ' A' ' 113' ' ' ARG . 7.1 p -135.86 133.89 51.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.187 177.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.843 ' HB2' ' CD1' ' A' ' 58' ' ' ILE . 1.7 mm? -140.55 141.82 35.21 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 1.024 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.6 mp -120.18 132.92 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.692 ' OD1' ' HA ' ' A' ' 19' ' ' PRO . 59.7 m-20 53.7 37.68 0.44 Allowed Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.838 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 95.0 Cg_exo -57.1 148.29 70.11 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 123.011 2.474 . . . . 0.0 114.129 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.462 ' O ' ' HB ' ' A' ' 108' ' ' ILE . 11.6 pt-20 -135.85 144.61 45.73 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 1.021 ' HB2' ' HE2' ' A' ' 134' ' ' MET . 44.5 tp -80.04 138.03 36.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.319 0.58 . . . . 0.0 111.98 -178.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.9 ' CD2' ' HG3' ' A' ' 109' ' ' ARG . 2.8 mm? -112.99 -39.33 4.25 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.971 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.601 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 85.2 tt0 -160.02 145.37 15.22 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 121.269 0.557 . . . . 0.0 111.695 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.948 ' HA ' HG11 ' A' ' 106' ' ' VAL . 10.8 ptpp? -138.52 149.58 45.51 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.482 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.1 p -159.02 149.21 19.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.801 0.334 . . . . 0.0 111.444 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.609 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 76.83 149.55 3.19 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.783 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -117.64 113.68 22.27 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.884 0.849 . . . . 0.0 112.406 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.714 HG21 ' HG2' ' A' ' 104' ' ' GLU . 1.7 p -112.08 160.37 17.59 Favored 'General case' 0 CA--C 1.485 -1.52 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.716 ' O ' HD11 ' A' ' 86' ' ' ILE . . . -151.28 118.68 0.93 Allowed Glycine 0 C--N 1.311 -0.852 0 CA-C-N 112.392 -2.186 . . . . 0.0 110.509 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.716 HD11 ' O ' ' A' ' 85' ' ' GLY . 47.8 mm -147.76 139.92 18.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-N 117.383 0.592 . . . . 0.0 111.183 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 50.5 mt-10 -71.19 137.32 48.63 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 123.322 1.534 . . . . 0.0 111.833 -176.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 1.039 ' HG2' ' H27' ' A' ' 149' ' ' BB2 . 42.3 mt-10 -155.15 161.68 41.17 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 112.477 -2.147 . . . . 0.0 111.91 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.868 ' O ' ' H51' ' A' ' 149' ' ' BB2 . . . -121.43 164.3 14.65 Favored Glycine 0 CA--C 1.5 -0.853 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.696 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 5.7 m -118.59 139.02 52.15 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.264 0.554 . . . . 0.0 111.854 -177.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.982 HD23 H171 ' A' ' 149' ' ' BB2 . 2.4 mm? -49.64 -26.83 3.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.433 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.843 ' CB ' HG12 ' A' ' 8' ' ' ILE . 57.4 m -78.82 -36.52 42.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.43 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.864 HG23 ' HD2' ' A' ' 94' ' ' PRO . 43.6 mm -85.85 150.1 52.33 Favored Pre-proline 0 N--CA 1.45 -0.425 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.392 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.864 ' HD2' HG23 ' A' ' 93' ' ' ILE . 94.4 Cg_endo -72.4 49.25 1.38 Allowed 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.494 2.129 . . . . 0.0 113.976 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.537 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 40.0 tt0 73.9 15.68 3.82 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.113 0.482 . . . . 0.0 111.984 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.693 ' HB2' HG21 ' A' ' 93' ' ' ILE . 84.6 mt-30 -78.53 89.02 4.47 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.789 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 18.8 mtm105 -84.95 132.44 34.36 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.794 0.807 . . . . 0.0 111.817 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -134.48 153.42 51.94 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 114.433 -1.258 . . . . 0.0 109.82 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.667 HD21 ' HA3' ' A' ' 85' ' ' GLY . 6.9 tt -76.12 115.99 16.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.652 0.739 . . . . 0.0 111.146 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.972 HG11 ' HB2' ' A' ' 142' ' ' PHE . 17.3 t -111.0 136.09 20.81 Favored Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.665 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.83 ' HD2' HG12 ' A' ' 100' ' ' VAL . 91.8 Cg_endo -84.23 126.37 3.71 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 122.725 2.283 . . . . 0.0 112.655 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.907 HH21 HG13 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -145.6 166.76 24.8 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.102 0.961 . . . . 0.0 109.004 178.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.609 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -67.9 154.07 42.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 118.599 0.636 . . . . 0.0 110.473 -178.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.714 ' HG2' HG21 ' A' ' 84' ' ' THR . 2.7 tm-20 -73.48 -41.26 63.36 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.393 -175.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.788 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 56.6 mttp -139.24 140.43 37.7 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.479 0.657 . . . . 0.0 109.433 177.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.948 HG11 ' HA ' ' A' ' 80' ' ' LYS . 26.1 m -150.14 136.37 12.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.455 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.978 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 46.5 mmtt -107.47 127.49 53.65 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.699 ' HA ' ' CD2' ' A' ' 78' ' ' LEU . 1.5 pp -135.09 156.54 39.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -176.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.9 ' HG3' ' CD2' ' A' ' 78' ' ' LEU . 92.7 mtt180 -103.3 138.17 40.43 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.502 -178.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.766 ' HB2' ' HB3' ' A' ' 72' ' ' LEU . . . -160.66 170.13 21.44 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.856 -176.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 1.024 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.6 pp -118.76 151.9 37.18 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 176.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.661 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 17.0 t70 -84.7 162.87 19.51 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.668 -176.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.92 ' HB2' HG22 ' A' ' 71' ' ' VAL . 50.7 ttp85 -53.5 -17.71 2.23 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.816 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -79.0 -28.81 43.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.819 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.636 ' HA2' HG23 ' A' ' 23' ' ' VAL . . . 109.33 35.49 2.28 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.475 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -128.77 102.8 19.44 Favored Pre-proline 0 C--O 1.236 0.376 0 CA-C-N 116.971 0.386 . . . . 0.0 110.891 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.7 Cg_exo -72.8 115.64 4.42 Favored 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 121.83 1.687 . . . . 0.0 115.696 -177.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.661 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 12.3 p90 -129.52 167.06 18.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.562 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.735 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 6.2 mp0 -107.35 130.3 54.81 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.911 HD22 ' O ' ' A' ' 120' ' ' LEU . 0.2 OUTLIER -127.31 141.45 51.7 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 121.785 0.802 . . . . 0.0 111.703 -178.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.978 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 11.4 pt-20 -94.13 123.69 37.67 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.998 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.867 ' O ' ' HB3' ' A' ' 127' ' ' ALA . . . -115.67 135.19 54.3 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.586 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.788 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.2 m-20 -126.94 163.12 24.37 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.761 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 50.55 -139.46 21.94 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 120.218 1.372 . . . . 0.0 115.726 177.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.792 HD21 HG11 ' A' ' 62' ' ' VAL . 25.6 tp -54.69 -30.3 55.32 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.38 -0.91 . . . . 0.0 111.643 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.742 HD21 ' CD1' ' A' ' 70' ' ' LEU . 0.5 OUTLIER -71.38 -53.32 14.49 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.56 0.695 . . . . 0.0 109.286 179.451 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.867 ' HB3' ' O ' ' A' ' 122' ' ' ALA . . . -59.46 -39.77 84.71 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.332 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.786 HG21 ' HG3' ' A' ' 102' ' ' ARG . 45.9 mm -67.0 -54.51 23.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.347 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 1.047 ' HB3' ' H91' ' A' ' 149' ' ' BB2 . 73.0 m -60.61 -50.44 73.51 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.614 HG23 ' N ' ' A' ' 131' ' ' GLN . 21.2 tt -58.61 -44.59 89.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.697 0.284 . . . . 0.0 110.961 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.652 ' HG2' ' O ' ' A' ' 127' ' ' ALA . 22.7 pt20 -65.84 -37.65 86.79 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.593 ' HD2' ' HN1' ' A' ' 149' ' ' BB2 . 75.8 t60 -60.15 -47.12 87.27 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.548 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.829 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 3.0 mm-40 -60.1 -38.03 81.77 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 1.021 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 72.4 mtp -58.07 -45.01 87.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 122.344 1.069 . . . . 0.0 109.183 177.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.903 ' O ' HG12 ' A' ' 138' ' ' VAL . 57.0 m-20 -67.76 -48.73 65.56 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.0 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.678 ' CE1' ' HG2' ' A' ' 50' ' ' GLN . 6.4 t-80 -57.71 -52.87 63.66 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.393 0.616 . . . . 0.0 111.648 -178.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 1.029 ' HA ' HG22 ' A' ' 49' ' ' THR . 0.2 OUTLIER -64.95 -28.8 69.77 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 119.822 -0.751 . . . . 0.0 111.762 -179.291 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.903 HG12 ' O ' ' A' ' 135' ' ' ASP . 11.5 p -81.47 24.16 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 122.08 0.943 . . . . 0.0 109.364 175.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.589 ' O ' ' HA ' ' A' ' 14' ' ' ARG . . . 68.41 -3.63 5.82 Favored Glycine 0 CA--C 1.484 -1.886 0 CA-C-N 113.769 -1.56 . . . . 0.0 113.217 175.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.889 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 11.4 ptmt -87.6 142.25 27.99 Favored 'General case' 0 N--CA 1.408 -2.552 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.605 HD12 ' CE1' ' A' ' 136' ' ' HIS . 3.8 mm? -134.9 151.37 50.83 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 120.866 -0.333 . . . . 0.0 110.182 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.972 ' HB2' HG11 ' A' ' 100' ' ' VAL . 14.1 p90 -54.39 -37.43 65.02 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.421 ' N ' ' CD1' ' A' ' 142' ' ' PHE . 15.6 tpt -52.31 -26.56 12.42 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.54 0.686 . . . . 0.0 111.003 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -56.57 -21.56 27.4 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.208 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -122.05 4.66 9.85 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -177.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.623 HD21 ' O ' ' A' ' 142' ' ' PHE . 3.9 mm? -86.26 145.55 26.9 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.731 0.3 . . . . 0.0 111.087 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 82.5 p . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.971 179.616 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' BB2 . . . . . 1.047 ' H91' ' HB3' ' A' ' 129' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 48.4 t . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.866 0.365 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.802 ' CG1' HG21 ' A' ' 37' ' ' THR . 40.5 t -88.22 134.04 29.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.119 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.999 HD22 HG13 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -79.1 -143.43 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.34 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -107.31 104.49 14.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 118.174 0.443 . . . . 0.0 110.363 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.1 t -87.77 125.11 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 121.557 0.694 . . . . 0.0 111.967 -178.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.988 ' HB2' HD21 ' A' ' 13' ' ' LEU . 20.9 mt -87.63 138.68 31.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.07 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 32.7 m-70 -111.69 149.39 31.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.172 0.511 . . . . 0.0 111.91 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.788 HG12 ' CB ' ' A' ' 92' ' ' SER . 47.1 mm -57.21 145.41 66.48 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.392 178.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.522 ' CA ' HG22 ' A' ' 8' ' ' ILE . 72.7 Cg_endo -92.68 52.48 1.0 Allowed 'Cis proline' 0 C--N 1.353 0.808 0 C-N-CA 124.597 -1.001 . . . . 0.0 112.872 0.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.998 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 9.4 t0 -53.81 134.45 42.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.972 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -59.23 -45.22 91.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.425 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.712 ' HB2' HD12 ' A' ' 6' ' ' LEU . 28.2 mtt-85 -59.29 -23.78 62.71 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.998 ' HG ' ' HB3' ' A' ' 10' ' ' ASP . 11.2 mt -73.48 -33.06 64.64 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 119.661 1.119 . . . . 0.0 108.393 178.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.678 ' C ' ' HA3' ' A' ' 139' ' ' GLY . 15.0 mmm180 -98.34 11.19 38.81 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.784 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.521 ' HB2' ' HA ' ' A' ' 12' ' ' ARG . 62.3 tttp -87.06 148.05 25.43 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.217 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.702 HG13 HG23 ' A' ' 138' ' ' VAL . 48.9 t -82.41 118.65 30.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.777 ' HB2' ' HG2' ' A' ' 56' ' ' ARG . . . -78.08 146.5 35.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.272 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -103.83 127.99 28.22 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.616 ' HD3' ' CD ' ' A' ' 56' ' ' ARG . 64.4 Cg_endo -78.24 115.51 3.73 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.206 1.937 . . . . 0.0 110.984 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.645 HG13 ' N ' ' A' ' 21' ' ' GLU . 21.7 t -68.32 144.27 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 CA-C-O 122.717 1.246 . . . . 0.0 113.28 -175.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.645 ' N ' HG13 ' A' ' 20' ' ' VAL . 96.5 mt-10 -67.79 -26.52 66.13 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 112.731 -2.031 . . . . 0.0 112.203 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.545 ' O ' HG11 ' A' ' 20' ' ' VAL . 42.4 tt0 -154.47 145.17 22.39 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.168 -178.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.959 HG22 ' HA2' ' A' ' 115' ' ' GLY . 4.6 t -79.6 103.8 6.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -178.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 1.012 ' HB2' HD13 ' A' ' 27' ' ' ILE . 1.9 m120 -93.19 155.6 17.35 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.701 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.7 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -56.17 -25.92 48.6 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.278 0.561 . . . . 0.0 110.88 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.473 ' HA ' ' OE1' ' A' ' 26' ' ' GLU . 4.2 mm-40 -75.29 -40.45 58.62 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 1.012 HD13 ' HB2' ' A' ' 24' ' ' ASN . 1.8 mp -66.76 -35.01 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 113.86 -1.518 . . . . 0.0 110.238 178.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -70.39 -38.88 74.75 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 122.208 -0.307 . . . . 0.0 110.715 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.7 ' HG3' ' O ' ' A' ' 25' ' ' ALA . 39.8 mtp85 -64.05 -39.0 93.12 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.785 ' O ' ' HG3' ' A' ' 34' ' ' MET . 3.0 mt -56.88 -49.16 79.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.771 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.818 HG13 HG21 ' A' ' 71' ' ' VAL . 9.6 t -67.36 -41.13 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 CA-C-O 121.004 0.43 . . . . 0.0 110.815 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.808 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 21.1 m-20 -54.74 -43.53 72.77 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.351 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.526 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 19.1 m-20 -76.4 -29.3 57.03 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.546 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.83 ' HE1' ' O ' ' A' ' 57' ' ' ILE . 85.0 mtp -59.87 -46.07 90.46 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.247 -178.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.808 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 13.2 p90 -69.9 -45.24 68.04 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 176.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.764 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 40.3 mt-10 -52.37 -38.52 59.05 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 121.707 0.765 . . . . 0.0 109.291 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.811 ' OG1' HD21 ' A' ' 3' ' ' LEU . 88.6 m -70.35 -61.72 1.66 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.273 -1.331 . . . . 0.0 107.833 177.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 1.015 ' HE3' ' HB2' ' A' ' 61' ' ' ASP . 2.8 ttp -45.77 -40.78 10.01 Favored 'General case' 0 CA--C 1.46 -2.488 0 C-N-CA 124.321 1.048 . . . . 0.0 110.059 -171.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.672 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 18.6 m-85 -70.1 -43.09 71.77 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.097 178.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 37' ' ' THR . . . -60.85 -25.17 66.45 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.75 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 1.051 ' HG2' HD12 ' A' ' 91' ' ' LEU . 17.0 tp10 -88.76 -11.46 44.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.645 -1.161 . . . . 0.0 108.469 176.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 64.31 26.41 13.65 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.943 -176.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.488 ' HA2' H182 ' A' ' 149' ' ' BB2 . . . -81.31 142.67 23.21 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 113.947 -1.479 . . . . 0.0 111.276 178.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.988 HG23 HG22 ' A' ' 62' ' ' VAL . 42.6 mm -79.33 -0.95 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 117.293 0.547 . . . . 0.0 112.208 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.874 ' HA3' ' H92' ' A' ' 149' ' ' BB2 . . . 179.0 135.27 2.32 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 118.928 -0.929 . . . . 0.0 111.437 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.995 HD12 ' HG ' ' A' ' 91' ' ' LEU . 4.5 tp -125.17 133.96 52.59 Favored 'General case' 0 C--N 1.354 0.783 0 CA-C-N 119.332 1.566 . . . . 0.0 111.64 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.527 ' HB3' ' OE1' ' A' ' 133' ' ' GLU . . . -99.83 131.36 45.85 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 122.184 0.194 . . . . 0.0 111.151 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.697 ' O ' HG21 ' A' ' 51' ' ' VAL . . . -30.38 -54.87 0.19 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.654 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 82.7 p -53.1 -36.21 60.49 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.482 0.658 . . . . 0.0 111.829 -178.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.727 ' HB2' HD11 ' A' ' 46' ' ' LEU . 86.0 mt-30 -63.85 -42.26 97.61 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.998 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.999 HG13 HD22 ' A' ' 3' ' ' LEU . 0.8 OUTLIER -83.49 16.6 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.932 ' HA ' HD13 ' A' ' 6' ' ' LEU . 37.8 t70 73.79 29.86 1.42 Allowed 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 177.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.826 HD11 ' O ' ' A' ' 55' ' ' GLN . 1.0 OUTLIER -121.25 109.51 25.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 C-N-CA 119.179 -1.009 . . . . 0.0 110.609 177.303 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 21.6 p-80 -76.47 63.6 2.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.378 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.826 ' O ' HD11 ' A' ' 53' ' ' ILE . 88.9 mt-30 -153.94 132.47 12.12 Favored 'General case' 0 C--O 1.219 -0.512 0 CA-C-N 114.194 -1.366 . . . . 0.0 107.875 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.777 ' HG2' ' HB2' ' A' ' 17' ' ' ALA . 74.7 mtp180 -63.01 69.03 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -177.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.83 ' O ' ' HE1' ' A' ' 34' ' ' MET . 8.1 mm -111.81 123.06 67.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.987 HD12 ' HB2' ' A' ' 72' ' ' LEU . 2.0 pp -128.24 144.36 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 119.698 -0.801 . . . . 0.0 112.977 -177.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.566 HG22 ' H ' ' A' ' 46' ' ' LEU . 33.2 m -127.47 137.64 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.676 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.983 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 2.2 mt -115.59 151.03 17.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.57 0.7 . . . . 0.0 110.972 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 1.015 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 34.6 t70 -135.2 24.1 3.52 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.858 -178.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.988 HG22 HG23 ' A' ' 44' ' ' ILE . 23.5 t -94.82 113.48 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.46 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.524 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 50.7 m -37.56 81.19 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -177.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 62' ' ' VAL . 41.2 tt0 -72.55 -25.2 61.28 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.999 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.457 ' C ' ' H ' ' A' ' 67' ' ' ASP . 9.2 t-20 -165.99 -141.87 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.763 HH11 ' HA ' ' A' ' 66' ' ' ARG . 2.3 mmm180 -83.57 38.48 0.63 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.457 ' H ' ' C ' ' A' ' 65' ' ' ASN . 59.2 m-20 -160.28 126.19 4.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.958 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.524 ' HG2' ' HA ' ' A' ' 63' ' ' SER . 44.5 mt-10 -111.27 61.78 0.61 Allowed 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.011 0.434 . . . . 0.0 112.119 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.614 ' HD3' ' O ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -151.75 96.28 2.22 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.241 0.544 . . . . 0.0 110.528 -179.061 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.983 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 7.9 mp -111.52 137.64 49.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.027 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.888 HG23 ' HB2' ' A' ' 113' ' ' ARG . 9.0 p -133.08 132.87 58.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.73 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.987 ' HB2' HD12 ' A' ' 58' ' ' ILE . 3.3 mm? -141.86 143.04 33.16 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 177.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.994 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.9 mp -121.03 136.21 58.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.761 0.315 . . . . 0.0 110.588 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.749 HD22 HD21 ' A' ' 111' ' ' LEU . 13.4 p30 45.49 40.23 0.6 Allowed Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 113.826 1.046 . . . . 0.0 113.826 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.777 ' HG3' ' HB2' ' A' ' 110' ' ' ALA . 99.2 Cg_exo -56.56 150.96 48.97 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.831 2.354 . . . . 0.0 113.151 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -135.63 143.79 45.73 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 1.048 ' HB2' ' HE2' ' A' ' 134' ' ' MET . 1.5 tt -80.57 133.69 35.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.274 0.559 . . . . 0.0 111.723 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.908 HD22 ' HE ' ' A' ' 109' ' ' ARG . 4.8 mp -108.54 -44.78 4.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.207 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.598 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 5.2 tp10 -152.25 146.95 25.81 Favored 'General case' 0 N--CA 1.46 0.065 0 CA-C-O 121.095 0.474 . . . . 0.0 111.325 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.974 ' HD2' HD13 ' A' ' 77' ' ' LEU . 10.9 ptmm? -147.67 145.12 28.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.349 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.3 t -160.14 151.78 19.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.463 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.736 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 80.85 160.42 23.86 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.492 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -137.1 113.37 9.95 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.954 0.883 . . . . 0.0 113.065 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.627 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.5 p -105.59 161.59 14.24 Favored 'General case' 0 CA--C 1.487 -1.468 0 CA-C-N 114.061 -1.427 . . . . 0.0 114.761 178.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.729 ' O ' HD11 ' A' ' 86' ' ' ILE . . . -146.03 114.81 0.77 Allowed Glycine 0 C--N 1.309 -0.928 0 CA-C-N 112.818 -1.992 . . . . 0.0 110.396 177.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.729 HD11 ' O ' ' A' ' 85' ' ' GLY . 49.3 mm -146.9 137.86 18.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-N 117.368 0.584 . . . . 0.0 111.206 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.495 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 50.4 mt-10 -71.41 137.23 48.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 123.193 1.473 . . . . 0.0 112.066 -176.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.949 ' HG2' ' H27' ' A' ' 149' ' ' BB2 . 40.8 mt-10 -154.76 161.62 41.44 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 112.196 -2.275 . . . . 0.0 111.079 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.874 ' O ' ' H51' ' A' ' 149' ' ' BB2 . . . -120.32 163.84 13.98 Favored Glycine 0 CA--C 1.499 -0.937 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.751 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 13.1 m -117.86 140.88 49.08 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 117.729 0.765 . . . . 0.0 111.101 -178.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 1.051 HD12 ' HG2' ' A' ' 41' ' ' GLU . 2.2 mm? -47.47 -26.65 1.44 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.971 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.788 ' CB ' HG12 ' A' ' 8' ' ' ILE . 54.1 m -79.36 -35.69 40.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.924 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 1.02 HG23 ' HD2' ' A' ' 94' ' ' PRO . 59.0 mt -85.5 149.01 50.81 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.648 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 1.02 ' HD2' HG23 ' A' ' 93' ' ' ILE . 96.7 Cg_endo -73.07 50.53 1.85 Allowed 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 122.38 2.053 . . . . 0.0 113.865 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 94' ' ' PRO . 51.2 mt-10 76.03 13.99 2.62 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.984 0.421 . . . . 0.0 112.009 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.712 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . 99.1 mm-40 -78.6 88.56 4.52 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.67 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 15.6 mtt85 -85.18 132.46 34.29 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.649 0.737 . . . . 0.0 111.722 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -134.73 155.86 49.82 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 114.581 -1.191 . . . . 0.0 109.479 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.604 ' HG ' ' N ' ' A' ' 86' ' ' ILE . 7.6 tt -76.38 113.8 14.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.666 0.746 . . . . 0.0 111.813 -178.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.801 ' HB ' ' CZ ' ' A' ' 102' ' ' ARG . 40.3 t -104.29 132.25 21.15 Favored Pre-proline 0 N--CA 1.47 0.572 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.939 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.627 ' HA ' ' O ' ' A' ' 84' ' ' THR . 92.2 Cg_endo -84.26 127.45 3.95 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.596 2.197 . . . . 0.0 112.496 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.85 ' HB2' ' OE1' ' A' ' 131' ' ' GLN . 0.0 OUTLIER -144.39 166.98 23.57 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.54 0.736 . . . . 0.0 109.357 178.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.736 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.69 155.62 39.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 118.307 0.503 . . . . 0.0 110.301 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -73.12 -41.32 64.12 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.19 -176.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.822 ' HZ2' ' HB3' ' A' ' 123' ' ' ASP . 66.8 mttm -139.67 140.5 36.9 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.467 0.651 . . . . 0.0 109.505 177.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.742 HG13 ' HA ' ' A' ' 80' ' ' LYS . 30.6 m -147.5 136.95 16.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.186 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 1.057 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 52.1 mmtt -107.58 126.02 52.03 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.853 ' CD1' HD11 ' A' ' 130' ' ' ILE . 1.7 pp -136.34 151.3 28.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -176.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.908 ' HE ' HD22 ' A' ' 78' ' ' LEU . 94.4 mtt180 -102.17 138.89 38.51 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.865 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.777 ' HB2' ' HG3' ' A' ' 75' ' ' PRO . . . -159.98 168.73 25.0 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.866 -177.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.994 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.4 pp -116.42 151.58 35.71 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.567 ' O ' HD12 ' A' ' 111' ' ' LEU . 17.9 t70 -85.96 164.48 17.39 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.873 -176.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.888 ' HB2' HG23 ' A' ' 71' ' ' VAL . 48.0 ttp180 -52.01 -20.36 2.36 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.016 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -79.12 -25.67 42.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.526 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.959 ' HA2' HG22 ' A' ' 23' ' ' VAL . . . 105.91 36.28 2.8 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.223 -0.989 . . . . 0.0 113.525 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -128.64 102.82 19.77 Favored Pre-proline 0 C--O 1.237 0.403 0 CA-C-N 116.736 0.268 . . . . 0.0 110.737 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.563 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 32.1 Cg_exo -72.89 115.12 4.23 Favored 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 121.748 1.632 . . . . 0.0 115.389 -177.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.411 ' N ' ' O ' ' A' ' 110' ' ' ALA . 0.4 OUTLIER -126.32 167.05 16.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.422 -178.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.639 ' CG ' ' HG2' ' A' ' 109' ' ' ARG . 3.1 mp0 -107.33 130.18 54.81 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.784 HD12 ' CD1' ' A' ' 130' ' ' ILE . 4.4 pp -126.6 133.62 51.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.342 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 1.057 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 15.5 pt-20 -96.32 123.9 40.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.984 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.988 ' HB3' HD21 ' A' ' 126' ' ' LEU . . . -116.63 136.47 52.94 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.822 ' HB3' ' HZ2' ' A' ' 105' ' ' LYS . 41.6 m-20 -127.15 162.71 25.47 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.761 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 51.58 -138.67 28.49 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 120.539 1.518 . . . . 0.0 115.271 177.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.527 ' H ' ' CD2' ' A' ' 125' ' ' LEU . 2.6 mm? -53.37 -32.4 49.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.899 -0.651 . . . . 0.0 111.401 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.988 HD21 ' HB3' ' A' ' 122' ' ' ALA . 0.6 OUTLIER -70.77 -52.64 19.38 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.847 0.832 . . . . 0.0 109.487 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.903 ' HB3' ' O ' ' A' ' 122' ' ' ALA . . . -59.73 -39.5 84.95 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.551 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.761 HG12 ' O ' ' A' ' 124' ' ' GLY . 46.5 mm -68.97 -56.04 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -178.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.836 ' HB2' ' H91' ' A' ' 149' ' ' BB2 . 29.7 p -58.15 -49.93 75.29 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.853 HD11 ' CD1' ' A' ' 108' ' ' ILE . 19.1 tt -59.34 -44.19 91.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.179 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.85 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.0 pt20 -67.79 -39.76 84.01 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.39 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.648 ' HA ' ' OD1' ' A' ' 135' ' ' ASP . 69.0 t60 -57.04 -47.37 81.1 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.568 0.699 . . . . 0.0 109.869 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.904 ' O ' HD21 ' A' ' 137' ' ' LEU . 48.0 mm-40 -61.35 -39.6 91.2 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.272 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 1.048 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 74.6 mtp -58.43 -49.66 76.51 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.476 0.655 . . . . 0.0 111.005 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.908 ' O ' HG13 ' A' ' 138' ' ' VAL . 5.6 p-10 -65.78 -45.03 83.99 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.756 178.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.916 ' HA ' ' CD2' ' A' ' 141' ' ' LEU . 9.0 t-80 -55.94 -52.53 63.82 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 121.466 -0.771 . . . . 0.0 111.17 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.904 HD21 ' O ' ' A' ' 133' ' ' GLU . 1.3 pp -59.17 -30.97 68.57 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.2 -178.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.935 HG12 ' HG2' ' A' ' 140' ' ' LYS . 12.7 p -86.07 22.76 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-O 122.264 1.03 . . . . 0.0 109.268 176.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.678 ' HA3' ' C ' ' A' ' 14' ' ' ARG . . . 55.6 37.85 69.22 Favored Glycine 0 CA--C 1.484 -1.9 0 CA-C-N 113.493 -1.685 . . . . 0.0 112.415 176.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.935 ' HG2' HG12 ' A' ' 138' ' ' VAL . 3.7 ptmt -135.71 106.16 6.45 Favored 'General case' 0 N--CA 1.421 -1.91 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.754 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.916 ' CD2' ' HA ' ' A' ' 136' ' ' HIS . 3.2 mm? -127.39 148.14 50.27 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 120.894 -1.129 . . . . 0.0 109.522 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.637 ' HB2' ' CG1' ' A' ' 100' ' ' VAL . 6.4 m-85 -62.6 -36.98 84.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.929 0.395 . . . . 0.0 111.47 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.932 ' HA ' HD23 ' A' ' 146' ' ' LEU . 15.8 tpt -54.8 -25.07 25.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.696 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.578 ' OD2' ' HD3' ' A' ' 14' ' ' ARG . 8.8 t70 -50.11 -24.95 3.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.501 -178.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -129.62 47.07 2.54 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 120.911 0.386 . . . . 0.0 110.596 -177.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.932 HD23 ' HA ' ' A' ' 143' ' ' MET . 3.0 mm? -91.04 138.42 31.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.022 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 80.5 p . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.963 179.719 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' BB2 . . . . . 1.007 H173 HD11 ' A' ' 91' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 46.0 t . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.869 0.366 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.854 HG11 HG21 ' A' ' 37' ' ' THR . 41.9 t -83.55 131.31 34.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.523 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 1.009 HD11 ' HB ' ' A' ' 51' ' ' VAL . 1.9 pt? -83.1 -148.76 0.09 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.262 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -102.28 106.34 17.13 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.994 0.426 . . . . 0.0 110.831 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.517 HG11 HD13 ' A' ' 91' ' ' LEU . 45.2 t -88.84 127.63 41.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.372 0.606 . . . . 0.0 111.539 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.883 HD13 ' HA ' ' A' ' 52' ' ' ASP . 24.9 mt -83.9 142.7 30.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.805 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.441 ' N ' ' CD2' ' A' ' 7' ' ' HIS . 5.0 m170 -114.08 145.43 41.62 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.075 0.464 . . . . 0.0 111.911 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.79 HD12 ' CD1' ' A' ' 13' ' ' LEU . 2.9 mp -55.8 146.95 44.61 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.883 178.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.404 ' HA ' ' CG2' ' A' ' 8' ' ' ILE . 74.8 Cg_endo -93.17 52.13 1.06 Allowed 'Cis proline' 0 C--N 1.354 0.838 0 C-N-CA 124.38 -1.092 . . . . 0.0 113.47 0.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.56 133.74 50.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.914 0.388 . . . . 0.0 110.853 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -58.8 -41.09 85.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.59 -179.149 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.631 ' HB2' HD12 ' A' ' 6' ' ' LEU . 42.8 mtt180 -58.18 -25.03 61.05 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.846 HD23 ' HB2' ' A' ' 6' ' ' LEU . 11.3 mt -75.6 -33.14 60.54 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 120.378 1.445 . . . . 0.0 108.425 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.585 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 20.6 mmm-85 -93.29 8.76 39.04 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 113.762 -1.563 . . . . 0.0 109.297 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.427 ' CB ' ' HA ' ' A' ' 12' ' ' ARG . 63.7 tttm -90.36 148.94 22.51 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.748 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.761 HG13 HG21 ' A' ' 138' ' ' VAL . 58.7 t -83.4 124.21 39.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.998 0.428 . . . . 0.0 109.871 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.751 ' HB2' ' CG ' ' A' ' 56' ' ' ARG . . . -80.8 148.53 29.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.002 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -109.07 130.74 22.37 Favored Pre-proline 0 C--N 1.327 -0.405 0 C-N-CA 121.165 -0.214 . . . . 0.0 110.634 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.881 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 60.8 Cg_endo -79.62 113.89 3.15 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 121.99 1.794 . . . . 0.0 110.821 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.631 HG11 ' N ' ' A' ' 21' ' ' GLU . 16.7 t -68.56 144.92 13.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 122.629 1.204 . . . . 0.0 113.558 -175.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.631 ' N ' HG11 ' A' ' 20' ' ' VAL . 69.9 mm-40 -61.54 -27.38 68.57 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 113.143 -1.844 . . . . 0.0 112.349 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -156.76 151.77 26.13 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.789 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.671 HG22 ' HA2' ' A' ' 115' ' ' GLY . 3.2 t -80.38 103.65 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -178.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 1.109 ' H ' HD13 ' A' ' 27' ' ' ILE . 2.2 m120 -85.7 153.26 22.46 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.167 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.569 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -54.69 -31.95 58.72 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.44 0.638 . . . . 0.0 110.085 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.532 ' HG2' ' NH2' ' A' ' 29' ' ' ARG . 49.7 mt-10 -71.52 -38.05 71.13 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 1.109 HD13 ' H ' ' A' ' 24' ' ' ASN . 68.5 mt -65.86 -38.79 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 113.964 -1.471 . . . . 0.0 110.494 178.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.641 ' CD ' HG11 ' A' ' 23' ' ' VAL . 13.6 mm-40 -66.94 -40.57 87.62 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.746 -0.206 . . . . 0.0 110.976 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.569 ' HG3' ' O ' ' A' ' 25' ' ' ALA . 83.9 mtm180 -63.88 -38.65 91.88 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.822 ' O ' ' HG3' ' A' ' 34' ' ' MET . 5.0 mt -56.28 -50.77 69.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.496 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.63 HG11 ' CG2' ' A' ' 71' ' ' VAL . 13.7 t -66.19 -41.47 89.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.95 0.405 . . . . 0.0 111.39 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.887 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -56.59 -42.56 78.9 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -179.26 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.492 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 14.8 m-20 -76.29 -30.15 57.66 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.768 176.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.822 ' HG3' ' O ' ' A' ' 30' ' ' ILE . 23.0 mtm -60.26 -46.84 88.4 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.297 -177.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.887 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 9.6 p90 -69.58 -43.67 72.36 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.607 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 56.1 mm-40 -52.97 -42.03 65.12 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.854 HG21 HG11 ' A' ' 2' ' ' VAL . 98.9 m -69.51 -61.72 1.67 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 118.722 -1.191 . . . . 0.0 108.104 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 1.006 ' HE3' ' HB2' ' A' ' 61' ' ' ASP . 1.7 ttp -46.38 -40.58 12.26 Favored 'General case' 0 CA--C 1.468 -2.202 0 C-N-CA 124.057 0.943 . . . . 0.0 110.18 -171.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.743 ' OH ' ' HA ' ' A' ' 69' ' ' ARG . 45.2 m-85 -69.95 -41.5 74.47 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.023 177.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 37' ' ' THR . . . -61.93 -23.09 66.14 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.008 -0.997 . . . . 0.0 109.561 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 1.055 ' HG2' HD12 ' A' ' 91' ' ' LEU . 13.8 tp10 -90.16 -11.62 40.61 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.177 -1.374 . . . . 0.0 108.267 177.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 63.68 28.75 15.03 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.762 -176.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.445 ' HA3' H172 ' A' ' 149' ' ' BB2 . . . -84.78 141.83 19.7 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 113.683 -1.599 . . . . 0.0 110.691 178.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.844 HD13 ' C25' ' A' ' 149' ' ' BB2 . 47.2 mt -79.43 2.18 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 117.859 0.829 . . . . 0.0 111.919 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 1.079 ' HA3' H113 ' A' ' 149' ' ' BB2 . . . 177.25 133.57 1.85 Allowed Glycine 0 CA--C 1.523 0.539 0 CA-C-O 119.06 -0.856 . . . . 0.0 112.043 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 1.081 HD13 ' HG ' ' A' ' 91' ' ' LEU . 8.8 tt -126.62 135.36 51.11 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 119.116 1.458 . . . . 0.0 110.967 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.594 ' O ' HD21 ' A' ' 46' ' ' LEU . . . -97.99 134.6 40.87 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.727 ' HA ' ' SD ' ' A' ' 34' ' ' MET . . . -31.01 -55.05 0.22 Allowed 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.962 1.468 . . . . 0.0 114.962 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.514 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 81.3 p -53.09 -36.26 60.5 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.523 0.677 . . . . 0.0 112.361 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.647 ' NE2' ' HB3' ' A' ' 90' ' ' CYS . 47.1 mt-30 -63.93 -40.77 97.24 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.486 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 1.009 ' HB ' HD11 ' A' ' 3' ' ' LEU . 1.2 m -85.63 17.3 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.607 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.883 ' HA ' HD13 ' A' ' 6' ' ' LEU . 50.8 t0 77.89 26.6 0.61 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 176.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.829 HD11 ' O ' ' A' ' 55' ' ' GLN . 1.0 OUTLIER -121.35 109.84 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 C-N-CA 118.985 -1.086 . . . . 0.0 111.243 177.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.479 ' HD2' ' CZ ' ' A' ' 12' ' ' ARG . 6.8 p80 -76.46 59.47 1.47 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.791 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.829 ' O ' HD11 ' A' ' 53' ' ' ILE . 7.1 mp0 -148.75 134.05 18.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.449 -1.251 . . . . 0.0 108.075 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.881 ' HD2' ' HD3' ' A' ' 19' ' ' PRO . 68.0 mtt-85 -63.13 68.65 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -177.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.653 HG13 HD12 ' A' ' 53' ' ' ILE . 7.4 mm -112.77 122.84 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.993 HD13 ' HB2' ' A' ' 72' ' ' LEU . 2.2 pp -126.24 148.03 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -177.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.554 HG22 ' H ' ' A' ' 46' ' ' LEU . 32.6 m -129.06 138.49 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.212 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 1.088 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 10.9 mm -115.77 151.95 17.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-O 121.483 0.659 . . . . 0.0 109.859 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 1.006 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 10.0 t70 -139.78 43.31 1.97 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.821 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 1.006 HG13 ' H ' ' A' ' 63' ' ' SER . 13.9 t -89.61 -167.25 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.129 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 1.006 ' H ' HG13 ' A' ' 62' ' ' VAL . 53.1 m -94.87 89.8 5.78 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 119.687 -0.197 . . . . 0.0 110.748 177.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.742 ' HB2' HD13 ' A' ' 70' ' ' LEU . 5.2 tp10 -60.96 -36.26 78.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.243 0.544 . . . . 0.0 110.051 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -161.99 -66.16 0.05 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.093 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -130.99 -36.75 1.32 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.066 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -113.06 127.49 56.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.473 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.598 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 42.2 mt-10 -72.93 134.91 44.95 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.951 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.743 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 71.7 ttt180 173.65 69.2 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 1.088 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 9.4 mp -108.56 137.1 47.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.695 0.283 . . . . 0.0 111.656 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.774 HG21 ' HB2' ' A' ' 113' ' ' ARG . 14.6 p -135.57 135.96 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.993 ' HB2' HD13 ' A' ' 58' ' ' ILE . 3.0 mm? -143.91 147.29 33.79 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.539 -0.171 . . . . 0.0 110.539 177.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 1.068 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.7 mp -122.11 136.5 58.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.564 0.221 . . . . 0.0 110.419 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.694 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 8.2 m120 50.38 37.98 0.47 Allowed Pre-proline 0 CA--C 1.55 0.96 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.852 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 79.6 Cg_exo -58.23 147.48 83.92 Favored 'Trans proline' 0 N--CA 1.486 1.085 0 C-N-CA 123.137 2.558 . . . . 0.0 114.844 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.431 ' O ' ' HB ' ' A' ' 108' ' ' ILE . 11.8 pt-20 -136.37 140.51 43.3 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 1.079 ' HB2' ' HE2' ' A' ' 134' ' ' MET . 1.7 tt -81.95 134.51 35.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.177 0.513 . . . . 0.0 111.267 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.859 HD22 ' CG ' ' A' ' 109' ' ' ARG . 5.9 mp -109.57 -43.76 4.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.13 -178.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 39.3 tt0 -147.54 149.73 33.17 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.05 0.452 . . . . 0.0 111.611 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 1.04 ' HE3' HD12 ' A' ' 77' ' ' LEU . 9.2 ptpp? -147.6 143.86 28.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.83 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.6 p -155.4 147.22 23.28 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.786 0.327 . . . . 0.0 111.257 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.721 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 81.22 147.82 5.79 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.114 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -115.57 114.29 24.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.724 0.773 . . . . 0.0 112.542 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.737 ' HG1' HD12 ' A' ' 128' ' ' ILE . 1.7 p -116.51 161.14 19.59 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 115.505 1.669 . . . . 0.0 115.505 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.807 ' HA3' HD22 ' A' ' 99' ' ' LEU . . . -150.09 119.17 1.0 Allowed Glycine 0 C--N 1.312 -0.764 0 CA-C-N 112.363 -2.198 . . . . 0.0 111.499 178.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.726 HD11 ' O ' ' A' ' 85' ' ' GLY . 49.5 mm -146.45 136.44 17.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 117.278 0.539 . . . . 0.0 111.373 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.558 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 50.2 mt-10 -72.47 141.23 48.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 122.841 1.305 . . . . 0.0 112.657 -176.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 1.04 ' HG2' ' H27' ' A' ' 149' ' ' BB2 . 55.2 mt-10 -153.71 163.97 39.1 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 112.713 -2.039 . . . . 0.0 111.538 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.729 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -120.36 168.59 13.88 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.785 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 90.3 m -114.12 140.02 48.84 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.215 -0.594 . . . . 0.0 112.03 -177.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 1.081 ' HG ' HD13 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -53.87 -16.65 1.91 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.845 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.834 ' CB ' HD11 ' A' ' 13' ' ' LEU . 22.0 m -102.96 -31.55 10.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.507 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.994 HG21 ' HD2' ' A' ' 94' ' ' PRO . 48.0 mt -85.17 151.06 56.32 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.332 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.994 ' HD2' HG21 ' A' ' 93' ' ' ILE . 68.3 Cg_endo -63.05 -148.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.21 1.94 . . . . 0.0 111.349 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -78.4 12.43 1.96 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.145 0.498 . . . . 0.0 110.815 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.562 ' HG3' ' HG2' ' A' ' 94' ' ' PRO . 85.1 mt-30 -78.93 81.49 5.2 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.213 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.729 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 55.5 mtm-85 -86.8 133.73 33.62 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.109 0.481 . . . . 0.0 109.931 178.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -125.06 146.03 49.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.054 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.807 HD22 ' HA3' ' A' ' 85' ' ' GLY . 7.3 tt -76.1 113.69 13.91 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.847 0.832 . . . . 0.0 110.779 -178.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.781 ' CG1' HH21 ' A' ' 102' ' ' ARG . 48.8 t -101.82 128.79 27.96 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.706 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.936 ' HD2' ' CD2' ' A' ' 142' ' ' PHE . 87.6 Cg_endo -83.0 126.13 4.32 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.163 1.908 . . . . 0.0 111.57 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.913 HH11 HG23 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -144.11 166.71 24.23 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.378 179.432 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.721 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.05 155.09 40.28 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.881 0.372 . . . . 0.0 110.461 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.419 ' OE1' HG21 ' A' ' 84' ' ' THR . 16.7 tp10 -72.26 -40.89 67.33 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.475 -175.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 1.01 ' HZ1' ' HB3' ' A' ' 123' ' ' ASP . 67.1 mttm -140.42 140.22 35.41 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.395 0.617 . . . . 0.0 109.507 176.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.976 HG11 ' HA ' ' A' ' 80' ' ' LYS . 25.3 m -150.42 141.37 16.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.417 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.933 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 23.7 mmtp -108.0 126.48 52.77 Favored 'General case' 0 C--O 1.227 -0.093 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.845 HG23 ' HA ' ' A' ' 77' ' ' LEU . 1.8 pp -135.36 152.9 32.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -176.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.859 ' CG ' HD22 ' A' ' 78' ' ' LEU . 44.2 mtm180 -103.45 140.73 37.09 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.926 0.87 . . . . 0.0 111.507 -178.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.654 ' HB2' ' HB3' ' A' ' 72' ' ' LEU . . . -161.14 169.51 22.18 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.483 -177.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 1.068 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 1.9 pp -116.64 149.76 39.22 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 176.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.791 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 23.1 t70 -84.41 163.66 19.36 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.587 -176.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.774 ' HB2' HG21 ' A' ' 71' ' ' VAL . 14.5 ttp-105 -53.48 -17.24 1.85 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.865 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -79.13 -28.35 42.9 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.948 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.671 ' HA2' HG22 ' A' ' 23' ' ' VAL . . . 107.63 35.8 2.55 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.622 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -128.82 103.25 19.1 Favored Pre-proline 0 C--O 1.237 0.43 0 CA-C-N 116.699 0.25 . . . . 0.0 110.705 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.578 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 32.7 Cg_exo -71.99 114.51 3.99 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 121.34 1.36 . . . . 0.0 114.619 -177.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.791 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 10.2 p90 -127.16 168.6 14.45 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.484 -178.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.654 ' HG2' ' HD2' ' A' ' 109' ' ' ARG . 29.8 mt-10 -107.03 129.72 54.76 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.686 HD22 HD12 ' A' ' 72' ' ' LEU . 4.3 pp -123.45 132.63 53.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.434 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.933 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 9.0 pm0 -92.54 123.38 35.8 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.54 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 1.052 ' HB3' HD23 ' A' ' 126' ' ' LEU . . . -117.05 133.54 55.87 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 120.47 -0.492 . . . . 0.0 112.134 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 1.01 ' HB3' ' HZ1' ' A' ' 105' ' ' LYS . 29.4 m-20 -127.81 160.73 30.86 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.64 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 54.9 -138.09 42.7 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 120.952 1.705 . . . . 0.0 114.779 177.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.568 ' H ' HD12 ' A' ' 125' ' ' LEU . 4.7 mp -54.24 -32.29 55.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.2 -0.5 . . . . 0.0 111.333 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 1.052 HD23 ' HB3' ' A' ' 122' ' ' ALA . 0.6 OUTLIER -70.72 -51.79 25.15 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.394 0.616 . . . . 0.0 109.676 179.707 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.737 ' O ' ' HG3' ' A' ' 131' ' ' GLN . . . -61.67 -46.76 88.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.949 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.913 HG23 HH11 ' A' ' 102' ' ' ARG . 47.3 mm -64.43 -55.67 20.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -177.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 1.06 ' HB3' H112 ' A' ' 149' ' ' BB2 . 78.0 m -58.56 -48.08 82.1 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.817 HD11 ' CD1' ' A' ' 108' ' ' ILE . 20.2 tt -59.35 -41.86 85.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.157 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.825 ' CG ' HG21 ' A' ' 106' ' ' VAL . 70.5 mt-30 -64.86 -38.51 91.22 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.761 0.315 . . . . 0.0 110.185 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.929 ' HD2' ' H81' ' A' ' 149' ' ' BB2 . 79.6 t60 -58.7 -45.54 89.27 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.295 0.569 . . . . 0.0 110.401 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.909 ' O ' HD21 ' A' ' 137' ' ' LEU . 4.5 mm-40 -60.72 -43.2 98.15 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.732 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 1.079 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 70.2 mtp -57.85 -48.55 79.47 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.374 0.607 . . . . 0.0 110.934 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.826 ' O ' HG12 ' A' ' 138' ' ' VAL . 2.5 p30 -65.14 -46.32 81.4 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.114 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.936 ' HA ' HD12 ' A' ' 141' ' ' LEU . 11.7 t-80 -58.95 -51.69 68.95 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 121.698 -0.626 . . . . 0.0 111.527 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.909 HD21 ' O ' ' A' ' 133' ' ' GLU . 1.4 pp -60.12 -31.42 70.04 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.952 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.953 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 14.2 p -82.98 25.49 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-O 122.487 1.136 . . . . 0.0 109.825 177.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.633 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 60.13 6.49 5.64 Favored Glycine 0 CA--C 1.487 -1.682 0 CA-C-N 113.082 -1.872 . . . . 0.0 113.382 176.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.953 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 14.3 ptmt -93.77 137.23 33.23 Favored 'General case' 0 N--CA 1.413 -2.297 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.936 HD12 ' HA ' ' A' ' 136' ' ' HIS . 3.1 mm? -141.37 141.51 33.81 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.936 ' CD2' ' HD2' ' A' ' 101' ' ' PRO . 6.2 m-85 -62.86 -30.12 71.27 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.72 ' HE2' ' CD1' ' A' ' 93' ' ' ILE . 48.9 ttm -56.5 -29.0 61.29 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.442 0.639 . . . . 0.0 110.198 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -60.66 -22.54 63.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.689 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -116.63 13.55 15.26 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.051 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.455 ' HG ' ' HA ' ' A' ' 143' ' ' MET . 85.9 mt -90.56 143.05 27.12 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.643 0.259 . . . . 0.0 110.833 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 86.9 p . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.929 179.807 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' BB2 . . . . . 1.079 H113 ' HA3' ' A' ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 53.3 m . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.839 0.352 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.702 HG11 ' HA ' ' A' ' 37' ' ' THR . 30.9 m -84.14 132.8 30.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.987 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.715 ' H ' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -85.28 -172.8 4.35 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.605 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.682 ' NE2' ' H ' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -79.88 111.09 15.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.28 0.562 . . . . 0.0 110.993 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.0 t -89.52 131.4 36.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.975 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.992 ' HB2' HD21 ' A' ' 13' ' ' LEU . 30.5 mt -86.81 147.5 25.8 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.556 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.478 ' HA ' ' CA ' ' A' ' 92' ' ' SER . 3.2 m80 -122.74 144.34 49.23 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.637 ' CD1' HD12 ' A' ' 13' ' ' LEU . 35.5 mm -67.44 135.88 93.17 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.526 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -78.92 144.5 73.88 Favored 'Cis proline' 0 C--N 1.352 0.736 0 C-N-CA 124.614 -0.994 . . . . 0.0 111.551 -0.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 1.027 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 9.1 t0 -164.0 129.14 2.87 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.404 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.471 ' HG2' ' N ' ' A' ' 12' ' ' ARG . 0.6 OUTLIER -58.08 -45.43 87.15 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.526 -178.769 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.551 ' HB2' HD11 ' A' ' 6' ' ' LEU . 23.2 mmt-85 -58.29 -28.41 64.97 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 1.027 ' HG ' ' HB3' ' A' ' 10' ' ' ASP . 9.7 mt -77.4 -32.13 54.59 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 120.613 1.551 . . . . 0.0 108.306 177.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.816 ' HD3' ' OD1' ' A' ' 144' ' ' ASP . 14.6 mmm180 -93.38 11.76 27.19 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 114.105 -1.407 . . . . 0.0 109.13 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.434 ' HB2' ' HA ' ' A' ' 12' ' ' ARG . 59.5 tptt -89.86 147.93 23.47 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.678 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.65 HG13 HG21 ' A' ' 138' ' ' VAL . 74.6 t -82.56 128.9 38.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.756 ' HB2' ' CG ' ' A' ' 56' ' ' ARG . . . -86.97 142.63 27.82 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.77 ' HB2' ' HZ2' ' A' ' 18' ' ' LYS . 4.7 ttmp? -105.57 129.8 24.09 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.877 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 56.8 Cg_endo -81.45 112.94 2.54 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 121.653 1.568 . . . . 0.0 110.812 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.615 HG11 ' N ' ' A' ' 21' ' ' GLU . 15.9 t -69.66 144.66 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 CA-C-O 122.552 1.168 . . . . 0.0 113.213 -175.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.615 ' N ' HG11 ' A' ' 20' ' ' VAL . 69.9 mm-40 -61.07 -23.41 65.45 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 113.019 -1.9 . . . . 0.0 112.438 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -161.18 139.85 9.89 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.183 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.794 HG23 HD11 ' A' ' 111' ' ' LEU . 2.6 t -79.43 118.88 27.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.856 ' H ' HD11 ' A' ' 27' ' ' ILE . 50.3 m-80 -104.27 -176.66 3.14 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.894 -0.504 . . . . 0.0 110.655 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.675 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -68.79 -25.41 64.69 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.456 0.646 . . . . 0.0 110.48 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.463 ' HA ' ' OE1' ' A' ' 26' ' ' GLU . 4.3 mm-40 -75.12 -43.19 54.15 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.856 HD11 ' H ' ' A' ' 24' ' ' ASN . 54.2 mt -65.04 -40.1 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 114.086 -1.416 . . . . 0.0 110.695 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.824 ' HG2' ' O ' ' A' ' 24' ' ' ASN . 1.6 mm100 -64.96 -40.8 95.56 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 122.431 -0.168 . . . . 0.0 111.064 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.675 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 26.5 mmm180 -61.86 -38.73 89.36 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.785 ' O ' ' HG3' ' A' ' 34' ' ' MET . 4.2 mt -57.76 -49.22 81.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.829 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.734 ' CG1' HG23 ' A' ' 71' ' ' VAL . 25.3 t -67.97 -41.72 84.88 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 CA-C-O 120.919 0.39 . . . . 0.0 111.339 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.84 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 27.9 m-20 -53.74 -45.97 70.72 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.121 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.453 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 3.0 p30 -74.57 -29.63 61.42 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.137 176.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.876 ' HG2' HG22 ' A' ' 51' ' ' VAL . 82.6 mtp -61.12 -46.93 88.57 Favored 'General case' 0 C--N 1.346 0.434 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.851 -178.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.84 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 22.5 p90 -70.82 -47.85 57.24 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.627 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 30.4 mm-40 -50.83 -41.59 57.69 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.702 ' HA ' HG11 ' A' ' 2' ' ' VAL . 48.4 m -70.34 -60.28 2.37 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.201 -1.363 . . . . 0.0 108.907 177.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.949 ' HE3' ' HB2' ' A' ' 61' ' ' ASP . 1.2 ttp -47.13 -39.72 14.08 Favored 'General case' 0 CA--C 1.464 -2.33 0 C-N-CA 124.046 0.939 . . . . 0.0 110.401 -171.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.656 ' OH ' ' HA ' ' A' ' 69' ' ' ARG . 68.2 m-85 -70.72 -42.1 71.02 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.146 177.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.593 ' HB1' HG11 ' A' ' 2' ' ' VAL . . . -60.95 -25.28 66.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.371 -0.831 . . . . 0.0 108.987 178.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 1.042 ' HG2' HD11 ' A' ' 91' ' ' LEU . 11.4 tp10 -87.02 -10.72 52.4 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 114.303 -1.317 . . . . 0.0 108.669 176.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 63.76 23.62 13.52 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.21 -176.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.6 140.79 23.88 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.324 177.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 1.02 HG22 HG22 ' A' ' 62' ' ' VAL . 43.2 mm -78.67 -0.8 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 117.464 0.632 . . . . 0.0 111.756 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.888 ' HA3' ' C10' ' A' ' 149' ' ' BB2 . . . 177.91 136.05 2.42 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 118.68 -1.067 . . . . 0.0 110.872 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.97 HD22 HG13 ' A' ' 51' ' ' VAL . 8.9 tt -127.98 135.37 49.83 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-N 119.714 1.757 . . . . 0.0 111.03 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.567 ' O ' HD23 ' A' ' 46' ' ' LEU . . . -97.43 134.16 41.06 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.741 ' O ' HG23 ' A' ' 51' ' ' VAL . . . -31.11 -53.68 0.21 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 137' ' ' LEU . 57.0 p -53.36 -35.32 60.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.77 0.795 . . . . 0.0 111.268 -178.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.743 ' NE2' HD23 ' A' ' 91' ' ' LEU . 74.8 mt-30 -64.22 -41.84 96.85 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.175 -1.375 . . . . 0.0 109.813 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.97 HG13 HD22 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -84.8 16.27 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-O 121.195 0.521 . . . . 0.0 112.132 179.763 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.956 ' HA ' HD12 ' A' ' 6' ' ' LEU . 50.5 t0 75.36 30.04 0.87 Allowed 'General case' 0 C--O 1.233 0.185 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 176.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.818 HD11 ' O ' ' A' ' 55' ' ' GLN . 1.1 pp -123.54 111.41 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 C-N-CA 119.228 -0.989 . . . . 0.0 110.898 177.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.9 p-80 -76.3 62.68 1.82 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.992 0.901 . . . . 0.0 110.586 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.818 ' O ' HD11 ' A' ' 53' ' ' ILE . 89.6 mt-30 -151.94 134.83 15.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.25 -1.341 . . . . 0.0 107.691 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.877 ' HD2' ' HD3' ' A' ' 19' ' ' PRO . 65.0 mtt-85 -64.26 70.74 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.803 ' O ' ' HE1' ' A' ' 34' ' ' MET . 9.1 mm -112.09 122.74 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 1.101 HD12 ' HB2' ' A' ' 72' ' ' LEU . 1.8 pp -126.17 144.34 36.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 119.836 -0.746 . . . . 0.0 112.913 -177.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.673 HG23 ' H ' ' A' ' 46' ' ' LEU . 33.5 m -127.22 137.12 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 1.061 HD11 H111 ' A' ' 149' ' ' BB2 . 6.1 mm -114.73 149.99 16.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.748 0.785 . . . . 0.0 109.555 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.949 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 58.5 t0 -137.35 27.84 2.81 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.442 -178.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 1.02 HG22 HG22 ' A' ' 44' ' ' ILE . 28.7 t -96.38 111.8 27.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.253 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.702 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 80.4 p -38.05 80.5 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -177.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.785 ' OE1' HD23 ' A' ' 70' ' ' LEU . 39.4 tt0 -70.29 -18.44 63.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.431 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.646 ' OD1' ' HG3' ' A' ' 66' ' ' ARG . 11.4 t-20 -164.64 -132.99 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.802 178.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.646 ' HG3' ' OD1' ' A' ' 65' ' ' ASN . 82.3 mtm180 -74.93 -57.49 3.87 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.86 0.362 . . . . 0.0 111.129 -178.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -95.75 125.97 40.69 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.98 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.702 ' HG2' ' HA ' ' A' ' 63' ' ' SER . 55.8 mt-10 -81.68 125.75 30.96 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.224 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.656 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 32.2 ttm180 170.67 76.08 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.981 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 1.023 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 61.2 mt -102.48 132.35 48.58 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-O 120.834 0.349 . . . . 0.0 111.557 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.838 ' O ' HD12 ' A' ' 72' ' ' LEU . 8.6 p -135.03 134.22 53.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.544 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 1.101 ' HB2' HD12 ' A' ' 58' ' ' ILE . 10.4 mp -140.6 142.45 35.05 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 1.024 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.7 mp -119.97 133.04 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-O 120.678 0.275 . . . . 0.0 110.413 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.727 ' OD1' ' HA ' ' A' ' 19' ' ' PRO . 66.8 m-20 54.2 37.14 0.39 Allowed Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.924 ' HG2' HG12 ' A' ' 58' ' ' ILE . 97.0 Cg_exo -56.65 150.17 54.43 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 C-N-CA 123.032 2.488 . . . . 0.0 114.016 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.642 ' OE2' ' HD2' ' A' ' 109' ' ' ARG . 23.0 pt-20 -138.45 143.12 39.51 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.864 HD23 ' N ' ' A' ' 78' ' ' LEU . 1.6 tt -80.24 135.19 36.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.434 0.635 . . . . 0.0 111.958 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.864 ' N ' HD23 ' A' ' 77' ' ' LEU . 5.2 mp -109.75 -40.4 4.82 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.283 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 85.2 tt0 -156.05 154.62 31.29 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.277 0.561 . . . . 0.0 111.802 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.842 ' CB ' HG12 ' A' ' 106' ' ' VAL . 9.1 ptpp? -147.56 151.07 35.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.231 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 46.4 t -160.33 147.07 15.77 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.697 0.284 . . . . 0.0 111.318 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.642 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 75.16 161.71 9.42 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.571 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -135.76 113.29 10.8 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.867 0.841 . . . . 0.0 112.972 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.763 ' HB ' HH12 ' A' ' 102' ' ' ARG . 1.6 p -105.68 162.37 13.58 Favored 'General case' 0 CA--C 1.489 -1.402 0 N-CA-C 115.011 1.486 . . . . 0.0 115.011 178.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.701 ' O ' HD11 ' A' ' 86' ' ' ILE . . . -148.98 118.47 0.96 Allowed Glycine 0 C--N 1.314 -0.677 0 CA-C-N 113.035 -1.893 . . . . 0.0 110.866 178.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.719 ' HB ' ' NH2' ' A' ' 102' ' ' ARG . 47.2 mm -148.19 140.28 18.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 117.472 0.636 . . . . 0.0 111.602 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 55.7 mp0 -71.24 135.37 47.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 123.365 1.555 . . . . 0.0 112.368 -176.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.998 ' HG2' ' H27' ' A' ' 149' ' ' BB2 . 80.2 mt-10 -152.26 161.34 42.76 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 112.324 -2.216 . . . . 0.0 112.039 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.916 ' O ' ' H51' ' A' ' 149' ' ' BB2 . . . -121.16 164.13 14.46 Favored Glycine 0 CA--C 1.501 -0.811 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.816 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 22.4 m -113.39 141.23 47.31 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.594 0.712 . . . . 0.0 112.656 -177.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 1.078 HD13 H173 ' A' ' 149' ' ' BB2 . 2.2 mm? -50.27 -26.98 5.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.818 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.653 ' HB3' ' CD1' ' A' ' 13' ' ' LEU . 61.2 m -85.3 -31.59 22.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.299 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 1.111 HG21 ' HD2' ' A' ' 94' ' ' PRO . 58.7 mt -85.28 148.22 49.36 Favored Pre-proline 0 N--CA 1.448 -0.537 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.188 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 1.111 ' HD2' HG21 ' A' ' 93' ' ' ILE . 64.2 Cg_endo -76.46 49.75 2.74 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.392 2.061 . . . . 0.0 114.901 -178.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.587 ' HB2' ' O ' ' A' ' 94' ' ' PRO . 0.3 OUTLIER 77.63 12.13 2.02 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 178.514 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.544 ' HB2' HG22 ' A' ' 93' ' ' ILE . 83.2 mt-30 -78.98 87.78 4.78 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 178.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.766 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 52.7 mtm-85 -85.64 132.88 34.08 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.787 0.803 . . . . 0.0 112.282 -178.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.664 ' HB2' ' HE2' ' A' ' 143' ' ' MET . . . -133.88 154.73 50.85 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.423 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.603 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.8 tt -76.56 112.27 12.93 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.85 0.834 . . . . 0.0 112.181 -177.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.667 HG22 ' HD2' ' A' ' 101' ' ' PRO . 11.1 p -99.86 133.12 21.91 Favored Pre-proline 0 N--CA 1.469 0.477 0 CA-C-N 114.593 -1.185 . . . . 0.0 112.372 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.667 ' HD2' HG22 ' A' ' 100' ' ' VAL . 96.6 Cg_endo -87.22 126.45 2.34 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 122.635 2.224 . . . . 0.0 112.485 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.81 ' CZ ' HG23 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -145.53 167.71 22.36 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.001 0.92 . . . . 0.0 110.259 179.83 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.642 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.44 155.85 39.04 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.804 0.335 . . . . 0.0 110.15 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -73.35 -42.0 62.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.936 -176.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.669 ' HB3' ' OD1' ' A' ' 123' ' ' ASP . 59.7 mttp -140.63 141.04 35.13 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.376 0.607 . . . . 0.0 110.155 177.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.842 HG12 ' CB ' ' A' ' 80' ' ' LYS . 22.4 m -149.25 138.84 15.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.346 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.966 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 20.1 mmtp -108.21 126.46 52.83 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.789 ' HA ' ' CD1' ' A' ' 78' ' ' LEU . 1.4 pp -135.89 154.75 34.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -176.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.833 ' HG3' ' CD1' ' A' ' 78' ' ' LEU . 92.6 mtt180 -101.41 137.98 39.03 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.319 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.728 ' HB2' ' HG3' ' A' ' 75' ' ' PRO . . . -159.34 169.36 24.18 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.504 -1.225 . . . . 0.0 111.093 -177.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 1.024 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.7 pp -118.94 154.75 32.5 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 177.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.59 ' O ' HD12 ' A' ' 111' ' ' LEU . 19.5 t70 -89.09 162.59 15.89 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.197 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.657 ' H ' HG13 ' A' ' 71' ' ' VAL . 13.1 ttp-105 -54.44 -15.32 1.62 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.832 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -78.95 -29.48 44.01 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.727 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 109.23 34.1 2.6 Favored Glycine 0 C--N 1.34 0.797 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.886 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -128.72 102.86 19.54 Favored Pre-proline 0 C--O 1.237 0.432 0 CA-C-N 116.764 0.282 . . . . 0.0 111.166 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.59 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 33.1 Cg_exo -73.26 116.81 4.84 Favored 'Trans proline' 0 C--N 1.36 1.169 0 C-N-CA 122.015 1.81 . . . . 0.0 115.094 -178.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.545 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 12.6 p90 -128.4 166.48 18.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.568 -178.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.778 ' HG2' ' HG2' ' A' ' 109' ' ' ARG . 22.4 mt-10 -107.73 131.96 53.88 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.873 HD21 ' O ' ' A' ' 120' ' ' LEU . 0.3 OUTLIER -129.64 141.84 50.85 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.663 0.744 . . . . 0.0 111.742 -179.465 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.966 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 11.3 pt-20 -95.19 123.43 38.69 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.536 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.808 ' CB ' HD13 ' A' ' 126' ' ' LEU . . . -115.82 134.87 54.56 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.958 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.734 ' CA ' ' HB3' ' A' ' 127' ' ' ALA . 37.7 m-20 -126.44 162.22 26.1 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.773 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 48.4 -132.9 20.48 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-N 119.85 1.205 . . . . 0.0 115.705 177.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.42 ' HA ' HD22 ' A' ' 125' ' ' LEU . 80.9 mt -54.7 -35.74 63.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.74 -0.73 . . . . 0.0 111.774 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.808 HD13 ' CB ' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -70.72 -52.03 23.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.799 0.809 . . . . 0.0 109.225 179.854 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.734 ' HB3' ' CA ' ' A' ' 123' ' ' ASP . . . -58.65 -40.25 82.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.346 -1.297 . . . . 0.0 111.691 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.81 HG23 ' CZ ' ' A' ' 102' ' ' ARG . 50.8 mm -68.41 -55.89 14.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.879 -178.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.807 ' HB2' ' C9 ' ' A' ' 149' ' ' BB2 . 29.4 p -57.88 -50.48 73.17 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.615 HG21 ' N ' ' A' ' 131' ' ' GLN . 19.4 tt -59.04 -43.69 89.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.957 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.795 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 21.9 pt20 -68.41 -40.04 81.41 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.627 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.639 ' CD2' ' HN1' ' A' ' 149' ' ' BB2 . 67.8 t60 -59.27 -47.44 85.34 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.077 0.465 . . . . 0.0 109.776 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.899 ' O ' HD22 ' A' ' 137' ' ' LEU . 3.5 mm-40 -58.63 -42.68 88.83 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.512 -179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.918 ' HA ' HD21 ' A' ' 137' ' ' LEU . 30.2 mtm -57.21 -47.3 81.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.634 0.73 . . . . 0.0 110.16 178.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.873 ' O ' HG13 ' A' ' 138' ' ' VAL . 31.9 m-20 -62.77 -48.31 79.71 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.095 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.909 ' HA ' HD13 ' A' ' 141' ' ' LEU . 8.4 t-80 -58.16 -52.93 63.52 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.271 0.557 . . . . 0.0 111.376 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.918 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.6 pp -58.67 -31.52 68.26 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.701 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.926 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 12.9 p -85.54 25.09 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-O 122.187 0.994 . . . . 0.0 109.83 176.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 55.91 30.67 57.41 Favored Glycine 0 CA--C 1.485 -1.843 0 CA-C-N 113.578 -1.646 . . . . 0.0 112.942 176.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.926 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 5.8 ptmt -127.54 109.99 12.28 Favored 'General case' 0 N--CA 1.424 -1.763 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.303 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.909 HD13 ' HA ' ' A' ' 136' ' ' HIS . 5.4 mp -127.22 144.76 50.97 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 120.772 -1.205 . . . . 0.0 108.284 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.55 ' CD2' ' HD2' ' A' ' 101' ' ' PRO . 18.2 m-85 -62.47 -33.16 74.29 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.286 0.494 . . . . 0.0 111.798 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.827 ' HA ' HD11 ' A' ' 146' ' ' LEU . 45.1 tpp -60.18 -27.06 66.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.33 0.586 . . . . 0.0 111.075 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.816 ' OD1' ' HD3' ' A' ' 14' ' ' ARG . 32.6 m-20 -52.6 -26.61 13.98 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.694 -178.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -127.99 43.65 3.09 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 121.218 -0.193 . . . . 0.0 110.786 -177.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.827 HD11 ' HA ' ' A' ' 143' ' ' MET . 4.8 mp -92.63 142.07 27.78 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.17 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 48.0 t . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.917 179.548 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' BB2 . . . . . 1.078 H173 HD13 ' A' ' 91' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.468 ' HA ' ' OE1' ' A' ' 36' ' ' GLU . 79.4 p . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.87 0.367 . . . . 0.0 111.211 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.765 HG12 HG21 ' A' ' 37' ' ' THR . 40.1 t -84.03 126.24 40.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.597 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.762 HD21 ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -87.93 -174.15 4.58 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.752 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.603 ' N ' HD22 ' A' ' 3' ' ' LEU . 8.4 tt0 -80.52 109.84 15.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.035 0.445 . . . . 0.0 111.073 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.506 HG22 HG23 ' A' ' 37' ' ' THR . 36.2 t -89.47 131.64 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.783 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.946 ' HB2' HD22 ' A' ' 13' ' ' LEU . 45.3 mt -84.06 142.68 30.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.862 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 5.1 m170 -119.14 145.51 45.91 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.207 0.527 . . . . 0.0 112.044 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.749 HG12 ' HB3' ' A' ' 92' ' ' SER . 51.2 mm -54.19 146.03 32.72 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.827 178.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.62 ' CA ' HG23 ' A' ' 8' ' ' ILE . 64.8 Cg_endo -91.86 50.2 1.12 Allowed 'Cis proline' 0 C--N 1.355 0.898 0 C-N-CA 124.644 -0.982 . . . . 0.0 113.123 0.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.856 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 9.7 t70 -53.56 131.48 38.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.799 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -59.17 -41.71 89.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.423 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.646 ' HB2' HD11 ' A' ' 6' ' ' LEU . 10.5 mtt85 -60.19 -23.55 64.08 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.946 HD22 ' HB2' ' A' ' 6' ' ' LEU . 9.8 mt -76.31 -31.73 58.35 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 120.413 1.46 . . . . 0.0 108.134 177.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.553 ' HD2' ' O ' ' A' ' 139' ' ' GLY . 24.0 mmm-85 -91.58 1.7 56.96 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 113.93 -1.486 . . . . 0.0 109.09 178.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.54 ' HD3' ' HB3' ' A' ' 54' ' ' HIS . 62.6 tttp -83.97 150.56 25.57 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.126 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 138' ' ' VAL . 84.3 t -82.89 136.22 23.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.179 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.767 ' C ' ' HG3' ' A' ' 56' ' ' ARG . . . -90.7 139.96 30.23 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -104.81 129.28 25.17 Favored Pre-proline 0 C--N 1.323 -0.58 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.546 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.917 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 68.3 Cg_endo -77.5 114.67 3.75 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 121.824 1.682 . . . . 0.0 110.197 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.627 HG11 ' N ' ' A' ' 21' ' ' GLU . 17.3 t -70.09 144.83 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 122.488 1.137 . . . . 0.0 113.285 -176.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.627 ' N ' HG11 ' A' ' 20' ' ' VAL . 56.1 mt-10 -62.44 -25.59 68.05 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 113.322 -1.763 . . . . 0.0 112.103 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.407 ' O ' HG12 ' A' ' 20' ' ' VAL . 88.9 tt0 -159.29 143.9 15.44 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.537 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.865 HG21 HD12 ' A' ' 111' ' ' LEU . 2.9 t -79.26 107.2 11.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -178.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 1.012 HD21 HD12 ' A' ' 27' ' ' ILE . 64.1 m-80 -87.87 153.04 21.63 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.455 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.797 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -54.44 -26.99 34.06 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 121.078 0.466 . . . . 0.0 110.64 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -72.47 -40.39 66.98 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 177.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 1.012 HD12 HD21 ' A' ' 24' ' ' ASN . 62.9 mt -62.92 -47.59 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.038 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -57.89 -39.86 78.9 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.916 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.797 ' HG3' ' O ' ' A' ' 25' ' ' ALA . 19.7 mtm105 -59.62 -40.36 87.29 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.806 ' O ' ' HG3' ' A' ' 34' ' ' MET . 4.3 mt -58.6 -49.78 81.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.624 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.789 HG13 ' CG2' ' A' ' 71' ' ' VAL . 5.0 t -67.22 -42.34 87.81 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-O 120.746 0.308 . . . . 0.0 111.619 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.851 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -54.35 -43.08 70.97 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.641 -179.604 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.543 ' HB3' HD12 ' A' ' 3' ' ' LEU . 53.6 m-20 -74.96 -30.95 61.35 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.613 176.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.806 ' HG3' ' O ' ' A' ' 30' ' ' ILE . 79.8 mtp -60.08 -47.76 84.54 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.162 -177.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.851 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 15.6 p90 -68.97 -43.54 74.77 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.787 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 31.9 mt-10 -51.41 -43.56 61.99 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.765 HG21 HG12 ' A' ' 2' ' ' VAL . 97.3 m -70.98 -61.91 1.59 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 118.876 -1.13 . . . . 0.0 109.092 177.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 1.076 ' HE3' ' HB2' ' A' ' 61' ' ' ASP . 1.8 ttp -45.51 -44.74 12.8 Favored 'General case' 0 CA--C 1.458 -2.576 0 C-N-CA 123.618 0.767 . . . . 0.0 109.978 -170.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.868 ' HH ' ' HA ' ' A' ' 69' ' ' ARG . 58.9 m-85 -70.26 -40.63 74.26 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.197 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.39 -27.32 67.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.863 0.839 . . . . 0.0 108.764 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.82 ' HG2' ' CD2' ' A' ' 91' ' ' LEU . 10.5 tp10 -85.49 -10.48 56.0 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.19 177.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 63.44 29.46 15.5 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.892 -176.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.69 143.29 20.64 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.865 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.898 HD13 H251 ' A' ' 149' ' ' BB2 . 56.7 mt -78.77 -0.96 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 117.976 0.888 . . . . 0.0 112.065 -178.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.919 ' HA3' ' C10' ' A' ' 149' ' ' BB2 . . . 176.49 135.3 2.13 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-O 119.26 -0.744 . . . . 0.0 112.54 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.856 HD11 HD11 ' A' ' 91' ' ' LEU . 3.2 tp -125.22 133.56 52.68 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 118.618 1.209 . . . . 0.0 111.001 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -97.4 132.89 42.69 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 111.421 0.156 . . . . 0.0 111.421 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.772 ' O ' HG22 ' A' ' 51' ' ' VAL . . . -34.56 -52.51 0.51 Allowed 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.549 HG22 ' O ' ' A' ' 137' ' ' LEU . 59.9 p -53.67 -37.27 63.03 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.898 0.856 . . . . 0.0 110.656 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.675 ' HB2' HD13 ' A' ' 46' ' ' LEU . 73.8 mt-30 -66.93 -38.36 86.04 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.006 -1.452 . . . . 0.0 109.854 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.815 ' CG1' HD21 ' A' ' 46' ' ' LEU . 0.8 OUTLIER -83.8 11.62 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 179.113 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.911 ' HA ' HD12 ' A' ' 6' ' ' LEU . 54.6 t0 79.35 31.52 0.27 Allowed 'General case' 0 N--CA 1.46 0.06 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 176.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.824 HD11 ' O ' ' A' ' 55' ' ' GLN . 1.2 pp -128.28 114.02 32.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.605 177.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.54 ' HB3' ' HD3' ' A' ' 15' ' ' LYS . 6.0 p80 -76.23 65.37 2.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.923 0.868 . . . . 0.0 110.587 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.824 ' O ' HD11 ' A' ' 53' ' ' ILE . 88.5 mt-30 -155.77 134.84 12.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.676 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.917 ' HD2' ' HD3' ' A' ' 19' ' ' PRO . 99.0 mtt180 -62.74 69.06 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -178.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.781 ' O ' ' HE1' ' A' ' 34' ' ' MET . 8.4 mm -113.76 122.3 67.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.919 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 2.4 pp -131.31 146.89 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -177.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.9 m -127.83 138.69 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.266 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.828 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 2.2 mt -115.98 144.12 24.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 122.332 1.063 . . . . 0.0 112.233 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 1.076 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 52.4 t0 -122.78 50.07 1.56 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 113.506 -1.679 . . . . 0.0 107.666 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.656 ' HB ' HD21 ' A' ' 126' ' ' LEU . 24.6 t -126.67 74.76 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 112.243 -2.253 . . . . 0.0 105.869 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.983 ' HG ' ' HA ' ' A' ' 68' ' ' GLU . 40.3 m -95.29 -40.12 9.7 Favored 'General case' 0 CA--C 1.486 -1.482 0 CA-C-N 112.596 -2.093 . . . . 0.0 109.523 177.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 49.08 64.28 1.79 Allowed 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 113.391 -1.731 . . . . 0.0 109.862 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.53 ' ND2' ' H ' ' A' ' 66' ' ' ARG . 49.0 t30 -165.88 -131.8 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.834 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.53 ' H ' ' ND2' ' A' ' 65' ' ' ASN . 40.3 mmm-85 -79.04 -61.88 1.87 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.169 0.509 . . . . 0.0 111.184 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -126.41 138.14 53.51 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.474 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.983 ' HA ' ' HG ' ' A' ' 63' ' ' SER . 0.3 OUTLIER -88.79 145.97 25.28 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.939 179.757 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.868 ' HA ' ' HH ' ' A' ' 39' ' ' TYR . 34.6 ttm180 -176.62 65.73 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.828 ' CB ' ' HB ' ' A' ' 60' ' ' ILE . 8.8 mp -100.45 129.46 46.42 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.881 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.8 HG23 ' HB2' ' A' ' 113' ' ' ARG . 13.4 p -133.87 131.32 56.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.211 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.919 ' HB2' ' CD1' ' A' ' 58' ' ' ILE . 2.9 mm? -141.75 143.91 33.74 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.398 177.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 1.044 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.6 mp -122.31 135.87 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 O-C-N 122.168 -0.332 . . . . 0.0 110.441 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.685 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 8.0 m120 52.34 37.14 0.4 Allowed Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.844 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 97.4 Cg_exo -56.46 150.93 48.37 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 122.949 2.433 . . . . 0.0 114.091 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.541 ' HG3' HD21 ' A' ' 78' ' ' LEU . 11.9 pt-20 -138.72 145.57 40.46 Favored 'General case' 0 C--N 1.335 -0.055 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.855 ' N ' ' HE2' ' A' ' 134' ' ' MET . 9.5 tp -80.69 138.07 36.34 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.111 0.481 . . . . 0.0 110.901 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.883 ' CD2' ' HG3' ' A' ' 109' ' ' ARG . 3.0 mm? -114.27 -36.17 4.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.243 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.465 ' O ' ' HB ' ' A' ' 106' ' ' VAL . 16.5 tp10 -160.9 147.6 15.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.055 0.455 . . . . 0.0 111.86 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.965 ' HA ' HG11 ' A' ' 106' ' ' VAL . 19.6 ptpt -140.48 150.22 43.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.91 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.6 p -157.73 147.61 20.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.779 0.324 . . . . 0.0 111.243 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.745 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 73.46 165.27 10.08 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.791 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -139.79 113.16 8.38 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.689 0.757 . . . . 0.0 112.697 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.663 ' HB ' HH12 ' A' ' 102' ' ' ARG . 1.4 p -102.26 160.18 14.75 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.738 ' O ' HD11 ' A' ' 86' ' ' ILE . . . -139.82 104.73 0.43 Allowed Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 113.077 -1.874 . . . . 0.0 111.856 178.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.796 ' HB ' ' NH2' ' A' ' 102' ' ' ARG . 49.8 mm -147.1 140.32 19.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.595 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 92.5 mt-10 -74.01 143.81 45.4 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 122.589 1.185 . . . . 0.0 112.619 -178.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.918 ' HG3' ' H27' ' A' ' 149' ' ' BB2 . 10.1 mp0 -151.1 169.68 21.26 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 113.192 -1.822 . . . . 0.0 108.608 177.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.737 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -118.77 165.29 12.96 Favored Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 119.322 -1.418 . . . . 0.0 109.92 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.846 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 19.9 m -119.07 130.65 55.73 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.856 HD11 HD11 ' A' ' 46' ' ' LEU . 13.4 mt -57.5 -13.32 3.52 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.784 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.838 ' HB3' HD11 ' A' ' 13' ' ' LEU . 58.0 m -83.26 -37.2 23.83 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.817 HG22 ' HB2' ' A' ' 96' ' ' GLN . 48.4 mm -86.41 149.99 50.53 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.557 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.789 ' HD2' HG21 ' A' ' 93' ' ' ILE . 68.0 Cg_endo -75.2 48.43 2.05 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.584 2.189 . . . . 0.0 114.744 -178.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.592 ' HB2' ' O ' ' A' ' 94' ' ' PRO . 7.8 mp0 82.88 9.27 0.66 Allowed 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.817 ' HB2' HG22 ' A' ' 93' ' ' ILE . 2.6 mm100 -78.25 88.99 4.3 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.737 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 40.9 mtm-85 -84.44 133.54 34.49 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.627 0.727 . . . . 0.0 111.493 -178.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -132.11 151.0 52.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.13 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.62 ' HG ' ' N ' ' A' ' 86' ' ' ILE . 6.9 tt -75.58 135.73 40.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.808 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 1.021 HG22 ' HB3' ' A' ' 142' ' ' PHE . 13.6 p -130.09 140.29 38.2 Favored Pre-proline 0 C--O 1.232 0.181 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.393 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.76 ' HD2' HG23 ' A' ' 100' ' ' VAL . 97.1 Cg_endo -88.16 122.7 1.57 Allowed 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.377 1.385 . . . . 0.0 113.552 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.796 ' NH2' ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -142.74 165.45 27.36 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 113.545 -1.661 . . . . 0.0 110.783 178.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.745 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.74 154.04 42.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.9 0.381 . . . . 0.0 110.377 -178.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.408 ' OE1' ' HA ' ' A' ' 104' ' ' GLU . 5.1 tp10 -73.06 -42.03 63.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.66 -176.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.771 ' HG2' ' HB3' ' A' ' 123' ' ' ASP . 4.7 mtpm? -139.5 138.32 36.26 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.489 0.661 . . . . 0.0 109.674 177.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.965 HG11 ' HA ' ' A' ' 80' ' ' LYS . 25.1 m -147.02 141.63 20.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.736 -1.12 . . . . 0.0 112.122 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.942 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 31.9 mmtm -107.2 126.04 51.88 Favored 'General case' 0 N--CA 1.461 0.101 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.928 HD11 HD11 ' A' ' 130' ' ' ILE . 2.0 pp -129.61 161.82 38.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.883 ' HG3' ' CD2' ' A' ' 78' ' ' LEU . 45.4 mtm180 -113.24 138.17 50.4 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-O 120.843 0.354 . . . . 0.0 110.083 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.722 ' HB2' ' HB3' ' A' ' 72' ' ' LEU . . . -156.44 167.89 29.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.658 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 1.044 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.2 pp -114.03 151.66 32.13 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.582 ' O ' HD13 ' A' ' 111' ' ' LEU . 10.7 t70 -87.9 164.37 15.89 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.692 -177.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.8 ' HB2' HG23 ' A' ' 71' ' ' VAL . 49.1 ttp180 -51.66 -21.36 2.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.311 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.55 -21.75 44.75 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.908 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.5 37.27 3.31 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.992 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -128.64 102.82 19.78 Favored Pre-proline 0 C--O 1.238 0.457 0 CA-C-N 117.054 0.427 . . . . 0.0 110.708 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.565 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 32.2 Cg_exo -73.18 114.16 3.97 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 121.616 1.544 . . . . 0.0 114.959 -177.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.407 ' CE2' ' HB2' ' A' ' 112' ' ' ASP . 0.4 OUTLIER -125.58 169.56 12.35 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.417 -178.52 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.698 ' HG2' ' HD2' ' A' ' 109' ' ' ARG . 34.9 mt-10 -106.75 129.4 54.63 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.02 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.839 ' HG ' HD13 ' A' ' 108' ' ' ILE . 4.1 pp -123.39 133.01 54.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.848 -178.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.942 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 15.4 pt-20 -92.48 124.37 36.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.673 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 1.021 ' HB3' HD12 ' A' ' 126' ' ' LEU . . . -116.39 134.59 54.7 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.771 ' HB3' ' HG2' ' A' ' 105' ' ' LYS . 25.2 m-20 -126.81 164.54 21.14 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.602 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 46.78 -134.56 11.13 Favored Glycine 0 C--N 1.347 1.188 0 CA-C-N 120.722 1.601 . . . . 0.0 116.44 177.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.791 ' H ' HD12 ' A' ' 125' ' ' LEU . 4.8 mp -54.64 -33.99 61.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.431 -0.884 . . . . 0.0 111.619 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 1.021 HD12 ' HB3' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -70.95 -53.35 15.24 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.239 -0.584 . . . . 0.0 109.796 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.785 ' O ' ' HG3' ' A' ' 131' ' ' GLN . . . -59.44 -47.12 86.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.93 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.701 HD12 ' HG2' ' A' ' 102' ' ' ARG . 49.9 mm -61.28 -55.69 22.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.084 -178.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.896 ' HB3' H112 ' A' ' 149' ' ' BB2 . 82.2 m -57.45 -50.89 71.55 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.928 HD11 HD11 ' A' ' 108' ' ' ILE . 18.7 tt -59.0 -41.35 82.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.826 -0.17 . . . . 0.0 111.413 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.865 ' CG ' HG21 ' A' ' 106' ' ' VAL . 66.0 mt-30 -65.99 -40.83 91.51 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.522 ' CD2' ' HO2' ' A' ' 149' ' ' BB2 . 9.1 t-160 -56.08 -47.74 77.42 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.882 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.841 ' O ' HD21 ' A' ' 137' ' ' LEU . 3.7 mm-40 -58.71 -46.08 88.11 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.098 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.921 ' HA ' HD23 ' A' ' 137' ' ' LEU . 1.9 mmm -55.68 -47.54 76.59 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.466 0.65 . . . . 0.0 110.037 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.839 ' O ' HG11 ' A' ' 138' ' ' VAL . 31.3 m-20 -61.6 -49.24 77.39 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.205 178.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.692 ' CD2' ' HG ' ' A' ' 141' ' ' LEU . 10.3 t-80 -59.25 -50.76 72.79 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 121.768 -0.583 . . . . 0.0 111.171 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.921 HD23 ' HA ' ' A' ' 134' ' ' MET . 1.6 pp -58.27 -31.27 67.29 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.726 -178.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.839 HG11 ' O ' ' A' ' 135' ' ' ASP . 13.8 p -83.04 20.5 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-O 122.803 1.287 . . . . 0.0 108.755 175.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.754 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 65.84 7.3 35.13 Favored Glycine 0 CA--C 1.494 -1.278 0 CA-C-N 112.501 -2.136 . . . . 0.0 112.843 176.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.838 ' C ' HD13 ' A' ' 141' ' ' LEU . 4.6 ptmt -97.85 119.35 36.3 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 119.53 -0.868 . . . . 0.0 108.716 179.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.838 HD13 ' C ' ' A' ' 140' ' ' LYS . 6.4 mp -122.71 157.99 31.09 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 121.9 -0.5 . . . . 0.0 110.187 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 1.021 ' HB3' HG22 ' A' ' 100' ' ' VAL . 8.1 p90 -58.08 -32.01 67.64 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.448 ' N ' ' CD1' ' A' ' 142' ' ' PHE . 16.1 tpt -63.1 -25.98 68.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.256 0.55 . . . . 0.0 110.664 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.512 ' HB2' ' O ' ' A' ' 141' ' ' LEU . 1.2 m-20 -59.09 -26.78 64.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.884 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -119.18 21.48 12.26 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.638 HD11 ' O ' ' A' ' 142' ' ' PHE . 4.8 mp -92.16 141.77 28.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.589 0.233 . . . . 0.0 111.025 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 48.2 t . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.891 179.359 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' BB2 . . . . . 0.919 ' C10' ' HA3' ' A' ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.416 ' HB3' ' OE1' ' A' ' 36' ' ' GLU . 52.0 m . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.93 0.395 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.827 ' CG1' ' HA ' ' A' ' 37' ' ' THR . 28.3 m -84.0 138.14 19.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.783 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.843 HD22 ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -79.01 -159.3 0.18 Allowed 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.108 179.858 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.736 ' N ' HD23 ' A' ' 3' ' ' LEU . 2.2 tp-100 -88.31 105.58 17.66 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.254 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.463 HG21 HG23 ' A' ' 37' ' ' THR . 46.4 t -88.33 127.0 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 121.333 0.587 . . . . 0.0 111.483 -179.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 1.035 ' HB2' HD21 ' A' ' 13' ' ' LEU . 24.4 mt -88.08 144.29 26.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.222 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 4.3 m80 -120.85 145.99 47.04 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.948 ' CD1' HD12 ' A' ' 13' ' ' LEU . 44.5 mm -69.29 135.79 88.94 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.674 178.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.435 ' HA ' HG22 ' A' ' 8' ' ' ILE . 74.1 Cg_endo -76.48 141.74 70.95 Favored 'Cis proline' 0 C--N 1.352 0.729 0 C-N-CA 124.145 -1.19 . . . . 0.0 112.031 -0.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.968 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 8.4 t0 -163.39 125.18 2.47 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.271 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.419 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 23.7 pt-20 -57.53 -46.23 84.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.74 -178.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.684 ' CZ ' ' HD2' ' A' ' 54' ' ' HIS . 14.8 mmt85 -56.21 -30.1 61.83 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 1.035 HD21 ' HB2' ' A' ' 6' ' ' LEU . 11.5 mt -75.78 -33.29 60.17 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 120.098 1.317 . . . . 0.0 109.054 178.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.642 ' C ' ' HA3' ' A' ' 139' ' ' GLY . 26.6 mmt-85 -96.21 13.29 27.91 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.299 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.572 ' HZ1' ' HE ' ' A' ' 12' ' ' ARG . 88.4 tttt -91.65 149.93 21.4 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.128 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.526 ' HA ' ' HA ' ' A' ' 138' ' ' VAL . 49.5 t -82.95 122.13 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.801 ' HB2' ' CG ' ' A' ' 56' ' ' ARG . . . -80.02 145.57 32.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.856 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.589 ' HB3' HE22 ' A' ' 55' ' ' GLN . 83.4 tttt -101.81 134.22 20.28 Favored Pre-proline 0 C--N 1.326 -0.442 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.788 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -77.36 115.52 3.94 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.365 2.044 . . . . 0.0 111.261 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.653 HG11 ' O ' ' A' ' 22' ' ' GLU . 24.9 t -68.94 144.98 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 122.526 1.155 . . . . 0.0 113.022 -176.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.638 ' N ' HG13 ' A' ' 20' ' ' VAL . 4.3 mm-40 -67.45 -29.24 68.65 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 113.303 -1.771 . . . . 0.0 111.734 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.653 ' O ' HG11 ' A' ' 20' ' ' VAL . 16.9 tp10 -156.57 154.17 29.81 Favored 'General case' 0 CA--C 1.527 0.063 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.178 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.966 HG21 ' HA2' ' A' ' 115' ' ' GLY . 6.3 t -80.07 102.38 5.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -178.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 1.024 ' HB2' HD12 ' A' ' 27' ' ' ILE . 62.3 m-80 -89.04 151.16 22.42 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.569 -177.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.404 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -55.48 -28.21 53.12 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.508 0.67 . . . . 0.0 110.534 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.956 ' HG3' HD13 ' A' ' 27' ' ' ILE . 21.7 pt-20 -74.02 -36.92 64.48 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 177.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 1.024 HD12 ' HB2' ' A' ' 24' ' ' ASN . 1.7 mp -67.46 -38.79 81.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.952 177.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -65.78 -40.29 91.84 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 122.401 -0.187 . . . . 0.0 110.938 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.444 HH11 ' HG2' ' A' ' 29' ' ' ARG . 47.7 mmt-85 -64.94 -38.41 90.89 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.784 ' O ' ' HG3' ' A' ' 34' ' ' MET . 4.7 mt -55.39 -50.47 65.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.177 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.926 ' CG1' HG21 ' A' ' 71' ' ' VAL . 19.2 t -66.87 -40.4 85.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-O 121.218 0.533 . . . . 0.0 110.408 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.82 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 71.1 m-20 -53.06 -46.08 68.39 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.072 -178.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.691 ' HB3' HD13 ' A' ' 3' ' ' LEU . 1.5 m-20 -75.13 -29.25 60.46 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.07 176.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.784 ' HG3' ' O ' ' A' ' 30' ' ' ILE . 83.2 mtp -59.46 -46.63 88.22 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.171 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.82 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 13.9 p90 -70.2 -44.18 69.2 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.747 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 85.9 mt-10 -51.61 -44.48 62.9 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.622 0.725 . . . . 0.0 109.376 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.827 ' HA ' ' CG1' ' A' ' 2' ' ' VAL . 96.7 m -70.5 -61.35 1.8 Allowed 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 118.592 -1.243 . . . . 0.0 108.709 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 1.028 ' HE3' ' HB2' ' A' ' 61' ' ' ASP . 2.0 ttp -45.68 -41.5 10.52 Favored 'General case' 0 CA--C 1.463 -2.393 0 C-N-CA 123.878 0.871 . . . . 0.0 110.133 -171.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.697 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 55.9 m-85 -70.4 -42.13 72.08 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.083 177.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.424 ' HB1' HG11 ' A' ' 2' ' ' VAL . . . -61.16 -24.47 66.32 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.491 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.971 ' HG2' HD13 ' A' ' 91' ' ' LEU . 11.9 tp10 -88.81 -11.56 44.49 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.482 177.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 64.83 26.54 12.94 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 122.047 0.927 . . . . 0.0 109.927 -176.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.48 141.58 22.16 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 113.76 -1.564 . . . . 0.0 110.67 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.999 HG23 HG23 ' A' ' 62' ' ' VAL . 53.1 mt -80.0 0.68 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 117.643 0.722 . . . . 0.0 112.266 -178.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 1.006 ' HA3' H112 ' A' ' 149' ' ' BB2 . . . 178.09 135.54 2.31 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-O 119.022 -0.877 . . . . 0.0 111.926 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 1.022 HD12 ' HG ' ' A' ' 91' ' ' LEU . 5.4 tp -125.68 134.24 51.9 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-N 118.993 1.397 . . . . 0.0 111.56 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -98.9 132.33 44.31 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.734 ' O ' HG23 ' A' ' 51' ' ' VAL . . . -29.85 -54.59 0.16 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.575 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 58.4 p -53.97 -36.64 63.1 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.698 0.761 . . . . 0.0 111.81 -178.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.672 ' NE2' HD22 ' A' ' 91' ' ' LEU . 85.5 mt-30 -64.51 -40.62 95.97 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.627 -1.169 . . . . 0.0 110.028 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.857 ' CG1' HD23 ' A' ' 46' ' ' LEU . 0.8 OUTLIER -84.36 17.37 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 112.665 0.616 . . . . 0.0 112.665 -179.84 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.848 ' HA ' HD12 ' A' ' 6' ' ' LEU . 11.1 t0 77.51 26.86 0.65 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 176.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.822 HD11 ' O ' ' A' ' 55' ' ' GLN . 1.0 OUTLIER -124.13 110.7 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 C-N-CA 118.915 -1.114 . . . . 0.0 111.77 178.644 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.684 ' HD2' ' CZ ' ' A' ' 12' ' ' ARG . 6.9 p80 -76.48 60.5 1.61 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.611 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.822 ' O ' HD11 ' A' ' 53' ' ' ILE . 2.5 mm100 -149.67 134.18 17.53 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 114.342 -1.299 . . . . 0.0 107.788 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.801 ' CG ' ' HB2' ' A' ' 17' ' ' ALA . 75.7 mtp180 -64.11 68.62 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -177.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.686 HG13 HD12 ' A' ' 53' ' ' ILE . 8.5 mm -110.49 122.16 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.905 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 1.5 pp -121.95 140.73 44.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.0 -0.68 . . . . 0.0 112.285 -178.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.477 HG11 ' O ' ' A' ' 46' ' ' LEU . 1.5 p -125.16 134.5 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 1.034 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 9.1 mm -114.36 155.27 15.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.616 0.722 . . . . 0.0 110.921 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 1.028 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 31.9 t70 -142.57 28.56 1.62 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.659 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.999 HG23 HG23 ' A' ' 44' ' ' ILE . 39.3 t -94.22 107.54 19.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.81 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.718 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 79.6 p -37.05 84.59 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -176.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.76 ' OE1' HD21 ' A' ' 70' ' ' LEU . 38.8 tt0 -62.52 -18.06 61.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.956 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.891 ' OD1' ' HG2' ' A' ' 66' ' ' ARG . 26.1 t-20 -164.1 -85.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.105 0.479 . . . . 0.0 110.895 178.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.891 ' HG2' ' OD1' ' A' ' 65' ' ' ASN . 39.0 mmm-85 -119.27 -52.29 2.28 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.457 0.646 . . . . 0.0 110.354 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -99.43 126.3 45.31 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.309 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.718 ' HG2' ' HA ' ' A' ' 63' ' ' SER . 56.9 mt-10 -84.65 133.1 34.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.833 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.587 ' HB2' ' O ' ' A' ' 68' ' ' GLU . 40.7 ttm-85 171.22 70.53 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.135 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 1.034 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 47.8 mt -103.72 134.38 47.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.915 0.388 . . . . 0.0 111.716 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.926 HG21 ' CG1' ' A' ' 31' ' ' VAL . 6.3 p -134.88 135.9 52.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.308 178.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.905 ' HB2' ' CD1' ' A' ' 58' ' ' ILE . 3.0 mm? -141.63 142.12 33.42 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 177.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 1.004 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.6 mp -121.71 135.05 63.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.702 0.286 . . . . 0.0 110.336 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.694 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 7.3 m120 54.48 34.86 0.26 Allowed Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.87 ' HG2' HG12 ' A' ' 58' ' ' ILE . 89.3 Cg_exo -56.39 146.8 71.58 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.766 2.311 . . . . 0.0 113.707 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -138.0 145.51 41.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.797 ' HB2' ' HE3' ' A' ' 134' ' ' MET . 29.8 tp -79.12 138.2 37.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.424 0.63 . . . . 0.0 112.084 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.849 ' CD2' ' HG3' ' A' ' 109' ' ' ARG . 2.7 mm? -112.77 -43.55 3.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.474 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.556 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 39.2 tt0 -157.21 147.81 21.31 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.211 0.529 . . . . 0.0 111.949 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.88 ' HA ' HG12 ' A' ' 106' ' ' VAL . 19.3 ptpt -143.08 146.01 33.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.34 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.0 t -157.07 149.81 23.47 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.352 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.734 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 78.11 156.12 8.52 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.718 -0.754 . . . . 0.0 111.499 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -131.3 113.22 13.53 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.965 0.888 . . . . 0.0 112.632 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.777 ' HB ' HH12 ' A' ' 102' ' ' ARG . 1.5 p -105.98 161.9 14.06 Favored 'General case' 0 CA--C 1.487 -1.447 0 CA-C-N 114.016 -1.447 . . . . 0.0 114.894 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.81 ' HA3' HD23 ' A' ' 99' ' ' LEU . . . -149.22 118.05 0.92 Allowed Glycine 0 C--N 1.314 -0.674 0 CA-C-N 113.103 -1.862 . . . . 0.0 111.047 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.71 ' N ' ' HG ' ' A' ' 99' ' ' LEU . 32.5 mt -148.79 140.45 17.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 117.432 0.616 . . . . 0.0 111.84 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 55.8 mt-10 -71.14 139.18 50.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 123.135 1.445 . . . . 0.0 112.104 -176.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 1.03 ' HG2' ' H27' ' A' ' 149' ' ' BB2 . 84.1 mt-10 -157.5 162.44 38.88 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 112.543 -2.117 . . . . 0.0 111.774 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.877 ' O ' ' H51' ' A' ' 149' ' ' BB2 . . . -120.94 162.97 14.53 Favored Glycine 0 CA--C 1.5 -0.905 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.704 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 11.2 m -116.28 139.38 50.44 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 117.564 0.682 . . . . 0.0 110.763 -178.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 1.022 ' HG ' HD12 ' A' ' 46' ' ' LEU . 2.5 mm? -47.25 -20.58 0.2 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.501 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.865 ' CB ' HG12 ' A' ' 8' ' ' ILE . 31.5 m -86.53 -41.82 14.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.537 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 1.064 HG22 ' HD2' ' A' ' 94' ' ' PRO . 44.0 mm -86.37 152.8 55.67 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.199 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 1.064 ' HD2' HG22 ' A' ' 93' ' ' ILE . 64.8 Cg_endo -61.75 -144.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.636 2.224 . . . . 0.0 111.647 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.406 ' H ' ' HB2' ' A' ' 94' ' ' PRO . 8.8 mp0 -81.43 11.39 4.54 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.27 0.557 . . . . 0.0 110.616 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.538 ' HG3' ' HG2' ' A' ' 94' ' ' PRO . 85.4 mt-30 -78.29 83.78 4.52 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.111 -178.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.744 ' HG2' ' N ' ' A' ' 89' ' ' GLY . 74.9 mtm180 -85.58 133.22 34.07 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.36 0.6 . . . . 0.0 110.375 178.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -125.1 147.31 49.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.414 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.81 HD23 ' HA3' ' A' ' 85' ' ' GLY . 7.7 tt -75.26 111.94 11.03 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.707 0.765 . . . . 0.0 110.512 -178.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.666 ' CG2' ' HB2' ' A' ' 142' ' ' PHE . 12.2 p -97.93 133.05 23.67 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.93 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.63 ' HD2' HG22 ' A' ' 100' ' ' VAL . 95.6 Cg_endo -88.29 125.71 1.86 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.391 2.061 . . . . 0.0 112.227 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.946 ' HG3' HG21 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -144.4 166.77 24.16 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.798 0.839 . . . . 0.0 109.653 179.84 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.734 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.29 154.62 41.39 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.883 0.373 . . . . 0.0 110.1 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -73.06 -40.56 64.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.72 -176.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.754 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 89.3 mttt -139.82 140.34 36.57 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.34 0.59 . . . . 0.0 109.481 177.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.88 HG12 ' HA ' ' A' ' 80' ' ' LYS . 30.3 m -149.03 140.17 17.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.07 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.936 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 23.4 mmtp -107.63 126.42 52.55 Favored 'General case' 0 N--CA 1.461 0.091 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.857 HD11 HD11 ' A' ' 130' ' ' ILE . 1.7 pp -135.4 151.05 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -176.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.849 ' HG3' ' CD2' ' A' ' 78' ' ' LEU . 91.8 mtt180 -102.36 137.54 40.47 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.205 -178.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.708 ' HB2' ' HG3' ' A' ' 75' ' ' PRO . . . -160.64 169.01 23.73 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.908 -177.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 1.004 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.4 pp -116.39 151.64 35.54 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.716 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 18.9 t70 -83.66 165.4 18.99 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -176.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.832 ' HB2' HG13 ' A' ' 71' ' ' VAL . 52.9 ttp180 -52.2 -20.95 2.92 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.58 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -79.37 -25.85 42.14 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.699 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.966 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 106.31 36.57 2.65 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.712 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -128.44 102.6 20.48 Favored Pre-proline 0 C--O 1.236 0.377 0 CA-C-N 117.067 0.433 . . . . 0.0 110.731 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.568 ' HA ' ' CA ' ' A' ' 111' ' ' LEU . 34.2 Cg_exo -71.92 114.98 4.13 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 121.777 1.651 . . . . 0.0 115.596 -177.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.716 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 12.1 p90 -128.06 168.08 15.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.574 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.527 ' CG ' ' HG2' ' A' ' 109' ' ' ARG . 27.7 mp0 -107.35 130.28 54.81 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.691 HD23 HD12 ' A' ' 72' ' ' LEU . 4.3 pp -126.33 133.73 51.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.566 -178.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.936 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 11.5 pt-20 -93.04 123.8 36.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.629 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.992 ' HB3' HD13 ' A' ' 126' ' ' LEU . . . -116.83 134.97 54.13 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.754 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.2 m-20 -127.04 162.49 25.91 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.647 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 51.83 -136.35 33.34 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 120.293 1.406 . . . . 0.0 115.426 177.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 74.4 mt -54.84 -33.8 62.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.719 -0.741 . . . . 0.0 111.706 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.992 HD13 ' HB3' ' A' ' 122' ' ' ALA . 0.3 OUTLIER -71.47 -51.6 22.87 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.851 0.834 . . . . 0.0 109.15 179.619 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.754 ' HB3' ' CA ' ' A' ' 123' ' ' ASP . . . -58.82 -43.0 90.53 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.258 -1.337 . . . . 0.0 111.91 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.946 HG21 ' HG3' ' A' ' 102' ' ' ARG . 50.3 mm -67.96 -55.72 15.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.826 ' HB3' ' H91' ' A' ' 149' ' ' BB2 . 84.2 m -58.73 -50.67 73.06 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.857 HD11 HD11 ' A' ' 108' ' ' ILE . 20.4 tt -58.24 -43.84 86.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.13 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.757 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.4 pt20 -67.73 -37.9 82.83 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.083 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.867 ' CE1' ' H52' ' A' ' 149' ' ' BB2 . 3.8 t-160 -58.88 -47.4 85.06 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.864 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.6 mm-40 -59.61 -42.43 92.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.083 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.932 ' HA ' HD22 ' A' ' 137' ' ' LEU . 30.1 mtm -57.33 -47.48 81.44 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.832 0.825 . . . . 0.0 109.902 178.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.901 ' O ' HG11 ' A' ' 138' ' ' VAL . 57.8 m-20 -62.51 -47.59 83.28 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.197 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.902 ' HA ' ' CD2' ' A' ' 141' ' ' LEU . 6.2 t-80 -59.45 -52.96 63.37 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.123 0.487 . . . . 0.0 111.557 -178.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.932 HD22 ' HA ' ' A' ' 134' ' ' MET . 1.5 pp -57.93 -31.47 66.84 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.308 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 1.029 HG13 ' HG2' ' A' ' 140' ' ' LYS . 14.7 p -86.86 22.78 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-O 122.356 1.074 . . . . 0.0 109.359 176.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.642 ' HA3' ' C ' ' A' ' 14' ' ' ARG . . . 53.28 38.45 56.99 Favored Glycine 0 CA--C 1.481 -2.041 0 CA-C-N 113.331 -1.759 . . . . 0.0 112.17 176.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 1.029 ' HG2' HG13 ' A' ' 138' ' ' VAL . 2.4 ptmt -136.13 103.55 5.37 Favored 'General case' 0 N--CA 1.42 -1.935 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.83 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.902 ' CD2' ' HA ' ' A' ' 136' ' ' HIS . 3.1 mm? -123.61 149.06 45.81 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 120.822 -1.174 . . . . 0.0 109.05 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.666 ' HB2' ' CG2' ' A' ' 100' ' ' VAL . 8.9 m-85 -60.2 -39.35 86.27 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.821 ' HA ' ' HG ' ' A' ' 146' ' ' LEU . 46.6 ttm -55.91 -25.97 45.37 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.094 0.473 . . . . 0.0 111.487 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.501 ' CG ' ' HE ' ' A' ' 14' ' ' ARG . 31.3 t70 -55.4 -25.95 38.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.335 -178.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -118.27 37.78 3.91 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 120.555 0.217 . . . . 0.0 110.905 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.821 ' HG ' ' HA ' ' A' ' 143' ' ' MET . 49.4 mt -92.39 139.12 30.92 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.667 0.27 . . . . 0.0 110.993 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 54.0 m . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.975 179.784 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' BB2 . . . . . 1.03 ' H27' ' HG2' ' A' ' 88' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 79.8 p . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.834 0.35 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.887 HG13 ' HA ' ' A' ' 37' ' ' THR . 27.1 m -84.22 133.64 28.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.388 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.994 HD11 ' HB ' ' A' ' 51' ' ' VAL . 1.1 pt? -79.68 -158.69 0.17 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.53 ' HG3' ' HB3' ' A' ' 52' ' ' ASP . 23.4 pt20 -88.66 104.43 16.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.882 0.372 . . . . 0.0 111.88 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.503 HG13 ' CD1' ' A' ' 91' ' ' LEU . 49.1 t -89.38 131.66 36.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-O 121.251 0.548 . . . . 0.0 111.953 -178.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 1.0 ' HB2' HD21 ' A' ' 13' ' ' LEU . 22.6 mt -91.08 140.11 30.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.998 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.612 ' HA ' ' CA ' ' A' ' 92' ' ' SER . 37.1 m-70 -112.53 140.6 47.15 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.743 HG12 ' HB2' ' A' ' 92' ' ' SER . 37.1 mm -61.81 132.88 93.51 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.81 176.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -79.89 148.25 78.78 Favored 'Cis proline' 0 C--N 1.352 0.719 0 C-N-CA 124.795 -0.919 . . . . 0.0 111.67 -0.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 1.033 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 9.0 t0 -165.1 131.09 2.73 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.403 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.413 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 23.8 pt-20 -58.45 -45.8 87.85 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.774 0.321 . . . . 0.0 110.643 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.658 ' O ' ' HB ' ' A' ' 49' ' ' THR . 14.7 mmt85 -59.67 -26.44 65.55 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 1.033 ' HG ' ' HB3' ' A' ' 10' ' ' ASP . 9.9 mt -77.42 -31.43 54.02 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 120.736 1.607 . . . . 0.0 108.39 177.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.672 ' C ' ' HA3' ' A' ' 139' ' ' GLY . 25.2 mmm-85 -94.46 10.43 34.52 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.108 -1.406 . . . . 0.0 109.173 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.714 ' HZ2' ' HB2' ' A' ' 54' ' ' HIS . 64.2 tttm -84.64 141.2 30.8 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.196 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.614 ' CG1' HG23 ' A' ' 138' ' ' VAL . 61.8 t -84.22 94.95 3.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.201 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.677 ' HB2' ' HG3' ' A' ' 56' ' ' ARG . . . -57.71 145.12 35.54 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.887 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -104.42 134.77 19.51 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.596 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.633 ' HD3' ' HD3' ' A' ' 56' ' ' ARG . 58.8 Cg_endo -80.26 115.74 3.24 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.235 1.957 . . . . 0.0 110.384 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.62 HG13 ' N ' ' A' ' 21' ' ' GLU . 16.4 t -69.23 144.3 14.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 122.476 1.131 . . . . 0.0 113.177 -175.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.62 ' N ' HG13 ' A' ' 20' ' ' VAL . 69.8 mm-40 -62.48 -23.59 66.99 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 113.197 -1.82 . . . . 0.0 112.57 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -160.03 148.0 16.82 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 121.034 -0.267 . . . . 0.0 110.744 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.941 HG21 ' HA2' ' A' ' 115' ' ' GLY . 3.0 t -82.44 105.83 12.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.868 HD21 HD13 ' A' ' 27' ' ' ILE . 64.8 m-80 -89.23 157.85 18.09 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.988 -178.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.522 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -54.53 -31.48 56.38 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.509 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -71.28 -37.57 71.87 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 177.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.868 HD13 HD21 ' A' ' 24' ' ' ASN . 63.4 mt -64.25 -47.15 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.143 178.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.415 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 51.0 mt-30 -57.65 -39.86 78.0 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.027 0.441 . . . . 0.0 110.733 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.522 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 38.9 mmt180 -60.99 -40.09 92.15 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.543 0.687 . . . . 0.0 109.159 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.819 ' O ' ' HG3' ' A' ' 34' ' ' MET . 4.6 mt -58.62 -49.66 81.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.879 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.599 ' CG1' HG21 ' A' ' 71' ' ' VAL . 17.9 t -68.47 -41.32 83.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.916 0.388 . . . . 0.0 111.422 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.831 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 47.8 m-20 -53.24 -46.11 69.01 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.588 0.709 . . . . 0.0 111.53 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.545 ' HB3' HD21 ' A' ' 3' ' ' LEU . 1.4 m-20 -74.71 -30.21 61.46 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.661 176.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.819 ' HG3' ' O ' ' A' ' 30' ' ' ILE . 87.3 mtp -59.61 -47.0 87.29 Favored 'General case' 0 C--N 1.345 0.378 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.723 -177.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.831 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 17.4 p90 -69.54 -44.38 71.05 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.745 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 77.9 mt-10 -51.65 -42.64 62.23 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.887 ' HA ' HG13 ' A' ' 2' ' ' VAL . 76.8 m -69.33 -60.42 2.35 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 118.79 -1.164 . . . . 0.0 108.487 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 1.123 ' HE3' ' HB2' ' A' ' 61' ' ' ASP . 3.2 ttp -46.24 -43.33 15.38 Favored 'General case' 0 CA--C 1.463 -2.385 0 C-N-CA 123.749 0.819 . . . . 0.0 109.869 -170.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.693 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 58.9 m-85 -68.96 -42.02 77.21 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.878 178.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.496 ' HB1' ' CG1' ' A' ' 2' ' ' VAL . . . -60.14 -28.9 68.27 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.626 0.727 . . . . 0.0 109.045 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 1.065 ' HG2' HD22 ' A' ' 91' ' ' LEU . 3.2 tp10 -83.95 -10.15 58.16 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 114.392 -1.276 . . . . 0.0 108.835 177.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 62.41 25.42 15.16 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.916 -176.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.96 140.61 22.53 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.187 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 1.009 HG22 HG21 ' A' ' 62' ' ' VAL . 38.5 mt -79.2 0.42 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 117.829 0.815 . . . . 0.0 111.93 -178.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.751 ' HA3' H101 ' A' ' 149' ' ' BB2 . . . -179.75 133.5 2.04 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-O 119.215 -0.77 . . . . 0.0 112.066 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.98 ' HB2' ' HG3' ' A' ' 38' ' ' MET . 9.2 tp -125.31 135.37 52.42 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-N 119.531 1.665 . . . . 0.0 111.712 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -101.45 130.63 47.73 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.689 ' O ' HG22 ' A' ' 51' ' ' VAL . . . -29.31 -56.16 0.15 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 115.902 1.815 . . . . 0.0 115.902 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.658 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 77.2 p -53.82 -34.73 60.11 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.725 0.774 . . . . 0.0 111.378 -178.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.487 ' NE2' ' HB3' ' A' ' 90' ' ' CYS . 37.2 mt-30 -65.34 -38.52 90.34 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.168 -1.378 . . . . 0.0 109.843 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.994 ' HB ' HD11 ' A' ' 3' ' ' LEU . 1.6 m -89.1 13.42 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 121.013 0.435 . . . . 0.0 111.752 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.954 ' HA ' HD13 ' A' ' 6' ' ' LEU . 38.2 t70 77.13 35.27 0.36 Allowed 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 176.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.808 HD13 ' HB2' ' A' ' 55' ' ' GLN . 1.2 pp -125.81 110.87 25.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 119.495 -0.882 . . . . 0.0 109.706 176.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.714 ' HB2' ' HZ2' ' A' ' 15' ' ' LYS . 23.4 p-80 -75.99 64.76 1.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 122.098 0.952 . . . . 0.0 110.145 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.808 ' HB2' HD13 ' A' ' 53' ' ' ILE . 89.3 mt-30 -153.97 131.83 11.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.934 -1.485 . . . . 0.0 108.146 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.677 ' HG3' ' HB2' ' A' ' 17' ' ' ALA . 60.1 mtp85 -62.81 74.55 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 -178.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.729 ' O ' ' HE1' ' A' ' 34' ' ' MET . 29.7 mm -116.56 124.2 72.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 1.014 HD12 ' HB2' ' A' ' 72' ' ' LEU . 1.9 pp -127.67 145.51 34.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -177.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.683 HG21 ' H ' ' A' ' 46' ' ' LEU . 33.7 m -127.44 136.33 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.123 179.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.954 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 1.3 mt -116.44 147.92 19.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.785 0.803 . . . . 0.0 110.698 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 1.123 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 33.2 t70 -136.07 30.23 3.04 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.217 -178.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 1.009 HG21 HG22 ' A' ' 44' ' ' ILE . 24.4 t -98.15 112.4 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.16 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.603 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 78.6 p -39.95 76.38 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -178.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.558 ' N ' ' O ' ' A' ' 62' ' ' VAL . 34.6 tp10 -75.72 -11.5 60.01 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.41 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.627 ' OD1' ' HG2' ' A' ' 66' ' ' ARG . 10.3 t-20 -164.41 -136.14 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.877 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.627 ' HG2' ' OD1' ' A' ' 65' ' ' ASN . 26.7 mmm180 -76.02 -58.78 3.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.84 0.353 . . . . 0.0 111.166 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.23 130.32 40.53 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.015 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.603 ' HG2' ' HA ' ' A' ' 63' ' ' SER . 49.8 mt-10 -86.42 121.19 28.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.871 178.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.62 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 72.9 ttt180 172.48 76.28 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.401 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.954 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 65.0 mt -104.28 133.1 49.77 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.637 HG13 ' H ' ' A' ' 113' ' ' ARG . 14.5 p -135.01 134.38 53.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.291 177.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 1.014 ' HB2' HD12 ' A' ' 58' ' ' ILE . 3.0 mm? -140.01 141.73 36.3 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 177.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.991 HG13 HD11 ' A' ' 111' ' ' LEU . 3.5 mm -120.43 134.32 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 121.232 0.539 . . . . 0.0 111.548 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.682 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 6.7 m120 51.36 38.68 0.54 Allowed Pre-proline 0 C--N 1.317 -0.807 0 CA-C-N 115.217 -0.902 . . . . 0.0 112.323 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.746 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 84.5 Cg_exo -54.92 149.78 40.7 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.974 2.449 . . . . 0.0 114.104 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.458 ' HG3' HD13 ' A' ' 78' ' ' LEU . 15.7 pt-20 -135.79 142.36 44.89 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 1.028 ' HB2' ' HE2' ' A' ' 134' ' ' MET . 1.7 tt -81.79 134.21 35.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.643 0.735 . . . . 0.0 111.806 -178.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.873 ' N ' HD22 ' A' ' 77' ' ' LEU . 6.7 mp -110.74 -37.51 5.41 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.691 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.543 ' C ' ' HE2' ' A' ' 80' ' ' LYS . 85.2 tt0 -160.28 153.71 22.19 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.186 0.517 . . . . 0.0 111.782 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.99 ' HZ2' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -148.03 151.7 36.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.378 179.125 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.7 m -160.46 141.55 12.06 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.578 0.228 . . . . 0.0 110.984 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.769 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 80.35 168.33 38.0 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.235 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -146.26 113.73 6.33 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.672 0.749 . . . . 0.0 112.926 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.823 ' HG1' HD11 ' A' ' 128' ' ' ILE . 1.5 p -99.54 160.91 13.94 Favored 'General case' 0 CA--C 1.49 -1.331 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.764 ' O ' HD11 ' A' ' 86' ' ' ILE . . . -134.44 100.51 0.38 Allowed Glycine 0 C--N 1.317 -0.475 0 CA-C-N 113.064 -1.88 . . . . 0.0 111.132 178.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.764 HD11 ' O ' ' A' ' 85' ' ' GLY . 39.5 mm -143.73 135.51 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -178.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.601 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 49.0 mt-10 -72.96 143.89 47.48 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 122.389 1.09 . . . . 0.0 112.499 -178.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.915 ' HG2' ' H27' ' A' ' 149' ' ' BB2 . 50.4 mt-10 -154.16 166.15 34.0 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 113.619 -1.628 . . . . 0.0 109.053 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.754 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -119.87 159.61 14.89 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 119.304 -1.427 . . . . 0.0 109.623 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.832 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 69.2 m -111.71 138.83 47.76 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.552 -177.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 1.065 HD22 ' HG2' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -50.04 -32.36 15.24 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.535 0.683 . . . . 0.0 110.0 -179.636 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.743 ' HB2' HG12 ' A' ' 8' ' ' ILE . 11.4 m -77.78 -27.14 50.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.7 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 1.062 HG22 ' HD2' ' A' ' 94' ' ' PRO . 48.5 mt -85.96 148.3 47.76 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.617 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 1.062 ' HD2' HG22 ' A' ' 93' ' ' ILE . 59.3 Cg_endo -78.24 47.67 2.46 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.438 2.092 . . . . 0.0 114.14 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.576 ' HB2' ' O ' ' A' ' 94' ' ' PRO . 7.9 mp0 80.22 4.66 1.84 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.827 0.346 . . . . 0.0 111.653 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.604 ' HG3' ' HG2' ' A' ' 94' ' ' PRO . 84.7 mt-30 -77.97 90.02 4.15 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 1.0 HH11 H232 ' A' ' 149' ' ' BB2 . 81.1 mtm180 -84.13 133.47 34.62 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.652 0.739 . . . . 0.0 111.377 -178.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.84 148.28 49.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.874 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.612 ' HG ' ' N ' ' A' ' 86' ' ' ILE . 6.9 tt -75.23 135.73 40.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.208 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.796 HG11 ' NH1' ' A' ' 102' ' ' ARG . 55.8 t -131.97 131.49 22.61 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.173 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.881 ' HG2' ' CE2' ' A' ' 142' ' ' PHE . 74.3 Cg_endo -78.24 125.43 7.1 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.692 1.595 . . . . 0.0 113.137 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.949 ' HG2' HD13 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -141.42 165.51 27.31 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.413 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.769 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -69.38 154.75 41.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.727 0.299 . . . . 0.0 110.513 -178.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -73.41 -43.33 60.68 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.243 -176.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.772 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 84.2 mttt -139.47 138.19 36.19 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.416 0.627 . . . . 0.0 109.624 176.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.921 HG11 ' HA ' ' A' ' 80' ' ' LYS . 28.3 m -144.52 140.38 23.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.991 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 1.07 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 23.6 mmtp -107.99 125.92 52.1 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.714 ' CD1' HD11 ' A' ' 130' ' ' ILE . 1.9 pp -132.0 161.36 41.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -177.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.857 ' HG3' ' CD1' ' A' ' 78' ' ' LEU . 92.2 mtt180 -109.58 137.53 47.28 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.782 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.579 ' HB2' ' HB3' ' A' ' 72' ' ' LEU . . . -155.1 166.5 33.38 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.655 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.991 HD11 HG13 ' A' ' 73' ' ' ILE . 2.0 pp -116.46 150.47 37.81 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.538 ' O ' HD13 ' A' ' 111' ' ' LEU . 22.0 t70 -84.0 171.33 13.06 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.579 -175.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.778 ' HD2' ' OD1' ' A' ' 32' ' ' ASP . 50.8 ttp180 -54.49 -23.43 16.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.798 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.52 -14.41 58.89 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.873 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.941 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 93.15 40.09 4.94 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.02 -1.086 . . . . 0.0 114.593 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -128.11 102.49 21.49 Favored Pre-proline 0 N--CA 1.469 0.479 0 CA-C-N 117.59 0.695 . . . . 0.0 110.389 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.611 ' HG3' HD22 ' A' ' 111' ' ' LEU . 32.3 Cg_exo -73.56 115.23 4.26 Favored 'Trans proline' 0 C--N 1.359 1.108 0 N-CA-C 116.249 1.596 . . . . 0.0 116.249 -177.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.64 168.95 13.01 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.739 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.689 ' HG2' ' HG2' ' A' ' 109' ' ' ARG . 36.1 mt-10 -107.6 130.03 54.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.008 0.432 . . . . 0.0 110.278 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.733 HD12 ' CD1' ' A' ' 130' ' ' ILE . 4.1 pp -126.71 134.27 50.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.804 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 1.07 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 15.5 pt-20 -96.79 124.35 40.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.004 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.897 ' HB3' HD23 ' A' ' 126' ' ' LEU . . . -116.71 135.79 53.49 Favored 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.772 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.3 m-20 -125.99 164.71 20.24 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.708 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 45.14 -132.53 8.26 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 120.627 1.558 . . . . 0.0 116.194 177.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.756 HD11 ' H ' ' A' ' 125' ' ' LEU . 5.0 mp -54.09 -35.83 62.53 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.739 -0.731 . . . . 0.0 111.361 -178.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.897 HD23 ' HB3' ' A' ' 122' ' ' ALA . 0.6 OUTLIER -70.44 -53.02 18.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.581 0.705 . . . . 0.0 109.655 179.721 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.751 ' HB3' ' CA ' ' A' ' 123' ' ' ASP . . . -58.46 -41.09 84.38 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.884 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.949 HD13 ' HG2' ' A' ' 102' ' ' ARG . 51.0 mm -68.8 -54.87 18.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.522 -178.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 1.017 ' HB2' H112 ' A' ' 149' ' ' BB2 . 31.4 p -57.77 -50.33 73.61 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.733 ' CD1' HD12 ' A' ' 120' ' ' LEU . 20.6 tt -60.07 -43.9 93.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.609 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.856 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 23.3 pt20 -66.97 -37.42 84.21 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.231 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.637 ' HA ' ' OD1' ' A' ' 135' ' ' ASP . 8.5 t-160 -56.04 -47.11 78.48 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.773 ' HG2' H102 ' A' ' 149' ' ' BB2 . 3.8 mm-40 -60.68 -43.03 98.21 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.711 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 1.028 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 76.2 mtp -61.0 -49.49 77.24 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.453 0.569 . . . . 0.0 111.66 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.876 ' O ' HG13 ' A' ' 138' ' ' VAL . 6.6 p-10 -65.18 -45.85 83.19 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.552 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.851 ' HA ' ' CD2' ' A' ' 141' ' ' LEU . 18.3 t-80 -59.67 -52.34 65.93 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 121.9 -0.5 . . . . 0.0 112.035 -178.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.897 HD21 HG22 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -62.51 -29.41 70.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.656 -177.206 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.946 HG12 ' HG2' ' A' ' 140' ' ' LYS . 8.4 p -81.15 21.56 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 CA-C-O 123.067 1.413 . . . . 0.0 107.816 173.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.774 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 56.16 24.7 44.93 Favored Glycine 0 CA--C 1.487 -1.7 0 CA-C-N 111.934 -2.394 . . . . 0.0 112.587 176.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.946 ' HG2' HG12 ' A' ' 138' ' ' VAL . 6.2 ptmt -115.27 117.33 30.18 Favored 'General case' 0 N--CA 1.427 -1.576 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.435 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.851 ' CD2' ' HA ' ' A' ' 136' ' ' HIS . 3.6 mm? -135.88 147.7 48.3 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.881 ' CE2' ' HG2' ' A' ' 101' ' ' PRO . 4.1 m-85 -61.97 -32.64 73.1 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.946 ' HA ' ' HG ' ' A' ' 146' ' ' LEU . 23.5 ttt -51.92 -24.19 6.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.16 0.505 . . . . 0.0 111.697 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -48.96 -24.32 1.45 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.965 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -129.73 44.87 2.9 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 120.701 0.286 . . . . 0.0 111.034 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.946 ' HG ' ' HA ' ' A' ' 143' ' ' MET . 34.9 mt -93.79 142.39 27.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.135 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 45.5 t . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.952 179.403 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' BB2 . . . . . 1.017 H112 ' HB2' ' A' ' 129' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.8 t . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.876 0.37 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.408 HG12 ' CB ' ' A' ' 40' ' ' ALA . 21.7 m -84.09 138.49 19.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.771 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.85 HD22 ' HB ' ' A' ' 51' ' ' VAL . 61.5 tp -77.45 162.37 27.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.374 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -78.82 106.48 10.86 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.251 0.548 . . . . 0.0 110.282 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.567 ' CG2' HG23 ' A' ' 37' ' ' THR . 33.4 t -89.93 131.69 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.788 -178.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.914 HD11 ' HA ' ' A' ' 52' ' ' ASP . 39.1 mt -89.49 149.35 22.95 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.135 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.559 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 1.9 m80 -124.37 149.79 46.26 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.655 HD12 ' CB ' ' A' ' 92' ' ' SER . 2.9 mp -55.81 145.54 51.71 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.835 178.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -92.35 51.19 1.06 Allowed 'Cis proline' 0 C--N 1.355 0.916 0 C-N-CA 124.572 -1.012 . . . . 0.0 112.915 0.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.691 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 9.9 t70 -55.65 130.86 44.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.896 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -59.17 -40.13 84.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.016 0.436 . . . . 0.0 111.139 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.686 ' HB2' HD13 ' A' ' 6' ' ' LEU . 19.0 mmt-85 -57.65 -26.07 61.09 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.645 0.979 . . . . 0.0 113.645 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.691 ' HG ' ' HB3' ' A' ' 10' ' ' ASP . 8.8 mt -76.21 -33.24 59.26 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 120.61 1.55 . . . . 0.0 108.434 177.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.854 ' NH1' ' HB2' ' A' ' 144' ' ' ASP . 32.1 mmt180 -91.82 7.99 39.28 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.631 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.757 ' HZ2' ' CG ' ' A' ' 54' ' ' HIS . 87.8 tttt -88.3 148.39 24.33 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.089 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.677 HG13 HG21 ' A' ' 138' ' ' VAL . 97.1 t -82.68 128.79 38.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.765 ' HB2' ' CG ' ' A' ' 56' ' ' ARG . . . -86.24 143.57 27.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.394 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.814 ' HD3' ' HD2' ' A' ' 19' ' ' PRO . 7.6 tmtt? -106.33 130.16 23.39 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.913 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 60.9 Cg_endo -78.14 116.47 3.93 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.342 2.028 . . . . 0.0 111.26 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.632 HG11 ' N ' ' A' ' 21' ' ' GLU . 19.3 t -67.08 144.7 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-O 122.803 1.287 . . . . 0.0 113.14 -175.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.632 ' N ' HG11 ' A' ' 20' ' ' VAL . 97.9 mt-10 -62.96 -24.51 67.92 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 112.57 -2.105 . . . . 0.0 112.68 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -161.01 143.52 12.54 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.975 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.823 HG23 HD23 ' A' ' 111' ' ' LEU . 3.3 t -79.55 107.7 12.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 1.034 ' H ' HD11 ' A' ' 27' ' ' ILE . 57.4 m-80 -98.06 158.51 15.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.686 -178.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.722 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -55.72 -23.82 31.21 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.215 0.531 . . . . 0.0 110.678 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.469 ' HA ' ' OE1' ' A' ' 26' ' ' GLU . 4.3 mm-40 -74.05 -41.83 61.18 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 176.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 1.034 HD11 ' H ' ' A' ' 24' ' ' ASN . 69.0 mt -64.01 -48.24 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.245 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -57.15 -40.06 76.48 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.722 ' HG3' ' O ' ' A' ' 25' ' ' ALA . 99.3 mtt180 -61.76 -39.8 92.93 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.771 HG22 HD11 ' A' ' 53' ' ' ILE . 4.1 mt -56.91 -50.01 77.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 114.832 -1.076 . . . . 0.0 112.075 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.827 HG11 ' CG2' ' A' ' 71' ' ' VAL . 10.5 t -68.58 -42.16 83.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 120.842 0.353 . . . . 0.0 111.432 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.776 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -55.76 -39.48 71.26 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.33 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.509 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 31.6 m-20 -76.07 -30.45 58.35 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.985 175.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.714 ' HG3' ' O ' ' A' ' 30' ' ' ILE . 15.2 mtm -60.58 -46.66 89.42 Favored 'General case' 0 C--N 1.347 0.465 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.44 -177.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.776 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 14.0 p90 -69.05 -46.43 67.91 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.542 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 27.2 mm-40 -51.05 -38.57 52.31 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.567 HG23 ' CG2' ' A' ' 5' ' ' VAL . 57.5 m -69.83 -62.31 1.44 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 118.725 -1.19 . . . . 0.0 108.272 177.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.987 ' HE3' ' HB2' ' A' ' 61' ' ' ASP . 2.9 ttp -46.58 -44.25 17.9 Favored 'General case' 0 CA--C 1.458 -2.578 0 C-N-CA 124.016 0.926 . . . . 0.0 110.412 -170.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.708 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 70.0 m-85 -67.67 -41.73 83.24 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.794 178.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.408 ' CB ' HG12 ' A' ' 2' ' ' VAL . . . -60.38 -26.67 66.82 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.773 0.796 . . . . 0.0 109.038 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 1.121 ' HG2' HD11 ' A' ' 91' ' ' LEU . 2.6 tp10 -86.74 -10.89 52.63 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 114.361 -1.29 . . . . 0.0 109.155 177.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 63.94 26.6 14.22 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.107 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.572 ' HA2' ' C18' ' A' ' 149' ' ' BB2 . . . -80.56 144.49 25.54 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.111 178.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 1.033 HG21 HG23 ' A' ' 62' ' ' VAL . 46.0 mm -79.25 -3.93 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 117.631 0.715 . . . . 0.0 112.141 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.843 ' HA3' H113 ' A' ' 149' ' ' BB2 . . . 179.19 137.9 3.07 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-O 119.109 -0.828 . . . . 0.0 111.302 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 1.022 HD12 ' HG ' ' A' ' 91' ' ' LEU . 2.3 tp -124.39 135.22 53.12 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.285 1.542 . . . . 0.0 110.828 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -103.68 130.62 51.18 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 122.085 -0.384 . . . . 0.0 111.299 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.577 ' O ' HG21 ' A' ' 51' ' ' VAL . . . -28.51 -57.99 0.13 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 116.647 2.092 . . . . 0.0 116.647 -177.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 74.9 p -53.42 -34.69 58.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 122.098 0.951 . . . . 0.0 111.478 -177.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.67 ' HB2' HD11 ' A' ' 46' ' ' LEU . 23.2 mt-30 -63.56 -38.47 91.26 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 113.929 -1.487 . . . . 0.0 110.686 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.85 ' HB ' HD22 ' A' ' 3' ' ' LEU . 1.5 m -92.52 19.44 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.914 ' HA ' HD11 ' A' ' 6' ' ' LEU . 37.5 t70 78.25 25.99 0.58 Allowed 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 176.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.82 HD13 ' HB ' ' A' ' 57' ' ' ILE . 11.9 pt -120.36 108.56 23.38 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.131 177.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.757 ' CG ' ' HZ2' ' A' ' 15' ' ' LYS . 7.8 p80 -75.41 51.2 0.56 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-O 122.16 0.981 . . . . 0.0 109.905 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.533 ' O ' HG12 ' A' ' 57' ' ' ILE . 83.2 mt-30 -139.01 132.52 30.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 113.892 -1.504 . . . . 0.0 107.716 178.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.913 ' HD2' ' HD3' ' A' ' 19' ' ' PRO . 96.0 mtt180 -61.79 72.52 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -178.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.82 ' HB ' HD13 ' A' ' 53' ' ' ILE . 10.3 mm -116.35 122.75 70.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.944 HD12 ' HB2' ' A' ' 72' ' ' LEU . 1.8 pp -127.0 145.4 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 -177.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.641 HG22 ' H ' ' A' ' 46' ' ' LEU . 33.9 m -128.71 134.95 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.362 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 1.058 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 1.6 mt -116.54 145.45 22.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.504 0.669 . . . . 0.0 110.344 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.987 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 28.0 t70 -124.69 16.29 8.75 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.391 -178.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 1.033 HG23 HG21 ' A' ' 44' ' ' ILE . 29.8 t -88.05 114.04 26.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.598 178.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.519 ' N ' ' HG2' ' A' ' 68' ' ' GLU . 81.4 p -42.42 81.51 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 62' ' ' VAL . 65.0 mm-40 -128.84 -17.38 4.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.47 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.861 ' HB2' HD22 ' A' ' 70' ' ' LEU . 43.3 t30 -105.06 -35.19 7.72 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 122.015 -0.428 . . . . 0.0 110.886 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.808 ' HA ' ' HE ' ' A' ' 66' ' ' ARG . 2.4 mmp_? -161.34 -91.13 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 68' ' ' GLU . 1.4 m-20 -130.23 55.52 1.8 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.153 177.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.519 ' HG2' ' N ' ' A' ' 63' ' ' SER . 94.7 mt-10 71.78 101.38 0.07 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.997 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.552 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 35.5 ttt85 175.2 64.11 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.83 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 1.058 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 63.8 mt -102.69 135.16 44.84 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.827 ' CG2' HG11 ' A' ' 31' ' ' VAL . 12.5 p -134.74 130.5 52.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.083 178.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.944 ' HB2' HD12 ' A' ' 58' ' ' ILE . 90.6 mt -141.37 142.2 33.78 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.59 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 1.021 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.6 mp -121.27 134.87 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-O 120.652 0.263 . . . . 0.0 110.901 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.686 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 7.2 m120 57.02 37.56 0.38 Allowed Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.89 ' HG2' HG12 ' A' ' 58' ' ' ILE . 88.4 Cg_exo -56.59 145.72 79.48 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 122.838 2.359 . . . . 0.0 114.101 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.468 ' CG ' ' HB2' ' A' ' 109' ' ' ARG . 15.2 pt-20 -136.89 142.22 42.75 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.955 HD22 ' HZ2' ' A' ' 80' ' ' LYS . 1.7 tt -81.84 133.27 35.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.375 0.607 . . . . 0.0 111.753 -178.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.995 HD23 ' HE ' ' A' ' 109' ' ' ARG . 4.8 mp -108.82 -39.14 5.43 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.997 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.486 ' O ' HD23 ' A' ' 77' ' ' LEU . 42.4 tt0 -156.36 152.83 28.06 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 121.192 0.52 . . . . 0.0 111.764 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.955 ' HZ2' HD22 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -147.28 149.81 33.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.936 179.385 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.3 p -160.07 152.94 21.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.79 0.329 . . . . 0.0 111.571 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.676 ' C ' ' HG3' ' A' ' 104' ' ' GLU . . . 73.63 146.33 0.92 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.749 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.98 112.62 24.58 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 121.631 0.729 . . . . 0.0 111.229 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 1.045 HG21 ' HG2' ' A' ' 104' ' ' GLU . 1.6 p -114.81 160.94 18.86 Favored 'General case' 0 CA--C 1.484 -1.595 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.759 ' HA3' HD22 ' A' ' 99' ' ' LEU . . . -155.83 123.26 1.3 Allowed Glycine 0 C--N 1.311 -0.855 0 CA-C-N 113.01 -1.904 . . . . 0.0 110.95 178.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.449 ' N ' ' HG ' ' A' ' 99' ' ' LEU . 34.4 mt -147.34 139.18 18.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-N 117.643 0.722 . . . . 0.0 111.834 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 56.1 mt-10 -71.23 135.15 47.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 123.538 1.637 . . . . 0.0 112.349 -176.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.934 ' HG2' ' H27' ' A' ' 149' ' ' BB2 . 41.0 mt-10 -154.24 166.61 32.61 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 112.132 -2.304 . . . . 0.0 111.425 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.778 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -120.73 163.3 14.32 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.829 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 65.1 m -109.64 137.42 47.49 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.865 0.364 . . . . 0.0 110.926 -177.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 1.121 HD11 ' HG2' ' A' ' 41' ' ' GLU . 3.1 mm? -51.53 -38.66 55.24 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.73 0.776 . . . . 0.0 109.719 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.655 ' CB ' HD12 ' A' ' 8' ' ' ILE . 22.8 m -77.12 -26.66 53.45 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.59 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.734 ' CG1' ' HB2' ' A' ' 90' ' ' CYS . 53.1 mt -85.31 149.52 52.48 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.729 ' HD2' ' CG2' ' A' ' 93' ' ' ILE . 66.6 Cg_endo -75.68 47.08 1.81 Allowed 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.118 1.878 . . . . 0.0 115.446 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.567 ' HB2' ' O ' ' A' ' 94' ' ' PRO . 8.3 mp0 77.26 11.54 2.28 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.579 ' HG2' ' HG2' ' A' ' 94' ' ' PRO . 9.7 mm-40 -78.69 88.99 4.57 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.778 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 18.4 mtm105 -84.86 132.13 34.43 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.852 0.834 . . . . 0.0 111.638 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 87' ' ' GLU . . . -135.15 155.55 50.51 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.273 -1.33 . . . . 0.0 109.22 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.759 HD22 ' HA3' ' A' ' 85' ' ' GLY . 7.5 tt -76.52 110.86 11.42 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.828 0.823 . . . . 0.0 111.532 -177.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.794 ' HB ' ' CZ ' ' A' ' 102' ' ' ARG . 40.3 t -98.4 126.16 40.53 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 114.415 -1.266 . . . . 0.0 112.021 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.591 ' HG2' ' CD2' ' A' ' 142' ' ' PHE . 81.7 Cg_endo -78.84 126.55 7.31 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.318 2.012 . . . . 0.0 112.277 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.857 ' HB2' ' OE1' ' A' ' 131' ' ' GLN . 0.0 OUTLIER -145.03 166.77 24.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.637 179.011 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.59 154.94 40.95 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.208 0.527 . . . . 0.0 110.283 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 1.045 ' HG2' HG21 ' A' ' 84' ' ' THR . 50.0 mt-10 -73.61 -42.19 61.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.645 -176.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 1.042 ' HZ1' ' HB3' ' A' ' 123' ' ' ASP . 66.5 mttm -140.41 139.62 35.3 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.801 HG13 ' CB ' ' A' ' 80' ' ' LYS . 28.7 m -149.98 141.63 17.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.437 -178.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.671 ' CE ' ' HB3' ' A' ' 121' ' ' GLU . 0.4 OUTLIER -107.65 125.15 51.0 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.46 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.736 ' HA ' ' CD1' ' A' ' 78' ' ' LEU . 1.4 pp -135.42 151.8 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -176.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.995 ' HE ' HD23 ' A' ' 78' ' ' LEU . 94.2 mtt180 -100.81 138.54 37.73 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 122.214 1.007 . . . . 0.0 111.128 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.707 ' HB2' ' HB3' ' A' ' 72' ' ' LEU . . . -158.8 169.35 24.57 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.759 -176.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 1.021 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.9 pp -120.27 154.78 34.46 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.587 ' O ' HD13 ' A' ' 111' ' ' LEU . 25.1 t70 -88.15 164.43 15.69 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.443 0.64 . . . . 0.0 111.991 -176.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.806 ' HB2' HG12 ' A' ' 71' ' ' VAL . 24.6 ttm180 -52.62 -20.29 2.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.055 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -81.88 -22.22 37.0 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.03 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.635 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 105.11 35.86 3.06 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 119.893 -1.146 . . . . 0.0 113.857 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -128.62 102.4 20.16 Favored Pre-proline 0 C--O 1.235 0.325 0 CA-C-N 117.344 0.572 . . . . 0.0 111.185 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.58 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 36.4 Cg_exo -74.03 116.72 4.75 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 121.914 1.743 . . . . 0.0 115.715 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.427 ' N ' ' O ' ' A' ' 110' ' ' ALA . 0.5 OUTLIER -129.04 165.78 20.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.418 -179.278 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.819 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 5.8 mp0 -107.72 135.19 49.56 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.877 ' O ' HD23 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -132.39 142.26 49.22 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.679 0.752 . . . . 0.0 111.911 -179.137 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.671 ' HB3' ' CE ' ' A' ' 107' ' ' LYS . 15.2 pt-20 -94.13 123.44 37.51 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.877 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.871 ' CB ' ' HG ' ' A' ' 126' ' ' LEU . . . -115.85 134.47 54.96 Favored 'General case' 0 C--O 1.22 -0.489 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.572 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 1.042 ' HB3' ' HZ1' ' A' ' 105' ' ' LYS . 38.7 m-20 -127.04 162.19 26.64 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.758 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 48.42 -134.77 19.25 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 120.436 1.471 . . . . 0.0 115.491 177.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.913 ' H ' HD21 ' A' ' 125' ' ' LEU . 2.6 mm? -53.84 -35.17 61.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.052 -0.574 . . . . 0.0 111.34 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.871 ' HG ' ' CB ' ' A' ' 122' ' ' ALA . 3.7 tp -70.22 -52.34 23.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.372 0.606 . . . . 0.0 109.81 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.719 ' HB3' ' CA ' ' A' ' 123' ' ' ASP . . . -58.93 -42.94 90.91 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.328 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.758 HG12 ' O ' ' A' ' 124' ' ' GLY . 47.1 mm -67.17 -56.11 14.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.993 ' HB2' H112 ' A' ' 149' ' ' BB2 . 31.4 p -56.47 -50.21 72.4 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.619 HG21 ' N ' ' A' ' 131' ' ' GLN . 19.1 tt -58.91 -44.24 90.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.155 -178.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.857 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 23.1 pt20 -68.16 -37.77 81.38 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.071 178.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.72 ' HA ' ' OD2' ' A' ' 135' ' ' ASP . 10.9 t-160 -56.58 -50.0 73.23 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.57 0.7 . . . . 0.0 110.105 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.934 ' O ' HD22 ' A' ' 137' ' ' LEU . 3.2 mm-40 -60.1 -42.24 94.27 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.576 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.875 ' HA ' HD21 ' A' ' 137' ' ' LEU . 74.2 mtp -57.18 -48.74 77.99 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.279 0.562 . . . . 0.0 111.059 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.89 ' O ' HG13 ' A' ' 138' ' ' VAL . 3.3 p30 -66.38 -46.53 76.35 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.416 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.885 ' HA ' HD12 ' A' ' 141' ' ' LEU . 10.7 t-80 -56.12 -51.46 67.84 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.489 0.661 . . . . 0.0 110.768 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.934 HD22 ' O ' ' A' ' 133' ' ' GLU . 1.2 pp -61.35 -30.16 70.35 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.955 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.946 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 14.6 p -86.58 25.94 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-O 122.292 1.044 . . . . 0.0 109.549 176.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.598 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 59.32 15.31 30.43 Favored Glycine 0 CA--C 1.49 -1.511 0 CA-C-N 113.395 -1.73 . . . . 0.0 113.359 176.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.946 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 9.9 ptmt -110.15 119.68 40.06 Favored 'General case' 0 N--CA 1.424 -1.746 0 C-N-CA 119.617 -0.833 . . . . 0.0 108.932 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.885 HD12 ' HA ' ' A' ' 136' ' ' HIS . 9.4 mp -133.56 138.8 46.22 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.336 -0.853 . . . . 0.0 108.753 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.591 ' CD2' ' HG2' ' A' ' 101' ' ' PRO . 20.1 m-85 -63.81 -33.25 75.26 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 121.985 -0.447 . . . . 0.0 111.661 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.945 ' HA ' HD23 ' A' ' 146' ' ' LEU . 16.1 tpt -52.01 -23.88 5.82 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.336 0.589 . . . . 0.0 111.213 178.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.854 ' HB2' ' NH1' ' A' ' 14' ' ' ARG . 38.8 t70 -49.23 -25.04 2.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.681 -178.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -130.05 46.19 2.69 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.141 -177.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.945 HD23 ' HA ' ' A' ' 143' ' ' MET . 3.7 mm? -91.28 140.75 29.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.902 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 48.1 t . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.194 -0.908 . . . . 0.0 111.024 179.453 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' BB2 . . . . . 0.993 H112 ' HB2' ' A' ' 129' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.579 ' O ' ' HB3' ' A' ' 36' ' ' GLU . 47.4 t . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.841 0.353 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.532 ' CG1' HG21 ' A' ' 37' ' ' THR . 43.2 t -119.78 138.47 50.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.227 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.852 HD21 ' HB ' ' A' ' 51' ' ' VAL . 58.5 tp -77.11 165.74 24.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.404 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -78.82 107.11 11.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.084 0.469 . . . . 0.0 110.271 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.55 ' CG2' HG23 ' A' ' 37' ' ' THR . 39.0 t -89.69 131.58 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.652 -178.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 1.029 ' HB2' HD22 ' A' ' 13' ' ' LEU . 16.7 mt -93.52 141.33 28.59 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.497 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 35.2 m-70 -117.92 145.29 44.77 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.873 HG12 ' CB ' ' A' ' 92' ' ' SER . 49.8 mm -61.0 133.56 92.58 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.229 177.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.66 145.35 69.87 Favored 'Cis proline' 0 C--N 1.353 0.779 0 C-N-CA 124.51 -1.037 . . . . 0.0 111.951 -0.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.968 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 8.8 t70 -165.04 127.1 2.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.402 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 16.1 pt-20 -58.44 -45.79 87.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.658 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.578 ' HB2' HD13 ' A' ' 6' ' ' LEU . 15.1 mmt85 -56.59 -27.97 59.21 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 1.029 HD22 ' HB2' ' A' ' 6' ' ' LEU . 10.0 mt -77.01 -35.09 57.3 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 120.585 1.539 . . . . 0.0 107.972 177.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.76 ' NH1' ' HB3' ' A' ' 14' ' ' ARG . 2.1 mmm180 -89.2 11.18 19.48 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.802 -1.545 . . . . 0.0 109.395 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.719 ' HD3' ' HB3' ' A' ' 54' ' ' HIS . 59.5 tttp -85.6 137.71 32.67 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.568 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.674 ' CG1' HG23 ' A' ' 138' ' ' VAL . 58.4 t -84.1 94.4 3.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.237 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.597 ' HB2' ' CG ' ' A' ' 56' ' ' ARG . . . -54.0 148.31 10.95 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -106.43 132.73 20.66 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.798 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.651 ' HD3' ' CD ' ' A' ' 56' ' ' ARG . 66.1 Cg_endo -78.2 114.72 3.61 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.174 1.916 . . . . 0.0 110.684 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.621 HG12 ' N ' ' A' ' 21' ' ' GLU . 17.8 t -69.14 144.4 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-O 122.521 1.153 . . . . 0.0 113.126 -175.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.621 ' N ' HG12 ' A' ' 20' ' ' VAL . 97.1 mt-10 -63.47 -24.55 67.87 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 113.311 -1.768 . . . . 0.0 111.867 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.49 ' O ' HG13 ' A' ' 20' ' ' VAL . 42.4 tt0 -161.16 140.71 10.51 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.864 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.829 HG22 HD11 ' A' ' 111' ' ' LEU . 2.8 t -78.96 110.95 15.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 1.03 ' H ' HD13 ' A' ' 27' ' ' ILE . 60.8 m-80 -92.98 163.3 13.72 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.613 0.244 . . . . 0.0 110.995 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.586 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -56.04 -30.67 62.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.993 0.425 . . . . 0.0 110.819 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.572 ' O ' HD12 ' A' ' 30' ' ' ILE . 55.7 mt-10 -71.72 -40.07 69.71 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 1.03 HD13 ' H ' ' A' ' 24' ' ' ASN . 58.3 mt -62.7 -46.64 95.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.911 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.551 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 13.1 mt-30 -57.92 -39.23 77.49 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.597 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.586 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 41.0 mmt-85 -60.16 -40.98 91.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.864 0.84 . . . . 0.0 108.987 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.807 ' O ' ' HG3' ' A' ' 34' ' ' MET . 1.6 mp -58.89 -48.61 85.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 114.455 -1.248 . . . . 0.0 112.119 179.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.769 HG11 ' CG2' ' A' ' 71' ' ' VAL . 6.5 t -68.33 -41.81 83.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-O 120.845 0.355 . . . . 0.0 111.448 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.846 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -55.27 -42.36 73.48 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.526 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.515 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 56.8 m-20 -75.95 -30.18 58.58 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.632 176.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.826 ' HG2' HG23 ' A' ' 51' ' ' VAL . 83.7 mtp -59.86 -47.09 87.15 Favored 'General case' 0 C--N 1.347 0.473 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.531 -177.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.846 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 14.4 p90 -69.49 -44.28 71.44 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.776 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 76.6 mt-10 -51.78 -40.66 60.72 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.55 HG23 ' CG2' ' A' ' 5' ' ' VAL . 41.8 m -68.84 -61.92 1.6 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.576 -1.193 . . . . 0.0 107.864 178.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.944 ' HE3' ' HB2' ' A' ' 61' ' ' ASP . 2.8 ttp -46.11 -41.72 12.76 Favored 'General case' 0 CA--C 1.458 -2.581 0 C-N-CA 124.103 0.961 . . . . 0.0 110.21 -170.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.713 ' OH ' ' HA ' ' A' ' 69' ' ' ARG . 48.2 m-85 -69.22 -41.79 76.58 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.328 178.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.483 ' CB ' HG22 ' A' ' 2' ' ' VAL . . . -61.0 -27.45 68.32 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.611 0.72 . . . . 0.0 109.139 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.984 ' HG2' HD12 ' A' ' 91' ' ' LEU . 10.5 tp10 -85.53 -10.69 55.64 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.795 176.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 62.21 28.62 17.15 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.859 0.838 . . . . 0.0 109.95 -176.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -83.43 143.41 21.76 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 114.0 -1.455 . . . . 0.0 111.122 178.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 1.026 HG21 HG22 ' A' ' 62' ' ' VAL . 47.7 mt -78.98 -2.54 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 117.709 0.754 . . . . 0.0 111.976 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.856 ' HA3' ' C10' ' A' ' 149' ' ' BB2 . . . 179.83 133.59 2.03 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-O 119.102 -0.832 . . . . 0.0 111.606 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 1.025 HD12 ' HG ' ' A' ' 91' ' ' LEU . 4.1 tp -124.56 134.55 52.94 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 119.063 1.432 . . . . 0.0 111.329 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -101.06 129.69 46.97 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.644 ' O ' HG21 ' A' ' 51' ' ' VAL . . . -27.21 -56.82 0.09 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 116.099 1.889 . . . . 0.0 116.099 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.669 HG23 ' O ' ' A' ' 137' ' ' LEU . 70.1 p -53.54 -34.38 58.01 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.8 0.81 . . . . 0.0 111.727 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.794 ' NE2' HD23 ' A' ' 91' ' ' LEU . 85.1 mt-30 -64.56 -40.9 96.4 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.347 -1.297 . . . . 0.0 109.947 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.852 ' HB ' HD21 ' A' ' 3' ' ' LEU . 1.0 OUTLIER -87.86 15.73 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.98 ' HA ' HD11 ' A' ' 6' ' ' LEU . 38.2 t70 77.51 33.06 0.41 Allowed 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 176.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.808 HD11 ' O ' ' A' ' 55' ' ' GLN . 1.1 pp -125.93 110.45 23.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 119.155 -1.018 . . . . 0.0 110.301 177.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.719 ' HB3' ' HD3' ' A' ' 15' ' ' LYS . 0.5 OUTLIER -75.91 63.53 1.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.472 -179.109 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.808 ' O ' HD11 ' A' ' 53' ' ' ILE . 69.1 mt-30 -154.53 133.85 12.58 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 114.196 -1.365 . . . . 0.0 108.535 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.784 ' HA ' HD11 ' A' ' 137' ' ' LEU . 54.3 mtp85 -64.37 72.46 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -177.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.784 ' O ' ' HE1' ' A' ' 34' ' ' MET . 7.1 mm -115.27 125.03 72.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.914 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 2.1 pp -131.28 147.77 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.578 HG22 ' H ' ' A' ' 46' ' ' LEU . 33.4 m -127.72 139.74 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.485 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.994 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 7.4 mm -115.11 151.41 16.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.692 0.758 . . . . 0.0 110.033 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.944 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 10.7 t70 -138.99 39.88 2.14 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.079 -178.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 1.026 HG22 HG21 ' A' ' 44' ' ' ILE . 33.1 t -105.92 111.47 35.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.359 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.728 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 61.9 m -34.1 89.77 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -175.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.828 ' HG3' HD11 ' A' ' 70' ' ' LEU . 55.5 mt-10 -62.08 -26.84 68.51 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 113.987 -1.461 . . . . 0.0 111.571 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.571 ' ND2' ' HG2' ' A' ' 66' ' ' ARG . 50.6 t30 -168.16 -85.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 122.221 1.01 . . . . 0.0 109.576 177.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.571 ' HG2' ' ND2' ' A' ' 65' ' ' ASN . 26.7 mmm180 -110.37 -55.66 2.44 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 114.093 -1.412 . . . . 0.0 111.107 178.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -99.5 131.68 45.34 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.752 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.728 ' HG2' ' HA ' ' A' ' 63' ' ' SER . 47.7 mt-10 -91.38 132.26 36.32 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.072 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.713 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 72.9 ttt180 175.39 71.79 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.413 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.994 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 6.1 mp -102.47 132.54 48.44 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.911 HG23 ' HB2' ' A' ' 113' ' ' ARG . 9.6 p -133.91 131.05 56.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.367 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.914 ' HB2' ' CD1' ' A' ' 58' ' ' ILE . 93.5 mt -141.16 139.04 33.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.924 -0.125 . . . . 0.0 110.999 178.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.992 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.7 mp -119.53 135.71 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-O 120.595 0.236 . . . . 0.0 110.944 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.688 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 8.1 m120 55.17 34.68 0.25 Allowed Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.822 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 88.8 Cg_exo -55.91 148.02 59.46 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.649 2.233 . . . . 0.0 113.482 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.426 ' HG3' HD13 ' A' ' 78' ' ' LEU . 15.6 pt-20 -136.93 143.28 42.82 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 1.022 HD11 ' HZ1' ' A' ' 80' ' ' LYS . 1.7 tt -80.47 135.04 36.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.782 0.801 . . . . 0.0 111.544 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.877 ' N ' HD21 ' A' ' 77' ' ' LEU . 7.3 mp -110.45 -40.2 4.7 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.335 -1.302 . . . . 0.0 112.062 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.526 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 42.2 tt0 -160.34 154.0 22.5 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.179 0.514 . . . . 0.0 111.538 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 1.022 ' HZ1' HD11 ' A' ' 77' ' ' LEU . 9.6 ptpp? -147.83 150.63 34.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.212 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.5 t -160.58 144.65 13.9 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.548 0.213 . . . . 0.0 110.958 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.774 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 81.24 169.85 42.6 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.85 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 102' ' ' ARG . 87.9 tt0 -147.38 113.6 5.88 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 117.788 0.794 . . . . 0.0 113.116 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.604 ' HG1' HD12 ' A' ' 128' ' ' ILE . 1.4 p -98.72 159.9 14.63 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.646 ' CA ' HD22 ' A' ' 99' ' ' LEU . . . -137.87 103.02 0.4 Allowed Glycine 0 C--N 1.317 -0.528 0 CA-C-N 113.193 -1.821 . . . . 0.0 112.1 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.695 ' HB ' ' NH2' ' A' ' 102' ' ' ARG . 21.2 mt -147.07 138.92 18.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 56.3 mt-10 -71.09 143.47 50.63 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 122.682 1.229 . . . . 0.0 112.211 -178.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.919 ' HG2' ' H27' ' A' ' 149' ' ' BB2 . 93.3 mt-10 -157.8 161.45 38.41 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.581 -1.645 . . . . 0.0 109.754 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.893 ' O ' ' H51' ' A' ' 149' ' ' BB2 . . . -120.24 159.11 15.24 Favored Glycine 0 CA--C 1.501 -0.809 0 C-N-CA 119.44 -1.362 . . . . 0.0 110.184 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.763 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 16.4 m -112.9 138.35 49.89 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.61 0.719 . . . . 0.0 112.207 -177.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 1.042 HD11 H173 ' A' ' 149' ' ' BB2 . 2.3 mm? -48.96 -23.37 1.1 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.375 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.873 ' CB ' HG12 ' A' ' 8' ' ' ILE . 52.7 m -83.89 -34.98 24.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.158 0.504 . . . . 0.0 110.566 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.765 HG22 ' HB2' ' A' ' 96' ' ' GLN . 45.2 mm -85.53 149.68 52.25 Favored Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.418 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.734 ' HD2' ' CG2' ' A' ' 93' ' ' ILE . 91.8 Cg_endo -73.32 48.93 1.6 Allowed 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.605 2.203 . . . . 0.0 114.254 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.541 ' HB2' ' O ' ' A' ' 94' ' ' PRO . 56.3 mt-10 77.05 14.68 1.95 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.765 ' HB2' HG22 ' A' ' 93' ' ' ILE . 25.8 mt-30 -78.83 87.58 4.69 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.855 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 18.2 mtm105 -85.19 133.71 34.18 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.759 0.79 . . . . 0.0 111.87 -178.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.463 ' C ' ' HA ' ' A' ' 87' ' ' GLU . . . -134.53 154.28 51.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.353 -1.294 . . . . 0.0 109.993 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.707 HD23 ' N ' ' A' ' 100' ' ' VAL . 6.5 tt -74.9 136.29 41.45 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.923 HG12 ' HB2' ' A' ' 142' ' ' PHE . 21.0 t -133.46 137.9 30.07 Favored Pre-proline 0 N--CA 1.454 -0.237 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.529 -178.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.703 ' HG2' ' CE2' ' A' ' 145' ' ' TYR . 90.5 Cg_endo -85.66 125.31 2.82 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 121.704 1.603 . . . . 0.0 113.574 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.774 ' HG3' HG23 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -142.05 166.29 25.11 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 113.627 -1.624 . . . . 0.0 110.684 178.643 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.774 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.47 156.05 38.7 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 120.649 0.261 . . . . 0.0 110.519 -178.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -73.2 -44.55 59.55 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.505 -176.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.805 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 81.4 mttt -139.61 138.14 35.91 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 121.658 0.742 . . . . 0.0 109.694 177.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.852 HG12 ' CB ' ' A' ' 80' ' ' LYS . 33.8 m -139.85 138.23 38.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.939 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 1.08 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 53.2 mmtt -107.5 125.72 51.62 Favored 'General case' 0 C--O 1.224 -0.27 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.777 ' CD1' HD11 ' A' ' 130' ' ' ILE . 1.8 pp -131.23 162.97 38.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -177.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.868 ' CG ' HD22 ' A' ' 78' ' ' LEU . 94.9 mtt180 -112.05 139.01 47.92 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.998 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.701 ' HB2' ' HG3' ' A' ' 75' ' ' PRO . . . -158.06 167.3 30.25 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 120.729 0.3 . . . . 0.0 111.095 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.992 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.4 pp -115.48 153.97 30.17 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 177.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.571 ' O ' HD12 ' A' ' 111' ' ' LEU . 10.3 t70 -90.77 163.27 14.52 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.581 -177.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.911 ' HB2' HG23 ' A' ' 71' ' ' VAL . 46.3 ttp180 -51.6 -19.21 1.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.101 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -78.99 -26.67 43.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.532 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.35 35.0 2.77 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.132 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.686 ' HB3' ' HZ3' ' A' ' 116' ' ' LYS . 6.6 mtpm? -128.76 102.83 19.47 Favored Pre-proline 0 C--O 1.238 0.488 0 CA-C-N 116.799 0.3 . . . . 0.0 111.167 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 34.2 Cg_exo -74.14 116.56 4.68 Favored 'Trans proline' 0 C--N 1.36 1.164 0 C-N-CA 122.009 1.806 . . . . 0.0 114.903 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.0 167.92 14.65 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.32 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.708 ' HG2' ' HG2' ' A' ' 109' ' ' ARG . 78.9 mt-10 -107.68 129.99 54.97 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.953 0.406 . . . . 0.0 109.974 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.71 ' CD2' HD13 ' A' ' 72' ' ' LEU . 4.1 pp -127.19 132.91 50.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.347 0.594 . . . . 0.0 112.084 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 1.08 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 23.0 pt-20 -92.0 125.63 36.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.527 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.848 ' O ' ' HB3' ' A' ' 127' ' ' ALA . . . -116.08 135.56 53.83 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.805 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.1 m-20 -126.82 163.62 23.18 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.754 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 46.92 -135.5 10.78 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-N 119.787 1.176 . . . . 0.0 115.811 177.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.717 ' H ' HD21 ' A' ' 125' ' ' LEU . 1.6 pt? -54.73 -32.57 59.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.563 -0.819 . . . . 0.0 111.674 -178.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.651 HD11 ' C ' ' A' ' 126' ' ' LEU . 0.5 OUTLIER -70.89 -53.9 13.42 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.743 179.88 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.848 ' HB3' ' O ' ' A' ' 122' ' ' ALA . . . -58.92 -42.87 90.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.492 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.774 HG23 ' HG3' ' A' ' 102' ' ' ARG . 49.7 mm -62.52 -55.05 26.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.43 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.915 ' HB2' ' H91' ' A' ' 149' ' ' BB2 . 30.4 p -60.47 -51.57 68.92 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.777 HD11 ' CD1' ' A' ' 108' ' ' ILE . 20.8 tt -60.08 -42.06 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 111.445 0.165 . . . . 0.0 111.445 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.675 ' HG2' ' O ' ' A' ' 127' ' ' ALA . 20.9 pt20 -67.24 -41.68 85.23 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.607 ' CD2' ' HN1' ' A' ' 149' ' ' BB2 . 65.4 t60 -57.83 -44.8 86.7 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.672 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.842 ' O ' HD21 ' A' ' 137' ' ' LEU . 3.8 mm-40 -60.45 -45.37 93.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 118.902 -0.57 . . . . 0.0 111.814 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.921 ' HA ' HD23 ' A' ' 137' ' ' LEU . 36.9 mtm -56.7 -47.69 79.36 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 119.06 0.845 . . . . 0.0 109.913 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.857 ' O ' HG12 ' A' ' 138' ' ' VAL . 30.9 m-20 -61.83 -49.17 77.37 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.98 178.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.44 ' CE1' ' CG ' ' A' ' 50' ' ' GLN . 12.2 t-80 -56.27 -51.81 66.79 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 121.739 -0.601 . . . . 0.0 110.908 -179.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.921 HD23 ' HA ' ' A' ' 134' ' ' MET . 1.3 pp -60.4 -30.93 69.91 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.481 -0.782 . . . . 0.0 111.775 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.857 HG12 ' O ' ' A' ' 135' ' ' ASP . 14.9 p -80.49 21.05 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 CA-C-O 123.208 1.48 . . . . 0.0 108.947 175.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.841 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 69.27 -2.37 9.98 Favored Glycine 0 CA--C 1.492 -1.377 0 CA-C-N 111.723 -2.49 . . . . 0.0 112.452 176.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.744 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 1.3 ptmt -88.68 117.14 27.45 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.556 HD13 ' C ' ' A' ' 140' ' ' LYS . 6.3 mp -113.44 168.76 9.47 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 121.827 -0.546 . . . . 0.0 110.852 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.923 ' HB2' HG12 ' A' ' 100' ' ' VAL . 31.3 p90 -52.93 -39.15 62.62 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.634 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.424 ' HE3' ' HB2' ' A' ' 143' ' ' MET . 46.9 tpp -54.06 -39.25 66.08 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.246 0.546 . . . . 0.0 110.666 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -55.05 -22.65 16.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.21 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.703 ' CE2' ' HG2' ' A' ' 101' ' ' PRO . 19.9 t80 -108.85 -12.63 14.88 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.93 -178.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.554 HD22 ' HD1' ' A' ' 142' ' ' PHE . 6.9 mp -83.68 154.71 23.52 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.992 -0.442 . . . . 0.0 110.794 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 40.2 t . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.339 -0.838 . . . . 0.0 111.014 179.601 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' BB2 . . . . . 1.042 H173 HD11 ' A' ' 91' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.859 0.361 . . . . 0.0 111.216 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.749 HG12 ' HA ' ' A' ' 37' ' ' THR . 31.5 m -84.19 137.28 21.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.378 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 1.034 HD23 HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -79.09 -141.25 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -112.2 106.83 15.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.953 0.406 . . . . 0.0 110.617 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.733 HG11 HD11 ' A' ' 91' ' ' LEU . 48.2 t -89.19 126.23 42.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.518 0.675 . . . . 0.0 111.47 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.993 ' HB2' HD23 ' A' ' 13' ' ' LEU . 23.1 mt -83.49 141.99 31.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.603 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.772 ' HA ' ' HB3' ' A' ' 92' ' ' SER . 1.7 m80 -111.48 145.48 38.94 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.959 HD12 HD12 ' A' ' 13' ' ' LEU . 42.5 mm -57.77 145.41 70.77 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.279 178.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.427 ' CA ' HG23 ' A' ' 8' ' ' ILE . 73.8 Cg_endo -92.14 51.68 1.02 Allowed 'Cis proline' 0 C--N 1.353 0.81 0 C-N-CA 124.442 -1.066 . . . . 0.0 112.942 0.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.877 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 9.4 t0 -52.72 134.64 36.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.951 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -58.62 -44.75 90.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.514 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.665 ' HB2' HD11 ' A' ' 6' ' ' LEU . 11.3 mtt85 -58.91 -24.19 62.1 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 1.013 HD11 ' HG ' ' A' ' 92' ' ' SER . 11.6 mt -75.42 -33.13 60.92 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 120.205 1.366 . . . . 0.0 108.3 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.661 HH21 ' HE3' ' A' ' 143' ' ' MET . 22.8 mmt180 -92.11 8.02 39.79 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 113.841 -1.527 . . . . 0.0 109.397 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.42 ' HD3' ' HB3' ' A' ' 54' ' ' HIS . 88.5 tttt -89.86 148.96 22.86 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.186 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 66.8 t -83.67 126.23 40.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.091 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.802 ' HB2' ' CG ' ' A' ' 56' ' ' ARG . . . -83.53 147.8 27.57 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.297 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.732 ' HD3' ' CD ' ' A' ' 19' ' ' PRO . 5.7 tmtm? -110.48 132.31 21.61 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.79 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 63.6 Cg_endo -77.62 116.14 4.0 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.378 2.052 . . . . 0.0 111.732 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.624 HG12 ' N ' ' A' ' 21' ' ' GLU . 22.0 t -68.01 144.95 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 CA-C-O 122.869 1.319 . . . . 0.0 113.087 -175.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.624 ' N ' HG12 ' A' ' 20' ' ' VAL . 55.6 mt-10 -63.73 -29.4 70.62 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 112.893 -1.958 . . . . 0.0 111.897 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.509 ' O ' HG13 ' A' ' 20' ' ' VAL . 88.8 tt0 -157.11 145.05 19.19 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.8 -178.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.76 HG21 HD13 ' A' ' 111' ' ' LEU . 3.5 t -79.41 105.18 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.814 ' HB2' HG13 ' A' ' 27' ' ' ILE . 2.1 m120 -87.05 153.08 21.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.908 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.456 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -54.57 -30.23 53.69 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.452 0.644 . . . . 0.0 110.207 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -72.82 -37.63 67.42 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.814 HG13 ' HB2' ' A' ' 24' ' ' ASN . 67.7 mt -67.0 -36.36 76.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.355 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -68.33 -39.49 81.92 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.372 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 40.1 mmt180 -64.09 -38.86 92.6 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.768 ' CG2' HD11 ' A' ' 53' ' ' ILE . 2.9 mt -55.7 -49.19 75.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.614 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.645 ' CG1' HG22 ' A' ' 71' ' ' VAL . 19.8 t -66.33 -40.97 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 121.135 0.493 . . . . 0.0 110.941 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.841 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 26.5 m-20 -53.84 -46.27 71.17 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.575 -178.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.504 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 1.5 m-20 -74.54 -30.11 61.63 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.907 176.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.765 ' HG3' ' O ' ' A' ' 30' ' ' ILE . 85.2 mtp -60.21 -46.31 90.18 Favored 'General case' 0 C--N 1.345 0.408 0 C-N-CA 120.566 -0.454 . . . . 0.0 109.841 -176.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.841 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 11.9 p90 -69.79 -44.76 69.41 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.609 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 31.8 mm-40 -53.34 -39.23 63.96 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.799 ' OG1' HD22 ' A' ' 3' ' ' LEU . 76.9 m -70.51 -60.4 2.28 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 118.28 -1.368 . . . . 0.0 108.613 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 1.032 ' HE3' ' HB2' ' A' ' 61' ' ' ASP . 2.6 ttp -46.76 -41.03 14.61 Favored 'General case' 0 CA--C 1.463 -2.378 0 C-N-CA 124.101 0.96 . . . . 0.0 109.958 -172.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.702 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 60.5 m-85 -70.32 -42.06 72.43 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.312 177.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 37' ' ' THR . . . -61.07 -24.86 66.53 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.577 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 1.047 ' HG2' HD21 ' A' ' 91' ' ' LEU . 3.1 tp10 -88.94 -11.19 45.14 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 114.345 -1.298 . . . . 0.0 108.337 177.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 64.11 26.68 14.0 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.7 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.87 142.52 23.5 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 113.89 -1.504 . . . . 0.0 110.596 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 1.0 HG23 HG21 ' A' ' 62' ' ' VAL . 46.1 mm -79.52 1.2 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 117.611 0.706 . . . . 0.0 111.997 -178.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.845 ' HA3' ' C10' ' A' ' 149' ' ' BB2 . . . 176.38 137.86 2.73 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 118.838 -0.979 . . . . 0.0 111.371 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.908 HD23 ' CG1' ' A' ' 51' ' ' VAL . 10.7 tp -126.38 134.54 51.02 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-N 119.505 1.653 . . . . 0.0 111.265 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -98.83 132.15 44.4 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.766 ' O ' HG23 ' A' ' 51' ' ' VAL . . . -31.22 -54.88 0.23 Allowed 'General case' 0 C--N 1.343 0.285 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.558 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 80.6 p -52.86 -36.07 58.53 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.891 0.853 . . . . 0.0 111.031 -177.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 44.1 mt-30 -65.84 -40.56 91.88 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.328 -1.306 . . . . 0.0 110.202 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 1.034 HG13 HD23 ' A' ' 3' ' ' LEU . 1.0 OUTLIER -83.81 16.08 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 179.558 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.905 ' HA ' HD12 ' A' ' 6' ' ' LEU . 36.1 t70 76.93 27.67 0.7 Allowed 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 177.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.837 HD13 ' HB ' ' A' ' 57' ' ' ILE . 13.4 pt -122.26 110.94 28.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 C-N-CA 119.036 -1.066 . . . . 0.0 111.386 177.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.42 ' HB3' ' HD3' ' A' ' 15' ' ' LYS . 7.4 p80 -76.33 52.11 0.74 Allowed 'General case' 0 N--CA 1.46 0.075 0 CA-C-O 122.241 1.019 . . . . 0.0 109.767 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.43 ' O ' HG12 ' A' ' 57' ' ' ILE . 25.7 mt-30 -140.6 132.31 27.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 113.817 -1.538 . . . . 0.0 107.752 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.861 ' HG2' ' CD1' ' A' ' 137' ' ' LEU . 99.1 mtt180 -61.78 68.1 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -178.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.837 ' HB ' HD13 ' A' ' 53' ' ' ILE . 10.9 mm -111.88 121.65 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.898 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 2.2 pp -129.69 145.74 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -177.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.532 HG21 ' H ' ' A' ' 46' ' ' LEU . 32.6 m -126.0 139.88 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.293 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 1.011 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 11.9 mm -115.45 151.88 17.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.688 0.756 . . . . 0.0 110.154 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 1.032 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 34.9 t70 -141.82 37.78 1.63 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.391 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 1.0 HG21 HG23 ' A' ' 44' ' ' ILE . 38.8 t -99.79 108.12 22.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.378 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.709 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 79.1 p -34.08 86.87 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -175.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 62' ' ' VAL . 38.3 tt0 -61.3 -22.76 65.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 113.627 -1.624 . . . . 0.0 111.899 178.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -164.75 -74.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.627 0.727 . . . . 0.0 110.02 177.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.499 ' HG2' HH11 ' A' ' 66' ' ' ARG . 39.1 mmt-85 -129.24 -48.27 1.2 Allowed 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.954 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -105.7 127.74 53.25 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.256 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.709 ' HG2' ' HA ' ' A' ' 63' ' ' SER . 48.1 mt-10 -87.17 139.93 30.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.189 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.698 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER 173.89 66.76 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.76 0.314 . . . . 0.0 111.671 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 1.011 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 4.0 mm? -103.84 132.64 49.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.937 0.399 . . . . 0.0 111.817 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.717 HG21 ' HB2' ' A' ' 113' ' ' ARG . 12.3 p -134.58 134.46 54.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.226 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.898 ' HB2' ' CD1' ' A' ' 58' ' ' ILE . 3.0 mm? -142.14 146.55 35.47 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.531 -0.174 . . . . 0.0 110.531 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.993 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.8 mp -122.92 136.44 59.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.732 0.301 . . . . 0.0 110.595 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.693 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 6.9 m120 51.65 37.62 0.44 Allowed Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.857 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 91.1 Cg_exo -57.51 148.26 73.7 Favored 'Trans proline' 0 N--CA 1.488 1.152 0 C-N-CA 123.046 2.497 . . . . 0.0 114.302 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -137.49 142.95 41.5 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.735 ' N ' ' HE2' ' A' ' 134' ' ' MET . 10.2 tp -80.28 136.84 36.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.109 0.481 . . . . 0.0 111.015 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.821 ' CD2' ' HG3' ' A' ' 109' ' ' ARG . 2.7 mm? -109.94 -44.48 3.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.068 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.537 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 17.2 tp10 -153.34 144.18 22.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.05 0.452 . . . . 0.0 111.932 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.967 ' HA ' HG13 ' A' ' 106' ' ' VAL . 19.3 ptpt -138.14 142.53 40.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.347 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.1 p -151.75 150.49 30.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.854 0.359 . . . . 0.0 111.052 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.614 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 76.91 143.72 1.64 Allowed Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.524 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -109.87 113.8 26.84 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.81 0.814 . . . . 0.0 111.896 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.992 ' HG1' HD11 ' A' ' 128' ' ' ILE . 1.7 p -117.21 160.99 20.2 Favored 'General case' 0 CA--C 1.487 -1.447 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.737 ' CA ' HD21 ' A' ' 99' ' ' LEU . . . -154.03 124.06 1.5 Allowed Glycine 0 C--N 1.314 -0.69 0 CA-C-N 112.536 -2.12 . . . . 0.0 111.228 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.728 HD11 ' O ' ' A' ' 85' ' ' GLY . 48.8 mm -147.07 137.52 17.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 117.507 0.653 . . . . 0.0 111.46 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 56.0 mt-10 -71.38 139.78 49.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 123.21 1.481 . . . . 0.0 112.606 -176.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.949 ' HG2' ' H27' ' A' ' 149' ' ' BB2 . 40.6 mt-10 -155.78 166.25 34.05 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 112.376 -2.193 . . . . 0.0 111.901 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.745 ' N ' ' HG2' ' A' ' 97' ' ' ARG . . . -120.88 168.27 14.04 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.784 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 87.3 m -113.46 142.74 45.55 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.34 0.57 . . . . 0.0 111.041 -177.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 1.047 HD21 ' HG2' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -53.36 -15.54 1.05 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.511 -179.417 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 1.013 ' HG ' HD11 ' A' ' 13' ' ' LEU . 4.3 m -100.77 -33.48 10.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.2 0.524 . . . . 0.0 110.471 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 1.022 HG23 ' HD2' ' A' ' 94' ' ' PRO . 57.4 mt -85.54 150.78 54.71 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.586 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 1.022 ' HD2' HG23 ' A' ' 93' ' ' ILE . 66.0 Cg_endo -62.63 -146.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.414 2.076 . . . . 0.0 111.812 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.415 ' H ' ' HB2' ' A' ' 94' ' ' PRO . 23.6 pt-20 -79.63 12.73 2.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.13 0.49 . . . . 0.0 110.986 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.53 ' HG2' ' HG2' ' A' ' 94' ' ' PRO . 10.1 mm-40 -78.95 81.85 5.19 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.127 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.754 HH11 H232 ' A' ' 149' ' ' BB2 . 84.7 mtm180 -86.44 133.33 33.77 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.142 0.496 . . . . 0.0 110.18 178.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -125.73 148.93 48.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.796 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.737 HD21 ' CA ' ' A' ' 85' ' ' GLY . 7.4 tt -76.08 113.61 13.8 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.979 0.895 . . . . 0.0 111.208 -177.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 1.015 HG22 ' HB3' ' A' ' 142' ' ' PHE . 14.0 p -103.7 129.21 25.77 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 114.572 -1.194 . . . . 0.0 111.575 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.616 ' HA ' ' O ' ' A' ' 84' ' ' THR . 87.8 Cg_endo -83.55 126.61 4.15 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 122.67 2.247 . . . . 0.0 113.844 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 1.048 ' HG2' HD13 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -143.63 166.96 23.41 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.595 1.158 . . . . 0.0 109.288 179.381 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.646 ' O ' HD12 ' A' ' 128' ' ' ILE . . . -68.18 155.33 39.86 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.914 0.388 . . . . 0.0 110.302 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -73.25 -40.37 64.69 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.483 -175.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.72 ' HB3' ' OD1' ' A' ' 123' ' ' ASP . 96.0 mttt -140.03 140.91 36.3 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 176.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.967 HG13 ' HA ' ' A' ' 80' ' ' LYS . 19.4 m -152.94 141.54 14.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.836 -1.075 . . . . 0.0 112.58 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.891 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 31.9 mmtm -107.52 127.03 53.26 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.88 HD11 HD11 ' A' ' 130' ' ' ILE . 1.8 pp -134.57 150.95 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -176.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.821 ' HG3' ' CD2' ' A' ' 78' ' ' LEU . 43.7 mtm180 -103.42 140.5 37.38 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-O 122.277 1.037 . . . . 0.0 111.602 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.691 ' HB2' ' HB3' ' A' ' 72' ' ' LEU . . . -160.54 168.73 24.41 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.779 -176.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.993 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.3 pp -116.15 151.21 36.1 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.766 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 20.5 t70 -85.53 163.84 18.15 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.742 -176.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.717 ' HB2' HG21 ' A' ' 71' ' ' VAL . 13.2 ttp-105 -52.71 -19.29 2.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.046 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -79.41 -26.12 41.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.434 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.588 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 106.77 35.99 2.68 Favored Glycine 0 C--N 1.34 0.792 0 C-N-CA 120.168 -1.015 . . . . 0.0 113.545 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -128.57 102.93 19.87 Favored Pre-proline 0 C--O 1.238 0.5 0 CA-C-N 116.859 0.33 . . . . 0.0 110.694 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.581 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 32.1 Cg_exo -72.67 115.2 4.25 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 121.307 1.338 . . . . 0.0 114.563 -177.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.766 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 10.4 p90 -127.15 168.75 14.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.551 -178.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 109' ' ' ARG . 3.0 mp0 -107.1 130.11 54.73 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.694 HD21 HD12 ' A' ' 72' ' ' LEU . 4.3 pp -122.81 132.56 54.26 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.416 -178.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.891 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 15.3 pt-20 -92.17 123.97 35.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.789 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 1.057 ' HB3' HD12 ' A' ' 126' ' ' LEU . . . -118.58 133.64 55.71 Favored 'General case' 0 C--O 1.22 -0.472 0 C-N-CA 120.456 -0.498 . . . . 0.0 112.13 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.72 ' OD1' ' HB3' ' A' ' 105' ' ' LYS . 31.5 m-20 -127.38 161.54 28.43 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.55 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 55.1 -140.59 38.86 Favored Glycine 0 C--N 1.346 1.109 0 C-N-CA 118.94 -1.6 . . . . 0.0 115.145 177.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.525 ' H ' ' CD1' ' A' ' 125' ' ' LEU . 4.6 mp -54.9 -30.69 58.86 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.831 -0.684 . . . . 0.0 111.62 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 1.057 HD12 ' HB3' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -71.22 -51.77 22.79 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.677 0.751 . . . . 0.0 109.209 179.607 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.75 ' O ' ' HG3' ' A' ' 131' ' ' GLN . . . -60.22 -47.01 87.77 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.767 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 1.048 HD13 ' HG2' ' A' ' 102' ' ' ARG . 46.9 mm -63.69 -55.01 25.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -177.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.969 ' HB3' ' H91' ' A' ' 149' ' ' BB2 . 81.8 m -58.19 -48.61 79.79 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.88 HD11 HD11 ' A' ' 108' ' ' ILE . 20.0 tt -59.01 -40.93 81.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.854 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.776 ' CD ' HG22 ' A' ' 106' ' ' VAL . 69.2 mt-30 -67.59 -40.76 84.81 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.463 ' HD1' ' NH2' ' A' ' 102' ' ' ARG . 79.7 t60 -57.72 -45.87 85.16 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.021 0.439 . . . . 0.0 110.026 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.894 ' O ' HD21 ' A' ' 137' ' ' LEU . 4.2 mm-40 -59.99 -42.57 94.48 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.227 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.908 ' HA ' HD23 ' A' ' 137' ' ' LEU . 3.0 mmm -56.83 -47.55 80.06 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.772 0.796 . . . . 0.0 109.999 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.861 ' O ' HG13 ' A' ' 138' ' ' VAL . 32.3 m-20 -65.4 -48.37 73.07 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.701 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.713 ' CE1' HD21 ' A' ' 141' ' ' LEU . 16.2 t-80 -57.38 -50.77 71.93 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.722 -0.611 . . . . 0.0 111.051 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.908 HD23 ' HA ' ' A' ' 134' ' ' MET . 1.6 pp -60.7 -30.7 70.11 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.812 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.892 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 11.9 p -84.19 24.83 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-O 122.412 1.101 . . . . 0.0 109.957 177.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 66.76 3.03 19.45 Favored Glycine 0 CA--C 1.487 -1.673 0 CA-C-N 113.423 -1.717 . . . . 0.0 113.262 176.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.892 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 9.4 ptmt -95.45 133.86 38.94 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.834 HD12 ' C ' ' A' ' 140' ' ' LYS . 11.1 mp -135.99 153.03 51.51 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 1.015 ' HB3' HG22 ' A' ' 100' ' ' VAL . 8.5 p90 -53.39 -33.84 55.39 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.661 ' HE3' HH21 ' A' ' 14' ' ' ARG . 57.2 ttp -59.99 -27.32 66.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.154 0.502 . . . . 0.0 110.867 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.493 ' HB2' ' NH1' ' A' ' 14' ' ' ARG . 61.8 t0 -58.7 -25.29 62.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.159 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -116.43 10.29 14.59 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.563 HD12 ' O ' ' A' ' 142' ' ' PHE . 6.5 mp -91.22 143.59 26.5 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.788 0.328 . . . . 0.0 111.42 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 48.2 t . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.9 179.448 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' BB2 . . . . . 0.969 ' H91' ' HB3' ' A' ' 129' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 79.2 p . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.852 0.358 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.713 ' CG1' HG21 ' A' ' 37' ' ' THR . 37.2 t -84.24 136.21 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.833 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.844 HD13 ' O ' ' A' ' 51' ' ' VAL . 3.4 pp -78.75 -175.97 4.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.746 0.308 . . . . 0.0 110.548 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.768 ' N ' HD11 ' A' ' 3' ' ' LEU . 52.2 tt0 -83.25 107.62 15.91 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.817 0.341 . . . . 0.0 110.643 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.463 HG23 HG23 ' A' ' 37' ' ' THR . 39.1 t -89.56 131.5 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 121.229 0.538 . . . . 0.0 112.235 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 1.053 ' HB2' HD22 ' A' ' 13' ' ' LEU . 14.7 mt -88.31 140.25 29.67 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.931 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.605 ' HB3' ' O ' ' A' ' 92' ' ' SER . 41.4 m-70 -116.71 144.33 44.56 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.795 ' CD1' HD11 ' A' ' 13' ' ' LEU . 43.5 mm -62.95 135.56 96.2 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.999 177.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.45 ' HA ' HG21 ' A' ' 8' ' ' ILE . 84.2 Cg_endo -80.2 145.5 71.87 Favored 'Cis proline' 0 C--N 1.354 0.818 0 C-N-CA 124.387 -1.089 . . . . 0.0 112.006 -0.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.974 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 8.9 t70 -165.88 128.44 2.02 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.426 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.434 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 24.1 pt-20 -58.19 -46.0 86.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.592 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.568 ' O ' ' HB ' ' A' ' 49' ' ' THR . 20.2 mmt-85 -56.09 -28.73 58.9 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 1.053 HD22 ' HB2' ' A' ' 6' ' ' LEU . 10.1 mt -76.72 -34.27 58.13 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 120.339 1.427 . . . . 0.0 108.786 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.807 ' NH1' ' HB3' ' A' ' 14' ' ' ARG . 1.7 mmm180 -91.99 11.1 26.28 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.029 178.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.827 ' HD3' ' N ' ' A' ' 16' ' ' VAL . 11.2 tmtt? -84.3 139.37 32.36 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.482 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.959 HG12 HG23 ' A' ' 138' ' ' VAL . 46.0 t -84.29 93.93 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.79 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.645 ' HB2' ' CG ' ' A' ' 56' ' ' ARG . . . -53.88 147.85 11.38 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.337 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -104.25 131.24 22.1 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.746 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.545 ' HD3' ' HD3' ' A' ' 56' ' ' ARG . 69.2 Cg_endo -77.52 114.67 3.75 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.097 1.864 . . . . 0.0 110.56 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.638 HG13 ' N ' ' A' ' 21' ' ' GLU . 19.7 t -69.36 144.57 13.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 122.624 1.202 . . . . 0.0 113.313 -175.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.638 ' N ' HG13 ' A' ' 20' ' ' VAL . 55.1 mt-10 -66.12 -24.68 66.72 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 113.266 -1.788 . . . . 0.0 111.915 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.553 ' O ' HG11 ' A' ' 20' ' ' VAL . 88.7 tt0 -160.96 141.0 10.98 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.658 0.266 . . . . 0.0 110.734 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.868 ' CG2' HD22 ' A' ' 111' ' ' LEU . 2.8 t -79.18 109.82 14.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 1.058 ' H ' HD11 ' A' ' 27' ' ' ILE . 60.1 m-80 -92.07 164.55 13.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.52 0.2 . . . . 0.0 110.94 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.708 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -56.22 -30.72 62.72 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.176 0.513 . . . . 0.0 110.762 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -71.52 -39.6 70.64 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 177.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 1.058 HD11 ' H ' ' A' ' 24' ' ' ASN . 59.6 mt -63.26 -47.24 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.132 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.506 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 11.5 mt-30 -57.83 -39.25 77.2 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-O 120.896 0.379 . . . . 0.0 110.701 178.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.708 ' HG3' ' O ' ' A' ' 25' ' ' ALA . 99.6 mtt180 -60.3 -39.86 88.44 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.812 ' O ' ' HG3' ' A' ' 34' ' ' MET . 3.3 mt -60.06 -48.54 87.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 114.641 -1.163 . . . . 0.0 112.108 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.717 HG12 ' CG2' ' A' ' 71' ' ' VAL . 12.5 t -68.49 -42.63 83.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-O 120.862 0.363 . . . . 0.0 111.378 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.837 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -55.17 -42.02 72.61 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.516 -179.705 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.488 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 23.4 m-20 -75.23 -30.3 60.52 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.348 175.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.812 ' HG3' ' O ' ' A' ' 30' ' ' ILE . 86.5 mtp -60.54 -46.83 88.73 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.857 -177.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.837 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 14.1 p90 -69.38 -44.43 71.52 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.772 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 34.0 mt-10 -51.36 -42.1 61.09 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.713 HG21 ' CG1' ' A' ' 2' ' ' VAL . 73.7 m -69.3 -62.08 1.53 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.493 -1.23 . . . . 0.0 108.236 178.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 1.042 ' HE3' ' HB2' ' A' ' 61' ' ' ASP . 3.4 ttp -45.91 -42.53 12.86 Favored 'General case' 0 CA--C 1.454 -2.739 0 C-N-CA 124.183 0.993 . . . . 0.0 110.563 -170.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.681 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 50.2 m-85 -69.42 -41.58 76.18 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.569 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.608 ' CB ' HG21 ' A' ' 2' ' ' VAL . . . -60.8 -28.69 68.96 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.796 0.807 . . . . 0.0 109.003 178.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 1.064 ' HG2' HD13 ' A' ' 91' ' ' LEU . 11.0 tp10 -84.33 -10.11 57.88 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 114.248 -1.342 . . . . 0.0 108.788 177.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 61.57 26.12 15.89 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 121.914 0.864 . . . . 0.0 109.987 -176.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.73 142.21 23.37 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 113.993 -1.458 . . . . 0.0 110.757 178.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 1.015 HD13 H251 ' A' ' 149' ' ' BB2 . 49.2 mt -78.57 -2.54 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 117.702 0.751 . . . . 0.0 111.925 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.865 ' HA3' ' C10' ' A' ' 149' ' ' BB2 . . . -179.28 133.33 2.04 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-O 119.114 -0.826 . . . . 0.0 111.794 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.993 HD12 ' HG ' ' A' ' 91' ' ' LEU . 5.8 tp -124.45 133.99 53.2 Favored 'General case' 0 C--N 1.351 0.632 0 CA-C-N 119.085 1.442 . . . . 0.0 111.278 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -100.44 129.27 46.38 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.218 0.207 . . . . 0.0 111.236 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.62 ' CB ' HD11 ' A' ' 53' ' ' ILE . . . -27.06 -55.74 0.08 Allowed 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 116.126 1.898 . . . . 0.0 116.126 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.686 HG21 ' O ' ' A' ' 137' ' ' LEU . 66.2 p -53.29 -33.87 55.02 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.882 0.848 . . . . 0.0 112.032 -178.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.842 ' NE2' HD23 ' A' ' 91' ' ' LEU . 82.4 mt-30 -63.93 -42.68 97.3 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.15 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.844 ' O ' HD13 ' A' ' 3' ' ' LEU . 0.9 OUTLIER -86.9 16.2 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.969 ' HA ' HD11 ' A' ' 6' ' ' LEU . 53.6 t0 77.43 34.05 0.38 Allowed 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 176.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.824 HD11 ' O ' ' A' ' 55' ' ' GLN . 1.0 OUTLIER -125.39 109.18 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.302 177.08 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -75.74 63.34 1.61 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.206 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.824 ' O ' HD11 ' A' ' 53' ' ' ILE . 88.9 mt-30 -153.96 134.0 13.19 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 114.156 -1.384 . . . . 0.0 108.425 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.724 ' HG2' ' CD1' ' A' ' 137' ' ' LEU . 77.4 mtp180 -65.13 72.38 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -177.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.801 ' O ' ' HE1' ' A' ' 34' ' ' MET . 6.7 mm -114.84 124.93 71.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 1.05 HD13 ' HB2' ' A' ' 72' ' ' LEU . 2.2 pp -131.41 147.26 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.546 HG22 ' H ' ' A' ' 46' ' ' LEU . 34.1 m -128.84 138.15 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.709 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.938 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 2.2 mt -116.92 142.92 28.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.835 0.826 . . . . 0.0 110.821 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 1.042 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 11.4 t70 -124.87 25.86 7.24 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.18 -1.373 . . . . 0.0 110.294 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.992 HG22 HG23 ' A' ' 44' ' ' ILE . 21.9 t -95.68 116.56 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.57 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.571 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 64.1 m -34.42 85.58 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -176.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 62' ' ' VAL . 42.3 tt0 -58.13 -22.15 49.78 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.176 178.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.874 ' OD1' ' HG3' ' A' ' 66' ' ' ARG . 24.9 t-20 -165.17 -79.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.49 0.662 . . . . 0.0 109.566 177.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.874 ' HG3' ' OD1' ' A' ' 65' ' ' ASN . 76.4 mtp180 -123.24 -49.76 1.92 Allowed 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.136 178.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -99.85 128.43 45.94 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.953 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.571 ' HG2' ' HA ' ' A' ' 63' ' ' SER . 96.2 mt-10 -84.12 130.07 34.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.295 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.661 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 32.8 ttm180 175.02 68.61 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.35 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.938 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 67.2 mt -100.72 132.42 46.12 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.867 HG22 ' HB2' ' A' ' 113' ' ' ARG . 9.9 p -134.38 130.09 53.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.106 178.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 1.05 ' HB2' HD13 ' A' ' 58' ' ' ILE . 2.8 mm? -141.07 139.54 34.07 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.505 -0.183 . . . . 0.0 110.505 178.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 1.007 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.7 mp -118.79 134.99 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 110.345 -0.243 . . . . 0.0 110.345 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.685 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 8.6 m120 54.04 35.56 0.29 Allowed Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.811 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 95.2 Cg_exo -55.83 150.1 47.38 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.72 2.28 . . . . 0.0 113.639 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.62 ' CD ' HH21 ' A' ' 109' ' ' ARG . 15.6 pt-20 -136.74 144.22 43.72 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 1.024 ' HB2' ' HE2' ' A' ' 134' ' ' MET . 1.4 tt -81.82 136.28 35.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.534 0.683 . . . . 0.0 111.215 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.886 ' N ' HD21 ' A' ' 77' ' ' LEU . 7.5 mp -116.61 -37.81 3.62 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.308 -178.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 5.2 tp10 -155.36 146.85 22.96 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.107 0.479 . . . . 0.0 111.13 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.717 ' HA ' HG11 ' A' ' 106' ' ' VAL . 12.8 ptmt -148.4 147.38 29.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.258 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 52.8 m -160.56 145.4 14.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.675 0.274 . . . . 0.0 111.303 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.814 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 84.76 169.75 46.22 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.175 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -146.97 113.53 6.0 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.642 ' HG1' HD12 ' A' ' 128' ' ' ILE . 1.5 p -101.94 159.87 14.98 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 115.132 1.531 . . . . 0.0 115.132 178.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.769 ' O ' HD11 ' A' ' 86' ' ' ILE . . . -137.12 102.61 0.39 Allowed Glycine 0 C--N 1.316 -0.532 0 CA-C-N 112.856 -1.974 . . . . 0.0 111.589 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.769 HD11 ' O ' ' A' ' 85' ' ' GLY . 39.8 mm -145.54 136.97 19.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 56.3 mt-10 -71.31 144.36 49.98 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 122.476 1.131 . . . . 0.0 111.779 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.94 ' HG2' ' H27' ' A' ' 149' ' ' BB2 . 55.0 mt-10 -158.06 162.06 38.06 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 113.933 -1.485 . . . . 0.0 109.618 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.885 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -119.96 158.01 15.44 Favored Glycine 0 CA--C 1.499 -0.942 0 C-N-CA 119.271 -1.442 . . . . 0.0 110.15 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.771 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 20.5 m -111.88 137.3 50.04 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.564 0.697 . . . . 0.0 111.893 -177.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 1.064 HD13 ' HG2' ' A' ' 41' ' ' GLU . 2.3 mm? -48.35 -23.03 0.79 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.591 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.701 ' CB ' HG12 ' A' ' 8' ' ' ILE . 48.7 m -84.25 -34.05 23.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.649 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.767 HG21 ' HD2' ' A' ' 94' ' ' PRO . 62.6 mt -85.6 148.85 50.14 Favored Pre-proline 0 N--CA 1.45 -0.442 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.758 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.767 ' HD2' HG21 ' A' ' 93' ' ' ILE . 94.7 Cg_endo -73.1 48.48 1.46 Allowed 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.573 2.182 . . . . 0.0 114.156 -178.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.538 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 37.7 tt0 78.25 14.39 1.46 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 122.671 0.388 . . . . 0.0 111.989 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.709 ' HB2' HG23 ' A' ' 93' ' ' ILE . 10.3 mm-40 -78.71 87.67 4.61 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.885 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 18.5 mtm105 -85.26 133.07 34.18 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.851 0.834 . . . . 0.0 111.903 -178.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.873 ' HB2' ' HE2' ' A' ' 143' ' ' MET . . . -134.47 153.45 51.92 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.249 -1.341 . . . . 0.0 109.624 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.752 ' HG ' ' N ' ' A' ' 86' ' ' ILE . 6.8 tt -75.16 136.33 41.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.458 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.818 ' HB ' ' CZ ' ' A' ' 102' ' ' ARG . 89.7 t -130.14 132.92 24.39 Favored Pre-proline 0 CA--C 1.53 0.177 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 84' ' ' THR . 2.1 Cg_endo -81.3 124.1 4.67 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.693 1.595 . . . . 0.0 112.7 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.863 ' HB2' ' OE1' ' A' ' 131' ' ' GLN . 0.0 OUTLIER -142.15 166.4 24.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.765 179.112 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.814 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.67 156.22 38.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.666 0.269 . . . . 0.0 110.286 -178.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -72.82 -43.96 62.06 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.422 -176.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.715 ' HB3' ' OD1' ' A' ' 123' ' ' ASP . 56.6 mttp -139.44 138.24 36.29 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.72 0.771 . . . . 0.0 109.611 176.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.717 HG11 ' HA ' ' A' ' 80' ' ' LYS . 28.4 m -140.05 138.6 37.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.043 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 1.048 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 32.9 mmtm -107.22 125.27 50.9 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.906 HD13 ' CG ' ' A' ' 120' ' ' LEU . 2.1 pp -128.37 161.46 36.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -177.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.818 ' HG3' ' CD1' ' A' ' 78' ' ' LEU . 68.0 mtm180 -114.28 140.15 48.83 Favored 'General case' 0 N--CA 1.461 0.104 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.77 ' HB2' ' HG3' ' A' ' 75' ' ' PRO . . . -159.58 168.29 26.46 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.966 -178.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 1.007 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.5 pp -113.59 152.99 29.58 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.572 ' O ' HD11 ' A' ' 111' ' ' LEU . 11.2 t70 -90.79 164.37 14.11 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 119.716 -0.793 . . . . 0.0 111.42 -177.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.867 ' HB2' HG22 ' A' ' 71' ' ' VAL . 15.1 ttm105 -51.57 -19.2 1.38 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.237 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.24 -26.56 42.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.602 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 106.81 34.63 2.98 Favored Glycine 0 C--N 1.337 0.619 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.948 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 1.061 ' HZ1' ' HB2' ' A' ' 116' ' ' LYS . 9.7 mtmp? -128.63 103.17 19.62 Favored Pre-proline 0 C--O 1.237 0.416 0 C-N-CA 121.228 -0.189 . . . . 0.0 111.236 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.584 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.4 Cg_exo -72.84 116.06 4.58 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 121.799 1.666 . . . . 0.0 114.802 -178.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.474 ' HE1' HD13 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -126.45 168.62 13.97 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.372 -179.626 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.676 ' HG2' ' CG ' ' A' ' 109' ' ' ARG . 80.2 mt-10 -107.52 129.64 54.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.121 0.486 . . . . 0.0 110.16 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.906 ' CG ' HD13 ' A' ' 108' ' ' ILE . 4.2 pp -123.08 129.04 50.95 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.752 -178.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 1.048 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 9.3 pm0 -92.76 124.36 36.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.27 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.934 ' HB3' HD12 ' A' ' 126' ' ' LEU . . . -116.35 137.18 52.36 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.715 ' OD1' ' HB3' ' A' ' 105' ' ' LYS . 34.3 m-20 -126.96 163.8 22.88 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.798 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 47.5 -135.47 13.62 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 119.996 1.271 . . . . 0.0 115.864 177.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.0 mt -54.66 -32.73 59.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.654 -0.773 . . . . 0.0 111.667 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.934 HD12 ' HB3' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -71.31 -54.01 12.29 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.842 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.868 ' HB3' ' O ' ' A' ' 122' ' ' ALA . . . -58.85 -42.98 90.62 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.469 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.798 HG12 ' O ' ' A' ' 124' ' ' GLY . 49.2 mm -62.17 -54.47 33.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.559 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.924 ' HB3' ' H91' ' A' ' 149' ' ' BB2 . 73.4 m -60.12 -50.72 72.59 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.832 ' CD1' HG12 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -58.88 -44.1 89.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 121.201 -0.199 . . . . 0.0 110.567 -179.674 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.863 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.9 pt20 -67.72 -38.35 83.48 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.735 ' HA ' ' OD2' ' A' ' 135' ' ' ASP . 68.7 t60 -59.22 -46.1 89.35 Favored 'General case' 0 C--O 1.226 -0.16 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.86 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.9 mm-40 -59.67 -45.02 93.33 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.271 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 1.024 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 72.6 mtp -56.84 -48.51 77.9 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 118.913 0.779 . . . . 0.0 110.865 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.872 ' O ' HG13 ' A' ' 138' ' ' VAL . 2.4 p30 -63.35 -46.68 85.42 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.37 178.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.916 ' HA ' HD11 ' A' ' 141' ' ' LEU . 7.8 t-80 -58.03 -52.6 64.86 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.814 -0.554 . . . . 0.0 111.476 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.912 HD22 ' HA ' ' A' ' 134' ' ' MET . 1.5 pp -59.21 -32.68 70.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.553 -177.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.959 HG23 HG12 ' A' ' 16' ' ' VAL . 10.3 p -80.09 19.02 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 CA-C-O 123.101 1.429 . . . . 0.0 108.856 175.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.804 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 61.5 20.52 59.12 Favored Glycine 0 CA--C 1.489 -1.537 0 CA-C-N 111.779 -2.464 . . . . 0.0 112.313 176.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.916 ' HG2' HG12 ' A' ' 138' ' ' VAL . 7.2 ptmt -111.57 115.02 28.47 Favored 'General case' 0 N--CA 1.424 -1.739 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.046 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.916 HD11 ' HA ' ' A' ' 136' ' ' HIS . 7.7 mp -127.88 132.27 49.37 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.687 ' HB2' ' CG1' ' A' ' 100' ' ' VAL . 9.0 m-85 -58.54 -40.09 82.03 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.873 ' HE2' ' HB2' ' A' ' 98' ' ' ALA . 44.6 ttm -61.51 -27.37 68.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.288 0.566 . . . . 0.0 111.124 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.786 ' OD2' ' HD3' ' A' ' 14' ' ' ARG . 0.8 OUTLIER -55.74 -22.45 23.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.828 179.337 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -120.03 40.04 3.53 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.715 -178.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.802 ' HG ' ' HA ' ' A' ' 143' ' ' MET . 47.5 mt -93.11 140.84 29.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.049 179.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 57.2 m . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.991 179.648 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' BB2 . . . . . 1.024 H173 HD12 ' A' ' 91' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.3 t . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.811 0.339 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.931 HG13 ' HA ' ' A' ' 37' ' ' THR . 27.9 m -83.85 136.21 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.963 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.876 HD11 ' OG1' ' A' ' 37' ' ' THR . 0.0 OUTLIER -85.71 -170.15 2.97 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.595 179.88 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.683 ' N ' HD22 ' A' ' 3' ' ' LEU . 70.9 tp60 -84.52 108.4 17.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.736 0.303 . . . . 0.0 110.798 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.656 HG12 ' O ' ' A' ' 50' ' ' GLN . 43.0 t -89.79 131.82 36.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.25 0.548 . . . . 0.0 111.767 -179.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 1.026 ' HB2' HD23 ' A' ' 13' ' ' LEU . 21.5 mt -85.03 141.73 30.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.071 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 2.8 m80 -119.77 144.35 47.33 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.739 HG12 ' HB3' ' A' ' 92' ' ' SER . 50.7 mm -60.71 134.28 92.02 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.29 177.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -83.02 138.88 35.56 Favored 'Cis proline' 0 C--N 1.352 0.739 0 C-N-CA 124.48 -1.05 . . . . 0.0 111.896 -0.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.67 ' HB2' HD12 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -155.86 128.99 8.11 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.562 179.672 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -58.46 -44.71 89.36 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.517 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.557 ' HB2' HD12 ' A' ' 6' ' ' LEU . 24.1 mtt180 -60.5 -24.86 65.63 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 1.026 HD23 ' HB2' ' A' ' 6' ' ' LEU . 10.3 mt -78.41 -31.03 48.03 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 120.892 1.678 . . . . 0.0 107.617 176.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.65 HH12 ' CG ' ' A' ' 144' ' ' ASP . 15.7 mmm180 -91.8 8.77 35.59 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 113.767 -1.56 . . . . 0.0 109.12 178.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.55 ' HD3' ' HB3' ' A' ' 54' ' ' HIS . 60.2 tttp -88.19 143.5 27.01 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.08 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 138' ' ' VAL . 56.4 t -83.99 100.24 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.029 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.673 ' C ' ' HG3' ' A' ' 56' ' ' ARG . . . -58.74 143.78 45.85 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.944 0.402 . . . . 0.0 111.44 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.698 ' HD3' ' N ' ' A' ' 19' ' ' PRO . 1.7 tmtp? -108.94 132.47 21.16 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.183 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.922 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 56.4 Cg_endo -80.35 115.7 3.21 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.29 1.994 . . . . 0.0 111.057 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.599 HG11 ' N ' ' A' ' 21' ' ' GLU . 17.1 t -70.14 144.42 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-O 122.497 1.142 . . . . 0.0 112.665 -176.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.599 ' N ' HG11 ' A' ' 20' ' ' VAL . 8.7 mp0 -60.4 -22.95 63.95 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 113.29 -1.777 . . . . 0.0 112.29 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -161.17 140.31 10.22 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 120.801 0.334 . . . . 0.0 111.157 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.912 HG21 HD13 ' A' ' 111' ' ' LEU . 2.7 t -83.02 117.99 29.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.138 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.891 ' O ' ' HG3' ' A' ' 28' ' ' GLN . 9.8 p30 -105.76 -168.66 1.47 Allowed 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 122.295 -0.253 . . . . 0.0 110.353 -178.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.651 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -73.31 -25.83 60.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.779 0.323 . . . . 0.0 111.434 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.574 ' HB2' ' OD1' ' A' ' 24' ' ' ASN . 4.6 mm-40 -72.89 -40.21 65.74 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.537 HD12 ' HA ' ' A' ' 23' ' ' VAL . 50.8 mt -65.78 -46.04 89.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.166 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.891 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 45.5 mt-30 -57.09 -40.28 76.69 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.705 0.288 . . . . 0.0 110.444 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.651 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 39.4 mmt180 -61.52 -41.16 96.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.654 0.74 . . . . 0.0 109.074 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.813 ' O ' ' HG3' ' A' ' 34' ' ' MET . 4.8 mt -59.72 -50.12 81.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.742 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.676 HG12 ' CG2' ' A' ' 71' ' ' VAL . 10.8 t -67.87 -43.8 85.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-O 120.843 0.354 . . . . 0.0 111.723 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.823 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 26.0 m-20 -54.37 -41.8 69.58 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.404 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.644 ' CB ' HD12 ' A' ' 3' ' ' LEU . 55.9 m-20 -74.39 -31.17 62.25 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.077 176.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.813 ' HG3' ' O ' ' A' ' 30' ' ' ILE . 85.1 mtp -60.3 -47.1 87.47 Favored 'General case' 0 C--N 1.346 0.453 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.869 -177.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.823 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 15.9 p90 -69.35 -44.51 71.45 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' A' ' 32' ' ' ASP . 3.3 mm-40 -51.22 -43.79 61.5 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.931 ' HA ' HG13 ' A' ' 2' ' ' VAL . 96.6 m -70.06 -59.98 2.57 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 118.723 -1.191 . . . . 0.0 109.267 177.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 1.008 ' HE3' ' HB2' ' A' ' 61' ' ' ASP . 3.7 ttp -46.32 -42.5 14.81 Favored 'General case' 0 CA--C 1.461 -2.45 0 C-N-CA 123.42 0.688 . . . . 0.0 109.646 -170.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.747 ' OH ' ' HA ' ' A' ' 69' ' ' ARG . 60.4 m-85 -69.56 -42.35 74.68 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.593 178.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.566 ' HB1' HG13 ' A' ' 2' ' ' VAL . . . -59.84 -28.4 67.47 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.912 ' HG2' HD23 ' A' ' 91' ' ' LEU . 17.6 tp10 -84.9 -10.81 56.73 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.708 177.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 63.87 24.2 13.63 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.952 -176.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.467 ' HA2' ' C18' ' A' ' 149' ' ' BB2 . . . -78.1 142.18 26.0 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 114.143 -1.39 . . . . 0.0 110.595 177.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.981 HG21 HG23 ' A' ' 62' ' ' VAL . 44.2 mm -78.77 -2.18 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 117.566 0.683 . . . . 0.0 112.195 -178.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.847 ' HA3' ' C10' ' A' ' 149' ' ' BB2 . . . 179.36 135.5 2.41 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-O 118.88 -0.956 . . . . 0.0 111.769 -178.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.967 ' HB2' ' HG3' ' A' ' 38' ' ' MET . 9.1 tp -125.85 135.16 51.64 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.437 1.619 . . . . 0.0 111.743 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.502 ' HB3' HE21 ' A' ' 50' ' ' GLN . . . -99.5 129.97 45.72 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.817 ' O ' HG21 ' A' ' 51' ' ' VAL . . . -30.72 -54.51 0.2 Allowed 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.73 HG21 ' O ' ' A' ' 137' ' ' LEU . 66.6 p -53.53 -35.41 60.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.775 0.798 . . . . 0.0 111.364 -178.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.656 ' O ' HG12 ' A' ' 5' ' ' VAL . 55.8 mt-30 -66.35 -37.36 85.16 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.078 179.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.898 ' CG1' HD23 ' A' ' 46' ' ' LEU . 1.1 m -86.4 12.13 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.926 ' HA ' HD13 ' A' ' 6' ' ' LEU . 55.3 t0 78.96 32.37 0.28 Allowed 'General case' 0 C--O 1.23 0.059 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 176.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.793 HD11 ' O ' ' A' ' 55' ' ' GLN . 1.2 pp -127.31 111.75 26.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.065 177.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.55 ' HB3' ' HD3' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -76.23 65.05 2.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.089 0.947 . . . . 0.0 110.466 -179.034 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.793 ' O ' HD11 ' A' ' 53' ' ' ILE . 28.3 mt-30 -154.88 134.54 12.75 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 114.169 -1.378 . . . . 0.0 108.527 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.922 ' HD2' ' HD3' ' A' ' 19' ' ' PRO . 77.8 mtt-85 -63.34 70.82 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -177.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.727 HG23 ' SD ' ' A' ' 34' ' ' MET . 8.7 mm -112.9 122.74 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.919 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 1.7 pp -128.61 146.03 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 119.635 -0.826 . . . . 0.0 113.177 -177.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.708 HG23 ' H ' ' A' ' 46' ' ' LEU . 33.8 m -128.05 138.75 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.96 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.947 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 12.1 mm -116.13 150.57 18.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.642 0.734 . . . . 0.0 109.859 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 1.008 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 28.9 t70 -132.7 21.72 4.25 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.508 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.981 HG23 HG21 ' A' ' 44' ' ' ILE . 32.6 t -94.74 114.73 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.328 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.726 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 80.0 p -38.02 83.28 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -177.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.568 ' HB2' HD11 ' A' ' 70' ' ' LEU . 4.6 tm-20 -69.4 -22.04 63.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.868 178.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.711 ' OD1' ' HG2' ' A' ' 66' ' ' ARG . 14.6 t-20 -163.87 -127.97 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.464 178.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.711 ' HG2' ' OD1' ' A' ' 65' ' ' ASN . 2.6 mmp_? -73.6 -55.13 6.69 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.653 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -97.86 130.46 44.76 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.937 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.726 ' HG2' ' HA ' ' A' ' 63' ' ' SER . 54.2 mt-10 -86.78 78.61 9.05 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.747 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 78.8 ttt180 -145.94 86.55 1.72 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -178.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.947 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 44.0 mt -104.73 133.55 49.37 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -178.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.8 ' C ' HD11 ' A' ' 72' ' ' LEU . 14.4 p -135.07 133.15 53.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.56 177.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 1.023 HD21 HD23 ' A' ' 120' ' ' LEU . 10.4 mp -138.96 139.79 38.05 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.996 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 2.6 mm -118.86 132.49 68.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.102 0.477 . . . . 0.0 111.197 -178.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.698 ' OD1' ' HA ' ' A' ' 19' ' ' PRO . 68.4 m-20 50.7 38.0 0.47 Allowed Pre-proline 0 CA--C 1.547 0.843 0 CA-C-N 115.003 -0.999 . . . . 0.0 113.075 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.763 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 96.2 Cg_exo -55.85 152.33 36.26 Favored 'Trans proline' 0 N--CA 1.487 1.135 0 C-N-CA 123.027 2.485 . . . . 0.0 114.156 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.432 ' HG3' HD13 ' A' ' 78' ' ' LEU . 15.7 pt-20 -137.14 143.25 42.37 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 1.073 ' HB2' ' HE2' ' A' ' 134' ' ' MET . 1.8 tt -81.14 135.44 35.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.711 0.767 . . . . 0.0 111.609 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.904 ' N ' HD22 ' A' ' 77' ' ' LEU . 6.9 mp -111.99 -37.3 5.13 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.045 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 37.6 tt0 -161.0 156.09 24.23 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 121.271 0.557 . . . . 0.0 112.004 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.803 ' CB ' HG12 ' A' ' 106' ' ' VAL . 18.3 ptpt -148.07 153.14 38.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.06 178.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.6 p -159.62 146.38 16.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.852 0.358 . . . . 0.0 111.24 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.741 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 69.73 173.22 10.59 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.843 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.676 ' N ' ' HG3' ' A' ' 104' ' ' GLU . 56.1 mt-10 -146.62 113.89 6.26 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.541 ' OG1' HD11 ' A' ' 128' ' ' ILE . 1.5 p -96.03 159.89 14.73 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 178.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.764 ' O ' HD11 ' A' ' 86' ' ' ILE . . . -135.63 100.81 0.36 Allowed Glycine 0 C--N 1.319 -0.406 0 CA-C-N 113.452 -1.704 . . . . 0.0 111.878 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.764 HD11 ' O ' ' A' ' 85' ' ' GLY . 39.6 mm -145.15 136.94 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -178.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.602 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 47.6 mt-10 -73.35 143.41 46.88 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 122.845 1.307 . . . . 0.0 112.968 -177.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.849 ' HG2' ' H27' ' A' ' 149' ' ' BB2 . 95.2 mt-10 -154.96 166.27 34.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 113.502 -1.681 . . . . 0.0 109.515 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.784 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -119.86 165.31 13.5 Favored Glycine 0 CA--C 1.498 -0.993 0 C-N-CA 119.339 -1.41 . . . . 0.0 110.225 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 1.035 ' HB2' HD11 ' A' ' 93' ' ' ILE . 95.3 m -118.2 140.22 50.12 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.879 -176.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.912 HD23 ' HG2' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -56.9 -23.43 44.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.627 178.741 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.739 ' HB3' HG12 ' A' ' 8' ' ' ILE . 58.7 m -79.45 -38.51 34.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.407 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 1.035 HD11 ' HB2' ' A' ' 90' ' ' CYS . 2.6 mp -86.3 149.62 49.99 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.397 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.73 ' HD2' ' CG2' ' A' ' 93' ' ' ILE . 84.9 Cg_endo -73.66 50.12 1.97 Allowed 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.636 2.224 . . . . 0.0 114.349 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.529 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 39.4 tt0 78.03 12.34 1.8 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 178.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.79 ' HB2' HG21 ' A' ' 93' ' ' ILE . 25.9 mt-30 -78.43 88.9 4.41 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.784 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 45.8 mtm-85 -84.85 133.61 34.31 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.757 0.789 . . . . 0.0 111.437 -178.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 87' ' ' GLU . . . -134.62 153.92 51.75 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.113 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.676 ' C ' HD22 ' A' ' 99' ' ' LEU . 6.6 tt -75.13 136.95 41.07 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.991 HG13 ' HB3' ' A' ' 142' ' ' PHE . 21.9 t -132.04 134.23 24.91 Favored Pre-proline 0 C--N 1.339 0.138 0 C-N-CA 120.461 -0.495 . . . . 0.0 110.986 -178.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -79.75 123.14 5.17 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 121.409 1.406 . . . . 0.0 112.321 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.892 ' CZ ' ' HB ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -144.08 165.75 26.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.653 178.455 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.741 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.72 154.02 42.71 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.014 0.435 . . . . 0.0 109.96 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.676 ' HG3' ' N ' ' A' ' 83' ' ' GLU . 46.8 mt-10 -73.95 -42.29 60.73 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.336 -176.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.652 ' HG2' ' HB3' ' A' ' 123' ' ' ASP . 93.6 mttt -139.79 137.98 35.46 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.683 0.754 . . . . 0.0 109.677 176.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.803 HG12 ' CB ' ' A' ' 80' ' ' LYS . 28.9 m -141.44 142.04 29.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.754 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.989 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 23.6 mmtp -108.13 125.67 51.87 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.73 ' CD1' HD11 ' A' ' 130' ' ' ILE . 1.9 pp -130.71 161.75 40.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -177.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.893 ' CG ' HD21 ' A' ' 78' ' ' LEU . 93.7 mtt180 -111.0 138.34 47.52 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.728 ' HB2' ' HG3' ' A' ' 75' ' ' PRO . . . -155.23 166.34 33.87 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.828 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.996 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.2 pp -117.27 152.01 35.74 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.595 ' OD1' HG12 ' A' ' 71' ' ' VAL . 20.0 t70 -85.25 168.78 14.42 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 119.326 -0.95 . . . . 0.0 112.404 -176.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.767 ' HB2' HG23 ' A' ' 71' ' ' VAL . 46.5 ttp85 -54.87 -20.26 8.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.689 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -79.71 -19.4 48.96 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.523 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.548 ' HA2' HD13 ' A' ' 111' ' ' LEU . . . 98.83 39.13 3.68 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.156 -1.021 . . . . 0.0 114.141 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.674 ' HB3' ' NZ ' ' A' ' 116' ' ' LYS . 2.2 mmmp? -128.28 102.21 21.27 Favored Pre-proline 0 N--CA 1.467 0.397 0 CA-C-N 117.516 0.658 . . . . 0.0 110.82 178.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.568 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.8 Cg_exo -74.58 115.56 4.34 Favored 'Trans proline' 0 C--N 1.361 1.188 0 C-N-CA 121.733 1.622 . . . . 0.0 116.061 -177.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -125.42 168.49 13.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.043 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.728 ' HG2' ' HG2' ' A' ' 109' ' ' ARG . 35.2 mt-10 -108.09 130.63 55.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.972 0.415 . . . . 0.0 110.305 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 1.023 HD23 HD21 ' A' ' 72' ' ' LEU . 4.1 pp -128.48 135.72 49.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.222 0.534 . . . . 0.0 112.092 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.989 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 11.7 pt-20 -95.5 125.63 40.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.974 178.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.889 ' CB ' HD13 ' A' ' 126' ' ' LEU . . . -116.55 135.72 53.58 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.704 ' CA ' ' HB3' ' A' ' 127' ' ' ALA . 24.0 m-20 -125.84 165.04 19.42 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.765 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 46.81 -136.79 9.57 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 120.125 1.329 . . . . 0.0 116.261 176.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.745 HD11 ' CG1' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -54.76 -32.79 60.46 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.319 -0.941 . . . . 0.0 111.341 -178.387 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.889 HD13 ' CB ' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -71.46 -52.64 17.35 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 121.626 0.727 . . . . 0.0 109.455 179.536 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.704 ' HB3' ' CA ' ' A' ' 123' ' ' ASP . . . -58.24 -40.77 82.62 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.58 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.856 HD13 ' HG2' ' A' ' 102' ' ' ARG . 49.7 mm -68.6 -54.42 21.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.437 -179.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.845 ' HB2' ' H91' ' A' ' 149' ' ' BB2 . 31.9 p -57.67 -50.92 71.6 Favored 'General case' 0 C--N 1.334 -0.089 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.73 HD11 ' CD1' ' A' ' 108' ' ' ILE . 20.7 tt -60.55 -44.0 95.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.41 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.825 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 21.5 pt20 -67.85 -38.33 83.03 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.226 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.742 ' HA ' ' OD2' ' A' ' 135' ' ' ASP . 7.8 t-160 -58.45 -46.93 85.57 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.876 ' O ' HD23 ' A' ' 137' ' ' LEU . 4.1 mm-40 -59.42 -44.42 92.86 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.802 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 1.073 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 75.2 mtp -57.01 -48.84 77.52 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 118.411 0.551 . . . . 0.0 110.969 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.811 ' O ' HG11 ' A' ' 138' ' ' VAL . 2.6 p30 -64.24 -47.26 80.34 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.474 -0.49 . . . . 0.0 109.785 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.715 ' CE1' HD12 ' A' ' 141' ' ' LEU . 20.6 t-80 -56.47 -51.79 67.15 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 121.589 -0.694 . . . . 0.0 110.94 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.887 HD22 ' HA ' ' A' ' 134' ' ' MET . 1.3 pp -60.6 -31.31 70.47 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 119.895 -0.722 . . . . 0.0 112.053 -177.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.811 HG11 ' O ' ' A' ' 135' ' ' ASP . 14.7 p -80.6 23.09 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-O 122.966 1.365 . . . . 0.0 109.815 176.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.862 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 64.45 6.34 21.21 Favored Glycine 0 CA--C 1.491 -1.426 0 CA-C-N 112.482 -2.144 . . . . 0.0 112.896 176.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.796 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 4.5 ptmt -94.09 123.63 37.58 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.715 HD12 ' CE1' ' A' ' 136' ' ' HIS . 2.5 mm? -121.57 160.52 24.16 Favored 'General case' 0 N--CA 1.438 -1.06 0 O-C-N 121.474 -0.766 . . . . 0.0 110.646 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.991 ' HB3' HG13 ' A' ' 100' ' ' VAL . 13.9 p90 -60.23 -34.63 73.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.389 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.504 ' HA ' ' HB2' ' A' ' 146' ' ' LEU . 49.6 ttm -59.73 -26.09 65.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.052 0.453 . . . . 0.0 111.04 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.65 ' CG ' HH12 ' A' ' 14' ' ' ARG . 61.0 t0 -57.48 -25.37 59.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.884 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -128.02 16.0 6.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.154 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.504 ' HB2' ' HA ' ' A' ' 143' ' ' MET . 1.3 mp -90.31 141.79 28.37 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.72 0.295 . . . . 0.0 110.902 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 55.3 m . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.835 179.469 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' BB2 . . . . . 0.9 H111 HD11 ' A' ' 60' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.861 0.363 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.443 HG11 ' CB ' ' A' ' 40' ' ' ALA . 20.1 m -84.01 138.6 18.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.662 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.924 HD21 ' HB ' ' A' ' 51' ' ' VAL . 58.6 tp -77.82 158.08 29.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.284 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -78.56 106.07 10.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.127 0.489 . . . . 0.0 109.946 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.772 HG12 ' O ' ' A' ' 50' ' ' GLN . 37.3 t -90.51 131.98 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.668 -178.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.916 HD13 ' HA ' ' A' ' 52' ' ' ASP . 29.6 mt -83.49 140.79 32.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.951 179.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 19.5 m-70 -111.18 142.93 42.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.202 0.525 . . . . 0.0 112.33 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.865 HD12 HD12 ' A' ' 13' ' ' LEU . 49.6 mm -50.87 144.81 12.8 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.799 178.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.48 ' CA ' HG23 ' A' ' 8' ' ' ILE . 79.1 Cg_endo -98.18 55.48 1.04 Allowed 'Cis proline' 0 C--N 1.354 0.837 0 C-N-CA 124.844 -0.898 . . . . 0.0 113.159 0.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.573 ' OD2' ' HB3' ' A' ' 6' ' ' LEU . 66.8 m-20 -55.11 140.89 36.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.375 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 23.9 pt-20 -58.84 -45.54 89.81 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.656 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.751 HH21 HG21 ' A' ' 49' ' ' THR . 0.0 OUTLIER -56.8 -24.91 54.07 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 179.711 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.865 HD12 HD12 ' A' ' 8' ' ' ILE . 8.2 mt -76.77 -32.87 58.01 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 121.193 1.815 . . . . 0.0 108.509 178.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.575 ' HE ' ' CG ' ' A' ' 144' ' ' ASP . 24.3 mmt-85 -94.76 5.89 50.54 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 114.159 -1.382 . . . . 0.0 109.716 178.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.75 ' HD3' ' NH1' ' A' ' 12' ' ' ARG . 75.7 tttt -93.13 155.74 17.29 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.811 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 138' ' ' VAL . 64.3 t -82.5 136.17 23.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.293 0.568 . . . . 0.0 111.335 -178.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.734 ' HB2' ' HG2' ' A' ' 56' ' ' ARG . . . -87.18 141.13 28.88 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.67 ' HD3' ' N ' ' A' ' 19' ' ' PRO . 1.9 tmtp? -102.42 127.92 29.41 Favored Pre-proline 0 C--N 1.324 -0.503 0 C-N-CA 120.717 -0.393 . . . . 0.0 109.976 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.731 ' HB3' ' HD3' ' A' ' 56' ' ' ARG . 61.9 Cg_endo -78.81 115.02 3.52 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.14 1.893 . . . . 0.0 111.151 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.646 HG11 ' N ' ' A' ' 21' ' ' GLU . 19.8 t -70.07 145.0 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 CA-C-O 122.569 1.176 . . . . 0.0 113.232 -176.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.646 ' N ' HG11 ' A' ' 20' ' ' VAL . 51.6 mt-10 -65.93 -22.59 66.5 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 113.189 -1.823 . . . . 0.0 112.636 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.409 ' O ' HG12 ' A' ' 20' ' ' VAL . 5.0 tp10 -159.55 151.38 20.45 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.199 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.835 HG21 ' HA2' ' A' ' 115' ' ' GLY . 4.4 t -80.1 101.71 5.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 1.066 ' HB2' HD12 ' A' ' 27' ' ' ILE . 59.9 m-80 -91.53 160.33 15.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.933 -177.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.524 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -56.39 -32.97 65.3 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.494 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -71.78 -37.45 70.45 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 1.066 HD12 ' HB2' ' A' ' 24' ' ' ASN . 1.7 mp -64.24 -47.93 87.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.084 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.573 ' CD ' HG13 ' A' ' 23' ' ' VAL . 11.0 mm-40 -57.94 -40.51 80.68 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.788 0.328 . . . . 0.0 111.096 178.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.524 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 39.3 mmt180 -61.16 -41.3 96.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.808 0.813 . . . . 0.0 109.315 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.763 ' O ' ' HG3' ' A' ' 34' ' ' MET . 6.9 mt -59.37 -50.58 79.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 114.486 -1.233 . . . . 0.0 112.322 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.683 HG13 ' CG2' ' A' ' 71' ' ' VAL . 9.4 t -67.04 -42.15 88.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-O 120.846 0.355 . . . . 0.0 111.66 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.88 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -56.24 -42.44 77.35 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.96 -179.37 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.625 ' HB3' ' HB2' ' A' ' 3' ' ' LEU . 1.4 m-20 -75.07 -30.73 61.04 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.157 176.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.764 ' HE1' ' O ' ' A' ' 57' ' ' ILE . 79.3 mtp -60.58 -47.84 84.4 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.007 -177.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.88 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 15.9 p90 -69.02 -43.76 74.13 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.61 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 52.9 mm-40 -52.43 -41.05 62.91 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.747 HG23 ' CG2' ' A' ' 5' ' ' VAL . 31.0 m -69.98 -62.16 1.49 Allowed 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 118.792 -1.163 . . . . 0.0 108.757 177.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.923 ' HE3' ' HB2' ' A' ' 61' ' ' ASP . 1.4 ttp -46.3 -42.63 14.89 Favored 'General case' 0 CA--C 1.46 -2.496 0 C-N-CA 123.611 0.764 . . . . 0.0 110.016 -170.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.82 ' HH ' ' HA ' ' A' ' 69' ' ' ARG . 66.7 m-85 -69.29 -41.65 76.51 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.389 178.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.443 ' CB ' HG11 ' A' ' 2' ' ' VAL . . . -60.06 -28.49 67.83 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 1.053 ' HG2' HD23 ' A' ' 91' ' ' LEU . 3.0 tp10 -84.62 -10.38 57.41 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.977 177.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 63.37 25.59 14.66 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.953 -176.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.492 ' HA2' ' C18' ' A' ' 149' ' ' BB2 . . . -80.43 142.73 24.15 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.856 177.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.938 ' CG2' HG21 ' A' ' 62' ' ' VAL . 46.1 mm -78.99 -1.71 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 117.576 0.688 . . . . 0.0 112.254 -178.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.942 ' HA3' H101 ' A' ' 149' ' ' BB2 . . . 179.12 135.94 2.5 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 118.948 -0.918 . . . . 0.0 112.024 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.878 ' HB2' ' HG3' ' A' ' 38' ' ' MET . 6.9 tp -126.82 134.54 50.52 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.359 1.58 . . . . 0.0 112.295 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.558 ' HB3' ' OE1' ' A' ' 133' ' ' GLU . . . -97.8 131.1 44.6 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 122.386 0.274 . . . . 0.0 111.39 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.808 ' O ' HG22 ' A' ' 51' ' ' VAL . . . -33.73 -54.12 0.45 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -178.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.751 HG21 HH21 ' A' ' 12' ' ' ARG . 81.8 p -52.84 -35.77 57.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.722 0.772 . . . . 0.0 111.176 -178.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.772 ' O ' HG12 ' A' ' 5' ' ' VAL . 53.4 mt-30 -66.85 -36.76 83.07 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.023 178.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.924 ' HB ' HD21 ' A' ' 3' ' ' LEU . 1.3 m -87.21 13.49 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.916 ' HA ' HD13 ' A' ' 6' ' ' LEU . 54.5 t0 77.75 32.4 0.4 Allowed 'General case' 0 C--O 1.23 0.075 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 176.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.816 HD11 ' O ' ' A' ' 55' ' ' GLN . 1.2 pp -127.11 112.76 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.201 177.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.72 ' HA ' ' NH2' ' A' ' 12' ' ' ARG . 0.4 OUTLIER -76.0 67.02 2.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.862 0.839 . . . . 0.0 110.517 -179.439 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.816 ' O ' HD11 ' A' ' 53' ' ' ILE . 89.2 mt-30 -157.59 134.05 9.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.691 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.768 ' HA ' HD11 ' A' ' 137' ' ' LEU . 52.2 mtp85 -62.84 70.69 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -178.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.764 ' O ' ' HE1' ' A' ' 34' ' ' MET . 8.5 mm -113.16 122.35 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.897 HD12 ' HB2' ' A' ' 72' ' ' LEU . 2.1 pp -129.02 146.37 34.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.877 -178.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.66 HG22 ' H ' ' A' ' 46' ' ' LEU . 33.3 m -127.82 138.6 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.652 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 1.033 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 12.1 mm -115.1 149.23 17.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.617 0.722 . . . . 0.0 109.301 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.923 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 57.0 t0 -134.2 30.58 3.59 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.767 -178.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.938 HG21 ' CG2' ' A' ' 44' ' ' ILE . 30.4 t -98.45 111.32 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.877 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.604 ' N ' ' HG2' ' A' ' 68' ' ' GLU . 56.0 m -35.29 89.32 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -175.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.539 ' HB2' HD22 ' A' ' 70' ' ' LEU . 37.1 tt0 -54.56 -22.1 12.22 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 114.288 -1.323 . . . . 0.0 111.554 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -165.6 -76.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.858 0.837 . . . . 0.0 109.653 177.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -120.11 -45.74 2.45 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.116 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -106.22 133.27 51.19 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.416 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.604 ' HG2' ' N ' ' A' ' 63' ' ' SER . 98.4 mt-10 -84.77 126.85 33.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.81 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.82 ' HA ' ' HH ' ' A' ' 39' ' ' TYR . 73.8 ttt180 178.23 68.83 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.135 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 1.033 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 4.0 mm? -103.89 133.11 49.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.786 0.327 . . . . 0.0 111.473 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.808 HG21 ' HB2' ' A' ' 113' ' ' ARG . 10.6 p -135.38 133.3 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.593 178.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.897 ' HB2' HD12 ' A' ' 58' ' ' ILE . 1.5 mm? -140.71 142.2 34.86 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 177.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 1.039 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.7 mp -121.14 135.22 62.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 117.987 0.358 . . . . 0.0 110.679 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.692 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 7.9 m120 54.46 37.07 0.38 Allowed Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.857 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 99.5 Cg_exo -56.71 148.63 64.25 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 123.058 2.505 . . . . 0.0 114.408 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.505 ' O ' ' HB ' ' A' ' 108' ' ' ILE . 15.8 pt-20 -139.61 143.04 37.07 Favored 'General case' 0 C--O 1.23 0.079 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.731 ' HB2' ' HE3' ' A' ' 134' ' ' MET . 8.5 tp -80.07 138.02 36.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.443 0.639 . . . . 0.0 111.43 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 1.055 HD21 ' HE ' ' A' ' 109' ' ' ARG . 6.8 mp -113.13 -36.91 4.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.181 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 41.4 tt0 -159.0 149.55 19.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.208 0.528 . . . . 0.0 111.42 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.886 ' HA ' HG11 ' A' ' 106' ' ' VAL . 12.5 ptmt -146.47 149.59 33.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.282 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 81.2 p -158.58 145.04 17.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.526 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.764 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 79.12 154.74 8.48 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.117 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 -127.36 113.82 16.75 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.783 0.801 . . . . 0.0 112.316 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.632 ' OG1' HD11 ' A' ' 128' ' ' ILE . 1.5 p -106.44 160.89 15.06 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 115.645 1.721 . . . . 0.0 115.645 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.689 ' CA ' HD22 ' A' ' 99' ' ' LEU . . . -140.39 105.92 0.46 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 113.046 -1.888 . . . . 0.0 111.584 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.682 ' N ' ' HG ' ' A' ' 99' ' ' LEU . 20.4 mt -144.99 135.45 19.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -178.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.599 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 52.8 mt-10 -72.73 143.28 48.07 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 122.818 1.294 . . . . 0.0 113.37 -177.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.922 ' HG2' ' H27' ' A' ' 149' ' ' BB2 . 55.6 mt-10 -156.54 168.64 26.77 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 113.301 -1.772 . . . . 0.0 109.289 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.668 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -120.06 165.97 13.58 Favored Glycine 0 CA--C 1.5 -0.867 0 C-N-CA 119.421 -1.371 . . . . 0.0 110.628 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.795 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 63.0 m -115.71 137.65 51.87 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.921 -177.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 1.053 HD23 ' HG2' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -50.89 -33.27 23.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.65 0.738 . . . . 0.0 109.403 179.647 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.638 ' HB3' ' CD1' ' A' ' 13' ' ' LEU . 60.1 m -76.92 -30.56 56.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.829 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.928 HG22 ' HD2' ' A' ' 94' ' ' PRO . 57.7 mt -85.91 148.36 48.04 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.928 ' HD2' HG22 ' A' ' 93' ' ' ILE . 68.9 Cg_endo -75.36 47.73 1.91 Allowed 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.475 2.117 . . . . 0.0 114.183 -178.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.513 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 39.7 tt0 78.77 10.78 1.67 Allowed 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 122.696 0.398 . . . . 0.0 111.988 179.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.565 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . 84.9 mt-30 -78.27 88.8 4.32 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.939 -0.764 . . . . 0.0 108.939 178.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.668 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 42.9 mtm-85 -84.87 133.15 34.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.67 0.748 . . . . 0.0 111.659 -178.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.762 ' CB ' ' HE2' ' A' ' 143' ' ' MET . . . -134.2 153.94 51.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.839 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.689 HD22 ' CA ' ' A' ' 85' ' ' GLY . 6.9 tt -75.53 135.95 40.59 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.875 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.806 HG12 ' NH1' ' A' ' 102' ' ' ARG . 60.2 t -130.38 134.64 26.32 Favored Pre-proline 0 N--CA 1.454 -0.265 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.743 ' HD2' ' CD2' ' A' ' 142' ' ' PHE . 88.2 Cg_endo -82.71 124.12 3.91 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.395 1.397 . . . . 0.0 113.721 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 1.031 ' HG2' HD13 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -141.99 164.95 28.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 113.914 -1.494 . . . . 0.0 110.22 179.204 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.764 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.86 154.85 41.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.809 0.338 . . . . 0.0 110.913 -178.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.495 ' OE1' ' HA ' ' A' ' 104' ' ' GLU . 28.2 tp10 -72.66 -43.93 62.51 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.283 -176.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.762 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 55.8 mttm -139.13 138.36 36.94 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.463 0.649 . . . . 0.0 109.495 176.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.906 HG23 ' CG ' ' A' ' 131' ' ' GLN . 25.8 m -147.49 140.43 19.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.614 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.878 ' HD2' ' CB ' ' A' ' 121' ' ' GLU . 51.3 mmtt -107.41 125.37 51.13 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.676 ' CG2' HD12 ' A' ' 77' ' ' LEU . 1.4 pp -129.95 160.75 40.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 1.055 ' HE ' HD21 ' A' ' 78' ' ' LEU . 92.7 mtt180 -107.51 135.01 49.69 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-O 121.142 0.496 . . . . 0.0 110.326 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.756 ' HB2' ' HB3' ' A' ' 72' ' ' LEU . . . -155.75 167.5 30.2 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.184 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 1.039 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.3 pp -115.54 151.69 34.4 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.583 ' O ' HD12 ' A' ' 111' ' ' LEU . 19.8 t70 -86.67 163.46 17.36 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.604 -176.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.808 ' HB2' HG21 ' A' ' 71' ' ' VAL . 14.4 ttp-105 -54.75 -16.44 2.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.77 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.37 -25.7 42.14 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.975 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.835 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 105.91 35.51 2.97 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.573 -0.822 . . . . 0.0 113.837 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -128.92 102.98 18.93 Favored Pre-proline 0 C--O 1.238 0.485 0 CA-C-N 116.967 0.383 . . . . 0.0 111.139 178.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.562 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 32.5 Cg_exo -73.23 114.76 4.12 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 121.653 1.569 . . . . 0.0 114.994 -177.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -129.6 168.93 15.69 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.908 -178.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.832 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 6.2 mp0 -106.63 130.11 54.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.91 0.386 . . . . 0.0 109.981 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.873 HD21 ' O ' ' A' ' 120' ' ' LEU . 0.2 OUTLIER -124.45 141.78 51.82 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.881 0.848 . . . . 0.0 112.017 -178.57 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.878 ' CB ' ' HD2' ' A' ' 107' ' ' LYS . 15.3 pt-20 -94.84 123.33 38.24 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.998 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.637 ' HB3' HD22 ' A' ' 126' ' ' LEU . . . -116.52 134.17 55.16 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.453 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.762 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.2 m-20 -126.76 163.62 23.14 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.734 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 45.89 -133.75 9.61 Favored Glycine 0 C--N 1.348 1.198 0 CA-C-N 120.832 1.651 . . . . 0.0 116.224 176.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.0 mt -53.38 -35.06 59.91 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.444 -0.878 . . . . 0.0 111.444 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.637 HD22 ' HB3' ' A' ' 122' ' ' ALA . 0.6 OUTLIER -70.68 -53.67 14.81 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.311 0.577 . . . . 0.0 110.116 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.734 ' O ' ' HG3' ' A' ' 131' ' ' GLN . . . -59.0 -42.95 91.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.699 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 1.031 HD13 ' HG2' ' A' ' 102' ' ' ARG . 49.5 mm -64.72 -55.47 20.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.366 -178.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.988 ' HB2' H112 ' A' ' 149' ' ' BB2 . 28.9 p -57.76 -49.71 75.69 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -178.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.6 HD12 HG12 ' A' ' 108' ' ' ILE . 19.3 tt -59.26 -42.42 87.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.906 ' CG ' HG23 ' A' ' 106' ' ' VAL . 66.5 mt-30 -65.79 -40.57 92.07 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 178.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.652 ' HA ' ' OD2' ' A' ' 135' ' ' ASP . 74.1 t60 -56.0 -49.2 74.3 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.524 0.678 . . . . 0.0 110.219 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.864 ' CG ' H102 ' A' ' 149' ' ' BB2 . 24.0 mm-40 -60.7 -42.44 97.18 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.083 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.916 ' HA ' HD23 ' A' ' 137' ' ' LEU . 35.5 mtm -58.16 -49.62 76.36 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.351 0.978 . . . . 0.0 110.968 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.871 ' O ' HG12 ' A' ' 138' ' ' VAL . 4.1 p30 -63.0 -46.09 89.31 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.681 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.873 ' HA ' HD13 ' A' ' 141' ' ' LEU . 11.7 t-80 -56.76 -51.57 68.38 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 121.78 -0.575 . . . . 0.0 111.039 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.916 HD23 ' HA ' ' A' ' 134' ' ' MET . 1.2 pp -59.76 -30.72 69.05 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.799 -177.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.871 HG12 ' O ' ' A' ' 135' ' ' ASP . 10.7 p -83.11 20.48 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-O 123.083 1.42 . . . . 0.0 108.22 174.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.781 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 60.36 17.49 46.99 Favored Glycine 0 CA--C 1.491 -1.455 0 CA-C-N 112.106 -2.316 . . . . 0.0 112.553 176.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.929 ' HB2' ' HZ3' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -106.59 118.21 36.08 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.064 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.873 HD13 ' HA ' ' A' ' 136' ' ' HIS . 8.3 mp -132.69 144.62 50.44 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.743 ' CD2' ' HD2' ' A' ' 101' ' ' PRO . 7.4 m-85 -63.86 -34.24 77.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 118.226 0.466 . . . . 0.0 111.068 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.775 ' HA ' HD12 ' A' ' 146' ' ' LEU . 46.4 tpp -55.08 -26.68 39.56 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.291 0.567 . . . . 0.0 110.73 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.575 ' CG ' ' HE ' ' A' ' 14' ' ' ARG . 38.7 t70 -54.69 -25.0 24.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.895 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -128.31 40.62 3.63 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.114 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.775 HD12 ' HA ' ' A' ' 143' ' ' MET . 4.8 mp -92.35 147.01 23.25 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.722 0.296 . . . . 0.0 111.091 178.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 46.9 t . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.18 -0.914 . . . . 0.0 111.068 179.5 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' BB2 . . . . . 0.988 H112 ' HB2' ' A' ' 129' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.602 ' O ' ' HB3' ' A' ' 36' ' ' GLU . 46.9 t . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.864 0.364 . . . . 0.0 111.016 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.511 ' CG1' HG21 ' A' ' 37' ' ' THR . 42.2 t -120.18 138.7 49.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.276 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.836 ' CD2' ' HB ' ' A' ' 51' ' ' VAL . 58.4 tp -77.39 161.74 27.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.335 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 71.0 tp60 -78.44 106.67 10.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.03 0.443 . . . . 0.0 110.03 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.781 HG12 ' O ' ' A' ' 50' ' ' GLN . 39.5 t -90.08 131.94 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.647 -178.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 1.029 ' HB2' HD23 ' A' ' 13' ' ' LEU . 25.5 mt -85.01 140.73 30.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.479 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 39.2 m-70 -115.79 141.78 47.63 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -178.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.647 HD12 HD13 ' A' ' 13' ' ' LEU . 41.4 mm -62.77 134.5 95.48 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.889 177.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.3 144.81 78.83 Favored 'Cis proline' 0 C--N 1.352 0.754 0 C-N-CA 124.615 -0.994 . . . . 0.0 111.815 -0.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.949 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.6 t70 -164.56 126.46 2.23 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.505 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.533 ' HG2' ' N ' ' A' ' 12' ' ' ARG . 10.5 pm0 -58.28 -45.49 87.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.551 -178.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.678 ' HD3' ' HE3' ' A' ' 15' ' ' LYS . 14.2 mmt-85 -58.13 -27.63 63.92 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 1.029 HD23 ' HB2' ' A' ' 6' ' ' LEU . 9.6 mt -77.58 -31.3 53.0 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 120.814 1.643 . . . . 0.0 108.86 177.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.607 ' C ' ' HA3' ' A' ' 139' ' ' GLY . 13.5 mmt85 -95.54 10.0 38.14 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 114.147 -1.388 . . . . 0.0 109.308 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 1.105 ' HZ1' ' HB2' ' A' ' 54' ' ' HIS . 20.4 ttpp -92.05 146.49 23.69 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.204 -179.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.894 HG13 HG23 ' A' ' 138' ' ' VAL . 44.5 t -84.15 95.26 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.535 -178.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.549 ' C ' ' HG3' ' A' ' 56' ' ' ARG . . . -54.8 148.24 13.42 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-O 121.053 0.454 . . . . 0.0 111.868 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.406 ' HB3' ' OE1' ' A' ' 55' ' ' GLN . 54.2 tttp -103.21 129.42 25.58 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.902 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.66 ' HD3' ' HD3' ' A' ' 56' ' ' ARG . 60.1 Cg_endo -79.64 116.48 3.52 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.428 2.085 . . . . 0.0 110.506 179.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.637 HG11 ' N ' ' A' ' 21' ' ' GLU . 20.9 t -71.27 144.71 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-O 122.552 1.168 . . . . 0.0 113.143 -176.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.637 ' N ' HG11 ' A' ' 20' ' ' VAL . 96.8 mt-10 -69.15 -21.13 64.02 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 113.121 -1.854 . . . . 0.0 112.329 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.551 ' O ' HG12 ' A' ' 20' ' ' VAL . 88.7 tt0 -159.25 142.03 14.16 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 121.157 -0.217 . . . . 0.0 110.566 -179.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.949 HG23 HD12 ' A' ' 111' ' ' LEU . 2.8 t -80.51 106.01 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 -178.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 1.004 HD21 HD12 ' A' ' 27' ' ' ILE . 64.5 m-80 -89.34 159.05 17.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.692 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.55 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -54.17 -30.54 49.83 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.024 0.44 . . . . 0.0 110.69 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -71.81 -39.66 69.7 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 1.004 HD12 HD21 ' A' ' 24' ' ' ASN . 60.6 mt -63.56 -47.6 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.297 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.499 ' HG2' HG12 ' A' ' 23' ' ' VAL . 11.6 mt-30 -57.85 -40.34 79.87 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.77 0.319 . . . . 0.0 110.627 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.55 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 40.0 mmt-85 -59.84 -40.45 88.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.811 0.815 . . . . 0.0 108.866 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.769 ' O ' ' HG3' ' A' ' 34' ' ' MET . 4.4 mt -59.64 -49.48 83.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 114.419 -1.264 . . . . 0.0 111.846 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.767 HG23 HG21 ' A' ' 57' ' ' ILE . 18.7 t -66.82 -42.21 88.86 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-O 120.839 0.352 . . . . 0.0 111.395 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.845 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -55.32 -43.91 75.32 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.997 -179.321 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.606 ' HB3' ' HB2' ' A' ' 3' ' ' LEU . 31.9 m-20 -75.29 -30.83 60.5 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.355 176.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.791 ' HG2' HG23 ' A' ' 51' ' ' VAL . 79.2 mtp -59.55 -47.22 86.38 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.566 -177.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.845 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 13.6 p90 -69.05 -43.99 73.54 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 177.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.758 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 81.7 mt-10 -51.85 -40.31 60.35 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.657 HG23 ' CG2' ' A' ' 5' ' ' VAL . 37.2 m -69.8 -61.45 1.77 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 119.042 -1.063 . . . . 0.0 108.638 177.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 1.0 ' HE3' ' HB2' ' A' ' 61' ' ' ASP . 3.3 ttp -46.22 -43.81 15.72 Favored 'General case' 0 CA--C 1.459 -2.528 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.861 -170.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.706 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 70.2 m-85 -69.63 -41.62 75.41 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.635 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.491 ' CB ' HG22 ' A' ' 2' ' ' VAL . . . -60.23 -28.62 68.16 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 178.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 1.071 ' HG2' HD22 ' A' ' 91' ' ' LEU . 3.2 tp10 -84.72 -10.06 57.62 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 114.407 -1.269 . . . . 0.0 108.876 177.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 62.01 26.05 15.68 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.824 -176.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.89 143.13 25.1 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.373 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.977 HG23 HG23 ' A' ' 62' ' ' VAL . 40.6 mt -78.99 -0.78 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 117.941 0.87 . . . . 0.0 112.008 -178.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.822 ' HA3' H113 ' A' ' 149' ' ' BB2 . . . 179.33 135.3 2.36 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 118.972 -0.904 . . . . 0.0 112.005 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.91 ' HB2' ' HG3' ' A' ' 38' ' ' MET . 9.0 tp -126.51 135.43 51.31 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.535 1.667 . . . . 0.0 112.084 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -99.68 130.73 45.93 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.776 ' O ' HG21 ' A' ' 51' ' ' VAL . . . -29.7 -56.15 0.16 Allowed 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.736 HG21 ' O ' ' A' ' 137' ' ' LEU . 75.7 p -53.16 -35.02 59.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.964 0.888 . . . . 0.0 111.167 -178.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.781 ' O ' HG12 ' A' ' 5' ' ' VAL . 36.6 mt-30 -66.1 -38.08 87.36 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.174 -1.375 . . . . 0.0 110.358 179.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.906 ' CG1' HD22 ' A' ' 46' ' ' LEU . 1.4 m -87.61 15.29 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.905 ' HA ' HD11 ' A' ' 6' ' ' LEU . 56.0 t0 76.53 32.89 0.54 Allowed 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 176.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.804 HD11 ' O ' ' A' ' 55' ' ' GLN . 1.2 pp -126.91 111.12 24.77 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.404 177.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 1.105 ' HB2' ' HZ1' ' A' ' 15' ' ' LYS . 0.5 OUTLIER -75.6 64.89 1.73 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.942 0.877 . . . . 0.0 110.59 -179.207 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.804 ' O ' HD11 ' A' ' 53' ' ' ILE . 11.8 mm100 -155.48 134.8 12.36 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 114.359 -1.291 . . . . 0.0 108.385 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.712 ' HG2' ' CD1' ' A' ' 137' ' ' LEU . 77.1 mtp180 -65.37 72.4 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -177.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.767 HG21 HG23 ' A' ' 31' ' ' VAL . 7.4 mm -113.52 122.99 68.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 1.026 HD12 ' HB2' ' A' ' 72' ' ' LEU . 1.9 pp -127.11 145.52 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -177.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.663 HG22 ' H ' ' A' ' 46' ' ' LEU . 32.8 m -127.48 138.41 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.369 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 1.035 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 13.5 mm -115.88 152.69 17.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.571 0.701 . . . . 0.0 110.58 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 1.0 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 36.6 t70 -146.11 34.12 1.0 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.417 -178.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.977 HG23 HG23 ' A' ' 44' ' ' ILE . 38.8 t -95.76 111.35 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.289 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.569 ' HB3' ' OE2' ' A' ' 68' ' ' GLU . 78.3 p -38.26 77.71 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -176.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 62' ' ' VAL . 87.9 tt0 -67.0 -9.73 42.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.529 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.795 ' OD1' ' HG2' ' A' ' 66' ' ' ARG . 25.1 t-20 -165.51 -84.99 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.725 0.774 . . . . 0.0 110.379 177.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.795 ' HG2' ' OD1' ' A' ' 65' ' ' ASN . 18.6 mmt85 -121.94 -48.58 2.12 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.719 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -114.62 133.63 55.69 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.458 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.569 ' OE2' ' HB3' ' A' ' 63' ' ' SER . 49.8 mp0 -84.14 132.6 34.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.905 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.598 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 76.0 ttt180 -174.92 62.1 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.152 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 1.035 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 40.8 mt -104.91 133.48 49.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.455 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.803 HG23 ' HB2' ' A' ' 113' ' ' ARG . 9.9 p -134.82 133.02 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.023 178.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 1.026 ' HB2' HD12 ' A' ' 58' ' ' ILE . 87.3 mt -141.85 141.95 33.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.907 -0.133 . . . . 0.0 111.252 178.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 1.038 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.9 mp -118.24 134.09 62.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 110.418 -0.215 . . . . 0.0 110.418 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.657 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 15.4 p30 46.32 40.75 0.71 Allowed Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.808 ' HG3' ' HB2' ' A' ' 110' ' ' ALA . 92.5 Cg_exo -56.79 155.43 27.26 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.987 2.458 . . . . 0.0 113.247 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.441 ' HG3' HD11 ' A' ' 78' ' ' LEU . 11.7 pt-20 -137.78 143.75 41.25 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 1.047 ' HB2' ' HE2' ' A' ' 134' ' ' MET . 1.8 tt -81.3 133.93 35.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.609 0.719 . . . . 0.0 111.506 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.901 HD22 ' CG ' ' A' ' 109' ' ' ARG . 6.8 mp -109.3 -38.83 5.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.541 -1.208 . . . . 0.0 111.905 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 42.7 tt0 -160.28 155.66 25.16 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.264 0.554 . . . . 0.0 112.056 -179.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.852 ' CB ' HG12 ' A' ' 106' ' ' VAL . 18.7 ptpt -148.25 151.53 35.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.451 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.403 ' HG ' ' C ' ' A' ' 80' ' ' LYS . 53.2 m -160.08 143.46 13.94 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.679 0.276 . . . . 0.0 111.193 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.739 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 81.98 159.72 25.28 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.556 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -130.67 114.0 14.87 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.531 0.682 . . . . 0.0 112.617 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.5 p -107.76 159.31 16.59 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 179.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.768 ' O ' HD11 ' A' ' 86' ' ' ILE . . . -140.06 103.44 0.37 Allowed Glycine 0 C--N 1.318 -0.461 0 CA-C-N 113.039 -1.891 . . . . 0.0 111.63 178.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.768 HD11 ' O ' ' A' ' 85' ' ' GLY . 40.7 mm -144.67 135.86 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -178.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.601 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 48.8 mt-10 -72.27 143.68 48.66 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 122.577 1.18 . . . . 0.0 112.736 -178.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.934 ' HG2' ' H27' ' A' ' 149' ' ' BB2 . 50.3 mt-10 -155.61 164.16 39.0 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 113.727 -1.579 . . . . 0.0 109.482 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.763 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -118.68 163.29 13.16 Favored Glycine 0 CA--C 1.498 -1.016 0 C-N-CA 119.258 -1.449 . . . . 0.0 110.235 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.813 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 71.8 m -111.71 137.8 49.12 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.886 -177.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 1.071 HD22 ' HG2' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -50.01 -33.51 18.29 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.678 0.752 . . . . 0.0 109.891 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.605 ' HB3' ' CD1' ' A' ' 13' ' ' LEU . 29.2 m -77.55 -29.98 52.48 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.801 -179.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.997 HG21 ' HD2' ' A' ' 94' ' ' PRO . 59.9 mt -85.9 148.37 48.09 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.997 ' HD2' HG21 ' A' ' 93' ' ' ILE . 66.9 Cg_endo -75.51 47.7 1.94 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.522 2.148 . . . . 0.0 114.552 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.604 ' HB2' ' O ' ' A' ' 94' ' ' PRO . 0.3 OUTLIER 79.41 10.11 1.53 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 179.067 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.55 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . 98.4 mm-40 -78.16 88.88 4.25 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.926 HH11 H232 ' A' ' 149' ' ' BB2 . 77.7 mtm180 -84.52 133.23 34.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.729 0.776 . . . . 0.0 111.652 -178.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -129.63 149.68 51.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.651 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.616 ' HG ' ' N ' ' A' ' 86' ' ' ILE . 6.9 tt -75.07 135.39 41.22 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.685 0.279 . . . . 0.0 110.462 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.791 HG12 ' NH1' ' A' ' 102' ' ' ARG . 57.6 t -130.25 130.61 23.07 Favored Pre-proline 0 N--CA 1.453 -0.31 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 84' ' ' THR . 5.8 Cg_exo -77.95 123.85 6.47 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 121.741 1.628 . . . . 0.0 112.587 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.92 ' HB3' HH11 ' A' ' 102' ' ' ARG . 0.0 OUTLIER -142.75 165.28 27.8 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.085 -1.416 . . . . 0.0 110.4 179.39 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.739 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.64 154.94 40.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.721 0.296 . . . . 0.0 110.656 -178.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.407 ' OE1' HG21 ' A' ' 84' ' ' THR . 16.6 tp10 -72.77 -43.08 63.29 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.231 -176.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.789 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 82.3 mttt -139.6 138.27 36.04 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.48 0.657 . . . . 0.0 109.621 176.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.852 HG12 ' CB ' ' A' ' 80' ' ' LYS . 27.4 m -142.51 141.49 27.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.852 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.954 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 52.8 mmtt -107.73 125.77 51.8 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.841 HD11 HD11 ' A' ' 130' ' ' ILE . 2.0 pp -130.86 160.1 42.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -177.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.901 ' CG ' HD22 ' A' ' 78' ' ' LEU . 95.4 mtt180 -109.84 137.8 47.12 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.808 ' HB2' ' HG3' ' A' ' 75' ' ' PRO . . . -156.94 167.49 30.31 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.761 -0.2 . . . . 0.0 111.108 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 1.038 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.0 pp -113.9 151.86 31.61 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.574 ' O ' HD13 ' A' ' 111' ' ' LEU . 9.4 t70 -89.06 162.7 15.86 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.503 -177.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.803 ' HB2' HG23 ' A' ' 71' ' ' VAL . 48.4 ttp85 -52.75 -18.6 1.92 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.235 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -79.25 -25.06 42.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.343 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.435 ' HA2' HG23 ' A' ' 23' ' ' VAL . . . 105.92 35.85 2.89 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.698 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -128.79 102.93 19.3 Favored Pre-proline 0 C--O 1.237 0.423 0 CA-C-N 116.986 0.393 . . . . 0.0 111.248 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.576 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.6 Cg_exo -73.54 114.84 4.14 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 121.703 1.602 . . . . 0.0 114.729 -177.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.18 168.75 13.62 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.683 -178.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.84 ' HG2' ' HG2' ' A' ' 109' ' ' ARG . 33.2 mt-10 -107.39 130.06 54.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.051 0.453 . . . . 0.0 110.132 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.881 HD22 HD12 ' A' ' 72' ' ' LEU . 4.1 pp -127.48 134.72 49.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.97 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.954 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 11.5 pt-20 -93.53 125.11 37.96 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.843 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.812 ' HB3' HD11 ' A' ' 126' ' ' LEU . . . -116.19 135.43 53.92 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.789 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.1 m-20 -126.31 164.49 20.92 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.751 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 47.16 -135.3 11.95 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 120.187 1.358 . . . . 0.0 116.302 176.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 125' ' ' LEU . 87.2 mt -54.04 -33.74 58.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.493 -0.854 . . . . 0.0 111.721 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.812 HD11 ' HB3' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -71.26 -53.46 14.24 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.762 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.676 ' O ' ' HG2' ' A' ' 131' ' ' GLN . . . -59.3 -46.19 89.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.876 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.751 HG12 ' O ' ' A' ' 124' ' ' GLY . 47.3 mm -61.54 -56.02 20.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.095 -178.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.931 ' HB3' ' H91' ' A' ' 149' ' ' BB2 . 73.5 m -60.0 -51.22 70.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.841 HD11 HD11 ' A' ' 108' ' ' ILE . 20.3 tt -59.11 -42.07 85.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 121.21 -0.196 . . . . 0.0 111.004 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.841 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.4 pt20 -67.81 -37.77 82.42 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.409 ' CD2' ' O2 ' ' A' ' 149' ' ' BB2 . 72.5 t60 -59.52 -44.94 93.04 Favored 'General case' 0 CA--C 1.521 -0.146 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.859 ' O ' HD21 ' A' ' 137' ' ' LEU . 4.2 mm-40 -59.3 -44.53 92.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.173 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 1.047 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 74.3 mtp -57.42 -48.32 79.42 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.544 0.687 . . . . 0.0 110.28 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.857 ' O ' HG12 ' A' ' 138' ' ' VAL . 30.5 m-20 -61.32 -48.63 80.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.157 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.897 ' HA ' HD11 ' A' ' 141' ' ' LEU . 21.4 t-80 -59.99 -51.43 69.71 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.861 0.362 . . . . 0.0 111.65 -178.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.906 HD23 ' HA ' ' A' ' 134' ' ' MET . 1.4 pp -58.76 -32.98 69.77 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.481 -177.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.959 HG11 ' HG2' ' A' ' 140' ' ' LYS . 8.2 p -82.07 20.56 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-O 123.085 1.421 . . . . 0.0 108.854 175.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.826 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 59.44 14.66 28.43 Favored Glycine 0 CA--C 1.49 -1.474 0 CA-C-N 112.178 -2.283 . . . . 0.0 112.622 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.959 ' HG2' HG11 ' A' ' 138' ' ' VAL . 8.5 ptmt -103.71 116.25 31.98 Favored 'General case' 0 N--CA 1.426 -1.65 0 C-N-CA 119.466 -0.893 . . . . 0.0 108.816 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.897 HD11 ' HA ' ' A' ' 136' ' ' HIS . 7.7 mp -128.88 141.83 51.16 Favored 'General case' 0 N--CA 1.446 -0.666 0 O-C-N 121.266 -0.896 . . . . 0.0 108.61 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.61 ' HB2' ' CG1' ' A' ' 100' ' ' VAL . 7.2 m-85 -63.53 -34.89 78.79 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.061 0.392 . . . . 0.0 111.509 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.856 ' HA ' ' HG ' ' A' ' 146' ' ' LEU . 15.9 tmm? -55.73 -25.39 40.21 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.508 0.67 . . . . 0.0 110.711 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -52.26 -23.83 6.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.845 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -122.0 41.64 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.732 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.856 ' HG ' ' HA ' ' A' ' 143' ' ' MET . 40.5 mt -93.57 139.85 30.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.876 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 83.2 p . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.999 179.492 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' BB2 . . . . . 0.934 ' H27' ' HG2' ' A' ' 88' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 80.2 p . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.878 0.37 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.587 HG13 ' HA ' ' A' ' 37' ' ' THR . 30.5 m -84.17 133.93 28.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.428 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.824 HD13 ' O ' ' A' ' 51' ' ' VAL . 3.0 pp -79.63 -172.4 3.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.565 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.757 ' N ' HD11 ' A' ' 3' ' ' LEU . 40.8 tt0 -82.37 108.98 16.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.782 0.325 . . . . 0.0 110.454 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.9 t -88.42 129.85 38.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.385 0.612 . . . . 0.0 112.03 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.961 HD12 ' HA ' ' A' ' 52' ' ' ASP . 23.7 mt -88.15 147.39 24.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.655 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.436 ' HA ' ' O ' ' A' ' 92' ' ' SER . 47.5 m-70 -128.19 146.06 50.84 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.782 HD12 ' CD1' ' A' ' 13' ' ' LEU . 3.3 mp -64.22 135.23 96.24 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.205 177.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.39 140.83 58.48 Favored 'Cis proline' 0 C--N 1.352 0.741 0 C-N-CA 124.253 -1.145 . . . . 0.0 111.804 -0.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.875 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.7 t70 -160.85 125.17 3.56 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.475 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.553 ' HG2' ' N ' ' A' ' 12' ' ' ARG . 2.7 pm0 -57.8 -43.81 85.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.418 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.643 ' HE ' ' HE3' ' A' ' 15' ' ' LYS . 15.5 mmt85 -55.99 -30.05 61.2 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.934 HD12 ' HB3' ' A' ' 92' ' ' SER . 9.8 mt -77.1 -32.7 56.79 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 120.891 1.678 . . . . 0.0 108.661 177.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.594 HH12 ' HA ' ' A' ' 144' ' ' ASP . 15.9 mmt180 -91.66 8.83 34.98 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 113.998 -1.455 . . . . 0.0 109.165 179.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.643 ' HE3' ' HE ' ' A' ' 12' ' ' ARG . 24.9 ttmm -91.26 148.05 22.62 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.05 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.64 HG13 HG23 ' A' ' 138' ' ' VAL . 85.5 t -82.78 129.83 36.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.789 ' HB2' ' HG3' ' A' ' 56' ' ' ARG . . . -90.45 144.31 25.92 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.384 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.755 ' HD3' ' CD ' ' A' ' 19' ' ' PRO . 2.0 tmtp? -106.35 133.14 20.37 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.755 ' CD ' ' HD3' ' A' ' 18' ' ' LYS . 45.7 Cg_endo -82.09 114.71 2.57 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 121.934 1.756 . . . . 0.0 110.73 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.607 HG13 ' N ' ' A' ' 21' ' ' GLU . 16.0 t -67.68 144.33 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 CA-C-O 122.574 1.178 . . . . 0.0 113.247 -175.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.607 ' N ' HG13 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -63.82 -23.45 67.36 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 112.924 -1.944 . . . . 0.0 112.639 -179.298 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -158.67 144.51 16.72 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.13 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.907 ' CG2' HD21 ' A' ' 111' ' ' LEU . 3.1 t -81.45 107.4 13.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -178.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.981 ' HB2' HD12 ' A' ' 27' ' ' ILE . 55.0 m-80 -95.38 157.79 15.74 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.769 -178.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.516 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -55.18 -24.22 25.73 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.282 0.563 . . . . 0.0 110.808 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.488 ' O ' HD12 ' A' ' 30' ' ' ILE . 70.8 mm-40 -74.45 -44.92 49.52 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 177.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.981 HD12 ' HB2' ' A' ' 24' ' ' ASN . 2.0 mp -64.72 -34.34 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 113.793 -1.548 . . . . 0.0 110.153 178.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.507 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 75.0 mt-30 -68.16 -40.59 82.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 122.297 -0.252 . . . . 0.0 110.713 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 40.3 mmt180 -61.44 -39.3 90.33 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.85 ' CG2' HD11 ' A' ' 53' ' ' ILE . 1.6 mp -57.75 -48.53 83.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.087 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.575 ' CG1' HG23 ' A' ' 71' ' ' VAL . 27.6 t -68.11 -42.26 84.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.97 0.414 . . . . 0.0 111.156 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.831 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -56.39 -42.19 77.5 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.058 -179.254 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.491 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 17.5 m-20 -75.78 -30.11 58.98 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.261 176.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.817 ' HE1' ' O ' ' A' ' 57' ' ' ILE . 87.6 mtp -60.92 -46.27 91.33 Favored 'General case' 0 C--N 1.345 0.395 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.516 -177.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.831 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 13.5 p90 -69.59 -45.91 67.53 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.583 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 29.4 mm-40 -52.51 -38.44 59.61 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.587 ' HA ' HG13 ' A' ' 2' ' ' VAL . 61.6 m -69.9 -62.23 1.47 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.487 -1.233 . . . . 0.0 107.857 178.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 1.015 ' HE3' ' HB2' ' A' ' 61' ' ' ASP . 3.7 ttp -46.65 -41.85 15.43 Favored 'General case' 0 CA--C 1.461 -2.472 0 C-N-CA 124.042 0.937 . . . . 0.0 110.72 -171.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.704 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 70.9 m-85 -70.48 -42.32 71.55 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.38 178.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.549 ' HB1' HG13 ' A' ' 2' ' ' VAL . . . -61.4 -24.31 66.42 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.358 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 1.091 ' HG2' HD12 ' A' ' 91' ' ' LEU . 3.1 tp10 -89.05 -10.7 46.49 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 114.47 -1.241 . . . . 0.0 108.566 177.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 62.96 26.7 15.65 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.818 -176.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.97 145.17 26.91 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.974 178.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.987 HG21 HG23 ' A' ' 62' ' ' VAL . 44.1 mm -79.3 -1.56 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 117.418 0.609 . . . . 0.0 112.028 -178.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.847 ' HA3' ' C10' ' A' ' 149' ' ' BB2 . . . 177.54 142.06 4.38 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -178.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.959 HD11 ' HG ' ' A' ' 91' ' ' LEU . 4.7 tp -126.21 135.63 51.85 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.528 1.664 . . . . 0.0 110.479 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -105.9 132.2 52.29 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.526 ' HB1' ' CG1' ' A' ' 53' ' ' ILE . . . -28.73 -56.76 0.13 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 -178.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 1.008 HG22 ' HA ' ' A' ' 137' ' ' LEU . 67.6 p -53.17 -34.64 57.78 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 121.953 0.883 . . . . 0.0 111.164 -178.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.718 ' HB2' HD13 ' A' ' 46' ' ' LEU . 50.3 mt-30 -63.94 -43.83 94.67 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.25 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.824 ' O ' HD13 ' A' ' 3' ' ' LEU . 1.0 OUTLIER -86.76 15.07 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.961 ' HA ' HD12 ' A' ' 6' ' ' LEU . 36.5 t70 78.29 27.87 0.5 Allowed 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 176.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.937 HD13 ' HB ' ' A' ' 57' ' ' ILE . 10.7 pt -119.36 109.83 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 C-N-CA 119.045 -1.062 . . . . 0.0 110.858 177.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.578 ' HB3' ' HD2' ' A' ' 15' ' ' LYS . 25.2 p-80 -75.84 49.18 0.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 122.063 0.935 . . . . 0.0 109.946 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.456 ' H ' ' C ' ' A' ' 53' ' ' ILE . 27.9 mt-30 -136.48 130.62 32.83 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.789 ' HG3' ' HB2' ' A' ' 17' ' ' ALA . 60.3 mtp85 -62.46 75.14 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.937 ' HB ' HD13 ' A' ' 53' ' ' ILE . 15.0 mt -119.83 124.62 73.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 1.038 HD11 ' HG2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -131.57 148.5 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -178.069 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.568 ' CG2' ' HB3' ' A' ' 46' ' ' LEU . 32.8 m -124.34 138.85 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 1.02 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 6.1 mm -113.57 150.86 15.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-O 121.739 0.781 . . . . 0.0 110.137 -179.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 1.015 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 36.1 t70 -140.16 27.6 2.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.895 -177.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.987 HG23 HG21 ' A' ' 44' ' ' ILE . 41.1 t -92.5 108.86 20.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.219 178.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.517 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 63.0 m -35.95 85.4 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -175.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 62' ' ' VAL . 42.9 tt0 -48.67 -50.19 34.27 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.838 178.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -133.84 -67.1 0.61 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.123 178.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.418 ' HG2' HH11 ' A' ' 66' ' ' ARG . 69.3 mtt-85 -133.27 -42.86 0.86 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.174 0.512 . . . . 0.0 110.374 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -105.65 133.99 49.49 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.167 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.517 ' HG2' ' HA ' ' A' ' 63' ' ' SER . 92.0 mt-10 -86.75 130.6 34.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.197 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.615 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 34.3 ttp85 177.17 66.76 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.863 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 1.02 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 62.0 mt -106.79 135.43 48.34 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-O 120.692 0.282 . . . . 0.0 111.431 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.836 HG22 ' HB2' ' A' ' 113' ' ' ARG . 12.7 p -134.94 135.16 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.25 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.944 ' HB2' HD12 ' A' ' 58' ' ' ILE . 3.2 mm? -141.63 144.35 34.13 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 177.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.967 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.5 mp -124.33 135.78 62.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.9 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.69 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 6.1 m120 49.57 35.48 0.28 Allowed Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 178.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 1.038 ' HG2' HD11 ' A' ' 58' ' ' ILE . 80.2 Cg_exo -60.91 157.18 39.72 Favored 'Trans proline' 0 N--CA 1.485 1.02 0 C-N-CA 122.809 2.34 . . . . 0.0 114.761 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -138.05 141.78 40.33 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 1.022 HD12 ' HE3' ' A' ' 80' ' ' LYS . 1.5 tt -80.23 131.64 35.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.151 0.5 . . . . 0.0 111.369 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.795 ' CD2' ' HG3' ' A' ' 109' ' ' ARG . 2.7 mm? -104.24 -39.06 6.64 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.872 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.62 ' O ' HD21 ' A' ' 77' ' ' LEU . 40.0 tp10 -152.68 152.01 31.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.138 0.495 . . . . 0.0 111.521 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 1.022 ' HE3' HD12 ' A' ' 77' ' ' LEU . 9.2 ptpp? -147.67 148.48 31.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.437 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.8 m -158.58 147.8 19.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.254 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.647 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 73.23 158.67 4.93 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.495 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -133.92 114.38 13.22 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 122.292 1.044 . . . . 0.0 113.356 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.63 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.7 p -103.73 162.11 13.36 Favored 'General case' 0 CA--C 1.488 -1.435 0 CA-C-N 113.244 -1.798 . . . . 0.0 115.232 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.718 ' O ' HD11 ' A' ' 86' ' ' ILE . . . -148.29 117.9 0.93 Allowed Glycine 0 C--N 1.314 -0.66 0 CA-C-N 112.54 -2.118 . . . . 0.0 110.418 177.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.718 HD11 ' O ' ' A' ' 85' ' ' GLY . 48.3 mm -147.04 138.47 18.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 117.297 0.549 . . . . 0.0 111.284 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 56.3 mt-10 -72.26 139.0 47.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 123.297 1.523 . . . . 0.0 111.613 -176.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 1.009 ' HG2' ' H27' ' A' ' 149' ' ' BB2 . 47.2 mt-10 -155.92 161.42 40.55 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 112.693 -2.049 . . . . 0.0 111.392 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.94 ' O ' ' H51' ' A' ' 149' ' ' BB2 . . . -120.15 165.51 13.64 Favored Glycine 0 CA--C 1.496 -1.127 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.788 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 20.5 m -114.92 137.08 52.39 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.512 0.672 . . . . 0.0 112.331 -177.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 1.091 HD12 ' HG2' ' A' ' 41' ' ' GLU . 2.3 mm? -46.77 -40.35 13.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.453 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.934 ' HB3' HD12 ' A' ' 13' ' ' LEU . 51.0 m -78.18 -27.51 47.97 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.091 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 1.085 HG23 ' HD2' ' A' ' 94' ' ' PRO . 54.4 mt -85.54 150.39 53.82 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 1.085 ' HD2' HG23 ' A' ' 93' ' ' ILE . 94.4 Cg_endo -71.96 44.84 0.69 Allowed 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 122.18 1.92 . . . . 0.0 114.885 -178.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.554 ' HB2' ' O ' ' A' ' 94' ' ' PRO . 0.3 OUTLIER 74.53 15.59 3.35 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 178.198 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.66 ' HG3' ' HG2' ' A' ' 94' ' ' PRO . 25.9 mt-30 -78.41 89.62 4.41 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.803 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 47.9 mtm-85 -84.37 132.5 34.59 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.837 0.827 . . . . 0.0 111.892 -178.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -135.74 153.68 51.49 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.492 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.577 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.3 tt -76.34 114.23 14.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.61 0.719 . . . . 0.0 111.752 -178.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 1.027 HG21 ' HB3' ' A' ' 142' ' ' PHE . 13.7 p -106.56 129.66 24.11 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 114.931 -1.031 . . . . 0.0 112.181 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.63 ' HA ' ' O ' ' A' ' 84' ' ' THR . 1.1 Cg_endo -84.22 127.09 3.88 Favored 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 123.56 2.84 . . . . 0.0 113.921 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.902 ' NE ' HG11 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -143.82 167.61 21.91 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.512 1.125 . . . . 0.0 109.471 179.12 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.36 155.33 40.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 118.357 0.526 . . . . 0.0 109.969 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -73.63 -41.94 62.11 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.972 -175.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.699 ' O ' HG12 ' A' ' 106' ' ' VAL . 61.3 mttp -140.04 140.54 36.19 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.381 0.61 . . . . 0.0 109.573 177.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.85 HG22 ' CG ' ' A' ' 131' ' ' GLN . 22.5 m -151.36 140.2 14.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.598 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.954 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 52.8 mmtt -107.34 126.34 52.33 Favored 'General case' 0 CA--C 1.524 -0.026 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.872 HG23 ' HA ' ' A' ' 77' ' ' LEU . 1.7 pp -135.72 154.06 33.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -176.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.795 ' HG3' ' CD2' ' A' ' 78' ' ' LEU . 50.1 mtm180 -103.07 139.53 38.48 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.532 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.905 ' HB2' ' HG3' ' A' ' 75' ' ' PRO . . . -160.45 169.73 22.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.642 -176.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.967 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.3 pp -118.26 151.44 37.66 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.64 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 8.5 t70 -87.64 161.44 17.68 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.257 -176.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.836 ' HB2' HG22 ' A' ' 71' ' ' VAL . 52.0 ttp85 -52.74 -17.28 1.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.099 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.56 -29.32 46.21 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.799 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.509 ' HA2' HG22 ' A' ' 23' ' ' VAL . . . 109.2 35.58 2.29 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.45 -0.881 . . . . 0.0 113.24 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -128.79 102.99 19.26 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 121.177 -0.209 . . . . 0.0 110.972 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.589 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.3 Cg_exo -73.76 115.1 4.21 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 121.553 1.502 . . . . 0.0 114.757 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.64 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 11.0 p90 -127.38 169.01 14.05 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.442 -177.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.638 ' HG2' ' CG ' ' A' ' 109' ' ' ARG . 31.1 mt-10 -106.65 129.9 54.48 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.707 HD22 HD12 ' A' ' 72' ' ' LEU . 4.3 pp -125.72 134.66 51.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.476 -178.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.954 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 15.3 pt-20 -92.99 123.88 36.56 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.636 178.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.949 ' HB3' HD13 ' A' ' 126' ' ' LEU . . . -117.71 134.01 55.34 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.696 ' CA ' ' HB3' ' A' ' 127' ' ' ALA . 22.9 m-20 -126.96 162.86 24.97 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.747 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 50.92 -136.68 28.97 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 120.265 1.393 . . . . 0.0 115.658 177.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.964 ' H ' HD13 ' A' ' 125' ' ' LEU . 4.7 mp -55.23 -33.24 62.94 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.684 -0.758 . . . . 0.0 111.706 -178.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.949 HD13 ' HB3' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -71.03 -52.12 21.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.866 0.841 . . . . 0.0 109.203 179.692 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.732 ' O ' ' HG3' ' A' ' 131' ' ' GLN . . . -59.01 -41.23 87.2 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.194 -1.366 . . . . 0.0 111.703 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.747 HG12 ' O ' ' A' ' 124' ' ' GLY . 50.5 mm -68.43 -54.99 17.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.841 ' HB2' ' H91' ' A' ' 149' ' ' BB2 . 30.4 p -58.13 -47.73 82.39 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.844 HD11 ' CD1' ' A' ' 108' ' ' ILE . 19.5 tt -59.05 -44.03 90.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.867 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.85 ' CG ' HG22 ' A' ' 106' ' ' VAL . 69.5 mt-30 -64.72 -44.94 88.57 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 178.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.602 ' CD2' ' HN1' ' A' ' 149' ' ' BB2 . 76.0 t60 -56.44 -47.75 78.45 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.243 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.795 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 3.3 mm-40 -60.23 -38.86 84.7 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 110.552 -0.166 . . . . 0.0 110.552 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.851 ' HE3' ' HB2' ' A' ' 77' ' ' LEU . 28.4 mtm -58.77 -45.66 89.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 122.338 1.066 . . . . 0.0 109.384 177.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.919 ' O ' HG11 ' A' ' 138' ' ' VAL . 0.9 OUTLIER -66.58 -48.55 69.25 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.999 179.394 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.651 ' CE1' ' HG2' ' A' ' 50' ' ' GLN . 7.8 t-80 -57.15 -53.0 63.06 Favored 'General case' 0 C--N 1.32 -0.712 0 O-C-N 121.512 -0.742 . . . . 0.0 111.491 -178.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 1.008 ' HA ' HG22 ' A' ' 49' ' ' THR . 0.2 OUTLIER -65.17 -27.85 69.0 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 119.908 -0.717 . . . . 0.0 111.903 -179.449 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.919 HG11 ' O ' ' A' ' 135' ' ' ASP . 10.9 p -81.16 23.62 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-O 122.056 0.932 . . . . 0.0 109.211 175.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.526 ' H ' ' C ' ' A' ' 137' ' ' LEU . . . 67.94 3.67 30.44 Favored Glycine 0 CA--C 1.486 -1.752 0 CA-C-N 113.793 -1.549 . . . . 0.0 113.245 175.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.89 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 10.4 ptmt -97.95 135.03 40.25 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.826 HD12 ' O ' ' A' ' 140' ' ' LYS . 10.5 mp -139.33 149.55 44.34 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -178.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 1.027 ' HB3' HG21 ' A' ' 100' ' ' VAL . 9.6 p90 -54.36 -35.07 62.38 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.576 ' HE3' HG12 ' A' ' 8' ' ' ILE . 56.5 ttp -61.22 -28.31 69.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.158 0.504 . . . . 0.0 110.745 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.594 ' HA ' HH12 ' A' ' 14' ' ' ARG . 9.0 t70 -59.94 -25.24 65.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.919 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -121.05 14.4 11.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.413 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.407 ' HB2' ' HA ' ' A' ' 143' ' ' MET . 1.8 mp -91.15 139.43 30.76 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.672 0.272 . . . . 0.0 110.906 179.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 63.7 m . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.891 179.344 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' BB2 . . . . . 1.037 H173 HD11 ' A' ' 91' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 79.7 p . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.865 0.364 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.591 HG12 ' HB1' ' A' ' 40' ' ' ALA . 30.9 m -84.09 138.12 19.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.643 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.968 HD13 ' HB ' ' A' ' 51' ' ' VAL . 3.1 pp -79.03 -179.09 6.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.246 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.614 ' N ' HD11 ' A' ' 3' ' ' LEU . 2.2 tp-100 -80.63 108.8 14.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.753 0.311 . . . . 0.0 110.883 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.589 ' CG2' HG23 ' A' ' 37' ' ' THR . 46.6 t -89.21 131.64 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-O 121.216 0.531 . . . . 0.0 111.366 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.952 HD12 ' HA ' ' A' ' 52' ' ' ASP . 26.1 mt -85.21 143.22 28.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.463 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 26.0 m-70 -116.64 144.11 44.8 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.507 0.67 . . . . 0.0 112.63 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.633 HD12 ' CD1' ' A' ' 13' ' ' LEU . 42.8 mm -53.45 144.04 33.86 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.707 178.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.485 ' CA ' HG23 ' A' ' 8' ' ' ILE . 64.3 Cg_endo -93.49 54.12 0.94 Allowed 'Cis proline' 0 C--N 1.356 0.933 0 C-N-CA 124.727 -0.947 . . . . 0.0 113.036 0.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.922 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 9.8 t70 -55.32 134.55 50.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.037 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.423 ' HG2' ' N ' ' A' ' 12' ' ' ARG . 0.7 OUTLIER -59.65 -42.76 93.52 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.961 0.41 . . . . 0.0 111.213 -179.495 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.684 ' HB2' HD11 ' A' ' 6' ' ' LEU . 14.0 mmt85 -59.19 -23.53 62.32 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.922 ' HG ' ' HB3' ' A' ' 10' ' ' ASP . 9.2 mt -76.22 -32.7 59.07 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 120.172 1.351 . . . . 0.0 107.692 177.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 16.3 mmm180 -90.86 3.17 55.23 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 113.857 -1.52 . . . . 0.0 109.554 178.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.839 ' HE2' ' HD1' ' A' ' 54' ' ' HIS . 62.3 tttp -82.09 146.88 29.4 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.671 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.51 HG13 HG23 ' A' ' 138' ' ' VAL . 96.4 t -82.14 135.4 25.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.756 ' HB2' ' HG2' ' A' ' 56' ' ' ARG . . . -91.4 139.68 30.48 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -103.21 130.57 23.37 Favored Pre-proline 0 C--N 1.322 -0.612 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.316 178.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.478 ' HD3' ' CD ' ' A' ' 56' ' ' ARG . 67.9 Cg_endo -77.11 114.75 3.85 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.032 1.821 . . . . 0.0 110.454 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.623 HG13 ' N ' ' A' ' 21' ' ' GLU . 17.4 t -68.98 144.51 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-O 122.426 1.108 . . . . 0.0 113.308 -176.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.623 ' N ' HG13 ' A' ' 20' ' ' VAL . 69.6 mm-40 -63.65 -24.35 67.75 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 113.443 -1.708 . . . . 0.0 112.073 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.432 ' O ' HG11 ' A' ' 20' ' ' VAL . 88.8 tt0 -161.03 143.46 12.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.875 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.874 HG23 HD13 ' A' ' 111' ' ' LEU . 3.2 t -78.88 107.24 11.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.894 ' HB2' HD13 ' A' ' 27' ' ' ILE . 56.2 m-80 -91.36 159.9 15.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.317 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.588 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -56.81 -29.14 62.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.927 0.394 . . . . 0.0 110.941 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 1.039 ' HG2' HH22 ' A' ' 29' ' ' ARG . 94.7 mt-10 -71.88 -42.83 66.35 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.894 HD13 ' HB2' ' A' ' 24' ' ' ASN . 1.8 mp -62.28 -45.93 97.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.791 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.655 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 54.5 mt-30 -57.38 -40.22 77.7 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.501 178.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 1.039 HH22 ' HG2' ' A' ' 26' ' ' GLU . 75.9 mtm-85 -61.76 -38.83 89.46 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.908 HG22 HD11 ' A' ' 57' ' ' ILE . 1.6 mp -58.77 -49.12 83.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.056 178.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.698 HG13 ' CG2' ' A' ' 71' ' ' VAL . 5.3 t -65.97 -42.19 91.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.527 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.837 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 21.5 m-20 -54.43 -45.04 72.93 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.838 -179.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.484 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 54.4 m-20 -74.88 -30.72 61.39 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.64 176.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.796 ' HG2' HG23 ' A' ' 51' ' ' VAL . 79.7 mtp -59.88 -47.18 86.81 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.543 -177.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.837 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 14.4 p90 -69.31 -43.85 72.93 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.759 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 75.0 mt-10 -51.91 -41.89 62.34 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.589 HG23 ' CG2' ' A' ' 5' ' ' VAL . 57.2 m -68.51 -60.27 2.55 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 119.105 -1.038 . . . . 0.0 108.608 178.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 1.05 ' HE3' ' HB2' ' A' ' 61' ' ' ASP . 3.6 ttp -47.12 -42.42 19.16 Favored 'General case' 0 CA--C 1.466 -2.262 0 O-C-N 124.118 0.886 . . . . 0.0 109.729 -170.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.713 ' OH ' ' HA ' ' A' ' 69' ' ' ARG . 68.6 m-85 -69.32 -42.37 75.47 Favored 'General case' 0 C--N 1.285 -2.233 0 O-C-N 124.101 0.876 . . . . 0.0 110.578 178.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.591 ' HB1' HG12 ' A' ' 2' ' ' VAL . . . -60.09 -28.86 68.17 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.925 ' HG2' HD22 ' A' ' 91' ' ' LEU . 3.1 tp10 -84.1 -10.79 57.53 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.484 -1.234 . . . . 0.0 108.777 177.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 62.8 25.1 14.92 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.74 -176.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.73 145.17 29.79 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 114.142 -1.39 . . . . 0.0 110.524 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 1.02 HG21 HG22 ' A' ' 62' ' ' VAL . 46.0 mm -77.96 -2.5 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 117.621 0.711 . . . . 0.0 111.687 -178.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.998 ' HA3' H101 ' A' ' 149' ' ' BB2 . . . 176.29 138.34 2.85 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-O 119.045 -0.864 . . . . 0.0 111.552 -178.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.941 HD12 ' HG ' ' A' ' 91' ' ' LEU . 9.2 tp -125.6 135.03 51.75 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 118.821 1.311 . . . . 0.0 110.744 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -103.87 132.75 49.82 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.646 0.26 . . . . 0.0 111.553 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.704 ' HB3' ' O ' ' A' ' 57' ' ' ILE . . . -30.72 -56.14 0.21 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -177.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.682 ' CG2' ' HA ' ' A' ' 137' ' ' LEU . 42.9 p -52.92 -35.38 58.32 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 122.168 0.985 . . . . 0.0 110.876 -178.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.552 ' HG2' ' CE1' ' A' ' 136' ' ' HIS . 15.8 mt-30 -64.58 -39.44 93.75 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.666 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.968 ' HB ' HD13 ' A' ' 3' ' ' LEU . 1.7 m -88.25 14.76 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.952 ' HA ' HD12 ' A' ' 6' ' ' LEU . 37.5 t70 79.11 31.45 0.29 Allowed 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 176.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.968 HD12 HD11 ' A' ' 57' ' ' ILE . 1.2 pp -126.45 111.22 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.446 177.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.839 ' HD1' ' HE2' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -75.55 64.17 1.61 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.976 0.893 . . . . 0.0 110.518 -179.278 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.802 ' O ' HD11 ' A' ' 53' ' ' ILE . 88.0 mt-30 -153.54 135.21 14.44 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.444 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.756 ' HG2' ' HB2' ' A' ' 17' ' ' ALA . 75.2 mtp180 -64.66 69.04 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -178.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.968 HD11 HD12 ' A' ' 53' ' ' ILE . 7.2 mt -112.14 123.26 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.797 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -130.72 147.4 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-O 121.811 0.815 . . . . 0.0 112.783 -178.253 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.601 HG22 ' H ' ' A' ' 46' ' ' LEU . 34.0 m -129.08 137.96 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.44 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.907 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 1.8 mt -116.81 149.3 19.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.718 0.77 . . . . 0.0 111.262 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 1.05 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 33.8 t70 -136.84 31.95 2.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.449 -1.251 . . . . 0.0 110.35 -178.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 1.02 HG22 HG21 ' A' ' 44' ' ' ILE . 24.0 t -96.22 110.43 24.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.953 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.699 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 56.0 m -36.33 78.84 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -176.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.742 ' OE1' HD13 ' A' ' 70' ' ' LEU . 39.0 tt0 -65.76 -22.03 66.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.121 178.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.511 ' ND2' ' H ' ' A' ' 66' ' ' ARG . 52.0 t30 -167.25 -126.3 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.417 177.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.511 ' H ' ' ND2' ' A' ' 65' ' ' ASN . 99.3 mtt180 -74.2 -54.56 7.48 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.773 -178.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -106.35 133.15 51.48 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.699 ' HG2' ' HA ' ' A' ' 63' ' ' SER . 56.0 mt-10 -85.18 127.8 34.42 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.496 178.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.713 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 40.1 ttm-85 177.12 71.84 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.907 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 3.7 mm? -103.32 132.29 49.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.913 0.387 . . . . 0.0 111.872 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.941 HG21 ' HB2' ' A' ' 113' ' ' ARG . 11.5 p -134.33 130.95 54.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.981 178.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.851 HD22 HD22 ' A' ' 120' ' ' LEU . 10.5 mp -139.88 140.02 36.38 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.938 -0.119 . . . . 0.0 111.019 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.984 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.6 mp -119.93 134.47 63.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.678 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 8.2 m120 54.43 35.93 0.31 Allowed Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.73 ' HG2' HG22 ' A' ' 58' ' ' ILE . 91.1 Cg_exo -55.3 148.56 50.14 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.752 2.301 . . . . 0.0 113.607 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.676 ' HG3' HD23 ' A' ' 78' ' ' LEU . 15.7 pt-20 -135.83 144.25 45.58 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.894 HD21 ' N ' ' A' ' 78' ' ' LEU . 1.8 tt -83.49 135.18 34.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.385 0.612 . . . . 0.0 111.02 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.97 HD21 ' HG3' ' A' ' 109' ' ' ARG . 3.3 mm? -116.76 -31.95 5.3 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.65 -178.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 36.6 tt0 -160.33 151.81 19.6 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.17 0.51 . . . . 0.0 111.854 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.814 ' CB ' HG13 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -148.39 151.78 35.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.088 178.792 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 81.0 p -160.36 145.2 14.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.73 0.3 . . . . 0.0 111.5 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.8 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 75.52 169.89 27.13 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.43 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 102' ' ' ARG . 52.3 mm-40 -146.78 114.71 6.52 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.801 0.81 . . . . 0.0 113.152 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.599 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.4 p -97.03 160.1 14.53 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 178.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.735 ' O ' HD11 ' A' ' 86' ' ' ILE . . . -137.99 100.53 0.31 Allowed Glycine 0 CA--C 1.522 0.52 0 CA-C-N 113.186 -1.825 . . . . 0.0 111.394 178.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.777 ' N ' HH12 ' A' ' 102' ' ' ARG . 47.7 mm -147.75 141.14 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.578 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 55.4 mt-10 -72.72 143.21 48.11 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 122.359 1.076 . . . . 0.0 112.437 -177.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.895 ' HG2' ' H27' ' A' ' 149' ' ' BB2 . 54.6 mt-10 -155.77 162.78 40.45 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.157 -1.383 . . . . 0.0 109.768 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.781 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -120.23 160.49 14.83 Favored Glycine 0 CA--C 1.5 -0.857 0 C-N-CA 119.456 -1.355 . . . . 0.0 111.223 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.794 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 57.1 m -110.16 139.68 45.05 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.691 0.281 . . . . 0.0 110.668 -177.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.941 ' HG ' HD12 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -52.43 -31.25 33.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.494 0.664 . . . . 0.0 109.855 179.72 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.594 ' HB3' ' CD1' ' A' ' 13' ' ' LEU . 49.8 m -77.74 -29.44 51.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.711 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 1.097 HG21 ' HD2' ' A' ' 94' ' ' PRO . 58.0 mt -85.45 148.46 49.5 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 1.097 ' HD2' HG21 ' A' ' 93' ' ' ILE . 76.1 Cg_endo -74.87 48.09 1.88 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.296 1.997 . . . . 0.0 114.023 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.555 ' HB2' ' O ' ' A' ' 94' ' ' PRO . 50.9 mt-10 77.27 10.41 2.45 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 179.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.612 ' HG2' ' HG2' ' A' ' 94' ' ' PRO . 98.4 mm-40 -78.34 88.29 4.36 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.781 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 20.0 mtm105 -84.59 133.86 34.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.497 0.665 . . . . 0.0 111.384 -178.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.429 ' CB ' HD13 ' A' ' 146' ' ' LEU . . . -133.01 150.46 52.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.133 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.728 ' HG ' ' N ' ' A' ' 86' ' ' ILE . 6.7 tt -75.43 135.57 40.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.317 -179.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 1.002 HG23 ' HB3' ' A' ' 142' ' ' PHE . 46.1 t -136.94 138.58 26.27 Favored Pre-proline 0 N--CA 1.464 0.243 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.684 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.932 ' HG2' ' HE2' ' A' ' 145' ' ' TYR . 3.4 Cg_exo -80.49 125.48 5.67 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.408 2.072 . . . . 0.0 113.424 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 1.037 ' HE ' HG21 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -143.79 166.07 25.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.066 -1.424 . . . . 0.0 109.988 177.936 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.8 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.24 153.06 44.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.962 0.346 . . . . 0.0 110.583 -178.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.417 ' OE1' ' HA ' ' A' ' 104' ' ' GLU . 5.1 tp10 -74.29 -41.97 60.33 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.638 -176.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.806 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 48.6 mttp -139.8 137.93 35.42 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.61 0.719 . . . . 0.0 109.634 177.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.814 HG13 ' CB ' ' A' ' 80' ' ' LYS . 32.0 m -142.9 143.16 25.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.046 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.963 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 31.8 mmtm -107.48 125.58 51.43 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.84 HD13 ' HG ' ' A' ' 120' ' ' LEU . 2.1 pp -128.79 162.09 36.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -177.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.97 ' HG3' HD21 ' A' ' 78' ' ' LEU . 26.6 mtt-85 -116.03 139.4 50.31 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.624 ' CB ' HD23 ' A' ' 72' ' ' LEU . . . -158.98 168.26 27.23 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.671 0.272 . . . . 0.0 111.449 -178.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.984 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.1 pp -113.87 152.32 30.9 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.586 ' O ' HD11 ' A' ' 111' ' ' LEU . 15.7 t70 -88.58 162.75 16.2 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.021 -0.672 . . . . 0.0 111.569 -177.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.941 ' HB2' HG21 ' A' ' 71' ' ' VAL . 46.2 ttp180 -52.67 -18.91 2.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.969 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -78.96 -25.59 43.53 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.438 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 106.44 35.61 2.83 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.518 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -128.74 102.79 19.54 Favored Pre-proline 0 C--O 1.238 0.479 0 CA-C-N 117.036 0.418 . . . . 0.0 111.178 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.581 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.9 Cg_exo -73.28 115.27 4.28 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 121.838 1.692 . . . . 0.0 114.975 -177.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -124.52 168.43 13.1 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.712 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.509 ' HG2' ' HD3' ' A' ' 109' ' ' ARG . 23.0 mt-10 -107.79 131.61 54.28 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.851 HD22 HD22 ' A' ' 72' ' ' LEU . 3.9 pp -131.57 133.91 45.51 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.963 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 15.5 pt-20 -94.15 125.52 38.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.766 178.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.993 ' HB3' HD13 ' A' ' 126' ' ' LEU . . . -116.96 136.01 53.27 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.806 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.1 m-20 -126.3 164.44 21.03 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.683 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 45.55 -130.5 9.36 Favored Glycine 0 C--N 1.346 1.118 0 N-CA-C 116.431 1.332 . . . . 0.0 116.431 176.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.572 ' HB3' HG11 ' A' ' 62' ' ' VAL . 86.6 mt -55.18 -36.49 65.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.692 -0.754 . . . . 0.0 111.703 -178.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.993 HD13 ' HB3' ' A' ' 122' ' ' ALA . 0.3 OUTLIER -71.31 -52.9 16.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.471 0.653 . . . . 0.0 109.884 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.681 ' HB3' ' CA ' ' A' ' 123' ' ' ASP . . . -58.39 -46.01 87.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.913 -1.039 . . . . 0.0 112.163 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 1.037 HG21 ' HE ' ' A' ' 102' ' ' ARG . 49.3 mm -63.76 -56.04 19.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.807 0.336 . . . . 0.0 111.107 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 1.048 ' HB3' H112 ' A' ' 149' ' ' BB2 . 74.6 m -60.92 -50.53 73.04 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.812 HD11 HD11 ' A' ' 108' ' ' ILE . 20.3 tt -58.77 -43.73 88.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.328 -178.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.664 ' HG2' ' O ' ' A' ' 127' ' ' ALA . 22.9 pt20 -65.68 -37.63 87.04 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.497 ' CD2' ' CE1' ' A' ' 142' ' ' PHE . 10.3 t-160 -56.65 -48.87 76.61 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.281 179.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.886 ' CG ' H102 ' A' ' 149' ' ' BB2 . 2.8 mm-40 -60.93 -45.86 92.99 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 119.09 -0.481 . . . . 0.0 111.217 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.931 ' HA ' HD21 ' A' ' 137' ' ' LEU . 75.2 mtp -55.55 -47.78 75.8 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 118.965 0.802 . . . . 0.0 109.893 179.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.854 ' O ' HG11 ' A' ' 138' ' ' VAL . 1.1 m-20 -62.02 -48.49 80.05 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.376 178.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.807 ' CE1' HD22 ' A' ' 141' ' ' LEU . 10.4 t-80 -57.31 -49.99 74.34 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.294 0.569 . . . . 0.0 110.82 -178.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.931 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.5 pp -60.58 -30.51 69.86 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.032 -178.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.854 HG11 ' O ' ' A' ' 135' ' ' ASP . 12.9 p -81.78 22.18 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 CA-C-O 122.726 1.251 . . . . 0.0 109.051 175.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.589 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 70.85 -3.19 13.5 Favored Glycine 0 CA--C 1.494 -1.256 0 CA-C-N 112.629 -2.078 . . . . 0.0 113.035 176.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.796 ' C ' HD12 ' A' ' 141' ' ' LEU . 1.6 ptmt -90.0 121.17 31.84 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.807 HD22 ' CE1' ' A' ' 136' ' ' HIS . 6.7 mp -117.74 165.53 13.52 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 121.24 0.543 . . . . 0.0 111.469 -178.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 1.002 ' HB3' HG23 ' A' ' 100' ' ' VAL . 4.3 m-30 -54.93 -40.13 69.59 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.423 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.463 ' HB2' ' HE1' ' A' ' 143' ' ' MET . 47.4 ttm -56.79 -27.29 59.49 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.306 0.574 . . . . 0.0 110.93 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.429 ' HB3' ' O ' ' A' ' 141' ' ' LEU . 8.1 t70 -57.2 -22.89 44.01 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.07 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.932 ' HE2' ' HG2' ' A' ' 101' ' ' PRO . 22.8 t80 -111.2 5.05 19.72 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -177.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.429 HD13 ' CB ' ' A' ' 98' ' ' ALA . 96.1 mt -92.98 149.1 21.46 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 122.169 -0.332 . . . . 0.0 110.726 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 83.5 p . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.969 179.311 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' BB2 . . . . . 1.048 H112 ' HB3' ' A' ' 129' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 79.8 p . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.821 0.343 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.649 ' CG1' ' HA ' ' A' ' 37' ' ' THR . 30.8 m -84.03 131.9 32.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.417 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.824 ' CD2' ' HB ' ' A' ' 51' ' ' VAL . 3.0 pp -79.87 -169.51 2.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.696 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.715 ' N ' HD12 ' A' ' 3' ' ' LEU . 4.0 tp-100 -84.64 111.72 19.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.859 0.361 . . . . 0.0 110.053 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.7 t -88.51 127.79 41.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.371 0.605 . . . . 0.0 111.828 -178.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.972 HD13 ' HA ' ' A' ' 52' ' ' ASP . 23.1 mt -87.14 142.69 27.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.361 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.554 ' HA ' ' HB3' ' A' ' 92' ' ' SER . 34.7 m-70 -116.16 147.06 41.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.245 0.545 . . . . 0.0 111.992 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.98 HD12 HD11 ' A' ' 13' ' ' LEU . 38.4 mm -58.27 147.0 68.91 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.358 178.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.537 ' CA ' HG21 ' A' ' 8' ' ' ILE . 78.2 Cg_endo -93.22 52.38 1.04 Allowed 'Cis proline' 0 C--N 1.354 0.854 0 C-N-CA 124.504 -1.04 . . . . 0.0 113.02 0.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.841 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.7 t70 -55.15 136.04 48.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.083 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -58.88 -44.3 91.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.377 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.628 ' HB2' HD12 ' A' ' 6' ' ' LEU . 14.9 mmt85 -57.44 -25.63 59.94 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.98 HD11 HD12 ' A' ' 8' ' ' ILE . 11.2 mt -74.82 -32.71 62.03 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 119.828 1.195 . . . . 0.0 109.025 178.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.479 ' HG3' HH11 ' A' ' 14' ' ' ARG . 13.6 mmt85 -95.23 6.94 47.66 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.227 -1.352 . . . . 0.0 109.605 178.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.689 ' HD3' ' HB3' ' A' ' 54' ' ' HIS . 88.6 tttt -82.78 147.93 28.11 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.53 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.4 t -82.48 127.89 39.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.787 ' HB2' ' HG3' ' A' ' 56' ' ' ARG . . . -91.36 140.53 29.69 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.218 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -105.01 136.88 19.1 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.418 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.446 ' HA ' ' ND2' ' A' ' 74' ' ' ASN . 51.8 Cg_endo -82.13 113.97 2.47 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 121.656 1.571 . . . . 0.0 110.279 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.619 HG12 ' N ' ' A' ' 21' ' ' GLU . 16.7 t -68.11 144.68 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 CA-C-O 122.852 1.31 . . . . 0.0 113.271 -175.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.619 ' N ' HG12 ' A' ' 20' ' ' VAL . 52.0 mt-10 -60.33 -27.9 67.72 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 112.775 -2.011 . . . . 0.0 112.232 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -156.95 144.28 18.84 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.885 -178.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.957 HG22 HD11 ' A' ' 111' ' ' LEU . 3.2 t -80.11 106.51 11.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -178.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.999 ' HB2' HD12 ' A' ' 27' ' ' ILE . 59.4 m-80 -91.43 153.66 19.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.048 -178.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.692 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -54.79 -25.38 27.76 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.272 0.558 . . . . 0.0 110.819 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.473 ' O ' HD12 ' A' ' 30' ' ' ILE . 55.2 mt-10 -74.28 -42.64 59.26 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 177.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.999 HD12 ' HB2' ' A' ' 24' ' ' ASN . 1.9 mp -66.46 -34.63 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.101 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -68.32 -39.3 82.0 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.779 -0.192 . . . . 0.0 110.549 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.692 ' HG3' ' O ' ' A' ' 25' ' ' ALA . 99.1 mtt180 -63.7 -39.12 93.53 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.824 ' O ' ' HG3' ' A' ' 34' ' ' MET . 1.6 mp -56.0 -48.47 78.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.826 178.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.717 HG23 ' CG2' ' A' ' 57' ' ' ILE . 15.0 t -67.14 -40.1 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.463 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.802 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 48.3 m-20 -52.85 -47.6 67.65 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.937 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.53 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 14.1 m-20 -74.44 -28.91 61.26 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.807 176.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.869 ' HG2' HG22 ' A' ' 51' ' ' VAL . 86.9 mtp -59.62 -47.04 87.16 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.169 -177.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.802 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 19.8 p90 -70.33 -46.17 64.73 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 176.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.633 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 3.8 mm-40 -52.25 -39.54 60.48 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.635 0.731 . . . . 0.0 109.182 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.649 ' HA ' ' CG1' ' A' ' 2' ' ' VAL . 76.5 m -69.14 -61.17 1.9 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.273 -1.33 . . . . 0.0 107.992 178.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.914 ' HE3' ' HB2' ' A' ' 61' ' ' ASP . 3.6 ttp -46.79 -41.1 14.87 Favored 'General case' 0 CA--C 1.46 -2.482 0 C-N-CA 124.535 1.134 . . . . 0.0 110.501 -172.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.755 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 60.3 m-85 -69.11 -42.79 75.62 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.097 178.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.6 ' HB1' HG13 ' A' ' 2' ' ' VAL . . . -61.62 -24.77 66.93 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.566 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 1.037 ' HG2' HD13 ' A' ' 91' ' ' LEU . 11.1 tp10 -87.97 -11.71 46.65 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.407 -1.269 . . . . 0.0 108.368 176.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 63.34 27.4 15.35 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-O 122.019 0.914 . . . . 0.0 109.855 -176.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.02 145.31 26.97 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 113.781 -1.554 . . . . 0.0 110.799 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.795 ' CG2' HG23 ' A' ' 62' ' ' VAL . 45.5 mm -79.34 -0.41 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 117.497 0.648 . . . . 0.0 111.931 -178.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.854 ' HA3' H113 ' A' ' 149' ' ' BB2 . . . 175.39 140.03 3.26 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 1.006 HD11 ' HG ' ' A' ' 91' ' ' LEU . 3.9 tp -124.45 136.74 54.27 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.396 1.598 . . . . 0.0 110.821 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.41 131.72 51.46 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.416 0.15 . . . . 0.0 111.165 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.659 ' HB1' ' CD1' ' A' ' 53' ' ' ILE . . . -31.06 -55.81 0.23 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 115.802 1.779 . . . . 0.0 115.802 -177.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.777 ' CG2' ' HA ' ' A' ' 137' ' ' LEU . 69.3 p -53.17 -35.39 59.75 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.665 0.745 . . . . 0.0 111.631 -177.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.733 ' HB2' HD13 ' A' ' 46' ' ' LEU . 64.6 mt-30 -64.02 -43.43 95.65 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.405 -1.271 . . . . 0.0 110.127 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.869 HG22 ' HG2' ' A' ' 34' ' ' MET . 0.8 OUTLIER -83.16 15.49 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.972 ' HA ' HD13 ' A' ' 6' ' ' LEU . 36.9 t70 77.29 28.65 0.6 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 176.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.81 HD11 ' O ' ' A' ' 55' ' ' GLN . 1.1 pp -122.73 110.78 27.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.982 177.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.689 ' HB3' ' HD3' ' A' ' 15' ' ' LYS . 21.5 p-80 -76.51 62.65 1.92 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 122.102 0.953 . . . . 0.0 110.376 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.81 ' O ' HD11 ' A' ' 53' ' ' ILE . 89.4 mt-30 -151.37 133.19 14.97 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.066 -1.425 . . . . 0.0 107.468 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.854 HH21 HG21 ' A' ' 138' ' ' VAL . 98.8 mtt180 -65.02 70.99 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -177.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.798 ' O ' ' HE1' ' A' ' 34' ' ' MET . 30.6 mm -113.95 124.33 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.925 HD12 ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -128.62 148.58 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -177.673 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.714 HG21 ' H ' ' A' ' 46' ' ' LEU . 30.8 m -129.29 140.35 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.71 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 1.107 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 9.5 mm -115.5 153.84 17.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.337 0.589 . . . . 0.0 109.882 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.914 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 38.5 t70 -145.29 39.84 1.2 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.62 -178.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.795 HG23 ' CG2' ' A' ' 44' ' ' ILE . 57.4 t -92.85 87.26 2.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.732 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 78.0 p -55.35 74.7 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 O-C-N 124.499 1.125 . . . . 0.0 112.131 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.712 ' H ' ' HG3' ' A' ' 68' ' ' GLU . 31.9 tp10 -44.63 -26.93 0.42 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.288 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.84 ' OD1' ' HG3' ' A' ' 66' ' ' ARG . 28.2 t-20 -122.01 -72.86 0.67 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.911 0.386 . . . . 0.0 111.654 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.84 ' HG3' ' OD1' ' A' ' 65' ' ' ASN . 78.3 mtp180 -123.47 -40.19 2.38 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.862 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.609 ' HA ' ' HB3' ' A' ' 63' ' ' SER . 4.1 m-20 -161.25 116.62 2.11 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.917 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.754 ' HG3' ' O ' ' A' ' 62' ' ' VAL . 3.5 mm-40 -96.3 152.39 18.63 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.626 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -143.06 86.43 1.92 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.295 -1.321 . . . . 0.0 108.331 -179.396 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 1.107 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 3.5 mm? -108.08 139.66 42.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.076 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.805 HG22 ' HB2' ' A' ' 113' ' ' ARG . 12.9 p -133.09 135.7 56.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.583 177.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.925 ' HB2' HD12 ' A' ' 58' ' ' ILE . 94.7 mt -140.86 140.88 34.67 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 178.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 1.023 HG13 HD13 ' A' ' 111' ' ' LEU . 3.3 mm -121.79 136.57 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-O 121.233 0.54 . . . . 0.0 111.013 -179.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.677 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 7.2 m120 49.0 38.69 0.52 Allowed Pre-proline 0 C--N 1.313 -0.996 0 CA-C-N 115.096 -0.957 . . . . 0.0 112.839 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.793 ' HG2' HG22 ' A' ' 58' ' ' ILE . 99.5 Cg_exo -56.42 145.67 77.89 Favored 'Trans proline' 0 N--CA 1.484 0.943 0 C-N-CA 122.958 2.439 . . . . 0.0 114.144 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.542 ' HG3' HD22 ' A' ' 78' ' ' LEU . 11.7 pt-20 -133.11 143.18 49.12 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 1.04 ' HB2' ' HE2' ' A' ' 134' ' ' MET . 1.7 tt -82.95 135.71 34.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.282 0.563 . . . . 0.0 111.39 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.86 ' N ' HD21 ' A' ' 77' ' ' LEU . 2.9 mm? -115.74 -40.59 3.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.84 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 87.4 tt0 -152.84 150.59 29.49 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.21 0.529 . . . . 0.0 111.511 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.848 ' HA ' HG11 ' A' ' 106' ' ' VAL . 9.2 ptpp? -147.18 147.4 30.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.267 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.1 t -158.22 147.99 19.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.673 0.273 . . . . 0.0 111.384 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.696 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 76.85 160.29 10.78 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.41 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -136.3 113.42 10.54 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.948 0.88 . . . . 0.0 112.736 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.728 ' HB ' HH12 ' A' ' 102' ' ' ARG . 1.7 p -105.24 161.88 13.9 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.74 ' HA3' HD22 ' A' ' 99' ' ' LEU . . . -147.45 116.86 0.87 Allowed Glycine 0 C--N 1.313 -0.701 0 CA-C-N 112.694 -2.048 . . . . 0.0 110.989 178.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.724 ' HB ' ' NH2' ' A' ' 102' ' ' ARG . 47.9 mm -147.79 139.21 18.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 117.306 0.553 . . . . 0.0 111.414 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 50.4 mt-10 -71.78 139.03 48.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 122.83 1.3 . . . . 0.0 112.019 -177.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.964 ' HG2' ' H27' ' A' ' 149' ' ' BB2 . 39.6 mt-10 -154.95 163.48 40.24 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 112.753 -2.021 . . . . 0.0 111.567 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.917 ' O ' ' H51' ' A' ' 149' ' ' BB2 . . . -121.49 165.62 14.44 Favored Glycine 0 CA--C 1.503 -0.714 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.768 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 13.1 m -116.21 140.76 48.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.898 0.849 . . . . 0.0 111.662 -177.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 1.037 HD13 ' HG2' ' A' ' 41' ' ' GLU . 2.4 mm? -48.62 -17.31 0.16 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.224 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.723 ' CB ' HD13 ' A' ' 13' ' ' LEU . 21.1 m -98.36 -34.39 10.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.255 0.55 . . . . 0.0 110.255 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 1.041 HG21 ' HD2' ' A' ' 94' ' ' PRO . 58.4 mt -85.85 151.44 55.04 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.546 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 1.041 ' HD2' HG21 ' A' ' 93' ' ' ILE . 63.1 Cg_endo -62.11 -145.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.406 2.071 . . . . 0.0 111.7 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.409 ' H ' ' HB2' ' A' ' 94' ' ' PRO . 4.5 mm-40 -80.93 12.85 3.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.179 0.514 . . . . 0.0 110.771 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.517 ' HG2' ' HG2' ' A' ' 94' ' ' PRO . 98.7 mm-40 -78.7 82.27 4.94 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.125 -178.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.599 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 13.7 mtt85 -86.73 132.45 33.86 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.03 0.443 . . . . 0.0 109.927 178.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.2 150.52 48.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.252 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.74 HD22 ' HA3' ' A' ' 85' ' ' GLY . 7.3 tt -76.02 113.92 14.07 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.727 0.775 . . . . 0.0 110.792 -178.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.818 HG11 ' HB3' ' A' ' 142' ' ' PHE . 23.4 t -103.57 133.7 20.14 Favored Pre-proline 0 N--CA 1.469 0.492 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.991 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.657 ' HD2' HG12 ' A' ' 100' ' ' VAL . 98.6 Cg_endo -87.58 126.36 2.2 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.524 2.15 . . . . 0.0 112.675 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.786 ' HG3' HG22 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -144.65 166.76 24.29 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.149 0.98 . . . . 0.0 109.764 179.438 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.696 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.41 155.3 40.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.852 0.358 . . . . 0.0 110.172 -179.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -72.67 -41.78 65.02 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.592 -175.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.759 ' HG2' ' HB3' ' A' ' 123' ' ' ASP . 95.4 mttt -140.61 140.17 35.03 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.49 0.662 . . . . 0.0 109.495 176.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.848 HG11 ' HA ' ' A' ' 80' ' ' LYS . 32.8 m -145.57 142.22 22.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.166 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.781 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 5.1 mmmt -107.43 126.22 52.22 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.839 HD11 HD11 ' A' ' 130' ' ' ILE . 1.8 pp -134.36 151.0 31.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -177.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 1.006 ' HE ' ' HG2' ' A' ' 119' ' ' GLU . 53.5 mtp180 -102.62 139.71 37.85 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.424 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.648 ' HB3' HD22 ' A' ' 72' ' ' LEU . . . -160.18 168.5 25.3 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.237 -176.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 1.023 HD13 HG13 ' A' ' 73' ' ' ILE . 2.0 pp -122.59 149.0 44.57 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.515 ' O ' HD12 ' A' ' 111' ' ' LEU . 13.5 t70 -81.67 169.11 17.4 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -175.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.805 ' HB2' HG22 ' A' ' 71' ' ' VAL . 43.2 ttp180 -50.93 -23.6 2.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.982 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -79.77 -21.45 44.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.158 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.816 ' HA2' HG22 ' A' ' 23' ' ' VAL . . . 101.37 38.74 3.19 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.151 -1.023 . . . . 0.0 113.983 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.927 ' HA ' ' HE3' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -127.13 102.24 24.5 Favored Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 117.188 0.494 . . . . 0.0 110.184 178.532 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.635 ' HG3' HD22 ' A' ' 111' ' ' LEU . 32.8 Cg_exo -74.63 115.41 4.29 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 121.643 1.562 . . . . 0.0 116.107 -177.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.444 ' N ' ' O ' ' A' ' 110' ' ' ALA . 0.4 OUTLIER -125.71 168.57 13.58 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.01 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 1.006 ' HG2' ' HE ' ' A' ' 109' ' ' ARG . 21.3 mt-10 -107.41 137.11 46.06 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.729 ' O ' HD11 ' A' ' 120' ' ' LEU . 4.3 pp -135.57 133.39 38.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.081 0.467 . . . . 0.0 111.841 -178.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.781 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 0.7 OUTLIER -95.5 123.71 39.17 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.767 178.706 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 1.029 ' HB3' HD13 ' A' ' 126' ' ' LEU . . . -116.45 135.13 54.1 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.759 ' HB3' ' HG2' ' A' ' 105' ' ' LYS . 16.9 m-20 -126.43 163.22 23.79 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.677 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 52.89 -139.02 33.47 Favored Glycine 0 C--N 1.346 1.101 0 C-N-CA 119.344 -1.408 . . . . 0.0 115.344 177.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.421 ' HA ' HD21 ' A' ' 125' ' ' LEU . 78.2 mt -54.38 -32.3 56.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.601 -0.8 . . . . 0.0 111.601 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 1.029 HD13 ' HB3' ' A' ' 122' ' ' ALA . 0.3 OUTLIER -71.42 -51.97 21.04 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.904 0.859 . . . . 0.0 109.308 179.523 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.719 ' HB3' ' CA ' ' A' ' 123' ' ' ASP . . . -58.58 -41.93 86.84 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.162 -1.381 . . . . 0.0 111.648 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.786 HG22 ' HG3' ' A' ' 102' ' ' ARG . 50.8 mm -67.45 -54.83 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -178.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.942 ' HB2' ' H91' ' A' ' 149' ' ' BB2 . 32.1 p -60.7 -49.07 79.0 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.839 HD11 HD11 ' A' ' 108' ' ' ILE . 19.8 tt -59.2 -46.51 92.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.386 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.701 ' HG2' ' O ' ' A' ' 127' ' ' ALA . 21.3 pt20 -65.71 -38.19 88.52 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.337 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.588 ' HD2' ' HN1' ' A' ' 149' ' ' BB2 . 73.4 t60 -59.27 -46.4 88.63 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.549 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.785 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 3.3 mm-40 -60.81 -38.37 85.17 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 1.04 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 75.8 mtp -58.22 -45.18 88.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 122.271 1.034 . . . . 0.0 109.422 177.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.919 ' O ' HG13 ' A' ' 138' ' ' VAL . 0.9 OUTLIER -68.14 -47.97 66.65 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.716 179.215 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.637 ' CE1' ' HG2' ' A' ' 50' ' ' GLN . 6.5 t-80 -57.98 -52.75 64.21 Favored 'General case' 0 C--N 1.317 -0.813 0 O-C-N 121.672 -0.642 . . . . 0.0 111.483 -178.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.815 HD11 ' HG2' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -65.41 -28.5 69.3 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.511 -179.506 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.919 HG13 ' O ' ' A' ' 135' ' ' ASP . 11.3 p -81.1 23.39 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-O 122.294 1.045 . . . . 0.0 109.218 175.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.536 ' H ' ' C ' ' A' ' 137' ' ' LEU . . . 67.49 -0.93 7.91 Favored Glycine 0 CA--C 1.485 -1.813 0 CA-C-N 113.532 -1.667 . . . . 0.0 113.144 175.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.909 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 11.2 ptmt -90.22 138.85 31.19 Favored 'General case' 0 N--CA 1.409 -2.479 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 178.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.835 HD12 ' O ' ' A' ' 140' ' ' LYS . 10.6 mp -139.18 149.7 44.72 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -178.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.818 ' HB3' HG11 ' A' ' 100' ' ' VAL . 49.2 p90 -54.7 -39.49 68.23 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -178.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.464 ' HA ' ' HB2' ' A' ' 146' ' ' LEU . 1.8 tmt? -59.48 -28.52 67.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.09 0.471 . . . . 0.0 110.842 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -59.06 -24.61 63.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.625 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -118.21 6.7 11.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.376 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.464 ' HB2' ' HA ' ' A' ' 143' ' ' MET . 2.3 mp -88.83 141.78 28.21 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.796 0.331 . . . . 0.0 110.999 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 48.2 t . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.831 179.592 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' BB2 . . . . . 1.037 H173 HD12 ' A' ' 91' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 54.6 m . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.863 0.363 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.494 HG13 ' HB1' ' A' ' 40' ' ' ALA . 31.1 m -83.97 135.42 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.365 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.846 HD12 ' O ' ' A' ' 51' ' ' VAL . 2.4 pp -79.53 -161.81 0.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.599 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.821 ' N ' HD13 ' A' ' 3' ' ' LEU . 2.2 tp-100 -94.66 108.17 20.16 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.925 0.393 . . . . 0.0 110.446 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.419 ' CG2' HG23 ' A' ' 37' ' ' THR . 40.9 t -88.59 129.37 39.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.4 0.619 . . . . 0.0 112.067 -178.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 1.063 ' HB2' HD23 ' A' ' 13' ' ' LEU . 21.5 mt -87.88 143.18 27.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.021 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 51.9 m-70 -120.78 145.73 47.25 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.822 HG12 ' CB ' ' A' ' 92' ' ' SER . 46.2 mm -66.05 134.41 94.93 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.676 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.8 141.36 66.57 Favored 'Cis proline' 0 C--N 1.351 0.685 0 C-N-CA 124.195 -1.169 . . . . 0.0 112.016 -0.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.982 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.7 t70 -161.24 126.28 3.6 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 12.0 pt-20 -58.21 -46.06 86.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.982 -178.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.544 ' O ' ' HB ' ' A' ' 49' ' ' THR . 25.1 mtt-85 -59.3 -26.16 64.74 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 1.063 HD23 ' HB2' ' A' ' 6' ' ' LEU . 10.7 mt -76.64 -33.38 58.35 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 120.284 1.402 . . . . 0.0 108.139 177.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.565 ' C ' ' HA3' ' A' ' 139' ' ' GLY . 14.1 mmt85 -94.11 11.01 31.47 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 113.854 -1.521 . . . . 0.0 109.303 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -92.76 150.67 20.5 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.283 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.525 HG12 HG22 ' A' ' 138' ' ' VAL . 61.8 t -83.47 124.06 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.819 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.767 ' HB2' ' CG ' ' A' ' 56' ' ' ARG . . . -80.99 147.45 30.21 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.634 ' HD3' ' N ' ' A' ' 19' ' ' PRO . 2.2 tmtp? -109.9 127.98 26.17 Favored Pre-proline 0 C--N 1.325 -0.486 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.217 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 1.027 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 65.6 Cg_endo -77.7 113.93 3.57 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 121.998 1.799 . . . . 0.0 110.815 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.617 HG12 ' N ' ' A' ' 21' ' ' GLU . 18.0 t -68.45 144.46 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-O 122.609 1.195 . . . . 0.0 113.29 -175.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.617 ' N ' HG12 ' A' ' 20' ' ' VAL . 46.5 mm-40 -60.76 -27.97 68.36 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 112.97 -1.923 . . . . 0.0 111.995 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -157.79 143.02 16.88 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.242 -178.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.863 HG21 HD12 ' A' ' 111' ' ' LEU . 3.2 t -79.75 108.46 13.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.998 ' HB2' HD12 ' A' ' 27' ' ' ILE . 54.6 m-80 -93.32 173.51 7.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.813 -179.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.605 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -65.75 -28.54 69.11 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.376 0.607 . . . . 0.0 110.859 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.46 ' HA ' ' OE1' ' A' ' 26' ' ' GLU . 4.3 mm-40 -73.92 -39.72 63.61 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.998 HD12 ' HB2' ' A' ' 24' ' ' ASN . 1.9 mp -66.91 -37.49 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.166 178.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.804 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 16.9 mt-30 -66.18 -40.46 90.48 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.233 -0.292 . . . . 0.0 110.719 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 14.0 mmp_? -63.33 -39.58 94.93 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.876 HG21 HD12 ' A' ' 57' ' ' ILE . 4.8 mt -55.34 -50.17 67.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.381 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.618 ' CG1' HG23 ' A' ' 71' ' ' VAL . 15.9 t -65.25 -41.62 91.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.072 0.463 . . . . 0.0 111.045 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.829 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 27.3 m-20 -54.97 -43.58 73.64 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.475 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.522 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 1.4 m-20 -75.81 -29.77 58.79 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.923 176.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.792 ' HG3' ' O ' ' A' ' 30' ' ' ILE . 22.0 mtm -60.14 -46.69 88.82 Favored 'General case' 0 C--N 1.347 0.467 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.534 -177.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.829 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 14.9 p90 -69.87 -45.45 67.68 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.61 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 3.8 mm-40 -52.65 -39.38 61.76 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.719 0.771 . . . . 0.0 108.996 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.468 ' OG1' ' HG ' ' A' ' 3' ' ' LEU . 61.8 m -70.06 -61.78 1.64 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.455 -1.248 . . . . 0.0 107.642 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.859 ' HG3' ' HB2' ' A' ' 46' ' ' LEU . 1.0 OUTLIER -46.52 -41.11 13.7 Favored 'General case' 0 CA--C 1.462 -2.416 0 C-N-CA 123.958 0.903 . . . . 0.0 110.431 -170.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.696 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 58.5 m-85 -70.37 -42.43 71.79 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.281 178.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.494 ' HB1' HG13 ' A' ' 2' ' ' VAL . . . -61.05 -24.61 66.33 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.416 178.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.98 ' HG2' HD13 ' A' ' 91' ' ' LEU . 11.7 tp10 -88.89 -11.4 44.7 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.475 177.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 65.43 23.93 11.95 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.042 -176.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.07 141.89 24.66 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 114.027 -1.442 . . . . 0.0 110.372 177.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 1.051 HD13 H251 ' A' ' 149' ' ' BB2 . 46.3 mt -81.33 1.41 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 117.648 0.724 . . . . 0.0 112.638 -178.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.838 ' HA3' ' C10' ' A' ' 149' ' ' BB2 . . . 178.73 133.78 1.98 Allowed Glycine 0 CA--C 1.528 0.867 0 CA-C-O 118.913 -0.937 . . . . 0.0 111.409 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 1.031 HD13 ' HG ' ' A' ' 91' ' ' LEU . 4.9 tp -126.02 134.33 51.48 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.15 1.475 . . . . 0.0 112.161 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -98.3 131.88 44.25 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.292 0.237 . . . . 0.0 111.448 178.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.733 ' HA ' ' SD ' ' A' ' 34' ' ' MET . . . -30.01 -55.64 0.18 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 137' ' ' LEU . 67.3 p -53.25 -36.01 60.63 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.462 0.648 . . . . 0.0 112.039 -177.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.818 ' NE2' HD21 ' A' ' 91' ' ' LEU . 85.8 mt-30 -63.83 -41.92 97.73 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.231 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.846 ' O ' HD12 ' A' ' 3' ' ' LEU . 1.0 OUTLIER -83.74 16.49 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.447 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.925 ' HA ' HD13 ' A' ' 6' ' ' LEU . 50.5 t0 77.37 28.29 0.61 Allowed 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 176.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 1.103 HD12 HD13 ' A' ' 57' ' ' ILE . 1.0 OUTLIER -122.23 110.7 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 119.204 -0.999 . . . . 0.0 111.247 177.883 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -76.76 63.19 2.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.493 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.812 ' O ' HD11 ' A' ' 53' ' ' ILE . 94.7 mm-40 -152.96 134.33 14.31 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.237 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 1.027 ' HD2' ' HD3' ' A' ' 19' ' ' PRO . 98.8 mtt180 -64.5 66.72 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -177.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 1.103 HD13 HD12 ' A' ' 53' ' ' ILE . 6.2 mt -111.1 123.22 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.872 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 1.8 pp -128.32 146.37 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 119.665 -0.814 . . . . 0.0 113.12 -177.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.555 HG21 ' H ' ' A' ' 46' ' ' LEU . 30.5 m -126.24 139.11 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.7 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 1.094 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 7.9 mm -116.16 153.39 17.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.55 0.69 . . . . 0.0 110.392 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.847 ' HB3' ' C ' ' A' ' 44' ' ' ILE . 31.3 t70 -139.46 17.85 2.55 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.363 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 1.022 HG23 HG23 ' A' ' 44' ' ' ILE . 32.4 t -91.69 116.2 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.106 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.348 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.869 ' HB3' ' OE2' ' A' ' 68' ' ' GLU . 79.5 p -38.88 78.25 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -177.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.685 ' OE1' HD22 ' A' ' 70' ' ' LEU . 40.5 tt0 -68.87 -21.68 64.24 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.736 178.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.509 ' CG ' ' H ' ' A' ' 66' ' ' ARG . 0.7 OUTLIER -163.3 -138.23 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.868 178.729 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.509 ' H ' ' CG ' ' A' ' 65' ' ' ASN . 70.8 mtp180 -74.52 -56.67 4.58 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.34 120.25 23.53 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.964 178.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.869 ' OE2' ' HB3' ' A' ' 63' ' ' SER . 45.5 mt-10 -93.17 75.99 4.63 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.504 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 48.0 ttp180 -152.58 95.63 2.04 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.87 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 1.094 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 56.3 mt -111.23 138.97 47.02 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.801 HG22 ' HB2' ' A' ' 113' ' ' ARG . 11.8 p -134.82 135.29 53.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.607 177.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.872 ' HB2' ' CD1' ' A' ' 58' ' ' ILE . 1.8 mm? -140.4 140.77 35.55 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 1.053 HG13 HD11 ' A' ' 111' ' ' LEU . 3.5 mm -119.51 136.03 57.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.172 0.51 . . . . 0.0 110.952 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.69 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 8.0 m120 51.57 37.6 0.44 Allowed Pre-proline 0 C--N 1.312 -1.027 0 CA-C-N 115.349 -0.842 . . . . 0.0 112.379 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.85 ' HG2' HG12 ' A' ' 58' ' ' ILE . 77.6 Cg_exo -55.08 144.5 68.96 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 122.949 2.433 . . . . 0.0 114.102 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.523 ' HG3' HD23 ' A' ' 78' ' ' LEU . 11.5 pt-20 -135.45 145.43 47.19 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 1.024 ' HB2' ' HE2' ' A' ' 134' ' ' MET . 1.5 tt -81.2 137.69 35.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.309 0.576 . . . . 0.0 111.817 -178.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.86 ' N ' HD23 ' A' ' 77' ' ' LEU . 2.9 mm? -118.9 -50.71 2.38 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.624 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 1.037 ' HB3' ' HD3' ' A' ' 107' ' ' LYS . 39.3 tp10 -140.5 146.51 38.26 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 120.883 0.373 . . . . 0.0 110.886 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.843 ' NZ ' HD21 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -147.32 145.66 29.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.098 179.492 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.3 t -159.07 156.58 29.47 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.787 0.327 . . . . 0.0 111.592 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.745 ' C ' ' HG3' ' A' ' 104' ' ' GLU . . . 67.53 159.62 1.17 Allowed Glycine 0 CA--C 1.506 -0.5 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.352 -179.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.713 ' N ' ' HG3' ' A' ' 104' ' ' GLU . 57.6 mt-10 -131.89 113.0 12.93 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 122.006 0.908 . . . . 0.0 113.002 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.723 HG21 ' HG2' ' A' ' 104' ' ' GLU . 1.5 p -103.54 161.36 13.95 Favored 'General case' 0 CA--C 1.486 -1.505 0 CA-C-N 113.812 -1.54 . . . . 0.0 114.733 178.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.725 ' CA ' HD21 ' A' ' 99' ' ' LEU . . . -149.84 118.34 0.93 Allowed Glycine 0 C--N 1.311 -0.828 0 CA-C-N 112.911 -1.949 . . . . 0.0 111.373 178.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.525 ' N ' ' HG ' ' A' ' 99' ' ' LEU . 32.4 mt -148.16 138.69 17.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 117.278 0.539 . . . . 0.0 111.733 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 95.3 mt-10 -70.82 137.98 49.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 123.072 1.415 . . . . 0.0 112.313 -176.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 1.002 ' HG2' ' H27' ' A' ' 149' ' ' BB2 . 46.8 mt-10 -156.42 160.43 39.6 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 112.652 -2.067 . . . . 0.0 111.351 -179.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.901 ' O ' ' H51' ' A' ' 149' ' ' BB2 . . . -120.57 165.0 13.89 Favored Glycine 0 CA--C 1.501 -0.783 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.732 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 18.2 m -116.09 140.81 48.9 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 117.897 0.848 . . . . 0.0 111.995 -177.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 1.036 HD12 H173 ' A' ' 149' ' ' BB2 . 2.3 mm? -47.69 -26.52 1.57 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.88 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.822 ' CB ' HG12 ' A' ' 8' ' ' ILE . 49.9 m -79.77 -38.08 33.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.871 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 1.031 HG21 ' HD2' ' A' ' 94' ' ' PRO . 68.9 mt -86.1 149.97 51.32 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.971 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 1.031 ' HD2' HG21 ' A' ' 93' ' ' ILE . 85.6 Cg_endo -70.98 49.16 0.93 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.609 2.206 . . . . 0.0 113.945 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.541 ' HB2' ' O ' ' A' ' 94' ' ' PRO . 0.3 OUTLIER 74.19 20.07 2.77 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 178.841 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.76 ' HB2' HG22 ' A' ' 93' ' ' ILE . 84.3 mt-30 -78.76 88.85 4.61 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.726 ' HA ' ' O ' ' A' ' 88' ' ' GLU . 12.9 mtt85 -85.31 132.49 34.24 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.757 0.789 . . . . 0.0 112.115 -178.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -134.19 153.34 51.9 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.792 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.725 HD21 ' CA ' ' A' ' 85' ' ' GLY . 7.5 tt -75.67 112.7 12.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.681 0.753 . . . . 0.0 110.757 -178.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.886 HG13 ' NH1' ' A' ' 102' ' ' ARG . 29.5 t -98.6 128.93 31.37 Favored Pre-proline 0 N--CA 1.468 0.434 0 CA-C-N 114.724 -1.126 . . . . 0.0 112.011 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.524 ' HD2' ' CD2' ' A' ' 142' ' ' PHE . 1.1 Cg_endo -83.4 125.69 3.99 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.726 2.284 . . . . 0.0 112.031 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.953 ' HB3' HH11 ' A' ' 102' ' ' ARG . 0.0 OUTLIER -145.86 167.17 23.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.312 179.759 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.619 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.62 155.17 40.53 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.745 ' HG3' ' C ' ' A' ' 82' ' ' GLY . 95.1 mt-10 -72.88 -39.87 66.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.867 -175.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.678 ' HB3' ' OD1' ' A' ' 123' ' ' ASP . 59.1 mttp -139.73 140.56 36.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.263 0.554 . . . . 0.0 109.722 177.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.777 HG13 ' HA ' ' A' ' 80' ' ' LYS . 35.2 m -149.71 140.02 16.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.511 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 1.037 ' HD3' ' HB3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -108.09 127.75 54.07 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.874 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.581 HD13 HD23 ' A' ' 120' ' ' LEU . 1.5 pp -133.03 150.15 32.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -177.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.845 ' HG3' ' CD2' ' A' ' 78' ' ' LEU . 96.4 mtt180 -102.18 137.69 40.12 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.66 -178.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.494 ' CB ' ' HB3' ' A' ' 72' ' ' LEU . . . -161.57 169.7 21.22 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 114.746 -1.115 . . . . 0.0 111.023 -176.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 1.053 HD11 HG13 ' A' ' 73' ' ' ILE . 1.9 pp -119.35 149.12 42.35 Favored 'General case' 0 C--O 1.218 -0.59 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 176.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.514 ' HB2' ' CE2' ' A' ' 118' ' ' PHE . 12.8 t70 -81.75 167.8 18.72 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 119.877 -0.729 . . . . 0.0 112.642 -175.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.801 ' HB2' HG22 ' A' ' 71' ' ' VAL . 51.0 ttp180 -50.28 -22.45 1.79 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.971 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -79.4 -25.07 42.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.898 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.755 ' HA2' HD12 ' A' ' 111' ' ' LEU . . . 104.83 37.91 2.65 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.189 -1.005 . . . . 0.0 113.834 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -128.36 102.73 20.6 Favored Pre-proline 0 C--O 1.235 0.342 0 CA-C-N 117.054 0.427 . . . . 0.0 110.473 178.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.588 ' HA ' ' CA ' ' A' ' 111' ' ' LEU . 36.8 Cg_exo -71.56 114.86 4.07 Favored 'Trans proline' 0 C--N 1.358 1.075 0 N-CA-C 116.409 1.657 . . . . 0.0 116.409 -176.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.514 ' CE2' ' HB2' ' A' ' 112' ' ' ASP . 0.3 OUTLIER -127.0 160.72 30.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.731 -179.227 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.648 ' HG2' ' HG2' ' A' ' 109' ' ' ARG . 21.5 mt-10 -107.42 130.69 54.79 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.893 HD21 ' O ' ' A' ' 120' ' ' LEU . 0.2 OUTLIER -131.66 141.59 49.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.795 0.807 . . . . 0.0 111.887 -179.019 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 107' ' ' LYS . 11.4 pt-20 -97.16 125.52 41.72 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.979 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.88 ' CB ' ' HG ' ' A' ' 126' ' ' LEU . . . -115.01 135.41 54.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.839 0.352 . . . . 0.0 111.391 -179.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.801 ' CA ' ' HB3' ' A' ' 127' ' ' ALA . 31.3 m-20 -126.66 160.76 29.8 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.788 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 51.73 -138.78 28.94 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 120.645 1.566 . . . . 0.0 115.159 177.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.516 ' H ' ' CD1' ' A' ' 125' ' ' LEU . 4.9 mp -53.5 -32.96 52.61 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.225 -0.488 . . . . 0.0 111.309 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.88 ' HG ' ' CB ' ' A' ' 122' ' ' ALA . 4.0 tp -70.78 -52.17 22.36 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.649 0.738 . . . . 0.0 109.418 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.801 ' HB3' ' CA ' ' A' ' 123' ' ' ASP . . . -58.55 -42.34 87.67 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.713 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.788 HG12 ' O ' ' A' ' 124' ' ' GLY . 44.5 mm -67.85 -54.65 21.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.852 ' HB2' ' H91' ' A' ' 149' ' ' BB2 . 30.0 p -58.19 -50.2 74.36 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -178.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.644 HG22 ' N ' ' A' ' 131' ' ' GLN . 14.2 tt -59.57 -44.21 92.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.121 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.845 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.0 pt20 -68.39 -39.42 81.71 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.518 178.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.609 ' CD2' ' HN1' ' A' ' 149' ' ' BB2 . 68.7 t60 -59.44 -47.24 86.24 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.067 0.461 . . . . 0.0 109.794 178.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.881 ' O ' HD22 ' A' ' 137' ' ' LEU . 3.7 mm-40 -59.61 -40.41 87.47 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.586 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 1.024 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 75.5 mtp -57.52 -47.64 81.43 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.838 0.828 . . . . 0.0 109.872 178.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.872 ' O ' HG11 ' A' ' 138' ' ' VAL . 31.4 m-20 -63.38 -47.13 83.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.976 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.913 ' HA ' ' CD2' ' A' ' 141' ' ' LEU . 4.6 t-80 -59.07 -53.0 63.29 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 121.103 0.478 . . . . 0.0 111.593 -178.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.899 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.7 pp -58.64 -31.76 68.43 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.518 -178.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 1.046 HG13 ' HG2' ' A' ' 140' ' ' LYS . 14.9 p -86.44 23.85 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 122.329 1.061 . . . . 0.0 109.548 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.61 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 53.85 34.94 52.05 Favored Glycine 0 CA--C 1.482 -1.969 0 CA-C-N 113.388 -1.733 . . . . 0.0 112.432 176.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 1.046 ' HG2' HG13 ' A' ' 138' ' ' VAL . 3.6 ptmt -133.17 105.92 7.29 Favored 'General case' 0 N--CA 1.423 -1.807 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.334 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.913 ' CD2' ' HA ' ' A' ' 136' ' ' HIS . 3.3 mm? -122.86 151.36 41.79 Favored 'General case' 0 N--CA 1.446 -0.666 0 O-C-N 120.814 -1.179 . . . . 0.0 109.474 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.579 ' HB2' ' CG1' ' A' ' 100' ' ' VAL . 8.8 m-85 -64.72 -27.35 68.85 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.98 ' HA ' HD21 ' A' ' 146' ' ' LEU . 1.9 tmt? -58.83 -24.9 62.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.514 0.673 . . . . 0.0 110.183 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.415 ' CG ' ' HE ' ' A' ' 14' ' ' ARG . 67.9 m-20 -54.8 -25.63 29.48 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.314 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -122.46 36.37 4.65 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -178.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.98 HD21 ' HA ' ' A' ' 143' ' ' MET . 2.8 mm? -85.66 144.27 27.93 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.789 0.328 . . . . 0.0 111.269 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 46.7 t . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.004 179.779 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' BB2 . . . . . 1.051 H251 HD13 ' A' ' 44' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.7 t . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.835 0.35 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.713 HG13 HG21 ' A' ' 37' ' ' THR . 38.2 t -84.11 128.33 38.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.619 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.842 HD21 ' HB ' ' A' ' 51' ' ' VAL . 3.1 pp -79.63 -173.39 3.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.797 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.825 ' N ' HD13 ' A' ' 3' ' ' LEU . 70.9 tp60 -83.1 106.82 15.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.026 0.441 . . . . 0.0 110.59 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.431 ' CG2' HG23 ' A' ' 37' ' ' THR . 40.6 t -87.65 127.95 40.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.543 0.687 . . . . 0.0 112.201 -178.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.924 ' HB2' HD22 ' A' ' 13' ' ' LEU . 35.1 mt -85.96 138.88 31.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.193 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 28.8 m-70 -113.44 147.47 37.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.083 0.468 . . . . 0.0 112.141 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.927 HD12 HD13 ' A' ' 13' ' ' LEU . 42.9 mm -57.26 148.08 54.5 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.426 178.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.582 ' CA ' HG21 ' A' ' 8' ' ' ILE . 69.5 Cg_endo -93.49 51.84 1.1 Allowed 'Cis proline' 0 C--N 1.353 0.802 0 C-N-CA 124.707 -0.956 . . . . 0.0 112.881 0.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.893 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.7 t70 -55.66 135.78 51.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.057 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -59.37 -44.98 92.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.999 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.645 ' HB2' HD12 ' A' ' 6' ' ' LEU . 15.1 mmt85 -56.06 -25.47 45.29 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.927 HD13 HD12 ' A' ' 8' ' ' ILE . 10.7 mt -75.42 -33.86 60.96 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 119.46 1.027 . . . . 0.0 108.679 178.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.743 ' HD3' ' CG ' ' A' ' 144' ' ' ASP . 14.9 mmm180 -96.23 13.01 28.88 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 114.086 -1.416 . . . . 0.0 109.442 178.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.851 ' HD3' ' N ' ' A' ' 16' ' ' VAL . 1.1 tmtp? -87.01 145.38 26.51 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.918 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.851 ' N ' ' HD3' ' A' ' 15' ' ' LYS . 49.1 t -81.86 118.95 30.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.762 ' HB2' ' CG ' ' A' ' 56' ' ' ARG . . . -78.16 150.84 33.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.824 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.774 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -114.65 133.08 22.6 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.133 178.803 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.796 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 61.2 Cg_endo -78.81 115.94 3.67 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.454 2.103 . . . . 0.0 111.43 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.599 HG13 ' N ' ' A' ' 21' ' ' GLU . 19.9 t -67.85 144.43 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 CA-C-O 122.618 1.199 . . . . 0.0 113.096 -175.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.599 ' N ' HG13 ' A' ' 20' ' ' VAL . 51.3 mt-10 -61.62 -28.22 69.21 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 113.058 -1.883 . . . . 0.0 112.111 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -156.57 145.74 20.42 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 120.746 -0.381 . . . . 0.0 111.547 -178.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.863 ' CG2' HD22 ' A' ' 111' ' ' LEU . 3.9 t -79.15 105.87 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -178.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 1.055 ' HB2' HD12 ' A' ' 27' ' ' ILE . 57.4 m-80 -93.31 153.81 18.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.779 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.815 ' HB2' HH12 ' A' ' 29' ' ' ARG . . . -54.72 -24.17 20.97 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.254 0.549 . . . . 0.0 110.711 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -74.95 -41.06 60.35 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 177.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 1.055 HD12 ' HB2' ' A' ' 24' ' ' ASN . 1.8 mp -68.08 -33.96 63.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-N 113.846 -1.524 . . . . 0.0 110.108 178.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -69.94 -40.07 75.7 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 122.354 -0.216 . . . . 0.0 110.575 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.815 HH12 ' HB2' ' A' ' 25' ' ' ALA . 67.7 mtt85 -64.26 -38.01 89.53 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.787 ' CG2' HD11 ' A' ' 53' ' ' ILE . 4.8 mt -55.46 -50.3 66.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.302 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.875 HG13 ' CG2' ' A' ' 71' ' ' VAL . 3.8 t -67.9 -40.67 83.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.02 0.438 . . . . 0.0 110.201 178.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.811 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 12.8 m-20 -55.32 -41.38 72.35 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.73 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.481 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 52.7 m-20 -76.32 -30.21 57.6 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.158 176.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.777 ' HG3' ' O ' ' A' ' 30' ' ' ILE . 85.4 mtp -60.31 -46.25 90.54 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.268 -177.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.811 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 11.0 p90 -69.57 -44.51 70.68 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.548 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 31.2 mm-40 -53.01 -39.97 63.52 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.713 HG21 HG13 ' A' ' 2' ' ' VAL . 74.7 m -71.49 -62.6 1.35 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 118.377 -1.329 . . . . 0.0 107.886 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 1.063 ' HE3' ' HB2' ' A' ' 61' ' ' ASP . 2.0 ttp -46.91 -40.4 14.04 Favored 'General case' 0 CA--C 1.467 -2.237 0 C-N-CA 124.015 0.926 . . . . 0.0 110.145 -170.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.692 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 50.6 m-85 -70.51 -42.27 71.52 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.985 177.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.609 ' CB ' HG22 ' A' ' 2' ' ' VAL . . . -61.25 -23.23 65.5 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.566 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 1.077 ' HG2' HD13 ' A' ' 91' ' ' LEU . 11.5 tp10 -90.25 -11.38 41.07 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 114.434 -1.257 . . . . 0.0 108.273 177.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 64.12 28.55 14.16 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.889 -176.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.48 143.66 21.02 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 113.678 -1.601 . . . . 0.0 111.207 178.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.813 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 45.7 mm -79.36 -1.44 4.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 117.323 0.561 . . . . 0.0 112.061 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.838 ' HA3' ' H92' ' A' ' 149' ' ' BB2 . . . 177.87 135.88 2.37 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-O 119.28 -0.733 . . . . 0.0 111.721 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.958 HD12 ' HG ' ' A' ' 91' ' ' LEU . 5.0 tp -125.01 133.67 52.88 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.347 1.074 . . . . 0.0 111.305 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -100.42 132.33 45.86 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.619 ' HB1' HD13 ' A' ' 53' ' ' ILE . . . -26.9 -56.5 0.09 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.637 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 70.4 p -53.34 -35.81 60.64 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.65 0.738 . . . . 0.0 111.756 -177.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.866 ' NE2' HD21 ' A' ' 91' ' ' LEU . 8.8 mt-30 -64.52 -41.57 96.31 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.59 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.85 ' CG1' HD21 ' A' ' 46' ' ' LEU . 1.1 m -85.76 18.57 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.812 ' HA ' HD13 ' A' ' 6' ' ' LEU . 8.4 t0 78.43 28.09 0.48 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 176.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.875 HD13 ' HB ' ' A' ' 57' ' ' ILE . 11.1 pt -123.05 110.35 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 118.857 -1.137 . . . . 0.0 111.783 177.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.605 ' HB2' ' NZ ' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -76.82 51.74 0.79 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 121.888 0.851 . . . . 0.0 109.531 179.206 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.518 ' O ' HG12 ' A' ' 57' ' ' ILE . 26.2 mt-30 -140.52 129.94 23.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.103 -1.408 . . . . 0.0 107.501 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.796 ' HD2' ' HD3' ' A' ' 19' ' ' PRO . 73.3 mtt-85 -59.83 68.34 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.875 ' HB ' HD13 ' A' ' 53' ' ' ILE . 11.1 mm -112.08 122.31 66.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.907 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 1.9 pp -127.82 143.46 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 119.607 -0.837 . . . . 0.0 113.174 -177.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.567 HG23 ' HB3' ' A' ' 35' ' ' PHE . 1.4 p -127.96 134.13 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.679 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 1.041 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 2.0 mt -114.93 151.94 16.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.445 0.64 . . . . 0.0 111.111 -177.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 1.063 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 11.4 t70 -129.65 25.73 5.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.614 -1.176 . . . . 0.0 110.83 -177.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.899 HG22 ' CG2' ' A' ' 60' ' ' ILE . 11.7 t -79.46 -161.33 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.72 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 54.1 m -95.17 85.85 4.42 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.196 -0.315 . . . . 0.0 111.194 177.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.717 ' OE1' HD23 ' A' ' 70' ' ' LEU . 36.9 tt0 -61.58 -47.75 84.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.967 0.889 . . . . 0.0 109.551 178.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.75 ' ND2' ' HG3' ' A' ' 66' ' ' ARG . 53.9 t30 -165.84 -119.22 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 113.922 -1.49 . . . . 0.0 108.616 178.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.75 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 98.5 mtt180 -69.15 -46.39 67.71 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -103.17 122.67 45.19 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.596 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.72 ' HG2' ' HA ' ' A' ' 63' ' ' SER . 47.7 mt-10 -78.16 83.76 4.42 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.006 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.634 ' HG3' ' HH ' ' A' ' 39' ' ' TYR . 51.5 ttt-85 -153.85 100.44 2.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.68 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 1.041 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 48.5 mt -112.09 138.87 48.15 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -179.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.995 HG21 ' HB2' ' A' ' 113' ' ' ARG . 8.8 p -134.03 131.23 55.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.408 177.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.907 ' HB2' ' CD1' ' A' ' 58' ' ' ILE . 89.6 mt -142.41 143.18 32.54 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 121.31 -0.156 . . . . 0.0 110.919 177.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 1.016 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.6 mp -120.68 134.39 64.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.69 0.281 . . . . 0.0 110.743 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.664 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 7.4 m120 53.72 34.78 0.26 Allowed Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.816 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 84.5 Cg_exo -55.16 146.75 57.99 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.521 2.147 . . . . 0.0 113.571 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -135.99 149.23 48.77 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 1.087 ' HB2' ' HE2' ' A' ' 134' ' ' MET . 27.9 tp -79.63 138.3 37.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.42 0.629 . . . . 0.0 112.082 -178.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.867 ' CD2' ' HG3' ' A' ' 109' ' ' ARG . 2.6 mm? -114.26 -45.35 3.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.425 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.593 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 38.2 tt0 -158.06 146.82 19.16 Favored 'General case' 0 C--O 1.23 0.035 0 CA-C-O 121.114 0.483 . . . . 0.0 111.637 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.84 ' CB ' HG11 ' A' ' 106' ' ' VAL . 19.3 ptpt -143.59 146.91 33.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.045 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.4 p -159.67 150.98 19.76 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.733 0.301 . . . . 0.0 111.291 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.721 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 79.75 159.08 16.84 Favored Glycine 0 C--N 1.335 0.472 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.414 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -134.02 113.4 12.09 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.896 0.855 . . . . 0.0 112.93 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.599 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.6 p -106.97 161.53 14.64 Favored 'General case' 0 CA--C 1.486 -1.485 0 CA-C-N 113.902 -1.499 . . . . 0.0 114.936 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.699 ' HA3' HD22 ' A' ' 99' ' ' LEU . . . -146.95 115.86 0.81 Allowed Glycine 0 C--N 1.311 -0.861 0 CA-C-N 112.671 -2.059 . . . . 0.0 110.873 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.582 ' N ' ' HG ' ' A' ' 99' ' ' LEU . 34.1 mt -147.97 139.09 17.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 117.293 0.546 . . . . 0.0 111.618 -178.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.495 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 50.5 mt-10 -71.65 138.55 48.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 123.193 1.473 . . . . 0.0 112.082 -175.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 1.002 ' HG2' ' H27' ' A' ' 149' ' ' BB2 . 46.0 mt-10 -157.41 162.25 39.0 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 112.672 -2.058 . . . . 0.0 111.098 -179.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.854 ' O ' ' H51' ' A' ' 149' ' ' BB2 . . . -122.01 161.53 16.12 Favored Glycine 0 CA--C 1.501 -0.817 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.667 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 17.9 m -114.63 140.43 48.82 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.313 0.578 . . . . 0.0 111.344 -178.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 1.077 HD13 ' HG2' ' A' ' 41' ' ' GLU . 2.4 mm? -48.14 -22.8 0.69 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.333 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.866 ' HG ' HD12 ' A' ' 13' ' ' LEU . 54.0 m -83.28 -34.76 25.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.921 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.974 HG23 ' HD2' ' A' ' 94' ' ' PRO . 49.5 mm -85.43 149.41 51.89 Favored Pre-proline 0 N--CA 1.451 -0.381 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.226 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.974 ' HD2' HG23 ' A' ' 93' ' ' ILE . 92.1 Cg_endo -73.11 50.32 1.82 Allowed 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.493 2.129 . . . . 0.0 114.033 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.517 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 39.5 tt0 75.61 14.4 2.81 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.041 0.448 . . . . 0.0 111.871 178.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.762 ' HB2' HG21 ' A' ' 93' ' ' ILE . 10.0 mm-40 -78.85 88.89 4.66 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.748 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 18.5 mtm105 -85.31 132.62 34.22 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 121.637 0.732 . . . . 0.0 111.836 -178.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.404 ' CB ' HD21 ' A' ' 146' ' ' LEU . . . -135.16 155.85 50.0 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 114.539 -1.209 . . . . 0.0 109.432 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.699 HD22 ' HA3' ' A' ' 85' ' ' GLY . 7.6 tt -76.23 115.28 15.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.419 0.628 . . . . 0.0 111.773 -178.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.804 ' HB ' ' CZ ' ' A' ' 102' ' ' ARG . 39.0 t -107.01 131.95 21.29 Favored Pre-proline 0 N--CA 1.475 0.815 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.991 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.612 ' HD2' HG13 ' A' ' 100' ' ' VAL . 85.3 Cg_endo -82.92 127.47 4.79 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.663 2.242 . . . . 0.0 112.519 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.804 ' CZ ' ' HB ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -144.68 167.26 22.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.224 179.351 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.721 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.79 155.48 40.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 118.34 0.518 . . . . 0.0 110.1 -179.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -73.38 -41.2 63.67 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.895 -175.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.669 ' HB3' ' OD1' ' A' ' 123' ' ' ASP . 95.4 mttt -139.64 140.23 36.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.249 0.547 . . . . 0.0 109.619 177.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.84 HG11 ' CB ' ' A' ' 80' ' ' LYS . 35.1 m -146.78 139.44 19.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.311 -178.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.957 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 56.1 mmtt -106.6 127.05 53.03 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.841 HD13 ' CG ' ' A' ' 120' ' ' LEU . 2.3 pp -133.83 146.81 31.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -176.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.867 ' HG3' ' CD2' ' A' ' 78' ' ' LEU . 68.7 mtm180 -103.6 139.32 39.06 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.68 -178.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.778 ' HB3' HD23 ' A' ' 72' ' ' LEU . . . -161.05 169.42 22.51 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.037 -176.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 1.016 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.5 pp -116.48 151.83 35.28 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.571 ' O ' HD12 ' A' ' 111' ' ' LEU . 16.8 t70 -85.24 163.61 18.56 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.231 0.539 . . . . 0.0 112.053 -177.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.995 ' HB2' HG21 ' A' ' 71' ' ' VAL . 13.1 ttp-105 -51.93 -20.11 2.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.076 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -79.4 -26.44 41.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.633 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.663 ' HA2' HG23 ' A' ' 23' ' ' VAL . . . 107.3 35.98 2.58 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.199 -1.001 . . . . 0.0 113.491 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -128.46 102.68 20.36 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.781 0.291 . . . . 0.0 110.804 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.588 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.9 Cg_exo -72.6 116.27 4.65 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 121.65 1.567 . . . . 0.0 115.663 -177.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.431 ' CE2' ' HB2' ' A' ' 112' ' ' ASP . 0.4 OUTLIER -126.97 165.13 20.01 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.269 -178.655 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.523 ' HG3' ' CG ' ' A' ' 109' ' ' ARG . 5.9 mp0 -107.33 130.68 54.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.028 0.442 . . . . 0.0 109.837 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.841 ' CG ' HD13 ' A' ' 108' ' ' ILE . 4.4 pp -124.53 130.94 53.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.571 -178.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.957 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 15.3 pt-20 -91.5 123.79 35.18 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.951 ' HB3' HD13 ' A' ' 126' ' ' LEU . . . -116.24 135.62 53.74 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.669 ' OD1' ' HB3' ' A' ' 105' ' ' LYS . 45.4 m-20 -127.1 161.36 28.62 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.799 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 51.68 -137.88 30.3 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 120.334 1.425 . . . . 0.0 115.279 177.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 81.1 mt -54.05 -32.28 54.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.816 -0.692 . . . . 0.0 111.737 -178.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.951 HD13 ' HB3' ' A' ' 122' ' ' ALA . 0.3 OUTLIER -71.11 -52.58 18.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.663 0.744 . . . . 0.0 109.362 179.769 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.879 ' HB3' ' O ' ' A' ' 122' ' ' ALA . . . -59.85 -40.9 90.16 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.569 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.799 HG12 ' O ' ' A' ' 124' ' ' GLY . 46.4 mm -66.01 -54.31 28.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.698 -178.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.76 ' HB3' ' C9 ' ' A' ' 149' ' ' BB2 . 85.5 m -60.42 -49.39 77.76 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.765 ' CD1' HG12 ' A' ' 108' ' ' ILE . 0.1 OUTLIER -59.22 -44.72 92.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.557 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.801 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.3 pt20 -67.7 -39.14 84.42 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.683 0.278 . . . . 0.0 110.282 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.627 ' CD2' ' HN1' ' A' ' 149' ' ' BB2 . 71.3 t60 -59.86 -46.05 90.53 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.12 0.486 . . . . 0.0 109.88 178.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.876 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.5 mm-40 -60.32 -40.74 91.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.921 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 1.087 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 73.2 mtp -57.78 -48.07 80.75 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.751 0.786 . . . . 0.0 109.948 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.887 ' O ' HG13 ' A' ' 138' ' ' VAL . 30.6 m-20 -62.76 -46.75 86.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.811 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.926 ' HA ' ' CD2' ' A' ' 141' ' ' LEU . 4.7 t-80 -59.57 -52.72 64.35 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.206 0.527 . . . . 0.0 111.675 -178.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.894 HD22 ' HA ' ' A' ' 134' ' ' MET . 1.5 pp -59.18 -30.38 68.15 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.315 -178.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.932 HG12 ' HG2' ' A' ' 140' ' ' LYS . 13.4 p -86.1 22.7 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-O 122.094 0.949 . . . . 0.0 109.356 176.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.691 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 55.88 38.75 75.54 Favored Glycine 0 CA--C 1.483 -1.966 0 CA-C-N 113.678 -1.601 . . . . 0.0 112.662 176.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.932 ' HG2' HG12 ' A' ' 138' ' ' VAL . 3.4 ptmt -137.66 108.81 6.79 Favored 'General case' 0 N--CA 1.426 -1.658 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.708 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.926 ' CD2' ' HA ' ' A' ' 136' ' ' HIS . 3.3 mm? -132.07 143.56 50.12 Favored 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 120.942 -1.099 . . . . 0.0 108.858 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.545 ' HB2' ' CG1' ' A' ' 100' ' ' VAL . 7.9 m-85 -60.28 -40.68 91.31 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.926 ' HA ' HD11 ' A' ' 146' ' ' LEU . 46.3 ttm -61.09 -26.73 67.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.563 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.743 ' CG ' ' HD3' ' A' ' 14' ' ' ARG . 38.8 t70 -52.47 -25.85 11.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.033 -179.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -125.58 45.87 2.51 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.536 -177.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.926 HD11 ' HA ' ' A' ' 143' ' ' MET . 6.0 mp -92.39 146.2 23.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.033 177.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.7 t . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.193 -0.908 . . . . 0.0 111.067 179.614 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' BB2 . . . . . 1.002 ' H27' ' HG2' ' A' ' 88' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.894 0.378 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.609 HG13 ' HA ' ' A' ' 37' ' ' THR . 31.5 m -83.98 134.99 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.481 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.799 ' CD2' ' HB ' ' A' ' 51' ' ' VAL . 3.2 pp -79.74 -165.97 0.91 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.593 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.665 ' N ' HD12 ' A' ' 3' ' ' LEU . 40.7 tt0 -89.92 109.76 20.76 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.952 0.406 . . . . 0.0 110.473 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.43 ' CG2' HG23 ' A' ' 37' ' ' THR . 43.4 t -88.66 129.84 39.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.413 0.625 . . . . 0.0 112.079 -178.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 1.04 ' HB2' HD21 ' A' ' 13' ' ' LEU . 15.3 mt -89.95 143.21 26.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.923 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 44.0 m-70 -121.77 147.93 45.3 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -179.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.948 HD12 HD13 ' A' ' 13' ' ' LEU . 50.3 mm -63.68 135.78 96.43 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.145 178.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.443 ' HA ' HG21 ' A' ' 8' ' ' ILE . 3.9 Cg_exo -80.38 142.73 61.83 Favored 'Cis proline' 0 C--N 1.351 0.708 0 C-N-CA 124.605 -0.998 . . . . 0.0 111.746 -0.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.956 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.7 t70 -163.53 126.9 2.7 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.459 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.413 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 11.9 pt-20 -58.08 -46.07 86.08 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.598 -178.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.98 ' HA ' ' HZ1' ' A' ' 15' ' ' LYS . 16.0 mmt85 -56.28 -29.05 60.65 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 1.04 HD21 ' HB2' ' A' ' 6' ' ' LEU . 10.0 mt -76.43 -34.28 58.77 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 120.068 1.303 . . . . 0.0 108.559 177.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.783 ' NH1' ' HB3' ' A' ' 14' ' ' ARG . 2.2 mmm180 -93.42 13.0 22.97 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 113.877 -1.51 . . . . 0.0 109.182 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.98 ' HZ1' ' HA ' ' A' ' 12' ' ' ARG . 4.5 ttmp? -88.66 145.65 25.54 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.207 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.705 HG12 HG21 ' A' ' 138' ' ' VAL . 59.5 t -82.43 121.49 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.771 ' HB2' ' CG ' ' A' ' 56' ' ' ARG . . . -82.13 145.82 29.92 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.411 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -107.95 128.96 24.8 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.708 ' HA ' ' OD1' ' A' ' 74' ' ' ASN . 64.0 Cg_endo -78.97 113.54 3.26 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 121.725 1.617 . . . . 0.0 110.665 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.613 HG11 ' N ' ' A' ' 21' ' ' GLU . 16.5 t -68.97 144.43 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-O 122.469 1.128 . . . . 0.0 113.132 -175.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.613 ' N ' HG11 ' A' ' 20' ' ' VAL . 97.8 mt-10 -60.49 -24.75 65.53 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 113.125 -1.852 . . . . 0.0 112.368 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -157.28 142.71 17.28 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.296 -179.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.844 HG21 HD11 ' A' ' 111' ' ' LEU . 2.9 t -80.07 108.1 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -178.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 1.064 HD21 HD12 ' A' ' 27' ' ' ILE . 63.1 m-80 -90.85 155.36 18.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.658 -178.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.664 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -55.29 -25.49 34.46 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.35 0.595 . . . . 0.0 110.49 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.403 ' OE2' HG12 ' A' ' 27' ' ' ILE . 0.6 OUTLIER -75.11 -38.99 60.92 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 177.745 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 1.064 HD12 HD21 ' A' ' 24' ' ' ASN . 57.4 mt -66.06 -35.6 75.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 114.297 -1.32 . . . . 0.0 110.168 177.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -69.38 -39.21 78.15 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.254 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 38.1 mmm-85 -61.32 -39.24 89.79 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.788 ' O ' ' HG3' ' A' ' 34' ' ' MET . 3.0 mt -58.24 -48.69 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.2 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.722 HG11 ' CG2' ' A' ' 71' ' ' VAL . 8.7 t -67.9 -41.85 85.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 120.968 0.413 . . . . 0.0 111.557 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.83 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -55.8 -42.4 75.55 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.999 -179.412 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.482 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 15.5 m-20 -75.48 -29.91 59.74 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.284 176.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.788 ' HG3' ' O ' ' A' ' 30' ' ' ILE . 83.1 mtp -60.28 -46.51 89.58 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.315 -177.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.83 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 13.4 p90 -69.7 -45.2 68.81 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.755 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 37.9 mt-10 -51.84 -40.42 60.49 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 121.762 0.791 . . . . 0.0 108.904 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.609 ' HA ' HG13 ' A' ' 2' ' ' VAL . 56.6 m -70.24 -62.23 1.47 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.33 -1.305 . . . . 0.0 108.176 178.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 1.038 ' HE3' ' HB2' ' A' ' 61' ' ' ASP . 2.8 ttp -46.31 -41.4 13.21 Favored 'General case' 0 CA--C 1.46 -2.485 0 C-N-CA 124.144 0.978 . . . . 0.0 110.364 -171.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.705 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 61.7 m-85 -70.55 -42.69 70.84 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.686 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.555 ' HB1' HG13 ' A' ' 2' ' ' VAL . . . -61.4 -24.27 66.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.841 0.829 . . . . 0.0 109.395 179.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.946 ' HG2' HD12 ' A' ' 91' ' ' LEU . 11.6 tp10 -88.74 -11.23 45.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.471 177.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 64.27 25.42 13.53 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.956 -176.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.15 142.38 26.18 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 113.839 -1.528 . . . . 0.0 110.714 177.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.922 HG22 HG22 ' A' ' 62' ' ' VAL . 44.3 mm -79.15 -2.34 5.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 117.354 0.577 . . . . 0.0 112.139 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.875 ' HA3' ' C10' ' A' ' 149' ' ' BB2 . . . 177.97 134.91 2.15 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 118.759 -1.023 . . . . 0.0 111.291 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 1.002 HD11 ' HG ' ' A' ' 91' ' ' LEU . 7.6 tp -124.52 134.97 52.84 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 119.29 1.545 . . . . 0.0 111.973 -179.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -100.31 130.34 46.41 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.484 0.183 . . . . 0.0 111.299 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.673 ' HB3' ' O ' ' A' ' 57' ' ' ILE . . . -28.61 -54.43 0.11 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -179.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.601 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 69.1 p -52.96 -35.45 58.94 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.458 0.647 . . . . 0.0 112.221 -177.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.765 HE22 HD22 ' A' ' 91' ' ' LEU . 34.2 mt-30 -65.22 -42.05 93.81 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.154 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.865 ' CG1' HD22 ' A' ' 46' ' ' LEU . 0.8 OUTLIER -82.42 15.69 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 179.781 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.961 ' HA ' HD11 ' A' ' 6' ' ' LEU . 35.0 t70 77.46 30.07 0.52 Allowed 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 176.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.821 HD11 ' O ' ' A' ' 55' ' ' GLN . 1.1 pp -123.74 111.37 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.318 177.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.629 ' HB3' ' HD2' ' A' ' 15' ' ' LYS . 6.8 p80 -76.68 61.65 1.86 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.677 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.821 ' O ' HD11 ' A' ' 53' ' ' ILE . 89.0 mt-30 -151.57 134.3 15.59 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 114.495 -1.229 . . . . 0.0 107.942 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.771 ' CG ' ' HB2' ' A' ' 17' ' ' ALA . 76.3 mtp180 -64.0 69.3 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -177.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.765 ' O ' ' HE1' ' A' ' 34' ' ' MET . 8.0 mm -111.27 123.47 67.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.811 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -131.43 147.39 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 121.975 0.893 . . . . 0.0 112.965 -177.779 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.65 HG21 ' H ' ' A' ' 46' ' ' LEU . 32.9 m -127.71 139.21 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.092 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 1.017 HD11 H111 ' A' ' 149' ' ' BB2 . 9.2 mm -114.69 150.73 16.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.646 0.736 . . . . 0.0 109.943 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 1.038 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 33.4 t70 -138.62 28.82 2.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.735 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.922 HG22 HG22 ' A' ' 44' ' ' ILE . 40.4 t -93.71 106.74 18.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.556 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.706 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 79.8 p -38.35 81.59 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -177.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 62' ' ' VAL . 17.5 tp10 -69.22 -14.47 62.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.686 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.563 ' ND2' ' H ' ' A' ' 66' ' ' ARG . 46.2 t30 -165.12 -139.98 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.563 ' H ' ' ND2' ' A' ' 65' ' ' ASN . 39.5 mmm-85 -74.07 -52.37 12.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.685 0.278 . . . . 0.0 110.416 -178.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.91 126.98 41.54 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.986 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.706 ' HG2' ' HA ' ' A' ' 63' ' ' SER . 43.5 mt-10 -89.0 132.35 34.77 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.47 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.687 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 41.7 ttm-85 173.29 72.03 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.935 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 8.5 mp -102.87 132.35 49.13 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.991 0.424 . . . . 0.0 111.908 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.934 HG21 ' HB2' ' A' ' 113' ' ' ARG . 9.6 p -133.14 134.33 57.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.06 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.811 ' HB2' ' CD1' ' A' ' 58' ' ' ILE . 90.6 mt -141.74 140.95 33.23 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 121.384 -0.126 . . . . 0.0 111.009 178.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.992 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.8 mp -120.2 133.65 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-O 120.838 0.351 . . . . 0.0 110.923 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.708 ' OD1' ' HA ' ' A' ' 19' ' ' PRO . 64.5 m-20 51.72 36.32 0.34 Allowed Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 113.863 1.061 . . . . 0.0 113.863 178.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.777 ' HG3' ' HB2' ' A' ' 110' ' ' ALA . 90.1 Cg_exo -55.65 149.5 48.86 Favored 'Trans proline' 0 N--CA 1.484 0.917 0 C-N-CA 122.708 2.272 . . . . 0.0 113.415 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.434 ' OE2' ' HD2' ' A' ' 109' ' ' ARG . 23.0 pt-20 -135.91 145.88 46.76 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 1.102 ' HB2' ' HE2' ' A' ' 134' ' ' MET . 30.1 tp -79.71 138.38 37.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.38 0.61 . . . . 0.0 112.278 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 1.054 HD22 ' HE ' ' A' ' 109' ' ' ARG . 5.4 mp -112.17 -44.04 3.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.632 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 38.4 tt0 -158.79 147.79 18.74 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 121.141 0.496 . . . . 0.0 111.831 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.745 ' HA ' HG13 ' A' ' 106' ' ' VAL . 19.4 ptpt -142.3 147.46 36.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.054 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.2 t -160.03 148.02 16.83 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.702 0.287 . . . . 0.0 111.221 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.737 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 82.97 163.93 34.89 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.515 -179.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -140.55 113.59 8.38 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.922 0.861 . . . . 0.0 113.106 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.626 ' HG1' HD13 ' A' ' 128' ' ' ILE . 1.6 p -106.09 161.56 14.39 Favored 'General case' 0 CA--C 1.486 -1.481 0 CA-C-N 113.999 -1.455 . . . . 0.0 114.864 178.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.433 ' C ' HG13 ' A' ' 86' ' ' ILE . . . -145.47 114.12 0.74 Allowed Glycine 0 C--N 1.312 -0.781 0 CA-C-N 112.849 -1.978 . . . . 0.0 110.653 178.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.783 ' HB ' ' NH2' ' A' ' 102' ' ' ARG . 34.0 mt -148.67 139.56 17.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-N 117.264 0.532 . . . . 0.0 111.826 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 50.4 mt-10 -72.19 138.09 47.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 123.195 1.474 . . . . 0.0 112.581 -176.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.947 ' HG2' ' H27' ' A' ' 149' ' ' BB2 . 39.1 mt-10 -155.29 160.26 40.64 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 112.358 -2.201 . . . . 0.0 111.212 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.899 ' O ' ' H51' ' A' ' 149' ' ' BB2 . . . -120.12 159.56 15.04 Favored Glycine 0 CA--C 1.499 -0.911 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.996 ' HB2' HD13 ' A' ' 93' ' ' ILE . 21.8 m -114.27 139.91 49.03 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 117.688 0.744 . . . . 0.0 111.175 -177.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 1.002 ' HG ' HD11 ' A' ' 46' ' ' LEU . 2.4 mm? -49.44 -22.47 1.19 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.036 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.919 ' HB3' HD12 ' A' ' 13' ' ' LEU . 54.4 m -79.41 -38.54 34.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.277 179.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.996 HD13 ' HB2' ' A' ' 90' ' ' CYS . 3.2 mp -86.13 148.64 48.16 Favored Pre-proline 0 N--CA 1.448 -0.547 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.886 ' HD2' HG21 ' A' ' 93' ' ' ILE . 81.8 Cg_endo -73.88 52.41 2.58 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.439 2.093 . . . . 0.0 114.54 -178.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.538 ' HB2' ' O ' ' A' ' 94' ' ' PRO . 50.3 mt-10 78.63 12.67 1.48 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 178.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.703 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . 25.7 mt-30 -79.0 88.42 4.77 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 178.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.866 ' NH1' H232 ' A' ' 149' ' ' BB2 . 40.2 mtt180 -85.17 132.53 34.28 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.573 0.701 . . . . 0.0 111.613 -178.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -135.35 155.46 50.55 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 114.691 -1.141 . . . . 0.0 109.716 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.66 ' HG ' ' N ' ' A' ' 86' ' ' ILE . 7.3 tt -76.41 114.85 15.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.439 0.638 . . . . 0.0 111.985 -178.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.73 ' HB ' HH11 ' A' ' 102' ' ' ARG . 42.6 t -104.36 132.8 20.62 Favored Pre-proline 0 N--CA 1.47 0.573 0 CA-C-N 114.931 -1.031 . . . . 0.0 112.062 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' A' ' 84' ' ' THR . 2.1 Cg_endo -84.35 125.99 3.56 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.843 2.362 . . . . 0.0 111.804 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.783 ' NH2' ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -144.61 167.51 22.36 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.56 0.744 . . . . 0.0 109.98 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.737 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.79 154.86 41.22 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.836 0.351 . . . . 0.0 110.179 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -73.77 -41.16 62.81 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.146 -176.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.776 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 91.4 mttt -139.91 141.2 36.54 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.745 HG13 ' HA ' ' A' ' 80' ' ' LYS . 29.4 m -149.06 139.0 16.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.333 -179.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 1.0 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 51.0 mmtt -107.98 126.4 52.67 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.818 ' CD1' HD11 ' A' ' 130' ' ' ILE . 1.6 pp -136.1 152.76 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -176.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 1.054 ' HE ' HD22 ' A' ' 78' ' ' LEU . 93.7 mtt180 -102.68 138.78 39.12 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.93 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.777 ' HB2' ' HG3' ' A' ' 75' ' ' PRO . . . -160.04 167.82 27.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.102 -177.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.992 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.6 pp -117.12 153.25 33.11 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.597 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 10.1 t70 -88.2 162.97 16.38 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.519 -177.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.934 ' HB2' HG21 ' A' ' 71' ' ' VAL . 50.1 ttp85 -51.39 -19.04 1.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.251 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -79.1 -27.67 42.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.381 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.43 35.92 2.37 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.348 -0.93 . . . . 0.0 113.329 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -128.74 102.88 19.47 Favored Pre-proline 0 C--O 1.237 0.406 0 CA-C-N 116.815 0.308 . . . . 0.0 110.914 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.5 Cg_exo -73.4 116.08 4.57 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 121.766 1.644 . . . . 0.0 115.145 -177.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.597 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 10.9 p90 -126.13 166.65 16.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.312 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.729 ' HG2' ' HG2' ' A' ' 109' ' ' ARG . 30.7 mt-10 -107.5 130.51 54.84 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.743 HD11 ' CD1' ' A' ' 130' ' ' ILE . 4.3 pp -127.44 133.88 49.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.591 -178.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 1.0 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 9.1 pm0 -94.45 123.66 38.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.627 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.962 ' HB3' HD22 ' A' ' 126' ' ' LEU . . . -116.82 135.11 54.0 Favored 'General case' 0 C--O 1.222 -0.364 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.817 ' CA ' ' HB3' ' A' ' 127' ' ' ALA . 1.2 m-20 -126.66 162.35 25.97 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.703 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 49.9 -134.77 26.54 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 120.418 1.463 . . . . 0.0 115.252 177.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.526 HD12 ' CG1' ' A' ' 62' ' ' VAL . 1.7 pt? -53.78 -35.46 61.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.032 -0.584 . . . . 0.0 111.462 -179.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.962 HD22 ' HB3' ' A' ' 122' ' ' ALA . 0.6 OUTLIER -70.51 -52.01 24.85 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.996 0.903 . . . . 0.0 109.281 179.563 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.817 ' HB3' ' CA ' ' A' ' 123' ' ' ASP . . . -58.45 -41.5 85.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.925 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.703 HG12 ' O ' ' A' ' 124' ' ' GLY . 50.6 mm -68.54 -54.99 17.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.816 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 29.3 p -59.03 -50.74 72.93 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.818 HD11 ' CD1' ' A' ' 108' ' ' ILE . 17.9 tt -59.65 -43.85 92.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.189 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.672 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.0 pt20 -67.73 -40.63 84.18 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.176 178.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.633 ' CD2' ' HN1' ' A' ' 149' ' ' BB2 . 69.9 t60 -58.5 -45.78 88.04 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.206 0.527 . . . . 0.0 109.931 178.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.879 ' O ' HD21 ' A' ' 137' ' ' LEU . 3.2 mm-40 -59.81 -41.77 92.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.708 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 1.102 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 74.8 mtp -57.25 -47.83 80.38 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.736 0.779 . . . . 0.0 110.08 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.866 ' O ' HG12 ' A' ' 138' ' ' VAL . 1.4 m-20 -63.16 -47.12 84.0 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.951 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.935 ' NE2' HD21 ' A' ' 141' ' ' LEU . 8.7 t-80 -58.97 -53.11 62.16 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.176 0.512 . . . . 0.0 111.472 -178.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.907 HD23 ' HA ' ' A' ' 134' ' ' MET . 1.6 pp -58.65 -31.4 68.13 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.644 -178.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.963 HG11 ' HG2' ' A' ' 140' ' ' LYS . 14.5 p -85.05 24.58 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-O 122.283 1.04 . . . . 0.0 109.816 176.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 55.84 30.81 57.49 Favored Glycine 0 CA--C 1.486 -1.757 0 CA-C-N 113.48 -1.691 . . . . 0.0 112.679 176.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.963 ' HG2' HG11 ' A' ' 138' ' ' VAL . 5.8 ptmt -128.5 107.88 10.08 Favored 'General case' 0 N--CA 1.425 -1.704 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.626 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.935 HD21 ' NE2' ' A' ' 136' ' ' HIS . 4.6 mp -124.17 139.35 54.01 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 120.81 -1.181 . . . . 0.0 108.125 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.603 ' HB2' ' CG1' ' A' ' 100' ' ' VAL . 8.9 m-85 -59.77 -40.51 88.44 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.981 -0.449 . . . . 0.0 111.874 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.947 ' HA ' HD11 ' A' ' 146' ' ' LEU . 45.0 ttm -60.48 -26.38 66.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.175 0.512 . . . . 0.0 111.479 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.72 ' OD1' ' HD3' ' A' ' 14' ' ' ARG . 38.7 t70 -52.39 -25.22 9.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.184 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -122.96 43.07 3.03 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 120.716 0.294 . . . . 0.0 111.062 -177.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.947 HD11 ' HA ' ' A' ' 143' ' ' MET . 6.0 mp -91.08 142.33 27.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.115 178.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 55.7 m . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.984 179.529 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' BB2 . . . . . 1.017 H111 HD11 ' A' ' 60' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.922 HG12 ' HA ' ' A' ' 37' ' ' THR . 25.5 m . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.672 0.273 . . . . 0.0 111.327 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.895 HD11 ' HB ' ' A' ' 51' ' ' VAL . 2.0 pt? -80.46 -147.47 0.05 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.536 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 19.3 tt0 -98.58 104.76 16.83 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.938 0.399 . . . . 0.0 110.889 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.583 ' CG2' HG21 ' A' ' 37' ' ' THR . 40.4 t -88.36 126.38 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-O 121.496 0.665 . . . . 0.0 112.152 -178.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.054 ' HB2' HD21 ' A' ' 13' ' ' LEU . 50.2 mt -85.86 144.97 27.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.22 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 53.6 m-70 -123.01 144.05 49.52 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -178.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.006 HD13 HD12 ' A' ' 13' ' ' LEU . 49.3 mm -65.8 132.67 94.85 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.787 177.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -77.31 143.74 75.76 Favored 'Cis proline' 0 C--N 1.35 0.641 0 C-N-CA 124.553 -1.019 . . . . 0.0 111.778 -0.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.996 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.7 t70 -162.51 126.79 3.11 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.471 ' CD ' ' H ' ' A' ' 11' ' ' GLU . 0.6 OUTLIER -57.9 -45.85 85.84 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.754 -178.444 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.743 ' HB2' HD13 ' A' ' 6' ' ' LEU . 21.4 mtt-85 -59.89 -26.83 66.2 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 1.054 HD21 ' HB2' ' A' ' 6' ' ' LEU . 10.6 mt -77.66 -30.56 52.14 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 120.964 1.711 . . . . 0.0 108.586 177.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.618 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 15.0 mmm180 -95.11 8.62 42.43 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.072 -1.422 . . . . 0.0 109.059 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -90.17 147.67 23.44 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.7 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.579 HG13 HG23 ' A' ' 138' ' ' VAL . 90.4 t -81.93 128.83 38.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.834 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -90.28 145.4 25.01 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.832 ' HD3' ' HD2' ' A' ' 19' ' ' PRO . 8.0 tmtt? -107.11 131.42 21.71 Favored Pre-proline 0 C--N 1.318 -0.768 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.832 ' HD2' ' HD3' ' A' ' 18' ' ' LYS . 54.1 Cg_endo -81.56 114.44 2.7 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.774 1.649 . . . . 0.0 110.333 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.73 HG12 ' H ' ' A' ' 22' ' ' GLU . 19.4 t -68.97 144.88 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 CA-C-O 122.692 1.234 . . . . 0.0 113.342 -175.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -63.31 -21.26 66.15 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 112.861 -1.972 . . . . 0.0 112.986 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.73 ' H ' HG12 ' A' ' 20' ' ' VAL . 39.0 tt0 -157.84 144.51 17.82 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.166 -178.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.6 HG22 HD21 ' A' ' 111' ' ' LEU . 3.2 t -79.64 106.85 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -178.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 1.003 ' HB2' HD13 ' A' ' 27' ' ' ILE . 29.1 m120 -92.61 153.22 19.13 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.802 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -54.14 -24.19 16.93 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.241 0.543 . . . . 0.0 110.782 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 1.092 ' HG3' HD12 ' A' ' 27' ' ' ILE . 13.9 pt-20 -75.15 -42.19 56.66 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 177.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 1.092 HD12 ' HG3' ' A' ' 26' ' ' GLU . 2.0 mp -65.19 -35.72 76.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.748 177.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 75.4 mt-30 -66.32 -40.57 90.03 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 122.349 -0.22 . . . . 0.0 110.493 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.5 ' HG3' ' O ' ' A' ' 25' ' ' ALA . 67.9 mtt85 -62.83 -38.69 91.77 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.805 ' O ' ' HG3' ' A' ' 34' ' ' MET . 1.6 mp -56.07 -49.97 72.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.927 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.785 HG11 ' CG2' ' A' ' 71' ' ' VAL . 36.7 t -67.25 -43.14 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.924 0.392 . . . . 0.0 111.17 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.848 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -55.45 -41.11 72.42 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.067 -179.103 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.506 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 1.3 m-20 -76.37 -30.22 57.46 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.318 176.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.967 ' HG2' HG21 ' A' ' 51' ' ' VAL . 32.5 mtm -60.74 -44.59 96.49 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 120.55 -0.46 . . . . 0.0 109.95 -178.049 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.848 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 10.6 p90 -70.17 -46.19 65.15 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' ' 32' ' ' ASP . 29.7 mm-40 -51.86 -40.99 61.51 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 121.634 0.731 . . . . 0.0 109.411 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.922 ' HA ' HG12 ' A' ' 2' ' ' VAL . 91.6 m -70.43 -61.84 1.62 Allowed 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 118.479 -1.288 . . . . 0.0 108.411 177.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.793 ' HG3' ' HB2' ' A' ' 46' ' ' LEU . 2.1 ttp -46.16 -41.06 12.08 Favored 'General case' 0 CA--C 1.46 -2.483 0 C-N-CA 124.346 1.058 . . . . 0.0 110.775 -171.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.718 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 45.8 m-85 -70.07 -42.61 72.59 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.751 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.528 ' HB3' ' CG1' ' A' ' 2' ' ' VAL . . . -61.26 -24.33 66.31 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.436 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 1.119 ' HG2' HD12 ' A' ' 91' ' ' LEU . 16.5 tp10 -89.11 -11.24 44.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.466 177.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.443 ' H ' ' C ' ' A' ' 39' ' ' TYR . 5.0 mm-40 63.8 25.41 14.09 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.048 -176.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.35 144.53 25.84 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.819 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.775 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 51.6 mt -79.92 0.73 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 117.823 0.811 . . . . 0.0 112.062 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.531 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 178.03 140.34 3.77 Favored Glycine 0 CA--C 1.517 0.198 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.026 HD13 ' HG ' ' A' ' 91' ' ' LEU . 7.0 tp -127.4 135.22 50.17 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.855 1.327 . . . . 0.0 109.66 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.47 133.3 49.57 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 122.033 -0.417 . . . . 0.0 111.621 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.845 ' HB1' ' CD1' ' A' ' 53' ' ' ILE . . . -26.82 -57.24 0.09 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 116.113 1.894 . . . . 0.0 116.113 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.823 ' CG2' ' HA ' ' A' ' 137' ' ' LEU . 70.1 p -54.44 -34.87 62.25 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 121.969 0.89 . . . . 0.0 112.199 -178.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.824 ' OE1' HD12 ' A' ' 46' ' ' LEU . 57.4 mt-30 -62.14 -40.0 94.49 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.547 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.967 HG21 ' HG2' ' A' ' 34' ' ' MET . 1.7 m -93.41 18.35 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.89 ' OD2' HD21 ' A' ' 6' ' ' LEU . 6.6 t0 80.13 25.51 0.35 Allowed 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 176.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.845 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -119.18 107.42 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 118.759 -1.176 . . . . 0.0 111.004 178.056 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -75.91 60.58 1.38 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 122.18 0.99 . . . . 0.0 110.642 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.784 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 88.5 mt-30 -147.19 131.64 17.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.945 -1.479 . . . . 0.0 107.058 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.995 ' HA ' HD22 ' A' ' 137' ' ' LEU . 75.9 mtp180 -64.67 75.63 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.742 HD12 HG21 ' A' ' 30' ' ' ILE . 23.0 mt -117.25 125.06 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.956 HD11 ' HB2' ' A' ' 72' ' ' LEU . 1.8 pp -122.65 142.45 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 120.119 -0.632 . . . . 0.0 112.254 -177.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.612 HG12 ' O ' ' A' ' 46' ' ' LEU . 2.5 p -127.79 132.53 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.061 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 1.8 mt -114.65 154.89 15.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.898 0.856 . . . . 0.0 111.985 -177.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.782 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 14.9 t70 -145.12 31.86 1.12 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 113.986 -1.461 . . . . 0.0 110.068 -177.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.72 HG13 ' CD2' ' A' ' 125' ' ' LEU . 48.1 t . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.652 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.2 ttt85 . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.912 0.387 . . . . 0.0 111.389 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 1.061 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 55.3 mt -103.37 133.27 48.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.804 0.335 . . . . 0.0 111.678 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.973 HG21 ' HB2' ' A' ' 113' ' ' ARG . 7.1 p -135.86 133.89 51.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.187 177.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.956 ' HB2' HD11 ' A' ' 58' ' ' ILE . 1.7 mm? -140.55 141.82 35.21 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.038 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.6 mp -120.18 132.92 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.798 ' ND2' HG22 ' A' ' 73' ' ' ILE . 59.7 m-20 53.7 37.68 0.44 Allowed Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.863 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 95.0 Cg_exo -57.1 148.29 70.11 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 123.011 2.474 . . . . 0.0 114.129 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.469 ' O ' ' HB ' ' A' ' 108' ' ' ILE . 11.6 pt-20 -135.85 144.61 45.73 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.889 ' HB2' ' HE1' ' A' ' 134' ' ' MET . 44.5 tp -80.04 138.03 36.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.319 0.58 . . . . 0.0 111.98 -178.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.053 HD21 ' HG3' ' A' ' 109' ' ' ARG . 2.8 mm? -112.99 -39.33 4.25 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.971 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.593 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 85.2 tt0 -160.02 145.37 15.22 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 121.269 0.557 . . . . 0.0 111.695 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.968 ' HA ' HG12 ' A' ' 106' ' ' VAL . 10.8 ptpp? -138.52 149.58 45.51 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.482 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.1 p -159.02 149.21 19.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.801 0.334 . . . . 0.0 111.444 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.633 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 76.83 149.55 3.19 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.783 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -117.64 113.68 22.27 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.884 0.849 . . . . 0.0 112.406 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.697 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.7 p -112.08 160.37 17.59 Favored 'General case' 0 CA--C 1.485 -1.52 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.713 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -151.28 118.68 0.93 Allowed Glycine 0 C--N 1.311 -0.852 0 CA-C-N 112.392 -2.186 . . . . 0.0 110.509 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.599 HD13 ' O ' ' A' ' 85' ' ' GLY . 47.8 mm -147.76 139.92 18.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-N 117.383 0.592 . . . . 0.0 111.183 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 50.5 mt-10 -71.19 137.32 48.63 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 123.322 1.534 . . . . 0.0 111.833 -176.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.72 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 42.3 mt-10 -155.15 161.68 41.17 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 112.477 -2.147 . . . . 0.0 111.91 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.807 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -121.43 164.3 14.65 Favored Glycine 0 CA--C 1.5 -0.853 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 5.7 m -118.59 139.02 52.15 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.264 0.554 . . . . 0.0 111.854 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.119 HD12 ' HG2' ' A' ' 41' ' ' GLU . 2.4 mm? -49.64 -26.83 3.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.433 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.86 ' CB ' HG12 ' A' ' 8' ' ' ILE . 57.4 m -78.82 -36.52 42.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.43 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.868 HD13 ' HB ' ' A' ' 8' ' ' ILE . 43.6 mm . . . . . 0 N--CA 1.45 -0.425 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.392 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.807 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 18.8 mtm105 . . . . . 0 N--CA 1.462 0.164 0 CA-C-O 121.794 0.807 . . . . 0.0 111.817 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -134.48 153.42 51.94 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 114.433 -1.258 . . . . 0.0 109.82 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.713 HD21 ' HA3' ' A' ' 85' ' ' GLY . 6.9 tt -76.12 115.99 16.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.652 0.739 . . . . 0.0 111.146 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.857 ' CG1' HH21 ' A' ' 102' ' ' ARG . 17.3 t -111.0 136.09 20.81 Favored Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.665 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.697 ' HA ' ' O ' ' A' ' 84' ' ' THR . 91.8 Cg_endo -84.23 126.37 3.71 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 122.725 2.283 . . . . 0.0 112.655 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.977 ' HG3' HG23 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -145.6 166.76 24.8 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.102 0.961 . . . . 0.0 109.004 178.96 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.633 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -67.9 154.07 42.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 118.599 0.636 . . . . 0.0 110.473 -178.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.578 ' OE1' ' HG3' ' A' ' 105' ' ' LYS . 2.7 tm-20 -73.48 -41.26 63.36 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.393 -175.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.791 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 56.6 mttp -139.24 140.43 37.7 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.479 0.657 . . . . 0.0 109.433 177.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.968 HG12 ' HA ' ' A' ' 80' ' ' LYS . 26.1 m -150.14 136.37 12.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.455 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.998 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 46.5 mmtt -107.47 127.49 53.65 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.999 ' HA ' HD23 ' A' ' 78' ' ' LEU . 1.5 pp -135.09 156.54 39.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -176.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 1.053 ' HG3' HD21 ' A' ' 78' ' ' LEU . 92.7 mtt180 -103.3 138.17 40.43 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.502 -178.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.829 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -160.66 170.13 21.44 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.856 -176.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 1.038 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.6 pp -118.76 151.9 37.18 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 176.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.672 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 17.0 t70 -84.7 162.87 19.51 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.668 -176.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.973 ' HB2' HG21 ' A' ' 71' ' ' VAL . 50.7 ttp85 -53.5 -17.71 2.23 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.816 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -79.0 -28.81 43.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.819 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.572 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 109.33 35.49 2.28 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.475 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -128.77 102.8 19.44 Favored Pre-proline 0 C--O 1.236 0.376 0 CA-C-N 116.971 0.386 . . . . 0.0 110.891 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.683 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.7 Cg_exo -72.8 115.64 4.42 Favored 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 121.83 1.687 . . . . 0.0 115.696 -177.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.672 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 12.3 p90 -129.52 167.06 18.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.562 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.741 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 6.2 mp0 -107.35 130.3 54.81 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.924 ' O ' HD23 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -127.31 141.45 51.7 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 121.785 0.802 . . . . 0.0 111.703 -178.954 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.998 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 11.4 pt-20 -94.13 123.69 37.67 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.998 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.923 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -115.67 135.19 54.3 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.586 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.791 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.2 m-20 -126.94 163.12 24.37 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.788 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 50.55 -139.46 21.94 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 120.218 1.372 . . . . 0.0 115.726 177.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.72 ' CD2' HG13 ' A' ' 62' ' ' VAL . 25.6 tp -54.69 -30.3 55.32 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.38 -0.91 . . . . 0.0 111.643 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.923 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.5 OUTLIER -71.38 -53.32 14.49 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.56 0.695 . . . . 0.0 109.286 179.451 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.831 ' HB1' HG22 ' A' ' 106' ' ' VAL . . . -59.46 -39.77 84.71 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.332 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.977 HG23 ' HG3' ' A' ' 102' ' ' ARG . 45.9 mm -67.0 -54.51 23.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.347 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 73.0 m -60.61 -50.44 73.51 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.945 HD11 HD11 ' A' ' 108' ' ' ILE . 21.2 tt -58.61 -44.59 89.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.697 0.284 . . . . 0.0 110.961 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.653 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.7 pt20 -65.84 -37.65 86.79 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.416 ' HB2' HH12 ' A' ' 102' ' ' ARG . 75.8 t60 -60.15 -47.12 87.27 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.548 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.849 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 3.0 mm-40 -60.1 -38.03 81.77 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.889 ' HE1' ' HB2' ' A' ' 77' ' ' LEU . 72.4 mtp -58.07 -45.01 87.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 122.344 1.069 . . . . 0.0 109.183 177.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.845 ' OD1' ' HD3' ' A' ' 140' ' ' LYS . 57.0 m-20 -67.76 -48.73 65.56 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.0 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.695 ' CE1' ' HG2' ' A' ' 50' ' ' GLN . 6.4 t-80 -57.71 -52.87 63.66 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.393 0.616 . . . . 0.0 111.648 -178.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.995 HD22 ' HA ' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -64.95 -28.8 69.77 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 119.822 -0.751 . . . . 0.0 111.762 -179.291 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.908 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 11.5 p -81.47 24.16 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 122.08 0.943 . . . . 0.0 109.364 175.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.618 ' O ' ' HA ' ' A' ' 14' ' ' ARG . . . 68.41 -3.63 5.82 Favored Glycine 0 CA--C 1.484 -1.886 0 CA-C-N 113.769 -1.56 . . . . 0.0 113.217 175.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.908 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 11.4 ptmt . . . . . 0 N--CA 1.408 -2.552 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 1.007 HG13 HG23 ' A' ' 37' ' ' THR . 40.5 t . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.61 0.243 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 1.042 HD11 ' HB ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -79.1 -143.43 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.34 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.426 ' H ' ' HG ' ' A' ' 3' ' ' LEU . 66.0 tt0 -107.31 104.49 14.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 118.174 0.443 . . . . 0.0 110.363 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.529 ' CG2' HG21 ' A' ' 37' ' ' THR . 44.1 t -87.77 125.11 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 121.557 0.694 . . . . 0.0 111.967 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.032 ' HB2' HD21 ' A' ' 13' ' ' LEU . 20.9 mt -87.63 138.68 31.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.07 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.577 ' C ' HD11 ' A' ' 13' ' ' LEU . 32.7 m-70 -111.69 149.39 31.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.172 0.511 . . . . 0.0 111.91 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.017 HD13 HD12 ' A' ' 13' ' ' LEU . 47.1 mm -57.21 145.41 66.48 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.392 178.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.554 ' HA ' HG23 ' A' ' 8' ' ' ILE . 72.7 Cg_endo -92.68 52.48 1.0 Allowed 'Cis proline' 0 C--N 1.353 0.808 0 C-N-CA 124.597 -1.001 . . . . 0.0 112.872 0.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 1.009 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 9.4 t0 -53.81 134.45 42.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.972 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 23.8 pt-20 -59.23 -45.22 91.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.425 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.676 ' O ' ' HB ' ' A' ' 49' ' ' THR . 28.2 mtt-85 -59.29 -23.78 62.71 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 1.032 HD21 ' HB2' ' A' ' 6' ' ' LEU . 11.2 mt -73.48 -33.06 64.64 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 119.661 1.119 . . . . 0.0 108.393 178.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.698 ' C ' ' HA3' ' A' ' 139' ' ' GLY . 15.0 mmm180 -98.34 11.19 38.81 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.784 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.579 ' HB2' ' HA ' ' A' ' 12' ' ' ARG . 62.3 tttp -87.06 148.05 25.43 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.217 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.951 HG13 HG23 ' A' ' 138' ' ' VAL . 48.9 t -82.41 118.65 30.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.771 ' HB3' HD12 ' A' ' 137' ' ' LEU . . . -78.08 146.5 35.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.272 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -103.83 127.99 28.22 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.603 ' HD3' ' CD ' ' A' ' 56' ' ' ARG . 64.4 Cg_endo -78.24 115.51 3.73 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.206 1.937 . . . . 0.0 110.984 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.9 HG12 ' H ' ' A' ' 22' ' ' GLU . 21.7 t -68.32 144.27 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 CA-C-O 122.717 1.246 . . . . 0.0 113.28 -175.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -67.79 -26.52 66.13 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 112.731 -2.031 . . . . 0.0 112.203 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.9 ' H ' HG12 ' A' ' 20' ' ' VAL . 42.4 tt0 -154.47 145.17 22.39 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.168 -178.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 1.034 HG21 ' HA2' ' A' ' 115' ' ' GLY . 4.6 t -79.6 103.8 6.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -178.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.932 ' CB ' HD13 ' A' ' 27' ' ' ILE . 14.8 m-20 -93.19 155.6 17.35 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.701 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.705 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -56.17 -25.92 48.6 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.278 0.561 . . . . 0.0 110.88 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.51 ' HA ' ' OE1' ' A' ' 26' ' ' GLU . 4.2 mm-40 -75.29 -40.45 58.62 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.932 HD13 ' CB ' ' A' ' 24' ' ' ASN . 1.8 mp -66.76 -35.01 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 113.86 -1.518 . . . . 0.0 110.238 178.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -70.39 -38.88 74.75 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 122.208 -0.307 . . . . 0.0 110.715 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.705 ' HG3' ' O ' ' A' ' 25' ' ' ALA . 39.8 mtp85 -64.05 -39.0 93.12 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.784 ' O ' ' HG3' ' A' ' 34' ' ' MET . 3.0 mt -56.88 -49.16 79.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.771 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.915 HG22 ' CG2' ' A' ' 57' ' ' ILE . 9.6 t -67.36 -41.13 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 CA-C-O 121.004 0.43 . . . . 0.0 110.815 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.84 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 21.1 m-20 -54.74 -43.53 72.77 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.351 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.521 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 19.1 m-20 -76.4 -29.3 57.03 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.546 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' MET . . . . . 1.042 ' HG2' HG21 ' A' ' 51' ' ' VAL . 85.0 mtp -59.87 -46.07 90.46 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.247 -178.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.84 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 13.2 p90 -69.9 -45.24 68.04 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 176.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.758 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 40.3 mt-10 -52.37 -38.52 59.05 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 121.707 0.765 . . . . 0.0 109.291 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . 1.007 HG23 HG13 ' A' ' 2' ' ' VAL . 88.6 m -70.35 -61.72 1.66 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.273 -1.331 . . . . 0.0 107.833 177.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.924 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 2.8 ttp -45.77 -40.78 10.01 Favored 'General case' 0 CA--C 1.46 -2.488 0 C-N-CA 124.321 1.048 . . . . 0.0 110.059 -171.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.677 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 18.6 m-85 -70.1 -43.09 71.77 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.097 178.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 37' ' ' THR . . . -60.85 -25.17 66.45 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.75 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 1.057 ' HG2' HD12 ' A' ' 91' ' ' LEU . 17.0 tp10 -88.76 -11.46 44.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.645 -1.161 . . . . 0.0 108.469 176.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.439 ' H ' ' C ' ' A' ' 39' ' ' TYR . 18.2 mt-10 64.31 26.41 13.65 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.943 -176.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.31 142.67 23.21 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 113.947 -1.479 . . . . 0.0 111.276 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.863 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 42.6 mm -79.33 -0.95 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 117.293 0.547 . . . . 0.0 112.208 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.486 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 179.0 135.27 2.32 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 118.928 -0.929 . . . . 0.0 111.437 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.069 HD13 ' HG ' ' A' ' 91' ' ' LEU . 4.5 tp -125.17 133.96 52.59 Favored 'General case' 0 C--N 1.354 0.783 0 CA-C-N 119.332 1.566 . . . . 0.0 111.64 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.803 ' HB2' ' OE1' ' A' ' 133' ' ' GLU . . . -99.83 131.36 45.85 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 122.184 0.194 . . . . 0.0 111.151 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.867 ' HB1' ' CG1' ' A' ' 53' ' ' ILE . . . -30.38 -54.87 0.19 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.676 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 82.7 p -53.1 -36.21 60.49 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.482 0.658 . . . . 0.0 111.829 -178.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.768 ' OE1' HD12 ' A' ' 46' ' ' LEU . 86.0 mt-30 -63.85 -42.26 97.61 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.998 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 1.042 HG21 ' HG2' ' A' ' 34' ' ' MET . 0.8 OUTLIER -83.49 16.6 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.875 ' HA ' HD11 ' A' ' 6' ' ' LEU . 37.8 t70 73.79 29.86 1.42 Allowed 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 177.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.867 ' CG1' ' HB1' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -121.25 109.51 25.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 C-N-CA 119.179 -1.009 . . . . 0.0 110.609 177.303 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 21.6 p-80 -76.47 63.6 2.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.378 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.759 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 88.9 mt-30 -153.94 132.47 12.12 Favored 'General case' 0 C--O 1.219 -0.512 0 CA-C-N 114.194 -1.366 . . . . 0.0 107.875 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.68 ' N ' ' HB1' ' A' ' 17' ' ' ALA . 74.7 mtp180 -63.01 69.03 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -177.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.915 ' CG2' HG22 ' A' ' 31' ' ' VAL . 8.1 mm -111.81 123.06 67.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.029 HD11 ' HB2' ' A' ' 72' ' ' LEU . 2.0 pp -128.24 144.36 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 119.698 -0.801 . . . . 0.0 112.977 -177.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 46' ' ' LEU . 33.2 m -127.47 137.64 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.676 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.019 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 2.2 mt -115.59 151.03 17.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.57 0.7 . . . . 0.0 110.972 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.924 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 34.6 t70 -135.2 24.1 3.52 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.858 -178.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.806 HG22 ' CG2' ' A' ' 44' ' ' ILE . 23.5 t . . . . . 0 N--CA 1.466 0.349 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.46 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.63 ' HD3' ' O ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.793 0 CA-C-O 121.241 0.544 . . . . 0.0 110.528 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 1.019 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 7.9 mp -111.52 137.64 49.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.027 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.847 HG21 ' HB2' ' A' ' 113' ' ' ARG . 9.0 p -133.08 132.87 58.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.73 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.029 ' HB2' HD11 ' A' ' 58' ' ' ILE . 3.3 mm? -141.86 143.04 33.16 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 177.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.013 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.9 mp -121.03 136.21 58.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.761 0.315 . . . . 0.0 110.588 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.67 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 0.6 OUTLIER 45.49 40.23 0.6 Allowed Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 113.826 1.046 . . . . 0.0 113.826 -179.698 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.776 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 99.2 Cg_exo -56.56 150.96 48.97 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.831 2.354 . . . . 0.0 113.151 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -135.63 143.79 45.73 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.759 HD23 ' N ' ' A' ' 78' ' ' LEU . 1.5 tt -80.57 133.69 35.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.274 0.559 . . . . 0.0 111.723 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.062 HD13 ' HA ' ' A' ' 108' ' ' ILE . 4.8 mp -108.54 -44.78 4.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.207 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.59 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 5.2 tp10 -152.25 146.95 25.81 Favored 'General case' 0 N--CA 1.46 0.065 0 CA-C-O 121.095 0.474 . . . . 0.0 111.325 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.814 ' CB ' HG12 ' A' ' 106' ' ' VAL . 10.9 ptmm? -147.67 145.12 28.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.349 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.3 t -160.14 151.78 19.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.463 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.76 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 80.85 160.42 23.86 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.492 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -137.1 113.37 9.95 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.954 0.883 . . . . 0.0 113.065 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.661 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.5 p -105.59 161.59 14.24 Favored 'General case' 0 CA--C 1.487 -1.468 0 CA-C-N 114.061 -1.427 . . . . 0.0 114.761 178.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.783 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -146.03 114.81 0.77 Allowed Glycine 0 C--N 1.309 -0.928 0 CA-C-N 112.818 -1.992 . . . . 0.0 110.396 177.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.635 HD13 ' O ' ' A' ' 85' ' ' GLY . 49.3 mm -146.9 137.86 18.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-N 117.368 0.584 . . . . 0.0 111.206 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 50.4 mt-10 -71.41 137.23 48.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 123.193 1.473 . . . . 0.0 112.066 -176.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.676 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 40.8 mt-10 -154.76 161.62 41.44 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 112.196 -2.275 . . . . 0.0 111.079 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.7 ' HA3' ' HG2' ' A' ' 97' ' ' ARG . . . -120.32 163.84 13.98 Favored Glycine 0 CA--C 1.499 -0.937 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 13.1 m -117.86 140.88 49.08 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 117.729 0.765 . . . . 0.0 111.101 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.069 ' HG ' HD13 ' A' ' 46' ' ' LEU . 2.2 mm? -47.47 -26.65 1.44 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.971 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.883 ' CB ' HD13 ' A' ' 13' ' ' LEU . 54.1 m -79.36 -35.69 40.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.924 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 59.0 mt . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.648 -179.861 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.7 ' HG2' ' HA3' ' A' ' 89' ' ' GLY . 15.6 mtt85 . . . . . 0 N--CA 1.463 0.195 0 CA-C-O 121.649 0.737 . . . . 0.0 111.722 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 87' ' ' GLU . . . -134.73 155.86 49.82 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 114.581 -1.191 . . . . 0.0 109.479 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.783 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.6 tt -76.38 113.8 14.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.666 0.746 . . . . 0.0 111.813 -178.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.818 ' HB ' ' CZ ' ' A' ' 102' ' ' ARG . 40.3 t -104.29 132.25 21.15 Favored Pre-proline 0 N--CA 1.47 0.572 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.939 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.661 ' HA ' ' O ' ' A' ' 84' ' ' THR . 92.2 Cg_endo -84.26 127.45 3.95 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.596 2.197 . . . . 0.0 112.496 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.865 ' HB2' ' OE1' ' A' ' 131' ' ' GLN . 0.0 OUTLIER -144.39 166.98 23.57 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.54 0.736 . . . . 0.0 109.357 178.939 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.76 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.69 155.62 39.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 118.307 0.503 . . . . 0.0 110.301 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -73.12 -41.32 64.12 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.19 -176.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.699 ' HB3' ' OD1' ' A' ' 123' ' ' ASP . 66.8 mttm -139.67 140.5 36.9 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.467 0.651 . . . . 0.0 109.505 177.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.814 HG12 ' CB ' ' A' ' 80' ' ' LYS . 30.6 m -147.5 136.95 16.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.186 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 1.071 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 52.1 mmtt -107.58 126.02 52.03 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 1.062 ' HA ' HD13 ' A' ' 78' ' ' LEU . 1.7 pp -136.34 151.3 28.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -176.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 1.009 ' HG3' HD11 ' A' ' 78' ' ' LEU . 94.4 mtt180 -102.17 138.89 38.51 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.865 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.875 ' HB3' HD12 ' A' ' 72' ' ' LEU . . . -159.98 168.73 25.0 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.866 -177.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 1.013 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.4 pp -116.42 151.58 35.71 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.473 ' OD1' HG13 ' A' ' 71' ' ' VAL . 17.9 t70 -85.96 164.48 17.39 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.873 -176.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.847 ' HB2' HG21 ' A' ' 71' ' ' VAL . 48.0 ttp180 -52.01 -20.36 2.36 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.016 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -79.12 -25.67 42.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.526 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 1.034 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 105.91 36.28 2.8 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.223 -0.989 . . . . 0.0 113.525 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -128.64 102.82 19.77 Favored Pre-proline 0 C--O 1.237 0.403 0 CA-C-N 116.736 0.268 . . . . 0.0 110.737 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.66 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 32.1 Cg_exo -72.89 115.12 4.23 Favored 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 121.748 1.632 . . . . 0.0 115.389 -177.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.41 ' CE2' ' HB2' ' A' ' 112' ' ' ASP . 0.4 OUTLIER -126.32 167.05 16.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.422 -178.941 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.639 ' CG ' ' HG2' ' A' ' 109' ' ' ARG . 3.1 mp0 -107.33 130.18 54.81 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.794 HD11 ' CD1' ' A' ' 130' ' ' ILE . 4.4 pp -126.6 133.62 51.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.342 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 1.071 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 15.5 pt-20 -96.32 123.9 40.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.984 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.772 ' O ' ' HB2' ' A' ' 127' ' ' ALA . . . -116.63 136.47 52.94 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.699 ' OD1' ' HB3' ' A' ' 105' ' ' LYS . 41.6 m-20 -127.15 162.71 25.47 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.785 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 51.58 -138.67 28.49 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 120.539 1.518 . . . . 0.0 115.271 177.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.69 HD22 ' H ' ' A' ' 125' ' ' LEU . 2.6 mm? -53.37 -32.4 49.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.899 -0.651 . . . . 0.0 111.401 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.732 HD22 ' CB ' ' A' ' 122' ' ' ALA . 0.6 OUTLIER -70.77 -52.64 19.38 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.847 0.832 . . . . 0.0 109.487 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.772 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -59.73 -39.5 84.95 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.551 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.857 HD12 ' HG2' ' A' ' 102' ' ' ARG . 46.5 mm -68.97 -56.04 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -178.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.524 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 29.7 p -58.15 -49.93 75.29 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 1.016 HD11 HD11 ' A' ' 108' ' ' ILE . 19.1 tt -59.34 -44.19 91.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.179 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.865 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.0 pt20 -67.79 -39.76 84.01 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.39 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.647 ' HA ' ' OD1' ' A' ' 135' ' ' ASP . 69.0 t60 -57.04 -47.37 81.1 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.568 0.699 . . . . 0.0 109.869 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.912 ' O ' HD23 ' A' ' 137' ' ' LEU . 48.0 mm-40 -61.35 -39.6 91.2 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.272 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.882 ' HA ' HD21 ' A' ' 137' ' ' LEU . 74.6 mtp -58.43 -49.66 76.51 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.476 0.655 . . . . 0.0 111.005 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.699 ' O ' HG12 ' A' ' 138' ' ' VAL . 5.6 p-10 -65.78 -45.03 83.99 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.756 178.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.44 ' CE1' ' CG ' ' A' ' 50' ' ' GLN . 9.0 t-80 -55.94 -52.53 63.82 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 121.466 -0.771 . . . . 0.0 111.17 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.912 HD23 ' O ' ' A' ' 133' ' ' GLU . 1.3 pp -59.17 -30.97 68.57 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.2 -178.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.951 HG23 HG13 ' A' ' 16' ' ' VAL . 12.7 p -86.07 22.76 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-O 122.264 1.03 . . . . 0.0 109.268 176.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.698 ' HA3' ' C ' ' A' ' 14' ' ' ARG . . . 55.6 37.85 69.22 Favored Glycine 0 CA--C 1.484 -1.9 0 CA-C-N 113.493 -1.685 . . . . 0.0 112.415 176.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.934 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 3.7 ptmt . . . . . 0 N--CA 1.421 -1.91 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.754 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.954 HG13 HG23 ' A' ' 37' ' ' THR . 41.9 t . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.613 0.244 . . . . 0.0 110.523 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 1.016 HD11 ' HB ' ' A' ' 51' ' ' VAL . 1.9 pt? -83.1 -148.76 0.09 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.262 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.42 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 65.2 tt0 -102.28 106.34 17.13 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.994 0.426 . . . . 0.0 110.831 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.552 HG11 HD12 ' A' ' 91' ' ' LEU . 45.2 t -88.84 127.63 41.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.372 0.606 . . . . 0.0 111.539 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.959 ' HB2' HD21 ' A' ' 13' ' ' LEU . 24.9 mt -83.9 142.7 30.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.805 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -114.08 145.43 41.62 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.075 0.464 . . . . 0.0 111.911 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.63 HD12 ' H ' ' A' ' 8' ' ' ILE . 2.9 mp -55.8 146.95 44.61 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.883 178.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.583 ' HA ' HG23 ' A' ' 8' ' ' ILE . 74.8 Cg_endo -93.17 52.13 1.06 Allowed 'Cis proline' 0 C--N 1.354 0.838 0 C-N-CA 124.38 -1.092 . . . . 0.0 113.47 0.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.56 133.74 50.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.914 0.388 . . . . 0.0 110.853 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.492 ' CD ' ' H ' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -58.8 -41.09 85.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.59 -179.149 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.613 ' HB2' HD13 ' A' ' 6' ' ' LEU . 42.8 mtt180 -58.18 -25.03 61.05 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.959 HD21 ' HB2' ' A' ' 6' ' ' LEU . 11.3 mt -75.6 -33.14 60.54 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 120.378 1.445 . . . . 0.0 108.425 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.612 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 20.6 mmm-85 -93.29 8.76 39.04 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 113.762 -1.563 . . . . 0.0 109.297 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.484 ' HB2' ' HA ' ' A' ' 12' ' ' ARG . 63.7 tttm -90.36 148.94 22.51 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.748 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.935 HG13 HG23 ' A' ' 138' ' ' VAL . 58.7 t -83.4 124.21 39.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.998 0.428 . . . . 0.0 109.871 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.794 ' HB3' HD12 ' A' ' 137' ' ' LEU . . . -80.8 148.53 29.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.002 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -109.07 130.74 22.37 Favored Pre-proline 0 C--N 1.327 -0.405 0 C-N-CA 121.165 -0.214 . . . . 0.0 110.634 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.873 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 60.8 Cg_endo -79.62 113.89 3.15 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 121.99 1.794 . . . . 0.0 110.821 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.738 HG12 ' H ' ' A' ' 22' ' ' GLU . 16.7 t -68.56 144.92 13.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 122.629 1.204 . . . . 0.0 113.558 -175.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.4 ' N ' HG12 ' A' ' 20' ' ' VAL . 69.9 mm-40 -61.54 -27.38 68.57 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 113.143 -1.844 . . . . 0.0 112.349 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.738 ' H ' HG12 ' A' ' 20' ' ' VAL . 5.0 tp10 -156.76 151.77 26.13 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.789 -178.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.678 HG21 ' HA2' ' A' ' 115' ' ' GLY . 3.2 t -80.38 103.65 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -178.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 1.083 ' H ' HD12 ' A' ' 27' ' ' ILE . 22.6 m-20 -85.7 153.26 22.46 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.167 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.576 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -54.69 -31.95 58.72 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.44 0.638 . . . . 0.0 110.085 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.536 ' HG2' ' NH2' ' A' ' 29' ' ' ARG . 49.7 mt-10 -71.52 -38.05 71.13 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 1.083 HD12 ' H ' ' A' ' 24' ' ' ASN . 68.5 mt -65.86 -38.79 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 113.964 -1.471 . . . . 0.0 110.494 178.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -66.94 -40.57 87.62 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.746 -0.206 . . . . 0.0 110.976 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.576 ' HG3' ' O ' ' A' ' 25' ' ' ALA . 83.9 mtm180 -63.88 -38.65 91.88 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.842 ' O ' ' HG3' ' A' ' 34' ' ' MET . 5.0 mt -56.28 -50.77 69.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.496 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.874 HG22 ' CG2' ' A' ' 57' ' ' ILE . 13.7 t -66.19 -41.47 89.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.95 0.405 . . . . 0.0 111.39 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.923 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -56.59 -42.56 78.9 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -179.26 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.493 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 14.8 m-20 -76.29 -30.15 57.66 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.768 176.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.961 ' HE1' HG22 ' A' ' 57' ' ' ILE . 23.0 mtm -60.26 -46.84 88.4 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.297 -177.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.923 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 9.6 p90 -69.58 -43.67 72.36 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.61 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 56.1 mm-40 -52.97 -42.03 65.12 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.954 HG23 HG13 ' A' ' 2' ' ' VAL . 98.9 m -69.51 -61.72 1.67 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 118.722 -1.191 . . . . 0.0 108.104 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.882 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 1.7 ttp -46.38 -40.58 12.26 Favored 'General case' 0 CA--C 1.468 -2.202 0 C-N-CA 124.057 0.943 . . . . 0.0 110.18 -171.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.74 ' OH ' ' HA ' ' A' ' 69' ' ' ARG . 45.2 m-85 -69.95 -41.5 74.47 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.023 177.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 37' ' ' THR . . . -61.93 -23.09 66.14 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.008 -0.997 . . . . 0.0 109.561 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.706 ' HG2' ' CD1' ' A' ' 91' ' ' LEU . 13.8 tp10 -90.16 -11.62 40.61 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.177 -1.374 . . . . 0.0 108.267 177.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.445 ' H ' ' C ' ' A' ' 39' ' ' TYR . 22.1 mt-10 63.68 28.75 15.03 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.762 -176.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.78 141.83 19.7 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 113.683 -1.599 . . . . 0.0 110.691 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.797 HG23 ' O ' ' A' ' 61' ' ' ASP . 47.2 mt -79.43 2.18 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 117.859 0.829 . . . . 0.0 111.919 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.511 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 177.25 133.57 1.85 Allowed Glycine 0 CA--C 1.523 0.539 0 CA-C-O 119.06 -0.856 . . . . 0.0 112.043 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.098 HD12 ' HG ' ' A' ' 91' ' ' LEU . 8.8 tt -126.62 135.36 51.11 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 119.116 1.458 . . . . 0.0 110.967 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.655 ' N ' HD23 ' A' ' 46' ' ' LEU . . . -97.99 134.6 40.87 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.867 ' HB1' ' CG1' ' A' ' 53' ' ' ILE . . . -31.01 -55.05 0.22 Allowed 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.962 1.468 . . . . 0.0 114.962 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.537 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 81.3 p -53.09 -36.26 60.5 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.523 0.677 . . . . 0.0 112.361 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.572 HE21 ' H ' ' A' ' 47' ' ' ALA . 27.6 mt-30 -63.93 -40.77 97.24 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.486 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 1.016 ' HB ' HD11 ' A' ' 3' ' ' LEU . 1.2 m -85.63 17.3 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.607 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.911 ' HA ' HD11 ' A' ' 6' ' ' LEU . 50.8 t0 77.89 26.6 0.61 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 176.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.867 ' CG1' ' HB1' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -121.35 109.84 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 C-N-CA 118.985 -1.086 . . . . 0.0 111.243 177.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.481 ' HD2' ' CZ ' ' A' ' 12' ' ' ARG . 6.8 p80 -76.46 59.47 1.47 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.791 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.722 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 7.1 mp0 -148.75 134.05 18.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.449 -1.251 . . . . 0.0 108.075 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.873 ' HD2' ' HD3' ' A' ' 19' ' ' PRO . 68.0 mtt-85 -63.13 68.65 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -177.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.961 HG22 ' HE1' ' A' ' 34' ' ' MET . 7.4 mm -112.77 122.84 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.038 HD11 ' HB2' ' A' ' 72' ' ' LEU . 2.2 pp -126.24 148.03 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -177.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.621 HG22 ' O ' ' A' ' 46' ' ' LEU . 32.6 m -129.06 138.49 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.212 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.075 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 10.9 mm -115.77 151.95 17.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-O 121.483 0.659 . . . . 0.0 109.859 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.882 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 10.0 t70 -139.78 43.31 1.97 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.821 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.859 HG23 ' CG2' ' A' ' 60' ' ' ILE . 13.9 t . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.129 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.74 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 71.7 ttt180 . . . . . 0 N--CA 1.472 0.633 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 1.075 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 9.4 mp -108.56 137.1 47.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.695 0.283 . . . . 0.0 111.656 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.794 ' C ' HD22 ' A' ' 72' ' ' LEU . 14.6 p -135.57 135.96 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.038 ' HB2' HD11 ' A' ' 58' ' ' ILE . 3.0 mm? -143.91 147.29 33.79 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.539 -0.171 . . . . 0.0 110.539 177.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.064 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.7 mp -122.11 136.5 58.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.564 0.221 . . . . 0.0 110.419 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.713 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 58.9 m-20 50.38 37.98 0.47 Allowed Pre-proline 0 CA--C 1.55 0.96 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.869 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 79.6 Cg_exo -58.23 147.48 83.92 Favored 'Trans proline' 0 N--CA 1.486 1.085 0 C-N-CA 123.137 2.558 . . . . 0.0 114.844 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.433 ' O ' ' HB ' ' A' ' 108' ' ' ILE . 11.8 pt-20 -136.37 140.51 43.3 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.907 ' HA ' HG22 ' A' ' 108' ' ' ILE . 1.7 tt -81.95 134.51 35.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.177 0.513 . . . . 0.0 111.267 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.039 HD13 ' HA ' ' A' ' 108' ' ' ILE . 5.9 mp -109.57 -43.76 4.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.13 -178.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 39.3 tt0 -147.54 149.73 33.17 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.05 0.452 . . . . 0.0 111.611 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.968 ' HA ' HG12 ' A' ' 106' ' ' VAL . 9.2 ptpp? -147.6 143.86 28.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.83 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.6 p -155.4 147.22 23.28 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.786 0.327 . . . . 0.0 111.257 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.742 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 81.22 147.82 5.79 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.114 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -115.57 114.29 24.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.724 0.773 . . . . 0.0 112.542 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.769 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.7 p -116.51 161.14 19.59 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 115.505 1.669 . . . . 0.0 115.505 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.829 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -150.09 119.17 1.0 Allowed Glycine 0 C--N 1.312 -0.764 0 CA-C-N 112.363 -2.198 . . . . 0.0 111.499 178.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.638 HD13 ' O ' ' A' ' 85' ' ' GLY . 49.5 mm -146.45 136.44 17.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 117.278 0.539 . . . . 0.0 111.373 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 50.2 mt-10 -72.47 141.23 48.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 122.841 1.305 . . . . 0.0 112.657 -176.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.614 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 55.2 mt-10 -153.71 163.97 39.1 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 112.713 -2.039 . . . . 0.0 111.538 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.736 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -120.36 168.59 13.88 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.718 ' HB2' ' CG1' ' A' ' 93' ' ' ILE . 90.3 m -114.12 140.02 48.84 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.215 -0.594 . . . . 0.0 112.03 -177.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.098 ' HG ' HD12 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -53.87 -16.65 1.91 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.845 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.563 ' CB ' HD13 ' A' ' 13' ' ' LEU . 22.0 m -102.96 -31.55 10.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.507 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.718 ' CG1' ' HB2' ' A' ' 90' ' ' CYS . 48.0 mt . . . . . 0 CA--C 1.534 0.347 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.332 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.736 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 55.5 mtm-85 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 121.109 0.481 . . . . 0.0 109.931 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -125.06 146.03 49.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.054 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.829 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.3 tt -76.1 113.69 13.91 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.847 0.832 . . . . 0.0 110.779 -178.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.811 ' CG1' HH21 ' A' ' 102' ' ' ARG . 48.8 t -101.82 128.79 27.96 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.706 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.769 ' HA ' ' O ' ' A' ' 84' ' ' THR . 87.6 Cg_endo -83.0 126.13 4.32 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.163 1.908 . . . . 0.0 111.57 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.811 HH21 ' CG1' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -144.11 166.71 24.23 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.378 179.432 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.742 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.05 155.09 40.28 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.881 0.372 . . . . 0.0 110.461 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -72.26 -40.89 67.33 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.475 -175.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.732 ' HB3' ' OD1' ' A' ' 123' ' ' ASP . 67.1 mttm -140.42 140.22 35.41 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.395 0.617 . . . . 0.0 109.507 176.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.968 HG12 ' HA ' ' A' ' 80' ' ' LYS . 25.3 m -150.42 141.37 16.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.417 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.957 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 23.7 mmtp -108.0 126.48 52.77 Favored 'General case' 0 C--O 1.227 -0.093 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 1.039 ' HA ' HD13 ' A' ' 78' ' ' LEU . 1.8 pp -135.36 152.9 32.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -176.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 1.027 ' HG3' HD11 ' A' ' 78' ' ' LEU . 44.2 mtm180 -103.45 140.73 37.09 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.926 0.87 . . . . 0.0 111.507 -178.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.733 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -161.14 169.51 22.18 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.483 -177.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 1.064 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 1.9 pp -116.64 149.76 39.22 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 176.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.809 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 23.1 t70 -84.41 163.66 19.36 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.587 -176.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.764 ' HD2' ' OD1' ' A' ' 32' ' ' ASP . 14.5 ttp-105 -53.48 -17.24 1.85 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.865 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -79.13 -28.35 42.9 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.948 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.678 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 107.63 35.8 2.55 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.622 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -128.82 103.25 19.1 Favored Pre-proline 0 C--O 1.237 0.43 0 CA-C-N 116.699 0.25 . . . . 0.0 110.705 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.692 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 32.7 Cg_exo -71.99 114.51 3.99 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 121.34 1.36 . . . . 0.0 114.619 -177.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.809 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 10.2 p90 -127.16 168.6 14.45 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.484 -178.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.669 ' HG2' ' HD2' ' A' ' 109' ' ' ARG . 29.8 mt-10 -107.03 129.72 54.76 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.723 ' O ' HD12 ' A' ' 120' ' ' LEU . 4.3 pp -123.45 132.63 53.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.434 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.957 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 9.0 pm0 -92.54 123.38 35.8 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.54 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.808 ' O ' ' HB2' ' A' ' 127' ' ' ALA . . . -117.05 133.54 55.87 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 120.47 -0.492 . . . . 0.0 112.134 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.732 ' OD1' ' HB3' ' A' ' 105' ' ' LYS . 29.4 m-20 -127.81 160.73 30.86 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.663 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 54.9 -138.09 42.7 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 120.952 1.705 . . . . 0.0 114.779 177.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.679 HD12 ' H ' ' A' ' 125' ' ' LEU . 4.7 mp -54.24 -32.29 55.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.2 -0.5 . . . . 0.0 111.333 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.747 HD22 ' CB ' ' A' ' 122' ' ' ALA . 0.6 OUTLIER -70.72 -51.79 25.15 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.394 0.616 . . . . 0.0 109.676 179.707 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.808 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -61.67 -46.76 88.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.949 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.778 HG23 ' CG ' ' A' ' 102' ' ' ARG . 47.3 mm -64.43 -55.67 20.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -177.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 78.0 m -58.56 -48.08 82.1 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.912 HD11 HD11 ' A' ' 108' ' ' ILE . 20.2 tt -59.35 -41.86 85.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.157 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.798 ' CG ' HG21 ' A' ' 106' ' ' VAL . 36.8 mt-30 -64.86 -38.51 91.22 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.761 0.315 . . . . 0.0 110.185 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.754 ' HA ' ' OD2' ' A' ' 135' ' ' ASP . 79.6 t60 -58.7 -45.54 89.27 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.295 0.569 . . . . 0.0 110.401 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.916 ' O ' HD23 ' A' ' 137' ' ' LEU . 4.5 mm-40 -60.72 -43.2 98.15 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.732 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.917 ' HA ' HD21 ' A' ' 137' ' ' LEU . 70.2 mtp -57.85 -48.55 79.47 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.374 0.607 . . . . 0.0 110.934 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.754 ' OD2' ' HA ' ' A' ' 132' ' ' HIS . 2.5 p30 -65.14 -46.32 81.4 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.114 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.479 ' CE1' ' HG2' ' A' ' 50' ' ' GLN . 11.7 t-80 -58.95 -51.69 68.95 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 121.698 -0.626 . . . . 0.0 111.527 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.917 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.4 pp -60.12 -31.42 70.04 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.952 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.979 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 14.2 p -82.98 25.49 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-O 122.487 1.136 . . . . 0.0 109.825 177.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.648 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 60.13 6.49 5.64 Favored Glycine 0 CA--C 1.487 -1.682 0 CA-C-N 113.082 -1.872 . . . . 0.0 113.382 176.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.979 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 14.3 ptmt . . . . . 0 N--CA 1.413 -2.297 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 1.037 HG12 ' HA ' ' A' ' 37' ' ' THR . 30.9 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.649 0.262 . . . . 0.0 110.987 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.787 HD13 ' OG1' ' A' ' 37' ' ' THR . 0.0 OUTLIER -85.28 -172.8 4.35 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.605 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.604 ' O ' ' HG2' ' A' ' 4' ' ' GLN . 7.9 pm0 -79.88 111.09 15.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.28 0.562 . . . . 0.0 110.993 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.627 ' CG2' HG21 ' A' ' 37' ' ' THR . 39.0 t -89.52 131.4 36.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.975 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.057 ' HB2' HD21 ' A' ' 13' ' ' LEU . 30.5 mt -86.81 147.5 25.8 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.556 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.522 ' C ' HD11 ' A' ' 13' ' ' LEU . 3.2 m80 -122.74 144.34 49.23 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.01 HD13 HD12 ' A' ' 13' ' ' LEU . 35.5 mm -67.44 135.88 93.17 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.526 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -78.92 144.5 73.88 Favored 'Cis proline' 0 C--N 1.352 0.736 0 C-N-CA 124.614 -0.994 . . . . 0.0 111.551 -0.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 1.004 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 9.1 t0 -164.0 129.14 2.87 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.404 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.462 ' HG2' ' N ' ' A' ' 12' ' ' ARG . 0.6 OUTLIER -58.08 -45.43 87.15 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.526 -178.769 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.623 ' HB2' HD13 ' A' ' 6' ' ' LEU . 23.2 mmt-85 -58.29 -28.41 64.97 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 1.057 HD21 ' HB2' ' A' ' 6' ' ' LEU . 9.7 mt -77.4 -32.13 54.59 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 120.613 1.551 . . . . 0.0 108.306 177.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.482 ' C ' ' HA3' ' A' ' 139' ' ' GLY . 14.6 mmm180 -93.38 11.76 27.19 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 114.105 -1.407 . . . . 0.0 109.13 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.488 ' HB2' ' HA ' ' A' ' 12' ' ' ARG . 59.5 tptt -89.86 147.93 23.47 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.678 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.94 HG13 HG23 ' A' ' 138' ' ' VAL . 74.6 t -82.56 128.9 38.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.758 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -86.97 142.63 27.82 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.584 ' NZ ' ' HB2' ' A' ' 18' ' ' LYS . 4.7 ttmp? -105.57 129.8 24.09 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.854 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 56.8 Cg_endo -81.45 112.94 2.54 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 121.653 1.568 . . . . 0.0 110.812 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.698 HG12 ' H ' ' A' ' 22' ' ' GLU . 15.9 t -69.66 144.66 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 CA-C-O 122.552 1.168 . . . . 0.0 113.213 -175.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -61.07 -23.41 65.45 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 113.019 -1.9 . . . . 0.0 112.438 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.698 ' H ' HG12 ' A' ' 20' ' ' VAL . 42.8 tt0 -161.18 139.85 9.89 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.183 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.493 ' CG1' ' NE2' ' A' ' 28' ' ' GLN . 2.6 t -79.43 118.88 27.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.839 ' H ' HD12 ' A' ' 27' ' ' ILE . 24.7 m120 -104.27 -176.66 3.14 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.894 -0.504 . . . . 0.0 110.655 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.698 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -68.79 -25.41 64.69 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.456 0.646 . . . . 0.0 110.48 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.504 ' HA ' ' OE1' ' A' ' 26' ' ' GLU . 4.3 mm-40 -75.12 -43.19 54.15 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.839 HD12 ' H ' ' A' ' 24' ' ' ASN . 54.2 mt -65.04 -40.1 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 114.086 -1.416 . . . . 0.0 110.695 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.834 ' HG2' ' O ' ' A' ' 24' ' ' ASN . 32.6 mm-40 -64.96 -40.8 95.56 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 122.431 -0.168 . . . . 0.0 111.064 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.698 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 26.5 mmm180 -61.86 -38.73 89.36 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.784 ' O ' ' HG3' ' A' ' 34' ' ' MET . 4.2 mt -57.76 -49.22 81.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.829 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.869 HG22 ' CG2' ' A' ' 57' ' ' ILE . 25.3 t -67.97 -41.72 84.88 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 CA-C-O 120.919 0.39 . . . . 0.0 111.339 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.884 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 27.9 m-20 -53.74 -45.97 70.72 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.121 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.502 ' OD1' HD12 ' A' ' 3' ' ' LEU . 3.0 p30 -74.57 -29.63 61.42 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.137 176.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.939 ' HG2' HG21 ' A' ' 51' ' ' VAL . 82.6 mtp -61.12 -46.93 88.57 Favored 'General case' 0 C--N 1.346 0.434 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.851 -178.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.884 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 22.5 p90 -70.82 -47.85 57.24 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.622 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 30.4 mm-40 -50.83 -41.59 57.69 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . 1.037 ' HA ' HG12 ' A' ' 2' ' ' VAL . 48.4 m -70.34 -60.28 2.37 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.201 -1.363 . . . . 0.0 108.907 177.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.819 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 1.2 ttp -47.13 -39.72 14.08 Favored 'General case' 0 CA--C 1.464 -2.33 0 C-N-CA 124.046 0.939 . . . . 0.0 110.401 -171.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.664 ' OH ' ' HA ' ' A' ' 69' ' ' ARG . 68.2 m-85 -70.72 -42.1 71.02 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.146 177.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.565 ' CB ' HG11 ' A' ' 2' ' ' VAL . . . -60.95 -25.28 66.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.371 -0.831 . . . . 0.0 108.987 178.063 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.821 ' HG2' HD12 ' A' ' 91' ' ' LEU . 11.4 tp10 -87.02 -10.72 52.4 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 114.303 -1.317 . . . . 0.0 108.669 176.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.44 ' H ' ' C ' ' A' ' 39' ' ' TYR . 4.9 mm-40 63.76 23.62 13.52 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.21 -176.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.6 140.79 23.88 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.324 177.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.817 HG22 HG22 ' A' ' 62' ' ' VAL . 43.2 mm -78.67 -0.8 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 117.464 0.632 . . . . 0.0 111.756 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.545 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 177.91 136.05 2.42 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 118.68 -1.067 . . . . 0.0 110.872 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.813 ' HB2' ' HG3' ' A' ' 38' ' ' MET . 8.9 tt -127.98 135.37 49.83 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-N 119.714 1.757 . . . . 0.0 111.03 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.606 ' N ' HD23 ' A' ' 46' ' ' LEU . . . -97.43 134.16 41.06 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.881 ' HB1' ' CG1' ' A' ' 53' ' ' ILE . . . -31.11 -53.68 0.21 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.552 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 57.0 p -53.36 -35.32 60.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.77 0.795 . . . . 0.0 111.268 -178.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.751 ' OE1' HD23 ' A' ' 91' ' ' LEU . 74.8 mt-30 -64.22 -41.84 96.85 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.175 -1.375 . . . . 0.0 109.813 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.939 HG21 ' HG2' ' A' ' 34' ' ' MET . 0.9 OUTLIER -84.8 16.27 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-O 121.195 0.521 . . . . 0.0 112.132 179.763 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.846 ' HA ' HD11 ' A' ' 6' ' ' LEU . 50.5 t0 75.36 30.04 0.87 Allowed 'General case' 0 C--O 1.233 0.185 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 176.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.881 ' CG1' ' HB1' ' A' ' 48' ' ' ALA . 1.1 pp -123.54 111.41 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 C-N-CA 119.228 -0.989 . . . . 0.0 110.898 177.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.9 p-80 -76.3 62.68 1.82 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.992 0.901 . . . . 0.0 110.586 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.752 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 89.6 mt-30 -151.94 134.83 15.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.25 -1.341 . . . . 0.0 107.691 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.869 ' HG2' ' CD1' ' A' ' 137' ' ' LEU . 65.0 mtt-85 -64.26 70.74 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.869 ' CG2' HG22 ' A' ' 31' ' ' VAL . 9.1 mm -112.09 122.74 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.08 HD11 ' HB2' ' A' ' 72' ' ' LEU . 1.8 pp -126.17 144.34 36.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 119.836 -0.746 . . . . 0.0 112.913 -177.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.717 HG22 ' O ' ' A' ' 46' ' ' LEU . 33.5 m -127.22 137.12 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.067 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 6.1 mm -114.73 149.99 16.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.748 0.785 . . . . 0.0 109.555 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.819 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 58.5 t0 -137.35 27.84 2.81 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.442 -178.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.817 HG22 HG22 ' A' ' 44' ' ' ILE . 28.7 t . . . . . 0 C--N 1.332 -0.164 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.253 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.664 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 32.2 ttm180 . . . . . 0 N--CA 1.462 0.174 0 CA-C-O 120.638 0.256 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 1.067 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 61.2 mt -102.48 132.35 48.58 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-O 120.834 0.349 . . . . 0.0 111.557 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.866 ' O ' HD12 ' A' ' 72' ' ' LEU . 8.6 p -135.03 134.22 53.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.544 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.08 ' HB2' HD11 ' A' ' 58' ' ' ILE . 10.4 mp -140.6 142.45 35.05 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.047 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.7 mp -119.97 133.04 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-O 120.678 0.275 . . . . 0.0 110.413 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.792 ' ND2' HG22 ' A' ' 73' ' ' ILE . 66.8 m-20 54.2 37.14 0.39 Allowed Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.936 ' HG2' HG12 ' A' ' 58' ' ' ILE . 97.0 Cg_exo -56.65 150.17 54.43 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 C-N-CA 123.032 2.488 . . . . 0.0 114.016 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.656 ' OE2' ' HD2' ' A' ' 109' ' ' ARG . 23.0 pt-20 -138.45 143.12 39.51 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.815 ' HB2' ' HE3' ' A' ' 134' ' ' MET . 1.6 tt -80.24 135.19 36.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.434 0.635 . . . . 0.0 111.958 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.086 HD11 ' HG3' ' A' ' 109' ' ' ARG . 5.2 mp -109.75 -40.4 4.82 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.283 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 85.2 tt0 -156.05 154.62 31.29 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.277 0.561 . . . . 0.0 111.802 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.888 ' HA ' HG12 ' A' ' 106' ' ' VAL . 9.1 ptpp? -147.56 151.07 35.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.231 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 46.4 t -160.33 147.07 15.77 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.697 0.284 . . . . 0.0 111.318 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.661 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 75.16 161.71 9.42 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.571 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -135.76 113.29 10.8 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.867 0.841 . . . . 0.0 112.972 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.863 ' HB ' HH12 ' A' ' 102' ' ' ARG . 1.6 p -105.68 162.37 13.58 Favored 'General case' 0 CA--C 1.489 -1.402 0 N-CA-C 115.011 1.486 . . . . 0.0 115.011 178.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.699 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -148.98 118.47 0.96 Allowed Glycine 0 C--N 1.314 -0.677 0 CA-C-N 113.035 -1.893 . . . . 0.0 110.866 178.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.757 ' HB ' ' NH2' ' A' ' 102' ' ' ARG . 47.2 mm -148.19 140.28 18.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 117.472 0.636 . . . . 0.0 111.602 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 55.7 mp0 -71.24 135.37 47.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 123.365 1.555 . . . . 0.0 112.368 -176.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.692 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 80.2 mt-10 -152.26 161.34 42.76 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 112.324 -2.216 . . . . 0.0 112.039 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.778 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -121.16 164.13 14.46 Favored Glycine 0 CA--C 1.501 -0.811 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.43 ' HB2' HG13 ' A' ' 93' ' ' ILE . 22.4 m -113.39 141.23 47.31 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.594 0.712 . . . . 0.0 112.656 -177.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.853 HD22 ' H ' ' A' ' 91' ' ' LEU . 2.2 mm? -50.27 -26.98 5.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.818 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.848 ' CB ' HD13 ' A' ' 13' ' ' LEU . 61.2 m -85.3 -31.59 22.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.299 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.43 HG13 ' HB2' ' A' ' 90' ' ' CYS . 58.7 mt . . . . . 0 N--CA 1.448 -0.537 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.188 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.778 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 52.7 mtm-85 . . . . . 0 N--CA 1.465 0.283 0 CA-C-O 121.787 0.803 . . . . 0.0 112.282 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -133.88 154.73 50.85 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.423 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.699 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.8 tt -76.56 112.27 12.93 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.85 0.834 . . . . 0.0 112.181 -177.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.471 HG13 ' CD ' ' A' ' 102' ' ' ARG . 11.1 p -99.86 133.12 21.91 Favored Pre-proline 0 N--CA 1.469 0.477 0 CA-C-N 114.593 -1.185 . . . . 0.0 112.372 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' ' 84' ' ' THR . 96.6 Cg_endo -87.22 126.45 2.34 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 122.635 2.224 . . . . 0.0 112.485 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.876 ' HG2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -145.53 167.71 22.36 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.001 0.92 . . . . 0.0 110.259 179.83 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.661 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.44 155.85 39.04 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.804 0.335 . . . . 0.0 110.15 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -73.35 -42.0 62.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.936 -176.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.668 ' HB3' ' OD1' ' A' ' 123' ' ' ASP . 59.7 mttp -140.63 141.04 35.13 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.376 0.607 . . . . 0.0 110.155 177.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.888 HG12 ' HA ' ' A' ' 80' ' ' LYS . 22.4 m -149.25 138.84 15.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.346 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.992 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 20.1 mmtp -108.21 126.46 52.83 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 1.046 ' HA ' HD13 ' A' ' 78' ' ' LEU . 1.4 pp -135.89 154.75 34.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -176.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 1.086 ' HG3' HD11 ' A' ' 78' ' ' LEU . 92.6 mtt180 -101.41 137.98 39.03 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.319 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.688 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -159.34 169.36 24.18 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.504 -1.225 . . . . 0.0 111.093 -177.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 1.047 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.7 pp -118.94 154.75 32.5 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 177.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.55 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 19.5 t70 -89.09 162.59 15.89 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.197 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.738 ' HB2' HG21 ' A' ' 71' ' ' VAL . 13.1 ttp-105 -54.44 -15.32 1.62 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.832 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -78.95 -29.48 44.01 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.727 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 109.23 34.1 2.6 Favored Glycine 0 C--N 1.34 0.797 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.886 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -128.72 102.86 19.54 Favored Pre-proline 0 C--O 1.237 0.432 0 CA-C-N 116.764 0.282 . . . . 0.0 111.166 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.685 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 33.1 Cg_exo -73.26 116.81 4.84 Favored 'Trans proline' 0 C--N 1.36 1.169 0 C-N-CA 122.015 1.81 . . . . 0.0 115.094 -178.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.55 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 12.6 p90 -128.4 166.48 18.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.568 -178.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.764 ' HG2' ' HG2' ' A' ' 109' ' ' ARG . 22.4 mt-10 -107.73 131.96 53.88 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.871 ' O ' HD23 ' A' ' 120' ' ' LEU . 0.3 OUTLIER -129.64 141.84 50.85 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.663 0.744 . . . . 0.0 111.742 -179.465 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.992 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 11.3 pt-20 -95.19 123.43 38.69 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.536 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.927 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -115.82 134.87 54.56 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.958 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.668 ' OD1' ' HB3' ' A' ' 105' ' ' LYS . 37.7 m-20 -126.44 162.22 26.1 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.797 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 48.4 -132.9 20.48 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-N 119.85 1.205 . . . . 0.0 115.705 177.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 80.9 mt -54.7 -35.74 63.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.74 -0.73 . . . . 0.0 111.774 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.927 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -70.72 -52.03 23.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.799 0.809 . . . . 0.0 109.225 179.854 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.756 ' HB2' ' C ' ' A' ' 122' ' ' ALA . . . -58.65 -40.25 82.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.346 -1.297 . . . . 0.0 111.691 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.876 HD12 ' HG2' ' A' ' 102' ' ' ARG . 50.8 mm -68.41 -55.89 14.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.879 -178.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.774 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 29.4 p -57.88 -50.48 73.17 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.992 HD11 HD11 ' A' ' 108' ' ' ILE . 19.4 tt -59.04 -43.69 89.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.957 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.811 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 21.9 pt20 -68.41 -40.04 81.41 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.627 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -59.27 -47.44 85.34 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.077 0.465 . . . . 0.0 109.776 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.88 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.5 mm-40 -58.63 -42.68 88.83 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.512 -179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.975 ' HA ' HD21 ' A' ' 137' ' ' LEU . 30.2 mtm -57.21 -47.3 81.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.634 0.73 . . . . 0.0 110.16 178.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.678 ' O ' HG12 ' A' ' 138' ' ' VAL . 31.9 m-20 -62.77 -48.31 79.71 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.095 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.541 ' CE1' ' HG2' ' A' ' 50' ' ' GLN . 8.4 t-80 -58.16 -52.93 63.52 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.271 0.557 . . . . 0.0 111.376 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.975 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.6 pp -58.67 -31.52 68.26 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.701 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.944 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 12.9 p -85.54 25.09 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-O 122.187 0.994 . . . . 0.0 109.83 176.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.515 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 55.91 30.67 57.41 Favored Glycine 0 CA--C 1.485 -1.843 0 CA-C-N 113.578 -1.646 . . . . 0.0 112.942 176.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.944 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 5.8 ptmt . . . . . 0 N--CA 1.424 -1.763 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.303 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.841 HG13 HG23 ' A' ' 37' ' ' THR . 40.1 t . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.497 0.189 . . . . 0.0 110.597 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.929 HD13 ' H ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -87.93 -174.15 4.58 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.752 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -80.52 109.84 15.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.035 0.445 . . . . 0.0 111.073 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.648 ' CG2' HG21 ' A' ' 37' ' ' THR . 36.2 t -89.47 131.64 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.783 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.003 ' HB2' HD21 ' A' ' 13' ' ' LEU . 45.3 mt -84.06 142.68 30.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.862 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 1.0 OUTLIER -119.14 145.51 45.91 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.207 0.527 . . . . 0.0 112.044 -179.62 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.039 HD13 HD12 ' A' ' 13' ' ' LEU . 51.2 mm -54.19 146.03 32.72 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.827 178.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.663 ' HA ' HG23 ' A' ' 8' ' ' ILE . 64.8 Cg_endo -91.86 50.2 1.12 Allowed 'Cis proline' 0 C--N 1.355 0.898 0 C-N-CA 124.644 -0.982 . . . . 0.0 113.123 0.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.87 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 9.7 t70 -53.56 131.48 38.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.799 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -59.17 -41.71 89.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.423 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.744 ' HB2' HD13 ' A' ' 6' ' ' LEU . 10.5 mtt85 -60.19 -23.55 64.08 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 1.039 HD12 HD13 ' A' ' 8' ' ' ILE . 9.8 mt -76.31 -31.73 58.35 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 120.413 1.46 . . . . 0.0 108.134 177.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.558 ' HD2' ' O ' ' A' ' 139' ' ' GLY . 24.0 mmm-85 -91.58 1.7 56.96 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 113.93 -1.486 . . . . 0.0 109.09 178.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.562 ' HD3' ' HB3' ' A' ' 54' ' ' HIS . 62.6 tttp -83.97 150.56 25.57 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.126 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.592 HG13 HG23 ' A' ' 138' ' ' VAL . 84.3 t -82.89 136.22 23.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.179 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.79 ' C ' ' HG3' ' A' ' 56' ' ' ARG . . . -90.7 139.96 30.23 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -104.81 129.28 25.17 Favored Pre-proline 0 C--N 1.323 -0.58 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.546 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.923 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 68.3 Cg_endo -77.5 114.67 3.75 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 121.824 1.682 . . . . 0.0 110.197 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.753 HG12 ' H ' ' A' ' 22' ' ' GLU . 17.3 t -70.09 144.83 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 122.488 1.137 . . . . 0.0 113.285 -176.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -62.44 -25.59 68.05 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 113.322 -1.763 . . . . 0.0 112.103 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.753 ' H ' HG12 ' A' ' 20' ' ' VAL . 88.9 tt0 -159.29 143.9 15.44 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.537 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.539 HG22 HD21 ' A' ' 111' ' ' LEU . 2.9 t -79.26 107.2 11.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -178.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 1.082 ' H ' HD12 ' A' ' 27' ' ' ILE . 32.0 m120 -87.87 153.04 21.63 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.455 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.813 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -54.44 -26.99 34.06 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 121.078 0.466 . . . . 0.0 110.64 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -72.47 -40.39 66.98 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 177.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 1.082 HD12 ' H ' ' A' ' 24' ' ' ASN . 62.9 mt -62.92 -47.59 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.038 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -57.89 -39.86 78.9 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.916 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.813 ' HG3' ' O ' ' A' ' 25' ' ' ALA . 19.7 mtm105 -59.62 -40.36 87.29 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.808 ' O ' ' HG3' ' A' ' 34' ' ' MET . 4.3 mt -58.6 -49.78 81.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.624 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.924 HG22 ' CG2' ' A' ' 57' ' ' ILE . 5.0 t -67.22 -42.34 87.81 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-O 120.746 0.308 . . . . 0.0 111.619 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.88 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -54.35 -43.08 70.97 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.641 -179.604 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.562 ' C ' HD12 ' A' ' 3' ' ' LEU . 53.6 m-20 -74.96 -30.95 61.35 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.613 176.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' MET . . . . . 1.07 ' HG2' HG21 ' A' ' 51' ' ' VAL . 79.8 mtp -60.08 -47.76 84.54 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.162 -177.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.88 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 15.6 p90 -68.97 -43.54 74.77 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.781 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 31.9 mt-10 -51.41 -43.56 61.99 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.857 ' OG1' HD13 ' A' ' 3' ' ' LEU . 97.3 m -70.98 -61.91 1.59 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 118.876 -1.13 . . . . 0.0 109.092 177.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.99 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 1.8 ttp -45.51 -44.74 12.8 Favored 'General case' 0 CA--C 1.458 -2.576 0 C-N-CA 123.618 0.767 . . . . 0.0 109.978 -170.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.717 ' HH ' ' N ' ' A' ' 69' ' ' ARG . 58.9 m-85 -70.26 -40.63 74.26 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.197 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.39 -27.32 67.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.863 0.839 . . . . 0.0 108.764 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 1.01 ' HG2' HD22 ' A' ' 91' ' ' LEU . 10.5 tp10 -85.49 -10.48 56.0 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.19 177.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.431 ' H ' ' C ' ' A' ' 39' ' ' TYR . 51.5 mt-10 63.44 29.46 15.5 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.892 -176.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.69 143.29 20.64 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.865 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.817 HG23 ' O ' ' A' ' 61' ' ' ASP . 56.7 mt -78.77 -0.96 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 117.976 0.888 . . . . 0.0 112.065 -178.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.548 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 176.49 135.3 2.13 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-O 119.26 -0.744 . . . . 0.0 112.54 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.926 ' CD1' HD12 ' A' ' 91' ' ' LEU . 3.2 tp -125.22 133.56 52.68 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 118.618 1.209 . . . . 0.0 111.001 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -97.4 132.89 42.69 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 111.421 0.156 . . . . 0.0 111.421 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.912 ' HB1' ' CG1' ' A' ' 53' ' ' ILE . . . -34.56 -52.51 0.51 Allowed 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.525 HG21 ' O ' ' A' ' 137' ' ' LEU . 59.9 p -53.67 -37.27 63.03 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.898 0.856 . . . . 0.0 110.656 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.498 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 73.8 mt-30 -66.93 -38.36 86.04 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.006 -1.452 . . . . 0.0 109.854 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 1.07 HG21 ' HG2' ' A' ' 34' ' ' MET . 0.8 OUTLIER -83.8 11.62 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 179.113 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.875 ' HA ' ' CD1' ' A' ' 6' ' ' LEU . 54.6 t0 79.35 31.52 0.27 Allowed 'General case' 0 N--CA 1.46 0.06 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 176.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.912 ' CG1' ' HB1' ' A' ' 48' ' ' ALA . 1.2 pp -128.28 114.02 32.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.605 177.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.562 ' HB3' ' HD3' ' A' ' 15' ' ' LYS . 6.0 p80 -76.23 65.37 2.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.923 0.868 . . . . 0.0 110.587 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.777 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 88.5 mt-30 -155.77 134.84 12.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.676 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.923 ' HD2' ' HD3' ' A' ' 19' ' ' PRO . 99.0 mtt180 -62.74 69.06 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -178.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.924 ' CG2' HG22 ' A' ' 31' ' ' VAL . 8.4 mm -113.76 122.3 67.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.041 HD11 ' HB2' ' A' ' 72' ' ' LEU . 2.4 pp -131.31 146.89 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -177.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.9 m -127.83 138.69 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.266 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.84 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 2.2 mt -115.98 144.12 24.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 122.332 1.063 . . . . 0.0 112.233 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.99 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 52.4 t0 -122.78 50.07 1.56 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 113.506 -1.679 . . . . 0.0 107.666 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.736 HG22 ' CG2' ' A' ' 44' ' ' ILE . 24.6 t . . . . . 0 N--CA 1.444 -0.745 0 CA-C-N 112.243 -2.253 . . . . 0.0 105.869 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.717 ' N ' ' HH ' ' A' ' 39' ' ' TYR . 34.6 ttm180 . . . . . 0 CA--C 1.536 0.42 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.84 ' CB ' ' HB ' ' A' ' 60' ' ' ILE . 8.8 mp -100.45 129.46 46.42 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.881 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.794 ' C ' HD22 ' A' ' 72' ' ' LEU . 13.4 p -133.87 131.32 56.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.211 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.041 ' HB2' HD11 ' A' ' 58' ' ' ILE . 2.9 mm? -141.75 143.91 33.74 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.398 177.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.073 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.6 mp -122.31 135.87 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 O-C-N 122.168 -0.332 . . . . 0.0 110.441 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.707 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 61.3 m-20 52.34 37.14 0.4 Allowed Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.867 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 97.4 Cg_exo -56.46 150.93 48.37 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 122.949 2.433 . . . . 0.0 114.091 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -138.72 145.57 40.46 Favored 'General case' 0 C--N 1.335 -0.055 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.805 ' HA ' HG22 ' A' ' 108' ' ' ILE . 9.5 tp -80.69 138.07 36.34 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.111 0.481 . . . . 0.0 110.901 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.047 HD23 ' HA ' ' A' ' 108' ' ' ILE . 3.0 mm? -114.27 -36.17 4.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.243 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.466 ' O ' ' HB ' ' A' ' 106' ' ' VAL . 16.5 tp10 -160.9 147.6 15.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.055 0.455 . . . . 0.0 111.86 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 1.057 ' HA ' HG12 ' A' ' 106' ' ' VAL . 19.6 ptpt -140.48 150.22 43.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.91 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.6 p -157.73 147.61 20.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.779 0.324 . . . . 0.0 111.243 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.766 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 73.46 165.27 10.08 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.791 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -139.79 113.16 8.38 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.689 0.757 . . . . 0.0 112.697 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.766 ' HB ' HH12 ' A' ' 102' ' ' ARG . 1.4 p -102.26 160.18 14.75 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.637 ' O ' HD13 ' A' ' 86' ' ' ILE . . . -139.82 104.73 0.43 Allowed Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 113.077 -1.874 . . . . 0.0 111.856 178.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.842 ' HB ' ' NH2' ' A' ' 102' ' ' ARG . 49.8 mm -147.1 140.32 19.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.639 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 92.5 mt-10 -74.01 143.81 45.4 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 122.589 1.185 . . . . 0.0 112.619 -178.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.548 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 10.1 mp0 -151.1 169.68 21.26 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 113.192 -1.822 . . . . 0.0 108.608 177.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.76 ' HA3' ' HG2' ' A' ' 97' ' ' ARG . . . -118.77 165.29 12.96 Favored Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 119.322 -1.418 . . . . 0.0 109.92 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 19.9 m -119.07 130.65 55.73 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.01 HD22 ' HG2' ' A' ' 41' ' ' GLU . 13.4 mt -57.5 -13.32 3.52 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.784 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.914 ' CB ' HD13 ' A' ' 13' ' ' LEU . 58.0 m -83.26 -37.2 23.83 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.685 ' CD1' HG13 ' A' ' 8' ' ' ILE . 48.4 mm . . . . . 0 CA--C 1.534 0.339 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.557 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.76 ' HG2' ' HA3' ' A' ' 89' ' ' GLY . 40.9 mtm-85 . . . . . 0 N--CA 1.463 0.186 0 CA-C-O 121.627 0.727 . . . . 0.0 111.493 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -132.11 151.0 52.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.13 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.687 HD23 ' N ' ' A' ' 100' ' ' VAL . 6.9 tt -75.58 135.73 40.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.808 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.687 ' N ' HD23 ' A' ' 99' ' ' LEU . 13.6 p -130.09 140.29 38.2 Favored Pre-proline 0 C--O 1.232 0.181 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.393 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 84' ' ' THR . 97.1 Cg_endo -88.16 122.7 1.57 Allowed 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.377 1.385 . . . . 0.0 113.552 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.913 ' HG2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -142.74 165.45 27.36 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 113.545 -1.661 . . . . 0.0 110.783 178.961 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.766 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.74 154.04 42.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.9 0.381 . . . . 0.0 110.377 -178.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.445 ' OE1' HG21 ' A' ' 84' ' ' THR . 5.1 tp10 -73.06 -42.03 63.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.66 -176.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.764 ' HG2' ' HB3' ' A' ' 123' ' ' ASP . 4.7 mtpm? -139.5 138.32 36.26 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.489 0.661 . . . . 0.0 109.674 177.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 1.057 HG12 ' HA ' ' A' ' 80' ' ' LYS . 25.1 m -147.02 141.63 20.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.736 -1.12 . . . . 0.0 112.122 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.964 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 31.9 mmtm -107.2 126.04 51.88 Favored 'General case' 0 N--CA 1.461 0.101 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 1.047 ' HA ' HD23 ' A' ' 78' ' ' LEU . 2.0 pp -129.61 161.82 38.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 1.034 ' HG3' HD21 ' A' ' 78' ' ' LEU . 45.4 mtm180 -113.24 138.17 50.4 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-O 120.843 0.354 . . . . 0.0 110.083 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.807 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -156.44 167.89 29.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.658 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 1.073 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.2 pp -114.03 151.66 32.13 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.445 ' O ' HD12 ' A' ' 111' ' ' LEU . 10.7 t70 -87.9 164.37 15.89 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.692 -177.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.768 ' HD2' ' OD1' ' A' ' 32' ' ' ASP . 49.1 ttp180 -51.66 -21.36 2.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.311 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.55 -21.75 44.75 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.908 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.5 37.27 3.31 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.992 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -128.64 102.82 19.78 Favored Pre-proline 0 C--O 1.238 0.457 0 CA-C-N 117.054 0.427 . . . . 0.0 110.708 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.661 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 32.2 Cg_exo -73.18 114.16 3.97 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 121.616 1.544 . . . . 0.0 114.959 -177.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 112' ' ' ASP . 0.4 OUTLIER -125.58 169.56 12.35 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.417 -178.52 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.718 ' HG2' ' HD2' ' A' ' 109' ' ' ARG . 34.9 mt-10 -106.75 129.4 54.63 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.02 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.721 ' O ' HD12 ' A' ' 120' ' ' LEU . 4.1 pp -123.39 133.01 54.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.848 -178.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.964 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 15.4 pt-20 -92.48 124.37 36.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.673 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.936 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -116.39 134.59 54.7 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.764 ' HB3' ' HG2' ' A' ' 105' ' ' LYS . 25.2 m-20 -126.81 164.54 21.14 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.628 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 46.78 -134.56 11.13 Favored Glycine 0 C--N 1.347 1.188 0 CA-C-N 120.722 1.601 . . . . 0.0 116.44 177.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.686 HD12 ' H ' ' A' ' 125' ' ' LEU . 4.8 mp -54.64 -33.99 61.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.431 -0.884 . . . . 0.0 111.619 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.936 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -70.95 -53.35 15.24 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.239 -0.584 . . . . 0.0 109.796 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.799 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -59.44 -47.12 86.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.93 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.913 HD12 ' HG2' ' A' ' 102' ' ' ARG . 49.9 mm -61.28 -55.69 22.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.084 -178.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.464 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 82.2 m -57.45 -50.89 71.55 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.673 HD11 HD11 ' A' ' 108' ' ' ILE . 18.7 tt -59.0 -41.35 82.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.826 -0.17 . . . . 0.0 111.413 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.864 ' CG ' HG21 ' A' ' 106' ' ' VAL . 36.1 mt-30 -65.99 -40.83 91.51 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.401 ' NE2' ' HD2' ' A' ' 136' ' ' HIS . 9.1 t-160 -56.08 -47.74 77.42 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.882 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.804 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.7 mm-40 -58.71 -46.08 88.11 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.098 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.985 ' HA ' HD21 ' A' ' 137' ' ' LEU . 1.9 mmm -55.68 -47.54 76.59 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.466 0.65 . . . . 0.0 110.037 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.656 ' O ' HG12 ' A' ' 138' ' ' VAL . 31.3 m-20 -61.6 -49.24 77.39 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.205 178.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.472 ' CE1' ' HG2' ' A' ' 50' ' ' GLN . 10.3 t-80 -59.25 -50.76 72.79 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 121.768 -0.583 . . . . 0.0 111.171 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.985 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.6 pp -58.27 -31.27 67.29 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.726 -178.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.847 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 13.8 p -83.04 20.5 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-O 122.803 1.287 . . . . 0.0 108.755 175.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.768 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 65.84 7.3 35.13 Favored Glycine 0 CA--C 1.494 -1.278 0 CA-C-N 112.501 -2.136 . . . . 0.0 112.843 176.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.847 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 4.6 ptmt . . . . . 0 N--CA 1.429 -1.492 0 C-N-CA 119.53 -0.868 . . . . 0.0 108.716 179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.921 HG12 ' HA ' ' A' ' 37' ' ' THR . 28.3 m . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.371 0.129 . . . . 0.0 110.783 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.96 HD13 ' H ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -79.01 -159.3 0.18 Allowed 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.108 179.858 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.686 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 27.4 tp60 -88.31 105.58 17.66 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.254 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.62 ' CG2' HG21 ' A' ' 37' ' ' THR . 46.4 t -88.33 127.0 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 121.333 0.587 . . . . 0.0 111.483 -179.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.07 ' HB2' HD21 ' A' ' 13' ' ' LEU . 24.4 mt -88.08 144.29 26.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.222 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 4.3 m80 -120.85 145.99 47.04 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.003 HD13 HD12 ' A' ' 13' ' ' LEU . 44.5 mm -69.29 135.79 88.94 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.674 178.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.48 141.74 70.95 Favored 'Cis proline' 0 C--N 1.352 0.729 0 C-N-CA 124.145 -1.19 . . . . 0.0 112.031 -0.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.97 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 8.4 t0 -163.39 125.18 2.47 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.271 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.431 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 23.7 pt-20 -57.53 -46.23 84.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.74 -178.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.61 ' HB2' HD13 ' A' ' 6' ' ' LEU . 14.8 mmt85 -56.21 -30.1 61.83 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 1.07 HD21 ' HB2' ' A' ' 6' ' ' LEU . 11.5 mt -75.78 -33.29 60.17 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 120.098 1.317 . . . . 0.0 109.054 178.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.669 ' C ' ' HA3' ' A' ' 139' ' ' GLY . 26.6 mmt-85 -96.21 13.29 27.91 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.299 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.422 ' HD3' ' HD3' ' A' ' 12' ' ' ARG . 88.4 tttt -91.65 149.93 21.4 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.128 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 1.004 HG13 HG23 ' A' ' 138' ' ' VAL . 49.5 t -82.95 122.13 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.796 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -80.02 145.57 32.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.856 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -101.81 134.22 20.28 Favored Pre-proline 0 C--N 1.326 -0.442 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.788 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -77.36 115.52 3.94 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.365 2.044 . . . . 0.0 111.261 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.882 HG12 ' H ' ' A' ' 22' ' ' GLU . 24.9 t -68.94 144.98 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 122.526 1.155 . . . . 0.0 113.022 -176.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.475 ' OE1' ' HA ' ' A' ' 21' ' ' GLU . 4.3 mm-40 -67.45 -29.24 68.65 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 113.303 -1.771 . . . . 0.0 111.734 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.882 ' H ' HG12 ' A' ' 20' ' ' VAL . 16.9 tp10 -156.57 154.17 29.81 Favored 'General case' 0 CA--C 1.527 0.063 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.178 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.981 HG21 ' HA2' ' A' ' 115' ' ' GLY . 6.3 t -80.07 102.38 5.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -178.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.943 ' CB ' HD13 ' A' ' 27' ' ' ILE . 31.7 m120 -89.04 151.16 22.42 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.569 -177.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.421 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -55.48 -28.21 53.12 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.508 0.67 . . . . 0.0 110.534 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 1.073 ' HG3' HD12 ' A' ' 27' ' ' ILE . 21.7 pt-20 -74.02 -36.92 64.48 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 177.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 1.073 HD12 ' HG3' ' A' ' 26' ' ' GLU . 1.7 mp -67.46 -38.79 81.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.952 177.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -65.78 -40.29 91.84 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 122.401 -0.187 . . . . 0.0 110.938 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.449 HH11 ' HG2' ' A' ' 29' ' ' ARG . 47.7 mmt-85 -64.94 -38.41 90.89 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.786 ' O ' ' HG3' ' A' ' 34' ' ' MET . 4.7 mt -55.39 -50.47 65.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.177 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.892 HG11 ' CG2' ' A' ' 71' ' ' VAL . 19.2 t -66.87 -40.4 85.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-O 121.218 0.533 . . . . 0.0 110.408 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.869 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 71.1 m-20 -53.06 -46.08 68.39 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.072 -178.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.62 ' CB ' HD12 ' A' ' 3' ' ' LEU . 1.5 m-20 -75.13 -29.25 60.46 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.07 176.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' MET . . . . . 1.003 ' HG2' HG21 ' A' ' 51' ' ' VAL . 83.2 mtp -59.46 -46.63 88.22 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.171 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.869 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 13.9 p90 -70.2 -44.18 69.2 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.737 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 85.9 mt-10 -51.61 -44.48 62.9 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.622 0.725 . . . . 0.0 109.376 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.921 ' HA ' HG12 ' A' ' 2' ' ' VAL . 96.7 m -70.5 -61.35 1.8 Allowed 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 118.592 -1.243 . . . . 0.0 108.709 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' MET . . . . . 1.038 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 2.0 ttp -45.68 -41.5 10.52 Favored 'General case' 0 CA--C 1.463 -2.393 0 C-N-CA 123.878 0.871 . . . . 0.0 110.133 -171.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.7 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 55.9 m-85 -70.4 -42.13 72.08 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.083 177.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.467 ' HB3' ' CG1' ' A' ' 2' ' ' VAL . . . -61.16 -24.47 66.32 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.491 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 1.047 ' HG2' HD12 ' A' ' 91' ' ' LEU . 11.9 tp10 -88.81 -11.56 44.49 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.482 177.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.444 ' H ' ' C ' ' A' ' 39' ' ' TYR . 18.5 mt-10 64.83 26.54 12.94 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 122.047 0.927 . . . . 0.0 109.927 -176.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.48 141.58 22.16 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 113.76 -1.564 . . . . 0.0 110.67 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.807 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 53.1 mt -80.0 0.68 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 117.643 0.722 . . . . 0.0 112.266 -178.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.499 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 178.09 135.54 2.31 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-O 119.022 -0.877 . . . . 0.0 111.926 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.994 HD13 ' HG ' ' A' ' 91' ' ' LEU . 5.4 tp -125.68 134.24 51.9 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-N 118.993 1.397 . . . . 0.0 111.56 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -98.9 132.33 44.31 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.875 ' HB1' ' CD1' ' A' ' 53' ' ' ILE . . . -29.85 -54.59 0.16 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.597 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 58.4 p -53.97 -36.64 63.1 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.698 0.761 . . . . 0.0 111.81 -178.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.741 ' OE1' HD12 ' A' ' 46' ' ' LEU . 85.5 mt-30 -64.51 -40.62 95.97 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.627 -1.169 . . . . 0.0 110.028 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 1.003 HG21 ' HG2' ' A' ' 34' ' ' MET . 0.8 OUTLIER -84.36 17.37 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 112.665 0.616 . . . . 0.0 112.665 -179.84 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.896 ' HA ' HD11 ' A' ' 6' ' ' LEU . 11.1 t0 77.51 26.86 0.65 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 176.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.875 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -124.13 110.7 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 C-N-CA 118.915 -1.114 . . . . 0.0 111.77 178.644 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.626 ' O ' ' HD2' ' A' ' 54' ' ' HIS . 2.6 p-80 -76.48 60.5 1.61 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.611 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.782 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 39.4 mm-40 -149.67 134.18 17.53 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 114.342 -1.299 . . . . 0.0 107.788 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.796 ' N ' ' HB1' ' A' ' 17' ' ' ALA . 75.7 mtp180 -64.11 68.62 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -177.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.831 ' CG2' HG22 ' A' ' 31' ' ' VAL . 8.5 mm -110.49 122.16 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.998 HD11 ' HB2' ' A' ' 72' ' ' LEU . 1.5 pp -121.95 140.73 44.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.0 -0.68 . . . . 0.0 112.285 -178.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.57 HG12 ' O ' ' A' ' 46' ' ' LEU . 1.5 p -125.16 134.5 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.044 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 9.1 mm -114.36 155.27 15.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.616 0.722 . . . . 0.0 110.921 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 1.038 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 31.9 t70 -142.57 28.56 1.62 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.659 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.766 HG22 ' CG2' ' A' ' 44' ' ' ILE . 39.3 t . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.81 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.54 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 40.7 ttm-85 . . . . . 0 N--CA 1.465 0.292 0 CA-C-O 120.743 0.306 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 1.044 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 47.8 mt -103.72 134.38 47.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.915 0.388 . . . . 0.0 111.716 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.892 ' CG2' HG11 ' A' ' 31' ' ' VAL . 6.3 p -134.88 135.9 52.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.308 178.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.998 ' HB2' HD11 ' A' ' 58' ' ' ILE . 3.0 mm? -141.63 142.12 33.42 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 177.007 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.017 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.6 mp -121.71 135.05 63.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.702 0.286 . . . . 0.0 110.336 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.717 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 45.5 m-20 54.48 34.86 0.26 Allowed Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.907 ' HG2' HG12 ' A' ' 58' ' ' ILE . 89.3 Cg_exo -56.39 146.8 71.58 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.766 2.311 . . . . 0.0 113.707 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -138.0 145.51 41.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.782 HD21 ' HE3' ' A' ' 80' ' ' LYS . 29.8 tp -79.12 138.2 37.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.424 0.63 . . . . 0.0 112.084 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.035 HD21 ' HG3' ' A' ' 109' ' ' ARG . 2.7 mm? -112.77 -43.55 3.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.474 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 39.2 tt0 -157.21 147.81 21.31 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.211 0.529 . . . . 0.0 111.949 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.895 ' HA ' HG12 ' A' ' 106' ' ' VAL . 19.3 ptpt -143.08 146.01 33.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.34 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.0 t -157.07 149.81 23.47 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.352 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.759 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 78.11 156.12 8.52 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.718 -0.754 . . . . 0.0 111.499 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -131.3 113.22 13.53 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.965 0.888 . . . . 0.0 112.632 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.872 ' HB ' HH12 ' A' ' 102' ' ' ARG . 1.5 p -105.98 161.9 14.06 Favored 'General case' 0 CA--C 1.487 -1.447 0 CA-C-N 114.016 -1.447 . . . . 0.0 114.894 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.843 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -149.22 118.05 0.92 Allowed Glycine 0 C--N 1.314 -0.674 0 CA-C-N 113.103 -1.862 . . . . 0.0 111.047 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.719 ' N ' ' HG ' ' A' ' 99' ' ' LEU . 32.5 mt -148.79 140.45 17.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 117.432 0.616 . . . . 0.0 111.84 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 55.8 mt-10 -71.14 139.18 50.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 123.135 1.445 . . . . 0.0 112.104 -176.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.627 ' HA ' ' HD2' ' A' ' 97' ' ' ARG . 84.1 mt-10 -157.5 162.44 38.88 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 112.543 -2.117 . . . . 0.0 111.774 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.744 ' N ' ' HG2' ' A' ' 97' ' ' ARG . . . -120.94 162.97 14.53 Favored Glycine 0 CA--C 1.5 -0.905 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 11.2 m -116.28 139.38 50.44 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 117.564 0.682 . . . . 0.0 110.763 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.047 HD12 ' HG2' ' A' ' 41' ' ' GLU . 2.5 mm? -47.25 -20.58 0.2 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.501 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.897 ' CB ' HG12 ' A' ' 8' ' ' ILE . 31.5 m -86.53 -41.82 14.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.537 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.784 HD13 ' HB ' ' A' ' 8' ' ' ILE . 44.0 mm . . . . . 0 CA--C 1.539 0.553 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.199 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.744 ' HG2' ' N ' ' A' ' 89' ' ' GLY . 74.9 mtm180 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 121.36 0.6 . . . . 0.0 110.375 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -125.1 147.31 49.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.414 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.843 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.7 tt -75.26 111.94 11.03 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.707 0.765 . . . . 0.0 110.512 -178.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.53 HG13 ' CD ' ' A' ' 102' ' ' ARG . 12.2 p -97.93 133.05 23.67 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.93 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.594 ' HA ' ' O ' ' A' ' 84' ' ' THR . 95.6 Cg_endo -88.29 125.71 1.86 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.391 2.061 . . . . 0.0 112.227 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.96 ' HG3' HG23 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -144.4 166.77 24.16 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.798 0.839 . . . . 0.0 109.653 179.84 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.759 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.29 154.62 41.39 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.883 0.373 . . . . 0.0 110.1 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -73.06 -40.56 64.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.72 -176.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.751 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 89.3 mttt -139.82 140.34 36.57 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.34 0.59 . . . . 0.0 109.481 177.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.895 HG12 ' HA ' ' A' ' 80' ' ' LYS . 30.3 m -149.03 140.17 17.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.07 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.989 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 23.4 mmtp -107.63 126.42 52.55 Favored 'General case' 0 N--CA 1.461 0.091 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 1.053 HD11 HD11 ' A' ' 130' ' ' ILE . 1.7 pp -135.4 151.05 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -176.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 1.035 ' HG3' HD21 ' A' ' 78' ' ' LEU . 91.8 mtt180 -102.36 137.54 40.47 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.205 -178.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.726 ' HB3' HD12 ' A' ' 72' ' ' LEU . . . -160.64 169.01 23.73 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.908 -177.018 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 1.017 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.4 pp -116.39 151.64 35.54 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.732 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 18.9 t70 -83.66 165.4 18.99 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -176.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.824 ' HB2' HG21 ' A' ' 71' ' ' VAL . 52.9 ttp180 -52.2 -20.95 2.92 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.58 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -79.37 -25.85 42.14 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.699 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.981 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 106.31 36.57 2.65 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.712 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -128.44 102.6 20.48 Favored Pre-proline 0 C--O 1.236 0.377 0 CA-C-N 117.067 0.433 . . . . 0.0 110.731 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.679 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 34.2 Cg_exo -71.92 114.98 4.13 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 121.777 1.651 . . . . 0.0 115.596 -177.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.732 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 12.1 p90 -128.06 168.08 15.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.574 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.525 ' CG ' ' HG2' ' A' ' 109' ' ' ARG . 27.7 mp0 -107.35 130.28 54.81 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.727 ' O ' HD12 ' A' ' 120' ' ' LEU . 4.3 pp -126.33 133.73 51.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.566 -178.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.989 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 11.5 pt-20 -93.04 123.8 36.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.629 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.939 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -116.83 134.97 54.13 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.751 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.2 m-20 -127.04 162.49 25.91 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.67 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 51.83 -136.35 33.34 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 120.293 1.406 . . . . 0.0 115.426 177.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 74.4 mt -54.84 -33.8 62.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.719 -0.741 . . . . 0.0 111.706 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.939 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.3 OUTLIER -71.47 -51.6 22.87 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.851 0.834 . . . . 0.0 109.15 179.619 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.738 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -58.82 -43.0 90.53 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.258 -1.337 . . . . 0.0 111.91 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.96 HG23 ' HG3' ' A' ' 102' ' ' ARG . 50.3 mm -67.96 -55.72 15.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.547 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 84.2 m -58.73 -50.67 73.06 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 1.053 HD11 HD11 ' A' ' 108' ' ' ILE . 20.4 tt -58.24 -43.84 86.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.13 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.776 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.4 pt20 -67.73 -37.9 82.83 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.083 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.579 ' NE2' ' HD2' ' A' ' 136' ' ' HIS . 3.8 t-160 -58.88 -47.4 85.06 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.872 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.6 mm-40 -59.61 -42.43 92.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.083 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.961 ' HA ' HD21 ' A' ' 137' ' ' LEU . 30.1 mtm -57.33 -47.48 81.44 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.832 0.825 . . . . 0.0 109.902 178.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.611 ' HB3' ' O ' ' A' ' 140' ' ' LYS . 57.8 m-20 -62.51 -47.59 83.28 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.197 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.579 ' HD2' ' NE2' ' A' ' 132' ' ' HIS . 6.2 t-80 -59.45 -52.96 63.37 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.123 0.487 . . . . 0.0 111.557 -178.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.961 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.5 pp -57.93 -31.47 66.84 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.308 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 1.004 HG23 HG13 ' A' ' 16' ' ' VAL . 14.7 p -86.86 22.78 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-O 122.356 1.074 . . . . 0.0 109.359 176.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.669 ' HA3' ' C ' ' A' ' 14' ' ' ARG . . . 53.28 38.45 56.99 Favored Glycine 0 CA--C 1.481 -2.041 0 CA-C-N 113.331 -1.759 . . . . 0.0 112.17 176.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.962 ' HG2' HG13 ' A' ' 138' ' ' VAL . 2.4 ptmt . . . . . 0 N--CA 1.42 -1.935 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.83 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.878 ' CG1' ' HA ' ' A' ' 37' ' ' THR . 27.1 m . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.787 0.327 . . . . 0.0 111.388 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.98 HD11 ' HB ' ' A' ' 51' ' ' VAL . 1.1 pt? -79.68 -158.69 0.17 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.561 ' HG3' ' HB3' ' A' ' 52' ' ' ASP . 23.4 pt20 -88.66 104.43 16.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.882 0.372 . . . . 0.0 111.88 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.036 HG11 HD12 ' A' ' 91' ' ' LEU . 49.1 t -89.38 131.66 36.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-O 121.251 0.548 . . . . 0.0 111.953 -178.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.138 ' HB2' HD21 ' A' ' 13' ' ' LEU . 22.6 mt -91.08 140.11 30.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.998 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.621 ' HA ' ' CA ' ' A' ' 92' ' ' SER . 37.1 m-70 -112.53 140.6 47.15 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.083 HD13 HD12 ' A' ' 13' ' ' LEU . 37.1 mm -61.81 132.88 93.51 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.81 176.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -79.89 148.25 78.78 Favored 'Cis proline' 0 C--N 1.352 0.719 0 C-N-CA 124.795 -0.919 . . . . 0.0 111.67 -0.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 1.028 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 9.0 t0 -165.1 131.09 2.73 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.403 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 23.8 pt-20 -58.45 -45.8 87.85 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.774 0.321 . . . . 0.0 110.643 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.676 ' O ' ' HB ' ' A' ' 49' ' ' THR . 14.7 mmt85 -59.67 -26.44 65.55 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 1.138 HD21 ' HB2' ' A' ' 6' ' ' LEU . 9.9 mt -77.42 -31.43 54.02 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 120.736 1.607 . . . . 0.0 108.39 177.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.689 ' C ' ' HA3' ' A' ' 139' ' ' GLY . 25.2 mmm-85 -94.46 10.43 34.52 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.108 -1.406 . . . . 0.0 109.173 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.654 ' NZ ' ' HB2' ' A' ' 54' ' ' HIS . 64.2 tttm -84.64 141.2 30.8 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.196 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.933 HG13 ' CG2' ' A' ' 138' ' ' VAL . 61.8 t -84.22 94.95 3.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.201 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.848 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -57.71 145.12 35.54 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.887 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -104.42 134.77 19.51 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.596 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.639 ' HD3' ' HD3' ' A' ' 56' ' ' ARG . 58.8 Cg_endo -80.26 115.74 3.24 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.235 1.957 . . . . 0.0 110.384 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.759 HG12 ' H ' ' A' ' 22' ' ' GLU . 16.4 t -69.23 144.3 14.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 122.476 1.131 . . . . 0.0 113.177 -175.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -62.48 -23.59 66.99 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 113.197 -1.82 . . . . 0.0 112.57 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.759 ' H ' HG12 ' A' ' 20' ' ' VAL . 34.8 tp10 -160.03 148.0 16.82 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 121.034 -0.267 . . . . 0.0 110.744 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.868 HG21 ' HA2' ' A' ' 115' ' ' GLY . 3.0 t -82.44 105.83 12.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 1.045 ' H ' HD12 ' A' ' 27' ' ' ILE . 32.4 m120 -89.23 157.85 18.09 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.988 -178.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.544 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -54.53 -31.48 56.38 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.509 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -71.28 -37.57 71.87 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 177.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 1.045 HD12 ' H ' ' A' ' 24' ' ' ASN . 63.4 mt -64.25 -47.15 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.143 178.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 51.0 mt-30 -57.65 -39.86 78.0 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.027 0.441 . . . . 0.0 110.733 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.544 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 38.9 mmt180 -60.99 -40.09 92.15 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.543 0.687 . . . . 0.0 109.159 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.825 ' O ' ' HG3' ' A' ' 34' ' ' MET . 4.6 mt -58.62 -49.66 81.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.879 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.819 HG21 ' CD1' ' A' ' 73' ' ' ILE . 17.9 t -68.47 -41.32 83.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.916 0.388 . . . . 0.0 111.422 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.877 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 47.8 m-20 -53.24 -46.11 69.01 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.588 0.709 . . . . 0.0 111.53 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.498 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 1.4 m-20 -74.71 -30.21 61.46 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.661 176.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' MET . . . . . 1.039 ' HG2' HG21 ' A' ' 51' ' ' VAL . 87.3 mtp -59.61 -47.0 87.29 Favored 'General case' 0 C--N 1.345 0.378 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.723 -177.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.877 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 17.4 p90 -69.54 -44.38 71.05 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.743 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 77.9 mt-10 -51.65 -42.64 62.23 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.878 ' HA ' ' CG1' ' A' ' 2' ' ' VAL . 76.8 m -69.33 -60.42 2.35 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 118.79 -1.164 . . . . 0.0 108.487 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' MET . . . . . 1.016 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 3.2 ttp -46.24 -43.33 15.38 Favored 'General case' 0 CA--C 1.463 -2.385 0 C-N-CA 123.749 0.819 . . . . 0.0 109.869 -170.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.698 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 58.9 m-85 -68.96 -42.02 77.21 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.878 178.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.55 ' HB3' ' CG1' ' A' ' 2' ' ' VAL . . . -60.14 -28.9 68.27 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.626 0.727 . . . . 0.0 109.045 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.782 ' HG2' ' CD2' ' A' ' 91' ' ' LEU . 3.2 tp10 -83.95 -10.15 58.16 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 114.392 -1.276 . . . . 0.0 108.835 177.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.436 ' H ' ' C ' ' A' ' 39' ' ' TYR . 19.2 mt-10 62.41 25.42 15.16 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.916 -176.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.96 140.61 22.53 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.187 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.83 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 38.5 mt -79.2 0.42 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 117.829 0.815 . . . . 0.0 111.93 -178.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.497 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . -179.75 133.5 2.04 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-O 119.215 -0.77 . . . . 0.0 112.066 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.985 ' HB2' ' HG3' ' A' ' 38' ' ' MET . 9.2 tp -125.31 135.37 52.42 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-N 119.531 1.665 . . . . 0.0 111.712 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.634 ' H ' HE21 ' A' ' 50' ' ' GLN . . . -101.45 130.63 47.73 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.887 ' HB1' ' CG1' ' A' ' 53' ' ' ILE . . . -29.31 -56.16 0.15 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 115.902 1.815 . . . . 0.0 115.902 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.676 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 77.2 p -53.82 -34.73 60.11 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.725 0.774 . . . . 0.0 111.378 -178.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.634 HE21 ' H ' ' A' ' 47' ' ' ALA . 24.2 mt-30 -65.34 -38.52 90.34 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.168 -1.378 . . . . 0.0 109.843 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 1.039 HG21 ' HG2' ' A' ' 34' ' ' MET . 1.6 m -89.1 13.42 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 121.013 0.435 . . . . 0.0 111.752 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.813 ' HA ' HD11 ' A' ' 6' ' ' LEU . 38.2 t70 77.13 35.27 0.36 Allowed 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 176.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.887 ' CG1' ' HB1' ' A' ' 48' ' ' ALA . 1.2 pp -125.81 110.87 25.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 119.495 -0.882 . . . . 0.0 109.706 176.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.654 ' HB2' ' NZ ' ' A' ' 15' ' ' LYS . 23.4 p-80 -75.99 64.76 1.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 122.098 0.952 . . . . 0.0 110.145 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.813 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 33.5 mt-30 -153.97 131.83 11.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.934 -1.485 . . . . 0.0 108.146 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 1.043 ' HA ' HD22 ' A' ' 137' ' ' LEU . 60.1 mtp85 -62.81 74.55 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 -178.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.769 ' CG2' HG22 ' A' ' 31' ' ' VAL . 29.7 mm -116.56 124.2 72.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.081 HD11 ' HB2' ' A' ' 72' ' ' LEU . 1.9 pp -127.67 145.51 34.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -177.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.651 HG22 ' O ' ' A' ' 46' ' ' LEU . 33.7 m -127.44 136.33 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.123 179.021 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.969 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 1.3 mt -116.44 147.92 19.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.785 0.803 . . . . 0.0 110.698 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 1.016 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 33.2 t70 -136.07 30.23 3.04 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.217 -178.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.815 HG22 HG22 ' A' ' 44' ' ' ILE . 24.4 t . . . . . 0 N--CA 1.462 0.147 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.16 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.629 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 72.9 ttt180 . . . . . 0 N--CA 1.466 0.358 0 CA-C-O 120.798 0.332 . . . . 0.0 111.401 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.969 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 65.0 mt -104.28 133.1 49.77 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.804 ' C ' HD22 ' A' ' 72' ' ' LEU . 14.5 p -135.01 134.38 53.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.291 177.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.081 ' HB2' HD11 ' A' ' 58' ' ' ILE . 3.0 mm? -140.01 141.73 36.3 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 177.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.985 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 3.5 mm -120.43 134.32 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 121.232 0.539 . . . . 0.0 111.548 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.7 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 6.7 m120 51.36 38.68 0.54 Allowed Pre-proline 0 C--N 1.317 -0.807 0 CA-C-N 115.217 -0.902 . . . . 0.0 112.323 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.77 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 84.5 Cg_exo -54.92 149.78 40.7 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.974 2.449 . . . . 0.0 114.104 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.44 ' O ' ' HB ' ' A' ' 108' ' ' ILE . 15.7 pt-20 -135.79 142.36 44.89 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.809 HD23 ' N ' ' A' ' 78' ' ' LEU . 1.7 tt -81.79 134.21 35.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.643 0.735 . . . . 0.0 111.806 -178.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.116 HD11 ' HG3' ' A' ' 109' ' ' ARG . 6.7 mp -110.74 -37.51 5.41 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.691 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.569 ' C ' ' HE2' ' A' ' 80' ' ' LYS . 85.2 tt0 -160.28 153.71 22.19 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.186 0.517 . . . . 0.0 111.782 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.901 ' HA ' HG12 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -148.03 151.7 36.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.378 179.125 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.7 m -160.46 141.55 12.06 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.578 0.228 . . . . 0.0 110.984 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.783 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 80.35 168.33 38.0 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.235 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -146.26 113.73 6.33 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.672 0.749 . . . . 0.0 112.926 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.554 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.5 p -99.54 160.91 13.94 Favored 'General case' 0 CA--C 1.49 -1.331 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.718 ' O ' HD13 ' A' ' 86' ' ' ILE . . . -134.44 100.51 0.38 Allowed Glycine 0 C--N 1.317 -0.475 0 CA-C-N 113.064 -1.88 . . . . 0.0 111.132 178.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.718 HD13 ' O ' ' A' ' 85' ' ' GLY . 39.5 mm -143.73 135.51 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -178.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.645 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 49.0 mt-10 -72.96 143.89 47.48 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 122.389 1.09 . . . . 0.0 112.499 -178.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.552 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 50.4 mt-10 -154.16 166.15 34.0 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 113.619 -1.628 . . . . 0.0 109.053 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.771 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -119.87 159.61 14.89 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 119.304 -1.427 . . . . 0.0 109.623 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.749 ' HB2' HG13 ' A' ' 93' ' ' ILE . 69.2 m -111.71 138.83 47.76 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.552 -177.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.036 HD12 HG11 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -50.04 -32.36 15.24 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.535 0.683 . . . . 0.0 110.0 -179.636 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.792 ' HB2' HG12 ' A' ' 8' ' ' ILE . 11.4 m -77.78 -27.14 50.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.7 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.749 HG13 ' HB2' ' A' ' 90' ' ' CYS . 48.5 mt . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.617 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.771 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 81.1 mtm180 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 121.652 0.739 . . . . 0.0 111.377 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.84 148.28 49.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.874 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.682 HD23 ' N ' ' A' ' 100' ' ' VAL . 6.9 tt -75.23 135.73 40.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.208 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.775 ' HB ' ' NH2' ' A' ' 102' ' ' ARG . 55.8 t -131.97 131.49 22.61 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.173 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.554 ' HA ' ' O ' ' A' ' 84' ' ' THR . 74.3 Cg_endo -78.24 125.43 7.1 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.692 1.595 . . . . 0.0 113.137 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.892 ' HG2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -141.42 165.51 27.31 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.413 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.783 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -69.38 154.75 41.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.727 0.299 . . . . 0.0 110.513 -178.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -73.41 -43.33 60.68 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.243 -176.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.782 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 84.2 mttt -139.47 138.19 36.19 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.416 0.627 . . . . 0.0 109.624 176.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.901 HG12 ' HA ' ' A' ' 80' ' ' LYS . 28.3 m -144.52 140.38 23.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.991 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 1.052 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 23.6 mmtp -107.99 125.92 52.1 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 1.056 ' HA ' HD13 ' A' ' 78' ' ' LEU . 1.9 pp -132.0 161.36 41.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -177.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 1.116 ' HG3' HD11 ' A' ' 78' ' ' LEU . 92.2 mtt180 -109.58 137.53 47.28 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.782 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.73 ' HB3' HD12 ' A' ' 72' ' ' LEU . . . -155.1 166.5 33.38 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.655 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.985 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.0 pp -116.46 150.47 37.81 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.623 ' O ' HD12 ' A' ' 111' ' ' LEU . 22.0 t70 -84.0 171.33 13.06 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.579 -175.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.776 ' HD2' ' OD1' ' A' ' 32' ' ' ASP . 50.8 ttp180 -54.49 -23.43 16.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.798 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.52 -14.41 58.89 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.873 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.868 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 93.15 40.09 4.94 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.02 -1.086 . . . . 0.0 114.593 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -128.11 102.49 21.49 Favored Pre-proline 0 N--CA 1.469 0.479 0 CA-C-N 117.59 0.695 . . . . 0.0 110.389 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.668 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 32.3 Cg_exo -73.56 115.23 4.26 Favored 'Trans proline' 0 C--N 1.359 1.108 0 N-CA-C 116.249 1.596 . . . . 0.0 116.249 -177.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.64 168.95 13.01 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.739 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.667 ' HG2' ' HG2' ' A' ' 109' ' ' ARG . 36.1 mt-10 -107.6 130.03 54.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.008 0.432 . . . . 0.0 110.278 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.751 HD11 ' CD1' ' A' ' 130' ' ' ILE . 4.1 pp -126.71 134.27 50.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.804 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 1.052 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 15.5 pt-20 -96.79 124.35 40.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.004 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.739 ' O ' ' HB2' ' A' ' 127' ' ' ALA . . . -116.71 135.79 53.49 Favored 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.782 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.3 m-20 -125.99 164.71 20.24 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.737 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 45.14 -132.53 8.26 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 120.627 1.558 . . . . 0.0 116.194 177.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.678 HD12 ' H ' ' A' ' 125' ' ' LEU . 5.0 mp -54.09 -35.83 62.53 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.739 -0.731 . . . . 0.0 111.361 -178.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.723 HD22 ' CB ' ' A' ' 122' ' ' ALA . 0.6 OUTLIER -70.44 -53.02 18.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.581 0.705 . . . . 0.0 109.655 179.721 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -58.46 -41.09 84.38 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.884 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.892 HD12 ' HG2' ' A' ' 102' ' ' ARG . 51.0 mm -68.8 -54.87 18.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.522 -178.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.493 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 31.4 p -57.77 -50.33 73.61 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.824 HD11 HD11 ' A' ' 108' ' ' ILE . 20.6 tt -60.07 -43.9 93.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.609 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.878 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 23.3 pt20 -66.97 -37.42 84.21 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.231 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.629 ' HA ' ' OD1' ' A' ' 135' ' ' ASP . 8.5 t-160 -56.04 -47.11 78.48 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.717 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 3.8 mm-40 -60.68 -43.03 98.21 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.711 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.784 ' HE1' ' N ' ' A' ' 77' ' ' LEU . 76.2 mtp -61.0 -49.49 77.24 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.453 0.569 . . . . 0.0 111.66 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.629 ' OD1' ' HA ' ' A' ' 132' ' ' HIS . 6.6 p-10 -65.18 -45.85 83.19 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.552 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.471 ' HD2' ' NE2' ' A' ' 132' ' ' HIS . 18.3 t-80 -59.67 -52.34 65.93 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 121.9 -0.5 . . . . 0.0 112.035 -178.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 1.043 HD22 ' HA ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER -62.51 -29.41 70.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.656 -177.206 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.933 ' CG2' HG13 ' A' ' 16' ' ' VAL . 8.4 p -81.15 21.56 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 CA-C-O 123.067 1.413 . . . . 0.0 107.816 173.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.799 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 56.16 24.7 44.93 Favored Glycine 0 CA--C 1.487 -1.7 0 CA-C-N 111.934 -2.394 . . . . 0.0 112.587 176.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.91 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 6.2 ptmt . . . . . 0 N--CA 1.427 -1.576 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.435 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.7 m . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.121 0.486 . . . . 0.0 111.771 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.968 HD23 ' HB ' ' A' ' 51' ' ' VAL . 61.5 tp -77.45 162.37 27.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.374 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -78.82 106.48 10.86 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.251 0.548 . . . . 0.0 110.282 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.677 HG22 HG12 ' A' ' 51' ' ' VAL . 33.4 t -89.93 131.69 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.788 -178.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.828 ' CD1' ' HA ' ' A' ' 52' ' ' ASP . 39.1 mt -89.49 149.35 22.95 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.135 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.582 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 1.9 m80 -124.37 149.79 46.26 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.61 HD12 ' H ' ' A' ' 8' ' ' ILE . 2.9 mp -55.81 145.54 51.71 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.835 178.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.517 ' HA ' HG23 ' A' ' 8' ' ' ILE . 71.5 Cg_endo -92.35 51.19 1.06 Allowed 'Cis proline' 0 C--N 1.355 0.916 0 C-N-CA 124.572 -1.012 . . . . 0.0 112.915 0.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.693 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 9.9 t70 -55.65 130.86 44.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.896 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -59.17 -40.13 84.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.016 0.436 . . . . 0.0 111.139 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.647 ' HB2' HD13 ' A' ' 6' ' ' LEU . 19.0 mmt-85 -57.65 -26.07 61.09 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.645 0.979 . . . . 0.0 113.645 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.792 HD21 ' HB2' ' A' ' 6' ' ' LEU . 8.8 mt -76.21 -33.24 59.26 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 120.61 1.55 . . . . 0.0 108.434 177.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.44 ' C ' ' HA3' ' A' ' 139' ' ' GLY . 32.1 mmt180 -91.82 7.99 39.28 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.631 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.537 ' HD3' ' HB3' ' A' ' 54' ' ' HIS . 87.8 tttt -88.3 148.39 24.33 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.089 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.763 HG13 HG23 ' A' ' 138' ' ' VAL . 97.1 t -82.68 128.79 38.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.936 ' HB3' HD12 ' A' ' 137' ' ' LEU . . . -86.24 143.57 27.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.394 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.811 ' HD3' ' CD ' ' A' ' 19' ' ' PRO . 7.6 tmtt? -106.33 130.16 23.39 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.889 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 60.9 Cg_endo -78.14 116.47 3.93 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.342 2.028 . . . . 0.0 111.26 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.747 HG12 ' H ' ' A' ' 22' ' ' GLU . 19.3 t -67.08 144.7 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-O 122.803 1.287 . . . . 0.0 113.14 -175.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.96 -24.51 67.92 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 112.57 -2.105 . . . . 0.0 112.68 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.747 ' H ' HG12 ' A' ' 20' ' ' VAL . 88.6 tt0 -161.01 143.52 12.54 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.975 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.57 HG21 ' HA2' ' A' ' 115' ' ' GLY . 3.3 t -79.55 107.7 12.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 1.041 ' H ' HD12 ' A' ' 27' ' ' ILE . 29.3 m120 -98.06 158.51 15.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.686 -178.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.73 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -55.72 -23.82 31.21 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.215 0.531 . . . . 0.0 110.678 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.513 ' HA ' ' OE1' ' A' ' 26' ' ' GLU . 4.3 mm-40 -74.05 -41.83 61.18 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 176.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 1.041 HD12 ' H ' ' A' ' 24' ' ' ASN . 69.0 mt -64.01 -48.24 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.245 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -57.15 -40.06 76.48 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.73 ' HG3' ' O ' ' A' ' 25' ' ' ALA . 99.3 mtt180 -61.76 -39.8 92.93 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.747 ' CG2' HD13 ' A' ' 53' ' ' ILE . 4.1 mt -56.91 -50.01 77.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 114.832 -1.076 . . . . 0.0 112.075 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.766 HG22 ' CG2' ' A' ' 57' ' ' ILE . 10.5 t -68.58 -42.16 83.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 120.842 0.353 . . . . 0.0 111.432 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.813 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -55.76 -39.48 71.26 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.33 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.497 ' HB3' ' HB2' ' A' ' 3' ' ' LEU . 31.6 m-20 -76.07 -30.45 58.35 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.985 175.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.98 ' HE1' HG22 ' A' ' 57' ' ' ILE . 15.2 mtm -60.58 -46.66 89.42 Favored 'General case' 0 C--N 1.347 0.465 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.44 -177.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.813 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 14.0 p90 -69.05 -46.43 67.91 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.555 ' HG2' ' O ' ' A' ' 32' ' ' ASP . 27.2 mm-40 -51.05 -38.57 52.31 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.672 HG21 ' CG2' ' A' ' 5' ' ' VAL . 57.5 m -69.83 -62.31 1.44 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 118.725 -1.19 . . . . 0.0 108.272 177.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.932 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 2.9 ttp -46.58 -44.25 17.9 Favored 'General case' 0 CA--C 1.458 -2.578 0 C-N-CA 124.016 0.926 . . . . 0.0 110.412 -170.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.713 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 70.0 m-85 -67.67 -41.73 83.24 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.794 178.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.38 -26.67 66.82 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.773 0.796 . . . . 0.0 109.038 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.965 ' HG2' HD12 ' A' ' 91' ' ' LEU . 2.6 tp10 -86.74 -10.89 52.63 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 114.361 -1.29 . . . . 0.0 109.155 177.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.445 ' H ' ' C ' ' A' ' 39' ' ' TYR . 27.7 mm-40 63.94 26.6 14.22 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.107 -176.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.56 144.49 25.54 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.111 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.857 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 46.0 mm -79.25 -3.93 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 117.631 0.715 . . . . 0.0 112.141 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.543 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 179.19 137.9 3.07 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-O 119.109 -0.828 . . . . 0.0 111.302 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.067 HD13 ' HG ' ' A' ' 91' ' ' LEU . 2.3 tp -124.39 135.22 53.12 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.285 1.542 . . . . 0.0 110.828 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -103.68 130.62 51.18 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 122.085 -0.384 . . . . 0.0 111.299 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.956 ' HB1' HG13 ' A' ' 53' ' ' ILE . . . -28.51 -57.99 0.13 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 116.647 2.092 . . . . 0.0 116.647 -177.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.519 ' CG2' ' HA ' ' A' ' 137' ' ' LEU . 74.9 p -53.42 -34.69 58.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 122.098 0.951 . . . . 0.0 111.478 -177.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.621 ' HG2' ' CE1' ' A' ' 136' ' ' HIS . 23.2 mt-30 -63.56 -38.47 91.26 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 113.929 -1.487 . . . . 0.0 110.686 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.968 ' HB ' HD23 ' A' ' 3' ' ' LEU . 1.5 m -92.52 19.44 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.828 ' HA ' ' CD1' ' A' ' 6' ' ' LEU . 37.5 t70 78.25 25.99 0.58 Allowed 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 176.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.956 HG13 ' HB1' ' A' ' 48' ' ' ALA . 11.9 pt -120.36 108.56 23.38 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.131 177.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.602 ' O ' ' HD2' ' A' ' 54' ' ' HIS . 2.9 p-80 -75.41 51.2 0.56 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-O 122.16 0.981 . . . . 0.0 109.905 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.546 ' O ' HG12 ' A' ' 57' ' ' ILE . 83.2 mt-30 -139.01 132.52 30.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 113.892 -1.504 . . . . 0.0 107.716 178.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.889 ' HD2' ' HD3' ' A' ' 19' ' ' PRO . 96.0 mtt180 -61.79 72.52 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -178.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.98 HG22 ' HE1' ' A' ' 34' ' ' MET . 10.3 mm -116.35 122.75 70.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.101 HD11 ' HB2' ' A' ' 72' ' ' LEU . 1.8 pp -127.0 145.4 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 -177.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.61 ' CG2' ' HB3' ' A' ' 46' ' ' LEU . 33.9 m -128.71 134.95 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.362 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.045 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 1.6 mt -116.54 145.45 22.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.504 0.669 . . . . 0.0 110.344 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.932 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 28.0 t70 -124.69 16.29 8.75 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.391 -178.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.787 HG22 ' CG2' ' A' ' 44' ' ' ILE . 29.8 t . . . . . 0 C--N 1.332 -0.155 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.598 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.552 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 35.5 ttt85 . . . . . 0 N--CA 1.465 0.319 0 CA-C-O 120.847 0.356 . . . . 0.0 110.83 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 1.045 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 63.8 mt -102.69 135.16 44.84 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.721 ' CG2' HG11 ' A' ' 31' ' ' VAL . 12.5 p -134.74 130.5 52.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.083 178.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.101 ' HB2' HD11 ' A' ' 58' ' ' ILE . 90.6 mt -141.37 142.2 33.78 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.59 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.049 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.6 mp -121.27 134.87 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-O 120.652 0.263 . . . . 0.0 110.901 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.709 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 52.6 m-20 57.02 37.56 0.38 Allowed Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.914 ' HG2' HG12 ' A' ' 58' ' ' ILE . 88.4 Cg_exo -56.59 145.72 79.48 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 122.838 2.359 . . . . 0.0 114.101 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.487 ' HG2' ' HB2' ' A' ' 109' ' ' ARG . 15.2 pt-20 -136.89 142.22 42.75 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.786 HD23 ' N ' ' A' ' 78' ' ' LEU . 1.7 tt -81.84 133.27 35.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.375 0.607 . . . . 0.0 111.753 -178.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.114 HD13 ' HA ' ' A' ' 108' ' ' ILE . 4.8 mp -108.82 -39.14 5.43 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.997 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.443 ' O ' HD21 ' A' ' 77' ' ' LEU . 42.4 tt0 -156.36 152.83 28.06 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 121.192 0.52 . . . . 0.0 111.764 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 1.056 ' HA ' HG12 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -147.28 149.81 33.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.936 179.385 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.3 p -160.07 152.94 21.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.79 0.329 . . . . 0.0 111.571 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.684 ' C ' ' HG3' ' A' ' 104' ' ' GLU . . . 73.63 146.33 0.92 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.749 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.408 ' N ' ' HG3' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -110.98 112.62 24.58 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 121.631 0.729 . . . . 0.0 111.229 -179.771 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . 1.035 HG23 ' HG2' ' A' ' 104' ' ' GLU . 1.6 p -114.81 160.94 18.86 Favored 'General case' 0 CA--C 1.484 -1.595 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.801 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -155.83 123.26 1.3 Allowed Glycine 0 C--N 1.311 -0.855 0 CA-C-N 113.01 -1.904 . . . . 0.0 110.95 178.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.451 ' N ' ' HG ' ' A' ' 99' ' ' LEU . 34.4 mt -147.34 139.18 18.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-N 117.643 0.722 . . . . 0.0 111.834 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 56.1 mt-10 -71.23 135.15 47.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 123.538 1.637 . . . . 0.0 112.349 -176.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.702 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 41.0 mt-10 -154.24 166.61 32.61 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 112.132 -2.304 . . . . 0.0 111.425 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.791 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -120.73 163.3 14.32 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.754 ' HB2' ' CG1' ' A' ' 93' ' ' ILE . 65.1 m -109.64 137.42 47.49 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.865 0.364 . . . . 0.0 110.926 -177.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.067 ' HG ' HD13 ' A' ' 46' ' ' LEU . 3.1 mm? -51.53 -38.66 55.24 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.73 0.776 . . . . 0.0 109.719 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.64 ' CB ' HD13 ' A' ' 13' ' ' LEU . 22.8 m -77.12 -26.66 53.45 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.59 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.754 ' CG1' ' HB2' ' A' ' 90' ' ' CYS . 53.1 mt . . . . . 0 CA--C 1.533 0.293 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.791 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 18.4 mtm105 . . . . . 0 N--CA 1.464 0.248 0 CA-C-O 121.852 0.834 . . . . 0.0 111.638 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 87' ' ' GLU . . . -135.15 155.55 50.51 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.273 -1.33 . . . . 0.0 109.22 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.801 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.5 tt -76.52 110.86 11.42 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.828 0.823 . . . . 0.0 111.532 -177.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.816 ' HB ' ' CZ ' ' A' ' 102' ' ' ARG . 40.3 t -98.4 126.16 40.53 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 114.415 -1.266 . . . . 0.0 112.021 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.574 ' HA ' ' O ' ' A' ' 84' ' ' THR . 81.7 Cg_endo -78.84 126.55 7.31 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.318 2.012 . . . . 0.0 112.277 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.89 ' HG2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -145.03 166.77 24.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.637 179.011 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.59 154.94 40.95 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.208 0.527 . . . . 0.0 110.283 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 1.035 ' HG2' HG23 ' A' ' 84' ' ' THR . 50.0 mt-10 -73.61 -42.19 61.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.645 -176.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.797 ' NZ ' ' HB3' ' A' ' 123' ' ' ASP . 66.5 mttm -140.41 139.62 35.3 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 1.056 HG12 ' HA ' ' A' ' 80' ' ' LYS . 28.7 m -149.98 141.63 17.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.437 -178.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.697 ' CE ' ' HB3' ' A' ' 121' ' ' GLU . 0.4 OUTLIER -107.65 125.15 51.0 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.46 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 1.114 ' HA ' HD13 ' A' ' 78' ' ' LEU . 1.4 pp -135.42 151.8 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -176.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 1.042 ' HG3' HD11 ' A' ' 78' ' ' LEU . 94.2 mtt180 -100.81 138.54 37.73 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 122.214 1.007 . . . . 0.0 111.128 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.842 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -158.8 169.35 24.57 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.759 -176.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 1.049 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.9 pp -120.27 154.78 34.46 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.455 ' O ' HD12 ' A' ' 111' ' ' LEU . 25.1 t70 -88.15 164.43 15.69 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.443 0.64 . . . . 0.0 111.991 -176.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.72 ' HB2' HG11 ' A' ' 71' ' ' VAL . 24.6 ttm180 -52.62 -20.29 2.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.055 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -81.88 -22.22 37.0 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.03 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.57 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 105.11 35.86 3.06 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 119.893 -1.146 . . . . 0.0 113.857 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -128.62 102.4 20.16 Favored Pre-proline 0 C--O 1.235 0.325 0 CA-C-N 117.344 0.572 . . . . 0.0 111.185 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.676 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 36.4 Cg_exo -74.03 116.72 4.75 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 121.914 1.743 . . . . 0.0 115.715 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.427 ' N ' ' O ' ' A' ' 110' ' ' ALA . 0.5 OUTLIER -129.04 165.78 20.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.418 -179.278 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.84 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 5.8 mp0 -107.72 135.19 49.56 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.888 ' O ' HD23 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -132.39 142.26 49.22 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.679 0.752 . . . . 0.0 111.911 -179.137 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.697 ' HB3' ' CE ' ' A' ' 107' ' ' LYS . 15.2 pt-20 -94.13 123.44 37.51 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.877 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.895 ' CB ' ' HG ' ' A' ' 126' ' ' LEU . . . -115.85 134.47 54.96 Favored 'General case' 0 C--O 1.22 -0.489 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.572 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.797 ' HB3' ' NZ ' ' A' ' 105' ' ' LYS . 38.7 m-20 -127.04 162.19 26.64 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.78 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 48.42 -134.77 19.25 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 120.436 1.471 . . . . 0.0 115.491 177.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.657 HD22 ' H ' ' A' ' 125' ' ' LEU . 2.6 mm? -53.84 -35.17 61.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.052 -0.574 . . . . 0.0 111.34 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.895 ' HG ' ' CB ' ' A' ' 122' ' ' ALA . 3.7 tp -70.22 -52.34 23.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.372 0.606 . . . . 0.0 109.81 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.779 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -58.93 -42.94 90.91 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.328 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.89 HD12 ' HG2' ' A' ' 102' ' ' ARG . 47.1 mm -67.17 -56.11 14.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 31.4 p -56.47 -50.21 72.4 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 1.037 HD11 HD11 ' A' ' 108' ' ' ILE . 19.1 tt -58.91 -44.24 90.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.155 -178.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.876 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 23.1 pt20 -68.16 -37.77 81.38 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.071 178.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.726 ' HA ' ' OD2' ' A' ' 135' ' ' ASP . 10.9 t-160 -56.58 -50.0 73.23 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.57 0.7 . . . . 0.0 110.105 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.953 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.2 mm-40 -60.1 -42.24 94.27 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.576 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.878 ' HA ' HD21 ' A' ' 137' ' ' LEU . 74.2 mtp -57.18 -48.74 77.99 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.279 0.562 . . . . 0.0 111.059 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.726 ' OD2' ' HA ' ' A' ' 132' ' ' HIS . 3.3 p30 -66.38 -46.53 76.35 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.416 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.621 ' CE1' ' HG2' ' A' ' 50' ' ' GLN . 10.7 t-80 -56.12 -51.46 67.84 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.489 0.661 . . . . 0.0 110.768 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.953 HD23 ' O ' ' A' ' 133' ' ' GLU . 1.2 pp -61.35 -30.16 70.35 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.955 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.966 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 14.6 p -86.58 25.94 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-O 122.292 1.044 . . . . 0.0 109.549 176.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.614 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 59.32 15.31 30.43 Favored Glycine 0 CA--C 1.49 -1.511 0 CA-C-N 113.395 -1.73 . . . . 0.0 113.359 176.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.966 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 9.9 ptmt . . . . . 0 N--CA 1.424 -1.746 0 C-N-CA 119.617 -0.833 . . . . 0.0 108.932 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.725 HG13 ' HA ' ' A' ' 37' ' ' THR . 43.2 t . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.952 0.406 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 1.027 HD23 ' HB ' ' A' ' 51' ' ' VAL . 58.5 tp -77.11 165.74 24.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.404 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -78.82 107.11 11.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.084 0.469 . . . . 0.0 110.271 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.652 ' CG2' HG21 ' A' ' 37' ' ' THR . 39.0 t -89.69 131.58 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.652 -178.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.09 ' HB2' HD21 ' A' ' 13' ' ' LEU . 16.7 mt -93.52 141.33 28.59 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.497 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 35.2 m-70 -117.92 145.29 44.77 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.084 HD13 HD12 ' A' ' 13' ' ' LEU . 49.8 mm -61.0 133.56 92.58 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.229 177.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.66 145.35 69.87 Favored 'Cis proline' 0 C--N 1.353 0.779 0 C-N-CA 124.51 -1.037 . . . . 0.0 111.951 -0.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.992 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 8.8 t70 -165.04 127.1 2.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.402 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 16.1 pt-20 -58.44 -45.79 87.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.658 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.589 ' O ' ' HB ' ' A' ' 49' ' ' THR . 15.1 mmt85 -56.59 -27.97 59.21 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 1.09 HD21 ' HB2' ' A' ' 6' ' ' LEU . 10.0 mt -77.01 -35.09 57.3 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 120.585 1.539 . . . . 0.0 107.972 177.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.774 ' HB3' ' NH1' ' A' ' 14' ' ' ARG . 2.1 mmm180 -89.2 11.18 19.48 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.802 -1.545 . . . . 0.0 109.395 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.763 ' HD3' ' HB3' ' A' ' 54' ' ' HIS . 59.5 tttp -85.6 137.71 32.67 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.568 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.914 HG13 HG23 ' A' ' 138' ' ' VAL . 58.4 t -84.1 94.4 3.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.237 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.794 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -54.0 148.31 10.95 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -106.43 132.73 20.66 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.798 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.643 ' HD3' ' HD3' ' A' ' 56' ' ' ARG . 66.1 Cg_endo -78.2 114.72 3.61 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.174 1.916 . . . . 0.0 110.684 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.817 HG12 ' H ' ' A' ' 22' ' ' GLU . 17.8 t -69.14 144.4 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-O 122.521 1.153 . . . . 0.0 113.126 -175.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.47 -24.55 67.87 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 113.311 -1.768 . . . . 0.0 111.867 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.817 ' H ' HG12 ' A' ' 20' ' ' VAL . 42.4 tt0 -161.16 140.71 10.51 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.864 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.509 HG22 HD21 ' A' ' 111' ' ' LEU . 2.8 t -78.96 110.95 15.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 1.033 ' H ' HD12 ' A' ' 27' ' ' ILE . 30.8 m120 -92.98 163.3 13.72 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.613 0.244 . . . . 0.0 110.995 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.606 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -56.04 -30.67 62.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.993 0.425 . . . . 0.0 110.819 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.723 ' O ' HD13 ' A' ' 30' ' ' ILE . 55.7 mt-10 -71.72 -40.07 69.71 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 1.033 HD12 ' H ' ' A' ' 24' ' ' ASN . 58.3 mt -62.7 -46.64 95.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.911 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.564 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 48.1 mt-30 -57.92 -39.23 77.49 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.597 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.606 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 41.0 mmt-85 -60.16 -40.98 91.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.864 0.84 . . . . 0.0 108.987 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.809 ' O ' ' HG3' ' A' ' 34' ' ' MET . 1.6 mp -58.89 -48.61 85.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 114.455 -1.248 . . . . 0.0 112.119 179.109 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.895 HG22 ' CG2' ' A' ' 57' ' ' ILE . 6.5 t -68.33 -41.81 83.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-O 120.845 0.355 . . . . 0.0 111.448 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.873 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -55.27 -42.36 73.48 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.526 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.545 ' HB3' ' HB2' ' A' ' 3' ' ' LEU . 56.8 m-20 -75.95 -30.18 58.58 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.632 176.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' MET . . . . . 1.063 ' HG2' HG21 ' A' ' 51' ' ' VAL . 83.7 mtp -59.86 -47.09 87.15 Favored 'General case' 0 C--N 1.347 0.473 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.531 -177.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.873 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 14.4 p90 -69.49 -44.28 71.44 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.774 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 76.6 mt-10 -51.78 -40.66 60.72 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.725 ' HA ' HG13 ' A' ' 2' ' ' VAL . 41.8 m -68.84 -61.92 1.6 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.576 -1.193 . . . . 0.0 107.864 178.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.895 ' HG3' ' HB2' ' A' ' 46' ' ' LEU . 2.8 ttp -46.11 -41.72 12.76 Favored 'General case' 0 CA--C 1.458 -2.581 0 C-N-CA 124.103 0.961 . . . . 0.0 110.21 -170.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.717 ' OH ' ' HA ' ' A' ' 69' ' ' ARG . 48.2 m-85 -69.22 -41.79 76.58 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.328 178.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.0 -27.45 68.32 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.611 0.72 . . . . 0.0 109.139 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 1.026 ' HG2' HD12 ' A' ' 91' ' ' LEU . 10.5 tp10 -85.53 -10.69 55.64 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.795 176.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.442 ' H ' ' C ' ' A' ' 39' ' ' TYR . 20.7 mt-10 62.21 28.62 17.15 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.859 0.838 . . . . 0.0 109.95 -176.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -83.43 143.41 21.76 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 114.0 -1.455 . . . . 0.0 111.122 178.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.812 ' CG2' HG22 ' A' ' 62' ' ' VAL . 47.7 mt -78.98 -2.54 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 117.709 0.754 . . . . 0.0 111.976 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.484 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 179.83 133.59 2.03 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-O 119.102 -0.832 . . . . 0.0 111.606 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.089 HD13 ' HG ' ' A' ' 91' ' ' LEU . 4.1 tp -124.56 134.55 52.94 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 119.063 1.432 . . . . 0.0 111.329 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -101.06 129.69 46.97 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.871 ' HB1' ' CD1' ' A' ' 53' ' ' ILE . . . -27.21 -56.82 0.09 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 116.099 1.889 . . . . 0.0 116.099 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.614 HG21 ' O ' ' A' ' 137' ' ' LEU . 70.1 p -53.54 -34.38 58.01 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.8 0.81 . . . . 0.0 111.727 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.691 ' OE1' HD12 ' A' ' 46' ' ' LEU . 85.1 mt-30 -64.56 -40.9 96.4 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.347 -1.297 . . . . 0.0 109.947 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 1.063 HG21 ' HG2' ' A' ' 34' ' ' MET . 1.0 OUTLIER -87.86 15.73 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.889 ' HA ' HD11 ' A' ' 6' ' ' LEU . 38.2 t70 77.51 33.06 0.41 Allowed 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 176.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.871 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 1.1 pp -125.93 110.45 23.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 119.155 -1.018 . . . . 0.0 110.301 177.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.763 ' HB3' ' HD3' ' A' ' 15' ' ' LYS . 0.5 OUTLIER -75.91 63.53 1.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.472 -179.109 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.726 ' C ' ' HB1' ' A' ' 17' ' ' ALA . 69.1 mt-30 -154.53 133.85 12.58 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 114.196 -1.365 . . . . 0.0 108.535 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.794 ' N ' ' HB1' ' A' ' 17' ' ' ALA . 54.3 mtp85 -64.37 72.46 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -177.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.895 ' CG2' HG22 ' A' ' 31' ' ' VAL . 7.1 mm -115.27 125.03 72.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.976 HD11 ' HB2' ' A' ' 72' ' ' LEU . 2.1 pp -131.28 147.77 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 46' ' ' LEU . 33.4 m -127.72 139.74 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.485 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.029 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 7.4 mm -115.11 151.41 16.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.692 0.758 . . . . 0.0 110.033 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.817 ' HB2' ' CE ' ' A' ' 38' ' ' MET . 10.7 t70 -138.99 39.88 2.14 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.079 -178.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.812 HG22 ' CG2' ' A' ' 44' ' ' ILE . 33.1 t . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.359 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.717 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 72.9 ttt180 . . . . . 0 N--CA 1.467 0.413 0 CA-C-O 120.5 0.191 . . . . 0.0 111.413 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 1.029 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 6.1 mp -102.47 132.54 48.44 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.825 HG21 ' HB2' ' A' ' 113' ' ' ARG . 9.6 p -133.91 131.05 56.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.367 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.976 ' HB2' HD11 ' A' ' 58' ' ' ILE . 93.5 mt -141.16 139.04 33.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.924 -0.125 . . . . 0.0 110.999 178.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.013 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.7 mp -119.53 135.71 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-O 120.595 0.236 . . . . 0.0 110.944 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.709 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 55.0 m-20 55.17 34.68 0.25 Allowed Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.839 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 88.8 Cg_exo -55.91 148.02 59.46 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.649 2.233 . . . . 0.0 113.482 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -136.93 143.28 42.82 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.815 HD23 ' N ' ' A' ' 78' ' ' LEU . 1.7 tt -80.47 135.04 36.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.782 0.801 . . . . 0.0 111.544 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.046 HD13 ' HA ' ' A' ' 108' ' ' ILE . 7.3 mp -110.45 -40.2 4.7 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.335 -1.302 . . . . 0.0 112.062 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 42.2 tt0 -160.34 154.0 22.5 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.179 0.514 . . . . 0.0 111.538 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.821 ' CB ' HG12 ' A' ' 106' ' ' VAL . 9.6 ptpp? -147.83 150.63 34.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.212 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.5 t -160.58 144.65 13.9 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.548 0.213 . . . . 0.0 110.958 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.791 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 81.24 169.85 42.6 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.85 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' A' ' 102' ' ' ARG . 87.9 tt0 -147.38 113.6 5.88 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 117.788 0.794 . . . . 0.0 113.116 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.4 p -98.72 159.9 14.63 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.642 ' CA ' HD21 ' A' ' 99' ' ' LEU . . . -137.87 103.02 0.4 Allowed Glycine 0 C--N 1.317 -0.528 0 CA-C-N 113.193 -1.821 . . . . 0.0 112.1 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.734 ' HB ' ' NH2' ' A' ' 102' ' ' ARG . 21.2 mt -147.07 138.92 18.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.612 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 56.3 mt-10 -71.09 143.47 50.63 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 122.682 1.229 . . . . 0.0 112.211 -178.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.634 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 93.3 mt-10 -157.8 161.45 38.41 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.581 -1.645 . . . . 0.0 109.754 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.875 ' HA3' ' HG2' ' A' ' 97' ' ' ARG . . . -120.24 159.11 15.24 Favored Glycine 0 CA--C 1.501 -0.809 0 C-N-CA 119.44 -1.362 . . . . 0.0 110.184 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 16.4 m -112.9 138.35 49.89 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.61 0.719 . . . . 0.0 112.207 -177.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.089 ' HG ' HD13 ' A' ' 46' ' ' LEU . 2.3 mm? -48.96 -23.37 1.1 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.375 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.882 ' CB ' HG12 ' A' ' 8' ' ' ILE . 52.7 m -83.89 -34.98 24.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.158 0.504 . . . . 0.0 110.566 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.873 HD13 ' HB ' ' A' ' 8' ' ' ILE . 45.2 mm . . . . . 0 N--CA 1.45 -0.462 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.418 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.875 ' HG2' ' HA3' ' A' ' 89' ' ' GLY . 18.2 mtm105 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 121.759 0.79 . . . . 0.0 111.87 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 87' ' ' GLU . . . -134.53 154.28 51.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.353 -1.294 . . . . 0.0 109.993 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.713 HD23 ' N ' ' A' ' 100' ' ' VAL . 6.5 tt -74.9 136.29 41.45 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.713 ' N ' HD23 ' A' ' 99' ' ' LEU . 21.0 t -133.46 137.9 30.07 Favored Pre-proline 0 N--CA 1.454 -0.237 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.529 -178.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.486 ' HA ' ' O ' ' A' ' 84' ' ' THR . 90.5 Cg_endo -85.66 125.31 2.82 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 121.704 1.603 . . . . 0.0 113.574 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.856 ' HG2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -142.05 166.29 25.11 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 113.627 -1.624 . . . . 0.0 110.684 178.643 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.791 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.47 156.05 38.7 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 120.649 0.261 . . . . 0.0 110.519 -178.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -73.2 -44.55 59.55 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.505 -176.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.806 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 81.4 mttt -139.61 138.14 35.91 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 121.658 0.742 . . . . 0.0 109.694 177.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.857 HG22 ' HB1' ' A' ' 127' ' ' ALA . 33.8 m -139.85 138.23 38.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.939 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 1.132 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 53.2 mmtt -107.5 125.72 51.62 Favored 'General case' 0 C--O 1.224 -0.27 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 1.046 ' HA ' HD13 ' A' ' 78' ' ' LEU . 1.8 pp -131.23 162.97 38.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -177.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 1.035 ' HG3' HD11 ' A' ' 78' ' ' LEU . 94.9 mtt180 -112.05 139.01 47.92 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.998 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.764 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -158.06 167.3 30.25 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 120.729 0.3 . . . . 0.0 111.095 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 1.013 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.4 pp -115.48 153.97 30.17 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 177.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.416 ' O ' HD12 ' A' ' 111' ' ' LEU . 10.3 t70 -90.77 163.27 14.52 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.581 -177.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.825 ' HB2' HG21 ' A' ' 71' ' ' VAL . 46.3 ttp180 -51.6 -19.21 1.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.101 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -78.99 -26.67 43.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.532 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.35 35.0 2.77 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.132 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.613 ' NZ ' ' HB3' ' A' ' 116' ' ' LYS . 6.6 mtpm? -128.76 102.83 19.47 Favored Pre-proline 0 C--O 1.238 0.488 0 CA-C-N 116.799 0.3 . . . . 0.0 111.167 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.652 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 34.2 Cg_exo -74.14 116.56 4.68 Favored 'Trans proline' 0 C--N 1.36 1.164 0 C-N-CA 122.009 1.806 . . . . 0.0 114.903 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.0 167.92 14.65 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.32 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.673 ' HG2' ' HG2' ' A' ' 109' ' ' ARG . 78.9 mt-10 -107.68 129.99 54.97 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.953 0.406 . . . . 0.0 109.974 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.707 ' O ' HD12 ' A' ' 120' ' ' LEU . 4.1 pp -127.19 132.91 50.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.347 0.594 . . . . 0.0 112.084 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 1.132 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 23.0 pt-20 -92.0 125.63 36.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.527 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.931 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -116.08 135.56 53.83 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.806 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.1 m-20 -126.82 163.62 23.18 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.777 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 46.92 -135.5 10.78 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-N 119.787 1.176 . . . . 0.0 115.811 177.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.637 HD23 ' H ' ' A' ' 125' ' ' LEU . 1.6 pt? -54.73 -32.57 59.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.563 -0.819 . . . . 0.0 111.674 -178.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.931 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.5 OUTLIER -70.89 -53.9 13.42 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.743 179.88 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.857 ' HB1' HG22 ' A' ' 106' ' ' VAL . . . -58.92 -42.87 90.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.492 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.856 HD12 ' HG2' ' A' ' 102' ' ' ARG . 49.7 mm -62.52 -55.05 26.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.43 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.668 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 30.4 p -60.47 -51.57 68.92 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.856 HD11 HD11 ' A' ' 108' ' ' ILE . 20.8 tt -60.08 -42.06 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 111.445 0.165 . . . . 0.0 111.445 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.69 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 20.9 pt20 -67.24 -41.68 85.23 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -57.83 -44.8 86.7 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.672 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.855 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.8 mm-40 -60.45 -45.37 93.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 118.902 -0.57 . . . . 0.0 111.814 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.933 ' HA ' HD21 ' A' ' 137' ' ' LEU . 36.9 mtm -56.7 -47.69 79.36 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 119.06 0.845 . . . . 0.0 109.913 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.745 ' O ' HG12 ' A' ' 138' ' ' VAL . 30.9 m-20 -61.83 -49.17 77.37 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.98 178.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.44 ' CE1' ' CG ' ' A' ' 50' ' ' GLN . 12.2 t-80 -56.27 -51.81 66.79 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 121.739 -0.601 . . . . 0.0 110.908 -179.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.933 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.3 pp -60.4 -30.93 69.91 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.481 -0.782 . . . . 0.0 111.775 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.914 HG23 HG13 ' A' ' 16' ' ' VAL . 14.9 p -80.49 21.05 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 CA-C-O 123.208 1.48 . . . . 0.0 108.947 175.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.86 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 69.27 -2.37 9.98 Favored Glycine 0 CA--C 1.492 -1.377 0 CA-C-N 111.723 -2.49 . . . . 0.0 112.452 176.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.766 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 1.3 ptmt . . . . . 0 N--CA 1.428 -1.525 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 1.044 HG12 ' HA ' ' A' ' 37' ' ' THR . 31.5 m . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.779 0.324 . . . . 0.0 111.378 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 1.043 HD11 ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -79.09 -141.25 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.43 ' H ' ' HG ' ' A' ' 3' ' ' LEU . 4.0 tp-100 -112.2 106.83 15.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.953 0.406 . . . . 0.0 110.617 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.017 HG11 HD12 ' A' ' 91' ' ' LEU . 48.2 t -89.19 126.23 42.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.518 0.675 . . . . 0.0 111.47 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.028 ' HB2' HD21 ' A' ' 13' ' ' LEU . 23.1 mt -83.49 141.99 31.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.603 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.772 ' HA ' ' HB3' ' A' ' 92' ' ' SER . 1.7 m80 -111.48 145.48 38.94 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.07 HD13 HD12 ' A' ' 13' ' ' LEU . 42.5 mm -57.77 145.41 70.77 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.279 178.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.522 ' HA ' HG23 ' A' ' 8' ' ' ILE . 73.8 Cg_endo -92.14 51.68 1.02 Allowed 'Cis proline' 0 C--N 1.353 0.81 0 C-N-CA 124.442 -1.066 . . . . 0.0 112.942 0.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.881 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 9.4 t0 -52.72 134.64 36.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.951 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.404 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 12.1 pt-20 -58.62 -44.75 90.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.514 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.672 ' HB2' HD13 ' A' ' 6' ' ' LEU . 11.3 mtt85 -58.91 -24.19 62.1 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 1.07 HD12 HD13 ' A' ' 8' ' ' ILE . 11.6 mt -75.42 -33.13 60.92 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 120.205 1.366 . . . . 0.0 108.3 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 22.8 mmt180 -92.11 8.02 39.79 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 113.841 -1.527 . . . . 0.0 109.397 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 12' ' ' ARG . 88.5 tttt -89.86 148.96 22.86 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.186 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.802 HG13 HG23 ' A' ' 138' ' ' VAL . 66.8 t -83.67 126.23 40.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.091 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.759 ' C ' ' HG3' ' A' ' 56' ' ' ARG . . . -83.53 147.8 27.57 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.297 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.741 ' HD3' ' CD ' ' A' ' 19' ' ' PRO . 5.7 tmtm? -110.48 132.31 21.61 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.776 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 63.6 Cg_endo -77.62 116.14 4.0 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.378 2.052 . . . . 0.0 111.732 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.853 HG12 ' H ' ' A' ' 22' ' ' GLU . 22.0 t -68.01 144.95 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 CA-C-O 122.869 1.319 . . . . 0.0 113.087 -175.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -63.73 -29.4 70.62 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 112.893 -1.958 . . . . 0.0 111.897 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.853 ' H ' HG12 ' A' ' 20' ' ' VAL . 88.8 tt0 -157.11 145.05 19.19 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.8 -178.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.538 HG21 ' HA2' ' A' ' 115' ' ' GLY . 3.5 t -79.41 105.18 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 1.063 ' H ' HD12 ' A' ' 27' ' ' ILE . 19.7 m-20 -87.05 153.08 21.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.908 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.474 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -54.57 -30.23 53.69 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.452 0.644 . . . . 0.0 110.207 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -72.82 -37.63 67.42 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 1.063 HD12 ' H ' ' A' ' 24' ' ' ASN . 67.7 mt -67.0 -36.36 76.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.355 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -68.33 -39.49 81.92 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.372 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 40.1 mmt180 -64.09 -38.86 92.6 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.768 ' O ' ' HG3' ' A' ' 34' ' ' MET . 2.9 mt -55.7 -49.19 75.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.614 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.686 HG22 ' CG2' ' A' ' 57' ' ' ILE . 19.8 t -66.33 -40.97 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 121.135 0.493 . . . . 0.0 110.941 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.884 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 26.5 m-20 -53.84 -46.27 71.17 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.575 -178.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.501 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 1.5 m-20 -74.54 -30.11 61.63 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.907 176.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' MET . . . . . 1.011 ' HG2' HG21 ' A' ' 51' ' ' VAL . 85.2 mtp -60.21 -46.31 90.18 Favored 'General case' 0 C--N 1.345 0.408 0 C-N-CA 120.566 -0.454 . . . . 0.0 109.841 -176.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.884 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 11.9 p90 -69.79 -44.76 69.41 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.606 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 31.8 mm-40 -53.34 -39.23 63.96 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . 1.044 ' HA ' HG12 ' A' ' 2' ' ' VAL . 76.9 m -70.51 -60.4 2.28 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 118.28 -1.368 . . . . 0.0 108.613 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.973 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 2.6 ttp -46.76 -41.03 14.61 Favored 'General case' 0 CA--C 1.463 -2.378 0 C-N-CA 124.101 0.96 . . . . 0.0 109.958 -172.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.708 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 60.5 m-85 -70.32 -42.06 72.43 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.312 177.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 37' ' ' THR . . . -61.07 -24.86 66.53 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.577 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.794 ' HG2' ' CD2' ' A' ' 91' ' ' LEU . 3.1 tp10 -88.94 -11.19 45.14 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 114.345 -1.298 . . . . 0.0 108.337 177.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.444 ' H ' ' C ' ' A' ' 39' ' ' TYR . 54.0 mt-10 64.11 26.68 14.0 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.7 -176.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.87 142.52 23.5 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 113.89 -1.504 . . . . 0.0 110.596 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.809 HG22 HG22 ' A' ' 62' ' ' VAL . 46.1 mm -79.52 1.2 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 117.611 0.706 . . . . 0.0 111.997 -178.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.547 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 176.38 137.86 2.73 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 118.838 -0.979 . . . . 0.0 111.371 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.875 ' HB2' ' HG3' ' A' ' 38' ' ' MET . 10.7 tp -126.38 134.54 51.02 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-N 119.505 1.653 . . . . 0.0 111.265 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.65 ' H ' HE21 ' A' ' 50' ' ' GLN . . . -98.83 132.15 44.4 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.935 ' HB1' HG13 ' A' ' 53' ' ' ILE . . . -31.22 -54.88 0.23 Allowed 'General case' 0 C--N 1.343 0.285 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.579 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 80.6 p -52.86 -36.07 58.53 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.891 0.853 . . . . 0.0 111.031 -177.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.65 HE21 ' H ' ' A' ' 47' ' ' ALA . 28.6 mt-30 -65.84 -40.56 91.88 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.328 -1.306 . . . . 0.0 110.202 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 1.043 ' HB ' HD11 ' A' ' 3' ' ' LEU . 1.0 OUTLIER -83.81 16.08 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 179.558 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.949 ' HA ' HD11 ' A' ' 6' ' ' LEU . 36.1 t70 76.93 27.67 0.7 Allowed 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 177.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.935 HG13 ' HB1' ' A' ' 48' ' ' ALA . 13.4 pt -122.26 110.94 28.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 C-N-CA 119.036 -1.066 . . . . 0.0 111.386 177.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.45 ' HB3' ' HD3' ' A' ' 15' ' ' LYS . 7.4 p80 -76.33 52.11 0.74 Allowed 'General case' 0 N--CA 1.46 0.075 0 CA-C-O 122.241 1.019 . . . . 0.0 109.767 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.496 ' C ' ' HB1' ' A' ' 17' ' ' ALA . 83.9 mt-30 -140.6 132.31 27.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 113.817 -1.538 . . . . 0.0 107.752 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.867 ' HG2' ' CD1' ' A' ' 137' ' ' LEU . 99.1 mtt180 -61.78 68.1 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -178.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.935 ' HB ' HD11 ' A' ' 53' ' ' ILE . 10.9 mm -111.88 121.65 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.136 HD11 ' HB2' ' A' ' 72' ' ' LEU . 2.2 pp -129.69 145.74 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -177.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.471 HG23 ' H ' ' A' ' 46' ' ' LEU . 32.6 m -126.0 139.88 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.293 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.056 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 11.9 mm -115.45 151.88 17.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.688 0.756 . . . . 0.0 110.154 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.973 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 34.9 t70 -141.82 37.78 1.63 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.391 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.809 HG22 HG22 ' A' ' 44' ' ' ILE . 38.8 t . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.378 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.705 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.497 0 CA-C-O 120.76 0.314 . . . . 0.0 111.671 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 1.056 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 4.0 mm? -103.84 132.64 49.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.937 0.399 . . . . 0.0 111.817 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.785 ' C ' HD22 ' A' ' 72' ' ' LEU . 12.3 p -134.58 134.46 54.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.226 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.136 ' HB2' HD11 ' A' ' 58' ' ' ILE . 3.0 mm? -142.14 146.55 35.47 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.531 -0.174 . . . . 0.0 110.531 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.012 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.8 mp -122.92 136.44 59.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.732 0.301 . . . . 0.0 110.595 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.716 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 45.3 m-20 51.65 37.62 0.44 Allowed Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.875 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 91.1 Cg_exo -57.51 148.26 73.7 Favored 'Trans proline' 0 N--CA 1.488 1.152 0 C-N-CA 123.046 2.497 . . . . 0.0 114.302 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -137.49 142.95 41.5 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.901 HD12 ' CG2' ' A' ' 108' ' ' ILE . 10.2 tp -80.28 136.84 36.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.109 0.481 . . . . 0.0 111.015 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.16 HD21 ' HG3' ' A' ' 109' ' ' ARG . 2.7 mm? -109.94 -44.48 3.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.068 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.513 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 17.2 tp10 -153.34 144.18 22.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.05 0.452 . . . . 0.0 111.932 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 1.043 ' HA ' HG12 ' A' ' 106' ' ' VAL . 19.3 ptpt -138.14 142.53 40.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.347 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.1 p -151.75 150.49 30.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.854 0.359 . . . . 0.0 111.052 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.631 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 76.91 143.72 1.64 Allowed Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.524 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -109.87 113.8 26.84 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.81 0.814 . . . . 0.0 111.896 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.638 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.7 p -117.21 160.99 20.2 Favored 'General case' 0 CA--C 1.487 -1.447 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.824 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -154.03 124.06 1.5 Allowed Glycine 0 C--N 1.314 -0.69 0 CA-C-N 112.536 -2.12 . . . . 0.0 111.228 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.619 HD13 ' O ' ' A' ' 85' ' ' GLY . 48.8 mm -147.07 137.52 17.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 117.507 0.653 . . . . 0.0 111.46 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 56.0 mt-10 -71.38 139.78 49.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 123.21 1.481 . . . . 0.0 112.606 -176.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.633 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 40.6 mt-10 -155.78 166.25 34.05 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 112.376 -2.193 . . . . 0.0 111.901 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.741 ' N ' ' HG2' ' A' ' 97' ' ' ARG . . . -120.88 168.27 14.04 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 87.3 m -113.46 142.74 45.55 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.34 0.57 . . . . 0.0 111.041 -177.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.017 HD12 HG11 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -53.36 -15.54 1.05 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.511 -179.417 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.815 ' HB2' HG12 ' A' ' 8' ' ' ILE . 4.3 m -100.77 -33.48 10.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.2 0.524 . . . . 0.0 110.471 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.568 ' CG1' HG13 ' A' ' 8' ' ' ILE . 57.4 mt . . . . . 0 CA--C 1.533 0.32 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.586 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.741 ' HG2' ' N ' ' A' ' 89' ' ' GLY . 84.7 mtm180 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 121.142 0.496 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -125.73 148.93 48.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.796 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.824 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.4 tt -76.08 113.61 13.8 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.979 0.895 . . . . 0.0 111.208 -177.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.823 HG13 ' NE ' ' A' ' 102' ' ' ARG . 14.0 p -103.7 129.21 25.77 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 114.572 -1.194 . . . . 0.0 111.575 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.638 ' HA ' ' O ' ' A' ' 84' ' ' THR . 87.8 Cg_endo -83.55 126.61 4.15 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 122.67 2.247 . . . . 0.0 113.844 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.91 ' HG2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -143.63 166.96 23.41 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.595 1.158 . . . . 0.0 109.288 179.381 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.631 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.18 155.33 39.86 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.914 0.388 . . . . 0.0 110.302 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -73.25 -40.37 64.69 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.483 -175.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.716 ' HB3' ' OD1' ' A' ' 123' ' ' ASP . 96.0 mttt -140.03 140.91 36.3 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 176.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 1.043 HG12 ' HA ' ' A' ' 80' ' ' LYS . 19.4 m -152.94 141.54 14.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.836 -1.075 . . . . 0.0 112.58 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.918 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 31.9 mmtm -107.52 127.03 53.26 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 1.079 ' HA ' HD23 ' A' ' 78' ' ' LEU . 1.8 pp -134.57 150.95 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -176.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 1.16 ' HG3' HD21 ' A' ' 78' ' ' LEU . 43.7 mtm180 -103.42 140.5 37.38 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-O 122.277 1.037 . . . . 0.0 111.602 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.757 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -160.54 168.73 24.41 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.779 -176.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 1.012 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.3 pp -116.15 151.21 36.1 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.781 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 20.5 t70 -85.53 163.84 18.15 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.742 -176.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.692 ' HB2' HG21 ' A' ' 71' ' ' VAL . 13.2 ttp-105 -52.71 -19.29 2.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.046 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -79.41 -26.12 41.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.434 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.538 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 106.77 35.99 2.68 Favored Glycine 0 C--N 1.34 0.792 0 C-N-CA 120.168 -1.015 . . . . 0.0 113.545 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -128.57 102.93 19.87 Favored Pre-proline 0 C--O 1.238 0.5 0 CA-C-N 116.859 0.33 . . . . 0.0 110.694 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.677 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 32.1 Cg_exo -72.67 115.2 4.25 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 121.307 1.338 . . . . 0.0 114.563 -177.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.781 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 10.4 p90 -127.15 168.75 14.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.551 -178.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 109' ' ' ARG . 3.0 mp0 -107.1 130.11 54.73 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.715 ' O ' HD12 ' A' ' 120' ' ' LEU . 4.3 pp -122.81 132.56 54.26 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.416 -178.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.918 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 15.3 pt-20 -92.17 123.97 35.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.789 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.937 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -118.58 133.64 55.71 Favored 'General case' 0 C--O 1.22 -0.472 0 C-N-CA 120.456 -0.498 . . . . 0.0 112.13 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.716 ' OD1' ' HB3' ' A' ' 105' ' ' LYS . 31.5 m-20 -127.38 161.54 28.43 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.576 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 55.1 -140.59 38.86 Favored Glycine 0 C--N 1.346 1.109 0 C-N-CA 118.94 -1.6 . . . . 0.0 115.145 177.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.69 HD12 ' H ' ' A' ' 125' ' ' LEU . 4.6 mp -54.9 -30.69 58.86 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.831 -0.684 . . . . 0.0 111.62 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.937 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -71.22 -51.77 22.79 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.677 0.751 . . . . 0.0 109.209 179.607 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.78 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -60.22 -47.01 87.77 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.767 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.91 HD12 ' HG2' ' A' ' 102' ' ' ARG . 46.9 mm -63.69 -55.01 25.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -177.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.579 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 81.8 m -58.19 -48.61 79.79 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.945 HD11 HD11 ' A' ' 108' ' ' ILE . 20.0 tt -59.01 -40.93 81.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.854 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.809 ' CG ' HG21 ' A' ' 106' ' ' VAL . 69.2 mt-30 -67.59 -40.76 84.81 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -57.72 -45.87 85.16 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.021 0.439 . . . . 0.0 110.026 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.903 ' O ' HD23 ' A' ' 137' ' ' LEU . 4.2 mm-40 -59.99 -42.57 94.48 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.227 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.947 ' HA ' HD21 ' A' ' 137' ' ' LEU . 3.0 mmm -56.83 -47.55 80.06 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.772 0.796 . . . . 0.0 109.999 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.766 ' O ' HG12 ' A' ' 138' ' ' VAL . 32.3 m-20 -65.4 -48.37 73.07 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.701 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.45 ' CE1' ' HG2' ' A' ' 50' ' ' GLN . 16.2 t-80 -57.38 -50.77 71.93 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.722 -0.611 . . . . 0.0 111.051 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.947 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.6 pp -60.7 -30.7 70.11 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.812 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.913 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 11.9 p -84.19 24.83 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-O 122.412 1.101 . . . . 0.0 109.957 177.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 66.76 3.03 19.45 Favored Glycine 0 CA--C 1.487 -1.673 0 CA-C-N 113.423 -1.717 . . . . 0.0 113.262 176.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.913 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 9.4 ptmt . . . . . 0 N--CA 1.416 -2.131 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.766 ' CG1' HG23 ' A' ' 37' ' ' THR . 37.2 t . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.631 0.253 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.825 HD11 ' CB ' ' A' ' 51' ' ' VAL . 3.4 pp -78.75 -175.97 4.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.746 0.308 . . . . 0.0 110.548 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -83.25 107.62 15.91 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.817 0.341 . . . . 0.0 110.643 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.558 ' CG2' HG21 ' A' ' 37' ' ' THR . 39.1 t -89.56 131.5 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 121.229 0.538 . . . . 0.0 112.235 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.08 ' HB2' HD21 ' A' ' 13' ' ' LEU . 14.7 mt -88.31 140.25 29.67 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.931 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.597 ' HB3' ' O ' ' A' ' 92' ' ' SER . 41.4 m-70 -116.71 144.33 44.56 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.053 HD13 HD12 ' A' ' 13' ' ' LEU . 43.5 mm -62.95 135.56 96.2 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.999 177.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -80.2 145.5 71.87 Favored 'Cis proline' 0 C--N 1.354 0.818 0 C-N-CA 124.387 -1.089 . . . . 0.0 112.006 -0.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.982 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 8.9 t70 -165.88 128.44 2.02 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.426 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.446 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 24.1 pt-20 -58.19 -46.0 86.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.592 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.622 ' HA ' ' HB2' ' A' ' 15' ' ' LYS . 20.2 mmt-85 -56.09 -28.73 58.9 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 1.08 HD21 ' HB2' ' A' ' 6' ' ' LEU . 10.1 mt -76.72 -34.27 58.13 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 120.339 1.427 . . . . 0.0 108.786 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.825 ' HB3' ' NH1' ' A' ' 14' ' ' ARG . 1.7 mmm180 -91.99 11.1 26.28 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.029 178.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.839 ' HD3' ' N ' ' A' ' 16' ' ' VAL . 11.2 tmtt? -84.3 139.37 32.36 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.482 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.891 HG13 HG23 ' A' ' 138' ' ' VAL . 46.0 t -84.29 93.93 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.79 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.799 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -53.88 147.85 11.38 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.337 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -104.25 131.24 22.1 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.746 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.547 ' HD3' ' HD3' ' A' ' 56' ' ' ARG . 69.2 Cg_endo -77.52 114.67 3.75 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.097 1.864 . . . . 0.0 110.56 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.858 HG12 ' H ' ' A' ' 22' ' ' GLU . 19.7 t -69.36 144.57 13.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 122.624 1.202 . . . . 0.0 113.313 -175.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -66.12 -24.68 66.72 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 113.266 -1.788 . . . . 0.0 111.915 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.858 ' H ' HG12 ' A' ' 20' ' ' VAL . 88.7 tt0 -160.96 141.0 10.98 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.658 0.266 . . . . 0.0 110.734 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.531 HG22 HD21 ' A' ' 111' ' ' LEU . 2.8 t -79.18 109.82 14.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 1.056 ' H ' HD12 ' A' ' 27' ' ' ILE . 30.9 m120 -92.07 164.55 13.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.52 0.2 . . . . 0.0 110.94 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.712 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -56.22 -30.72 62.72 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.176 0.513 . . . . 0.0 110.762 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -71.52 -39.6 70.64 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 177.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 1.056 HD12 ' H ' ' A' ' 24' ' ' ASN . 59.6 mt -63.26 -47.24 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.132 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.523 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 43.0 mt-30 -57.83 -39.25 77.2 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-O 120.896 0.379 . . . . 0.0 110.701 178.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.712 ' HG3' ' O ' ' A' ' 25' ' ' ALA . 99.6 mtt180 -60.3 -39.86 88.44 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.813 ' O ' ' HG3' ' A' ' 34' ' ' MET . 3.3 mt -60.06 -48.54 87.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 114.641 -1.163 . . . . 0.0 112.108 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.88 HG22 ' CG2' ' A' ' 57' ' ' ILE . 12.5 t -68.49 -42.63 83.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-O 120.862 0.363 . . . . 0.0 111.378 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.866 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -55.17 -42.02 72.61 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.516 -179.705 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.484 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 23.4 m-20 -75.23 -30.3 60.52 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.348 175.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' MET . . . . . 1.067 ' HG2' HG21 ' A' ' 51' ' ' VAL . 86.5 mtp -60.54 -46.83 88.73 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.857 -177.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.866 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 14.1 p90 -69.38 -44.43 71.52 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.055 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.762 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 34.0 mt-10 -51.36 -42.1 61.09 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.766 HG23 ' CG1' ' A' ' 2' ' ' VAL . 73.7 m -69.3 -62.08 1.53 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.493 -1.23 . . . . 0.0 108.236 178.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' MET . . . . . 1.004 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 3.4 ttp -45.91 -42.53 12.86 Favored 'General case' 0 CA--C 1.454 -2.739 0 C-N-CA 124.183 0.993 . . . . 0.0 110.563 -170.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.681 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 50.2 m-85 -69.42 -41.58 76.18 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.569 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.8 -28.69 68.96 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.796 0.807 . . . . 0.0 109.003 178.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.994 ' HG2' HD12 ' A' ' 91' ' ' LEU . 11.0 tp10 -84.33 -10.11 57.88 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 114.248 -1.342 . . . . 0.0 108.788 177.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.444 ' H ' ' C ' ' A' ' 39' ' ' TYR . 58.9 mt-10 61.57 26.12 15.89 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 121.914 0.864 . . . . 0.0 109.987 -176.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.73 142.21 23.37 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 113.993 -1.458 . . . . 0.0 110.757 178.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.866 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 49.2 mt -78.57 -2.54 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 117.702 0.751 . . . . 0.0 111.925 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.499 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . -179.28 133.33 2.04 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-O 119.114 -0.826 . . . . 0.0 111.794 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.021 HD13 ' HG ' ' A' ' 91' ' ' LEU . 5.8 tp -124.45 133.99 53.2 Favored 'General case' 0 C--N 1.351 0.632 0 CA-C-N 119.085 1.442 . . . . 0.0 111.278 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -100.44 129.27 46.38 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.218 0.207 . . . . 0.0 111.236 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.879 ' HB1' ' CG1' ' A' ' 53' ' ' ILE . . . -27.06 -55.74 0.08 Allowed 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 116.126 1.898 . . . . 0.0 116.126 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.588 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 66.2 p -53.29 -33.87 55.02 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.882 0.848 . . . . 0.0 112.032 -178.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.764 ' OE1' HD12 ' A' ' 46' ' ' LEU . 82.4 mt-30 -63.93 -42.68 97.3 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.15 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 1.067 HG21 ' HG2' ' A' ' 34' ' ' MET . 0.9 OUTLIER -86.9 16.2 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.876 ' HA ' HD11 ' A' ' 6' ' ' LEU . 53.6 t0 77.43 34.05 0.38 Allowed 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 176.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.879 ' CG1' ' HB1' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -125.39 109.18 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.302 177.08 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.74 63.34 1.61 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.206 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.74 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 88.9 mt-30 -153.96 134.0 13.19 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 114.156 -1.384 . . . . 0.0 108.425 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.799 ' N ' ' HB1' ' A' ' 17' ' ' ALA . 77.4 mtp180 -65.13 72.38 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -177.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.88 ' CG2' HG22 ' A' ' 31' ' ' VAL . 6.7 mm -114.84 124.93 71.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.065 HD11 ' HB2' ' A' ' 72' ' ' LEU . 2.2 pp -131.41 147.26 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 46' ' ' LEU . 34.1 m -128.84 138.15 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.709 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.954 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 2.2 mt -116.92 142.92 28.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.835 0.826 . . . . 0.0 110.821 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 1.004 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 11.4 t70 -124.87 25.86 7.24 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.18 -1.373 . . . . 0.0 110.294 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.793 HG22 ' CG2' ' A' ' 44' ' ' ILE . 21.9 t . . . . . 0 N--CA 1.465 0.322 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.57 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.666 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 32.8 ttm180 . . . . . 0 N--CA 1.467 0.402 0 CA-C-O 120.81 0.338 . . . . 0.0 111.35 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.954 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 67.2 mt -100.72 132.42 46.12 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.829 HG21 ' HB2' ' A' ' 113' ' ' ARG . 9.9 p -134.38 130.09 53.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.106 178.062 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.065 ' HB2' HD11 ' A' ' 58' ' ' ILE . 2.8 mm? -141.07 139.54 34.07 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.505 -0.183 . . . . 0.0 110.505 178.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.042 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.7 mp -118.79 134.99 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 110.345 -0.243 . . . . 0.0 110.345 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.707 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 53.3 m-20 54.04 35.56 0.29 Allowed Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.834 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 95.2 Cg_exo -55.83 150.1 47.38 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.72 2.28 . . . . 0.0 113.639 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.642 ' CD ' HH21 ' A' ' 109' ' ' ARG . 15.6 pt-20 -136.74 144.22 43.72 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.898 ' CB ' ' HE1' ' A' ' 134' ' ' MET . 1.4 tt -81.82 136.28 35.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.534 0.683 . . . . 0.0 111.215 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.863 HD11 ' HG3' ' A' ' 109' ' ' ARG . 7.5 mp -116.61 -37.81 3.62 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.308 -178.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 5.2 tp10 -155.36 146.85 22.96 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.107 0.479 . . . . 0.0 111.13 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.823 ' CB ' HG12 ' A' ' 106' ' ' VAL . 12.8 ptmt -148.4 147.38 29.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.258 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 52.8 m -160.56 145.4 14.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.675 0.274 . . . . 0.0 111.303 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.836 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 84.76 169.75 46.22 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.175 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 102' ' ' ARG . 56.7 mt-10 -146.97 113.53 6.0 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.5 p -101.94 159.87 14.98 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 115.132 1.531 . . . . 0.0 115.132 178.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.696 ' O ' HD13 ' A' ' 86' ' ' ILE . . . -137.12 102.61 0.39 Allowed Glycine 0 C--N 1.316 -0.532 0 CA-C-N 112.856 -1.974 . . . . 0.0 111.589 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.752 ' N ' ' HG ' ' A' ' 99' ' ' LEU . 39.8 mm -145.54 136.97 19.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.611 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 56.3 mt-10 -71.31 144.36 49.98 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 122.476 1.131 . . . . 0.0 111.779 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.619 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 55.0 mt-10 -158.06 162.06 38.06 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 113.933 -1.485 . . . . 0.0 109.618 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.908 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -119.96 158.01 15.44 Favored Glycine 0 CA--C 1.499 -0.942 0 C-N-CA 119.271 -1.442 . . . . 0.0 110.15 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.473 ' HG ' ' CD2' ' A' ' 136' ' ' HIS . 20.5 m -111.88 137.3 50.04 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.564 0.697 . . . . 0.0 111.893 -177.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.021 ' HG ' HD13 ' A' ' 46' ' ' LEU . 2.3 mm? -48.35 -23.03 0.79 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.591 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.873 ' CB ' HD13 ' A' ' 13' ' ' LEU . 48.7 m -84.25 -34.05 23.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.649 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.6 mt . . . . . 0 N--CA 1.45 -0.442 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.758 -179.811 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.908 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 18.5 mtm105 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.851 0.834 . . . . 0.0 111.903 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.423 ' C ' ' HA ' ' A' ' 87' ' ' GLU . . . -134.47 153.45 51.92 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.249 -1.341 . . . . 0.0 109.624 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.752 ' HG ' ' N ' ' A' ' 86' ' ' ILE . 6.8 tt -75.16 136.33 41.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.458 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.838 ' HB ' ' CZ ' ' A' ' 102' ' ' ARG . 89.7 t -130.14 132.92 24.39 Favored Pre-proline 0 CA--C 1.53 0.177 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' A' ' 84' ' ' THR . 2.1 Cg_endo -81.3 124.1 4.67 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.693 1.595 . . . . 0.0 112.7 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.881 ' HB2' ' OE1' ' A' ' 131' ' ' GLN . 0.0 OUTLIER -142.15 166.4 24.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.765 179.112 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.836 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.67 156.22 38.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.666 0.269 . . . . 0.0 110.286 -178.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -72.82 -43.96 62.06 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.422 -176.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.716 ' HB3' ' OD1' ' A' ' 123' ' ' ASP . 56.6 mttp -139.44 138.24 36.29 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.72 0.771 . . . . 0.0 109.611 176.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.891 HG22 ' HB1' ' A' ' 127' ' ' ALA . 28.4 m -140.05 138.6 37.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.043 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 1.093 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 32.9 mmtm -107.22 125.27 50.9 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.841 HG12 ' CD1' ' A' ' 130' ' ' ILE . 2.1 pp -128.37 161.46 36.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -177.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.863 ' HG3' HD11 ' A' ' 78' ' ' LEU . 68.0 mtm180 -114.28 140.15 48.83 Favored 'General case' 0 N--CA 1.461 0.104 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.847 ' HB3' HD12 ' A' ' 72' ' ' LEU . . . -159.58 168.29 26.46 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.966 -178.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 1.042 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.5 pp -113.59 152.99 29.58 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.304 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.461 ' HB2' ' CE2' ' A' ' 118' ' ' PHE . 11.2 t70 -90.79 164.37 14.11 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 119.716 -0.793 . . . . 0.0 111.42 -177.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.829 ' HB2' HG21 ' A' ' 71' ' ' VAL . 15.1 ttm105 -51.57 -19.2 1.38 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.237 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.24 -26.56 42.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.602 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 106.81 34.63 2.98 Favored Glycine 0 C--N 1.337 0.619 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.948 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.678 ' NZ ' ' HB2' ' A' ' 116' ' ' LYS . 9.7 mtmp? -128.63 103.17 19.62 Favored Pre-proline 0 C--O 1.237 0.416 0 C-N-CA 121.228 -0.189 . . . . 0.0 111.236 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.663 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.4 Cg_exo -72.84 116.06 4.58 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 121.799 1.666 . . . . 0.0 114.802 -178.081 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.461 ' CE2' ' HB2' ' A' ' 112' ' ' ASP . 0.4 OUTLIER -126.45 168.62 13.97 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.372 -179.626 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.672 ' HG2' ' CG ' ' A' ' 109' ' ' ARG . 80.2 mt-10 -107.52 129.64 54.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.121 0.486 . . . . 0.0 110.16 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.71 ' O ' HD12 ' A' ' 120' ' ' LEU . 4.2 pp -123.08 129.04 50.95 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.752 -178.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 1.093 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 9.3 pm0 -92.76 124.36 36.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.27 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.937 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -116.35 137.18 52.36 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.716 ' OD1' ' HB3' ' A' ' 105' ' ' LYS . 34.3 m-20 -126.96 163.8 22.88 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.059 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.823 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 47.5 -135.47 13.62 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 119.996 1.271 . . . . 0.0 115.864 177.112 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.0 mt -54.66 -32.73 59.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.654 -0.773 . . . . 0.0 111.667 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.937 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -71.31 -54.01 12.29 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.842 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.891 ' HB1' HG22 ' A' ' 106' ' ' VAL . . . -58.85 -42.98 90.62 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.469 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.874 HD12 ' HG2' ' A' ' 102' ' ' ARG . 49.2 mm -62.17 -54.47 33.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.559 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.549 ' SG ' HG21 ' A' ' 62' ' ' VAL . 73.4 m -60.12 -50.72 72.59 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.841 ' CD1' HG12 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -58.88 -44.1 89.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 121.201 -0.199 . . . . 0.0 110.567 -179.674 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.881 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.9 pt20 -67.72 -38.35 83.48 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.738 ' HA ' ' OD2' ' A' ' 135' ' ' ASP . 68.7 t60 -59.22 -46.1 89.35 Favored 'General case' 0 C--O 1.226 -0.16 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.866 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.9 mm-40 -59.67 -45.02 93.33 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.271 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.937 ' HA ' HD21 ' A' ' 137' ' ' LEU . 72.6 mtp -56.84 -48.51 77.9 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 118.913 0.779 . . . . 0.0 110.865 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.738 ' OD2' ' HA ' ' A' ' 132' ' ' HIS . 2.4 p30 -63.35 -46.68 85.42 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.37 178.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.473 ' CD2' ' HG ' ' A' ' 90' ' ' CYS . 7.8 t-80 -58.03 -52.6 64.86 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.814 -0.554 . . . . 0.0 111.476 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.937 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.5 pp -59.21 -32.68 70.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.553 -177.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.925 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 10.3 p -80.09 19.02 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 CA-C-O 123.101 1.429 . . . . 0.0 108.856 175.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.826 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 61.5 20.52 59.12 Favored Glycine 0 CA--C 1.489 -1.537 0 CA-C-N 111.779 -2.464 . . . . 0.0 112.313 176.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.925 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 7.2 ptmt . . . . . 0 N--CA 1.424 -1.739 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.046 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 1.004 HG12 ' HA ' ' A' ' 37' ' ' THR . 27.9 m . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.571 0.224 . . . . 0.0 110.963 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.983 HD13 ' H ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -85.71 -170.15 2.97 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.595 179.88 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 70.9 tp60 -84.52 108.4 17.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.736 0.303 . . . . 0.0 110.798 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.78 HG11 HD12 ' A' ' 91' ' ' LEU . 43.0 t -89.79 131.82 36.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.25 0.548 . . . . 0.0 111.767 -179.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.089 ' HB2' HD21 ' A' ' 13' ' ' LEU . 21.5 mt -85.03 141.73 30.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.071 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.565 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 2.8 m80 -119.77 144.35 47.33 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.094 HD13 HD12 ' A' ' 13' ' ' LEU . 50.7 mm -60.71 134.28 92.02 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.29 177.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -83.02 138.88 35.56 Favored 'Cis proline' 0 C--N 1.352 0.739 0 C-N-CA 124.48 -1.05 . . . . 0.0 111.896 -0.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.629 ' CB ' ' HG ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -155.86 128.99 8.11 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.562 179.672 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 12.0 pt-20 -58.46 -44.71 89.36 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.517 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.702 ' HB2' HD13 ' A' ' 6' ' ' LEU . 24.1 mtt180 -60.5 -24.86 65.63 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 1.094 HD12 HD13 ' A' ' 8' ' ' ILE . 10.3 mt -78.41 -31.03 48.03 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 120.892 1.678 . . . . 0.0 107.617 176.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.618 ' C ' ' HA3' ' A' ' 139' ' ' GLY . 15.7 mmm180 -91.8 8.77 35.59 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 113.767 -1.56 . . . . 0.0 109.12 178.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.585 ' HB2' ' HA ' ' A' ' 12' ' ' ARG . 60.2 tttp -88.19 143.5 27.01 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.08 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 1.013 HG13 HG23 ' A' ' 138' ' ' VAL . 56.4 t -83.99 100.24 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.029 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.808 ' HB3' HD12 ' A' ' 137' ' ' LEU . . . -58.74 143.78 45.85 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.944 0.402 . . . . 0.0 111.44 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.721 ' HD3' ' N ' ' A' ' 19' ' ' PRO . 1.7 tmtp? -108.94 132.47 21.16 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.183 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.919 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 56.4 Cg_endo -80.35 115.7 3.21 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.29 1.994 . . . . 0.0 111.057 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.7 HG12 ' H ' ' A' ' 22' ' ' GLU . 17.1 t -70.14 144.42 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-O 122.497 1.142 . . . . 0.0 112.665 -176.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -60.4 -22.95 63.95 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 113.29 -1.777 . . . . 0.0 112.29 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.7 ' H ' HG12 ' A' ' 20' ' ' VAL . 42.3 tt0 -161.17 140.31 10.22 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 120.801 0.334 . . . . 0.0 111.157 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.734 ' HA ' HD12 ' A' ' 27' ' ' ILE . 2.7 t -83.02 117.99 29.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.138 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.909 ' O ' ' HG3' ' A' ' 28' ' ' GLN . 9.8 p30 -105.76 -168.66 1.47 Allowed 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 122.295 -0.253 . . . . 0.0 110.353 -178.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.668 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -73.31 -25.83 60.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.779 0.323 . . . . 0.0 111.434 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.573 ' HB2' ' OD1' ' A' ' 24' ' ' ASN . 4.6 mm-40 -72.89 -40.21 65.74 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.734 HD12 ' HA ' ' A' ' 23' ' ' VAL . 50.8 mt -65.78 -46.04 89.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.166 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.909 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 45.5 mt-30 -57.09 -40.28 76.69 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.705 0.288 . . . . 0.0 110.444 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.668 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 39.4 mmt180 -61.52 -41.16 96.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.654 0.74 . . . . 0.0 109.074 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.818 ' O ' ' HG3' ' A' ' 34' ' ' MET . 4.8 mt -59.72 -50.12 81.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.742 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.898 HG22 ' CG2' ' A' ' 57' ' ' ILE . 10.8 t -67.87 -43.8 85.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-O 120.843 0.354 . . . . 0.0 111.723 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.864 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 26.0 m-20 -54.37 -41.8 69.58 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.404 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.635 ' CB ' HD12 ' A' ' 3' ' ' LEU . 55.9 m-20 -74.39 -31.17 62.25 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.077 176.155 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' MET . . . . . 1.01 ' HG2' HG21 ' A' ' 51' ' ' VAL . 85.1 mtp -60.3 -47.1 87.47 Favored 'General case' 0 C--N 1.346 0.453 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.869 -177.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.864 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 15.9 p90 -69.35 -44.51 71.45 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.565 ' HG2' ' O ' ' A' ' 32' ' ' ASP . 3.3 mm-40 -51.22 -43.79 61.5 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . 1.004 ' HA ' HG12 ' A' ' 2' ' ' VAL . 96.6 m -70.06 -59.98 2.57 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 118.723 -1.191 . . . . 0.0 109.267 177.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.994 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 3.7 ttp -46.32 -42.5 14.81 Favored 'General case' 0 CA--C 1.461 -2.45 0 C-N-CA 123.42 0.688 . . . . 0.0 109.646 -170.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.751 ' OH ' ' HA ' ' A' ' 69' ' ' ARG . 60.4 m-85 -69.56 -42.35 74.68 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.593 178.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.494 ' CB ' HG11 ' A' ' 2' ' ' VAL . . . -59.84 -28.4 67.47 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.797 ' HG2' ' CD2' ' A' ' 91' ' ' LEU . 17.6 tp10 -84.9 -10.81 56.73 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.708 177.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.442 ' H ' ' C ' ' A' ' 39' ' ' TYR . 7.4 mm-40 63.87 24.2 13.63 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.952 -176.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.1 142.18 26.0 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 114.143 -1.39 . . . . 0.0 110.595 177.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.868 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 44.2 mm -78.77 -2.18 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 117.566 0.683 . . . . 0.0 112.195 -178.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.541 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 179.36 135.5 2.41 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-O 118.88 -0.956 . . . . 0.0 111.769 -178.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.967 ' HB2' ' HG3' ' A' ' 38' ' ' MET . 9.1 tp -125.85 135.16 51.64 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.437 1.619 . . . . 0.0 111.743 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -99.5 129.97 45.72 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.874 ' HB1' ' CD1' ' A' ' 53' ' ' ILE . . . -30.72 -54.51 0.2 Allowed 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.675 HG21 ' O ' ' A' ' 137' ' ' LEU . 66.6 p -53.53 -35.41 60.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.775 0.798 . . . . 0.0 111.364 -178.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.539 ' O ' HG13 ' A' ' 5' ' ' VAL . 55.8 mt-30 -66.35 -37.36 85.16 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.078 179.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 1.01 HG21 ' HG2' ' A' ' 34' ' ' MET . 1.1 m -86.4 12.13 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.89 ' HA ' HD11 ' A' ' 6' ' ' LEU . 55.3 t0 78.96 32.37 0.28 Allowed 'General case' 0 C--O 1.23 0.059 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 176.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.874 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 1.2 pp -127.31 111.75 26.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.065 177.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.579 ' HB3' ' HD3' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -76.23 65.05 2.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.089 0.947 . . . . 0.0 110.466 -179.034 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.729 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 89.5 mt-30 -154.88 134.54 12.75 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 114.169 -1.378 . . . . 0.0 108.527 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.919 ' HD2' ' HD3' ' A' ' 19' ' ' PRO . 77.8 mtt-85 -63.34 70.82 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -177.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.898 ' CG2' HG22 ' A' ' 31' ' ' VAL . 8.7 mm -112.9 122.74 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.111 HD11 ' HB2' ' A' ' 72' ' ' LEU . 1.7 pp -128.61 146.03 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 119.635 -0.826 . . . . 0.0 113.177 -177.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.662 HG22 ' O ' ' A' ' 46' ' ' LEU . 33.8 m -128.05 138.75 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.96 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.984 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 12.1 mm -116.13 150.57 18.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.642 0.734 . . . . 0.0 109.859 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.994 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 28.9 t70 -132.7 21.72 4.25 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.508 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.927 HG11 HD12 ' A' ' 125' ' ' LEU . 32.6 t . . . . . 0 N--CA 1.464 0.226 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.328 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.751 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 78.8 ttt180 . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.984 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 44.0 mt -104.73 133.55 49.37 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -178.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.822 ' O ' HD12 ' A' ' 72' ' ' LEU . 14.4 p -135.07 133.15 53.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.56 177.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.111 ' HB2' HD11 ' A' ' 58' ' ' ILE . 10.4 mp -138.96 139.79 38.05 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.999 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 2.6 mm -118.86 132.49 68.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.102 0.477 . . . . 0.0 111.197 -178.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.723 ' OD1' ' HA ' ' A' ' 19' ' ' PRO . 68.4 m-20 50.7 38.0 0.47 Allowed Pre-proline 0 CA--C 1.547 0.843 0 CA-C-N 115.003 -0.999 . . . . 0.0 113.075 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.784 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 96.2 Cg_exo -55.85 152.33 36.26 Favored 'Trans proline' 0 N--CA 1.487 1.135 0 C-N-CA 123.027 2.485 . . . . 0.0 114.156 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -137.14 143.25 42.37 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.829 HD23 ' N ' ' A' ' 78' ' ' LEU . 1.8 tt -81.14 135.44 35.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.711 0.767 . . . . 0.0 111.609 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.062 HD11 ' HG3' ' A' ' 109' ' ' ARG . 6.9 mp -111.99 -37.3 5.13 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.045 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 37.6 tt0 -161.0 156.09 24.23 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 121.271 0.557 . . . . 0.0 112.004 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.855 ' HA ' HG12 ' A' ' 106' ' ' VAL . 18.3 ptpt -148.07 153.14 38.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.06 178.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.6 p -159.62 146.38 16.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.852 0.358 . . . . 0.0 111.24 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.76 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 69.73 173.22 10.59 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.843 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.696 ' N ' ' HG3' ' A' ' 104' ' ' GLU . 56.1 mt-10 -146.62 113.89 6.26 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.714 HG23 ' HG2' ' A' ' 104' ' ' GLU . 1.5 p -96.03 159.89 14.73 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 178.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.699 ' O ' HD13 ' A' ' 86' ' ' ILE . . . -135.63 100.81 0.36 Allowed Glycine 0 C--N 1.319 -0.406 0 CA-C-N 113.452 -1.704 . . . . 0.0 111.878 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.699 HD13 ' O ' ' A' ' 85' ' ' GLY . 39.6 mm -145.15 136.94 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -178.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.632 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 47.6 mt-10 -73.35 143.41 46.88 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 122.845 1.307 . . . . 0.0 112.968 -177.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.608 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 95.2 mt-10 -154.96 166.27 34.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 113.502 -1.681 . . . . 0.0 109.515 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.803 ' HA3' ' HG2' ' A' ' 97' ' ' ARG . . . -119.86 165.31 13.5 Favored Glycine 0 CA--C 1.498 -0.993 0 C-N-CA 119.339 -1.41 . . . . 0.0 110.225 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 1.085 ' HB2' HD13 ' A' ' 93' ' ' ILE . 95.3 m -118.2 140.22 50.12 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.879 -176.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.797 ' CD2' ' HG2' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -56.9 -23.43 44.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.627 178.741 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.906 ' CB ' HD13 ' A' ' 13' ' ' LEU . 58.7 m -79.45 -38.51 34.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.407 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 1.085 HD13 ' HB2' ' A' ' 90' ' ' CYS . 2.6 mp . . . . . 0 CA--C 1.535 0.367 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.397 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.803 ' HG2' ' HA3' ' A' ' 89' ' ' GLY . 45.8 mtm-85 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.757 0.789 . . . . 0.0 111.437 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 87' ' ' GLU . . . -134.62 153.92 51.75 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.113 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.744 HD23 ' N ' ' A' ' 100' ' ' VAL . 6.6 tt -75.13 136.95 41.07 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.912 ' HB ' ' CZ ' ' A' ' 102' ' ' ARG . 21.9 t -132.04 134.23 24.91 Favored Pre-proline 0 C--N 1.339 0.138 0 C-N-CA 120.461 -0.495 . . . . 0.0 110.986 -178.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 100' ' ' VAL . 4.1 Cg_exo -79.75 123.14 5.17 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 121.409 1.406 . . . . 0.0 112.321 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.912 ' CZ ' ' HB ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -144.08 165.75 26.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.653 178.455 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.76 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.72 154.02 42.71 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.014 0.435 . . . . 0.0 109.96 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.714 ' HG2' HG23 ' A' ' 84' ' ' THR . 46.8 mt-10 -73.95 -42.29 60.73 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.336 -176.083 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.642 ' HG2' ' HB3' ' A' ' 123' ' ' ASP . 93.6 mttt -139.79 137.98 35.46 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.683 0.754 . . . . 0.0 109.677 176.406 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.855 HG12 ' HA ' ' A' ' 80' ' ' LYS . 28.9 m -141.44 142.04 29.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.754 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 1.044 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 23.6 mmtp -108.13 125.67 51.87 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 1.033 ' HA ' HD13 ' A' ' 78' ' ' LEU . 1.9 pp -130.71 161.75 40.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -177.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 1.062 ' HG3' HD11 ' A' ' 78' ' ' LEU . 93.7 mtt180 -111.0 138.34 47.52 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.546 ' CB ' HD23 ' A' ' 72' ' ' LEU . . . -155.23 166.34 33.87 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.828 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.999 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.2 pp -117.27 152.01 35.74 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.611 ' O ' HD12 ' A' ' 111' ' ' LEU . 20.0 t70 -85.25 168.78 14.42 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 119.326 -0.95 . . . . 0.0 112.404 -176.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.669 ' HB2' HG21 ' A' ' 71' ' ' VAL . 46.5 ttp85 -54.87 -20.26 8.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.689 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -79.71 -19.4 48.96 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.523 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.607 ' HA2' HD13 ' A' ' 111' ' ' LEU . . . 98.83 39.13 3.68 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.156 -1.021 . . . . 0.0 114.141 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.673 ' NZ ' ' HB3' ' A' ' 116' ' ' LYS . 2.2 mmmp? -128.28 102.21 21.27 Favored Pre-proline 0 N--CA 1.467 0.397 0 CA-C-N 117.516 0.658 . . . . 0.0 110.82 178.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.651 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.8 Cg_exo -74.58 115.56 4.34 Favored 'Trans proline' 0 C--N 1.361 1.188 0 C-N-CA 121.733 1.622 . . . . 0.0 116.061 -177.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -125.42 168.49 13.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.043 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.705 ' HG2' ' HG2' ' A' ' 109' ' ' ARG . 35.2 mt-10 -108.09 130.63 55.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.972 0.415 . . . . 0.0 110.305 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.976 HD21 HD21 ' A' ' 72' ' ' LEU . 4.1 pp -128.48 135.72 49.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.222 0.534 . . . . 0.0 112.092 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 1.044 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 11.7 pt-20 -95.5 125.63 40.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.974 178.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.922 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -116.55 135.72 53.58 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.642 ' HB3' ' HG2' ' A' ' 105' ' ' LYS . 24.0 m-20 -125.84 165.04 19.42 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.789 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 46.81 -136.79 9.57 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 120.125 1.329 . . . . 0.0 116.261 176.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.927 HD12 HG11 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -54.76 -32.79 60.46 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.319 -0.941 . . . . 0.0 111.341 -178.387 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.922 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -71.46 -52.64 17.35 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 121.626 0.727 . . . . 0.0 109.455 179.536 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.786 ' HB2' ' C ' ' A' ' 122' ' ' ALA . . . -58.24 -40.77 82.62 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.58 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.879 HD12 ' HG2' ' A' ' 102' ' ' ARG . 49.7 mm -68.6 -54.42 21.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.437 -179.014 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.737 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 31.9 p -57.67 -50.92 71.6 Favored 'General case' 0 C--N 1.334 -0.089 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.008 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.763 HD11 HD11 ' A' ' 108' ' ' ILE . 20.7 tt -60.55 -44.0 95.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.41 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.844 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 21.5 pt20 -67.85 -38.33 83.03 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.226 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.753 ' HA ' ' OD2' ' A' ' 135' ' ' ASP . 7.8 t-160 -58.45 -46.93 85.57 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.89 ' O ' HD23 ' A' ' 137' ' ' LEU . 4.1 mm-40 -59.42 -44.42 92.86 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.802 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.92 ' HA ' HD21 ' A' ' 137' ' ' LEU . 75.2 mtp -57.01 -48.84 77.52 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 118.411 0.551 . . . . 0.0 110.969 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.753 ' OD2' ' HA ' ' A' ' 132' ' ' HIS . 2.6 p30 -64.24 -47.26 80.34 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.474 -0.49 . . . . 0.0 109.785 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.463 ' CE1' ' HG2' ' A' ' 50' ' ' GLN . 20.6 t-80 -56.47 -51.79 67.15 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 121.589 -0.694 . . . . 0.0 110.94 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.92 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.3 pp -60.6 -31.31 70.47 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 119.895 -0.722 . . . . 0.0 112.053 -177.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 1.013 HG23 HG13 ' A' ' 16' ' ' VAL . 14.7 p -80.6 23.09 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-O 122.966 1.365 . . . . 0.0 109.815 176.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.878 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 64.45 6.34 21.21 Favored Glycine 0 CA--C 1.491 -1.426 0 CA-C-N 112.482 -2.144 . . . . 0.0 112.896 176.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.822 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 4.5 ptmt . . . . . 0 N--CA 1.43 -1.44 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.1 m . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.026 0.441 . . . . 0.0 111.662 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.962 HD23 ' HB ' ' A' ' 51' ' ' VAL . 58.6 tp -77.82 158.08 29.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.284 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -78.56 106.07 10.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.127 0.489 . . . . 0.0 109.946 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.044 HG11 HD12 ' A' ' 91' ' ' LEU . 37.3 t -90.51 131.98 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.668 -178.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.01 ' HB2' HD21 ' A' ' 13' ' ' LEU . 29.6 mt -83.49 140.79 32.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.951 179.093 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 19.5 m-70 -111.18 142.93 42.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.202 0.525 . . . . 0.0 112.33 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.931 HD13 HD12 ' A' ' 13' ' ' LEU . 49.6 mm -50.87 144.81 12.8 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.799 178.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.524 ' HA ' HG23 ' A' ' 8' ' ' ILE . 79.1 Cg_endo -98.18 55.48 1.04 Allowed 'Cis proline' 0 C--N 1.354 0.837 0 C-N-CA 124.844 -0.898 . . . . 0.0 113.159 0.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.583 ' OD2' ' HB3' ' A' ' 6' ' ' LEU . 66.8 m-20 -55.11 140.89 36.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.375 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.427 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 23.9 pt-20 -58.84 -45.54 89.81 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.656 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.79 HH21 HG22 ' A' ' 49' ' ' THR . 0.0 OUTLIER -56.8 -24.91 54.07 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 179.711 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 1.01 HD21 ' HB2' ' A' ' 6' ' ' LEU . 8.2 mt -76.77 -32.87 58.01 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 121.193 1.815 . . . . 0.0 108.509 178.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.55 HH11 ' HG2' ' A' ' 14' ' ' ARG . 24.3 mmt-85 -94.76 5.89 50.54 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 114.159 -1.382 . . . . 0.0 109.716 178.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.763 ' HD3' ' NH1' ' A' ' 12' ' ' ARG . 75.7 tttt -93.13 155.74 17.29 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.811 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.824 HG13 HG23 ' A' ' 138' ' ' VAL . 64.3 t -82.5 136.17 23.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.293 0.568 . . . . 0.0 111.335 -178.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.043 ' HB3' HD12 ' A' ' 137' ' ' LEU . . . -87.18 141.13 28.88 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.311 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.693 ' HD3' ' N ' ' A' ' 19' ' ' PRO . 1.9 tmtp? -102.42 127.92 29.41 Favored Pre-proline 0 C--N 1.324 -0.503 0 C-N-CA 120.717 -0.393 . . . . 0.0 109.976 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.699 ' HB3' ' HD3' ' A' ' 56' ' ' ARG . 61.9 Cg_endo -78.81 115.02 3.52 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.14 1.893 . . . . 0.0 111.151 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.791 HG12 ' H ' ' A' ' 22' ' ' GLU . 19.8 t -70.07 145.0 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 CA-C-O 122.569 1.176 . . . . 0.0 113.232 -176.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.404 ' N ' HG12 ' A' ' 20' ' ' VAL . 51.6 mt-10 -65.93 -22.59 66.5 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 113.189 -1.823 . . . . 0.0 112.636 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.791 ' H ' HG12 ' A' ' 20' ' ' VAL . 5.0 tp10 -159.55 151.38 20.45 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.199 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.896 HG21 ' HA2' ' A' ' 115' ' ' GLY . 4.4 t -80.1 101.71 5.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.944 ' CB ' HD13 ' A' ' 27' ' ' ILE . 30.7 m120 -91.53 160.33 15.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.933 -177.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.545 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -56.39 -32.97 65.3 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.494 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -71.78 -37.45 70.45 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.944 HD13 ' CB ' ' A' ' 24' ' ' ASN . 1.7 mp -64.24 -47.93 87.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.084 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -57.94 -40.51 80.68 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.788 0.328 . . . . 0.0 111.096 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.545 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 39.3 mmt180 -61.16 -41.3 96.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.808 0.813 . . . . 0.0 109.315 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.771 ' O ' ' HG3' ' A' ' 34' ' ' MET . 6.9 mt -59.37 -50.58 79.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 114.486 -1.233 . . . . 0.0 112.322 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.932 HG22 ' CG2' ' A' ' 57' ' ' ILE . 9.4 t -67.04 -42.15 88.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-O 120.846 0.355 . . . . 0.0 111.66 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.917 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -56.24 -42.44 77.35 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.96 -179.37 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.665 ' HB3' ' HB2' ' A' ' 3' ' ' LEU . 1.4 m-20 -75.07 -30.73 61.04 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.157 176.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' MET . . . . . 1.088 ' HG2' HG21 ' A' ' 51' ' ' VAL . 79.3 mtp -60.58 -47.84 84.4 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.007 -177.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.917 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 15.9 p90 -69.02 -43.76 74.13 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.61 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 52.9 mm-40 -52.43 -41.05 62.91 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.781 HG21 ' CG2' ' A' ' 5' ' ' VAL . 31.0 m -69.98 -62.16 1.49 Allowed 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 118.792 -1.163 . . . . 0.0 108.757 177.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.89 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 1.4 ttp -46.3 -42.63 14.89 Favored 'General case' 0 CA--C 1.46 -2.496 0 C-N-CA 123.611 0.764 . . . . 0.0 110.016 -170.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.681 ' OH ' ' HA ' ' A' ' 69' ' ' ARG . 66.7 m-85 -69.29 -41.65 76.51 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.389 178.179 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.06 -28.49 67.83 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.8 ' HG2' ' CD2' ' A' ' 91' ' ' LEU . 3.0 tp10 -84.62 -10.38 57.41 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.977 177.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.436 ' H ' ' C ' ' A' ' 39' ' ' TYR . 51.3 mt-10 63.37 25.59 14.66 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.953 -176.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.43 142.73 24.15 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.856 177.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.812 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 46.1 mm -78.99 -1.71 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 117.576 0.688 . . . . 0.0 112.254 -178.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.494 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 179.12 135.94 2.5 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 118.948 -0.918 . . . . 0.0 112.024 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.878 ' HB2' ' HG3' ' A' ' 38' ' ' MET . 6.9 tp -126.82 134.54 50.52 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.359 1.58 . . . . 0.0 112.295 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.833 ' HB2' ' OE1' ' A' ' 133' ' ' GLU . . . -97.8 131.1 44.6 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 122.386 0.274 . . . . 0.0 111.39 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.911 ' HB1' ' CG1' ' A' ' 53' ' ' ILE . . . -33.73 -54.12 0.45 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -178.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.79 HG22 HH21 ' A' ' 12' ' ' ARG . 81.8 p -52.84 -35.77 57.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.722 0.772 . . . . 0.0 111.176 -178.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.543 ' O ' HG13 ' A' ' 5' ' ' VAL . 53.4 mt-30 -66.85 -36.76 83.07 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.023 178.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 1.088 HG21 ' HG2' ' A' ' 34' ' ' MET . 1.3 m -87.21 13.49 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.843 ' HA ' HD11 ' A' ' 6' ' ' LEU . 54.5 t0 77.75 32.4 0.4 Allowed 'General case' 0 C--O 1.23 0.075 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 176.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.911 ' CG1' ' HB1' ' A' ' 48' ' ' ALA . 1.2 pp -127.11 112.76 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.201 177.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.738 ' HA ' ' NH2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -76.0 67.02 2.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.862 0.839 . . . . 0.0 110.517 -179.439 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.77 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 89.2 mt-30 -157.59 134.05 9.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.691 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.739 ' N ' ' HB1' ' A' ' 17' ' ' ALA . 52.2 mtp85 -62.84 70.69 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -178.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.932 ' CG2' HG22 ' A' ' 31' ' ' VAL . 8.5 mm -113.16 122.35 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.073 HD11 ' HB2' ' A' ' 72' ' ' LEU . 2.1 pp -129.02 146.37 34.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.877 -178.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.588 HG23 ' H ' ' A' ' 46' ' ' LEU . 33.3 m -127.82 138.6 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.652 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.079 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 12.1 mm -115.1 149.23 17.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.617 0.722 . . . . 0.0 109.301 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.89 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 57.0 t0 -134.2 30.58 3.59 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.767 -178.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.801 HG22 ' CG2' ' A' ' 44' ' ' ILE . 30.4 t . . . . . 0 N--CA 1.463 0.185 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.877 179.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.681 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 73.8 ttt180 . . . . . 0 N--CA 1.465 0.299 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 1.079 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 4.0 mm? -103.89 133.11 49.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.786 0.327 . . . . 0.0 111.473 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.811 HG21 ' HB2' ' A' ' 113' ' ' ARG . 10.6 p -135.38 133.3 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.593 178.48 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.073 ' HB2' HD11 ' A' ' 58' ' ' ILE . 1.5 mm? -140.71 142.2 34.86 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 177.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.066 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.7 mp -121.14 135.22 62.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 117.987 0.358 . . . . 0.0 110.679 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.72 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 50.3 m-20 54.46 37.07 0.38 Allowed Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.884 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 99.5 Cg_exo -56.71 148.63 64.25 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 123.058 2.505 . . . . 0.0 114.408 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.511 ' O ' ' HB ' ' A' ' 108' ' ' ILE . 15.8 pt-20 -139.61 143.04 37.07 Favored 'General case' 0 C--O 1.23 0.079 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.884 HD12 HG22 ' A' ' 108' ' ' ILE . 8.5 tp -80.07 138.02 36.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.443 0.639 . . . . 0.0 111.43 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.091 HD11 ' HG3' ' A' ' 109' ' ' ARG . 6.8 mp -113.13 -36.91 4.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.181 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.433 ' O ' ' HB ' ' A' ' 106' ' ' VAL . 41.4 tt0 -159.0 149.55 19.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.208 0.528 . . . . 0.0 111.42 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 1.077 ' HA ' HG12 ' A' ' 106' ' ' VAL . 12.5 ptmt -146.47 149.59 33.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.282 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 81.2 p -158.58 145.04 17.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.526 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.783 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 79.12 154.74 8.48 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.117 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 -127.36 113.82 16.75 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.783 0.801 . . . . 0.0 112.316 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.588 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.5 p -106.44 160.89 15.06 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 115.645 1.721 . . . . 0.0 115.645 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.739 ' CA ' HD21 ' A' ' 99' ' ' LEU . . . -140.39 105.92 0.46 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 113.046 -1.888 . . . . 0.0 111.584 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.683 ' N ' ' HG ' ' A' ' 99' ' ' LEU . 20.4 mt -144.99 135.45 19.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -178.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 52.8 mt-10 -72.73 143.28 48.07 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 122.818 1.294 . . . . 0.0 113.37 -177.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.589 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 55.6 mt-10 -156.54 168.64 26.77 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 113.301 -1.772 . . . . 0.0 109.289 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.685 ' HA3' ' HG2' ' A' ' 97' ' ' ARG . . . -120.06 165.97 13.58 Favored Glycine 0 CA--C 1.5 -0.867 0 C-N-CA 119.421 -1.371 . . . . 0.0 110.628 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.551 ' HB2' HG13 ' A' ' 93' ' ' ILE . 63.0 m -115.71 137.65 51.87 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.921 -177.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.044 HD12 HG11 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -50.89 -33.27 23.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.65 0.738 . . . . 0.0 109.403 179.647 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.893 ' CB ' HD13 ' A' ' 13' ' ' LEU . 60.1 m -76.92 -30.56 56.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.829 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.551 HG13 ' HB2' ' A' ' 90' ' ' CYS . 57.7 mt . . . . . 0 C--N 1.327 -0.382 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.685 ' HG2' ' HA3' ' A' ' 89' ' ' GLY . 42.9 mtm-85 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 121.67 0.748 . . . . 0.0 111.659 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -134.2 153.94 51.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.839 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.739 HD21 ' CA ' ' A' ' 85' ' ' GLY . 6.9 tt -75.53 135.95 40.59 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.875 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.678 ' N ' HD23 ' A' ' 99' ' ' LEU . 60.2 t -130.38 134.64 26.32 Favored Pre-proline 0 N--CA 1.454 -0.265 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.588 ' HA ' ' O ' ' A' ' 84' ' ' THR . 88.2 Cg_endo -82.71 124.12 3.91 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.395 1.397 . . . . 0.0 113.721 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.906 ' HG2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -141.99 164.95 28.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 113.914 -1.494 . . . . 0.0 110.22 179.204 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.783 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.86 154.85 41.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.809 0.338 . . . . 0.0 110.913 -178.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.534 ' OE1' HG21 ' A' ' 84' ' ' THR . 28.2 tp10 -72.66 -43.93 62.51 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.283 -176.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.764 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 55.8 mttm -139.13 138.36 36.94 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.463 0.649 . . . . 0.0 109.495 176.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 1.077 HG12 ' HA ' ' A' ' 80' ' ' LYS . 25.8 m -147.49 140.43 19.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.614 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.907 ' HD2' ' CB ' ' A' ' 121' ' ' GLU . 51.3 mmtt -107.41 125.37 51.13 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 1.08 ' HA ' HD13 ' A' ' 78' ' ' LEU . 1.4 pp -129.95 160.75 40.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.179 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 1.091 ' HG3' HD11 ' A' ' 78' ' ' LEU . 92.7 mtt180 -107.51 135.01 49.69 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-O 121.142 0.496 . . . . 0.0 110.326 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.904 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -155.75 167.5 30.2 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.184 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 1.066 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.3 pp -115.54 151.69 34.4 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.446 ' OD1' HG13 ' A' ' 71' ' ' VAL . 19.8 t70 -86.67 163.46 17.36 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.604 -176.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.811 ' HB2' HG21 ' A' ' 71' ' ' VAL . 14.4 ttp-105 -54.75 -16.44 2.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.77 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.37 -25.7 42.14 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.975 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.896 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 105.91 35.51 2.97 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.573 -0.822 . . . . 0.0 113.837 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -128.92 102.98 18.93 Favored Pre-proline 0 C--O 1.238 0.485 0 CA-C-N 116.967 0.383 . . . . 0.0 111.139 178.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.679 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 32.5 Cg_exo -73.23 114.76 4.12 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 121.653 1.569 . . . . 0.0 114.994 -177.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -129.6 168.93 15.69 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.908 -178.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.864 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 6.2 mp0 -106.63 130.11 54.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.91 0.386 . . . . 0.0 109.981 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.9 ' O ' HD23 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -124.45 141.78 51.82 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.881 0.848 . . . . 0.0 112.017 -178.57 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.907 ' CB ' ' HD2' ' A' ' 107' ' ' LYS . 15.3 pt-20 -94.84 123.33 38.24 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.998 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.779 ' O ' ' HB2' ' A' ' 127' ' ' ALA . . . -116.52 134.17 55.16 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.453 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.764 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.2 m-20 -126.76 163.62 23.14 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.76 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 45.89 -133.75 9.61 Favored Glycine 0 C--N 1.348 1.198 0 CA-C-N 120.832 1.651 . . . . 0.0 116.224 176.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.0 mt -53.38 -35.06 59.91 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.444 -0.878 . . . . 0.0 111.444 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.543 HD22 ' CB ' ' A' ' 122' ' ' ALA . 0.6 OUTLIER -70.68 -53.67 14.81 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.311 0.577 . . . . 0.0 110.116 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.779 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -59.0 -42.95 91.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.699 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.906 HD12 ' HG2' ' A' ' 102' ' ' ARG . 49.5 mm -64.72 -55.47 20.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.366 -178.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.453 ' SG ' HG21 ' A' ' 62' ' ' VAL . 28.9 p -57.76 -49.71 75.69 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -178.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.679 HD11 HD11 ' A' ' 108' ' ' ILE . 19.3 tt -59.26 -42.42 87.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.878 ' CG ' HG21 ' A' ' 106' ' ' VAL . 66.5 mt-30 -65.79 -40.57 92.07 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 178.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.659 ' HA ' ' OD2' ' A' ' 135' ' ' ASP . 74.1 t60 -56.0 -49.2 74.3 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.524 0.678 . . . . 0.0 110.219 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.873 ' O ' HD23 ' A' ' 137' ' ' LEU . 24.0 mm-40 -60.7 -42.44 97.18 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.083 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.93 ' HA ' HD21 ' A' ' 137' ' ' LEU . 35.5 mtm -58.16 -49.62 76.36 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.351 0.978 . . . . 0.0 110.968 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.659 ' OD2' ' HA ' ' A' ' 132' ' ' HIS . 4.1 p30 -63.0 -46.09 89.31 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.681 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.461 ' CE1' ' HG2' ' A' ' 50' ' ' GLN . 11.7 t-80 -56.76 -51.57 68.38 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 121.78 -0.575 . . . . 0.0 111.039 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 1.043 HD12 ' HB3' ' A' ' 17' ' ' ALA . 1.2 pp -59.76 -30.72 69.05 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.799 -177.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.824 HG23 HG13 ' A' ' 16' ' ' VAL . 10.7 p -83.11 20.48 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-O 123.083 1.42 . . . . 0.0 108.22 174.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.805 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 60.36 17.49 46.99 Favored Glycine 0 CA--C 1.491 -1.455 0 CA-C-N 112.106 -2.316 . . . . 0.0 112.553 176.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.775 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.431 -1.424 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.749 HG13 ' HA ' ' A' ' 37' ' ' THR . 42.2 t . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.926 0.393 . . . . 0.0 111.276 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 1.074 HD23 ' HB ' ' A' ' 51' ' ' VAL . 58.4 tp -77.39 161.74 27.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.335 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 71.0 tp60 -78.44 106.67 10.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.03 0.443 . . . . 0.0 110.03 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.042 HG11 HD12 ' A' ' 91' ' ' LEU . 39.5 t -90.08 131.94 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.647 -178.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.083 ' HB2' HD21 ' A' ' 13' ' ' LEU . 25.5 mt -85.01 140.73 30.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.479 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 39.2 m-70 -115.79 141.78 47.63 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -178.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.083 HD13 HD12 ' A' ' 13' ' ' LEU . 41.4 mm -62.77 134.5 95.48 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.889 177.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.3 144.81 78.83 Favored 'Cis proline' 0 C--N 1.352 0.754 0 C-N-CA 124.615 -0.994 . . . . 0.0 111.815 -0.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.982 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.6 t70 -164.56 126.46 2.23 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.505 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.528 ' HG2' ' N ' ' A' ' 12' ' ' ARG . 10.5 pm0 -58.28 -45.49 87.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.551 -178.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.715 ' HD3' ' HE3' ' A' ' 15' ' ' LYS . 14.2 mmt-85 -58.13 -27.63 63.92 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 1.083 HD12 HD13 ' A' ' 8' ' ' ILE . 9.6 mt -77.58 -31.3 53.0 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 120.814 1.643 . . . . 0.0 108.86 177.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.627 ' C ' ' HA3' ' A' ' 139' ' ' GLY . 13.5 mmt85 -95.54 10.0 38.14 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 114.147 -1.388 . . . . 0.0 109.308 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.808 ' NZ ' ' HB2' ' A' ' 54' ' ' HIS . 20.4 ttpp -92.05 146.49 23.69 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.204 -179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.893 ' CG1' HG23 ' A' ' 138' ' ' VAL . 44.5 t -84.15 95.26 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.535 -178.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.58 ' HB1' ' C ' ' A' ' 55' ' ' GLN . . . -54.8 148.24 13.42 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-O 121.053 0.454 . . . . 0.0 111.868 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.418 ' HB3' ' OE1' ' A' ' 55' ' ' GLN . 54.2 tttp -103.21 129.42 25.58 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.902 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.663 ' CD ' ' HD3' ' A' ' 56' ' ' ARG . 60.1 Cg_endo -79.64 116.48 3.52 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.428 2.085 . . . . 0.0 110.506 179.132 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.871 HG12 ' H ' ' A' ' 22' ' ' GLU . 20.9 t -71.27 144.71 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-O 122.552 1.168 . . . . 0.0 113.143 -176.019 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -69.15 -21.13 64.02 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 113.121 -1.854 . . . . 0.0 112.329 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.871 ' H ' HG12 ' A' ' 20' ' ' VAL . 88.7 tt0 -159.25 142.03 14.16 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 121.157 -0.217 . . . . 0.0 110.566 -179.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.596 HG21 ' CD1' ' A' ' 111' ' ' LEU . 2.8 t -80.51 106.01 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 -178.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 1.065 ' H ' HD12 ' A' ' 27' ' ' ILE . 32.0 m120 -89.34 159.05 17.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.692 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.568 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -54.17 -30.54 49.83 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.024 0.44 . . . . 0.0 110.69 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -71.81 -39.66 69.7 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 1.065 HD12 ' H ' ' A' ' 24' ' ' ASN . 60.6 mt -63.56 -47.6 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.297 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 43.5 mt-30 -57.85 -40.34 79.87 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.77 0.319 . . . . 0.0 110.627 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 40.0 mmt-85 -59.84 -40.45 88.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.811 0.815 . . . . 0.0 108.866 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.771 ' O ' ' HG3' ' A' ' 34' ' ' MET . 4.4 mt -59.64 -49.48 83.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 114.419 -1.264 . . . . 0.0 111.846 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.9 HG22 ' CG2' ' A' ' 57' ' ' ILE . 18.7 t -66.82 -42.21 88.86 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-O 120.839 0.352 . . . . 0.0 111.395 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.878 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -55.32 -43.91 75.32 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.997 -179.321 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.648 ' HB3' ' HB2' ' A' ' 3' ' ' LEU . 31.9 m-20 -75.29 -30.83 60.5 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.355 176.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' MET . . . . . 1.004 ' HG2' HG21 ' A' ' 51' ' ' VAL . 79.2 mtp -59.55 -47.22 86.38 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.566 -177.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.878 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 13.6 p90 -69.05 -43.99 73.54 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 177.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.759 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 81.7 mt-10 -51.85 -40.31 60.35 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.749 ' HA ' HG13 ' A' ' 2' ' ' VAL . 37.2 m -69.8 -61.45 1.77 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 119.042 -1.063 . . . . 0.0 108.638 177.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.952 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 3.3 ttp -46.22 -43.81 15.72 Favored 'General case' 0 CA--C 1.459 -2.528 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.861 -170.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.711 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 70.2 m-85 -69.63 -41.62 75.41 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.635 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.23 -28.62 68.16 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.811 ' HG2' ' CD2' ' A' ' 91' ' ' LEU . 3.2 tp10 -84.72 -10.06 57.62 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 114.407 -1.269 . . . . 0.0 108.876 177.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.441 ' H ' ' C ' ' A' ' 39' ' ' TYR . 58.1 mt-10 62.01 26.05 15.68 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.824 -176.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.89 143.13 25.1 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.373 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.805 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 40.6 mt -78.99 -0.78 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 117.941 0.87 . . . . 0.0 112.008 -178.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.549 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 179.33 135.3 2.36 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 118.972 -0.904 . . . . 0.0 112.005 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.995 HD13 HD23 ' A' ' 91' ' ' LEU . 9.0 tp -126.51 135.43 51.31 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.535 1.667 . . . . 0.0 112.084 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.615 ' H ' HE21 ' A' ' 50' ' ' GLN . . . -99.68 130.73 45.93 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.889 ' HB1' ' CD1' ' A' ' 53' ' ' ILE . . . -29.7 -56.15 0.16 Allowed 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.59 HG21 ' O ' ' A' ' 137' ' ' LEU . 75.7 p -53.16 -35.02 59.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.964 0.888 . . . . 0.0 111.167 -178.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.615 HE21 ' H ' ' A' ' 47' ' ' ALA . 27.4 mt-30 -66.1 -38.08 87.36 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.174 -1.375 . . . . 0.0 110.358 179.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 1.074 ' HB ' HD23 ' A' ' 3' ' ' LEU . 1.4 m -87.61 15.29 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.871 ' HA ' ' CD1' ' A' ' 6' ' ' LEU . 56.0 t0 76.53 32.89 0.54 Allowed 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 176.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.889 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 1.2 pp -126.91 111.12 24.77 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.404 177.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.808 ' HB2' ' NZ ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -75.6 64.89 1.73 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.942 0.877 . . . . 0.0 110.59 -179.207 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.71 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 11.8 mm100 -155.48 134.8 12.36 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 114.359 -1.291 . . . . 0.0 108.385 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.709 ' HG2' ' CD1' ' A' ' 137' ' ' LEU . 77.1 mtp180 -65.37 72.4 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -177.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.9 ' CG2' HG22 ' A' ' 31' ' ' VAL . 7.4 mm -113.52 122.99 68.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.005 HD11 ' HB2' ' A' ' 72' ' ' LEU . 1.9 pp -127.11 145.52 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -177.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 46' ' ' LEU . 32.8 m -127.48 138.41 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.369 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.053 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 13.5 mm -115.88 152.69 17.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.571 0.701 . . . . 0.0 110.58 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.952 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 36.6 t70 -146.11 34.12 1.0 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.417 -178.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.782 HG22 HG22 ' A' ' 44' ' ' ILE . 38.8 t . . . . . 0 N--CA 1.465 0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.289 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.605 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 76.0 ttt180 . . . . . 0 N--CA 1.462 0.143 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 1.053 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 40.8 mt -104.91 133.48 49.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.455 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.762 HG21 ' HB2' ' A' ' 113' ' ' ARG . 9.9 p -134.82 133.02 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.023 178.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.005 ' HB2' HD11 ' A' ' 58' ' ' ILE . 87.3 mt -141.85 141.95 33.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.907 -0.133 . . . . 0.0 111.252 178.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.072 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.9 mp -118.24 134.09 62.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 110.418 -0.215 . . . . 0.0 110.418 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.678 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 0.5 OUTLIER 46.32 40.75 0.71 Allowed Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -179.43 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.754 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 92.5 Cg_exo -56.79 155.43 27.26 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.987 2.458 . . . . 0.0 113.247 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -137.78 143.75 41.25 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.972 ' HB2' ' HE1' ' A' ' 134' ' ' MET . 1.8 tt -81.3 133.93 35.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.609 0.719 . . . . 0.0 111.506 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.048 HD11 ' HG3' ' A' ' 109' ' ' ARG . 6.8 mp -109.3 -38.83 5.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.541 -1.208 . . . . 0.0 111.905 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 42.7 tt0 -160.28 155.66 25.16 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.264 0.554 . . . . 0.0 112.056 -179.136 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.842 ' HA ' HG12 ' A' ' 106' ' ' VAL . 18.7 ptpt -148.25 151.53 35.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.451 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 53.2 m -160.08 143.46 13.94 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.679 0.276 . . . . 0.0 111.193 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.758 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 81.98 159.72 25.28 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.556 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -130.67 114.0 14.87 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.531 0.682 . . . . 0.0 112.617 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.5 p -107.76 159.31 16.59 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 179.299 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.71 ' O ' HD13 ' A' ' 86' ' ' ILE . . . -140.06 103.44 0.37 Allowed Glycine 0 C--N 1.318 -0.461 0 CA-C-N 113.039 -1.891 . . . . 0.0 111.63 178.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.71 HD13 ' O ' ' A' ' 85' ' ' GLY . 40.7 mm -144.67 135.86 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -178.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.639 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 48.8 mt-10 -72.27 143.68 48.66 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 122.577 1.18 . . . . 0.0 112.736 -178.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.592 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 50.3 mt-10 -155.61 164.16 39.0 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 113.727 -1.579 . . . . 0.0 109.482 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.781 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -118.68 163.29 13.16 Favored Glycine 0 CA--C 1.498 -1.016 0 C-N-CA 119.258 -1.449 . . . . 0.0 110.235 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.542 ' HB2' HG13 ' A' ' 93' ' ' ILE . 71.8 m -111.71 137.8 49.12 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.886 -177.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.042 HD12 HG11 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -50.01 -33.51 18.29 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.678 0.752 . . . . 0.0 109.891 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.853 ' CB ' HD13 ' A' ' 13' ' ' LEU . 29.2 m -77.55 -29.98 52.48 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.801 -179.268 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.542 HG13 ' HB2' ' A' ' 90' ' ' CYS . 59.9 mt . . . . . 0 C--N 1.327 -0.377 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.781 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 77.7 mtm180 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 121.729 0.776 . . . . 0.0 111.652 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -129.63 149.68 51.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.651 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.683 HD23 ' N ' ' A' ' 100' ' ' VAL . 6.9 tt -75.07 135.39 41.22 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.685 0.279 . . . . 0.0 110.462 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.79 ' HB ' ' NH2' ' A' ' 102' ' ' ARG . 57.6 t -130.25 130.61 23.07 Favored Pre-proline 0 N--CA 1.453 -0.31 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 84' ' ' THR . 5.8 Cg_exo -77.95 123.85 6.47 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 121.741 1.628 . . . . 0.0 112.587 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.942 HH11 ' HB3' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -142.75 165.28 27.8 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.085 -1.416 . . . . 0.0 110.4 179.39 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.758 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.64 154.94 40.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.721 0.296 . . . . 0.0 110.656 -178.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -72.77 -43.08 63.29 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.231 -176.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.793 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 82.3 mttt -139.6 138.27 36.04 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.48 0.657 . . . . 0.0 109.621 176.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.842 HG12 ' HA ' ' A' ' 80' ' ' LYS . 27.4 m -142.51 141.49 27.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.852 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.985 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 52.8 mmtt -107.73 125.77 51.8 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 1.0 ' HA ' HD13 ' A' ' 78' ' ' LEU . 2.0 pp -130.86 160.1 42.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -177.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 1.048 ' HG3' HD11 ' A' ' 78' ' ' LEU . 95.4 mtt180 -109.84 137.8 47.12 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.862 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -156.94 167.49 30.31 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.761 -0.2 . . . . 0.0 111.108 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 1.072 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.0 pp -113.9 151.86 31.61 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.415 ' O ' HD12 ' A' ' 111' ' ' LEU . 9.4 t70 -89.06 162.7 15.86 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.503 -177.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.812 ' HD2' ' OD1' ' A' ' 32' ' ' ASP . 48.4 ttp85 -52.75 -18.6 1.92 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.235 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -79.25 -25.06 42.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.343 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.92 35.85 2.89 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.698 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -128.79 102.93 19.3 Favored Pre-proline 0 C--O 1.237 0.423 0 CA-C-N 116.986 0.393 . . . . 0.0 111.248 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.663 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.6 Cg_exo -73.54 114.84 4.14 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 121.703 1.602 . . . . 0.0 114.729 -177.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.18 168.75 13.62 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.683 -178.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.813 ' HG2' ' HG2' ' A' ' 109' ' ' ARG . 33.2 mt-10 -107.39 130.06 54.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.051 0.453 . . . . 0.0 110.132 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.939 HD21 HD11 ' A' ' 72' ' ' LEU . 4.1 pp -127.48 134.72 49.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.97 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.985 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 11.5 pt-20 -93.53 125.11 37.96 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.843 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.939 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -116.19 135.43 53.92 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.793 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.1 m-20 -126.31 164.49 20.92 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.778 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 47.16 -135.3 11.95 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 120.187 1.358 . . . . 0.0 116.302 176.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.45 ' HB3' HG11 ' A' ' 62' ' ' VAL . 87.2 mt -54.04 -33.74 58.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.493 -0.854 . . . . 0.0 111.721 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.939 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -71.26 -53.46 14.24 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.762 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.777 ' HB2' ' C ' ' A' ' 122' ' ' ALA . . . -59.3 -46.19 89.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.876 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.832 HD12 ' HG2' ' A' ' 102' ' ' ARG . 47.3 mm -61.54 -56.02 20.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.095 -178.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.68 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 73.5 m -60.0 -51.22 70.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.707 HG22 ' O ' ' A' ' 126' ' ' LEU . 20.3 tt -59.11 -42.07 85.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 121.21 -0.196 . . . . 0.0 111.004 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.864 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.4 pt20 -67.81 -37.77 82.42 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -59.52 -44.94 93.04 Favored 'General case' 0 CA--C 1.521 -0.146 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.871 ' O ' HD23 ' A' ' 137' ' ' LEU . 4.2 mm-40 -59.3 -44.53 92.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.173 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.972 ' HE1' ' HB2' ' A' ' 77' ' ' LEU . 74.3 mtp -57.42 -48.32 79.42 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.544 0.687 . . . . 0.0 110.28 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.518 ' O ' HG12 ' A' ' 138' ' ' VAL . 30.5 m-20 -61.32 -48.63 80.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.157 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.45 ' CE1' ' HG2' ' A' ' 50' ' ' GLN . 21.4 t-80 -59.99 -51.43 69.71 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.861 0.362 . . . . 0.0 111.65 -178.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.937 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.4 pp -58.76 -32.98 69.77 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.481 -177.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.933 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 8.2 p -82.07 20.56 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-O 123.085 1.421 . . . . 0.0 108.854 175.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.847 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 59.44 14.66 28.43 Favored Glycine 0 CA--C 1.49 -1.474 0 CA-C-N 112.178 -2.283 . . . . 0.0 112.622 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.933 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 8.5 ptmt . . . . . 0 N--CA 1.426 -1.65 0 C-N-CA 119.466 -0.893 . . . . 0.0 108.816 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.965 HG12 ' HA ' ' A' ' 37' ' ' THR . 30.5 m . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.848 0.356 . . . . 0.0 111.428 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.933 HD21 ' HB ' ' A' ' 51' ' ' VAL . 3.0 pp -79.63 -172.4 3.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.565 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -82.37 108.98 16.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.782 0.325 . . . . 0.0 110.454 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.528 HG22 HG21 ' A' ' 37' ' ' THR . 37.9 t -88.42 129.85 38.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.385 0.612 . . . . 0.0 112.03 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.972 ' HB2' HD21 ' A' ' 13' ' ' LEU . 23.7 mt -88.15 147.39 24.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.655 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 -128.19 146.06 50.84 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.667 HD12 ' H ' ' A' ' 8' ' ' ILE . 3.3 mp -64.22 135.23 96.24 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.205 177.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.39 140.83 58.48 Favored 'Cis proline' 0 C--N 1.352 0.741 0 C-N-CA 124.253 -1.145 . . . . 0.0 111.804 -0.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.87 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.7 t70 -160.85 125.17 3.56 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.475 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.549 ' HG2' ' N ' ' A' ' 12' ' ' ARG . 2.7 pm0 -57.8 -43.81 85.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.418 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.669 ' HE ' ' HE3' ' A' ' 15' ' ' LYS . 15.5 mmt85 -55.99 -30.05 61.2 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.972 HD21 ' HB2' ' A' ' 6' ' ' LEU . 9.8 mt -77.1 -32.7 56.79 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 120.891 1.678 . . . . 0.0 108.661 177.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -91.66 8.83 34.98 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 113.998 -1.455 . . . . 0.0 109.165 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.669 ' HE3' ' HE ' ' A' ' 12' ' ' ARG . 24.9 ttmm -91.26 148.05 22.62 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.05 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.546 HG13 HG23 ' A' ' 138' ' ' VAL . 85.5 t -82.78 129.83 36.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.87 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -90.45 144.31 25.92 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.384 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.766 ' HD3' ' CD ' ' A' ' 19' ' ' PRO . 2.0 tmtp? -106.35 133.14 20.37 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.766 ' CD ' ' HD3' ' A' ' 18' ' ' LYS . 45.7 Cg_endo -82.09 114.71 2.57 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 121.934 1.756 . . . . 0.0 110.73 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.745 HG12 ' H ' ' A' ' 22' ' ' GLU . 16.0 t -67.68 144.33 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 CA-C-O 122.574 1.178 . . . . 0.0 113.247 -175.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.82 -23.45 67.36 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 112.924 -1.944 . . . . 0.0 112.639 -179.298 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.745 ' H ' HG12 ' A' ' 20' ' ' VAL . 88.7 tt0 -158.67 144.51 16.72 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.13 -178.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.502 HG22 HD21 ' A' ' 111' ' ' LEU . 3.1 t -81.45 107.4 13.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -178.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 1.034 ' HB2' HD13 ' A' ' 27' ' ' ILE . 28.4 m120 -95.38 157.79 15.74 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.769 -178.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.534 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -55.18 -24.22 25.73 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.282 0.563 . . . . 0.0 110.808 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.753 ' O ' HD13 ' A' ' 30' ' ' ILE . 70.8 mm-40 -74.45 -44.92 49.52 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 177.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 1.034 HD13 ' HB2' ' A' ' 24' ' ' ASN . 2.0 mp -64.72 -34.34 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 113.793 -1.548 . . . . 0.0 110.153 178.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.515 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 75.0 mt-30 -68.16 -40.59 82.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 122.297 -0.252 . . . . 0.0 110.713 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.534 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 40.3 mmt180 -61.44 -39.3 90.33 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.846 ' CG2' HD13 ' A' ' 53' ' ' ILE . 1.6 mp -57.75 -48.53 83.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.087 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.584 HG22 ' CG2' ' A' ' 57' ' ' ILE . 27.6 t -68.11 -42.26 84.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.97 0.414 . . . . 0.0 111.156 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.872 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -56.39 -42.19 77.5 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.058 -179.254 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.491 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 17.5 m-20 -75.78 -30.11 58.98 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.261 176.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' MET . . . . . 1.095 ' HG2' HG21 ' A' ' 51' ' ' VAL . 87.6 mtp -60.92 -46.27 91.33 Favored 'General case' 0 C--N 1.345 0.395 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.516 -177.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.872 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 13.5 p90 -69.59 -45.91 67.53 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.578 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 29.4 mm-40 -52.51 -38.44 59.61 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.965 ' HA ' HG12 ' A' ' 2' ' ' VAL . 61.6 m -69.9 -62.23 1.47 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.487 -1.233 . . . . 0.0 107.857 178.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.887 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 3.7 ttp -46.65 -41.85 15.43 Favored 'General case' 0 CA--C 1.461 -2.472 0 C-N-CA 124.042 0.937 . . . . 0.0 110.72 -171.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.708 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 70.9 m-85 -70.48 -42.32 71.55 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.38 178.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.457 ' CB ' HG11 ' A' ' 2' ' ' VAL . . . -61.4 -24.31 66.42 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.358 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.937 ' HG2' HD12 ' A' ' 91' ' ' LEU . 3.1 tp10 -89.05 -10.7 46.49 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 114.47 -1.241 . . . . 0.0 108.566 177.181 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.443 ' H ' ' C ' ' A' ' 39' ' ' TYR . 23.4 mt-10 62.96 26.7 15.65 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.818 -176.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.97 145.17 26.91 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.974 178.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.803 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 44.1 mm -79.3 -1.56 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 117.418 0.609 . . . . 0.0 112.028 -178.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.548 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 177.54 142.06 4.38 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -178.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.018 HD13 ' HG ' ' A' ' 91' ' ' LEU . 4.7 tp -126.21 135.63 51.85 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.528 1.664 . . . . 0.0 110.479 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -105.9 132.2 52.29 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.989 ' HB1' HG13 ' A' ' 53' ' ' ILE . . . -28.73 -56.76 0.13 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 -178.159 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.884 HG23 ' HA ' ' A' ' 137' ' ' LEU . 67.6 p -53.17 -34.64 57.78 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 121.953 0.883 . . . . 0.0 111.164 -178.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.856 ' OE1' HD23 ' A' ' 91' ' ' LEU . 50.3 mt-30 -63.94 -43.83 94.67 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.25 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 1.095 HG21 ' HG2' ' A' ' 34' ' ' MET . 1.0 OUTLIER -86.76 15.07 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.86 ' HA ' HD11 ' A' ' 6' ' ' LEU . 36.5 t70 78.29 27.87 0.5 Allowed 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 176.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 1.015 HD11 ' HB ' ' A' ' 57' ' ' ILE . 10.7 pt -119.36 109.83 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 C-N-CA 119.045 -1.062 . . . . 0.0 110.858 177.019 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.629 ' HB3' ' HD2' ' A' ' 15' ' ' LYS . 25.2 p-80 -75.84 49.18 0.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 122.063 0.935 . . . . 0.0 109.946 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.642 ' C ' ' HB1' ' A' ' 17' ' ' ALA . 89.1 mt-30 -136.48 130.62 32.83 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 1.085 ' HA ' HD22 ' A' ' 137' ' ' LEU . 60.3 mtp85 -62.46 75.14 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.015 ' HB ' HD11 ' A' ' 53' ' ' ILE . 15.0 mt -119.83 124.62 73.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.876 HD11 ' HG2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -131.57 148.5 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -178.069 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.589 ' CG2' ' HB3' ' A' ' 46' ' ' LEU . 32.8 m -124.34 138.85 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.046 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 6.1 mm -113.57 150.86 15.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-O 121.739 0.781 . . . . 0.0 110.137 -179.064 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.887 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 36.1 t70 -140.16 27.6 2.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.895 -177.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.785 HG22 ' CG2' ' A' ' 44' ' ' ILE . 41.1 t . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.219 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.623 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 34.3 ttp85 . . . . . 0 N--CA 1.465 0.314 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 1.046 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 62.0 mt -106.79 135.43 48.34 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-O 120.692 0.282 . . . . 0.0 111.431 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.818 HG21 ' HB2' ' A' ' 113' ' ' ARG . 12.7 p -134.94 135.16 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.25 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.816 ' HB2' HD11 ' A' ' 58' ' ' ILE . 3.2 mm? -141.63 144.35 34.13 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 177.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.998 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.5 mp -124.33 135.78 62.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.9 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.715 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 6.1 m120 49.57 35.48 0.28 Allowed Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 178.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.876 ' HG2' HD11 ' A' ' 58' ' ' ILE . 80.2 Cg_exo -60.91 157.18 39.72 Favored 'Trans proline' 0 N--CA 1.485 1.02 0 C-N-CA 122.809 2.34 . . . . 0.0 114.761 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.423 ' O ' HD22 ' A' ' 78' ' ' LEU . 11.3 pt-20 -138.05 141.78 40.33 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.945 ' HA ' HG22 ' A' ' 108' ' ' ILE . 1.5 tt -80.23 131.64 35.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.151 0.5 . . . . 0.0 111.369 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.113 HD23 ' HA ' ' A' ' 108' ' ' ILE . 2.7 mm? -104.24 -39.06 6.64 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.872 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.614 ' O ' HD21 ' A' ' 77' ' ' LEU . 40.0 tp10 -152.68 152.01 31.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.138 0.495 . . . . 0.0 111.521 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 1.018 ' HA ' HG12 ' A' ' 106' ' ' VAL . 9.2 ptpp? -147.67 148.48 31.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.437 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.8 m -158.58 147.8 19.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.254 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.666 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 73.23 158.67 4.93 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.495 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -133.92 114.38 13.22 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 122.292 1.044 . . . . 0.0 113.356 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.647 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.7 p -103.73 162.11 13.36 Favored 'General case' 0 CA--C 1.488 -1.435 0 CA-C-N 113.244 -1.798 . . . . 0.0 115.232 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.8 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -148.29 117.9 0.93 Allowed Glycine 0 C--N 1.314 -0.66 0 CA-C-N 112.54 -2.118 . . . . 0.0 110.418 177.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.608 HD13 ' O ' ' A' ' 85' ' ' GLY . 48.3 mm -147.04 138.47 18.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 117.297 0.549 . . . . 0.0 111.284 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 56.3 mt-10 -72.26 139.0 47.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 123.297 1.523 . . . . 0.0 111.613 -176.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.724 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 47.2 mt-10 -155.92 161.42 40.55 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 112.693 -2.049 . . . . 0.0 111.392 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.827 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -120.15 165.51 13.64 Favored Glycine 0 CA--C 1.496 -1.127 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.503 ' HB2' ' CG1' ' A' ' 93' ' ' ILE . 20.5 m -114.92 137.08 52.39 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.512 0.672 . . . . 0.0 112.331 -177.034 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.018 ' HG ' HD13 ' A' ' 46' ' ' LEU . 2.3 mm? -46.77 -40.35 13.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.453 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.691 ' CB ' HD13 ' A' ' 13' ' ' LEU . 51.0 m -78.18 -27.51 47.97 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.091 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.667 ' CG1' HD13 ' A' ' 8' ' ' ILE . 54.4 mt . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.827 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 47.9 mtm-85 . . . . . 0 C--O 1.233 0.21 0 CA-C-O 121.837 0.827 . . . . 0.0 111.892 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -135.74 153.68 51.49 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.492 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.8 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.3 tt -76.34 114.23 14.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.61 0.719 . . . . 0.0 111.752 -178.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.814 HG13 ' NE ' ' A' ' 102' ' ' ARG . 13.7 p -106.56 129.66 24.11 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 114.931 -1.031 . . . . 0.0 112.181 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.647 ' HA ' ' O ' ' A' ' 84' ' ' THR . 1.1 Cg_endo -84.22 127.09 3.88 Favored 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 123.56 2.84 . . . . 0.0 113.921 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.978 ' HG2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -143.82 167.61 21.91 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.512 1.125 . . . . 0.0 109.471 179.12 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.666 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.36 155.33 40.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 118.357 0.526 . . . . 0.0 109.969 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -73.63 -41.94 62.11 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.972 -175.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.558 ' HG2' ' HB3' ' A' ' 123' ' ' ASP . 61.3 mttp -140.04 140.54 36.19 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.381 0.61 . . . . 0.0 109.573 177.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 1.018 HG12 ' HA ' ' A' ' 80' ' ' LYS . 22.5 m -151.36 140.2 14.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.598 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.988 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 52.8 mmtt -107.34 126.34 52.33 Favored 'General case' 0 CA--C 1.524 -0.026 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 1.113 ' HA ' HD23 ' A' ' 78' ' ' LEU . 1.7 pp -135.72 154.06 33.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -176.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 1.022 ' HG3' HD21 ' A' ' 78' ' ' LEU . 50.1 mtm180 -103.07 139.53 38.48 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.532 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.768 ' CB ' ' HG3' ' A' ' 75' ' ' PRO . . . -160.45 169.73 22.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.642 -176.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.998 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.3 pp -118.26 151.44 37.66 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.043 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.656 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 8.5 t70 -87.64 161.44 17.68 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.257 -176.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.818 ' HB2' HG21 ' A' ' 71' ' ' VAL . 52.0 ttp85 -52.74 -17.28 1.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.099 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.56 -29.32 46.21 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.799 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.434 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 109.2 35.58 2.29 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.45 -0.881 . . . . 0.0 113.24 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -128.79 102.99 19.26 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 121.177 -0.209 . . . . 0.0 110.972 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.686 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.3 Cg_exo -73.76 115.1 4.21 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 121.553 1.502 . . . . 0.0 114.757 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.656 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 11.0 p90 -127.38 169.01 14.05 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.442 -177.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.639 ' HG2' ' CG ' ' A' ' 109' ' ' ARG . 31.1 mt-10 -106.65 129.9 54.48 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.727 ' O ' HD12 ' A' ' 120' ' ' LEU . 4.3 pp -125.72 134.66 51.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.476 -178.277 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.988 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 15.3 pt-20 -92.99 123.88 36.56 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.636 178.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.917 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -117.71 134.01 55.34 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.024 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.558 ' HB3' ' HG2' ' A' ' 105' ' ' LYS . 22.9 m-20 -126.96 162.86 24.97 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.021 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.772 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 50.92 -136.68 28.97 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 120.265 1.393 . . . . 0.0 115.658 177.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.68 HD12 ' H ' ' A' ' 125' ' ' LEU . 4.7 mp -55.23 -33.24 62.94 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.684 -0.758 . . . . 0.0 111.706 -178.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.917 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -71.03 -52.12 21.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.866 0.841 . . . . 0.0 109.203 179.692 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.766 ' HB2' ' C ' ' A' ' 122' ' ' ALA . . . -59.01 -41.23 87.2 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.194 -1.366 . . . . 0.0 111.703 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.978 HD12 ' HG2' ' A' ' 102' ' ' ARG . 50.5 mm -68.43 -54.99 17.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.035 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.637 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 30.4 p -58.13 -47.73 82.39 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 1.053 HD11 HD11 ' A' ' 108' ' ' ILE . 19.5 tt -59.05 -44.03 90.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.867 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.85 ' CG ' HG21 ' A' ' 106' ' ' VAL . 69.5 mt-30 -64.72 -44.94 88.57 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 178.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 76.0 t60 -56.44 -47.75 78.45 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.243 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.814 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 3.3 mm-40 -60.23 -38.86 84.7 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 110.552 -0.166 . . . . 0.0 110.552 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.686 ' CE ' ' HB2' ' A' ' 77' ' ' LEU . 28.4 mtm -58.77 -45.66 89.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 122.338 1.066 . . . . 0.0 109.384 177.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.813 ' O ' HG12 ' A' ' 138' ' ' VAL . 0.9 OUTLIER -66.58 -48.55 69.25 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.999 179.394 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.673 ' CE1' ' HG2' ' A' ' 50' ' ' GLN . 7.8 t-80 -57.15 -53.0 63.06 Favored 'General case' 0 C--N 1.32 -0.712 0 O-C-N 121.512 -0.742 . . . . 0.0 111.491 -178.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 1.085 HD22 ' HA ' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -65.17 -27.85 69.0 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 119.908 -0.717 . . . . 0.0 111.903 -179.449 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.91 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 10.9 p -81.16 23.62 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-O 122.056 0.932 . . . . 0.0 109.211 175.138 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 137' ' ' LEU . . . 67.94 3.67 30.44 Favored Glycine 0 CA--C 1.486 -1.752 0 CA-C-N 113.793 -1.549 . . . . 0.0 113.245 175.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.91 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 10.4 ptmt . . . . . 0 N--CA 1.417 -2.106 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.926 HG12 ' HA ' ' A' ' 37' ' ' THR . 30.9 m . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.733 0.301 . . . . 0.0 111.643 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.851 HD11 ' CB ' ' A' ' 51' ' ' VAL . 3.1 pp -79.03 -179.09 6.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.246 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.9 tp60 -80.63 108.8 14.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.753 0.311 . . . . 0.0 110.883 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.888 HG11 HD12 ' A' ' 91' ' ' LEU . 46.6 t -89.21 131.64 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-O 121.216 0.531 . . . . 0.0 111.366 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.029 ' HB2' HD21 ' A' ' 13' ' ' LEU . 26.1 mt -85.21 143.22 28.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.463 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 26.0 m-70 -116.64 144.11 44.8 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.507 0.67 . . . . 0.0 112.63 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.043 HD13 HD12 ' A' ' 13' ' ' LEU . 42.8 mm -53.45 144.04 33.86 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.707 178.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.513 ' HA ' HG23 ' A' ' 8' ' ' ILE . 64.3 Cg_endo -93.49 54.12 0.94 Allowed 'Cis proline' 0 C--N 1.356 0.933 0 C-N-CA 124.727 -0.947 . . . . 0.0 113.036 0.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.93 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 9.8 t70 -55.32 134.55 50.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.037 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.477 ' CD ' ' H ' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -59.65 -42.76 93.52 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.961 0.41 . . . . 0.0 111.213 -179.495 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.705 ' HB2' HD13 ' A' ' 6' ' ' LEU . 14.0 mmt85 -59.19 -23.53 62.32 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 1.043 HD12 HD13 ' A' ' 8' ' ' ILE . 9.2 mt -76.22 -32.7 59.07 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 120.172 1.351 . . . . 0.0 107.692 177.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 16.3 mmm180 -90.86 3.17 55.23 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 113.857 -1.52 . . . . 0.0 109.554 178.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.828 ' HD3' ' HB3' ' A' ' 54' ' ' HIS . 62.3 tttp -82.09 146.88 29.4 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.671 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.507 HG13 HG23 ' A' ' 138' ' ' VAL . 96.4 t -82.14 135.4 25.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.742 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -91.4 139.68 30.48 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -103.21 130.57 23.37 Favored Pre-proline 0 C--N 1.322 -0.612 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.316 178.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.464 ' HD3' ' CD ' ' A' ' 56' ' ' ARG . 67.9 Cg_endo -77.11 114.75 3.85 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.032 1.821 . . . . 0.0 110.454 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.777 HG12 ' H ' ' A' ' 22' ' ' GLU . 17.4 t -68.98 144.51 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-O 122.426 1.108 . . . . 0.0 113.308 -176.2 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -63.65 -24.35 67.75 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 113.443 -1.708 . . . . 0.0 112.073 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.777 ' H ' HG12 ' A' ' 20' ' ' VAL . 88.8 tt0 -161.03 143.46 12.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.875 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.537 HG21 ' CD1' ' A' ' 111' ' ' LEU . 3.2 t -78.88 107.24 11.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.961 ' HB2' HD13 ' A' ' 27' ' ' ILE . 29.4 m120 -91.36 159.9 15.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.317 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.599 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -56.81 -29.14 62.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.927 0.394 . . . . 0.0 110.941 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 1.03 ' HG2' HH22 ' A' ' 29' ' ' ARG . 94.7 mt-10 -71.88 -42.83 66.35 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.104 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.961 HD13 ' HB2' ' A' ' 24' ' ' ASN . 1.8 mp -62.28 -45.93 97.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.791 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.667 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 54.5 mt-30 -57.38 -40.22 77.7 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.501 178.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 1.03 HH22 ' HG2' ' A' ' 26' ' ' GLU . 75.9 mtm-85 -61.76 -38.83 89.46 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.828 HG21 HD12 ' A' ' 57' ' ' ILE . 1.6 mp -58.77 -49.12 83.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.056 178.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.935 HG22 ' CG2' ' A' ' 57' ' ' ILE . 5.3 t -65.97 -42.19 91.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.527 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.875 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 21.5 m-20 -54.43 -45.04 72.93 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.838 -179.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.485 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 54.4 m-20 -74.88 -30.72 61.39 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.64 176.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' MET . . . . . 1.007 ' HG2' HG21 ' A' ' 51' ' ' VAL . 79.7 mtp -59.88 -47.18 86.81 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.543 -177.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.875 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 14.4 p90 -69.31 -43.85 72.93 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.759 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 75.0 mt-10 -51.91 -41.89 62.34 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.926 ' HA ' HG12 ' A' ' 2' ' ' VAL . 57.2 m -68.51 -60.27 2.55 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 119.105 -1.038 . . . . 0.0 108.608 178.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.981 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 3.6 ttp -47.12 -42.42 19.16 Favored 'General case' 0 CA--C 1.466 -2.262 0 O-C-N 124.118 0.886 . . . . 0.0 109.729 -170.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.728 ' OH ' ' HA ' ' A' ' 69' ' ' ARG . 68.6 m-85 -69.32 -42.37 75.47 Favored 'General case' 0 C--N 1.285 -2.233 0 O-C-N 124.101 0.876 . . . . 0.0 110.578 178.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.486 ' CB ' HG11 ' A' ' 2' ' ' VAL . . . -60.09 -28.86 68.17 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.202 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.798 ' HG2' ' CD2' ' A' ' 91' ' ' LEU . 3.1 tp10 -84.1 -10.79 57.53 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.484 -1.234 . . . . 0.0 108.777 177.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.444 ' H ' ' C ' ' A' ' 39' ' ' TYR . 8.6 mm-40 62.8 25.1 14.92 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.74 -176.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.73 145.17 29.79 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 114.142 -1.39 . . . . 0.0 110.524 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.907 HG22 HG22 ' A' ' 62' ' ' VAL . 46.0 mm -77.96 -2.5 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 117.621 0.711 . . . . 0.0 111.687 -178.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.65 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 176.29 138.34 2.85 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-O 119.045 -0.864 . . . . 0.0 111.552 -178.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.827 ' HB2' ' HG3' ' A' ' 38' ' ' MET . 9.2 tp -125.6 135.03 51.75 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 118.821 1.311 . . . . 0.0 110.744 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.598 ' H ' HE21 ' A' ' 50' ' ' GLN . . . -103.87 132.75 49.82 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.646 0.26 . . . . 0.0 111.553 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.881 ' HB1' ' CD1' ' A' ' 53' ' ' ILE . . . -30.72 -56.14 0.21 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -177.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.711 ' CG2' ' HA ' ' A' ' 137' ' ' LEU . 42.9 p -52.92 -35.38 58.32 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 122.168 0.985 . . . . 0.0 110.876 -178.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.598 HE21 ' H ' ' A' ' 47' ' ' ALA . 18.7 mt-30 -64.58 -39.44 93.75 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.666 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 1.007 HG21 ' HG2' ' A' ' 34' ' ' MET . 1.7 m -88.25 14.76 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.859 ' HA ' HD11 ' A' ' 6' ' ' LEU . 37.5 t70 79.11 31.45 0.29 Allowed 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 176.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.881 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 1.2 pp -126.45 111.22 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.446 177.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.828 ' HB3' ' HD3' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -75.55 64.17 1.61 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.976 0.893 . . . . 0.0 110.518 -179.278 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.769 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 88.0 mt-30 -153.54 135.21 14.44 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.444 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.742 ' N ' ' HB1' ' A' ' 17' ' ' ALA . 75.2 mtp180 -64.66 69.04 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -178.01 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.935 ' CG2' HG22 ' A' ' 31' ' ' VAL . 7.2 mt -112.14 123.26 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.818 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -130.72 147.4 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-O 121.811 0.815 . . . . 0.0 112.783 -178.253 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.613 HG22 ' O ' ' A' ' 46' ' ' LEU . 34.0 m -129.08 137.96 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.44 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.926 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 1.8 mt -116.81 149.3 19.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.718 0.77 . . . . 0.0 111.262 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.981 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 33.8 t70 -136.84 31.95 2.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.449 -1.251 . . . . 0.0 110.35 -178.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.907 HG22 HG22 ' A' ' 44' ' ' ILE . 24.0 t . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.953 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.728 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 40.1 ttm-85 . . . . . 0 N--CA 1.465 0.317 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.926 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 3.7 mm? -103.32 132.29 49.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.913 0.387 . . . . 0.0 111.872 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.843 ' O ' HD12 ' A' ' 72' ' ' LEU . 11.5 p -134.33 130.95 54.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.981 178.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.02 HD21 HD21 ' A' ' 120' ' ' LEU . 10.5 mp -139.88 140.02 36.38 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.938 -0.119 . . . . 0.0 111.019 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.01 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.6 mp -119.93 134.47 63.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.704 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 56.6 m-20 54.43 35.93 0.31 Allowed Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.778 ' HG2' HG23 ' A' ' 58' ' ' ILE . 91.1 Cg_exo -55.3 148.56 50.14 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.752 2.301 . . . . 0.0 113.607 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.61 ' HG3' HD21 ' A' ' 78' ' ' LEU . 15.7 pt-20 -135.83 144.25 45.58 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.815 HD23 ' N ' ' A' ' 78' ' ' LEU . 1.8 tt -83.49 135.18 34.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.385 0.612 . . . . 0.0 111.02 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.922 ' CD2' ' HG3' ' A' ' 109' ' ' ARG . 3.3 mm? -116.76 -31.95 5.3 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.65 -178.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 36.6 tt0 -160.33 151.81 19.6 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.17 0.51 . . . . 0.0 111.854 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.895 ' HA ' HG12 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -148.39 151.78 35.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.088 178.792 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 81.0 p -160.36 145.2 14.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.73 0.3 . . . . 0.0 111.5 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.814 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 75.52 169.89 27.13 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.43 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 102' ' ' ARG . 52.3 mm-40 -146.78 114.71 6.52 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.801 0.81 . . . . 0.0 113.152 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.614 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.4 p -97.03 160.1 14.53 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 178.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.698 ' CA ' HD21 ' A' ' 99' ' ' LEU . . . -137.99 100.53 0.31 Allowed Glycine 0 CA--C 1.522 0.52 0 CA-C-N 113.186 -1.825 . . . . 0.0 111.394 178.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.808 ' N ' HH12 ' A' ' 102' ' ' ARG . 47.7 mm -147.75 141.14 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.604 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 55.4 mt-10 -72.72 143.21 48.11 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 122.359 1.076 . . . . 0.0 112.437 -177.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.618 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 54.6 mt-10 -155.77 162.78 40.45 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.157 -1.383 . . . . 0.0 109.768 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.797 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -120.23 160.49 14.83 Favored Glycine 0 CA--C 1.5 -0.857 0 C-N-CA 119.456 -1.355 . . . . 0.0 111.223 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.62 ' HB2' HG13 ' A' ' 93' ' ' ILE . 57.1 m -110.16 139.68 45.05 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.691 0.281 . . . . 0.0 110.668 -177.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.888 HD12 HG11 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -52.43 -31.25 33.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.494 0.664 . . . . 0.0 109.855 179.72 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.803 ' CB ' HD13 ' A' ' 13' ' ' LEU . 49.8 m -77.74 -29.44 51.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.711 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.62 HG13 ' HB2' ' A' ' 90' ' ' CYS . 58.0 mt . . . . . 0 C--N 1.327 -0.398 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.797 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 20.0 mtm105 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.497 0.665 . . . . 0.0 111.384 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.414 ' C ' ' HA ' ' A' ' 87' ' ' GLU . . . -133.01 150.46 52.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.133 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.735 ' HG ' ' N ' ' A' ' 86' ' ' ILE . 6.7 tt -75.43 135.57 40.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.317 -179.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.696 ' N ' HD23 ' A' ' 99' ' ' LEU . 46.1 t -136.94 138.58 26.27 Favored Pre-proline 0 N--CA 1.464 0.243 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.684 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.614 ' HA ' ' O ' ' A' ' 84' ' ' THR . 3.4 Cg_exo -80.49 125.48 5.67 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.408 2.072 . . . . 0.0 113.424 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.882 ' HE ' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -143.79 166.07 25.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.066 -1.424 . . . . 0.0 109.988 177.936 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.814 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.24 153.06 44.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.962 0.346 . . . . 0.0 110.583 -178.43 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.416 ' OE1' ' HA ' ' A' ' 104' ' ' GLU . 5.1 tp10 -74.29 -41.97 60.33 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.638 -176.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.808 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 48.6 mttp -139.8 137.93 35.42 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.61 0.719 . . . . 0.0 109.634 177.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.895 HG12 ' HA ' ' A' ' 80' ' ' LYS . 32.0 m -142.9 143.16 25.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.046 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 1.028 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 31.8 mmtm -107.48 125.58 51.43 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.716 ' HA ' HD23 ' A' ' 78' ' ' LEU . 2.1 pp -128.79 162.09 36.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -177.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.922 ' HG3' ' CD2' ' A' ' 78' ' ' LEU . 26.6 mtt-85 -116.03 139.4 50.31 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.625 ' CB ' HD23 ' A' ' 72' ' ' LEU . . . -158.98 168.26 27.23 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.671 0.272 . . . . 0.0 111.449 -178.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 1.01 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.1 pp -113.87 152.32 30.9 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.47 ' O ' HD12 ' A' ' 111' ' ' LEU . 15.7 t70 -88.58 162.75 16.2 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.021 -0.672 . . . . 0.0 111.569 -177.361 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.811 ' HB2' HG21 ' A' ' 71' ' ' VAL . 46.2 ttp180 -52.67 -18.91 2.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.969 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -78.96 -25.59 43.53 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.438 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 106.44 35.61 2.83 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.518 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -128.74 102.79 19.54 Favored Pre-proline 0 C--O 1.238 0.479 0 CA-C-N 117.036 0.418 . . . . 0.0 111.178 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.667 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.9 Cg_exo -73.28 115.27 4.28 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 121.838 1.692 . . . . 0.0 114.975 -177.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -124.52 168.43 13.1 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.712 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 109' ' ' ARG . 23.0 mt-10 -107.79 131.61 54.28 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 1.02 HD21 HD21 ' A' ' 72' ' ' LEU . 3.9 pp -131.57 133.91 45.51 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 1.028 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 15.5 pt-20 -94.15 125.52 38.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.766 178.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.933 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -116.96 136.01 53.27 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.808 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.1 m-20 -126.3 164.44 21.03 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.712 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 45.55 -130.5 9.36 Favored Glycine 0 C--N 1.346 1.118 0 N-CA-C 116.431 1.332 . . . . 0.0 116.431 176.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.437 ' HB3' ' CG1' ' A' ' 62' ' ' VAL . 86.6 mt -55.18 -36.49 65.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.692 -0.754 . . . . 0.0 111.703 -178.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.933 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.3 OUTLIER -71.31 -52.9 16.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.471 0.653 . . . . 0.0 109.884 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.785 ' HB2' ' C ' ' A' ' 122' ' ' ALA . . . -58.39 -46.01 87.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.913 -1.039 . . . . 0.0 112.163 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.882 HD12 ' HE ' ' A' ' 102' ' ' ARG . 49.3 mm -63.76 -56.04 19.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.807 0.336 . . . . 0.0 111.107 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.437 ' SG ' HG21 ' A' ' 62' ' ' VAL . 74.6 m -60.92 -50.53 73.04 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.696 HG22 ' O ' ' A' ' 126' ' ' LEU . 20.3 tt -58.77 -43.73 88.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.328 -178.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.659 ' HG2' ' O ' ' A' ' 127' ' ' ALA . 22.9 pt20 -65.68 -37.63 87.04 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -56.65 -48.87 76.61 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.281 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.807 ' O ' HD23 ' A' ' 137' ' ' LEU . 2.8 mm-40 -60.93 -45.86 92.99 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 119.09 -0.481 . . . . 0.0 111.217 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.962 ' HA ' HD21 ' A' ' 137' ' ' LEU . 75.2 mtp -55.55 -47.78 75.8 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 118.965 0.802 . . . . 0.0 109.893 179.032 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.778 ' O ' HG12 ' A' ' 138' ' ' VAL . 1.1 m-20 -62.02 -48.49 80.05 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.376 178.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.563 ' CE1' ' HG2' ' A' ' 50' ' ' GLN . 10.4 t-80 -57.31 -49.99 74.34 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.294 0.569 . . . . 0.0 110.82 -178.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.962 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.5 pp -60.58 -30.51 69.86 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.032 -178.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.778 HG12 ' O ' ' A' ' 135' ' ' ASP . 12.9 p -81.78 22.18 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 CA-C-O 122.726 1.251 . . . . 0.0 109.051 175.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.603 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 70.85 -3.19 13.5 Favored Glycine 0 CA--C 1.494 -1.256 0 CA-C-N 112.629 -2.078 . . . . 0.0 113.035 176.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.752 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 1.6 ptmt . . . . . 0 N--CA 1.433 -1.305 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 1.051 HG12 ' HA ' ' A' ' 37' ' ' THR . 30.8 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.875 0.369 . . . . 0.0 111.417 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 1.046 HD21 ' HB ' ' A' ' 51' ' ' VAL . 3.0 pp -79.87 -169.51 2.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.696 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.409 ' HA ' ' OE1' ' A' ' 4' ' ' GLN . 4.0 tp-100 -84.64 111.72 19.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.859 0.361 . . . . 0.0 110.053 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.642 HG22 HG21 ' A' ' 37' ' ' THR . 40.7 t -88.51 127.79 41.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.371 0.605 . . . . 0.0 111.828 -178.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.039 ' HB2' HD21 ' A' ' 13' ' ' LEU . 23.1 mt -87.14 142.69 27.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.361 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.549 ' HA ' ' HB3' ' A' ' 92' ' ' SER . 34.7 m-70 -116.16 147.06 41.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.245 0.545 . . . . 0.0 111.992 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.097 HD13 HD12 ' A' ' 13' ' ' LEU . 38.4 mm -58.27 147.0 68.91 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.358 178.128 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.591 ' HA ' HG23 ' A' ' 8' ' ' ILE . 78.2 Cg_endo -93.22 52.38 1.04 Allowed 'Cis proline' 0 C--N 1.354 0.854 0 C-N-CA 124.504 -1.04 . . . . 0.0 113.02 0.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.839 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.7 t70 -55.15 136.04 48.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.083 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -58.88 -44.3 91.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.377 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.608 ' HE ' ' HZ3' ' A' ' 15' ' ' LYS . 14.9 mmt85 -57.44 -25.63 59.94 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 1.097 HD12 HD13 ' A' ' 8' ' ' ILE . 11.2 mt -74.82 -32.71 62.03 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 119.828 1.195 . . . . 0.0 109.025 178.411 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.489 ' HG3' HH11 ' A' ' 14' ' ' ARG . 13.6 mmt85 -95.23 6.94 47.66 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.227 -1.352 . . . . 0.0 109.605 178.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.715 ' HD3' ' HB3' ' A' ' 54' ' ' HIS . 88.6 tttt -82.78 147.93 28.11 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.53 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.4 t -82.48 127.89 39.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.85 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -91.36 140.53 29.69 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.218 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -105.01 136.88 19.1 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.418 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.47 ' HA ' ' ND2' ' A' ' 74' ' ' ASN . 51.8 Cg_endo -82.13 113.97 2.47 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 121.656 1.571 . . . . 0.0 110.279 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.715 HG12 ' H ' ' A' ' 22' ' ' GLU . 16.7 t -68.11 144.68 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 CA-C-O 122.852 1.31 . . . . 0.0 113.271 -175.038 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -60.33 -27.9 67.72 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 112.775 -2.011 . . . . 0.0 112.232 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.715 ' H ' HG12 ' A' ' 20' ' ' VAL . 39.0 tt0 -156.95 144.28 18.84 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.885 -178.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.736 HG21 ' HA2' ' A' ' 115' ' ' GLY . 3.2 t -80.11 106.51 11.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -178.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.918 ' HB2' ' CD1' ' A' ' 27' ' ' ILE . 30.5 m120 -91.43 153.66 19.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.048 -178.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.7 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -54.79 -25.38 27.76 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.272 0.558 . . . . 0.0 110.819 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.742 ' O ' HD13 ' A' ' 30' ' ' ILE . 55.2 mt-10 -74.28 -42.64 59.26 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 177.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.918 ' CD1' ' HB2' ' A' ' 24' ' ' ASN . 1.9 mp -66.46 -34.63 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.101 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -68.32 -39.3 82.0 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.779 -0.192 . . . . 0.0 110.549 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.7 ' HG3' ' O ' ' A' ' 25' ' ' ALA . 99.1 mtt180 -63.7 -39.12 93.53 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.832 ' O ' ' HG3' ' A' ' 34' ' ' MET . 1.6 mp -56.0 -48.47 78.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.826 178.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.964 HG22 HG21 ' A' ' 57' ' ' ILE . 15.0 t -67.14 -40.1 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.463 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.851 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 48.3 m-20 -52.85 -47.6 67.65 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.937 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.53 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 14.1 m-20 -74.44 -28.91 61.26 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.807 176.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.965 ' HG2' HG21 ' A' ' 51' ' ' VAL . 86.9 mtp -59.62 -47.04 87.16 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.169 -177.27 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.851 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 19.8 p90 -70.33 -46.17 64.73 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 176.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.631 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 3.8 mm-40 -52.25 -39.54 60.48 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.635 0.731 . . . . 0.0 109.182 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . 1.051 ' HA ' HG12 ' A' ' 2' ' ' VAL . 76.5 m -69.14 -61.17 1.9 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.273 -1.33 . . . . 0.0 107.992 178.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.87 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 3.6 ttp -46.79 -41.1 14.87 Favored 'General case' 0 CA--C 1.46 -2.482 0 C-N-CA 124.535 1.134 . . . . 0.0 110.501 -172.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.761 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 60.3 m-85 -69.11 -42.79 75.62 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.097 178.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.56 ' CB ' HG11 ' A' ' 2' ' ' VAL . . . -61.62 -24.77 66.93 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.566 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.938 ' HG2' HD12 ' A' ' 91' ' ' LEU . 11.1 tp10 -87.97 -11.71 46.65 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.407 -1.269 . . . . 0.0 108.368 176.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.447 ' H ' ' C ' ' A' ' 39' ' ' TYR . 58.0 mt-10 63.34 27.4 15.35 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-O 122.019 0.914 . . . . 0.0 109.855 -176.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.02 145.31 26.97 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 113.781 -1.554 . . . . 0.0 110.799 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.718 ' CG2' HG22 ' A' ' 62' ' ' VAL . 45.5 mm -79.34 -0.41 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 117.497 0.648 . . . . 0.0 111.931 -178.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.55 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 175.39 140.03 3.26 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.989 HD13 ' HG ' ' A' ' 91' ' ' LEU . 3.9 tp -124.45 136.74 54.27 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.396 1.598 . . . . 0.0 110.821 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.46 ' H ' HD12 ' A' ' 46' ' ' LEU . . . -104.41 131.72 51.46 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.416 0.15 . . . . 0.0 111.165 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.848 ' HB1' ' CD1' ' A' ' 53' ' ' ILE . . . -31.06 -55.81 0.23 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 115.802 1.779 . . . . 0.0 115.802 -177.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.82 ' CG2' ' HA ' ' A' ' 137' ' ' LEU . 69.3 p -53.17 -35.39 59.75 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.665 0.745 . . . . 0.0 111.631 -177.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.726 ' OE1' HD12 ' A' ' 46' ' ' LEU . 64.6 mt-30 -64.02 -43.43 95.65 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.405 -1.271 . . . . 0.0 110.127 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 1.046 ' HB ' HD21 ' A' ' 3' ' ' LEU . 0.8 OUTLIER -83.16 15.49 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.883 ' HA ' HD11 ' A' ' 6' ' ' LEU . 36.9 t70 77.29 28.65 0.6 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 176.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.848 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 1.1 pp -122.73 110.78 27.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.982 177.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.715 ' HB3' ' HD3' ' A' ' 15' ' ' LYS . 5.8 p80 -76.51 62.65 1.92 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 122.102 0.953 . . . . 0.0 110.376 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.768 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 89.4 mt-30 -151.37 133.19 14.97 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.066 -1.425 . . . . 0.0 107.468 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 1.112 ' HA ' HD22 ' A' ' 137' ' ' LEU . 98.8 mtt180 -65.02 70.99 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -177.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.964 HG21 HG22 ' A' ' 31' ' ' VAL . 30.6 mm -113.95 124.33 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.898 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -128.62 148.58 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -177.673 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 46' ' ' LEU . 30.8 m -129.29 140.35 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.71 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.093 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 9.5 mm -115.5 153.84 17.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.337 0.589 . . . . 0.0 109.882 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.87 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 38.5 t70 -145.29 39.84 1.2 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.62 -178.059 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.718 HG22 ' CG2' ' A' ' 44' ' ' ILE . 57.4 t . . . . . 0 C--N 1.325 -0.472 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.651 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 1.093 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 3.5 mm? -108.08 139.66 42.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.076 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.72 HG21 ' HB2' ' A' ' 113' ' ' ARG . 12.9 p -133.09 135.7 56.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.583 177.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.898 ' HB2' ' CD1' ' A' ' 58' ' ' ILE . 94.7 mt -140.86 140.88 34.67 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 178.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.913 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 3.3 mm -121.79 136.57 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-O 121.233 0.54 . . . . 0.0 111.013 -179.29 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.7 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 7.2 m120 49.0 38.69 0.52 Allowed Pre-proline 0 C--N 1.313 -0.996 0 CA-C-N 115.096 -0.957 . . . . 0.0 112.839 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.88 ' HG2' HG23 ' A' ' 58' ' ' ILE . 99.5 Cg_exo -56.42 145.67 77.89 Favored 'Trans proline' 0 N--CA 1.484 0.943 0 C-N-CA 122.958 2.439 . . . . 0.0 114.144 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.504 ' CG ' ' HB2' ' A' ' 109' ' ' ARG . 11.7 pt-20 -133.11 143.18 49.12 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.801 HD23 ' N ' ' A' ' 78' ' ' LEU . 1.7 tt -82.95 135.71 34.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.282 0.563 . . . . 0.0 111.39 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.024 HD21 ' HG3' ' A' ' 109' ' ' ARG . 2.9 mm? -115.74 -40.59 3.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.84 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 87.4 tt0 -152.84 150.59 29.49 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.21 0.529 . . . . 0.0 111.511 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.817 ' HA ' HG12 ' A' ' 106' ' ' VAL . 9.2 ptpp? -147.18 147.4 30.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.267 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.1 t -158.22 147.99 19.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.673 0.273 . . . . 0.0 111.384 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.717 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 76.85 160.29 10.78 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.41 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -136.3 113.42 10.54 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.948 0.88 . . . . 0.0 112.736 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.831 ' HB ' HH12 ' A' ' 102' ' ' ARG . 1.7 p -105.24 161.88 13.9 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.772 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -147.45 116.86 0.87 Allowed Glycine 0 C--N 1.313 -0.701 0 CA-C-N 112.694 -2.048 . . . . 0.0 110.989 178.07 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.761 ' HB ' ' NH2' ' A' ' 102' ' ' ARG . 47.9 mm -147.79 139.21 18.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 117.306 0.553 . . . . 0.0 111.414 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 50.4 mt-10 -71.78 139.03 48.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 122.83 1.3 . . . . 0.0 112.019 -177.035 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.608 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 39.6 mt-10 -154.95 163.48 40.24 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 112.753 -2.021 . . . . 0.0 111.567 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.609 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -121.49 165.62 14.44 Favored Glycine 0 CA--C 1.503 -0.714 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 13.1 m -116.21 140.76 48.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.898 0.849 . . . . 0.0 111.662 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.989 ' HG ' HD13 ' A' ' 46' ' ' LEU . 2.4 mm? -48.62 -17.31 0.16 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.224 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.714 ' CB ' HD13 ' A' ' 13' ' ' LEU . 21.1 m -98.36 -34.39 10.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.255 0.55 . . . . 0.0 110.255 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.463 ' CG1' HG13 ' A' ' 8' ' ' ILE . 58.4 mt . . . . . 0 CA--C 1.535 0.395 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.546 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.609 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 13.7 mtt85 . . . . . 0 CA--C 1.528 0.134 0 CA-C-O 121.03 0.443 . . . . 0.0 109.927 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.2 150.52 48.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.252 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.772 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.3 tt -76.02 113.92 14.07 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.727 0.775 . . . . 0.0 110.792 -178.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.412 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 23.4 t -103.57 133.7 20.14 Favored Pre-proline 0 N--CA 1.469 0.492 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.991 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.554 ' HA ' ' O ' ' A' ' 84' ' ' THR . 98.6 Cg_endo -87.58 126.36 2.2 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.524 2.15 . . . . 0.0 112.675 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.889 ' HG2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -144.65 166.76 24.29 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.149 0.98 . . . . 0.0 109.764 179.438 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.717 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.41 155.3 40.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.852 0.358 . . . . 0.0 110.172 -179.066 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -72.67 -41.78 65.02 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.592 -175.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.749 ' HG2' ' HB3' ' A' ' 123' ' ' ASP . 95.4 mttt -140.61 140.17 35.03 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.49 0.662 . . . . 0.0 109.495 176.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.817 HG12 ' HA ' ' A' ' 80' ' ' LYS . 32.8 m -145.57 142.22 22.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.166 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.817 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 5.1 mmmt -107.43 126.22 52.22 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.974 HD11 HD11 ' A' ' 130' ' ' ILE . 1.8 pp -134.36 151.0 31.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -177.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 1.037 ' HE ' ' HG2' ' A' ' 119' ' ' GLU . 53.5 mtp180 -102.62 139.71 37.85 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.424 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.606 ' HB3' HD22 ' A' ' 72' ' ' LEU . . . -160.18 168.5 25.3 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.237 -176.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.913 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.0 pp -122.59 149.0 44.57 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.591 ' O ' HD12 ' A' ' 111' ' ' LEU . 13.5 t70 -81.67 169.11 17.4 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -175.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.804 ' HD2' ' OD1' ' A' ' 32' ' ' ASP . 43.2 ttp180 -50.93 -23.6 2.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.982 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -79.77 -21.45 44.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.158 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.752 ' HA2' HD13 ' A' ' 111' ' ' LEU . . . 101.37 38.74 3.19 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.151 -1.023 . . . . 0.0 113.983 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.936 ' HE3' ' HA ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -127.13 102.24 24.5 Favored Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 117.188 0.494 . . . . 0.0 110.184 178.532 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.662 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 32.8 Cg_exo -74.63 115.41 4.29 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 121.643 1.562 . . . . 0.0 116.107 -177.138 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.444 ' N ' ' O ' ' A' ' 110' ' ' ALA . 0.4 OUTLIER -125.71 168.57 13.58 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.01 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 1.037 ' HG2' ' HE ' ' A' ' 109' ' ' ARG . 21.3 mt-10 -107.41 137.11 46.06 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.74 ' O ' HD12 ' A' ' 120' ' ' LEU . 4.3 pp -135.57 133.39 38.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.081 0.467 . . . . 0.0 111.841 -178.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.817 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 0.7 OUTLIER -95.5 123.71 39.17 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.767 178.706 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.937 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -116.45 135.13 54.1 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.749 ' HB3' ' HG2' ' A' ' 105' ' ' LYS . 16.9 m-20 -126.43 163.22 23.79 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.699 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 52.89 -139.02 33.47 Favored Glycine 0 C--N 1.346 1.101 0 C-N-CA 119.344 -1.408 . . . . 0.0 115.344 177.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 78.2 mt -54.38 -32.3 56.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.601 -0.8 . . . . 0.0 111.601 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.937 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.3 OUTLIER -71.42 -51.97 21.04 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.904 0.859 . . . . 0.0 109.308 179.523 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.751 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -58.58 -41.93 86.84 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.162 -1.381 . . . . 0.0 111.648 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.889 HD12 ' HG2' ' A' ' 102' ' ' ARG . 50.8 mm -67.45 -54.83 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -178.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.608 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 32.1 p -60.7 -49.07 79.0 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.974 HD11 HD11 ' A' ' 108' ' ' ILE . 19.8 tt -59.2 -46.51 92.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.386 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.694 ' HG2' ' O ' ' A' ' 127' ' ' ALA . 21.3 pt20 -65.71 -38.19 88.52 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.337 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -59.27 -46.4 88.63 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.549 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.804 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 3.3 mm-40 -60.81 -38.37 85.17 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.748 ' CE ' ' HB2' ' A' ' 77' ' ' LEU . 75.8 mtp -58.22 -45.18 88.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 122.271 1.034 . . . . 0.0 109.422 177.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.763 ' O ' HG12 ' A' ' 138' ' ' VAL . 0.9 OUTLIER -68.14 -47.97 66.65 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.716 179.215 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.653 ' CE1' ' HG2' ' A' ' 50' ' ' GLN . 6.5 t-80 -57.98 -52.75 64.21 Favored 'General case' 0 C--N 1.317 -0.813 0 O-C-N 121.672 -0.642 . . . . 0.0 111.483 -178.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 1.112 HD22 ' HA ' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -65.41 -28.5 69.3 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.511 -179.506 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.929 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 11.3 p -81.1 23.39 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-O 122.294 1.045 . . . . 0.0 109.218 175.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 137' ' ' LEU . . . 67.49 -0.93 7.91 Favored Glycine 0 CA--C 1.485 -1.813 0 CA-C-N 113.532 -1.667 . . . . 0.0 113.144 175.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.929 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 11.2 ptmt . . . . . 0 N--CA 1.409 -2.479 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 178.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.83 HG12 ' HA ' ' A' ' 37' ' ' THR . 31.1 m . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.847 0.356 . . . . 0.0 111.365 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.923 HD21 ' HB ' ' A' ' 51' ' ' VAL . 2.4 pp -79.53 -161.81 0.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.599 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.5 tp60 -94.66 108.17 20.16 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.925 0.393 . . . . 0.0 110.446 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.537 ' CG2' HG21 ' A' ' 37' ' ' THR . 40.9 t -88.59 129.37 39.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.4 0.619 . . . . 0.0 112.067 -178.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.075 ' HB2' HD21 ' A' ' 13' ' ' LEU . 21.5 mt -87.88 143.18 27.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.021 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 51.9 m-70 -120.78 145.73 47.25 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.099 HD13 HD12 ' A' ' 13' ' ' LEU . 46.2 mm -66.05 134.41 94.93 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.676 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.8 141.36 66.57 Favored 'Cis proline' 0 C--N 1.351 0.685 0 C-N-CA 124.195 -1.169 . . . . 0.0 112.016 -0.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.989 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.7 t70 -161.24 126.28 3.6 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 12.0 pt-20 -58.21 -46.06 86.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.982 -178.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.578 ' HB2' HD13 ' A' ' 6' ' ' LEU . 25.1 mtt-85 -59.3 -26.16 64.74 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 1.099 HD12 HD13 ' A' ' 8' ' ' ILE . 10.7 mt -76.64 -33.38 58.35 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 120.284 1.402 . . . . 0.0 108.139 177.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.587 ' C ' ' HA3' ' A' ' 139' ' ' GLY . 14.1 mmt85 -94.11 11.01 31.47 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 113.854 -1.521 . . . . 0.0 109.303 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.438 ' HB2' ' HA ' ' A' ' 12' ' ' ARG . 61.8 tttp -92.76 150.67 20.5 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.283 -178.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.989 HG13 HG23 ' A' ' 138' ' ' VAL . 61.8 t -83.47 124.06 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.819 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.738 ' C ' ' HG3' ' A' ' 56' ' ' ARG . . . -80.99 147.45 30.21 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.652 ' HD3' ' N ' ' A' ' 19' ' ' PRO . 2.2 tmtp? -109.9 127.98 26.17 Favored Pre-proline 0 C--N 1.325 -0.486 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.217 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.995 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 65.6 Cg_endo -77.7 113.93 3.57 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 121.998 1.799 . . . . 0.0 110.815 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.758 HG12 ' H ' ' A' ' 22' ' ' GLU . 18.0 t -68.45 144.46 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-O 122.609 1.195 . . . . 0.0 113.29 -175.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -60.76 -27.97 68.36 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 112.97 -1.923 . . . . 0.0 111.995 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.758 ' H ' HG12 ' A' ' 20' ' ' VAL . 39.4 tt0 -157.79 143.02 16.88 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.242 -178.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.713 HG21 HD11 ' A' ' 111' ' ' LEU . 3.2 t -79.75 108.46 13.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 1.033 ' HB2' HD13 ' A' ' 27' ' ' ILE . 28.4 m120 -93.32 173.51 7.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.813 -179.006 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.625 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -65.75 -28.54 69.11 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.376 0.607 . . . . 0.0 110.859 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.498 ' HA ' ' OE1' ' A' ' 26' ' ' GLU . 4.3 mm-40 -73.92 -39.72 63.61 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 1.033 HD13 ' HB2' ' A' ' 24' ' ' ASN . 1.9 mp -66.91 -37.49 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.166 178.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.823 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 60.7 mt-30 -66.18 -40.46 90.48 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.233 -0.292 . . . . 0.0 110.719 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.625 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 14.0 mmp_? -63.33 -39.58 94.93 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.857 HG21 HD12 ' A' ' 57' ' ' ILE . 4.8 mt -55.34 -50.17 67.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.381 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.903 HG22 ' CG2' ' A' ' 57' ' ' ILE . 15.9 t -65.25 -41.62 91.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.072 0.463 . . . . 0.0 111.045 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.873 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 27.3 m-20 -54.97 -43.58 73.64 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.475 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.529 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 1.4 m-20 -75.81 -29.77 58.79 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.923 176.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.978 ' HE1' HG22 ' A' ' 57' ' ' ILE . 22.0 mtm -60.14 -46.69 88.82 Favored 'General case' 0 C--N 1.347 0.467 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.534 -177.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.873 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 14.9 p90 -69.87 -45.45 67.68 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.053 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.605 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 3.8 mm-40 -52.65 -39.38 61.76 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.719 0.771 . . . . 0.0 108.996 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.83 ' HA ' HG12 ' A' ' 2' ' ' VAL . 61.8 m -70.06 -61.78 1.64 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.455 -1.248 . . . . 0.0 107.642 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.879 ' HG3' ' HB2' ' A' ' 46' ' ' LEU . 1.0 OUTLIER -46.52 -41.11 13.7 Favored 'General case' 0 CA--C 1.462 -2.416 0 C-N-CA 123.958 0.903 . . . . 0.0 110.431 -170.945 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.701 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 58.5 m-85 -70.37 -42.43 71.79 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.281 178.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.05 -24.61 66.33 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.416 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 1.024 ' HG2' HD12 ' A' ' 91' ' ' LEU . 11.7 tp10 -88.89 -11.4 44.7 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.475 177.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.439 ' H ' ' C ' ' A' ' 39' ' ' TYR . 18.4 mt-10 65.43 23.93 11.95 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.042 -176.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.453 ' O ' ' HE3' ' A' ' 38' ' ' MET . . . -79.07 141.89 24.66 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 114.027 -1.442 . . . . 0.0 110.372 177.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.86 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 46.3 mt -81.33 1.41 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 117.648 0.724 . . . . 0.0 112.638 -178.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.424 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 178.73 133.78 1.98 Allowed Glycine 0 CA--C 1.528 0.867 0 CA-C-O 118.913 -0.937 . . . . 0.0 111.409 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.024 HD13 ' HG ' ' A' ' 91' ' ' LEU . 4.9 tp -126.02 134.33 51.48 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.15 1.475 . . . . 0.0 112.161 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -98.3 131.88 44.25 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.292 0.237 . . . . 0.0 111.448 178.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.894 ' HB1' ' CD1' ' A' ' 53' ' ' ILE . . . -30.01 -55.64 0.18 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.565 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 67.3 p -53.25 -36.01 60.63 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.462 0.648 . . . . 0.0 112.039 -177.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.774 ' OE1' HD12 ' A' ' 46' ' ' LEU . 85.8 mt-30 -63.83 -41.92 97.73 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.231 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.923 ' HB ' HD21 ' A' ' 3' ' ' LEU . 1.0 OUTLIER -83.74 16.49 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.447 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.933 ' HA ' HD11 ' A' ' 6' ' ' LEU . 50.5 t0 77.37 28.29 0.61 Allowed 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 176.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.894 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -122.23 110.7 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 119.204 -0.999 . . . . 0.0 111.247 177.883 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -76.76 63.19 2.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.493 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.735 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 94.7 mm-40 -152.96 134.33 14.31 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.237 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.995 ' HD2' ' HD3' ' A' ' 19' ' ' PRO . 98.8 mtt180 -64.5 66.72 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -177.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.978 HG22 ' HE1' ' A' ' 34' ' ' MET . 6.2 mt -111.1 123.22 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.138 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.082 HD11 ' HB2' ' A' ' 72' ' ' LEU . 1.8 pp -128.32 146.37 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 119.665 -0.814 . . . . 0.0 113.12 -177.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 46' ' ' LEU . 30.5 m -126.24 139.11 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.7 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.099 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 7.9 mm -116.16 153.39 17.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.55 0.69 . . . . 0.0 110.392 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.86 ' HB3' ' C ' ' A' ' 44' ' ' ILE . 31.3 t70 -139.46 17.85 2.55 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.363 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.776 ' H ' HG22 ' A' ' 60' ' ' ILE . 32.4 t . . . . . 0 N--CA 1.461 0.106 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.348 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.507 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 48.0 ttp180 . . . . . 0 N--CA 1.451 -0.422 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 1.099 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 56.3 mt -111.23 138.97 47.02 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.795 HG21 ' HB2' ' A' ' 113' ' ' ARG . 11.8 p -134.82 135.29 53.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.607 177.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.082 ' HB2' HD11 ' A' ' 58' ' ' ILE . 1.8 mm? -140.4 140.77 35.55 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.061 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 3.5 mm -119.51 136.03 57.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.172 0.51 . . . . 0.0 110.952 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.716 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 60.5 m-20 51.57 37.6 0.44 Allowed Pre-proline 0 C--N 1.312 -1.027 0 CA-C-N 115.349 -0.842 . . . . 0.0 112.379 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.874 ' HG2' HG12 ' A' ' 58' ' ' ILE . 77.6 Cg_exo -55.08 144.5 68.96 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 122.949 2.433 . . . . 0.0 114.102 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.5 ' CG ' ' HB2' ' A' ' 109' ' ' ARG . 11.5 pt-20 -135.45 145.43 47.19 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.817 HD22 ' NZ ' ' A' ' 80' ' ' LYS . 1.5 tt -81.2 137.69 35.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.309 0.576 . . . . 0.0 111.817 -178.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.902 HD21 ' HG3' ' A' ' 109' ' ' ARG . 2.9 mm? -118.9 -50.71 2.38 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.624 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 1.018 ' HB3' ' HD3' ' A' ' 107' ' ' LYS . 39.3 tp10 -140.5 146.51 38.26 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 120.883 0.373 . . . . 0.0 110.886 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.817 ' NZ ' HD22 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -147.32 145.66 29.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.098 179.492 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.3 t -159.07 156.58 29.47 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.787 0.327 . . . . 0.0 111.592 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.753 ' C ' ' HG3' ' A' ' 104' ' ' GLU . . . 67.53 159.62 1.17 Allowed Glycine 0 CA--C 1.506 -0.5 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.352 -179.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.734 ' N ' ' HG3' ' A' ' 104' ' ' GLU . 57.6 mt-10 -131.89 113.0 12.93 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 122.006 0.908 . . . . 0.0 113.002 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.913 HG23 ' HG2' ' A' ' 104' ' ' GLU . 1.5 p -103.54 161.36 13.95 Favored 'General case' 0 CA--C 1.486 -1.505 0 CA-C-N 113.812 -1.54 . . . . 0.0 114.733 178.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.772 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -149.84 118.34 0.93 Allowed Glycine 0 C--N 1.311 -0.828 0 CA-C-N 112.911 -1.949 . . . . 0.0 111.373 178.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.529 ' N ' ' HG ' ' A' ' 99' ' ' LEU . 32.4 mt -148.16 138.69 17.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 117.278 0.539 . . . . 0.0 111.733 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.533 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 95.3 mt-10 -70.82 137.98 49.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 123.072 1.415 . . . . 0.0 112.313 -176.138 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.732 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 46.8 mt-10 -156.42 160.43 39.6 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 112.652 -2.067 . . . . 0.0 111.351 -179.034 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.658 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -120.57 165.0 13.89 Favored Glycine 0 CA--C 1.501 -0.783 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 18.2 m -116.09 140.81 48.9 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 117.897 0.848 . . . . 0.0 111.995 -177.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.024 ' HG ' HD13 ' A' ' 46' ' ' LEU . 2.3 mm? -47.69 -26.52 1.57 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.88 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.852 ' CB ' HD13 ' A' ' 13' ' ' LEU . 49.9 m -79.77 -38.08 33.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.871 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.9 mt . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.971 -179.634 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.732 ' HA ' ' O ' ' A' ' 88' ' ' GLU . 12.9 mtt85 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 121.757 0.789 . . . . 0.0 112.115 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -134.19 153.34 51.9 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.792 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.772 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.5 tt -75.67 112.7 12.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.681 0.753 . . . . 0.0 110.757 -178.365 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.589 HG12 ' NH1' ' A' ' 102' ' ' ARG . 29.5 t -98.6 128.93 31.37 Favored Pre-proline 0 N--CA 1.468 0.434 0 CA-C-N 114.724 -1.126 . . . . 0.0 112.011 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 100' ' ' VAL . 1.1 Cg_endo -83.4 125.69 3.99 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.726 2.284 . . . . 0.0 112.031 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.976 HH11 ' HB3' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -145.86 167.17 23.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.312 179.759 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.638 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.62 155.17 40.53 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.913 ' HG2' HG23 ' A' ' 84' ' ' THR . 95.1 mt-10 -72.88 -39.87 66.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.867 -175.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.679 ' HB3' ' OD1' ' A' ' 123' ' ' ASP . 59.1 mttp -139.73 140.56 36.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.263 0.554 . . . . 0.0 109.722 177.034 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.797 HG12 ' CB ' ' A' ' 80' ' ' LYS . 35.2 m -149.71 140.02 16.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.511 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 1.018 ' HD3' ' HB3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -108.09 127.75 54.07 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.874 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.89 ' HA ' HD23 ' A' ' 78' ' ' LEU . 1.5 pp -133.03 150.15 32.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -177.082 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.902 ' HG3' HD21 ' A' ' 78' ' ' LEU . 96.4 mtt180 -102.18 137.69 40.12 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.66 -178.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.504 ' CB ' ' HB3' ' A' ' 72' ' ' LEU . . . -161.57 169.7 21.22 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 114.746 -1.115 . . . . 0.0 111.023 -176.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 1.061 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 1.9 pp -119.35 149.12 42.35 Favored 'General case' 0 C--O 1.218 -0.59 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 176.221 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.624 ' O ' HD12 ' A' ' 111' ' ' LEU . 12.8 t70 -81.75 167.8 18.72 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 119.877 -0.729 . . . . 0.0 112.642 -175.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.795 ' HB2' HG21 ' A' ' 71' ' ' VAL . 51.0 ttp180 -50.28 -22.45 1.79 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.971 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -79.4 -25.07 42.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.898 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.748 ' HA2' HD13 ' A' ' 111' ' ' LEU . . . 104.83 37.91 2.65 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.189 -1.005 . . . . 0.0 113.834 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -128.36 102.73 20.6 Favored Pre-proline 0 C--O 1.235 0.342 0 CA-C-N 117.054 0.427 . . . . 0.0 110.473 178.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.709 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 36.8 Cg_exo -71.56 114.86 4.07 Favored 'Trans proline' 0 C--N 1.358 1.075 0 N-CA-C 116.409 1.657 . . . . 0.0 116.409 -176.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.524 ' CE2' ' HB2' ' A' ' 112' ' ' ASP . 0.3 OUTLIER -127.0 160.72 30.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.731 -179.227 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.628 ' HG2' ' HG2' ' A' ' 109' ' ' ARG . 21.5 mt-10 -107.42 130.69 54.79 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.909 ' O ' HD23 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -131.66 141.59 49.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.795 0.807 . . . . 0.0 111.887 -179.019 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 107' ' ' LYS . 11.4 pt-20 -97.16 125.52 41.72 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.979 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.903 ' CB ' ' HG ' ' A' ' 126' ' ' LEU . . . -115.01 135.41 54.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.839 0.352 . . . . 0.0 111.391 -179.077 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.679 ' OD1' ' HB3' ' A' ' 105' ' ' LYS . 31.3 m-20 -126.66 160.76 29.8 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.808 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 51.73 -138.78 28.94 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 120.645 1.566 . . . . 0.0 115.159 177.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.672 HD12 ' H ' ' A' ' 125' ' ' LEU . 4.9 mp -53.5 -32.96 52.61 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.225 -0.488 . . . . 0.0 111.309 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.903 ' HG ' ' CB ' ' A' ' 122' ' ' ALA . 4.0 tp -70.78 -52.17 22.36 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.649 0.738 . . . . 0.0 109.418 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.738 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -58.55 -42.34 87.67 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.713 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.93 HD12 ' HG2' ' A' ' 102' ' ' ARG . 44.5 mm -67.85 -54.65 21.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.697 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 30.0 p -58.19 -50.2 74.36 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -178.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.883 HD11 HD11 ' A' ' 108' ' ' ILE . 14.2 tt -59.57 -44.21 92.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.121 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.866 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.0 pt20 -68.39 -39.42 81.71 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.518 178.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -59.44 -47.24 86.24 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.067 0.461 . . . . 0.0 109.794 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.877 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.7 mm-40 -59.61 -40.41 87.47 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.586 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.946 ' HA ' HD21 ' A' ' 137' ' ' LEU . 75.5 mtp -57.52 -47.64 81.43 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.838 0.828 . . . . 0.0 109.872 178.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.572 ' O ' HG12 ' A' ' 138' ' ' VAL . 31.4 m-20 -63.38 -47.13 83.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.976 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.449 ' CE1' ' CG ' ' A' ' 50' ' ' GLN . 4.6 t-80 -59.07 -53.0 63.29 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 121.103 0.478 . . . . 0.0 111.593 -178.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.946 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.7 pp -58.64 -31.76 68.43 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.518 -178.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.989 HG23 HG13 ' A' ' 16' ' ' VAL . 14.9 p -86.44 23.85 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 122.329 1.061 . . . . 0.0 109.548 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.627 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 53.85 34.94 52.05 Favored Glycine 0 CA--C 1.482 -1.969 0 CA-C-N 113.388 -1.733 . . . . 0.0 112.432 176.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.968 ' HG2' HG13 ' A' ' 138' ' ' VAL . 3.6 ptmt . . . . . 0 N--CA 1.423 -1.807 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.334 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.818 HG13 HG23 ' A' ' 37' ' ' THR . 38.2 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.676 0.274 . . . . 0.0 110.619 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.964 HD21 ' HB ' ' A' ' 51' ' ' VAL . 3.1 pp -79.63 -173.39 3.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.797 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.458 ' N ' HD12 ' A' ' 3' ' ' LEU . 70.9 tp60 -83.1 106.82 15.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.026 0.441 . . . . 0.0 110.59 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.586 HG22 HG21 ' A' ' 37' ' ' THR . 40.6 t -87.65 127.95 40.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.543 0.687 . . . . 0.0 112.201 -178.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.99 ' HB2' HD21 ' A' ' 13' ' ' LEU . 35.1 mt -85.96 138.88 31.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.193 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.523 ' C ' HD11 ' A' ' 13' ' ' LEU . 28.8 m-70 -113.44 147.47 37.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.083 0.468 . . . . 0.0 112.141 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.048 HD13 HD12 ' A' ' 13' ' ' LEU . 42.9 mm -57.26 148.08 54.5 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.426 178.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.635 ' HA ' HG23 ' A' ' 8' ' ' ILE . 69.5 Cg_endo -93.49 51.84 1.1 Allowed 'Cis proline' 0 C--N 1.353 0.802 0 C-N-CA 124.707 -0.956 . . . . 0.0 112.881 0.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.886 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.7 t70 -55.66 135.78 51.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.057 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -59.37 -44.98 92.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.999 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.657 ' O ' ' HB ' ' A' ' 49' ' ' THR . 15.1 mmt85 -56.06 -25.47 45.29 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 1.048 HD12 HD13 ' A' ' 8' ' ' ILE . 10.7 mt -75.42 -33.86 60.96 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 119.46 1.027 . . . . 0.0 108.679 178.187 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.683 ' C ' ' HA3' ' A' ' 139' ' ' GLY . 14.9 mmm180 -96.23 13.01 28.88 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 114.086 -1.416 . . . . 0.0 109.442 178.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.867 ' HD3' ' N ' ' A' ' 16' ' ' VAL . 1.1 tmtp? -87.01 145.38 26.51 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.918 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.94 HG13 HG23 ' A' ' 138' ' ' VAL . 49.1 t -81.86 118.95 30.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.792 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -78.16 150.84 33.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.824 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.787 ' HD3' ' O ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -114.65 133.08 22.6 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.133 178.803 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.763 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 61.2 Cg_endo -78.81 115.94 3.67 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.454 2.103 . . . . 0.0 111.43 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.767 HG12 ' H ' ' A' ' 22' ' ' GLU . 19.9 t -67.85 144.43 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 CA-C-O 122.618 1.199 . . . . 0.0 113.096 -175.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -61.62 -28.22 69.21 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 113.058 -1.883 . . . . 0.0 112.111 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.767 ' H ' HG12 ' A' ' 20' ' ' VAL . 38.9 tt0 -156.57 145.74 20.42 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 120.746 -0.381 . . . . 0.0 111.547 -178.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.626 HG21 ' HA2' ' A' ' 115' ' ' GLY . 3.9 t -79.15 105.87 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -178.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.91 ' HB2' HD13 ' A' ' 27' ' ' ILE . 29.6 m120 -93.31 153.81 18.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.779 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.647 ' HB1' HH12 ' A' ' 29' ' ' ARG . . . -54.72 -24.17 20.97 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.254 0.549 . . . . 0.0 110.711 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -74.95 -41.06 60.35 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 177.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.91 HD13 ' HB2' ' A' ' 24' ' ' ASN . 1.8 mp -68.08 -33.96 63.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-N 113.846 -1.524 . . . . 0.0 110.108 178.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -69.94 -40.07 75.7 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 122.354 -0.216 . . . . 0.0 110.575 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.647 HH12 ' HB1' ' A' ' 25' ' ' ALA . 67.7 mtt85 -64.26 -38.01 89.53 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.802 ' CG2' HD13 ' A' ' 53' ' ' ILE . 4.8 mt -55.46 -50.3 66.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.302 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.785 HG22 ' CG2' ' A' ' 57' ' ' ILE . 3.8 t -67.9 -40.67 83.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.02 0.438 . . . . 0.0 110.201 178.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.83 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 12.8 m-20 -55.32 -41.38 72.35 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.73 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.485 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 52.7 m-20 -76.32 -30.21 57.6 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.158 176.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' MET . . . . . 1.092 ' HG2' HG21 ' A' ' 51' ' ' VAL . 85.4 mtp -60.31 -46.25 90.54 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.268 -177.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.83 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 11.0 p90 -69.57 -44.51 70.68 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 32' ' ' ASP . 31.2 mm-40 -53.01 -39.97 63.52 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.818 HG23 HG13 ' A' ' 2' ' ' VAL . 74.7 m -71.49 -62.6 1.35 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 118.377 -1.329 . . . . 0.0 107.886 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' MET . . . . . 1.008 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 2.0 ttp -46.91 -40.4 14.04 Favored 'General case' 0 CA--C 1.467 -2.237 0 C-N-CA 124.015 0.926 . . . . 0.0 110.145 -170.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.698 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 50.6 m-85 -70.51 -42.27 71.52 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.985 177.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 37' ' ' THR . . . -61.25 -23.23 65.5 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.566 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 1.014 ' HG2' HD12 ' A' ' 91' ' ' LEU . 11.5 tp10 -90.25 -11.38 41.07 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 114.434 -1.257 . . . . 0.0 108.273 177.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.443 ' H ' ' C ' ' A' ' 39' ' ' TYR . 21.6 mt-10 64.12 28.55 14.16 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.889 -176.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.48 143.66 21.02 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 113.678 -1.601 . . . . 0.0 111.207 178.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.832 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 45.7 mm -79.36 -1.44 4.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 117.323 0.561 . . . . 0.0 112.061 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.537 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 177.87 135.88 2.37 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-O 119.28 -0.733 . . . . 0.0 111.721 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.089 HD13 ' HG ' ' A' ' 91' ' ' LEU . 5.0 tp -125.01 133.67 52.88 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.347 1.074 . . . . 0.0 111.305 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -100.42 132.33 45.86 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.962 ' HB1' HG13 ' A' ' 53' ' ' ILE . . . -26.9 -56.5 0.09 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.657 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 70.4 p -53.34 -35.81 60.64 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.65 0.738 . . . . 0.0 111.756 -177.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.816 ' NE2' HD23 ' A' ' 91' ' ' LEU . 8.8 mt-30 -64.52 -41.57 96.31 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.59 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 1.092 HG21 ' HG2' ' A' ' 34' ' ' MET . 1.1 m -85.76 18.57 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.904 ' OD2' HD21 ' A' ' 6' ' ' LEU . 8.4 t0 78.43 28.09 0.48 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 176.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.962 HG13 ' HB1' ' A' ' 48' ' ' ALA . 11.1 pt -123.05 110.35 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 118.857 -1.137 . . . . 0.0 111.783 177.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.618 ' HB2' ' NZ ' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -76.82 51.74 0.79 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 121.888 0.851 . . . . 0.0 109.531 179.206 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.533 ' O ' HG12 ' A' ' 57' ' ' ILE . 85.2 mt-30 -140.52 129.94 23.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.103 -1.408 . . . . 0.0 107.501 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.792 ' N ' ' HB1' ' A' ' 17' ' ' ALA . 73.3 mtt-85 -59.83 68.34 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.936 ' HB ' HD11 ' A' ' 53' ' ' ILE . 11.1 mm -112.08 122.31 66.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.058 HD11 ' HB2' ' A' ' 72' ' ' LEU . 1.9 pp -127.82 143.46 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 119.607 -0.837 . . . . 0.0 113.174 -177.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.67 HG21 ' HB3' ' A' ' 35' ' ' PHE . 1.4 p -127.96 134.13 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.679 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.049 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 2.0 mt -114.93 151.94 16.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.445 0.64 . . . . 0.0 111.111 -177.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 1.008 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 11.4 t70 -129.65 25.73 5.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.614 -1.176 . . . . 0.0 110.83 -177.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.851 HG23 ' CG2' ' A' ' 60' ' ' ILE . 11.7 t . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.534 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 51.5 ttt-85 . . . . . 0 N--CA 1.456 -0.166 0 CA-C-O 120.779 0.323 . . . . 0.0 110.68 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 1.049 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 48.5 mt -112.09 138.87 48.15 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -179.022 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.999 HG21 ' HB2' ' A' ' 113' ' ' ARG . 8.8 p -134.03 131.23 55.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.408 177.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.058 ' HB2' HD11 ' A' ' 58' ' ' ILE . 89.6 mt -142.41 143.18 32.54 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 121.31 -0.156 . . . . 0.0 110.919 177.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.054 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.6 mp -120.68 134.39 64.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.69 0.281 . . . . 0.0 110.743 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.688 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 50.4 m-20 53.72 34.78 0.26 Allowed Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.846 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 84.5 Cg_exo -55.16 146.75 57.99 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.521 2.147 . . . . 0.0 113.571 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -135.99 149.23 48.77 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.959 ' HB2' ' HE1' ' A' ' 134' ' ' MET . 27.9 tp -79.63 138.3 37.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.42 0.629 . . . . 0.0 112.082 -178.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.066 HD21 ' HG3' ' A' ' 109' ' ' ARG . 2.6 mm? -114.26 -45.35 3.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.425 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.587 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 38.2 tt0 -158.06 146.82 19.16 Favored 'General case' 0 C--O 1.23 0.035 0 CA-C-O 121.114 0.483 . . . . 0.0 111.637 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.879 ' HE3' HD21 ' A' ' 77' ' ' LEU . 19.3 ptpt -143.59 146.91 33.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.045 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.4 p -159.67 150.98 19.76 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.733 0.301 . . . . 0.0 111.291 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.744 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 79.75 159.08 16.84 Favored Glycine 0 C--N 1.335 0.472 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.414 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -134.02 113.4 12.09 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.896 0.855 . . . . 0.0 112.93 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.643 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.6 p -106.97 161.53 14.64 Favored 'General case' 0 CA--C 1.486 -1.485 0 CA-C-N 113.902 -1.499 . . . . 0.0 114.936 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.746 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -146.95 115.86 0.81 Allowed Glycine 0 C--N 1.311 -0.861 0 CA-C-N 112.671 -2.059 . . . . 0.0 110.873 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.589 ' N ' ' HG ' ' A' ' 99' ' ' LEU . 34.1 mt -147.97 139.09 17.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 117.293 0.546 . . . . 0.0 111.618 -178.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 50.5 mt-10 -71.65 138.55 48.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 123.193 1.473 . . . . 0.0 112.082 -175.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.673 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 46.0 mt-10 -157.41 162.25 39.0 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 112.672 -2.058 . . . . 0.0 111.098 -179.075 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.764 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -122.01 161.53 16.12 Favored Glycine 0 CA--C 1.501 -0.817 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.436 ' HG ' ' CD2' ' A' ' 136' ' ' HIS . 17.9 m -114.63 140.43 48.82 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.313 0.578 . . . . 0.0 111.344 -178.015 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.089 ' HG ' HD13 ' A' ' 46' ' ' LEU . 2.4 mm? -48.14 -22.8 0.69 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.333 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.863 ' CB ' HG12 ' A' ' 8' ' ' ILE . 54.0 m -83.28 -34.76 25.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.921 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.574 ' CD1' HG13 ' A' ' 8' ' ' ILE . 49.5 mm . . . . . 0 N--CA 1.451 -0.381 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.226 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.764 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 18.5 mtm105 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 121.637 0.732 . . . . 0.0 111.836 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -135.16 155.85 50.0 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 114.539 -1.209 . . . . 0.0 109.432 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.746 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.6 tt -76.23 115.28 15.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.419 0.628 . . . . 0.0 111.773 -178.091 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.826 ' HB ' ' CZ ' ' A' ' 102' ' ' ARG . 39.0 t -107.01 131.95 21.29 Favored Pre-proline 0 N--CA 1.475 0.815 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.991 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.643 ' HA ' ' O ' ' A' ' 84' ' ' THR . 85.3 Cg_endo -82.92 127.47 4.79 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.663 2.242 . . . . 0.0 112.519 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.948 ' HG3' HG23 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -144.68 167.26 22.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.224 179.351 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.744 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.79 155.48 40.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 118.34 0.518 . . . . 0.0 110.1 -179.075 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -73.38 -41.2 63.67 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.895 -175.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.672 ' HB3' ' OD1' ' A' ' 123' ' ' ASP . 95.4 mttt -139.64 140.23 36.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.249 0.547 . . . . 0.0 109.619 177.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.869 HG22 ' HB1' ' A' ' 127' ' ' ALA . 35.1 m -146.78 139.44 19.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.311 -178.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 1.014 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 56.1 mmtt -106.6 127.05 53.03 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 1.014 ' HA ' HD23 ' A' ' 78' ' ' LEU . 2.3 pp -133.83 146.81 31.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -176.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 1.066 ' HG3' HD21 ' A' ' 78' ' ' LEU . 68.7 mtm180 -103.6 139.32 39.06 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.68 -178.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.704 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -161.05 169.42 22.51 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.037 -176.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 1.054 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.5 pp -116.48 151.83 35.28 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.473 ' O ' HD12 ' A' ' 111' ' ' LEU . 16.8 t70 -85.24 163.61 18.56 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.231 0.539 . . . . 0.0 112.053 -177.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.999 ' HB2' HG21 ' A' ' 71' ' ' VAL . 13.1 ttp-105 -51.93 -20.11 2.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.076 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -79.4 -26.44 41.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.633 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.626 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 107.3 35.98 2.58 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.199 -1.001 . . . . 0.0 113.491 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -128.46 102.68 20.36 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.781 0.291 . . . . 0.0 110.804 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.672 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.9 Cg_exo -72.6 116.27 4.65 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 121.65 1.567 . . . . 0.0 115.663 -177.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 112' ' ' ASP . 0.4 OUTLIER -126.97 165.13 20.01 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.269 -178.655 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.545 ' HG3' ' CG ' ' A' ' 109' ' ' ARG . 5.9 mp0 -107.33 130.68 54.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.028 0.442 . . . . 0.0 109.837 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.729 HD21 ' CD1' ' A' ' 72' ' ' LEU . 4.4 pp -124.53 130.94 53.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.571 -178.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 1.014 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 15.3 pt-20 -91.5 123.79 35.18 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.401 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.917 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -116.24 135.62 53.74 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.672 ' OD1' ' HB3' ' A' ' 105' ' ' LYS . 45.4 m-20 -127.1 161.36 28.62 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.825 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 51.68 -137.88 30.3 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 120.334 1.425 . . . . 0.0 115.279 177.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 81.1 mt -54.05 -32.28 54.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.816 -0.692 . . . . 0.0 111.737 -178.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.917 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.3 OUTLIER -71.11 -52.58 18.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.663 0.744 . . . . 0.0 109.362 179.769 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.869 ' HB1' HG22 ' A' ' 106' ' ' VAL . . . -59.85 -40.9 90.16 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.569 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.948 HG23 ' HG3' ' A' ' 102' ' ' ARG . 46.4 mm -66.01 -54.31 28.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.698 -178.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.66 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 85.5 m -60.42 -49.39 77.76 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.768 ' CD1' HG12 ' A' ' 108' ' ' ILE . 0.1 OUTLIER -59.22 -44.72 92.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.557 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.818 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.3 pt20 -67.7 -39.14 84.42 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.683 0.278 . . . . 0.0 110.282 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -59.86 -46.05 90.53 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.12 0.486 . . . . 0.0 109.88 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.885 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.5 mm-40 -60.32 -40.74 91.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.921 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.959 ' HE1' ' HB2' ' A' ' 77' ' ' LEU . 73.2 mtp -57.78 -48.07 80.75 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.751 0.786 . . . . 0.0 109.948 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.653 ' O ' HG12 ' A' ' 138' ' ' VAL . 30.6 m-20 -62.76 -46.75 86.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.811 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.448 ' CE1' ' CG ' ' A' ' 50' ' ' GLN . 4.7 t-80 -59.57 -52.72 64.35 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.206 0.527 . . . . 0.0 111.675 -178.155 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.927 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.5 pp -59.18 -30.38 68.15 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.315 -178.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.94 HG23 HG13 ' A' ' 16' ' ' VAL . 13.4 p -86.1 22.7 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-O 122.094 0.949 . . . . 0.0 109.356 176.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.711 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 55.88 38.75 75.54 Favored Glycine 0 CA--C 1.483 -1.966 0 CA-C-N 113.678 -1.601 . . . . 0.0 112.662 176.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.932 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 3.4 ptmt . . . . . 0 N--CA 1.426 -1.658 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.708 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.94 HG12 ' HA ' ' A' ' 37' ' ' THR . 31.5 m . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.905 0.383 . . . . 0.0 111.481 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 1.004 HD21 ' HB ' ' A' ' 51' ' ' VAL . 3.2 pp -79.74 -165.97 0.91 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.593 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.439 ' N ' HD12 ' A' ' 3' ' ' LEU . 40.7 tt0 -89.92 109.76 20.76 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.952 0.406 . . . . 0.0 110.473 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.567 ' CG2' HG21 ' A' ' 37' ' ' THR . 43.4 t -88.66 129.84 39.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.413 0.625 . . . . 0.0 112.079 -178.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.082 ' HB2' HD21 ' A' ' 13' ' ' LEU . 15.3 mt -89.95 143.21 26.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.923 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 44.0 m-70 -121.77 147.93 45.3 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -179.082 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.033 HD13 HD12 ' A' ' 13' ' ' LEU . 50.3 mm -63.68 135.78 96.43 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.145 178.098 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -80.38 142.73 61.83 Favored 'Cis proline' 0 C--N 1.351 0.708 0 C-N-CA 124.605 -0.998 . . . . 0.0 111.746 -0.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.948 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.7 t70 -163.53 126.9 2.7 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.459 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 11.9 pt-20 -58.08 -46.07 86.08 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.598 -178.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 1.024 ' HA ' ' HZ3' ' A' ' 15' ' ' LYS . 16.0 mmt85 -56.28 -29.05 60.65 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 1.082 HD21 ' HB2' ' A' ' 6' ' ' LEU . 10.0 mt -76.43 -34.28 58.77 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 120.068 1.303 . . . . 0.0 108.559 177.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.796 ' HB3' ' NH1' ' A' ' 14' ' ' ARG . 2.2 mmm180 -93.42 13.0 22.97 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 113.877 -1.51 . . . . 0.0 109.182 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 1.024 ' HZ3' ' HA ' ' A' ' 12' ' ' ARG . 4.5 ttmp? -88.66 145.65 25.54 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.207 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 1.04 HG13 HG23 ' A' ' 138' ' ' VAL . 59.5 t -82.43 121.49 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.75 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -82.13 145.82 29.92 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.411 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -107.95 128.96 24.8 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.745 ' HA ' ' OD1' ' A' ' 74' ' ' ASN . 64.0 Cg_endo -78.97 113.54 3.26 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 121.725 1.617 . . . . 0.0 110.665 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.726 HG12 ' H ' ' A' ' 22' ' ' GLU . 16.5 t -68.97 144.43 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-O 122.469 1.128 . . . . 0.0 113.132 -175.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -60.49 -24.75 65.53 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 113.125 -1.852 . . . . 0.0 112.368 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.726 ' H ' HG12 ' A' ' 20' ' ' VAL . 42.7 tt0 -157.28 142.71 17.28 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.296 -179.035 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.542 HG22 HD21 ' A' ' 111' ' ' LEU . 2.9 t -80.07 108.1 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -178.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 1.038 ' H ' HD12 ' A' ' 27' ' ' ILE . 31.3 m120 -90.85 155.36 18.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.658 -178.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.687 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -55.29 -25.49 34.46 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.35 0.595 . . . . 0.0 110.49 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.434 ' OE2' HG12 ' A' ' 27' ' ' ILE . 0.6 OUTLIER -75.11 -38.99 60.92 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 177.745 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 1.038 HD12 ' H ' ' A' ' 24' ' ' ASN . 57.4 mt -66.06 -35.6 75.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 114.297 -1.32 . . . . 0.0 110.168 177.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -69.38 -39.21 78.15 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.254 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.687 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 38.1 mmm-85 -61.32 -39.24 89.79 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.792 ' O ' ' HG3' ' A' ' 34' ' ' MET . 3.0 mt -58.24 -48.69 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.2 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.903 HG22 ' CG2' ' A' ' 57' ' ' ILE . 8.7 t -67.9 -41.85 85.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 120.968 0.413 . . . . 0.0 111.557 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.862 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -55.8 -42.4 75.55 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.999 -179.412 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.483 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 15.5 m-20 -75.48 -29.91 59.74 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.284 176.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' MET . . . . . 1.008 ' HG2' HG21 ' A' ' 51' ' ' VAL . 83.1 mtp -60.28 -46.51 89.58 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.315 -177.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.862 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 13.4 p90 -69.7 -45.2 68.81 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.213 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.751 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 37.9 mt-10 -51.84 -40.42 60.49 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 121.762 0.791 . . . . 0.0 108.904 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.94 ' HA ' HG12 ' A' ' 2' ' ' VAL . 56.6 m -70.24 -62.23 1.47 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.33 -1.305 . . . . 0.0 108.176 178.468 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.955 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 2.8 ttp -46.31 -41.4 13.21 Favored 'General case' 0 CA--C 1.46 -2.485 0 C-N-CA 124.144 0.978 . . . . 0.0 110.364 -171.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.709 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 61.7 m-85 -70.55 -42.69 70.84 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.686 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.5 ' CB ' HG11 ' A' ' 2' ' ' VAL . . . -61.4 -24.27 66.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.841 0.829 . . . . 0.0 109.395 179.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 1.052 ' HG2' HD12 ' A' ' 91' ' ' LEU . 11.6 tp10 -88.74 -11.23 45.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.471 177.247 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.447 ' H ' ' C ' ' A' ' 39' ' ' TYR . 21.8 mt-10 64.27 25.42 13.53 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.956 -176.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.15 142.38 26.18 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 113.839 -1.528 . . . . 0.0 110.714 177.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.811 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 44.3 mm -79.15 -2.34 5.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 117.354 0.577 . . . . 0.0 112.139 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.524 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 177.97 134.91 2.15 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 118.759 -1.023 . . . . 0.0 111.291 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.04 HD13 ' HG ' ' A' ' 91' ' ' LEU . 7.6 tp -124.52 134.97 52.84 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 119.29 1.545 . . . . 0.0 111.973 -179.067 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.451 ' H ' HE21 ' A' ' 50' ' ' GLN . . . -100.31 130.34 46.41 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.484 0.183 . . . . 0.0 111.299 178.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.872 ' HB1' ' CD1' ' A' ' 53' ' ' ILE . . . -28.61 -54.43 0.11 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -179.075 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.622 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 69.1 p -52.96 -35.45 58.94 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.458 0.647 . . . . 0.0 112.221 -177.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.919 ' NE2' HD23 ' A' ' 91' ' ' LEU . 34.2 mt-30 -65.22 -42.05 93.81 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.154 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 1.008 HG21 ' HG2' ' A' ' 34' ' ' MET . 0.8 OUTLIER -82.42 15.69 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 179.781 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.872 ' HA ' HD11 ' A' ' 6' ' ' LEU . 35.0 t70 77.46 30.07 0.52 Allowed 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 176.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.872 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 1.1 pp -123.74 111.37 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.318 177.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.679 ' HB3' ' HD2' ' A' ' 15' ' ' LYS . 6.8 p80 -76.68 61.65 1.86 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.677 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.725 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 89.0 mt-30 -151.57 134.3 15.59 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 114.495 -1.229 . . . . 0.0 107.942 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.75 ' N ' ' HB1' ' A' ' 17' ' ' ALA . 76.3 mtp180 -64.0 69.3 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -177.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.903 ' CG2' HG22 ' A' ' 31' ' ' VAL . 8.0 mm -111.27 123.47 67.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.83 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -131.43 147.39 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 121.975 0.893 . . . . 0.0 112.965 -177.779 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.588 HG22 ' O ' ' A' ' 46' ' ' LEU . 32.9 m -127.71 139.21 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.092 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.969 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 9.2 mm -114.69 150.73 16.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.646 0.736 . . . . 0.0 109.943 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.955 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 33.4 t70 -138.62 28.82 2.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.735 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.772 HG22 ' CG2' ' A' ' 44' ' ' ILE . 40.4 t . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.556 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.699 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 41.7 ttm-85 . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.969 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 8.5 mp -102.87 132.35 49.13 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.991 0.424 . . . . 0.0 111.908 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.93 HG21 ' HB2' ' A' ' 113' ' ' ARG . 9.6 p -133.14 134.33 57.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.06 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.83 ' HB2' ' CD1' ' A' ' 58' ' ' ILE . 90.6 mt -141.74 140.95 33.23 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 121.384 -0.126 . . . . 0.0 111.009 178.235 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.03 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.8 mp -120.2 133.65 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-O 120.838 0.351 . . . . 0.0 110.923 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.792 ' ND2' HG22 ' A' ' 73' ' ' ILE . 64.5 m-20 51.72 36.32 0.34 Allowed Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 113.863 1.061 . . . . 0.0 113.863 178.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.742 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 90.1 Cg_exo -55.65 149.5 48.86 Favored 'Trans proline' 0 N--CA 1.484 0.917 0 C-N-CA 122.708 2.272 . . . . 0.0 113.415 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.45 ' OE2' ' HD2' ' A' ' 109' ' ' ARG . 23.0 pt-20 -135.91 145.88 46.76 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.77 HD21 ' HE3' ' A' ' 80' ' ' LYS . 30.1 tp -79.71 138.38 37.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.38 0.61 . . . . 0.0 112.278 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.06 HD11 ' HG3' ' A' ' 109' ' ' ARG . 5.4 mp -112.17 -44.04 3.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.632 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.561 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 38.4 tt0 -158.79 147.79 18.74 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 121.141 0.496 . . . . 0.0 111.831 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.874 ' HA ' HG12 ' A' ' 106' ' ' VAL . 19.4 ptpt -142.3 147.46 36.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.054 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.2 t -160.03 148.02 16.83 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.702 0.287 . . . . 0.0 111.221 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.759 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 82.97 163.93 34.89 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.515 -179.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -140.55 113.59 8.38 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.922 0.861 . . . . 0.0 113.106 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.6 p -106.09 161.56 14.39 Favored 'General case' 0 CA--C 1.486 -1.481 0 CA-C-N 113.999 -1.455 . . . . 0.0 114.864 178.46 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.702 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -145.47 114.12 0.74 Allowed Glycine 0 C--N 1.312 -0.781 0 CA-C-N 112.849 -1.978 . . . . 0.0 110.653 178.068 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.826 ' HB ' ' NH2' ' A' ' 102' ' ' ARG . 34.0 mt -148.67 139.56 17.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-N 117.264 0.532 . . . . 0.0 111.826 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 50.4 mt-10 -72.19 138.09 47.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 123.195 1.474 . . . . 0.0 112.581 -176.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.674 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 39.1 mt-10 -155.29 160.26 40.64 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 112.358 -2.201 . . . . 0.0 111.212 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.791 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -120.12 159.56 15.04 Favored Glycine 0 CA--C 1.499 -0.911 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 1.038 ' HB2' HD13 ' A' ' 93' ' ' ILE . 21.8 m -114.27 139.91 49.03 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 117.688 0.744 . . . . 0.0 111.175 -177.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.052 HD12 ' HG2' ' A' ' 41' ' ' GLU . 2.4 mm? -49.44 -22.47 1.19 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.036 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.94 ' HB3' HD13 ' A' ' 13' ' ' LEU . 54.4 m -79.41 -38.54 34.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.277 179.076 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 1.038 HD13 ' HB2' ' A' ' 90' ' ' CYS . 3.2 mp . . . . . 0 N--CA 1.448 -0.547 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.791 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 40.2 mtt180 . . . . . 0 N--CA 1.465 0.286 0 CA-C-O 121.573 0.701 . . . . 0.0 111.613 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -135.35 155.46 50.55 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 114.691 -1.141 . . . . 0.0 109.716 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.702 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.3 tt -76.41 114.85 15.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.439 0.638 . . . . 0.0 111.985 -178.061 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.758 ' HB ' HH11 ' A' ' 102' ' ' ARG . 42.6 t -104.36 132.8 20.62 Favored Pre-proline 0 N--CA 1.47 0.573 0 CA-C-N 114.931 -1.031 . . . . 0.0 112.062 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.584 ' HA ' ' O ' ' A' ' 84' ' ' THR . 2.1 Cg_endo -84.35 125.99 3.56 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.843 2.362 . . . . 0.0 111.804 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.826 ' NH2' ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -144.61 167.51 22.36 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.56 0.744 . . . . 0.0 109.98 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.759 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.79 154.86 41.22 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.836 0.351 . . . . 0.0 110.179 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -73.77 -41.16 62.81 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.146 -176.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.777 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 91.4 mttt -139.91 141.2 36.54 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.874 HG12 ' HA ' ' A' ' 80' ' ' LYS . 29.4 m -149.06 139.0 16.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.333 -179.159 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 1.058 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 51.0 mmtt -107.98 126.4 52.67 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.052 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 1.112 HD11 HD11 ' A' ' 130' ' ' ILE . 1.6 pp -136.1 152.76 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -176.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 1.06 ' HG3' HD11 ' A' ' 78' ' ' LEU . 93.7 mtt180 -102.68 138.78 39.12 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.93 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.605 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -160.04 167.82 27.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.102 -177.41 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 1.03 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.6 pp -117.12 153.25 33.11 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.609 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 10.1 t70 -88.2 162.97 16.38 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.519 -177.286 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.93 ' HB2' HG21 ' A' ' 71' ' ' VAL . 50.1 ttp85 -51.39 -19.04 1.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.251 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -79.1 -27.67 42.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.381 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.43 35.92 2.37 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.348 -0.93 . . . . 0.0 113.329 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -128.74 102.88 19.47 Favored Pre-proline 0 C--O 1.237 0.406 0 CA-C-N 116.815 0.308 . . . . 0.0 110.914 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.656 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.5 Cg_exo -73.4 116.08 4.57 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 121.766 1.644 . . . . 0.0 115.145 -177.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.609 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 10.9 p90 -126.13 166.65 16.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.312 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.706 ' HG2' ' HG2' ' A' ' 109' ' ' ARG . 30.7 mt-10 -107.5 130.51 54.84 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.817 HD11 ' CD1' ' A' ' 130' ' ' ILE . 4.3 pp -127.44 133.88 49.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.591 -178.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 1.058 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 9.1 pm0 -94.45 123.66 38.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.627 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.807 ' CB ' HD22 ' A' ' 126' ' ' LEU . . . -116.82 135.11 54.0 Favored 'General case' 0 C--O 1.222 -0.364 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.777 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.2 m-20 -126.66 162.35 25.97 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.478 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.728 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 49.9 -134.77 26.54 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 120.418 1.463 . . . . 0.0 115.252 177.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.742 HD12 ' CG1' ' A' ' 62' ' ' VAL . 1.7 pt? -53.78 -35.46 61.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.032 -0.584 . . . . 0.0 111.462 -179.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.807 HD22 ' CB ' ' A' ' 122' ' ' ALA . 0.6 OUTLIER -70.51 -52.01 24.85 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.996 0.903 . . . . 0.0 109.281 179.563 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.713 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -58.45 -41.5 85.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.925 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.817 HG23 ' HG3' ' A' ' 102' ' ' ARG . 50.6 mm -68.54 -54.99 17.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.221 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.827 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 29.3 p -59.03 -50.74 72.93 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 1.112 HD11 HD11 ' A' ' 108' ' ' ILE . 17.9 tt -59.65 -43.85 92.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.189 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.693 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.0 pt20 -67.73 -40.63 84.18 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.176 178.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 69.9 t60 -58.5 -45.78 88.04 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.206 0.527 . . . . 0.0 109.931 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.878 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.2 mm-40 -59.81 -41.77 92.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.708 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.947 ' HA ' HD21 ' A' ' 137' ' ' LEU . 74.8 mtp -57.25 -47.83 80.38 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.736 0.779 . . . . 0.0 110.08 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.643 ' O ' HG12 ' A' ' 138' ' ' VAL . 1.4 m-20 -63.16 -47.12 84.0 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.951 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.47 ' CE1' ' CG ' ' A' ' 50' ' ' GLN . 8.7 t-80 -58.97 -53.11 62.16 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.176 0.512 . . . . 0.0 111.472 -178.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.947 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.6 pp -58.65 -31.4 68.13 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.644 -178.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 1.04 HG23 HG13 ' A' ' 16' ' ' VAL . 14.5 p -85.05 24.58 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-O 122.283 1.04 . . . . 0.0 109.816 176.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.48 ' HA3' ' C ' ' A' ' 14' ' ' ARG . . . 55.84 30.81 57.49 Favored Glycine 0 CA--C 1.486 -1.757 0 CA-C-N 113.48 -1.691 . . . . 0.0 112.679 176.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.956 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 5.8 ptmt . . . . . 0 N--CA 1.425 -1.704 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.626 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 52.4 m . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.981 0.42 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.922 HG12 ' HA ' ' A' ' 37' ' ' THR . 25.5 m -84.32 133.16 29.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.327 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.895 HD11 ' HB ' ' A' ' 51' ' ' VAL . 2.0 pt? -80.46 -147.47 0.05 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.536 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 19.3 tt0 -98.58 104.76 16.83 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.938 0.399 . . . . 0.0 110.889 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.583 ' CG2' HG21 ' A' ' 37' ' ' THR . 40.4 t -88.36 126.38 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-O 121.496 0.665 . . . . 0.0 112.152 -178.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.054 ' HB2' HD21 ' A' ' 13' ' ' LEU . 50.2 mt -85.86 144.97 27.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.22 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 53.6 m-70 -123.01 144.05 49.52 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -178.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.006 HD13 HD12 ' A' ' 13' ' ' LEU . 49.3 mm -65.8 132.67 94.85 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.787 177.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -77.31 143.74 75.76 Favored 'Cis proline' 0 C--N 1.35 0.641 0 C-N-CA 124.553 -1.019 . . . . 0.0 111.778 -0.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.996 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.7 t70 -162.51 126.79 3.11 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.471 ' CD ' ' H ' ' A' ' 11' ' ' GLU . 0.6 OUTLIER -57.9 -45.85 85.84 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.754 -178.444 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.743 ' HB2' HD13 ' A' ' 6' ' ' LEU . 21.4 mtt-85 -59.89 -26.83 66.2 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 1.054 HD21 ' HB2' ' A' ' 6' ' ' LEU . 10.6 mt -77.66 -30.56 52.14 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 120.964 1.711 . . . . 0.0 108.586 177.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.618 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 15.0 mmm180 -95.11 8.62 42.43 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.072 -1.422 . . . . 0.0 109.059 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -90.17 147.67 23.44 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.7 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.579 HG13 HG23 ' A' ' 138' ' ' VAL . 90.4 t -81.93 128.83 38.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.834 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -90.28 145.4 25.01 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.832 ' HD3' ' HD2' ' A' ' 19' ' ' PRO . 8.0 tmtt? -107.11 131.42 21.71 Favored Pre-proline 0 C--N 1.318 -0.768 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.832 ' HD2' ' HD3' ' A' ' 18' ' ' LYS . 54.1 Cg_endo -81.56 114.44 2.7 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.774 1.649 . . . . 0.0 110.333 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.73 HG12 ' H ' ' A' ' 22' ' ' GLU . 19.4 t -68.97 144.88 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 CA-C-O 122.692 1.234 . . . . 0.0 113.342 -175.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -63.31 -21.26 66.15 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 112.861 -1.972 . . . . 0.0 112.986 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.73 ' H ' HG12 ' A' ' 20' ' ' VAL . 39.0 tt0 -157.84 144.51 17.82 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.166 -178.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.6 HG22 HD21 ' A' ' 111' ' ' LEU . 3.2 t -79.64 106.85 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -178.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 1.003 ' HB2' HD13 ' A' ' 27' ' ' ILE . 29.1 m120 -92.61 153.22 19.13 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.802 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -54.14 -24.19 16.93 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.241 0.543 . . . . 0.0 110.782 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 1.092 ' HG3' HD12 ' A' ' 27' ' ' ILE . 13.9 pt-20 -75.15 -42.19 56.66 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 177.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 1.092 HD12 ' HG3' ' A' ' 26' ' ' GLU . 2.0 mp -65.19 -35.72 76.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.748 177.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 75.4 mt-30 -66.32 -40.57 90.03 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 122.349 -0.22 . . . . 0.0 110.493 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.5 ' HG3' ' O ' ' A' ' 25' ' ' ALA . 67.9 mtt85 -62.83 -38.69 91.77 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.805 ' O ' ' HG3' ' A' ' 34' ' ' MET . 1.6 mp -56.07 -49.97 72.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.927 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.785 HG11 ' CG2' ' A' ' 71' ' ' VAL . 36.7 t -67.25 -43.14 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.924 0.392 . . . . 0.0 111.17 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.848 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -55.45 -41.11 72.42 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.067 -179.103 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.506 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 1.3 m-20 -76.37 -30.22 57.46 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.318 176.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.967 ' HG2' HG21 ' A' ' 51' ' ' VAL . 32.5 mtm -60.74 -44.59 96.49 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 120.55 -0.46 . . . . 0.0 109.95 -178.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.848 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 10.6 p90 -70.17 -46.19 65.15 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' ' 32' ' ' ASP . 29.7 mm-40 -51.86 -40.99 61.51 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 121.634 0.731 . . . . 0.0 109.411 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.922 ' HA ' HG12 ' A' ' 2' ' ' VAL . 91.6 m -70.43 -61.84 1.62 Allowed 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 118.479 -1.288 . . . . 0.0 108.411 177.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.793 ' HG3' ' HB2' ' A' ' 46' ' ' LEU . 2.1 ttp -46.16 -41.06 12.08 Favored 'General case' 0 CA--C 1.46 -2.483 0 C-N-CA 124.346 1.058 . . . . 0.0 110.775 -171.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.718 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 45.8 m-85 -70.07 -42.61 72.59 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.751 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.528 ' HB3' ' CG1' ' A' ' 2' ' ' VAL . . . -61.26 -24.33 66.31 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.436 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 1.119 ' HG2' HD12 ' A' ' 91' ' ' LEU . 16.5 tp10 -89.11 -11.24 44.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.466 177.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.443 ' H ' ' C ' ' A' ' 39' ' ' TYR . 5.0 mm-40 63.8 25.41 14.09 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.048 -176.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.598 ' HA2' H182 ' A' ' 149' ' ' BB2 . . . -80.35 144.53 25.84 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.819 178.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.775 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 51.6 mt -79.92 0.73 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 117.823 0.811 . . . . 0.0 112.062 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.842 ' HA3' ' C10' ' A' ' 149' ' ' BB2 . . . 178.03 140.34 3.77 Favored Glycine 0 CA--C 1.517 0.198 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.026 HD13 ' HG ' ' A' ' 91' ' ' LEU . 7.0 tp -127.4 135.22 50.17 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.855 1.327 . . . . 0.0 109.66 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.47 133.3 49.57 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 122.033 -0.417 . . . . 0.0 111.621 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.845 ' HB1' ' CD1' ' A' ' 53' ' ' ILE . . . -26.82 -57.24 0.09 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 116.113 1.894 . . . . 0.0 116.113 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.823 ' CG2' ' HA ' ' A' ' 137' ' ' LEU . 70.1 p -54.44 -34.87 62.25 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 121.969 0.89 . . . . 0.0 112.199 -178.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.824 ' OE1' HD12 ' A' ' 46' ' ' LEU . 57.4 mt-30 -62.14 -40.0 94.49 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.547 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.967 HG21 ' HG2' ' A' ' 34' ' ' MET . 1.7 m -93.41 18.35 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.89 ' OD2' HD21 ' A' ' 6' ' ' LEU . 6.6 t0 80.13 25.51 0.35 Allowed 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 176.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.845 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -119.18 107.42 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 118.759 -1.176 . . . . 0.0 111.004 178.056 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -75.91 60.58 1.38 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 122.18 0.99 . . . . 0.0 110.642 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.784 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 88.5 mt-30 -147.19 131.64 17.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.945 -1.479 . . . . 0.0 107.058 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.995 ' HA ' HD22 ' A' ' 137' ' ' LEU . 75.9 mtp180 -64.67 75.63 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.742 HD12 HG21 ' A' ' 30' ' ' ILE . 23.0 mt -117.25 125.06 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.956 HD11 ' HB2' ' A' ' 72' ' ' LEU . 1.8 pp -122.65 142.45 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 120.119 -0.632 . . . . 0.0 112.254 -177.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.612 HG12 ' O ' ' A' ' 46' ' ' LEU . 2.5 p -127.79 132.53 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.061 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 1.8 mt -114.65 154.89 15.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.898 0.856 . . . . 0.0 111.985 -177.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.782 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 14.9 t70 -145.12 31.86 1.12 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 113.986 -1.461 . . . . 0.0 110.068 -177.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.72 HG13 ' CD2' ' A' ' 125' ' ' LEU . 48.1 t -89.89 107.03 17.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.652 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.715 ' HA ' ' HG3' ' A' ' 68' ' ' GLU . 80.5 p -55.8 65.75 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -177.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 62' ' ' VAL . 88.6 tt0 -75.81 7.54 3.81 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.324 178.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.48 ' CG ' ' H ' ' A' ' 66' ' ' ARG . 49.7 t-20 -163.28 -139.47 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.881 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.48 ' H ' ' CG ' ' A' ' 65' ' ' ASN . 39.6 mmt180 -75.64 -58.63 3.17 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -115.48 135.5 54.04 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.715 ' HG3' ' HA ' ' A' ' 63' ' ' SER . 2.9 mp0 -79.69 129.81 34.8 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.305 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 68' ' ' GLU . 39.2 ttt85 -179.94 63.77 0.01 OUTLIER 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.912 0.387 . . . . 0.0 111.389 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 1.061 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 55.3 mt -103.37 133.27 48.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.804 0.335 . . . . 0.0 111.678 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.973 HG21 ' HB2' ' A' ' 113' ' ' ARG . 7.1 p -135.86 133.89 51.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.187 177.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.956 ' HB2' HD11 ' A' ' 58' ' ' ILE . 1.7 mm? -140.55 141.82 35.21 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.038 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.6 mp -120.18 132.92 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.798 ' ND2' HG22 ' A' ' 73' ' ' ILE . 59.7 m-20 53.7 37.68 0.44 Allowed Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.863 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 95.0 Cg_exo -57.1 148.29 70.11 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 123.011 2.474 . . . . 0.0 114.129 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.469 ' O ' ' HB ' ' A' ' 108' ' ' ILE . 11.6 pt-20 -135.85 144.61 45.73 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.889 ' HB2' ' HE1' ' A' ' 134' ' ' MET . 44.5 tp -80.04 138.03 36.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.319 0.58 . . . . 0.0 111.98 -178.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.053 HD21 ' HG3' ' A' ' 109' ' ' ARG . 2.8 mm? -112.99 -39.33 4.25 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.971 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.593 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 85.2 tt0 -160.02 145.37 15.22 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 121.269 0.557 . . . . 0.0 111.695 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.968 ' HA ' HG12 ' A' ' 106' ' ' VAL . 10.8 ptpp? -138.52 149.58 45.51 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.482 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.1 p -159.02 149.21 19.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.801 0.334 . . . . 0.0 111.444 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.633 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 76.83 149.55 3.19 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.783 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -117.64 113.68 22.27 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.884 0.849 . . . . 0.0 112.406 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.697 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.7 p -112.08 160.37 17.59 Favored 'General case' 0 CA--C 1.485 -1.52 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.713 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -151.28 118.68 0.93 Allowed Glycine 0 C--N 1.311 -0.852 0 CA-C-N 112.392 -2.186 . . . . 0.0 110.509 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.599 HD13 ' O ' ' A' ' 85' ' ' GLY . 47.8 mm -147.76 139.92 18.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-N 117.383 0.592 . . . . 0.0 111.183 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 50.5 mt-10 -71.19 137.32 48.63 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 123.322 1.534 . . . . 0.0 111.833 -176.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.72 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 42.3 mt-10 -155.15 161.68 41.17 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 112.477 -2.147 . . . . 0.0 111.91 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.884 ' O ' ' H52' ' A' ' 149' ' ' BB2 . . . -121.43 164.3 14.65 Favored Glycine 0 CA--C 1.5 -0.853 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.706 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 5.7 m -118.59 139.02 52.15 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.264 0.554 . . . . 0.0 111.854 -177.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.119 HD12 ' HG2' ' A' ' 41' ' ' GLU . 2.4 mm? -49.64 -26.83 3.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.433 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.86 ' CB ' HG12 ' A' ' 8' ' ' ILE . 57.4 m -78.82 -36.52 42.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.43 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.868 HD13 ' HB ' ' A' ' 8' ' ' ILE . 43.6 mm -85.85 150.1 52.33 Favored Pre-proline 0 N--CA 1.45 -0.425 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.392 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.842 ' HD2' HG23 ' A' ' 93' ' ' ILE . 94.4 Cg_endo -72.4 49.25 1.38 Allowed 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.494 2.129 . . . . 0.0 113.976 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.55 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 40.0 tt0 73.9 15.68 3.82 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.113 0.482 . . . . 0.0 111.984 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.657 ' HG3' ' HG2' ' A' ' 94' ' ' PRO . 84.6 mt-30 -78.53 89.02 4.47 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.807 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 18.8 mtm105 -84.95 132.44 34.36 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.794 0.807 . . . . 0.0 111.817 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -134.48 153.42 51.94 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 114.433 -1.258 . . . . 0.0 109.82 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.713 HD21 ' HA3' ' A' ' 85' ' ' GLY . 6.9 tt -76.12 115.99 16.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.652 0.739 . . . . 0.0 111.146 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.857 ' CG1' HH21 ' A' ' 102' ' ' ARG . 17.3 t -111.0 136.09 20.81 Favored Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.665 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.697 ' HA ' ' O ' ' A' ' 84' ' ' THR . 91.8 Cg_endo -84.23 126.37 3.71 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 122.725 2.283 . . . . 0.0 112.655 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.977 ' HG3' HG23 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -145.6 166.76 24.8 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.102 0.961 . . . . 0.0 109.004 178.96 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.633 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -67.9 154.07 42.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 118.599 0.636 . . . . 0.0 110.473 -178.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.578 ' OE1' ' HG3' ' A' ' 105' ' ' LYS . 2.7 tm-20 -73.48 -41.26 63.36 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.393 -175.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.791 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 56.6 mttp -139.24 140.43 37.7 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.479 0.657 . . . . 0.0 109.433 177.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.968 HG12 ' HA ' ' A' ' 80' ' ' LYS . 26.1 m -150.14 136.37 12.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.455 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.998 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 46.5 mmtt -107.47 127.49 53.65 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.999 ' HA ' HD23 ' A' ' 78' ' ' LEU . 1.5 pp -135.09 156.54 39.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -176.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 1.053 ' HG3' HD21 ' A' ' 78' ' ' LEU . 92.7 mtt180 -103.3 138.17 40.43 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.502 -178.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.829 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -160.66 170.13 21.44 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.856 -176.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 1.038 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.6 pp -118.76 151.9 37.18 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 176.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.672 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 17.0 t70 -84.7 162.87 19.51 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.668 -176.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.973 ' HB2' HG21 ' A' ' 71' ' ' VAL . 50.7 ttp85 -53.5 -17.71 2.23 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.816 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -79.0 -28.81 43.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.819 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.572 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 109.33 35.49 2.28 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.475 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -128.77 102.8 19.44 Favored Pre-proline 0 C--O 1.236 0.376 0 CA-C-N 116.971 0.386 . . . . 0.0 110.891 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.683 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.7 Cg_exo -72.8 115.64 4.42 Favored 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 121.83 1.687 . . . . 0.0 115.696 -177.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.672 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 12.3 p90 -129.52 167.06 18.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.562 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.741 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 6.2 mp0 -107.35 130.3 54.81 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.924 ' O ' HD23 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -127.31 141.45 51.7 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 121.785 0.802 . . . . 0.0 111.703 -178.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.998 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 11.4 pt-20 -94.13 123.69 37.67 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.998 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.923 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -115.67 135.19 54.3 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.586 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.791 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.2 m-20 -126.94 163.12 24.37 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.788 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 50.55 -139.46 21.94 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 120.218 1.372 . . . . 0.0 115.726 177.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.72 ' CD2' HG13 ' A' ' 62' ' ' VAL . 25.6 tp -54.69 -30.3 55.32 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.38 -0.91 . . . . 0.0 111.643 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.923 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.5 OUTLIER -71.38 -53.32 14.49 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.56 0.695 . . . . 0.0 109.286 179.451 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.831 ' HB1' HG22 ' A' ' 106' ' ' VAL . . . -59.46 -39.77 84.71 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.332 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.977 HG23 ' HG3' ' A' ' 102' ' ' ARG . 45.9 mm -67.0 -54.51 23.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.347 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 1.018 ' HB3' ' H91' ' A' ' 149' ' ' BB2 . 73.0 m -60.61 -50.44 73.51 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.945 HD11 HD11 ' A' ' 108' ' ' ILE . 21.2 tt -58.61 -44.59 89.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.697 0.284 . . . . 0.0 110.961 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.653 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.7 pt20 -65.84 -37.65 86.79 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.606 ' HD2' ' HN1' ' A' ' 149' ' ' BB2 . 75.8 t60 -60.15 -47.12 87.27 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.548 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.849 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 3.0 mm-40 -60.1 -38.03 81.77 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.889 ' HE1' ' HB2' ' A' ' 77' ' ' LEU . 72.4 mtp -58.07 -45.01 87.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 122.344 1.069 . . . . 0.0 109.183 177.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.845 ' OD1' ' HD3' ' A' ' 140' ' ' LYS . 57.0 m-20 -67.76 -48.73 65.56 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.0 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.695 ' CE1' ' HG2' ' A' ' 50' ' ' GLN . 6.4 t-80 -57.71 -52.87 63.66 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.393 0.616 . . . . 0.0 111.648 -178.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.995 HD22 ' HA ' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -64.95 -28.8 69.77 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 119.822 -0.751 . . . . 0.0 111.762 -179.291 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.908 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 11.5 p -81.47 24.16 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 122.08 0.943 . . . . 0.0 109.364 175.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.618 ' O ' ' HA ' ' A' ' 14' ' ' ARG . . . 68.41 -3.63 5.82 Favored Glycine 0 CA--C 1.484 -1.886 0 CA-C-N 113.769 -1.56 . . . . 0.0 113.217 175.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.908 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 11.4 ptmt -87.6 142.25 27.99 Favored 'General case' 0 N--CA 1.408 -2.552 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.796 HD22 ' C ' ' A' ' 140' ' ' LYS . 3.8 mm? -134.9 151.37 50.83 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 120.866 -0.333 . . . . 0.0 110.182 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.717 ' O ' HD23 ' A' ' 146' ' ' LEU . 14.1 p90 -54.39 -37.43 65.02 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.421 ' N ' ' CD1' ' A' ' 142' ' ' PHE . 15.6 tpt -52.31 -26.56 12.42 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.54 0.686 . . . . 0.0 111.003 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -56.57 -21.56 27.4 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.208 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -122.05 4.66 9.85 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -177.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.717 HD23 ' O ' ' A' ' 142' ' ' PHE . 3.9 mm? -86.26 145.55 26.9 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.731 0.3 . . . . 0.0 111.087 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 82.5 p . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.971 179.616 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 149' ' ' BB2 . . . . . 1.018 ' H91' ' HB3' ' A' ' 129' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 48.4 t . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.866 0.365 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 1.007 HG13 HG23 ' A' ' 37' ' ' THR . 40.5 t -88.22 134.04 29.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.119 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 1.042 HD11 ' HB ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -79.1 -143.43 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.34 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.426 ' H ' ' HG ' ' A' ' 3' ' ' LEU . 66.0 tt0 -107.31 104.49 14.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 118.174 0.443 . . . . 0.0 110.363 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.529 ' CG2' HG21 ' A' ' 37' ' ' THR . 44.1 t -87.77 125.11 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 121.557 0.694 . . . . 0.0 111.967 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.032 ' HB2' HD21 ' A' ' 13' ' ' LEU . 20.9 mt -87.63 138.68 31.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.07 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.577 ' C ' HD11 ' A' ' 13' ' ' LEU . 32.7 m-70 -111.69 149.39 31.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.172 0.511 . . . . 0.0 111.91 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.017 HD13 HD12 ' A' ' 13' ' ' LEU . 47.1 mm -57.21 145.41 66.48 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.392 178.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.554 ' HA ' HG23 ' A' ' 8' ' ' ILE . 72.7 Cg_endo -92.68 52.48 1.0 Allowed 'Cis proline' 0 C--N 1.353 0.808 0 C-N-CA 124.597 -1.001 . . . . 0.0 112.872 0.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 1.009 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 9.4 t0 -53.81 134.45 42.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.972 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 23.8 pt-20 -59.23 -45.22 91.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.425 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.676 ' O ' ' HB ' ' A' ' 49' ' ' THR . 28.2 mtt-85 -59.29 -23.78 62.71 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 1.032 HD21 ' HB2' ' A' ' 6' ' ' LEU . 11.2 mt -73.48 -33.06 64.64 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 119.661 1.119 . . . . 0.0 108.393 178.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.698 ' C ' ' HA3' ' A' ' 139' ' ' GLY . 15.0 mmm180 -98.34 11.19 38.81 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.784 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.579 ' HB2' ' HA ' ' A' ' 12' ' ' ARG . 62.3 tttp -87.06 148.05 25.43 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.217 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.951 HG13 HG23 ' A' ' 138' ' ' VAL . 48.9 t -82.41 118.65 30.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.771 ' HB3' HD12 ' A' ' 137' ' ' LEU . . . -78.08 146.5 35.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.272 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -103.83 127.99 28.22 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.603 ' HD3' ' CD ' ' A' ' 56' ' ' ARG . 64.4 Cg_endo -78.24 115.51 3.73 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.206 1.937 . . . . 0.0 110.984 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.9 HG12 ' H ' ' A' ' 22' ' ' GLU . 21.7 t -68.32 144.27 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 CA-C-O 122.717 1.246 . . . . 0.0 113.28 -175.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -67.79 -26.52 66.13 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 112.731 -2.031 . . . . 0.0 112.203 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.9 ' H ' HG12 ' A' ' 20' ' ' VAL . 42.4 tt0 -154.47 145.17 22.39 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.168 -178.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 1.034 HG21 ' HA2' ' A' ' 115' ' ' GLY . 4.6 t -79.6 103.8 6.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -178.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.932 ' CB ' HD13 ' A' ' 27' ' ' ILE . 14.8 m-20 -93.19 155.6 17.35 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.701 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.705 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -56.17 -25.92 48.6 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.278 0.561 . . . . 0.0 110.88 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.51 ' HA ' ' OE1' ' A' ' 26' ' ' GLU . 4.2 mm-40 -75.29 -40.45 58.62 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.932 HD13 ' CB ' ' A' ' 24' ' ' ASN . 1.8 mp -66.76 -35.01 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 113.86 -1.518 . . . . 0.0 110.238 178.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -70.39 -38.88 74.75 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 122.208 -0.307 . . . . 0.0 110.715 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.705 ' HG3' ' O ' ' A' ' 25' ' ' ALA . 39.8 mtp85 -64.05 -39.0 93.12 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.784 ' O ' ' HG3' ' A' ' 34' ' ' MET . 3.0 mt -56.88 -49.16 79.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.771 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.915 HG22 ' CG2' ' A' ' 57' ' ' ILE . 9.6 t -67.36 -41.13 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 CA-C-O 121.004 0.43 . . . . 0.0 110.815 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.84 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 21.1 m-20 -54.74 -43.53 72.77 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.351 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.521 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 19.1 m-20 -76.4 -29.3 57.03 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.546 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' MET . . . . . 1.042 ' HG2' HG21 ' A' ' 51' ' ' VAL . 85.0 mtp -59.87 -46.07 90.46 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.247 -178.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.84 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 13.2 p90 -69.9 -45.24 68.04 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 176.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.758 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 40.3 mt-10 -52.37 -38.52 59.05 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 121.707 0.765 . . . . 0.0 109.291 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . 1.007 HG23 HG13 ' A' ' 2' ' ' VAL . 88.6 m -70.35 -61.72 1.66 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.273 -1.331 . . . . 0.0 107.833 177.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.924 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 2.8 ttp -45.77 -40.78 10.01 Favored 'General case' 0 CA--C 1.46 -2.488 0 C-N-CA 124.321 1.048 . . . . 0.0 110.059 -171.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.677 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 18.6 m-85 -70.1 -43.09 71.77 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.097 178.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 37' ' ' THR . . . -60.85 -25.17 66.45 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.75 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 1.057 ' HG2' HD12 ' A' ' 91' ' ' LEU . 17.0 tp10 -88.76 -11.46 44.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.645 -1.161 . . . . 0.0 108.469 176.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.439 ' H ' ' C ' ' A' ' 39' ' ' TYR . 18.2 mt-10 64.31 26.41 13.65 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.943 -176.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.966 ' HA2' H182 ' A' ' 149' ' ' BB2 . . . -81.31 142.67 23.21 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 113.947 -1.479 . . . . 0.0 111.276 178.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.863 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 42.6 mm -79.33 -0.95 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 117.293 0.547 . . . . 0.0 112.208 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.855 ' HA3' H113 ' A' ' 149' ' ' BB2 . . . 179.0 135.27 2.32 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 118.928 -0.929 . . . . 0.0 111.437 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.069 HD13 ' HG ' ' A' ' 91' ' ' LEU . 4.5 tp -125.17 133.96 52.59 Favored 'General case' 0 C--N 1.354 0.783 0 CA-C-N 119.332 1.566 . . . . 0.0 111.64 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.803 ' HB2' ' OE1' ' A' ' 133' ' ' GLU . . . -99.83 131.36 45.85 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 122.184 0.194 . . . . 0.0 111.151 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.867 ' HB1' ' CG1' ' A' ' 53' ' ' ILE . . . -30.38 -54.87 0.19 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.676 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 82.7 p -53.1 -36.21 60.49 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.482 0.658 . . . . 0.0 111.829 -178.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.768 ' OE1' HD12 ' A' ' 46' ' ' LEU . 86.0 mt-30 -63.85 -42.26 97.61 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.998 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.042 HG21 ' HG2' ' A' ' 34' ' ' MET . 0.8 OUTLIER -83.49 16.6 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.875 ' HA ' HD11 ' A' ' 6' ' ' LEU . 37.8 t70 73.79 29.86 1.42 Allowed 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 177.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.867 ' CG1' ' HB1' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -121.25 109.51 25.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 C-N-CA 119.179 -1.009 . . . . 0.0 110.609 177.303 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 21.6 p-80 -76.47 63.6 2.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.378 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.759 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 88.9 mt-30 -153.94 132.47 12.12 Favored 'General case' 0 C--O 1.219 -0.512 0 CA-C-N 114.194 -1.366 . . . . 0.0 107.875 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.68 ' N ' ' HB1' ' A' ' 17' ' ' ALA . 74.7 mtp180 -63.01 69.03 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -177.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.915 ' CG2' HG22 ' A' ' 31' ' ' VAL . 8.1 mm -111.81 123.06 67.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.029 HD11 ' HB2' ' A' ' 72' ' ' LEU . 2.0 pp -128.24 144.36 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 119.698 -0.801 . . . . 0.0 112.977 -177.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 46' ' ' LEU . 33.2 m -127.47 137.64 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.676 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.019 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 2.2 mt -115.59 151.03 17.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.57 0.7 . . . . 0.0 110.972 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.924 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 34.6 t70 -135.2 24.1 3.52 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.858 -178.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.806 HG22 ' CG2' ' A' ' 44' ' ' ILE . 23.5 t -94.82 113.48 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.46 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.499 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 50.7 m -37.56 81.19 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -177.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 62' ' ' VAL . 41.2 tt0 -72.55 -25.2 61.28 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.999 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.419 ' C ' ' H ' ' A' ' 67' ' ' ASP . 9.2 t-20 -165.99 -141.87 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.828 HH11 ' HA ' ' A' ' 66' ' ' ARG . 2.3 mmm180 -83.57 38.48 0.63 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.419 ' H ' ' C ' ' A' ' 65' ' ' ASN . 59.2 m-20 -160.28 126.19 4.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.958 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.499 ' HG2' ' HA ' ' A' ' 63' ' ' SER . 44.5 mt-10 -111.27 61.78 0.61 Allowed 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.011 0.434 . . . . 0.0 112.119 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.63 ' HD3' ' O ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -151.75 96.28 2.22 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.241 0.544 . . . . 0.0 110.528 -179.061 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 1.019 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 7.9 mp -111.52 137.64 49.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.027 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.847 HG21 ' HB2' ' A' ' 113' ' ' ARG . 9.0 p -133.08 132.87 58.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.73 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.029 ' HB2' HD11 ' A' ' 58' ' ' ILE . 3.3 mm? -141.86 143.04 33.16 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 177.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.013 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.9 mp -121.03 136.21 58.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.761 0.315 . . . . 0.0 110.588 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.67 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 0.6 OUTLIER 45.49 40.23 0.6 Allowed Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 113.826 1.046 . . . . 0.0 113.826 -179.698 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.776 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 99.2 Cg_exo -56.56 150.96 48.97 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.831 2.354 . . . . 0.0 113.151 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -135.63 143.79 45.73 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.759 HD23 ' N ' ' A' ' 78' ' ' LEU . 1.5 tt -80.57 133.69 35.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.274 0.559 . . . . 0.0 111.723 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.062 HD13 ' HA ' ' A' ' 108' ' ' ILE . 4.8 mp -108.54 -44.78 4.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.207 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.59 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 5.2 tp10 -152.25 146.95 25.81 Favored 'General case' 0 N--CA 1.46 0.065 0 CA-C-O 121.095 0.474 . . . . 0.0 111.325 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.814 ' CB ' HG12 ' A' ' 106' ' ' VAL . 10.9 ptmm? -147.67 145.12 28.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.349 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.3 t -160.14 151.78 19.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.463 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.76 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 80.85 160.42 23.86 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.492 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -137.1 113.37 9.95 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.954 0.883 . . . . 0.0 113.065 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.661 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.5 p -105.59 161.59 14.24 Favored 'General case' 0 CA--C 1.487 -1.468 0 CA-C-N 114.061 -1.427 . . . . 0.0 114.761 178.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.783 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -146.03 114.81 0.77 Allowed Glycine 0 C--N 1.309 -0.928 0 CA-C-N 112.818 -1.992 . . . . 0.0 110.396 177.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.635 HD13 ' O ' ' A' ' 85' ' ' GLY . 49.3 mm -146.9 137.86 18.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-N 117.368 0.584 . . . . 0.0 111.206 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 50.4 mt-10 -71.41 137.23 48.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 123.193 1.473 . . . . 0.0 112.066 -176.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.774 ' HB3' H262 ' A' ' 149' ' ' BB2 . 40.8 mt-10 -154.76 161.62 41.44 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 112.196 -2.275 . . . . 0.0 111.079 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.888 ' O ' ' H52' ' A' ' 149' ' ' BB2 . . . -120.32 163.84 13.98 Favored Glycine 0 CA--C 1.499 -0.937 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.765 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 13.1 m -117.86 140.88 49.08 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 117.729 0.765 . . . . 0.0 111.101 -178.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.069 ' HG ' HD13 ' A' ' 46' ' ' LEU . 2.2 mm? -47.47 -26.65 1.44 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.971 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.883 ' CB ' HD13 ' A' ' 13' ' ' LEU . 54.1 m -79.36 -35.69 40.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.924 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.754 ' CG2' ' HD2' ' A' ' 94' ' ' PRO . 59.0 mt -85.5 149.01 50.81 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.648 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.754 ' HD2' ' CG2' ' A' ' 93' ' ' ILE . 96.7 Cg_endo -73.07 50.53 1.85 Allowed 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 122.38 2.053 . . . . 0.0 113.865 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 94' ' ' PRO . 51.2 mt-10 76.03 13.99 2.62 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.984 0.421 . . . . 0.0 112.009 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.751 ' HB2' HG21 ' A' ' 93' ' ' ILE . 99.1 mm-40 -78.6 88.56 4.52 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.7 ' HG2' ' HA3' ' A' ' 89' ' ' GLY . 15.6 mtt85 -85.18 132.46 34.29 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.649 0.737 . . . . 0.0 111.722 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 87' ' ' GLU . . . -134.73 155.86 49.82 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 114.581 -1.191 . . . . 0.0 109.479 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.783 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.6 tt -76.38 113.8 14.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.666 0.746 . . . . 0.0 111.813 -178.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.997 HG13 ' HB2' ' A' ' 142' ' ' PHE . 40.3 t -104.29 132.25 21.15 Favored Pre-proline 0 N--CA 1.47 0.572 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.939 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.661 ' HA ' ' O ' ' A' ' 84' ' ' THR . 92.2 Cg_endo -84.26 127.45 3.95 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.596 2.197 . . . . 0.0 112.496 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.865 ' HB2' ' OE1' ' A' ' 131' ' ' GLN . 0.0 OUTLIER -144.39 166.98 23.57 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.54 0.736 . . . . 0.0 109.357 178.939 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.76 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.69 155.62 39.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 118.307 0.503 . . . . 0.0 110.301 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -73.12 -41.32 64.12 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.19 -176.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.699 ' HB3' ' OD1' ' A' ' 123' ' ' ASP . 66.8 mttm -139.67 140.5 36.9 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.467 0.651 . . . . 0.0 109.505 177.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.814 HG12 ' CB ' ' A' ' 80' ' ' LYS . 30.6 m -147.5 136.95 16.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.186 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 1.071 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 52.1 mmtt -107.58 126.02 52.03 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 1.062 ' HA ' HD13 ' A' ' 78' ' ' LEU . 1.7 pp -136.34 151.3 28.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -176.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 1.009 ' HG3' HD11 ' A' ' 78' ' ' LEU . 94.4 mtt180 -102.17 138.89 38.51 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.865 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.875 ' HB3' HD12 ' A' ' 72' ' ' LEU . . . -159.98 168.73 25.0 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.866 -177.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 1.013 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.4 pp -116.42 151.58 35.71 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.473 ' OD1' HG13 ' A' ' 71' ' ' VAL . 17.9 t70 -85.96 164.48 17.39 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.873 -176.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.847 ' HB2' HG21 ' A' ' 71' ' ' VAL . 48.0 ttp180 -52.01 -20.36 2.36 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.016 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -79.12 -25.67 42.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.526 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 1.034 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 105.91 36.28 2.8 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.223 -0.989 . . . . 0.0 113.525 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -128.64 102.82 19.77 Favored Pre-proline 0 C--O 1.237 0.403 0 CA-C-N 116.736 0.268 . . . . 0.0 110.737 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.66 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 32.1 Cg_exo -72.89 115.12 4.23 Favored 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 121.748 1.632 . . . . 0.0 115.389 -177.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.41 ' CE2' ' HB2' ' A' ' 112' ' ' ASP . 0.4 OUTLIER -126.32 167.05 16.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.422 -178.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.639 ' CG ' ' HG2' ' A' ' 109' ' ' ARG . 3.1 mp0 -107.33 130.18 54.81 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.794 HD11 ' CD1' ' A' ' 130' ' ' ILE . 4.4 pp -126.6 133.62 51.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.342 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 1.071 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 15.5 pt-20 -96.32 123.9 40.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.984 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.772 ' O ' ' HB2' ' A' ' 127' ' ' ALA . . . -116.63 136.47 52.94 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.699 ' OD1' ' HB3' ' A' ' 105' ' ' LYS . 41.6 m-20 -127.15 162.71 25.47 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.785 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 51.58 -138.67 28.49 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 120.539 1.518 . . . . 0.0 115.271 177.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.69 HD22 ' H ' ' A' ' 125' ' ' LEU . 2.6 mm? -53.37 -32.4 49.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.899 -0.651 . . . . 0.0 111.401 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.732 HD22 ' CB ' ' A' ' 122' ' ' ALA . 0.6 OUTLIER -70.77 -52.64 19.38 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.847 0.832 . . . . 0.0 109.487 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.772 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -59.73 -39.5 84.95 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.551 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.857 HD12 ' HG2' ' A' ' 102' ' ' ARG . 46.5 mm -68.97 -56.04 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -178.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.849 ' HB2' ' H91' ' A' ' 149' ' ' BB2 . 29.7 p -58.15 -49.93 75.29 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 1.016 HD11 HD11 ' A' ' 108' ' ' ILE . 19.1 tt -59.34 -44.19 91.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.179 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.865 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.0 pt20 -67.79 -39.76 84.01 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.39 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.647 ' HA ' ' OD1' ' A' ' 135' ' ' ASP . 69.0 t60 -57.04 -47.37 81.1 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.568 0.699 . . . . 0.0 109.869 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.912 ' O ' HD23 ' A' ' 137' ' ' LEU . 48.0 mm-40 -61.35 -39.6 91.2 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.272 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.882 ' HA ' HD21 ' A' ' 137' ' ' LEU . 74.6 mtp -58.43 -49.66 76.51 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.476 0.655 . . . . 0.0 111.005 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.771 ' OD2' HD13 ' A' ' 141' ' ' LEU . 5.6 p-10 -65.78 -45.03 83.99 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.756 178.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 1.007 ' HA ' HD21 ' A' ' 141' ' ' LEU . 9.0 t-80 -55.94 -52.53 63.82 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 121.466 -0.771 . . . . 0.0 111.17 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.912 HD23 ' O ' ' A' ' 133' ' ' GLU . 1.3 pp -59.17 -30.97 68.57 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.2 -178.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.951 HG23 HG13 ' A' ' 16' ' ' VAL . 12.7 p -86.07 22.76 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-O 122.264 1.03 . . . . 0.0 109.268 176.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.698 ' HA3' ' C ' ' A' ' 14' ' ' ARG . . . 55.6 37.85 69.22 Favored Glycine 0 CA--C 1.484 -1.9 0 CA-C-N 113.493 -1.685 . . . . 0.0 112.415 176.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.934 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 3.7 ptmt -135.71 106.16 6.45 Favored 'General case' 0 N--CA 1.421 -1.91 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.754 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 1.007 HD21 ' HA ' ' A' ' 136' ' ' HIS . 3.2 mm? -127.39 148.14 50.27 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 120.894 -1.129 . . . . 0.0 109.522 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.997 ' HB2' HG13 ' A' ' 100' ' ' VAL . 6.4 m-85 -62.6 -36.98 84.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.929 0.395 . . . . 0.0 111.47 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' MET . . . . . 1.026 ' HA ' HD23 ' A' ' 146' ' ' LEU . 15.8 tpt -54.8 -25.07 25.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.696 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.57 ' OD2' ' HD3' ' A' ' 14' ' ' ARG . 8.8 t70 -50.11 -24.95 3.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.501 -178.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -129.62 47.07 2.54 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 120.911 0.386 . . . . 0.0 110.596 -177.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 1.026 HD23 ' HA ' ' A' ' 143' ' ' MET . 3.0 mm? -91.04 138.42 31.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.022 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 80.5 p . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.963 179.719 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 149' ' ' BB2 . . . . . 0.966 H182 ' HA2' ' A' ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 46.0 t . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.869 0.366 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.954 HG13 HG23 ' A' ' 37' ' ' THR . 41.9 t -83.55 131.31 34.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.523 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 1.016 HD11 ' HB ' ' A' ' 51' ' ' VAL . 1.9 pt? -83.1 -148.76 0.09 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.262 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.42 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 65.2 tt0 -102.28 106.34 17.13 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.994 0.426 . . . . 0.0 110.831 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.552 HG11 HD12 ' A' ' 91' ' ' LEU . 45.2 t -88.84 127.63 41.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.372 0.606 . . . . 0.0 111.539 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.959 ' HB2' HD21 ' A' ' 13' ' ' LEU . 24.9 mt -83.9 142.7 30.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.805 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -114.08 145.43 41.62 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.075 0.464 . . . . 0.0 111.911 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.63 HD12 ' H ' ' A' ' 8' ' ' ILE . 2.9 mp -55.8 146.95 44.61 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.883 178.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.583 ' HA ' HG23 ' A' ' 8' ' ' ILE . 74.8 Cg_endo -93.17 52.13 1.06 Allowed 'Cis proline' 0 C--N 1.354 0.838 0 C-N-CA 124.38 -1.092 . . . . 0.0 113.47 0.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.56 133.74 50.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.914 0.388 . . . . 0.0 110.853 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.492 ' CD ' ' H ' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -58.8 -41.09 85.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.59 -179.149 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.613 ' HB2' HD13 ' A' ' 6' ' ' LEU . 42.8 mtt180 -58.18 -25.03 61.05 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.959 HD21 ' HB2' ' A' ' 6' ' ' LEU . 11.3 mt -75.6 -33.14 60.54 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 120.378 1.445 . . . . 0.0 108.425 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.612 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 20.6 mmm-85 -93.29 8.76 39.04 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 113.762 -1.563 . . . . 0.0 109.297 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.484 ' HB2' ' HA ' ' A' ' 12' ' ' ARG . 63.7 tttm -90.36 148.94 22.51 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.748 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.935 HG13 HG23 ' A' ' 138' ' ' VAL . 58.7 t -83.4 124.21 39.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.998 0.428 . . . . 0.0 109.871 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.794 ' HB3' HD12 ' A' ' 137' ' ' LEU . . . -80.8 148.53 29.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.002 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -109.07 130.74 22.37 Favored Pre-proline 0 C--N 1.327 -0.405 0 C-N-CA 121.165 -0.214 . . . . 0.0 110.634 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.873 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 60.8 Cg_endo -79.62 113.89 3.15 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 121.99 1.794 . . . . 0.0 110.821 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.738 HG12 ' H ' ' A' ' 22' ' ' GLU . 16.7 t -68.56 144.92 13.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 122.629 1.204 . . . . 0.0 113.558 -175.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.4 ' N ' HG12 ' A' ' 20' ' ' VAL . 69.9 mm-40 -61.54 -27.38 68.57 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 113.143 -1.844 . . . . 0.0 112.349 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.738 ' H ' HG12 ' A' ' 20' ' ' VAL . 5.0 tp10 -156.76 151.77 26.13 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.789 -178.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.678 HG21 ' HA2' ' A' ' 115' ' ' GLY . 3.2 t -80.38 103.65 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -178.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 1.083 ' H ' HD12 ' A' ' 27' ' ' ILE . 22.6 m-20 -85.7 153.26 22.46 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.167 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.576 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -54.69 -31.95 58.72 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.44 0.638 . . . . 0.0 110.085 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.536 ' HG2' ' NH2' ' A' ' 29' ' ' ARG . 49.7 mt-10 -71.52 -38.05 71.13 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 1.083 HD12 ' H ' ' A' ' 24' ' ' ASN . 68.5 mt -65.86 -38.79 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 113.964 -1.471 . . . . 0.0 110.494 178.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -66.94 -40.57 87.62 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.746 -0.206 . . . . 0.0 110.976 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.576 ' HG3' ' O ' ' A' ' 25' ' ' ALA . 83.9 mtm180 -63.88 -38.65 91.88 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.842 ' O ' ' HG3' ' A' ' 34' ' ' MET . 5.0 mt -56.28 -50.77 69.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.496 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.874 HG22 ' CG2' ' A' ' 57' ' ' ILE . 13.7 t -66.19 -41.47 89.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.95 0.405 . . . . 0.0 111.39 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.923 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -56.59 -42.56 78.9 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -179.26 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.493 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 14.8 m-20 -76.29 -30.15 57.66 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.768 176.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.961 ' HE1' HG22 ' A' ' 57' ' ' ILE . 23.0 mtm -60.26 -46.84 88.4 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.297 -177.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.923 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 9.6 p90 -69.58 -43.67 72.36 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.61 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 56.1 mm-40 -52.97 -42.03 65.12 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.954 HG23 HG13 ' A' ' 2' ' ' VAL . 98.9 m -69.51 -61.72 1.67 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 118.722 -1.191 . . . . 0.0 108.104 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.882 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 1.7 ttp -46.38 -40.58 12.26 Favored 'General case' 0 CA--C 1.468 -2.202 0 C-N-CA 124.057 0.943 . . . . 0.0 110.18 -171.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.74 ' OH ' ' HA ' ' A' ' 69' ' ' ARG . 45.2 m-85 -69.95 -41.5 74.47 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.023 177.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 37' ' ' THR . . . -61.93 -23.09 66.14 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.008 -0.997 . . . . 0.0 109.561 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.706 ' HG2' ' CD1' ' A' ' 91' ' ' LEU . 13.8 tp10 -90.16 -11.62 40.61 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.177 -1.374 . . . . 0.0 108.267 177.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.445 ' H ' ' C ' ' A' ' 39' ' ' TYR . 22.1 mt-10 63.68 28.75 15.03 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.762 -176.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.916 ' HA3' H173 ' A' ' 149' ' ' BB2 . . . -84.78 141.83 19.7 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 113.683 -1.599 . . . . 0.0 110.691 178.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.797 HG23 ' O ' ' A' ' 61' ' ' ASP . 47.2 mt -79.43 2.18 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 117.859 0.829 . . . . 0.0 111.919 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.829 ' HA3' ' C11' ' A' ' 149' ' ' BB2 . . . 177.25 133.57 1.85 Allowed Glycine 0 CA--C 1.523 0.539 0 CA-C-O 119.06 -0.856 . . . . 0.0 112.043 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.098 HD12 ' HG ' ' A' ' 91' ' ' LEU . 8.8 tt -126.62 135.36 51.11 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 119.116 1.458 . . . . 0.0 110.967 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.655 ' N ' HD23 ' A' ' 46' ' ' LEU . . . -97.99 134.6 40.87 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.867 ' HB1' ' CG1' ' A' ' 53' ' ' ILE . . . -31.01 -55.05 0.22 Allowed 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.962 1.468 . . . . 0.0 114.962 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.537 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 81.3 p -53.09 -36.26 60.5 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.523 0.677 . . . . 0.0 112.361 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.572 HE21 ' H ' ' A' ' 47' ' ' ALA . 27.6 mt-30 -63.93 -40.77 97.24 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.486 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.016 ' HB ' HD11 ' A' ' 3' ' ' LEU . 1.2 m -85.63 17.3 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.607 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.911 ' HA ' HD11 ' A' ' 6' ' ' LEU . 50.8 t0 77.89 26.6 0.61 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 176.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.867 ' CG1' ' HB1' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -121.35 109.84 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 C-N-CA 118.985 -1.086 . . . . 0.0 111.243 177.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.481 ' HD2' ' CZ ' ' A' ' 12' ' ' ARG . 6.8 p80 -76.46 59.47 1.47 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.791 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.722 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 7.1 mp0 -148.75 134.05 18.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.449 -1.251 . . . . 0.0 108.075 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.873 ' HD2' ' HD3' ' A' ' 19' ' ' PRO . 68.0 mtt-85 -63.13 68.65 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -177.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.961 HG22 ' HE1' ' A' ' 34' ' ' MET . 7.4 mm -112.77 122.84 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.038 HD11 ' HB2' ' A' ' 72' ' ' LEU . 2.2 pp -126.24 148.03 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -177.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.621 HG22 ' O ' ' A' ' 46' ' ' LEU . 32.6 m -129.06 138.49 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.212 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.075 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 10.9 mm -115.77 151.95 17.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-O 121.483 0.659 . . . . 0.0 109.859 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.882 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 10.0 t70 -139.78 43.31 1.97 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.821 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.979 HG12 ' H ' ' A' ' 63' ' ' SER . 13.9 t -89.61 -167.25 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.129 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.979 ' H ' HG12 ' A' ' 62' ' ' VAL . 53.1 m -94.87 89.8 5.78 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 119.687 -0.197 . . . . 0.0 110.748 177.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.635 ' HB2' HD11 ' A' ' 70' ' ' LEU . 5.2 tp10 -60.96 -36.26 78.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.243 0.544 . . . . 0.0 110.051 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -161.99 -66.16 0.05 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.093 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -130.99 -36.75 1.32 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.066 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -113.06 127.49 56.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.473 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.593 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 42.2 mt-10 -72.93 134.91 44.95 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.951 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.74 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 71.7 ttt180 173.65 69.2 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 1.075 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 9.4 mp -108.56 137.1 47.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.695 0.283 . . . . 0.0 111.656 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.794 ' C ' HD22 ' A' ' 72' ' ' LEU . 14.6 p -135.57 135.96 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.038 ' HB2' HD11 ' A' ' 58' ' ' ILE . 3.0 mm? -143.91 147.29 33.79 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.539 -0.171 . . . . 0.0 110.539 177.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.064 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.7 mp -122.11 136.5 58.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.564 0.221 . . . . 0.0 110.419 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.713 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 58.9 m-20 50.38 37.98 0.47 Allowed Pre-proline 0 CA--C 1.55 0.96 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.869 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 79.6 Cg_exo -58.23 147.48 83.92 Favored 'Trans proline' 0 N--CA 1.486 1.085 0 C-N-CA 123.137 2.558 . . . . 0.0 114.844 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.433 ' O ' ' HB ' ' A' ' 108' ' ' ILE . 11.8 pt-20 -136.37 140.51 43.3 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.907 ' HA ' HG22 ' A' ' 108' ' ' ILE . 1.7 tt -81.95 134.51 35.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.177 0.513 . . . . 0.0 111.267 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.039 HD13 ' HA ' ' A' ' 108' ' ' ILE . 5.9 mp -109.57 -43.76 4.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.13 -178.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 39.3 tt0 -147.54 149.73 33.17 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.05 0.452 . . . . 0.0 111.611 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.968 ' HA ' HG12 ' A' ' 106' ' ' VAL . 9.2 ptpp? -147.6 143.86 28.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.83 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.6 p -155.4 147.22 23.28 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.786 0.327 . . . . 0.0 111.257 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.742 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 81.22 147.82 5.79 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.114 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -115.57 114.29 24.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.724 0.773 . . . . 0.0 112.542 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.769 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.7 p -116.51 161.14 19.59 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 115.505 1.669 . . . . 0.0 115.505 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.829 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -150.09 119.17 1.0 Allowed Glycine 0 C--N 1.312 -0.764 0 CA-C-N 112.363 -2.198 . . . . 0.0 111.499 178.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.638 HD13 ' O ' ' A' ' 85' ' ' GLY . 49.5 mm -146.45 136.44 17.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 117.278 0.539 . . . . 0.0 111.373 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 50.2 mt-10 -72.47 141.23 48.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 122.841 1.305 . . . . 0.0 112.657 -176.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.681 ' HG2' ' O27' ' A' ' 149' ' ' BB2 . 55.2 mt-10 -153.71 163.97 39.1 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 112.713 -2.039 . . . . 0.0 111.538 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.736 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -120.36 168.59 13.88 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.796 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 90.3 m -114.12 140.02 48.84 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.215 -0.594 . . . . 0.0 112.03 -177.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.098 ' HG ' HD12 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -53.87 -16.65 1.91 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.845 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.563 ' CB ' HD13 ' A' ' 13' ' ' LEU . 22.0 m -102.96 -31.55 10.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.507 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.85 HD13 ' HE3' ' A' ' 143' ' ' MET . 48.0 mt -85.17 151.06 56.32 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.332 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.771 ' HD2' ' CG2' ' A' ' 93' ' ' ILE . 68.3 Cg_endo -63.05 -148.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.21 1.94 . . . . 0.0 111.349 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.43 ' H ' ' HB2' ' A' ' 94' ' ' PRO . 95.2 mt-10 -78.4 12.43 1.96 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.145 0.498 . . . . 0.0 110.815 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.571 ' HG3' ' HG2' ' A' ' 94' ' ' PRO . 85.1 mt-30 -78.93 81.49 5.2 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.213 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.736 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 55.5 mtm-85 -86.8 133.73 33.62 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.109 0.481 . . . . 0.0 109.931 178.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -125.06 146.03 49.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.054 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.829 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.3 tt -76.1 113.69 13.91 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.847 0.832 . . . . 0.0 110.779 -178.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.902 HG13 ' CG ' ' A' ' 142' ' ' PHE . 48.8 t -101.82 128.79 27.96 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.706 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.957 ' HD2' ' CD2' ' A' ' 142' ' ' PHE . 87.6 Cg_endo -83.0 126.13 4.32 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.163 1.908 . . . . 0.0 111.57 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.811 HH21 ' CG1' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -144.11 166.71 24.23 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.378 179.432 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.742 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.05 155.09 40.28 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.881 0.372 . . . . 0.0 110.461 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -72.26 -40.89 67.33 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.475 -175.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.732 ' HB3' ' OD1' ' A' ' 123' ' ' ASP . 67.1 mttm -140.42 140.22 35.41 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.395 0.617 . . . . 0.0 109.507 176.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.968 HG12 ' HA ' ' A' ' 80' ' ' LYS . 25.3 m -150.42 141.37 16.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.417 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.957 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 23.7 mmtp -108.0 126.48 52.77 Favored 'General case' 0 C--O 1.227 -0.093 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 1.039 ' HA ' HD13 ' A' ' 78' ' ' LEU . 1.8 pp -135.36 152.9 32.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -176.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 1.027 ' HG3' HD11 ' A' ' 78' ' ' LEU . 44.2 mtm180 -103.45 140.73 37.09 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.926 0.87 . . . . 0.0 111.507 -178.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.733 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -161.14 169.51 22.18 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.483 -177.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 1.064 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 1.9 pp -116.64 149.76 39.22 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 176.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.809 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 23.1 t70 -84.41 163.66 19.36 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.587 -176.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.764 ' HD2' ' OD1' ' A' ' 32' ' ' ASP . 14.5 ttp-105 -53.48 -17.24 1.85 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.865 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -79.13 -28.35 42.9 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.948 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.678 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 107.63 35.8 2.55 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.622 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -128.82 103.25 19.1 Favored Pre-proline 0 C--O 1.237 0.43 0 CA-C-N 116.699 0.25 . . . . 0.0 110.705 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.692 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 32.7 Cg_exo -71.99 114.51 3.99 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 121.34 1.36 . . . . 0.0 114.619 -177.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.809 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 10.2 p90 -127.16 168.6 14.45 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.484 -178.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.669 ' HG2' ' HD2' ' A' ' 109' ' ' ARG . 29.8 mt-10 -107.03 129.72 54.76 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.723 ' O ' HD12 ' A' ' 120' ' ' LEU . 4.3 pp -123.45 132.63 53.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.434 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.957 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 9.0 pm0 -92.54 123.38 35.8 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.54 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.808 ' O ' ' HB2' ' A' ' 127' ' ' ALA . . . -117.05 133.54 55.87 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 120.47 -0.492 . . . . 0.0 112.134 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.732 ' OD1' ' HB3' ' A' ' 105' ' ' LYS . 29.4 m-20 -127.81 160.73 30.86 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.663 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 54.9 -138.09 42.7 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 120.952 1.705 . . . . 0.0 114.779 177.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.679 HD12 ' H ' ' A' ' 125' ' ' LEU . 4.7 mp -54.24 -32.29 55.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.2 -0.5 . . . . 0.0 111.333 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.747 HD22 ' CB ' ' A' ' 122' ' ' ALA . 0.6 OUTLIER -70.72 -51.79 25.15 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.394 0.616 . . . . 0.0 109.676 179.707 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.808 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -61.67 -46.76 88.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.949 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.778 HG23 ' CG ' ' A' ' 102' ' ' ARG . 47.3 mm -64.43 -55.67 20.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -177.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 1.066 ' HB3' H112 ' A' ' 149' ' ' BB2 . 78.0 m -58.56 -48.08 82.1 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.912 HD11 HD11 ' A' ' 108' ' ' ILE . 20.2 tt -59.35 -41.86 85.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.157 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.798 ' CG ' HG21 ' A' ' 106' ' ' VAL . 36.8 mt-30 -64.86 -38.51 91.22 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.761 0.315 . . . . 0.0 110.185 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.963 ' HD2' ' H81' ' A' ' 149' ' ' BB2 . 79.6 t60 -58.7 -45.54 89.27 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.295 0.569 . . . . 0.0 110.401 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.916 ' O ' HD23 ' A' ' 137' ' ' LEU . 4.5 mm-40 -60.72 -43.2 98.15 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.732 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.917 ' HA ' HD21 ' A' ' 137' ' ' LEU . 70.2 mtp -57.85 -48.55 79.47 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.374 0.607 . . . . 0.0 110.934 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.754 ' OD2' ' HA ' ' A' ' 132' ' ' HIS . 2.5 p30 -65.14 -46.32 81.4 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.114 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.894 ' CG ' HD11 ' A' ' 141' ' ' LEU . 11.7 t-80 -58.95 -51.69 68.95 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 121.698 -0.626 . . . . 0.0 111.527 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.917 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.4 pp -60.12 -31.42 70.04 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.952 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.979 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 14.2 p -82.98 25.49 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-O 122.487 1.136 . . . . 0.0 109.825 177.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.648 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 60.13 6.49 5.64 Favored Glycine 0 CA--C 1.487 -1.682 0 CA-C-N 113.082 -1.872 . . . . 0.0 113.382 176.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.979 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 14.3 ptmt -93.77 137.23 33.23 Favored 'General case' 0 N--CA 1.413 -2.297 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.894 HD11 ' CG ' ' A' ' 136' ' ' HIS . 3.1 mm? -141.37 141.51 33.81 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.957 ' CD2' ' HD2' ' A' ' 101' ' ' PRO . 6.2 m-85 -62.86 -30.12 71.27 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.85 ' HE3' HD13 ' A' ' 93' ' ' ILE . 48.9 ttm -56.5 -29.0 61.29 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.442 0.639 . . . . 0.0 110.198 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -60.66 -22.54 63.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.689 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -116.63 13.55 15.26 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.051 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.455 ' HG ' ' HA ' ' A' ' 143' ' ' MET . 85.9 mt -90.56 143.05 27.12 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.643 0.259 . . . . 0.0 110.833 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 86.9 p . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.929 179.807 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 149' ' ' BB2 . . . . . 1.066 H112 ' HB3' ' A' ' 129' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 53.3 m . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.839 0.352 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 1.037 HG12 ' HA ' ' A' ' 37' ' ' THR . 30.9 m -84.14 132.8 30.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.987 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.787 HD13 ' OG1' ' A' ' 37' ' ' THR . 0.0 OUTLIER -85.28 -172.8 4.35 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.605 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.604 ' O ' ' HG2' ' A' ' 4' ' ' GLN . 7.9 pm0 -79.88 111.09 15.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.28 0.562 . . . . 0.0 110.993 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.627 ' CG2' HG21 ' A' ' 37' ' ' THR . 39.0 t -89.52 131.4 36.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.975 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.057 ' HB2' HD21 ' A' ' 13' ' ' LEU . 30.5 mt -86.81 147.5 25.8 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.556 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.522 ' C ' HD11 ' A' ' 13' ' ' LEU . 3.2 m80 -122.74 144.34 49.23 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.01 HD13 HD12 ' A' ' 13' ' ' LEU . 35.5 mm -67.44 135.88 93.17 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.526 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -78.92 144.5 73.88 Favored 'Cis proline' 0 C--N 1.352 0.736 0 C-N-CA 124.614 -0.994 . . . . 0.0 111.551 -0.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 1.004 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 9.1 t0 -164.0 129.14 2.87 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.404 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.462 ' HG2' ' N ' ' A' ' 12' ' ' ARG . 0.6 OUTLIER -58.08 -45.43 87.15 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.526 -178.769 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.623 ' HB2' HD13 ' A' ' 6' ' ' LEU . 23.2 mmt-85 -58.29 -28.41 64.97 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 1.057 HD21 ' HB2' ' A' ' 6' ' ' LEU . 9.7 mt -77.4 -32.13 54.59 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 120.613 1.551 . . . . 0.0 108.306 177.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.84 ' HD3' ' OD1' ' A' ' 144' ' ' ASP . 14.6 mmm180 -93.38 11.76 27.19 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 114.105 -1.407 . . . . 0.0 109.13 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.488 ' HB2' ' HA ' ' A' ' 12' ' ' ARG . 59.5 tptt -89.86 147.93 23.47 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.678 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.94 HG13 HG23 ' A' ' 138' ' ' VAL . 74.6 t -82.56 128.9 38.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.758 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -86.97 142.63 27.82 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.584 ' NZ ' ' HB2' ' A' ' 18' ' ' LYS . 4.7 ttmp? -105.57 129.8 24.09 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.854 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 56.8 Cg_endo -81.45 112.94 2.54 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 121.653 1.568 . . . . 0.0 110.812 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.698 HG12 ' H ' ' A' ' 22' ' ' GLU . 15.9 t -69.66 144.66 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 CA-C-O 122.552 1.168 . . . . 0.0 113.213 -175.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -61.07 -23.41 65.45 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 113.019 -1.9 . . . . 0.0 112.438 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.698 ' H ' HG12 ' A' ' 20' ' ' VAL . 42.8 tt0 -161.18 139.85 9.89 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.183 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.493 ' CG1' ' NE2' ' A' ' 28' ' ' GLN . 2.6 t -79.43 118.88 27.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.839 ' H ' HD12 ' A' ' 27' ' ' ILE . 24.7 m120 -104.27 -176.66 3.14 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.894 -0.504 . . . . 0.0 110.655 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.698 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -68.79 -25.41 64.69 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.456 0.646 . . . . 0.0 110.48 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.504 ' HA ' ' OE1' ' A' ' 26' ' ' GLU . 4.3 mm-40 -75.12 -43.19 54.15 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.839 HD12 ' H ' ' A' ' 24' ' ' ASN . 54.2 mt -65.04 -40.1 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 114.086 -1.416 . . . . 0.0 110.695 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.834 ' HG2' ' O ' ' A' ' 24' ' ' ASN . 32.6 mm-40 -64.96 -40.8 95.56 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 122.431 -0.168 . . . . 0.0 111.064 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.698 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 26.5 mmm180 -61.86 -38.73 89.36 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.784 ' O ' ' HG3' ' A' ' 34' ' ' MET . 4.2 mt -57.76 -49.22 81.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.829 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.869 HG22 ' CG2' ' A' ' 57' ' ' ILE . 25.3 t -67.97 -41.72 84.88 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 CA-C-O 120.919 0.39 . . . . 0.0 111.339 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.884 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 27.9 m-20 -53.74 -45.97 70.72 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.121 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.502 ' OD1' HD12 ' A' ' 3' ' ' LEU . 3.0 p30 -74.57 -29.63 61.42 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.137 176.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.939 ' HG2' HG21 ' A' ' 51' ' ' VAL . 82.6 mtp -61.12 -46.93 88.57 Favored 'General case' 0 C--N 1.346 0.434 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.851 -178.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.884 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 22.5 p90 -70.82 -47.85 57.24 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.622 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 30.4 mm-40 -50.83 -41.59 57.69 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . 1.037 ' HA ' HG12 ' A' ' 2' ' ' VAL . 48.4 m -70.34 -60.28 2.37 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.201 -1.363 . . . . 0.0 108.907 177.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.819 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 1.2 ttp -47.13 -39.72 14.08 Favored 'General case' 0 CA--C 1.464 -2.33 0 C-N-CA 124.046 0.939 . . . . 0.0 110.401 -171.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.664 ' OH ' ' HA ' ' A' ' 69' ' ' ARG . 68.2 m-85 -70.72 -42.1 71.02 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.146 177.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.565 ' CB ' HG11 ' A' ' 2' ' ' VAL . . . -60.95 -25.28 66.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.371 -0.831 . . . . 0.0 108.987 178.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.821 ' HG2' HD12 ' A' ' 91' ' ' LEU . 11.4 tp10 -87.02 -10.72 52.4 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 114.303 -1.317 . . . . 0.0 108.669 176.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.44 ' H ' ' C ' ' A' ' 39' ' ' TYR . 4.9 mm-40 63.76 23.62 13.52 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.21 -176.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.72 ' HA2' H182 ' A' ' 149' ' ' BB2 . . . -78.6 140.79 23.88 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.324 177.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.817 HG22 HG22 ' A' ' 62' ' ' VAL . 43.2 mm -78.67 -0.8 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 117.464 0.632 . . . . 0.0 111.756 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.897 ' HA3' ' C10' ' A' ' 149' ' ' BB2 . . . 177.91 136.05 2.42 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 118.68 -1.067 . . . . 0.0 110.872 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.813 ' HB2' ' HG3' ' A' ' 38' ' ' MET . 8.9 tt -127.98 135.37 49.83 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-N 119.714 1.757 . . . . 0.0 111.03 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.606 ' N ' HD23 ' A' ' 46' ' ' LEU . . . -97.43 134.16 41.06 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.881 ' HB1' ' CG1' ' A' ' 53' ' ' ILE . . . -31.11 -53.68 0.21 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.552 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 57.0 p -53.36 -35.32 60.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.77 0.795 . . . . 0.0 111.268 -178.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.751 ' OE1' HD23 ' A' ' 91' ' ' LEU . 74.8 mt-30 -64.22 -41.84 96.85 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.175 -1.375 . . . . 0.0 109.813 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.939 HG21 ' HG2' ' A' ' 34' ' ' MET . 0.9 OUTLIER -84.8 16.27 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-O 121.195 0.521 . . . . 0.0 112.132 179.763 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.846 ' HA ' HD11 ' A' ' 6' ' ' LEU . 50.5 t0 75.36 30.04 0.87 Allowed 'General case' 0 C--O 1.233 0.185 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 176.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.881 ' CG1' ' HB1' ' A' ' 48' ' ' ALA . 1.1 pp -123.54 111.41 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 C-N-CA 119.228 -0.989 . . . . 0.0 110.898 177.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.9 p-80 -76.3 62.68 1.82 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.992 0.901 . . . . 0.0 110.586 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.752 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 89.6 mt-30 -151.94 134.83 15.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.25 -1.341 . . . . 0.0 107.691 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.869 ' HG2' ' CD1' ' A' ' 137' ' ' LEU . 65.0 mtt-85 -64.26 70.74 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.869 ' CG2' HG22 ' A' ' 31' ' ' VAL . 9.1 mm -112.09 122.74 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.08 HD11 ' HB2' ' A' ' 72' ' ' LEU . 1.8 pp -126.17 144.34 36.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 119.836 -0.746 . . . . 0.0 112.913 -177.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.717 HG22 ' O ' ' A' ' 46' ' ' LEU . 33.5 m -127.22 137.12 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.067 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 6.1 mm -114.73 149.99 16.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.748 0.785 . . . . 0.0 109.555 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.819 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 58.5 t0 -137.35 27.84 2.81 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.442 -178.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.817 HG22 HG22 ' A' ' 44' ' ' ILE . 28.7 t -96.38 111.8 27.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.253 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.692 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 80.4 p -38.05 80.5 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -177.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.628 ' HB2' HD11 ' A' ' 70' ' ' LEU . 39.4 tt0 -70.29 -18.44 63.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.431 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.659 ' OD1' ' HG3' ' A' ' 66' ' ' ARG . 11.4 t-20 -164.64 -132.99 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.802 178.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.659 ' HG3' ' OD1' ' A' ' 65' ' ' ASN . 82.3 mtm180 -74.93 -57.49 3.87 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.86 0.362 . . . . 0.0 111.129 -178.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -95.75 125.97 40.69 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.98 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.692 ' HG2' ' HA ' ' A' ' 63' ' ' SER . 55.8 mt-10 -81.68 125.75 30.96 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.224 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.664 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 32.2 ttm180 170.67 76.08 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.981 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 1.067 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 61.2 mt -102.48 132.35 48.58 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-O 120.834 0.349 . . . . 0.0 111.557 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.866 ' O ' HD12 ' A' ' 72' ' ' LEU . 8.6 p -135.03 134.22 53.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.544 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.08 ' HB2' HD11 ' A' ' 58' ' ' ILE . 10.4 mp -140.6 142.45 35.05 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.047 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.7 mp -119.97 133.04 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-O 120.678 0.275 . . . . 0.0 110.413 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.792 ' ND2' HG22 ' A' ' 73' ' ' ILE . 66.8 m-20 54.2 37.14 0.39 Allowed Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.936 ' HG2' HG12 ' A' ' 58' ' ' ILE . 97.0 Cg_exo -56.65 150.17 54.43 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 C-N-CA 123.032 2.488 . . . . 0.0 114.016 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.656 ' OE2' ' HD2' ' A' ' 109' ' ' ARG . 23.0 pt-20 -138.45 143.12 39.51 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.815 ' HB2' ' HE3' ' A' ' 134' ' ' MET . 1.6 tt -80.24 135.19 36.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.434 0.635 . . . . 0.0 111.958 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.086 HD11 ' HG3' ' A' ' 109' ' ' ARG . 5.2 mp -109.75 -40.4 4.82 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.283 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 85.2 tt0 -156.05 154.62 31.29 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.277 0.561 . . . . 0.0 111.802 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.888 ' HA ' HG12 ' A' ' 106' ' ' VAL . 9.1 ptpp? -147.56 151.07 35.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.231 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 46.4 t -160.33 147.07 15.77 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.697 0.284 . . . . 0.0 111.318 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.661 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 75.16 161.71 9.42 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.571 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -135.76 113.29 10.8 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.867 0.841 . . . . 0.0 112.972 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.863 ' HB ' HH12 ' A' ' 102' ' ' ARG . 1.6 p -105.68 162.37 13.58 Favored 'General case' 0 CA--C 1.489 -1.402 0 N-CA-C 115.011 1.486 . . . . 0.0 115.011 178.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.699 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -148.98 118.47 0.96 Allowed Glycine 0 C--N 1.314 -0.677 0 CA-C-N 113.035 -1.893 . . . . 0.0 110.866 178.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.757 ' HB ' ' NH2' ' A' ' 102' ' ' ARG . 47.2 mm -148.19 140.28 18.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 117.472 0.636 . . . . 0.0 111.602 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 55.7 mp0 -71.24 135.37 47.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 123.365 1.555 . . . . 0.0 112.368 -176.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.795 ' HB3' H262 ' A' ' 149' ' ' BB2 . 80.2 mt-10 -152.26 161.34 42.76 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 112.324 -2.216 . . . . 0.0 112.039 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.923 ' O ' ' H52' ' A' ' 149' ' ' BB2 . . . -121.16 164.13 14.46 Favored Glycine 0 CA--C 1.501 -0.811 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.822 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 22.4 m -113.39 141.23 47.31 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.594 0.712 . . . . 0.0 112.656 -177.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.904 HD13 H171 ' A' ' 149' ' ' BB2 . 2.2 mm? -50.27 -26.98 5.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.818 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.848 ' CB ' HD13 ' A' ' 13' ' ' LEU . 61.2 m -85.3 -31.59 22.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.299 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.721 ' CG2' ' HD2' ' A' ' 94' ' ' PRO . 58.7 mt -85.28 148.22 49.36 Favored Pre-proline 0 N--CA 1.448 -0.537 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.188 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.721 ' HD2' ' CG2' ' A' ' 93' ' ' ILE . 64.2 Cg_endo -76.46 49.75 2.74 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.392 2.061 . . . . 0.0 114.901 -178.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.591 ' HB2' ' O ' ' A' ' 94' ' ' PRO . 0.3 OUTLIER 77.63 12.13 2.02 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 178.514 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.508 ' HG3' ' HG2' ' A' ' 94' ' ' PRO . 83.2 mt-30 -78.98 87.78 4.78 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 178.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.778 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 52.7 mtm-85 -85.64 132.88 34.08 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.787 0.803 . . . . 0.0 112.282 -178.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.619 ' HB3' ' HE2' ' A' ' 143' ' ' MET . . . -133.88 154.73 50.85 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.423 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.699 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.8 tt -76.56 112.27 12.93 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.85 0.834 . . . . 0.0 112.181 -177.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.783 HG23 ' HB2' ' A' ' 142' ' ' PHE . 11.1 p -99.86 133.12 21.91 Favored Pre-proline 0 N--CA 1.469 0.477 0 CA-C-N 114.593 -1.185 . . . . 0.0 112.372 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.549 ' HD2' ' CD2' ' A' ' 142' ' ' PHE . 96.6 Cg_endo -87.22 126.45 2.34 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 122.635 2.224 . . . . 0.0 112.485 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.876 ' HG2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -145.53 167.71 22.36 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.001 0.92 . . . . 0.0 110.259 179.83 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.661 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.44 155.85 39.04 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.804 0.335 . . . . 0.0 110.15 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -73.35 -42.0 62.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.936 -176.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.668 ' HB3' ' OD1' ' A' ' 123' ' ' ASP . 59.7 mttp -140.63 141.04 35.13 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.376 0.607 . . . . 0.0 110.155 177.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.888 HG12 ' HA ' ' A' ' 80' ' ' LYS . 22.4 m -149.25 138.84 15.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.346 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.992 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 20.1 mmtp -108.21 126.46 52.83 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 1.046 ' HA ' HD13 ' A' ' 78' ' ' LEU . 1.4 pp -135.89 154.75 34.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -176.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 1.086 ' HG3' HD11 ' A' ' 78' ' ' LEU . 92.6 mtt180 -101.41 137.98 39.03 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.319 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.688 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -159.34 169.36 24.18 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.504 -1.225 . . . . 0.0 111.093 -177.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 1.047 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.7 pp -118.94 154.75 32.5 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 177.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.55 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 19.5 t70 -89.09 162.59 15.89 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.197 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.738 ' HB2' HG21 ' A' ' 71' ' ' VAL . 13.1 ttp-105 -54.44 -15.32 1.62 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.832 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -78.95 -29.48 44.01 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.727 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 109.23 34.1 2.6 Favored Glycine 0 C--N 1.34 0.797 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.886 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -128.72 102.86 19.54 Favored Pre-proline 0 C--O 1.237 0.432 0 CA-C-N 116.764 0.282 . . . . 0.0 111.166 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.685 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 33.1 Cg_exo -73.26 116.81 4.84 Favored 'Trans proline' 0 C--N 1.36 1.169 0 C-N-CA 122.015 1.81 . . . . 0.0 115.094 -178.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.55 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 12.6 p90 -128.4 166.48 18.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.568 -178.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.764 ' HG2' ' HG2' ' A' ' 109' ' ' ARG . 22.4 mt-10 -107.73 131.96 53.88 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.871 ' O ' HD23 ' A' ' 120' ' ' LEU . 0.3 OUTLIER -129.64 141.84 50.85 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.663 0.744 . . . . 0.0 111.742 -179.465 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.992 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 11.3 pt-20 -95.19 123.43 38.69 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.536 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.927 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -115.82 134.87 54.56 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.958 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.668 ' OD1' ' HB3' ' A' ' 105' ' ' LYS . 37.7 m-20 -126.44 162.22 26.1 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.797 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 48.4 -132.9 20.48 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-N 119.85 1.205 . . . . 0.0 115.705 177.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 80.9 mt -54.7 -35.74 63.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.74 -0.73 . . . . 0.0 111.774 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.927 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -70.72 -52.03 23.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.799 0.809 . . . . 0.0 109.225 179.854 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.756 ' HB2' ' C ' ' A' ' 122' ' ' ALA . . . -58.65 -40.25 82.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.346 -1.297 . . . . 0.0 111.691 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.876 HD12 ' HG2' ' A' ' 102' ' ' ARG . 50.8 mm -68.41 -55.89 14.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.879 -178.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.841 ' HB2' ' C9 ' ' A' ' 149' ' ' BB2 . 29.4 p -57.88 -50.48 73.17 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.992 HD11 HD11 ' A' ' 108' ' ' ILE . 19.4 tt -59.04 -43.69 89.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.957 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.811 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 21.9 pt20 -68.41 -40.04 81.41 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.627 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.655 ' CD2' ' HN1' ' A' ' 149' ' ' BB2 . 67.8 t60 -59.27 -47.44 85.34 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.077 0.465 . . . . 0.0 109.776 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.88 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.5 mm-40 -58.63 -42.68 88.83 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.512 -179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.975 ' HA ' HD21 ' A' ' 137' ' ' LEU . 30.2 mtm -57.21 -47.3 81.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.634 0.73 . . . . 0.0 110.16 178.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.678 ' O ' HG12 ' A' ' 138' ' ' VAL . 31.9 m-20 -62.77 -48.31 79.71 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.095 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 1.005 ' CE1' HD21 ' A' ' 141' ' ' LEU . 8.4 t-80 -58.16 -52.93 63.52 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.271 0.557 . . . . 0.0 111.376 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.975 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.6 pp -58.67 -31.52 68.26 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.701 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.944 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 12.9 p -85.54 25.09 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-O 122.187 0.994 . . . . 0.0 109.83 176.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.515 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 55.91 30.67 57.41 Favored Glycine 0 CA--C 1.485 -1.843 0 CA-C-N 113.578 -1.646 . . . . 0.0 112.942 176.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.944 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 5.8 ptmt -127.54 109.99 12.28 Favored 'General case' 0 N--CA 1.424 -1.763 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.303 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 1.005 HD21 ' CE1' ' A' ' 136' ' ' HIS . 5.4 mp -127.22 144.76 50.97 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 120.772 -1.205 . . . . 0.0 108.284 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.783 ' HB2' HG23 ' A' ' 100' ' ' VAL . 18.2 m-85 -62.47 -33.16 74.29 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.286 0.494 . . . . 0.0 111.798 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.796 ' HA ' HD13 ' A' ' 146' ' ' LEU . 45.1 tpp -60.18 -27.06 66.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.33 0.586 . . . . 0.0 111.075 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.84 ' OD1' ' HD3' ' A' ' 14' ' ' ARG . 32.6 m-20 -52.6 -26.61 13.98 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.694 -178.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -127.99 43.65 3.09 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 121.218 -0.193 . . . . 0.0 110.786 -177.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.796 HD13 ' HA ' ' A' ' 143' ' ' MET . 4.8 mp -92.63 142.07 27.78 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.17 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 48.0 t . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.917 179.548 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 149' ' ' BB2 . . . . . 0.923 ' H52' ' O ' ' A' ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.493 ' HA ' ' OE1' ' A' ' 36' ' ' GLU . 79.4 p . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.87 0.367 . . . . 0.0 111.211 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.841 HG13 HG23 ' A' ' 37' ' ' THR . 40.1 t -84.03 126.24 40.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.597 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.929 HD13 ' H ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -87.93 -174.15 4.58 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.752 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -80.52 109.84 15.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.035 0.445 . . . . 0.0 111.073 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.648 ' CG2' HG21 ' A' ' 37' ' ' THR . 36.2 t -89.47 131.64 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.783 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.003 ' HB2' HD21 ' A' ' 13' ' ' LEU . 45.3 mt -84.06 142.68 30.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.862 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 1.0 OUTLIER -119.14 145.51 45.91 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.207 0.527 . . . . 0.0 112.044 -179.62 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.039 HD13 HD12 ' A' ' 13' ' ' LEU . 51.2 mm -54.19 146.03 32.72 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.827 178.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.663 ' HA ' HG23 ' A' ' 8' ' ' ILE . 64.8 Cg_endo -91.86 50.2 1.12 Allowed 'Cis proline' 0 C--N 1.355 0.898 0 C-N-CA 124.644 -0.982 . . . . 0.0 113.123 0.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.87 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 9.7 t70 -53.56 131.48 38.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.799 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -59.17 -41.71 89.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.423 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.744 ' HB2' HD13 ' A' ' 6' ' ' LEU . 10.5 mtt85 -60.19 -23.55 64.08 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 1.039 HD12 HD13 ' A' ' 8' ' ' ILE . 9.8 mt -76.31 -31.73 58.35 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 120.413 1.46 . . . . 0.0 108.134 177.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.558 ' HD2' ' O ' ' A' ' 139' ' ' GLY . 24.0 mmm-85 -91.58 1.7 56.96 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 113.93 -1.486 . . . . 0.0 109.09 178.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.562 ' HD3' ' HB3' ' A' ' 54' ' ' HIS . 62.6 tttp -83.97 150.56 25.57 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.126 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.592 HG13 HG23 ' A' ' 138' ' ' VAL . 84.3 t -82.89 136.22 23.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.179 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.79 ' C ' ' HG3' ' A' ' 56' ' ' ARG . . . -90.7 139.96 30.23 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -104.81 129.28 25.17 Favored Pre-proline 0 C--N 1.323 -0.58 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.546 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.923 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 68.3 Cg_endo -77.5 114.67 3.75 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 121.824 1.682 . . . . 0.0 110.197 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.753 HG12 ' H ' ' A' ' 22' ' ' GLU . 17.3 t -70.09 144.83 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 122.488 1.137 . . . . 0.0 113.285 -176.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -62.44 -25.59 68.05 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 113.322 -1.763 . . . . 0.0 112.103 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.753 ' H ' HG12 ' A' ' 20' ' ' VAL . 88.9 tt0 -159.29 143.9 15.44 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.537 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.539 HG22 HD21 ' A' ' 111' ' ' LEU . 2.9 t -79.26 107.2 11.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -178.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 1.082 ' H ' HD12 ' A' ' 27' ' ' ILE . 32.0 m120 -87.87 153.04 21.63 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.455 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.813 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -54.44 -26.99 34.06 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 121.078 0.466 . . . . 0.0 110.64 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -72.47 -40.39 66.98 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 177.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 1.082 HD12 ' H ' ' A' ' 24' ' ' ASN . 62.9 mt -62.92 -47.59 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.038 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -57.89 -39.86 78.9 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.916 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.813 ' HG3' ' O ' ' A' ' 25' ' ' ALA . 19.7 mtm105 -59.62 -40.36 87.29 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.808 ' O ' ' HG3' ' A' ' 34' ' ' MET . 4.3 mt -58.6 -49.78 81.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.624 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.924 HG22 ' CG2' ' A' ' 57' ' ' ILE . 5.0 t -67.22 -42.34 87.81 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-O 120.746 0.308 . . . . 0.0 111.619 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.88 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -54.35 -43.08 70.97 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.641 -179.604 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.562 ' C ' HD12 ' A' ' 3' ' ' LEU . 53.6 m-20 -74.96 -30.95 61.35 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.613 176.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' MET . . . . . 1.07 ' HG2' HG21 ' A' ' 51' ' ' VAL . 79.8 mtp -60.08 -47.76 84.54 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.162 -177.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.88 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 15.6 p90 -68.97 -43.54 74.77 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.781 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 31.9 mt-10 -51.41 -43.56 61.99 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.857 ' OG1' HD13 ' A' ' 3' ' ' LEU . 97.3 m -70.98 -61.91 1.59 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 118.876 -1.13 . . . . 0.0 109.092 177.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.99 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 1.8 ttp -45.51 -44.74 12.8 Favored 'General case' 0 CA--C 1.458 -2.576 0 C-N-CA 123.618 0.767 . . . . 0.0 109.978 -170.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.578 ' CD2' ' HE2' ' A' ' 38' ' ' MET . 58.9 m-85 -70.26 -40.63 74.26 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.197 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.39 -27.32 67.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.863 0.839 . . . . 0.0 108.764 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 1.01 ' HG2' HD22 ' A' ' 91' ' ' LEU . 10.5 tp10 -85.49 -10.48 56.0 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.19 177.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.431 ' H ' ' C ' ' A' ' 39' ' ' TYR . 51.5 mt-10 63.44 29.46 15.5 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.892 -176.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.807 ' HA2' H182 ' A' ' 149' ' ' BB2 . . . -84.69 143.29 20.64 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.865 178.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.817 HG23 ' O ' ' A' ' 61' ' ' ASP . 56.7 mt -78.77 -0.96 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 117.976 0.888 . . . . 0.0 112.065 -178.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.937 ' HA3' ' C10' ' A' ' 149' ' ' BB2 . . . 176.49 135.3 2.13 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-O 119.26 -0.744 . . . . 0.0 112.54 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.926 ' CD1' HD12 ' A' ' 91' ' ' LEU . 3.2 tp -125.22 133.56 52.68 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 118.618 1.209 . . . . 0.0 111.001 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -97.4 132.89 42.69 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 111.421 0.156 . . . . 0.0 111.421 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.912 ' HB1' ' CG1' ' A' ' 53' ' ' ILE . . . -34.56 -52.51 0.51 Allowed 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.525 HG21 ' O ' ' A' ' 137' ' ' LEU . 59.9 p -53.67 -37.27 63.03 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.898 0.856 . . . . 0.0 110.656 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.534 ' NE2' ' CE1' ' A' ' 136' ' ' HIS . 73.8 mt-30 -66.93 -38.36 86.04 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.006 -1.452 . . . . 0.0 109.854 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.07 HG21 ' HG2' ' A' ' 34' ' ' MET . 0.8 OUTLIER -83.8 11.62 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 179.113 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.875 ' HA ' ' CD1' ' A' ' 6' ' ' LEU . 54.6 t0 79.35 31.52 0.27 Allowed 'General case' 0 N--CA 1.46 0.06 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 176.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.912 ' CG1' ' HB1' ' A' ' 48' ' ' ALA . 1.2 pp -128.28 114.02 32.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.605 177.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.562 ' HB3' ' HD3' ' A' ' 15' ' ' LYS . 6.0 p80 -76.23 65.37 2.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.923 0.868 . . . . 0.0 110.587 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.777 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 88.5 mt-30 -155.77 134.84 12.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.676 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.923 ' HD2' ' HD3' ' A' ' 19' ' ' PRO . 99.0 mtt180 -62.74 69.06 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -178.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.924 ' CG2' HG22 ' A' ' 31' ' ' VAL . 8.4 mm -113.76 122.3 67.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.041 HD11 ' HB2' ' A' ' 72' ' ' LEU . 2.4 pp -131.31 146.89 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -177.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.9 m -127.83 138.69 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.266 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.928 HG23 ' C11' ' A' ' 149' ' ' BB2 . 2.2 mt -115.98 144.12 24.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 122.332 1.063 . . . . 0.0 112.233 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.99 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 52.4 t0 -122.78 50.07 1.56 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 113.506 -1.679 . . . . 0.0 107.666 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.736 HG22 ' CG2' ' A' ' 44' ' ' ILE . 24.6 t -126.67 74.76 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 112.243 -2.253 . . . . 0.0 105.869 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.814 ' OG ' ' HA ' ' A' ' 68' ' ' GLU . 40.3 m -95.29 -40.12 9.7 Favored 'General case' 0 CA--C 1.486 -1.482 0 CA-C-N 112.596 -2.093 . . . . 0.0 109.523 177.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 49.08 64.28 1.79 Allowed 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 113.391 -1.731 . . . . 0.0 109.862 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.426 ' CG ' ' H ' ' A' ' 66' ' ' ARG . 13.1 t-20 -165.88 -131.8 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.834 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.47 ' HG3' HH11 ' A' ' 66' ' ' ARG . 40.3 mmm-85 -79.04 -61.88 1.87 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.169 0.509 . . . . 0.0 111.184 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -126.41 138.14 53.51 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.474 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.814 ' HA ' ' OG ' ' A' ' 63' ' ' SER . 0.3 OUTLIER -88.79 145.97 25.28 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.939 179.757 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.452 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 34.6 ttm180 -176.62 65.73 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.84 ' CB ' ' HB ' ' A' ' 60' ' ' ILE . 8.8 mp -100.45 129.46 46.42 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.881 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.794 ' C ' HD22 ' A' ' 72' ' ' LEU . 13.4 p -133.87 131.32 56.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.211 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.041 ' HB2' HD11 ' A' ' 58' ' ' ILE . 2.9 mm? -141.75 143.91 33.74 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.398 177.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.073 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.6 mp -122.31 135.87 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 O-C-N 122.168 -0.332 . . . . 0.0 110.441 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.707 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 61.3 m-20 52.34 37.14 0.4 Allowed Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.867 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 97.4 Cg_exo -56.46 150.93 48.37 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 122.949 2.433 . . . . 0.0 114.091 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -138.72 145.57 40.46 Favored 'General case' 0 C--N 1.335 -0.055 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.805 ' HA ' HG22 ' A' ' 108' ' ' ILE . 9.5 tp -80.69 138.07 36.34 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.111 0.481 . . . . 0.0 110.901 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.047 HD23 ' HA ' ' A' ' 108' ' ' ILE . 3.0 mm? -114.27 -36.17 4.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.243 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.466 ' O ' ' HB ' ' A' ' 106' ' ' VAL . 16.5 tp10 -160.9 147.6 15.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.055 0.455 . . . . 0.0 111.86 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 1.057 ' HA ' HG12 ' A' ' 106' ' ' VAL . 19.6 ptpt -140.48 150.22 43.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.91 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.6 p -157.73 147.61 20.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.779 0.324 . . . . 0.0 111.243 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.766 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 73.46 165.27 10.08 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.791 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -139.79 113.16 8.38 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.689 0.757 . . . . 0.0 112.697 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.766 ' HB ' HH12 ' A' ' 102' ' ' ARG . 1.4 p -102.26 160.18 14.75 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.637 ' O ' HD13 ' A' ' 86' ' ' ILE . . . -139.82 104.73 0.43 Allowed Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 113.077 -1.874 . . . . 0.0 111.856 178.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.842 ' HB ' ' NH2' ' A' ' 102' ' ' ARG . 49.8 mm -147.1 140.32 19.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.639 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 92.5 mt-10 -74.01 143.81 45.4 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 122.589 1.185 . . . . 0.0 112.619 -178.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.715 ' HA ' ' O27' ' A' ' 149' ' ' BB2 . 10.1 mp0 -151.1 169.68 21.26 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 113.192 -1.822 . . . . 0.0 108.608 177.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.76 ' HA3' ' HG2' ' A' ' 97' ' ' ARG . . . -118.77 165.29 12.96 Favored Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 119.322 -1.418 . . . . 0.0 109.92 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.863 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 19.9 m -119.07 130.65 55.73 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.01 HD22 ' HG2' ' A' ' 41' ' ' GLU . 13.4 mt -57.5 -13.32 3.52 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.784 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.914 ' CB ' HD13 ' A' ' 13' ' ' LEU . 58.0 m -83.26 -37.2 23.83 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.812 HG23 ' HD2' ' A' ' 94' ' ' PRO . 48.4 mm -86.41 149.99 50.53 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.557 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.812 ' HD2' HG23 ' A' ' 93' ' ' ILE . 68.0 Cg_endo -75.2 48.43 2.05 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.584 2.189 . . . . 0.0 114.744 -178.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.597 ' HB2' ' O ' ' A' ' 94' ' ' PRO . 7.8 mp0 82.88 9.27 0.66 Allowed 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.761 ' HB2' HG21 ' A' ' 93' ' ' ILE . 41.0 mm-40 -78.25 88.99 4.3 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.76 ' HG2' ' HA3' ' A' ' 89' ' ' GLY . 40.9 mtm-85 -84.44 133.54 34.49 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.627 0.727 . . . . 0.0 111.493 -178.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -132.11 151.0 52.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.13 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.687 HD23 ' N ' ' A' ' 100' ' ' VAL . 6.9 tt -75.58 135.73 40.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.808 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.709 ' CG2' ' HB3' ' A' ' 142' ' ' PHE . 13.6 p -130.09 140.29 38.2 Favored Pre-proline 0 C--O 1.232 0.181 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.393 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 84' ' ' THR . 97.1 Cg_endo -88.16 122.7 1.57 Allowed 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.377 1.385 . . . . 0.0 113.552 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.913 ' HG2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -142.74 165.45 27.36 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 113.545 -1.661 . . . . 0.0 110.783 178.961 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.766 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.74 154.04 42.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.9 0.381 . . . . 0.0 110.377 -178.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.445 ' OE1' HG21 ' A' ' 84' ' ' THR . 5.1 tp10 -73.06 -42.03 63.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.66 -176.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.764 ' HG2' ' HB3' ' A' ' 123' ' ' ASP . 4.7 mtpm? -139.5 138.32 36.26 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.489 0.661 . . . . 0.0 109.674 177.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 1.057 HG12 ' HA ' ' A' ' 80' ' ' LYS . 25.1 m -147.02 141.63 20.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.736 -1.12 . . . . 0.0 112.122 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.964 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 31.9 mmtm -107.2 126.04 51.88 Favored 'General case' 0 N--CA 1.461 0.101 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 1.047 ' HA ' HD23 ' A' ' 78' ' ' LEU . 2.0 pp -129.61 161.82 38.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 1.034 ' HG3' HD21 ' A' ' 78' ' ' LEU . 45.4 mtm180 -113.24 138.17 50.4 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-O 120.843 0.354 . . . . 0.0 110.083 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.807 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -156.44 167.89 29.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.658 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 1.073 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.2 pp -114.03 151.66 32.13 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.445 ' O ' HD12 ' A' ' 111' ' ' LEU . 10.7 t70 -87.9 164.37 15.89 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.692 -177.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.768 ' HD2' ' OD1' ' A' ' 32' ' ' ASP . 49.1 ttp180 -51.66 -21.36 2.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.311 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.55 -21.75 44.75 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.908 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.5 37.27 3.31 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.992 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -128.64 102.82 19.78 Favored Pre-proline 0 C--O 1.238 0.457 0 CA-C-N 117.054 0.427 . . . . 0.0 110.708 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.661 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 32.2 Cg_exo -73.18 114.16 3.97 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 121.616 1.544 . . . . 0.0 114.959 -177.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 112' ' ' ASP . 0.4 OUTLIER -125.58 169.56 12.35 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.417 -178.52 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.718 ' HG2' ' HD2' ' A' ' 109' ' ' ARG . 34.9 mt-10 -106.75 129.4 54.63 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.02 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.721 ' O ' HD12 ' A' ' 120' ' ' LEU . 4.1 pp -123.39 133.01 54.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.848 -178.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.964 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 15.4 pt-20 -92.48 124.37 36.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.673 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.936 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -116.39 134.59 54.7 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.764 ' HB3' ' HG2' ' A' ' 105' ' ' LYS . 25.2 m-20 -126.81 164.54 21.14 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.628 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 46.78 -134.56 11.13 Favored Glycine 0 C--N 1.347 1.188 0 CA-C-N 120.722 1.601 . . . . 0.0 116.44 177.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.686 HD12 ' H ' ' A' ' 125' ' ' LEU . 4.8 mp -54.64 -33.99 61.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.431 -0.884 . . . . 0.0 111.619 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.936 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -70.95 -53.35 15.24 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.239 -0.584 . . . . 0.0 109.796 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.799 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -59.44 -47.12 86.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.93 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.913 HD12 ' HG2' ' A' ' 102' ' ' ARG . 49.9 mm -61.28 -55.69 22.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.084 -178.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.986 ' HB3' H112 ' A' ' 149' ' ' BB2 . 82.2 m -57.45 -50.89 71.55 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.673 HD11 HD11 ' A' ' 108' ' ' ILE . 18.7 tt -59.0 -41.35 82.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.826 -0.17 . . . . 0.0 111.413 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.864 ' CG ' HG21 ' A' ' 106' ' ' VAL . 36.1 mt-30 -65.99 -40.83 91.51 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -56.08 -47.74 77.42 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.882 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.804 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.7 mm-40 -58.71 -46.08 88.11 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.098 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.985 ' HA ' HD21 ' A' ' 137' ' ' LEU . 1.9 mmm -55.68 -47.54 76.59 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.466 0.65 . . . . 0.0 110.037 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.656 ' O ' HG12 ' A' ' 138' ' ' VAL . 31.3 m-20 -61.6 -49.24 77.39 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.205 178.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.621 ' NE2' HD21 ' A' ' 141' ' ' LEU . 1.6 t60 -59.25 -50.76 72.79 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 121.768 -0.583 . . . . 0.0 111.171 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.985 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.6 pp -58.27 -31.27 67.29 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.726 -178.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.847 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 13.8 p -83.04 20.5 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-O 122.803 1.287 . . . . 0.0 108.755 175.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.768 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 65.84 7.3 35.13 Favored Glycine 0 CA--C 1.494 -1.278 0 CA-C-N 112.501 -2.136 . . . . 0.0 112.843 176.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.847 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 4.6 ptmt -97.85 119.35 36.3 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 119.53 -0.868 . . . . 0.0 108.716 179.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.716 HD12 ' C ' ' A' ' 140' ' ' LYS . 6.4 mp -122.71 157.99 31.09 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 121.9 -0.5 . . . . 0.0 110.187 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.757 ' O ' HD13 ' A' ' 146' ' ' LEU . 8.1 p90 -58.08 -32.01 67.64 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.448 ' N ' ' CD1' ' A' ' 142' ' ' PHE . 16.1 tpt -63.1 -25.98 68.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.256 0.55 . . . . 0.0 110.664 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 141' ' ' LEU . 1.2 m-20 -59.09 -26.78 64.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.884 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -119.18 21.48 12.26 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.757 HD13 ' O ' ' A' ' 142' ' ' PHE . 4.8 mp -92.16 141.77 28.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.589 0.233 . . . . 0.0 111.025 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 48.2 t . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.891 179.359 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 149' ' ' BB2 . . . . . 0.986 H112 ' HB3' ' A' ' 129' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.442 ' HB3' ' OE1' ' A' ' 36' ' ' GLU . 52.0 m . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.93 0.395 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.921 HG12 ' HA ' ' A' ' 37' ' ' THR . 28.3 m -84.0 138.14 19.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.783 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.96 HD13 ' H ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -79.01 -159.3 0.18 Allowed 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.108 179.858 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.686 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 27.4 tp60 -88.31 105.58 17.66 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.254 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.62 ' CG2' HG21 ' A' ' 37' ' ' THR . 46.4 t -88.33 127.0 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 121.333 0.587 . . . . 0.0 111.483 -179.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.07 ' HB2' HD21 ' A' ' 13' ' ' LEU . 24.4 mt -88.08 144.29 26.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.222 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 4.3 m80 -120.85 145.99 47.04 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.003 HD13 HD12 ' A' ' 13' ' ' LEU . 44.5 mm -69.29 135.79 88.94 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.674 178.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.48 141.74 70.95 Favored 'Cis proline' 0 C--N 1.352 0.729 0 C-N-CA 124.145 -1.19 . . . . 0.0 112.031 -0.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.97 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 8.4 t0 -163.39 125.18 2.47 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.271 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.431 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 23.7 pt-20 -57.53 -46.23 84.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.74 -178.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.61 ' HB2' HD13 ' A' ' 6' ' ' LEU . 14.8 mmt85 -56.21 -30.1 61.83 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 1.07 HD21 ' HB2' ' A' ' 6' ' ' LEU . 11.5 mt -75.78 -33.29 60.17 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 120.098 1.317 . . . . 0.0 109.054 178.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.669 ' C ' ' HA3' ' A' ' 139' ' ' GLY . 26.6 mmt-85 -96.21 13.29 27.91 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.299 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.422 ' HD3' ' HD3' ' A' ' 12' ' ' ARG . 88.4 tttt -91.65 149.93 21.4 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.128 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 1.004 HG13 HG23 ' A' ' 138' ' ' VAL . 49.5 t -82.95 122.13 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.796 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -80.02 145.57 32.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.856 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -101.81 134.22 20.28 Favored Pre-proline 0 C--N 1.326 -0.442 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.788 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -77.36 115.52 3.94 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.365 2.044 . . . . 0.0 111.261 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.882 HG12 ' H ' ' A' ' 22' ' ' GLU . 24.9 t -68.94 144.98 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 122.526 1.155 . . . . 0.0 113.022 -176.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.475 ' OE1' ' HA ' ' A' ' 21' ' ' GLU . 4.3 mm-40 -67.45 -29.24 68.65 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 113.303 -1.771 . . . . 0.0 111.734 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.882 ' H ' HG12 ' A' ' 20' ' ' VAL . 16.9 tp10 -156.57 154.17 29.81 Favored 'General case' 0 CA--C 1.527 0.063 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.178 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.981 HG21 ' HA2' ' A' ' 115' ' ' GLY . 6.3 t -80.07 102.38 5.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -178.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.943 ' CB ' HD13 ' A' ' 27' ' ' ILE . 31.7 m120 -89.04 151.16 22.42 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.569 -177.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.421 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -55.48 -28.21 53.12 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.508 0.67 . . . . 0.0 110.534 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 1.073 ' HG3' HD12 ' A' ' 27' ' ' ILE . 21.7 pt-20 -74.02 -36.92 64.48 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 177.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 1.073 HD12 ' HG3' ' A' ' 26' ' ' GLU . 1.7 mp -67.46 -38.79 81.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.952 177.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -65.78 -40.29 91.84 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 122.401 -0.187 . . . . 0.0 110.938 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.449 HH11 ' HG2' ' A' ' 29' ' ' ARG . 47.7 mmt-85 -64.94 -38.41 90.89 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.786 ' O ' ' HG3' ' A' ' 34' ' ' MET . 4.7 mt -55.39 -50.47 65.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.177 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.892 HG11 ' CG2' ' A' ' 71' ' ' VAL . 19.2 t -66.87 -40.4 85.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-O 121.218 0.533 . . . . 0.0 110.408 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.869 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 71.1 m-20 -53.06 -46.08 68.39 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.072 -178.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.62 ' CB ' HD12 ' A' ' 3' ' ' LEU . 1.5 m-20 -75.13 -29.25 60.46 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.07 176.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' MET . . . . . 1.003 ' HG2' HG21 ' A' ' 51' ' ' VAL . 83.2 mtp -59.46 -46.63 88.22 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.171 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.869 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 13.9 p90 -70.2 -44.18 69.2 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.737 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 85.9 mt-10 -51.61 -44.48 62.9 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.622 0.725 . . . . 0.0 109.376 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.921 ' HA ' HG12 ' A' ' 2' ' ' VAL . 96.7 m -70.5 -61.35 1.8 Allowed 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 118.592 -1.243 . . . . 0.0 108.709 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' MET . . . . . 1.038 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 2.0 ttp -45.68 -41.5 10.52 Favored 'General case' 0 CA--C 1.463 -2.393 0 C-N-CA 123.878 0.871 . . . . 0.0 110.133 -171.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.7 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 55.9 m-85 -70.4 -42.13 72.08 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.083 177.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.467 ' HB3' ' CG1' ' A' ' 2' ' ' VAL . . . -61.16 -24.47 66.32 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.491 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 1.047 ' HG2' HD12 ' A' ' 91' ' ' LEU . 11.9 tp10 -88.81 -11.56 44.49 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.482 177.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.444 ' H ' ' C ' ' A' ' 39' ' ' TYR . 18.5 mt-10 64.83 26.54 12.94 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 122.047 0.927 . . . . 0.0 109.927 -176.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.48 141.58 22.16 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 113.76 -1.564 . . . . 0.0 110.67 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.807 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 53.1 mt -80.0 0.68 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 117.643 0.722 . . . . 0.0 112.266 -178.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 1.006 ' HA3' H113 ' A' ' 149' ' ' BB2 . . . 178.09 135.54 2.31 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-O 119.022 -0.877 . . . . 0.0 111.926 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.994 HD13 ' HG ' ' A' ' 91' ' ' LEU . 5.4 tp -125.68 134.24 51.9 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-N 118.993 1.397 . . . . 0.0 111.56 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -98.9 132.33 44.31 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.875 ' HB1' ' CD1' ' A' ' 53' ' ' ILE . . . -29.85 -54.59 0.16 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.597 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 58.4 p -53.97 -36.64 63.1 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.698 0.761 . . . . 0.0 111.81 -178.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.741 ' OE1' HD12 ' A' ' 46' ' ' LEU . 85.5 mt-30 -64.51 -40.62 95.97 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.627 -1.169 . . . . 0.0 110.028 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.003 HG21 ' HG2' ' A' ' 34' ' ' MET . 0.8 OUTLIER -84.36 17.37 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 112.665 0.616 . . . . 0.0 112.665 -179.84 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.896 ' HA ' HD11 ' A' ' 6' ' ' LEU . 11.1 t0 77.51 26.86 0.65 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 176.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.875 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -124.13 110.7 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 C-N-CA 118.915 -1.114 . . . . 0.0 111.77 178.644 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.626 ' O ' ' HD2' ' A' ' 54' ' ' HIS . 2.6 p-80 -76.48 60.5 1.61 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.611 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.782 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 39.4 mm-40 -149.67 134.18 17.53 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 114.342 -1.299 . . . . 0.0 107.788 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.796 ' N ' ' HB1' ' A' ' 17' ' ' ALA . 75.7 mtp180 -64.11 68.62 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -177.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.831 ' CG2' HG22 ' A' ' 31' ' ' VAL . 8.5 mm -110.49 122.16 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.998 HD11 ' HB2' ' A' ' 72' ' ' LEU . 1.5 pp -121.95 140.73 44.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.0 -0.68 . . . . 0.0 112.285 -178.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.57 HG12 ' O ' ' A' ' 46' ' ' LEU . 1.5 p -125.16 134.5 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.044 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 9.1 mm -114.36 155.27 15.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.616 0.722 . . . . 0.0 110.921 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 1.038 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 31.9 t70 -142.57 28.56 1.62 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.659 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.766 HG22 ' CG2' ' A' ' 44' ' ' ILE . 39.3 t -94.22 107.54 19.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.81 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.726 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 79.6 p -37.05 84.59 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -176.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.791 ' OE1' HD21 ' A' ' 70' ' ' LEU . 38.8 tt0 -62.52 -18.06 61.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.956 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.904 ' OD1' ' HG2' ' A' ' 66' ' ' ARG . 26.1 t-20 -164.1 -85.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.105 0.479 . . . . 0.0 110.895 178.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.904 ' HG2' ' OD1' ' A' ' 65' ' ' ASN . 39.0 mmm-85 -119.27 -52.29 2.28 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.457 0.646 . . . . 0.0 110.354 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -99.43 126.3 45.31 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.309 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.726 ' HG2' ' HA ' ' A' ' 63' ' ' SER . 56.9 mt-10 -84.65 133.1 34.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.833 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.592 ' HB2' ' O ' ' A' ' 68' ' ' GLU . 40.7 ttm-85 171.22 70.53 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.135 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 1.044 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 47.8 mt -103.72 134.38 47.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.915 0.388 . . . . 0.0 111.716 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.892 ' CG2' HG11 ' A' ' 31' ' ' VAL . 6.3 p -134.88 135.9 52.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.308 178.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.998 ' HB2' HD11 ' A' ' 58' ' ' ILE . 3.0 mm? -141.63 142.12 33.42 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 177.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.017 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.6 mp -121.71 135.05 63.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.702 0.286 . . . . 0.0 110.336 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.717 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 45.5 m-20 54.48 34.86 0.26 Allowed Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.907 ' HG2' HG12 ' A' ' 58' ' ' ILE . 89.3 Cg_exo -56.39 146.8 71.58 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.766 2.311 . . . . 0.0 113.707 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -138.0 145.51 41.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.782 HD21 ' HE3' ' A' ' 80' ' ' LYS . 29.8 tp -79.12 138.2 37.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.424 0.63 . . . . 0.0 112.084 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.035 HD21 ' HG3' ' A' ' 109' ' ' ARG . 2.7 mm? -112.77 -43.55 3.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.474 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 39.2 tt0 -157.21 147.81 21.31 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.211 0.529 . . . . 0.0 111.949 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.895 ' HA ' HG12 ' A' ' 106' ' ' VAL . 19.3 ptpt -143.08 146.01 33.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.34 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.0 t -157.07 149.81 23.47 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.352 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.759 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 78.11 156.12 8.52 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.718 -0.754 . . . . 0.0 111.499 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -131.3 113.22 13.53 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.965 0.888 . . . . 0.0 112.632 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.872 ' HB ' HH12 ' A' ' 102' ' ' ARG . 1.5 p -105.98 161.9 14.06 Favored 'General case' 0 CA--C 1.487 -1.447 0 CA-C-N 114.016 -1.447 . . . . 0.0 114.894 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.843 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -149.22 118.05 0.92 Allowed Glycine 0 C--N 1.314 -0.674 0 CA-C-N 113.103 -1.862 . . . . 0.0 111.047 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.719 ' N ' ' HG ' ' A' ' 99' ' ' LEU . 32.5 mt -148.79 140.45 17.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 117.432 0.616 . . . . 0.0 111.84 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 55.8 mt-10 -71.14 139.18 50.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 123.135 1.445 . . . . 0.0 112.104 -176.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.744 ' HB3' H262 ' A' ' 149' ' ' BB2 . 84.1 mt-10 -157.5 162.44 38.88 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 112.543 -2.117 . . . . 0.0 111.774 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.891 ' O ' ' H52' ' A' ' 149' ' ' BB2 . . . -120.94 162.97 14.53 Favored Glycine 0 CA--C 1.5 -0.905 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.721 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 11.2 m -116.28 139.38 50.44 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 117.564 0.682 . . . . 0.0 110.763 -178.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.047 HD12 ' HG2' ' A' ' 41' ' ' GLU . 2.5 mm? -47.25 -20.58 0.2 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.501 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.897 ' CB ' HG12 ' A' ' 8' ' ' ILE . 31.5 m -86.53 -41.82 14.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.537 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.884 HG23 ' HD2' ' A' ' 94' ' ' PRO . 44.0 mm -86.37 152.8 55.67 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.199 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.884 ' HD2' HG23 ' A' ' 93' ' ' ILE . 64.8 Cg_endo -61.75 -144.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.636 2.224 . . . . 0.0 111.647 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.456 ' H ' ' HB2' ' A' ' 94' ' ' PRO . 8.8 mp0 -81.43 11.39 4.54 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.27 0.557 . . . . 0.0 110.616 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.543 ' HG3' ' HG2' ' A' ' 94' ' ' PRO . 85.4 mt-30 -78.29 83.78 4.52 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.111 -178.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.744 ' HG2' ' N ' ' A' ' 89' ' ' GLY . 74.9 mtm180 -85.58 133.22 34.07 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.36 0.6 . . . . 0.0 110.375 178.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -125.1 147.31 49.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.414 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.843 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.7 tt -75.26 111.94 11.03 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.707 0.765 . . . . 0.0 110.512 -178.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 1.119 HG23 ' HB2' ' A' ' 142' ' ' PHE . 12.2 p -97.93 133.05 23.67 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.93 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.61 ' HD2' ' CD2' ' A' ' 142' ' ' PHE . 95.6 Cg_endo -88.29 125.71 1.86 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.391 2.061 . . . . 0.0 112.227 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.96 ' HG3' HG23 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -144.4 166.77 24.16 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.798 0.839 . . . . 0.0 109.653 179.84 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.759 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.29 154.62 41.39 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.883 0.373 . . . . 0.0 110.1 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -73.06 -40.56 64.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.72 -176.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.751 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 89.3 mttt -139.82 140.34 36.57 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.34 0.59 . . . . 0.0 109.481 177.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.895 HG12 ' HA ' ' A' ' 80' ' ' LYS . 30.3 m -149.03 140.17 17.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.07 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.989 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 23.4 mmtp -107.63 126.42 52.55 Favored 'General case' 0 N--CA 1.461 0.091 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 1.053 HD11 HD11 ' A' ' 130' ' ' ILE . 1.7 pp -135.4 151.05 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -176.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 1.035 ' HG3' HD21 ' A' ' 78' ' ' LEU . 91.8 mtt180 -102.36 137.54 40.47 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.205 -178.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.726 ' HB3' HD12 ' A' ' 72' ' ' LEU . . . -160.64 169.01 23.73 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.908 -177.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 1.017 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.4 pp -116.39 151.64 35.54 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.732 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 18.9 t70 -83.66 165.4 18.99 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -176.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.824 ' HB2' HG21 ' A' ' 71' ' ' VAL . 52.9 ttp180 -52.2 -20.95 2.92 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.58 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -79.37 -25.85 42.14 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.699 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.981 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 106.31 36.57 2.65 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.712 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -128.44 102.6 20.48 Favored Pre-proline 0 C--O 1.236 0.377 0 CA-C-N 117.067 0.433 . . . . 0.0 110.731 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.679 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 34.2 Cg_exo -71.92 114.98 4.13 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 121.777 1.651 . . . . 0.0 115.596 -177.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.732 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 12.1 p90 -128.06 168.08 15.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.574 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.525 ' CG ' ' HG2' ' A' ' 109' ' ' ARG . 27.7 mp0 -107.35 130.28 54.81 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.727 ' O ' HD12 ' A' ' 120' ' ' LEU . 4.3 pp -126.33 133.73 51.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.566 -178.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.989 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 11.5 pt-20 -93.04 123.8 36.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.629 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.939 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -116.83 134.97 54.13 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.751 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.2 m-20 -127.04 162.49 25.91 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.67 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 51.83 -136.35 33.34 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 120.293 1.406 . . . . 0.0 115.426 177.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 74.4 mt -54.84 -33.8 62.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.719 -0.741 . . . . 0.0 111.706 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.939 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.3 OUTLIER -71.47 -51.6 22.87 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.851 0.834 . . . . 0.0 109.15 179.619 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.738 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -58.82 -43.0 90.53 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.258 -1.337 . . . . 0.0 111.91 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.96 HG23 ' HG3' ' A' ' 102' ' ' ARG . 50.3 mm -67.96 -55.72 15.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.819 ' HB3' ' H91' ' A' ' 149' ' ' BB2 . 84.2 m -58.73 -50.67 73.06 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 1.053 HD11 HD11 ' A' ' 108' ' ' ILE . 20.4 tt -58.24 -43.84 86.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.13 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.776 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.4 pt20 -67.73 -37.9 82.83 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.083 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.662 ' NE2' ' H51' ' A' ' 149' ' ' BB2 . 0.1 OUTLIER -58.88 -47.4 85.06 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.515 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.872 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.6 mm-40 -59.61 -42.43 92.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.083 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.961 ' HA ' HD21 ' A' ' 137' ' ' LEU . 30.1 mtm -57.33 -47.48 81.44 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.832 0.825 . . . . 0.0 109.902 178.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.611 ' HB3' ' O ' ' A' ' 140' ' ' LYS . 57.8 m-20 -62.51 -47.59 83.28 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.197 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 1.025 ' HA ' HD21 ' A' ' 141' ' ' LEU . 6.2 t-80 -59.45 -52.96 63.37 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.123 0.487 . . . . 0.0 111.557 -178.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.961 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.5 pp -57.93 -31.47 66.84 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.308 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 1.004 HG23 HG13 ' A' ' 16' ' ' VAL . 14.7 p -86.86 22.78 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-O 122.356 1.074 . . . . 0.0 109.359 176.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.669 ' HA3' ' C ' ' A' ' 14' ' ' ARG . . . 53.28 38.45 56.99 Favored Glycine 0 CA--C 1.481 -2.041 0 CA-C-N 113.331 -1.759 . . . . 0.0 112.17 176.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.962 ' HG2' HG13 ' A' ' 138' ' ' VAL . 2.4 ptmt -136.13 103.55 5.37 Favored 'General case' 0 N--CA 1.42 -1.935 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.83 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 1.025 HD21 ' HA ' ' A' ' 136' ' ' HIS . 3.1 mm? -123.61 149.06 45.81 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 120.822 -1.174 . . . . 0.0 109.05 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 1.119 ' HB2' HG23 ' A' ' 100' ' ' VAL . 8.9 m-85 -60.2 -39.35 86.27 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.836 ' HA ' ' HG ' ' A' ' 146' ' ' LEU . 46.6 ttm -55.91 -25.97 45.37 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.094 0.473 . . . . 0.0 111.487 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.536 ' CG ' ' HE ' ' A' ' 14' ' ' ARG . 31.3 t70 -55.4 -25.95 38.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.335 -178.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -118.27 37.78 3.91 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 120.555 0.217 . . . . 0.0 110.905 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.836 ' HG ' ' HA ' ' A' ' 143' ' ' MET . 49.4 mt -92.39 139.12 30.92 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.667 0.27 . . . . 0.0 110.993 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 54.0 m . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.975 179.784 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 149' ' ' BB2 . . . . . 1.006 H113 ' HA3' ' A' ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 79.8 p . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.834 0.35 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.878 ' CG1' ' HA ' ' A' ' 37' ' ' THR . 27.1 m -84.22 133.64 28.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.388 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.98 HD11 ' HB ' ' A' ' 51' ' ' VAL . 1.1 pt? -79.68 -158.69 0.17 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.561 ' HG3' ' HB3' ' A' ' 52' ' ' ASP . 23.4 pt20 -88.66 104.43 16.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.882 0.372 . . . . 0.0 111.88 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.036 HG11 HD12 ' A' ' 91' ' ' LEU . 49.1 t -89.38 131.66 36.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-O 121.251 0.548 . . . . 0.0 111.953 -178.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.138 ' HB2' HD21 ' A' ' 13' ' ' LEU . 22.6 mt -91.08 140.11 30.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.998 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.621 ' HA ' ' CA ' ' A' ' 92' ' ' SER . 37.1 m-70 -112.53 140.6 47.15 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.083 HD13 HD12 ' A' ' 13' ' ' LEU . 37.1 mm -61.81 132.88 93.51 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.81 176.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -79.89 148.25 78.78 Favored 'Cis proline' 0 C--N 1.352 0.719 0 C-N-CA 124.795 -0.919 . . . . 0.0 111.67 -0.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 1.028 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 9.0 t0 -165.1 131.09 2.73 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.403 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 23.8 pt-20 -58.45 -45.8 87.85 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.774 0.321 . . . . 0.0 110.643 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.676 ' O ' ' HB ' ' A' ' 49' ' ' THR . 14.7 mmt85 -59.67 -26.44 65.55 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 1.138 HD21 ' HB2' ' A' ' 6' ' ' LEU . 9.9 mt -77.42 -31.43 54.02 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 120.736 1.607 . . . . 0.0 108.39 177.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.689 ' C ' ' HA3' ' A' ' 139' ' ' GLY . 25.2 mmm-85 -94.46 10.43 34.52 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.108 -1.406 . . . . 0.0 109.173 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.654 ' NZ ' ' HB2' ' A' ' 54' ' ' HIS . 64.2 tttm -84.64 141.2 30.8 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.196 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.933 HG13 ' CG2' ' A' ' 138' ' ' VAL . 61.8 t -84.22 94.95 3.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.201 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.848 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -57.71 145.12 35.54 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.887 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -104.42 134.77 19.51 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.596 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.639 ' HD3' ' HD3' ' A' ' 56' ' ' ARG . 58.8 Cg_endo -80.26 115.74 3.24 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.235 1.957 . . . . 0.0 110.384 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.759 HG12 ' H ' ' A' ' 22' ' ' GLU . 16.4 t -69.23 144.3 14.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 122.476 1.131 . . . . 0.0 113.177 -175.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -62.48 -23.59 66.99 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 113.197 -1.82 . . . . 0.0 112.57 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.759 ' H ' HG12 ' A' ' 20' ' ' VAL . 34.8 tp10 -160.03 148.0 16.82 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 121.034 -0.267 . . . . 0.0 110.744 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.868 HG21 ' HA2' ' A' ' 115' ' ' GLY . 3.0 t -82.44 105.83 12.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 1.045 ' H ' HD12 ' A' ' 27' ' ' ILE . 32.4 m120 -89.23 157.85 18.09 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.988 -178.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.544 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -54.53 -31.48 56.38 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.509 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -71.28 -37.57 71.87 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 177.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 1.045 HD12 ' H ' ' A' ' 24' ' ' ASN . 63.4 mt -64.25 -47.15 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.143 178.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 51.0 mt-30 -57.65 -39.86 78.0 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.027 0.441 . . . . 0.0 110.733 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.544 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 38.9 mmt180 -60.99 -40.09 92.15 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.543 0.687 . . . . 0.0 109.159 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.825 ' O ' ' HG3' ' A' ' 34' ' ' MET . 4.6 mt -58.62 -49.66 81.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.879 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.819 HG21 ' CD1' ' A' ' 73' ' ' ILE . 17.9 t -68.47 -41.32 83.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.916 0.388 . . . . 0.0 111.422 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.877 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 47.8 m-20 -53.24 -46.11 69.01 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.588 0.709 . . . . 0.0 111.53 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.498 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 1.4 m-20 -74.71 -30.21 61.46 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.661 176.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' MET . . . . . 1.039 ' HG2' HG21 ' A' ' 51' ' ' VAL . 87.3 mtp -59.61 -47.0 87.29 Favored 'General case' 0 C--N 1.345 0.378 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.723 -177.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.877 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 17.4 p90 -69.54 -44.38 71.05 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.743 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 77.9 mt-10 -51.65 -42.64 62.23 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.878 ' HA ' ' CG1' ' A' ' 2' ' ' VAL . 76.8 m -69.33 -60.42 2.35 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 118.79 -1.164 . . . . 0.0 108.487 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' MET . . . . . 1.016 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 3.2 ttp -46.24 -43.33 15.38 Favored 'General case' 0 CA--C 1.463 -2.385 0 C-N-CA 123.749 0.819 . . . . 0.0 109.869 -170.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.698 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 58.9 m-85 -68.96 -42.02 77.21 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.878 178.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.55 ' HB3' ' CG1' ' A' ' 2' ' ' VAL . . . -60.14 -28.9 68.27 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.626 0.727 . . . . 0.0 109.045 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.782 ' HG2' ' CD2' ' A' ' 91' ' ' LEU . 3.2 tp10 -83.95 -10.15 58.16 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 114.392 -1.276 . . . . 0.0 108.835 177.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.436 ' H ' ' C ' ' A' ' 39' ' ' TYR . 19.2 mt-10 62.41 25.42 15.16 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.916 -176.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.866 ' HA3' H173 ' A' ' 149' ' ' BB2 . . . -79.96 140.61 22.53 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.187 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.83 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 38.5 mt -79.2 0.42 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 117.829 0.815 . . . . 0.0 111.93 -178.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.753 ' HA3' H101 ' A' ' 149' ' ' BB2 . . . -179.75 133.5 2.04 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-O 119.215 -0.77 . . . . 0.0 112.066 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.985 ' HB2' ' HG3' ' A' ' 38' ' ' MET . 9.2 tp -125.31 135.37 52.42 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-N 119.531 1.665 . . . . 0.0 111.712 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.48 ' HB1' ' HB3' ' A' ' 137' ' ' LEU . . . -101.45 130.63 47.73 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.887 ' HB1' ' CG1' ' A' ' 53' ' ' ILE . . . -29.31 -56.16 0.15 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 115.902 1.815 . . . . 0.0 115.902 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.676 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 77.2 p -53.82 -34.73 60.11 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.725 0.774 . . . . 0.0 111.378 -178.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.597 ' NE2' ' CE1' ' A' ' 136' ' ' HIS . 37.2 mt-30 -65.34 -38.52 90.34 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.168 -1.378 . . . . 0.0 109.843 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.039 HG21 ' HG2' ' A' ' 34' ' ' MET . 1.6 m -89.1 13.42 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 121.013 0.435 . . . . 0.0 111.752 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.813 ' HA ' HD11 ' A' ' 6' ' ' LEU . 38.2 t70 77.13 35.27 0.36 Allowed 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 176.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.887 ' CG1' ' HB1' ' A' ' 48' ' ' ALA . 1.2 pp -125.81 110.87 25.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 119.495 -0.882 . . . . 0.0 109.706 176.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.654 ' HB2' ' NZ ' ' A' ' 15' ' ' LYS . 23.4 p-80 -75.99 64.76 1.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 122.098 0.952 . . . . 0.0 110.145 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.813 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 33.5 mt-30 -153.97 131.83 11.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.934 -1.485 . . . . 0.0 108.146 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 1.043 ' HA ' HD22 ' A' ' 137' ' ' LEU . 60.1 mtp85 -62.81 74.55 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 -178.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.769 ' CG2' HG22 ' A' ' 31' ' ' VAL . 29.7 mm -116.56 124.2 72.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.081 HD11 ' HB2' ' A' ' 72' ' ' LEU . 1.9 pp -127.67 145.51 34.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -177.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.651 HG22 ' O ' ' A' ' 46' ' ' LEU . 33.7 m -127.44 136.33 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.123 179.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.969 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 1.3 mt -116.44 147.92 19.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.785 0.803 . . . . 0.0 110.698 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 1.016 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 33.2 t70 -136.07 30.23 3.04 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.217 -178.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.815 HG22 HG22 ' A' ' 44' ' ' ILE . 24.4 t -98.15 112.4 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.16 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.612 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 78.6 p -39.95 76.38 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -178.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.801 ' OE2' HD12 ' A' ' 126' ' ' LEU . 34.6 tp10 -75.72 -11.5 60.01 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.41 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.635 ' OD1' ' HG2' ' A' ' 66' ' ' ARG . 10.3 t-20 -164.41 -136.14 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.877 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.635 ' HG2' ' OD1' ' A' ' 65' ' ' ASN . 26.7 mmm180 -76.02 -58.78 3.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.84 0.353 . . . . 0.0 111.166 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.23 130.32 40.53 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.015 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.612 ' HG2' ' HA ' ' A' ' 63' ' ' SER . 49.8 mt-10 -86.42 121.19 28.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.871 178.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.629 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 72.9 ttt180 172.48 76.28 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.401 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.969 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 65.0 mt -104.28 133.1 49.77 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.804 ' C ' HD22 ' A' ' 72' ' ' LEU . 14.5 p -135.01 134.38 53.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.291 177.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.081 ' HB2' HD11 ' A' ' 58' ' ' ILE . 3.0 mm? -140.01 141.73 36.3 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 177.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.985 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 3.5 mm -120.43 134.32 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 121.232 0.539 . . . . 0.0 111.548 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.7 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 6.7 m120 51.36 38.68 0.54 Allowed Pre-proline 0 C--N 1.317 -0.807 0 CA-C-N 115.217 -0.902 . . . . 0.0 112.323 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.77 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 84.5 Cg_exo -54.92 149.78 40.7 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.974 2.449 . . . . 0.0 114.104 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.44 ' O ' ' HB ' ' A' ' 108' ' ' ILE . 15.7 pt-20 -135.79 142.36 44.89 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.809 HD23 ' N ' ' A' ' 78' ' ' LEU . 1.7 tt -81.79 134.21 35.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.643 0.735 . . . . 0.0 111.806 -178.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.116 HD11 ' HG3' ' A' ' 109' ' ' ARG . 6.7 mp -110.74 -37.51 5.41 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.691 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.569 ' C ' ' HE2' ' A' ' 80' ' ' LYS . 85.2 tt0 -160.28 153.71 22.19 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.186 0.517 . . . . 0.0 111.782 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.901 ' HA ' HG12 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -148.03 151.7 36.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.378 179.125 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.7 m -160.46 141.55 12.06 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.578 0.228 . . . . 0.0 110.984 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.783 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 80.35 168.33 38.0 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.235 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -146.26 113.73 6.33 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.672 0.749 . . . . 0.0 112.926 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.554 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.5 p -99.54 160.91 13.94 Favored 'General case' 0 CA--C 1.49 -1.331 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.718 ' O ' HD13 ' A' ' 86' ' ' ILE . . . -134.44 100.51 0.38 Allowed Glycine 0 C--N 1.317 -0.475 0 CA-C-N 113.064 -1.88 . . . . 0.0 111.132 178.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.718 HD13 ' O ' ' A' ' 85' ' ' GLY . 39.5 mm -143.73 135.51 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -178.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.645 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 49.0 mt-10 -72.96 143.89 47.48 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 122.389 1.09 . . . . 0.0 112.499 -178.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.67 ' HB3' H262 ' A' ' 149' ' ' BB2 . 50.4 mt-10 -154.16 166.15 34.0 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 113.619 -1.628 . . . . 0.0 109.053 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.771 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -119.87 159.61 14.89 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 119.304 -1.427 . . . . 0.0 109.623 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.855 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 69.2 m -111.71 138.83 47.76 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.552 -177.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.036 HD12 HG11 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -50.04 -32.36 15.24 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.535 0.683 . . . . 0.0 110.0 -179.636 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.792 ' HB2' HG12 ' A' ' 8' ' ' ILE . 11.4 m -77.78 -27.14 50.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.7 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.749 HG13 ' HB2' ' A' ' 90' ' ' CYS . 48.5 mt -85.96 148.3 47.76 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.617 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.722 ' HD2' ' CG2' ' A' ' 93' ' ' ILE . 59.3 Cg_endo -78.24 47.67 2.46 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.438 2.092 . . . . 0.0 114.14 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.577 ' HB2' ' O ' ' A' ' 94' ' ' PRO . 7.9 mp0 80.22 4.66 1.84 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.827 0.346 . . . . 0.0 111.653 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.61 ' HG3' ' HG2' ' A' ' 94' ' ' PRO . 84.7 mt-30 -77.97 90.02 4.15 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 1.014 HH11 H231 ' A' ' 149' ' ' BB2 . 81.1 mtm180 -84.13 133.47 34.62 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.652 0.739 . . . . 0.0 111.377 -178.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.84 148.28 49.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.874 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.682 HD23 ' N ' ' A' ' 100' ' ' VAL . 6.9 tt -75.23 135.73 40.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.208 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 1.015 HG13 ' HB2' ' A' ' 142' ' ' PHE . 55.8 t -131.97 131.49 22.61 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.173 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.896 ' HG2' ' CE2' ' A' ' 142' ' ' PHE . 74.3 Cg_endo -78.24 125.43 7.1 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.692 1.595 . . . . 0.0 113.137 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.892 ' HG2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -141.42 165.51 27.31 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.413 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.783 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -69.38 154.75 41.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.727 0.299 . . . . 0.0 110.513 -178.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -73.41 -43.33 60.68 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.243 -176.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.782 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 84.2 mttt -139.47 138.19 36.19 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.416 0.627 . . . . 0.0 109.624 176.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.901 HG12 ' HA ' ' A' ' 80' ' ' LYS . 28.3 m -144.52 140.38 23.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.991 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 1.052 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 23.6 mmtp -107.99 125.92 52.1 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 1.056 ' HA ' HD13 ' A' ' 78' ' ' LEU . 1.9 pp -132.0 161.36 41.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -177.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 1.116 ' HG3' HD11 ' A' ' 78' ' ' LEU . 92.2 mtt180 -109.58 137.53 47.28 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.782 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.73 ' HB3' HD12 ' A' ' 72' ' ' LEU . . . -155.1 166.5 33.38 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.655 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.985 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.0 pp -116.46 150.47 37.81 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.623 ' O ' HD12 ' A' ' 111' ' ' LEU . 22.0 t70 -84.0 171.33 13.06 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.579 -175.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.776 ' HD2' ' OD1' ' A' ' 32' ' ' ASP . 50.8 ttp180 -54.49 -23.43 16.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.798 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.52 -14.41 58.89 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.873 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.868 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 93.15 40.09 4.94 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.02 -1.086 . . . . 0.0 114.593 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -128.11 102.49 21.49 Favored Pre-proline 0 N--CA 1.469 0.479 0 CA-C-N 117.59 0.695 . . . . 0.0 110.389 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.668 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 32.3 Cg_exo -73.56 115.23 4.26 Favored 'Trans proline' 0 C--N 1.359 1.108 0 N-CA-C 116.249 1.596 . . . . 0.0 116.249 -177.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.64 168.95 13.01 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.739 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.667 ' HG2' ' HG2' ' A' ' 109' ' ' ARG . 36.1 mt-10 -107.6 130.03 54.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.008 0.432 . . . . 0.0 110.278 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.751 HD11 ' CD1' ' A' ' 130' ' ' ILE . 4.1 pp -126.71 134.27 50.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.804 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 1.052 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 15.5 pt-20 -96.79 124.35 40.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.004 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.739 ' O ' ' HB2' ' A' ' 127' ' ' ALA . . . -116.71 135.79 53.49 Favored 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.782 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.3 m-20 -125.99 164.71 20.24 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.737 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 45.14 -132.53 8.26 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 120.627 1.558 . . . . 0.0 116.194 177.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.678 HD12 ' H ' ' A' ' 125' ' ' LEU . 5.0 mp -54.09 -35.83 62.53 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.739 -0.731 . . . . 0.0 111.361 -178.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.801 HD12 ' OE2' ' A' ' 64' ' ' GLU . 0.6 OUTLIER -70.44 -53.02 18.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.581 0.705 . . . . 0.0 109.655 179.721 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -58.46 -41.09 84.38 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.884 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.892 HD12 ' HG2' ' A' ' 102' ' ' ARG . 51.0 mm -68.8 -54.87 18.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.522 -178.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.885 ' HB2' H112 ' A' ' 149' ' ' BB2 . 31.4 p -57.77 -50.33 73.61 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.824 HD11 HD11 ' A' ' 108' ' ' ILE . 20.6 tt -60.07 -43.9 93.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.609 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.878 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 23.3 pt20 -66.97 -37.42 84.21 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.231 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.629 ' HA ' ' OD1' ' A' ' 135' ' ' ASP . 8.5 t-160 -56.04 -47.11 78.48 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.815 ' HG2' H102 ' A' ' 149' ' ' BB2 . 3.8 mm-40 -60.68 -43.03 98.21 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.711 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.784 ' HE1' ' N ' ' A' ' 77' ' ' LEU . 76.2 mtp -61.0 -49.49 77.24 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.453 0.569 . . . . 0.0 111.66 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.708 ' OD2' HD13 ' A' ' 141' ' ' LEU . 6.6 p-10 -65.18 -45.85 83.19 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.552 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.898 ' CB ' HD11 ' A' ' 141' ' ' LEU . 2.6 t60 -59.67 -52.34 65.93 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 121.9 -0.5 . . . . 0.0 112.035 -178.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 1.043 HD22 ' HA ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER -62.51 -29.41 70.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.656 -177.206 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.933 ' CG2' HG13 ' A' ' 16' ' ' VAL . 8.4 p -81.15 21.56 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 CA-C-O 123.067 1.413 . . . . 0.0 107.816 173.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.799 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 56.16 24.7 44.93 Favored Glycine 0 CA--C 1.487 -1.7 0 CA-C-N 111.934 -2.394 . . . . 0.0 112.587 176.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.91 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 6.2 ptmt -115.27 117.33 30.18 Favored 'General case' 0 N--CA 1.427 -1.576 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.435 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.898 HD11 ' CB ' ' A' ' 136' ' ' HIS . 3.6 mm? -135.88 147.7 48.3 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 1.015 ' HB2' HG13 ' A' ' 100' ' ' VAL . 4.1 m-85 -61.97 -32.64 73.1 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.969 ' HA ' ' HG ' ' A' ' 146' ' ' LEU . 23.5 ttt -51.92 -24.19 6.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.16 0.505 . . . . 0.0 111.697 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -48.96 -24.32 1.45 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.965 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -129.73 44.87 2.9 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 120.701 0.286 . . . . 0.0 111.034 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.969 ' HG ' ' HA ' ' A' ' 143' ' ' MET . 34.9 mt -93.79 142.39 27.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.135 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 45.5 t . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.952 179.403 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 149' ' ' BB2 . . . . . 1.014 H231 HH11 ' A' ' 97' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.8 t . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.876 0.37 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.7 m -84.09 138.49 19.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.771 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.968 HD23 ' HB ' ' A' ' 51' ' ' VAL . 61.5 tp -77.45 162.37 27.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.374 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -78.82 106.48 10.86 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.251 0.548 . . . . 0.0 110.282 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.677 HG22 HG12 ' A' ' 51' ' ' VAL . 33.4 t -89.93 131.69 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.788 -178.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.828 ' CD1' ' HA ' ' A' ' 52' ' ' ASP . 39.1 mt -89.49 149.35 22.95 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.135 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.582 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 1.9 m80 -124.37 149.79 46.26 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.61 HD12 ' H ' ' A' ' 8' ' ' ILE . 2.9 mp -55.81 145.54 51.71 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.835 178.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.517 ' HA ' HG23 ' A' ' 8' ' ' ILE . 71.5 Cg_endo -92.35 51.19 1.06 Allowed 'Cis proline' 0 C--N 1.355 0.916 0 C-N-CA 124.572 -1.012 . . . . 0.0 112.915 0.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.693 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 9.9 t70 -55.65 130.86 44.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.896 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -59.17 -40.13 84.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.016 0.436 . . . . 0.0 111.139 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.647 ' HB2' HD13 ' A' ' 6' ' ' LEU . 19.0 mmt-85 -57.65 -26.07 61.09 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.645 0.979 . . . . 0.0 113.645 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.792 HD21 ' HB2' ' A' ' 6' ' ' LEU . 8.8 mt -76.21 -33.24 59.26 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 120.61 1.55 . . . . 0.0 108.434 177.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.873 ' NH1' ' HB2' ' A' ' 144' ' ' ASP . 32.1 mmt180 -91.82 7.99 39.28 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.631 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.537 ' HD3' ' HB3' ' A' ' 54' ' ' HIS . 87.8 tttt -88.3 148.39 24.33 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.089 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.763 HG13 HG23 ' A' ' 138' ' ' VAL . 97.1 t -82.68 128.79 38.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.936 ' HB3' HD12 ' A' ' 137' ' ' LEU . . . -86.24 143.57 27.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.394 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.811 ' HD3' ' CD ' ' A' ' 19' ' ' PRO . 7.6 tmtt? -106.33 130.16 23.39 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.889 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 60.9 Cg_endo -78.14 116.47 3.93 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.342 2.028 . . . . 0.0 111.26 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.747 HG12 ' H ' ' A' ' 22' ' ' GLU . 19.3 t -67.08 144.7 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-O 122.803 1.287 . . . . 0.0 113.14 -175.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.96 -24.51 67.92 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 112.57 -2.105 . . . . 0.0 112.68 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.747 ' H ' HG12 ' A' ' 20' ' ' VAL . 88.6 tt0 -161.01 143.52 12.54 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.975 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.57 HG21 ' HA2' ' A' ' 115' ' ' GLY . 3.3 t -79.55 107.7 12.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 1.041 ' H ' HD12 ' A' ' 27' ' ' ILE . 29.3 m120 -98.06 158.51 15.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.686 -178.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.73 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -55.72 -23.82 31.21 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.215 0.531 . . . . 0.0 110.678 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.513 ' HA ' ' OE1' ' A' ' 26' ' ' GLU . 4.3 mm-40 -74.05 -41.83 61.18 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 176.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 1.041 HD12 ' H ' ' A' ' 24' ' ' ASN . 69.0 mt -64.01 -48.24 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.245 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -57.15 -40.06 76.48 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.73 ' HG3' ' O ' ' A' ' 25' ' ' ALA . 99.3 mtt180 -61.76 -39.8 92.93 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.747 ' CG2' HD13 ' A' ' 53' ' ' ILE . 4.1 mt -56.91 -50.01 77.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 114.832 -1.076 . . . . 0.0 112.075 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.766 HG22 ' CG2' ' A' ' 57' ' ' ILE . 10.5 t -68.58 -42.16 83.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 120.842 0.353 . . . . 0.0 111.432 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.813 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -55.76 -39.48 71.26 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.33 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.497 ' HB3' ' HB2' ' A' ' 3' ' ' LEU . 31.6 m-20 -76.07 -30.45 58.35 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.985 175.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.98 ' HE1' HG22 ' A' ' 57' ' ' ILE . 15.2 mtm -60.58 -46.66 89.42 Favored 'General case' 0 C--N 1.347 0.465 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.44 -177.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.813 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 14.0 p90 -69.05 -46.43 67.91 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.555 ' HG2' ' O ' ' A' ' 32' ' ' ASP . 27.2 mm-40 -51.05 -38.57 52.31 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.672 HG21 ' CG2' ' A' ' 5' ' ' VAL . 57.5 m -69.83 -62.31 1.44 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 118.725 -1.19 . . . . 0.0 108.272 177.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.932 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 2.9 ttp -46.58 -44.25 17.9 Favored 'General case' 0 CA--C 1.458 -2.578 0 C-N-CA 124.016 0.926 . . . . 0.0 110.412 -170.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.713 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 70.0 m-85 -67.67 -41.73 83.24 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.794 178.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.38 -26.67 66.82 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.773 0.796 . . . . 0.0 109.038 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.965 ' HG2' HD12 ' A' ' 91' ' ' LEU . 2.6 tp10 -86.74 -10.89 52.63 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 114.361 -1.29 . . . . 0.0 109.155 177.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.445 ' H ' ' C ' ' A' ' 39' ' ' TYR . 27.7 mm-40 63.94 26.6 14.22 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.107 -176.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.979 ' HA2' H182 ' A' ' 149' ' ' BB2 . . . -80.56 144.49 25.54 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.111 178.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.857 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 46.0 mm -79.25 -3.93 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 117.631 0.715 . . . . 0.0 112.141 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.738 ' HA3' ' C11' ' A' ' 149' ' ' BB2 . . . 179.19 137.9 3.07 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-O 119.109 -0.828 . . . . 0.0 111.302 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.067 HD13 ' HG ' ' A' ' 91' ' ' LEU . 2.3 tp -124.39 135.22 53.12 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.285 1.542 . . . . 0.0 110.828 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -103.68 130.62 51.18 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 122.085 -0.384 . . . . 0.0 111.299 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.956 ' HB1' HG13 ' A' ' 53' ' ' ILE . . . -28.51 -57.99 0.13 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 116.647 2.092 . . . . 0.0 116.647 -177.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.519 ' CG2' ' HA ' ' A' ' 137' ' ' LEU . 74.9 p -53.42 -34.69 58.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 122.098 0.951 . . . . 0.0 111.478 -177.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.621 ' HG2' ' CE1' ' A' ' 136' ' ' HIS . 23.2 mt-30 -63.56 -38.47 91.26 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 113.929 -1.487 . . . . 0.0 110.686 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.968 ' HB ' HD23 ' A' ' 3' ' ' LEU . 1.5 m -92.52 19.44 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.828 ' HA ' ' CD1' ' A' ' 6' ' ' LEU . 37.5 t70 78.25 25.99 0.58 Allowed 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 176.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.956 HG13 ' HB1' ' A' ' 48' ' ' ALA . 11.9 pt -120.36 108.56 23.38 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.131 177.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.602 ' O ' ' HD2' ' A' ' 54' ' ' HIS . 2.9 p-80 -75.41 51.2 0.56 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-O 122.16 0.981 . . . . 0.0 109.905 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.546 ' O ' HG12 ' A' ' 57' ' ' ILE . 83.2 mt-30 -139.01 132.52 30.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 113.892 -1.504 . . . . 0.0 107.716 178.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.889 ' HD2' ' HD3' ' A' ' 19' ' ' PRO . 96.0 mtt180 -61.79 72.52 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -178.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.98 HG22 ' HE1' ' A' ' 34' ' ' MET . 10.3 mm -116.35 122.75 70.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.101 HD11 ' HB2' ' A' ' 72' ' ' LEU . 1.8 pp -127.0 145.4 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 -177.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.61 ' CG2' ' HB3' ' A' ' 46' ' ' LEU . 33.9 m -128.71 134.95 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.362 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.045 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 1.6 mt -116.54 145.45 22.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.504 0.669 . . . . 0.0 110.344 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.932 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 28.0 t70 -124.69 16.29 8.75 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.391 -178.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.787 HG22 ' CG2' ' A' ' 44' ' ' ILE . 29.8 t -88.05 114.04 26.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.598 178.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.547 ' N ' ' HG2' ' A' ' 68' ' ' GLU . 81.4 p -42.42 81.51 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.683 ' HB2' HD11 ' A' ' 70' ' ' LEU . 65.0 mm-40 -128.84 -17.38 4.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.47 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.603 ' O ' ' HG2' ' A' ' 66' ' ' ARG . 43.3 t30 -105.06 -35.19 7.72 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 122.015 -0.428 . . . . 0.0 110.886 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.864 ' HE ' ' HA ' ' A' ' 66' ' ' ARG . 2.4 mmp_? -161.34 -91.13 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 68' ' ' GLU . 1.4 m-20 -130.23 55.52 1.8 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.153 177.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.547 ' HG2' ' N ' ' A' ' 63' ' ' SER . 94.7 mt-10 71.78 101.38 0.07 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.997 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.552 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 35.5 ttt85 175.2 64.11 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.83 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 1.045 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 63.8 mt -102.69 135.16 44.84 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.721 ' CG2' HG11 ' A' ' 31' ' ' VAL . 12.5 p -134.74 130.5 52.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.083 178.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.101 ' HB2' HD11 ' A' ' 58' ' ' ILE . 90.6 mt -141.37 142.2 33.78 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.59 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.049 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.6 mp -121.27 134.87 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-O 120.652 0.263 . . . . 0.0 110.901 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.709 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 52.6 m-20 57.02 37.56 0.38 Allowed Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.914 ' HG2' HG12 ' A' ' 58' ' ' ILE . 88.4 Cg_exo -56.59 145.72 79.48 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 122.838 2.359 . . . . 0.0 114.101 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.487 ' HG2' ' HB2' ' A' ' 109' ' ' ARG . 15.2 pt-20 -136.89 142.22 42.75 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.786 HD23 ' N ' ' A' ' 78' ' ' LEU . 1.7 tt -81.84 133.27 35.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.375 0.607 . . . . 0.0 111.753 -178.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.114 HD13 ' HA ' ' A' ' 108' ' ' ILE . 4.8 mp -108.82 -39.14 5.43 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.997 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.443 ' O ' HD21 ' A' ' 77' ' ' LEU . 42.4 tt0 -156.36 152.83 28.06 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 121.192 0.52 . . . . 0.0 111.764 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 1.056 ' HA ' HG12 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -147.28 149.81 33.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.936 179.385 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.3 p -160.07 152.94 21.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.79 0.329 . . . . 0.0 111.571 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.684 ' C ' ' HG3' ' A' ' 104' ' ' GLU . . . 73.63 146.33 0.92 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.749 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.408 ' N ' ' HG3' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -110.98 112.62 24.58 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 121.631 0.729 . . . . 0.0 111.229 -179.771 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . 1.035 HG23 ' HG2' ' A' ' 104' ' ' GLU . 1.6 p -114.81 160.94 18.86 Favored 'General case' 0 CA--C 1.484 -1.595 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.801 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -155.83 123.26 1.3 Allowed Glycine 0 C--N 1.311 -0.855 0 CA-C-N 113.01 -1.904 . . . . 0.0 110.95 178.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.451 ' N ' ' HG ' ' A' ' 99' ' ' LEU . 34.4 mt -147.34 139.18 18.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-N 117.643 0.722 . . . . 0.0 111.834 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 56.1 mt-10 -71.23 135.15 47.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 123.538 1.637 . . . . 0.0 112.349 -176.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.758 ' HG2' ' O27' ' A' ' 149' ' ' BB2 . 41.0 mt-10 -154.24 166.61 32.61 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 112.132 -2.304 . . . . 0.0 111.425 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.791 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -120.73 163.3 14.32 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.847 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 65.1 m -109.64 137.42 47.49 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.865 0.364 . . . . 0.0 110.926 -177.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.067 ' HG ' HD13 ' A' ' 46' ' ' LEU . 3.1 mm? -51.53 -38.66 55.24 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.73 0.776 . . . . 0.0 109.719 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.64 ' CB ' HD13 ' A' ' 13' ' ' LEU . 22.8 m -77.12 -26.66 53.45 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.59 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.754 ' CG1' ' HB2' ' A' ' 90' ' ' CYS . 53.1 mt -85.31 149.52 52.48 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.738 ' HD2' HG23 ' A' ' 93' ' ' ILE . 66.6 Cg_endo -75.68 47.08 1.81 Allowed 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.118 1.878 . . . . 0.0 115.446 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.569 ' HB2' ' O ' ' A' ' 94' ' ' PRO . 8.3 mp0 77.26 11.54 2.28 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.607 ' HG2' ' HG2' ' A' ' 94' ' ' PRO . 9.7 mm-40 -78.69 88.99 4.57 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.791 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 18.4 mtm105 -84.86 132.13 34.43 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.852 0.834 . . . . 0.0 111.638 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 87' ' ' GLU . . . -135.15 155.55 50.51 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.273 -1.33 . . . . 0.0 109.22 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.801 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.5 tt -76.52 110.86 11.42 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.828 0.823 . . . . 0.0 111.532 -177.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.97 HG13 ' HB2' ' A' ' 142' ' ' PHE . 40.3 t -98.4 126.16 40.53 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 114.415 -1.266 . . . . 0.0 112.021 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.607 ' HG2' ' CD2' ' A' ' 142' ' ' PHE . 81.7 Cg_endo -78.84 126.55 7.31 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.318 2.012 . . . . 0.0 112.277 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.89 ' HG2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -145.03 166.77 24.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.637 179.011 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.59 154.94 40.95 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.208 0.527 . . . . 0.0 110.283 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 1.035 ' HG2' HG23 ' A' ' 84' ' ' THR . 50.0 mt-10 -73.61 -42.19 61.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.645 -176.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.797 ' NZ ' ' HB3' ' A' ' 123' ' ' ASP . 66.5 mttm -140.41 139.62 35.3 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 1.056 HG12 ' HA ' ' A' ' 80' ' ' LYS . 28.7 m -149.98 141.63 17.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.437 -178.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.697 ' CE ' ' HB3' ' A' ' 121' ' ' GLU . 0.4 OUTLIER -107.65 125.15 51.0 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.46 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 1.114 ' HA ' HD13 ' A' ' 78' ' ' LEU . 1.4 pp -135.42 151.8 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -176.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 1.042 ' HG3' HD11 ' A' ' 78' ' ' LEU . 94.2 mtt180 -100.81 138.54 37.73 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 122.214 1.007 . . . . 0.0 111.128 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.842 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -158.8 169.35 24.57 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.759 -176.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 1.049 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.9 pp -120.27 154.78 34.46 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.455 ' O ' HD12 ' A' ' 111' ' ' LEU . 25.1 t70 -88.15 164.43 15.69 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.443 0.64 . . . . 0.0 111.991 -176.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.72 ' HB2' HG11 ' A' ' 71' ' ' VAL . 24.6 ttm180 -52.62 -20.29 2.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.055 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -81.88 -22.22 37.0 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.03 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.57 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 105.11 35.86 3.06 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 119.893 -1.146 . . . . 0.0 113.857 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -128.62 102.4 20.16 Favored Pre-proline 0 C--O 1.235 0.325 0 CA-C-N 117.344 0.572 . . . . 0.0 111.185 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.676 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 36.4 Cg_exo -74.03 116.72 4.75 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 121.914 1.743 . . . . 0.0 115.715 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.427 ' N ' ' O ' ' A' ' 110' ' ' ALA . 0.5 OUTLIER -129.04 165.78 20.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.418 -179.278 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.84 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 5.8 mp0 -107.72 135.19 49.56 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.888 ' O ' HD23 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -132.39 142.26 49.22 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.679 0.752 . . . . 0.0 111.911 -179.137 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.697 ' HB3' ' CE ' ' A' ' 107' ' ' LYS . 15.2 pt-20 -94.13 123.44 37.51 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.877 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.895 ' CB ' ' HG ' ' A' ' 126' ' ' LEU . . . -115.85 134.47 54.96 Favored 'General case' 0 C--O 1.22 -0.489 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.572 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.797 ' HB3' ' NZ ' ' A' ' 105' ' ' LYS . 38.7 m-20 -127.04 162.19 26.64 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.78 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 48.42 -134.77 19.25 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 120.436 1.471 . . . . 0.0 115.491 177.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.657 HD22 ' H ' ' A' ' 125' ' ' LEU . 2.6 mm? -53.84 -35.17 61.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.052 -0.574 . . . . 0.0 111.34 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.895 ' HG ' ' CB ' ' A' ' 122' ' ' ALA . 3.7 tp -70.22 -52.34 23.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.372 0.606 . . . . 0.0 109.81 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.779 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -58.93 -42.94 90.91 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.328 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.89 HD12 ' HG2' ' A' ' 102' ' ' ARG . 47.1 mm -67.17 -56.11 14.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.987 ' HB2' H112 ' A' ' 149' ' ' BB2 . 31.4 p -56.47 -50.21 72.4 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 1.037 HD11 HD11 ' A' ' 108' ' ' ILE . 19.1 tt -58.91 -44.24 90.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.155 -178.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.876 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 23.1 pt20 -68.16 -37.77 81.38 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.071 178.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.726 ' HA ' ' OD2' ' A' ' 135' ' ' ASP . 10.9 t-160 -56.58 -50.0 73.23 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.57 0.7 . . . . 0.0 110.105 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.953 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.2 mm-40 -60.1 -42.24 94.27 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.576 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.878 ' HA ' HD21 ' A' ' 137' ' ' LEU . 74.2 mtp -57.18 -48.74 77.99 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.279 0.562 . . . . 0.0 111.059 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.726 ' OD2' ' HA ' ' A' ' 132' ' ' HIS . 3.3 p30 -66.38 -46.53 76.35 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.416 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.96 ' CE1' HD21 ' A' ' 141' ' ' LEU . 10.7 t-80 -56.12 -51.46 67.84 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.489 0.661 . . . . 0.0 110.768 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.953 HD23 ' O ' ' A' ' 133' ' ' GLU . 1.2 pp -61.35 -30.16 70.35 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.955 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.966 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 14.6 p -86.58 25.94 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-O 122.292 1.044 . . . . 0.0 109.549 176.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.614 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 59.32 15.31 30.43 Favored Glycine 0 CA--C 1.49 -1.511 0 CA-C-N 113.395 -1.73 . . . . 0.0 113.359 176.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.966 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 9.9 ptmt -110.15 119.68 40.06 Favored 'General case' 0 N--CA 1.424 -1.746 0 C-N-CA 119.617 -0.833 . . . . 0.0 108.932 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.96 HD21 ' CE1' ' A' ' 136' ' ' HIS . 9.4 mp -133.56 138.8 46.22 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.336 -0.853 . . . . 0.0 108.753 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.97 ' HB2' HG13 ' A' ' 100' ' ' VAL . 20.1 m-85 -63.81 -33.25 75.26 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 121.985 -0.447 . . . . 0.0 111.661 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' MET . . . . . 1.035 ' HA ' HD23 ' A' ' 146' ' ' LEU . 16.1 tpt -52.01 -23.88 5.82 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.336 0.589 . . . . 0.0 111.213 178.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.873 ' HB2' ' NH1' ' A' ' 14' ' ' ARG . 38.8 t70 -49.23 -25.04 2.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.681 -178.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -130.05 46.19 2.69 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.141 -177.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 1.035 HD23 ' HA ' ' A' ' 143' ' ' MET . 3.7 mm? -91.28 140.75 29.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.902 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 48.1 t . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.194 -0.908 . . . . 0.0 111.024 179.453 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 149' ' ' BB2 . . . . . 0.987 H112 ' HB2' ' A' ' 129' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.598 ' O ' ' HB3' ' A' ' 36' ' ' GLU . 47.4 t . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.841 0.353 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.725 HG13 ' HA ' ' A' ' 37' ' ' THR . 43.2 t -119.78 138.47 50.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.227 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 1.027 HD23 ' HB ' ' A' ' 51' ' ' VAL . 58.5 tp -77.11 165.74 24.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.404 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -78.82 107.11 11.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.084 0.469 . . . . 0.0 110.271 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.652 ' CG2' HG21 ' A' ' 37' ' ' THR . 39.0 t -89.69 131.58 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.652 -178.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.09 ' HB2' HD21 ' A' ' 13' ' ' LEU . 16.7 mt -93.52 141.33 28.59 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.497 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 35.2 m-70 -117.92 145.29 44.77 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.084 HD13 HD12 ' A' ' 13' ' ' LEU . 49.8 mm -61.0 133.56 92.58 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.229 177.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.66 145.35 69.87 Favored 'Cis proline' 0 C--N 1.353 0.779 0 C-N-CA 124.51 -1.037 . . . . 0.0 111.951 -0.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.992 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 8.8 t70 -165.04 127.1 2.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.402 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 16.1 pt-20 -58.44 -45.79 87.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.658 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.589 ' O ' ' HB ' ' A' ' 49' ' ' THR . 15.1 mmt85 -56.59 -27.97 59.21 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 1.09 HD21 ' HB2' ' A' ' 6' ' ' LEU . 10.0 mt -77.01 -35.09 57.3 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 120.585 1.539 . . . . 0.0 107.972 177.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.774 ' HB3' ' NH1' ' A' ' 14' ' ' ARG . 2.1 mmm180 -89.2 11.18 19.48 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.802 -1.545 . . . . 0.0 109.395 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.763 ' HD3' ' HB3' ' A' ' 54' ' ' HIS . 59.5 tttp -85.6 137.71 32.67 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.568 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.914 HG13 HG23 ' A' ' 138' ' ' VAL . 58.4 t -84.1 94.4 3.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.237 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.794 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -54.0 148.31 10.95 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -106.43 132.73 20.66 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.798 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.643 ' HD3' ' HD3' ' A' ' 56' ' ' ARG . 66.1 Cg_endo -78.2 114.72 3.61 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.174 1.916 . . . . 0.0 110.684 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.817 HG12 ' H ' ' A' ' 22' ' ' GLU . 17.8 t -69.14 144.4 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-O 122.521 1.153 . . . . 0.0 113.126 -175.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.47 -24.55 67.87 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 113.311 -1.768 . . . . 0.0 111.867 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.817 ' H ' HG12 ' A' ' 20' ' ' VAL . 42.4 tt0 -161.16 140.71 10.51 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.864 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.509 HG22 HD21 ' A' ' 111' ' ' LEU . 2.8 t -78.96 110.95 15.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 1.033 ' H ' HD12 ' A' ' 27' ' ' ILE . 30.8 m120 -92.98 163.3 13.72 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.613 0.244 . . . . 0.0 110.995 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.606 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -56.04 -30.67 62.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.993 0.425 . . . . 0.0 110.819 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.723 ' O ' HD13 ' A' ' 30' ' ' ILE . 55.7 mt-10 -71.72 -40.07 69.71 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 1.033 HD12 ' H ' ' A' ' 24' ' ' ASN . 58.3 mt -62.7 -46.64 95.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.911 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.564 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 48.1 mt-30 -57.92 -39.23 77.49 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.597 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.606 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 41.0 mmt-85 -60.16 -40.98 91.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.864 0.84 . . . . 0.0 108.987 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.809 ' O ' ' HG3' ' A' ' 34' ' ' MET . 1.6 mp -58.89 -48.61 85.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 114.455 -1.248 . . . . 0.0 112.119 179.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.895 HG22 ' CG2' ' A' ' 57' ' ' ILE . 6.5 t -68.33 -41.81 83.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-O 120.845 0.355 . . . . 0.0 111.448 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.873 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -55.27 -42.36 73.48 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.526 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.545 ' HB3' ' HB2' ' A' ' 3' ' ' LEU . 56.8 m-20 -75.95 -30.18 58.58 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.632 176.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' MET . . . . . 1.063 ' HG2' HG21 ' A' ' 51' ' ' VAL . 83.7 mtp -59.86 -47.09 87.15 Favored 'General case' 0 C--N 1.347 0.473 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.531 -177.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.873 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 14.4 p90 -69.49 -44.28 71.44 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.774 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 76.6 mt-10 -51.78 -40.66 60.72 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.725 ' HA ' HG13 ' A' ' 2' ' ' VAL . 41.8 m -68.84 -61.92 1.6 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.576 -1.193 . . . . 0.0 107.864 178.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.895 ' HG3' ' HB2' ' A' ' 46' ' ' LEU . 2.8 ttp -46.11 -41.72 12.76 Favored 'General case' 0 CA--C 1.458 -2.581 0 C-N-CA 124.103 0.961 . . . . 0.0 110.21 -170.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.717 ' OH ' ' HA ' ' A' ' 69' ' ' ARG . 48.2 m-85 -69.22 -41.79 76.58 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.328 178.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.0 -27.45 68.32 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.611 0.72 . . . . 0.0 109.139 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 1.026 ' HG2' HD12 ' A' ' 91' ' ' LEU . 10.5 tp10 -85.53 -10.69 55.64 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.795 176.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.442 ' H ' ' C ' ' A' ' 39' ' ' TYR . 20.7 mt-10 62.21 28.62 17.15 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.859 0.838 . . . . 0.0 109.95 -176.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.458 ' HA2' H182 ' A' ' 149' ' ' BB2 . . . -83.43 143.41 21.76 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 114.0 -1.455 . . . . 0.0 111.122 178.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.812 ' CG2' HG22 ' A' ' 62' ' ' VAL . 47.7 mt -78.98 -2.54 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 117.709 0.754 . . . . 0.0 111.976 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.904 ' HA3' H113 ' A' ' 149' ' ' BB2 . . . 179.83 133.59 2.03 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-O 119.102 -0.832 . . . . 0.0 111.606 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.089 HD13 ' HG ' ' A' ' 91' ' ' LEU . 4.1 tp -124.56 134.55 52.94 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 119.063 1.432 . . . . 0.0 111.329 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -101.06 129.69 46.97 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.871 ' HB1' ' CD1' ' A' ' 53' ' ' ILE . . . -27.21 -56.82 0.09 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 116.099 1.889 . . . . 0.0 116.099 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.614 HG21 ' O ' ' A' ' 137' ' ' LEU . 70.1 p -53.54 -34.38 58.01 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.8 0.81 . . . . 0.0 111.727 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.691 ' OE1' HD12 ' A' ' 46' ' ' LEU . 85.1 mt-30 -64.56 -40.9 96.4 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.347 -1.297 . . . . 0.0 109.947 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.063 HG21 ' HG2' ' A' ' 34' ' ' MET . 1.0 OUTLIER -87.86 15.73 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.889 ' HA ' HD11 ' A' ' 6' ' ' LEU . 38.2 t70 77.51 33.06 0.41 Allowed 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 176.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.871 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 1.1 pp -125.93 110.45 23.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 119.155 -1.018 . . . . 0.0 110.301 177.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.763 ' HB3' ' HD3' ' A' ' 15' ' ' LYS . 0.5 OUTLIER -75.91 63.53 1.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.472 -179.109 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.726 ' C ' ' HB1' ' A' ' 17' ' ' ALA . 69.1 mt-30 -154.53 133.85 12.58 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 114.196 -1.365 . . . . 0.0 108.535 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.794 ' N ' ' HB1' ' A' ' 17' ' ' ALA . 54.3 mtp85 -64.37 72.46 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -177.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.895 ' CG2' HG22 ' A' ' 31' ' ' VAL . 7.1 mm -115.27 125.03 72.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.976 HD11 ' HB2' ' A' ' 72' ' ' LEU . 2.1 pp -131.28 147.77 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 46' ' ' LEU . 33.4 m -127.72 139.74 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.485 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.029 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 7.4 mm -115.11 151.41 16.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.692 0.758 . . . . 0.0 110.033 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.817 ' HB2' ' CE ' ' A' ' 38' ' ' MET . 10.7 t70 -138.99 39.88 2.14 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.079 -178.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.812 HG22 ' CG2' ' A' ' 44' ' ' ILE . 33.1 t -105.92 111.47 35.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.359 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.737 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 61.9 m -34.1 89.77 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -175.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 1.056 ' HG3' HD11 ' A' ' 70' ' ' LEU . 55.5 mt-10 -62.08 -26.84 68.51 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 113.987 -1.461 . . . . 0.0 111.571 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.43 ' OD1' ' HG2' ' A' ' 66' ' ' ARG . 15.6 t-20 -168.16 -85.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 122.221 1.01 . . . . 0.0 109.576 177.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.43 ' HG2' ' OD1' ' A' ' 65' ' ' ASN . 26.7 mmm180 -110.37 -55.66 2.44 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 114.093 -1.412 . . . . 0.0 111.107 178.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -99.5 131.68 45.34 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.752 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.737 ' HG2' ' HA ' ' A' ' 63' ' ' SER . 47.7 mt-10 -91.38 132.26 36.32 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.072 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.717 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 72.9 ttt180 175.39 71.79 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.413 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 1.056 HD11 ' HG3' ' A' ' 64' ' ' GLU . 6.1 mp -102.47 132.54 48.44 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.825 HG21 ' HB2' ' A' ' 113' ' ' ARG . 9.6 p -133.91 131.05 56.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.367 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.976 ' HB2' HD11 ' A' ' 58' ' ' ILE . 93.5 mt -141.16 139.04 33.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.924 -0.125 . . . . 0.0 110.999 178.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.013 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.7 mp -119.53 135.71 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-O 120.595 0.236 . . . . 0.0 110.944 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.709 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 55.0 m-20 55.17 34.68 0.25 Allowed Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.839 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 88.8 Cg_exo -55.91 148.02 59.46 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.649 2.233 . . . . 0.0 113.482 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -136.93 143.28 42.82 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.815 HD23 ' N ' ' A' ' 78' ' ' LEU . 1.7 tt -80.47 135.04 36.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.782 0.801 . . . . 0.0 111.544 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.046 HD13 ' HA ' ' A' ' 108' ' ' ILE . 7.3 mp -110.45 -40.2 4.7 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.335 -1.302 . . . . 0.0 112.062 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 42.2 tt0 -160.34 154.0 22.5 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.179 0.514 . . . . 0.0 111.538 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.821 ' CB ' HG12 ' A' ' 106' ' ' VAL . 9.6 ptpp? -147.83 150.63 34.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.212 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.5 t -160.58 144.65 13.9 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.548 0.213 . . . . 0.0 110.958 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.791 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 81.24 169.85 42.6 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.85 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' A' ' 102' ' ' ARG . 87.9 tt0 -147.38 113.6 5.88 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 117.788 0.794 . . . . 0.0 113.116 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.4 p -98.72 159.9 14.63 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.642 ' CA ' HD21 ' A' ' 99' ' ' LEU . . . -137.87 103.02 0.4 Allowed Glycine 0 C--N 1.317 -0.528 0 CA-C-N 113.193 -1.821 . . . . 0.0 112.1 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.734 ' HB ' ' NH2' ' A' ' 102' ' ' ARG . 21.2 mt -147.07 138.92 18.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.612 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 56.3 mt-10 -71.09 143.47 50.63 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 122.682 1.229 . . . . 0.0 112.211 -178.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.693 ' HB3' H262 ' A' ' 149' ' ' BB2 . 93.3 mt-10 -157.8 161.45 38.41 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.581 -1.645 . . . . 0.0 109.754 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.897 ' O ' ' H52' ' A' ' 149' ' ' BB2 . . . -120.24 159.11 15.24 Favored Glycine 0 CA--C 1.501 -0.809 0 C-N-CA 119.44 -1.362 . . . . 0.0 110.184 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.774 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 16.4 m -112.9 138.35 49.89 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.61 0.719 . . . . 0.0 112.207 -177.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.089 ' HG ' HD13 ' A' ' 46' ' ' LEU . 2.3 mm? -48.96 -23.37 1.1 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.375 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.882 ' CB ' HG12 ' A' ' 8' ' ' ILE . 52.7 m -83.89 -34.98 24.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.158 0.504 . . . . 0.0 110.566 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.873 HD13 ' HB ' ' A' ' 8' ' ' ILE . 45.2 mm -85.53 149.68 52.25 Favored Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.418 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.839 ' HD2' HG23 ' A' ' 93' ' ' ILE . 91.8 Cg_endo -73.32 48.93 1.6 Allowed 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.605 2.203 . . . . 0.0 114.254 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.54 ' HB2' ' O ' ' A' ' 94' ' ' PRO . 56.3 mt-10 77.05 14.68 1.95 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.7 ' HB2' HG21 ' A' ' 93' ' ' ILE . 84.0 mt-30 -78.83 87.58 4.69 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.875 ' HG2' ' HA3' ' A' ' 89' ' ' GLY . 18.2 mtm105 -85.19 133.71 34.18 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.759 0.79 . . . . 0.0 111.87 -178.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 87' ' ' GLU . . . -134.53 154.28 51.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.353 -1.294 . . . . 0.0 109.993 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.713 HD23 ' N ' ' A' ' 100' ' ' VAL . 6.5 tt -74.9 136.29 41.45 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.713 ' N ' HD23 ' A' ' 99' ' ' LEU . 21.0 t -133.46 137.9 30.07 Favored Pre-proline 0 N--CA 1.454 -0.237 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.529 -178.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.737 ' HG2' ' CE2' ' A' ' 145' ' ' TYR . 90.5 Cg_endo -85.66 125.31 2.82 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 121.704 1.603 . . . . 0.0 113.574 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.856 ' HG2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -142.05 166.29 25.11 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 113.627 -1.624 . . . . 0.0 110.684 178.643 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.791 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.47 156.05 38.7 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 120.649 0.261 . . . . 0.0 110.519 -178.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -73.2 -44.55 59.55 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.505 -176.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.806 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 81.4 mttt -139.61 138.14 35.91 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 121.658 0.742 . . . . 0.0 109.694 177.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.857 HG22 ' HB1' ' A' ' 127' ' ' ALA . 33.8 m -139.85 138.23 38.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.939 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 1.132 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 53.2 mmtt -107.5 125.72 51.62 Favored 'General case' 0 C--O 1.224 -0.27 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 1.046 ' HA ' HD13 ' A' ' 78' ' ' LEU . 1.8 pp -131.23 162.97 38.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -177.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 1.035 ' HG3' HD11 ' A' ' 78' ' ' LEU . 94.9 mtt180 -112.05 139.01 47.92 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.998 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.764 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -158.06 167.3 30.25 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 120.729 0.3 . . . . 0.0 111.095 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 1.013 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.4 pp -115.48 153.97 30.17 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 177.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.416 ' O ' HD12 ' A' ' 111' ' ' LEU . 10.3 t70 -90.77 163.27 14.52 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.581 -177.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.825 ' HB2' HG21 ' A' ' 71' ' ' VAL . 46.3 ttp180 -51.6 -19.21 1.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.101 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -78.99 -26.67 43.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.532 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.35 35.0 2.77 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.132 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.613 ' NZ ' ' HB3' ' A' ' 116' ' ' LYS . 6.6 mtpm? -128.76 102.83 19.47 Favored Pre-proline 0 C--O 1.238 0.488 0 CA-C-N 116.799 0.3 . . . . 0.0 111.167 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.652 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 34.2 Cg_exo -74.14 116.56 4.68 Favored 'Trans proline' 0 C--N 1.36 1.164 0 C-N-CA 122.009 1.806 . . . . 0.0 114.903 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.0 167.92 14.65 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.32 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.673 ' HG2' ' HG2' ' A' ' 109' ' ' ARG . 78.9 mt-10 -107.68 129.99 54.97 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.953 0.406 . . . . 0.0 109.974 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.707 ' O ' HD12 ' A' ' 120' ' ' LEU . 4.1 pp -127.19 132.91 50.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.347 0.594 . . . . 0.0 112.084 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 1.132 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 23.0 pt-20 -92.0 125.63 36.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.527 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.931 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -116.08 135.56 53.83 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.806 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.1 m-20 -126.82 163.62 23.18 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.777 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 46.92 -135.5 10.78 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-N 119.787 1.176 . . . . 0.0 115.811 177.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.637 HD23 ' H ' ' A' ' 125' ' ' LEU . 1.6 pt? -54.73 -32.57 59.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.563 -0.819 . . . . 0.0 111.674 -178.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.931 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.5 OUTLIER -70.89 -53.9 13.42 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.743 179.88 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.857 ' HB1' HG22 ' A' ' 106' ' ' VAL . . . -58.92 -42.87 90.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.492 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.856 HD12 ' HG2' ' A' ' 102' ' ' ARG . 49.7 mm -62.52 -55.05 26.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.43 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.945 ' HB2' ' H91' ' A' ' 149' ' ' BB2 . 30.4 p -60.47 -51.57 68.92 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.856 HD11 HD11 ' A' ' 108' ' ' ILE . 20.8 tt -60.08 -42.06 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 111.445 0.165 . . . . 0.0 111.445 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.69 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 20.9 pt20 -67.24 -41.68 85.23 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.617 ' CD2' ' HN1' ' A' ' 149' ' ' BB2 . 65.4 t60 -57.83 -44.8 86.7 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.672 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.855 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.8 mm-40 -60.45 -45.37 93.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 118.902 -0.57 . . . . 0.0 111.814 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.933 ' HA ' HD21 ' A' ' 137' ' ' LEU . 36.9 mtm -56.7 -47.69 79.36 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 119.06 0.845 . . . . 0.0 109.913 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.745 ' O ' HG12 ' A' ' 138' ' ' VAL . 30.9 m-20 -61.83 -49.17 77.37 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.98 178.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.44 ' CE1' ' CG ' ' A' ' 50' ' ' GLN . 12.2 t-80 -56.27 -51.81 66.79 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 121.739 -0.601 . . . . 0.0 110.908 -179.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.933 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.3 pp -60.4 -30.93 69.91 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.481 -0.782 . . . . 0.0 111.775 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.914 HG23 HG13 ' A' ' 16' ' ' VAL . 14.9 p -80.49 21.05 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 CA-C-O 123.208 1.48 . . . . 0.0 108.947 175.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.86 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 69.27 -2.37 9.98 Favored Glycine 0 CA--C 1.492 -1.377 0 CA-C-N 111.723 -2.49 . . . . 0.0 112.452 176.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.766 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 1.3 ptmt -88.68 117.14 27.45 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.617 HD12 ' C ' ' A' ' 140' ' ' LYS . 6.3 mp -113.44 168.76 9.47 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 121.827 -0.546 . . . . 0.0 110.852 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.667 ' HB2' ' CG2' ' A' ' 100' ' ' VAL . 31.3 p90 -52.93 -39.15 62.62 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.634 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 46.9 tpp -54.06 -39.25 66.08 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.246 0.546 . . . . 0.0 110.666 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -55.05 -22.65 16.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.21 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.737 ' CE2' ' HG2' ' A' ' 101' ' ' PRO . 19.9 t80 -108.85 -12.63 14.88 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.93 -178.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.9 mp -83.68 154.71 23.52 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.992 -0.442 . . . . 0.0 110.794 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 40.2 t . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.339 -0.838 . . . . 0.0 111.014 179.601 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 149' ' ' BB2 . . . . . 0.945 ' H91' ' HB2' ' A' ' 129' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.859 0.361 . . . . 0.0 111.216 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 1.044 HG12 ' HA ' ' A' ' 37' ' ' THR . 31.5 m -84.19 137.28 21.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.378 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 1.043 HD11 ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -79.09 -141.25 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.43 ' H ' ' HG ' ' A' ' 3' ' ' LEU . 4.0 tp-100 -112.2 106.83 15.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.953 0.406 . . . . 0.0 110.617 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.017 HG11 HD12 ' A' ' 91' ' ' LEU . 48.2 t -89.19 126.23 42.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.518 0.675 . . . . 0.0 111.47 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.028 ' HB2' HD21 ' A' ' 13' ' ' LEU . 23.1 mt -83.49 141.99 31.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.603 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.772 ' HA ' ' HB3' ' A' ' 92' ' ' SER . 1.7 m80 -111.48 145.48 38.94 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.07 HD13 HD12 ' A' ' 13' ' ' LEU . 42.5 mm -57.77 145.41 70.77 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.279 178.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.522 ' HA ' HG23 ' A' ' 8' ' ' ILE . 73.8 Cg_endo -92.14 51.68 1.02 Allowed 'Cis proline' 0 C--N 1.353 0.81 0 C-N-CA 124.442 -1.066 . . . . 0.0 112.942 0.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.881 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 9.4 t0 -52.72 134.64 36.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.951 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.404 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 12.1 pt-20 -58.62 -44.75 90.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.514 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.672 ' HB2' HD13 ' A' ' 6' ' ' LEU . 11.3 mtt85 -58.91 -24.19 62.1 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 1.07 HD12 HD13 ' A' ' 8' ' ' ILE . 11.6 mt -75.42 -33.13 60.92 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 120.205 1.366 . . . . 0.0 108.3 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.651 HH21 ' HE2' ' A' ' 143' ' ' MET . 22.8 mmt180 -92.11 8.02 39.79 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 113.841 -1.527 . . . . 0.0 109.397 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 12' ' ' ARG . 88.5 tttt -89.86 148.96 22.86 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.186 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.802 HG13 HG23 ' A' ' 138' ' ' VAL . 66.8 t -83.67 126.23 40.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.091 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.759 ' C ' ' HG3' ' A' ' 56' ' ' ARG . . . -83.53 147.8 27.57 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.297 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.741 ' HD3' ' CD ' ' A' ' 19' ' ' PRO . 5.7 tmtm? -110.48 132.31 21.61 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.776 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 63.6 Cg_endo -77.62 116.14 4.0 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.378 2.052 . . . . 0.0 111.732 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.853 HG12 ' H ' ' A' ' 22' ' ' GLU . 22.0 t -68.01 144.95 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 CA-C-O 122.869 1.319 . . . . 0.0 113.087 -175.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -63.73 -29.4 70.62 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 112.893 -1.958 . . . . 0.0 111.897 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.853 ' H ' HG12 ' A' ' 20' ' ' VAL . 88.8 tt0 -157.11 145.05 19.19 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.8 -178.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.538 HG21 ' HA2' ' A' ' 115' ' ' GLY . 3.5 t -79.41 105.18 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 1.063 ' H ' HD12 ' A' ' 27' ' ' ILE . 19.7 m-20 -87.05 153.08 21.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.908 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.474 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -54.57 -30.23 53.69 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.452 0.644 . . . . 0.0 110.207 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -72.82 -37.63 67.42 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 1.063 HD12 ' H ' ' A' ' 24' ' ' ASN . 67.7 mt -67.0 -36.36 76.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.355 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -68.33 -39.49 81.92 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.372 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 40.1 mmt180 -64.09 -38.86 92.6 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.768 ' O ' ' HG3' ' A' ' 34' ' ' MET . 2.9 mt -55.7 -49.19 75.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.614 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.686 HG22 ' CG2' ' A' ' 57' ' ' ILE . 19.8 t -66.33 -40.97 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 121.135 0.493 . . . . 0.0 110.941 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.884 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 26.5 m-20 -53.84 -46.27 71.17 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.575 -178.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.501 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 1.5 m-20 -74.54 -30.11 61.63 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.907 176.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' MET . . . . . 1.011 ' HG2' HG21 ' A' ' 51' ' ' VAL . 85.2 mtp -60.21 -46.31 90.18 Favored 'General case' 0 C--N 1.345 0.408 0 C-N-CA 120.566 -0.454 . . . . 0.0 109.841 -176.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.884 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 11.9 p90 -69.79 -44.76 69.41 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.606 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 31.8 mm-40 -53.34 -39.23 63.96 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . 1.044 ' HA ' HG12 ' A' ' 2' ' ' VAL . 76.9 m -70.51 -60.4 2.28 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 118.28 -1.368 . . . . 0.0 108.613 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.973 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 2.6 ttp -46.76 -41.03 14.61 Favored 'General case' 0 CA--C 1.463 -2.378 0 C-N-CA 124.101 0.96 . . . . 0.0 109.958 -172.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.708 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 60.5 m-85 -70.32 -42.06 72.43 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.312 177.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 37' ' ' THR . . . -61.07 -24.86 66.53 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.577 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.794 ' HG2' ' CD2' ' A' ' 91' ' ' LEU . 3.1 tp10 -88.94 -11.19 45.14 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 114.345 -1.298 . . . . 0.0 108.337 177.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.444 ' H ' ' C ' ' A' ' 39' ' ' TYR . 54.0 mt-10 64.11 26.68 14.0 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.7 -176.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.587 ' HA3' H173 ' A' ' 149' ' ' BB2 . . . -80.87 142.52 23.5 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 113.89 -1.504 . . . . 0.0 110.596 178.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.809 HG22 HG22 ' A' ' 62' ' ' VAL . 46.1 mm -79.52 1.2 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 117.611 0.706 . . . . 0.0 111.997 -178.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.851 ' HA3' ' C10' ' A' ' 149' ' ' BB2 . . . 176.38 137.86 2.73 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 118.838 -0.979 . . . . 0.0 111.371 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.875 ' HB2' ' HG3' ' A' ' 38' ' ' MET . 10.7 tp -126.38 134.54 51.02 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-N 119.505 1.653 . . . . 0.0 111.265 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -98.83 132.15 44.4 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.935 ' HB1' HG13 ' A' ' 53' ' ' ILE . . . -31.22 -54.88 0.23 Allowed 'General case' 0 C--N 1.343 0.285 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.579 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 80.6 p -52.86 -36.07 58.53 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.891 0.853 . . . . 0.0 111.031 -177.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.45 ' HG2' ' CE1' ' A' ' 136' ' ' HIS . 44.1 mt-30 -65.84 -40.56 91.88 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.328 -1.306 . . . . 0.0 110.202 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.043 ' HB ' HD11 ' A' ' 3' ' ' LEU . 1.0 OUTLIER -83.81 16.08 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 179.558 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.949 ' HA ' HD11 ' A' ' 6' ' ' LEU . 36.1 t70 76.93 27.67 0.7 Allowed 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 177.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.935 HG13 ' HB1' ' A' ' 48' ' ' ALA . 13.4 pt -122.26 110.94 28.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 C-N-CA 119.036 -1.066 . . . . 0.0 111.386 177.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.45 ' HB3' ' HD3' ' A' ' 15' ' ' LYS . 7.4 p80 -76.33 52.11 0.74 Allowed 'General case' 0 N--CA 1.46 0.075 0 CA-C-O 122.241 1.019 . . . . 0.0 109.767 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.496 ' C ' ' HB1' ' A' ' 17' ' ' ALA . 83.9 mt-30 -140.6 132.31 27.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 113.817 -1.538 . . . . 0.0 107.752 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.867 ' HG2' ' CD1' ' A' ' 137' ' ' LEU . 99.1 mtt180 -61.78 68.1 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -178.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.935 ' HB ' HD11 ' A' ' 53' ' ' ILE . 10.9 mm -111.88 121.65 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.136 HD11 ' HB2' ' A' ' 72' ' ' LEU . 2.2 pp -129.69 145.74 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -177.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.471 HG23 ' H ' ' A' ' 46' ' ' LEU . 32.6 m -126.0 139.88 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.293 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.056 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 11.9 mm -115.45 151.88 17.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.688 0.756 . . . . 0.0 110.154 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.973 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 34.9 t70 -141.82 37.78 1.63 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.391 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.809 HG22 HG22 ' A' ' 44' ' ' ILE . 38.8 t -99.79 108.12 22.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.378 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.746 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 79.1 p -34.08 86.87 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -175.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.469 ' OE1' HD11 ' A' ' 70' ' ' LEU . 38.3 tt0 -61.3 -22.76 65.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 113.627 -1.624 . . . . 0.0 111.899 178.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -164.75 -74.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.627 0.727 . . . . 0.0 110.02 177.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.506 HH11 ' HG2' ' A' ' 66' ' ' ARG . 39.1 mmt-85 -129.24 -48.27 1.2 Allowed 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.954 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -105.7 127.74 53.25 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.256 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.746 ' HG2' ' HA ' ' A' ' 63' ' ' SER . 48.1 mt-10 -87.17 139.93 30.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.189 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.705 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER 173.89 66.76 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.76 0.314 . . . . 0.0 111.671 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 1.056 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 4.0 mm? -103.84 132.64 49.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.937 0.399 . . . . 0.0 111.817 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.785 ' C ' HD22 ' A' ' 72' ' ' LEU . 12.3 p -134.58 134.46 54.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.226 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.136 ' HB2' HD11 ' A' ' 58' ' ' ILE . 3.0 mm? -142.14 146.55 35.47 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.531 -0.174 . . . . 0.0 110.531 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.012 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.8 mp -122.92 136.44 59.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.732 0.301 . . . . 0.0 110.595 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.716 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 45.3 m-20 51.65 37.62 0.44 Allowed Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.875 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 91.1 Cg_exo -57.51 148.26 73.7 Favored 'Trans proline' 0 N--CA 1.488 1.152 0 C-N-CA 123.046 2.497 . . . . 0.0 114.302 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -137.49 142.95 41.5 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.901 HD12 ' CG2' ' A' ' 108' ' ' ILE . 10.2 tp -80.28 136.84 36.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.109 0.481 . . . . 0.0 111.015 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.16 HD21 ' HG3' ' A' ' 109' ' ' ARG . 2.7 mm? -109.94 -44.48 3.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.068 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.513 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 17.2 tp10 -153.34 144.18 22.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.05 0.452 . . . . 0.0 111.932 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 1.043 ' HA ' HG12 ' A' ' 106' ' ' VAL . 19.3 ptpt -138.14 142.53 40.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.347 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.1 p -151.75 150.49 30.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.854 0.359 . . . . 0.0 111.052 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.631 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 76.91 143.72 1.64 Allowed Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.524 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -109.87 113.8 26.84 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.81 0.814 . . . . 0.0 111.896 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.638 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.7 p -117.21 160.99 20.2 Favored 'General case' 0 CA--C 1.487 -1.447 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.824 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -154.03 124.06 1.5 Allowed Glycine 0 C--N 1.314 -0.69 0 CA-C-N 112.536 -2.12 . . . . 0.0 111.228 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.619 HD13 ' O ' ' A' ' 85' ' ' GLY . 48.8 mm -147.07 137.52 17.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 117.507 0.653 . . . . 0.0 111.46 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 56.0 mt-10 -71.38 139.78 49.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 123.21 1.481 . . . . 0.0 112.606 -176.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.764 ' HG2' ' O27' ' A' ' 149' ' ' BB2 . 40.6 mt-10 -155.78 166.25 34.05 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 112.376 -2.193 . . . . 0.0 111.901 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.741 ' N ' ' HG2' ' A' ' 97' ' ' ARG . . . -120.88 168.27 14.04 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.804 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 87.3 m -113.46 142.74 45.55 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.34 0.57 . . . . 0.0 111.041 -177.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.017 HD12 HG11 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -53.36 -15.54 1.05 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.511 -179.417 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.815 ' HB2' HG12 ' A' ' 8' ' ' ILE . 4.3 m -100.77 -33.48 10.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.2 0.524 . . . . 0.0 110.471 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.769 ' CG2' ' HD2' ' A' ' 94' ' ' PRO . 57.4 mt -85.54 150.78 54.71 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.586 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.769 ' HD2' ' CG2' ' A' ' 93' ' ' ILE . 66.0 Cg_endo -62.63 -146.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.414 2.076 . . . . 0.0 111.812 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -79.63 12.73 2.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.13 0.49 . . . . 0.0 110.986 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.572 ' HG2' ' HG2' ' A' ' 94' ' ' PRO . 10.1 mm-40 -78.95 81.85 5.19 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.127 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.761 HH11 H231 ' A' ' 149' ' ' BB2 . 84.7 mtm180 -86.44 133.33 33.77 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.142 0.496 . . . . 0.0 110.18 178.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -125.73 148.93 48.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.796 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.824 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.4 tt -76.08 113.61 13.8 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.979 0.895 . . . . 0.0 111.208 -177.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.823 HG13 ' NE ' ' A' ' 102' ' ' ARG . 14.0 p -103.7 129.21 25.77 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 114.572 -1.194 . . . . 0.0 111.575 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.638 ' HA ' ' O ' ' A' ' 84' ' ' THR . 87.8 Cg_endo -83.55 126.61 4.15 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 122.67 2.247 . . . . 0.0 113.844 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.91 ' HG2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -143.63 166.96 23.41 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.595 1.158 . . . . 0.0 109.288 179.381 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.631 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.18 155.33 39.86 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.914 0.388 . . . . 0.0 110.302 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -73.25 -40.37 64.69 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.483 -175.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.716 ' HB3' ' OD1' ' A' ' 123' ' ' ASP . 96.0 mttt -140.03 140.91 36.3 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 176.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 1.043 HG12 ' HA ' ' A' ' 80' ' ' LYS . 19.4 m -152.94 141.54 14.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.836 -1.075 . . . . 0.0 112.58 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.918 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 31.9 mmtm -107.52 127.03 53.26 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 1.079 ' HA ' HD23 ' A' ' 78' ' ' LEU . 1.8 pp -134.57 150.95 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -176.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 1.16 ' HG3' HD21 ' A' ' 78' ' ' LEU . 43.7 mtm180 -103.42 140.5 37.38 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-O 122.277 1.037 . . . . 0.0 111.602 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.757 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -160.54 168.73 24.41 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.779 -176.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 1.012 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.3 pp -116.15 151.21 36.1 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.781 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 20.5 t70 -85.53 163.84 18.15 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.742 -176.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.692 ' HB2' HG21 ' A' ' 71' ' ' VAL . 13.2 ttp-105 -52.71 -19.29 2.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.046 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -79.41 -26.12 41.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.434 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.538 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 106.77 35.99 2.68 Favored Glycine 0 C--N 1.34 0.792 0 C-N-CA 120.168 -1.015 . . . . 0.0 113.545 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -128.57 102.93 19.87 Favored Pre-proline 0 C--O 1.238 0.5 0 CA-C-N 116.859 0.33 . . . . 0.0 110.694 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.677 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 32.1 Cg_exo -72.67 115.2 4.25 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 121.307 1.338 . . . . 0.0 114.563 -177.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.781 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 10.4 p90 -127.15 168.75 14.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.551 -178.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 109' ' ' ARG . 3.0 mp0 -107.1 130.11 54.73 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.715 ' O ' HD12 ' A' ' 120' ' ' LEU . 4.3 pp -122.81 132.56 54.26 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.416 -178.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.918 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 15.3 pt-20 -92.17 123.97 35.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.789 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.937 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -118.58 133.64 55.71 Favored 'General case' 0 C--O 1.22 -0.472 0 C-N-CA 120.456 -0.498 . . . . 0.0 112.13 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.716 ' OD1' ' HB3' ' A' ' 105' ' ' LYS . 31.5 m-20 -127.38 161.54 28.43 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.576 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 55.1 -140.59 38.86 Favored Glycine 0 C--N 1.346 1.109 0 C-N-CA 118.94 -1.6 . . . . 0.0 115.145 177.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.69 HD12 ' H ' ' A' ' 125' ' ' LEU . 4.6 mp -54.9 -30.69 58.86 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.831 -0.684 . . . . 0.0 111.62 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.937 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -71.22 -51.77 22.79 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.677 0.751 . . . . 0.0 109.209 179.607 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.78 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -60.22 -47.01 87.77 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.767 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.91 HD12 ' HG2' ' A' ' 102' ' ' ARG . 46.9 mm -63.69 -55.01 25.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -177.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.947 ' HB3' ' H91' ' A' ' 149' ' ' BB2 . 81.8 m -58.19 -48.61 79.79 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.945 HD11 HD11 ' A' ' 108' ' ' ILE . 20.0 tt -59.01 -40.93 81.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.854 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.809 ' CG ' HG21 ' A' ' 106' ' ' VAL . 69.2 mt-30 -67.59 -40.76 84.81 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.493 ' HD1' ' NH2' ' A' ' 102' ' ' ARG . 79.7 t60 -57.72 -45.87 85.16 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.021 0.439 . . . . 0.0 110.026 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.903 ' O ' HD23 ' A' ' 137' ' ' LEU . 4.2 mm-40 -59.99 -42.57 94.48 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.227 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.947 ' HA ' HD21 ' A' ' 137' ' ' LEU . 3.0 mmm -56.83 -47.55 80.06 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.772 0.796 . . . . 0.0 109.999 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.766 ' O ' HG12 ' A' ' 138' ' ' VAL . 32.3 m-20 -65.4 -48.37 73.07 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.701 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.671 ' CE1' HD21 ' A' ' 141' ' ' LEU . 16.2 t-80 -57.38 -50.77 71.93 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.722 -0.611 . . . . 0.0 111.051 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.947 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.6 pp -60.7 -30.7 70.11 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.812 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.913 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 11.9 p -84.19 24.83 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-O 122.412 1.101 . . . . 0.0 109.957 177.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 66.76 3.03 19.45 Favored Glycine 0 CA--C 1.487 -1.673 0 CA-C-N 113.423 -1.717 . . . . 0.0 113.262 176.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.913 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 9.4 ptmt -95.45 133.86 38.94 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.78 HD12 ' O ' ' A' ' 140' ' ' LYS . 11.1 mp -135.99 153.03 51.51 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.809 ' HB3' ' CG2' ' A' ' 100' ' ' VAL . 8.5 p90 -53.39 -33.84 55.39 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.651 ' HE2' HH21 ' A' ' 14' ' ' ARG . 57.2 ttp -59.99 -27.32 66.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.154 0.502 . . . . 0.0 110.867 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.502 ' CB ' HH12 ' A' ' 14' ' ' ARG . 61.8 t0 -58.7 -25.29 62.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.159 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -116.43 10.29 14.59 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.654 HD13 ' O ' ' A' ' 142' ' ' PHE . 6.5 mp -91.22 143.59 26.5 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.788 0.328 . . . . 0.0 111.42 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 48.2 t . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.9 179.448 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 149' ' ' BB2 . . . . . 0.947 ' H91' ' HB3' ' A' ' 129' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 79.2 p . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.852 0.358 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.766 ' CG1' HG23 ' A' ' 37' ' ' THR . 37.2 t -84.24 136.21 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.833 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.825 HD11 ' CB ' ' A' ' 51' ' ' VAL . 3.4 pp -78.75 -175.97 4.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.746 0.308 . . . . 0.0 110.548 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -83.25 107.62 15.91 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.817 0.341 . . . . 0.0 110.643 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.558 ' CG2' HG21 ' A' ' 37' ' ' THR . 39.1 t -89.56 131.5 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 121.229 0.538 . . . . 0.0 112.235 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.08 ' HB2' HD21 ' A' ' 13' ' ' LEU . 14.7 mt -88.31 140.25 29.67 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.931 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.597 ' HB3' ' O ' ' A' ' 92' ' ' SER . 41.4 m-70 -116.71 144.33 44.56 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.053 HD13 HD12 ' A' ' 13' ' ' LEU . 43.5 mm -62.95 135.56 96.2 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.999 177.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -80.2 145.5 71.87 Favored 'Cis proline' 0 C--N 1.354 0.818 0 C-N-CA 124.387 -1.089 . . . . 0.0 112.006 -0.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.982 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 8.9 t70 -165.88 128.44 2.02 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.426 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.446 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 24.1 pt-20 -58.19 -46.0 86.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.592 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.622 ' HA ' ' HB2' ' A' ' 15' ' ' LYS . 20.2 mmt-85 -56.09 -28.73 58.9 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 1.08 HD21 ' HB2' ' A' ' 6' ' ' LEU . 10.1 mt -76.72 -34.27 58.13 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 120.339 1.427 . . . . 0.0 108.786 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.825 ' HB3' ' NH1' ' A' ' 14' ' ' ARG . 1.7 mmm180 -91.99 11.1 26.28 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.029 178.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.839 ' HD3' ' N ' ' A' ' 16' ' ' VAL . 11.2 tmtt? -84.3 139.37 32.36 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.482 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.891 HG13 HG23 ' A' ' 138' ' ' VAL . 46.0 t -84.29 93.93 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.79 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.799 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -53.88 147.85 11.38 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.337 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -104.25 131.24 22.1 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.746 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.547 ' HD3' ' HD3' ' A' ' 56' ' ' ARG . 69.2 Cg_endo -77.52 114.67 3.75 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.097 1.864 . . . . 0.0 110.56 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.858 HG12 ' H ' ' A' ' 22' ' ' GLU . 19.7 t -69.36 144.57 13.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 122.624 1.202 . . . . 0.0 113.313 -175.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -66.12 -24.68 66.72 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 113.266 -1.788 . . . . 0.0 111.915 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.858 ' H ' HG12 ' A' ' 20' ' ' VAL . 88.7 tt0 -160.96 141.0 10.98 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.658 0.266 . . . . 0.0 110.734 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.531 HG22 HD21 ' A' ' 111' ' ' LEU . 2.8 t -79.18 109.82 14.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 1.056 ' H ' HD12 ' A' ' 27' ' ' ILE . 30.9 m120 -92.07 164.55 13.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.52 0.2 . . . . 0.0 110.94 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.712 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -56.22 -30.72 62.72 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.176 0.513 . . . . 0.0 110.762 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -71.52 -39.6 70.64 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 177.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 1.056 HD12 ' H ' ' A' ' 24' ' ' ASN . 59.6 mt -63.26 -47.24 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.132 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.523 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 43.0 mt-30 -57.83 -39.25 77.2 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-O 120.896 0.379 . . . . 0.0 110.701 178.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.712 ' HG3' ' O ' ' A' ' 25' ' ' ALA . 99.6 mtt180 -60.3 -39.86 88.44 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.813 ' O ' ' HG3' ' A' ' 34' ' ' MET . 3.3 mt -60.06 -48.54 87.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 114.641 -1.163 . . . . 0.0 112.108 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.88 HG22 ' CG2' ' A' ' 57' ' ' ILE . 12.5 t -68.49 -42.63 83.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-O 120.862 0.363 . . . . 0.0 111.378 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.866 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -55.17 -42.02 72.61 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.516 -179.705 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.484 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 23.4 m-20 -75.23 -30.3 60.52 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.348 175.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' MET . . . . . 1.067 ' HG2' HG21 ' A' ' 51' ' ' VAL . 86.5 mtp -60.54 -46.83 88.73 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.857 -177.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.866 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 14.1 p90 -69.38 -44.43 71.52 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.762 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 34.0 mt-10 -51.36 -42.1 61.09 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.766 HG23 ' CG1' ' A' ' 2' ' ' VAL . 73.7 m -69.3 -62.08 1.53 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.493 -1.23 . . . . 0.0 108.236 178.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' MET . . . . . 1.004 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 3.4 ttp -45.91 -42.53 12.86 Favored 'General case' 0 CA--C 1.454 -2.739 0 C-N-CA 124.183 0.993 . . . . 0.0 110.563 -170.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.681 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 50.2 m-85 -69.42 -41.58 76.18 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.569 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.8 -28.69 68.96 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.796 0.807 . . . . 0.0 109.003 178.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.994 ' HG2' HD12 ' A' ' 91' ' ' LEU . 11.0 tp10 -84.33 -10.11 57.88 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 114.248 -1.342 . . . . 0.0 108.788 177.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.444 ' H ' ' C ' ' A' ' 39' ' ' TYR . 58.9 mt-10 61.57 26.12 15.89 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 121.914 0.864 . . . . 0.0 109.987 -176.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.672 ' HA2' H182 ' A' ' 149' ' ' BB2 . . . -80.73 142.21 23.37 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 113.993 -1.458 . . . . 0.0 110.757 178.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.866 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 49.2 mt -78.57 -2.54 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 117.702 0.751 . . . . 0.0 111.925 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.884 ' HA3' ' C10' ' A' ' 149' ' ' BB2 . . . -179.28 133.33 2.04 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-O 119.114 -0.826 . . . . 0.0 111.794 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.021 HD13 ' HG ' ' A' ' 91' ' ' LEU . 5.8 tp -124.45 133.99 53.2 Favored 'General case' 0 C--N 1.351 0.632 0 CA-C-N 119.085 1.442 . . . . 0.0 111.278 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -100.44 129.27 46.38 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.218 0.207 . . . . 0.0 111.236 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.879 ' HB1' ' CG1' ' A' ' 53' ' ' ILE . . . -27.06 -55.74 0.08 Allowed 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 116.126 1.898 . . . . 0.0 116.126 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.588 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 66.2 p -53.29 -33.87 55.02 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.882 0.848 . . . . 0.0 112.032 -178.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.764 ' OE1' HD12 ' A' ' 46' ' ' LEU . 82.4 mt-30 -63.93 -42.68 97.3 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.15 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.067 HG21 ' HG2' ' A' ' 34' ' ' MET . 0.9 OUTLIER -86.9 16.2 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.876 ' HA ' HD11 ' A' ' 6' ' ' LEU . 53.6 t0 77.43 34.05 0.38 Allowed 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 176.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.879 ' CG1' ' HB1' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -125.39 109.18 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.302 177.08 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.74 63.34 1.61 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.206 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.74 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 88.9 mt-30 -153.96 134.0 13.19 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 114.156 -1.384 . . . . 0.0 108.425 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.799 ' N ' ' HB1' ' A' ' 17' ' ' ALA . 77.4 mtp180 -65.13 72.38 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -177.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.88 ' CG2' HG22 ' A' ' 31' ' ' VAL . 6.7 mm -114.84 124.93 71.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.065 HD11 ' HB2' ' A' ' 72' ' ' LEU . 2.2 pp -131.41 147.26 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 46' ' ' LEU . 34.1 m -128.84 138.15 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.709 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.006 HG23 H112 ' A' ' 149' ' ' BB2 . 2.2 mt -116.92 142.92 28.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.835 0.826 . . . . 0.0 110.821 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 1.004 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 11.4 t70 -124.87 25.86 7.24 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.18 -1.373 . . . . 0.0 110.294 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.793 HG22 ' CG2' ' A' ' 44' ' ' ILE . 21.9 t -95.68 116.56 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.57 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.604 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 64.1 m -34.42 85.58 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -176.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.424 ' CD ' HD21 ' A' ' 70' ' ' LEU . 42.3 tt0 -58.13 -22.15 49.78 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.176 178.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.89 ' OD1' ' HG3' ' A' ' 66' ' ' ARG . 24.9 t-20 -165.17 -79.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.49 0.662 . . . . 0.0 109.566 177.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.89 ' HG3' ' OD1' ' A' ' 65' ' ' ASN . 76.4 mtp180 -123.24 -49.76 1.92 Allowed 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.136 178.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -99.85 128.43 45.94 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.953 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.604 ' HG2' ' HA ' ' A' ' 63' ' ' SER . 96.2 mt-10 -84.12 130.07 34.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.295 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.666 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 32.8 ttm180 175.02 68.61 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.35 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.954 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 67.2 mt -100.72 132.42 46.12 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.829 HG21 ' HB2' ' A' ' 113' ' ' ARG . 9.9 p -134.38 130.09 53.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.106 178.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.065 ' HB2' HD11 ' A' ' 58' ' ' ILE . 2.8 mm? -141.07 139.54 34.07 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.505 -0.183 . . . . 0.0 110.505 178.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.042 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.7 mp -118.79 134.99 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 110.345 -0.243 . . . . 0.0 110.345 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.707 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 53.3 m-20 54.04 35.56 0.29 Allowed Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.834 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 95.2 Cg_exo -55.83 150.1 47.38 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.72 2.28 . . . . 0.0 113.639 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.642 ' CD ' HH21 ' A' ' 109' ' ' ARG . 15.6 pt-20 -136.74 144.22 43.72 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.898 ' CB ' ' HE1' ' A' ' 134' ' ' MET . 1.4 tt -81.82 136.28 35.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.534 0.683 . . . . 0.0 111.215 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.863 HD11 ' HG3' ' A' ' 109' ' ' ARG . 7.5 mp -116.61 -37.81 3.62 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.308 -178.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 5.2 tp10 -155.36 146.85 22.96 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.107 0.479 . . . . 0.0 111.13 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.823 ' CB ' HG12 ' A' ' 106' ' ' VAL . 12.8 ptmt -148.4 147.38 29.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.258 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 52.8 m -160.56 145.4 14.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.675 0.274 . . . . 0.0 111.303 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.836 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 84.76 169.75 46.22 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.175 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 102' ' ' ARG . 56.7 mt-10 -146.97 113.53 6.0 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.5 p -101.94 159.87 14.98 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 115.132 1.531 . . . . 0.0 115.132 178.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.696 ' O ' HD13 ' A' ' 86' ' ' ILE . . . -137.12 102.61 0.39 Allowed Glycine 0 C--N 1.316 -0.532 0 CA-C-N 112.856 -1.974 . . . . 0.0 111.589 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.752 ' N ' ' HG ' ' A' ' 99' ' ' LEU . 39.8 mm -145.54 136.97 19.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.611 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 56.3 mt-10 -71.31 144.36 49.98 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 122.476 1.131 . . . . 0.0 111.779 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.693 ' HB3' H262 ' A' ' 149' ' ' BB2 . 55.0 mt-10 -158.06 162.06 38.06 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 113.933 -1.485 . . . . 0.0 109.618 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.908 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -119.96 158.01 15.44 Favored Glycine 0 CA--C 1.499 -0.942 0 C-N-CA 119.271 -1.442 . . . . 0.0 110.15 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.786 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 20.5 m -111.88 137.3 50.04 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.564 0.697 . . . . 0.0 111.893 -177.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.021 ' HG ' HD13 ' A' ' 46' ' ' LEU . 2.3 mm? -48.35 -23.03 0.79 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.591 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.873 ' CB ' HD13 ' A' ' 13' ' ' LEU . 48.7 m -84.25 -34.05 23.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.649 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.752 ' CG2' ' HD2' ' A' ' 94' ' ' PRO . 62.6 mt -85.6 148.85 50.14 Favored Pre-proline 0 N--CA 1.45 -0.442 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.758 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.752 ' HD2' ' CG2' ' A' ' 93' ' ' ILE . 94.7 Cg_endo -73.1 48.48 1.46 Allowed 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.573 2.182 . . . . 0.0 114.156 -178.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.55 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 37.7 tt0 78.25 14.39 1.46 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 122.671 0.388 . . . . 0.0 111.989 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.743 ' HB2' HG21 ' A' ' 93' ' ' ILE . 10.3 mm-40 -78.71 87.67 4.61 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.908 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 18.5 mtm105 -85.26 133.07 34.18 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.851 0.834 . . . . 0.0 111.903 -178.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.931 ' H ' ' HE1' ' A' ' 143' ' ' MET . . . -134.47 153.45 51.92 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.249 -1.341 . . . . 0.0 109.624 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.752 ' HG ' ' N ' ' A' ' 86' ' ' ILE . 6.8 tt -75.16 136.33 41.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.458 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.919 HG13 ' HB2' ' A' ' 142' ' ' PHE . 89.7 t -130.14 132.92 24.39 Favored Pre-proline 0 CA--C 1.53 0.177 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' A' ' 84' ' ' THR . 2.1 Cg_endo -81.3 124.1 4.67 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.693 1.595 . . . . 0.0 112.7 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.881 ' HB2' ' OE1' ' A' ' 131' ' ' GLN . 0.0 OUTLIER -142.15 166.4 24.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.765 179.112 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.836 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.67 156.22 38.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.666 0.269 . . . . 0.0 110.286 -178.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -72.82 -43.96 62.06 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.422 -176.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.716 ' HB3' ' OD1' ' A' ' 123' ' ' ASP . 56.6 mttp -139.44 138.24 36.29 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.72 0.771 . . . . 0.0 109.611 176.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.891 HG22 ' HB1' ' A' ' 127' ' ' ALA . 28.4 m -140.05 138.6 37.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.043 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 1.093 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 32.9 mmtm -107.22 125.27 50.9 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.841 HG12 ' CD1' ' A' ' 130' ' ' ILE . 2.1 pp -128.37 161.46 36.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -177.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.863 ' HG3' HD11 ' A' ' 78' ' ' LEU . 68.0 mtm180 -114.28 140.15 48.83 Favored 'General case' 0 N--CA 1.461 0.104 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.847 ' HB3' HD12 ' A' ' 72' ' ' LEU . . . -159.58 168.29 26.46 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.966 -178.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 1.042 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.5 pp -113.59 152.99 29.58 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.461 ' HB2' ' CE2' ' A' ' 118' ' ' PHE . 11.2 t70 -90.79 164.37 14.11 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 119.716 -0.793 . . . . 0.0 111.42 -177.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.829 ' HB2' HG21 ' A' ' 71' ' ' VAL . 15.1 ttm105 -51.57 -19.2 1.38 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.237 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.24 -26.56 42.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.602 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 106.81 34.63 2.98 Favored Glycine 0 C--N 1.337 0.619 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.948 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.678 ' NZ ' ' HB2' ' A' ' 116' ' ' LYS . 9.7 mtmp? -128.63 103.17 19.62 Favored Pre-proline 0 C--O 1.237 0.416 0 C-N-CA 121.228 -0.189 . . . . 0.0 111.236 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.663 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.4 Cg_exo -72.84 116.06 4.58 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 121.799 1.666 . . . . 0.0 114.802 -178.081 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.461 ' CE2' ' HB2' ' A' ' 112' ' ' ASP . 0.4 OUTLIER -126.45 168.62 13.97 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.372 -179.626 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.672 ' HG2' ' CG ' ' A' ' 109' ' ' ARG . 80.2 mt-10 -107.52 129.64 54.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.121 0.486 . . . . 0.0 110.16 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.71 ' O ' HD12 ' A' ' 120' ' ' LEU . 4.2 pp -123.08 129.04 50.95 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.752 -178.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 1.093 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 9.3 pm0 -92.76 124.36 36.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.27 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.937 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -116.35 137.18 52.36 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.716 ' OD1' ' HB3' ' A' ' 105' ' ' LYS . 34.3 m-20 -126.96 163.8 22.88 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.823 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 47.5 -135.47 13.62 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 119.996 1.271 . . . . 0.0 115.864 177.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.0 mt -54.66 -32.73 59.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.654 -0.773 . . . . 0.0 111.667 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.937 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -71.31 -54.01 12.29 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.842 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.891 ' HB1' HG22 ' A' ' 106' ' ' VAL . . . -58.85 -42.98 90.62 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.469 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.874 HD12 ' HG2' ' A' ' 102' ' ' ARG . 49.2 mm -62.17 -54.47 33.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.559 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.894 ' HB3' ' H91' ' A' ' 149' ' ' BB2 . 73.4 m -60.12 -50.72 72.59 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.841 ' CD1' HG12 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -58.88 -44.1 89.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 121.201 -0.199 . . . . 0.0 110.567 -179.674 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.881 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.9 pt20 -67.72 -38.35 83.48 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.738 ' HA ' ' OD2' ' A' ' 135' ' ' ASP . 68.7 t60 -59.22 -46.1 89.35 Favored 'General case' 0 C--O 1.226 -0.16 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.866 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.9 mm-40 -59.67 -45.02 93.33 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.271 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.937 ' HA ' HD21 ' A' ' 137' ' ' LEU . 72.6 mtp -56.84 -48.51 77.9 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 118.913 0.779 . . . . 0.0 110.865 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.738 ' OD2' ' HA ' ' A' ' 132' ' ' HIS . 2.4 p30 -63.35 -46.68 85.42 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.37 178.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.992 ' CE1' HD21 ' A' ' 141' ' ' LEU . 7.8 t-80 -58.03 -52.6 64.86 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.814 -0.554 . . . . 0.0 111.476 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.937 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.5 pp -59.21 -32.68 70.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.553 -177.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.925 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 10.3 p -80.09 19.02 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 CA-C-O 123.101 1.429 . . . . 0.0 108.856 175.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.826 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 61.5 20.52 59.12 Favored Glycine 0 CA--C 1.489 -1.537 0 CA-C-N 111.779 -2.464 . . . . 0.0 112.313 176.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.925 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 7.2 ptmt -111.57 115.02 28.47 Favored 'General case' 0 N--CA 1.424 -1.739 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.046 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.992 HD21 ' CE1' ' A' ' 136' ' ' HIS . 7.7 mp -127.88 132.27 49.37 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.919 ' HB2' HG13 ' A' ' 100' ' ' VAL . 9.0 m-85 -58.54 -40.09 82.03 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.931 ' HE1' ' H ' ' A' ' 98' ' ' ALA . 44.6 ttm -61.51 -27.37 68.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.288 0.566 . . . . 0.0 111.124 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.801 ' OD2' ' HD3' ' A' ' 14' ' ' ARG . 0.8 OUTLIER -55.74 -22.45 23.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.828 179.337 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -120.03 40.04 3.53 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.715 -178.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.911 HD12 ' HG3' ' A' ' 143' ' ' MET . 47.5 mt -93.11 140.84 29.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.049 179.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 57.2 m . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.991 179.648 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 149' ' ' BB2 . . . . . 1.006 H112 HG23 ' A' ' 60' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.3 t . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.811 0.339 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 1.004 HG12 ' HA ' ' A' ' 37' ' ' THR . 27.9 m -83.85 136.21 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.963 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.983 HD13 ' H ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -85.71 -170.15 2.97 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.595 179.88 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 70.9 tp60 -84.52 108.4 17.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.736 0.303 . . . . 0.0 110.798 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.78 HG11 HD12 ' A' ' 91' ' ' LEU . 43.0 t -89.79 131.82 36.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.25 0.548 . . . . 0.0 111.767 -179.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.089 ' HB2' HD21 ' A' ' 13' ' ' LEU . 21.5 mt -85.03 141.73 30.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.071 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.565 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 2.8 m80 -119.77 144.35 47.33 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.094 HD13 HD12 ' A' ' 13' ' ' LEU . 50.7 mm -60.71 134.28 92.02 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.29 177.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -83.02 138.88 35.56 Favored 'Cis proline' 0 C--N 1.352 0.739 0 C-N-CA 124.48 -1.05 . . . . 0.0 111.896 -0.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.629 ' CB ' ' HG ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -155.86 128.99 8.11 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.562 179.672 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 12.0 pt-20 -58.46 -44.71 89.36 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.517 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.702 ' HB2' HD13 ' A' ' 6' ' ' LEU . 24.1 mtt180 -60.5 -24.86 65.63 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 1.094 HD12 HD13 ' A' ' 8' ' ' ILE . 10.3 mt -78.41 -31.03 48.03 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 120.892 1.678 . . . . 0.0 107.617 176.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.677 HH12 ' CG ' ' A' ' 144' ' ' ASP . 15.7 mmm180 -91.8 8.77 35.59 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 113.767 -1.56 . . . . 0.0 109.12 178.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.585 ' HB2' ' HA ' ' A' ' 12' ' ' ARG . 60.2 tttp -88.19 143.5 27.01 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.08 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 1.013 HG13 HG23 ' A' ' 138' ' ' VAL . 56.4 t -83.99 100.24 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.029 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.808 ' HB3' HD12 ' A' ' 137' ' ' LEU . . . -58.74 143.78 45.85 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.944 0.402 . . . . 0.0 111.44 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.721 ' HD3' ' N ' ' A' ' 19' ' ' PRO . 1.7 tmtp? -108.94 132.47 21.16 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.183 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.919 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 56.4 Cg_endo -80.35 115.7 3.21 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.29 1.994 . . . . 0.0 111.057 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.7 HG12 ' H ' ' A' ' 22' ' ' GLU . 17.1 t -70.14 144.42 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-O 122.497 1.142 . . . . 0.0 112.665 -176.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -60.4 -22.95 63.95 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 113.29 -1.777 . . . . 0.0 112.29 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.7 ' H ' HG12 ' A' ' 20' ' ' VAL . 42.3 tt0 -161.17 140.31 10.22 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 120.801 0.334 . . . . 0.0 111.157 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.734 ' HA ' HD12 ' A' ' 27' ' ' ILE . 2.7 t -83.02 117.99 29.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.138 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.909 ' O ' ' HG3' ' A' ' 28' ' ' GLN . 9.8 p30 -105.76 -168.66 1.47 Allowed 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 122.295 -0.253 . . . . 0.0 110.353 -178.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.668 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -73.31 -25.83 60.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.779 0.323 . . . . 0.0 111.434 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.573 ' HB2' ' OD1' ' A' ' 24' ' ' ASN . 4.6 mm-40 -72.89 -40.21 65.74 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.734 HD12 ' HA ' ' A' ' 23' ' ' VAL . 50.8 mt -65.78 -46.04 89.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.166 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.909 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 45.5 mt-30 -57.09 -40.28 76.69 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.705 0.288 . . . . 0.0 110.444 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.668 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 39.4 mmt180 -61.52 -41.16 96.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.654 0.74 . . . . 0.0 109.074 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.818 ' O ' ' HG3' ' A' ' 34' ' ' MET . 4.8 mt -59.72 -50.12 81.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.742 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.898 HG22 ' CG2' ' A' ' 57' ' ' ILE . 10.8 t -67.87 -43.8 85.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-O 120.843 0.354 . . . . 0.0 111.723 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.864 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 26.0 m-20 -54.37 -41.8 69.58 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.404 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.635 ' CB ' HD12 ' A' ' 3' ' ' LEU . 55.9 m-20 -74.39 -31.17 62.25 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.077 176.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' MET . . . . . 1.01 ' HG2' HG21 ' A' ' 51' ' ' VAL . 85.1 mtp -60.3 -47.1 87.47 Favored 'General case' 0 C--N 1.346 0.453 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.869 -177.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.864 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 15.9 p90 -69.35 -44.51 71.45 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.565 ' HG2' ' O ' ' A' ' 32' ' ' ASP . 3.3 mm-40 -51.22 -43.79 61.5 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . 1.004 ' HA ' HG12 ' A' ' 2' ' ' VAL . 96.6 m -70.06 -59.98 2.57 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 118.723 -1.191 . . . . 0.0 109.267 177.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.994 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 3.7 ttp -46.32 -42.5 14.81 Favored 'General case' 0 CA--C 1.461 -2.45 0 C-N-CA 123.42 0.688 . . . . 0.0 109.646 -170.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.751 ' OH ' ' HA ' ' A' ' 69' ' ' ARG . 60.4 m-85 -69.56 -42.35 74.68 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.593 178.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.494 ' CB ' HG11 ' A' ' 2' ' ' VAL . . . -59.84 -28.4 67.47 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.797 ' HG2' ' CD2' ' A' ' 91' ' ' LEU . 17.6 tp10 -84.9 -10.81 56.73 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.708 177.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.442 ' H ' ' C ' ' A' ' 39' ' ' TYR . 7.4 mm-40 63.87 24.2 13.63 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.952 -176.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.834 ' HA2' H182 ' A' ' 149' ' ' BB2 . . . -78.1 142.18 26.0 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 114.143 -1.39 . . . . 0.0 110.595 177.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.868 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 44.2 mm -78.77 -2.18 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 117.566 0.683 . . . . 0.0 112.195 -178.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.855 ' HA3' ' C10' ' A' ' 149' ' ' BB2 . . . 179.36 135.5 2.41 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-O 118.88 -0.956 . . . . 0.0 111.769 -178.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.967 ' HB2' ' HG3' ' A' ' 38' ' ' MET . 9.1 tp -125.85 135.16 51.64 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.437 1.619 . . . . 0.0 111.743 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -99.5 129.97 45.72 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.874 ' HB1' ' CD1' ' A' ' 53' ' ' ILE . . . -30.72 -54.51 0.2 Allowed 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.675 HG21 ' O ' ' A' ' 137' ' ' LEU . 66.6 p -53.53 -35.41 60.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.775 0.798 . . . . 0.0 111.364 -178.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.62 HE22 ' C3 ' ' A' ' 149' ' ' BB2 . 55.8 mt-30 -66.35 -37.36 85.16 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.078 179.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.01 HG21 ' HG2' ' A' ' 34' ' ' MET . 1.1 m -86.4 12.13 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.89 ' HA ' HD11 ' A' ' 6' ' ' LEU . 55.3 t0 78.96 32.37 0.28 Allowed 'General case' 0 C--O 1.23 0.059 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 176.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.874 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 1.2 pp -127.31 111.75 26.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.065 177.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.579 ' HB3' ' HD3' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -76.23 65.05 2.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.089 0.947 . . . . 0.0 110.466 -179.034 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.729 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 89.5 mt-30 -154.88 134.54 12.75 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 114.169 -1.378 . . . . 0.0 108.527 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.919 ' HD2' ' HD3' ' A' ' 19' ' ' PRO . 77.8 mtt-85 -63.34 70.82 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -177.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.898 ' CG2' HG22 ' A' ' 31' ' ' VAL . 8.7 mm -112.9 122.74 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.111 HD11 ' HB2' ' A' ' 72' ' ' LEU . 1.7 pp -128.61 146.03 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 119.635 -0.826 . . . . 0.0 113.177 -177.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.662 HG22 ' O ' ' A' ' 46' ' ' LEU . 33.8 m -128.05 138.75 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.96 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.984 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 12.1 mm -116.13 150.57 18.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.642 0.734 . . . . 0.0 109.859 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.994 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 28.9 t70 -132.7 21.72 4.25 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.508 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.927 HG11 HD12 ' A' ' 125' ' ' LEU . 32.6 t -94.74 114.73 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.328 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.712 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 80.0 p -38.02 83.28 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -177.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.844 ' HB2' HD11 ' A' ' 70' ' ' LEU . 4.6 tm-20 -69.4 -22.04 63.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.868 178.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.72 ' OD1' ' HG2' ' A' ' 66' ' ' ARG . 14.6 t-20 -163.87 -127.97 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.464 178.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.72 ' HG2' ' OD1' ' A' ' 65' ' ' ASN . 2.6 mmp_? -73.6 -55.13 6.69 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.653 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -97.86 130.46 44.76 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.937 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.712 ' HG2' ' HA ' ' A' ' 63' ' ' SER . 54.2 mt-10 -86.78 78.61 9.05 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.751 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 78.8 ttt180 -145.94 86.55 1.72 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -178.334 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.984 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 44.0 mt -104.73 133.55 49.37 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -178.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.822 ' O ' HD12 ' A' ' 72' ' ' LEU . 14.4 p -135.07 133.15 53.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.56 177.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.111 ' HB2' HD11 ' A' ' 58' ' ' ILE . 10.4 mp -138.96 139.79 38.05 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.999 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 2.6 mm -118.86 132.49 68.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.102 0.477 . . . . 0.0 111.197 -178.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.723 ' OD1' ' HA ' ' A' ' 19' ' ' PRO . 68.4 m-20 50.7 38.0 0.47 Allowed Pre-proline 0 CA--C 1.547 0.843 0 CA-C-N 115.003 -0.999 . . . . 0.0 113.075 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.784 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 96.2 Cg_exo -55.85 152.33 36.26 Favored 'Trans proline' 0 N--CA 1.487 1.135 0 C-N-CA 123.027 2.485 . . . . 0.0 114.156 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -137.14 143.25 42.37 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.829 HD23 ' N ' ' A' ' 78' ' ' LEU . 1.8 tt -81.14 135.44 35.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.711 0.767 . . . . 0.0 111.609 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.062 HD11 ' HG3' ' A' ' 109' ' ' ARG . 6.9 mp -111.99 -37.3 5.13 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.045 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 37.6 tt0 -161.0 156.09 24.23 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 121.271 0.557 . . . . 0.0 112.004 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.855 ' HA ' HG12 ' A' ' 106' ' ' VAL . 18.3 ptpt -148.07 153.14 38.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.06 178.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.6 p -159.62 146.38 16.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.852 0.358 . . . . 0.0 111.24 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.76 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 69.73 173.22 10.59 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.843 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.696 ' N ' ' HG3' ' A' ' 104' ' ' GLU . 56.1 mt-10 -146.62 113.89 6.26 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.714 HG23 ' HG2' ' A' ' 104' ' ' GLU . 1.5 p -96.03 159.89 14.73 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 178.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.699 ' O ' HD13 ' A' ' 86' ' ' ILE . . . -135.63 100.81 0.36 Allowed Glycine 0 C--N 1.319 -0.406 0 CA-C-N 113.452 -1.704 . . . . 0.0 111.878 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.699 HD13 ' O ' ' A' ' 85' ' ' GLY . 39.6 mm -145.15 136.94 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -178.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.632 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 47.6 mt-10 -73.35 143.41 46.88 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 122.845 1.307 . . . . 0.0 112.968 -177.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.708 ' HB3' H262 ' A' ' 149' ' ' BB2 . 95.2 mt-10 -154.96 166.27 34.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 113.502 -1.681 . . . . 0.0 109.515 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.803 ' HA3' ' HG2' ' A' ' 97' ' ' ARG . . . -119.86 165.31 13.5 Favored Glycine 0 CA--C 1.498 -0.993 0 C-N-CA 119.339 -1.41 . . . . 0.0 110.225 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 1.085 ' HB2' HD13 ' A' ' 93' ' ' ILE . 95.3 m -118.2 140.22 50.12 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.879 -176.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.797 ' CD2' ' HG2' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -56.9 -23.43 44.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.627 178.741 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.906 ' CB ' HD13 ' A' ' 13' ' ' LEU . 58.7 m -79.45 -38.51 34.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.407 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 1.085 HD13 ' HB2' ' A' ' 90' ' ' CYS . 2.6 mp -86.3 149.62 49.99 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.397 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.874 ' HD2' HG23 ' A' ' 93' ' ' ILE . 84.9 Cg_endo -73.66 50.12 1.97 Allowed 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.636 2.224 . . . . 0.0 114.349 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.543 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 39.4 tt0 78.03 12.34 1.8 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 178.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.731 ' HB2' HG21 ' A' ' 93' ' ' ILE . 84.5 mt-30 -78.43 88.9 4.41 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.803 ' HG2' ' HA3' ' A' ' 89' ' ' GLY . 45.8 mtm-85 -84.85 133.61 34.31 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.757 0.789 . . . . 0.0 111.437 -178.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 87' ' ' GLU . . . -134.62 153.92 51.75 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.113 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.744 HD23 ' N ' ' A' ' 100' ' ' VAL . 6.6 tt -75.13 136.95 41.07 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.912 ' HB ' ' CZ ' ' A' ' 102' ' ' ARG . 21.9 t -132.04 134.23 24.91 Favored Pre-proline 0 C--N 1.339 0.138 0 C-N-CA 120.461 -0.495 . . . . 0.0 110.986 -178.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 100' ' ' VAL . 4.1 Cg_exo -79.75 123.14 5.17 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 121.409 1.406 . . . . 0.0 112.321 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.912 ' CZ ' ' HB ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -144.08 165.75 26.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.653 178.455 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.76 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.72 154.02 42.71 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.014 0.435 . . . . 0.0 109.96 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.714 ' HG2' HG23 ' A' ' 84' ' ' THR . 46.8 mt-10 -73.95 -42.29 60.73 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.336 -176.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.642 ' HG2' ' HB3' ' A' ' 123' ' ' ASP . 93.6 mttt -139.79 137.98 35.46 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.683 0.754 . . . . 0.0 109.677 176.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.855 HG12 ' HA ' ' A' ' 80' ' ' LYS . 28.9 m -141.44 142.04 29.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.754 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 1.044 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 23.6 mmtp -108.13 125.67 51.87 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 1.033 ' HA ' HD13 ' A' ' 78' ' ' LEU . 1.9 pp -130.71 161.75 40.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -177.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 1.062 ' HG3' HD11 ' A' ' 78' ' ' LEU . 93.7 mtt180 -111.0 138.34 47.52 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.546 ' CB ' HD23 ' A' ' 72' ' ' LEU . . . -155.23 166.34 33.87 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.828 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.999 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.2 pp -117.27 152.01 35.74 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.611 ' O ' HD12 ' A' ' 111' ' ' LEU . 20.0 t70 -85.25 168.78 14.42 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 119.326 -0.95 . . . . 0.0 112.404 -176.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.669 ' HB2' HG21 ' A' ' 71' ' ' VAL . 46.5 ttp85 -54.87 -20.26 8.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.689 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -79.71 -19.4 48.96 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.523 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.607 ' HA2' HD13 ' A' ' 111' ' ' LEU . . . 98.83 39.13 3.68 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.156 -1.021 . . . . 0.0 114.141 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.673 ' NZ ' ' HB3' ' A' ' 116' ' ' LYS . 2.2 mmmp? -128.28 102.21 21.27 Favored Pre-proline 0 N--CA 1.467 0.397 0 CA-C-N 117.516 0.658 . . . . 0.0 110.82 178.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.651 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.8 Cg_exo -74.58 115.56 4.34 Favored 'Trans proline' 0 C--N 1.361 1.188 0 C-N-CA 121.733 1.622 . . . . 0.0 116.061 -177.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -125.42 168.49 13.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.043 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.705 ' HG2' ' HG2' ' A' ' 109' ' ' ARG . 35.2 mt-10 -108.09 130.63 55.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.972 0.415 . . . . 0.0 110.305 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.976 HD21 HD21 ' A' ' 72' ' ' LEU . 4.1 pp -128.48 135.72 49.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.222 0.534 . . . . 0.0 112.092 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 1.044 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 11.7 pt-20 -95.5 125.63 40.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.974 178.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.922 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -116.55 135.72 53.58 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.642 ' HB3' ' HG2' ' A' ' 105' ' ' LYS . 24.0 m-20 -125.84 165.04 19.42 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.789 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 46.81 -136.79 9.57 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 120.125 1.329 . . . . 0.0 116.261 176.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.927 HD12 HG11 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -54.76 -32.79 60.46 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.319 -0.941 . . . . 0.0 111.341 -178.387 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.922 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -71.46 -52.64 17.35 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 121.626 0.727 . . . . 0.0 109.455 179.536 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.786 ' HB2' ' C ' ' A' ' 122' ' ' ALA . . . -58.24 -40.77 82.62 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.58 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.879 HD12 ' HG2' ' A' ' 102' ' ' ARG . 49.7 mm -68.6 -54.42 21.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.437 -179.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.898 ' HB2' ' H91' ' A' ' 149' ' ' BB2 . 31.9 p -57.67 -50.92 71.6 Favored 'General case' 0 C--N 1.334 -0.089 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.763 HD11 HD11 ' A' ' 108' ' ' ILE . 20.7 tt -60.55 -44.0 95.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.41 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.844 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 21.5 pt20 -67.85 -38.33 83.03 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.226 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.753 ' HA ' ' OD2' ' A' ' 135' ' ' ASP . 7.8 t-160 -58.45 -46.93 85.57 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.89 ' O ' HD23 ' A' ' 137' ' ' LEU . 4.1 mm-40 -59.42 -44.42 92.86 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.802 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.92 ' HA ' HD21 ' A' ' 137' ' ' LEU . 75.2 mtp -57.01 -48.84 77.52 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 118.411 0.551 . . . . 0.0 110.969 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.753 ' OD2' ' HA ' ' A' ' 132' ' ' HIS . 2.6 p30 -64.24 -47.26 80.34 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.474 -0.49 . . . . 0.0 109.785 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.634 ' CD2' HD12 ' A' ' 141' ' ' LEU . 20.6 t-80 -56.47 -51.79 67.15 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 121.589 -0.694 . . . . 0.0 110.94 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.92 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.3 pp -60.6 -31.31 70.47 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 119.895 -0.722 . . . . 0.0 112.053 -177.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 1.013 HG23 HG13 ' A' ' 16' ' ' VAL . 14.7 p -80.6 23.09 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-O 122.966 1.365 . . . . 0.0 109.815 176.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.878 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 64.45 6.34 21.21 Favored Glycine 0 CA--C 1.491 -1.426 0 CA-C-N 112.482 -2.144 . . . . 0.0 112.896 176.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.822 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 4.5 ptmt -94.09 123.63 37.58 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.634 HD12 ' CD2' ' A' ' 136' ' ' HIS . 2.5 mm? -121.57 160.52 24.16 Favored 'General case' 0 N--CA 1.438 -1.06 0 O-C-N 121.474 -0.766 . . . . 0.0 110.646 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.698 ' CD2' HG21 ' A' ' 100' ' ' VAL . 13.9 p90 -60.23 -34.63 73.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.389 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.531 ' HA ' ' HB2' ' A' ' 146' ' ' LEU . 49.6 ttm -59.73 -26.09 65.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.052 0.453 . . . . 0.0 111.04 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.677 ' CG ' HH12 ' A' ' 14' ' ' ARG . 61.0 t0 -57.48 -25.37 59.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.884 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -128.02 16.0 6.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.154 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.531 ' HB2' ' HA ' ' A' ' 143' ' ' MET . 1.3 mp -90.31 141.79 28.37 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.72 0.295 . . . . 0.0 110.902 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 55.3 m . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.835 179.469 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 149' ' ' BB2 . . . . . 0.92 ' H72' ' HN1' ' A' ' 149' ' ' BB2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.861 0.363 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.1 m -84.01 138.6 18.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.662 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.962 HD23 ' HB ' ' A' ' 51' ' ' VAL . 58.6 tp -77.82 158.08 29.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.284 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -78.56 106.07 10.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.127 0.489 . . . . 0.0 109.946 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.044 HG11 HD12 ' A' ' 91' ' ' LEU . 37.3 t -90.51 131.98 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.668 -178.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.01 ' HB2' HD21 ' A' ' 13' ' ' LEU . 29.6 mt -83.49 140.79 32.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.951 179.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 19.5 m-70 -111.18 142.93 42.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.202 0.525 . . . . 0.0 112.33 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.931 HD13 HD12 ' A' ' 13' ' ' LEU . 49.6 mm -50.87 144.81 12.8 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.799 178.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.524 ' HA ' HG23 ' A' ' 8' ' ' ILE . 79.1 Cg_endo -98.18 55.48 1.04 Allowed 'Cis proline' 0 C--N 1.354 0.837 0 C-N-CA 124.844 -0.898 . . . . 0.0 113.159 0.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.583 ' OD2' ' HB3' ' A' ' 6' ' ' LEU . 66.8 m-20 -55.11 140.89 36.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.375 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.427 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 23.9 pt-20 -58.84 -45.54 89.81 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.656 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.79 HH21 HG22 ' A' ' 49' ' ' THR . 0.0 OUTLIER -56.8 -24.91 54.07 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 179.711 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 1.01 HD21 ' HB2' ' A' ' 6' ' ' LEU . 8.2 mt -76.77 -32.87 58.01 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 121.193 1.815 . . . . 0.0 108.509 178.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.624 ' HE ' ' CG ' ' A' ' 144' ' ' ASP . 24.3 mmt-85 -94.76 5.89 50.54 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 114.159 -1.382 . . . . 0.0 109.716 178.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.763 ' HD3' ' NH1' ' A' ' 12' ' ' ARG . 75.7 tttt -93.13 155.74 17.29 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.811 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.824 HG13 HG23 ' A' ' 138' ' ' VAL . 64.3 t -82.5 136.17 23.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.293 0.568 . . . . 0.0 111.335 -178.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.043 ' HB3' HD12 ' A' ' 137' ' ' LEU . . . -87.18 141.13 28.88 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.693 ' HD3' ' N ' ' A' ' 19' ' ' PRO . 1.9 tmtp? -102.42 127.92 29.41 Favored Pre-proline 0 C--N 1.324 -0.503 0 C-N-CA 120.717 -0.393 . . . . 0.0 109.976 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.699 ' HB3' ' HD3' ' A' ' 56' ' ' ARG . 61.9 Cg_endo -78.81 115.02 3.52 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.14 1.893 . . . . 0.0 111.151 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.791 HG12 ' H ' ' A' ' 22' ' ' GLU . 19.8 t -70.07 145.0 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 CA-C-O 122.569 1.176 . . . . 0.0 113.232 -176.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.404 ' N ' HG12 ' A' ' 20' ' ' VAL . 51.6 mt-10 -65.93 -22.59 66.5 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 113.189 -1.823 . . . . 0.0 112.636 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.791 ' H ' HG12 ' A' ' 20' ' ' VAL . 5.0 tp10 -159.55 151.38 20.45 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.199 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.896 HG21 ' HA2' ' A' ' 115' ' ' GLY . 4.4 t -80.1 101.71 5.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.944 ' CB ' HD13 ' A' ' 27' ' ' ILE . 30.7 m120 -91.53 160.33 15.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.933 -177.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.545 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -56.39 -32.97 65.3 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.494 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -71.78 -37.45 70.45 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.944 HD13 ' CB ' ' A' ' 24' ' ' ASN . 1.7 mp -64.24 -47.93 87.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.084 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -57.94 -40.51 80.68 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.788 0.328 . . . . 0.0 111.096 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.545 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 39.3 mmt180 -61.16 -41.3 96.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.808 0.813 . . . . 0.0 109.315 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.771 ' O ' ' HG3' ' A' ' 34' ' ' MET . 6.9 mt -59.37 -50.58 79.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 114.486 -1.233 . . . . 0.0 112.322 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.932 HG22 ' CG2' ' A' ' 57' ' ' ILE . 9.4 t -67.04 -42.15 88.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-O 120.846 0.355 . . . . 0.0 111.66 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.917 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -56.24 -42.44 77.35 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.96 -179.37 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.665 ' HB3' ' HB2' ' A' ' 3' ' ' LEU . 1.4 m-20 -75.07 -30.73 61.04 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.157 176.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' MET . . . . . 1.088 ' HG2' HG21 ' A' ' 51' ' ' VAL . 79.3 mtp -60.58 -47.84 84.4 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.007 -177.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.917 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 15.9 p90 -69.02 -43.76 74.13 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.61 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 52.9 mm-40 -52.43 -41.05 62.91 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.781 HG21 ' CG2' ' A' ' 5' ' ' VAL . 31.0 m -69.98 -62.16 1.49 Allowed 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 118.792 -1.163 . . . . 0.0 108.757 177.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.89 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 1.4 ttp -46.3 -42.63 14.89 Favored 'General case' 0 CA--C 1.46 -2.496 0 C-N-CA 123.611 0.764 . . . . 0.0 110.016 -170.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.681 ' OH ' ' HA ' ' A' ' 69' ' ' ARG . 66.7 m-85 -69.29 -41.65 76.51 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.389 178.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.06 -28.49 67.83 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.8 ' HG2' ' CD2' ' A' ' 91' ' ' LEU . 3.0 tp10 -84.62 -10.38 57.41 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.977 177.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.436 ' H ' ' C ' ' A' ' 39' ' ' TYR . 51.3 mt-10 63.37 25.59 14.66 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.953 -176.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.882 ' HA3' H173 ' A' ' 149' ' ' BB2 . . . -80.43 142.73 24.15 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.856 177.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.812 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 46.1 mm -78.99 -1.71 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 117.576 0.688 . . . . 0.0 112.254 -178.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.927 ' HA3' H101 ' A' ' 149' ' ' BB2 . . . 179.12 135.94 2.5 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 118.948 -0.918 . . . . 0.0 112.024 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.878 ' HB2' ' HG3' ' A' ' 38' ' ' MET . 6.9 tp -126.82 134.54 50.52 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.359 1.58 . . . . 0.0 112.295 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.833 ' HB2' ' OE1' ' A' ' 133' ' ' GLU . . . -97.8 131.1 44.6 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 122.386 0.274 . . . . 0.0 111.39 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.911 ' HB1' ' CG1' ' A' ' 53' ' ' ILE . . . -33.73 -54.12 0.45 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -178.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.79 HG22 HH21 ' A' ' 12' ' ' ARG . 81.8 p -52.84 -35.77 57.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.722 0.772 . . . . 0.0 111.176 -178.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.595 HE22 ' C3 ' ' A' ' 149' ' ' BB2 . 53.4 mt-30 -66.85 -36.76 83.07 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.023 178.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.088 HG21 ' HG2' ' A' ' 34' ' ' MET . 1.3 m -87.21 13.49 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.843 ' HA ' HD11 ' A' ' 6' ' ' LEU . 54.5 t0 77.75 32.4 0.4 Allowed 'General case' 0 C--O 1.23 0.075 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 176.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.911 ' CG1' ' HB1' ' A' ' 48' ' ' ALA . 1.2 pp -127.11 112.76 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.201 177.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.738 ' HA ' ' NH2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -76.0 67.02 2.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.862 0.839 . . . . 0.0 110.517 -179.439 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.77 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 89.2 mt-30 -157.59 134.05 9.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.691 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.739 ' N ' ' HB1' ' A' ' 17' ' ' ALA . 52.2 mtp85 -62.84 70.69 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -178.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.932 ' CG2' HG22 ' A' ' 31' ' ' VAL . 8.5 mm -113.16 122.35 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.073 HD11 ' HB2' ' A' ' 72' ' ' LEU . 2.1 pp -129.02 146.37 34.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.877 -178.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.588 HG23 ' H ' ' A' ' 46' ' ' LEU . 33.3 m -127.82 138.6 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.652 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.079 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 12.1 mm -115.1 149.23 17.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.617 0.722 . . . . 0.0 109.301 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.89 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 57.0 t0 -134.2 30.58 3.59 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.767 -178.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.801 HG22 ' CG2' ' A' ' 44' ' ' ILE . 30.4 t -98.45 111.32 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.877 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.622 ' N ' ' HG2' ' A' ' 68' ' ' GLU . 56.0 m -35.29 89.32 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -175.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.857 ' HB2' HD21 ' A' ' 70' ' ' LEU . 37.1 tt0 -54.56 -22.1 12.22 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 114.288 -1.323 . . . . 0.0 111.554 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -165.6 -76.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.858 0.837 . . . . 0.0 109.653 177.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -120.11 -45.74 2.45 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.116 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -106.22 133.27 51.19 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.416 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.622 ' HG2' ' N ' ' A' ' 63' ' ' SER . 98.4 mt-10 -84.77 126.85 33.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.81 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.681 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 73.8 ttt180 178.23 68.83 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.135 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 1.079 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 4.0 mm? -103.89 133.11 49.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.786 0.327 . . . . 0.0 111.473 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.811 HG21 ' HB2' ' A' ' 113' ' ' ARG . 10.6 p -135.38 133.3 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.593 178.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.073 ' HB2' HD11 ' A' ' 58' ' ' ILE . 1.5 mm? -140.71 142.2 34.86 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 177.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.066 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.7 mp -121.14 135.22 62.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 117.987 0.358 . . . . 0.0 110.679 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.72 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 50.3 m-20 54.46 37.07 0.38 Allowed Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.884 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 99.5 Cg_exo -56.71 148.63 64.25 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 123.058 2.505 . . . . 0.0 114.408 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.511 ' O ' ' HB ' ' A' ' 108' ' ' ILE . 15.8 pt-20 -139.61 143.04 37.07 Favored 'General case' 0 C--O 1.23 0.079 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.884 HD12 HG22 ' A' ' 108' ' ' ILE . 8.5 tp -80.07 138.02 36.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.443 0.639 . . . . 0.0 111.43 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.091 HD11 ' HG3' ' A' ' 109' ' ' ARG . 6.8 mp -113.13 -36.91 4.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.181 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.433 ' O ' ' HB ' ' A' ' 106' ' ' VAL . 41.4 tt0 -159.0 149.55 19.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.208 0.528 . . . . 0.0 111.42 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 1.077 ' HA ' HG12 ' A' ' 106' ' ' VAL . 12.5 ptmt -146.47 149.59 33.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.282 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 81.2 p -158.58 145.04 17.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.526 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.783 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 79.12 154.74 8.48 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.117 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 -127.36 113.82 16.75 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.783 0.801 . . . . 0.0 112.316 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.588 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.5 p -106.44 160.89 15.06 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 115.645 1.721 . . . . 0.0 115.645 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.739 ' CA ' HD21 ' A' ' 99' ' ' LEU . . . -140.39 105.92 0.46 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 113.046 -1.888 . . . . 0.0 111.584 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.683 ' N ' ' HG ' ' A' ' 99' ' ' LEU . 20.4 mt -144.99 135.45 19.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -178.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 52.8 mt-10 -72.73 143.28 48.07 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 122.818 1.294 . . . . 0.0 113.37 -177.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.707 ' HG2' ' O27' ' A' ' 149' ' ' BB2 . 55.6 mt-10 -156.54 168.64 26.77 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 113.301 -1.772 . . . . 0.0 109.289 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.685 ' HA3' ' HG2' ' A' ' 97' ' ' ARG . . . -120.06 165.97 13.58 Favored Glycine 0 CA--C 1.5 -0.867 0 C-N-CA 119.421 -1.371 . . . . 0.0 110.628 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.812 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 63.0 m -115.71 137.65 51.87 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.921 -177.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.044 HD12 HG11 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -50.89 -33.27 23.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.65 0.738 . . . . 0.0 109.403 179.647 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.893 ' CB ' HD13 ' A' ' 13' ' ' LEU . 60.1 m -76.92 -30.56 56.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.829 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.728 ' CG2' ' HD2' ' A' ' 94' ' ' PRO . 57.7 mt -85.91 148.36 48.04 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.728 ' HD2' ' CG2' ' A' ' 93' ' ' ILE . 68.9 Cg_endo -75.36 47.73 1.91 Allowed 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.475 2.117 . . . . 0.0 114.183 -178.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.53 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 39.7 tt0 78.77 10.78 1.67 Allowed 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 122.696 0.398 . . . . 0.0 111.988 179.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.57 ' HG3' ' HG2' ' A' ' 94' ' ' PRO . 84.9 mt-30 -78.27 88.8 4.32 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.939 -0.764 . . . . 0.0 108.939 178.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.685 ' HG2' ' HA3' ' A' ' 89' ' ' GLY . 42.9 mtm-85 -84.87 133.15 34.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.67 0.748 . . . . 0.0 111.659 -178.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.746 ' HB3' ' HE2' ' A' ' 143' ' ' MET . . . -134.2 153.94 51.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.839 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.739 HD21 ' CA ' ' A' ' 85' ' ' GLY . 6.9 tt -75.53 135.95 40.59 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.875 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.776 HG13 ' CG ' ' A' ' 142' ' ' PHE . 60.2 t -130.38 134.64 26.32 Favored Pre-proline 0 N--CA 1.454 -0.265 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.75 ' HD2' ' CD2' ' A' ' 142' ' ' PHE . 88.2 Cg_endo -82.71 124.12 3.91 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.395 1.397 . . . . 0.0 113.721 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.906 ' HG2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -141.99 164.95 28.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 113.914 -1.494 . . . . 0.0 110.22 179.204 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.783 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.86 154.85 41.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.809 0.338 . . . . 0.0 110.913 -178.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.534 ' OE1' HG21 ' A' ' 84' ' ' THR . 28.2 tp10 -72.66 -43.93 62.51 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.283 -176.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.764 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 55.8 mttm -139.13 138.36 36.94 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.463 0.649 . . . . 0.0 109.495 176.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 1.077 HG12 ' HA ' ' A' ' 80' ' ' LYS . 25.8 m -147.49 140.43 19.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.614 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.907 ' HD2' ' CB ' ' A' ' 121' ' ' GLU . 51.3 mmtt -107.41 125.37 51.13 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 1.08 ' HA ' HD13 ' A' ' 78' ' ' LEU . 1.4 pp -129.95 160.75 40.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 1.091 ' HG3' HD11 ' A' ' 78' ' ' LEU . 92.7 mtt180 -107.51 135.01 49.69 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-O 121.142 0.496 . . . . 0.0 110.326 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.904 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -155.75 167.5 30.2 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.184 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 1.066 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.3 pp -115.54 151.69 34.4 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.446 ' OD1' HG13 ' A' ' 71' ' ' VAL . 19.8 t70 -86.67 163.46 17.36 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.604 -176.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.811 ' HB2' HG21 ' A' ' 71' ' ' VAL . 14.4 ttp-105 -54.75 -16.44 2.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.77 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.37 -25.7 42.14 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.975 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.896 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 105.91 35.51 2.97 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.573 -0.822 . . . . 0.0 113.837 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -128.92 102.98 18.93 Favored Pre-proline 0 C--O 1.238 0.485 0 CA-C-N 116.967 0.383 . . . . 0.0 111.139 178.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.679 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 32.5 Cg_exo -73.23 114.76 4.12 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 121.653 1.569 . . . . 0.0 114.994 -177.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -129.6 168.93 15.69 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.908 -178.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.864 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 6.2 mp0 -106.63 130.11 54.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.91 0.386 . . . . 0.0 109.981 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.9 ' O ' HD23 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -124.45 141.78 51.82 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.881 0.848 . . . . 0.0 112.017 -178.57 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.907 ' CB ' ' HD2' ' A' ' 107' ' ' LYS . 15.3 pt-20 -94.84 123.33 38.24 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.998 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.779 ' O ' ' HB2' ' A' ' 127' ' ' ALA . . . -116.52 134.17 55.16 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.453 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.764 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.2 m-20 -126.76 163.62 23.14 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.76 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 45.89 -133.75 9.61 Favored Glycine 0 C--N 1.348 1.198 0 CA-C-N 120.832 1.651 . . . . 0.0 116.224 176.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.0 mt -53.38 -35.06 59.91 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.444 -0.878 . . . . 0.0 111.444 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.543 HD22 ' CB ' ' A' ' 122' ' ' ALA . 0.6 OUTLIER -70.68 -53.67 14.81 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.311 0.577 . . . . 0.0 110.116 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.779 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -59.0 -42.95 91.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.699 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.906 HD12 ' HG2' ' A' ' 102' ' ' ARG . 49.5 mm -64.72 -55.47 20.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.366 -178.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.797 ' HB2' ' C11' ' A' ' 149' ' ' BB2 . 28.9 p -57.76 -49.71 75.69 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -178.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.679 HD11 HD11 ' A' ' 108' ' ' ILE . 19.3 tt -59.26 -42.42 87.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.878 ' CG ' HG21 ' A' ' 106' ' ' VAL . 66.5 mt-30 -65.79 -40.57 92.07 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 178.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.689 ' HD2' ' H81' ' A' ' 149' ' ' BB2 . 74.1 t60 -56.0 -49.2 74.3 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.524 0.678 . . . . 0.0 110.219 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.89 ' CG ' H102 ' A' ' 149' ' ' BB2 . 24.0 mm-40 -60.7 -42.44 97.18 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.083 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.93 ' HA ' HD21 ' A' ' 137' ' ' LEU . 35.5 mtm -58.16 -49.62 76.36 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.351 0.978 . . . . 0.0 110.968 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.659 ' OD2' ' HA ' ' A' ' 132' ' ' HIS . 4.1 p30 -63.0 -46.09 89.31 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.681 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.981 ' CE1' HD21 ' A' ' 141' ' ' LEU . 11.7 t-80 -56.76 -51.57 68.38 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 121.78 -0.575 . . . . 0.0 111.039 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 1.043 HD12 ' HB3' ' A' ' 17' ' ' ALA . 1.2 pp -59.76 -30.72 69.05 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.799 -177.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.824 HG23 HG13 ' A' ' 16' ' ' VAL . 10.7 p -83.11 20.48 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-O 123.083 1.42 . . . . 0.0 108.22 174.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.805 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 60.36 17.49 46.99 Favored Glycine 0 CA--C 1.491 -1.455 0 CA-C-N 112.106 -2.316 . . . . 0.0 112.553 176.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.775 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -106.59 118.21 36.08 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.064 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.981 HD21 ' CE1' ' A' ' 136' ' ' HIS . 8.3 mp -132.69 144.62 50.44 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.776 ' CG ' HG13 ' A' ' 100' ' ' VAL . 7.4 m-85 -63.86 -34.24 77.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 118.226 0.466 . . . . 0.0 111.068 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.788 ' HA ' HD13 ' A' ' 146' ' ' LEU . 46.4 tpp -55.08 -26.68 39.56 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.291 0.567 . . . . 0.0 110.73 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.624 ' CG ' ' HE ' ' A' ' 14' ' ' ARG . 38.7 t70 -54.69 -25.0 24.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.895 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -128.31 40.62 3.63 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.114 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.788 HD13 ' HA ' ' A' ' 143' ' ' MET . 4.8 mp -92.35 147.01 23.25 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.722 0.296 . . . . 0.0 111.091 178.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 46.9 t . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.18 -0.914 . . . . 0.0 111.068 179.5 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 149' ' ' BB2 . . . . . 0.927 H101 ' HA3' ' A' ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.622 ' O ' ' HB3' ' A' ' 36' ' ' GLU . 46.9 t . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.864 0.364 . . . . 0.0 111.016 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.749 HG13 ' HA ' ' A' ' 37' ' ' THR . 42.2 t -120.18 138.7 49.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.276 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 1.074 HD23 ' HB ' ' A' ' 51' ' ' VAL . 58.4 tp -77.39 161.74 27.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.335 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 71.0 tp60 -78.44 106.67 10.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.03 0.443 . . . . 0.0 110.03 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.042 HG11 HD12 ' A' ' 91' ' ' LEU . 39.5 t -90.08 131.94 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.647 -178.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.083 ' HB2' HD21 ' A' ' 13' ' ' LEU . 25.5 mt -85.01 140.73 30.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.479 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 39.2 m-70 -115.79 141.78 47.63 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -178.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.083 HD13 HD12 ' A' ' 13' ' ' LEU . 41.4 mm -62.77 134.5 95.48 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.889 177.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.3 144.81 78.83 Favored 'Cis proline' 0 C--N 1.352 0.754 0 C-N-CA 124.615 -0.994 . . . . 0.0 111.815 -0.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.982 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.6 t70 -164.56 126.46 2.23 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.505 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.528 ' HG2' ' N ' ' A' ' 12' ' ' ARG . 10.5 pm0 -58.28 -45.49 87.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.551 -178.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.715 ' HD3' ' HE3' ' A' ' 15' ' ' LYS . 14.2 mmt-85 -58.13 -27.63 63.92 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 1.083 HD12 HD13 ' A' ' 8' ' ' ILE . 9.6 mt -77.58 -31.3 53.0 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 120.814 1.643 . . . . 0.0 108.86 177.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.627 ' C ' ' HA3' ' A' ' 139' ' ' GLY . 13.5 mmt85 -95.54 10.0 38.14 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 114.147 -1.388 . . . . 0.0 109.308 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.808 ' NZ ' ' HB2' ' A' ' 54' ' ' HIS . 20.4 ttpp -92.05 146.49 23.69 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.204 -179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.893 ' CG1' HG23 ' A' ' 138' ' ' VAL . 44.5 t -84.15 95.26 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.535 -178.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.58 ' HB1' ' C ' ' A' ' 55' ' ' GLN . . . -54.8 148.24 13.42 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-O 121.053 0.454 . . . . 0.0 111.868 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.418 ' HB3' ' OE1' ' A' ' 55' ' ' GLN . 54.2 tttp -103.21 129.42 25.58 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.902 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.663 ' CD ' ' HD3' ' A' ' 56' ' ' ARG . 60.1 Cg_endo -79.64 116.48 3.52 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.428 2.085 . . . . 0.0 110.506 179.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.871 HG12 ' H ' ' A' ' 22' ' ' GLU . 20.9 t -71.27 144.71 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-O 122.552 1.168 . . . . 0.0 113.143 -176.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -69.15 -21.13 64.02 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 113.121 -1.854 . . . . 0.0 112.329 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.871 ' H ' HG12 ' A' ' 20' ' ' VAL . 88.7 tt0 -159.25 142.03 14.16 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 121.157 -0.217 . . . . 0.0 110.566 -179.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.596 HG21 ' CD1' ' A' ' 111' ' ' LEU . 2.8 t -80.51 106.01 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 -178.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 1.065 ' H ' HD12 ' A' ' 27' ' ' ILE . 32.0 m120 -89.34 159.05 17.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.692 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.568 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -54.17 -30.54 49.83 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.024 0.44 . . . . 0.0 110.69 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -71.81 -39.66 69.7 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 1.065 HD12 ' H ' ' A' ' 24' ' ' ASN . 60.6 mt -63.56 -47.6 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.297 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 43.5 mt-30 -57.85 -40.34 79.87 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.77 0.319 . . . . 0.0 110.627 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 40.0 mmt-85 -59.84 -40.45 88.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.811 0.815 . . . . 0.0 108.866 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.771 ' O ' ' HG3' ' A' ' 34' ' ' MET . 4.4 mt -59.64 -49.48 83.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 114.419 -1.264 . . . . 0.0 111.846 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.9 HG22 ' CG2' ' A' ' 57' ' ' ILE . 18.7 t -66.82 -42.21 88.86 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-O 120.839 0.352 . . . . 0.0 111.395 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.878 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -55.32 -43.91 75.32 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.997 -179.321 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.648 ' HB3' ' HB2' ' A' ' 3' ' ' LEU . 31.9 m-20 -75.29 -30.83 60.5 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.355 176.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' MET . . . . . 1.004 ' HG2' HG21 ' A' ' 51' ' ' VAL . 79.2 mtp -59.55 -47.22 86.38 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.566 -177.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.878 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 13.6 p90 -69.05 -43.99 73.54 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 177.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.759 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 81.7 mt-10 -51.85 -40.31 60.35 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.749 ' HA ' HG13 ' A' ' 2' ' ' VAL . 37.2 m -69.8 -61.45 1.77 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 119.042 -1.063 . . . . 0.0 108.638 177.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.952 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 3.3 ttp -46.22 -43.81 15.72 Favored 'General case' 0 CA--C 1.459 -2.528 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.861 -170.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.711 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 70.2 m-85 -69.63 -41.62 75.41 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.635 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.23 -28.62 68.16 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.811 ' HG2' ' CD2' ' A' ' 91' ' ' LEU . 3.2 tp10 -84.72 -10.06 57.62 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 114.407 -1.269 . . . . 0.0 108.876 177.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.441 ' H ' ' C ' ' A' ' 39' ' ' TYR . 58.1 mt-10 62.01 26.05 15.68 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.824 -176.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.608 ' HA3' H173 ' A' ' 149' ' ' BB2 . . . -79.89 143.13 25.1 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.373 177.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.805 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 40.6 mt -78.99 -0.78 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 117.941 0.87 . . . . 0.0 112.008 -178.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.824 ' HA3' ' C10' ' A' ' 149' ' ' BB2 . . . 179.33 135.3 2.36 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 118.972 -0.904 . . . . 0.0 112.005 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.995 HD13 HD23 ' A' ' 91' ' ' LEU . 9.0 tp -126.51 135.43 51.31 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.535 1.667 . . . . 0.0 112.084 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -99.68 130.73 45.93 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.889 ' HB1' ' CD1' ' A' ' 53' ' ' ILE . . . -29.7 -56.15 0.16 Allowed 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.59 HG21 ' O ' ' A' ' 137' ' ' LEU . 75.7 p -53.16 -35.02 59.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.964 0.888 . . . . 0.0 111.167 -178.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.612 ' O ' HG13 ' A' ' 5' ' ' VAL . 36.6 mt-30 -66.1 -38.08 87.36 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.174 -1.375 . . . . 0.0 110.358 179.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.074 ' HB ' HD23 ' A' ' 3' ' ' LEU . 1.4 m -87.61 15.29 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.871 ' HA ' ' CD1' ' A' ' 6' ' ' LEU . 56.0 t0 76.53 32.89 0.54 Allowed 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 176.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.889 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 1.2 pp -126.91 111.12 24.77 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.404 177.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.808 ' HB2' ' NZ ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -75.6 64.89 1.73 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.942 0.877 . . . . 0.0 110.59 -179.207 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.71 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 11.8 mm100 -155.48 134.8 12.36 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 114.359 -1.291 . . . . 0.0 108.385 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.709 ' HG2' ' CD1' ' A' ' 137' ' ' LEU . 77.1 mtp180 -65.37 72.4 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -177.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.9 ' CG2' HG22 ' A' ' 31' ' ' VAL . 7.4 mm -113.52 122.99 68.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.005 HD11 ' HB2' ' A' ' 72' ' ' LEU . 1.9 pp -127.11 145.52 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -177.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 46' ' ' LEU . 32.8 m -127.48 138.41 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.369 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.053 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 13.5 mm -115.88 152.69 17.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.571 0.701 . . . . 0.0 110.58 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.952 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 36.6 t70 -146.11 34.12 1.0 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.417 -178.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.782 HG22 HG22 ' A' ' 44' ' ' ILE . 38.8 t -95.76 111.35 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.289 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.585 ' HB3' ' OE2' ' A' ' 68' ' ' GLU . 78.3 p -38.26 77.71 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -176.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 62' ' ' VAL . 87.9 tt0 -67.0 -9.73 42.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.529 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.81 ' OD1' ' HG2' ' A' ' 66' ' ' ARG . 25.1 t-20 -165.51 -84.99 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.725 0.774 . . . . 0.0 110.379 177.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.81 ' HG2' ' OD1' ' A' ' 65' ' ' ASN . 18.6 mmt85 -121.94 -48.58 2.12 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.719 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -114.62 133.63 55.69 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.458 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.585 ' OE2' ' HB3' ' A' ' 63' ' ' SER . 49.8 mp0 -84.14 132.6 34.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.905 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.605 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 76.0 ttt180 -174.92 62.1 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.152 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 1.053 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 40.8 mt -104.91 133.48 49.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.455 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.762 HG21 ' HB2' ' A' ' 113' ' ' ARG . 9.9 p -134.82 133.02 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.023 178.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.005 ' HB2' HD11 ' A' ' 58' ' ' ILE . 87.3 mt -141.85 141.95 33.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.907 -0.133 . . . . 0.0 111.252 178.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.072 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.9 mp -118.24 134.09 62.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 110.418 -0.215 . . . . 0.0 110.418 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.678 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 0.5 OUTLIER 46.32 40.75 0.71 Allowed Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -179.43 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.754 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 92.5 Cg_exo -56.79 155.43 27.26 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.987 2.458 . . . . 0.0 113.247 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -137.78 143.75 41.25 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.972 ' HB2' ' HE1' ' A' ' 134' ' ' MET . 1.8 tt -81.3 133.93 35.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.609 0.719 . . . . 0.0 111.506 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.048 HD11 ' HG3' ' A' ' 109' ' ' ARG . 6.8 mp -109.3 -38.83 5.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.541 -1.208 . . . . 0.0 111.905 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 42.7 tt0 -160.28 155.66 25.16 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.264 0.554 . . . . 0.0 112.056 -179.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.842 ' HA ' HG12 ' A' ' 106' ' ' VAL . 18.7 ptpt -148.25 151.53 35.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.451 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 53.2 m -160.08 143.46 13.94 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.679 0.276 . . . . 0.0 111.193 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.758 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 81.98 159.72 25.28 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.556 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -130.67 114.0 14.87 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.531 0.682 . . . . 0.0 112.617 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.5 p -107.76 159.31 16.59 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 179.299 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.71 ' O ' HD13 ' A' ' 86' ' ' ILE . . . -140.06 103.44 0.37 Allowed Glycine 0 C--N 1.318 -0.461 0 CA-C-N 113.039 -1.891 . . . . 0.0 111.63 178.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.71 HD13 ' O ' ' A' ' 85' ' ' GLY . 40.7 mm -144.67 135.86 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -178.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.639 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 48.8 mt-10 -72.27 143.68 48.66 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 122.577 1.18 . . . . 0.0 112.736 -178.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.672 ' HB3' H262 ' A' ' 149' ' ' BB2 . 50.3 mt-10 -155.61 164.16 39.0 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 113.727 -1.579 . . . . 0.0 109.482 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.781 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -118.68 163.29 13.16 Favored Glycine 0 CA--C 1.498 -1.016 0 C-N-CA 119.258 -1.449 . . . . 0.0 110.235 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.835 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 71.8 m -111.71 137.8 49.12 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.886 -177.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.042 HD12 HG11 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -50.01 -33.51 18.29 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.678 0.752 . . . . 0.0 109.891 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.853 ' CB ' HD13 ' A' ' 13' ' ' LEU . 29.2 m -77.55 -29.98 52.48 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.801 -179.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.724 ' CG2' ' HD2' ' A' ' 94' ' ' PRO . 59.9 mt -85.9 148.37 48.09 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.724 ' HD2' ' CG2' ' A' ' 93' ' ' ILE . 66.9 Cg_endo -75.51 47.7 1.94 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.522 2.148 . . . . 0.0 114.552 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.61 ' HB2' ' O ' ' A' ' 94' ' ' PRO . 0.3 OUTLIER 79.41 10.11 1.53 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 179.067 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.556 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . 98.4 mm-40 -78.16 88.88 4.25 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.966 HH11 H231 ' A' ' 149' ' ' BB2 . 77.7 mtm180 -84.52 133.23 34.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.729 0.776 . . . . 0.0 111.652 -178.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -129.63 149.68 51.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.651 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.683 HD23 ' N ' ' A' ' 100' ' ' VAL . 6.9 tt -75.07 135.39 41.22 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.685 0.279 . . . . 0.0 110.462 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.846 HG13 ' HB2' ' A' ' 142' ' ' PHE . 57.6 t -130.25 130.61 23.07 Favored Pre-proline 0 N--CA 1.453 -0.31 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 84' ' ' THR . 5.8 Cg_exo -77.95 123.85 6.47 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 121.741 1.628 . . . . 0.0 112.587 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.942 HH11 ' HB3' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -142.75 165.28 27.8 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.085 -1.416 . . . . 0.0 110.4 179.39 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.758 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.64 154.94 40.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.721 0.296 . . . . 0.0 110.656 -178.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -72.77 -43.08 63.29 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.231 -176.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.793 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 82.3 mttt -139.6 138.27 36.04 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.48 0.657 . . . . 0.0 109.621 176.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.842 HG12 ' HA ' ' A' ' 80' ' ' LYS . 27.4 m -142.51 141.49 27.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.852 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.985 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 52.8 mmtt -107.73 125.77 51.8 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 1.0 ' HA ' HD13 ' A' ' 78' ' ' LEU . 2.0 pp -130.86 160.1 42.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -177.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 1.048 ' HG3' HD11 ' A' ' 78' ' ' LEU . 95.4 mtt180 -109.84 137.8 47.12 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.862 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -156.94 167.49 30.31 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.761 -0.2 . . . . 0.0 111.108 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 1.072 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.0 pp -113.9 151.86 31.61 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.415 ' O ' HD12 ' A' ' 111' ' ' LEU . 9.4 t70 -89.06 162.7 15.86 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.503 -177.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.812 ' HD2' ' OD1' ' A' ' 32' ' ' ASP . 48.4 ttp85 -52.75 -18.6 1.92 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.235 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -79.25 -25.06 42.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.343 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.92 35.85 2.89 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.698 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -128.79 102.93 19.3 Favored Pre-proline 0 C--O 1.237 0.423 0 CA-C-N 116.986 0.393 . . . . 0.0 111.248 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.663 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.6 Cg_exo -73.54 114.84 4.14 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 121.703 1.602 . . . . 0.0 114.729 -177.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.18 168.75 13.62 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.683 -178.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.813 ' HG2' ' HG2' ' A' ' 109' ' ' ARG . 33.2 mt-10 -107.39 130.06 54.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.051 0.453 . . . . 0.0 110.132 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.939 HD21 HD11 ' A' ' 72' ' ' LEU . 4.1 pp -127.48 134.72 49.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.97 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.985 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 11.5 pt-20 -93.53 125.11 37.96 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.843 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.939 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -116.19 135.43 53.92 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.793 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.1 m-20 -126.31 164.49 20.92 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.778 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 47.16 -135.3 11.95 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 120.187 1.358 . . . . 0.0 116.302 176.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.45 ' HB3' HG11 ' A' ' 62' ' ' VAL . 87.2 mt -54.04 -33.74 58.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.493 -0.854 . . . . 0.0 111.721 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.939 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -71.26 -53.46 14.24 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.762 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.777 ' HB2' ' C ' ' A' ' 122' ' ' ALA . . . -59.3 -46.19 89.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.876 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.832 HD12 ' HG2' ' A' ' 102' ' ' ARG . 47.3 mm -61.54 -56.02 20.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.095 -178.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.911 ' HB3' ' H91' ' A' ' 149' ' ' BB2 . 73.5 m -60.0 -51.22 70.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.707 HG22 ' O ' ' A' ' 126' ' ' LEU . 20.3 tt -59.11 -42.07 85.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 121.21 -0.196 . . . . 0.0 111.004 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.864 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.4 pt20 -67.81 -37.77 82.42 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.409 ' CD2' ' O2 ' ' A' ' 149' ' ' BB2 . 72.5 t60 -59.52 -44.94 93.04 Favored 'General case' 0 CA--C 1.521 -0.146 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.871 ' O ' HD23 ' A' ' 137' ' ' LEU . 4.2 mm-40 -59.3 -44.53 92.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.173 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.972 ' HE1' ' HB2' ' A' ' 77' ' ' LEU . 74.3 mtp -57.42 -48.32 79.42 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.544 0.687 . . . . 0.0 110.28 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.518 ' O ' HG12 ' A' ' 138' ' ' VAL . 30.5 m-20 -61.32 -48.63 80.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.157 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.847 ' HA ' ' CD1' ' A' ' 141' ' ' LEU . 21.4 t-80 -59.99 -51.43 69.71 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.861 0.362 . . . . 0.0 111.65 -178.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.937 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.4 pp -58.76 -32.98 69.77 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.481 -177.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.933 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 8.2 p -82.07 20.56 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-O 123.085 1.421 . . . . 0.0 108.854 175.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.847 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 59.44 14.66 28.43 Favored Glycine 0 CA--C 1.49 -1.474 0 CA-C-N 112.178 -2.283 . . . . 0.0 112.622 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.933 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 8.5 ptmt -103.71 116.25 31.98 Favored 'General case' 0 N--CA 1.426 -1.65 0 C-N-CA 119.466 -0.893 . . . . 0.0 108.816 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.847 ' CD1' ' HA ' ' A' ' 136' ' ' HIS . 7.7 mp -128.88 141.83 51.16 Favored 'General case' 0 N--CA 1.446 -0.666 0 O-C-N 121.266 -0.896 . . . . 0.0 108.61 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.846 ' HB2' HG13 ' A' ' 100' ' ' VAL . 7.2 m-85 -63.53 -34.89 78.79 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.061 0.392 . . . . 0.0 111.509 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' MET . . . . . 1.002 ' HG2' HD12 ' A' ' 146' ' ' LEU . 15.9 tmm? -55.73 -25.39 40.21 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.508 0.67 . . . . 0.0 110.711 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -52.26 -23.83 6.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.845 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -122.0 41.64 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.732 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 1.002 HD12 ' HG2' ' A' ' 143' ' ' MET . 40.5 mt -93.57 139.85 30.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.876 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 83.2 p . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.999 179.492 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 149' ' ' BB2 . . . . . 0.966 H231 HH11 ' A' ' 97' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 80.2 p . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.878 0.37 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.965 HG12 ' HA ' ' A' ' 37' ' ' THR . 30.5 m -84.17 133.93 28.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.428 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.933 HD21 ' HB ' ' A' ' 51' ' ' VAL . 3.0 pp -79.63 -172.4 3.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.565 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -82.37 108.98 16.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.782 0.325 . . . . 0.0 110.454 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.528 HG22 HG21 ' A' ' 37' ' ' THR . 37.9 t -88.42 129.85 38.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.385 0.612 . . . . 0.0 112.03 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.972 ' HB2' HD21 ' A' ' 13' ' ' LEU . 23.7 mt -88.15 147.39 24.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.655 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 -128.19 146.06 50.84 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.669 HG21 ' CE ' ' A' ' 143' ' ' MET . 3.3 mp -64.22 135.23 96.24 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.205 177.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.39 140.83 58.48 Favored 'Cis proline' 0 C--N 1.352 0.741 0 C-N-CA 124.253 -1.145 . . . . 0.0 111.804 -0.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.87 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.7 t70 -160.85 125.17 3.56 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.475 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.549 ' HG2' ' N ' ' A' ' 12' ' ' ARG . 2.7 pm0 -57.8 -43.81 85.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.418 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.669 ' HE ' ' HE3' ' A' ' 15' ' ' LYS . 15.5 mmt85 -55.99 -30.05 61.2 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.972 HD21 ' HB2' ' A' ' 6' ' ' LEU . 9.8 mt -77.1 -32.7 56.79 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 120.891 1.678 . . . . 0.0 108.661 177.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.628 HH12 ' HA ' ' A' ' 144' ' ' ASP . 15.9 mmt180 -91.66 8.83 34.98 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 113.998 -1.455 . . . . 0.0 109.165 179.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.669 ' HE3' ' HE ' ' A' ' 12' ' ' ARG . 24.9 ttmm -91.26 148.05 22.62 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.05 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.546 HG13 HG23 ' A' ' 138' ' ' VAL . 85.5 t -82.78 129.83 36.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.87 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -90.45 144.31 25.92 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.384 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.766 ' HD3' ' CD ' ' A' ' 19' ' ' PRO . 2.0 tmtp? -106.35 133.14 20.37 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.766 ' CD ' ' HD3' ' A' ' 18' ' ' LYS . 45.7 Cg_endo -82.09 114.71 2.57 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 121.934 1.756 . . . . 0.0 110.73 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.745 HG12 ' H ' ' A' ' 22' ' ' GLU . 16.0 t -67.68 144.33 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 CA-C-O 122.574 1.178 . . . . 0.0 113.247 -175.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.82 -23.45 67.36 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 112.924 -1.944 . . . . 0.0 112.639 -179.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.745 ' H ' HG12 ' A' ' 20' ' ' VAL . 88.7 tt0 -158.67 144.51 16.72 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.13 -178.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.502 HG22 HD21 ' A' ' 111' ' ' LEU . 3.1 t -81.45 107.4 13.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -178.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 1.034 ' HB2' HD13 ' A' ' 27' ' ' ILE . 28.4 m120 -95.38 157.79 15.74 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.769 -178.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.534 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -55.18 -24.22 25.73 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.282 0.563 . . . . 0.0 110.808 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.753 ' O ' HD13 ' A' ' 30' ' ' ILE . 70.8 mm-40 -74.45 -44.92 49.52 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 177.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 1.034 HD13 ' HB2' ' A' ' 24' ' ' ASN . 2.0 mp -64.72 -34.34 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 113.793 -1.548 . . . . 0.0 110.153 178.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.515 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 75.0 mt-30 -68.16 -40.59 82.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 122.297 -0.252 . . . . 0.0 110.713 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.534 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 40.3 mmt180 -61.44 -39.3 90.33 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.846 ' CG2' HD13 ' A' ' 53' ' ' ILE . 1.6 mp -57.75 -48.53 83.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.087 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.584 HG22 ' CG2' ' A' ' 57' ' ' ILE . 27.6 t -68.11 -42.26 84.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.97 0.414 . . . . 0.0 111.156 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.872 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -56.39 -42.19 77.5 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.058 -179.254 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.491 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 17.5 m-20 -75.78 -30.11 58.98 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.261 176.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' MET . . . . . 1.095 ' HG2' HG21 ' A' ' 51' ' ' VAL . 87.6 mtp -60.92 -46.27 91.33 Favored 'General case' 0 C--N 1.345 0.395 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.516 -177.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.872 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 13.5 p90 -69.59 -45.91 67.53 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.578 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 29.4 mm-40 -52.51 -38.44 59.61 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.965 ' HA ' HG12 ' A' ' 2' ' ' VAL . 61.6 m -69.9 -62.23 1.47 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.487 -1.233 . . . . 0.0 107.857 178.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.887 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 3.7 ttp -46.65 -41.85 15.43 Favored 'General case' 0 CA--C 1.461 -2.472 0 C-N-CA 124.042 0.937 . . . . 0.0 110.72 -171.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.708 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 70.9 m-85 -70.48 -42.32 71.55 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.38 178.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.457 ' CB ' HG11 ' A' ' 2' ' ' VAL . . . -61.4 -24.31 66.42 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.358 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.937 ' HG2' HD12 ' A' ' 91' ' ' LEU . 3.1 tp10 -89.05 -10.7 46.49 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 114.47 -1.241 . . . . 0.0 108.566 177.181 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.443 ' H ' ' C ' ' A' ' 39' ' ' TYR . 23.4 mt-10 62.96 26.7 15.65 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.818 -176.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.611 ' HA2' H182 ' A' ' 149' ' ' BB2 . . . -79.97 145.17 26.91 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.974 178.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.803 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 44.1 mm -79.3 -1.56 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 117.418 0.609 . . . . 0.0 112.028 -178.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.893 ' HA3' H113 ' A' ' 149' ' ' BB2 . . . 177.54 142.06 4.38 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -178.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.018 HD13 ' HG ' ' A' ' 91' ' ' LEU . 4.7 tp -126.21 135.63 51.85 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.528 1.664 . . . . 0.0 110.479 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -105.9 132.2 52.29 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.989 ' HB1' HG13 ' A' ' 53' ' ' ILE . . . -28.73 -56.76 0.13 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 -178.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.884 HG23 ' HA ' ' A' ' 137' ' ' LEU . 67.6 p -53.17 -34.64 57.78 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 121.953 0.883 . . . . 0.0 111.164 -178.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.856 ' OE1' HD23 ' A' ' 91' ' ' LEU . 50.3 mt-30 -63.94 -43.83 94.67 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.25 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.095 HG21 ' HG2' ' A' ' 34' ' ' MET . 1.0 OUTLIER -86.76 15.07 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.86 ' HA ' HD11 ' A' ' 6' ' ' LEU . 36.5 t70 78.29 27.87 0.5 Allowed 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 176.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 1.015 HD11 ' HB ' ' A' ' 57' ' ' ILE . 10.7 pt -119.36 109.83 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 C-N-CA 119.045 -1.062 . . . . 0.0 110.858 177.019 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.629 ' HB3' ' HD2' ' A' ' 15' ' ' LYS . 25.2 p-80 -75.84 49.18 0.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 122.063 0.935 . . . . 0.0 109.946 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.642 ' C ' ' HB1' ' A' ' 17' ' ' ALA . 89.1 mt-30 -136.48 130.62 32.83 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 1.085 ' HA ' HD22 ' A' ' 137' ' ' LEU . 60.3 mtp85 -62.46 75.14 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.015 ' HB ' HD11 ' A' ' 53' ' ' ILE . 15.0 mt -119.83 124.62 73.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.876 HD11 ' HG2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -131.57 148.5 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -178.069 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.589 ' CG2' ' HB3' ' A' ' 46' ' ' LEU . 32.8 m -124.34 138.85 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.046 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 6.1 mm -113.57 150.86 15.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-O 121.739 0.781 . . . . 0.0 110.137 -179.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.887 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 36.1 t70 -140.16 27.6 2.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.895 -177.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.785 HG22 ' CG2' ' A' ' 44' ' ' ILE . 41.1 t -92.5 108.86 20.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.219 178.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.523 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 63.0 m -35.95 85.4 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -175.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 62' ' ' VAL . 42.9 tt0 -48.67 -50.19 34.27 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.838 178.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -133.84 -67.1 0.61 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.123 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.422 HH11 ' HG2' ' A' ' 66' ' ' ARG . 69.3 mtt-85 -133.27 -42.86 0.86 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.174 0.512 . . . . 0.0 110.374 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -105.65 133.99 49.49 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.167 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.523 ' HG2' ' HA ' ' A' ' 63' ' ' SER . 92.0 mt-10 -86.75 130.6 34.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.197 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.623 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 34.3 ttp85 177.17 66.76 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.863 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 1.046 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 62.0 mt -106.79 135.43 48.34 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-O 120.692 0.282 . . . . 0.0 111.431 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.818 HG21 ' HB2' ' A' ' 113' ' ' ARG . 12.7 p -134.94 135.16 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.25 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.816 ' HB2' HD11 ' A' ' 58' ' ' ILE . 3.2 mm? -141.63 144.35 34.13 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 177.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.998 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.5 mp -124.33 135.78 62.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.9 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.715 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 6.1 m120 49.57 35.48 0.28 Allowed Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 178.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.876 ' HG2' HD11 ' A' ' 58' ' ' ILE . 80.2 Cg_exo -60.91 157.18 39.72 Favored 'Trans proline' 0 N--CA 1.485 1.02 0 C-N-CA 122.809 2.34 . . . . 0.0 114.761 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.423 ' O ' HD22 ' A' ' 78' ' ' LEU . 11.3 pt-20 -138.05 141.78 40.33 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.945 ' HA ' HG22 ' A' ' 108' ' ' ILE . 1.5 tt -80.23 131.64 35.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.151 0.5 . . . . 0.0 111.369 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.113 HD23 ' HA ' ' A' ' 108' ' ' ILE . 2.7 mm? -104.24 -39.06 6.64 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.872 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.614 ' O ' HD21 ' A' ' 77' ' ' LEU . 40.0 tp10 -152.68 152.01 31.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.138 0.495 . . . . 0.0 111.521 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 1.018 ' HA ' HG12 ' A' ' 106' ' ' VAL . 9.2 ptpp? -147.67 148.48 31.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.437 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.8 m -158.58 147.8 19.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.254 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.666 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 73.23 158.67 4.93 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.495 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -133.92 114.38 13.22 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 122.292 1.044 . . . . 0.0 113.356 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.647 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.7 p -103.73 162.11 13.36 Favored 'General case' 0 CA--C 1.488 -1.435 0 CA-C-N 113.244 -1.798 . . . . 0.0 115.232 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.8 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -148.29 117.9 0.93 Allowed Glycine 0 C--N 1.314 -0.66 0 CA-C-N 112.54 -2.118 . . . . 0.0 110.418 177.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.608 HD13 ' O ' ' A' ' 85' ' ' GLY . 48.3 mm -147.04 138.47 18.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 117.297 0.549 . . . . 0.0 111.284 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 56.3 mt-10 -72.26 139.0 47.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 123.297 1.523 . . . . 0.0 111.613 -176.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.73 ' HG2' ' O27' ' A' ' 149' ' ' BB2 . 47.2 mt-10 -155.92 161.42 40.55 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 112.693 -2.049 . . . . 0.0 111.392 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.948 ' O ' ' H52' ' A' ' 149' ' ' BB2 . . . -120.15 165.51 13.64 Favored Glycine 0 CA--C 1.496 -1.127 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.799 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 20.5 m -114.92 137.08 52.39 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.512 0.672 . . . . 0.0 112.331 -177.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.018 ' HG ' HD13 ' A' ' 46' ' ' LEU . 2.3 mm? -46.77 -40.35 13.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.453 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.691 ' CB ' HD13 ' A' ' 13' ' ' LEU . 51.0 m -78.18 -27.51 47.97 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.091 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.75 ' CG2' ' HD2' ' A' ' 94' ' ' PRO . 54.4 mt -85.54 150.39 53.82 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.75 ' HD2' ' CG2' ' A' ' 93' ' ' ILE . 94.4 Cg_endo -71.96 44.84 0.69 Allowed 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 122.18 1.92 . . . . 0.0 114.885 -178.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.562 ' HB2' ' O ' ' A' ' 94' ' ' PRO . 0.3 OUTLIER 74.53 15.59 3.35 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 178.198 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.668 ' HG3' ' HG2' ' A' ' 94' ' ' PRO . 84.2 mt-30 -78.41 89.62 4.41 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.827 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 47.9 mtm-85 -84.37 132.5 34.59 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.837 0.827 . . . . 0.0 111.892 -178.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -135.74 153.68 51.49 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.492 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.8 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.3 tt -76.34 114.23 14.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.61 0.719 . . . . 0.0 111.752 -178.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.814 HG13 ' NE ' ' A' ' 102' ' ' ARG . 13.7 p -106.56 129.66 24.11 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 114.931 -1.031 . . . . 0.0 112.181 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.647 ' HA ' ' O ' ' A' ' 84' ' ' THR . 1.1 Cg_endo -84.22 127.09 3.88 Favored 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 123.56 2.84 . . . . 0.0 113.921 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.978 ' HG2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -143.82 167.61 21.91 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.512 1.125 . . . . 0.0 109.471 179.12 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.666 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.36 155.33 40.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 118.357 0.526 . . . . 0.0 109.969 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -73.63 -41.94 62.11 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.972 -175.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.558 ' HG2' ' HB3' ' A' ' 123' ' ' ASP . 61.3 mttp -140.04 140.54 36.19 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.381 0.61 . . . . 0.0 109.573 177.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 1.018 HG12 ' HA ' ' A' ' 80' ' ' LYS . 22.5 m -151.36 140.2 14.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.598 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.988 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 52.8 mmtt -107.34 126.34 52.33 Favored 'General case' 0 CA--C 1.524 -0.026 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 1.113 ' HA ' HD23 ' A' ' 78' ' ' LEU . 1.7 pp -135.72 154.06 33.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -176.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 1.022 ' HG3' HD21 ' A' ' 78' ' ' LEU . 50.1 mtm180 -103.07 139.53 38.48 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.532 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.768 ' CB ' ' HG3' ' A' ' 75' ' ' PRO . . . -160.45 169.73 22.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.642 -176.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.998 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.3 pp -118.26 151.44 37.66 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.656 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 8.5 t70 -87.64 161.44 17.68 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.257 -176.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.818 ' HB2' HG21 ' A' ' 71' ' ' VAL . 52.0 ttp85 -52.74 -17.28 1.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.099 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.56 -29.32 46.21 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.799 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.434 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 109.2 35.58 2.29 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.45 -0.881 . . . . 0.0 113.24 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -128.79 102.99 19.26 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 121.177 -0.209 . . . . 0.0 110.972 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.686 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.3 Cg_exo -73.76 115.1 4.21 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 121.553 1.502 . . . . 0.0 114.757 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.656 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 11.0 p90 -127.38 169.01 14.05 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.442 -177.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.639 ' HG2' ' CG ' ' A' ' 109' ' ' ARG . 31.1 mt-10 -106.65 129.9 54.48 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.727 ' O ' HD12 ' A' ' 120' ' ' LEU . 4.3 pp -125.72 134.66 51.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.476 -178.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.988 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 15.3 pt-20 -92.99 123.88 36.56 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.636 178.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.917 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -117.71 134.01 55.34 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.024 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.558 ' HB3' ' HG2' ' A' ' 105' ' ' LYS . 22.9 m-20 -126.96 162.86 24.97 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.772 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 50.92 -136.68 28.97 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 120.265 1.393 . . . . 0.0 115.658 177.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.68 HD12 ' H ' ' A' ' 125' ' ' LEU . 4.7 mp -55.23 -33.24 62.94 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.684 -0.758 . . . . 0.0 111.706 -178.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.917 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -71.03 -52.12 21.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.866 0.841 . . . . 0.0 109.203 179.692 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.766 ' HB2' ' C ' ' A' ' 122' ' ' ALA . . . -59.01 -41.23 87.2 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.194 -1.366 . . . . 0.0 111.703 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.978 HD12 ' HG2' ' A' ' 102' ' ' ARG . 50.5 mm -68.43 -54.99 17.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.875 ' HB2' ' H91' ' A' ' 149' ' ' BB2 . 30.4 p -58.13 -47.73 82.39 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 1.053 HD11 HD11 ' A' ' 108' ' ' ILE . 19.5 tt -59.05 -44.03 90.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.867 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.85 ' CG ' HG21 ' A' ' 106' ' ' VAL . 69.5 mt-30 -64.72 -44.94 88.57 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 178.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.592 ' CD2' ' HN1' ' A' ' 149' ' ' BB2 . 76.0 t60 -56.44 -47.75 78.45 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.243 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.814 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 3.3 mm-40 -60.23 -38.86 84.7 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 110.552 -0.166 . . . . 0.0 110.552 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.686 ' CE ' ' HB2' ' A' ' 77' ' ' LEU . 28.4 mtm -58.77 -45.66 89.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 122.338 1.066 . . . . 0.0 109.384 177.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.813 ' O ' HG12 ' A' ' 138' ' ' VAL . 0.9 OUTLIER -66.58 -48.55 69.25 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.999 179.394 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.702 ' CE1' HD21 ' A' ' 141' ' ' LEU . 7.8 t-80 -57.15 -53.0 63.06 Favored 'General case' 0 C--N 1.32 -0.712 0 O-C-N 121.512 -0.742 . . . . 0.0 111.491 -178.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 1.085 HD22 ' HA ' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -65.17 -27.85 69.0 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 119.908 -0.717 . . . . 0.0 111.903 -179.449 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.91 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 10.9 p -81.16 23.62 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-O 122.056 0.932 . . . . 0.0 109.211 175.138 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 137' ' ' LEU . . . 67.94 3.67 30.44 Favored Glycine 0 CA--C 1.486 -1.752 0 CA-C-N 113.793 -1.549 . . . . 0.0 113.245 175.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.91 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 10.4 ptmt -97.95 135.03 40.25 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.882 HD12 ' O ' ' A' ' 140' ' ' LYS . 10.5 mp -139.33 149.55 44.34 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -178.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.729 ' HB3' ' CG2' ' A' ' 100' ' ' VAL . 9.6 p90 -54.36 -35.07 62.38 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.669 ' CE ' HG21 ' A' ' 8' ' ' ILE . 56.5 ttp -61.22 -28.31 69.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.158 0.504 . . . . 0.0 110.745 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.628 ' HA ' HH12 ' A' ' 14' ' ' ARG . 9.0 t70 -59.94 -25.24 65.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.919 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -121.05 14.4 11.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.413 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.432 ' HB2' ' HA ' ' A' ' 143' ' ' MET . 1.8 mp -91.15 139.43 30.76 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.672 0.272 . . . . 0.0 110.906 179.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 63.7 m . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.891 179.344 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 149' ' ' BB2 . . . . . 0.948 ' H52' ' O ' ' A' ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 79.7 p . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.865 0.364 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.926 HG12 ' HA ' ' A' ' 37' ' ' THR . 30.9 m -84.09 138.12 19.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.643 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.851 HD11 ' CB ' ' A' ' 51' ' ' VAL . 3.1 pp -79.03 -179.09 6.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.246 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.9 tp60 -80.63 108.8 14.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.753 0.311 . . . . 0.0 110.883 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.888 HG11 HD12 ' A' ' 91' ' ' LEU . 46.6 t -89.21 131.64 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-O 121.216 0.531 . . . . 0.0 111.366 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.029 ' HB2' HD21 ' A' ' 13' ' ' LEU . 26.1 mt -85.21 143.22 28.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.463 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 26.0 m-70 -116.64 144.11 44.8 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.507 0.67 . . . . 0.0 112.63 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.043 HD13 HD12 ' A' ' 13' ' ' LEU . 42.8 mm -53.45 144.04 33.86 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.707 178.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.513 ' HA ' HG23 ' A' ' 8' ' ' ILE . 64.3 Cg_endo -93.49 54.12 0.94 Allowed 'Cis proline' 0 C--N 1.356 0.933 0 C-N-CA 124.727 -0.947 . . . . 0.0 113.036 0.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.93 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 9.8 t70 -55.32 134.55 50.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.037 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.477 ' CD ' ' H ' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -59.65 -42.76 93.52 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.961 0.41 . . . . 0.0 111.213 -179.495 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.705 ' HB2' HD13 ' A' ' 6' ' ' LEU . 14.0 mmt85 -59.19 -23.53 62.32 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 1.043 HD12 HD13 ' A' ' 8' ' ' ILE . 9.2 mt -76.22 -32.7 59.07 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 120.172 1.351 . . . . 0.0 107.692 177.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 16.3 mmm180 -90.86 3.17 55.23 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 113.857 -1.52 . . . . 0.0 109.554 178.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.828 ' HD3' ' HB3' ' A' ' 54' ' ' HIS . 62.3 tttp -82.09 146.88 29.4 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.671 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.507 HG13 HG23 ' A' ' 138' ' ' VAL . 96.4 t -82.14 135.4 25.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.742 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -91.4 139.68 30.48 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -103.21 130.57 23.37 Favored Pre-proline 0 C--N 1.322 -0.612 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.316 178.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.464 ' HD3' ' CD ' ' A' ' 56' ' ' ARG . 67.9 Cg_endo -77.11 114.75 3.85 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.032 1.821 . . . . 0.0 110.454 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.777 HG12 ' H ' ' A' ' 22' ' ' GLU . 17.4 t -68.98 144.51 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-O 122.426 1.108 . . . . 0.0 113.308 -176.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -63.65 -24.35 67.75 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 113.443 -1.708 . . . . 0.0 112.073 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.777 ' H ' HG12 ' A' ' 20' ' ' VAL . 88.8 tt0 -161.03 143.46 12.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.875 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.537 HG21 ' CD1' ' A' ' 111' ' ' LEU . 3.2 t -78.88 107.24 11.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.961 ' HB2' HD13 ' A' ' 27' ' ' ILE . 29.4 m120 -91.36 159.9 15.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.317 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.599 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -56.81 -29.14 62.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.927 0.394 . . . . 0.0 110.941 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 1.03 ' HG2' HH22 ' A' ' 29' ' ' ARG . 94.7 mt-10 -71.88 -42.83 66.35 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.104 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.961 HD13 ' HB2' ' A' ' 24' ' ' ASN . 1.8 mp -62.28 -45.93 97.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.791 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.667 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 54.5 mt-30 -57.38 -40.22 77.7 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.501 178.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 1.03 HH22 ' HG2' ' A' ' 26' ' ' GLU . 75.9 mtm-85 -61.76 -38.83 89.46 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.828 HG21 HD12 ' A' ' 57' ' ' ILE . 1.6 mp -58.77 -49.12 83.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.056 178.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.935 HG22 ' CG2' ' A' ' 57' ' ' ILE . 5.3 t -65.97 -42.19 91.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.527 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.875 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 21.5 m-20 -54.43 -45.04 72.93 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.838 -179.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.485 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 54.4 m-20 -74.88 -30.72 61.39 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.64 176.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' MET . . . . . 1.007 ' HG2' HG21 ' A' ' 51' ' ' VAL . 79.7 mtp -59.88 -47.18 86.81 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.543 -177.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.875 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 14.4 p90 -69.31 -43.85 72.93 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.759 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 75.0 mt-10 -51.91 -41.89 62.34 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.926 ' HA ' HG12 ' A' ' 2' ' ' VAL . 57.2 m -68.51 -60.27 2.55 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 119.105 -1.038 . . . . 0.0 108.608 178.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.981 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 3.6 ttp -47.12 -42.42 19.16 Favored 'General case' 0 CA--C 1.466 -2.262 0 O-C-N 124.118 0.886 . . . . 0.0 109.729 -170.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.728 ' OH ' ' HA ' ' A' ' 69' ' ' ARG . 68.6 m-85 -69.32 -42.37 75.47 Favored 'General case' 0 C--N 1.285 -2.233 0 O-C-N 124.101 0.876 . . . . 0.0 110.578 178.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.486 ' CB ' HG11 ' A' ' 2' ' ' VAL . . . -60.09 -28.86 68.17 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.202 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.798 ' HG2' ' CD2' ' A' ' 91' ' ' LEU . 3.1 tp10 -84.1 -10.79 57.53 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.484 -1.234 . . . . 0.0 108.777 177.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.444 ' H ' ' C ' ' A' ' 39' ' ' TYR . 8.6 mm-40 62.8 25.1 14.92 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.74 -176.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.803 ' HA2' H182 ' A' ' 149' ' ' BB2 . . . -77.73 145.17 29.79 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 114.142 -1.39 . . . . 0.0 110.524 177.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.907 HG22 HG22 ' A' ' 62' ' ' VAL . 46.0 mm -77.96 -2.5 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 117.621 0.711 . . . . 0.0 111.687 -178.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.949 ' HA3' H101 ' A' ' 149' ' ' BB2 . . . 176.29 138.34 2.85 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-O 119.045 -0.864 . . . . 0.0 111.552 -178.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.827 ' HB2' ' HG3' ' A' ' 38' ' ' MET . 9.2 tp -125.6 135.03 51.75 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 118.821 1.311 . . . . 0.0 110.744 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -103.87 132.75 49.82 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.646 0.26 . . . . 0.0 111.553 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.881 ' HB1' ' CD1' ' A' ' 53' ' ' ILE . . . -30.72 -56.14 0.21 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -177.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.711 ' CG2' ' HA ' ' A' ' 137' ' ' LEU . 42.9 p -52.92 -35.38 58.32 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 122.168 0.985 . . . . 0.0 110.876 -178.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.618 ' NE2' ' CE1' ' A' ' 136' ' ' HIS . 15.8 mt-30 -64.58 -39.44 93.75 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.666 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.007 HG21 ' HG2' ' A' ' 34' ' ' MET . 1.7 m -88.25 14.76 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.859 ' HA ' HD11 ' A' ' 6' ' ' LEU . 37.5 t70 79.11 31.45 0.29 Allowed 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 176.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.881 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 1.2 pp -126.45 111.22 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.446 177.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.828 ' HB3' ' HD3' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -75.55 64.17 1.61 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.976 0.893 . . . . 0.0 110.518 -179.278 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.769 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 88.0 mt-30 -153.54 135.21 14.44 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.444 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.742 ' N ' ' HB1' ' A' ' 17' ' ' ALA . 75.2 mtp180 -64.66 69.04 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -178.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.935 ' CG2' HG22 ' A' ' 31' ' ' VAL . 7.2 mt -112.14 123.26 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.818 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -130.72 147.4 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-O 121.811 0.815 . . . . 0.0 112.783 -178.253 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.613 HG22 ' O ' ' A' ' 46' ' ' LEU . 34.0 m -129.08 137.96 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.44 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.926 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 1.8 mt -116.81 149.3 19.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.718 0.77 . . . . 0.0 111.262 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.981 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 33.8 t70 -136.84 31.95 2.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.449 -1.251 . . . . 0.0 110.35 -178.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.907 HG22 HG22 ' A' ' 44' ' ' ILE . 24.0 t -96.22 110.43 24.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.953 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.747 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 56.0 m -36.33 78.84 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -176.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.797 ' OE1' HD11 ' A' ' 70' ' ' LEU . 39.0 tt0 -65.76 -22.03 66.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.121 178.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -167.25 -126.3 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.417 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -74.2 -54.56 7.48 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.773 -178.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -106.35 133.15 51.48 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.747 ' HG2' ' HA ' ' A' ' 63' ' ' SER . 56.0 mt-10 -85.18 127.8 34.42 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.496 178.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.728 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 40.1 ttm-85 177.12 71.84 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.926 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 3.7 mm? -103.32 132.29 49.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.913 0.387 . . . . 0.0 111.872 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.843 ' O ' HD12 ' A' ' 72' ' ' LEU . 11.5 p -134.33 130.95 54.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.981 178.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.02 HD21 HD21 ' A' ' 120' ' ' LEU . 10.5 mp -139.88 140.02 36.38 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.938 -0.119 . . . . 0.0 111.019 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.01 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.6 mp -119.93 134.47 63.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.704 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 56.6 m-20 54.43 35.93 0.31 Allowed Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.778 ' HG2' HG23 ' A' ' 58' ' ' ILE . 91.1 Cg_exo -55.3 148.56 50.14 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.752 2.301 . . . . 0.0 113.607 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.61 ' HG3' HD21 ' A' ' 78' ' ' LEU . 15.7 pt-20 -135.83 144.25 45.58 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.815 HD23 ' N ' ' A' ' 78' ' ' LEU . 1.8 tt -83.49 135.18 34.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.385 0.612 . . . . 0.0 111.02 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.922 ' CD2' ' HG3' ' A' ' 109' ' ' ARG . 3.3 mm? -116.76 -31.95 5.3 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.65 -178.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 36.6 tt0 -160.33 151.81 19.6 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.17 0.51 . . . . 0.0 111.854 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.895 ' HA ' HG12 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -148.39 151.78 35.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.088 178.792 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 81.0 p -160.36 145.2 14.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.73 0.3 . . . . 0.0 111.5 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.814 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 75.52 169.89 27.13 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.43 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 102' ' ' ARG . 52.3 mm-40 -146.78 114.71 6.52 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.801 0.81 . . . . 0.0 113.152 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.614 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.4 p -97.03 160.1 14.53 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 178.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.698 ' CA ' HD21 ' A' ' 99' ' ' LEU . . . -137.99 100.53 0.31 Allowed Glycine 0 CA--C 1.522 0.52 0 CA-C-N 113.186 -1.825 . . . . 0.0 111.394 178.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.808 ' N ' HH12 ' A' ' 102' ' ' ARG . 47.7 mm -147.75 141.14 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.604 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 55.4 mt-10 -72.72 143.21 48.11 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 122.359 1.076 . . . . 0.0 112.437 -177.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.749 ' HG2' ' O27' ' A' ' 149' ' ' BB2 . 54.6 mt-10 -155.77 162.78 40.45 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.157 -1.383 . . . . 0.0 109.768 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.797 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -120.23 160.49 14.83 Favored Glycine 0 CA--C 1.5 -0.857 0 C-N-CA 119.456 -1.355 . . . . 0.0 111.223 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.813 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 57.1 m -110.16 139.68 45.05 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.691 0.281 . . . . 0.0 110.668 -177.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.888 HD12 HG11 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -52.43 -31.25 33.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.494 0.664 . . . . 0.0 109.855 179.72 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.803 ' CB ' HD13 ' A' ' 13' ' ' LEU . 49.8 m -77.74 -29.44 51.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.711 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.725 ' CG2' ' HD2' ' A' ' 94' ' ' PRO . 58.0 mt -85.45 148.46 49.5 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.725 ' HD2' ' CG2' ' A' ' 93' ' ' ILE . 76.1 Cg_endo -74.87 48.09 1.88 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.296 1.997 . . . . 0.0 114.023 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.558 ' HB2' ' O ' ' A' ' 94' ' ' PRO . 50.9 mt-10 77.27 10.41 2.45 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 179.151 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.642 ' HG2' ' HG2' ' A' ' 94' ' ' PRO . 98.4 mm-40 -78.34 88.29 4.36 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.797 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 20.0 mtm105 -84.59 133.86 34.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.497 0.665 . . . . 0.0 111.384 -178.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.414 ' C ' ' HA ' ' A' ' 87' ' ' GLU . . . -133.01 150.46 52.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.133 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.735 ' HG ' ' N ' ' A' ' 86' ' ' ILE . 6.7 tt -75.43 135.57 40.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.317 -179.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.959 HG21 ' HB3' ' A' ' 142' ' ' PHE . 46.1 t -136.94 138.58 26.27 Favored Pre-proline 0 N--CA 1.464 0.243 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.684 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.953 ' HG2' ' HE2' ' A' ' 145' ' ' TYR . 3.4 Cg_exo -80.49 125.48 5.67 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.408 2.072 . . . . 0.0 113.424 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.882 ' HE ' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -143.79 166.07 25.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.066 -1.424 . . . . 0.0 109.988 177.936 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.814 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.24 153.06 44.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.962 0.346 . . . . 0.0 110.583 -178.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.416 ' OE1' ' HA ' ' A' ' 104' ' ' GLU . 5.1 tp10 -74.29 -41.97 60.33 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.638 -176.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.808 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 48.6 mttp -139.8 137.93 35.42 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.61 0.719 . . . . 0.0 109.634 177.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.895 HG12 ' HA ' ' A' ' 80' ' ' LYS . 32.0 m -142.9 143.16 25.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.046 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 1.028 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 31.8 mmtm -107.48 125.58 51.43 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.716 ' HA ' HD23 ' A' ' 78' ' ' LEU . 2.1 pp -128.79 162.09 36.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -177.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.922 ' HG3' ' CD2' ' A' ' 78' ' ' LEU . 26.6 mtt-85 -116.03 139.4 50.31 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.625 ' CB ' HD23 ' A' ' 72' ' ' LEU . . . -158.98 168.26 27.23 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.671 0.272 . . . . 0.0 111.449 -178.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 1.01 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.1 pp -113.87 152.32 30.9 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.47 ' O ' HD12 ' A' ' 111' ' ' LEU . 15.7 t70 -88.58 162.75 16.2 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.021 -0.672 . . . . 0.0 111.569 -177.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.811 ' HB2' HG21 ' A' ' 71' ' ' VAL . 46.2 ttp180 -52.67 -18.91 2.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.969 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -78.96 -25.59 43.53 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.438 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 106.44 35.61 2.83 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.518 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -128.74 102.79 19.54 Favored Pre-proline 0 C--O 1.238 0.479 0 CA-C-N 117.036 0.418 . . . . 0.0 111.178 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.667 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.9 Cg_exo -73.28 115.27 4.28 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 121.838 1.692 . . . . 0.0 114.975 -177.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -124.52 168.43 13.1 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.712 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 109' ' ' ARG . 23.0 mt-10 -107.79 131.61 54.28 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 1.02 HD21 HD21 ' A' ' 72' ' ' LEU . 3.9 pp -131.57 133.91 45.51 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 1.028 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 15.5 pt-20 -94.15 125.52 38.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.766 178.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.933 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -116.96 136.01 53.27 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.808 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.1 m-20 -126.3 164.44 21.03 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.712 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 45.55 -130.5 9.36 Favored Glycine 0 C--N 1.346 1.118 0 N-CA-C 116.431 1.332 . . . . 0.0 116.431 176.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.437 ' HB3' ' CG1' ' A' ' 62' ' ' VAL . 86.6 mt -55.18 -36.49 65.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.692 -0.754 . . . . 0.0 111.703 -178.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.933 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.3 OUTLIER -71.31 -52.9 16.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.471 0.653 . . . . 0.0 109.884 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.785 ' HB2' ' C ' ' A' ' 122' ' ' ALA . . . -58.39 -46.01 87.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.913 -1.039 . . . . 0.0 112.163 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.882 HD12 ' HE ' ' A' ' 102' ' ' ARG . 49.3 mm -63.76 -56.04 19.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.807 0.336 . . . . 0.0 111.107 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.879 ' HB3' ' C11' ' A' ' 149' ' ' BB2 . 74.6 m -60.92 -50.53 73.04 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.696 HG22 ' O ' ' A' ' 126' ' ' LEU . 20.3 tt -58.77 -43.73 88.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.328 -178.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.659 ' HG2' ' O ' ' A' ' 127' ' ' ALA . 22.9 pt20 -65.68 -37.63 87.04 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.497 ' CD2' ' CE1' ' A' ' 142' ' ' PHE . 10.3 t-160 -56.65 -48.87 76.61 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.281 179.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.915 ' CG ' H102 ' A' ' 149' ' ' BB2 . 2.8 mm-40 -60.93 -45.86 92.99 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 119.09 -0.481 . . . . 0.0 111.217 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.962 ' HA ' HD21 ' A' ' 137' ' ' LEU . 75.2 mtp -55.55 -47.78 75.8 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 118.965 0.802 . . . . 0.0 109.893 179.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.778 ' O ' HG12 ' A' ' 138' ' ' VAL . 1.1 m-20 -62.02 -48.49 80.05 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.376 178.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.618 ' CE1' ' NE2' ' A' ' 50' ' ' GLN . 1.7 t60 -57.31 -49.99 74.34 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.294 0.569 . . . . 0.0 110.82 -178.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.962 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.5 pp -60.58 -30.51 69.86 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.032 -178.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.778 HG12 ' O ' ' A' ' 135' ' ' ASP . 12.9 p -81.78 22.18 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 CA-C-O 122.726 1.251 . . . . 0.0 109.051 175.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.603 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 70.85 -3.19 13.5 Favored Glycine 0 CA--C 1.494 -1.256 0 CA-C-N 112.629 -2.078 . . . . 0.0 113.035 176.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.752 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 1.6 ptmt -90.0 121.17 31.84 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.68 HD12 ' C ' ' A' ' 140' ' ' LYS . 6.7 mp -117.74 165.53 13.52 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 121.24 0.543 . . . . 0.0 111.469 -178.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.959 ' HB3' HG21 ' A' ' 100' ' ' VAL . 4.3 m-30 -54.93 -40.13 69.59 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.423 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 47.4 ttm -56.79 -27.29 59.49 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.306 0.574 . . . . 0.0 110.93 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.45 ' HB3' ' O ' ' A' ' 141' ' ' LEU . 8.1 t70 -57.2 -22.89 44.01 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.07 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.953 ' HE2' ' HG2' ' A' ' 101' ' ' PRO . 22.8 t80 -111.2 5.05 19.72 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -177.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 96.1 mt -92.98 149.1 21.46 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 122.169 -0.332 . . . . 0.0 110.726 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 83.5 p . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.969 179.311 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 149' ' ' BB2 . . . . . 0.949 H101 ' HA3' ' A' ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 79.8 p . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.821 0.343 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 1.051 HG12 ' HA ' ' A' ' 37' ' ' THR . 30.8 m -84.03 131.9 32.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.417 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 1.046 HD21 ' HB ' ' A' ' 51' ' ' VAL . 3.0 pp -79.87 -169.51 2.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.696 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.409 ' HA ' ' OE1' ' A' ' 4' ' ' GLN . 4.0 tp-100 -84.64 111.72 19.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.859 0.361 . . . . 0.0 110.053 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.642 HG22 HG21 ' A' ' 37' ' ' THR . 40.7 t -88.51 127.79 41.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.371 0.605 . . . . 0.0 111.828 -178.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.039 ' HB2' HD21 ' A' ' 13' ' ' LEU . 23.1 mt -87.14 142.69 27.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.361 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.549 ' HA ' ' HB3' ' A' ' 92' ' ' SER . 34.7 m-70 -116.16 147.06 41.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.245 0.545 . . . . 0.0 111.992 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.097 HD13 HD12 ' A' ' 13' ' ' LEU . 38.4 mm -58.27 147.0 68.91 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.358 178.128 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.591 ' HA ' HG23 ' A' ' 8' ' ' ILE . 78.2 Cg_endo -93.22 52.38 1.04 Allowed 'Cis proline' 0 C--N 1.354 0.854 0 C-N-CA 124.504 -1.04 . . . . 0.0 113.02 0.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.839 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.7 t70 -55.15 136.04 48.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.083 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -58.88 -44.3 91.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.377 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.608 ' HE ' ' HZ3' ' A' ' 15' ' ' LYS . 14.9 mmt85 -57.44 -25.63 59.94 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 1.097 HD12 HD13 ' A' ' 8' ' ' ILE . 11.2 mt -74.82 -32.71 62.03 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 119.828 1.195 . . . . 0.0 109.025 178.411 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.489 ' HG3' HH11 ' A' ' 14' ' ' ARG . 13.6 mmt85 -95.23 6.94 47.66 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.227 -1.352 . . . . 0.0 109.605 178.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.715 ' HD3' ' HB3' ' A' ' 54' ' ' HIS . 88.6 tttt -82.78 147.93 28.11 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.53 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.4 t -82.48 127.89 39.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.85 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -91.36 140.53 29.69 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.218 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -105.01 136.88 19.1 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.418 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.47 ' HA ' ' ND2' ' A' ' 74' ' ' ASN . 51.8 Cg_endo -82.13 113.97 2.47 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 121.656 1.571 . . . . 0.0 110.279 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.715 HG12 ' H ' ' A' ' 22' ' ' GLU . 16.7 t -68.11 144.68 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 CA-C-O 122.852 1.31 . . . . 0.0 113.271 -175.038 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -60.33 -27.9 67.72 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 112.775 -2.011 . . . . 0.0 112.232 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.715 ' H ' HG12 ' A' ' 20' ' ' VAL . 39.0 tt0 -156.95 144.28 18.84 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.885 -178.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.736 HG21 ' HA2' ' A' ' 115' ' ' GLY . 3.2 t -80.11 106.51 11.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -178.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.918 ' HB2' ' CD1' ' A' ' 27' ' ' ILE . 30.5 m120 -91.43 153.66 19.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.048 -178.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.7 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -54.79 -25.38 27.76 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.272 0.558 . . . . 0.0 110.819 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.742 ' O ' HD13 ' A' ' 30' ' ' ILE . 55.2 mt-10 -74.28 -42.64 59.26 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 177.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.918 ' CD1' ' HB2' ' A' ' 24' ' ' ASN . 1.9 mp -66.46 -34.63 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.101 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -68.32 -39.3 82.0 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.779 -0.192 . . . . 0.0 110.549 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.7 ' HG3' ' O ' ' A' ' 25' ' ' ALA . 99.1 mtt180 -63.7 -39.12 93.53 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.832 ' O ' ' HG3' ' A' ' 34' ' ' MET . 1.6 mp -56.0 -48.47 78.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.826 178.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.964 HG22 HG21 ' A' ' 57' ' ' ILE . 15.0 t -67.14 -40.1 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.463 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.851 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 48.3 m-20 -52.85 -47.6 67.65 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.937 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.53 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 14.1 m-20 -74.44 -28.91 61.26 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.807 176.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.965 ' HG2' HG21 ' A' ' 51' ' ' VAL . 86.9 mtp -59.62 -47.04 87.16 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.169 -177.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.851 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 19.8 p90 -70.33 -46.17 64.73 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 176.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.631 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 3.8 mm-40 -52.25 -39.54 60.48 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.635 0.731 . . . . 0.0 109.182 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . 1.051 ' HA ' HG12 ' A' ' 2' ' ' VAL . 76.5 m -69.14 -61.17 1.9 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.273 -1.33 . . . . 0.0 107.992 178.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.87 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 3.6 ttp -46.79 -41.1 14.87 Favored 'General case' 0 CA--C 1.46 -2.482 0 C-N-CA 124.535 1.134 . . . . 0.0 110.501 -172.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.761 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 60.3 m-85 -69.11 -42.79 75.62 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.097 178.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.56 ' CB ' HG11 ' A' ' 2' ' ' VAL . . . -61.62 -24.77 66.93 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.566 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.938 ' HG2' HD12 ' A' ' 91' ' ' LEU . 11.1 tp10 -87.97 -11.71 46.65 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.407 -1.269 . . . . 0.0 108.368 176.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.447 ' H ' ' C ' ' A' ' 39' ' ' TYR . 58.0 mt-10 63.34 27.4 15.35 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-O 122.019 0.914 . . . . 0.0 109.855 -176.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.535 ' HA2' H182 ' A' ' 149' ' ' BB2 . . . -80.02 145.31 26.97 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 113.781 -1.554 . . . . 0.0 110.799 178.088 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.743 ' CG1' H251 ' A' ' 149' ' ' BB2 . 45.5 mm -79.34 -0.41 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 117.497 0.648 . . . . 0.0 111.931 -178.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.959 ' HA3' H113 ' A' ' 149' ' ' BB2 . . . 175.39 140.03 3.26 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.989 HD13 ' HG ' ' A' ' 91' ' ' LEU . 3.9 tp -124.45 136.74 54.27 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.396 1.598 . . . . 0.0 110.821 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.46 ' H ' HD12 ' A' ' 46' ' ' LEU . . . -104.41 131.72 51.46 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.416 0.15 . . . . 0.0 111.165 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.848 ' HB1' ' CD1' ' A' ' 53' ' ' ILE . . . -31.06 -55.81 0.23 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 115.802 1.779 . . . . 0.0 115.802 -177.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.82 ' CG2' ' HA ' ' A' ' 137' ' ' LEU . 69.3 p -53.17 -35.39 59.75 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.665 0.745 . . . . 0.0 111.631 -177.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.726 ' OE1' HD12 ' A' ' 46' ' ' LEU . 64.6 mt-30 -64.02 -43.43 95.65 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.405 -1.271 . . . . 0.0 110.127 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.046 ' HB ' HD21 ' A' ' 3' ' ' LEU . 0.8 OUTLIER -83.16 15.49 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.883 ' HA ' HD11 ' A' ' 6' ' ' LEU . 36.9 t70 77.29 28.65 0.6 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 176.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.848 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 1.1 pp -122.73 110.78 27.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.982 177.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.715 ' HB3' ' HD3' ' A' ' 15' ' ' LYS . 5.8 p80 -76.51 62.65 1.92 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 122.102 0.953 . . . . 0.0 110.376 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.768 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 89.4 mt-30 -151.37 133.19 14.97 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.066 -1.425 . . . . 0.0 107.468 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 1.112 ' HA ' HD22 ' A' ' 137' ' ' LEU . 98.8 mtt180 -65.02 70.99 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -177.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.964 HG21 HG22 ' A' ' 31' ' ' VAL . 30.6 mm -113.95 124.33 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.898 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -128.62 148.58 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -177.673 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 46' ' ' LEU . 30.8 m -129.29 140.35 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.71 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.093 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 9.5 mm -115.5 153.84 17.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.337 0.589 . . . . 0.0 109.882 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.87 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 38.5 t70 -145.29 39.84 1.2 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.62 -178.059 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.767 ' O ' ' HG3' ' A' ' 68' ' ' GLU . 57.4 t -92.85 87.26 2.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.78 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 78.0 p -55.35 74.7 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 O-C-N 124.499 1.125 . . . . 0.0 112.131 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.768 ' H ' ' HG3' ' A' ' 68' ' ' GLU . 31.9 tp10 -44.63 -26.93 0.42 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.288 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.859 ' OD1' ' HG3' ' A' ' 66' ' ' ARG . 28.2 t-20 -122.01 -72.86 0.67 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.911 0.386 . . . . 0.0 111.654 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.859 ' HG3' ' OD1' ' A' ' 65' ' ' ASN . 78.3 mtp180 -123.47 -40.19 2.38 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.862 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.624 ' HA ' ' HB3' ' A' ' 63' ' ' SER . 4.1 m-20 -161.25 116.62 2.11 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.917 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.78 ' HG2' ' HA ' ' A' ' 63' ' ' SER . 3.5 mm-40 -96.3 152.39 18.63 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.651 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -143.06 86.43 1.92 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.295 -1.321 . . . . 0.0 108.331 -179.396 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 1.093 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 3.5 mm? -108.08 139.66 42.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.076 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.72 HG21 ' HB2' ' A' ' 113' ' ' ARG . 12.9 p -133.09 135.7 56.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.583 177.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.898 ' HB2' ' CD1' ' A' ' 58' ' ' ILE . 94.7 mt -140.86 140.88 34.67 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 178.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.913 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 3.3 mm -121.79 136.57 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-O 121.233 0.54 . . . . 0.0 111.013 -179.29 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.7 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 7.2 m120 49.0 38.69 0.52 Allowed Pre-proline 0 C--N 1.313 -0.996 0 CA-C-N 115.096 -0.957 . . . . 0.0 112.839 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.88 ' HG2' HG23 ' A' ' 58' ' ' ILE . 99.5 Cg_exo -56.42 145.67 77.89 Favored 'Trans proline' 0 N--CA 1.484 0.943 0 C-N-CA 122.958 2.439 . . . . 0.0 114.144 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.504 ' CG ' ' HB2' ' A' ' 109' ' ' ARG . 11.7 pt-20 -133.11 143.18 49.12 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.801 HD23 ' N ' ' A' ' 78' ' ' LEU . 1.7 tt -82.95 135.71 34.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.282 0.563 . . . . 0.0 111.39 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.024 HD21 ' HG3' ' A' ' 109' ' ' ARG . 2.9 mm? -115.74 -40.59 3.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.84 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 87.4 tt0 -152.84 150.59 29.49 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.21 0.529 . . . . 0.0 111.511 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.817 ' HA ' HG12 ' A' ' 106' ' ' VAL . 9.2 ptpp? -147.18 147.4 30.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.267 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.1 t -158.22 147.99 19.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.673 0.273 . . . . 0.0 111.384 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.717 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 76.85 160.29 10.78 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.41 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -136.3 113.42 10.54 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.948 0.88 . . . . 0.0 112.736 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.831 ' HB ' HH12 ' A' ' 102' ' ' ARG . 1.7 p -105.24 161.88 13.9 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.772 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -147.45 116.86 0.87 Allowed Glycine 0 C--N 1.313 -0.701 0 CA-C-N 112.694 -2.048 . . . . 0.0 110.989 178.07 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.761 ' HB ' ' NH2' ' A' ' 102' ' ' ARG . 47.9 mm -147.79 139.21 18.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 117.306 0.553 . . . . 0.0 111.414 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 50.4 mt-10 -71.78 139.03 48.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 122.83 1.3 . . . . 0.0 112.019 -177.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.796 ' HB3' H262 ' A' ' 149' ' ' BB2 . 39.6 mt-10 -154.95 163.48 40.24 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 112.753 -2.021 . . . . 0.0 111.567 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.929 ' O ' ' H52' ' A' ' 149' ' ' BB2 . . . -121.49 165.62 14.44 Favored Glycine 0 CA--C 1.503 -0.714 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.782 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 13.1 m -116.21 140.76 48.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.898 0.849 . . . . 0.0 111.662 -177.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.989 ' HG ' HD13 ' A' ' 46' ' ' LEU . 2.4 mm? -48.62 -17.31 0.16 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.224 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.714 ' CB ' HD13 ' A' ' 13' ' ' LEU . 21.1 m -98.36 -34.39 10.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.255 0.55 . . . . 0.0 110.255 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.772 ' CG2' ' HD2' ' A' ' 94' ' ' PRO . 58.4 mt -85.85 151.44 55.04 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.546 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.772 ' HD2' ' CG2' ' A' ' 93' ' ' ILE . 63.1 Cg_endo -62.11 -145.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.406 2.071 . . . . 0.0 111.7 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.404 ' HA ' ' OE1' ' A' ' 95' ' ' GLU . 4.5 mm-40 -80.93 12.85 3.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.179 0.514 . . . . 0.0 110.771 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.557 ' HG2' ' HG2' ' A' ' 94' ' ' PRO . 98.7 mm-40 -78.7 82.27 4.94 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.125 -178.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.609 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 13.7 mtt85 -86.73 132.45 33.86 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.03 0.443 . . . . 0.0 109.927 178.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.2 150.52 48.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.252 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.772 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.3 tt -76.02 113.92 14.07 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.727 0.775 . . . . 0.0 110.792 -178.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.448 HG11 ' HB3' ' A' ' 142' ' ' PHE . 23.4 t -103.57 133.7 20.14 Favored Pre-proline 0 N--CA 1.469 0.492 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.991 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.554 ' HA ' ' O ' ' A' ' 84' ' ' THR . 98.6 Cg_endo -87.58 126.36 2.2 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.524 2.15 . . . . 0.0 112.675 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.889 ' HG2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -144.65 166.76 24.29 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.149 0.98 . . . . 0.0 109.764 179.438 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.717 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.41 155.3 40.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.852 0.358 . . . . 0.0 110.172 -179.066 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -72.67 -41.78 65.02 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.592 -175.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.749 ' HG2' ' HB3' ' A' ' 123' ' ' ASP . 95.4 mttt -140.61 140.17 35.03 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.49 0.662 . . . . 0.0 109.495 176.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.817 HG12 ' HA ' ' A' ' 80' ' ' LYS . 32.8 m -145.57 142.22 22.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.166 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.817 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 5.1 mmmt -107.43 126.22 52.22 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.974 HD11 HD11 ' A' ' 130' ' ' ILE . 1.8 pp -134.36 151.0 31.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -177.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 1.037 ' HE ' ' HG2' ' A' ' 119' ' ' GLU . 53.5 mtp180 -102.62 139.71 37.85 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.424 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.606 ' HB3' HD22 ' A' ' 72' ' ' LEU . . . -160.18 168.5 25.3 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.237 -176.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.913 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.0 pp -122.59 149.0 44.57 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.591 ' O ' HD12 ' A' ' 111' ' ' LEU . 13.5 t70 -81.67 169.11 17.4 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -175.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.804 ' HD2' ' OD1' ' A' ' 32' ' ' ASP . 43.2 ttp180 -50.93 -23.6 2.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.982 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -79.77 -21.45 44.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.158 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.752 ' HA2' HD13 ' A' ' 111' ' ' LEU . . . 101.37 38.74 3.19 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.151 -1.023 . . . . 0.0 113.983 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.936 ' HE3' ' HA ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -127.13 102.24 24.5 Favored Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 117.188 0.494 . . . . 0.0 110.184 178.532 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.662 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 32.8 Cg_exo -74.63 115.41 4.29 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 121.643 1.562 . . . . 0.0 116.107 -177.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.444 ' N ' ' O ' ' A' ' 110' ' ' ALA . 0.4 OUTLIER -125.71 168.57 13.58 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.01 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 1.037 ' HG2' ' HE ' ' A' ' 109' ' ' ARG . 21.3 mt-10 -107.41 137.11 46.06 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.74 ' O ' HD12 ' A' ' 120' ' ' LEU . 4.3 pp -135.57 133.39 38.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.081 0.467 . . . . 0.0 111.841 -178.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.817 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 0.7 OUTLIER -95.5 123.71 39.17 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.767 178.706 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.937 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -116.45 135.13 54.1 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.749 ' HB3' ' HG2' ' A' ' 105' ' ' LYS . 16.9 m-20 -126.43 163.22 23.79 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.699 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 52.89 -139.02 33.47 Favored Glycine 0 C--N 1.346 1.101 0 C-N-CA 119.344 -1.408 . . . . 0.0 115.344 177.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 78.2 mt -54.38 -32.3 56.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.601 -0.8 . . . . 0.0 111.601 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.937 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.3 OUTLIER -71.42 -51.97 21.04 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.904 0.859 . . . . 0.0 109.308 179.523 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.751 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -58.58 -41.93 86.84 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.162 -1.381 . . . . 0.0 111.648 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.889 HD12 ' HG2' ' A' ' 102' ' ' ARG . 50.8 mm -67.45 -54.83 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -178.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.957 ' HB2' ' H91' ' A' ' 149' ' ' BB2 . 32.1 p -60.7 -49.07 79.0 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.974 HD11 HD11 ' A' ' 108' ' ' ILE . 19.8 tt -59.2 -46.51 92.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.386 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.694 ' HG2' ' O ' ' A' ' 127' ' ' ALA . 21.3 pt20 -65.71 -38.19 88.52 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.337 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.596 ' HD2' ' HN1' ' A' ' 149' ' ' BB2 . 73.4 t60 -59.27 -46.4 88.63 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.549 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.804 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 3.3 mm-40 -60.81 -38.37 85.17 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.748 ' CE ' ' HB2' ' A' ' 77' ' ' LEU . 75.8 mtp -58.22 -45.18 88.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 122.271 1.034 . . . . 0.0 109.422 177.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.763 ' O ' HG12 ' A' ' 138' ' ' VAL . 0.9 OUTLIER -68.14 -47.97 66.65 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.716 179.215 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.653 ' CE1' ' HG2' ' A' ' 50' ' ' GLN . 6.5 t-80 -57.98 -52.75 64.21 Favored 'General case' 0 C--N 1.317 -0.813 0 O-C-N 121.672 -0.642 . . . . 0.0 111.483 -178.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 1.112 HD22 ' HA ' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -65.41 -28.5 69.3 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.511 -179.506 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.929 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 11.3 p -81.1 23.39 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-O 122.294 1.045 . . . . 0.0 109.218 175.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 137' ' ' LEU . . . 67.49 -0.93 7.91 Favored Glycine 0 CA--C 1.485 -1.813 0 CA-C-N 113.532 -1.667 . . . . 0.0 113.144 175.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.929 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 11.2 ptmt -90.22 138.85 31.19 Favored 'General case' 0 N--CA 1.409 -2.479 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 178.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.871 HD12 ' O ' ' A' ' 140' ' ' LYS . 10.6 mp -139.18 149.7 44.72 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -178.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.634 ' HE1' ' SG ' ' A' ' 90' ' ' CYS . 49.2 p90 -54.7 -39.49 68.23 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -178.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.494 ' HA ' ' HB2' ' A' ' 146' ' ' LEU . 1.8 tmt? -59.48 -28.52 67.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.09 0.471 . . . . 0.0 110.842 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -59.06 -24.61 63.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.625 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -118.21 6.7 11.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.376 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 143' ' ' MET . 2.3 mp -88.83 141.78 28.21 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.796 0.331 . . . . 0.0 110.999 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 48.2 t . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.831 179.592 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 149' ' ' BB2 . . . . . 0.959 H113 ' HA3' ' A' ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 54.6 m . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.863 0.363 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.83 HG12 ' HA ' ' A' ' 37' ' ' THR . 31.1 m -83.97 135.42 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.365 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.923 HD21 ' HB ' ' A' ' 51' ' ' VAL . 2.4 pp -79.53 -161.81 0.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.599 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.5 tp60 -94.66 108.17 20.16 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.925 0.393 . . . . 0.0 110.446 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.537 ' CG2' HG21 ' A' ' 37' ' ' THR . 40.9 t -88.59 129.37 39.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.4 0.619 . . . . 0.0 112.067 -178.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.075 ' HB2' HD21 ' A' ' 13' ' ' LEU . 21.5 mt -87.88 143.18 27.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.021 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 51.9 m-70 -120.78 145.73 47.25 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.099 HD13 HD12 ' A' ' 13' ' ' LEU . 46.2 mm -66.05 134.41 94.93 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.676 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.8 141.36 66.57 Favored 'Cis proline' 0 C--N 1.351 0.685 0 C-N-CA 124.195 -1.169 . . . . 0.0 112.016 -0.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.989 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.7 t70 -161.24 126.28 3.6 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 12.0 pt-20 -58.21 -46.06 86.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.982 -178.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.578 ' HB2' HD13 ' A' ' 6' ' ' LEU . 25.1 mtt-85 -59.3 -26.16 64.74 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 1.099 HD12 HD13 ' A' ' 8' ' ' ILE . 10.7 mt -76.64 -33.38 58.35 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 120.284 1.402 . . . . 0.0 108.139 177.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.587 ' C ' ' HA3' ' A' ' 139' ' ' GLY . 14.1 mmt85 -94.11 11.01 31.47 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 113.854 -1.521 . . . . 0.0 109.303 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.438 ' HB2' ' HA ' ' A' ' 12' ' ' ARG . 61.8 tttp -92.76 150.67 20.5 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.283 -178.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.989 HG13 HG23 ' A' ' 138' ' ' VAL . 61.8 t -83.47 124.06 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.819 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.738 ' C ' ' HG3' ' A' ' 56' ' ' ARG . . . -80.99 147.45 30.21 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.652 ' HD3' ' N ' ' A' ' 19' ' ' PRO . 2.2 tmtp? -109.9 127.98 26.17 Favored Pre-proline 0 C--N 1.325 -0.486 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.217 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.995 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 65.6 Cg_endo -77.7 113.93 3.57 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 121.998 1.799 . . . . 0.0 110.815 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.758 HG12 ' H ' ' A' ' 22' ' ' GLU . 18.0 t -68.45 144.46 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-O 122.609 1.195 . . . . 0.0 113.29 -175.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -60.76 -27.97 68.36 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 112.97 -1.923 . . . . 0.0 111.995 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.758 ' H ' HG12 ' A' ' 20' ' ' VAL . 39.4 tt0 -157.79 143.02 16.88 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.242 -178.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.713 HG21 HD11 ' A' ' 111' ' ' LEU . 3.2 t -79.75 108.46 13.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 1.033 ' HB2' HD13 ' A' ' 27' ' ' ILE . 28.4 m120 -93.32 173.51 7.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.813 -179.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.625 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -65.75 -28.54 69.11 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.376 0.607 . . . . 0.0 110.859 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.498 ' HA ' ' OE1' ' A' ' 26' ' ' GLU . 4.3 mm-40 -73.92 -39.72 63.61 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 1.033 HD13 ' HB2' ' A' ' 24' ' ' ASN . 1.9 mp -66.91 -37.49 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.166 178.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.823 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 60.7 mt-30 -66.18 -40.46 90.48 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.233 -0.292 . . . . 0.0 110.719 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.625 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 14.0 mmp_? -63.33 -39.58 94.93 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.857 HG21 HD12 ' A' ' 57' ' ' ILE . 4.8 mt -55.34 -50.17 67.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.381 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.903 HG22 ' CG2' ' A' ' 57' ' ' ILE . 15.9 t -65.25 -41.62 91.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.072 0.463 . . . . 0.0 111.045 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.873 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 27.3 m-20 -54.97 -43.58 73.64 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.475 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.529 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 1.4 m-20 -75.81 -29.77 58.79 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.923 176.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.978 ' HE1' HG22 ' A' ' 57' ' ' ILE . 22.0 mtm -60.14 -46.69 88.82 Favored 'General case' 0 C--N 1.347 0.467 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.534 -177.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.873 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 14.9 p90 -69.87 -45.45 67.68 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.053 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.605 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 3.8 mm-40 -52.65 -39.38 61.76 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.719 0.771 . . . . 0.0 108.996 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.83 ' HA ' HG12 ' A' ' 2' ' ' VAL . 61.8 m -70.06 -61.78 1.64 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.455 -1.248 . . . . 0.0 107.642 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.879 ' HG3' ' HB2' ' A' ' 46' ' ' LEU . 1.0 OUTLIER -46.52 -41.11 13.7 Favored 'General case' 0 CA--C 1.462 -2.416 0 C-N-CA 123.958 0.903 . . . . 0.0 110.431 -170.945 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.701 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 58.5 m-85 -70.37 -42.43 71.79 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.281 178.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.05 -24.61 66.33 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.416 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 1.024 ' HG2' HD12 ' A' ' 91' ' ' LEU . 11.7 tp10 -88.89 -11.4 44.7 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.475 177.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.439 ' H ' ' C ' ' A' ' 39' ' ' TYR . 18.4 mt-10 65.43 23.93 11.95 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.042 -176.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.481 ' HA2' H182 ' A' ' 149' ' ' BB2 . . . -79.07 141.89 24.66 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 114.027 -1.442 . . . . 0.0 110.372 177.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.86 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 46.3 mt -81.33 1.41 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 117.648 0.724 . . . . 0.0 112.638 -178.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.849 ' HA3' ' C10' ' A' ' 149' ' ' BB2 . . . 178.73 133.78 1.98 Allowed Glycine 0 CA--C 1.528 0.867 0 CA-C-O 118.913 -0.937 . . . . 0.0 111.409 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.024 HD13 ' HG ' ' A' ' 91' ' ' LEU . 4.9 tp -126.02 134.33 51.48 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.15 1.475 . . . . 0.0 112.161 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -98.3 131.88 44.25 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.292 0.237 . . . . 0.0 111.448 178.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.894 ' HB1' ' CD1' ' A' ' 53' ' ' ILE . . . -30.01 -55.64 0.18 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.565 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 67.3 p -53.25 -36.01 60.63 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.462 0.648 . . . . 0.0 112.039 -177.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.774 ' OE1' HD12 ' A' ' 46' ' ' LEU . 85.8 mt-30 -63.83 -41.92 97.73 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.231 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.923 ' HB ' HD21 ' A' ' 3' ' ' LEU . 1.0 OUTLIER -83.74 16.49 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.447 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.933 ' HA ' HD11 ' A' ' 6' ' ' LEU . 50.5 t0 77.37 28.29 0.61 Allowed 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 176.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.894 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -122.23 110.7 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 119.204 -0.999 . . . . 0.0 111.247 177.883 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -76.76 63.19 2.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.493 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.735 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 94.7 mm-40 -152.96 134.33 14.31 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.237 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.995 ' HD2' ' HD3' ' A' ' 19' ' ' PRO . 98.8 mtt180 -64.5 66.72 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -177.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.978 HG22 ' HE1' ' A' ' 34' ' ' MET . 6.2 mt -111.1 123.22 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.138 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.082 HD11 ' HB2' ' A' ' 72' ' ' LEU . 1.8 pp -128.32 146.37 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 119.665 -0.814 . . . . 0.0 113.12 -177.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 46' ' ' LEU . 30.5 m -126.24 139.11 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.7 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.099 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 7.9 mm -116.16 153.39 17.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.55 0.69 . . . . 0.0 110.392 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.86 ' HB3' ' C ' ' A' ' 44' ' ' ILE . 31.3 t70 -139.46 17.85 2.55 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.363 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.776 ' H ' HG22 ' A' ' 60' ' ' ILE . 32.4 t -91.69 116.2 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.106 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.348 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.887 ' HB3' ' OE2' ' A' ' 68' ' ' GLU . 79.5 p -38.88 78.25 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -177.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.928 ' HB2' HD11 ' A' ' 70' ' ' LEU . 40.5 tt0 -68.87 -21.68 64.24 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.736 178.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.461 ' CG ' ' H ' ' A' ' 66' ' ' ARG . 51.6 t-20 -163.3 -138.23 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.868 178.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.461 ' H ' ' CG ' ' A' ' 65' ' ' ASN . 70.8 mtp180 -74.52 -56.67 4.58 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.34 120.25 23.53 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.964 178.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.887 ' OE2' ' HB3' ' A' ' 63' ' ' SER . 45.5 mt-10 -93.17 75.99 4.63 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.507 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 48.0 ttp180 -152.58 95.63 2.04 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.87 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 1.099 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 56.3 mt -111.23 138.97 47.02 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.795 HG21 ' HB2' ' A' ' 113' ' ' ARG . 11.8 p -134.82 135.29 53.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.607 177.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.082 ' HB2' HD11 ' A' ' 58' ' ' ILE . 1.8 mm? -140.4 140.77 35.55 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.061 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 3.5 mm -119.51 136.03 57.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.172 0.51 . . . . 0.0 110.952 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.716 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 60.5 m-20 51.57 37.6 0.44 Allowed Pre-proline 0 C--N 1.312 -1.027 0 CA-C-N 115.349 -0.842 . . . . 0.0 112.379 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.874 ' HG2' HG12 ' A' ' 58' ' ' ILE . 77.6 Cg_exo -55.08 144.5 68.96 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 122.949 2.433 . . . . 0.0 114.102 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.5 ' CG ' ' HB2' ' A' ' 109' ' ' ARG . 11.5 pt-20 -135.45 145.43 47.19 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.817 HD22 ' NZ ' ' A' ' 80' ' ' LYS . 1.5 tt -81.2 137.69 35.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.309 0.576 . . . . 0.0 111.817 -178.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.902 HD21 ' HG3' ' A' ' 109' ' ' ARG . 2.9 mm? -118.9 -50.71 2.38 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.624 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 1.018 ' HB3' ' HD3' ' A' ' 107' ' ' LYS . 39.3 tp10 -140.5 146.51 38.26 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 120.883 0.373 . . . . 0.0 110.886 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.817 ' NZ ' HD22 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -147.32 145.66 29.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.098 179.492 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.3 t -159.07 156.58 29.47 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.787 0.327 . . . . 0.0 111.592 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.753 ' C ' ' HG3' ' A' ' 104' ' ' GLU . . . 67.53 159.62 1.17 Allowed Glycine 0 CA--C 1.506 -0.5 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.352 -179.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.734 ' N ' ' HG3' ' A' ' 104' ' ' GLU . 57.6 mt-10 -131.89 113.0 12.93 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 122.006 0.908 . . . . 0.0 113.002 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.913 HG23 ' HG2' ' A' ' 104' ' ' GLU . 1.5 p -103.54 161.36 13.95 Favored 'General case' 0 CA--C 1.486 -1.505 0 CA-C-N 113.812 -1.54 . . . . 0.0 114.733 178.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.772 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -149.84 118.34 0.93 Allowed Glycine 0 C--N 1.311 -0.828 0 CA-C-N 112.911 -1.949 . . . . 0.0 111.373 178.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.529 ' N ' ' HG ' ' A' ' 99' ' ' LEU . 32.4 mt -148.16 138.69 17.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 117.278 0.539 . . . . 0.0 111.733 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.533 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 95.3 mt-10 -70.82 137.98 49.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 123.072 1.415 . . . . 0.0 112.313 -176.138 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.732 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 46.8 mt-10 -156.42 160.43 39.6 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 112.652 -2.067 . . . . 0.0 111.351 -179.034 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.917 ' O ' ' H52' ' A' ' 149' ' ' BB2 . . . -120.57 165.0 13.89 Favored Glycine 0 CA--C 1.501 -0.783 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.745 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 18.2 m -116.09 140.81 48.9 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 117.897 0.848 . . . . 0.0 111.995 -177.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.024 ' HG ' HD13 ' A' ' 46' ' ' LEU . 2.3 mm? -47.69 -26.52 1.57 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.88 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.852 ' CB ' HD13 ' A' ' 13' ' ' LEU . 49.9 m -79.77 -38.08 33.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.871 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.77 HG23 ' HD2' ' A' ' 94' ' ' PRO . 68.9 mt -86.1 149.97 51.32 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.971 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.77 ' HD2' HG23 ' A' ' 93' ' ' ILE . 85.6 Cg_endo -70.98 49.16 0.93 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.609 2.206 . . . . 0.0 113.945 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.548 ' HB2' ' O ' ' A' ' 94' ' ' PRO . 0.3 OUTLIER 74.19 20.07 2.77 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 178.841 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.745 ' HB2' HG21 ' A' ' 93' ' ' ILE . 84.3 mt-30 -78.76 88.85 4.61 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.732 ' HA ' ' O ' ' A' ' 88' ' ' GLU . 12.9 mtt85 -85.31 132.49 34.24 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.757 0.789 . . . . 0.0 112.115 -178.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -134.19 153.34 51.9 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.792 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.772 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.5 tt -75.67 112.7 12.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.681 0.753 . . . . 0.0 110.757 -178.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.975 HG13 ' HB2' ' A' ' 142' ' ' PHE . 29.5 t -98.6 128.93 31.37 Favored Pre-proline 0 N--CA 1.468 0.434 0 CA-C-N 114.724 -1.126 . . . . 0.0 112.011 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.53 ' HD2' ' CD2' ' A' ' 142' ' ' PHE . 1.1 Cg_endo -83.4 125.69 3.99 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.726 2.284 . . . . 0.0 112.031 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.976 HH11 ' HB3' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -145.86 167.17 23.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.312 179.759 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.638 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.62 155.17 40.53 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.913 ' HG2' HG23 ' A' ' 84' ' ' THR . 95.1 mt-10 -72.88 -39.87 66.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.867 -175.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.679 ' HB3' ' OD1' ' A' ' 123' ' ' ASP . 59.1 mttp -139.73 140.56 36.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.263 0.554 . . . . 0.0 109.722 177.034 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.797 HG12 ' CB ' ' A' ' 80' ' ' LYS . 35.2 m -149.71 140.02 16.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.511 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 1.018 ' HD3' ' HB3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -108.09 127.75 54.07 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.874 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.89 ' HA ' HD23 ' A' ' 78' ' ' LEU . 1.5 pp -133.03 150.15 32.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -177.082 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.902 ' HG3' HD21 ' A' ' 78' ' ' LEU . 96.4 mtt180 -102.18 137.69 40.12 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.66 -178.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.504 ' CB ' ' HB3' ' A' ' 72' ' ' LEU . . . -161.57 169.7 21.22 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 114.746 -1.115 . . . . 0.0 111.023 -176.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 1.061 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 1.9 pp -119.35 149.12 42.35 Favored 'General case' 0 C--O 1.218 -0.59 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 176.221 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.624 ' O ' HD12 ' A' ' 111' ' ' LEU . 12.8 t70 -81.75 167.8 18.72 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 119.877 -0.729 . . . . 0.0 112.642 -175.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.795 ' HB2' HG21 ' A' ' 71' ' ' VAL . 51.0 ttp180 -50.28 -22.45 1.79 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.971 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -79.4 -25.07 42.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.898 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.748 ' HA2' HD13 ' A' ' 111' ' ' LEU . . . 104.83 37.91 2.65 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.189 -1.005 . . . . 0.0 113.834 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -128.36 102.73 20.6 Favored Pre-proline 0 C--O 1.235 0.342 0 CA-C-N 117.054 0.427 . . . . 0.0 110.473 178.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.709 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 36.8 Cg_exo -71.56 114.86 4.07 Favored 'Trans proline' 0 C--N 1.358 1.075 0 N-CA-C 116.409 1.657 . . . . 0.0 116.409 -176.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.524 ' CE2' ' HB2' ' A' ' 112' ' ' ASP . 0.3 OUTLIER -127.0 160.72 30.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.731 -179.227 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.628 ' HG2' ' HG2' ' A' ' 109' ' ' ARG . 21.5 mt-10 -107.42 130.69 54.79 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.909 ' O ' HD23 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -131.66 141.59 49.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.795 0.807 . . . . 0.0 111.887 -179.019 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 107' ' ' LYS . 11.4 pt-20 -97.16 125.52 41.72 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.979 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.903 ' CB ' ' HG ' ' A' ' 126' ' ' LEU . . . -115.01 135.41 54.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.839 0.352 . . . . 0.0 111.391 -179.077 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.679 ' OD1' ' HB3' ' A' ' 105' ' ' LYS . 31.3 m-20 -126.66 160.76 29.8 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.808 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 51.73 -138.78 28.94 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 120.645 1.566 . . . . 0.0 115.159 177.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.672 HD12 ' H ' ' A' ' 125' ' ' LEU . 4.9 mp -53.5 -32.96 52.61 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.225 -0.488 . . . . 0.0 111.309 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.903 ' HG ' ' CB ' ' A' ' 122' ' ' ALA . 4.0 tp -70.78 -52.17 22.36 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.649 0.738 . . . . 0.0 109.418 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.738 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -58.55 -42.34 87.67 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.713 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.93 HD12 ' HG2' ' A' ' 102' ' ' ARG . 44.5 mm -67.85 -54.65 21.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.875 ' HB2' ' H91' ' A' ' 149' ' ' BB2 . 30.0 p -58.19 -50.2 74.36 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -178.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.883 HD11 HD11 ' A' ' 108' ' ' ILE . 14.2 tt -59.57 -44.21 92.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.121 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.866 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.0 pt20 -68.39 -39.42 81.71 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.518 178.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.674 ' CE1' HD12 ' A' ' 141' ' ' LEU . 68.7 t60 -59.44 -47.24 86.24 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.067 0.461 . . . . 0.0 109.794 178.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.877 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.7 mm-40 -59.61 -40.41 87.47 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.586 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.946 ' HA ' HD21 ' A' ' 137' ' ' LEU . 75.5 mtp -57.52 -47.64 81.43 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.838 0.828 . . . . 0.0 109.872 178.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.572 ' O ' HG12 ' A' ' 138' ' ' VAL . 31.4 m-20 -63.38 -47.13 83.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.976 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.961 ' HA ' HD21 ' A' ' 141' ' ' LEU . 4.6 t-80 -59.07 -53.0 63.29 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 121.103 0.478 . . . . 0.0 111.593 -178.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.946 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.7 pp -58.64 -31.76 68.43 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.518 -178.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.989 HG23 HG13 ' A' ' 16' ' ' VAL . 14.9 p -86.44 23.85 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 122.329 1.061 . . . . 0.0 109.548 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.627 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 53.85 34.94 52.05 Favored Glycine 0 CA--C 1.482 -1.969 0 CA-C-N 113.388 -1.733 . . . . 0.0 112.432 176.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.968 ' HG2' HG13 ' A' ' 138' ' ' VAL . 3.6 ptmt -133.17 105.92 7.29 Favored 'General case' 0 N--CA 1.423 -1.807 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.334 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.961 HD21 ' HA ' ' A' ' 136' ' ' HIS . 3.3 mm? -122.86 151.36 41.79 Favored 'General case' 0 N--CA 1.446 -0.666 0 O-C-N 120.814 -1.179 . . . . 0.0 109.474 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.975 ' HB2' HG13 ' A' ' 100' ' ' VAL . 8.8 m-85 -64.72 -27.35 68.85 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.892 ' HA ' HD23 ' A' ' 146' ' ' LEU . 1.9 tmt? -58.83 -24.9 62.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.514 0.673 . . . . 0.0 110.183 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.449 ' CG ' ' HE ' ' A' ' 14' ' ' ARG . 67.9 m-20 -54.8 -25.63 29.48 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.314 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -122.46 36.37 4.65 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -178.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.892 HD23 ' HA ' ' A' ' 143' ' ' MET . 2.8 mm? -85.66 144.27 27.93 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.789 0.328 . . . . 0.0 111.269 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 46.7 t . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.004 179.779 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 149' ' ' BB2 . . . . . 0.917 ' H52' ' O ' ' A' ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.7 t . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.835 0.35 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.818 HG13 HG23 ' A' ' 37' ' ' THR . 38.2 t -84.11 128.33 38.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.619 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.964 HD21 ' HB ' ' A' ' 51' ' ' VAL . 3.1 pp -79.63 -173.39 3.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.797 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.458 ' N ' HD12 ' A' ' 3' ' ' LEU . 70.9 tp60 -83.1 106.82 15.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.026 0.441 . . . . 0.0 110.59 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.586 HG22 HG21 ' A' ' 37' ' ' THR . 40.6 t -87.65 127.95 40.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.543 0.687 . . . . 0.0 112.201 -178.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.99 ' HB2' HD21 ' A' ' 13' ' ' LEU . 35.1 mt -85.96 138.88 31.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.193 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.523 ' C ' HD11 ' A' ' 13' ' ' LEU . 28.8 m-70 -113.44 147.47 37.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.083 0.468 . . . . 0.0 112.141 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.048 HD13 HD12 ' A' ' 13' ' ' LEU . 42.9 mm -57.26 148.08 54.5 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.426 178.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.635 ' HA ' HG23 ' A' ' 8' ' ' ILE . 69.5 Cg_endo -93.49 51.84 1.1 Allowed 'Cis proline' 0 C--N 1.353 0.802 0 C-N-CA 124.707 -0.956 . . . . 0.0 112.881 0.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.886 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.7 t70 -55.66 135.78 51.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.057 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -59.37 -44.98 92.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.999 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.657 ' O ' ' HB ' ' A' ' 49' ' ' THR . 15.1 mmt85 -56.06 -25.47 45.29 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 1.048 HD12 HD13 ' A' ' 8' ' ' ILE . 10.7 mt -75.42 -33.86 60.96 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 119.46 1.027 . . . . 0.0 108.679 178.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.754 ' HD3' ' CG ' ' A' ' 144' ' ' ASP . 14.9 mmm180 -96.23 13.01 28.88 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 114.086 -1.416 . . . . 0.0 109.442 178.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.867 ' HD3' ' N ' ' A' ' 16' ' ' VAL . 1.1 tmtp? -87.01 145.38 26.51 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.918 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.94 HG13 HG23 ' A' ' 138' ' ' VAL . 49.1 t -81.86 118.95 30.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.792 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -78.16 150.84 33.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.824 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.787 ' HD3' ' O ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -114.65 133.08 22.6 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.133 178.803 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.763 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 61.2 Cg_endo -78.81 115.94 3.67 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.454 2.103 . . . . 0.0 111.43 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.767 HG12 ' H ' ' A' ' 22' ' ' GLU . 19.9 t -67.85 144.43 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 CA-C-O 122.618 1.199 . . . . 0.0 113.096 -175.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -61.62 -28.22 69.21 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 113.058 -1.883 . . . . 0.0 112.111 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.767 ' H ' HG12 ' A' ' 20' ' ' VAL . 38.9 tt0 -156.57 145.74 20.42 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 120.746 -0.381 . . . . 0.0 111.547 -178.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.626 HG21 ' HA2' ' A' ' 115' ' ' GLY . 3.9 t -79.15 105.87 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -178.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.91 ' HB2' HD13 ' A' ' 27' ' ' ILE . 29.6 m120 -93.31 153.81 18.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.779 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.647 ' HB1' HH12 ' A' ' 29' ' ' ARG . . . -54.72 -24.17 20.97 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.254 0.549 . . . . 0.0 110.711 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -74.95 -41.06 60.35 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 177.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.91 HD13 ' HB2' ' A' ' 24' ' ' ASN . 1.8 mp -68.08 -33.96 63.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-N 113.846 -1.524 . . . . 0.0 110.108 178.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -69.94 -40.07 75.7 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 122.354 -0.216 . . . . 0.0 110.575 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.647 HH12 ' HB1' ' A' ' 25' ' ' ALA . 67.7 mtt85 -64.26 -38.01 89.53 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.802 ' CG2' HD13 ' A' ' 53' ' ' ILE . 4.8 mt -55.46 -50.3 66.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.302 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.785 HG22 ' CG2' ' A' ' 57' ' ' ILE . 3.8 t -67.9 -40.67 83.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.02 0.438 . . . . 0.0 110.201 178.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.83 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 12.8 m-20 -55.32 -41.38 72.35 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.73 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.485 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 52.7 m-20 -76.32 -30.21 57.6 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.158 176.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' MET . . . . . 1.092 ' HG2' HG21 ' A' ' 51' ' ' VAL . 85.4 mtp -60.31 -46.25 90.54 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.268 -177.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.83 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 11.0 p90 -69.57 -44.51 70.68 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 32' ' ' ASP . 31.2 mm-40 -53.01 -39.97 63.52 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.818 HG23 HG13 ' A' ' 2' ' ' VAL . 74.7 m -71.49 -62.6 1.35 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 118.377 -1.329 . . . . 0.0 107.886 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' MET . . . . . 1.008 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 2.0 ttp -46.91 -40.4 14.04 Favored 'General case' 0 CA--C 1.467 -2.237 0 C-N-CA 124.015 0.926 . . . . 0.0 110.145 -170.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.698 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 50.6 m-85 -70.51 -42.27 71.52 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.985 177.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 37' ' ' THR . . . -61.25 -23.23 65.5 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.566 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 1.014 ' HG2' HD12 ' A' ' 91' ' ' LEU . 11.5 tp10 -90.25 -11.38 41.07 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 114.434 -1.257 . . . . 0.0 108.273 177.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.443 ' H ' ' C ' ' A' ' 39' ' ' TYR . 21.6 mt-10 64.12 28.55 14.16 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.889 -176.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.817 ' HA2' H182 ' A' ' 149' ' ' BB2 . . . -84.48 143.66 21.02 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 113.678 -1.601 . . . . 0.0 111.207 178.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.832 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 45.7 mm -79.36 -1.44 4.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 117.323 0.561 . . . . 0.0 112.061 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.825 ' HA3' ' H92' ' A' ' 149' ' ' BB2 . . . 177.87 135.88 2.37 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-O 119.28 -0.733 . . . . 0.0 111.721 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.089 HD13 ' HG ' ' A' ' 91' ' ' LEU . 5.0 tp -125.01 133.67 52.88 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.347 1.074 . . . . 0.0 111.305 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -100.42 132.33 45.86 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.962 ' HB1' HG13 ' A' ' 53' ' ' ILE . . . -26.9 -56.5 0.09 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.657 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 70.4 p -53.34 -35.81 60.64 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.65 0.738 . . . . 0.0 111.756 -177.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.816 ' NE2' HD23 ' A' ' 91' ' ' LEU . 8.8 mt-30 -64.52 -41.57 96.31 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.59 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.092 HG21 ' HG2' ' A' ' 34' ' ' MET . 1.1 m -85.76 18.57 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.904 ' OD2' HD21 ' A' ' 6' ' ' LEU . 8.4 t0 78.43 28.09 0.48 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 176.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.962 HG13 ' HB1' ' A' ' 48' ' ' ALA . 11.1 pt -123.05 110.35 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 118.857 -1.137 . . . . 0.0 111.783 177.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.618 ' HB2' ' NZ ' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -76.82 51.74 0.79 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 121.888 0.851 . . . . 0.0 109.531 179.206 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.533 ' O ' HG12 ' A' ' 57' ' ' ILE . 85.2 mt-30 -140.52 129.94 23.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.103 -1.408 . . . . 0.0 107.501 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.792 ' N ' ' HB1' ' A' ' 17' ' ' ALA . 73.3 mtt-85 -59.83 68.34 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.936 ' HB ' HD11 ' A' ' 53' ' ' ILE . 11.1 mm -112.08 122.31 66.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.058 HD11 ' HB2' ' A' ' 72' ' ' LEU . 1.9 pp -127.82 143.46 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 119.607 -0.837 . . . . 0.0 113.174 -177.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.67 HG21 ' HB3' ' A' ' 35' ' ' PHE . 1.4 p -127.96 134.13 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.679 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.049 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 2.0 mt -114.93 151.94 16.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.445 0.64 . . . . 0.0 111.111 -177.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 1.008 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 11.4 t70 -129.65 25.73 5.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.614 -1.176 . . . . 0.0 110.83 -177.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 1.085 HG12 ' H ' ' A' ' 63' ' ' SER . 11.7 t -79.46 -161.33 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . 1.085 ' H ' HG12 ' A' ' 62' ' ' VAL . 54.1 m -95.17 85.85 4.42 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.196 -0.315 . . . . 0.0 111.194 177.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.7 ' OE1' HD23 ' A' ' 70' ' ' LEU . 36.9 tt0 -61.58 -47.75 84.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.967 0.889 . . . . 0.0 109.551 178.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.612 ' OD1' ' HG3' ' A' ' 66' ' ' ARG . 14.2 t-20 -165.84 -119.22 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 113.922 -1.49 . . . . 0.0 108.616 178.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.612 ' HG3' ' OD1' ' A' ' 65' ' ' ASN . 98.5 mtt180 -69.15 -46.39 67.71 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.044 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -103.17 122.67 45.19 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.596 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.736 ' HG2' ' HA ' ' A' ' 63' ' ' SER . 47.7 mt-10 -78.16 83.76 4.42 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.006 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.534 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 51.5 ttt-85 -153.85 100.44 2.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.68 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 1.049 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 48.5 mt -112.09 138.87 48.15 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -179.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.999 HG21 ' HB2' ' A' ' 113' ' ' ARG . 8.8 p -134.03 131.23 55.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.408 177.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.058 ' HB2' HD11 ' A' ' 58' ' ' ILE . 89.6 mt -142.41 143.18 32.54 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 121.31 -0.156 . . . . 0.0 110.919 177.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.054 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.6 mp -120.68 134.39 64.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.69 0.281 . . . . 0.0 110.743 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.688 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 50.4 m-20 53.72 34.78 0.26 Allowed Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.846 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 84.5 Cg_exo -55.16 146.75 57.99 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.521 2.147 . . . . 0.0 113.571 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -135.99 149.23 48.77 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.959 ' HB2' ' HE1' ' A' ' 134' ' ' MET . 27.9 tp -79.63 138.3 37.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.42 0.629 . . . . 0.0 112.082 -178.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.066 HD21 ' HG3' ' A' ' 109' ' ' ARG . 2.6 mm? -114.26 -45.35 3.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.425 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.587 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 38.2 tt0 -158.06 146.82 19.16 Favored 'General case' 0 C--O 1.23 0.035 0 CA-C-O 121.114 0.483 . . . . 0.0 111.637 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.879 ' HE3' HD21 ' A' ' 77' ' ' LEU . 19.3 ptpt -143.59 146.91 33.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.045 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.4 p -159.67 150.98 19.76 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.733 0.301 . . . . 0.0 111.291 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.744 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 79.75 159.08 16.84 Favored Glycine 0 C--N 1.335 0.472 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.414 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -134.02 113.4 12.09 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.896 0.855 . . . . 0.0 112.93 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.643 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.6 p -106.97 161.53 14.64 Favored 'General case' 0 CA--C 1.486 -1.485 0 CA-C-N 113.902 -1.499 . . . . 0.0 114.936 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.746 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -146.95 115.86 0.81 Allowed Glycine 0 C--N 1.311 -0.861 0 CA-C-N 112.671 -2.059 . . . . 0.0 110.873 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.589 ' N ' ' HG ' ' A' ' 99' ' ' LEU . 34.1 mt -147.97 139.09 17.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 117.293 0.546 . . . . 0.0 111.618 -178.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 50.5 mt-10 -71.65 138.55 48.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 123.193 1.473 . . . . 0.0 112.082 -175.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.792 ' HB3' H262 ' A' ' 149' ' ' BB2 . 46.0 mt-10 -157.41 162.25 39.0 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 112.672 -2.058 . . . . 0.0 111.098 -179.075 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.871 ' O ' ' H52' ' A' ' 149' ' ' BB2 . . . -122.01 161.53 16.12 Favored Glycine 0 CA--C 1.501 -0.817 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.682 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 17.9 m -114.63 140.43 48.82 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.313 0.578 . . . . 0.0 111.344 -178.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.089 ' HG ' HD13 ' A' ' 46' ' ' LEU . 2.4 mm? -48.14 -22.8 0.69 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.333 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.863 ' CB ' HG12 ' A' ' 8' ' ' ILE . 54.0 m -83.28 -34.76 25.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.921 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.783 HG23 ' HD2' ' A' ' 94' ' ' PRO . 49.5 mm -85.43 149.41 51.89 Favored Pre-proline 0 N--CA 1.451 -0.381 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.226 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.783 ' HD2' HG23 ' A' ' 93' ' ' ILE . 92.1 Cg_endo -73.11 50.32 1.82 Allowed 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.493 2.129 . . . . 0.0 114.033 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.53 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 39.5 tt0 75.61 14.4 2.81 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.041 0.448 . . . . 0.0 111.871 178.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.703 ' HB2' HG21 ' A' ' 93' ' ' ILE . 10.0 mm-40 -78.85 88.89 4.66 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.764 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 18.5 mtm105 -85.31 132.62 34.22 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 121.637 0.732 . . . . 0.0 111.836 -178.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -135.16 155.85 50.0 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 114.539 -1.209 . . . . 0.0 109.432 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.746 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.6 tt -76.23 115.28 15.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.419 0.628 . . . . 0.0 111.773 -178.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.859 HG13 ' HB2' ' A' ' 142' ' ' PHE . 39.0 t -107.01 131.95 21.29 Favored Pre-proline 0 N--CA 1.475 0.815 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.991 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.643 ' HA ' ' O ' ' A' ' 84' ' ' THR . 85.3 Cg_endo -82.92 127.47 4.79 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.663 2.242 . . . . 0.0 112.519 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.948 ' HG3' HG23 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -144.68 167.26 22.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.224 179.351 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.744 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.79 155.48 40.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 118.34 0.518 . . . . 0.0 110.1 -179.075 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -73.38 -41.2 63.67 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.895 -175.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.672 ' HB3' ' OD1' ' A' ' 123' ' ' ASP . 95.4 mttt -139.64 140.23 36.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.249 0.547 . . . . 0.0 109.619 177.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.869 HG22 ' HB1' ' A' ' 127' ' ' ALA . 35.1 m -146.78 139.44 19.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.311 -178.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 1.014 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 56.1 mmtt -106.6 127.05 53.03 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 1.014 ' HA ' HD23 ' A' ' 78' ' ' LEU . 2.3 pp -133.83 146.81 31.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -176.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 1.066 ' HG3' HD21 ' A' ' 78' ' ' LEU . 68.7 mtm180 -103.6 139.32 39.06 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.68 -178.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.704 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -161.05 169.42 22.51 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.037 -176.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 1.054 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.5 pp -116.48 151.83 35.28 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.473 ' O ' HD12 ' A' ' 111' ' ' LEU . 16.8 t70 -85.24 163.61 18.56 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.231 0.539 . . . . 0.0 112.053 -177.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.999 ' HB2' HG21 ' A' ' 71' ' ' VAL . 13.1 ttp-105 -51.93 -20.11 2.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.076 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -79.4 -26.44 41.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.633 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.626 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 107.3 35.98 2.58 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.199 -1.001 . . . . 0.0 113.491 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -128.46 102.68 20.36 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.781 0.291 . . . . 0.0 110.804 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.672 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.9 Cg_exo -72.6 116.27 4.65 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 121.65 1.567 . . . . 0.0 115.663 -177.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 112' ' ' ASP . 0.4 OUTLIER -126.97 165.13 20.01 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.269 -178.655 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.545 ' HG3' ' CG ' ' A' ' 109' ' ' ARG . 5.9 mp0 -107.33 130.68 54.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.028 0.442 . . . . 0.0 109.837 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.729 HD21 ' CD1' ' A' ' 72' ' ' LEU . 4.4 pp -124.53 130.94 53.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.571 -178.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 1.014 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 15.3 pt-20 -91.5 123.79 35.18 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.917 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -116.24 135.62 53.74 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.672 ' OD1' ' HB3' ' A' ' 105' ' ' LYS . 45.4 m-20 -127.1 161.36 28.62 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.825 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 51.68 -137.88 30.3 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 120.334 1.425 . . . . 0.0 115.279 177.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 81.1 mt -54.05 -32.28 54.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.816 -0.692 . . . . 0.0 111.737 -178.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.917 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.3 OUTLIER -71.11 -52.58 18.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.663 0.744 . . . . 0.0 109.362 179.769 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.869 ' HB1' HG22 ' A' ' 106' ' ' VAL . . . -59.85 -40.9 90.16 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.569 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.948 HG23 ' HG3' ' A' ' 102' ' ' ARG . 46.4 mm -66.01 -54.31 28.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.698 -178.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.822 ' HB3' H112 ' A' ' 149' ' ' BB2 . 85.5 m -60.42 -49.39 77.76 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.768 ' CD1' HG12 ' A' ' 108' ' ' ILE . 0.1 OUTLIER -59.22 -44.72 92.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.557 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.818 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.3 pt20 -67.7 -39.14 84.42 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.683 0.278 . . . . 0.0 110.282 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.646 ' CD2' ' HN1' ' A' ' 149' ' ' BB2 . 71.3 t60 -59.86 -46.05 90.53 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.12 0.486 . . . . 0.0 109.88 178.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.885 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.5 mm-40 -60.32 -40.74 91.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.921 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.959 ' HE1' ' HB2' ' A' ' 77' ' ' LEU . 73.2 mtp -57.78 -48.07 80.75 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.751 0.786 . . . . 0.0 109.948 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.653 ' O ' HG12 ' A' ' 138' ' ' VAL . 30.6 m-20 -62.76 -46.75 86.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.811 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 1.066 ' HA ' HD21 ' A' ' 141' ' ' LEU . 4.7 t-80 -59.57 -52.72 64.35 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.206 0.527 . . . . 0.0 111.675 -178.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.927 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.5 pp -59.18 -30.38 68.15 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.315 -178.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.94 HG23 HG13 ' A' ' 16' ' ' VAL . 13.4 p -86.1 22.7 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-O 122.094 0.949 . . . . 0.0 109.356 176.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.711 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 55.88 38.75 75.54 Favored Glycine 0 CA--C 1.483 -1.966 0 CA-C-N 113.678 -1.601 . . . . 0.0 112.662 176.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.932 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 3.4 ptmt -137.66 108.81 6.79 Favored 'General case' 0 N--CA 1.426 -1.658 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.708 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 1.066 HD21 ' HA ' ' A' ' 136' ' ' HIS . 3.3 mm? -132.07 143.56 50.12 Favored 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 120.942 -1.099 . . . . 0.0 108.858 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.859 ' HB2' HG13 ' A' ' 100' ' ' VAL . 7.9 m-85 -60.28 -40.68 91.31 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' MET . . . . . 1.053 ' HA ' HD13 ' A' ' 146' ' ' LEU . 46.3 ttm -61.09 -26.73 67.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.563 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.754 ' CG ' ' HD3' ' A' ' 14' ' ' ARG . 38.8 t70 -52.47 -25.85 11.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.033 -179.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -125.58 45.87 2.51 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.536 -177.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 1.053 HD13 ' HA ' ' A' ' 143' ' ' MET . 6.0 mp -92.39 146.2 23.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.033 177.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.7 t . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.193 -0.908 . . . . 0.0 111.067 179.614 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 149' ' ' BB2 . . . . . 0.875 H171 HD13 ' A' ' 91' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.894 0.378 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.94 HG12 ' HA ' ' A' ' 37' ' ' THR . 31.5 m -83.98 134.99 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.481 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 1.004 HD21 ' HB ' ' A' ' 51' ' ' VAL . 3.2 pp -79.74 -165.97 0.91 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.593 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.439 ' N ' HD12 ' A' ' 3' ' ' LEU . 40.7 tt0 -89.92 109.76 20.76 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.952 0.406 . . . . 0.0 110.473 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.567 ' CG2' HG21 ' A' ' 37' ' ' THR . 43.4 t -88.66 129.84 39.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.413 0.625 . . . . 0.0 112.079 -178.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.082 ' HB2' HD21 ' A' ' 13' ' ' LEU . 15.3 mt -89.95 143.21 26.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.923 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 44.0 m-70 -121.77 147.93 45.3 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -179.082 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.033 HD13 HD12 ' A' ' 13' ' ' LEU . 50.3 mm -63.68 135.78 96.43 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.145 178.098 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -80.38 142.73 61.83 Favored 'Cis proline' 0 C--N 1.351 0.708 0 C-N-CA 124.605 -0.998 . . . . 0.0 111.746 -0.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.948 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.7 t70 -163.53 126.9 2.7 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.459 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 11.9 pt-20 -58.08 -46.07 86.08 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.598 -178.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 1.024 ' HA ' ' HZ3' ' A' ' 15' ' ' LYS . 16.0 mmt85 -56.28 -29.05 60.65 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 1.082 HD21 ' HB2' ' A' ' 6' ' ' LEU . 10.0 mt -76.43 -34.28 58.77 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 120.068 1.303 . . . . 0.0 108.559 177.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.796 ' HB3' ' NH1' ' A' ' 14' ' ' ARG . 2.2 mmm180 -93.42 13.0 22.97 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 113.877 -1.51 . . . . 0.0 109.182 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 1.024 ' HZ3' ' HA ' ' A' ' 12' ' ' ARG . 4.5 ttmp? -88.66 145.65 25.54 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.207 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 1.04 HG13 HG23 ' A' ' 138' ' ' VAL . 59.5 t -82.43 121.49 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.75 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -82.13 145.82 29.92 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.411 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -107.95 128.96 24.8 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.745 ' HA ' ' OD1' ' A' ' 74' ' ' ASN . 64.0 Cg_endo -78.97 113.54 3.26 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 121.725 1.617 . . . . 0.0 110.665 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.726 HG12 ' H ' ' A' ' 22' ' ' GLU . 16.5 t -68.97 144.43 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-O 122.469 1.128 . . . . 0.0 113.132 -175.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -60.49 -24.75 65.53 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 113.125 -1.852 . . . . 0.0 112.368 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.726 ' H ' HG12 ' A' ' 20' ' ' VAL . 42.7 tt0 -157.28 142.71 17.28 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.296 -179.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.542 HG22 HD21 ' A' ' 111' ' ' LEU . 2.9 t -80.07 108.1 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -178.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 1.038 ' H ' HD12 ' A' ' 27' ' ' ILE . 31.3 m120 -90.85 155.36 18.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.658 -178.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.687 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -55.29 -25.49 34.46 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.35 0.595 . . . . 0.0 110.49 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.434 ' OE2' HG12 ' A' ' 27' ' ' ILE . 0.6 OUTLIER -75.11 -38.99 60.92 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 177.745 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 1.038 HD12 ' H ' ' A' ' 24' ' ' ASN . 57.4 mt -66.06 -35.6 75.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 114.297 -1.32 . . . . 0.0 110.168 177.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -69.38 -39.21 78.15 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.254 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.687 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 38.1 mmm-85 -61.32 -39.24 89.79 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.792 ' O ' ' HG3' ' A' ' 34' ' ' MET . 3.0 mt -58.24 -48.69 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.2 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.903 HG22 ' CG2' ' A' ' 57' ' ' ILE . 8.7 t -67.9 -41.85 85.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 120.968 0.413 . . . . 0.0 111.557 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.862 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -55.8 -42.4 75.55 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.999 -179.412 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.483 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 15.5 m-20 -75.48 -29.91 59.74 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.284 176.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' MET . . . . . 1.008 ' HG2' HG21 ' A' ' 51' ' ' VAL . 83.1 mtp -60.28 -46.51 89.58 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.315 -177.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.862 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 13.4 p90 -69.7 -45.2 68.81 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.213 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.751 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 37.9 mt-10 -51.84 -40.42 60.49 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 121.762 0.791 . . . . 0.0 108.904 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.94 ' HA ' HG12 ' A' ' 2' ' ' VAL . 56.6 m -70.24 -62.23 1.47 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.33 -1.305 . . . . 0.0 108.176 178.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.955 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 2.8 ttp -46.31 -41.4 13.21 Favored 'General case' 0 CA--C 1.46 -2.485 0 C-N-CA 124.144 0.978 . . . . 0.0 110.364 -171.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.709 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 61.7 m-85 -70.55 -42.69 70.84 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.686 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.5 ' CB ' HG11 ' A' ' 2' ' ' VAL . . . -61.4 -24.27 66.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.841 0.829 . . . . 0.0 109.395 179.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 1.052 ' HG2' HD12 ' A' ' 91' ' ' LEU . 11.6 tp10 -88.74 -11.23 45.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.471 177.247 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.447 ' H ' ' C ' ' A' ' 39' ' ' TYR . 21.8 mt-10 64.27 25.42 13.53 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.956 -176.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.706 ' HA2' H182 ' A' ' 149' ' ' BB2 . . . -78.15 142.38 26.18 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 113.839 -1.528 . . . . 0.0 110.714 177.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.811 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 44.3 mm -79.15 -2.34 5.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 117.354 0.577 . . . . 0.0 112.139 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.899 ' HA3' ' C10' ' A' ' 149' ' ' BB2 . . . 177.97 134.91 2.15 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 118.759 -1.023 . . . . 0.0 111.291 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.04 HD13 ' HG ' ' A' ' 91' ' ' LEU . 7.6 tp -124.52 134.97 52.84 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 119.29 1.545 . . . . 0.0 111.973 -179.067 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.451 ' H ' HE21 ' A' ' 50' ' ' GLN . . . -100.31 130.34 46.41 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.484 0.183 . . . . 0.0 111.299 178.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.872 ' HB1' ' CD1' ' A' ' 53' ' ' ILE . . . -28.61 -54.43 0.11 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -179.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.622 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 69.1 p -52.96 -35.45 58.94 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.458 0.647 . . . . 0.0 112.221 -177.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.919 ' NE2' HD23 ' A' ' 91' ' ' LEU . 34.2 mt-30 -65.22 -42.05 93.81 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.154 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.008 HG21 ' HG2' ' A' ' 34' ' ' MET . 0.8 OUTLIER -82.42 15.69 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 179.781 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.872 ' HA ' HD11 ' A' ' 6' ' ' LEU . 35.0 t70 77.46 30.07 0.52 Allowed 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 176.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.872 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 1.1 pp -123.74 111.37 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.318 177.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.679 ' HB3' ' HD2' ' A' ' 15' ' ' LYS . 6.8 p80 -76.68 61.65 1.86 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.677 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.725 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 89.0 mt-30 -151.57 134.3 15.59 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 114.495 -1.229 . . . . 0.0 107.942 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.75 ' N ' ' HB1' ' A' ' 17' ' ' ALA . 76.3 mtp180 -64.0 69.3 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -177.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.903 ' CG2' HG22 ' A' ' 31' ' ' VAL . 8.0 mm -111.27 123.47 67.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.83 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -131.43 147.39 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 121.975 0.893 . . . . 0.0 112.965 -177.779 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.588 HG22 ' O ' ' A' ' 46' ' ' LEU . 32.9 m -127.71 139.21 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.092 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.969 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 9.2 mm -114.69 150.73 16.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.646 0.736 . . . . 0.0 109.943 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.955 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 33.4 t70 -138.62 28.82 2.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.735 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.772 HG22 ' CG2' ' A' ' 44' ' ' ILE . 40.4 t -93.71 106.74 18.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.556 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.694 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 79.8 p -38.35 81.59 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -177.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 62' ' ' VAL . 17.5 tp10 -69.22 -14.47 62.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.686 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.46 ' CG ' ' H ' ' A' ' 66' ' ' ARG . 12.0 t-20 -165.12 -139.98 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.493 ' HG3' HH11 ' A' ' 66' ' ' ARG . 39.5 mmm-85 -74.07 -52.37 12.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.685 0.278 . . . . 0.0 110.416 -178.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.91 126.98 41.54 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.986 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.694 ' HG2' ' HA ' ' A' ' 63' ' ' SER . 43.5 mt-10 -89.0 132.35 34.77 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.47 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.699 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 41.7 ttm-85 173.29 72.03 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.969 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 8.5 mp -102.87 132.35 49.13 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.991 0.424 . . . . 0.0 111.908 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.93 HG21 ' HB2' ' A' ' 113' ' ' ARG . 9.6 p -133.14 134.33 57.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.06 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.83 ' HB2' ' CD1' ' A' ' 58' ' ' ILE . 90.6 mt -141.74 140.95 33.23 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 121.384 -0.126 . . . . 0.0 111.009 178.235 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.03 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.8 mp -120.2 133.65 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-O 120.838 0.351 . . . . 0.0 110.923 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.792 ' ND2' HG22 ' A' ' 73' ' ' ILE . 64.5 m-20 51.72 36.32 0.34 Allowed Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 113.863 1.061 . . . . 0.0 113.863 178.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.742 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 90.1 Cg_exo -55.65 149.5 48.86 Favored 'Trans proline' 0 N--CA 1.484 0.917 0 C-N-CA 122.708 2.272 . . . . 0.0 113.415 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.45 ' OE2' ' HD2' ' A' ' 109' ' ' ARG . 23.0 pt-20 -135.91 145.88 46.76 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.77 HD21 ' HE3' ' A' ' 80' ' ' LYS . 30.1 tp -79.71 138.38 37.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.38 0.61 . . . . 0.0 112.278 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.06 HD11 ' HG3' ' A' ' 109' ' ' ARG . 5.4 mp -112.17 -44.04 3.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.632 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.561 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 38.4 tt0 -158.79 147.79 18.74 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 121.141 0.496 . . . . 0.0 111.831 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.874 ' HA ' HG12 ' A' ' 106' ' ' VAL . 19.4 ptpt -142.3 147.46 36.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.054 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.2 t -160.03 148.02 16.83 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.702 0.287 . . . . 0.0 111.221 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.759 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 82.97 163.93 34.89 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.515 -179.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -140.55 113.59 8.38 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.922 0.861 . . . . 0.0 113.106 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.6 p -106.09 161.56 14.39 Favored 'General case' 0 CA--C 1.486 -1.481 0 CA-C-N 113.999 -1.455 . . . . 0.0 114.864 178.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.702 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -145.47 114.12 0.74 Allowed Glycine 0 C--N 1.312 -0.781 0 CA-C-N 112.849 -1.978 . . . . 0.0 110.653 178.068 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.826 ' HB ' ' NH2' ' A' ' 102' ' ' ARG . 34.0 mt -148.67 139.56 17.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-N 117.264 0.532 . . . . 0.0 111.826 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 50.4 mt-10 -72.19 138.09 47.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 123.195 1.474 . . . . 0.0 112.581 -176.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.763 ' HB3' H262 ' A' ' 149' ' ' BB2 . 39.1 mt-10 -155.29 160.26 40.64 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 112.358 -2.201 . . . . 0.0 111.212 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.912 ' O ' ' H52' ' A' ' 149' ' ' BB2 . . . -120.12 159.56 15.04 Favored Glycine 0 CA--C 1.499 -0.911 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 1.038 ' HB2' HD13 ' A' ' 93' ' ' ILE . 21.8 m -114.27 139.91 49.03 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 117.688 0.744 . . . . 0.0 111.175 -177.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.052 HD12 ' HG2' ' A' ' 41' ' ' GLU . 2.4 mm? -49.44 -22.47 1.19 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.036 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.94 ' HB3' HD13 ' A' ' 13' ' ' LEU . 54.4 m -79.41 -38.54 34.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.277 179.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 1.038 HD13 ' HB2' ' A' ' 90' ' ' CYS . 3.2 mp -86.13 148.64 48.16 Favored Pre-proline 0 N--CA 1.448 -0.547 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.763 ' HD2' HG23 ' A' ' 93' ' ' ILE . 81.8 Cg_endo -73.88 52.41 2.58 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.439 2.093 . . . . 0.0 114.54 -178.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.537 ' HB2' ' O ' ' A' ' 94' ' ' PRO . 50.3 mt-10 78.63 12.67 1.48 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 178.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.792 ' HB2' HG21 ' A' ' 93' ' ' ILE . 83.8 mt-30 -79.0 88.42 4.77 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 178.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.889 ' NH1' H231 ' A' ' 149' ' ' BB2 . 40.2 mtt180 -85.17 132.53 34.28 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.573 0.701 . . . . 0.0 111.613 -178.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -135.35 155.46 50.55 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 114.691 -1.141 . . . . 0.0 109.716 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.702 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.3 tt -76.41 114.85 15.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.439 0.638 . . . . 0.0 111.985 -178.061 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.908 HG13 ' HB2' ' A' ' 142' ' ' PHE . 42.6 t -104.36 132.8 20.62 Favored Pre-proline 0 N--CA 1.47 0.573 0 CA-C-N 114.931 -1.031 . . . . 0.0 112.062 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.584 ' HA ' ' O ' ' A' ' 84' ' ' THR . 2.1 Cg_endo -84.35 125.99 3.56 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.843 2.362 . . . . 0.0 111.804 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.826 ' NH2' ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -144.61 167.51 22.36 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.56 0.744 . . . . 0.0 109.98 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.759 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.79 154.86 41.22 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.836 0.351 . . . . 0.0 110.179 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -73.77 -41.16 62.81 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.146 -176.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.777 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 91.4 mttt -139.91 141.2 36.54 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.874 HG12 ' HA ' ' A' ' 80' ' ' LYS . 29.4 m -149.06 139.0 16.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.333 -179.159 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 1.058 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 51.0 mmtt -107.98 126.4 52.67 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 1.112 HD11 HD11 ' A' ' 130' ' ' ILE . 1.6 pp -136.1 152.76 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -176.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 1.06 ' HG3' HD11 ' A' ' 78' ' ' LEU . 93.7 mtt180 -102.68 138.78 39.12 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.93 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.605 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -160.04 167.82 27.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.102 -177.41 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 1.03 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.6 pp -117.12 153.25 33.11 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.609 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 10.1 t70 -88.2 162.97 16.38 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.519 -177.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.93 ' HB2' HG21 ' A' ' 71' ' ' VAL . 50.1 ttp85 -51.39 -19.04 1.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.251 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -79.1 -27.67 42.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.381 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.43 35.92 2.37 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.348 -0.93 . . . . 0.0 113.329 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -128.74 102.88 19.47 Favored Pre-proline 0 C--O 1.237 0.406 0 CA-C-N 116.815 0.308 . . . . 0.0 110.914 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.656 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.5 Cg_exo -73.4 116.08 4.57 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 121.766 1.644 . . . . 0.0 115.145 -177.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.609 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 10.9 p90 -126.13 166.65 16.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.312 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.706 ' HG2' ' HG2' ' A' ' 109' ' ' ARG . 30.7 mt-10 -107.5 130.51 54.84 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.817 HD11 ' CD1' ' A' ' 130' ' ' ILE . 4.3 pp -127.44 133.88 49.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.591 -178.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 1.058 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 9.1 pm0 -94.45 123.66 38.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.627 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.807 ' CB ' HD22 ' A' ' 126' ' ' LEU . . . -116.82 135.11 54.0 Favored 'General case' 0 C--O 1.222 -0.364 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.777 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.2 m-20 -126.66 162.35 25.97 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.728 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 49.9 -134.77 26.54 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 120.418 1.463 . . . . 0.0 115.252 177.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.742 HD12 ' CG1' ' A' ' 62' ' ' VAL . 1.7 pt? -53.78 -35.46 61.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.032 -0.584 . . . . 0.0 111.462 -179.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.807 HD22 ' CB ' ' A' ' 122' ' ' ALA . 0.6 OUTLIER -70.51 -52.01 24.85 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.996 0.903 . . . . 0.0 109.281 179.563 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.713 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -58.45 -41.5 85.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.925 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.817 HG23 ' HG3' ' A' ' 102' ' ' ARG . 50.6 mm -68.54 -54.99 17.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.827 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 29.3 p -59.03 -50.74 72.93 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 1.112 HD11 HD11 ' A' ' 108' ' ' ILE . 17.9 tt -59.65 -43.85 92.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.189 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.693 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.0 pt20 -67.73 -40.63 84.18 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.176 178.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.641 ' CD2' ' HN1' ' A' ' 149' ' ' BB2 . 69.9 t60 -58.5 -45.78 88.04 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.206 0.527 . . . . 0.0 109.931 178.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.878 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.2 mm-40 -59.81 -41.77 92.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.708 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.947 ' HA ' HD21 ' A' ' 137' ' ' LEU . 74.8 mtp -57.25 -47.83 80.38 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.736 0.779 . . . . 0.0 110.08 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.643 ' O ' HG12 ' A' ' 138' ' ' VAL . 1.4 m-20 -63.16 -47.12 84.0 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.951 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.983 ' CE1' HD21 ' A' ' 141' ' ' LEU . 8.7 t-80 -58.97 -53.11 62.16 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.176 0.512 . . . . 0.0 111.472 -178.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.947 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.6 pp -58.65 -31.4 68.13 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.644 -178.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 1.04 HG23 HG13 ' A' ' 16' ' ' VAL . 14.5 p -85.05 24.58 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-O 122.283 1.04 . . . . 0.0 109.816 176.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.48 ' HA3' ' C ' ' A' ' 14' ' ' ARG . . . 55.84 30.81 57.49 Favored Glycine 0 CA--C 1.486 -1.757 0 CA-C-N 113.48 -1.691 . . . . 0.0 112.679 176.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.956 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 5.8 ptmt -128.5 107.88 10.08 Favored 'General case' 0 N--CA 1.425 -1.704 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.626 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.983 HD21 ' CE1' ' A' ' 136' ' ' HIS . 4.6 mp -124.17 139.35 54.01 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 120.81 -1.181 . . . . 0.0 108.125 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.908 ' HB2' HG13 ' A' ' 100' ' ' VAL . 8.9 m-85 -59.77 -40.51 88.44 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.981 -0.449 . . . . 0.0 111.874 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' MET . . . . . 1.023 ' HA ' HD13 ' A' ' 146' ' ' LEU . 45.0 ttm -60.48 -26.38 66.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.175 0.512 . . . . 0.0 111.479 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.727 ' OD1' ' HD3' ' A' ' 14' ' ' ARG . 38.7 t70 -52.39 -25.22 9.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.184 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -122.96 43.07 3.03 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 120.716 0.294 . . . . 0.0 111.062 -177.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 1.023 HD13 ' HA ' ' A' ' 143' ' ' MET . 6.0 mp -91.08 142.33 27.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.115 178.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 55.7 m . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.984 179.529 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 149' ' ' BB2 . . . . . 0.912 ' H52' ' O ' ' A' ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.922 HG12 ' HA ' ' A' ' 37' ' ' THR . 25.5 m . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.672 0.273 . . . . 0.0 111.327 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.895 HD11 ' HB ' ' A' ' 51' ' ' VAL . 2.0 pt? -80.46 -147.47 0.05 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.536 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 51.7 tt0 -98.58 104.76 16.83 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.938 0.399 . . . . 0.0 110.889 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.583 ' CG2' HG21 ' A' ' 37' ' ' THR . 40.4 t -88.36 126.38 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-O 121.496 0.665 . . . . 0.0 112.152 -178.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.054 ' HB2' HD21 ' A' ' 13' ' ' LEU . 50.2 mt -85.86 144.97 27.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.22 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 53.6 m-70 -123.01 144.05 49.52 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -178.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.006 HD13 HD12 ' A' ' 13' ' ' LEU . 49.3 mm -65.8 132.67 94.85 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.787 177.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -77.31 143.74 75.76 Favored 'Cis proline' 0 C--N 1.35 0.641 0 C-N-CA 124.553 -1.019 . . . . 0.0 111.778 -0.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.996 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.7 t70 -162.51 126.79 3.11 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.471 ' CD ' ' H ' ' A' ' 11' ' ' GLU . 0.6 OUTLIER -57.9 -45.85 85.84 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.754 -178.444 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.743 ' HB2' HD13 ' A' ' 6' ' ' LEU . 21.4 mtt-85 -59.89 -26.83 66.2 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 1.054 HD21 ' HB2' ' A' ' 6' ' ' LEU . 10.6 mt -77.66 -30.56 52.14 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 120.964 1.711 . . . . 0.0 108.586 177.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.618 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 15.0 mmm180 -95.11 8.62 42.43 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.072 -1.422 . . . . 0.0 109.059 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -90.17 147.67 23.44 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.7 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.579 HG13 HG23 ' A' ' 138' ' ' VAL . 90.4 t -81.93 128.83 38.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.834 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -90.28 145.4 25.01 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.832 ' HD3' ' HD2' ' A' ' 19' ' ' PRO . 8.0 tmtt? -107.11 131.42 21.71 Favored Pre-proline 0 C--N 1.318 -0.768 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.832 ' HD2' ' HD3' ' A' ' 18' ' ' LYS . 54.1 Cg_endo -81.56 114.44 2.7 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.774 1.649 . . . . 0.0 110.333 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.73 HG12 ' H ' ' A' ' 22' ' ' GLU . 19.4 t -68.97 144.88 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 CA-C-O 122.692 1.234 . . . . 0.0 113.342 -175.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -63.31 -21.26 66.15 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 112.861 -1.972 . . . . 0.0 112.986 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.73 ' H ' HG12 ' A' ' 20' ' ' VAL . 39.0 tt0 -157.84 144.51 17.82 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.166 -178.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.6 HG22 HD21 ' A' ' 111' ' ' LEU . 3.2 t -79.64 106.85 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -178.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 1.003 ' HB2' HD13 ' A' ' 27' ' ' ILE . 56.1 m-80 -92.61 153.22 19.13 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.802 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -54.14 -24.19 16.93 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.241 0.543 . . . . 0.0 110.782 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 1.092 ' HG3' HD12 ' A' ' 27' ' ' ILE . 13.9 pt-20 -75.15 -42.19 56.66 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 177.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 1.092 HD12 ' HG3' ' A' ' 26' ' ' GLU . 2.0 mp -65.19 -35.72 76.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.748 177.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 75.4 mt-30 -66.32 -40.57 90.03 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 122.349 -0.22 . . . . 0.0 110.493 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.5 ' HG3' ' O ' ' A' ' 25' ' ' ALA . 67.9 mtt85 -62.83 -38.69 91.77 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.805 ' O ' ' HG3' ' A' ' 34' ' ' MET . 1.6 mp -56.07 -49.97 72.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.927 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.785 HG11 ' CG2' ' A' ' 71' ' ' VAL . 36.7 t -67.25 -43.14 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.924 0.392 . . . . 0.0 111.17 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.848 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -55.45 -41.11 72.42 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.067 -179.103 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.506 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 1.3 m-20 -76.37 -30.22 57.46 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.318 176.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.967 ' HG2' HG21 ' A' ' 51' ' ' VAL . 32.5 mtm -60.74 -44.59 96.49 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 120.55 -0.46 . . . . 0.0 109.95 -178.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.848 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 10.6 p90 -70.17 -46.19 65.15 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' ' 32' ' ' ASP . 29.7 mm-40 -51.86 -40.99 61.51 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 121.634 0.731 . . . . 0.0 109.411 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.922 ' HA ' HG12 ' A' ' 2' ' ' VAL . 91.6 m -70.43 -61.84 1.62 Allowed 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 118.479 -1.288 . . . . 0.0 108.411 177.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.793 ' HG3' ' HB2' ' A' ' 46' ' ' LEU . 2.1 ttp -46.16 -41.06 12.08 Favored 'General case' 0 CA--C 1.46 -2.483 0 C-N-CA 124.346 1.058 . . . . 0.0 110.775 -171.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.718 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 45.8 m-85 -70.07 -42.61 72.59 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.751 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.528 ' HB3' ' CG1' ' A' ' 2' ' ' VAL . . . -61.26 -24.33 66.31 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.436 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 1.119 ' HG2' HD12 ' A' ' 91' ' ' LEU . 16.5 tp10 -89.11 -11.24 44.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.466 177.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.443 ' H ' ' C ' ' A' ' 39' ' ' TYR . 5.0 mm-40 63.8 25.41 14.09 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.048 -176.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.35 144.53 25.84 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.819 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.775 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 51.6 mt -79.92 0.73 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 117.823 0.811 . . . . 0.0 112.062 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.531 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 178.03 140.34 3.77 Favored Glycine 0 CA--C 1.517 0.198 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.026 HD13 ' HG ' ' A' ' 91' ' ' LEU . 7.0 tp -127.4 135.22 50.17 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.855 1.327 . . . . 0.0 109.66 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.47 133.3 49.57 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 122.033 -0.417 . . . . 0.0 111.621 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.845 ' HB1' ' CD1' ' A' ' 53' ' ' ILE . . . -26.82 -57.24 0.09 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 116.113 1.894 . . . . 0.0 116.113 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.823 ' CG2' ' HA ' ' A' ' 137' ' ' LEU . 70.1 p -54.44 -34.87 62.25 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 121.969 0.89 . . . . 0.0 112.199 -178.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.824 ' OE1' HD12 ' A' ' 46' ' ' LEU . 57.4 mt-30 -62.14 -40.0 94.49 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.547 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.967 HG21 ' HG2' ' A' ' 34' ' ' MET . 1.7 m -93.41 18.35 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.89 ' OD2' HD21 ' A' ' 6' ' ' LEU . 6.6 t0 80.13 25.51 0.35 Allowed 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 176.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.845 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -119.18 107.42 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 118.759 -1.176 . . . . 0.0 111.004 178.056 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -75.91 60.58 1.38 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 122.18 0.99 . . . . 0.0 110.642 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.784 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 88.5 mt-30 -147.19 131.64 17.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.945 -1.479 . . . . 0.0 107.058 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.995 ' HA ' HD22 ' A' ' 137' ' ' LEU . 75.9 mtp180 -64.67 75.63 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.742 HD12 HG21 ' A' ' 30' ' ' ILE . 23.0 mt -117.25 125.06 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.956 HD11 ' HB2' ' A' ' 72' ' ' LEU . 1.8 pp -122.65 142.45 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 120.119 -0.632 . . . . 0.0 112.254 -177.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.612 HG12 ' O ' ' A' ' 46' ' ' LEU . 2.5 p -127.79 132.53 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.061 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 1.8 mt -114.65 154.89 15.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.898 0.856 . . . . 0.0 111.985 -177.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.782 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 14.9 t70 -145.12 31.86 1.12 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 113.986 -1.461 . . . . 0.0 110.068 -177.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.72 HG13 ' CD2' ' A' ' 125' ' ' LEU . 48.1 t . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.652 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.2 ttt85 . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.912 0.387 . . . . 0.0 111.389 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 1.061 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 55.3 mt -103.37 133.27 48.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.804 0.335 . . . . 0.0 111.678 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.973 HG21 ' HB2' ' A' ' 113' ' ' ARG . 7.1 p -135.86 133.89 51.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.187 177.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.956 ' HB2' HD11 ' A' ' 58' ' ' ILE . 1.7 mm? -140.55 141.82 35.21 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.038 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.6 mp -120.18 132.92 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.798 ' ND2' HG22 ' A' ' 73' ' ' ILE . 59.7 m-20 53.7 37.68 0.44 Allowed Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.863 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 95.0 Cg_exo -57.1 148.29 70.11 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 123.011 2.474 . . . . 0.0 114.129 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.469 ' O ' ' HB ' ' A' ' 108' ' ' ILE . 11.6 pt-20 -135.85 144.61 45.73 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.889 ' HB2' ' HE1' ' A' ' 134' ' ' MET . 44.5 tp -80.04 138.03 36.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.319 0.58 . . . . 0.0 111.98 -178.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.053 HD21 ' HG3' ' A' ' 109' ' ' ARG . 2.8 mm? -112.99 -39.33 4.25 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.971 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.593 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 85.2 tt0 -160.02 145.37 15.22 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 121.269 0.557 . . . . 0.0 111.695 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.968 ' HA ' HG12 ' A' ' 106' ' ' VAL . 10.8 ptpp? -138.52 149.58 45.51 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.482 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.1 p -159.02 149.21 19.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.801 0.334 . . . . 0.0 111.444 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.633 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 76.83 149.55 3.19 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.783 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -117.64 113.68 22.27 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.884 0.849 . . . . 0.0 112.406 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.697 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.7 p -112.08 160.37 17.59 Favored 'General case' 0 CA--C 1.485 -1.52 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.713 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -151.28 118.68 0.93 Allowed Glycine 0 C--N 1.311 -0.852 0 CA-C-N 112.392 -2.186 . . . . 0.0 110.509 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.599 HD13 ' O ' ' A' ' 85' ' ' GLY . 47.8 mm -147.76 139.92 18.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-N 117.383 0.592 . . . . 0.0 111.183 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 50.5 mt-10 -71.19 137.32 48.63 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 123.322 1.534 . . . . 0.0 111.833 -176.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.72 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 42.3 mt-10 -155.15 161.68 41.17 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 112.477 -2.147 . . . . 0.0 111.91 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.807 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -121.43 164.3 14.65 Favored Glycine 0 CA--C 1.5 -0.853 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 5.7 m -118.59 139.02 52.15 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.264 0.554 . . . . 0.0 111.854 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.119 HD12 ' HG2' ' A' ' 41' ' ' GLU . 2.4 mm? -49.64 -26.83 3.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.433 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.86 ' CB ' HG12 ' A' ' 8' ' ' ILE . 57.4 m -78.82 -36.52 42.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.43 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.868 HD13 ' HB ' ' A' ' 8' ' ' ILE . 43.6 mm . . . . . 0 N--CA 1.45 -0.425 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.392 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.807 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 18.8 mtm105 . . . . . 0 N--CA 1.462 0.164 0 CA-C-O 121.794 0.807 . . . . 0.0 111.817 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -134.48 153.42 51.94 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 114.433 -1.258 . . . . 0.0 109.82 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.713 HD21 ' HA3' ' A' ' 85' ' ' GLY . 6.9 tt -76.12 115.99 16.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.652 0.739 . . . . 0.0 111.146 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.857 ' CG1' HH21 ' A' ' 102' ' ' ARG . 17.3 t -111.0 136.09 20.81 Favored Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.665 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.697 ' HA ' ' O ' ' A' ' 84' ' ' THR . 91.8 Cg_endo -84.23 126.37 3.71 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 122.725 2.283 . . . . 0.0 112.655 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.977 ' HG3' HG23 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -145.6 166.76 24.8 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.102 0.961 . . . . 0.0 109.004 178.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.633 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -67.9 154.07 42.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 118.599 0.636 . . . . 0.0 110.473 -178.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.578 ' OE1' ' HG3' ' A' ' 105' ' ' LYS . 2.7 tm-20 -73.48 -41.26 63.36 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.393 -175.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.791 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 56.6 mttp -139.24 140.43 37.7 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.479 0.657 . . . . 0.0 109.433 177.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.968 HG12 ' HA ' ' A' ' 80' ' ' LYS . 26.1 m -150.14 136.37 12.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.455 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.998 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 46.5 mmtt -107.47 127.49 53.65 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.999 ' HA ' HD23 ' A' ' 78' ' ' LEU . 1.5 pp -135.09 156.54 39.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -176.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 1.053 ' HG3' HD21 ' A' ' 78' ' ' LEU . 92.7 mtt180 -103.3 138.17 40.43 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.502 -178.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.829 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -160.66 170.13 21.44 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.856 -176.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 1.038 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.6 pp -118.76 151.9 37.18 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 176.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.672 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 17.0 t70 -84.7 162.87 19.51 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.668 -176.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.973 ' HB2' HG21 ' A' ' 71' ' ' VAL . 50.7 ttp85 -53.5 -17.71 2.23 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.816 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -79.0 -28.81 43.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.819 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.572 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 109.33 35.49 2.28 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.475 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -128.77 102.8 19.44 Favored Pre-proline 0 C--O 1.236 0.376 0 CA-C-N 116.971 0.386 . . . . 0.0 110.891 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.683 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.7 Cg_exo -72.8 115.64 4.42 Favored 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 121.83 1.687 . . . . 0.0 115.696 -177.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.672 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 12.3 p90 -129.52 167.06 18.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.562 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.741 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 6.2 mp0 -107.35 130.3 54.81 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.924 ' O ' HD23 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -127.31 141.45 51.7 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 121.785 0.802 . . . . 0.0 111.703 -178.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.998 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 11.4 pt-20 -94.13 123.69 37.67 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.998 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.923 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -115.67 135.19 54.3 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.586 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.791 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.2 m-20 -126.94 163.12 24.37 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.788 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 50.55 -139.46 21.94 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 120.218 1.372 . . . . 0.0 115.726 177.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.72 ' CD2' HG13 ' A' ' 62' ' ' VAL . 25.6 tp -54.69 -30.3 55.32 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.38 -0.91 . . . . 0.0 111.643 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.923 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.5 OUTLIER -71.38 -53.32 14.49 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.56 0.695 . . . . 0.0 109.286 179.451 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.831 ' HB1' HG22 ' A' ' 106' ' ' VAL . . . -59.46 -39.77 84.71 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.332 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.977 HG23 ' HG3' ' A' ' 102' ' ' ARG . 45.9 mm -67.0 -54.51 23.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.347 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 73.0 m -60.61 -50.44 73.51 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.945 HD11 HD11 ' A' ' 108' ' ' ILE . 21.2 tt -58.61 -44.59 89.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.697 0.284 . . . . 0.0 110.961 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.653 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.7 pt20 -65.84 -37.65 86.79 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.416 ' HB2' HH12 ' A' ' 102' ' ' ARG . 75.8 t60 -60.15 -47.12 87.27 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.548 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.849 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 3.0 mm-40 -60.1 -38.03 81.77 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.889 ' HE1' ' HB2' ' A' ' 77' ' ' LEU . 72.4 mtp -58.07 -45.01 87.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 122.344 1.069 . . . . 0.0 109.183 177.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.845 ' OD1' ' HD3' ' A' ' 140' ' ' LYS . 57.0 m-20 -67.76 -48.73 65.56 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.0 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.695 ' CE1' ' HG2' ' A' ' 50' ' ' GLN . 6.4 t-80 -57.71 -52.87 63.66 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.393 0.616 . . . . 0.0 111.648 -178.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.995 HD22 ' HA ' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -64.95 -28.8 69.77 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 119.822 -0.751 . . . . 0.0 111.762 -179.291 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.908 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 11.5 p -81.47 24.16 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 122.08 0.943 . . . . 0.0 109.364 175.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.618 ' O ' ' HA ' ' A' ' 14' ' ' ARG . . . 68.41 -3.63 5.82 Favored Glycine 0 CA--C 1.484 -1.886 0 CA-C-N 113.769 -1.56 . . . . 0.0 113.217 175.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.908 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 11.4 ptmt . . . . . 0 N--CA 1.408 -2.552 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 1.007 HG13 HG23 ' A' ' 37' ' ' THR . 40.5 t . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.61 0.243 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 1.042 HD11 ' HB ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -79.1 -143.43 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.34 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.426 ' H ' ' HG ' ' A' ' 3' ' ' LEU . 8.4 tt0 -107.31 104.49 14.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 118.174 0.443 . . . . 0.0 110.363 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.529 ' CG2' HG21 ' A' ' 37' ' ' THR . 44.1 t -87.77 125.11 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 121.557 0.694 . . . . 0.0 111.967 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.032 ' HB2' HD21 ' A' ' 13' ' ' LEU . 20.9 mt -87.63 138.68 31.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.07 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.577 ' C ' HD11 ' A' ' 13' ' ' LEU . 32.7 m-70 -111.69 149.39 31.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.172 0.511 . . . . 0.0 111.91 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.017 HD13 HD12 ' A' ' 13' ' ' LEU . 47.1 mm -57.21 145.41 66.48 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.392 178.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.554 ' HA ' HG23 ' A' ' 8' ' ' ILE . 72.7 Cg_endo -92.68 52.48 1.0 Allowed 'Cis proline' 0 C--N 1.353 0.808 0 C-N-CA 124.597 -1.001 . . . . 0.0 112.872 0.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 1.009 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 9.4 t0 -53.81 134.45 42.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.972 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 23.8 pt-20 -59.23 -45.22 91.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.425 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.676 ' O ' ' HB ' ' A' ' 49' ' ' THR . 28.2 mtt-85 -59.29 -23.78 62.71 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 1.032 HD21 ' HB2' ' A' ' 6' ' ' LEU . 11.2 mt -73.48 -33.06 64.64 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 119.661 1.119 . . . . 0.0 108.393 178.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.698 ' C ' ' HA3' ' A' ' 139' ' ' GLY . 15.0 mmm180 -98.34 11.19 38.81 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.784 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.579 ' HB2' ' HA ' ' A' ' 12' ' ' ARG . 62.3 tttp -87.06 148.05 25.43 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.217 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.951 HG13 HG23 ' A' ' 138' ' ' VAL . 48.9 t -82.41 118.65 30.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.771 ' HB3' HD12 ' A' ' 137' ' ' LEU . . . -78.08 146.5 35.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.272 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -103.83 127.99 28.22 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.603 ' HD3' ' CD ' ' A' ' 56' ' ' ARG . 64.4 Cg_endo -78.24 115.51 3.73 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.206 1.937 . . . . 0.0 110.984 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.9 HG12 ' H ' ' A' ' 22' ' ' GLU . 21.7 t -68.32 144.27 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 CA-C-O 122.717 1.246 . . . . 0.0 113.28 -175.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -67.79 -26.52 66.13 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 112.731 -2.031 . . . . 0.0 112.203 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.9 ' H ' HG12 ' A' ' 20' ' ' VAL . 42.4 tt0 -154.47 145.17 22.39 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.168 -178.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 1.034 HG21 ' HA2' ' A' ' 115' ' ' GLY . 4.6 t -79.6 103.8 6.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -178.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.932 ' CB ' HD13 ' A' ' 27' ' ' ILE . 1.9 m120 -93.19 155.6 17.35 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.701 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.705 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -56.17 -25.92 48.6 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.278 0.561 . . . . 0.0 110.88 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.51 ' HA ' ' OE1' ' A' ' 26' ' ' GLU . 4.2 mm-40 -75.29 -40.45 58.62 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.932 HD13 ' CB ' ' A' ' 24' ' ' ASN . 1.8 mp -66.76 -35.01 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 113.86 -1.518 . . . . 0.0 110.238 178.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -70.39 -38.88 74.75 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 122.208 -0.307 . . . . 0.0 110.715 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.705 ' HG3' ' O ' ' A' ' 25' ' ' ALA . 39.8 mtp85 -64.05 -39.0 93.12 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.784 ' O ' ' HG3' ' A' ' 34' ' ' MET . 3.0 mt -56.88 -49.16 79.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.771 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.915 HG22 ' CG2' ' A' ' 57' ' ' ILE . 9.6 t -67.36 -41.13 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 CA-C-O 121.004 0.43 . . . . 0.0 110.815 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.84 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 21.1 m-20 -54.74 -43.53 72.77 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.351 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.521 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 19.1 m-20 -76.4 -29.3 57.03 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.546 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 1.042 ' HG2' HG21 ' A' ' 51' ' ' VAL . 85.0 mtp -59.87 -46.07 90.46 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.247 -178.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.84 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 13.2 p90 -69.9 -45.24 68.04 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 176.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.758 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 40.3 mt-10 -52.37 -38.52 59.05 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 121.707 0.765 . . . . 0.0 109.291 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 1.007 HG23 HG13 ' A' ' 2' ' ' VAL . 88.6 m -70.35 -61.72 1.66 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.273 -1.331 . . . . 0.0 107.833 177.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.924 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 2.8 ttp -45.77 -40.78 10.01 Favored 'General case' 0 CA--C 1.46 -2.488 0 C-N-CA 124.321 1.048 . . . . 0.0 110.059 -171.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.677 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 18.6 m-85 -70.1 -43.09 71.77 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.097 178.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 37' ' ' THR . . . -60.85 -25.17 66.45 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.75 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 1.057 ' HG2' HD12 ' A' ' 91' ' ' LEU . 17.0 tp10 -88.76 -11.46 44.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.645 -1.161 . . . . 0.0 108.469 176.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.439 ' H ' ' C ' ' A' ' 39' ' ' TYR . 18.2 mt-10 64.31 26.41 13.65 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.943 -176.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.31 142.67 23.21 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 113.947 -1.479 . . . . 0.0 111.276 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.863 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 42.6 mm -79.33 -0.95 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 117.293 0.547 . . . . 0.0 112.208 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.486 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 179.0 135.27 2.32 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 118.928 -0.929 . . . . 0.0 111.437 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.069 HD13 ' HG ' ' A' ' 91' ' ' LEU . 4.5 tp -125.17 133.96 52.59 Favored 'General case' 0 C--N 1.354 0.783 0 CA-C-N 119.332 1.566 . . . . 0.0 111.64 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.803 ' HB2' ' OE1' ' A' ' 133' ' ' GLU . . . -99.83 131.36 45.85 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 122.184 0.194 . . . . 0.0 111.151 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.867 ' HB1' ' CG1' ' A' ' 53' ' ' ILE . . . -30.38 -54.87 0.19 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.676 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 82.7 p -53.1 -36.21 60.49 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.482 0.658 . . . . 0.0 111.829 -178.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.768 ' OE1' HD12 ' A' ' 46' ' ' LEU . 86.0 mt-30 -63.85 -42.26 97.61 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.998 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.042 HG21 ' HG2' ' A' ' 34' ' ' MET . 0.8 OUTLIER -83.49 16.6 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.875 ' HA ' HD11 ' A' ' 6' ' ' LEU . 37.8 t70 73.79 29.86 1.42 Allowed 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 177.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.867 ' CG1' ' HB1' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -121.25 109.51 25.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 C-N-CA 119.179 -1.009 . . . . 0.0 110.609 177.303 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 21.6 p-80 -76.47 63.6 2.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.378 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.759 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 88.9 mt-30 -153.94 132.47 12.12 Favored 'General case' 0 C--O 1.219 -0.512 0 CA-C-N 114.194 -1.366 . . . . 0.0 107.875 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.68 ' N ' ' HB1' ' A' ' 17' ' ' ALA . 74.7 mtp180 -63.01 69.03 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -177.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.915 ' CG2' HG22 ' A' ' 31' ' ' VAL . 8.1 mm -111.81 123.06 67.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.029 HD11 ' HB2' ' A' ' 72' ' ' LEU . 2.0 pp -128.24 144.36 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 119.698 -0.801 . . . . 0.0 112.977 -177.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 46' ' ' LEU . 33.2 m -127.47 137.64 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.676 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.019 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 2.2 mt -115.59 151.03 17.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.57 0.7 . . . . 0.0 110.972 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.924 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 34.6 t70 -135.2 24.1 3.52 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.858 -178.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.806 HG22 ' CG2' ' A' ' 44' ' ' ILE . 23.5 t . . . . . 0 N--CA 1.466 0.349 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.46 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.63 ' HD3' ' O ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.793 0 CA-C-O 121.241 0.544 . . . . 0.0 110.528 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 1.019 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 7.9 mp -111.52 137.64 49.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.027 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.847 HG21 ' HB2' ' A' ' 113' ' ' ARG . 9.0 p -133.08 132.87 58.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.73 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.029 ' HB2' HD11 ' A' ' 58' ' ' ILE . 3.3 mm? -141.86 143.04 33.16 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 177.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.013 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.9 mp -121.03 136.21 58.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.761 0.315 . . . . 0.0 110.588 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.72 ' ND2' HG22 ' A' ' 73' ' ' ILE . 13.4 p30 45.49 40.23 0.6 Allowed Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 113.826 1.046 . . . . 0.0 113.826 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.776 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 99.2 Cg_exo -56.56 150.96 48.97 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.831 2.354 . . . . 0.0 113.151 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -135.63 143.79 45.73 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.759 HD23 ' N ' ' A' ' 78' ' ' LEU . 1.5 tt -80.57 133.69 35.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.274 0.559 . . . . 0.0 111.723 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.062 HD13 ' HA ' ' A' ' 108' ' ' ILE . 4.8 mp -108.54 -44.78 4.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.207 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.59 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 5.2 tp10 -152.25 146.95 25.81 Favored 'General case' 0 N--CA 1.46 0.065 0 CA-C-O 121.095 0.474 . . . . 0.0 111.325 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.814 ' CB ' HG12 ' A' ' 106' ' ' VAL . 10.9 ptmm? -147.67 145.12 28.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.349 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.3 t -160.14 151.78 19.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.463 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.76 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 80.85 160.42 23.86 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.492 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -137.1 113.37 9.95 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.954 0.883 . . . . 0.0 113.065 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.661 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.5 p -105.59 161.59 14.24 Favored 'General case' 0 CA--C 1.487 -1.468 0 CA-C-N 114.061 -1.427 . . . . 0.0 114.761 178.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.783 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -146.03 114.81 0.77 Allowed Glycine 0 C--N 1.309 -0.928 0 CA-C-N 112.818 -1.992 . . . . 0.0 110.396 177.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.635 HD13 ' O ' ' A' ' 85' ' ' GLY . 49.3 mm -146.9 137.86 18.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-N 117.368 0.584 . . . . 0.0 111.206 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 50.4 mt-10 -71.41 137.23 48.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 123.193 1.473 . . . . 0.0 112.066 -176.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.676 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 40.8 mt-10 -154.76 161.62 41.44 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 112.196 -2.275 . . . . 0.0 111.079 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.7 ' HA3' ' HG2' ' A' ' 97' ' ' ARG . . . -120.32 163.84 13.98 Favored Glycine 0 CA--C 1.499 -0.937 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 13.1 m -117.86 140.88 49.08 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 117.729 0.765 . . . . 0.0 111.101 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.069 ' HG ' HD13 ' A' ' 46' ' ' LEU . 2.2 mm? -47.47 -26.65 1.44 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.971 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.883 ' CB ' HD13 ' A' ' 13' ' ' LEU . 54.1 m -79.36 -35.69 40.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.924 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 59.0 mt . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.648 -179.861 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.7 ' HG2' ' HA3' ' A' ' 89' ' ' GLY . 15.6 mtt85 . . . . . 0 N--CA 1.463 0.195 0 CA-C-O 121.649 0.737 . . . . 0.0 111.722 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 87' ' ' GLU . . . -134.73 155.86 49.82 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 114.581 -1.191 . . . . 0.0 109.479 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.783 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.6 tt -76.38 113.8 14.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.666 0.746 . . . . 0.0 111.813 -178.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.818 ' HB ' ' CZ ' ' A' ' 102' ' ' ARG . 40.3 t -104.29 132.25 21.15 Favored Pre-proline 0 N--CA 1.47 0.572 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.939 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.661 ' HA ' ' O ' ' A' ' 84' ' ' THR . 92.2 Cg_endo -84.26 127.45 3.95 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.596 2.197 . . . . 0.0 112.496 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.865 ' HB2' ' OE1' ' A' ' 131' ' ' GLN . 0.0 OUTLIER -144.39 166.98 23.57 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.54 0.736 . . . . 0.0 109.357 178.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.76 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.69 155.62 39.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 118.307 0.503 . . . . 0.0 110.301 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -73.12 -41.32 64.12 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.19 -176.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.699 ' HB3' ' OD1' ' A' ' 123' ' ' ASP . 66.8 mttm -139.67 140.5 36.9 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.467 0.651 . . . . 0.0 109.505 177.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.814 HG12 ' CB ' ' A' ' 80' ' ' LYS . 30.6 m -147.5 136.95 16.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.186 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 1.071 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 52.1 mmtt -107.58 126.02 52.03 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 1.062 ' HA ' HD13 ' A' ' 78' ' ' LEU . 1.7 pp -136.34 151.3 28.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -176.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 1.009 ' HG3' HD11 ' A' ' 78' ' ' LEU . 94.4 mtt180 -102.17 138.89 38.51 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.865 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.875 ' HB3' HD12 ' A' ' 72' ' ' LEU . . . -159.98 168.73 25.0 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.866 -177.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 1.013 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.4 pp -116.42 151.58 35.71 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.473 ' OD1' HG13 ' A' ' 71' ' ' VAL . 17.9 t70 -85.96 164.48 17.39 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.873 -176.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.847 ' HB2' HG21 ' A' ' 71' ' ' VAL . 48.0 ttp180 -52.01 -20.36 2.36 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.016 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -79.12 -25.67 42.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.526 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 1.034 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 105.91 36.28 2.8 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.223 -0.989 . . . . 0.0 113.525 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -128.64 102.82 19.77 Favored Pre-proline 0 C--O 1.237 0.403 0 CA-C-N 116.736 0.268 . . . . 0.0 110.737 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.66 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 32.1 Cg_exo -72.89 115.12 4.23 Favored 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 121.748 1.632 . . . . 0.0 115.389 -177.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.41 ' CE2' ' HB2' ' A' ' 112' ' ' ASP . 0.4 OUTLIER -126.32 167.05 16.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.422 -178.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.639 ' CG ' ' HG2' ' A' ' 109' ' ' ARG . 3.1 mp0 -107.33 130.18 54.81 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.794 HD11 ' CD1' ' A' ' 130' ' ' ILE . 4.4 pp -126.6 133.62 51.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.342 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 1.071 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 15.5 pt-20 -96.32 123.9 40.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.984 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.772 ' O ' ' HB2' ' A' ' 127' ' ' ALA . . . -116.63 136.47 52.94 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.699 ' OD1' ' HB3' ' A' ' 105' ' ' LYS . 41.6 m-20 -127.15 162.71 25.47 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.785 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 51.58 -138.67 28.49 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 120.539 1.518 . . . . 0.0 115.271 177.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.69 HD22 ' H ' ' A' ' 125' ' ' LEU . 2.6 mm? -53.37 -32.4 49.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.899 -0.651 . . . . 0.0 111.401 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.732 HD22 ' CB ' ' A' ' 122' ' ' ALA . 0.6 OUTLIER -70.77 -52.64 19.38 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.847 0.832 . . . . 0.0 109.487 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.772 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -59.73 -39.5 84.95 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.551 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.857 HD12 ' HG2' ' A' ' 102' ' ' ARG . 46.5 mm -68.97 -56.04 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -178.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.524 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 29.7 p -58.15 -49.93 75.29 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 1.016 HD11 HD11 ' A' ' 108' ' ' ILE . 19.1 tt -59.34 -44.19 91.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.179 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.865 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.0 pt20 -67.79 -39.76 84.01 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.39 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.647 ' HA ' ' OD1' ' A' ' 135' ' ' ASP . 69.0 t60 -57.04 -47.37 81.1 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.568 0.699 . . . . 0.0 109.869 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.912 ' O ' HD23 ' A' ' 137' ' ' LEU . 48.0 mm-40 -61.35 -39.6 91.2 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.272 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.882 ' HA ' HD21 ' A' ' 137' ' ' LEU . 74.6 mtp -58.43 -49.66 76.51 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.476 0.655 . . . . 0.0 111.005 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.699 ' O ' HG12 ' A' ' 138' ' ' VAL . 5.6 p-10 -65.78 -45.03 83.99 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.756 178.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.44 ' CE1' ' CG ' ' A' ' 50' ' ' GLN . 9.0 t-80 -55.94 -52.53 63.82 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 121.466 -0.771 . . . . 0.0 111.17 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.912 HD23 ' O ' ' A' ' 133' ' ' GLU . 1.3 pp -59.17 -30.97 68.57 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.2 -178.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.951 HG23 HG13 ' A' ' 16' ' ' VAL . 12.7 p -86.07 22.76 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-O 122.264 1.03 . . . . 0.0 109.268 176.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.698 ' HA3' ' C ' ' A' ' 14' ' ' ARG . . . 55.6 37.85 69.22 Favored Glycine 0 CA--C 1.484 -1.9 0 CA-C-N 113.493 -1.685 . . . . 0.0 112.415 176.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.934 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 3.7 ptmt . . . . . 0 N--CA 1.421 -1.91 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.754 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.954 HG13 HG23 ' A' ' 37' ' ' THR . 41.9 t . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.613 0.244 . . . . 0.0 110.523 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 1.016 HD11 ' HB ' ' A' ' 51' ' ' VAL . 1.9 pt? -83.1 -148.76 0.09 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.262 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.42 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 8.4 tt0 -102.28 106.34 17.13 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.994 0.426 . . . . 0.0 110.831 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.552 HG11 HD12 ' A' ' 91' ' ' LEU . 45.2 t -88.84 127.63 41.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.372 0.606 . . . . 0.0 111.539 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.959 ' HB2' HD21 ' A' ' 13' ' ' LEU . 24.9 mt -83.9 142.7 30.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.805 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.441 ' N ' ' CD2' ' A' ' 7' ' ' HIS . 5.0 m170 -114.08 145.43 41.62 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.075 0.464 . . . . 0.0 111.911 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.63 HD12 ' H ' ' A' ' 8' ' ' ILE . 2.9 mp -55.8 146.95 44.61 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.883 178.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.583 ' HA ' HG23 ' A' ' 8' ' ' ILE . 74.8 Cg_endo -93.17 52.13 1.06 Allowed 'Cis proline' 0 C--N 1.354 0.838 0 C-N-CA 124.38 -1.092 . . . . 0.0 113.47 0.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.56 133.74 50.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.914 0.388 . . . . 0.0 110.853 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.492 ' CD ' ' H ' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -58.8 -41.09 85.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.59 -179.149 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.613 ' HB2' HD13 ' A' ' 6' ' ' LEU . 42.8 mtt180 -58.18 -25.03 61.05 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.959 HD21 ' HB2' ' A' ' 6' ' ' LEU . 11.3 mt -75.6 -33.14 60.54 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 120.378 1.445 . . . . 0.0 108.425 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.612 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 20.6 mmm-85 -93.29 8.76 39.04 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 113.762 -1.563 . . . . 0.0 109.297 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.484 ' HB2' ' HA ' ' A' ' 12' ' ' ARG . 63.7 tttm -90.36 148.94 22.51 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.748 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.935 HG13 HG23 ' A' ' 138' ' ' VAL . 58.7 t -83.4 124.21 39.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.998 0.428 . . . . 0.0 109.871 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.794 ' HB3' HD12 ' A' ' 137' ' ' LEU . . . -80.8 148.53 29.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.002 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -109.07 130.74 22.37 Favored Pre-proline 0 C--N 1.327 -0.405 0 C-N-CA 121.165 -0.214 . . . . 0.0 110.634 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.873 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 60.8 Cg_endo -79.62 113.89 3.15 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 121.99 1.794 . . . . 0.0 110.821 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.738 HG12 ' H ' ' A' ' 22' ' ' GLU . 16.7 t -68.56 144.92 13.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 122.629 1.204 . . . . 0.0 113.558 -175.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.4 ' N ' HG12 ' A' ' 20' ' ' VAL . 69.9 mm-40 -61.54 -27.38 68.57 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 113.143 -1.844 . . . . 0.0 112.349 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.738 ' H ' HG12 ' A' ' 20' ' ' VAL . 5.0 tp10 -156.76 151.77 26.13 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.789 -178.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.678 HG21 ' HA2' ' A' ' 115' ' ' GLY . 3.2 t -80.38 103.65 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -178.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 1.083 ' H ' HD12 ' A' ' 27' ' ' ILE . 2.2 m120 -85.7 153.26 22.46 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.167 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.576 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -54.69 -31.95 58.72 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.44 0.638 . . . . 0.0 110.085 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.536 ' HG2' ' NH2' ' A' ' 29' ' ' ARG . 49.7 mt-10 -71.52 -38.05 71.13 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 1.083 HD12 ' H ' ' A' ' 24' ' ' ASN . 68.5 mt -65.86 -38.79 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 113.964 -1.471 . . . . 0.0 110.494 178.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -66.94 -40.57 87.62 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.746 -0.206 . . . . 0.0 110.976 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.576 ' HG3' ' O ' ' A' ' 25' ' ' ALA . 83.9 mtm180 -63.88 -38.65 91.88 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.842 ' O ' ' HG3' ' A' ' 34' ' ' MET . 5.0 mt -56.28 -50.77 69.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.496 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.874 HG22 ' CG2' ' A' ' 57' ' ' ILE . 13.7 t -66.19 -41.47 89.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.95 0.405 . . . . 0.0 111.39 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.923 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -56.59 -42.56 78.9 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -179.26 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.493 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 14.8 m-20 -76.29 -30.15 57.66 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.768 176.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.961 ' HE1' HG22 ' A' ' 57' ' ' ILE . 23.0 mtm -60.26 -46.84 88.4 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.297 -177.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.923 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 9.6 p90 -69.58 -43.67 72.36 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.61 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 56.1 mm-40 -52.97 -42.03 65.12 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.954 HG23 HG13 ' A' ' 2' ' ' VAL . 98.9 m -69.51 -61.72 1.67 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 118.722 -1.191 . . . . 0.0 108.104 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.882 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 1.7 ttp -46.38 -40.58 12.26 Favored 'General case' 0 CA--C 1.468 -2.202 0 C-N-CA 124.057 0.943 . . . . 0.0 110.18 -171.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.74 ' OH ' ' HA ' ' A' ' 69' ' ' ARG . 45.2 m-85 -69.95 -41.5 74.47 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.023 177.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 37' ' ' THR . . . -61.93 -23.09 66.14 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.008 -0.997 . . . . 0.0 109.561 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.706 ' HG2' ' CD1' ' A' ' 91' ' ' LEU . 13.8 tp10 -90.16 -11.62 40.61 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.177 -1.374 . . . . 0.0 108.267 177.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.445 ' H ' ' C ' ' A' ' 39' ' ' TYR . 22.1 mt-10 63.68 28.75 15.03 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.762 -176.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.78 141.83 19.7 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 113.683 -1.599 . . . . 0.0 110.691 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.797 HG23 ' O ' ' A' ' 61' ' ' ASP . 47.2 mt -79.43 2.18 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 117.859 0.829 . . . . 0.0 111.919 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.511 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 177.25 133.57 1.85 Allowed Glycine 0 CA--C 1.523 0.539 0 CA-C-O 119.06 -0.856 . . . . 0.0 112.043 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.098 HD12 ' HG ' ' A' ' 91' ' ' LEU . 8.8 tt -126.62 135.36 51.11 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 119.116 1.458 . . . . 0.0 110.967 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.655 ' N ' HD23 ' A' ' 46' ' ' LEU . . . -97.99 134.6 40.87 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.867 ' HB1' ' CG1' ' A' ' 53' ' ' ILE . . . -31.01 -55.05 0.22 Allowed 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.962 1.468 . . . . 0.0 114.962 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.537 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 81.3 p -53.09 -36.26 60.5 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.523 0.677 . . . . 0.0 112.361 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.654 ' NE2' ' HB3' ' A' ' 90' ' ' CYS . 47.1 mt-30 -63.93 -40.77 97.24 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.486 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.016 ' HB ' HD11 ' A' ' 3' ' ' LEU . 1.2 m -85.63 17.3 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.607 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.911 ' HA ' HD11 ' A' ' 6' ' ' LEU . 50.8 t0 77.89 26.6 0.61 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 176.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.867 ' CG1' ' HB1' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -121.35 109.84 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 C-N-CA 118.985 -1.086 . . . . 0.0 111.243 177.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.481 ' HD2' ' CZ ' ' A' ' 12' ' ' ARG . 6.8 p80 -76.46 59.47 1.47 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.791 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.722 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 7.1 mp0 -148.75 134.05 18.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.449 -1.251 . . . . 0.0 108.075 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.873 ' HD2' ' HD3' ' A' ' 19' ' ' PRO . 68.0 mtt-85 -63.13 68.65 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -177.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.961 HG22 ' HE1' ' A' ' 34' ' ' MET . 7.4 mm -112.77 122.84 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.038 HD11 ' HB2' ' A' ' 72' ' ' LEU . 2.2 pp -126.24 148.03 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -177.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.621 HG22 ' O ' ' A' ' 46' ' ' LEU . 32.6 m -129.06 138.49 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.212 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.075 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 10.9 mm -115.77 151.95 17.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-O 121.483 0.659 . . . . 0.0 109.859 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.882 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 10.0 t70 -139.78 43.31 1.97 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.821 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.859 HG23 ' CG2' ' A' ' 60' ' ' ILE . 13.9 t . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.129 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.74 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 71.7 ttt180 . . . . . 0 N--CA 1.472 0.633 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 1.075 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 9.4 mp -108.56 137.1 47.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.695 0.283 . . . . 0.0 111.656 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.794 ' C ' HD22 ' A' ' 72' ' ' LEU . 14.6 p -135.57 135.96 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.038 ' HB2' HD11 ' A' ' 58' ' ' ILE . 3.0 mm? -143.91 147.29 33.79 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.539 -0.171 . . . . 0.0 110.539 177.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.064 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.7 mp -122.11 136.5 58.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.564 0.221 . . . . 0.0 110.419 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.713 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 8.2 m120 50.38 37.98 0.47 Allowed Pre-proline 0 CA--C 1.55 0.96 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.869 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 79.6 Cg_exo -58.23 147.48 83.92 Favored 'Trans proline' 0 N--CA 1.486 1.085 0 C-N-CA 123.137 2.558 . . . . 0.0 114.844 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.433 ' O ' ' HB ' ' A' ' 108' ' ' ILE . 11.8 pt-20 -136.37 140.51 43.3 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.907 ' HA ' HG22 ' A' ' 108' ' ' ILE . 1.7 tt -81.95 134.51 35.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.177 0.513 . . . . 0.0 111.267 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.039 HD13 ' HA ' ' A' ' 108' ' ' ILE . 5.9 mp -109.57 -43.76 4.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.13 -178.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 39.3 tt0 -147.54 149.73 33.17 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.05 0.452 . . . . 0.0 111.611 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.968 ' HA ' HG12 ' A' ' 106' ' ' VAL . 9.2 ptpp? -147.6 143.86 28.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.83 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.6 p -155.4 147.22 23.28 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.786 0.327 . . . . 0.0 111.257 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.742 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 81.22 147.82 5.79 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.114 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -115.57 114.29 24.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.724 0.773 . . . . 0.0 112.542 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.769 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.7 p -116.51 161.14 19.59 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 115.505 1.669 . . . . 0.0 115.505 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.829 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -150.09 119.17 1.0 Allowed Glycine 0 C--N 1.312 -0.764 0 CA-C-N 112.363 -2.198 . . . . 0.0 111.499 178.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.638 HD13 ' O ' ' A' ' 85' ' ' GLY . 49.5 mm -146.45 136.44 17.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 117.278 0.539 . . . . 0.0 111.373 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 50.2 mt-10 -72.47 141.23 48.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 122.841 1.305 . . . . 0.0 112.657 -176.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.614 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 55.2 mt-10 -153.71 163.97 39.1 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 112.713 -2.039 . . . . 0.0 111.538 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.736 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -120.36 168.59 13.88 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.718 ' HB2' ' CG1' ' A' ' 93' ' ' ILE . 90.3 m -114.12 140.02 48.84 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.215 -0.594 . . . . 0.0 112.03 -177.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.098 ' HG ' HD12 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -53.87 -16.65 1.91 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.845 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.563 ' CB ' HD13 ' A' ' 13' ' ' LEU . 22.0 m -102.96 -31.55 10.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.507 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.718 ' CG1' ' HB2' ' A' ' 90' ' ' CYS . 48.0 mt . . . . . 0 CA--C 1.534 0.347 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.332 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.736 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 55.5 mtm-85 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 121.109 0.481 . . . . 0.0 109.931 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -125.06 146.03 49.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.054 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.829 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.3 tt -76.1 113.69 13.91 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.847 0.832 . . . . 0.0 110.779 -178.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.811 ' CG1' HH21 ' A' ' 102' ' ' ARG . 48.8 t -101.82 128.79 27.96 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.706 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.769 ' HA ' ' O ' ' A' ' 84' ' ' THR . 87.6 Cg_endo -83.0 126.13 4.32 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.163 1.908 . . . . 0.0 111.57 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.811 HH21 ' CG1' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -144.11 166.71 24.23 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.378 179.432 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.742 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.05 155.09 40.28 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.881 0.372 . . . . 0.0 110.461 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -72.26 -40.89 67.33 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.475 -175.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.732 ' HB3' ' OD1' ' A' ' 123' ' ' ASP . 67.1 mttm -140.42 140.22 35.41 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.395 0.617 . . . . 0.0 109.507 176.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.968 HG12 ' HA ' ' A' ' 80' ' ' LYS . 25.3 m -150.42 141.37 16.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.417 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.957 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 23.7 mmtp -108.0 126.48 52.77 Favored 'General case' 0 C--O 1.227 -0.093 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 1.039 ' HA ' HD13 ' A' ' 78' ' ' LEU . 1.8 pp -135.36 152.9 32.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -176.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 1.027 ' HG3' HD11 ' A' ' 78' ' ' LEU . 44.2 mtm180 -103.45 140.73 37.09 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.926 0.87 . . . . 0.0 111.507 -178.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.733 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -161.14 169.51 22.18 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.483 -177.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 1.064 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 1.9 pp -116.64 149.76 39.22 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 176.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.809 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 23.1 t70 -84.41 163.66 19.36 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.587 -176.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.764 ' HD2' ' OD1' ' A' ' 32' ' ' ASP . 14.5 ttp-105 -53.48 -17.24 1.85 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.865 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -79.13 -28.35 42.9 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.948 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.678 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 107.63 35.8 2.55 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.622 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -128.82 103.25 19.1 Favored Pre-proline 0 C--O 1.237 0.43 0 CA-C-N 116.699 0.25 . . . . 0.0 110.705 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.692 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 32.7 Cg_exo -71.99 114.51 3.99 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 121.34 1.36 . . . . 0.0 114.619 -177.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.809 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 10.2 p90 -127.16 168.6 14.45 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.484 -178.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.669 ' HG2' ' HD2' ' A' ' 109' ' ' ARG . 29.8 mt-10 -107.03 129.72 54.76 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.723 ' O ' HD12 ' A' ' 120' ' ' LEU . 4.3 pp -123.45 132.63 53.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.434 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.957 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 9.0 pm0 -92.54 123.38 35.8 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.54 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.808 ' O ' ' HB2' ' A' ' 127' ' ' ALA . . . -117.05 133.54 55.87 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 120.47 -0.492 . . . . 0.0 112.134 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.732 ' OD1' ' HB3' ' A' ' 105' ' ' LYS . 29.4 m-20 -127.81 160.73 30.86 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.663 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 54.9 -138.09 42.7 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 120.952 1.705 . . . . 0.0 114.779 177.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.679 HD12 ' H ' ' A' ' 125' ' ' LEU . 4.7 mp -54.24 -32.29 55.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.2 -0.5 . . . . 0.0 111.333 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.747 HD22 ' CB ' ' A' ' 122' ' ' ALA . 0.6 OUTLIER -70.72 -51.79 25.15 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.394 0.616 . . . . 0.0 109.676 179.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.808 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -61.67 -46.76 88.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.949 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.778 HG23 ' CG ' ' A' ' 102' ' ' ARG . 47.3 mm -64.43 -55.67 20.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -177.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 78.0 m -58.56 -48.08 82.1 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.912 HD11 HD11 ' A' ' 108' ' ' ILE . 20.2 tt -59.35 -41.86 85.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.157 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.798 ' CG ' HG21 ' A' ' 106' ' ' VAL . 70.5 mt-30 -64.86 -38.51 91.22 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.761 0.315 . . . . 0.0 110.185 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.754 ' HA ' ' OD2' ' A' ' 135' ' ' ASP . 79.6 t60 -58.7 -45.54 89.27 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.295 0.569 . . . . 0.0 110.401 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.916 ' O ' HD23 ' A' ' 137' ' ' LEU . 4.5 mm-40 -60.72 -43.2 98.15 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.732 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.917 ' HA ' HD21 ' A' ' 137' ' ' LEU . 70.2 mtp -57.85 -48.55 79.47 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.374 0.607 . . . . 0.0 110.934 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.754 ' OD2' ' HA ' ' A' ' 132' ' ' HIS . 2.5 p30 -65.14 -46.32 81.4 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.114 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.479 ' CE1' ' HG2' ' A' ' 50' ' ' GLN . 11.7 t-80 -58.95 -51.69 68.95 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 121.698 -0.626 . . . . 0.0 111.527 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.917 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.4 pp -60.12 -31.42 70.04 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.952 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.979 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 14.2 p -82.98 25.49 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-O 122.487 1.136 . . . . 0.0 109.825 177.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.648 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 60.13 6.49 5.64 Favored Glycine 0 CA--C 1.487 -1.682 0 CA-C-N 113.082 -1.872 . . . . 0.0 113.382 176.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.979 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 14.3 ptmt . . . . . 0 N--CA 1.413 -2.297 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 1.037 HG12 ' HA ' ' A' ' 37' ' ' THR . 30.9 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.649 0.262 . . . . 0.0 110.987 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.787 HD13 ' OG1' ' A' ' 37' ' ' THR . 0.0 OUTLIER -85.28 -172.8 4.35 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.605 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.739 ' H ' ' NE2' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -79.88 111.09 15.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.28 0.562 . . . . 0.0 110.993 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.627 ' CG2' HG21 ' A' ' 37' ' ' THR . 39.0 t -89.52 131.4 36.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.975 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.057 ' HB2' HD21 ' A' ' 13' ' ' LEU . 30.5 mt -86.81 147.5 25.8 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.556 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.522 ' C ' HD11 ' A' ' 13' ' ' LEU . 3.2 m80 -122.74 144.34 49.23 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.01 HD13 HD12 ' A' ' 13' ' ' LEU . 35.5 mm -67.44 135.88 93.17 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.526 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -78.92 144.5 73.88 Favored 'Cis proline' 0 C--N 1.352 0.736 0 C-N-CA 124.614 -0.994 . . . . 0.0 111.551 -0.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 1.004 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 9.1 t0 -164.0 129.14 2.87 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.404 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.462 ' HG2' ' N ' ' A' ' 12' ' ' ARG . 0.6 OUTLIER -58.08 -45.43 87.15 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.526 -178.769 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.623 ' HB2' HD13 ' A' ' 6' ' ' LEU . 23.2 mmt-85 -58.29 -28.41 64.97 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 1.057 HD21 ' HB2' ' A' ' 6' ' ' LEU . 9.7 mt -77.4 -32.13 54.59 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 120.613 1.551 . . . . 0.0 108.306 177.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.482 ' C ' ' HA3' ' A' ' 139' ' ' GLY . 14.6 mmm180 -93.38 11.76 27.19 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 114.105 -1.407 . . . . 0.0 109.13 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.488 ' HB2' ' HA ' ' A' ' 12' ' ' ARG . 59.5 tptt -89.86 147.93 23.47 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.678 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.94 HG13 HG23 ' A' ' 138' ' ' VAL . 74.6 t -82.56 128.9 38.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.758 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -86.97 142.63 27.82 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.584 ' NZ ' ' HB2' ' A' ' 18' ' ' LYS . 4.7 ttmp? -105.57 129.8 24.09 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.854 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 56.8 Cg_endo -81.45 112.94 2.54 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 121.653 1.568 . . . . 0.0 110.812 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.698 HG12 ' H ' ' A' ' 22' ' ' GLU . 15.9 t -69.66 144.66 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 CA-C-O 122.552 1.168 . . . . 0.0 113.213 -175.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -61.07 -23.41 65.45 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 113.019 -1.9 . . . . 0.0 112.438 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.698 ' H ' HG12 ' A' ' 20' ' ' VAL . 42.8 tt0 -161.18 139.85 9.89 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.183 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.481 HG21 ' CD1' ' A' ' 111' ' ' LEU . 2.6 t -79.43 118.88 27.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.839 ' H ' HD12 ' A' ' 27' ' ' ILE . 50.3 m-80 -104.27 -176.66 3.14 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.894 -0.504 . . . . 0.0 110.655 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.698 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -68.79 -25.41 64.69 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.456 0.646 . . . . 0.0 110.48 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.504 ' HA ' ' OE1' ' A' ' 26' ' ' GLU . 4.3 mm-40 -75.12 -43.19 54.15 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.839 HD12 ' H ' ' A' ' 24' ' ' ASN . 54.2 mt -65.04 -40.1 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 114.086 -1.416 . . . . 0.0 110.695 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.834 ' HG2' ' O ' ' A' ' 24' ' ' ASN . 1.6 mm100 -64.96 -40.8 95.56 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 122.431 -0.168 . . . . 0.0 111.064 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.698 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 26.5 mmm180 -61.86 -38.73 89.36 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.784 ' O ' ' HG3' ' A' ' 34' ' ' MET . 4.2 mt -57.76 -49.22 81.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.829 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.869 HG22 ' CG2' ' A' ' 57' ' ' ILE . 25.3 t -67.97 -41.72 84.88 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 CA-C-O 120.919 0.39 . . . . 0.0 111.339 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.884 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 27.9 m-20 -53.74 -45.97 70.72 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.121 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.502 ' OD1' HD12 ' A' ' 3' ' ' LEU . 3.0 p30 -74.57 -29.63 61.42 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.137 176.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.939 ' HG2' HG21 ' A' ' 51' ' ' VAL . 82.6 mtp -61.12 -46.93 88.57 Favored 'General case' 0 C--N 1.346 0.434 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.851 -178.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.884 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 22.5 p90 -70.82 -47.85 57.24 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.622 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 30.4 mm-40 -50.83 -41.59 57.69 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 1.037 ' HA ' HG12 ' A' ' 2' ' ' VAL . 48.4 m -70.34 -60.28 2.37 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.201 -1.363 . . . . 0.0 108.907 177.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.819 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 1.2 ttp -47.13 -39.72 14.08 Favored 'General case' 0 CA--C 1.464 -2.33 0 C-N-CA 124.046 0.939 . . . . 0.0 110.401 -171.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.664 ' OH ' ' HA ' ' A' ' 69' ' ' ARG . 68.2 m-85 -70.72 -42.1 71.02 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.146 177.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.565 ' CB ' HG11 ' A' ' 2' ' ' VAL . . . -60.95 -25.28 66.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.371 -0.831 . . . . 0.0 108.987 178.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.821 ' HG2' HD12 ' A' ' 91' ' ' LEU . 11.4 tp10 -87.02 -10.72 52.4 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 114.303 -1.317 . . . . 0.0 108.669 176.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.44 ' H ' ' C ' ' A' ' 39' ' ' TYR . 4.9 mm-40 63.76 23.62 13.52 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.21 -176.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.6 140.79 23.88 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.324 177.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.817 HG22 HG22 ' A' ' 62' ' ' VAL . 43.2 mm -78.67 -0.8 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 117.464 0.632 . . . . 0.0 111.756 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.545 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 177.91 136.05 2.42 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 118.68 -1.067 . . . . 0.0 110.872 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.813 ' HB2' ' HG3' ' A' ' 38' ' ' MET . 8.9 tt -127.98 135.37 49.83 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-N 119.714 1.757 . . . . 0.0 111.03 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.606 ' N ' HD23 ' A' ' 46' ' ' LEU . . . -97.43 134.16 41.06 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.881 ' HB1' ' CG1' ' A' ' 53' ' ' ILE . . . -31.11 -53.68 0.21 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.552 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 57.0 p -53.36 -35.32 60.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.77 0.795 . . . . 0.0 111.268 -178.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.751 ' OE1' HD23 ' A' ' 91' ' ' LEU . 74.8 mt-30 -64.22 -41.84 96.85 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.175 -1.375 . . . . 0.0 109.813 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.939 HG21 ' HG2' ' A' ' 34' ' ' MET . 0.9 OUTLIER -84.8 16.27 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-O 121.195 0.521 . . . . 0.0 112.132 179.763 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.846 ' HA ' HD11 ' A' ' 6' ' ' LEU . 50.5 t0 75.36 30.04 0.87 Allowed 'General case' 0 C--O 1.233 0.185 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 176.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.881 ' CG1' ' HB1' ' A' ' 48' ' ' ALA . 1.1 pp -123.54 111.41 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 C-N-CA 119.228 -0.989 . . . . 0.0 110.898 177.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.9 p-80 -76.3 62.68 1.82 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.992 0.901 . . . . 0.0 110.586 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.752 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 89.6 mt-30 -151.94 134.83 15.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.25 -1.341 . . . . 0.0 107.691 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.869 ' HG2' ' CD1' ' A' ' 137' ' ' LEU . 65.0 mtt-85 -64.26 70.74 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.869 ' CG2' HG22 ' A' ' 31' ' ' VAL . 9.1 mm -112.09 122.74 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.08 HD11 ' HB2' ' A' ' 72' ' ' LEU . 1.8 pp -126.17 144.34 36.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 119.836 -0.746 . . . . 0.0 112.913 -177.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.717 HG22 ' O ' ' A' ' 46' ' ' LEU . 33.5 m -127.22 137.12 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.067 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 6.1 mm -114.73 149.99 16.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.748 0.785 . . . . 0.0 109.555 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.819 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 58.5 t0 -137.35 27.84 2.81 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.442 -178.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.817 HG22 HG22 ' A' ' 44' ' ' ILE . 28.7 t . . . . . 0 C--N 1.332 -0.164 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.253 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.664 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 32.2 ttm180 . . . . . 0 N--CA 1.462 0.174 0 CA-C-O 120.638 0.256 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 1.067 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 61.2 mt -102.48 132.35 48.58 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-O 120.834 0.349 . . . . 0.0 111.557 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.866 ' O ' HD12 ' A' ' 72' ' ' LEU . 8.6 p -135.03 134.22 53.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.544 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.08 ' HB2' HD11 ' A' ' 58' ' ' ILE . 10.4 mp -140.6 142.45 35.05 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.047 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.7 mp -119.97 133.04 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-O 120.678 0.275 . . . . 0.0 110.413 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.792 ' ND2' HG22 ' A' ' 73' ' ' ILE . 66.8 m-20 54.2 37.14 0.39 Allowed Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.936 ' HG2' HG12 ' A' ' 58' ' ' ILE . 97.0 Cg_exo -56.65 150.17 54.43 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 C-N-CA 123.032 2.488 . . . . 0.0 114.016 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.656 ' OE2' ' HD2' ' A' ' 109' ' ' ARG . 23.0 pt-20 -138.45 143.12 39.51 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.815 ' HB2' ' HE3' ' A' ' 134' ' ' MET . 1.6 tt -80.24 135.19 36.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.434 0.635 . . . . 0.0 111.958 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.086 HD11 ' HG3' ' A' ' 109' ' ' ARG . 5.2 mp -109.75 -40.4 4.82 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.283 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 85.2 tt0 -156.05 154.62 31.29 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.277 0.561 . . . . 0.0 111.802 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.888 ' HA ' HG12 ' A' ' 106' ' ' VAL . 9.1 ptpp? -147.56 151.07 35.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.231 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 46.4 t -160.33 147.07 15.77 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.697 0.284 . . . . 0.0 111.318 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.661 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 75.16 161.71 9.42 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.571 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -135.76 113.29 10.8 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.867 0.841 . . . . 0.0 112.972 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.863 ' HB ' HH12 ' A' ' 102' ' ' ARG . 1.6 p -105.68 162.37 13.58 Favored 'General case' 0 CA--C 1.489 -1.402 0 N-CA-C 115.011 1.486 . . . . 0.0 115.011 178.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.699 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -148.98 118.47 0.96 Allowed Glycine 0 C--N 1.314 -0.677 0 CA-C-N 113.035 -1.893 . . . . 0.0 110.866 178.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.757 ' HB ' ' NH2' ' A' ' 102' ' ' ARG . 47.2 mm -148.19 140.28 18.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 117.472 0.636 . . . . 0.0 111.602 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 55.7 mp0 -71.24 135.37 47.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 123.365 1.555 . . . . 0.0 112.368 -176.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.692 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 80.2 mt-10 -152.26 161.34 42.76 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 112.324 -2.216 . . . . 0.0 112.039 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.778 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -121.16 164.13 14.46 Favored Glycine 0 CA--C 1.501 -0.811 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.43 ' HB2' HG13 ' A' ' 93' ' ' ILE . 22.4 m -113.39 141.23 47.31 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.594 0.712 . . . . 0.0 112.656 -177.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.853 HD22 ' H ' ' A' ' 91' ' ' LEU . 2.2 mm? -50.27 -26.98 5.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.818 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.848 ' CB ' HD13 ' A' ' 13' ' ' LEU . 61.2 m -85.3 -31.59 22.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.299 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.43 HG13 ' HB2' ' A' ' 90' ' ' CYS . 58.7 mt . . . . . 0 N--CA 1.448 -0.537 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.188 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.778 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 52.7 mtm-85 . . . . . 0 N--CA 1.465 0.283 0 CA-C-O 121.787 0.803 . . . . 0.0 112.282 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -133.88 154.73 50.85 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.423 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.699 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.8 tt -76.56 112.27 12.93 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.85 0.834 . . . . 0.0 112.181 -177.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.471 HG13 ' CD ' ' A' ' 102' ' ' ARG . 11.1 p -99.86 133.12 21.91 Favored Pre-proline 0 N--CA 1.469 0.477 0 CA-C-N 114.593 -1.185 . . . . 0.0 112.372 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' ' 84' ' ' THR . 96.6 Cg_endo -87.22 126.45 2.34 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 122.635 2.224 . . . . 0.0 112.485 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.876 ' HG2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -145.53 167.71 22.36 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.001 0.92 . . . . 0.0 110.259 179.83 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.661 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.44 155.85 39.04 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.804 0.335 . . . . 0.0 110.15 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -73.35 -42.0 62.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.936 -176.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.668 ' HB3' ' OD1' ' A' ' 123' ' ' ASP . 59.7 mttp -140.63 141.04 35.13 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.376 0.607 . . . . 0.0 110.155 177.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.888 HG12 ' HA ' ' A' ' 80' ' ' LYS . 22.4 m -149.25 138.84 15.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.346 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.992 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 20.1 mmtp -108.21 126.46 52.83 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 1.046 ' HA ' HD13 ' A' ' 78' ' ' LEU . 1.4 pp -135.89 154.75 34.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -176.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 1.086 ' HG3' HD11 ' A' ' 78' ' ' LEU . 92.6 mtt180 -101.41 137.98 39.03 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.319 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.688 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -159.34 169.36 24.18 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.504 -1.225 . . . . 0.0 111.093 -177.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 1.047 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.7 pp -118.94 154.75 32.5 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 177.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.55 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 19.5 t70 -89.09 162.59 15.89 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.197 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.738 ' HB2' HG21 ' A' ' 71' ' ' VAL . 13.1 ttp-105 -54.44 -15.32 1.62 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.832 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -78.95 -29.48 44.01 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.727 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 109.23 34.1 2.6 Favored Glycine 0 C--N 1.34 0.797 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.886 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -128.72 102.86 19.54 Favored Pre-proline 0 C--O 1.237 0.432 0 CA-C-N 116.764 0.282 . . . . 0.0 111.166 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.685 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 33.1 Cg_exo -73.26 116.81 4.84 Favored 'Trans proline' 0 C--N 1.36 1.169 0 C-N-CA 122.015 1.81 . . . . 0.0 115.094 -178.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.55 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 12.6 p90 -128.4 166.48 18.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.568 -178.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.764 ' HG2' ' HG2' ' A' ' 109' ' ' ARG . 22.4 mt-10 -107.73 131.96 53.88 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.871 ' O ' HD23 ' A' ' 120' ' ' LEU . 0.3 OUTLIER -129.64 141.84 50.85 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.663 0.744 . . . . 0.0 111.742 -179.465 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.992 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 11.3 pt-20 -95.19 123.43 38.69 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.536 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.927 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -115.82 134.87 54.56 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.958 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.668 ' OD1' ' HB3' ' A' ' 105' ' ' LYS . 37.7 m-20 -126.44 162.22 26.1 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.797 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 48.4 -132.9 20.48 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-N 119.85 1.205 . . . . 0.0 115.705 177.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 80.9 mt -54.7 -35.74 63.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.74 -0.73 . . . . 0.0 111.774 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.927 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -70.72 -52.03 23.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.799 0.809 . . . . 0.0 109.225 179.854 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.756 ' HB2' ' C ' ' A' ' 122' ' ' ALA . . . -58.65 -40.25 82.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.346 -1.297 . . . . 0.0 111.691 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.876 HD12 ' HG2' ' A' ' 102' ' ' ARG . 50.8 mm -68.41 -55.89 14.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.879 -178.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.774 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 29.4 p -57.88 -50.48 73.17 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.992 HD11 HD11 ' A' ' 108' ' ' ILE . 19.4 tt -59.04 -43.69 89.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.957 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.811 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 21.9 pt20 -68.41 -40.04 81.41 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.627 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -59.27 -47.44 85.34 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.077 0.465 . . . . 0.0 109.776 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.88 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.5 mm-40 -58.63 -42.68 88.83 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.512 -179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.975 ' HA ' HD21 ' A' ' 137' ' ' LEU . 30.2 mtm -57.21 -47.3 81.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.634 0.73 . . . . 0.0 110.16 178.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.678 ' O ' HG12 ' A' ' 138' ' ' VAL . 31.9 m-20 -62.77 -48.31 79.71 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.095 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.541 ' CE1' ' HG2' ' A' ' 50' ' ' GLN . 8.4 t-80 -58.16 -52.93 63.52 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.271 0.557 . . . . 0.0 111.376 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.975 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.6 pp -58.67 -31.52 68.26 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.701 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.944 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 12.9 p -85.54 25.09 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-O 122.187 0.994 . . . . 0.0 109.83 176.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.515 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 55.91 30.67 57.41 Favored Glycine 0 CA--C 1.485 -1.843 0 CA-C-N 113.578 -1.646 . . . . 0.0 112.942 176.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.944 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 5.8 ptmt . . . . . 0 N--CA 1.424 -1.763 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.303 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.841 HG13 HG23 ' A' ' 37' ' ' THR . 40.1 t . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.497 0.189 . . . . 0.0 110.597 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.929 HD13 ' H ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -87.93 -174.15 4.58 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.752 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -80.52 109.84 15.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.035 0.445 . . . . 0.0 111.073 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.648 ' CG2' HG21 ' A' ' 37' ' ' THR . 36.2 t -89.47 131.64 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.783 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.003 ' HB2' HD21 ' A' ' 13' ' ' LEU . 45.3 mt -84.06 142.68 30.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.862 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 5.1 m170 -119.14 145.51 45.91 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.207 0.527 . . . . 0.0 112.044 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.039 HD13 HD12 ' A' ' 13' ' ' LEU . 51.2 mm -54.19 146.03 32.72 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.827 178.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.663 ' HA ' HG23 ' A' ' 8' ' ' ILE . 64.8 Cg_endo -91.86 50.2 1.12 Allowed 'Cis proline' 0 C--N 1.355 0.898 0 C-N-CA 124.644 -0.982 . . . . 0.0 113.123 0.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.87 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 9.7 t70 -53.56 131.48 38.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.799 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -59.17 -41.71 89.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.423 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.744 ' HB2' HD13 ' A' ' 6' ' ' LEU . 10.5 mtt85 -60.19 -23.55 64.08 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 1.039 HD12 HD13 ' A' ' 8' ' ' ILE . 9.8 mt -76.31 -31.73 58.35 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 120.413 1.46 . . . . 0.0 108.134 177.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.558 ' HD2' ' O ' ' A' ' 139' ' ' GLY . 24.0 mmm-85 -91.58 1.7 56.96 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 113.93 -1.486 . . . . 0.0 109.09 178.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.562 ' HD3' ' HB3' ' A' ' 54' ' ' HIS . 62.6 tttp -83.97 150.56 25.57 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.126 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.592 HG13 HG23 ' A' ' 138' ' ' VAL . 84.3 t -82.89 136.22 23.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.179 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.79 ' C ' ' HG3' ' A' ' 56' ' ' ARG . . . -90.7 139.96 30.23 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -104.81 129.28 25.17 Favored Pre-proline 0 C--N 1.323 -0.58 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.546 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.923 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 68.3 Cg_endo -77.5 114.67 3.75 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 121.824 1.682 . . . . 0.0 110.197 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.753 HG12 ' H ' ' A' ' 22' ' ' GLU . 17.3 t -70.09 144.83 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 122.488 1.137 . . . . 0.0 113.285 -176.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -62.44 -25.59 68.05 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 113.322 -1.763 . . . . 0.0 112.103 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.753 ' H ' HG12 ' A' ' 20' ' ' VAL . 88.9 tt0 -159.29 143.9 15.44 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.537 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.539 HG22 HD21 ' A' ' 111' ' ' LEU . 2.9 t -79.26 107.2 11.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -178.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 1.082 ' H ' HD12 ' A' ' 27' ' ' ILE . 64.1 m-80 -87.87 153.04 21.63 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.455 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.813 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -54.44 -26.99 34.06 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 121.078 0.466 . . . . 0.0 110.64 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -72.47 -40.39 66.98 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 177.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 1.082 HD12 ' H ' ' A' ' 24' ' ' ASN . 62.9 mt -62.92 -47.59 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.038 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -57.89 -39.86 78.9 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.916 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.813 ' HG3' ' O ' ' A' ' 25' ' ' ALA . 19.7 mtm105 -59.62 -40.36 87.29 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.808 ' O ' ' HG3' ' A' ' 34' ' ' MET . 4.3 mt -58.6 -49.78 81.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.624 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.924 HG22 ' CG2' ' A' ' 57' ' ' ILE . 5.0 t -67.22 -42.34 87.81 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-O 120.746 0.308 . . . . 0.0 111.619 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.88 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -54.35 -43.08 70.97 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.641 -179.604 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.562 ' C ' HD12 ' A' ' 3' ' ' LEU . 53.6 m-20 -74.96 -30.95 61.35 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.613 176.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 1.07 ' HG2' HG21 ' A' ' 51' ' ' VAL . 79.8 mtp -60.08 -47.76 84.54 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.162 -177.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.88 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 15.6 p90 -68.97 -43.54 74.77 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.781 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 31.9 mt-10 -51.41 -43.56 61.99 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.857 ' OG1' HD13 ' A' ' 3' ' ' LEU . 97.3 m -70.98 -61.91 1.59 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 118.876 -1.13 . . . . 0.0 109.092 177.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.99 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 1.8 ttp -45.51 -44.74 12.8 Favored 'General case' 0 CA--C 1.458 -2.576 0 C-N-CA 123.618 0.767 . . . . 0.0 109.978 -170.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.717 ' HH ' ' N ' ' A' ' 69' ' ' ARG . 58.9 m-85 -70.26 -40.63 74.26 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.197 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.39 -27.32 67.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.863 0.839 . . . . 0.0 108.764 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 1.01 ' HG2' HD22 ' A' ' 91' ' ' LEU . 10.5 tp10 -85.49 -10.48 56.0 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.19 177.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.431 ' H ' ' C ' ' A' ' 39' ' ' TYR . 51.5 mt-10 63.44 29.46 15.5 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.892 -176.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.69 143.29 20.64 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.865 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.817 HG23 ' O ' ' A' ' 61' ' ' ASP . 56.7 mt -78.77 -0.96 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 117.976 0.888 . . . . 0.0 112.065 -178.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.548 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 176.49 135.3 2.13 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-O 119.26 -0.744 . . . . 0.0 112.54 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.926 ' CD1' HD12 ' A' ' 91' ' ' LEU . 3.2 tp -125.22 133.56 52.68 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 118.618 1.209 . . . . 0.0 111.001 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -97.4 132.89 42.69 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 111.421 0.156 . . . . 0.0 111.421 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.912 ' HB1' ' CG1' ' A' ' 53' ' ' ILE . . . -34.56 -52.51 0.51 Allowed 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.525 HG21 ' O ' ' A' ' 137' ' ' LEU . 59.9 p -53.67 -37.27 63.03 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.898 0.856 . . . . 0.0 110.656 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.498 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 73.8 mt-30 -66.93 -38.36 86.04 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.006 -1.452 . . . . 0.0 109.854 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.07 HG21 ' HG2' ' A' ' 34' ' ' MET . 0.8 OUTLIER -83.8 11.62 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 179.113 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.875 ' HA ' ' CD1' ' A' ' 6' ' ' LEU . 54.6 t0 79.35 31.52 0.27 Allowed 'General case' 0 N--CA 1.46 0.06 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 176.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.912 ' CG1' ' HB1' ' A' ' 48' ' ' ALA . 1.2 pp -128.28 114.02 32.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.605 177.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.562 ' HB3' ' HD3' ' A' ' 15' ' ' LYS . 6.0 p80 -76.23 65.37 2.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.923 0.868 . . . . 0.0 110.587 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.777 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 88.5 mt-30 -155.77 134.84 12.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.676 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.923 ' HD2' ' HD3' ' A' ' 19' ' ' PRO . 99.0 mtt180 -62.74 69.06 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -178.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.924 ' CG2' HG22 ' A' ' 31' ' ' VAL . 8.4 mm -113.76 122.3 67.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.041 HD11 ' HB2' ' A' ' 72' ' ' LEU . 2.4 pp -131.31 146.89 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -177.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.9 m -127.83 138.69 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.266 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.84 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 2.2 mt -115.98 144.12 24.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 122.332 1.063 . . . . 0.0 112.233 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.99 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 52.4 t0 -122.78 50.07 1.56 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 113.506 -1.679 . . . . 0.0 107.666 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.736 HG22 ' CG2' ' A' ' 44' ' ' ILE . 24.6 t . . . . . 0 N--CA 1.444 -0.745 0 CA-C-N 112.243 -2.253 . . . . 0.0 105.869 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.717 ' N ' ' HH ' ' A' ' 39' ' ' TYR . 34.6 ttm180 . . . . . 0 CA--C 1.536 0.42 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.84 ' CB ' ' HB ' ' A' ' 60' ' ' ILE . 8.8 mp -100.45 129.46 46.42 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.881 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.794 ' C ' HD22 ' A' ' 72' ' ' LEU . 13.4 p -133.87 131.32 56.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.211 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.041 ' HB2' HD11 ' A' ' 58' ' ' ILE . 2.9 mm? -141.75 143.91 33.74 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.398 177.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.073 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.6 mp -122.31 135.87 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 O-C-N 122.168 -0.332 . . . . 0.0 110.441 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.707 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 8.0 m120 52.34 37.14 0.4 Allowed Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.867 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 97.4 Cg_exo -56.46 150.93 48.37 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 122.949 2.433 . . . . 0.0 114.091 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -138.72 145.57 40.46 Favored 'General case' 0 C--N 1.335 -0.055 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.805 ' HA ' HG22 ' A' ' 108' ' ' ILE . 9.5 tp -80.69 138.07 36.34 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.111 0.481 . . . . 0.0 110.901 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.047 HD23 ' HA ' ' A' ' 108' ' ' ILE . 3.0 mm? -114.27 -36.17 4.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.243 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.466 ' O ' ' HB ' ' A' ' 106' ' ' VAL . 16.5 tp10 -160.9 147.6 15.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.055 0.455 . . . . 0.0 111.86 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 1.057 ' HA ' HG12 ' A' ' 106' ' ' VAL . 19.6 ptpt -140.48 150.22 43.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.91 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.6 p -157.73 147.61 20.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.779 0.324 . . . . 0.0 111.243 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.766 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 73.46 165.27 10.08 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.791 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -139.79 113.16 8.38 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.689 0.757 . . . . 0.0 112.697 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.766 ' HB ' HH12 ' A' ' 102' ' ' ARG . 1.4 p -102.26 160.18 14.75 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.637 ' O ' HD13 ' A' ' 86' ' ' ILE . . . -139.82 104.73 0.43 Allowed Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 113.077 -1.874 . . . . 0.0 111.856 178.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.842 ' HB ' ' NH2' ' A' ' 102' ' ' ARG . 49.8 mm -147.1 140.32 19.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.639 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 92.5 mt-10 -74.01 143.81 45.4 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 122.589 1.185 . . . . 0.0 112.619 -178.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.548 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 10.1 mp0 -151.1 169.68 21.26 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 113.192 -1.822 . . . . 0.0 108.608 177.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.76 ' HA3' ' HG2' ' A' ' 97' ' ' ARG . . . -118.77 165.29 12.96 Favored Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 119.322 -1.418 . . . . 0.0 109.92 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 19.9 m -119.07 130.65 55.73 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.01 HD22 ' HG2' ' A' ' 41' ' ' GLU . 13.4 mt -57.5 -13.32 3.52 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.784 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.914 ' CB ' HD13 ' A' ' 13' ' ' LEU . 58.0 m -83.26 -37.2 23.83 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.685 ' CD1' HG13 ' A' ' 8' ' ' ILE . 48.4 mm . . . . . 0 CA--C 1.534 0.339 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.557 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.76 ' HG2' ' HA3' ' A' ' 89' ' ' GLY . 40.9 mtm-85 . . . . . 0 N--CA 1.463 0.186 0 CA-C-O 121.627 0.727 . . . . 0.0 111.493 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -132.11 151.0 52.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.13 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.687 HD23 ' N ' ' A' ' 100' ' ' VAL . 6.9 tt -75.58 135.73 40.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.808 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.687 ' N ' HD23 ' A' ' 99' ' ' LEU . 13.6 p -130.09 140.29 38.2 Favored Pre-proline 0 C--O 1.232 0.181 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.393 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 84' ' ' THR . 97.1 Cg_endo -88.16 122.7 1.57 Allowed 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.377 1.385 . . . . 0.0 113.552 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.913 ' HG2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -142.74 165.45 27.36 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 113.545 -1.661 . . . . 0.0 110.783 178.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.766 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.74 154.04 42.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.9 0.381 . . . . 0.0 110.377 -178.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.445 ' OE1' HG21 ' A' ' 84' ' ' THR . 5.1 tp10 -73.06 -42.03 63.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.66 -176.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.764 ' HG2' ' HB3' ' A' ' 123' ' ' ASP . 4.7 mtpm? -139.5 138.32 36.26 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.489 0.661 . . . . 0.0 109.674 177.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 1.057 HG12 ' HA ' ' A' ' 80' ' ' LYS . 25.1 m -147.02 141.63 20.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.736 -1.12 . . . . 0.0 112.122 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.964 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 31.9 mmtm -107.2 126.04 51.88 Favored 'General case' 0 N--CA 1.461 0.101 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 1.047 ' HA ' HD23 ' A' ' 78' ' ' LEU . 2.0 pp -129.61 161.82 38.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 1.034 ' HG3' HD21 ' A' ' 78' ' ' LEU . 45.4 mtm180 -113.24 138.17 50.4 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-O 120.843 0.354 . . . . 0.0 110.083 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.807 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -156.44 167.89 29.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.658 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 1.073 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.2 pp -114.03 151.66 32.13 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.445 ' O ' HD12 ' A' ' 111' ' ' LEU . 10.7 t70 -87.9 164.37 15.89 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.692 -177.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.768 ' HD2' ' OD1' ' A' ' 32' ' ' ASP . 49.1 ttp180 -51.66 -21.36 2.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.311 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.55 -21.75 44.75 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.908 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.5 37.27 3.31 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.992 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -128.64 102.82 19.78 Favored Pre-proline 0 C--O 1.238 0.457 0 CA-C-N 117.054 0.427 . . . . 0.0 110.708 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.661 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 32.2 Cg_exo -73.18 114.16 3.97 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 121.616 1.544 . . . . 0.0 114.959 -177.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 112' ' ' ASP . 0.4 OUTLIER -125.58 169.56 12.35 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.417 -178.52 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.718 ' HG2' ' HD2' ' A' ' 109' ' ' ARG . 34.9 mt-10 -106.75 129.4 54.63 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.02 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.721 ' O ' HD12 ' A' ' 120' ' ' LEU . 4.1 pp -123.39 133.01 54.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.848 -178.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.964 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 15.4 pt-20 -92.48 124.37 36.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.673 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.936 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -116.39 134.59 54.7 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.764 ' HB3' ' HG2' ' A' ' 105' ' ' LYS . 25.2 m-20 -126.81 164.54 21.14 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.628 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 46.78 -134.56 11.13 Favored Glycine 0 C--N 1.347 1.188 0 CA-C-N 120.722 1.601 . . . . 0.0 116.44 177.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.686 HD12 ' H ' ' A' ' 125' ' ' LEU . 4.8 mp -54.64 -33.99 61.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.431 -0.884 . . . . 0.0 111.619 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.936 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -70.95 -53.35 15.24 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.239 -0.584 . . . . 0.0 109.796 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.799 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -59.44 -47.12 86.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.93 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.913 HD12 ' HG2' ' A' ' 102' ' ' ARG . 49.9 mm -61.28 -55.69 22.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.084 -178.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.464 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 82.2 m -57.45 -50.89 71.55 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.673 HD11 HD11 ' A' ' 108' ' ' ILE . 18.7 tt -59.0 -41.35 82.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.826 -0.17 . . . . 0.0 111.413 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.864 ' CG ' HG21 ' A' ' 106' ' ' VAL . 66.0 mt-30 -65.99 -40.83 91.51 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.401 ' NE2' ' HD2' ' A' ' 136' ' ' HIS . 9.1 t-160 -56.08 -47.74 77.42 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.882 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.804 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.7 mm-40 -58.71 -46.08 88.11 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.098 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.985 ' HA ' HD21 ' A' ' 137' ' ' LEU . 1.9 mmm -55.68 -47.54 76.59 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.466 0.65 . . . . 0.0 110.037 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.656 ' O ' HG12 ' A' ' 138' ' ' VAL . 31.3 m-20 -61.6 -49.24 77.39 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.205 178.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.472 ' CE1' ' HG2' ' A' ' 50' ' ' GLN . 10.3 t-80 -59.25 -50.76 72.79 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 121.768 -0.583 . . . . 0.0 111.171 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.985 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.6 pp -58.27 -31.27 67.29 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.726 -178.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.847 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 13.8 p -83.04 20.5 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-O 122.803 1.287 . . . . 0.0 108.755 175.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.768 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 65.84 7.3 35.13 Favored Glycine 0 CA--C 1.494 -1.278 0 CA-C-N 112.501 -2.136 . . . . 0.0 112.843 176.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.847 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 4.6 ptmt . . . . . 0 N--CA 1.429 -1.492 0 C-N-CA 119.53 -0.868 . . . . 0.0 108.716 179.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.921 HG12 ' HA ' ' A' ' 37' ' ' THR . 28.3 m . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.371 0.129 . . . . 0.0 110.783 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.96 HD13 ' H ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -79.01 -159.3 0.18 Allowed 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.108 179.858 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.686 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 2.2 tp-100 -88.31 105.58 17.66 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.254 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.62 ' CG2' HG21 ' A' ' 37' ' ' THR . 46.4 t -88.33 127.0 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 121.333 0.587 . . . . 0.0 111.483 -179.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.07 ' HB2' HD21 ' A' ' 13' ' ' LEU . 24.4 mt -88.08 144.29 26.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.222 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 4.3 m80 -120.85 145.99 47.04 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.003 HD13 HD12 ' A' ' 13' ' ' LEU . 44.5 mm -69.29 135.79 88.94 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.674 178.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.48 141.74 70.95 Favored 'Cis proline' 0 C--N 1.352 0.729 0 C-N-CA 124.145 -1.19 . . . . 0.0 112.031 -0.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.97 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 8.4 t0 -163.39 125.18 2.47 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.271 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.431 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 23.7 pt-20 -57.53 -46.23 84.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.74 -178.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.692 ' CZ ' ' HD2' ' A' ' 54' ' ' HIS . 14.8 mmt85 -56.21 -30.1 61.83 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 1.07 HD21 ' HB2' ' A' ' 6' ' ' LEU . 11.5 mt -75.78 -33.29 60.17 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 120.098 1.317 . . . . 0.0 109.054 178.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.669 ' C ' ' HA3' ' A' ' 139' ' ' GLY . 26.6 mmt-85 -96.21 13.29 27.91 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.299 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.45 ' HZ3' ' HE ' ' A' ' 12' ' ' ARG . 88.4 tttt -91.65 149.93 21.4 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.128 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 1.004 HG13 HG23 ' A' ' 138' ' ' VAL . 49.5 t -82.95 122.13 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.796 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -80.02 145.57 32.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.856 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.625 ' HB3' HE22 ' A' ' 55' ' ' GLN . 83.4 tttt -101.81 134.22 20.28 Favored Pre-proline 0 C--N 1.326 -0.442 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.788 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -77.36 115.52 3.94 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.365 2.044 . . . . 0.0 111.261 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.882 HG12 ' H ' ' A' ' 22' ' ' GLU . 24.9 t -68.94 144.98 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 122.526 1.155 . . . . 0.0 113.022 -176.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.475 ' OE1' ' HA ' ' A' ' 21' ' ' GLU . 4.3 mm-40 -67.45 -29.24 68.65 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 113.303 -1.771 . . . . 0.0 111.734 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.882 ' H ' HG12 ' A' ' 20' ' ' VAL . 16.9 tp10 -156.57 154.17 29.81 Favored 'General case' 0 CA--C 1.527 0.063 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.178 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.981 HG21 ' HA2' ' A' ' 115' ' ' GLY . 6.3 t -80.07 102.38 5.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -178.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.943 ' CB ' HD13 ' A' ' 27' ' ' ILE . 62.3 m-80 -89.04 151.16 22.42 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.569 -177.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.421 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -55.48 -28.21 53.12 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.508 0.67 . . . . 0.0 110.534 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 1.073 ' HG3' HD12 ' A' ' 27' ' ' ILE . 21.7 pt-20 -74.02 -36.92 64.48 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 177.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 1.073 HD12 ' HG3' ' A' ' 26' ' ' GLU . 1.7 mp -67.46 -38.79 81.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.952 177.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -65.78 -40.29 91.84 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 122.401 -0.187 . . . . 0.0 110.938 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.449 HH11 ' HG2' ' A' ' 29' ' ' ARG . 47.7 mmt-85 -64.94 -38.41 90.89 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.786 ' O ' ' HG3' ' A' ' 34' ' ' MET . 4.7 mt -55.39 -50.47 65.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.177 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.892 HG11 ' CG2' ' A' ' 71' ' ' VAL . 19.2 t -66.87 -40.4 85.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-O 121.218 0.533 . . . . 0.0 110.408 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.869 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 71.1 m-20 -53.06 -46.08 68.39 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.072 -178.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.62 ' CB ' HD12 ' A' ' 3' ' ' LEU . 1.5 m-20 -75.13 -29.25 60.46 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.07 176.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 1.003 ' HG2' HG21 ' A' ' 51' ' ' VAL . 83.2 mtp -59.46 -46.63 88.22 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.171 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.869 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 13.9 p90 -70.2 -44.18 69.2 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.737 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 85.9 mt-10 -51.61 -44.48 62.9 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.622 0.725 . . . . 0.0 109.376 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.921 ' HA ' HG12 ' A' ' 2' ' ' VAL . 96.7 m -70.5 -61.35 1.8 Allowed 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 118.592 -1.243 . . . . 0.0 108.709 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 1.038 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 2.0 ttp -45.68 -41.5 10.52 Favored 'General case' 0 CA--C 1.463 -2.393 0 C-N-CA 123.878 0.871 . . . . 0.0 110.133 -171.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.7 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 55.9 m-85 -70.4 -42.13 72.08 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.083 177.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.467 ' HB3' ' CG1' ' A' ' 2' ' ' VAL . . . -61.16 -24.47 66.32 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.491 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 1.047 ' HG2' HD12 ' A' ' 91' ' ' LEU . 11.9 tp10 -88.81 -11.56 44.49 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.482 177.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.444 ' H ' ' C ' ' A' ' 39' ' ' TYR . 18.5 mt-10 64.83 26.54 12.94 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 122.047 0.927 . . . . 0.0 109.927 -176.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.48 141.58 22.16 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 113.76 -1.564 . . . . 0.0 110.67 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.807 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 53.1 mt -80.0 0.68 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 117.643 0.722 . . . . 0.0 112.266 -178.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.499 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 178.09 135.54 2.31 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-O 119.022 -0.877 . . . . 0.0 111.926 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.994 HD13 ' HG ' ' A' ' 91' ' ' LEU . 5.4 tp -125.68 134.24 51.9 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-N 118.993 1.397 . . . . 0.0 111.56 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -98.9 132.33 44.31 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.875 ' HB1' ' CD1' ' A' ' 53' ' ' ILE . . . -29.85 -54.59 0.16 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.597 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 58.4 p -53.97 -36.64 63.1 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.698 0.761 . . . . 0.0 111.81 -178.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.741 ' OE1' HD12 ' A' ' 46' ' ' LEU . 85.5 mt-30 -64.51 -40.62 95.97 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.627 -1.169 . . . . 0.0 110.028 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.003 HG21 ' HG2' ' A' ' 34' ' ' MET . 0.8 OUTLIER -84.36 17.37 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 112.665 0.616 . . . . 0.0 112.665 -179.84 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.896 ' HA ' HD11 ' A' ' 6' ' ' LEU . 11.1 t0 77.51 26.86 0.65 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 176.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.875 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -124.13 110.7 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 C-N-CA 118.915 -1.114 . . . . 0.0 111.77 178.644 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.692 ' HD2' ' CZ ' ' A' ' 12' ' ' ARG . 6.9 p80 -76.48 60.5 1.61 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.611 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.782 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 2.5 mm100 -149.67 134.18 17.53 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 114.342 -1.299 . . . . 0.0 107.788 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.796 ' N ' ' HB1' ' A' ' 17' ' ' ALA . 75.7 mtp180 -64.11 68.62 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -177.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.831 ' CG2' HG22 ' A' ' 31' ' ' VAL . 8.5 mm -110.49 122.16 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.998 HD11 ' HB2' ' A' ' 72' ' ' LEU . 1.5 pp -121.95 140.73 44.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.0 -0.68 . . . . 0.0 112.285 -178.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.57 HG12 ' O ' ' A' ' 46' ' ' LEU . 1.5 p -125.16 134.5 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.044 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 9.1 mm -114.36 155.27 15.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.616 0.722 . . . . 0.0 110.921 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 1.038 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 31.9 t70 -142.57 28.56 1.62 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.659 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.766 HG22 ' CG2' ' A' ' 44' ' ' ILE . 39.3 t . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.81 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.54 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 40.7 ttm-85 . . . . . 0 N--CA 1.465 0.292 0 CA-C-O 120.743 0.306 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 1.044 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 47.8 mt -103.72 134.38 47.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.915 0.388 . . . . 0.0 111.716 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.892 ' CG2' HG11 ' A' ' 31' ' ' VAL . 6.3 p -134.88 135.9 52.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.308 178.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.998 ' HB2' HD11 ' A' ' 58' ' ' ILE . 3.0 mm? -141.63 142.12 33.42 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 177.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.017 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.6 mp -121.71 135.05 63.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.702 0.286 . . . . 0.0 110.336 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.717 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 7.3 m120 54.48 34.86 0.26 Allowed Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.907 ' HG2' HG12 ' A' ' 58' ' ' ILE . 89.3 Cg_exo -56.39 146.8 71.58 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.766 2.311 . . . . 0.0 113.707 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -138.0 145.51 41.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.782 HD21 ' HE3' ' A' ' 80' ' ' LYS . 29.8 tp -79.12 138.2 37.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.424 0.63 . . . . 0.0 112.084 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.035 HD21 ' HG3' ' A' ' 109' ' ' ARG . 2.7 mm? -112.77 -43.55 3.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.474 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 39.2 tt0 -157.21 147.81 21.31 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.211 0.529 . . . . 0.0 111.949 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.895 ' HA ' HG12 ' A' ' 106' ' ' VAL . 19.3 ptpt -143.08 146.01 33.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.34 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.0 t -157.07 149.81 23.47 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.352 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.759 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 78.11 156.12 8.52 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.718 -0.754 . . . . 0.0 111.499 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -131.3 113.22 13.53 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.965 0.888 . . . . 0.0 112.632 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.872 ' HB ' HH12 ' A' ' 102' ' ' ARG . 1.5 p -105.98 161.9 14.06 Favored 'General case' 0 CA--C 1.487 -1.447 0 CA-C-N 114.016 -1.447 . . . . 0.0 114.894 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.843 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -149.22 118.05 0.92 Allowed Glycine 0 C--N 1.314 -0.674 0 CA-C-N 113.103 -1.862 . . . . 0.0 111.047 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.719 ' N ' ' HG ' ' A' ' 99' ' ' LEU . 32.5 mt -148.79 140.45 17.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 117.432 0.616 . . . . 0.0 111.84 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 55.8 mt-10 -71.14 139.18 50.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 123.135 1.445 . . . . 0.0 112.104 -176.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.627 ' HA ' ' HD2' ' A' ' 97' ' ' ARG . 84.1 mt-10 -157.5 162.44 38.88 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 112.543 -2.117 . . . . 0.0 111.774 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.744 ' N ' ' HG2' ' A' ' 97' ' ' ARG . . . -120.94 162.97 14.53 Favored Glycine 0 CA--C 1.5 -0.905 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 11.2 m -116.28 139.38 50.44 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 117.564 0.682 . . . . 0.0 110.763 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.047 HD12 ' HG2' ' A' ' 41' ' ' GLU . 2.5 mm? -47.25 -20.58 0.2 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.501 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.897 ' CB ' HG12 ' A' ' 8' ' ' ILE . 31.5 m -86.53 -41.82 14.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.537 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.784 HD13 ' HB ' ' A' ' 8' ' ' ILE . 44.0 mm . . . . . 0 CA--C 1.539 0.553 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.199 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.744 ' HG2' ' N ' ' A' ' 89' ' ' GLY . 74.9 mtm180 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 121.36 0.6 . . . . 0.0 110.375 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -125.1 147.31 49.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.414 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.843 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.7 tt -75.26 111.94 11.03 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.707 0.765 . . . . 0.0 110.512 -178.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.53 HG13 ' CD ' ' A' ' 102' ' ' ARG . 12.2 p -97.93 133.05 23.67 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.93 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.594 ' HA ' ' O ' ' A' ' 84' ' ' THR . 95.6 Cg_endo -88.29 125.71 1.86 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.391 2.061 . . . . 0.0 112.227 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.96 ' HG3' HG23 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -144.4 166.77 24.16 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.798 0.839 . . . . 0.0 109.653 179.84 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.759 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.29 154.62 41.39 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.883 0.373 . . . . 0.0 110.1 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -73.06 -40.56 64.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.72 -176.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.751 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 89.3 mttt -139.82 140.34 36.57 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.34 0.59 . . . . 0.0 109.481 177.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.895 HG12 ' HA ' ' A' ' 80' ' ' LYS . 30.3 m -149.03 140.17 17.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.07 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.989 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 23.4 mmtp -107.63 126.42 52.55 Favored 'General case' 0 N--CA 1.461 0.091 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 1.053 HD11 HD11 ' A' ' 130' ' ' ILE . 1.7 pp -135.4 151.05 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -176.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 1.035 ' HG3' HD21 ' A' ' 78' ' ' LEU . 91.8 mtt180 -102.36 137.54 40.47 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.205 -178.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.726 ' HB3' HD12 ' A' ' 72' ' ' LEU . . . -160.64 169.01 23.73 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.908 -177.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 1.017 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.4 pp -116.39 151.64 35.54 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.732 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 18.9 t70 -83.66 165.4 18.99 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -176.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.824 ' HB2' HG21 ' A' ' 71' ' ' VAL . 52.9 ttp180 -52.2 -20.95 2.92 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.58 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -79.37 -25.85 42.14 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.699 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.981 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 106.31 36.57 2.65 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.712 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -128.44 102.6 20.48 Favored Pre-proline 0 C--O 1.236 0.377 0 CA-C-N 117.067 0.433 . . . . 0.0 110.731 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.679 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 34.2 Cg_exo -71.92 114.98 4.13 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 121.777 1.651 . . . . 0.0 115.596 -177.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.732 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 12.1 p90 -128.06 168.08 15.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.574 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.525 ' CG ' ' HG2' ' A' ' 109' ' ' ARG . 27.7 mp0 -107.35 130.28 54.81 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.727 ' O ' HD12 ' A' ' 120' ' ' LEU . 4.3 pp -126.33 133.73 51.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.566 -178.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.989 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 11.5 pt-20 -93.04 123.8 36.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.629 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.939 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -116.83 134.97 54.13 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.751 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.2 m-20 -127.04 162.49 25.91 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.67 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 51.83 -136.35 33.34 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 120.293 1.406 . . . . 0.0 115.426 177.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 74.4 mt -54.84 -33.8 62.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.719 -0.741 . . . . 0.0 111.706 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.939 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.3 OUTLIER -71.47 -51.6 22.87 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.851 0.834 . . . . 0.0 109.15 179.619 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.738 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -58.82 -43.0 90.53 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.258 -1.337 . . . . 0.0 111.91 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.96 HG23 ' HG3' ' A' ' 102' ' ' ARG . 50.3 mm -67.96 -55.72 15.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.547 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 84.2 m -58.73 -50.67 73.06 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 1.053 HD11 HD11 ' A' ' 108' ' ' ILE . 20.4 tt -58.24 -43.84 86.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.13 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.776 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.4 pt20 -67.73 -37.9 82.83 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.083 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.579 ' NE2' ' HD2' ' A' ' 136' ' ' HIS . 3.8 t-160 -58.88 -47.4 85.06 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.872 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.6 mm-40 -59.61 -42.43 92.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.083 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.961 ' HA ' HD21 ' A' ' 137' ' ' LEU . 30.1 mtm -57.33 -47.48 81.44 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.832 0.825 . . . . 0.0 109.902 178.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.611 ' HB3' ' O ' ' A' ' 140' ' ' LYS . 57.8 m-20 -62.51 -47.59 83.28 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.197 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.579 ' HD2' ' NE2' ' A' ' 132' ' ' HIS . 6.2 t-80 -59.45 -52.96 63.37 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.123 0.487 . . . . 0.0 111.557 -178.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.961 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.5 pp -57.93 -31.47 66.84 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.308 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 1.004 HG23 HG13 ' A' ' 16' ' ' VAL . 14.7 p -86.86 22.78 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-O 122.356 1.074 . . . . 0.0 109.359 176.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.669 ' HA3' ' C ' ' A' ' 14' ' ' ARG . . . 53.28 38.45 56.99 Favored Glycine 0 CA--C 1.481 -2.041 0 CA-C-N 113.331 -1.759 . . . . 0.0 112.17 176.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.962 ' HG2' HG13 ' A' ' 138' ' ' VAL . 2.4 ptmt . . . . . 0 N--CA 1.42 -1.935 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.83 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.878 ' CG1' ' HA ' ' A' ' 37' ' ' THR . 27.1 m . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.787 0.327 . . . . 0.0 111.388 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.98 HD11 ' HB ' ' A' ' 51' ' ' VAL . 1.1 pt? -79.68 -158.69 0.17 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.561 ' HG3' ' HB3' ' A' ' 52' ' ' ASP . 23.4 pt20 -88.66 104.43 16.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.882 0.372 . . . . 0.0 111.88 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.036 HG11 HD12 ' A' ' 91' ' ' LEU . 49.1 t -89.38 131.66 36.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-O 121.251 0.548 . . . . 0.0 111.953 -178.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.138 ' HB2' HD21 ' A' ' 13' ' ' LEU . 22.6 mt -91.08 140.11 30.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.998 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.621 ' HA ' ' CA ' ' A' ' 92' ' ' SER . 37.1 m-70 -112.53 140.6 47.15 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.083 HD13 HD12 ' A' ' 13' ' ' LEU . 37.1 mm -61.81 132.88 93.51 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.81 176.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -79.89 148.25 78.78 Favored 'Cis proline' 0 C--N 1.352 0.719 0 C-N-CA 124.795 -0.919 . . . . 0.0 111.67 -0.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 1.028 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 9.0 t0 -165.1 131.09 2.73 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.403 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 23.8 pt-20 -58.45 -45.8 87.85 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.774 0.321 . . . . 0.0 110.643 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.676 ' O ' ' HB ' ' A' ' 49' ' ' THR . 14.7 mmt85 -59.67 -26.44 65.55 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 1.138 HD21 ' HB2' ' A' ' 6' ' ' LEU . 9.9 mt -77.42 -31.43 54.02 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 120.736 1.607 . . . . 0.0 108.39 177.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.689 ' C ' ' HA3' ' A' ' 139' ' ' GLY . 25.2 mmm-85 -94.46 10.43 34.52 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.108 -1.406 . . . . 0.0 109.173 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.654 ' NZ ' ' HB2' ' A' ' 54' ' ' HIS . 64.2 tttm -84.64 141.2 30.8 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.196 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.933 HG13 ' CG2' ' A' ' 138' ' ' VAL . 61.8 t -84.22 94.95 3.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.201 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.848 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -57.71 145.12 35.54 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.887 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -104.42 134.77 19.51 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.596 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.639 ' HD3' ' HD3' ' A' ' 56' ' ' ARG . 58.8 Cg_endo -80.26 115.74 3.24 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.235 1.957 . . . . 0.0 110.384 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.759 HG12 ' H ' ' A' ' 22' ' ' GLU . 16.4 t -69.23 144.3 14.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 122.476 1.131 . . . . 0.0 113.177 -175.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -62.48 -23.59 66.99 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 113.197 -1.82 . . . . 0.0 112.57 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.759 ' H ' HG12 ' A' ' 20' ' ' VAL . 34.8 tp10 -160.03 148.0 16.82 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 121.034 -0.267 . . . . 0.0 110.744 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.868 HG21 ' HA2' ' A' ' 115' ' ' GLY . 3.0 t -82.44 105.83 12.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 1.045 ' H ' HD12 ' A' ' 27' ' ' ILE . 64.8 m-80 -89.23 157.85 18.09 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.988 -178.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.544 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -54.53 -31.48 56.38 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.509 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -71.28 -37.57 71.87 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 177.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 1.045 HD12 ' H ' ' A' ' 24' ' ' ASN . 63.4 mt -64.25 -47.15 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.143 178.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 51.0 mt-30 -57.65 -39.86 78.0 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.027 0.441 . . . . 0.0 110.733 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.544 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 38.9 mmt180 -60.99 -40.09 92.15 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.543 0.687 . . . . 0.0 109.159 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.825 ' O ' ' HG3' ' A' ' 34' ' ' MET . 4.6 mt -58.62 -49.66 81.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.879 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.819 HG21 ' CD1' ' A' ' 73' ' ' ILE . 17.9 t -68.47 -41.32 83.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.916 0.388 . . . . 0.0 111.422 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.877 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 47.8 m-20 -53.24 -46.11 69.01 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.588 0.709 . . . . 0.0 111.53 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.498 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 1.4 m-20 -74.71 -30.21 61.46 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.661 176.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 1.039 ' HG2' HG21 ' A' ' 51' ' ' VAL . 87.3 mtp -59.61 -47.0 87.29 Favored 'General case' 0 C--N 1.345 0.378 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.723 -177.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.877 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 17.4 p90 -69.54 -44.38 71.05 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.743 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 77.9 mt-10 -51.65 -42.64 62.23 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.878 ' HA ' ' CG1' ' A' ' 2' ' ' VAL . 76.8 m -69.33 -60.42 2.35 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 118.79 -1.164 . . . . 0.0 108.487 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 1.016 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 3.2 ttp -46.24 -43.33 15.38 Favored 'General case' 0 CA--C 1.463 -2.385 0 C-N-CA 123.749 0.819 . . . . 0.0 109.869 -170.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.698 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 58.9 m-85 -68.96 -42.02 77.21 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.878 178.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.55 ' HB3' ' CG1' ' A' ' 2' ' ' VAL . . . -60.14 -28.9 68.27 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.626 0.727 . . . . 0.0 109.045 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.782 ' HG2' ' CD2' ' A' ' 91' ' ' LEU . 3.2 tp10 -83.95 -10.15 58.16 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 114.392 -1.276 . . . . 0.0 108.835 177.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.436 ' H ' ' C ' ' A' ' 39' ' ' TYR . 19.2 mt-10 62.41 25.42 15.16 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.916 -176.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.96 140.61 22.53 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.187 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.83 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 38.5 mt -79.2 0.42 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 117.829 0.815 . . . . 0.0 111.93 -178.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.497 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . -179.75 133.5 2.04 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-O 119.215 -0.77 . . . . 0.0 112.066 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.985 ' HB2' ' HG3' ' A' ' 38' ' ' MET . 9.2 tp -125.31 135.37 52.42 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-N 119.531 1.665 . . . . 0.0 111.712 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.48 ' HB1' ' HB3' ' A' ' 137' ' ' LEU . . . -101.45 130.63 47.73 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.887 ' HB1' ' CG1' ' A' ' 53' ' ' ILE . . . -29.31 -56.16 0.15 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 115.902 1.815 . . . . 0.0 115.902 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.676 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 77.2 p -53.82 -34.73 60.11 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.725 0.774 . . . . 0.0 111.378 -178.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.492 ' NE2' ' HB3' ' A' ' 90' ' ' CYS . 37.2 mt-30 -65.34 -38.52 90.34 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.168 -1.378 . . . . 0.0 109.843 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.039 HG21 ' HG2' ' A' ' 34' ' ' MET . 1.6 m -89.1 13.42 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 121.013 0.435 . . . . 0.0 111.752 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.813 ' HA ' HD11 ' A' ' 6' ' ' LEU . 38.2 t70 77.13 35.27 0.36 Allowed 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 176.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.887 ' CG1' ' HB1' ' A' ' 48' ' ' ALA . 1.2 pp -125.81 110.87 25.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 119.495 -0.882 . . . . 0.0 109.706 176.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.654 ' HB2' ' NZ ' ' A' ' 15' ' ' LYS . 23.4 p-80 -75.99 64.76 1.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 122.098 0.952 . . . . 0.0 110.145 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.813 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 89.3 mt-30 -153.97 131.83 11.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.934 -1.485 . . . . 0.0 108.146 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 1.043 ' HA ' HD22 ' A' ' 137' ' ' LEU . 60.1 mtp85 -62.81 74.55 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 -178.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.769 ' CG2' HG22 ' A' ' 31' ' ' VAL . 29.7 mm -116.56 124.2 72.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.081 HD11 ' HB2' ' A' ' 72' ' ' LEU . 1.9 pp -127.67 145.51 34.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -177.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.651 HG22 ' O ' ' A' ' 46' ' ' LEU . 33.7 m -127.44 136.33 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.123 179.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.969 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 1.3 mt -116.44 147.92 19.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.785 0.803 . . . . 0.0 110.698 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 1.016 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 33.2 t70 -136.07 30.23 3.04 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.217 -178.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.815 HG22 HG22 ' A' ' 44' ' ' ILE . 24.4 t . . . . . 0 N--CA 1.462 0.147 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.16 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.629 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 72.9 ttt180 . . . . . 0 N--CA 1.466 0.358 0 CA-C-O 120.798 0.332 . . . . 0.0 111.401 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.969 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 65.0 mt -104.28 133.1 49.77 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.804 ' C ' HD22 ' A' ' 72' ' ' LEU . 14.5 p -135.01 134.38 53.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.291 177.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.081 ' HB2' HD11 ' A' ' 58' ' ' ILE . 3.0 mm? -140.01 141.73 36.3 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 177.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.985 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 3.5 mm -120.43 134.32 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 121.232 0.539 . . . . 0.0 111.548 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.7 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 6.7 m120 51.36 38.68 0.54 Allowed Pre-proline 0 C--N 1.317 -0.807 0 CA-C-N 115.217 -0.902 . . . . 0.0 112.323 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.77 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 84.5 Cg_exo -54.92 149.78 40.7 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.974 2.449 . . . . 0.0 114.104 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.44 ' O ' ' HB ' ' A' ' 108' ' ' ILE . 15.7 pt-20 -135.79 142.36 44.89 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.809 HD23 ' N ' ' A' ' 78' ' ' LEU . 1.7 tt -81.79 134.21 35.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.643 0.735 . . . . 0.0 111.806 -178.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.116 HD11 ' HG3' ' A' ' 109' ' ' ARG . 6.7 mp -110.74 -37.51 5.41 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.691 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.569 ' C ' ' HE2' ' A' ' 80' ' ' LYS . 85.2 tt0 -160.28 153.71 22.19 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.186 0.517 . . . . 0.0 111.782 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.901 ' HA ' HG12 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -148.03 151.7 36.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.378 179.125 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.7 m -160.46 141.55 12.06 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.578 0.228 . . . . 0.0 110.984 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.783 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 80.35 168.33 38.0 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.235 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -146.26 113.73 6.33 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.672 0.749 . . . . 0.0 112.926 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.554 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.5 p -99.54 160.91 13.94 Favored 'General case' 0 CA--C 1.49 -1.331 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.718 ' O ' HD13 ' A' ' 86' ' ' ILE . . . -134.44 100.51 0.38 Allowed Glycine 0 C--N 1.317 -0.475 0 CA-C-N 113.064 -1.88 . . . . 0.0 111.132 178.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.718 HD13 ' O ' ' A' ' 85' ' ' GLY . 39.5 mm -143.73 135.51 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -178.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.645 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 49.0 mt-10 -72.96 143.89 47.48 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 122.389 1.09 . . . . 0.0 112.499 -178.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.552 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 50.4 mt-10 -154.16 166.15 34.0 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 113.619 -1.628 . . . . 0.0 109.053 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.771 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -119.87 159.61 14.89 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 119.304 -1.427 . . . . 0.0 109.623 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.749 ' HB2' HG13 ' A' ' 93' ' ' ILE . 69.2 m -111.71 138.83 47.76 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.552 -177.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.036 HD12 HG11 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -50.04 -32.36 15.24 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.535 0.683 . . . . 0.0 110.0 -179.636 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.792 ' HB2' HG12 ' A' ' 8' ' ' ILE . 11.4 m -77.78 -27.14 50.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.7 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.749 HG13 ' HB2' ' A' ' 90' ' ' CYS . 48.5 mt . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.617 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.771 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 81.1 mtm180 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 121.652 0.739 . . . . 0.0 111.377 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.84 148.28 49.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.874 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.682 HD23 ' N ' ' A' ' 100' ' ' VAL . 6.9 tt -75.23 135.73 40.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.208 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.775 ' HB ' ' NH2' ' A' ' 102' ' ' ARG . 55.8 t -131.97 131.49 22.61 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.173 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.554 ' HA ' ' O ' ' A' ' 84' ' ' THR . 74.3 Cg_endo -78.24 125.43 7.1 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.692 1.595 . . . . 0.0 113.137 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.892 ' HG2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -141.42 165.51 27.31 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.413 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.783 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -69.38 154.75 41.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.727 0.299 . . . . 0.0 110.513 -178.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -73.41 -43.33 60.68 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.243 -176.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.782 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 84.2 mttt -139.47 138.19 36.19 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.416 0.627 . . . . 0.0 109.624 176.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.901 HG12 ' HA ' ' A' ' 80' ' ' LYS . 28.3 m -144.52 140.38 23.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.991 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 1.052 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 23.6 mmtp -107.99 125.92 52.1 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 1.056 ' HA ' HD13 ' A' ' 78' ' ' LEU . 1.9 pp -132.0 161.36 41.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -177.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 1.116 ' HG3' HD11 ' A' ' 78' ' ' LEU . 92.2 mtt180 -109.58 137.53 47.28 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.782 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.73 ' HB3' HD12 ' A' ' 72' ' ' LEU . . . -155.1 166.5 33.38 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.655 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.985 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.0 pp -116.46 150.47 37.81 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.623 ' O ' HD12 ' A' ' 111' ' ' LEU . 22.0 t70 -84.0 171.33 13.06 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.579 -175.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.776 ' HD2' ' OD1' ' A' ' 32' ' ' ASP . 50.8 ttp180 -54.49 -23.43 16.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.798 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.52 -14.41 58.89 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.873 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.868 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 93.15 40.09 4.94 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.02 -1.086 . . . . 0.0 114.593 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -128.11 102.49 21.49 Favored Pre-proline 0 N--CA 1.469 0.479 0 CA-C-N 117.59 0.695 . . . . 0.0 110.389 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.668 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 32.3 Cg_exo -73.56 115.23 4.26 Favored 'Trans proline' 0 C--N 1.359 1.108 0 N-CA-C 116.249 1.596 . . . . 0.0 116.249 -177.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.64 168.95 13.01 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.739 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.667 ' HG2' ' HG2' ' A' ' 109' ' ' ARG . 36.1 mt-10 -107.6 130.03 54.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.008 0.432 . . . . 0.0 110.278 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.751 HD11 ' CD1' ' A' ' 130' ' ' ILE . 4.1 pp -126.71 134.27 50.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.804 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 1.052 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 15.5 pt-20 -96.79 124.35 40.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.004 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.739 ' O ' ' HB2' ' A' ' 127' ' ' ALA . . . -116.71 135.79 53.49 Favored 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.782 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.3 m-20 -125.99 164.71 20.24 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.737 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 45.14 -132.53 8.26 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 120.627 1.558 . . . . 0.0 116.194 177.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.678 HD12 ' H ' ' A' ' 125' ' ' LEU . 5.0 mp -54.09 -35.83 62.53 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.739 -0.731 . . . . 0.0 111.361 -178.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.723 HD22 ' CB ' ' A' ' 122' ' ' ALA . 0.6 OUTLIER -70.44 -53.02 18.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.581 0.705 . . . . 0.0 109.655 179.721 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -58.46 -41.09 84.38 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.884 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.892 HD12 ' HG2' ' A' ' 102' ' ' ARG . 51.0 mm -68.8 -54.87 18.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.522 -178.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.493 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 31.4 p -57.77 -50.33 73.61 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.824 HD11 HD11 ' A' ' 108' ' ' ILE . 20.6 tt -60.07 -43.9 93.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.609 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.878 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 23.3 pt20 -66.97 -37.42 84.21 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.231 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.629 ' HA ' ' OD1' ' A' ' 135' ' ' ASP . 8.5 t-160 -56.04 -47.11 78.48 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.717 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 3.8 mm-40 -60.68 -43.03 98.21 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.711 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.784 ' HE1' ' N ' ' A' ' 77' ' ' LEU . 76.2 mtp -61.0 -49.49 77.24 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.453 0.569 . . . . 0.0 111.66 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.629 ' OD1' ' HA ' ' A' ' 132' ' ' HIS . 6.6 p-10 -65.18 -45.85 83.19 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.552 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.471 ' HD2' ' NE2' ' A' ' 132' ' ' HIS . 18.3 t-80 -59.67 -52.34 65.93 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 121.9 -0.5 . . . . 0.0 112.035 -178.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 1.043 HD22 ' HA ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER -62.51 -29.41 70.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.656 -177.206 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.933 ' CG2' HG13 ' A' ' 16' ' ' VAL . 8.4 p -81.15 21.56 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 CA-C-O 123.067 1.413 . . . . 0.0 107.816 173.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.799 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 56.16 24.7 44.93 Favored Glycine 0 CA--C 1.487 -1.7 0 CA-C-N 111.934 -2.394 . . . . 0.0 112.587 176.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.91 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 6.2 ptmt . . . . . 0 N--CA 1.427 -1.576 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.435 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.7 m . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.121 0.486 . . . . 0.0 111.771 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.968 HD23 ' HB ' ' A' ' 51' ' ' VAL . 61.5 tp -77.45 162.37 27.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.374 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -78.82 106.48 10.86 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.251 0.548 . . . . 0.0 110.282 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.677 HG22 HG12 ' A' ' 51' ' ' VAL . 33.4 t -89.93 131.69 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.788 -178.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.828 ' CD1' ' HA ' ' A' ' 52' ' ' ASP . 39.1 mt -89.49 149.35 22.95 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.135 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.582 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 1.9 m80 -124.37 149.79 46.26 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.61 HD12 ' H ' ' A' ' 8' ' ' ILE . 2.9 mp -55.81 145.54 51.71 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.835 178.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.517 ' HA ' HG23 ' A' ' 8' ' ' ILE . 71.5 Cg_endo -92.35 51.19 1.06 Allowed 'Cis proline' 0 C--N 1.355 0.916 0 C-N-CA 124.572 -1.012 . . . . 0.0 112.915 0.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.693 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 9.9 t70 -55.65 130.86 44.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.896 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -59.17 -40.13 84.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.016 0.436 . . . . 0.0 111.139 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.647 ' HB2' HD13 ' A' ' 6' ' ' LEU . 19.0 mmt-85 -57.65 -26.07 61.09 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.645 0.979 . . . . 0.0 113.645 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.792 HD21 ' HB2' ' A' ' 6' ' ' LEU . 8.8 mt -76.21 -33.24 59.26 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 120.61 1.55 . . . . 0.0 108.434 177.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.44 ' C ' ' HA3' ' A' ' 139' ' ' GLY . 32.1 mmt180 -91.82 7.99 39.28 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.631 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.537 ' HD3' ' HB3' ' A' ' 54' ' ' HIS . 87.8 tttt -88.3 148.39 24.33 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.089 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.763 HG13 HG23 ' A' ' 138' ' ' VAL . 97.1 t -82.68 128.79 38.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.936 ' HB3' HD12 ' A' ' 137' ' ' LEU . . . -86.24 143.57 27.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.394 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.811 ' HD3' ' CD ' ' A' ' 19' ' ' PRO . 7.6 tmtt? -106.33 130.16 23.39 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.889 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 60.9 Cg_endo -78.14 116.47 3.93 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.342 2.028 . . . . 0.0 111.26 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.747 HG12 ' H ' ' A' ' 22' ' ' GLU . 19.3 t -67.08 144.7 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-O 122.803 1.287 . . . . 0.0 113.14 -175.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.96 -24.51 67.92 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 112.57 -2.105 . . . . 0.0 112.68 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.747 ' H ' HG12 ' A' ' 20' ' ' VAL . 88.6 tt0 -161.01 143.52 12.54 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.975 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.57 HG21 ' HA2' ' A' ' 115' ' ' GLY . 3.3 t -79.55 107.7 12.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 1.041 ' H ' HD12 ' A' ' 27' ' ' ILE . 57.4 m-80 -98.06 158.51 15.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.686 -178.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.73 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -55.72 -23.82 31.21 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.215 0.531 . . . . 0.0 110.678 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.513 ' HA ' ' OE1' ' A' ' 26' ' ' GLU . 4.3 mm-40 -74.05 -41.83 61.18 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 176.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 1.041 HD12 ' H ' ' A' ' 24' ' ' ASN . 69.0 mt -64.01 -48.24 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.245 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -57.15 -40.06 76.48 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.73 ' HG3' ' O ' ' A' ' 25' ' ' ALA . 99.3 mtt180 -61.76 -39.8 92.93 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.747 ' CG2' HD13 ' A' ' 53' ' ' ILE . 4.1 mt -56.91 -50.01 77.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 114.832 -1.076 . . . . 0.0 112.075 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.766 HG22 ' CG2' ' A' ' 57' ' ' ILE . 10.5 t -68.58 -42.16 83.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 120.842 0.353 . . . . 0.0 111.432 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.813 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -55.76 -39.48 71.26 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.33 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.497 ' HB3' ' HB2' ' A' ' 3' ' ' LEU . 31.6 m-20 -76.07 -30.45 58.35 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.985 175.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.98 ' HE1' HG22 ' A' ' 57' ' ' ILE . 15.2 mtm -60.58 -46.66 89.42 Favored 'General case' 0 C--N 1.347 0.465 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.44 -177.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.813 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 14.0 p90 -69.05 -46.43 67.91 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.555 ' HG2' ' O ' ' A' ' 32' ' ' ASP . 27.2 mm-40 -51.05 -38.57 52.31 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.672 HG21 ' CG2' ' A' ' 5' ' ' VAL . 57.5 m -69.83 -62.31 1.44 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 118.725 -1.19 . . . . 0.0 108.272 177.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.932 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 2.9 ttp -46.58 -44.25 17.9 Favored 'General case' 0 CA--C 1.458 -2.578 0 C-N-CA 124.016 0.926 . . . . 0.0 110.412 -170.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.713 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 70.0 m-85 -67.67 -41.73 83.24 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.794 178.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.38 -26.67 66.82 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.773 0.796 . . . . 0.0 109.038 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.965 ' HG2' HD12 ' A' ' 91' ' ' LEU . 2.6 tp10 -86.74 -10.89 52.63 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 114.361 -1.29 . . . . 0.0 109.155 177.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.445 ' H ' ' C ' ' A' ' 39' ' ' TYR . 27.7 mm-40 63.94 26.6 14.22 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.107 -176.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.56 144.49 25.54 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.111 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.857 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 46.0 mm -79.25 -3.93 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 117.631 0.715 . . . . 0.0 112.141 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.543 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 179.19 137.9 3.07 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-O 119.109 -0.828 . . . . 0.0 111.302 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.067 HD13 ' HG ' ' A' ' 91' ' ' LEU . 2.3 tp -124.39 135.22 53.12 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.285 1.542 . . . . 0.0 110.828 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -103.68 130.62 51.18 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 122.085 -0.384 . . . . 0.0 111.299 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.956 ' HB1' HG13 ' A' ' 53' ' ' ILE . . . -28.51 -57.99 0.13 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 116.647 2.092 . . . . 0.0 116.647 -177.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.519 ' CG2' ' HA ' ' A' ' 137' ' ' LEU . 74.9 p -53.42 -34.69 58.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 122.098 0.951 . . . . 0.0 111.478 -177.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.621 ' HG2' ' CE1' ' A' ' 136' ' ' HIS . 23.2 mt-30 -63.56 -38.47 91.26 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 113.929 -1.487 . . . . 0.0 110.686 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.968 ' HB ' HD23 ' A' ' 3' ' ' LEU . 1.5 m -92.52 19.44 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.828 ' HA ' ' CD1' ' A' ' 6' ' ' LEU . 37.5 t70 78.25 25.99 0.58 Allowed 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 176.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.956 HG13 ' HB1' ' A' ' 48' ' ' ALA . 11.9 pt -120.36 108.56 23.38 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.131 177.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.554 ' HD2' ' HE ' ' A' ' 12' ' ' ARG . 7.8 p80 -75.41 51.2 0.56 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-O 122.16 0.981 . . . . 0.0 109.905 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.546 ' O ' HG12 ' A' ' 57' ' ' ILE . 83.2 mt-30 -139.01 132.52 30.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 113.892 -1.504 . . . . 0.0 107.716 178.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.889 ' HD2' ' HD3' ' A' ' 19' ' ' PRO . 96.0 mtt180 -61.79 72.52 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -178.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.98 HG22 ' HE1' ' A' ' 34' ' ' MET . 10.3 mm -116.35 122.75 70.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.101 HD11 ' HB2' ' A' ' 72' ' ' LEU . 1.8 pp -127.0 145.4 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 -177.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.61 ' CG2' ' HB3' ' A' ' 46' ' ' LEU . 33.9 m -128.71 134.95 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.362 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.045 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 1.6 mt -116.54 145.45 22.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.504 0.669 . . . . 0.0 110.344 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.932 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 28.0 t70 -124.69 16.29 8.75 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.391 -178.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.787 HG22 ' CG2' ' A' ' 44' ' ' ILE . 29.8 t . . . . . 0 C--N 1.332 -0.155 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.598 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.552 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 35.5 ttt85 . . . . . 0 N--CA 1.465 0.319 0 CA-C-O 120.847 0.356 . . . . 0.0 110.83 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 1.045 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 63.8 mt -102.69 135.16 44.84 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.721 ' CG2' HG11 ' A' ' 31' ' ' VAL . 12.5 p -134.74 130.5 52.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.083 178.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.101 ' HB2' HD11 ' A' ' 58' ' ' ILE . 90.6 mt -141.37 142.2 33.78 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.59 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.049 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.6 mp -121.27 134.87 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-O 120.652 0.263 . . . . 0.0 110.901 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.709 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 7.2 m120 57.02 37.56 0.38 Allowed Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.914 ' HG2' HG12 ' A' ' 58' ' ' ILE . 88.4 Cg_exo -56.59 145.72 79.48 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 122.838 2.359 . . . . 0.0 114.101 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.487 ' HG2' ' HB2' ' A' ' 109' ' ' ARG . 15.2 pt-20 -136.89 142.22 42.75 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.786 HD23 ' N ' ' A' ' 78' ' ' LEU . 1.7 tt -81.84 133.27 35.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.375 0.607 . . . . 0.0 111.753 -178.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.114 HD13 ' HA ' ' A' ' 108' ' ' ILE . 4.8 mp -108.82 -39.14 5.43 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.997 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.443 ' O ' HD21 ' A' ' 77' ' ' LEU . 42.4 tt0 -156.36 152.83 28.06 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 121.192 0.52 . . . . 0.0 111.764 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 1.056 ' HA ' HG12 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -147.28 149.81 33.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.936 179.385 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.3 p -160.07 152.94 21.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.79 0.329 . . . . 0.0 111.571 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.684 ' C ' ' HG3' ' A' ' 104' ' ' GLU . . . 73.63 146.33 0.92 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.749 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.408 ' N ' ' HG3' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -110.98 112.62 24.58 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 121.631 0.729 . . . . 0.0 111.229 -179.771 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 1.035 HG23 ' HG2' ' A' ' 104' ' ' GLU . 1.6 p -114.81 160.94 18.86 Favored 'General case' 0 CA--C 1.484 -1.595 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.801 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -155.83 123.26 1.3 Allowed Glycine 0 C--N 1.311 -0.855 0 CA-C-N 113.01 -1.904 . . . . 0.0 110.95 178.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.451 ' N ' ' HG ' ' A' ' 99' ' ' LEU . 34.4 mt -147.34 139.18 18.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-N 117.643 0.722 . . . . 0.0 111.834 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 56.1 mt-10 -71.23 135.15 47.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 123.538 1.637 . . . . 0.0 112.349 -176.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.702 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 41.0 mt-10 -154.24 166.61 32.61 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 112.132 -2.304 . . . . 0.0 111.425 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.791 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -120.73 163.3 14.32 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.754 ' HB2' ' CG1' ' A' ' 93' ' ' ILE . 65.1 m -109.64 137.42 47.49 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.865 0.364 . . . . 0.0 110.926 -177.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.067 ' HG ' HD13 ' A' ' 46' ' ' LEU . 3.1 mm? -51.53 -38.66 55.24 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.73 0.776 . . . . 0.0 109.719 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.64 ' CB ' HD13 ' A' ' 13' ' ' LEU . 22.8 m -77.12 -26.66 53.45 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.59 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.754 ' CG1' ' HB2' ' A' ' 90' ' ' CYS . 53.1 mt . . . . . 0 CA--C 1.533 0.293 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.791 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 18.4 mtm105 . . . . . 0 N--CA 1.464 0.248 0 CA-C-O 121.852 0.834 . . . . 0.0 111.638 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 87' ' ' GLU . . . -135.15 155.55 50.51 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.273 -1.33 . . . . 0.0 109.22 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.801 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.5 tt -76.52 110.86 11.42 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.828 0.823 . . . . 0.0 111.532 -177.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.816 ' HB ' ' CZ ' ' A' ' 102' ' ' ARG . 40.3 t -98.4 126.16 40.53 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 114.415 -1.266 . . . . 0.0 112.021 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.574 ' HA ' ' O ' ' A' ' 84' ' ' THR . 81.7 Cg_endo -78.84 126.55 7.31 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.318 2.012 . . . . 0.0 112.277 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.89 ' HG2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -145.03 166.77 24.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.637 179.011 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.59 154.94 40.95 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.208 0.527 . . . . 0.0 110.283 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 1.035 ' HG2' HG23 ' A' ' 84' ' ' THR . 50.0 mt-10 -73.61 -42.19 61.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.645 -176.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.797 ' NZ ' ' HB3' ' A' ' 123' ' ' ASP . 66.5 mttm -140.41 139.62 35.3 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 1.056 HG12 ' HA ' ' A' ' 80' ' ' LYS . 28.7 m -149.98 141.63 17.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.437 -178.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.697 ' CE ' ' HB3' ' A' ' 121' ' ' GLU . 0.4 OUTLIER -107.65 125.15 51.0 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.46 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 1.114 ' HA ' HD13 ' A' ' 78' ' ' LEU . 1.4 pp -135.42 151.8 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -176.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 1.042 ' HG3' HD11 ' A' ' 78' ' ' LEU . 94.2 mtt180 -100.81 138.54 37.73 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 122.214 1.007 . . . . 0.0 111.128 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.842 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -158.8 169.35 24.57 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.759 -176.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 1.049 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.9 pp -120.27 154.78 34.46 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.455 ' O ' HD12 ' A' ' 111' ' ' LEU . 25.1 t70 -88.15 164.43 15.69 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.443 0.64 . . . . 0.0 111.991 -176.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.72 ' HB2' HG11 ' A' ' 71' ' ' VAL . 24.6 ttm180 -52.62 -20.29 2.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.055 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -81.88 -22.22 37.0 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.03 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.57 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 105.11 35.86 3.06 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 119.893 -1.146 . . . . 0.0 113.857 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -128.62 102.4 20.16 Favored Pre-proline 0 C--O 1.235 0.325 0 CA-C-N 117.344 0.572 . . . . 0.0 111.185 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.676 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 36.4 Cg_exo -74.03 116.72 4.75 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 121.914 1.743 . . . . 0.0 115.715 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.427 ' N ' ' O ' ' A' ' 110' ' ' ALA . 0.5 OUTLIER -129.04 165.78 20.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.418 -179.278 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.84 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 5.8 mp0 -107.72 135.19 49.56 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.888 ' O ' HD23 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -132.39 142.26 49.22 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.679 0.752 . . . . 0.0 111.911 -179.137 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.697 ' HB3' ' CE ' ' A' ' 107' ' ' LYS . 15.2 pt-20 -94.13 123.44 37.51 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.877 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.895 ' CB ' ' HG ' ' A' ' 126' ' ' LEU . . . -115.85 134.47 54.96 Favored 'General case' 0 C--O 1.22 -0.489 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.572 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.797 ' HB3' ' NZ ' ' A' ' 105' ' ' LYS . 38.7 m-20 -127.04 162.19 26.64 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.78 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 48.42 -134.77 19.25 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 120.436 1.471 . . . . 0.0 115.491 177.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.657 HD22 ' H ' ' A' ' 125' ' ' LEU . 2.6 mm? -53.84 -35.17 61.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.052 -0.574 . . . . 0.0 111.34 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.895 ' HG ' ' CB ' ' A' ' 122' ' ' ALA . 3.7 tp -70.22 -52.34 23.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.372 0.606 . . . . 0.0 109.81 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.779 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -58.93 -42.94 90.91 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.328 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.89 HD12 ' HG2' ' A' ' 102' ' ' ARG . 47.1 mm -67.17 -56.11 14.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 31.4 p -56.47 -50.21 72.4 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 1.037 HD11 HD11 ' A' ' 108' ' ' ILE . 19.1 tt -58.91 -44.24 90.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.155 -178.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.876 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 23.1 pt20 -68.16 -37.77 81.38 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.071 178.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.726 ' HA ' ' OD2' ' A' ' 135' ' ' ASP . 10.9 t-160 -56.58 -50.0 73.23 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.57 0.7 . . . . 0.0 110.105 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.953 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.2 mm-40 -60.1 -42.24 94.27 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.576 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.878 ' HA ' HD21 ' A' ' 137' ' ' LEU . 74.2 mtp -57.18 -48.74 77.99 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.279 0.562 . . . . 0.0 111.059 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.726 ' OD2' ' HA ' ' A' ' 132' ' ' HIS . 3.3 p30 -66.38 -46.53 76.35 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.416 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.621 ' CE1' ' HG2' ' A' ' 50' ' ' GLN . 10.7 t-80 -56.12 -51.46 67.84 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.489 0.661 . . . . 0.0 110.768 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.953 HD23 ' O ' ' A' ' 133' ' ' GLU . 1.2 pp -61.35 -30.16 70.35 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.955 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.966 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 14.6 p -86.58 25.94 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-O 122.292 1.044 . . . . 0.0 109.549 176.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.614 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 59.32 15.31 30.43 Favored Glycine 0 CA--C 1.49 -1.511 0 CA-C-N 113.395 -1.73 . . . . 0.0 113.359 176.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.966 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 9.9 ptmt . . . . . 0 N--CA 1.424 -1.746 0 C-N-CA 119.617 -0.833 . . . . 0.0 108.932 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.725 HG13 ' HA ' ' A' ' 37' ' ' THR . 43.2 t . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.952 0.406 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 1.027 HD23 ' HB ' ' A' ' 51' ' ' VAL . 58.5 tp -77.11 165.74 24.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.404 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -78.82 107.11 11.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.084 0.469 . . . . 0.0 110.271 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.652 ' CG2' HG21 ' A' ' 37' ' ' THR . 39.0 t -89.69 131.58 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.652 -178.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.09 ' HB2' HD21 ' A' ' 13' ' ' LEU . 16.7 mt -93.52 141.33 28.59 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.497 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 35.2 m-70 -117.92 145.29 44.77 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.084 HD13 HD12 ' A' ' 13' ' ' LEU . 49.8 mm -61.0 133.56 92.58 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.229 177.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.66 145.35 69.87 Favored 'Cis proline' 0 C--N 1.353 0.779 0 C-N-CA 124.51 -1.037 . . . . 0.0 111.951 -0.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.992 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 8.8 t70 -165.04 127.1 2.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.402 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 16.1 pt-20 -58.44 -45.79 87.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.658 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.589 ' O ' ' HB ' ' A' ' 49' ' ' THR . 15.1 mmt85 -56.59 -27.97 59.21 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 1.09 HD21 ' HB2' ' A' ' 6' ' ' LEU . 10.0 mt -77.01 -35.09 57.3 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 120.585 1.539 . . . . 0.0 107.972 177.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.774 ' HB3' ' NH1' ' A' ' 14' ' ' ARG . 2.1 mmm180 -89.2 11.18 19.48 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.802 -1.545 . . . . 0.0 109.395 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.763 ' HD3' ' HB3' ' A' ' 54' ' ' HIS . 59.5 tttp -85.6 137.71 32.67 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.568 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.914 HG13 HG23 ' A' ' 138' ' ' VAL . 58.4 t -84.1 94.4 3.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.237 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.794 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -54.0 148.31 10.95 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -106.43 132.73 20.66 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.798 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.643 ' HD3' ' HD3' ' A' ' 56' ' ' ARG . 66.1 Cg_endo -78.2 114.72 3.61 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.174 1.916 . . . . 0.0 110.684 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.817 HG12 ' H ' ' A' ' 22' ' ' GLU . 17.8 t -69.14 144.4 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-O 122.521 1.153 . . . . 0.0 113.126 -175.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.47 -24.55 67.87 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 113.311 -1.768 . . . . 0.0 111.867 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.817 ' H ' HG12 ' A' ' 20' ' ' VAL . 42.4 tt0 -161.16 140.71 10.51 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.864 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.509 HG22 HD21 ' A' ' 111' ' ' LEU . 2.8 t -78.96 110.95 15.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 1.033 ' H ' HD12 ' A' ' 27' ' ' ILE . 60.8 m-80 -92.98 163.3 13.72 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.613 0.244 . . . . 0.0 110.995 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.606 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -56.04 -30.67 62.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.993 0.425 . . . . 0.0 110.819 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.723 ' O ' HD13 ' A' ' 30' ' ' ILE . 55.7 mt-10 -71.72 -40.07 69.71 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 1.033 HD12 ' H ' ' A' ' 24' ' ' ASN . 58.3 mt -62.7 -46.64 95.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.911 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.564 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 13.1 mt-30 -57.92 -39.23 77.49 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.597 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.606 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 41.0 mmt-85 -60.16 -40.98 91.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.864 0.84 . . . . 0.0 108.987 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.809 ' O ' ' HG3' ' A' ' 34' ' ' MET . 1.6 mp -58.89 -48.61 85.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 114.455 -1.248 . . . . 0.0 112.119 179.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.895 HG22 ' CG2' ' A' ' 57' ' ' ILE . 6.5 t -68.33 -41.81 83.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-O 120.845 0.355 . . . . 0.0 111.448 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.873 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -55.27 -42.36 73.48 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.526 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.545 ' HB3' ' HB2' ' A' ' 3' ' ' LEU . 56.8 m-20 -75.95 -30.18 58.58 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.632 176.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 1.063 ' HG2' HG21 ' A' ' 51' ' ' VAL . 83.7 mtp -59.86 -47.09 87.15 Favored 'General case' 0 C--N 1.347 0.473 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.531 -177.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.873 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 14.4 p90 -69.49 -44.28 71.44 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.774 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 76.6 mt-10 -51.78 -40.66 60.72 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.725 ' HA ' HG13 ' A' ' 2' ' ' VAL . 41.8 m -68.84 -61.92 1.6 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.576 -1.193 . . . . 0.0 107.864 178.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.895 ' HG3' ' HB2' ' A' ' 46' ' ' LEU . 2.8 ttp -46.11 -41.72 12.76 Favored 'General case' 0 CA--C 1.458 -2.581 0 C-N-CA 124.103 0.961 . . . . 0.0 110.21 -170.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.717 ' OH ' ' HA ' ' A' ' 69' ' ' ARG . 48.2 m-85 -69.22 -41.79 76.58 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.328 178.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.0 -27.45 68.32 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.611 0.72 . . . . 0.0 109.139 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 1.026 ' HG2' HD12 ' A' ' 91' ' ' LEU . 10.5 tp10 -85.53 -10.69 55.64 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.795 176.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.442 ' H ' ' C ' ' A' ' 39' ' ' TYR . 20.7 mt-10 62.21 28.62 17.15 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.859 0.838 . . . . 0.0 109.95 -176.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -83.43 143.41 21.76 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 114.0 -1.455 . . . . 0.0 111.122 178.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.812 ' CG2' HG22 ' A' ' 62' ' ' VAL . 47.7 mt -78.98 -2.54 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 117.709 0.754 . . . . 0.0 111.976 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.484 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 179.83 133.59 2.03 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-O 119.102 -0.832 . . . . 0.0 111.606 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.089 HD13 ' HG ' ' A' ' 91' ' ' LEU . 4.1 tp -124.56 134.55 52.94 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 119.063 1.432 . . . . 0.0 111.329 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -101.06 129.69 46.97 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.871 ' HB1' ' CD1' ' A' ' 53' ' ' ILE . . . -27.21 -56.82 0.09 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 116.099 1.889 . . . . 0.0 116.099 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.614 HG21 ' O ' ' A' ' 137' ' ' LEU . 70.1 p -53.54 -34.38 58.01 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.8 0.81 . . . . 0.0 111.727 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.691 ' OE1' HD12 ' A' ' 46' ' ' LEU . 85.1 mt-30 -64.56 -40.9 96.4 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.347 -1.297 . . . . 0.0 109.947 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.063 HG21 ' HG2' ' A' ' 34' ' ' MET . 1.0 OUTLIER -87.86 15.73 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.889 ' HA ' HD11 ' A' ' 6' ' ' LEU . 38.2 t70 77.51 33.06 0.41 Allowed 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 176.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.871 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 1.1 pp -125.93 110.45 23.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 119.155 -1.018 . . . . 0.0 110.301 177.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.763 ' HB3' ' HD3' ' A' ' 15' ' ' LYS . 0.5 OUTLIER -75.91 63.53 1.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.472 -179.109 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.726 ' C ' ' HB1' ' A' ' 17' ' ' ALA . 69.1 mt-30 -154.53 133.85 12.58 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 114.196 -1.365 . . . . 0.0 108.535 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.794 ' N ' ' HB1' ' A' ' 17' ' ' ALA . 54.3 mtp85 -64.37 72.46 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -177.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.895 ' CG2' HG22 ' A' ' 31' ' ' VAL . 7.1 mm -115.27 125.03 72.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.976 HD11 ' HB2' ' A' ' 72' ' ' LEU . 2.1 pp -131.28 147.77 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 46' ' ' LEU . 33.4 m -127.72 139.74 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.485 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.029 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 7.4 mm -115.11 151.41 16.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.692 0.758 . . . . 0.0 110.033 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.817 ' HB2' ' CE ' ' A' ' 38' ' ' MET . 10.7 t70 -138.99 39.88 2.14 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.079 -178.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.812 HG22 ' CG2' ' A' ' 44' ' ' ILE . 33.1 t . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.359 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.717 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 72.9 ttt180 . . . . . 0 N--CA 1.467 0.413 0 CA-C-O 120.5 0.191 . . . . 0.0 111.413 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 1.029 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 6.1 mp -102.47 132.54 48.44 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.825 HG21 ' HB2' ' A' ' 113' ' ' ARG . 9.6 p -133.91 131.05 56.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.367 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.976 ' HB2' HD11 ' A' ' 58' ' ' ILE . 93.5 mt -141.16 139.04 33.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.924 -0.125 . . . . 0.0 110.999 178.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.013 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.7 mp -119.53 135.71 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-O 120.595 0.236 . . . . 0.0 110.944 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.709 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 8.1 m120 55.17 34.68 0.25 Allowed Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.839 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 88.8 Cg_exo -55.91 148.02 59.46 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.649 2.233 . . . . 0.0 113.482 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -136.93 143.28 42.82 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.815 HD23 ' N ' ' A' ' 78' ' ' LEU . 1.7 tt -80.47 135.04 36.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.782 0.801 . . . . 0.0 111.544 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.046 HD13 ' HA ' ' A' ' 108' ' ' ILE . 7.3 mp -110.45 -40.2 4.7 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.335 -1.302 . . . . 0.0 112.062 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 42.2 tt0 -160.34 154.0 22.5 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.179 0.514 . . . . 0.0 111.538 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.821 ' CB ' HG12 ' A' ' 106' ' ' VAL . 9.6 ptpp? -147.83 150.63 34.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.212 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.5 t -160.58 144.65 13.9 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.548 0.213 . . . . 0.0 110.958 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.791 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 81.24 169.85 42.6 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.85 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' A' ' 102' ' ' ARG . 87.9 tt0 -147.38 113.6 5.88 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 117.788 0.794 . . . . 0.0 113.116 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.4 p -98.72 159.9 14.63 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.642 ' CA ' HD21 ' A' ' 99' ' ' LEU . . . -137.87 103.02 0.4 Allowed Glycine 0 C--N 1.317 -0.528 0 CA-C-N 113.193 -1.821 . . . . 0.0 112.1 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.734 ' HB ' ' NH2' ' A' ' 102' ' ' ARG . 21.2 mt -147.07 138.92 18.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.612 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 56.3 mt-10 -71.09 143.47 50.63 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 122.682 1.229 . . . . 0.0 112.211 -178.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.634 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 93.3 mt-10 -157.8 161.45 38.41 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.581 -1.645 . . . . 0.0 109.754 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.875 ' HA3' ' HG2' ' A' ' 97' ' ' ARG . . . -120.24 159.11 15.24 Favored Glycine 0 CA--C 1.501 -0.809 0 C-N-CA 119.44 -1.362 . . . . 0.0 110.184 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 16.4 m -112.9 138.35 49.89 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.61 0.719 . . . . 0.0 112.207 -177.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.089 ' HG ' HD13 ' A' ' 46' ' ' LEU . 2.3 mm? -48.96 -23.37 1.1 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.375 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.882 ' CB ' HG12 ' A' ' 8' ' ' ILE . 52.7 m -83.89 -34.98 24.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.158 0.504 . . . . 0.0 110.566 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.873 HD13 ' HB ' ' A' ' 8' ' ' ILE . 45.2 mm . . . . . 0 N--CA 1.45 -0.462 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.418 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.875 ' HG2' ' HA3' ' A' ' 89' ' ' GLY . 18.2 mtm105 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 121.759 0.79 . . . . 0.0 111.87 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 87' ' ' GLU . . . -134.53 154.28 51.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.353 -1.294 . . . . 0.0 109.993 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.713 HD23 ' N ' ' A' ' 100' ' ' VAL . 6.5 tt -74.9 136.29 41.45 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.713 ' N ' HD23 ' A' ' 99' ' ' LEU . 21.0 t -133.46 137.9 30.07 Favored Pre-proline 0 N--CA 1.454 -0.237 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.529 -178.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.486 ' HA ' ' O ' ' A' ' 84' ' ' THR . 90.5 Cg_endo -85.66 125.31 2.82 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 121.704 1.603 . . . . 0.0 113.574 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.856 ' HG2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -142.05 166.29 25.11 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 113.627 -1.624 . . . . 0.0 110.684 178.643 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.791 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.47 156.05 38.7 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 120.649 0.261 . . . . 0.0 110.519 -178.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -73.2 -44.55 59.55 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.505 -176.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.806 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 81.4 mttt -139.61 138.14 35.91 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 121.658 0.742 . . . . 0.0 109.694 177.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.857 HG22 ' HB1' ' A' ' 127' ' ' ALA . 33.8 m -139.85 138.23 38.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.939 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 1.132 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 53.2 mmtt -107.5 125.72 51.62 Favored 'General case' 0 C--O 1.224 -0.27 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 1.046 ' HA ' HD13 ' A' ' 78' ' ' LEU . 1.8 pp -131.23 162.97 38.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -177.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 1.035 ' HG3' HD11 ' A' ' 78' ' ' LEU . 94.9 mtt180 -112.05 139.01 47.92 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.998 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.764 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -158.06 167.3 30.25 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 120.729 0.3 . . . . 0.0 111.095 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 1.013 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.4 pp -115.48 153.97 30.17 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 177.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.416 ' O ' HD12 ' A' ' 111' ' ' LEU . 10.3 t70 -90.77 163.27 14.52 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.581 -177.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.825 ' HB2' HG21 ' A' ' 71' ' ' VAL . 46.3 ttp180 -51.6 -19.21 1.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.101 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -78.99 -26.67 43.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.532 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.35 35.0 2.77 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.132 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.613 ' NZ ' ' HB3' ' A' ' 116' ' ' LYS . 6.6 mtpm? -128.76 102.83 19.47 Favored Pre-proline 0 C--O 1.238 0.488 0 CA-C-N 116.799 0.3 . . . . 0.0 111.167 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.652 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 34.2 Cg_exo -74.14 116.56 4.68 Favored 'Trans proline' 0 C--N 1.36 1.164 0 C-N-CA 122.009 1.806 . . . . 0.0 114.903 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.0 167.92 14.65 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.32 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.673 ' HG2' ' HG2' ' A' ' 109' ' ' ARG . 78.9 mt-10 -107.68 129.99 54.97 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.953 0.406 . . . . 0.0 109.974 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.707 ' O ' HD12 ' A' ' 120' ' ' LEU . 4.1 pp -127.19 132.91 50.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.347 0.594 . . . . 0.0 112.084 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 1.132 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 23.0 pt-20 -92.0 125.63 36.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.527 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.931 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -116.08 135.56 53.83 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.806 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.1 m-20 -126.82 163.62 23.18 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.777 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 46.92 -135.5 10.78 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-N 119.787 1.176 . . . . 0.0 115.811 177.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.637 HD23 ' H ' ' A' ' 125' ' ' LEU . 1.6 pt? -54.73 -32.57 59.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.563 -0.819 . . . . 0.0 111.674 -178.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.931 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.5 OUTLIER -70.89 -53.9 13.42 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.743 179.88 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.857 ' HB1' HG22 ' A' ' 106' ' ' VAL . . . -58.92 -42.87 90.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.492 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.856 HD12 ' HG2' ' A' ' 102' ' ' ARG . 49.7 mm -62.52 -55.05 26.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.43 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.668 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 30.4 p -60.47 -51.57 68.92 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.856 HD11 HD11 ' A' ' 108' ' ' ILE . 20.8 tt -60.08 -42.06 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 111.445 0.165 . . . . 0.0 111.445 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.69 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 20.9 pt20 -67.24 -41.68 85.23 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -57.83 -44.8 86.7 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.672 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.855 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.8 mm-40 -60.45 -45.37 93.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 118.902 -0.57 . . . . 0.0 111.814 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.933 ' HA ' HD21 ' A' ' 137' ' ' LEU . 36.9 mtm -56.7 -47.69 79.36 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 119.06 0.845 . . . . 0.0 109.913 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.745 ' O ' HG12 ' A' ' 138' ' ' VAL . 30.9 m-20 -61.83 -49.17 77.37 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.98 178.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.44 ' CE1' ' CG ' ' A' ' 50' ' ' GLN . 12.2 t-80 -56.27 -51.81 66.79 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 121.739 -0.601 . . . . 0.0 110.908 -179.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.933 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.3 pp -60.4 -30.93 69.91 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.481 -0.782 . . . . 0.0 111.775 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.914 HG23 HG13 ' A' ' 16' ' ' VAL . 14.9 p -80.49 21.05 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 CA-C-O 123.208 1.48 . . . . 0.0 108.947 175.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.86 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 69.27 -2.37 9.98 Favored Glycine 0 CA--C 1.492 -1.377 0 CA-C-N 111.723 -2.49 . . . . 0.0 112.452 176.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.766 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 1.3 ptmt . . . . . 0 N--CA 1.428 -1.525 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 1.044 HG12 ' HA ' ' A' ' 37' ' ' THR . 31.5 m . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.779 0.324 . . . . 0.0 111.378 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 1.043 HD11 ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -79.09 -141.25 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.43 ' H ' ' HG ' ' A' ' 3' ' ' LEU . 4.0 tp-100 -112.2 106.83 15.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.953 0.406 . . . . 0.0 110.617 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.017 HG11 HD12 ' A' ' 91' ' ' LEU . 48.2 t -89.19 126.23 42.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.518 0.675 . . . . 0.0 111.47 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.028 ' HB2' HD21 ' A' ' 13' ' ' LEU . 23.1 mt -83.49 141.99 31.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.603 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.772 ' HA ' ' HB3' ' A' ' 92' ' ' SER . 1.7 m80 -111.48 145.48 38.94 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.07 HD13 HD12 ' A' ' 13' ' ' LEU . 42.5 mm -57.77 145.41 70.77 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.279 178.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.522 ' HA ' HG23 ' A' ' 8' ' ' ILE . 73.8 Cg_endo -92.14 51.68 1.02 Allowed 'Cis proline' 0 C--N 1.353 0.81 0 C-N-CA 124.442 -1.066 . . . . 0.0 112.942 0.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.881 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 9.4 t0 -52.72 134.64 36.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.951 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.404 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 12.1 pt-20 -58.62 -44.75 90.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.514 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.672 ' HB2' HD13 ' A' ' 6' ' ' LEU . 11.3 mtt85 -58.91 -24.19 62.1 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 1.07 HD12 HD13 ' A' ' 8' ' ' ILE . 11.6 mt -75.42 -33.13 60.92 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 120.205 1.366 . . . . 0.0 108.3 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 22.8 mmt180 -92.11 8.02 39.79 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 113.841 -1.527 . . . . 0.0 109.397 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 12' ' ' ARG . 88.5 tttt -89.86 148.96 22.86 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.186 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.802 HG13 HG23 ' A' ' 138' ' ' VAL . 66.8 t -83.67 126.23 40.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.091 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.759 ' C ' ' HG3' ' A' ' 56' ' ' ARG . . . -83.53 147.8 27.57 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.297 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.741 ' HD3' ' CD ' ' A' ' 19' ' ' PRO . 5.7 tmtm? -110.48 132.31 21.61 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.776 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 63.6 Cg_endo -77.62 116.14 4.0 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.378 2.052 . . . . 0.0 111.732 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.853 HG12 ' H ' ' A' ' 22' ' ' GLU . 22.0 t -68.01 144.95 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 CA-C-O 122.869 1.319 . . . . 0.0 113.087 -175.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -63.73 -29.4 70.62 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 112.893 -1.958 . . . . 0.0 111.897 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.853 ' H ' HG12 ' A' ' 20' ' ' VAL . 88.8 tt0 -157.11 145.05 19.19 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.8 -178.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.538 HG21 ' HA2' ' A' ' 115' ' ' GLY . 3.5 t -79.41 105.18 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 1.063 ' H ' HD12 ' A' ' 27' ' ' ILE . 2.1 m120 -87.05 153.08 21.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.908 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.474 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -54.57 -30.23 53.69 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.452 0.644 . . . . 0.0 110.207 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -72.82 -37.63 67.42 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 1.063 HD12 ' H ' ' A' ' 24' ' ' ASN . 67.7 mt -67.0 -36.36 76.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.355 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -68.33 -39.49 81.92 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.372 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 40.1 mmt180 -64.09 -38.86 92.6 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.768 ' O ' ' HG3' ' A' ' 34' ' ' MET . 2.9 mt -55.7 -49.19 75.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.614 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.686 HG22 ' CG2' ' A' ' 57' ' ' ILE . 19.8 t -66.33 -40.97 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 121.135 0.493 . . . . 0.0 110.941 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.884 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 26.5 m-20 -53.84 -46.27 71.17 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.575 -178.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.501 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 1.5 m-20 -74.54 -30.11 61.63 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.907 176.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 1.011 ' HG2' HG21 ' A' ' 51' ' ' VAL . 85.2 mtp -60.21 -46.31 90.18 Favored 'General case' 0 C--N 1.345 0.408 0 C-N-CA 120.566 -0.454 . . . . 0.0 109.841 -176.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.884 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 11.9 p90 -69.79 -44.76 69.41 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.606 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 31.8 mm-40 -53.34 -39.23 63.96 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 1.044 ' HA ' HG12 ' A' ' 2' ' ' VAL . 76.9 m -70.51 -60.4 2.28 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 118.28 -1.368 . . . . 0.0 108.613 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.973 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 2.6 ttp -46.76 -41.03 14.61 Favored 'General case' 0 CA--C 1.463 -2.378 0 C-N-CA 124.101 0.96 . . . . 0.0 109.958 -172.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.708 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 60.5 m-85 -70.32 -42.06 72.43 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.312 177.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 37' ' ' THR . . . -61.07 -24.86 66.53 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.577 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.794 ' HG2' ' CD2' ' A' ' 91' ' ' LEU . 3.1 tp10 -88.94 -11.19 45.14 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 114.345 -1.298 . . . . 0.0 108.337 177.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.444 ' H ' ' C ' ' A' ' 39' ' ' TYR . 54.0 mt-10 64.11 26.68 14.0 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.7 -176.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.87 142.52 23.5 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 113.89 -1.504 . . . . 0.0 110.596 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.809 HG22 HG22 ' A' ' 62' ' ' VAL . 46.1 mm -79.52 1.2 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 117.611 0.706 . . . . 0.0 111.997 -178.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.547 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 176.38 137.86 2.73 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 118.838 -0.979 . . . . 0.0 111.371 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.875 ' HB2' ' HG3' ' A' ' 38' ' ' MET . 10.7 tp -126.38 134.54 51.02 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-N 119.505 1.653 . . . . 0.0 111.265 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -98.83 132.15 44.4 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.935 ' HB1' HG13 ' A' ' 53' ' ' ILE . . . -31.22 -54.88 0.23 Allowed 'General case' 0 C--N 1.343 0.285 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.579 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 80.6 p -52.86 -36.07 58.53 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.891 0.853 . . . . 0.0 111.031 -177.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.45 ' HG2' ' CE1' ' A' ' 136' ' ' HIS . 44.1 mt-30 -65.84 -40.56 91.88 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.328 -1.306 . . . . 0.0 110.202 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.043 ' HB ' HD11 ' A' ' 3' ' ' LEU . 1.0 OUTLIER -83.81 16.08 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 179.558 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.949 ' HA ' HD11 ' A' ' 6' ' ' LEU . 36.1 t70 76.93 27.67 0.7 Allowed 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 177.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.935 HG13 ' HB1' ' A' ' 48' ' ' ALA . 13.4 pt -122.26 110.94 28.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 C-N-CA 119.036 -1.066 . . . . 0.0 111.386 177.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.45 ' HB3' ' HD3' ' A' ' 15' ' ' LYS . 7.4 p80 -76.33 52.11 0.74 Allowed 'General case' 0 N--CA 1.46 0.075 0 CA-C-O 122.241 1.019 . . . . 0.0 109.767 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.496 ' C ' ' HB1' ' A' ' 17' ' ' ALA . 25.7 mt-30 -140.6 132.31 27.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 113.817 -1.538 . . . . 0.0 107.752 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.867 ' HG2' ' CD1' ' A' ' 137' ' ' LEU . 99.1 mtt180 -61.78 68.1 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -178.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.935 ' HB ' HD11 ' A' ' 53' ' ' ILE . 10.9 mm -111.88 121.65 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.136 HD11 ' HB2' ' A' ' 72' ' ' LEU . 2.2 pp -129.69 145.74 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -177.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.471 HG23 ' H ' ' A' ' 46' ' ' LEU . 32.6 m -126.0 139.88 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.293 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.056 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 11.9 mm -115.45 151.88 17.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.688 0.756 . . . . 0.0 110.154 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.973 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 34.9 t70 -141.82 37.78 1.63 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.391 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.809 HG22 HG22 ' A' ' 44' ' ' ILE . 38.8 t . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.378 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.705 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.497 0 CA-C-O 120.76 0.314 . . . . 0.0 111.671 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 1.056 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 4.0 mm? -103.84 132.64 49.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.937 0.399 . . . . 0.0 111.817 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.785 ' C ' HD22 ' A' ' 72' ' ' LEU . 12.3 p -134.58 134.46 54.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.226 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.136 ' HB2' HD11 ' A' ' 58' ' ' ILE . 3.0 mm? -142.14 146.55 35.47 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.531 -0.174 . . . . 0.0 110.531 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.012 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.8 mp -122.92 136.44 59.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.732 0.301 . . . . 0.0 110.595 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.716 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 6.9 m120 51.65 37.62 0.44 Allowed Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.875 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 91.1 Cg_exo -57.51 148.26 73.7 Favored 'Trans proline' 0 N--CA 1.488 1.152 0 C-N-CA 123.046 2.497 . . . . 0.0 114.302 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -137.49 142.95 41.5 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.901 HD12 ' CG2' ' A' ' 108' ' ' ILE . 10.2 tp -80.28 136.84 36.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.109 0.481 . . . . 0.0 111.015 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.16 HD21 ' HG3' ' A' ' 109' ' ' ARG . 2.7 mm? -109.94 -44.48 3.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.068 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.513 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 17.2 tp10 -153.34 144.18 22.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.05 0.452 . . . . 0.0 111.932 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 1.043 ' HA ' HG12 ' A' ' 106' ' ' VAL . 19.3 ptpt -138.14 142.53 40.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.347 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.1 p -151.75 150.49 30.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.854 0.359 . . . . 0.0 111.052 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.631 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 76.91 143.72 1.64 Allowed Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.524 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -109.87 113.8 26.84 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.81 0.814 . . . . 0.0 111.896 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.638 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.7 p -117.21 160.99 20.2 Favored 'General case' 0 CA--C 1.487 -1.447 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.824 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -154.03 124.06 1.5 Allowed Glycine 0 C--N 1.314 -0.69 0 CA-C-N 112.536 -2.12 . . . . 0.0 111.228 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.619 HD13 ' O ' ' A' ' 85' ' ' GLY . 48.8 mm -147.07 137.52 17.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 117.507 0.653 . . . . 0.0 111.46 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 56.0 mt-10 -71.38 139.78 49.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 123.21 1.481 . . . . 0.0 112.606 -176.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.633 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 40.6 mt-10 -155.78 166.25 34.05 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 112.376 -2.193 . . . . 0.0 111.901 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.741 ' N ' ' HG2' ' A' ' 97' ' ' ARG . . . -120.88 168.27 14.04 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 87.3 m -113.46 142.74 45.55 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.34 0.57 . . . . 0.0 111.041 -177.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.017 HD12 HG11 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -53.36 -15.54 1.05 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.511 -179.417 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.815 ' HB2' HG12 ' A' ' 8' ' ' ILE . 4.3 m -100.77 -33.48 10.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.2 0.524 . . . . 0.0 110.471 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.568 ' CG1' HG13 ' A' ' 8' ' ' ILE . 57.4 mt . . . . . 0 CA--C 1.533 0.32 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.586 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.741 ' HG2' ' N ' ' A' ' 89' ' ' GLY . 84.7 mtm180 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 121.142 0.496 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -125.73 148.93 48.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.796 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.824 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.4 tt -76.08 113.61 13.8 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.979 0.895 . . . . 0.0 111.208 -177.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.823 HG13 ' NE ' ' A' ' 102' ' ' ARG . 14.0 p -103.7 129.21 25.77 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 114.572 -1.194 . . . . 0.0 111.575 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.638 ' HA ' ' O ' ' A' ' 84' ' ' THR . 87.8 Cg_endo -83.55 126.61 4.15 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 122.67 2.247 . . . . 0.0 113.844 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.91 ' HG2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -143.63 166.96 23.41 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.595 1.158 . . . . 0.0 109.288 179.381 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.631 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.18 155.33 39.86 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.914 0.388 . . . . 0.0 110.302 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -73.25 -40.37 64.69 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.483 -175.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.716 ' HB3' ' OD1' ' A' ' 123' ' ' ASP . 96.0 mttt -140.03 140.91 36.3 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 176.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 1.043 HG12 ' HA ' ' A' ' 80' ' ' LYS . 19.4 m -152.94 141.54 14.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.836 -1.075 . . . . 0.0 112.58 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.918 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 31.9 mmtm -107.52 127.03 53.26 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 1.079 ' HA ' HD23 ' A' ' 78' ' ' LEU . 1.8 pp -134.57 150.95 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -176.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 1.16 ' HG3' HD21 ' A' ' 78' ' ' LEU . 43.7 mtm180 -103.42 140.5 37.38 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-O 122.277 1.037 . . . . 0.0 111.602 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.757 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -160.54 168.73 24.41 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.779 -176.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 1.012 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.3 pp -116.15 151.21 36.1 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.781 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 20.5 t70 -85.53 163.84 18.15 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.742 -176.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.692 ' HB2' HG21 ' A' ' 71' ' ' VAL . 13.2 ttp-105 -52.71 -19.29 2.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.046 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -79.41 -26.12 41.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.434 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.538 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 106.77 35.99 2.68 Favored Glycine 0 C--N 1.34 0.792 0 C-N-CA 120.168 -1.015 . . . . 0.0 113.545 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -128.57 102.93 19.87 Favored Pre-proline 0 C--O 1.238 0.5 0 CA-C-N 116.859 0.33 . . . . 0.0 110.694 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.677 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 32.1 Cg_exo -72.67 115.2 4.25 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 121.307 1.338 . . . . 0.0 114.563 -177.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.781 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 10.4 p90 -127.15 168.75 14.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.551 -178.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 109' ' ' ARG . 3.0 mp0 -107.1 130.11 54.73 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.715 ' O ' HD12 ' A' ' 120' ' ' LEU . 4.3 pp -122.81 132.56 54.26 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.416 -178.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.918 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 15.3 pt-20 -92.17 123.97 35.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.789 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.937 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -118.58 133.64 55.71 Favored 'General case' 0 C--O 1.22 -0.472 0 C-N-CA 120.456 -0.498 . . . . 0.0 112.13 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.716 ' OD1' ' HB3' ' A' ' 105' ' ' LYS . 31.5 m-20 -127.38 161.54 28.43 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.576 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 55.1 -140.59 38.86 Favored Glycine 0 C--N 1.346 1.109 0 C-N-CA 118.94 -1.6 . . . . 0.0 115.145 177.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.69 HD12 ' H ' ' A' ' 125' ' ' LEU . 4.6 mp -54.9 -30.69 58.86 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.831 -0.684 . . . . 0.0 111.62 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.937 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -71.22 -51.77 22.79 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.677 0.751 . . . . 0.0 109.209 179.607 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.78 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -60.22 -47.01 87.77 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.767 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.91 HD12 ' HG2' ' A' ' 102' ' ' ARG . 46.9 mm -63.69 -55.01 25.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -177.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.579 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 81.8 m -58.19 -48.61 79.79 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.945 HD11 HD11 ' A' ' 108' ' ' ILE . 20.0 tt -59.01 -40.93 81.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.854 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.809 ' CG ' HG21 ' A' ' 106' ' ' VAL . 69.2 mt-30 -67.59 -40.76 84.81 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -57.72 -45.87 85.16 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.021 0.439 . . . . 0.0 110.026 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.903 ' O ' HD23 ' A' ' 137' ' ' LEU . 4.2 mm-40 -59.99 -42.57 94.48 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.227 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.947 ' HA ' HD21 ' A' ' 137' ' ' LEU . 3.0 mmm -56.83 -47.55 80.06 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.772 0.796 . . . . 0.0 109.999 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.766 ' O ' HG12 ' A' ' 138' ' ' VAL . 32.3 m-20 -65.4 -48.37 73.07 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.701 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.45 ' CE1' ' HG2' ' A' ' 50' ' ' GLN . 16.2 t-80 -57.38 -50.77 71.93 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.722 -0.611 . . . . 0.0 111.051 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.947 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.6 pp -60.7 -30.7 70.11 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.812 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.913 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 11.9 p -84.19 24.83 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-O 122.412 1.101 . . . . 0.0 109.957 177.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 66.76 3.03 19.45 Favored Glycine 0 CA--C 1.487 -1.673 0 CA-C-N 113.423 -1.717 . . . . 0.0 113.262 176.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.913 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 9.4 ptmt . . . . . 0 N--CA 1.416 -2.131 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.766 ' CG1' HG23 ' A' ' 37' ' ' THR . 37.2 t . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.631 0.253 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.825 HD11 ' CB ' ' A' ' 51' ' ' VAL . 3.4 pp -78.75 -175.97 4.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.746 0.308 . . . . 0.0 110.548 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -83.25 107.62 15.91 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.817 0.341 . . . . 0.0 110.643 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.558 ' CG2' HG21 ' A' ' 37' ' ' THR . 39.1 t -89.56 131.5 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 121.229 0.538 . . . . 0.0 112.235 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.08 ' HB2' HD21 ' A' ' 13' ' ' LEU . 14.7 mt -88.31 140.25 29.67 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.931 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.597 ' HB3' ' O ' ' A' ' 92' ' ' SER . 41.4 m-70 -116.71 144.33 44.56 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.053 HD13 HD12 ' A' ' 13' ' ' LEU . 43.5 mm -62.95 135.56 96.2 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.999 177.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -80.2 145.5 71.87 Favored 'Cis proline' 0 C--N 1.354 0.818 0 C-N-CA 124.387 -1.089 . . . . 0.0 112.006 -0.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.982 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 8.9 t70 -165.88 128.44 2.02 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.426 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.446 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 24.1 pt-20 -58.19 -46.0 86.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.592 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.622 ' HA ' ' HB2' ' A' ' 15' ' ' LYS . 20.2 mmt-85 -56.09 -28.73 58.9 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 1.08 HD21 ' HB2' ' A' ' 6' ' ' LEU . 10.1 mt -76.72 -34.27 58.13 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 120.339 1.427 . . . . 0.0 108.786 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.825 ' HB3' ' NH1' ' A' ' 14' ' ' ARG . 1.7 mmm180 -91.99 11.1 26.28 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.029 178.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.839 ' HD3' ' N ' ' A' ' 16' ' ' VAL . 11.2 tmtt? -84.3 139.37 32.36 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.482 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.891 HG13 HG23 ' A' ' 138' ' ' VAL . 46.0 t -84.29 93.93 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.79 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.799 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -53.88 147.85 11.38 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.337 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -104.25 131.24 22.1 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.746 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.547 ' HD3' ' HD3' ' A' ' 56' ' ' ARG . 69.2 Cg_endo -77.52 114.67 3.75 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.097 1.864 . . . . 0.0 110.56 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.858 HG12 ' H ' ' A' ' 22' ' ' GLU . 19.7 t -69.36 144.57 13.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 122.624 1.202 . . . . 0.0 113.313 -175.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -66.12 -24.68 66.72 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 113.266 -1.788 . . . . 0.0 111.915 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.858 ' H ' HG12 ' A' ' 20' ' ' VAL . 88.7 tt0 -160.96 141.0 10.98 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.658 0.266 . . . . 0.0 110.734 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.531 HG22 HD21 ' A' ' 111' ' ' LEU . 2.8 t -79.18 109.82 14.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 1.056 ' H ' HD12 ' A' ' 27' ' ' ILE . 60.1 m-80 -92.07 164.55 13.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.52 0.2 . . . . 0.0 110.94 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.712 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -56.22 -30.72 62.72 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.176 0.513 . . . . 0.0 110.762 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -71.52 -39.6 70.64 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 177.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 1.056 HD12 ' H ' ' A' ' 24' ' ' ASN . 59.6 mt -63.26 -47.24 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.132 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.523 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 11.5 mt-30 -57.83 -39.25 77.2 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-O 120.896 0.379 . . . . 0.0 110.701 178.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.712 ' HG3' ' O ' ' A' ' 25' ' ' ALA . 99.6 mtt180 -60.3 -39.86 88.44 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.813 ' O ' ' HG3' ' A' ' 34' ' ' MET . 3.3 mt -60.06 -48.54 87.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 114.641 -1.163 . . . . 0.0 112.108 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.88 HG22 ' CG2' ' A' ' 57' ' ' ILE . 12.5 t -68.49 -42.63 83.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-O 120.862 0.363 . . . . 0.0 111.378 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.866 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -55.17 -42.02 72.61 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.516 -179.705 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.484 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 23.4 m-20 -75.23 -30.3 60.52 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.348 175.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 1.067 ' HG2' HG21 ' A' ' 51' ' ' VAL . 86.5 mtp -60.54 -46.83 88.73 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.857 -177.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.866 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 14.1 p90 -69.38 -44.43 71.52 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.762 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 34.0 mt-10 -51.36 -42.1 61.09 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.766 HG23 ' CG1' ' A' ' 2' ' ' VAL . 73.7 m -69.3 -62.08 1.53 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.493 -1.23 . . . . 0.0 108.236 178.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 1.004 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 3.4 ttp -45.91 -42.53 12.86 Favored 'General case' 0 CA--C 1.454 -2.739 0 C-N-CA 124.183 0.993 . . . . 0.0 110.563 -170.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.681 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 50.2 m-85 -69.42 -41.58 76.18 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.569 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.8 -28.69 68.96 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.796 0.807 . . . . 0.0 109.003 178.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.994 ' HG2' HD12 ' A' ' 91' ' ' LEU . 11.0 tp10 -84.33 -10.11 57.88 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 114.248 -1.342 . . . . 0.0 108.788 177.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.444 ' H ' ' C ' ' A' ' 39' ' ' TYR . 58.9 mt-10 61.57 26.12 15.89 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 121.914 0.864 . . . . 0.0 109.987 -176.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.73 142.21 23.37 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 113.993 -1.458 . . . . 0.0 110.757 178.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.866 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 49.2 mt -78.57 -2.54 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 117.702 0.751 . . . . 0.0 111.925 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.499 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . -179.28 133.33 2.04 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-O 119.114 -0.826 . . . . 0.0 111.794 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.021 HD13 ' HG ' ' A' ' 91' ' ' LEU . 5.8 tp -124.45 133.99 53.2 Favored 'General case' 0 C--N 1.351 0.632 0 CA-C-N 119.085 1.442 . . . . 0.0 111.278 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -100.44 129.27 46.38 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.218 0.207 . . . . 0.0 111.236 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.879 ' HB1' ' CG1' ' A' ' 53' ' ' ILE . . . -27.06 -55.74 0.08 Allowed 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 116.126 1.898 . . . . 0.0 116.126 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.588 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 66.2 p -53.29 -33.87 55.02 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.882 0.848 . . . . 0.0 112.032 -178.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.764 ' OE1' HD12 ' A' ' 46' ' ' LEU . 82.4 mt-30 -63.93 -42.68 97.3 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.15 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.067 HG21 ' HG2' ' A' ' 34' ' ' MET . 0.9 OUTLIER -86.9 16.2 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.876 ' HA ' HD11 ' A' ' 6' ' ' LEU . 53.6 t0 77.43 34.05 0.38 Allowed 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 176.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.879 ' CG1' ' HB1' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -125.39 109.18 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.302 177.08 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -75.74 63.34 1.61 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.206 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.74 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 88.9 mt-30 -153.96 134.0 13.19 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 114.156 -1.384 . . . . 0.0 108.425 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.799 ' N ' ' HB1' ' A' ' 17' ' ' ALA . 77.4 mtp180 -65.13 72.38 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -177.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.88 ' CG2' HG22 ' A' ' 31' ' ' VAL . 6.7 mm -114.84 124.93 71.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.065 HD11 ' HB2' ' A' ' 72' ' ' LEU . 2.2 pp -131.41 147.26 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 46' ' ' LEU . 34.1 m -128.84 138.15 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.709 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.954 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 2.2 mt -116.92 142.92 28.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.835 0.826 . . . . 0.0 110.821 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 1.004 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 11.4 t70 -124.87 25.86 7.24 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.18 -1.373 . . . . 0.0 110.294 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.793 HG22 ' CG2' ' A' ' 44' ' ' ILE . 21.9 t . . . . . 0 N--CA 1.465 0.322 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.57 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.666 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 32.8 ttm180 . . . . . 0 N--CA 1.467 0.402 0 CA-C-O 120.81 0.338 . . . . 0.0 111.35 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.954 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 67.2 mt -100.72 132.42 46.12 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.829 HG21 ' HB2' ' A' ' 113' ' ' ARG . 9.9 p -134.38 130.09 53.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.106 178.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.065 ' HB2' HD11 ' A' ' 58' ' ' ILE . 2.8 mm? -141.07 139.54 34.07 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.505 -0.183 . . . . 0.0 110.505 178.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.042 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.7 mp -118.79 134.99 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 110.345 -0.243 . . . . 0.0 110.345 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.707 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 8.6 m120 54.04 35.56 0.29 Allowed Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.834 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 95.2 Cg_exo -55.83 150.1 47.38 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.72 2.28 . . . . 0.0 113.639 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.642 ' CD ' HH21 ' A' ' 109' ' ' ARG . 15.6 pt-20 -136.74 144.22 43.72 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.898 ' CB ' ' HE1' ' A' ' 134' ' ' MET . 1.4 tt -81.82 136.28 35.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.534 0.683 . . . . 0.0 111.215 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.863 HD11 ' HG3' ' A' ' 109' ' ' ARG . 7.5 mp -116.61 -37.81 3.62 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.308 -178.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 5.2 tp10 -155.36 146.85 22.96 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.107 0.479 . . . . 0.0 111.13 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.823 ' CB ' HG12 ' A' ' 106' ' ' VAL . 12.8 ptmt -148.4 147.38 29.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.258 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 52.8 m -160.56 145.4 14.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.675 0.274 . . . . 0.0 111.303 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.836 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 84.76 169.75 46.22 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.175 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 102' ' ' ARG . 56.7 mt-10 -146.97 113.53 6.0 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.5 p -101.94 159.87 14.98 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 115.132 1.531 . . . . 0.0 115.132 178.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.696 ' O ' HD13 ' A' ' 86' ' ' ILE . . . -137.12 102.61 0.39 Allowed Glycine 0 C--N 1.316 -0.532 0 CA-C-N 112.856 -1.974 . . . . 0.0 111.589 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.752 ' N ' ' HG ' ' A' ' 99' ' ' LEU . 39.8 mm -145.54 136.97 19.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.611 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 56.3 mt-10 -71.31 144.36 49.98 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 122.476 1.131 . . . . 0.0 111.779 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.619 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 55.0 mt-10 -158.06 162.06 38.06 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 113.933 -1.485 . . . . 0.0 109.618 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.908 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -119.96 158.01 15.44 Favored Glycine 0 CA--C 1.499 -0.942 0 C-N-CA 119.271 -1.442 . . . . 0.0 110.15 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.473 ' HG ' ' CD2' ' A' ' 136' ' ' HIS . 20.5 m -111.88 137.3 50.04 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.564 0.697 . . . . 0.0 111.893 -177.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.021 ' HG ' HD13 ' A' ' 46' ' ' LEU . 2.3 mm? -48.35 -23.03 0.79 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.591 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.873 ' CB ' HD13 ' A' ' 13' ' ' LEU . 48.7 m -84.25 -34.05 23.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.649 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.6 mt . . . . . 0 N--CA 1.45 -0.442 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.758 -179.811 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.908 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 18.5 mtm105 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.851 0.834 . . . . 0.0 111.903 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.423 ' C ' ' HA ' ' A' ' 87' ' ' GLU . . . -134.47 153.45 51.92 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.249 -1.341 . . . . 0.0 109.624 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.752 ' HG ' ' N ' ' A' ' 86' ' ' ILE . 6.8 tt -75.16 136.33 41.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.458 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.838 ' HB ' ' CZ ' ' A' ' 102' ' ' ARG . 89.7 t -130.14 132.92 24.39 Favored Pre-proline 0 CA--C 1.53 0.177 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' A' ' 84' ' ' THR . 2.1 Cg_endo -81.3 124.1 4.67 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.693 1.595 . . . . 0.0 112.7 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.881 ' HB2' ' OE1' ' A' ' 131' ' ' GLN . 0.0 OUTLIER -142.15 166.4 24.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.765 179.112 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.836 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.67 156.22 38.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.666 0.269 . . . . 0.0 110.286 -178.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -72.82 -43.96 62.06 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.422 -176.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.716 ' HB3' ' OD1' ' A' ' 123' ' ' ASP . 56.6 mttp -139.44 138.24 36.29 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.72 0.771 . . . . 0.0 109.611 176.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.891 HG22 ' HB1' ' A' ' 127' ' ' ALA . 28.4 m -140.05 138.6 37.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.043 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 1.093 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 32.9 mmtm -107.22 125.27 50.9 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.841 HG12 ' CD1' ' A' ' 130' ' ' ILE . 2.1 pp -128.37 161.46 36.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -177.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.863 ' HG3' HD11 ' A' ' 78' ' ' LEU . 68.0 mtm180 -114.28 140.15 48.83 Favored 'General case' 0 N--CA 1.461 0.104 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.847 ' HB3' HD12 ' A' ' 72' ' ' LEU . . . -159.58 168.29 26.46 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.966 -178.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 1.042 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.5 pp -113.59 152.99 29.58 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.461 ' HB2' ' CE2' ' A' ' 118' ' ' PHE . 11.2 t70 -90.79 164.37 14.11 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 119.716 -0.793 . . . . 0.0 111.42 -177.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.829 ' HB2' HG21 ' A' ' 71' ' ' VAL . 15.1 ttm105 -51.57 -19.2 1.38 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.237 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.24 -26.56 42.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.602 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 106.81 34.63 2.98 Favored Glycine 0 C--N 1.337 0.619 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.948 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.678 ' NZ ' ' HB2' ' A' ' 116' ' ' LYS . 9.7 mtmp? -128.63 103.17 19.62 Favored Pre-proline 0 C--O 1.237 0.416 0 C-N-CA 121.228 -0.189 . . . . 0.0 111.236 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.663 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.4 Cg_exo -72.84 116.06 4.58 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 121.799 1.666 . . . . 0.0 114.802 -178.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.461 ' CE2' ' HB2' ' A' ' 112' ' ' ASP . 0.4 OUTLIER -126.45 168.62 13.97 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.372 -179.626 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.672 ' HG2' ' CG ' ' A' ' 109' ' ' ARG . 80.2 mt-10 -107.52 129.64 54.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.121 0.486 . . . . 0.0 110.16 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.71 ' O ' HD12 ' A' ' 120' ' ' LEU . 4.2 pp -123.08 129.04 50.95 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.752 -178.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 1.093 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 9.3 pm0 -92.76 124.36 36.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.27 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.937 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -116.35 137.18 52.36 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.716 ' OD1' ' HB3' ' A' ' 105' ' ' LYS . 34.3 m-20 -126.96 163.8 22.88 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.823 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 47.5 -135.47 13.62 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 119.996 1.271 . . . . 0.0 115.864 177.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.0 mt -54.66 -32.73 59.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.654 -0.773 . . . . 0.0 111.667 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.937 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -71.31 -54.01 12.29 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.842 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.891 ' HB1' HG22 ' A' ' 106' ' ' VAL . . . -58.85 -42.98 90.62 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.469 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.874 HD12 ' HG2' ' A' ' 102' ' ' ARG . 49.2 mm -62.17 -54.47 33.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.559 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.549 ' SG ' HG21 ' A' ' 62' ' ' VAL . 73.4 m -60.12 -50.72 72.59 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.841 ' CD1' HG12 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -58.88 -44.1 89.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 121.201 -0.199 . . . . 0.0 110.567 -179.674 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.881 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.9 pt20 -67.72 -38.35 83.48 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.738 ' HA ' ' OD2' ' A' ' 135' ' ' ASP . 68.7 t60 -59.22 -46.1 89.35 Favored 'General case' 0 C--O 1.226 -0.16 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.866 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.9 mm-40 -59.67 -45.02 93.33 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.271 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.937 ' HA ' HD21 ' A' ' 137' ' ' LEU . 72.6 mtp -56.84 -48.51 77.9 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 118.913 0.779 . . . . 0.0 110.865 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.738 ' OD2' ' HA ' ' A' ' 132' ' ' HIS . 2.4 p30 -63.35 -46.68 85.42 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.37 178.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.473 ' CD2' ' HG ' ' A' ' 90' ' ' CYS . 7.8 t-80 -58.03 -52.6 64.86 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.814 -0.554 . . . . 0.0 111.476 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.937 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.5 pp -59.21 -32.68 70.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.553 -177.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.925 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 10.3 p -80.09 19.02 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 CA-C-O 123.101 1.429 . . . . 0.0 108.856 175.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.826 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 61.5 20.52 59.12 Favored Glycine 0 CA--C 1.489 -1.537 0 CA-C-N 111.779 -2.464 . . . . 0.0 112.313 176.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.925 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 7.2 ptmt . . . . . 0 N--CA 1.424 -1.739 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.046 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 1.004 HG12 ' HA ' ' A' ' 37' ' ' THR . 27.9 m . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.571 0.224 . . . . 0.0 110.963 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.983 HD13 ' H ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -85.71 -170.15 2.97 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.595 179.88 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 70.9 tp60 -84.52 108.4 17.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.736 0.303 . . . . 0.0 110.798 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.78 HG11 HD12 ' A' ' 91' ' ' LEU . 43.0 t -89.79 131.82 36.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.25 0.548 . . . . 0.0 111.767 -179.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.089 ' HB2' HD21 ' A' ' 13' ' ' LEU . 21.5 mt -85.03 141.73 30.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.071 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.565 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 2.8 m80 -119.77 144.35 47.33 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.094 HD13 HD12 ' A' ' 13' ' ' LEU . 50.7 mm -60.71 134.28 92.02 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.29 177.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -83.02 138.88 35.56 Favored 'Cis proline' 0 C--N 1.352 0.739 0 C-N-CA 124.48 -1.05 . . . . 0.0 111.896 -0.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.629 ' CB ' ' HG ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -155.86 128.99 8.11 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.562 179.672 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 12.0 pt-20 -58.46 -44.71 89.36 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.517 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.702 ' HB2' HD13 ' A' ' 6' ' ' LEU . 24.1 mtt180 -60.5 -24.86 65.63 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 1.094 HD12 HD13 ' A' ' 8' ' ' ILE . 10.3 mt -78.41 -31.03 48.03 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 120.892 1.678 . . . . 0.0 107.617 176.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.618 ' C ' ' HA3' ' A' ' 139' ' ' GLY . 15.7 mmm180 -91.8 8.77 35.59 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 113.767 -1.56 . . . . 0.0 109.12 178.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.585 ' HB2' ' HA ' ' A' ' 12' ' ' ARG . 60.2 tttp -88.19 143.5 27.01 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.08 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 1.013 HG13 HG23 ' A' ' 138' ' ' VAL . 56.4 t -83.99 100.24 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.029 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.808 ' HB3' HD12 ' A' ' 137' ' ' LEU . . . -58.74 143.78 45.85 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.944 0.402 . . . . 0.0 111.44 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.721 ' HD3' ' N ' ' A' ' 19' ' ' PRO . 1.7 tmtp? -108.94 132.47 21.16 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.183 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.919 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 56.4 Cg_endo -80.35 115.7 3.21 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.29 1.994 . . . . 0.0 111.057 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.7 HG12 ' H ' ' A' ' 22' ' ' GLU . 17.1 t -70.14 144.42 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-O 122.497 1.142 . . . . 0.0 112.665 -176.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -60.4 -22.95 63.95 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 113.29 -1.777 . . . . 0.0 112.29 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.7 ' H ' HG12 ' A' ' 20' ' ' VAL . 42.3 tt0 -161.17 140.31 10.22 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 120.801 0.334 . . . . 0.0 111.157 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.734 ' HA ' HD12 ' A' ' 27' ' ' ILE . 2.7 t -83.02 117.99 29.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.138 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.909 ' O ' ' HG3' ' A' ' 28' ' ' GLN . 9.8 p30 -105.76 -168.66 1.47 Allowed 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 122.295 -0.253 . . . . 0.0 110.353 -178.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.668 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -73.31 -25.83 60.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.779 0.323 . . . . 0.0 111.434 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.573 ' HB2' ' OD1' ' A' ' 24' ' ' ASN . 4.6 mm-40 -72.89 -40.21 65.74 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.734 HD12 ' HA ' ' A' ' 23' ' ' VAL . 50.8 mt -65.78 -46.04 89.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.166 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.909 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 45.5 mt-30 -57.09 -40.28 76.69 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.705 0.288 . . . . 0.0 110.444 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.668 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 39.4 mmt180 -61.52 -41.16 96.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.654 0.74 . . . . 0.0 109.074 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.818 ' O ' ' HG3' ' A' ' 34' ' ' MET . 4.8 mt -59.72 -50.12 81.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.742 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.898 HG22 ' CG2' ' A' ' 57' ' ' ILE . 10.8 t -67.87 -43.8 85.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-O 120.843 0.354 . . . . 0.0 111.723 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.864 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 26.0 m-20 -54.37 -41.8 69.58 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.404 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.635 ' CB ' HD12 ' A' ' 3' ' ' LEU . 55.9 m-20 -74.39 -31.17 62.25 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.077 176.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 1.01 ' HG2' HG21 ' A' ' 51' ' ' VAL . 85.1 mtp -60.3 -47.1 87.47 Favored 'General case' 0 C--N 1.346 0.453 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.869 -177.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.864 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 15.9 p90 -69.35 -44.51 71.45 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.565 ' HG2' ' O ' ' A' ' 32' ' ' ASP . 3.3 mm-40 -51.22 -43.79 61.5 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 1.004 ' HA ' HG12 ' A' ' 2' ' ' VAL . 96.6 m -70.06 -59.98 2.57 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 118.723 -1.191 . . . . 0.0 109.267 177.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.994 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 3.7 ttp -46.32 -42.5 14.81 Favored 'General case' 0 CA--C 1.461 -2.45 0 C-N-CA 123.42 0.688 . . . . 0.0 109.646 -170.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.751 ' OH ' ' HA ' ' A' ' 69' ' ' ARG . 60.4 m-85 -69.56 -42.35 74.68 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.593 178.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.494 ' CB ' HG11 ' A' ' 2' ' ' VAL . . . -59.84 -28.4 67.47 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.797 ' HG2' ' CD2' ' A' ' 91' ' ' LEU . 17.6 tp10 -84.9 -10.81 56.73 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.708 177.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.442 ' H ' ' C ' ' A' ' 39' ' ' TYR . 7.4 mm-40 63.87 24.2 13.63 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.952 -176.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.1 142.18 26.0 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 114.143 -1.39 . . . . 0.0 110.595 177.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.868 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 44.2 mm -78.77 -2.18 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 117.566 0.683 . . . . 0.0 112.195 -178.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.541 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 179.36 135.5 2.41 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-O 118.88 -0.956 . . . . 0.0 111.769 -178.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.967 ' HB2' ' HG3' ' A' ' 38' ' ' MET . 9.1 tp -125.85 135.16 51.64 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.437 1.619 . . . . 0.0 111.743 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -99.5 129.97 45.72 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.874 ' HB1' ' CD1' ' A' ' 53' ' ' ILE . . . -30.72 -54.51 0.2 Allowed 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.675 HG21 ' O ' ' A' ' 137' ' ' LEU . 66.6 p -53.53 -35.41 60.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.775 0.798 . . . . 0.0 111.364 -178.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.539 ' O ' HG13 ' A' ' 5' ' ' VAL . 55.8 mt-30 -66.35 -37.36 85.16 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.078 179.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.01 HG21 ' HG2' ' A' ' 34' ' ' MET . 1.1 m -86.4 12.13 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.89 ' HA ' HD11 ' A' ' 6' ' ' LEU . 55.3 t0 78.96 32.37 0.28 Allowed 'General case' 0 C--O 1.23 0.059 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 176.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.874 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 1.2 pp -127.31 111.75 26.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.065 177.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.579 ' HB3' ' HD3' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -76.23 65.05 2.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.089 0.947 . . . . 0.0 110.466 -179.034 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.729 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 28.3 mt-30 -154.88 134.54 12.75 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 114.169 -1.378 . . . . 0.0 108.527 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.919 ' HD2' ' HD3' ' A' ' 19' ' ' PRO . 77.8 mtt-85 -63.34 70.82 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -177.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.898 ' CG2' HG22 ' A' ' 31' ' ' VAL . 8.7 mm -112.9 122.74 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.111 HD11 ' HB2' ' A' ' 72' ' ' LEU . 1.7 pp -128.61 146.03 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 119.635 -0.826 . . . . 0.0 113.177 -177.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.662 HG22 ' O ' ' A' ' 46' ' ' LEU . 33.8 m -128.05 138.75 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.96 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.984 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 12.1 mm -116.13 150.57 18.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.642 0.734 . . . . 0.0 109.859 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.994 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 28.9 t70 -132.7 21.72 4.25 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.508 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.927 HG11 HD12 ' A' ' 125' ' ' LEU . 32.6 t . . . . . 0 N--CA 1.464 0.226 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.328 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.751 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 78.8 ttt180 . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.984 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 44.0 mt -104.73 133.55 49.37 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -178.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.822 ' O ' HD12 ' A' ' 72' ' ' LEU . 14.4 p -135.07 133.15 53.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.56 177.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.111 ' HB2' HD11 ' A' ' 58' ' ' ILE . 10.4 mp -138.96 139.79 38.05 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.999 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 2.6 mm -118.86 132.49 68.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.102 0.477 . . . . 0.0 111.197 -178.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.723 ' OD1' ' HA ' ' A' ' 19' ' ' PRO . 68.4 m-20 50.7 38.0 0.47 Allowed Pre-proline 0 CA--C 1.547 0.843 0 CA-C-N 115.003 -0.999 . . . . 0.0 113.075 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.784 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 96.2 Cg_exo -55.85 152.33 36.26 Favored 'Trans proline' 0 N--CA 1.487 1.135 0 C-N-CA 123.027 2.485 . . . . 0.0 114.156 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -137.14 143.25 42.37 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.829 HD23 ' N ' ' A' ' 78' ' ' LEU . 1.8 tt -81.14 135.44 35.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.711 0.767 . . . . 0.0 111.609 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.062 HD11 ' HG3' ' A' ' 109' ' ' ARG . 6.9 mp -111.99 -37.3 5.13 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.045 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 37.6 tt0 -161.0 156.09 24.23 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 121.271 0.557 . . . . 0.0 112.004 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.855 ' HA ' HG12 ' A' ' 106' ' ' VAL . 18.3 ptpt -148.07 153.14 38.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.06 178.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.6 p -159.62 146.38 16.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.852 0.358 . . . . 0.0 111.24 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.76 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 69.73 173.22 10.59 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.843 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.696 ' N ' ' HG3' ' A' ' 104' ' ' GLU . 56.1 mt-10 -146.62 113.89 6.26 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.714 HG23 ' HG2' ' A' ' 104' ' ' GLU . 1.5 p -96.03 159.89 14.73 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 178.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.699 ' O ' HD13 ' A' ' 86' ' ' ILE . . . -135.63 100.81 0.36 Allowed Glycine 0 C--N 1.319 -0.406 0 CA-C-N 113.452 -1.704 . . . . 0.0 111.878 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.699 HD13 ' O ' ' A' ' 85' ' ' GLY . 39.6 mm -145.15 136.94 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -178.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.632 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 47.6 mt-10 -73.35 143.41 46.88 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 122.845 1.307 . . . . 0.0 112.968 -177.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.608 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 95.2 mt-10 -154.96 166.27 34.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 113.502 -1.681 . . . . 0.0 109.515 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.803 ' HA3' ' HG2' ' A' ' 97' ' ' ARG . . . -119.86 165.31 13.5 Favored Glycine 0 CA--C 1.498 -0.993 0 C-N-CA 119.339 -1.41 . . . . 0.0 110.225 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 1.085 ' HB2' HD13 ' A' ' 93' ' ' ILE . 95.3 m -118.2 140.22 50.12 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.879 -176.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.797 ' CD2' ' HG2' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -56.9 -23.43 44.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.627 178.741 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.906 ' CB ' HD13 ' A' ' 13' ' ' LEU . 58.7 m -79.45 -38.51 34.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.407 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 1.085 HD13 ' HB2' ' A' ' 90' ' ' CYS . 2.6 mp . . . . . 0 CA--C 1.535 0.367 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.397 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.803 ' HG2' ' HA3' ' A' ' 89' ' ' GLY . 45.8 mtm-85 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.757 0.789 . . . . 0.0 111.437 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 87' ' ' GLU . . . -134.62 153.92 51.75 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.113 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.744 HD23 ' N ' ' A' ' 100' ' ' VAL . 6.6 tt -75.13 136.95 41.07 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.912 ' HB ' ' CZ ' ' A' ' 102' ' ' ARG . 21.9 t -132.04 134.23 24.91 Favored Pre-proline 0 C--N 1.339 0.138 0 C-N-CA 120.461 -0.495 . . . . 0.0 110.986 -178.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 100' ' ' VAL . 4.1 Cg_exo -79.75 123.14 5.17 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 121.409 1.406 . . . . 0.0 112.321 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.912 ' CZ ' ' HB ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -144.08 165.75 26.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.653 178.455 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.76 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.72 154.02 42.71 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.014 0.435 . . . . 0.0 109.96 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.714 ' HG2' HG23 ' A' ' 84' ' ' THR . 46.8 mt-10 -73.95 -42.29 60.73 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.336 -176.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.642 ' HG2' ' HB3' ' A' ' 123' ' ' ASP . 93.6 mttt -139.79 137.98 35.46 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.683 0.754 . . . . 0.0 109.677 176.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.855 HG12 ' HA ' ' A' ' 80' ' ' LYS . 28.9 m -141.44 142.04 29.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.754 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 1.044 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 23.6 mmtp -108.13 125.67 51.87 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 1.033 ' HA ' HD13 ' A' ' 78' ' ' LEU . 1.9 pp -130.71 161.75 40.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -177.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 1.062 ' HG3' HD11 ' A' ' 78' ' ' LEU . 93.7 mtt180 -111.0 138.34 47.52 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.546 ' CB ' HD23 ' A' ' 72' ' ' LEU . . . -155.23 166.34 33.87 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.828 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.999 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.2 pp -117.27 152.01 35.74 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.611 ' O ' HD12 ' A' ' 111' ' ' LEU . 20.0 t70 -85.25 168.78 14.42 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 119.326 -0.95 . . . . 0.0 112.404 -176.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.669 ' HB2' HG21 ' A' ' 71' ' ' VAL . 46.5 ttp85 -54.87 -20.26 8.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.689 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -79.71 -19.4 48.96 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.523 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.607 ' HA2' HD13 ' A' ' 111' ' ' LEU . . . 98.83 39.13 3.68 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.156 -1.021 . . . . 0.0 114.141 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.673 ' NZ ' ' HB3' ' A' ' 116' ' ' LYS . 2.2 mmmp? -128.28 102.21 21.27 Favored Pre-proline 0 N--CA 1.467 0.397 0 CA-C-N 117.516 0.658 . . . . 0.0 110.82 178.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.651 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.8 Cg_exo -74.58 115.56 4.34 Favored 'Trans proline' 0 C--N 1.361 1.188 0 C-N-CA 121.733 1.622 . . . . 0.0 116.061 -177.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -125.42 168.49 13.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.043 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.705 ' HG2' ' HG2' ' A' ' 109' ' ' ARG . 35.2 mt-10 -108.09 130.63 55.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.972 0.415 . . . . 0.0 110.305 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.976 HD21 HD21 ' A' ' 72' ' ' LEU . 4.1 pp -128.48 135.72 49.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.222 0.534 . . . . 0.0 112.092 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 1.044 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 11.7 pt-20 -95.5 125.63 40.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.974 178.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.922 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -116.55 135.72 53.58 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.642 ' HB3' ' HG2' ' A' ' 105' ' ' LYS . 24.0 m-20 -125.84 165.04 19.42 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.789 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 46.81 -136.79 9.57 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 120.125 1.329 . . . . 0.0 116.261 176.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.927 HD12 HG11 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -54.76 -32.79 60.46 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.319 -0.941 . . . . 0.0 111.341 -178.387 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.922 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -71.46 -52.64 17.35 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 121.626 0.727 . . . . 0.0 109.455 179.536 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.786 ' HB2' ' C ' ' A' ' 122' ' ' ALA . . . -58.24 -40.77 82.62 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.58 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.879 HD12 ' HG2' ' A' ' 102' ' ' ARG . 49.7 mm -68.6 -54.42 21.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.437 -179.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.737 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 31.9 p -57.67 -50.92 71.6 Favored 'General case' 0 C--N 1.334 -0.089 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.763 HD11 HD11 ' A' ' 108' ' ' ILE . 20.7 tt -60.55 -44.0 95.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.41 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.844 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 21.5 pt20 -67.85 -38.33 83.03 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.226 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.753 ' HA ' ' OD2' ' A' ' 135' ' ' ASP . 7.8 t-160 -58.45 -46.93 85.57 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.89 ' O ' HD23 ' A' ' 137' ' ' LEU . 4.1 mm-40 -59.42 -44.42 92.86 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.802 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.92 ' HA ' HD21 ' A' ' 137' ' ' LEU . 75.2 mtp -57.01 -48.84 77.52 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 118.411 0.551 . . . . 0.0 110.969 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.753 ' OD2' ' HA ' ' A' ' 132' ' ' HIS . 2.6 p30 -64.24 -47.26 80.34 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.474 -0.49 . . . . 0.0 109.785 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.463 ' CE1' ' HG2' ' A' ' 50' ' ' GLN . 20.6 t-80 -56.47 -51.79 67.15 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 121.589 -0.694 . . . . 0.0 110.94 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.92 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.3 pp -60.6 -31.31 70.47 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 119.895 -0.722 . . . . 0.0 112.053 -177.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 1.013 HG23 HG13 ' A' ' 16' ' ' VAL . 14.7 p -80.6 23.09 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-O 122.966 1.365 . . . . 0.0 109.815 176.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.878 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 64.45 6.34 21.21 Favored Glycine 0 CA--C 1.491 -1.426 0 CA-C-N 112.482 -2.144 . . . . 0.0 112.896 176.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.822 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 4.5 ptmt . . . . . 0 N--CA 1.43 -1.44 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.1 m . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.026 0.441 . . . . 0.0 111.662 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.962 HD23 ' HB ' ' A' ' 51' ' ' VAL . 58.6 tp -77.82 158.08 29.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.284 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -78.56 106.07 10.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.127 0.489 . . . . 0.0 109.946 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.044 HG11 HD12 ' A' ' 91' ' ' LEU . 37.3 t -90.51 131.98 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.668 -178.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.01 ' HB2' HD21 ' A' ' 13' ' ' LEU . 29.6 mt -83.49 140.79 32.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.951 179.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 19.5 m-70 -111.18 142.93 42.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.202 0.525 . . . . 0.0 112.33 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.931 HD13 HD12 ' A' ' 13' ' ' LEU . 49.6 mm -50.87 144.81 12.8 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.799 178.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.524 ' HA ' HG23 ' A' ' 8' ' ' ILE . 79.1 Cg_endo -98.18 55.48 1.04 Allowed 'Cis proline' 0 C--N 1.354 0.837 0 C-N-CA 124.844 -0.898 . . . . 0.0 113.159 0.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.583 ' OD2' ' HB3' ' A' ' 6' ' ' LEU . 66.8 m-20 -55.11 140.89 36.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.375 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.427 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 23.9 pt-20 -58.84 -45.54 89.81 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.656 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.79 HH21 HG22 ' A' ' 49' ' ' THR . 0.0 OUTLIER -56.8 -24.91 54.07 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 179.711 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 1.01 HD21 ' HB2' ' A' ' 6' ' ' LEU . 8.2 mt -76.77 -32.87 58.01 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 121.193 1.815 . . . . 0.0 108.509 178.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.55 HH11 ' HG2' ' A' ' 14' ' ' ARG . 24.3 mmt-85 -94.76 5.89 50.54 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 114.159 -1.382 . . . . 0.0 109.716 178.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.763 ' HD3' ' NH1' ' A' ' 12' ' ' ARG . 75.7 tttt -93.13 155.74 17.29 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.811 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.824 HG13 HG23 ' A' ' 138' ' ' VAL . 64.3 t -82.5 136.17 23.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.293 0.568 . . . . 0.0 111.335 -178.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.043 ' HB3' HD12 ' A' ' 137' ' ' LEU . . . -87.18 141.13 28.88 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.693 ' HD3' ' N ' ' A' ' 19' ' ' PRO . 1.9 tmtp? -102.42 127.92 29.41 Favored Pre-proline 0 C--N 1.324 -0.503 0 C-N-CA 120.717 -0.393 . . . . 0.0 109.976 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.699 ' HB3' ' HD3' ' A' ' 56' ' ' ARG . 61.9 Cg_endo -78.81 115.02 3.52 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.14 1.893 . . . . 0.0 111.151 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.791 HG12 ' H ' ' A' ' 22' ' ' GLU . 19.8 t -70.07 145.0 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 CA-C-O 122.569 1.176 . . . . 0.0 113.232 -176.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.404 ' N ' HG12 ' A' ' 20' ' ' VAL . 51.6 mt-10 -65.93 -22.59 66.5 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 113.189 -1.823 . . . . 0.0 112.636 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.791 ' H ' HG12 ' A' ' 20' ' ' VAL . 5.0 tp10 -159.55 151.38 20.45 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.199 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.896 HG21 ' HA2' ' A' ' 115' ' ' GLY . 4.4 t -80.1 101.71 5.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.944 ' CB ' HD13 ' A' ' 27' ' ' ILE . 59.9 m-80 -91.53 160.33 15.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.933 -177.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.545 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -56.39 -32.97 65.3 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.494 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -71.78 -37.45 70.45 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.944 HD13 ' CB ' ' A' ' 24' ' ' ASN . 1.7 mp -64.24 -47.93 87.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.084 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -57.94 -40.51 80.68 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.788 0.328 . . . . 0.0 111.096 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.545 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 39.3 mmt180 -61.16 -41.3 96.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.808 0.813 . . . . 0.0 109.315 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.771 ' O ' ' HG3' ' A' ' 34' ' ' MET . 6.9 mt -59.37 -50.58 79.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 114.486 -1.233 . . . . 0.0 112.322 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.932 HG22 ' CG2' ' A' ' 57' ' ' ILE . 9.4 t -67.04 -42.15 88.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-O 120.846 0.355 . . . . 0.0 111.66 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.917 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -56.24 -42.44 77.35 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.96 -179.37 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.665 ' HB3' ' HB2' ' A' ' 3' ' ' LEU . 1.4 m-20 -75.07 -30.73 61.04 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.157 176.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 1.088 ' HG2' HG21 ' A' ' 51' ' ' VAL . 79.3 mtp -60.58 -47.84 84.4 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.007 -177.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.917 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 15.9 p90 -69.02 -43.76 74.13 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.61 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 52.9 mm-40 -52.43 -41.05 62.91 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.781 HG21 ' CG2' ' A' ' 5' ' ' VAL . 31.0 m -69.98 -62.16 1.49 Allowed 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 118.792 -1.163 . . . . 0.0 108.757 177.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.89 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 1.4 ttp -46.3 -42.63 14.89 Favored 'General case' 0 CA--C 1.46 -2.496 0 C-N-CA 123.611 0.764 . . . . 0.0 110.016 -170.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.681 ' OH ' ' HA ' ' A' ' 69' ' ' ARG . 66.7 m-85 -69.29 -41.65 76.51 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.389 178.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.06 -28.49 67.83 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.8 ' HG2' ' CD2' ' A' ' 91' ' ' LEU . 3.0 tp10 -84.62 -10.38 57.41 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.977 177.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.436 ' H ' ' C ' ' A' ' 39' ' ' TYR . 51.3 mt-10 63.37 25.59 14.66 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.953 -176.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.43 142.73 24.15 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.856 177.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.812 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 46.1 mm -78.99 -1.71 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 117.576 0.688 . . . . 0.0 112.254 -178.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.494 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 179.12 135.94 2.5 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 118.948 -0.918 . . . . 0.0 112.024 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.878 ' HB2' ' HG3' ' A' ' 38' ' ' MET . 6.9 tp -126.82 134.54 50.52 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.359 1.58 . . . . 0.0 112.295 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.833 ' HB2' ' OE1' ' A' ' 133' ' ' GLU . . . -97.8 131.1 44.6 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 122.386 0.274 . . . . 0.0 111.39 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.911 ' HB1' ' CG1' ' A' ' 53' ' ' ILE . . . -33.73 -54.12 0.45 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -178.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.79 HG22 HH21 ' A' ' 12' ' ' ARG . 81.8 p -52.84 -35.77 57.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.722 0.772 . . . . 0.0 111.176 -178.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.543 ' O ' HG13 ' A' ' 5' ' ' VAL . 53.4 mt-30 -66.85 -36.76 83.07 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.023 178.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.088 HG21 ' HG2' ' A' ' 34' ' ' MET . 1.3 m -87.21 13.49 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.843 ' HA ' HD11 ' A' ' 6' ' ' LEU . 54.5 t0 77.75 32.4 0.4 Allowed 'General case' 0 C--O 1.23 0.075 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 176.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.911 ' CG1' ' HB1' ' A' ' 48' ' ' ALA . 1.2 pp -127.11 112.76 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.201 177.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.738 ' HA ' ' NH2' ' A' ' 12' ' ' ARG . 0.4 OUTLIER -76.0 67.02 2.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.862 0.839 . . . . 0.0 110.517 -179.439 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.77 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 89.2 mt-30 -157.59 134.05 9.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.691 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.739 ' N ' ' HB1' ' A' ' 17' ' ' ALA . 52.2 mtp85 -62.84 70.69 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -178.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.932 ' CG2' HG22 ' A' ' 31' ' ' VAL . 8.5 mm -113.16 122.35 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.073 HD11 ' HB2' ' A' ' 72' ' ' LEU . 2.1 pp -129.02 146.37 34.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.877 -178.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.588 HG23 ' H ' ' A' ' 46' ' ' LEU . 33.3 m -127.82 138.6 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.652 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.079 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 12.1 mm -115.1 149.23 17.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.617 0.722 . . . . 0.0 109.301 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.89 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 57.0 t0 -134.2 30.58 3.59 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.767 -178.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.801 HG22 ' CG2' ' A' ' 44' ' ' ILE . 30.4 t . . . . . 0 N--CA 1.463 0.185 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.877 179.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.681 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 73.8 ttt180 . . . . . 0 N--CA 1.465 0.299 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 1.079 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 4.0 mm? -103.89 133.11 49.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.786 0.327 . . . . 0.0 111.473 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.811 HG21 ' HB2' ' A' ' 113' ' ' ARG . 10.6 p -135.38 133.3 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.593 178.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.073 ' HB2' HD11 ' A' ' 58' ' ' ILE . 1.5 mm? -140.71 142.2 34.86 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 177.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.066 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.7 mp -121.14 135.22 62.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 117.987 0.358 . . . . 0.0 110.679 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.72 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 7.9 m120 54.46 37.07 0.38 Allowed Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.884 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 99.5 Cg_exo -56.71 148.63 64.25 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 123.058 2.505 . . . . 0.0 114.408 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.511 ' O ' ' HB ' ' A' ' 108' ' ' ILE . 15.8 pt-20 -139.61 143.04 37.07 Favored 'General case' 0 C--O 1.23 0.079 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.884 HD12 HG22 ' A' ' 108' ' ' ILE . 8.5 tp -80.07 138.02 36.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.443 0.639 . . . . 0.0 111.43 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.091 HD11 ' HG3' ' A' ' 109' ' ' ARG . 6.8 mp -113.13 -36.91 4.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.181 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.433 ' O ' ' HB ' ' A' ' 106' ' ' VAL . 41.4 tt0 -159.0 149.55 19.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.208 0.528 . . . . 0.0 111.42 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 1.077 ' HA ' HG12 ' A' ' 106' ' ' VAL . 12.5 ptmt -146.47 149.59 33.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.282 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 81.2 p -158.58 145.04 17.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.526 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.783 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 79.12 154.74 8.48 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.117 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 -127.36 113.82 16.75 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.783 0.801 . . . . 0.0 112.316 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.588 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.5 p -106.44 160.89 15.06 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 115.645 1.721 . . . . 0.0 115.645 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.739 ' CA ' HD21 ' A' ' 99' ' ' LEU . . . -140.39 105.92 0.46 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 113.046 -1.888 . . . . 0.0 111.584 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.683 ' N ' ' HG ' ' A' ' 99' ' ' LEU . 20.4 mt -144.99 135.45 19.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -178.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 52.8 mt-10 -72.73 143.28 48.07 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 122.818 1.294 . . . . 0.0 113.37 -177.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.589 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 55.6 mt-10 -156.54 168.64 26.77 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 113.301 -1.772 . . . . 0.0 109.289 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.685 ' HA3' ' HG2' ' A' ' 97' ' ' ARG . . . -120.06 165.97 13.58 Favored Glycine 0 CA--C 1.5 -0.867 0 C-N-CA 119.421 -1.371 . . . . 0.0 110.628 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.551 ' HB2' HG13 ' A' ' 93' ' ' ILE . 63.0 m -115.71 137.65 51.87 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.921 -177.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.044 HD12 HG11 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -50.89 -33.27 23.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.65 0.738 . . . . 0.0 109.403 179.647 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.893 ' CB ' HD13 ' A' ' 13' ' ' LEU . 60.1 m -76.92 -30.56 56.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.829 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.551 HG13 ' HB2' ' A' ' 90' ' ' CYS . 57.7 mt . . . . . 0 C--N 1.327 -0.382 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.685 ' HG2' ' HA3' ' A' ' 89' ' ' GLY . 42.9 mtm-85 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 121.67 0.748 . . . . 0.0 111.659 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -134.2 153.94 51.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.839 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.739 HD21 ' CA ' ' A' ' 85' ' ' GLY . 6.9 tt -75.53 135.95 40.59 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.875 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.678 ' N ' HD23 ' A' ' 99' ' ' LEU . 60.2 t -130.38 134.64 26.32 Favored Pre-proline 0 N--CA 1.454 -0.265 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.588 ' HA ' ' O ' ' A' ' 84' ' ' THR . 88.2 Cg_endo -82.71 124.12 3.91 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.395 1.397 . . . . 0.0 113.721 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.906 ' HG2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -141.99 164.95 28.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 113.914 -1.494 . . . . 0.0 110.22 179.204 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.783 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.86 154.85 41.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.809 0.338 . . . . 0.0 110.913 -178.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.534 ' OE1' HG21 ' A' ' 84' ' ' THR . 28.2 tp10 -72.66 -43.93 62.51 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.283 -176.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.764 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 55.8 mttm -139.13 138.36 36.94 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.463 0.649 . . . . 0.0 109.495 176.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 1.077 HG12 ' HA ' ' A' ' 80' ' ' LYS . 25.8 m -147.49 140.43 19.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.614 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.907 ' HD2' ' CB ' ' A' ' 121' ' ' GLU . 51.3 mmtt -107.41 125.37 51.13 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 1.08 ' HA ' HD13 ' A' ' 78' ' ' LEU . 1.4 pp -129.95 160.75 40.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 1.091 ' HG3' HD11 ' A' ' 78' ' ' LEU . 92.7 mtt180 -107.51 135.01 49.69 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-O 121.142 0.496 . . . . 0.0 110.326 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.904 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -155.75 167.5 30.2 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.184 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 1.066 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.3 pp -115.54 151.69 34.4 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.446 ' OD1' HG13 ' A' ' 71' ' ' VAL . 19.8 t70 -86.67 163.46 17.36 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.604 -176.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.811 ' HB2' HG21 ' A' ' 71' ' ' VAL . 14.4 ttp-105 -54.75 -16.44 2.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.77 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.37 -25.7 42.14 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.975 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.896 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 105.91 35.51 2.97 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.573 -0.822 . . . . 0.0 113.837 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -128.92 102.98 18.93 Favored Pre-proline 0 C--O 1.238 0.485 0 CA-C-N 116.967 0.383 . . . . 0.0 111.139 178.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.679 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 32.5 Cg_exo -73.23 114.76 4.12 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 121.653 1.569 . . . . 0.0 114.994 -177.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -129.6 168.93 15.69 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.908 -178.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.864 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 6.2 mp0 -106.63 130.11 54.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.91 0.386 . . . . 0.0 109.981 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.9 ' O ' HD23 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -124.45 141.78 51.82 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.881 0.848 . . . . 0.0 112.017 -178.57 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.907 ' CB ' ' HD2' ' A' ' 107' ' ' LYS . 15.3 pt-20 -94.84 123.33 38.24 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.998 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.779 ' O ' ' HB2' ' A' ' 127' ' ' ALA . . . -116.52 134.17 55.16 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.453 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.764 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.2 m-20 -126.76 163.62 23.14 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.76 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 45.89 -133.75 9.61 Favored Glycine 0 C--N 1.348 1.198 0 CA-C-N 120.832 1.651 . . . . 0.0 116.224 176.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.0 mt -53.38 -35.06 59.91 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.444 -0.878 . . . . 0.0 111.444 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.543 HD22 ' CB ' ' A' ' 122' ' ' ALA . 0.6 OUTLIER -70.68 -53.67 14.81 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.311 0.577 . . . . 0.0 110.116 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.779 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -59.0 -42.95 91.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.699 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.906 HD12 ' HG2' ' A' ' 102' ' ' ARG . 49.5 mm -64.72 -55.47 20.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.366 -178.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.453 ' SG ' HG21 ' A' ' 62' ' ' VAL . 28.9 p -57.76 -49.71 75.69 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -178.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.679 HD11 HD11 ' A' ' 108' ' ' ILE . 19.3 tt -59.26 -42.42 87.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.878 ' CG ' HG21 ' A' ' 106' ' ' VAL . 66.5 mt-30 -65.79 -40.57 92.07 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 178.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.659 ' HA ' ' OD2' ' A' ' 135' ' ' ASP . 74.1 t60 -56.0 -49.2 74.3 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.524 0.678 . . . . 0.0 110.219 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.873 ' O ' HD23 ' A' ' 137' ' ' LEU . 24.0 mm-40 -60.7 -42.44 97.18 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.083 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.93 ' HA ' HD21 ' A' ' 137' ' ' LEU . 35.5 mtm -58.16 -49.62 76.36 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.351 0.978 . . . . 0.0 110.968 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.659 ' OD2' ' HA ' ' A' ' 132' ' ' HIS . 4.1 p30 -63.0 -46.09 89.31 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.681 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.461 ' CE1' ' HG2' ' A' ' 50' ' ' GLN . 11.7 t-80 -56.76 -51.57 68.38 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 121.78 -0.575 . . . . 0.0 111.039 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 1.043 HD12 ' HB3' ' A' ' 17' ' ' ALA . 1.2 pp -59.76 -30.72 69.05 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.799 -177.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.824 HG23 HG13 ' A' ' 16' ' ' VAL . 10.7 p -83.11 20.48 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-O 123.083 1.42 . . . . 0.0 108.22 174.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.805 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 60.36 17.49 46.99 Favored Glycine 0 CA--C 1.491 -1.455 0 CA-C-N 112.106 -2.316 . . . . 0.0 112.553 176.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.775 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.431 -1.424 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.749 HG13 ' HA ' ' A' ' 37' ' ' THR . 42.2 t . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.926 0.393 . . . . 0.0 111.276 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 1.074 HD23 ' HB ' ' A' ' 51' ' ' VAL . 58.4 tp -77.39 161.74 27.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.335 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 71.0 tp60 -78.44 106.67 10.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.03 0.443 . . . . 0.0 110.03 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.042 HG11 HD12 ' A' ' 91' ' ' LEU . 39.5 t -90.08 131.94 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.647 -178.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.083 ' HB2' HD21 ' A' ' 13' ' ' LEU . 25.5 mt -85.01 140.73 30.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.479 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 39.2 m-70 -115.79 141.78 47.63 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -178.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.083 HD13 HD12 ' A' ' 13' ' ' LEU . 41.4 mm -62.77 134.5 95.48 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.889 177.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.3 144.81 78.83 Favored 'Cis proline' 0 C--N 1.352 0.754 0 C-N-CA 124.615 -0.994 . . . . 0.0 111.815 -0.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.982 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.6 t70 -164.56 126.46 2.23 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.505 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.528 ' HG2' ' N ' ' A' ' 12' ' ' ARG . 10.5 pm0 -58.28 -45.49 87.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.551 -178.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.715 ' HD3' ' HE3' ' A' ' 15' ' ' LYS . 14.2 mmt-85 -58.13 -27.63 63.92 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 1.083 HD12 HD13 ' A' ' 8' ' ' ILE . 9.6 mt -77.58 -31.3 53.0 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 120.814 1.643 . . . . 0.0 108.86 177.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.627 ' C ' ' HA3' ' A' ' 139' ' ' GLY . 13.5 mmt85 -95.54 10.0 38.14 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 114.147 -1.388 . . . . 0.0 109.308 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.808 ' NZ ' ' HB2' ' A' ' 54' ' ' HIS . 20.4 ttpp -92.05 146.49 23.69 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.204 -179.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.893 ' CG1' HG23 ' A' ' 138' ' ' VAL . 44.5 t -84.15 95.26 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.535 -178.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.58 ' HB1' ' C ' ' A' ' 55' ' ' GLN . . . -54.8 148.24 13.42 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-O 121.053 0.454 . . . . 0.0 111.868 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.418 ' HB3' ' OE1' ' A' ' 55' ' ' GLN . 54.2 tttp -103.21 129.42 25.58 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.902 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.663 ' CD ' ' HD3' ' A' ' 56' ' ' ARG . 60.1 Cg_endo -79.64 116.48 3.52 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.428 2.085 . . . . 0.0 110.506 179.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.871 HG12 ' H ' ' A' ' 22' ' ' GLU . 20.9 t -71.27 144.71 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-O 122.552 1.168 . . . . 0.0 113.143 -176.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -69.15 -21.13 64.02 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 113.121 -1.854 . . . . 0.0 112.329 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.871 ' H ' HG12 ' A' ' 20' ' ' VAL . 88.7 tt0 -159.25 142.03 14.16 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 121.157 -0.217 . . . . 0.0 110.566 -179.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.596 HG21 ' CD1' ' A' ' 111' ' ' LEU . 2.8 t -80.51 106.01 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 -178.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 1.065 ' H ' HD12 ' A' ' 27' ' ' ILE . 64.5 m-80 -89.34 159.05 17.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.692 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.568 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -54.17 -30.54 49.83 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.024 0.44 . . . . 0.0 110.69 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -71.81 -39.66 69.7 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 1.065 HD12 ' H ' ' A' ' 24' ' ' ASN . 60.6 mt -63.56 -47.6 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.297 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 11.6 mt-30 -57.85 -40.34 79.87 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.77 0.319 . . . . 0.0 110.627 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 40.0 mmt-85 -59.84 -40.45 88.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.811 0.815 . . . . 0.0 108.866 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.771 ' O ' ' HG3' ' A' ' 34' ' ' MET . 4.4 mt -59.64 -49.48 83.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 114.419 -1.264 . . . . 0.0 111.846 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.9 HG22 ' CG2' ' A' ' 57' ' ' ILE . 18.7 t -66.82 -42.21 88.86 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-O 120.839 0.352 . . . . 0.0 111.395 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.878 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -55.32 -43.91 75.32 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.997 -179.321 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.648 ' HB3' ' HB2' ' A' ' 3' ' ' LEU . 31.9 m-20 -75.29 -30.83 60.5 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.355 176.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 1.004 ' HG2' HG21 ' A' ' 51' ' ' VAL . 79.2 mtp -59.55 -47.22 86.38 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.566 -177.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.878 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 13.6 p90 -69.05 -43.99 73.54 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 177.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.759 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 81.7 mt-10 -51.85 -40.31 60.35 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.749 ' HA ' HG13 ' A' ' 2' ' ' VAL . 37.2 m -69.8 -61.45 1.77 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 119.042 -1.063 . . . . 0.0 108.638 177.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.952 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 3.3 ttp -46.22 -43.81 15.72 Favored 'General case' 0 CA--C 1.459 -2.528 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.861 -170.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.711 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 70.2 m-85 -69.63 -41.62 75.41 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.635 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.23 -28.62 68.16 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.811 ' HG2' ' CD2' ' A' ' 91' ' ' LEU . 3.2 tp10 -84.72 -10.06 57.62 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 114.407 -1.269 . . . . 0.0 108.876 177.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.441 ' H ' ' C ' ' A' ' 39' ' ' TYR . 58.1 mt-10 62.01 26.05 15.68 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.824 -176.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.89 143.13 25.1 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.373 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.805 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 40.6 mt -78.99 -0.78 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 117.941 0.87 . . . . 0.0 112.008 -178.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.549 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 179.33 135.3 2.36 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 118.972 -0.904 . . . . 0.0 112.005 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.995 HD13 HD23 ' A' ' 91' ' ' LEU . 9.0 tp -126.51 135.43 51.31 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.535 1.667 . . . . 0.0 112.084 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -99.68 130.73 45.93 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.889 ' HB1' ' CD1' ' A' ' 53' ' ' ILE . . . -29.7 -56.15 0.16 Allowed 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.59 HG21 ' O ' ' A' ' 137' ' ' LEU . 75.7 p -53.16 -35.02 59.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.964 0.888 . . . . 0.0 111.167 -178.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.612 ' O ' HG13 ' A' ' 5' ' ' VAL . 36.6 mt-30 -66.1 -38.08 87.36 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.174 -1.375 . . . . 0.0 110.358 179.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.074 ' HB ' HD23 ' A' ' 3' ' ' LEU . 1.4 m -87.61 15.29 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.871 ' HA ' ' CD1' ' A' ' 6' ' ' LEU . 56.0 t0 76.53 32.89 0.54 Allowed 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 176.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.889 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 1.2 pp -126.91 111.12 24.77 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.404 177.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.808 ' HB2' ' NZ ' ' A' ' 15' ' ' LYS . 0.5 OUTLIER -75.6 64.89 1.73 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.942 0.877 . . . . 0.0 110.59 -179.207 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.71 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 11.8 mm100 -155.48 134.8 12.36 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 114.359 -1.291 . . . . 0.0 108.385 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.709 ' HG2' ' CD1' ' A' ' 137' ' ' LEU . 77.1 mtp180 -65.37 72.4 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -177.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.9 ' CG2' HG22 ' A' ' 31' ' ' VAL . 7.4 mm -113.52 122.99 68.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.005 HD11 ' HB2' ' A' ' 72' ' ' LEU . 1.9 pp -127.11 145.52 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -177.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 46' ' ' LEU . 32.8 m -127.48 138.41 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.369 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.053 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 13.5 mm -115.88 152.69 17.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.571 0.701 . . . . 0.0 110.58 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.952 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 36.6 t70 -146.11 34.12 1.0 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.417 -178.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.782 HG22 HG22 ' A' ' 44' ' ' ILE . 38.8 t . . . . . 0 N--CA 1.465 0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.289 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.605 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 76.0 ttt180 . . . . . 0 N--CA 1.462 0.143 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 1.053 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 40.8 mt -104.91 133.48 49.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.455 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.762 HG21 ' HB2' ' A' ' 113' ' ' ARG . 9.9 p -134.82 133.02 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.023 178.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.005 ' HB2' HD11 ' A' ' 58' ' ' ILE . 87.3 mt -141.85 141.95 33.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.907 -0.133 . . . . 0.0 111.252 178.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.072 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.9 mp -118.24 134.09 62.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 110.418 -0.215 . . . . 0.0 110.418 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.681 ' ND2' HG22 ' A' ' 73' ' ' ILE . 15.4 p30 46.32 40.75 0.71 Allowed Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.754 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 92.5 Cg_exo -56.79 155.43 27.26 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.987 2.458 . . . . 0.0 113.247 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -137.78 143.75 41.25 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.972 ' HB2' ' HE1' ' A' ' 134' ' ' MET . 1.8 tt -81.3 133.93 35.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.609 0.719 . . . . 0.0 111.506 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.048 HD11 ' HG3' ' A' ' 109' ' ' ARG . 6.8 mp -109.3 -38.83 5.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.541 -1.208 . . . . 0.0 111.905 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 42.7 tt0 -160.28 155.66 25.16 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.264 0.554 . . . . 0.0 112.056 -179.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.842 ' HA ' HG12 ' A' ' 106' ' ' VAL . 18.7 ptpt -148.25 151.53 35.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.451 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 53.2 m -160.08 143.46 13.94 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.679 0.276 . . . . 0.0 111.193 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.758 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 81.98 159.72 25.28 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.556 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -130.67 114.0 14.87 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.531 0.682 . . . . 0.0 112.617 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.5 p -107.76 159.31 16.59 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 179.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.71 ' O ' HD13 ' A' ' 86' ' ' ILE . . . -140.06 103.44 0.37 Allowed Glycine 0 C--N 1.318 -0.461 0 CA-C-N 113.039 -1.891 . . . . 0.0 111.63 178.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.71 HD13 ' O ' ' A' ' 85' ' ' GLY . 40.7 mm -144.67 135.86 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -178.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.639 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 48.8 mt-10 -72.27 143.68 48.66 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 122.577 1.18 . . . . 0.0 112.736 -178.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.592 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 50.3 mt-10 -155.61 164.16 39.0 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 113.727 -1.579 . . . . 0.0 109.482 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.781 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -118.68 163.29 13.16 Favored Glycine 0 CA--C 1.498 -1.016 0 C-N-CA 119.258 -1.449 . . . . 0.0 110.235 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.542 ' HB2' HG13 ' A' ' 93' ' ' ILE . 71.8 m -111.71 137.8 49.12 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.886 -177.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.042 HD12 HG11 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -50.01 -33.51 18.29 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.678 0.752 . . . . 0.0 109.891 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.853 ' CB ' HD13 ' A' ' 13' ' ' LEU . 29.2 m -77.55 -29.98 52.48 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.801 -179.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.542 HG13 ' HB2' ' A' ' 90' ' ' CYS . 59.9 mt . . . . . 0 C--N 1.327 -0.377 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.781 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 77.7 mtm180 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 121.729 0.776 . . . . 0.0 111.652 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -129.63 149.68 51.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.651 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.683 HD23 ' N ' ' A' ' 100' ' ' VAL . 6.9 tt -75.07 135.39 41.22 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.685 0.279 . . . . 0.0 110.462 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.79 ' HB ' ' NH2' ' A' ' 102' ' ' ARG . 57.6 t -130.25 130.61 23.07 Favored Pre-proline 0 N--CA 1.453 -0.31 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 84' ' ' THR . 5.8 Cg_exo -77.95 123.85 6.47 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 121.741 1.628 . . . . 0.0 112.587 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.942 HH11 ' HB3' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -142.75 165.28 27.8 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.085 -1.416 . . . . 0.0 110.4 179.39 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.758 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.64 154.94 40.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.721 0.296 . . . . 0.0 110.656 -178.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -72.77 -43.08 63.29 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.231 -176.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.793 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 82.3 mttt -139.6 138.27 36.04 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.48 0.657 . . . . 0.0 109.621 176.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.842 HG12 ' HA ' ' A' ' 80' ' ' LYS . 27.4 m -142.51 141.49 27.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.852 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.985 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 52.8 mmtt -107.73 125.77 51.8 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 1.0 ' HA ' HD13 ' A' ' 78' ' ' LEU . 2.0 pp -130.86 160.1 42.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -177.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 1.048 ' HG3' HD11 ' A' ' 78' ' ' LEU . 95.4 mtt180 -109.84 137.8 47.12 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.862 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -156.94 167.49 30.31 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.761 -0.2 . . . . 0.0 111.108 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 1.072 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.0 pp -113.9 151.86 31.61 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.415 ' O ' HD12 ' A' ' 111' ' ' LEU . 9.4 t70 -89.06 162.7 15.86 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.503 -177.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.812 ' HD2' ' OD1' ' A' ' 32' ' ' ASP . 48.4 ttp85 -52.75 -18.6 1.92 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.235 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -79.25 -25.06 42.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.343 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.92 35.85 2.89 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.698 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -128.79 102.93 19.3 Favored Pre-proline 0 C--O 1.237 0.423 0 CA-C-N 116.986 0.393 . . . . 0.0 111.248 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.663 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.6 Cg_exo -73.54 114.84 4.14 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 121.703 1.602 . . . . 0.0 114.729 -177.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.18 168.75 13.62 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.683 -178.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.813 ' HG2' ' HG2' ' A' ' 109' ' ' ARG . 33.2 mt-10 -107.39 130.06 54.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.051 0.453 . . . . 0.0 110.132 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.939 HD21 HD11 ' A' ' 72' ' ' LEU . 4.1 pp -127.48 134.72 49.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.97 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.985 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 11.5 pt-20 -93.53 125.11 37.96 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.843 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.939 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -116.19 135.43 53.92 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.793 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.1 m-20 -126.31 164.49 20.92 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.778 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 47.16 -135.3 11.95 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 120.187 1.358 . . . . 0.0 116.302 176.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.45 ' HB3' HG11 ' A' ' 62' ' ' VAL . 87.2 mt -54.04 -33.74 58.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.493 -0.854 . . . . 0.0 111.721 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.939 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -71.26 -53.46 14.24 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.762 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.777 ' HB2' ' C ' ' A' ' 122' ' ' ALA . . . -59.3 -46.19 89.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.876 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.832 HD12 ' HG2' ' A' ' 102' ' ' ARG . 47.3 mm -61.54 -56.02 20.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.095 -178.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.68 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 73.5 m -60.0 -51.22 70.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.707 HG22 ' O ' ' A' ' 126' ' ' LEU . 20.3 tt -59.11 -42.07 85.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 121.21 -0.196 . . . . 0.0 111.004 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.864 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.4 pt20 -67.81 -37.77 82.42 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -59.52 -44.94 93.04 Favored 'General case' 0 CA--C 1.521 -0.146 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.871 ' O ' HD23 ' A' ' 137' ' ' LEU . 4.2 mm-40 -59.3 -44.53 92.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.173 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.972 ' HE1' ' HB2' ' A' ' 77' ' ' LEU . 74.3 mtp -57.42 -48.32 79.42 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.544 0.687 . . . . 0.0 110.28 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.518 ' O ' HG12 ' A' ' 138' ' ' VAL . 30.5 m-20 -61.32 -48.63 80.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.157 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.45 ' CE1' ' HG2' ' A' ' 50' ' ' GLN . 21.4 t-80 -59.99 -51.43 69.71 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.861 0.362 . . . . 0.0 111.65 -178.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.937 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.4 pp -58.76 -32.98 69.77 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.481 -177.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.933 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 8.2 p -82.07 20.56 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-O 123.085 1.421 . . . . 0.0 108.854 175.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.847 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 59.44 14.66 28.43 Favored Glycine 0 CA--C 1.49 -1.474 0 CA-C-N 112.178 -2.283 . . . . 0.0 112.622 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.933 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 8.5 ptmt . . . . . 0 N--CA 1.426 -1.65 0 C-N-CA 119.466 -0.893 . . . . 0.0 108.816 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.965 HG12 ' HA ' ' A' ' 37' ' ' THR . 30.5 m . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.848 0.356 . . . . 0.0 111.428 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.933 HD21 ' HB ' ' A' ' 51' ' ' VAL . 3.0 pp -79.63 -172.4 3.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.565 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -82.37 108.98 16.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.782 0.325 . . . . 0.0 110.454 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.528 HG22 HG21 ' A' ' 37' ' ' THR . 37.9 t -88.42 129.85 38.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.385 0.612 . . . . 0.0 112.03 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.972 ' HB2' HD21 ' A' ' 13' ' ' LEU . 23.7 mt -88.15 147.39 24.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.655 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 -128.19 146.06 50.84 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.667 HD12 ' H ' ' A' ' 8' ' ' ILE . 3.3 mp -64.22 135.23 96.24 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.205 177.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.39 140.83 58.48 Favored 'Cis proline' 0 C--N 1.352 0.741 0 C-N-CA 124.253 -1.145 . . . . 0.0 111.804 -0.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.87 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.7 t70 -160.85 125.17 3.56 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.475 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.549 ' HG2' ' N ' ' A' ' 12' ' ' ARG . 2.7 pm0 -57.8 -43.81 85.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.418 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.669 ' HE ' ' HE3' ' A' ' 15' ' ' LYS . 15.5 mmt85 -55.99 -30.05 61.2 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.972 HD21 ' HB2' ' A' ' 6' ' ' LEU . 9.8 mt -77.1 -32.7 56.79 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 120.891 1.678 . . . . 0.0 108.661 177.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -91.66 8.83 34.98 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 113.998 -1.455 . . . . 0.0 109.165 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.669 ' HE3' ' HE ' ' A' ' 12' ' ' ARG . 24.9 ttmm -91.26 148.05 22.62 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.05 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.546 HG13 HG23 ' A' ' 138' ' ' VAL . 85.5 t -82.78 129.83 36.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.87 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -90.45 144.31 25.92 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.384 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.766 ' HD3' ' CD ' ' A' ' 19' ' ' PRO . 2.0 tmtp? -106.35 133.14 20.37 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.766 ' CD ' ' HD3' ' A' ' 18' ' ' LYS . 45.7 Cg_endo -82.09 114.71 2.57 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 121.934 1.756 . . . . 0.0 110.73 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.745 HG12 ' H ' ' A' ' 22' ' ' GLU . 16.0 t -67.68 144.33 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 CA-C-O 122.574 1.178 . . . . 0.0 113.247 -175.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.82 -23.45 67.36 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 112.924 -1.944 . . . . 0.0 112.639 -179.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.745 ' H ' HG12 ' A' ' 20' ' ' VAL . 88.7 tt0 -158.67 144.51 16.72 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.13 -178.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.502 HG22 HD21 ' A' ' 111' ' ' LEU . 3.1 t -81.45 107.4 13.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -178.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 1.034 ' HB2' HD13 ' A' ' 27' ' ' ILE . 55.0 m-80 -95.38 157.79 15.74 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.769 -178.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.534 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -55.18 -24.22 25.73 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.282 0.563 . . . . 0.0 110.808 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.753 ' O ' HD13 ' A' ' 30' ' ' ILE . 70.8 mm-40 -74.45 -44.92 49.52 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 177.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 1.034 HD13 ' HB2' ' A' ' 24' ' ' ASN . 2.0 mp -64.72 -34.34 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 113.793 -1.548 . . . . 0.0 110.153 178.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.515 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 75.0 mt-30 -68.16 -40.59 82.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 122.297 -0.252 . . . . 0.0 110.713 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.534 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 40.3 mmt180 -61.44 -39.3 90.33 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.846 ' CG2' HD13 ' A' ' 53' ' ' ILE . 1.6 mp -57.75 -48.53 83.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.087 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.584 HG22 ' CG2' ' A' ' 57' ' ' ILE . 27.6 t -68.11 -42.26 84.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.97 0.414 . . . . 0.0 111.156 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.872 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -56.39 -42.19 77.5 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.058 -179.254 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.491 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 17.5 m-20 -75.78 -30.11 58.98 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.261 176.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 1.095 ' HG2' HG21 ' A' ' 51' ' ' VAL . 87.6 mtp -60.92 -46.27 91.33 Favored 'General case' 0 C--N 1.345 0.395 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.516 -177.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.872 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 13.5 p90 -69.59 -45.91 67.53 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.578 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 29.4 mm-40 -52.51 -38.44 59.61 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.965 ' HA ' HG12 ' A' ' 2' ' ' VAL . 61.6 m -69.9 -62.23 1.47 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.487 -1.233 . . . . 0.0 107.857 178.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.887 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 3.7 ttp -46.65 -41.85 15.43 Favored 'General case' 0 CA--C 1.461 -2.472 0 C-N-CA 124.042 0.937 . . . . 0.0 110.72 -171.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.708 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 70.9 m-85 -70.48 -42.32 71.55 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.38 178.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.457 ' CB ' HG11 ' A' ' 2' ' ' VAL . . . -61.4 -24.31 66.42 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.358 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.937 ' HG2' HD12 ' A' ' 91' ' ' LEU . 3.1 tp10 -89.05 -10.7 46.49 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 114.47 -1.241 . . . . 0.0 108.566 177.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.443 ' H ' ' C ' ' A' ' 39' ' ' TYR . 23.4 mt-10 62.96 26.7 15.65 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.818 -176.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.97 145.17 26.91 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.974 178.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.803 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 44.1 mm -79.3 -1.56 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 117.418 0.609 . . . . 0.0 112.028 -178.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.548 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 177.54 142.06 4.38 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -178.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.018 HD13 ' HG ' ' A' ' 91' ' ' LEU . 4.7 tp -126.21 135.63 51.85 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.528 1.664 . . . . 0.0 110.479 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -105.9 132.2 52.29 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.989 ' HB1' HG13 ' A' ' 53' ' ' ILE . . . -28.73 -56.76 0.13 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 -178.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.884 HG23 ' HA ' ' A' ' 137' ' ' LEU . 67.6 p -53.17 -34.64 57.78 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 121.953 0.883 . . . . 0.0 111.164 -178.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.856 ' OE1' HD23 ' A' ' 91' ' ' LEU . 50.3 mt-30 -63.94 -43.83 94.67 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.25 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.095 HG21 ' HG2' ' A' ' 34' ' ' MET . 1.0 OUTLIER -86.76 15.07 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.86 ' HA ' HD11 ' A' ' 6' ' ' LEU . 36.5 t70 78.29 27.87 0.5 Allowed 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 176.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 1.015 HD11 ' HB ' ' A' ' 57' ' ' ILE . 10.7 pt -119.36 109.83 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 C-N-CA 119.045 -1.062 . . . . 0.0 110.858 177.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.629 ' HB3' ' HD2' ' A' ' 15' ' ' LYS . 25.2 p-80 -75.84 49.18 0.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 122.063 0.935 . . . . 0.0 109.946 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.642 ' C ' ' HB1' ' A' ' 17' ' ' ALA . 27.9 mt-30 -136.48 130.62 32.83 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 1.085 ' HA ' HD22 ' A' ' 137' ' ' LEU . 60.3 mtp85 -62.46 75.14 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.015 ' HB ' HD11 ' A' ' 53' ' ' ILE . 15.0 mt -119.83 124.62 73.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.876 HD11 ' HG2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -131.57 148.5 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -178.069 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.589 ' CG2' ' HB3' ' A' ' 46' ' ' LEU . 32.8 m -124.34 138.85 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.046 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 6.1 mm -113.57 150.86 15.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-O 121.739 0.781 . . . . 0.0 110.137 -179.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.887 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 36.1 t70 -140.16 27.6 2.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.895 -177.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.785 HG22 ' CG2' ' A' ' 44' ' ' ILE . 41.1 t . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.219 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.623 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 34.3 ttp85 . . . . . 0 N--CA 1.465 0.314 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 1.046 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 62.0 mt -106.79 135.43 48.34 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-O 120.692 0.282 . . . . 0.0 111.431 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.818 HG21 ' HB2' ' A' ' 113' ' ' ARG . 12.7 p -134.94 135.16 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.25 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.816 ' HB2' HD11 ' A' ' 58' ' ' ILE . 3.2 mm? -141.63 144.35 34.13 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 177.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.998 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.5 mp -124.33 135.78 62.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.9 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.715 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 6.1 m120 49.57 35.48 0.28 Allowed Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 178.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.876 ' HG2' HD11 ' A' ' 58' ' ' ILE . 80.2 Cg_exo -60.91 157.18 39.72 Favored 'Trans proline' 0 N--CA 1.485 1.02 0 C-N-CA 122.809 2.34 . . . . 0.0 114.761 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.423 ' O ' HD22 ' A' ' 78' ' ' LEU . 11.3 pt-20 -138.05 141.78 40.33 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.945 ' HA ' HG22 ' A' ' 108' ' ' ILE . 1.5 tt -80.23 131.64 35.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.151 0.5 . . . . 0.0 111.369 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.113 HD23 ' HA ' ' A' ' 108' ' ' ILE . 2.7 mm? -104.24 -39.06 6.64 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.872 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.614 ' O ' HD21 ' A' ' 77' ' ' LEU . 40.0 tp10 -152.68 152.01 31.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.138 0.495 . . . . 0.0 111.521 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 1.018 ' HA ' HG12 ' A' ' 106' ' ' VAL . 9.2 ptpp? -147.67 148.48 31.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.437 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.8 m -158.58 147.8 19.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.254 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.666 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 73.23 158.67 4.93 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.495 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -133.92 114.38 13.22 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 122.292 1.044 . . . . 0.0 113.356 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.647 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.7 p -103.73 162.11 13.36 Favored 'General case' 0 CA--C 1.488 -1.435 0 CA-C-N 113.244 -1.798 . . . . 0.0 115.232 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.8 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -148.29 117.9 0.93 Allowed Glycine 0 C--N 1.314 -0.66 0 CA-C-N 112.54 -2.118 . . . . 0.0 110.418 177.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.608 HD13 ' O ' ' A' ' 85' ' ' GLY . 48.3 mm -147.04 138.47 18.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 117.297 0.549 . . . . 0.0 111.284 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 56.3 mt-10 -72.26 139.0 47.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 123.297 1.523 . . . . 0.0 111.613 -176.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.724 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 47.2 mt-10 -155.92 161.42 40.55 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 112.693 -2.049 . . . . 0.0 111.392 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.827 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -120.15 165.51 13.64 Favored Glycine 0 CA--C 1.496 -1.127 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.503 ' HB2' ' CG1' ' A' ' 93' ' ' ILE . 20.5 m -114.92 137.08 52.39 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.512 0.672 . . . . 0.0 112.331 -177.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.018 ' HG ' HD13 ' A' ' 46' ' ' LEU . 2.3 mm? -46.77 -40.35 13.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.453 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.691 ' CB ' HD13 ' A' ' 13' ' ' LEU . 51.0 m -78.18 -27.51 47.97 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.091 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.667 ' CG1' HD13 ' A' ' 8' ' ' ILE . 54.4 mt . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.827 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 47.9 mtm-85 . . . . . 0 C--O 1.233 0.21 0 CA-C-O 121.837 0.827 . . . . 0.0 111.892 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -135.74 153.68 51.49 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.492 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.8 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.3 tt -76.34 114.23 14.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.61 0.719 . . . . 0.0 111.752 -178.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.814 HG13 ' NE ' ' A' ' 102' ' ' ARG . 13.7 p -106.56 129.66 24.11 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 114.931 -1.031 . . . . 0.0 112.181 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.647 ' HA ' ' O ' ' A' ' 84' ' ' THR . 1.1 Cg_endo -84.22 127.09 3.88 Favored 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 123.56 2.84 . . . . 0.0 113.921 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.978 ' HG2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -143.82 167.61 21.91 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.512 1.125 . . . . 0.0 109.471 179.12 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.666 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.36 155.33 40.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 118.357 0.526 . . . . 0.0 109.969 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -73.63 -41.94 62.11 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.972 -175.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.558 ' HG2' ' HB3' ' A' ' 123' ' ' ASP . 61.3 mttp -140.04 140.54 36.19 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.381 0.61 . . . . 0.0 109.573 177.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 1.018 HG12 ' HA ' ' A' ' 80' ' ' LYS . 22.5 m -151.36 140.2 14.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.598 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.988 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 52.8 mmtt -107.34 126.34 52.33 Favored 'General case' 0 CA--C 1.524 -0.026 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 1.113 ' HA ' HD23 ' A' ' 78' ' ' LEU . 1.7 pp -135.72 154.06 33.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -176.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 1.022 ' HG3' HD21 ' A' ' 78' ' ' LEU . 50.1 mtm180 -103.07 139.53 38.48 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.532 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.768 ' CB ' ' HG3' ' A' ' 75' ' ' PRO . . . -160.45 169.73 22.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.642 -176.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.998 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.3 pp -118.26 151.44 37.66 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.656 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 8.5 t70 -87.64 161.44 17.68 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.257 -176.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.818 ' HB2' HG21 ' A' ' 71' ' ' VAL . 52.0 ttp85 -52.74 -17.28 1.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.099 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.56 -29.32 46.21 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.799 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.434 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 109.2 35.58 2.29 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.45 -0.881 . . . . 0.0 113.24 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -128.79 102.99 19.26 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 121.177 -0.209 . . . . 0.0 110.972 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.686 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.3 Cg_exo -73.76 115.1 4.21 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 121.553 1.502 . . . . 0.0 114.757 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.656 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 11.0 p90 -127.38 169.01 14.05 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.442 -177.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.639 ' HG2' ' CG ' ' A' ' 109' ' ' ARG . 31.1 mt-10 -106.65 129.9 54.48 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.727 ' O ' HD12 ' A' ' 120' ' ' LEU . 4.3 pp -125.72 134.66 51.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.476 -178.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.988 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 15.3 pt-20 -92.99 123.88 36.56 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.636 178.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.917 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -117.71 134.01 55.34 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.558 ' HB3' ' HG2' ' A' ' 105' ' ' LYS . 22.9 m-20 -126.96 162.86 24.97 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.772 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 50.92 -136.68 28.97 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 120.265 1.393 . . . . 0.0 115.658 177.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.68 HD12 ' H ' ' A' ' 125' ' ' LEU . 4.7 mp -55.23 -33.24 62.94 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.684 -0.758 . . . . 0.0 111.706 -178.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.917 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -71.03 -52.12 21.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.866 0.841 . . . . 0.0 109.203 179.692 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.766 ' HB2' ' C ' ' A' ' 122' ' ' ALA . . . -59.01 -41.23 87.2 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.194 -1.366 . . . . 0.0 111.703 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.978 HD12 ' HG2' ' A' ' 102' ' ' ARG . 50.5 mm -68.43 -54.99 17.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.637 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 30.4 p -58.13 -47.73 82.39 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 1.053 HD11 HD11 ' A' ' 108' ' ' ILE . 19.5 tt -59.05 -44.03 90.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.867 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.85 ' CG ' HG21 ' A' ' 106' ' ' VAL . 69.5 mt-30 -64.72 -44.94 88.57 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 178.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 76.0 t60 -56.44 -47.75 78.45 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.243 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.814 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 3.3 mm-40 -60.23 -38.86 84.7 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 110.552 -0.166 . . . . 0.0 110.552 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.686 ' CE ' ' HB2' ' A' ' 77' ' ' LEU . 28.4 mtm -58.77 -45.66 89.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 122.338 1.066 . . . . 0.0 109.384 177.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.813 ' O ' HG12 ' A' ' 138' ' ' VAL . 0.9 OUTLIER -66.58 -48.55 69.25 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.999 179.394 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.673 ' CE1' ' HG2' ' A' ' 50' ' ' GLN . 7.8 t-80 -57.15 -53.0 63.06 Favored 'General case' 0 C--N 1.32 -0.712 0 O-C-N 121.512 -0.742 . . . . 0.0 111.491 -178.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 1.085 HD22 ' HA ' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -65.17 -27.85 69.0 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 119.908 -0.717 . . . . 0.0 111.903 -179.449 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.91 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 10.9 p -81.16 23.62 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-O 122.056 0.932 . . . . 0.0 109.211 175.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 137' ' ' LEU . . . 67.94 3.67 30.44 Favored Glycine 0 CA--C 1.486 -1.752 0 CA-C-N 113.793 -1.549 . . . . 0.0 113.245 175.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.91 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 10.4 ptmt . . . . . 0 N--CA 1.417 -2.106 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.926 HG12 ' HA ' ' A' ' 37' ' ' THR . 30.9 m . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.733 0.301 . . . . 0.0 111.643 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.851 HD11 ' CB ' ' A' ' 51' ' ' VAL . 3.1 pp -79.03 -179.09 6.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.246 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.545 HE21 ' HA ' ' A' ' 4' ' ' GLN . 2.2 tp-100 -80.63 108.8 14.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.753 0.311 . . . . 0.0 110.883 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.888 HG11 HD12 ' A' ' 91' ' ' LEU . 46.6 t -89.21 131.64 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-O 121.216 0.531 . . . . 0.0 111.366 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.029 ' HB2' HD21 ' A' ' 13' ' ' LEU . 26.1 mt -85.21 143.22 28.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.463 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 26.0 m-70 -116.64 144.11 44.8 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.507 0.67 . . . . 0.0 112.63 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.043 HD13 HD12 ' A' ' 13' ' ' LEU . 42.8 mm -53.45 144.04 33.86 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.707 178.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.513 ' HA ' HG23 ' A' ' 8' ' ' ILE . 64.3 Cg_endo -93.49 54.12 0.94 Allowed 'Cis proline' 0 C--N 1.356 0.933 0 C-N-CA 124.727 -0.947 . . . . 0.0 113.036 0.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.93 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 9.8 t70 -55.32 134.55 50.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.037 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.477 ' CD ' ' H ' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -59.65 -42.76 93.52 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.961 0.41 . . . . 0.0 111.213 -179.495 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.705 ' HB2' HD13 ' A' ' 6' ' ' LEU . 14.0 mmt85 -59.19 -23.53 62.32 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 1.043 HD12 HD13 ' A' ' 8' ' ' ILE . 9.2 mt -76.22 -32.7 59.07 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 120.172 1.351 . . . . 0.0 107.692 177.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 16.3 mmm180 -90.86 3.17 55.23 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 113.857 -1.52 . . . . 0.0 109.554 178.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.828 ' HD3' ' HB3' ' A' ' 54' ' ' HIS . 62.3 tttp -82.09 146.88 29.4 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.671 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.507 HG13 HG23 ' A' ' 138' ' ' VAL . 96.4 t -82.14 135.4 25.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.742 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -91.4 139.68 30.48 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -103.21 130.57 23.37 Favored Pre-proline 0 C--N 1.322 -0.612 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.316 178.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.464 ' HD3' ' CD ' ' A' ' 56' ' ' ARG . 67.9 Cg_endo -77.11 114.75 3.85 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.032 1.821 . . . . 0.0 110.454 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.777 HG12 ' H ' ' A' ' 22' ' ' GLU . 17.4 t -68.98 144.51 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-O 122.426 1.108 . . . . 0.0 113.308 -176.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -63.65 -24.35 67.75 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 113.443 -1.708 . . . . 0.0 112.073 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.777 ' H ' HG12 ' A' ' 20' ' ' VAL . 88.8 tt0 -161.03 143.46 12.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.875 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.537 HG21 ' CD1' ' A' ' 111' ' ' LEU . 3.2 t -78.88 107.24 11.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.961 ' HB2' HD13 ' A' ' 27' ' ' ILE . 56.2 m-80 -91.36 159.9 15.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.317 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.599 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -56.81 -29.14 62.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.927 0.394 . . . . 0.0 110.941 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 1.03 ' HG2' HH22 ' A' ' 29' ' ' ARG . 94.7 mt-10 -71.88 -42.83 66.35 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.961 HD13 ' HB2' ' A' ' 24' ' ' ASN . 1.8 mp -62.28 -45.93 97.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.791 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.667 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 54.5 mt-30 -57.38 -40.22 77.7 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.501 178.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 1.03 HH22 ' HG2' ' A' ' 26' ' ' GLU . 75.9 mtm-85 -61.76 -38.83 89.46 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.828 HG21 HD12 ' A' ' 57' ' ' ILE . 1.6 mp -58.77 -49.12 83.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.056 178.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.935 HG22 ' CG2' ' A' ' 57' ' ' ILE . 5.3 t -65.97 -42.19 91.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.527 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.875 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 21.5 m-20 -54.43 -45.04 72.93 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.838 -179.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.485 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 54.4 m-20 -74.88 -30.72 61.39 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.64 176.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 1.007 ' HG2' HG21 ' A' ' 51' ' ' VAL . 79.7 mtp -59.88 -47.18 86.81 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.543 -177.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.875 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 14.4 p90 -69.31 -43.85 72.93 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.759 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 75.0 mt-10 -51.91 -41.89 62.34 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.926 ' HA ' HG12 ' A' ' 2' ' ' VAL . 57.2 m -68.51 -60.27 2.55 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 119.105 -1.038 . . . . 0.0 108.608 178.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.981 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 3.6 ttp -47.12 -42.42 19.16 Favored 'General case' 0 CA--C 1.466 -2.262 0 O-C-N 124.118 0.886 . . . . 0.0 109.729 -170.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.728 ' OH ' ' HA ' ' A' ' 69' ' ' ARG . 68.6 m-85 -69.32 -42.37 75.47 Favored 'General case' 0 C--N 1.285 -2.233 0 O-C-N 124.101 0.876 . . . . 0.0 110.578 178.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.486 ' CB ' HG11 ' A' ' 2' ' ' VAL . . . -60.09 -28.86 68.17 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.798 ' HG2' ' CD2' ' A' ' 91' ' ' LEU . 3.1 tp10 -84.1 -10.79 57.53 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.484 -1.234 . . . . 0.0 108.777 177.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.444 ' H ' ' C ' ' A' ' 39' ' ' TYR . 8.6 mm-40 62.8 25.1 14.92 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.74 -176.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.73 145.17 29.79 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 114.142 -1.39 . . . . 0.0 110.524 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.907 HG22 HG22 ' A' ' 62' ' ' VAL . 46.0 mm -77.96 -2.5 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 117.621 0.711 . . . . 0.0 111.687 -178.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.65 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 176.29 138.34 2.85 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-O 119.045 -0.864 . . . . 0.0 111.552 -178.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.827 ' HB2' ' HG3' ' A' ' 38' ' ' MET . 9.2 tp -125.6 135.03 51.75 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 118.821 1.311 . . . . 0.0 110.744 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -103.87 132.75 49.82 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.646 0.26 . . . . 0.0 111.553 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.881 ' HB1' ' CD1' ' A' ' 53' ' ' ILE . . . -30.72 -56.14 0.21 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -177.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.711 ' CG2' ' HA ' ' A' ' 137' ' ' LEU . 42.9 p -52.92 -35.38 58.32 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 122.168 0.985 . . . . 0.0 110.876 -178.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.563 ' HG2' ' CE1' ' A' ' 136' ' ' HIS . 15.8 mt-30 -64.58 -39.44 93.75 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.666 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.007 HG21 ' HG2' ' A' ' 34' ' ' MET . 1.7 m -88.25 14.76 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.859 ' HA ' HD11 ' A' ' 6' ' ' LEU . 37.5 t70 79.11 31.45 0.29 Allowed 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 176.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.881 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 1.2 pp -126.45 111.22 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.446 177.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.828 ' HB3' ' HD3' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -75.55 64.17 1.61 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.976 0.893 . . . . 0.0 110.518 -179.278 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.769 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 88.0 mt-30 -153.54 135.21 14.44 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.444 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.742 ' N ' ' HB1' ' A' ' 17' ' ' ALA . 75.2 mtp180 -64.66 69.04 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -178.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.935 ' CG2' HG22 ' A' ' 31' ' ' VAL . 7.2 mt -112.14 123.26 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.818 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -130.72 147.4 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-O 121.811 0.815 . . . . 0.0 112.783 -178.253 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.613 HG22 ' O ' ' A' ' 46' ' ' LEU . 34.0 m -129.08 137.96 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.44 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.926 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 1.8 mt -116.81 149.3 19.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.718 0.77 . . . . 0.0 111.262 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.981 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 33.8 t70 -136.84 31.95 2.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.449 -1.251 . . . . 0.0 110.35 -178.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.907 HG22 HG22 ' A' ' 44' ' ' ILE . 24.0 t . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.953 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.728 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 40.1 ttm-85 . . . . . 0 N--CA 1.465 0.317 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.926 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 3.7 mm? -103.32 132.29 49.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.913 0.387 . . . . 0.0 111.872 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.843 ' O ' HD12 ' A' ' 72' ' ' LEU . 11.5 p -134.33 130.95 54.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.981 178.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.02 HD21 HD21 ' A' ' 120' ' ' LEU . 10.5 mp -139.88 140.02 36.38 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.938 -0.119 . . . . 0.0 111.019 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.01 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.6 mp -119.93 134.47 63.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.704 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 8.2 m120 54.43 35.93 0.31 Allowed Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.778 ' HG2' HG23 ' A' ' 58' ' ' ILE . 91.1 Cg_exo -55.3 148.56 50.14 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.752 2.301 . . . . 0.0 113.607 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.61 ' HG3' HD21 ' A' ' 78' ' ' LEU . 15.7 pt-20 -135.83 144.25 45.58 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.815 HD23 ' N ' ' A' ' 78' ' ' LEU . 1.8 tt -83.49 135.18 34.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.385 0.612 . . . . 0.0 111.02 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.922 ' CD2' ' HG3' ' A' ' 109' ' ' ARG . 3.3 mm? -116.76 -31.95 5.3 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.65 -178.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 36.6 tt0 -160.33 151.81 19.6 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.17 0.51 . . . . 0.0 111.854 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.895 ' HA ' HG12 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -148.39 151.78 35.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.088 178.792 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 81.0 p -160.36 145.2 14.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.73 0.3 . . . . 0.0 111.5 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.814 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 75.52 169.89 27.13 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.43 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 102' ' ' ARG . 52.3 mm-40 -146.78 114.71 6.52 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.801 0.81 . . . . 0.0 113.152 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.614 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.4 p -97.03 160.1 14.53 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 178.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.698 ' CA ' HD21 ' A' ' 99' ' ' LEU . . . -137.99 100.53 0.31 Allowed Glycine 0 CA--C 1.522 0.52 0 CA-C-N 113.186 -1.825 . . . . 0.0 111.394 178.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.808 ' N ' HH12 ' A' ' 102' ' ' ARG . 47.7 mm -147.75 141.14 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.604 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 55.4 mt-10 -72.72 143.21 48.11 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 122.359 1.076 . . . . 0.0 112.437 -177.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.618 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 54.6 mt-10 -155.77 162.78 40.45 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.157 -1.383 . . . . 0.0 109.768 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.797 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -120.23 160.49 14.83 Favored Glycine 0 CA--C 1.5 -0.857 0 C-N-CA 119.456 -1.355 . . . . 0.0 111.223 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.62 ' HB2' HG13 ' A' ' 93' ' ' ILE . 57.1 m -110.16 139.68 45.05 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.691 0.281 . . . . 0.0 110.668 -177.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.888 HD12 HG11 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -52.43 -31.25 33.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.494 0.664 . . . . 0.0 109.855 179.72 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.803 ' CB ' HD13 ' A' ' 13' ' ' LEU . 49.8 m -77.74 -29.44 51.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.711 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.62 HG13 ' HB2' ' A' ' 90' ' ' CYS . 58.0 mt . . . . . 0 C--N 1.327 -0.398 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.797 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 20.0 mtm105 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.497 0.665 . . . . 0.0 111.384 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.414 ' C ' ' HA ' ' A' ' 87' ' ' GLU . . . -133.01 150.46 52.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.133 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.735 ' HG ' ' N ' ' A' ' 86' ' ' ILE . 6.7 tt -75.43 135.57 40.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.317 -179.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.696 ' N ' HD23 ' A' ' 99' ' ' LEU . 46.1 t -136.94 138.58 26.27 Favored Pre-proline 0 N--CA 1.464 0.243 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.684 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.614 ' HA ' ' O ' ' A' ' 84' ' ' THR . 3.4 Cg_exo -80.49 125.48 5.67 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.408 2.072 . . . . 0.0 113.424 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.882 ' HE ' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -143.79 166.07 25.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.066 -1.424 . . . . 0.0 109.988 177.936 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.814 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.24 153.06 44.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.962 0.346 . . . . 0.0 110.583 -178.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.416 ' OE1' ' HA ' ' A' ' 104' ' ' GLU . 5.1 tp10 -74.29 -41.97 60.33 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.638 -176.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.808 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 48.6 mttp -139.8 137.93 35.42 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.61 0.719 . . . . 0.0 109.634 177.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.895 HG12 ' HA ' ' A' ' 80' ' ' LYS . 32.0 m -142.9 143.16 25.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.046 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 1.028 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 31.8 mmtm -107.48 125.58 51.43 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.716 ' HA ' HD23 ' A' ' 78' ' ' LEU . 2.1 pp -128.79 162.09 36.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -177.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.922 ' HG3' ' CD2' ' A' ' 78' ' ' LEU . 26.6 mtt-85 -116.03 139.4 50.31 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.625 ' CB ' HD23 ' A' ' 72' ' ' LEU . . . -158.98 168.26 27.23 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.671 0.272 . . . . 0.0 111.449 -178.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 1.01 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.1 pp -113.87 152.32 30.9 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.47 ' O ' HD12 ' A' ' 111' ' ' LEU . 15.7 t70 -88.58 162.75 16.2 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.021 -0.672 . . . . 0.0 111.569 -177.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.811 ' HB2' HG21 ' A' ' 71' ' ' VAL . 46.2 ttp180 -52.67 -18.91 2.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.969 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -78.96 -25.59 43.53 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.438 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 106.44 35.61 2.83 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.518 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -128.74 102.79 19.54 Favored Pre-proline 0 C--O 1.238 0.479 0 CA-C-N 117.036 0.418 . . . . 0.0 111.178 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.667 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.9 Cg_exo -73.28 115.27 4.28 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 121.838 1.692 . . . . 0.0 114.975 -177.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -124.52 168.43 13.1 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.712 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 109' ' ' ARG . 23.0 mt-10 -107.79 131.61 54.28 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 1.02 HD21 HD21 ' A' ' 72' ' ' LEU . 3.9 pp -131.57 133.91 45.51 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 1.028 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 15.5 pt-20 -94.15 125.52 38.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.766 178.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.933 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -116.96 136.01 53.27 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.808 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.1 m-20 -126.3 164.44 21.03 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.712 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 45.55 -130.5 9.36 Favored Glycine 0 C--N 1.346 1.118 0 N-CA-C 116.431 1.332 . . . . 0.0 116.431 176.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.437 ' HB3' ' CG1' ' A' ' 62' ' ' VAL . 86.6 mt -55.18 -36.49 65.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.692 -0.754 . . . . 0.0 111.703 -178.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.933 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.3 OUTLIER -71.31 -52.9 16.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.471 0.653 . . . . 0.0 109.884 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.785 ' HB2' ' C ' ' A' ' 122' ' ' ALA . . . -58.39 -46.01 87.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.913 -1.039 . . . . 0.0 112.163 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.882 HD12 ' HE ' ' A' ' 102' ' ' ARG . 49.3 mm -63.76 -56.04 19.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.807 0.336 . . . . 0.0 111.107 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.437 ' SG ' HG21 ' A' ' 62' ' ' VAL . 74.6 m -60.92 -50.53 73.04 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.696 HG22 ' O ' ' A' ' 126' ' ' LEU . 20.3 tt -58.77 -43.73 88.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.328 -178.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.659 ' HG2' ' O ' ' A' ' 127' ' ' ALA . 22.9 pt20 -65.68 -37.63 87.04 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -56.65 -48.87 76.61 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.281 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.807 ' O ' HD23 ' A' ' 137' ' ' LEU . 2.8 mm-40 -60.93 -45.86 92.99 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 119.09 -0.481 . . . . 0.0 111.217 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.962 ' HA ' HD21 ' A' ' 137' ' ' LEU . 75.2 mtp -55.55 -47.78 75.8 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 118.965 0.802 . . . . 0.0 109.893 179.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.778 ' O ' HG12 ' A' ' 138' ' ' VAL . 1.1 m-20 -62.02 -48.49 80.05 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.376 178.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.563 ' CE1' ' HG2' ' A' ' 50' ' ' GLN . 10.4 t-80 -57.31 -49.99 74.34 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.294 0.569 . . . . 0.0 110.82 -178.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.962 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.5 pp -60.58 -30.51 69.86 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.032 -178.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.778 HG12 ' O ' ' A' ' 135' ' ' ASP . 12.9 p -81.78 22.18 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 CA-C-O 122.726 1.251 . . . . 0.0 109.051 175.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.603 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 70.85 -3.19 13.5 Favored Glycine 0 CA--C 1.494 -1.256 0 CA-C-N 112.629 -2.078 . . . . 0.0 113.035 176.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.752 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 1.6 ptmt . . . . . 0 N--CA 1.433 -1.305 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 1.051 HG12 ' HA ' ' A' ' 37' ' ' THR . 30.8 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.875 0.369 . . . . 0.0 111.417 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 1.046 HD21 ' HB ' ' A' ' 51' ' ' VAL . 3.0 pp -79.87 -169.51 2.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.696 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.409 ' HA ' ' OE1' ' A' ' 4' ' ' GLN . 4.0 tp-100 -84.64 111.72 19.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.859 0.361 . . . . 0.0 110.053 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.642 HG22 HG21 ' A' ' 37' ' ' THR . 40.7 t -88.51 127.79 41.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.371 0.605 . . . . 0.0 111.828 -178.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.039 ' HB2' HD21 ' A' ' 13' ' ' LEU . 23.1 mt -87.14 142.69 27.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.361 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.549 ' HA ' ' HB3' ' A' ' 92' ' ' SER . 34.7 m-70 -116.16 147.06 41.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.245 0.545 . . . . 0.0 111.992 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.097 HD13 HD12 ' A' ' 13' ' ' LEU . 38.4 mm -58.27 147.0 68.91 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.358 178.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.591 ' HA ' HG23 ' A' ' 8' ' ' ILE . 78.2 Cg_endo -93.22 52.38 1.04 Allowed 'Cis proline' 0 C--N 1.354 0.854 0 C-N-CA 124.504 -1.04 . . . . 0.0 113.02 0.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.839 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.7 t70 -55.15 136.04 48.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.083 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -58.88 -44.3 91.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.377 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.584 ' HB2' ' OD2' ' A' ' 10' ' ' ASP . 14.9 mmt85 -57.44 -25.63 59.94 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 1.097 HD12 HD13 ' A' ' 8' ' ' ILE . 11.2 mt -74.82 -32.71 62.03 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 119.828 1.195 . . . . 0.0 109.025 178.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.489 ' HG3' HH11 ' A' ' 14' ' ' ARG . 13.6 mmt85 -95.23 6.94 47.66 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.227 -1.352 . . . . 0.0 109.605 178.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.715 ' HD3' ' HB3' ' A' ' 54' ' ' HIS . 88.6 tttt -82.78 147.93 28.11 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.53 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.4 t -82.48 127.89 39.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.85 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -91.36 140.53 29.69 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.218 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -105.01 136.88 19.1 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.418 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.47 ' HA ' ' ND2' ' A' ' 74' ' ' ASN . 51.8 Cg_endo -82.13 113.97 2.47 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 121.656 1.571 . . . . 0.0 110.279 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.715 HG12 ' H ' ' A' ' 22' ' ' GLU . 16.7 t -68.11 144.68 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 CA-C-O 122.852 1.31 . . . . 0.0 113.271 -175.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -60.33 -27.9 67.72 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 112.775 -2.011 . . . . 0.0 112.232 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.715 ' H ' HG12 ' A' ' 20' ' ' VAL . 39.0 tt0 -156.95 144.28 18.84 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.885 -178.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.736 HG21 ' HA2' ' A' ' 115' ' ' GLY . 3.2 t -80.11 106.51 11.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -178.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.918 ' HB2' ' CD1' ' A' ' 27' ' ' ILE . 59.4 m-80 -91.43 153.66 19.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.048 -178.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.7 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -54.79 -25.38 27.76 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.272 0.558 . . . . 0.0 110.819 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.742 ' O ' HD13 ' A' ' 30' ' ' ILE . 55.2 mt-10 -74.28 -42.64 59.26 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 177.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.918 ' CD1' ' HB2' ' A' ' 24' ' ' ASN . 1.9 mp -66.46 -34.63 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.101 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -68.32 -39.3 82.0 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.779 -0.192 . . . . 0.0 110.549 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.7 ' HG3' ' O ' ' A' ' 25' ' ' ALA . 99.1 mtt180 -63.7 -39.12 93.53 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.832 ' O ' ' HG3' ' A' ' 34' ' ' MET . 1.6 mp -56.0 -48.47 78.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.826 178.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.964 HG22 HG21 ' A' ' 57' ' ' ILE . 15.0 t -67.14 -40.1 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.463 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.851 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 48.3 m-20 -52.85 -47.6 67.65 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.937 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.53 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 14.1 m-20 -74.44 -28.91 61.26 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.807 176.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.965 ' HG2' HG21 ' A' ' 51' ' ' VAL . 86.9 mtp -59.62 -47.04 87.16 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.169 -177.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.851 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 19.8 p90 -70.33 -46.17 64.73 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 176.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.631 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 3.8 mm-40 -52.25 -39.54 60.48 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.635 0.731 . . . . 0.0 109.182 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 1.051 ' HA ' HG12 ' A' ' 2' ' ' VAL . 76.5 m -69.14 -61.17 1.9 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.273 -1.33 . . . . 0.0 107.992 178.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.87 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 3.6 ttp -46.79 -41.1 14.87 Favored 'General case' 0 CA--C 1.46 -2.482 0 C-N-CA 124.535 1.134 . . . . 0.0 110.501 -172.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.761 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 60.3 m-85 -69.11 -42.79 75.62 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.097 178.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.56 ' CB ' HG11 ' A' ' 2' ' ' VAL . . . -61.62 -24.77 66.93 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.566 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.938 ' HG2' HD12 ' A' ' 91' ' ' LEU . 11.1 tp10 -87.97 -11.71 46.65 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.407 -1.269 . . . . 0.0 108.368 176.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.447 ' H ' ' C ' ' A' ' 39' ' ' TYR . 58.0 mt-10 63.34 27.4 15.35 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-O 122.019 0.914 . . . . 0.0 109.855 -176.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.02 145.31 26.97 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 113.781 -1.554 . . . . 0.0 110.799 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.718 ' CG2' HG22 ' A' ' 62' ' ' VAL . 45.5 mm -79.34 -0.41 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 117.497 0.648 . . . . 0.0 111.931 -178.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.55 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 175.39 140.03 3.26 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.989 HD13 ' HG ' ' A' ' 91' ' ' LEU . 3.9 tp -124.45 136.74 54.27 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.396 1.598 . . . . 0.0 110.821 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.46 ' H ' HD12 ' A' ' 46' ' ' LEU . . . -104.41 131.72 51.46 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.416 0.15 . . . . 0.0 111.165 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.848 ' HB1' ' CD1' ' A' ' 53' ' ' ILE . . . -31.06 -55.81 0.23 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 115.802 1.779 . . . . 0.0 115.802 -177.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.82 ' CG2' ' HA ' ' A' ' 137' ' ' LEU . 69.3 p -53.17 -35.39 59.75 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.665 0.745 . . . . 0.0 111.631 -177.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.726 ' OE1' HD12 ' A' ' 46' ' ' LEU . 64.6 mt-30 -64.02 -43.43 95.65 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.405 -1.271 . . . . 0.0 110.127 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.046 ' HB ' HD21 ' A' ' 3' ' ' LEU . 0.8 OUTLIER -83.16 15.49 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.883 ' HA ' HD11 ' A' ' 6' ' ' LEU . 36.9 t70 77.29 28.65 0.6 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 176.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.848 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 1.1 pp -122.73 110.78 27.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.982 177.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.715 ' HB3' ' HD3' ' A' ' 15' ' ' LYS . 21.5 p-80 -76.51 62.65 1.92 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 122.102 0.953 . . . . 0.0 110.376 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.768 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 89.4 mt-30 -151.37 133.19 14.97 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.066 -1.425 . . . . 0.0 107.468 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 1.112 ' HA ' HD22 ' A' ' 137' ' ' LEU . 98.8 mtt180 -65.02 70.99 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -177.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.964 HG21 HG22 ' A' ' 31' ' ' VAL . 30.6 mm -113.95 124.33 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.898 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -128.62 148.58 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -177.673 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 46' ' ' LEU . 30.8 m -129.29 140.35 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.71 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.093 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 9.5 mm -115.5 153.84 17.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.337 0.589 . . . . 0.0 109.882 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.87 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 38.5 t70 -145.29 39.84 1.2 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.62 -178.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.718 HG22 ' CG2' ' A' ' 44' ' ' ILE . 57.4 t . . . . . 0 C--N 1.325 -0.472 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.651 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 1.093 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 3.5 mm? -108.08 139.66 42.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.076 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.72 HG21 ' HB2' ' A' ' 113' ' ' ARG . 12.9 p -133.09 135.7 56.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.583 177.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.898 ' HB2' ' CD1' ' A' ' 58' ' ' ILE . 94.7 mt -140.86 140.88 34.67 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 178.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.913 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 3.3 mm -121.79 136.57 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-O 121.233 0.54 . . . . 0.0 111.013 -179.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.7 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 7.2 m120 49.0 38.69 0.52 Allowed Pre-proline 0 C--N 1.313 -0.996 0 CA-C-N 115.096 -0.957 . . . . 0.0 112.839 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.88 ' HG2' HG23 ' A' ' 58' ' ' ILE . 99.5 Cg_exo -56.42 145.67 77.89 Favored 'Trans proline' 0 N--CA 1.484 0.943 0 C-N-CA 122.958 2.439 . . . . 0.0 114.144 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.504 ' CG ' ' HB2' ' A' ' 109' ' ' ARG . 11.7 pt-20 -133.11 143.18 49.12 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.801 HD23 ' N ' ' A' ' 78' ' ' LEU . 1.7 tt -82.95 135.71 34.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.282 0.563 . . . . 0.0 111.39 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.024 HD21 ' HG3' ' A' ' 109' ' ' ARG . 2.9 mm? -115.74 -40.59 3.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.84 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 87.4 tt0 -152.84 150.59 29.49 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.21 0.529 . . . . 0.0 111.511 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.817 ' HA ' HG12 ' A' ' 106' ' ' VAL . 9.2 ptpp? -147.18 147.4 30.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.267 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.1 t -158.22 147.99 19.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.673 0.273 . . . . 0.0 111.384 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.717 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 76.85 160.29 10.78 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.41 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -136.3 113.42 10.54 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.948 0.88 . . . . 0.0 112.736 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.831 ' HB ' HH12 ' A' ' 102' ' ' ARG . 1.7 p -105.24 161.88 13.9 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.772 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -147.45 116.86 0.87 Allowed Glycine 0 C--N 1.313 -0.701 0 CA-C-N 112.694 -2.048 . . . . 0.0 110.989 178.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.761 ' HB ' ' NH2' ' A' ' 102' ' ' ARG . 47.9 mm -147.79 139.21 18.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 117.306 0.553 . . . . 0.0 111.414 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 50.4 mt-10 -71.78 139.03 48.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 122.83 1.3 . . . . 0.0 112.019 -177.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.608 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 39.6 mt-10 -154.95 163.48 40.24 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 112.753 -2.021 . . . . 0.0 111.567 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.609 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -121.49 165.62 14.44 Favored Glycine 0 CA--C 1.503 -0.714 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 13.1 m -116.21 140.76 48.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.898 0.849 . . . . 0.0 111.662 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.989 ' HG ' HD13 ' A' ' 46' ' ' LEU . 2.4 mm? -48.62 -17.31 0.16 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.224 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.714 ' CB ' HD13 ' A' ' 13' ' ' LEU . 21.1 m -98.36 -34.39 10.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.255 0.55 . . . . 0.0 110.255 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.463 ' CG1' HG13 ' A' ' 8' ' ' ILE . 58.4 mt . . . . . 0 CA--C 1.535 0.395 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.546 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.609 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 13.7 mtt85 . . . . . 0 CA--C 1.528 0.134 0 CA-C-O 121.03 0.443 . . . . 0.0 109.927 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.2 150.52 48.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.252 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.772 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.3 tt -76.02 113.92 14.07 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.727 0.775 . . . . 0.0 110.792 -178.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.412 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 23.4 t -103.57 133.7 20.14 Favored Pre-proline 0 N--CA 1.469 0.492 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.991 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.554 ' HA ' ' O ' ' A' ' 84' ' ' THR . 98.6 Cg_endo -87.58 126.36 2.2 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.524 2.15 . . . . 0.0 112.675 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.889 ' HG2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -144.65 166.76 24.29 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.149 0.98 . . . . 0.0 109.764 179.438 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.717 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.41 155.3 40.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.852 0.358 . . . . 0.0 110.172 -179.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -72.67 -41.78 65.02 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.592 -175.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.749 ' HG2' ' HB3' ' A' ' 123' ' ' ASP . 95.4 mttt -140.61 140.17 35.03 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.49 0.662 . . . . 0.0 109.495 176.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.817 HG12 ' HA ' ' A' ' 80' ' ' LYS . 32.8 m -145.57 142.22 22.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.166 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.817 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 5.1 mmmt -107.43 126.22 52.22 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.974 HD11 HD11 ' A' ' 130' ' ' ILE . 1.8 pp -134.36 151.0 31.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -177.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 1.037 ' HE ' ' HG2' ' A' ' 119' ' ' GLU . 53.5 mtp180 -102.62 139.71 37.85 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.424 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.606 ' HB3' HD22 ' A' ' 72' ' ' LEU . . . -160.18 168.5 25.3 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.237 -176.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.913 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.0 pp -122.59 149.0 44.57 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.591 ' O ' HD12 ' A' ' 111' ' ' LEU . 13.5 t70 -81.67 169.11 17.4 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -175.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.804 ' HD2' ' OD1' ' A' ' 32' ' ' ASP . 43.2 ttp180 -50.93 -23.6 2.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.982 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -79.77 -21.45 44.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.158 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.752 ' HA2' HD13 ' A' ' 111' ' ' LEU . . . 101.37 38.74 3.19 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.151 -1.023 . . . . 0.0 113.983 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.936 ' HE3' ' HA ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -127.13 102.24 24.5 Favored Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 117.188 0.494 . . . . 0.0 110.184 178.532 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.662 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 32.8 Cg_exo -74.63 115.41 4.29 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 121.643 1.562 . . . . 0.0 116.107 -177.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.444 ' N ' ' O ' ' A' ' 110' ' ' ALA . 0.4 OUTLIER -125.71 168.57 13.58 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.01 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 1.037 ' HG2' ' HE ' ' A' ' 109' ' ' ARG . 21.3 mt-10 -107.41 137.11 46.06 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.74 ' O ' HD12 ' A' ' 120' ' ' LEU . 4.3 pp -135.57 133.39 38.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.081 0.467 . . . . 0.0 111.841 -178.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.817 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 0.7 OUTLIER -95.5 123.71 39.17 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.767 178.706 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.937 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -116.45 135.13 54.1 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.749 ' HB3' ' HG2' ' A' ' 105' ' ' LYS . 16.9 m-20 -126.43 163.22 23.79 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.699 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 52.89 -139.02 33.47 Favored Glycine 0 C--N 1.346 1.101 0 C-N-CA 119.344 -1.408 . . . . 0.0 115.344 177.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 78.2 mt -54.38 -32.3 56.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.601 -0.8 . . . . 0.0 111.601 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.937 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.3 OUTLIER -71.42 -51.97 21.04 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.904 0.859 . . . . 0.0 109.308 179.523 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.751 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -58.58 -41.93 86.84 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.162 -1.381 . . . . 0.0 111.648 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.889 HD12 ' HG2' ' A' ' 102' ' ' ARG . 50.8 mm -67.45 -54.83 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -178.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.608 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 32.1 p -60.7 -49.07 79.0 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.974 HD11 HD11 ' A' ' 108' ' ' ILE . 19.8 tt -59.2 -46.51 92.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.386 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.694 ' HG2' ' O ' ' A' ' 127' ' ' ALA . 21.3 pt20 -65.71 -38.19 88.52 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.337 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -59.27 -46.4 88.63 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.549 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.804 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 3.3 mm-40 -60.81 -38.37 85.17 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.748 ' CE ' ' HB2' ' A' ' 77' ' ' LEU . 75.8 mtp -58.22 -45.18 88.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 122.271 1.034 . . . . 0.0 109.422 177.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.763 ' O ' HG12 ' A' ' 138' ' ' VAL . 0.9 OUTLIER -68.14 -47.97 66.65 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.716 179.215 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.653 ' CE1' ' HG2' ' A' ' 50' ' ' GLN . 6.5 t-80 -57.98 -52.75 64.21 Favored 'General case' 0 C--N 1.317 -0.813 0 O-C-N 121.672 -0.642 . . . . 0.0 111.483 -178.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 1.112 HD22 ' HA ' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -65.41 -28.5 69.3 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.511 -179.506 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.929 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 11.3 p -81.1 23.39 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-O 122.294 1.045 . . . . 0.0 109.218 175.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 137' ' ' LEU . . . 67.49 -0.93 7.91 Favored Glycine 0 CA--C 1.485 -1.813 0 CA-C-N 113.532 -1.667 . . . . 0.0 113.144 175.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.929 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 11.2 ptmt . . . . . 0 N--CA 1.409 -2.479 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 178.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.83 HG12 ' HA ' ' A' ' 37' ' ' THR . 31.1 m . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.847 0.356 . . . . 0.0 111.365 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.923 HD21 ' HB ' ' A' ' 51' ' ' VAL . 2.4 pp -79.53 -161.81 0.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.599 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.576 HE21 ' HA ' ' A' ' 4' ' ' GLN . 2.2 tp-100 -94.66 108.17 20.16 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.925 0.393 . . . . 0.0 110.446 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.537 ' CG2' HG21 ' A' ' 37' ' ' THR . 40.9 t -88.59 129.37 39.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.4 0.619 . . . . 0.0 112.067 -178.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.075 ' HB2' HD21 ' A' ' 13' ' ' LEU . 21.5 mt -87.88 143.18 27.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.021 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 51.9 m-70 -120.78 145.73 47.25 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.099 HD13 HD12 ' A' ' 13' ' ' LEU . 46.2 mm -66.05 134.41 94.93 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.676 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.8 141.36 66.57 Favored 'Cis proline' 0 C--N 1.351 0.685 0 C-N-CA 124.195 -1.169 . . . . 0.0 112.016 -0.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.989 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.7 t70 -161.24 126.28 3.6 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 12.0 pt-20 -58.21 -46.06 86.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.982 -178.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.578 ' HB2' HD13 ' A' ' 6' ' ' LEU . 25.1 mtt-85 -59.3 -26.16 64.74 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 1.099 HD12 HD13 ' A' ' 8' ' ' ILE . 10.7 mt -76.64 -33.38 58.35 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 120.284 1.402 . . . . 0.0 108.139 177.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.587 ' C ' ' HA3' ' A' ' 139' ' ' GLY . 14.1 mmt85 -94.11 11.01 31.47 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 113.854 -1.521 . . . . 0.0 109.303 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.438 ' HB2' ' HA ' ' A' ' 12' ' ' ARG . 61.8 tttp -92.76 150.67 20.5 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.283 -178.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.989 HG13 HG23 ' A' ' 138' ' ' VAL . 61.8 t -83.47 124.06 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.819 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.738 ' C ' ' HG3' ' A' ' 56' ' ' ARG . . . -80.99 147.45 30.21 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.652 ' HD3' ' N ' ' A' ' 19' ' ' PRO . 2.2 tmtp? -109.9 127.98 26.17 Favored Pre-proline 0 C--N 1.325 -0.486 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.217 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.995 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 65.6 Cg_endo -77.7 113.93 3.57 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 121.998 1.799 . . . . 0.0 110.815 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.758 HG12 ' H ' ' A' ' 22' ' ' GLU . 18.0 t -68.45 144.46 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-O 122.609 1.195 . . . . 0.0 113.29 -175.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -60.76 -27.97 68.36 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 112.97 -1.923 . . . . 0.0 111.995 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.758 ' H ' HG12 ' A' ' 20' ' ' VAL . 39.4 tt0 -157.79 143.02 16.88 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.242 -178.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.713 HG21 HD11 ' A' ' 111' ' ' LEU . 3.2 t -79.75 108.46 13.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 1.033 ' HB2' HD13 ' A' ' 27' ' ' ILE . 54.6 m-80 -93.32 173.51 7.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.813 -179.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.625 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -65.75 -28.54 69.11 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.376 0.607 . . . . 0.0 110.859 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.498 ' HA ' ' OE1' ' A' ' 26' ' ' GLU . 4.3 mm-40 -73.92 -39.72 63.61 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 1.033 HD13 ' HB2' ' A' ' 24' ' ' ASN . 1.9 mp -66.91 -37.49 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.166 178.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.823 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 16.9 mt-30 -66.18 -40.46 90.48 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.233 -0.292 . . . . 0.0 110.719 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.625 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 14.0 mmp_? -63.33 -39.58 94.93 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.857 HG21 HD12 ' A' ' 57' ' ' ILE . 4.8 mt -55.34 -50.17 67.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.381 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.903 HG22 ' CG2' ' A' ' 57' ' ' ILE . 15.9 t -65.25 -41.62 91.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.072 0.463 . . . . 0.0 111.045 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.873 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 27.3 m-20 -54.97 -43.58 73.64 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.475 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.529 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 1.4 m-20 -75.81 -29.77 58.79 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.923 176.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.978 ' HE1' HG22 ' A' ' 57' ' ' ILE . 22.0 mtm -60.14 -46.69 88.82 Favored 'General case' 0 C--N 1.347 0.467 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.534 -177.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.873 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 14.9 p90 -69.87 -45.45 67.68 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.605 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 3.8 mm-40 -52.65 -39.38 61.76 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.719 0.771 . . . . 0.0 108.996 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.83 ' HA ' HG12 ' A' ' 2' ' ' VAL . 61.8 m -70.06 -61.78 1.64 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.455 -1.248 . . . . 0.0 107.642 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.879 ' HG3' ' HB2' ' A' ' 46' ' ' LEU . 1.0 OUTLIER -46.52 -41.11 13.7 Favored 'General case' 0 CA--C 1.462 -2.416 0 C-N-CA 123.958 0.903 . . . . 0.0 110.431 -170.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.701 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 58.5 m-85 -70.37 -42.43 71.79 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.281 178.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.05 -24.61 66.33 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.416 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 1.024 ' HG2' HD12 ' A' ' 91' ' ' LEU . 11.7 tp10 -88.89 -11.4 44.7 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.475 177.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.439 ' H ' ' C ' ' A' ' 39' ' ' TYR . 18.4 mt-10 65.43 23.93 11.95 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.042 -176.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.453 ' O ' ' HE3' ' A' ' 38' ' ' MET . . . -79.07 141.89 24.66 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 114.027 -1.442 . . . . 0.0 110.372 177.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.86 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 46.3 mt -81.33 1.41 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 117.648 0.724 . . . . 0.0 112.638 -178.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.424 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 178.73 133.78 1.98 Allowed Glycine 0 CA--C 1.528 0.867 0 CA-C-O 118.913 -0.937 . . . . 0.0 111.409 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.024 HD13 ' HG ' ' A' ' 91' ' ' LEU . 4.9 tp -126.02 134.33 51.48 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.15 1.475 . . . . 0.0 112.161 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -98.3 131.88 44.25 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.292 0.237 . . . . 0.0 111.448 178.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.894 ' HB1' ' CD1' ' A' ' 53' ' ' ILE . . . -30.01 -55.64 0.18 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.565 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 67.3 p -53.25 -36.01 60.63 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.462 0.648 . . . . 0.0 112.039 -177.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.774 ' OE1' HD12 ' A' ' 46' ' ' LEU . 85.8 mt-30 -63.83 -41.92 97.73 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.231 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.923 ' HB ' HD21 ' A' ' 3' ' ' LEU . 1.0 OUTLIER -83.74 16.49 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.447 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.933 ' HA ' HD11 ' A' ' 6' ' ' LEU . 50.5 t0 77.37 28.29 0.61 Allowed 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 176.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.894 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -122.23 110.7 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 119.204 -0.999 . . . . 0.0 111.247 177.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -76.76 63.19 2.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.493 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.735 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 94.7 mm-40 -152.96 134.33 14.31 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.237 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.995 ' HD2' ' HD3' ' A' ' 19' ' ' PRO . 98.8 mtt180 -64.5 66.72 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -177.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.978 HG22 ' HE1' ' A' ' 34' ' ' MET . 6.2 mt -111.1 123.22 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.082 HD11 ' HB2' ' A' ' 72' ' ' LEU . 1.8 pp -128.32 146.37 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 119.665 -0.814 . . . . 0.0 113.12 -177.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 46' ' ' LEU . 30.5 m -126.24 139.11 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.7 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.099 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 7.9 mm -116.16 153.39 17.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.55 0.69 . . . . 0.0 110.392 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.86 ' HB3' ' C ' ' A' ' 44' ' ' ILE . 31.3 t70 -139.46 17.85 2.55 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.363 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.776 ' H ' HG22 ' A' ' 60' ' ' ILE . 32.4 t . . . . . 0 N--CA 1.461 0.106 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.348 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.507 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 48.0 ttp180 . . . . . 0 N--CA 1.451 -0.422 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 1.099 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 56.3 mt -111.23 138.97 47.02 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.795 HG21 ' HB2' ' A' ' 113' ' ' ARG . 11.8 p -134.82 135.29 53.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.607 177.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.082 ' HB2' HD11 ' A' ' 58' ' ' ILE . 1.8 mm? -140.4 140.77 35.55 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.061 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 3.5 mm -119.51 136.03 57.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.172 0.51 . . . . 0.0 110.952 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.716 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 8.0 m120 51.57 37.6 0.44 Allowed Pre-proline 0 C--N 1.312 -1.027 0 CA-C-N 115.349 -0.842 . . . . 0.0 112.379 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.874 ' HG2' HG12 ' A' ' 58' ' ' ILE . 77.6 Cg_exo -55.08 144.5 68.96 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 122.949 2.433 . . . . 0.0 114.102 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.5 ' CG ' ' HB2' ' A' ' 109' ' ' ARG . 11.5 pt-20 -135.45 145.43 47.19 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.817 HD22 ' NZ ' ' A' ' 80' ' ' LYS . 1.5 tt -81.2 137.69 35.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.309 0.576 . . . . 0.0 111.817 -178.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.902 HD21 ' HG3' ' A' ' 109' ' ' ARG . 2.9 mm? -118.9 -50.71 2.38 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.624 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 1.018 ' HB3' ' HD3' ' A' ' 107' ' ' LYS . 39.3 tp10 -140.5 146.51 38.26 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 120.883 0.373 . . . . 0.0 110.886 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.817 ' NZ ' HD22 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -147.32 145.66 29.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.098 179.492 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.3 t -159.07 156.58 29.47 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.787 0.327 . . . . 0.0 111.592 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.753 ' C ' ' HG3' ' A' ' 104' ' ' GLU . . . 67.53 159.62 1.17 Allowed Glycine 0 CA--C 1.506 -0.5 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.352 -179.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.734 ' N ' ' HG3' ' A' ' 104' ' ' GLU . 57.6 mt-10 -131.89 113.0 12.93 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 122.006 0.908 . . . . 0.0 113.002 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.913 HG23 ' HG2' ' A' ' 104' ' ' GLU . 1.5 p -103.54 161.36 13.95 Favored 'General case' 0 CA--C 1.486 -1.505 0 CA-C-N 113.812 -1.54 . . . . 0.0 114.733 178.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.772 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -149.84 118.34 0.93 Allowed Glycine 0 C--N 1.311 -0.828 0 CA-C-N 112.911 -1.949 . . . . 0.0 111.373 178.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.529 ' N ' ' HG ' ' A' ' 99' ' ' LEU . 32.4 mt -148.16 138.69 17.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 117.278 0.539 . . . . 0.0 111.733 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.533 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 95.3 mt-10 -70.82 137.98 49.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 123.072 1.415 . . . . 0.0 112.313 -176.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.732 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 46.8 mt-10 -156.42 160.43 39.6 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 112.652 -2.067 . . . . 0.0 111.351 -179.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.658 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -120.57 165.0 13.89 Favored Glycine 0 CA--C 1.501 -0.783 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 18.2 m -116.09 140.81 48.9 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 117.897 0.848 . . . . 0.0 111.995 -177.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.024 ' HG ' HD13 ' A' ' 46' ' ' LEU . 2.3 mm? -47.69 -26.52 1.57 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.88 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.852 ' CB ' HD13 ' A' ' 13' ' ' LEU . 49.9 m -79.77 -38.08 33.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.871 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.9 mt . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.971 -179.634 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.732 ' HA ' ' O ' ' A' ' 88' ' ' GLU . 12.9 mtt85 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 121.757 0.789 . . . . 0.0 112.115 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -134.19 153.34 51.9 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.792 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.772 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.5 tt -75.67 112.7 12.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.681 0.753 . . . . 0.0 110.757 -178.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.589 HG12 ' NH1' ' A' ' 102' ' ' ARG . 29.5 t -98.6 128.93 31.37 Favored Pre-proline 0 N--CA 1.468 0.434 0 CA-C-N 114.724 -1.126 . . . . 0.0 112.011 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 100' ' ' VAL . 1.1 Cg_endo -83.4 125.69 3.99 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.726 2.284 . . . . 0.0 112.031 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.976 HH11 ' HB3' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -145.86 167.17 23.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.312 179.759 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.638 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.62 155.17 40.53 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.913 ' HG2' HG23 ' A' ' 84' ' ' THR . 95.1 mt-10 -72.88 -39.87 66.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.867 -175.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.679 ' HB3' ' OD1' ' A' ' 123' ' ' ASP . 59.1 mttp -139.73 140.56 36.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.263 0.554 . . . . 0.0 109.722 177.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.797 HG12 ' CB ' ' A' ' 80' ' ' LYS . 35.2 m -149.71 140.02 16.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.511 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 1.018 ' HD3' ' HB3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -108.09 127.75 54.07 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.874 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.89 ' HA ' HD23 ' A' ' 78' ' ' LEU . 1.5 pp -133.03 150.15 32.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -177.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.902 ' HG3' HD21 ' A' ' 78' ' ' LEU . 96.4 mtt180 -102.18 137.69 40.12 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.66 -178.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.504 ' CB ' ' HB3' ' A' ' 72' ' ' LEU . . . -161.57 169.7 21.22 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 114.746 -1.115 . . . . 0.0 111.023 -176.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 1.061 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 1.9 pp -119.35 149.12 42.35 Favored 'General case' 0 C--O 1.218 -0.59 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 176.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.624 ' O ' HD12 ' A' ' 111' ' ' LEU . 12.8 t70 -81.75 167.8 18.72 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 119.877 -0.729 . . . . 0.0 112.642 -175.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.795 ' HB2' HG21 ' A' ' 71' ' ' VAL . 51.0 ttp180 -50.28 -22.45 1.79 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.971 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -79.4 -25.07 42.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.898 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.748 ' HA2' HD13 ' A' ' 111' ' ' LEU . . . 104.83 37.91 2.65 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.189 -1.005 . . . . 0.0 113.834 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -128.36 102.73 20.6 Favored Pre-proline 0 C--O 1.235 0.342 0 CA-C-N 117.054 0.427 . . . . 0.0 110.473 178.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.709 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 36.8 Cg_exo -71.56 114.86 4.07 Favored 'Trans proline' 0 C--N 1.358 1.075 0 N-CA-C 116.409 1.657 . . . . 0.0 116.409 -176.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.524 ' CE2' ' HB2' ' A' ' 112' ' ' ASP . 0.3 OUTLIER -127.0 160.72 30.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.731 -179.227 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.628 ' HG2' ' HG2' ' A' ' 109' ' ' ARG . 21.5 mt-10 -107.42 130.69 54.79 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.909 ' O ' HD23 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -131.66 141.59 49.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.795 0.807 . . . . 0.0 111.887 -179.019 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 107' ' ' LYS . 11.4 pt-20 -97.16 125.52 41.72 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.979 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.903 ' CB ' ' HG ' ' A' ' 126' ' ' LEU . . . -115.01 135.41 54.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.839 0.352 . . . . 0.0 111.391 -179.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.679 ' OD1' ' HB3' ' A' ' 105' ' ' LYS . 31.3 m-20 -126.66 160.76 29.8 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.808 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 51.73 -138.78 28.94 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 120.645 1.566 . . . . 0.0 115.159 177.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.672 HD12 ' H ' ' A' ' 125' ' ' LEU . 4.9 mp -53.5 -32.96 52.61 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.225 -0.488 . . . . 0.0 111.309 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.903 ' HG ' ' CB ' ' A' ' 122' ' ' ALA . 4.0 tp -70.78 -52.17 22.36 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.649 0.738 . . . . 0.0 109.418 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.738 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -58.55 -42.34 87.67 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.713 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.93 HD12 ' HG2' ' A' ' 102' ' ' ARG . 44.5 mm -67.85 -54.65 21.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.697 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 30.0 p -58.19 -50.2 74.36 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -178.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.883 HD11 HD11 ' A' ' 108' ' ' ILE . 14.2 tt -59.57 -44.21 92.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.121 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.866 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.0 pt20 -68.39 -39.42 81.71 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.518 178.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -59.44 -47.24 86.24 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.067 0.461 . . . . 0.0 109.794 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.877 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.7 mm-40 -59.61 -40.41 87.47 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.586 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.946 ' HA ' HD21 ' A' ' 137' ' ' LEU . 75.5 mtp -57.52 -47.64 81.43 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.838 0.828 . . . . 0.0 109.872 178.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.572 ' O ' HG12 ' A' ' 138' ' ' VAL . 31.4 m-20 -63.38 -47.13 83.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.976 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.449 ' CE1' ' CG ' ' A' ' 50' ' ' GLN . 4.6 t-80 -59.07 -53.0 63.29 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 121.103 0.478 . . . . 0.0 111.593 -178.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.946 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.7 pp -58.64 -31.76 68.43 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.518 -178.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.989 HG23 HG13 ' A' ' 16' ' ' VAL . 14.9 p -86.44 23.85 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 122.329 1.061 . . . . 0.0 109.548 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.627 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 53.85 34.94 52.05 Favored Glycine 0 CA--C 1.482 -1.969 0 CA-C-N 113.388 -1.733 . . . . 0.0 112.432 176.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.968 ' HG2' HG13 ' A' ' 138' ' ' VAL . 3.6 ptmt . . . . . 0 N--CA 1.423 -1.807 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.334 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.818 HG13 HG23 ' A' ' 37' ' ' THR . 38.2 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.676 0.274 . . . . 0.0 110.619 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.964 HD21 ' HB ' ' A' ' 51' ' ' VAL . 3.1 pp -79.63 -173.39 3.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.797 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.458 ' N ' HD12 ' A' ' 3' ' ' LEU . 70.9 tp60 -83.1 106.82 15.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.026 0.441 . . . . 0.0 110.59 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.586 HG22 HG21 ' A' ' 37' ' ' THR . 40.6 t -87.65 127.95 40.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.543 0.687 . . . . 0.0 112.201 -178.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.99 ' HB2' HD21 ' A' ' 13' ' ' LEU . 35.1 mt -85.96 138.88 31.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.193 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.523 ' C ' HD11 ' A' ' 13' ' ' LEU . 28.8 m-70 -113.44 147.47 37.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.083 0.468 . . . . 0.0 112.141 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.048 HD13 HD12 ' A' ' 13' ' ' LEU . 42.9 mm -57.26 148.08 54.5 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.426 178.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.635 ' HA ' HG23 ' A' ' 8' ' ' ILE . 69.5 Cg_endo -93.49 51.84 1.1 Allowed 'Cis proline' 0 C--N 1.353 0.802 0 C-N-CA 124.707 -0.956 . . . . 0.0 112.881 0.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.886 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.7 t70 -55.66 135.78 51.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.057 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -59.37 -44.98 92.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.999 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.657 ' O ' ' HB ' ' A' ' 49' ' ' THR . 15.1 mmt85 -56.06 -25.47 45.29 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 1.048 HD12 HD13 ' A' ' 8' ' ' ILE . 10.7 mt -75.42 -33.86 60.96 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 119.46 1.027 . . . . 0.0 108.679 178.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.683 ' C ' ' HA3' ' A' ' 139' ' ' GLY . 14.9 mmm180 -96.23 13.01 28.88 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 114.086 -1.416 . . . . 0.0 109.442 178.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.867 ' HD3' ' N ' ' A' ' 16' ' ' VAL . 1.1 tmtp? -87.01 145.38 26.51 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.918 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.94 HG13 HG23 ' A' ' 138' ' ' VAL . 49.1 t -81.86 118.95 30.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.792 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -78.16 150.84 33.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.824 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.787 ' HD3' ' O ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -114.65 133.08 22.6 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.133 178.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.763 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 61.2 Cg_endo -78.81 115.94 3.67 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.454 2.103 . . . . 0.0 111.43 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.767 HG12 ' H ' ' A' ' 22' ' ' GLU . 19.9 t -67.85 144.43 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 CA-C-O 122.618 1.199 . . . . 0.0 113.096 -175.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -61.62 -28.22 69.21 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 113.058 -1.883 . . . . 0.0 112.111 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.767 ' H ' HG12 ' A' ' 20' ' ' VAL . 38.9 tt0 -156.57 145.74 20.42 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 120.746 -0.381 . . . . 0.0 111.547 -178.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.626 HG21 ' HA2' ' A' ' 115' ' ' GLY . 3.9 t -79.15 105.87 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -178.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.91 ' HB2' HD13 ' A' ' 27' ' ' ILE . 57.4 m-80 -93.31 153.81 18.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.779 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.647 ' HB1' HH12 ' A' ' 29' ' ' ARG . . . -54.72 -24.17 20.97 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.254 0.549 . . . . 0.0 110.711 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -74.95 -41.06 60.35 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 177.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.91 HD13 ' HB2' ' A' ' 24' ' ' ASN . 1.8 mp -68.08 -33.96 63.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-N 113.846 -1.524 . . . . 0.0 110.108 178.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -69.94 -40.07 75.7 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 122.354 -0.216 . . . . 0.0 110.575 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.647 HH12 ' HB1' ' A' ' 25' ' ' ALA . 67.7 mtt85 -64.26 -38.01 89.53 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.802 ' CG2' HD13 ' A' ' 53' ' ' ILE . 4.8 mt -55.46 -50.3 66.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.302 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.785 HG22 ' CG2' ' A' ' 57' ' ' ILE . 3.8 t -67.9 -40.67 83.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.02 0.438 . . . . 0.0 110.201 178.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.83 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 12.8 m-20 -55.32 -41.38 72.35 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.73 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.485 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 52.7 m-20 -76.32 -30.21 57.6 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.158 176.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 1.092 ' HG2' HG21 ' A' ' 51' ' ' VAL . 85.4 mtp -60.31 -46.25 90.54 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.268 -177.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.83 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 11.0 p90 -69.57 -44.51 70.68 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 32' ' ' ASP . 31.2 mm-40 -53.01 -39.97 63.52 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.818 HG23 HG13 ' A' ' 2' ' ' VAL . 74.7 m -71.49 -62.6 1.35 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 118.377 -1.329 . . . . 0.0 107.886 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 1.008 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 2.0 ttp -46.91 -40.4 14.04 Favored 'General case' 0 CA--C 1.467 -2.237 0 C-N-CA 124.015 0.926 . . . . 0.0 110.145 -170.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.698 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 50.6 m-85 -70.51 -42.27 71.52 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.985 177.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 37' ' ' THR . . . -61.25 -23.23 65.5 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.566 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 1.014 ' HG2' HD12 ' A' ' 91' ' ' LEU . 11.5 tp10 -90.25 -11.38 41.07 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 114.434 -1.257 . . . . 0.0 108.273 177.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.443 ' H ' ' C ' ' A' ' 39' ' ' TYR . 21.6 mt-10 64.12 28.55 14.16 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.889 -176.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.48 143.66 21.02 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 113.678 -1.601 . . . . 0.0 111.207 178.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.832 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 45.7 mm -79.36 -1.44 4.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 117.323 0.561 . . . . 0.0 112.061 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.537 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 177.87 135.88 2.37 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-O 119.28 -0.733 . . . . 0.0 111.721 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.089 HD13 ' HG ' ' A' ' 91' ' ' LEU . 5.0 tp -125.01 133.67 52.88 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.347 1.074 . . . . 0.0 111.305 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -100.42 132.33 45.86 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.962 ' HB1' HG13 ' A' ' 53' ' ' ILE . . . -26.9 -56.5 0.09 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.657 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 70.4 p -53.34 -35.81 60.64 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.65 0.738 . . . . 0.0 111.756 -177.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.816 ' NE2' HD23 ' A' ' 91' ' ' LEU . 8.8 mt-30 -64.52 -41.57 96.31 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.59 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.092 HG21 ' HG2' ' A' ' 34' ' ' MET . 1.1 m -85.76 18.57 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.904 ' OD2' HD21 ' A' ' 6' ' ' LEU . 8.4 t0 78.43 28.09 0.48 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 176.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.962 HG13 ' HB1' ' A' ' 48' ' ' ALA . 11.1 pt -123.05 110.35 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 118.857 -1.137 . . . . 0.0 111.783 177.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.618 ' HB2' ' NZ ' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -76.82 51.74 0.79 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 121.888 0.851 . . . . 0.0 109.531 179.206 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.533 ' O ' HG12 ' A' ' 57' ' ' ILE . 26.2 mt-30 -140.52 129.94 23.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.103 -1.408 . . . . 0.0 107.501 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.792 ' N ' ' HB1' ' A' ' 17' ' ' ALA . 73.3 mtt-85 -59.83 68.34 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.936 ' HB ' HD11 ' A' ' 53' ' ' ILE . 11.1 mm -112.08 122.31 66.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.058 HD11 ' HB2' ' A' ' 72' ' ' LEU . 1.9 pp -127.82 143.46 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 119.607 -0.837 . . . . 0.0 113.174 -177.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.67 HG21 ' HB3' ' A' ' 35' ' ' PHE . 1.4 p -127.96 134.13 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.679 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.049 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 2.0 mt -114.93 151.94 16.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.445 0.64 . . . . 0.0 111.111 -177.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 1.008 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 11.4 t70 -129.65 25.73 5.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.614 -1.176 . . . . 0.0 110.83 -177.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.851 HG23 ' CG2' ' A' ' 60' ' ' ILE . 11.7 t . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.534 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 51.5 ttt-85 . . . . . 0 N--CA 1.456 -0.166 0 CA-C-O 120.779 0.323 . . . . 0.0 110.68 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 1.049 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 48.5 mt -112.09 138.87 48.15 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -179.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.999 HG21 ' HB2' ' A' ' 113' ' ' ARG . 8.8 p -134.03 131.23 55.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.408 177.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.058 ' HB2' HD11 ' A' ' 58' ' ' ILE . 89.6 mt -142.41 143.18 32.54 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 121.31 -0.156 . . . . 0.0 110.919 177.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.054 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.6 mp -120.68 134.39 64.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.69 0.281 . . . . 0.0 110.743 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.688 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 7.4 m120 53.72 34.78 0.26 Allowed Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.846 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 84.5 Cg_exo -55.16 146.75 57.99 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.521 2.147 . . . . 0.0 113.571 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -135.99 149.23 48.77 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.959 ' HB2' ' HE1' ' A' ' 134' ' ' MET . 27.9 tp -79.63 138.3 37.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.42 0.629 . . . . 0.0 112.082 -178.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.066 HD21 ' HG3' ' A' ' 109' ' ' ARG . 2.6 mm? -114.26 -45.35 3.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.425 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.587 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 38.2 tt0 -158.06 146.82 19.16 Favored 'General case' 0 C--O 1.23 0.035 0 CA-C-O 121.114 0.483 . . . . 0.0 111.637 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.879 ' HE3' HD21 ' A' ' 77' ' ' LEU . 19.3 ptpt -143.59 146.91 33.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.045 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.4 p -159.67 150.98 19.76 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.733 0.301 . . . . 0.0 111.291 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.744 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 79.75 159.08 16.84 Favored Glycine 0 C--N 1.335 0.472 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.414 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -134.02 113.4 12.09 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.896 0.855 . . . . 0.0 112.93 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.643 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.6 p -106.97 161.53 14.64 Favored 'General case' 0 CA--C 1.486 -1.485 0 CA-C-N 113.902 -1.499 . . . . 0.0 114.936 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.746 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -146.95 115.86 0.81 Allowed Glycine 0 C--N 1.311 -0.861 0 CA-C-N 112.671 -2.059 . . . . 0.0 110.873 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.589 ' N ' ' HG ' ' A' ' 99' ' ' LEU . 34.1 mt -147.97 139.09 17.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 117.293 0.546 . . . . 0.0 111.618 -178.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 50.5 mt-10 -71.65 138.55 48.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 123.193 1.473 . . . . 0.0 112.082 -175.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.673 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 46.0 mt-10 -157.41 162.25 39.0 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 112.672 -2.058 . . . . 0.0 111.098 -179.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.764 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -122.01 161.53 16.12 Favored Glycine 0 CA--C 1.501 -0.817 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.436 ' HG ' ' CD2' ' A' ' 136' ' ' HIS . 17.9 m -114.63 140.43 48.82 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.313 0.578 . . . . 0.0 111.344 -178.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.089 ' HG ' HD13 ' A' ' 46' ' ' LEU . 2.4 mm? -48.14 -22.8 0.69 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.333 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.863 ' CB ' HG12 ' A' ' 8' ' ' ILE . 54.0 m -83.28 -34.76 25.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.921 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.574 ' CD1' HG13 ' A' ' 8' ' ' ILE . 49.5 mm . . . . . 0 N--CA 1.451 -0.381 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.226 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.764 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 18.5 mtm105 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 121.637 0.732 . . . . 0.0 111.836 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -135.16 155.85 50.0 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 114.539 -1.209 . . . . 0.0 109.432 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.746 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.6 tt -76.23 115.28 15.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.419 0.628 . . . . 0.0 111.773 -178.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.826 ' HB ' ' CZ ' ' A' ' 102' ' ' ARG . 39.0 t -107.01 131.95 21.29 Favored Pre-proline 0 N--CA 1.475 0.815 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.991 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.643 ' HA ' ' O ' ' A' ' 84' ' ' THR . 85.3 Cg_endo -82.92 127.47 4.79 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.663 2.242 . . . . 0.0 112.519 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.948 ' HG3' HG23 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -144.68 167.26 22.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.224 179.351 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.744 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.79 155.48 40.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 118.34 0.518 . . . . 0.0 110.1 -179.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -73.38 -41.2 63.67 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.895 -175.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.672 ' HB3' ' OD1' ' A' ' 123' ' ' ASP . 95.4 mttt -139.64 140.23 36.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.249 0.547 . . . . 0.0 109.619 177.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.869 HG22 ' HB1' ' A' ' 127' ' ' ALA . 35.1 m -146.78 139.44 19.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.311 -178.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 1.014 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 56.1 mmtt -106.6 127.05 53.03 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 1.014 ' HA ' HD23 ' A' ' 78' ' ' LEU . 2.3 pp -133.83 146.81 31.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -176.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 1.066 ' HG3' HD21 ' A' ' 78' ' ' LEU . 68.7 mtm180 -103.6 139.32 39.06 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.68 -178.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.704 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -161.05 169.42 22.51 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.037 -176.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 1.054 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.5 pp -116.48 151.83 35.28 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.473 ' O ' HD12 ' A' ' 111' ' ' LEU . 16.8 t70 -85.24 163.61 18.56 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.231 0.539 . . . . 0.0 112.053 -177.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.999 ' HB2' HG21 ' A' ' 71' ' ' VAL . 13.1 ttp-105 -51.93 -20.11 2.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.076 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -79.4 -26.44 41.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.633 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.626 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 107.3 35.98 2.58 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.199 -1.001 . . . . 0.0 113.491 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -128.46 102.68 20.36 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.781 0.291 . . . . 0.0 110.804 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.672 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.9 Cg_exo -72.6 116.27 4.65 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 121.65 1.567 . . . . 0.0 115.663 -177.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 112' ' ' ASP . 0.4 OUTLIER -126.97 165.13 20.01 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.269 -178.655 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.545 ' HG3' ' CG ' ' A' ' 109' ' ' ARG . 5.9 mp0 -107.33 130.68 54.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.028 0.442 . . . . 0.0 109.837 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.729 HD21 ' CD1' ' A' ' 72' ' ' LEU . 4.4 pp -124.53 130.94 53.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.571 -178.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 1.014 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 15.3 pt-20 -91.5 123.79 35.18 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.917 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -116.24 135.62 53.74 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.672 ' OD1' ' HB3' ' A' ' 105' ' ' LYS . 45.4 m-20 -127.1 161.36 28.62 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.825 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 51.68 -137.88 30.3 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 120.334 1.425 . . . . 0.0 115.279 177.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 81.1 mt -54.05 -32.28 54.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.816 -0.692 . . . . 0.0 111.737 -178.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.917 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.3 OUTLIER -71.11 -52.58 18.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.663 0.744 . . . . 0.0 109.362 179.769 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.869 ' HB1' HG22 ' A' ' 106' ' ' VAL . . . -59.85 -40.9 90.16 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.569 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.948 HG23 ' HG3' ' A' ' 102' ' ' ARG . 46.4 mm -66.01 -54.31 28.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.698 -178.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.66 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 85.5 m -60.42 -49.39 77.76 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.768 ' CD1' HG12 ' A' ' 108' ' ' ILE . 0.1 OUTLIER -59.22 -44.72 92.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.557 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.818 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.3 pt20 -67.7 -39.14 84.42 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.683 0.278 . . . . 0.0 110.282 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -59.86 -46.05 90.53 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.12 0.486 . . . . 0.0 109.88 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.885 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.5 mm-40 -60.32 -40.74 91.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.921 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.959 ' HE1' ' HB2' ' A' ' 77' ' ' LEU . 73.2 mtp -57.78 -48.07 80.75 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.751 0.786 . . . . 0.0 109.948 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.653 ' O ' HG12 ' A' ' 138' ' ' VAL . 30.6 m-20 -62.76 -46.75 86.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.811 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.448 ' CE1' ' CG ' ' A' ' 50' ' ' GLN . 4.7 t-80 -59.57 -52.72 64.35 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.206 0.527 . . . . 0.0 111.675 -178.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.927 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.5 pp -59.18 -30.38 68.15 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.315 -178.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.94 HG23 HG13 ' A' ' 16' ' ' VAL . 13.4 p -86.1 22.7 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-O 122.094 0.949 . . . . 0.0 109.356 176.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.711 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 55.88 38.75 75.54 Favored Glycine 0 CA--C 1.483 -1.966 0 CA-C-N 113.678 -1.601 . . . . 0.0 112.662 176.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.932 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 3.4 ptmt . . . . . 0 N--CA 1.426 -1.658 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.708 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.94 HG12 ' HA ' ' A' ' 37' ' ' THR . 31.5 m . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.905 0.383 . . . . 0.0 111.481 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 1.004 HD21 ' HB ' ' A' ' 51' ' ' VAL . 3.2 pp -79.74 -165.97 0.91 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.593 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.439 ' N ' HD12 ' A' ' 3' ' ' LEU . 40.7 tt0 -89.92 109.76 20.76 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.952 0.406 . . . . 0.0 110.473 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.567 ' CG2' HG21 ' A' ' 37' ' ' THR . 43.4 t -88.66 129.84 39.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.413 0.625 . . . . 0.0 112.079 -178.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.082 ' HB2' HD21 ' A' ' 13' ' ' LEU . 15.3 mt -89.95 143.21 26.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.923 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 44.0 m-70 -121.77 147.93 45.3 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -179.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.033 HD13 HD12 ' A' ' 13' ' ' LEU . 50.3 mm -63.68 135.78 96.43 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.145 178.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -80.38 142.73 61.83 Favored 'Cis proline' 0 C--N 1.351 0.708 0 C-N-CA 124.605 -0.998 . . . . 0.0 111.746 -0.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.948 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.7 t70 -163.53 126.9 2.7 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.459 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 11.9 pt-20 -58.08 -46.07 86.08 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.598 -178.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 1.024 ' HA ' ' HZ3' ' A' ' 15' ' ' LYS . 16.0 mmt85 -56.28 -29.05 60.65 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 1.082 HD21 ' HB2' ' A' ' 6' ' ' LEU . 10.0 mt -76.43 -34.28 58.77 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 120.068 1.303 . . . . 0.0 108.559 177.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.796 ' HB3' ' NH1' ' A' ' 14' ' ' ARG . 2.2 mmm180 -93.42 13.0 22.97 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 113.877 -1.51 . . . . 0.0 109.182 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 1.024 ' HZ3' ' HA ' ' A' ' 12' ' ' ARG . 4.5 ttmp? -88.66 145.65 25.54 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.207 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 1.04 HG13 HG23 ' A' ' 138' ' ' VAL . 59.5 t -82.43 121.49 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.75 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -82.13 145.82 29.92 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.411 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -107.95 128.96 24.8 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.745 ' HA ' ' OD1' ' A' ' 74' ' ' ASN . 64.0 Cg_endo -78.97 113.54 3.26 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 121.725 1.617 . . . . 0.0 110.665 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.726 HG12 ' H ' ' A' ' 22' ' ' GLU . 16.5 t -68.97 144.43 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-O 122.469 1.128 . . . . 0.0 113.132 -175.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -60.49 -24.75 65.53 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 113.125 -1.852 . . . . 0.0 112.368 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.726 ' H ' HG12 ' A' ' 20' ' ' VAL . 42.7 tt0 -157.28 142.71 17.28 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.296 -179.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.542 HG22 HD21 ' A' ' 111' ' ' LEU . 2.9 t -80.07 108.1 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -178.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 1.038 ' H ' HD12 ' A' ' 27' ' ' ILE . 63.1 m-80 -90.85 155.36 18.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.658 -178.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.687 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -55.29 -25.49 34.46 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.35 0.595 . . . . 0.0 110.49 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.434 ' OE2' HG12 ' A' ' 27' ' ' ILE . 0.6 OUTLIER -75.11 -38.99 60.92 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 177.745 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 1.038 HD12 ' H ' ' A' ' 24' ' ' ASN . 57.4 mt -66.06 -35.6 75.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 114.297 -1.32 . . . . 0.0 110.168 177.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -69.38 -39.21 78.15 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.254 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.687 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 38.1 mmm-85 -61.32 -39.24 89.79 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.792 ' O ' ' HG3' ' A' ' 34' ' ' MET . 3.0 mt -58.24 -48.69 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.2 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.903 HG22 ' CG2' ' A' ' 57' ' ' ILE . 8.7 t -67.9 -41.85 85.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 120.968 0.413 . . . . 0.0 111.557 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.862 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -55.8 -42.4 75.55 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.999 -179.412 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.483 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 15.5 m-20 -75.48 -29.91 59.74 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.284 176.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 1.008 ' HG2' HG21 ' A' ' 51' ' ' VAL . 83.1 mtp -60.28 -46.51 89.58 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.315 -177.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.862 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 13.4 p90 -69.7 -45.2 68.81 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.751 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 37.9 mt-10 -51.84 -40.42 60.49 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 121.762 0.791 . . . . 0.0 108.904 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.94 ' HA ' HG12 ' A' ' 2' ' ' VAL . 56.6 m -70.24 -62.23 1.47 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.33 -1.305 . . . . 0.0 108.176 178.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.955 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 2.8 ttp -46.31 -41.4 13.21 Favored 'General case' 0 CA--C 1.46 -2.485 0 C-N-CA 124.144 0.978 . . . . 0.0 110.364 -171.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.709 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 61.7 m-85 -70.55 -42.69 70.84 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.686 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.5 ' CB ' HG11 ' A' ' 2' ' ' VAL . . . -61.4 -24.27 66.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.841 0.829 . . . . 0.0 109.395 179.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 1.052 ' HG2' HD12 ' A' ' 91' ' ' LEU . 11.6 tp10 -88.74 -11.23 45.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.471 177.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.447 ' H ' ' C ' ' A' ' 39' ' ' TYR . 21.8 mt-10 64.27 25.42 13.53 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.956 -176.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.15 142.38 26.18 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 113.839 -1.528 . . . . 0.0 110.714 177.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.811 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 44.3 mm -79.15 -2.34 5.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 117.354 0.577 . . . . 0.0 112.139 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.524 ' HA2' ' SD ' ' A' ' 38' ' ' MET . . . 177.97 134.91 2.15 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 118.759 -1.023 . . . . 0.0 111.291 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.04 HD13 ' HG ' ' A' ' 91' ' ' LEU . 7.6 tp -124.52 134.97 52.84 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 119.29 1.545 . . . . 0.0 111.973 -179.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.451 ' H ' HE21 ' A' ' 50' ' ' GLN . . . -100.31 130.34 46.41 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.484 0.183 . . . . 0.0 111.299 178.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.872 ' HB1' ' CD1' ' A' ' 53' ' ' ILE . . . -28.61 -54.43 0.11 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -179.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.622 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 69.1 p -52.96 -35.45 58.94 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.458 0.647 . . . . 0.0 112.221 -177.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.919 ' NE2' HD23 ' A' ' 91' ' ' LEU . 34.2 mt-30 -65.22 -42.05 93.81 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.154 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.008 HG21 ' HG2' ' A' ' 34' ' ' MET . 0.8 OUTLIER -82.42 15.69 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 179.781 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.872 ' HA ' HD11 ' A' ' 6' ' ' LEU . 35.0 t70 77.46 30.07 0.52 Allowed 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 176.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.872 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 1.1 pp -123.74 111.37 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.318 177.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.679 ' HB3' ' HD2' ' A' ' 15' ' ' LYS . 6.8 p80 -76.68 61.65 1.86 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.677 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.725 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 89.0 mt-30 -151.57 134.3 15.59 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 114.495 -1.229 . . . . 0.0 107.942 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.75 ' N ' ' HB1' ' A' ' 17' ' ' ALA . 76.3 mtp180 -64.0 69.3 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -177.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.903 ' CG2' HG22 ' A' ' 31' ' ' VAL . 8.0 mm -111.27 123.47 67.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.83 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -131.43 147.39 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 121.975 0.893 . . . . 0.0 112.965 -177.779 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.588 HG22 ' O ' ' A' ' 46' ' ' LEU . 32.9 m -127.71 139.21 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.092 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.969 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 9.2 mm -114.69 150.73 16.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.646 0.736 . . . . 0.0 109.943 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.955 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 33.4 t70 -138.62 28.82 2.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.735 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.772 HG22 ' CG2' ' A' ' 44' ' ' ILE . 40.4 t . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.556 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.699 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 41.7 ttm-85 . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.969 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 8.5 mp -102.87 132.35 49.13 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.991 0.424 . . . . 0.0 111.908 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.93 HG21 ' HB2' ' A' ' 113' ' ' ARG . 9.6 p -133.14 134.33 57.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.06 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.83 ' HB2' ' CD1' ' A' ' 58' ' ' ILE . 90.6 mt -141.74 140.95 33.23 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 121.384 -0.126 . . . . 0.0 111.009 178.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.03 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.8 mp -120.2 133.65 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-O 120.838 0.351 . . . . 0.0 110.923 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.792 ' ND2' HG22 ' A' ' 73' ' ' ILE . 64.5 m-20 51.72 36.32 0.34 Allowed Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 113.863 1.061 . . . . 0.0 113.863 178.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.742 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 90.1 Cg_exo -55.65 149.5 48.86 Favored 'Trans proline' 0 N--CA 1.484 0.917 0 C-N-CA 122.708 2.272 . . . . 0.0 113.415 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.45 ' OE2' ' HD2' ' A' ' 109' ' ' ARG . 23.0 pt-20 -135.91 145.88 46.76 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.77 HD21 ' HE3' ' A' ' 80' ' ' LYS . 30.1 tp -79.71 138.38 37.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.38 0.61 . . . . 0.0 112.278 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.06 HD11 ' HG3' ' A' ' 109' ' ' ARG . 5.4 mp -112.17 -44.04 3.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.632 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.561 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 38.4 tt0 -158.79 147.79 18.74 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 121.141 0.496 . . . . 0.0 111.831 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.874 ' HA ' HG12 ' A' ' 106' ' ' VAL . 19.4 ptpt -142.3 147.46 36.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.054 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.2 t -160.03 148.02 16.83 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.702 0.287 . . . . 0.0 111.221 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.759 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 82.97 163.93 34.89 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.515 -179.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -140.55 113.59 8.38 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.922 0.861 . . . . 0.0 113.106 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.6 p -106.09 161.56 14.39 Favored 'General case' 0 CA--C 1.486 -1.481 0 CA-C-N 113.999 -1.455 . . . . 0.0 114.864 178.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.702 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -145.47 114.12 0.74 Allowed Glycine 0 C--N 1.312 -0.781 0 CA-C-N 112.849 -1.978 . . . . 0.0 110.653 178.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.826 ' HB ' ' NH2' ' A' ' 102' ' ' ARG . 34.0 mt -148.67 139.56 17.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-N 117.264 0.532 . . . . 0.0 111.826 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 50.4 mt-10 -72.19 138.09 47.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 123.195 1.474 . . . . 0.0 112.581 -176.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.674 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 39.1 mt-10 -155.29 160.26 40.64 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 112.358 -2.201 . . . . 0.0 111.212 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.791 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -120.12 159.56 15.04 Favored Glycine 0 CA--C 1.499 -0.911 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 1.038 ' HB2' HD13 ' A' ' 93' ' ' ILE . 21.8 m -114.27 139.91 49.03 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 117.688 0.744 . . . . 0.0 111.175 -177.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.052 HD12 ' HG2' ' A' ' 41' ' ' GLU . 2.4 mm? -49.44 -22.47 1.19 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.036 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.94 ' HB3' HD13 ' A' ' 13' ' ' LEU . 54.4 m -79.41 -38.54 34.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.277 179.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 1.038 HD13 ' HB2' ' A' ' 90' ' ' CYS . 3.2 mp . . . . . 0 N--CA 1.448 -0.547 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.791 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 40.2 mtt180 . . . . . 0 N--CA 1.465 0.286 0 CA-C-O 121.573 0.701 . . . . 0.0 111.613 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -135.35 155.46 50.55 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 114.691 -1.141 . . . . 0.0 109.716 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.702 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.3 tt -76.41 114.85 15.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.439 0.638 . . . . 0.0 111.985 -178.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.758 ' HB ' HH11 ' A' ' 102' ' ' ARG . 42.6 t -104.36 132.8 20.62 Favored Pre-proline 0 N--CA 1.47 0.573 0 CA-C-N 114.931 -1.031 . . . . 0.0 112.062 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.584 ' HA ' ' O ' ' A' ' 84' ' ' THR . 2.1 Cg_endo -84.35 125.99 3.56 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.843 2.362 . . . . 0.0 111.804 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.826 ' NH2' ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -144.61 167.51 22.36 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.56 0.744 . . . . 0.0 109.98 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.759 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.79 154.86 41.22 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.836 0.351 . . . . 0.0 110.179 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -73.77 -41.16 62.81 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.146 -176.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.777 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 91.4 mttt -139.91 141.2 36.54 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.874 HG12 ' HA ' ' A' ' 80' ' ' LYS . 29.4 m -149.06 139.0 16.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.333 -179.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 1.058 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 51.0 mmtt -107.98 126.4 52.67 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 1.112 HD11 HD11 ' A' ' 130' ' ' ILE . 1.6 pp -136.1 152.76 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -176.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 1.06 ' HG3' HD11 ' A' ' 78' ' ' LEU . 93.7 mtt180 -102.68 138.78 39.12 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.93 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.605 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -160.04 167.82 27.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.102 -177.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 1.03 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.6 pp -117.12 153.25 33.11 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.609 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 10.1 t70 -88.2 162.97 16.38 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.519 -177.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.93 ' HB2' HG21 ' A' ' 71' ' ' VAL . 50.1 ttp85 -51.39 -19.04 1.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.251 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -79.1 -27.67 42.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.381 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.43 35.92 2.37 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.348 -0.93 . . . . 0.0 113.329 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -128.74 102.88 19.47 Favored Pre-proline 0 C--O 1.237 0.406 0 CA-C-N 116.815 0.308 . . . . 0.0 110.914 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.656 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.5 Cg_exo -73.4 116.08 4.57 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 121.766 1.644 . . . . 0.0 115.145 -177.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.609 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 10.9 p90 -126.13 166.65 16.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.312 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.706 ' HG2' ' HG2' ' A' ' 109' ' ' ARG . 30.7 mt-10 -107.5 130.51 54.84 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.817 HD11 ' CD1' ' A' ' 130' ' ' ILE . 4.3 pp -127.44 133.88 49.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.591 -178.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 1.058 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 9.1 pm0 -94.45 123.66 38.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.627 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.807 ' CB ' HD22 ' A' ' 126' ' ' LEU . . . -116.82 135.11 54.0 Favored 'General case' 0 C--O 1.222 -0.364 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.777 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.2 m-20 -126.66 162.35 25.97 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.728 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 49.9 -134.77 26.54 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 120.418 1.463 . . . . 0.0 115.252 177.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.742 HD12 ' CG1' ' A' ' 62' ' ' VAL . 1.7 pt? -53.78 -35.46 61.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.032 -0.584 . . . . 0.0 111.462 -179.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.807 HD22 ' CB ' ' A' ' 122' ' ' ALA . 0.6 OUTLIER -70.51 -52.01 24.85 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.996 0.903 . . . . 0.0 109.281 179.563 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.713 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -58.45 -41.5 85.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.925 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.817 HG23 ' HG3' ' A' ' 102' ' ' ARG . 50.6 mm -68.54 -54.99 17.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.827 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 29.3 p -59.03 -50.74 72.93 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 1.112 HD11 HD11 ' A' ' 108' ' ' ILE . 17.9 tt -59.65 -43.85 92.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.189 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.693 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.0 pt20 -67.73 -40.63 84.18 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.176 178.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 69.9 t60 -58.5 -45.78 88.04 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.206 0.527 . . . . 0.0 109.931 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.878 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.2 mm-40 -59.81 -41.77 92.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.708 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.947 ' HA ' HD21 ' A' ' 137' ' ' LEU . 74.8 mtp -57.25 -47.83 80.38 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.736 0.779 . . . . 0.0 110.08 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.643 ' O ' HG12 ' A' ' 138' ' ' VAL . 1.4 m-20 -63.16 -47.12 84.0 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.951 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.47 ' CE1' ' CG ' ' A' ' 50' ' ' GLN . 8.7 t-80 -58.97 -53.11 62.16 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.176 0.512 . . . . 0.0 111.472 -178.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.947 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.6 pp -58.65 -31.4 68.13 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.644 -178.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 1.04 HG23 HG13 ' A' ' 16' ' ' VAL . 14.5 p -85.05 24.58 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-O 122.283 1.04 . . . . 0.0 109.816 176.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.48 ' HA3' ' C ' ' A' ' 14' ' ' ARG . . . 55.84 30.81 57.49 Favored Glycine 0 CA--C 1.486 -1.757 0 CA-C-N 113.48 -1.691 . . . . 0.0 112.679 176.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.956 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 5.8 ptmt . . . . . 0 N--CA 1.425 -1.704 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.626 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 52.4 m . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.981 0.42 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.922 HG12 ' HA ' ' A' ' 37' ' ' THR . 25.5 m -84.32 133.16 29.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.327 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.895 HD11 ' HB ' ' A' ' 51' ' ' VAL . 2.0 pt? -80.46 -147.47 0.05 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.536 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 51.7 tt0 -98.58 104.76 16.83 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.938 0.399 . . . . 0.0 110.889 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.583 ' CG2' HG21 ' A' ' 37' ' ' THR . 40.4 t -88.36 126.38 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-O 121.496 0.665 . . . . 0.0 112.152 -178.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.054 ' HB2' HD21 ' A' ' 13' ' ' LEU . 50.2 mt -85.86 144.97 27.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.22 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 53.6 m-70 -123.01 144.05 49.52 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -178.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.006 HD13 HD12 ' A' ' 13' ' ' LEU . 49.3 mm -65.8 132.67 94.85 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.787 177.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -77.31 143.74 75.76 Favored 'Cis proline' 0 C--N 1.35 0.641 0 C-N-CA 124.553 -1.019 . . . . 0.0 111.778 -0.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.996 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.7 t70 -162.51 126.79 3.11 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.471 ' CD ' ' H ' ' A' ' 11' ' ' GLU . 0.6 OUTLIER -57.9 -45.85 85.84 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.754 -178.444 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.743 ' HB2' HD13 ' A' ' 6' ' ' LEU . 21.4 mtt-85 -59.89 -26.83 66.2 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 1.054 HD21 ' HB2' ' A' ' 6' ' ' LEU . 10.6 mt -77.66 -30.56 52.14 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 120.964 1.711 . . . . 0.0 108.586 177.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.618 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 15.0 mmm180 -95.11 8.62 42.43 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.072 -1.422 . . . . 0.0 109.059 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -90.17 147.67 23.44 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.7 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.579 HG13 HG23 ' A' ' 138' ' ' VAL . 90.4 t -81.93 128.83 38.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.834 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -90.28 145.4 25.01 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.832 ' HD3' ' HD2' ' A' ' 19' ' ' PRO . 8.0 tmtt? -107.11 131.42 21.71 Favored Pre-proline 0 C--N 1.318 -0.768 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.832 ' HD2' ' HD3' ' A' ' 18' ' ' LYS . 54.1 Cg_endo -81.56 114.44 2.7 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.774 1.649 . . . . 0.0 110.333 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.73 HG12 ' H ' ' A' ' 22' ' ' GLU . 19.4 t -68.97 144.88 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 CA-C-O 122.692 1.234 . . . . 0.0 113.342 -175.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -63.31 -21.26 66.15 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 112.861 -1.972 . . . . 0.0 112.986 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.73 ' H ' HG12 ' A' ' 20' ' ' VAL . 39.0 tt0 -157.84 144.51 17.82 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.166 -178.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.6 HG22 HD21 ' A' ' 111' ' ' LEU . 3.2 t -79.64 106.85 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -178.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 1.003 ' HB2' HD13 ' A' ' 27' ' ' ILE . 56.1 m-80 -92.61 153.22 19.13 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.802 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -54.14 -24.19 16.93 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.241 0.543 . . . . 0.0 110.782 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 1.092 ' HG3' HD12 ' A' ' 27' ' ' ILE . 13.9 pt-20 -75.15 -42.19 56.66 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 177.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 1.092 HD12 ' HG3' ' A' ' 26' ' ' GLU . 2.0 mp -65.19 -35.72 76.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.748 177.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 75.4 mt-30 -66.32 -40.57 90.03 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 122.349 -0.22 . . . . 0.0 110.493 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.5 ' HG3' ' O ' ' A' ' 25' ' ' ALA . 67.9 mtt85 -62.83 -38.69 91.77 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.805 ' O ' ' HG3' ' A' ' 34' ' ' MET . 1.6 mp -56.07 -49.97 72.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.927 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.785 HG11 ' CG2' ' A' ' 71' ' ' VAL . 36.7 t -67.25 -43.14 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.924 0.392 . . . . 0.0 111.17 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.848 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -55.45 -41.11 72.42 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.067 -179.103 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.506 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 1.3 m-20 -76.37 -30.22 57.46 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.318 176.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.967 ' HG2' HG21 ' A' ' 51' ' ' VAL . 32.5 mtm -60.74 -44.59 96.49 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 120.55 -0.46 . . . . 0.0 109.95 -178.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.848 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 10.6 p90 -70.17 -46.19 65.15 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' ' 32' ' ' ASP . 29.7 mm-40 -51.86 -40.99 61.51 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 121.634 0.731 . . . . 0.0 109.411 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.922 ' HA ' HG12 ' A' ' 2' ' ' VAL . 91.6 m -70.43 -61.84 1.62 Allowed 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 118.479 -1.288 . . . . 0.0 108.411 177.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.793 ' HG3' ' HB2' ' A' ' 46' ' ' LEU . 2.1 ttp -46.16 -41.06 12.08 Favored 'General case' 0 CA--C 1.46 -2.483 0 C-N-CA 124.346 1.058 . . . . 0.0 110.775 -171.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.718 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 45.8 m-85 -70.07 -42.61 72.59 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.751 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.528 ' HB3' ' CG1' ' A' ' 2' ' ' VAL . . . -61.26 -24.33 66.31 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.436 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 1.119 ' HG2' HD12 ' A' ' 91' ' ' LEU . 16.5 tp10 -89.11 -11.24 44.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.466 177.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.443 ' H ' ' C ' ' A' ' 39' ' ' TYR . 5.0 mm-40 63.8 25.41 14.09 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.048 -176.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.598 ' HA2' H182 ' A' ' 149' ' ' BB2 . . . -80.35 144.53 25.84 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.819 178.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.775 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 51.6 mt -79.92 0.73 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 117.823 0.811 . . . . 0.0 112.062 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.842 ' HA3' ' C10' ' A' ' 149' ' ' BB2 . . . 178.03 140.34 3.77 Favored Glycine 0 CA--C 1.517 0.198 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.026 HD13 ' HG ' ' A' ' 91' ' ' LEU . 7.0 tp -127.4 135.22 50.17 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.855 1.327 . . . . 0.0 109.66 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.47 133.3 49.57 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 122.033 -0.417 . . . . 0.0 111.621 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.845 ' HB1' ' CD1' ' A' ' 53' ' ' ILE . . . -26.82 -57.24 0.09 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 116.113 1.894 . . . . 0.0 116.113 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.823 ' CG2' ' HA ' ' A' ' 137' ' ' LEU . 70.1 p -54.44 -34.87 62.25 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 121.969 0.89 . . . . 0.0 112.199 -178.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.824 ' OE1' HD12 ' A' ' 46' ' ' LEU . 57.4 mt-30 -62.14 -40.0 94.49 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.547 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.967 HG21 ' HG2' ' A' ' 34' ' ' MET . 1.7 m -93.41 18.35 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.89 ' OD2' HD21 ' A' ' 6' ' ' LEU . 6.6 t0 80.13 25.51 0.35 Allowed 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 176.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.845 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -119.18 107.42 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 118.759 -1.176 . . . . 0.0 111.004 178.056 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -75.91 60.58 1.38 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 122.18 0.99 . . . . 0.0 110.642 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.784 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 88.5 mt-30 -147.19 131.64 17.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.945 -1.479 . . . . 0.0 107.058 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.995 ' HA ' HD22 ' A' ' 137' ' ' LEU . 75.9 mtp180 -64.67 75.63 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.742 HD12 HG21 ' A' ' 30' ' ' ILE . 23.0 mt -117.25 125.06 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.956 HD11 ' HB2' ' A' ' 72' ' ' LEU . 1.8 pp -122.65 142.45 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 120.119 -0.632 . . . . 0.0 112.254 -177.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.612 HG12 ' O ' ' A' ' 46' ' ' LEU . 2.5 p -127.79 132.53 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.061 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 1.8 mt -114.65 154.89 15.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.898 0.856 . . . . 0.0 111.985 -177.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.782 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 14.9 t70 -145.12 31.86 1.12 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 113.986 -1.461 . . . . 0.0 110.068 -177.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.72 HG13 ' CD2' ' A' ' 125' ' ' LEU . 48.1 t -89.89 107.03 17.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.652 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.715 ' HA ' ' HG3' ' A' ' 68' ' ' GLU . 80.5 p -55.8 65.75 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -177.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 62' ' ' VAL . 88.6 tt0 -75.81 7.54 3.81 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.324 178.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.48 ' CG ' ' H ' ' A' ' 66' ' ' ARG . 0.7 OUTLIER -163.28 -139.47 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.881 179.255 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.48 ' H ' ' CG ' ' A' ' 65' ' ' ASN . 39.6 mmt180 -75.64 -58.63 3.17 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -115.48 135.5 54.04 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.715 ' HG3' ' HA ' ' A' ' 63' ' ' SER . 2.9 mp0 -79.69 129.81 34.8 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.305 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 68' ' ' GLU . 39.2 ttt85 -179.94 63.77 0.01 OUTLIER 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.912 0.387 . . . . 0.0 111.389 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 1.061 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 55.3 mt -103.37 133.27 48.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.804 0.335 . . . . 0.0 111.678 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.973 HG21 ' HB2' ' A' ' 113' ' ' ARG . 7.1 p -135.86 133.89 51.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.187 177.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.956 ' HB2' HD11 ' A' ' 58' ' ' ILE . 1.7 mm? -140.55 141.82 35.21 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.038 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.6 mp -120.18 132.92 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.798 ' ND2' HG22 ' A' ' 73' ' ' ILE . 59.7 m-20 53.7 37.68 0.44 Allowed Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.863 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 95.0 Cg_exo -57.1 148.29 70.11 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 123.011 2.474 . . . . 0.0 114.129 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.469 ' O ' ' HB ' ' A' ' 108' ' ' ILE . 11.6 pt-20 -135.85 144.61 45.73 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.889 ' HB2' ' HE1' ' A' ' 134' ' ' MET . 44.5 tp -80.04 138.03 36.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.319 0.58 . . . . 0.0 111.98 -178.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.053 HD21 ' HG3' ' A' ' 109' ' ' ARG . 2.8 mm? -112.99 -39.33 4.25 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.971 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.593 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 85.2 tt0 -160.02 145.37 15.22 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 121.269 0.557 . . . . 0.0 111.695 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.968 ' HA ' HG12 ' A' ' 106' ' ' VAL . 10.8 ptpp? -138.52 149.58 45.51 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.482 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.1 p -159.02 149.21 19.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.801 0.334 . . . . 0.0 111.444 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.633 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 76.83 149.55 3.19 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.783 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -117.64 113.68 22.27 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.884 0.849 . . . . 0.0 112.406 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.697 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.7 p -112.08 160.37 17.59 Favored 'General case' 0 CA--C 1.485 -1.52 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.713 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -151.28 118.68 0.93 Allowed Glycine 0 C--N 1.311 -0.852 0 CA-C-N 112.392 -2.186 . . . . 0.0 110.509 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.599 HD13 ' O ' ' A' ' 85' ' ' GLY . 47.8 mm -147.76 139.92 18.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-N 117.383 0.592 . . . . 0.0 111.183 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 50.5 mt-10 -71.19 137.32 48.63 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 123.322 1.534 . . . . 0.0 111.833 -176.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.72 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 42.3 mt-10 -155.15 161.68 41.17 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 112.477 -2.147 . . . . 0.0 111.91 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.884 ' O ' ' H52' ' A' ' 149' ' ' BB2 . . . -121.43 164.3 14.65 Favored Glycine 0 CA--C 1.5 -0.853 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.706 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 5.7 m -118.59 139.02 52.15 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.264 0.554 . . . . 0.0 111.854 -177.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.119 HD12 ' HG2' ' A' ' 41' ' ' GLU . 2.4 mm? -49.64 -26.83 3.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.433 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.86 ' CB ' HG12 ' A' ' 8' ' ' ILE . 57.4 m -78.82 -36.52 42.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.43 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.868 HD13 ' HB ' ' A' ' 8' ' ' ILE . 43.6 mm -85.85 150.1 52.33 Favored Pre-proline 0 N--CA 1.45 -0.425 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.392 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.842 ' HD2' HG23 ' A' ' 93' ' ' ILE . 94.4 Cg_endo -72.4 49.25 1.38 Allowed 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.494 2.129 . . . . 0.0 113.976 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.55 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 40.0 tt0 73.9 15.68 3.82 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.113 0.482 . . . . 0.0 111.984 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.657 ' HG3' ' HG2' ' A' ' 94' ' ' PRO . 84.6 mt-30 -78.53 89.02 4.47 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.807 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 18.8 mtm105 -84.95 132.44 34.36 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.794 0.807 . . . . 0.0 111.817 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -134.48 153.42 51.94 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 114.433 -1.258 . . . . 0.0 109.82 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.713 HD21 ' HA3' ' A' ' 85' ' ' GLY . 6.9 tt -76.12 115.99 16.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.652 0.739 . . . . 0.0 111.146 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.857 ' CG1' HH21 ' A' ' 102' ' ' ARG . 17.3 t -111.0 136.09 20.81 Favored Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.665 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.697 ' HA ' ' O ' ' A' ' 84' ' ' THR . 91.8 Cg_endo -84.23 126.37 3.71 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 122.725 2.283 . . . . 0.0 112.655 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.977 ' HG3' HG23 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -145.6 166.76 24.8 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.102 0.961 . . . . 0.0 109.004 178.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.633 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -67.9 154.07 42.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 118.599 0.636 . . . . 0.0 110.473 -178.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.578 ' OE1' ' HG3' ' A' ' 105' ' ' LYS . 2.7 tm-20 -73.48 -41.26 63.36 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.393 -175.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.791 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 56.6 mttp -139.24 140.43 37.7 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.479 0.657 . . . . 0.0 109.433 177.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.968 HG12 ' HA ' ' A' ' 80' ' ' LYS . 26.1 m -150.14 136.37 12.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.455 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.998 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 46.5 mmtt -107.47 127.49 53.65 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.999 ' HA ' HD23 ' A' ' 78' ' ' LEU . 1.5 pp -135.09 156.54 39.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -176.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 1.053 ' HG3' HD21 ' A' ' 78' ' ' LEU . 92.7 mtt180 -103.3 138.17 40.43 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.502 -178.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.829 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -160.66 170.13 21.44 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.856 -176.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 1.038 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.6 pp -118.76 151.9 37.18 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 176.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.672 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 17.0 t70 -84.7 162.87 19.51 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.668 -176.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.973 ' HB2' HG21 ' A' ' 71' ' ' VAL . 50.7 ttp85 -53.5 -17.71 2.23 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.816 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -79.0 -28.81 43.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.819 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.572 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 109.33 35.49 2.28 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.475 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -128.77 102.8 19.44 Favored Pre-proline 0 C--O 1.236 0.376 0 CA-C-N 116.971 0.386 . . . . 0.0 110.891 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.683 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.7 Cg_exo -72.8 115.64 4.42 Favored 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 121.83 1.687 . . . . 0.0 115.696 -177.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.672 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 12.3 p90 -129.52 167.06 18.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.562 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.741 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 6.2 mp0 -107.35 130.3 54.81 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.924 ' O ' HD23 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -127.31 141.45 51.7 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 121.785 0.802 . . . . 0.0 111.703 -178.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.998 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 11.4 pt-20 -94.13 123.69 37.67 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.998 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.923 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -115.67 135.19 54.3 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.586 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.791 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.2 m-20 -126.94 163.12 24.37 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.788 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 50.55 -139.46 21.94 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 120.218 1.372 . . . . 0.0 115.726 177.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.72 ' CD2' HG13 ' A' ' 62' ' ' VAL . 25.6 tp -54.69 -30.3 55.32 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.38 -0.91 . . . . 0.0 111.643 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.923 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.5 OUTLIER -71.38 -53.32 14.49 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.56 0.695 . . . . 0.0 109.286 179.451 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.831 ' HB1' HG22 ' A' ' 106' ' ' VAL . . . -59.46 -39.77 84.71 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.332 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.977 HG23 ' HG3' ' A' ' 102' ' ' ARG . 45.9 mm -67.0 -54.51 23.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.347 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 1.018 ' HB3' ' H91' ' A' ' 149' ' ' BB2 . 73.0 m -60.61 -50.44 73.51 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.945 HD11 HD11 ' A' ' 108' ' ' ILE . 21.2 tt -58.61 -44.59 89.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.697 0.284 . . . . 0.0 110.961 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.653 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.7 pt20 -65.84 -37.65 86.79 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.606 ' HD2' ' HN1' ' A' ' 149' ' ' BB2 . 75.8 t60 -60.15 -47.12 87.27 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.548 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.849 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 3.0 mm-40 -60.1 -38.03 81.77 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.889 ' HE1' ' HB2' ' A' ' 77' ' ' LEU . 72.4 mtp -58.07 -45.01 87.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 122.344 1.069 . . . . 0.0 109.183 177.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.845 ' OD1' ' HD3' ' A' ' 140' ' ' LYS . 57.0 m-20 -67.76 -48.73 65.56 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.0 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.695 ' CE1' ' HG2' ' A' ' 50' ' ' GLN . 6.4 t-80 -57.71 -52.87 63.66 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.393 0.616 . . . . 0.0 111.648 -178.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.995 HD22 ' HA ' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -64.95 -28.8 69.77 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 119.822 -0.751 . . . . 0.0 111.762 -179.291 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.908 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 11.5 p -81.47 24.16 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 122.08 0.943 . . . . 0.0 109.364 175.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.618 ' O ' ' HA ' ' A' ' 14' ' ' ARG . . . 68.41 -3.63 5.82 Favored Glycine 0 CA--C 1.484 -1.886 0 CA-C-N 113.769 -1.56 . . . . 0.0 113.217 175.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.908 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 11.4 ptmt -87.6 142.25 27.99 Favored 'General case' 0 N--CA 1.408 -2.552 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.796 HD22 ' C ' ' A' ' 140' ' ' LYS . 3.8 mm? -134.9 151.37 50.83 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 120.866 -0.333 . . . . 0.0 110.182 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.717 ' O ' HD23 ' A' ' 146' ' ' LEU . 14.1 p90 -54.39 -37.43 65.02 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.421 ' N ' ' CD1' ' A' ' 142' ' ' PHE . 15.6 tpt -52.31 -26.56 12.42 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.54 0.686 . . . . 0.0 111.003 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -56.57 -21.56 27.4 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.208 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -122.05 4.66 9.85 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -177.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.717 HD23 ' O ' ' A' ' 142' ' ' PHE . 3.9 mm? -86.26 145.55 26.9 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.731 0.3 . . . . 0.0 111.087 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 82.5 p . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.971 179.616 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' BB2 . . . . . 1.018 ' H91' ' HB3' ' A' ' 129' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 48.4 t . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.866 0.365 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 1.007 HG13 HG23 ' A' ' 37' ' ' THR . 40.5 t -88.22 134.04 29.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.119 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 1.042 HD11 ' HB ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -79.1 -143.43 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.34 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.426 ' H ' ' HG ' ' A' ' 3' ' ' LEU . 8.4 tt0 -107.31 104.49 14.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 118.174 0.443 . . . . 0.0 110.363 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.529 ' CG2' HG21 ' A' ' 37' ' ' THR . 44.1 t -87.77 125.11 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 121.557 0.694 . . . . 0.0 111.967 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.032 ' HB2' HD21 ' A' ' 13' ' ' LEU . 20.9 mt -87.63 138.68 31.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.07 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.577 ' C ' HD11 ' A' ' 13' ' ' LEU . 32.7 m-70 -111.69 149.39 31.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.172 0.511 . . . . 0.0 111.91 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.017 HD13 HD12 ' A' ' 13' ' ' LEU . 47.1 mm -57.21 145.41 66.48 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.392 178.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.554 ' HA ' HG23 ' A' ' 8' ' ' ILE . 72.7 Cg_endo -92.68 52.48 1.0 Allowed 'Cis proline' 0 C--N 1.353 0.808 0 C-N-CA 124.597 -1.001 . . . . 0.0 112.872 0.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 1.009 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 9.4 t0 -53.81 134.45 42.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.972 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 23.8 pt-20 -59.23 -45.22 91.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.425 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.676 ' O ' ' HB ' ' A' ' 49' ' ' THR . 28.2 mtt-85 -59.29 -23.78 62.71 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 1.032 HD21 ' HB2' ' A' ' 6' ' ' LEU . 11.2 mt -73.48 -33.06 64.64 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 119.661 1.119 . . . . 0.0 108.393 178.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.698 ' C ' ' HA3' ' A' ' 139' ' ' GLY . 15.0 mmm180 -98.34 11.19 38.81 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.784 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.579 ' HB2' ' HA ' ' A' ' 12' ' ' ARG . 62.3 tttp -87.06 148.05 25.43 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.217 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.951 HG13 HG23 ' A' ' 138' ' ' VAL . 48.9 t -82.41 118.65 30.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.771 ' HB3' HD12 ' A' ' 137' ' ' LEU . . . -78.08 146.5 35.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.272 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -103.83 127.99 28.22 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.603 ' HD3' ' CD ' ' A' ' 56' ' ' ARG . 64.4 Cg_endo -78.24 115.51 3.73 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.206 1.937 . . . . 0.0 110.984 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.9 HG12 ' H ' ' A' ' 22' ' ' GLU . 21.7 t -68.32 144.27 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 CA-C-O 122.717 1.246 . . . . 0.0 113.28 -175.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -67.79 -26.52 66.13 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 112.731 -2.031 . . . . 0.0 112.203 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.9 ' H ' HG12 ' A' ' 20' ' ' VAL . 42.4 tt0 -154.47 145.17 22.39 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.168 -178.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 1.034 HG21 ' HA2' ' A' ' 115' ' ' GLY . 4.6 t -79.6 103.8 6.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -178.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.932 ' CB ' HD13 ' A' ' 27' ' ' ILE . 1.9 m120 -93.19 155.6 17.35 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.701 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.705 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -56.17 -25.92 48.6 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.278 0.561 . . . . 0.0 110.88 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.51 ' HA ' ' OE1' ' A' ' 26' ' ' GLU . 4.2 mm-40 -75.29 -40.45 58.62 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.932 HD13 ' CB ' ' A' ' 24' ' ' ASN . 1.8 mp -66.76 -35.01 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 113.86 -1.518 . . . . 0.0 110.238 178.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -70.39 -38.88 74.75 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 122.208 -0.307 . . . . 0.0 110.715 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.705 ' HG3' ' O ' ' A' ' 25' ' ' ALA . 39.8 mtp85 -64.05 -39.0 93.12 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.784 ' O ' ' HG3' ' A' ' 34' ' ' MET . 3.0 mt -56.88 -49.16 79.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.771 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.915 HG22 ' CG2' ' A' ' 57' ' ' ILE . 9.6 t -67.36 -41.13 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 CA-C-O 121.004 0.43 . . . . 0.0 110.815 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.84 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 21.1 m-20 -54.74 -43.53 72.77 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.351 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.521 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 19.1 m-20 -76.4 -29.3 57.03 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.546 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 1.042 ' HG2' HG21 ' A' ' 51' ' ' VAL . 85.0 mtp -59.87 -46.07 90.46 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.247 -178.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.84 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 13.2 p90 -69.9 -45.24 68.04 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 176.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.758 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 40.3 mt-10 -52.37 -38.52 59.05 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 121.707 0.765 . . . . 0.0 109.291 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 1.007 HG23 HG13 ' A' ' 2' ' ' VAL . 88.6 m -70.35 -61.72 1.66 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.273 -1.331 . . . . 0.0 107.833 177.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.924 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 2.8 ttp -45.77 -40.78 10.01 Favored 'General case' 0 CA--C 1.46 -2.488 0 C-N-CA 124.321 1.048 . . . . 0.0 110.059 -171.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.677 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 18.6 m-85 -70.1 -43.09 71.77 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.097 178.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 37' ' ' THR . . . -60.85 -25.17 66.45 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.75 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 1.057 ' HG2' HD12 ' A' ' 91' ' ' LEU . 17.0 tp10 -88.76 -11.46 44.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.645 -1.161 . . . . 0.0 108.469 176.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.439 ' H ' ' C ' ' A' ' 39' ' ' TYR . 18.2 mt-10 64.31 26.41 13.65 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.943 -176.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.966 ' HA2' H182 ' A' ' 149' ' ' BB2 . . . -81.31 142.67 23.21 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 113.947 -1.479 . . . . 0.0 111.276 178.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.863 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 42.6 mm -79.33 -0.95 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 117.293 0.547 . . . . 0.0 112.208 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.855 ' HA3' H113 ' A' ' 149' ' ' BB2 . . . 179.0 135.27 2.32 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 118.928 -0.929 . . . . 0.0 111.437 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.069 HD13 ' HG ' ' A' ' 91' ' ' LEU . 4.5 tp -125.17 133.96 52.59 Favored 'General case' 0 C--N 1.354 0.783 0 CA-C-N 119.332 1.566 . . . . 0.0 111.64 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.803 ' HB2' ' OE1' ' A' ' 133' ' ' GLU . . . -99.83 131.36 45.85 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 122.184 0.194 . . . . 0.0 111.151 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.867 ' HB1' ' CG1' ' A' ' 53' ' ' ILE . . . -30.38 -54.87 0.19 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.676 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 82.7 p -53.1 -36.21 60.49 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.482 0.658 . . . . 0.0 111.829 -178.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.768 ' OE1' HD12 ' A' ' 46' ' ' LEU . 86.0 mt-30 -63.85 -42.26 97.61 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.998 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.042 HG21 ' HG2' ' A' ' 34' ' ' MET . 0.8 OUTLIER -83.49 16.6 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.875 ' HA ' HD11 ' A' ' 6' ' ' LEU . 37.8 t70 73.79 29.86 1.42 Allowed 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 177.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.867 ' CG1' ' HB1' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -121.25 109.51 25.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 C-N-CA 119.179 -1.009 . . . . 0.0 110.609 177.303 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 21.6 p-80 -76.47 63.6 2.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.378 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.759 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 88.9 mt-30 -153.94 132.47 12.12 Favored 'General case' 0 C--O 1.219 -0.512 0 CA-C-N 114.194 -1.366 . . . . 0.0 107.875 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.68 ' N ' ' HB1' ' A' ' 17' ' ' ALA . 74.7 mtp180 -63.01 69.03 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -177.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.915 ' CG2' HG22 ' A' ' 31' ' ' VAL . 8.1 mm -111.81 123.06 67.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.029 HD11 ' HB2' ' A' ' 72' ' ' LEU . 2.0 pp -128.24 144.36 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 119.698 -0.801 . . . . 0.0 112.977 -177.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 46' ' ' LEU . 33.2 m -127.47 137.64 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.676 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.019 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 2.2 mt -115.59 151.03 17.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.57 0.7 . . . . 0.0 110.972 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.924 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 34.6 t70 -135.2 24.1 3.52 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.858 -178.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.806 HG22 ' CG2' ' A' ' 44' ' ' ILE . 23.5 t -94.82 113.48 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.46 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.499 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 50.7 m -37.56 81.19 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -177.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 62' ' ' VAL . 41.2 tt0 -72.55 -25.2 61.28 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.999 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.419 ' C ' ' H ' ' A' ' 67' ' ' ASP . 9.2 t-20 -165.99 -141.87 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.828 HH11 ' HA ' ' A' ' 66' ' ' ARG . 2.3 mmm180 -83.57 38.48 0.63 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.419 ' H ' ' C ' ' A' ' 65' ' ' ASN . 59.2 m-20 -160.28 126.19 4.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.958 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.499 ' HG2' ' HA ' ' A' ' 63' ' ' SER . 44.5 mt-10 -111.27 61.78 0.61 Allowed 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.011 0.434 . . . . 0.0 112.119 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.63 ' HD3' ' O ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -151.75 96.28 2.22 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.241 0.544 . . . . 0.0 110.528 -179.061 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 1.019 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 7.9 mp -111.52 137.64 49.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.027 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.847 HG21 ' HB2' ' A' ' 113' ' ' ARG . 9.0 p -133.08 132.87 58.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.73 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.029 ' HB2' HD11 ' A' ' 58' ' ' ILE . 3.3 mm? -141.86 143.04 33.16 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 177.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.013 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.9 mp -121.03 136.21 58.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.761 0.315 . . . . 0.0 110.588 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.72 ' ND2' HG22 ' A' ' 73' ' ' ILE . 13.4 p30 45.49 40.23 0.6 Allowed Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 113.826 1.046 . . . . 0.0 113.826 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.776 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 99.2 Cg_exo -56.56 150.96 48.97 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.831 2.354 . . . . 0.0 113.151 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -135.63 143.79 45.73 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.759 HD23 ' N ' ' A' ' 78' ' ' LEU . 1.5 tt -80.57 133.69 35.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.274 0.559 . . . . 0.0 111.723 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.062 HD13 ' HA ' ' A' ' 108' ' ' ILE . 4.8 mp -108.54 -44.78 4.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.207 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.59 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 5.2 tp10 -152.25 146.95 25.81 Favored 'General case' 0 N--CA 1.46 0.065 0 CA-C-O 121.095 0.474 . . . . 0.0 111.325 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.814 ' CB ' HG12 ' A' ' 106' ' ' VAL . 10.9 ptmm? -147.67 145.12 28.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.349 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.3 t -160.14 151.78 19.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.463 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.76 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 80.85 160.42 23.86 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.492 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -137.1 113.37 9.95 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.954 0.883 . . . . 0.0 113.065 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.661 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.5 p -105.59 161.59 14.24 Favored 'General case' 0 CA--C 1.487 -1.468 0 CA-C-N 114.061 -1.427 . . . . 0.0 114.761 178.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.783 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -146.03 114.81 0.77 Allowed Glycine 0 C--N 1.309 -0.928 0 CA-C-N 112.818 -1.992 . . . . 0.0 110.396 177.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.635 HD13 ' O ' ' A' ' 85' ' ' GLY . 49.3 mm -146.9 137.86 18.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-N 117.368 0.584 . . . . 0.0 111.206 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 50.4 mt-10 -71.41 137.23 48.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 123.193 1.473 . . . . 0.0 112.066 -176.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.774 ' HB3' H262 ' A' ' 149' ' ' BB2 . 40.8 mt-10 -154.76 161.62 41.44 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 112.196 -2.275 . . . . 0.0 111.079 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.888 ' O ' ' H52' ' A' ' 149' ' ' BB2 . . . -120.32 163.84 13.98 Favored Glycine 0 CA--C 1.499 -0.937 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.765 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 13.1 m -117.86 140.88 49.08 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 117.729 0.765 . . . . 0.0 111.101 -178.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.069 ' HG ' HD13 ' A' ' 46' ' ' LEU . 2.2 mm? -47.47 -26.65 1.44 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.971 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.883 ' CB ' HD13 ' A' ' 13' ' ' LEU . 54.1 m -79.36 -35.69 40.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.924 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.754 ' CG2' ' HD2' ' A' ' 94' ' ' PRO . 59.0 mt -85.5 149.01 50.81 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.648 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.754 ' HD2' ' CG2' ' A' ' 93' ' ' ILE . 96.7 Cg_endo -73.07 50.53 1.85 Allowed 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 122.38 2.053 . . . . 0.0 113.865 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 94' ' ' PRO . 51.2 mt-10 76.03 13.99 2.62 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.984 0.421 . . . . 0.0 112.009 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.751 ' HB2' HG21 ' A' ' 93' ' ' ILE . 99.1 mm-40 -78.6 88.56 4.52 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.7 ' HG2' ' HA3' ' A' ' 89' ' ' GLY . 15.6 mtt85 -85.18 132.46 34.29 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.649 0.737 . . . . 0.0 111.722 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 87' ' ' GLU . . . -134.73 155.86 49.82 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 114.581 -1.191 . . . . 0.0 109.479 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.783 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.6 tt -76.38 113.8 14.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.666 0.746 . . . . 0.0 111.813 -178.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.997 HG13 ' HB2' ' A' ' 142' ' ' PHE . 40.3 t -104.29 132.25 21.15 Favored Pre-proline 0 N--CA 1.47 0.572 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.939 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.661 ' HA ' ' O ' ' A' ' 84' ' ' THR . 92.2 Cg_endo -84.26 127.45 3.95 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.596 2.197 . . . . 0.0 112.496 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.865 ' HB2' ' OE1' ' A' ' 131' ' ' GLN . 0.0 OUTLIER -144.39 166.98 23.57 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.54 0.736 . . . . 0.0 109.357 178.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.76 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.69 155.62 39.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 118.307 0.503 . . . . 0.0 110.301 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -73.12 -41.32 64.12 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.19 -176.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.699 ' HB3' ' OD1' ' A' ' 123' ' ' ASP . 66.8 mttm -139.67 140.5 36.9 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.467 0.651 . . . . 0.0 109.505 177.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.814 HG12 ' CB ' ' A' ' 80' ' ' LYS . 30.6 m -147.5 136.95 16.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.186 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 1.071 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 52.1 mmtt -107.58 126.02 52.03 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 1.062 ' HA ' HD13 ' A' ' 78' ' ' LEU . 1.7 pp -136.34 151.3 28.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -176.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 1.009 ' HG3' HD11 ' A' ' 78' ' ' LEU . 94.4 mtt180 -102.17 138.89 38.51 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.865 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.875 ' HB3' HD12 ' A' ' 72' ' ' LEU . . . -159.98 168.73 25.0 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.866 -177.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 1.013 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.4 pp -116.42 151.58 35.71 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.473 ' OD1' HG13 ' A' ' 71' ' ' VAL . 17.9 t70 -85.96 164.48 17.39 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.873 -176.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.847 ' HB2' HG21 ' A' ' 71' ' ' VAL . 48.0 ttp180 -52.01 -20.36 2.36 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.016 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -79.12 -25.67 42.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.526 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 1.034 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 105.91 36.28 2.8 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.223 -0.989 . . . . 0.0 113.525 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -128.64 102.82 19.77 Favored Pre-proline 0 C--O 1.237 0.403 0 CA-C-N 116.736 0.268 . . . . 0.0 110.737 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.66 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 32.1 Cg_exo -72.89 115.12 4.23 Favored 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 121.748 1.632 . . . . 0.0 115.389 -177.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.41 ' CE2' ' HB2' ' A' ' 112' ' ' ASP . 0.4 OUTLIER -126.32 167.05 16.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.422 -178.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.639 ' CG ' ' HG2' ' A' ' 109' ' ' ARG . 3.1 mp0 -107.33 130.18 54.81 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.794 HD11 ' CD1' ' A' ' 130' ' ' ILE . 4.4 pp -126.6 133.62 51.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.342 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 1.071 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 15.5 pt-20 -96.32 123.9 40.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.984 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.772 ' O ' ' HB2' ' A' ' 127' ' ' ALA . . . -116.63 136.47 52.94 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.699 ' OD1' ' HB3' ' A' ' 105' ' ' LYS . 41.6 m-20 -127.15 162.71 25.47 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.785 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 51.58 -138.67 28.49 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 120.539 1.518 . . . . 0.0 115.271 177.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.69 HD22 ' H ' ' A' ' 125' ' ' LEU . 2.6 mm? -53.37 -32.4 49.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.899 -0.651 . . . . 0.0 111.401 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.732 HD22 ' CB ' ' A' ' 122' ' ' ALA . 0.6 OUTLIER -70.77 -52.64 19.38 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.847 0.832 . . . . 0.0 109.487 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.772 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -59.73 -39.5 84.95 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.551 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.857 HD12 ' HG2' ' A' ' 102' ' ' ARG . 46.5 mm -68.97 -56.04 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -178.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.849 ' HB2' ' H91' ' A' ' 149' ' ' BB2 . 29.7 p -58.15 -49.93 75.29 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 1.016 HD11 HD11 ' A' ' 108' ' ' ILE . 19.1 tt -59.34 -44.19 91.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.179 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.865 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.0 pt20 -67.79 -39.76 84.01 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.39 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.647 ' HA ' ' OD1' ' A' ' 135' ' ' ASP . 69.0 t60 -57.04 -47.37 81.1 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.568 0.699 . . . . 0.0 109.869 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.912 ' O ' HD23 ' A' ' 137' ' ' LEU . 48.0 mm-40 -61.35 -39.6 91.2 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.272 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.882 ' HA ' HD21 ' A' ' 137' ' ' LEU . 74.6 mtp -58.43 -49.66 76.51 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.476 0.655 . . . . 0.0 111.005 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.771 ' OD2' HD13 ' A' ' 141' ' ' LEU . 5.6 p-10 -65.78 -45.03 83.99 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.756 178.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 1.007 ' HA ' HD21 ' A' ' 141' ' ' LEU . 9.0 t-80 -55.94 -52.53 63.82 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 121.466 -0.771 . . . . 0.0 111.17 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.912 HD23 ' O ' ' A' ' 133' ' ' GLU . 1.3 pp -59.17 -30.97 68.57 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.2 -178.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.951 HG23 HG13 ' A' ' 16' ' ' VAL . 12.7 p -86.07 22.76 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-O 122.264 1.03 . . . . 0.0 109.268 176.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.698 ' HA3' ' C ' ' A' ' 14' ' ' ARG . . . 55.6 37.85 69.22 Favored Glycine 0 CA--C 1.484 -1.9 0 CA-C-N 113.493 -1.685 . . . . 0.0 112.415 176.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.934 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 3.7 ptmt -135.71 106.16 6.45 Favored 'General case' 0 N--CA 1.421 -1.91 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.754 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 1.007 HD21 ' HA ' ' A' ' 136' ' ' HIS . 3.2 mm? -127.39 148.14 50.27 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 120.894 -1.129 . . . . 0.0 109.522 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.997 ' HB2' HG13 ' A' ' 100' ' ' VAL . 6.4 m-85 -62.6 -36.98 84.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.929 0.395 . . . . 0.0 111.47 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 1.026 ' HA ' HD23 ' A' ' 146' ' ' LEU . 15.8 tpt -54.8 -25.07 25.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.696 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.57 ' OD2' ' HD3' ' A' ' 14' ' ' ARG . 8.8 t70 -50.11 -24.95 3.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.501 -178.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -129.62 47.07 2.54 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 120.911 0.386 . . . . 0.0 110.596 -177.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 1.026 HD23 ' HA ' ' A' ' 143' ' ' MET . 3.0 mm? -91.04 138.42 31.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.022 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 80.5 p . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.963 179.719 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' BB2 . . . . . 0.966 H182 ' HA2' ' A' ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 46.0 t . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.869 0.366 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.954 HG13 HG23 ' A' ' 37' ' ' THR . 41.9 t -83.55 131.31 34.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.523 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 1.016 HD11 ' HB ' ' A' ' 51' ' ' VAL . 1.9 pt? -83.1 -148.76 0.09 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.262 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.42 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 8.4 tt0 -102.28 106.34 17.13 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.994 0.426 . . . . 0.0 110.831 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.552 HG11 HD12 ' A' ' 91' ' ' LEU . 45.2 t -88.84 127.63 41.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.372 0.606 . . . . 0.0 111.539 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.959 ' HB2' HD21 ' A' ' 13' ' ' LEU . 24.9 mt -83.9 142.7 30.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.805 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.441 ' N ' ' CD2' ' A' ' 7' ' ' HIS . 5.0 m170 -114.08 145.43 41.62 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.075 0.464 . . . . 0.0 111.911 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.63 HD12 ' H ' ' A' ' 8' ' ' ILE . 2.9 mp -55.8 146.95 44.61 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.883 178.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.583 ' HA ' HG23 ' A' ' 8' ' ' ILE . 74.8 Cg_endo -93.17 52.13 1.06 Allowed 'Cis proline' 0 C--N 1.354 0.838 0 C-N-CA 124.38 -1.092 . . . . 0.0 113.47 0.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.56 133.74 50.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.914 0.388 . . . . 0.0 110.853 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.492 ' CD ' ' H ' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -58.8 -41.09 85.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.59 -179.149 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.613 ' HB2' HD13 ' A' ' 6' ' ' LEU . 42.8 mtt180 -58.18 -25.03 61.05 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.959 HD21 ' HB2' ' A' ' 6' ' ' LEU . 11.3 mt -75.6 -33.14 60.54 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 120.378 1.445 . . . . 0.0 108.425 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.612 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 20.6 mmm-85 -93.29 8.76 39.04 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 113.762 -1.563 . . . . 0.0 109.297 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.484 ' HB2' ' HA ' ' A' ' 12' ' ' ARG . 63.7 tttm -90.36 148.94 22.51 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.748 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.935 HG13 HG23 ' A' ' 138' ' ' VAL . 58.7 t -83.4 124.21 39.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.998 0.428 . . . . 0.0 109.871 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.794 ' HB3' HD12 ' A' ' 137' ' ' LEU . . . -80.8 148.53 29.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.002 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -109.07 130.74 22.37 Favored Pre-proline 0 C--N 1.327 -0.405 0 C-N-CA 121.165 -0.214 . . . . 0.0 110.634 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.873 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 60.8 Cg_endo -79.62 113.89 3.15 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 121.99 1.794 . . . . 0.0 110.821 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.738 HG12 ' H ' ' A' ' 22' ' ' GLU . 16.7 t -68.56 144.92 13.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 122.629 1.204 . . . . 0.0 113.558 -175.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.4 ' N ' HG12 ' A' ' 20' ' ' VAL . 69.9 mm-40 -61.54 -27.38 68.57 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 113.143 -1.844 . . . . 0.0 112.349 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.738 ' H ' HG12 ' A' ' 20' ' ' VAL . 5.0 tp10 -156.76 151.77 26.13 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.789 -178.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.678 HG21 ' HA2' ' A' ' 115' ' ' GLY . 3.2 t -80.38 103.65 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -178.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 1.083 ' H ' HD12 ' A' ' 27' ' ' ILE . 2.2 m120 -85.7 153.26 22.46 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.167 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.576 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -54.69 -31.95 58.72 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.44 0.638 . . . . 0.0 110.085 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.536 ' HG2' ' NH2' ' A' ' 29' ' ' ARG . 49.7 mt-10 -71.52 -38.05 71.13 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 1.083 HD12 ' H ' ' A' ' 24' ' ' ASN . 68.5 mt -65.86 -38.79 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 113.964 -1.471 . . . . 0.0 110.494 178.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -66.94 -40.57 87.62 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.746 -0.206 . . . . 0.0 110.976 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.576 ' HG3' ' O ' ' A' ' 25' ' ' ALA . 83.9 mtm180 -63.88 -38.65 91.88 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.842 ' O ' ' HG3' ' A' ' 34' ' ' MET . 5.0 mt -56.28 -50.77 69.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.496 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.874 HG22 ' CG2' ' A' ' 57' ' ' ILE . 13.7 t -66.19 -41.47 89.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.95 0.405 . . . . 0.0 111.39 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.923 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -56.59 -42.56 78.9 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -179.26 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.493 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 14.8 m-20 -76.29 -30.15 57.66 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.768 176.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.961 ' HE1' HG22 ' A' ' 57' ' ' ILE . 23.0 mtm -60.26 -46.84 88.4 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.297 -177.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.923 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 9.6 p90 -69.58 -43.67 72.36 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.61 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 56.1 mm-40 -52.97 -42.03 65.12 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.954 HG23 HG13 ' A' ' 2' ' ' VAL . 98.9 m -69.51 -61.72 1.67 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 118.722 -1.191 . . . . 0.0 108.104 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.882 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 1.7 ttp -46.38 -40.58 12.26 Favored 'General case' 0 CA--C 1.468 -2.202 0 C-N-CA 124.057 0.943 . . . . 0.0 110.18 -171.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.74 ' OH ' ' HA ' ' A' ' 69' ' ' ARG . 45.2 m-85 -69.95 -41.5 74.47 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.023 177.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 37' ' ' THR . . . -61.93 -23.09 66.14 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.008 -0.997 . . . . 0.0 109.561 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.706 ' HG2' ' CD1' ' A' ' 91' ' ' LEU . 13.8 tp10 -90.16 -11.62 40.61 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.177 -1.374 . . . . 0.0 108.267 177.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.445 ' H ' ' C ' ' A' ' 39' ' ' TYR . 22.1 mt-10 63.68 28.75 15.03 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.762 -176.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.916 ' HA3' H173 ' A' ' 149' ' ' BB2 . . . -84.78 141.83 19.7 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 113.683 -1.599 . . . . 0.0 110.691 178.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.797 HG23 ' O ' ' A' ' 61' ' ' ASP . 47.2 mt -79.43 2.18 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 117.859 0.829 . . . . 0.0 111.919 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.829 ' HA3' ' C11' ' A' ' 149' ' ' BB2 . . . 177.25 133.57 1.85 Allowed Glycine 0 CA--C 1.523 0.539 0 CA-C-O 119.06 -0.856 . . . . 0.0 112.043 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.098 HD12 ' HG ' ' A' ' 91' ' ' LEU . 8.8 tt -126.62 135.36 51.11 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 119.116 1.458 . . . . 0.0 110.967 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.655 ' N ' HD23 ' A' ' 46' ' ' LEU . . . -97.99 134.6 40.87 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.867 ' HB1' ' CG1' ' A' ' 53' ' ' ILE . . . -31.01 -55.05 0.22 Allowed 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.962 1.468 . . . . 0.0 114.962 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.537 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 81.3 p -53.09 -36.26 60.5 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.523 0.677 . . . . 0.0 112.361 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.654 ' NE2' ' HB3' ' A' ' 90' ' ' CYS . 47.1 mt-30 -63.93 -40.77 97.24 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.486 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.016 ' HB ' HD11 ' A' ' 3' ' ' LEU . 1.2 m -85.63 17.3 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.607 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.911 ' HA ' HD11 ' A' ' 6' ' ' LEU . 50.8 t0 77.89 26.6 0.61 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 176.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.867 ' CG1' ' HB1' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -121.35 109.84 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 C-N-CA 118.985 -1.086 . . . . 0.0 111.243 177.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.481 ' HD2' ' CZ ' ' A' ' 12' ' ' ARG . 6.8 p80 -76.46 59.47 1.47 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.791 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.722 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 7.1 mp0 -148.75 134.05 18.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.449 -1.251 . . . . 0.0 108.075 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.873 ' HD2' ' HD3' ' A' ' 19' ' ' PRO . 68.0 mtt-85 -63.13 68.65 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -177.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.961 HG22 ' HE1' ' A' ' 34' ' ' MET . 7.4 mm -112.77 122.84 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.038 HD11 ' HB2' ' A' ' 72' ' ' LEU . 2.2 pp -126.24 148.03 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -177.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.621 HG22 ' O ' ' A' ' 46' ' ' LEU . 32.6 m -129.06 138.49 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.212 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.075 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 10.9 mm -115.77 151.95 17.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-O 121.483 0.659 . . . . 0.0 109.859 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.882 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 10.0 t70 -139.78 43.31 1.97 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.821 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.979 HG12 ' H ' ' A' ' 63' ' ' SER . 13.9 t -89.61 -167.25 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.129 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.979 ' H ' HG12 ' A' ' 62' ' ' VAL . 53.1 m -94.87 89.8 5.78 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 119.687 -0.197 . . . . 0.0 110.748 177.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.635 ' HB2' HD11 ' A' ' 70' ' ' LEU . 5.2 tp10 -60.96 -36.26 78.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.243 0.544 . . . . 0.0 110.051 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -161.99 -66.16 0.05 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.093 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -130.99 -36.75 1.32 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.066 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -113.06 127.49 56.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.473 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.593 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 42.2 mt-10 -72.93 134.91 44.95 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.951 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.74 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 71.7 ttt180 173.65 69.2 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 1.075 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 9.4 mp -108.56 137.1 47.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.695 0.283 . . . . 0.0 111.656 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.794 ' C ' HD22 ' A' ' 72' ' ' LEU . 14.6 p -135.57 135.96 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.038 ' HB2' HD11 ' A' ' 58' ' ' ILE . 3.0 mm? -143.91 147.29 33.79 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.539 -0.171 . . . . 0.0 110.539 177.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.064 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.7 mp -122.11 136.5 58.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.564 0.221 . . . . 0.0 110.419 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.713 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 8.2 m120 50.38 37.98 0.47 Allowed Pre-proline 0 CA--C 1.55 0.96 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.869 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 79.6 Cg_exo -58.23 147.48 83.92 Favored 'Trans proline' 0 N--CA 1.486 1.085 0 C-N-CA 123.137 2.558 . . . . 0.0 114.844 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.433 ' O ' ' HB ' ' A' ' 108' ' ' ILE . 11.8 pt-20 -136.37 140.51 43.3 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.907 ' HA ' HG22 ' A' ' 108' ' ' ILE . 1.7 tt -81.95 134.51 35.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.177 0.513 . . . . 0.0 111.267 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.039 HD13 ' HA ' ' A' ' 108' ' ' ILE . 5.9 mp -109.57 -43.76 4.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.13 -178.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 39.3 tt0 -147.54 149.73 33.17 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.05 0.452 . . . . 0.0 111.611 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.968 ' HA ' HG12 ' A' ' 106' ' ' VAL . 9.2 ptpp? -147.6 143.86 28.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.83 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.6 p -155.4 147.22 23.28 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.786 0.327 . . . . 0.0 111.257 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.742 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 81.22 147.82 5.79 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.114 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -115.57 114.29 24.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.724 0.773 . . . . 0.0 112.542 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.769 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.7 p -116.51 161.14 19.59 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 115.505 1.669 . . . . 0.0 115.505 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.829 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -150.09 119.17 1.0 Allowed Glycine 0 C--N 1.312 -0.764 0 CA-C-N 112.363 -2.198 . . . . 0.0 111.499 178.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.638 HD13 ' O ' ' A' ' 85' ' ' GLY . 49.5 mm -146.45 136.44 17.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 117.278 0.539 . . . . 0.0 111.373 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 50.2 mt-10 -72.47 141.23 48.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 122.841 1.305 . . . . 0.0 112.657 -176.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.681 ' HG2' ' O27' ' A' ' 149' ' ' BB2 . 55.2 mt-10 -153.71 163.97 39.1 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 112.713 -2.039 . . . . 0.0 111.538 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.736 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -120.36 168.59 13.88 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.796 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 90.3 m -114.12 140.02 48.84 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.215 -0.594 . . . . 0.0 112.03 -177.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.098 ' HG ' HD12 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -53.87 -16.65 1.91 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.845 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.563 ' CB ' HD13 ' A' ' 13' ' ' LEU . 22.0 m -102.96 -31.55 10.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.507 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.85 HD13 ' HE3' ' A' ' 143' ' ' MET . 48.0 mt -85.17 151.06 56.32 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.332 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.771 ' HD2' ' CG2' ' A' ' 93' ' ' ILE . 68.3 Cg_endo -63.05 -148.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.21 1.94 . . . . 0.0 111.349 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.43 ' H ' ' HB2' ' A' ' 94' ' ' PRO . 95.2 mt-10 -78.4 12.43 1.96 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.145 0.498 . . . . 0.0 110.815 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.571 ' HG3' ' HG2' ' A' ' 94' ' ' PRO . 85.1 mt-30 -78.93 81.49 5.2 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.213 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.736 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 55.5 mtm-85 -86.8 133.73 33.62 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.109 0.481 . . . . 0.0 109.931 178.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -125.06 146.03 49.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.054 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.829 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.3 tt -76.1 113.69 13.91 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.847 0.832 . . . . 0.0 110.779 -178.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.902 HG13 ' CG ' ' A' ' 142' ' ' PHE . 48.8 t -101.82 128.79 27.96 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.706 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.957 ' HD2' ' CD2' ' A' ' 142' ' ' PHE . 87.6 Cg_endo -83.0 126.13 4.32 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.163 1.908 . . . . 0.0 111.57 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.811 HH21 ' CG1' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -144.11 166.71 24.23 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.378 179.432 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.742 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.05 155.09 40.28 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.881 0.372 . . . . 0.0 110.461 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -72.26 -40.89 67.33 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.475 -175.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.732 ' HB3' ' OD1' ' A' ' 123' ' ' ASP . 67.1 mttm -140.42 140.22 35.41 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.395 0.617 . . . . 0.0 109.507 176.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.968 HG12 ' HA ' ' A' ' 80' ' ' LYS . 25.3 m -150.42 141.37 16.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.417 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.957 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 23.7 mmtp -108.0 126.48 52.77 Favored 'General case' 0 C--O 1.227 -0.093 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 1.039 ' HA ' HD13 ' A' ' 78' ' ' LEU . 1.8 pp -135.36 152.9 32.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -176.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 1.027 ' HG3' HD11 ' A' ' 78' ' ' LEU . 44.2 mtm180 -103.45 140.73 37.09 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.926 0.87 . . . . 0.0 111.507 -178.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.733 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -161.14 169.51 22.18 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.483 -177.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 1.064 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 1.9 pp -116.64 149.76 39.22 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 176.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.809 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 23.1 t70 -84.41 163.66 19.36 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.587 -176.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.764 ' HD2' ' OD1' ' A' ' 32' ' ' ASP . 14.5 ttp-105 -53.48 -17.24 1.85 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.865 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -79.13 -28.35 42.9 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.948 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.678 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 107.63 35.8 2.55 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.622 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -128.82 103.25 19.1 Favored Pre-proline 0 C--O 1.237 0.43 0 CA-C-N 116.699 0.25 . . . . 0.0 110.705 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.692 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 32.7 Cg_exo -71.99 114.51 3.99 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 121.34 1.36 . . . . 0.0 114.619 -177.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.809 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 10.2 p90 -127.16 168.6 14.45 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.484 -178.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.669 ' HG2' ' HD2' ' A' ' 109' ' ' ARG . 29.8 mt-10 -107.03 129.72 54.76 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.723 ' O ' HD12 ' A' ' 120' ' ' LEU . 4.3 pp -123.45 132.63 53.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.434 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.957 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 9.0 pm0 -92.54 123.38 35.8 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.54 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.808 ' O ' ' HB2' ' A' ' 127' ' ' ALA . . . -117.05 133.54 55.87 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 120.47 -0.492 . . . . 0.0 112.134 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.732 ' OD1' ' HB3' ' A' ' 105' ' ' LYS . 29.4 m-20 -127.81 160.73 30.86 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.663 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 54.9 -138.09 42.7 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 120.952 1.705 . . . . 0.0 114.779 177.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.679 HD12 ' H ' ' A' ' 125' ' ' LEU . 4.7 mp -54.24 -32.29 55.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.2 -0.5 . . . . 0.0 111.333 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.747 HD22 ' CB ' ' A' ' 122' ' ' ALA . 0.6 OUTLIER -70.72 -51.79 25.15 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.394 0.616 . . . . 0.0 109.676 179.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.808 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -61.67 -46.76 88.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.949 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.778 HG23 ' CG ' ' A' ' 102' ' ' ARG . 47.3 mm -64.43 -55.67 20.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -177.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 1.066 ' HB3' H112 ' A' ' 149' ' ' BB2 . 78.0 m -58.56 -48.08 82.1 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.912 HD11 HD11 ' A' ' 108' ' ' ILE . 20.2 tt -59.35 -41.86 85.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.157 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.798 ' CG ' HG21 ' A' ' 106' ' ' VAL . 70.5 mt-30 -64.86 -38.51 91.22 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.761 0.315 . . . . 0.0 110.185 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.963 ' HD2' ' H81' ' A' ' 149' ' ' BB2 . 79.6 t60 -58.7 -45.54 89.27 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.295 0.569 . . . . 0.0 110.401 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.916 ' O ' HD23 ' A' ' 137' ' ' LEU . 4.5 mm-40 -60.72 -43.2 98.15 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.732 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.917 ' HA ' HD21 ' A' ' 137' ' ' LEU . 70.2 mtp -57.85 -48.55 79.47 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.374 0.607 . . . . 0.0 110.934 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.754 ' OD2' ' HA ' ' A' ' 132' ' ' HIS . 2.5 p30 -65.14 -46.32 81.4 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.114 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.894 ' CG ' HD11 ' A' ' 141' ' ' LEU . 11.7 t-80 -58.95 -51.69 68.95 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 121.698 -0.626 . . . . 0.0 111.527 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.917 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.4 pp -60.12 -31.42 70.04 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.952 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.979 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 14.2 p -82.98 25.49 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-O 122.487 1.136 . . . . 0.0 109.825 177.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.648 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 60.13 6.49 5.64 Favored Glycine 0 CA--C 1.487 -1.682 0 CA-C-N 113.082 -1.872 . . . . 0.0 113.382 176.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.979 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 14.3 ptmt -93.77 137.23 33.23 Favored 'General case' 0 N--CA 1.413 -2.297 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.894 HD11 ' CG ' ' A' ' 136' ' ' HIS . 3.1 mm? -141.37 141.51 33.81 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.957 ' CD2' ' HD2' ' A' ' 101' ' ' PRO . 6.2 m-85 -62.86 -30.12 71.27 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.85 ' HE3' HD13 ' A' ' 93' ' ' ILE . 48.9 ttm -56.5 -29.0 61.29 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.442 0.639 . . . . 0.0 110.198 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -60.66 -22.54 63.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.689 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -116.63 13.55 15.26 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.051 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.455 ' HG ' ' HA ' ' A' ' 143' ' ' MET . 85.9 mt -90.56 143.05 27.12 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.643 0.259 . . . . 0.0 110.833 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 86.9 p . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.929 179.807 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' BB2 . . . . . 1.066 H112 ' HB3' ' A' ' 129' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 53.3 m . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.839 0.352 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 1.037 HG12 ' HA ' ' A' ' 37' ' ' THR . 30.9 m -84.14 132.8 30.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.987 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.787 HD13 ' OG1' ' A' ' 37' ' ' THR . 0.0 OUTLIER -85.28 -172.8 4.35 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.605 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.739 ' H ' ' NE2' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -79.88 111.09 15.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.28 0.562 . . . . 0.0 110.993 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.627 ' CG2' HG21 ' A' ' 37' ' ' THR . 39.0 t -89.52 131.4 36.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.975 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.057 ' HB2' HD21 ' A' ' 13' ' ' LEU . 30.5 mt -86.81 147.5 25.8 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.556 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.522 ' C ' HD11 ' A' ' 13' ' ' LEU . 3.2 m80 -122.74 144.34 49.23 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.01 HD13 HD12 ' A' ' 13' ' ' LEU . 35.5 mm -67.44 135.88 93.17 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.526 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -78.92 144.5 73.88 Favored 'Cis proline' 0 C--N 1.352 0.736 0 C-N-CA 124.614 -0.994 . . . . 0.0 111.551 -0.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 1.004 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 9.1 t0 -164.0 129.14 2.87 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.404 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.462 ' HG2' ' N ' ' A' ' 12' ' ' ARG . 0.6 OUTLIER -58.08 -45.43 87.15 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.526 -178.769 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.623 ' HB2' HD13 ' A' ' 6' ' ' LEU . 23.2 mmt-85 -58.29 -28.41 64.97 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 1.057 HD21 ' HB2' ' A' ' 6' ' ' LEU . 9.7 mt -77.4 -32.13 54.59 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 120.613 1.551 . . . . 0.0 108.306 177.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.84 ' HD3' ' OD1' ' A' ' 144' ' ' ASP . 14.6 mmm180 -93.38 11.76 27.19 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 114.105 -1.407 . . . . 0.0 109.13 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.488 ' HB2' ' HA ' ' A' ' 12' ' ' ARG . 59.5 tptt -89.86 147.93 23.47 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.678 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.94 HG13 HG23 ' A' ' 138' ' ' VAL . 74.6 t -82.56 128.9 38.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.758 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -86.97 142.63 27.82 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.584 ' NZ ' ' HB2' ' A' ' 18' ' ' LYS . 4.7 ttmp? -105.57 129.8 24.09 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.854 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 56.8 Cg_endo -81.45 112.94 2.54 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 121.653 1.568 . . . . 0.0 110.812 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.698 HG12 ' H ' ' A' ' 22' ' ' GLU . 15.9 t -69.66 144.66 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 CA-C-O 122.552 1.168 . . . . 0.0 113.213 -175.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -61.07 -23.41 65.45 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 113.019 -1.9 . . . . 0.0 112.438 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.698 ' H ' HG12 ' A' ' 20' ' ' VAL . 42.8 tt0 -161.18 139.85 9.89 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.183 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.481 HG21 ' CD1' ' A' ' 111' ' ' LEU . 2.6 t -79.43 118.88 27.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.839 ' H ' HD12 ' A' ' 27' ' ' ILE . 50.3 m-80 -104.27 -176.66 3.14 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.894 -0.504 . . . . 0.0 110.655 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.698 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -68.79 -25.41 64.69 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.456 0.646 . . . . 0.0 110.48 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.504 ' HA ' ' OE1' ' A' ' 26' ' ' GLU . 4.3 mm-40 -75.12 -43.19 54.15 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.839 HD12 ' H ' ' A' ' 24' ' ' ASN . 54.2 mt -65.04 -40.1 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 114.086 -1.416 . . . . 0.0 110.695 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.834 ' HG2' ' O ' ' A' ' 24' ' ' ASN . 1.6 mm100 -64.96 -40.8 95.56 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 122.431 -0.168 . . . . 0.0 111.064 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.698 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 26.5 mmm180 -61.86 -38.73 89.36 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.784 ' O ' ' HG3' ' A' ' 34' ' ' MET . 4.2 mt -57.76 -49.22 81.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.829 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.869 HG22 ' CG2' ' A' ' 57' ' ' ILE . 25.3 t -67.97 -41.72 84.88 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 CA-C-O 120.919 0.39 . . . . 0.0 111.339 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.884 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 27.9 m-20 -53.74 -45.97 70.72 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.121 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.502 ' OD1' HD12 ' A' ' 3' ' ' LEU . 3.0 p30 -74.57 -29.63 61.42 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.137 176.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.939 ' HG2' HG21 ' A' ' 51' ' ' VAL . 82.6 mtp -61.12 -46.93 88.57 Favored 'General case' 0 C--N 1.346 0.434 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.851 -178.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.884 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 22.5 p90 -70.82 -47.85 57.24 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.622 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 30.4 mm-40 -50.83 -41.59 57.69 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 1.037 ' HA ' HG12 ' A' ' 2' ' ' VAL . 48.4 m -70.34 -60.28 2.37 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.201 -1.363 . . . . 0.0 108.907 177.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.819 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 1.2 ttp -47.13 -39.72 14.08 Favored 'General case' 0 CA--C 1.464 -2.33 0 C-N-CA 124.046 0.939 . . . . 0.0 110.401 -171.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.664 ' OH ' ' HA ' ' A' ' 69' ' ' ARG . 68.2 m-85 -70.72 -42.1 71.02 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.146 177.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.565 ' CB ' HG11 ' A' ' 2' ' ' VAL . . . -60.95 -25.28 66.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.371 -0.831 . . . . 0.0 108.987 178.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.821 ' HG2' HD12 ' A' ' 91' ' ' LEU . 11.4 tp10 -87.02 -10.72 52.4 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 114.303 -1.317 . . . . 0.0 108.669 176.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.44 ' H ' ' C ' ' A' ' 39' ' ' TYR . 4.9 mm-40 63.76 23.62 13.52 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.21 -176.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.72 ' HA2' H182 ' A' ' 149' ' ' BB2 . . . -78.6 140.79 23.88 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.324 177.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.817 HG22 HG22 ' A' ' 62' ' ' VAL . 43.2 mm -78.67 -0.8 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 117.464 0.632 . . . . 0.0 111.756 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.897 ' HA3' ' C10' ' A' ' 149' ' ' BB2 . . . 177.91 136.05 2.42 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 118.68 -1.067 . . . . 0.0 110.872 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.813 ' HB2' ' HG3' ' A' ' 38' ' ' MET . 8.9 tt -127.98 135.37 49.83 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-N 119.714 1.757 . . . . 0.0 111.03 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.606 ' N ' HD23 ' A' ' 46' ' ' LEU . . . -97.43 134.16 41.06 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.881 ' HB1' ' CG1' ' A' ' 53' ' ' ILE . . . -31.11 -53.68 0.21 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.552 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 57.0 p -53.36 -35.32 60.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.77 0.795 . . . . 0.0 111.268 -178.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.751 ' OE1' HD23 ' A' ' 91' ' ' LEU . 74.8 mt-30 -64.22 -41.84 96.85 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.175 -1.375 . . . . 0.0 109.813 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.939 HG21 ' HG2' ' A' ' 34' ' ' MET . 0.9 OUTLIER -84.8 16.27 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-O 121.195 0.521 . . . . 0.0 112.132 179.763 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.846 ' HA ' HD11 ' A' ' 6' ' ' LEU . 50.5 t0 75.36 30.04 0.87 Allowed 'General case' 0 C--O 1.233 0.185 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 176.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.881 ' CG1' ' HB1' ' A' ' 48' ' ' ALA . 1.1 pp -123.54 111.41 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 C-N-CA 119.228 -0.989 . . . . 0.0 110.898 177.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.9 p-80 -76.3 62.68 1.82 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.992 0.901 . . . . 0.0 110.586 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.752 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 89.6 mt-30 -151.94 134.83 15.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.25 -1.341 . . . . 0.0 107.691 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.869 ' HG2' ' CD1' ' A' ' 137' ' ' LEU . 65.0 mtt-85 -64.26 70.74 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.869 ' CG2' HG22 ' A' ' 31' ' ' VAL . 9.1 mm -112.09 122.74 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.08 HD11 ' HB2' ' A' ' 72' ' ' LEU . 1.8 pp -126.17 144.34 36.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 119.836 -0.746 . . . . 0.0 112.913 -177.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.717 HG22 ' O ' ' A' ' 46' ' ' LEU . 33.5 m -127.22 137.12 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.067 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 6.1 mm -114.73 149.99 16.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.748 0.785 . . . . 0.0 109.555 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.819 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 58.5 t0 -137.35 27.84 2.81 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.442 -178.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.817 HG22 HG22 ' A' ' 44' ' ' ILE . 28.7 t -96.38 111.8 27.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.253 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.692 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 80.4 p -38.05 80.5 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -177.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.628 ' HB2' HD11 ' A' ' 70' ' ' LEU . 39.4 tt0 -70.29 -18.44 63.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.431 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.659 ' OD1' ' HG3' ' A' ' 66' ' ' ARG . 11.4 t-20 -164.64 -132.99 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.802 178.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.659 ' HG3' ' OD1' ' A' ' 65' ' ' ASN . 82.3 mtm180 -74.93 -57.49 3.87 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.86 0.362 . . . . 0.0 111.129 -178.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -95.75 125.97 40.69 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.98 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.692 ' HG2' ' HA ' ' A' ' 63' ' ' SER . 55.8 mt-10 -81.68 125.75 30.96 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.224 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.664 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 32.2 ttm180 170.67 76.08 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.981 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 1.067 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 61.2 mt -102.48 132.35 48.58 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-O 120.834 0.349 . . . . 0.0 111.557 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.866 ' O ' HD12 ' A' ' 72' ' ' LEU . 8.6 p -135.03 134.22 53.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.544 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.08 ' HB2' HD11 ' A' ' 58' ' ' ILE . 10.4 mp -140.6 142.45 35.05 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.047 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.7 mp -119.97 133.04 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-O 120.678 0.275 . . . . 0.0 110.413 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.792 ' ND2' HG22 ' A' ' 73' ' ' ILE . 66.8 m-20 54.2 37.14 0.39 Allowed Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.936 ' HG2' HG12 ' A' ' 58' ' ' ILE . 97.0 Cg_exo -56.65 150.17 54.43 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 C-N-CA 123.032 2.488 . . . . 0.0 114.016 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.656 ' OE2' ' HD2' ' A' ' 109' ' ' ARG . 23.0 pt-20 -138.45 143.12 39.51 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.815 ' HB2' ' HE3' ' A' ' 134' ' ' MET . 1.6 tt -80.24 135.19 36.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.434 0.635 . . . . 0.0 111.958 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.086 HD11 ' HG3' ' A' ' 109' ' ' ARG . 5.2 mp -109.75 -40.4 4.82 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.283 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 85.2 tt0 -156.05 154.62 31.29 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.277 0.561 . . . . 0.0 111.802 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.888 ' HA ' HG12 ' A' ' 106' ' ' VAL . 9.1 ptpp? -147.56 151.07 35.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.231 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 46.4 t -160.33 147.07 15.77 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.697 0.284 . . . . 0.0 111.318 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.661 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 75.16 161.71 9.42 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.571 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -135.76 113.29 10.8 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.867 0.841 . . . . 0.0 112.972 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.863 ' HB ' HH12 ' A' ' 102' ' ' ARG . 1.6 p -105.68 162.37 13.58 Favored 'General case' 0 CA--C 1.489 -1.402 0 N-CA-C 115.011 1.486 . . . . 0.0 115.011 178.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.699 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -148.98 118.47 0.96 Allowed Glycine 0 C--N 1.314 -0.677 0 CA-C-N 113.035 -1.893 . . . . 0.0 110.866 178.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.757 ' HB ' ' NH2' ' A' ' 102' ' ' ARG . 47.2 mm -148.19 140.28 18.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 117.472 0.636 . . . . 0.0 111.602 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 55.7 mp0 -71.24 135.37 47.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 123.365 1.555 . . . . 0.0 112.368 -176.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.795 ' HB3' H262 ' A' ' 149' ' ' BB2 . 80.2 mt-10 -152.26 161.34 42.76 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 112.324 -2.216 . . . . 0.0 112.039 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.923 ' O ' ' H52' ' A' ' 149' ' ' BB2 . . . -121.16 164.13 14.46 Favored Glycine 0 CA--C 1.501 -0.811 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.822 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 22.4 m -113.39 141.23 47.31 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.594 0.712 . . . . 0.0 112.656 -177.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.904 HD13 H171 ' A' ' 149' ' ' BB2 . 2.2 mm? -50.27 -26.98 5.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.818 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.848 ' CB ' HD13 ' A' ' 13' ' ' LEU . 61.2 m -85.3 -31.59 22.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.299 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.721 ' CG2' ' HD2' ' A' ' 94' ' ' PRO . 58.7 mt -85.28 148.22 49.36 Favored Pre-proline 0 N--CA 1.448 -0.537 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.188 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.721 ' HD2' ' CG2' ' A' ' 93' ' ' ILE . 64.2 Cg_endo -76.46 49.75 2.74 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.392 2.061 . . . . 0.0 114.901 -178.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.591 ' HB2' ' O ' ' A' ' 94' ' ' PRO . 0.3 OUTLIER 77.63 12.13 2.02 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 178.514 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.508 ' HG3' ' HG2' ' A' ' 94' ' ' PRO . 83.2 mt-30 -78.98 87.78 4.78 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 178.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.778 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 52.7 mtm-85 -85.64 132.88 34.08 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.787 0.803 . . . . 0.0 112.282 -178.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.619 ' HB3' ' HE2' ' A' ' 143' ' ' MET . . . -133.88 154.73 50.85 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.423 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.699 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.8 tt -76.56 112.27 12.93 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.85 0.834 . . . . 0.0 112.181 -177.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.783 HG23 ' HB2' ' A' ' 142' ' ' PHE . 11.1 p -99.86 133.12 21.91 Favored Pre-proline 0 N--CA 1.469 0.477 0 CA-C-N 114.593 -1.185 . . . . 0.0 112.372 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.549 ' HD2' ' CD2' ' A' ' 142' ' ' PHE . 96.6 Cg_endo -87.22 126.45 2.34 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 122.635 2.224 . . . . 0.0 112.485 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.876 ' HG2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -145.53 167.71 22.36 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.001 0.92 . . . . 0.0 110.259 179.83 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.661 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.44 155.85 39.04 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.804 0.335 . . . . 0.0 110.15 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -73.35 -42.0 62.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.936 -176.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.668 ' HB3' ' OD1' ' A' ' 123' ' ' ASP . 59.7 mttp -140.63 141.04 35.13 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.376 0.607 . . . . 0.0 110.155 177.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.888 HG12 ' HA ' ' A' ' 80' ' ' LYS . 22.4 m -149.25 138.84 15.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.346 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.992 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 20.1 mmtp -108.21 126.46 52.83 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 1.046 ' HA ' HD13 ' A' ' 78' ' ' LEU . 1.4 pp -135.89 154.75 34.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -176.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 1.086 ' HG3' HD11 ' A' ' 78' ' ' LEU . 92.6 mtt180 -101.41 137.98 39.03 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.319 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.688 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -159.34 169.36 24.18 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.504 -1.225 . . . . 0.0 111.093 -177.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 1.047 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.7 pp -118.94 154.75 32.5 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 177.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.55 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 19.5 t70 -89.09 162.59 15.89 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.197 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.738 ' HB2' HG21 ' A' ' 71' ' ' VAL . 13.1 ttp-105 -54.44 -15.32 1.62 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.832 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -78.95 -29.48 44.01 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.727 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 109.23 34.1 2.6 Favored Glycine 0 C--N 1.34 0.797 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.886 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -128.72 102.86 19.54 Favored Pre-proline 0 C--O 1.237 0.432 0 CA-C-N 116.764 0.282 . . . . 0.0 111.166 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.685 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 33.1 Cg_exo -73.26 116.81 4.84 Favored 'Trans proline' 0 C--N 1.36 1.169 0 C-N-CA 122.015 1.81 . . . . 0.0 115.094 -178.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.55 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 12.6 p90 -128.4 166.48 18.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.568 -178.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.764 ' HG2' ' HG2' ' A' ' 109' ' ' ARG . 22.4 mt-10 -107.73 131.96 53.88 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.871 ' O ' HD23 ' A' ' 120' ' ' LEU . 0.3 OUTLIER -129.64 141.84 50.85 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.663 0.744 . . . . 0.0 111.742 -179.465 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.992 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 11.3 pt-20 -95.19 123.43 38.69 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.536 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.927 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -115.82 134.87 54.56 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.958 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.668 ' OD1' ' HB3' ' A' ' 105' ' ' LYS . 37.7 m-20 -126.44 162.22 26.1 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.797 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 48.4 -132.9 20.48 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-N 119.85 1.205 . . . . 0.0 115.705 177.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 80.9 mt -54.7 -35.74 63.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.74 -0.73 . . . . 0.0 111.774 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.927 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -70.72 -52.03 23.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.799 0.809 . . . . 0.0 109.225 179.854 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.756 ' HB2' ' C ' ' A' ' 122' ' ' ALA . . . -58.65 -40.25 82.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.346 -1.297 . . . . 0.0 111.691 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.876 HD12 ' HG2' ' A' ' 102' ' ' ARG . 50.8 mm -68.41 -55.89 14.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.879 -178.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.841 ' HB2' ' C9 ' ' A' ' 149' ' ' BB2 . 29.4 p -57.88 -50.48 73.17 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.992 HD11 HD11 ' A' ' 108' ' ' ILE . 19.4 tt -59.04 -43.69 89.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.957 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.811 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 21.9 pt20 -68.41 -40.04 81.41 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.627 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.655 ' CD2' ' HN1' ' A' ' 149' ' ' BB2 . 67.8 t60 -59.27 -47.44 85.34 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.077 0.465 . . . . 0.0 109.776 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.88 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.5 mm-40 -58.63 -42.68 88.83 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.512 -179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.975 ' HA ' HD21 ' A' ' 137' ' ' LEU . 30.2 mtm -57.21 -47.3 81.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.634 0.73 . . . . 0.0 110.16 178.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.678 ' O ' HG12 ' A' ' 138' ' ' VAL . 31.9 m-20 -62.77 -48.31 79.71 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.095 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 1.005 ' CE1' HD21 ' A' ' 141' ' ' LEU . 8.4 t-80 -58.16 -52.93 63.52 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.271 0.557 . . . . 0.0 111.376 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.975 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.6 pp -58.67 -31.52 68.26 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.701 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.944 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 12.9 p -85.54 25.09 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-O 122.187 0.994 . . . . 0.0 109.83 176.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.515 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 55.91 30.67 57.41 Favored Glycine 0 CA--C 1.485 -1.843 0 CA-C-N 113.578 -1.646 . . . . 0.0 112.942 176.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.944 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 5.8 ptmt -127.54 109.99 12.28 Favored 'General case' 0 N--CA 1.424 -1.763 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.303 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 1.005 HD21 ' CE1' ' A' ' 136' ' ' HIS . 5.4 mp -127.22 144.76 50.97 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 120.772 -1.205 . . . . 0.0 108.284 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.783 ' HB2' HG23 ' A' ' 100' ' ' VAL . 18.2 m-85 -62.47 -33.16 74.29 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.286 0.494 . . . . 0.0 111.798 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.796 ' HA ' HD13 ' A' ' 146' ' ' LEU . 45.1 tpp -60.18 -27.06 66.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.33 0.586 . . . . 0.0 111.075 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.84 ' OD1' ' HD3' ' A' ' 14' ' ' ARG . 32.6 m-20 -52.6 -26.61 13.98 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.694 -178.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -127.99 43.65 3.09 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 121.218 -0.193 . . . . 0.0 110.786 -177.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.796 HD13 ' HA ' ' A' ' 143' ' ' MET . 4.8 mp -92.63 142.07 27.78 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.17 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 48.0 t . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.917 179.548 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' BB2 . . . . . 0.923 ' H52' ' O ' ' A' ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.493 ' HA ' ' OE1' ' A' ' 36' ' ' GLU . 79.4 p . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.87 0.367 . . . . 0.0 111.211 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.841 HG13 HG23 ' A' ' 37' ' ' THR . 40.1 t -84.03 126.24 40.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.597 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.929 HD13 ' H ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -87.93 -174.15 4.58 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.752 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -80.52 109.84 15.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.035 0.445 . . . . 0.0 111.073 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.648 ' CG2' HG21 ' A' ' 37' ' ' THR . 36.2 t -89.47 131.64 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.783 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.003 ' HB2' HD21 ' A' ' 13' ' ' LEU . 45.3 mt -84.06 142.68 30.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.862 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 5.1 m170 -119.14 145.51 45.91 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.207 0.527 . . . . 0.0 112.044 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.039 HD13 HD12 ' A' ' 13' ' ' LEU . 51.2 mm -54.19 146.03 32.72 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.827 178.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.663 ' HA ' HG23 ' A' ' 8' ' ' ILE . 64.8 Cg_endo -91.86 50.2 1.12 Allowed 'Cis proline' 0 C--N 1.355 0.898 0 C-N-CA 124.644 -0.982 . . . . 0.0 113.123 0.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.87 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 9.7 t70 -53.56 131.48 38.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.799 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -59.17 -41.71 89.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.423 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.744 ' HB2' HD13 ' A' ' 6' ' ' LEU . 10.5 mtt85 -60.19 -23.55 64.08 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 1.039 HD12 HD13 ' A' ' 8' ' ' ILE . 9.8 mt -76.31 -31.73 58.35 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 120.413 1.46 . . . . 0.0 108.134 177.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.558 ' HD2' ' O ' ' A' ' 139' ' ' GLY . 24.0 mmm-85 -91.58 1.7 56.96 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 113.93 -1.486 . . . . 0.0 109.09 178.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.562 ' HD3' ' HB3' ' A' ' 54' ' ' HIS . 62.6 tttp -83.97 150.56 25.57 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.126 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.592 HG13 HG23 ' A' ' 138' ' ' VAL . 84.3 t -82.89 136.22 23.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.179 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.79 ' C ' ' HG3' ' A' ' 56' ' ' ARG . . . -90.7 139.96 30.23 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -104.81 129.28 25.17 Favored Pre-proline 0 C--N 1.323 -0.58 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.546 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.923 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 68.3 Cg_endo -77.5 114.67 3.75 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 121.824 1.682 . . . . 0.0 110.197 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.753 HG12 ' H ' ' A' ' 22' ' ' GLU . 17.3 t -70.09 144.83 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 122.488 1.137 . . . . 0.0 113.285 -176.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -62.44 -25.59 68.05 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 113.322 -1.763 . . . . 0.0 112.103 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.753 ' H ' HG12 ' A' ' 20' ' ' VAL . 88.9 tt0 -159.29 143.9 15.44 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.537 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.539 HG22 HD21 ' A' ' 111' ' ' LEU . 2.9 t -79.26 107.2 11.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -178.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 1.082 ' H ' HD12 ' A' ' 27' ' ' ILE . 64.1 m-80 -87.87 153.04 21.63 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.455 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.813 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -54.44 -26.99 34.06 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 121.078 0.466 . . . . 0.0 110.64 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -72.47 -40.39 66.98 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 177.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 1.082 HD12 ' H ' ' A' ' 24' ' ' ASN . 62.9 mt -62.92 -47.59 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.038 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -57.89 -39.86 78.9 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.916 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.813 ' HG3' ' O ' ' A' ' 25' ' ' ALA . 19.7 mtm105 -59.62 -40.36 87.29 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.808 ' O ' ' HG3' ' A' ' 34' ' ' MET . 4.3 mt -58.6 -49.78 81.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.624 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.924 HG22 ' CG2' ' A' ' 57' ' ' ILE . 5.0 t -67.22 -42.34 87.81 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-O 120.746 0.308 . . . . 0.0 111.619 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.88 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -54.35 -43.08 70.97 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.641 -179.604 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.562 ' C ' HD12 ' A' ' 3' ' ' LEU . 53.6 m-20 -74.96 -30.95 61.35 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.613 176.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 1.07 ' HG2' HG21 ' A' ' 51' ' ' VAL . 79.8 mtp -60.08 -47.76 84.54 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.162 -177.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.88 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 15.6 p90 -68.97 -43.54 74.77 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.781 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 31.9 mt-10 -51.41 -43.56 61.99 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.857 ' OG1' HD13 ' A' ' 3' ' ' LEU . 97.3 m -70.98 -61.91 1.59 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 118.876 -1.13 . . . . 0.0 109.092 177.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.99 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 1.8 ttp -45.51 -44.74 12.8 Favored 'General case' 0 CA--C 1.458 -2.576 0 C-N-CA 123.618 0.767 . . . . 0.0 109.978 -170.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.578 ' CD2' ' HE2' ' A' ' 38' ' ' MET . 58.9 m-85 -70.26 -40.63 74.26 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.197 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.39 -27.32 67.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.863 0.839 . . . . 0.0 108.764 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 1.01 ' HG2' HD22 ' A' ' 91' ' ' LEU . 10.5 tp10 -85.49 -10.48 56.0 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.19 177.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.431 ' H ' ' C ' ' A' ' 39' ' ' TYR . 51.5 mt-10 63.44 29.46 15.5 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.892 -176.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.807 ' HA2' H182 ' A' ' 149' ' ' BB2 . . . -84.69 143.29 20.64 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.865 178.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.817 HG23 ' O ' ' A' ' 61' ' ' ASP . 56.7 mt -78.77 -0.96 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 117.976 0.888 . . . . 0.0 112.065 -178.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.937 ' HA3' ' C10' ' A' ' 149' ' ' BB2 . . . 176.49 135.3 2.13 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-O 119.26 -0.744 . . . . 0.0 112.54 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.926 ' CD1' HD12 ' A' ' 91' ' ' LEU . 3.2 tp -125.22 133.56 52.68 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 118.618 1.209 . . . . 0.0 111.001 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -97.4 132.89 42.69 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 111.421 0.156 . . . . 0.0 111.421 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.912 ' HB1' ' CG1' ' A' ' 53' ' ' ILE . . . -34.56 -52.51 0.51 Allowed 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.525 HG21 ' O ' ' A' ' 137' ' ' LEU . 59.9 p -53.67 -37.27 63.03 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.898 0.856 . . . . 0.0 110.656 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.498 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 73.8 mt-30 -66.93 -38.36 86.04 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.006 -1.452 . . . . 0.0 109.854 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.07 HG21 ' HG2' ' A' ' 34' ' ' MET . 0.8 OUTLIER -83.8 11.62 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 179.113 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.875 ' HA ' ' CD1' ' A' ' 6' ' ' LEU . 54.6 t0 79.35 31.52 0.27 Allowed 'General case' 0 N--CA 1.46 0.06 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 176.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.912 ' CG1' ' HB1' ' A' ' 48' ' ' ALA . 1.2 pp -128.28 114.02 32.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.605 177.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.562 ' HB3' ' HD3' ' A' ' 15' ' ' LYS . 6.0 p80 -76.23 65.37 2.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.923 0.868 . . . . 0.0 110.587 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.777 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 88.5 mt-30 -155.77 134.84 12.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.676 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.923 ' HD2' ' HD3' ' A' ' 19' ' ' PRO . 99.0 mtt180 -62.74 69.06 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -178.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.924 ' CG2' HG22 ' A' ' 31' ' ' VAL . 8.4 mm -113.76 122.3 67.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.041 HD11 ' HB2' ' A' ' 72' ' ' LEU . 2.4 pp -131.31 146.89 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -177.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.9 m -127.83 138.69 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.266 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.928 HG23 ' C11' ' A' ' 149' ' ' BB2 . 2.2 mt -115.98 144.12 24.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 122.332 1.063 . . . . 0.0 112.233 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.99 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 52.4 t0 -122.78 50.07 1.56 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 113.506 -1.679 . . . . 0.0 107.666 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.736 HG22 ' CG2' ' A' ' 44' ' ' ILE . 24.6 t -126.67 74.76 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 112.243 -2.253 . . . . 0.0 105.869 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.814 ' OG ' ' HA ' ' A' ' 68' ' ' GLU . 40.3 m -95.29 -40.12 9.7 Favored 'General case' 0 CA--C 1.486 -1.482 0 CA-C-N 112.596 -2.093 . . . . 0.0 109.523 177.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 49.08 64.28 1.79 Allowed 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 113.391 -1.731 . . . . 0.0 109.862 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.573 ' ND2' ' H ' ' A' ' 66' ' ' ARG . 49.0 t30 -165.88 -131.8 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.834 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.573 ' H ' ' ND2' ' A' ' 65' ' ' ASN . 40.3 mmm-85 -79.04 -61.88 1.87 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.169 0.509 . . . . 0.0 111.184 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -126.41 138.14 53.51 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.474 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.814 ' HA ' ' OG ' ' A' ' 63' ' ' SER . 0.3 OUTLIER -88.79 145.97 25.28 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.939 179.757 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.452 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 34.6 ttm180 -176.62 65.73 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.84 ' CB ' ' HB ' ' A' ' 60' ' ' ILE . 8.8 mp -100.45 129.46 46.42 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.881 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.794 ' C ' HD22 ' A' ' 72' ' ' LEU . 13.4 p -133.87 131.32 56.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.211 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.041 ' HB2' HD11 ' A' ' 58' ' ' ILE . 2.9 mm? -141.75 143.91 33.74 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.398 177.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.073 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.6 mp -122.31 135.87 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 O-C-N 122.168 -0.332 . . . . 0.0 110.441 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.707 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 8.0 m120 52.34 37.14 0.4 Allowed Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.867 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 97.4 Cg_exo -56.46 150.93 48.37 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 122.949 2.433 . . . . 0.0 114.091 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -138.72 145.57 40.46 Favored 'General case' 0 C--N 1.335 -0.055 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.805 ' HA ' HG22 ' A' ' 108' ' ' ILE . 9.5 tp -80.69 138.07 36.34 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.111 0.481 . . . . 0.0 110.901 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.047 HD23 ' HA ' ' A' ' 108' ' ' ILE . 3.0 mm? -114.27 -36.17 4.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.243 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.466 ' O ' ' HB ' ' A' ' 106' ' ' VAL . 16.5 tp10 -160.9 147.6 15.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.055 0.455 . . . . 0.0 111.86 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 1.057 ' HA ' HG12 ' A' ' 106' ' ' VAL . 19.6 ptpt -140.48 150.22 43.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.91 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.6 p -157.73 147.61 20.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.779 0.324 . . . . 0.0 111.243 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.766 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 73.46 165.27 10.08 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.791 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -139.79 113.16 8.38 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.689 0.757 . . . . 0.0 112.697 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.766 ' HB ' HH12 ' A' ' 102' ' ' ARG . 1.4 p -102.26 160.18 14.75 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.637 ' O ' HD13 ' A' ' 86' ' ' ILE . . . -139.82 104.73 0.43 Allowed Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 113.077 -1.874 . . . . 0.0 111.856 178.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.842 ' HB ' ' NH2' ' A' ' 102' ' ' ARG . 49.8 mm -147.1 140.32 19.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.639 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 92.5 mt-10 -74.01 143.81 45.4 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 122.589 1.185 . . . . 0.0 112.619 -178.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.715 ' HA ' ' O27' ' A' ' 149' ' ' BB2 . 10.1 mp0 -151.1 169.68 21.26 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 113.192 -1.822 . . . . 0.0 108.608 177.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.76 ' HA3' ' HG2' ' A' ' 97' ' ' ARG . . . -118.77 165.29 12.96 Favored Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 119.322 -1.418 . . . . 0.0 109.92 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.863 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 19.9 m -119.07 130.65 55.73 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.01 HD22 ' HG2' ' A' ' 41' ' ' GLU . 13.4 mt -57.5 -13.32 3.52 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.784 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.914 ' CB ' HD13 ' A' ' 13' ' ' LEU . 58.0 m -83.26 -37.2 23.83 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.812 HG23 ' HD2' ' A' ' 94' ' ' PRO . 48.4 mm -86.41 149.99 50.53 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.557 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.812 ' HD2' HG23 ' A' ' 93' ' ' ILE . 68.0 Cg_endo -75.2 48.43 2.05 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.584 2.189 . . . . 0.0 114.744 -178.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.597 ' HB2' ' O ' ' A' ' 94' ' ' PRO . 7.8 mp0 82.88 9.27 0.66 Allowed 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.761 ' HB2' HG21 ' A' ' 93' ' ' ILE . 2.6 mm100 -78.25 88.99 4.3 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.76 ' HG2' ' HA3' ' A' ' 89' ' ' GLY . 40.9 mtm-85 -84.44 133.54 34.49 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.627 0.727 . . . . 0.0 111.493 -178.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -132.11 151.0 52.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.13 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.687 HD23 ' N ' ' A' ' 100' ' ' VAL . 6.9 tt -75.58 135.73 40.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.808 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.709 ' CG2' ' HB3' ' A' ' 142' ' ' PHE . 13.6 p -130.09 140.29 38.2 Favored Pre-proline 0 C--O 1.232 0.181 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.393 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 84' ' ' THR . 97.1 Cg_endo -88.16 122.7 1.57 Allowed 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.377 1.385 . . . . 0.0 113.552 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.913 ' HG2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -142.74 165.45 27.36 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 113.545 -1.661 . . . . 0.0 110.783 178.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.766 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.74 154.04 42.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.9 0.381 . . . . 0.0 110.377 -178.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.445 ' OE1' HG21 ' A' ' 84' ' ' THR . 5.1 tp10 -73.06 -42.03 63.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.66 -176.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.764 ' HG2' ' HB3' ' A' ' 123' ' ' ASP . 4.7 mtpm? -139.5 138.32 36.26 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.489 0.661 . . . . 0.0 109.674 177.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 1.057 HG12 ' HA ' ' A' ' 80' ' ' LYS . 25.1 m -147.02 141.63 20.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.736 -1.12 . . . . 0.0 112.122 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.964 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 31.9 mmtm -107.2 126.04 51.88 Favored 'General case' 0 N--CA 1.461 0.101 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 1.047 ' HA ' HD23 ' A' ' 78' ' ' LEU . 2.0 pp -129.61 161.82 38.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 1.034 ' HG3' HD21 ' A' ' 78' ' ' LEU . 45.4 mtm180 -113.24 138.17 50.4 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-O 120.843 0.354 . . . . 0.0 110.083 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.807 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -156.44 167.89 29.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.658 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 1.073 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.2 pp -114.03 151.66 32.13 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.445 ' O ' HD12 ' A' ' 111' ' ' LEU . 10.7 t70 -87.9 164.37 15.89 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.692 -177.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.768 ' HD2' ' OD1' ' A' ' 32' ' ' ASP . 49.1 ttp180 -51.66 -21.36 2.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.311 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.55 -21.75 44.75 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.908 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.5 37.27 3.31 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.992 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -128.64 102.82 19.78 Favored Pre-proline 0 C--O 1.238 0.457 0 CA-C-N 117.054 0.427 . . . . 0.0 110.708 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.661 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 32.2 Cg_exo -73.18 114.16 3.97 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 121.616 1.544 . . . . 0.0 114.959 -177.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 112' ' ' ASP . 0.4 OUTLIER -125.58 169.56 12.35 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.417 -178.52 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.718 ' HG2' ' HD2' ' A' ' 109' ' ' ARG . 34.9 mt-10 -106.75 129.4 54.63 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.02 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.721 ' O ' HD12 ' A' ' 120' ' ' LEU . 4.1 pp -123.39 133.01 54.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.848 -178.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.964 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 15.4 pt-20 -92.48 124.37 36.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.673 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.936 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -116.39 134.59 54.7 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.764 ' HB3' ' HG2' ' A' ' 105' ' ' LYS . 25.2 m-20 -126.81 164.54 21.14 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.628 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 46.78 -134.56 11.13 Favored Glycine 0 C--N 1.347 1.188 0 CA-C-N 120.722 1.601 . . . . 0.0 116.44 177.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.686 HD12 ' H ' ' A' ' 125' ' ' LEU . 4.8 mp -54.64 -33.99 61.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.431 -0.884 . . . . 0.0 111.619 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.936 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -70.95 -53.35 15.24 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.239 -0.584 . . . . 0.0 109.796 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.799 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -59.44 -47.12 86.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.93 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.913 HD12 ' HG2' ' A' ' 102' ' ' ARG . 49.9 mm -61.28 -55.69 22.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.084 -178.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.986 ' HB3' H112 ' A' ' 149' ' ' BB2 . 82.2 m -57.45 -50.89 71.55 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.673 HD11 HD11 ' A' ' 108' ' ' ILE . 18.7 tt -59.0 -41.35 82.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.826 -0.17 . . . . 0.0 111.413 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.864 ' CG ' HG21 ' A' ' 106' ' ' VAL . 66.0 mt-30 -65.99 -40.83 91.51 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.401 ' NE2' ' HD2' ' A' ' 136' ' ' HIS . 9.1 t-160 -56.08 -47.74 77.42 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.882 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.804 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.7 mm-40 -58.71 -46.08 88.11 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.098 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.985 ' HA ' HD21 ' A' ' 137' ' ' LEU . 1.9 mmm -55.68 -47.54 76.59 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.466 0.65 . . . . 0.0 110.037 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.656 ' O ' HG12 ' A' ' 138' ' ' VAL . 31.3 m-20 -61.6 -49.24 77.39 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.205 178.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.811 ' CE1' HD21 ' A' ' 141' ' ' LEU . 10.3 t-80 -59.25 -50.76 72.79 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 121.768 -0.583 . . . . 0.0 111.171 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.985 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.6 pp -58.27 -31.27 67.29 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.726 -178.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.847 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 13.8 p -83.04 20.5 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-O 122.803 1.287 . . . . 0.0 108.755 175.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.768 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 65.84 7.3 35.13 Favored Glycine 0 CA--C 1.494 -1.278 0 CA-C-N 112.501 -2.136 . . . . 0.0 112.843 176.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.847 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 4.6 ptmt -97.85 119.35 36.3 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 119.53 -0.868 . . . . 0.0 108.716 179.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.811 HD21 ' CE1' ' A' ' 136' ' ' HIS . 6.4 mp -122.71 157.99 31.09 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 121.9 -0.5 . . . . 0.0 110.187 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.757 ' O ' HD13 ' A' ' 146' ' ' LEU . 8.1 p90 -58.08 -32.01 67.64 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.448 ' N ' ' CD1' ' A' ' 142' ' ' PHE . 16.1 tpt -63.1 -25.98 68.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.256 0.55 . . . . 0.0 110.664 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 141' ' ' LEU . 1.2 m-20 -59.09 -26.78 64.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.884 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -119.18 21.48 12.26 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.757 HD13 ' O ' ' A' ' 142' ' ' PHE . 4.8 mp -92.16 141.77 28.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.589 0.233 . . . . 0.0 111.025 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 48.2 t . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.891 179.359 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' BB2 . . . . . 0.986 H112 ' HB3' ' A' ' 129' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.442 ' HB3' ' OE1' ' A' ' 36' ' ' GLU . 52.0 m . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.93 0.395 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.921 HG12 ' HA ' ' A' ' 37' ' ' THR . 28.3 m -84.0 138.14 19.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.783 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.96 HD13 ' H ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -79.01 -159.3 0.18 Allowed 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.108 179.858 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.686 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 2.2 tp-100 -88.31 105.58 17.66 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.254 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.62 ' CG2' HG21 ' A' ' 37' ' ' THR . 46.4 t -88.33 127.0 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 121.333 0.587 . . . . 0.0 111.483 -179.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.07 ' HB2' HD21 ' A' ' 13' ' ' LEU . 24.4 mt -88.08 144.29 26.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.222 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 4.3 m80 -120.85 145.99 47.04 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.003 HD13 HD12 ' A' ' 13' ' ' LEU . 44.5 mm -69.29 135.79 88.94 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.674 178.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.48 141.74 70.95 Favored 'Cis proline' 0 C--N 1.352 0.729 0 C-N-CA 124.145 -1.19 . . . . 0.0 112.031 -0.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.97 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 8.4 t0 -163.39 125.18 2.47 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.271 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.431 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 23.7 pt-20 -57.53 -46.23 84.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.74 -178.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.692 ' CZ ' ' HD2' ' A' ' 54' ' ' HIS . 14.8 mmt85 -56.21 -30.1 61.83 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 1.07 HD21 ' HB2' ' A' ' 6' ' ' LEU . 11.5 mt -75.78 -33.29 60.17 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 120.098 1.317 . . . . 0.0 109.054 178.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.669 ' C ' ' HA3' ' A' ' 139' ' ' GLY . 26.6 mmt-85 -96.21 13.29 27.91 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.299 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.45 ' HZ3' ' HE ' ' A' ' 12' ' ' ARG . 88.4 tttt -91.65 149.93 21.4 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.128 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 1.004 HG13 HG23 ' A' ' 138' ' ' VAL . 49.5 t -82.95 122.13 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.796 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -80.02 145.57 32.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.856 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.625 ' HB3' HE22 ' A' ' 55' ' ' GLN . 83.4 tttt -101.81 134.22 20.28 Favored Pre-proline 0 C--N 1.326 -0.442 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.788 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -77.36 115.52 3.94 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.365 2.044 . . . . 0.0 111.261 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.882 HG12 ' H ' ' A' ' 22' ' ' GLU . 24.9 t -68.94 144.98 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 122.526 1.155 . . . . 0.0 113.022 -176.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.475 ' OE1' ' HA ' ' A' ' 21' ' ' GLU . 4.3 mm-40 -67.45 -29.24 68.65 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 113.303 -1.771 . . . . 0.0 111.734 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.882 ' H ' HG12 ' A' ' 20' ' ' VAL . 16.9 tp10 -156.57 154.17 29.81 Favored 'General case' 0 CA--C 1.527 0.063 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.178 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.981 HG21 ' HA2' ' A' ' 115' ' ' GLY . 6.3 t -80.07 102.38 5.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -178.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.943 ' CB ' HD13 ' A' ' 27' ' ' ILE . 62.3 m-80 -89.04 151.16 22.42 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.569 -177.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.421 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -55.48 -28.21 53.12 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.508 0.67 . . . . 0.0 110.534 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 1.073 ' HG3' HD12 ' A' ' 27' ' ' ILE . 21.7 pt-20 -74.02 -36.92 64.48 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 177.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 1.073 HD12 ' HG3' ' A' ' 26' ' ' GLU . 1.7 mp -67.46 -38.79 81.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.952 177.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -65.78 -40.29 91.84 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 122.401 -0.187 . . . . 0.0 110.938 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.449 HH11 ' HG2' ' A' ' 29' ' ' ARG . 47.7 mmt-85 -64.94 -38.41 90.89 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.786 ' O ' ' HG3' ' A' ' 34' ' ' MET . 4.7 mt -55.39 -50.47 65.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.177 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.892 HG11 ' CG2' ' A' ' 71' ' ' VAL . 19.2 t -66.87 -40.4 85.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-O 121.218 0.533 . . . . 0.0 110.408 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.869 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 71.1 m-20 -53.06 -46.08 68.39 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.072 -178.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.62 ' CB ' HD12 ' A' ' 3' ' ' LEU . 1.5 m-20 -75.13 -29.25 60.46 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.07 176.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 1.003 ' HG2' HG21 ' A' ' 51' ' ' VAL . 83.2 mtp -59.46 -46.63 88.22 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.171 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.869 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 13.9 p90 -70.2 -44.18 69.2 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.737 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 85.9 mt-10 -51.61 -44.48 62.9 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.622 0.725 . . . . 0.0 109.376 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.921 ' HA ' HG12 ' A' ' 2' ' ' VAL . 96.7 m -70.5 -61.35 1.8 Allowed 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 118.592 -1.243 . . . . 0.0 108.709 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 1.038 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 2.0 ttp -45.68 -41.5 10.52 Favored 'General case' 0 CA--C 1.463 -2.393 0 C-N-CA 123.878 0.871 . . . . 0.0 110.133 -171.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.7 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 55.9 m-85 -70.4 -42.13 72.08 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.083 177.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.467 ' HB3' ' CG1' ' A' ' 2' ' ' VAL . . . -61.16 -24.47 66.32 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.491 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 1.047 ' HG2' HD12 ' A' ' 91' ' ' LEU . 11.9 tp10 -88.81 -11.56 44.49 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.482 177.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.444 ' H ' ' C ' ' A' ' 39' ' ' TYR . 18.5 mt-10 64.83 26.54 12.94 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 122.047 0.927 . . . . 0.0 109.927 -176.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.48 141.58 22.16 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 113.76 -1.564 . . . . 0.0 110.67 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.807 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 53.1 mt -80.0 0.68 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 117.643 0.722 . . . . 0.0 112.266 -178.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 1.006 ' HA3' H113 ' A' ' 149' ' ' BB2 . . . 178.09 135.54 2.31 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-O 119.022 -0.877 . . . . 0.0 111.926 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.994 HD13 ' HG ' ' A' ' 91' ' ' LEU . 5.4 tp -125.68 134.24 51.9 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-N 118.993 1.397 . . . . 0.0 111.56 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -98.9 132.33 44.31 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.875 ' HB1' ' CD1' ' A' ' 53' ' ' ILE . . . -29.85 -54.59 0.16 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.597 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 58.4 p -53.97 -36.64 63.1 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.698 0.761 . . . . 0.0 111.81 -178.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.741 ' OE1' HD12 ' A' ' 46' ' ' LEU . 85.5 mt-30 -64.51 -40.62 95.97 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.627 -1.169 . . . . 0.0 110.028 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.003 HG21 ' HG2' ' A' ' 34' ' ' MET . 0.8 OUTLIER -84.36 17.37 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 112.665 0.616 . . . . 0.0 112.665 -179.84 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.896 ' HA ' HD11 ' A' ' 6' ' ' LEU . 11.1 t0 77.51 26.86 0.65 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 176.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.875 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -124.13 110.7 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 C-N-CA 118.915 -1.114 . . . . 0.0 111.77 178.644 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.692 ' HD2' ' CZ ' ' A' ' 12' ' ' ARG . 6.9 p80 -76.48 60.5 1.61 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.611 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.782 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 2.5 mm100 -149.67 134.18 17.53 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 114.342 -1.299 . . . . 0.0 107.788 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.796 ' N ' ' HB1' ' A' ' 17' ' ' ALA . 75.7 mtp180 -64.11 68.62 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -177.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.831 ' CG2' HG22 ' A' ' 31' ' ' VAL . 8.5 mm -110.49 122.16 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.998 HD11 ' HB2' ' A' ' 72' ' ' LEU . 1.5 pp -121.95 140.73 44.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.0 -0.68 . . . . 0.0 112.285 -178.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.57 HG12 ' O ' ' A' ' 46' ' ' LEU . 1.5 p -125.16 134.5 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.044 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 9.1 mm -114.36 155.27 15.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.616 0.722 . . . . 0.0 110.921 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 1.038 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 31.9 t70 -142.57 28.56 1.62 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.659 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.766 HG22 ' CG2' ' A' ' 44' ' ' ILE . 39.3 t -94.22 107.54 19.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.81 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.726 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 79.6 p -37.05 84.59 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -176.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.791 ' OE1' HD21 ' A' ' 70' ' ' LEU . 38.8 tt0 -62.52 -18.06 61.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.956 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.904 ' OD1' ' HG2' ' A' ' 66' ' ' ARG . 26.1 t-20 -164.1 -85.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.105 0.479 . . . . 0.0 110.895 178.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.904 ' HG2' ' OD1' ' A' ' 65' ' ' ASN . 39.0 mmm-85 -119.27 -52.29 2.28 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.457 0.646 . . . . 0.0 110.354 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -99.43 126.3 45.31 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.309 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.726 ' HG2' ' HA ' ' A' ' 63' ' ' SER . 56.9 mt-10 -84.65 133.1 34.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.833 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.592 ' HB2' ' O ' ' A' ' 68' ' ' GLU . 40.7 ttm-85 171.22 70.53 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.135 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 1.044 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 47.8 mt -103.72 134.38 47.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.915 0.388 . . . . 0.0 111.716 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.892 ' CG2' HG11 ' A' ' 31' ' ' VAL . 6.3 p -134.88 135.9 52.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.308 178.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.998 ' HB2' HD11 ' A' ' 58' ' ' ILE . 3.0 mm? -141.63 142.12 33.42 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 177.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.017 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.6 mp -121.71 135.05 63.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.702 0.286 . . . . 0.0 110.336 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.717 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 7.3 m120 54.48 34.86 0.26 Allowed Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.907 ' HG2' HG12 ' A' ' 58' ' ' ILE . 89.3 Cg_exo -56.39 146.8 71.58 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.766 2.311 . . . . 0.0 113.707 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -138.0 145.51 41.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.782 HD21 ' HE3' ' A' ' 80' ' ' LYS . 29.8 tp -79.12 138.2 37.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.424 0.63 . . . . 0.0 112.084 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.035 HD21 ' HG3' ' A' ' 109' ' ' ARG . 2.7 mm? -112.77 -43.55 3.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.474 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 39.2 tt0 -157.21 147.81 21.31 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.211 0.529 . . . . 0.0 111.949 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.895 ' HA ' HG12 ' A' ' 106' ' ' VAL . 19.3 ptpt -143.08 146.01 33.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.34 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.0 t -157.07 149.81 23.47 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.352 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.759 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 78.11 156.12 8.52 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.718 -0.754 . . . . 0.0 111.499 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -131.3 113.22 13.53 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.965 0.888 . . . . 0.0 112.632 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.872 ' HB ' HH12 ' A' ' 102' ' ' ARG . 1.5 p -105.98 161.9 14.06 Favored 'General case' 0 CA--C 1.487 -1.447 0 CA-C-N 114.016 -1.447 . . . . 0.0 114.894 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.843 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -149.22 118.05 0.92 Allowed Glycine 0 C--N 1.314 -0.674 0 CA-C-N 113.103 -1.862 . . . . 0.0 111.047 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.719 ' N ' ' HG ' ' A' ' 99' ' ' LEU . 32.5 mt -148.79 140.45 17.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 117.432 0.616 . . . . 0.0 111.84 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 55.8 mt-10 -71.14 139.18 50.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 123.135 1.445 . . . . 0.0 112.104 -176.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.744 ' HB3' H262 ' A' ' 149' ' ' BB2 . 84.1 mt-10 -157.5 162.44 38.88 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 112.543 -2.117 . . . . 0.0 111.774 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.891 ' O ' ' H52' ' A' ' 149' ' ' BB2 . . . -120.94 162.97 14.53 Favored Glycine 0 CA--C 1.5 -0.905 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.721 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 11.2 m -116.28 139.38 50.44 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 117.564 0.682 . . . . 0.0 110.763 -178.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.047 HD12 ' HG2' ' A' ' 41' ' ' GLU . 2.5 mm? -47.25 -20.58 0.2 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.501 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.897 ' CB ' HG12 ' A' ' 8' ' ' ILE . 31.5 m -86.53 -41.82 14.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.537 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.884 HG23 ' HD2' ' A' ' 94' ' ' PRO . 44.0 mm -86.37 152.8 55.67 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.199 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.884 ' HD2' HG23 ' A' ' 93' ' ' ILE . 64.8 Cg_endo -61.75 -144.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.636 2.224 . . . . 0.0 111.647 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.456 ' H ' ' HB2' ' A' ' 94' ' ' PRO . 8.8 mp0 -81.43 11.39 4.54 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.27 0.557 . . . . 0.0 110.616 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.543 ' HG3' ' HG2' ' A' ' 94' ' ' PRO . 85.4 mt-30 -78.29 83.78 4.52 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.111 -178.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.744 ' HG2' ' N ' ' A' ' 89' ' ' GLY . 74.9 mtm180 -85.58 133.22 34.07 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.36 0.6 . . . . 0.0 110.375 178.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -125.1 147.31 49.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.414 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.843 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.7 tt -75.26 111.94 11.03 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.707 0.765 . . . . 0.0 110.512 -178.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 1.119 HG23 ' HB2' ' A' ' 142' ' ' PHE . 12.2 p -97.93 133.05 23.67 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.93 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.61 ' HD2' ' CD2' ' A' ' 142' ' ' PHE . 95.6 Cg_endo -88.29 125.71 1.86 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.391 2.061 . . . . 0.0 112.227 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.96 ' HG3' HG23 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -144.4 166.77 24.16 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.798 0.839 . . . . 0.0 109.653 179.84 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.759 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.29 154.62 41.39 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.883 0.373 . . . . 0.0 110.1 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -73.06 -40.56 64.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.72 -176.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.751 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 89.3 mttt -139.82 140.34 36.57 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.34 0.59 . . . . 0.0 109.481 177.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.895 HG12 ' HA ' ' A' ' 80' ' ' LYS . 30.3 m -149.03 140.17 17.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.07 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.989 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 23.4 mmtp -107.63 126.42 52.55 Favored 'General case' 0 N--CA 1.461 0.091 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 1.053 HD11 HD11 ' A' ' 130' ' ' ILE . 1.7 pp -135.4 151.05 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -176.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 1.035 ' HG3' HD21 ' A' ' 78' ' ' LEU . 91.8 mtt180 -102.36 137.54 40.47 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.205 -178.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.726 ' HB3' HD12 ' A' ' 72' ' ' LEU . . . -160.64 169.01 23.73 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.908 -177.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 1.017 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.4 pp -116.39 151.64 35.54 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.732 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 18.9 t70 -83.66 165.4 18.99 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -176.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.824 ' HB2' HG21 ' A' ' 71' ' ' VAL . 52.9 ttp180 -52.2 -20.95 2.92 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.58 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -79.37 -25.85 42.14 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.699 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.981 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 106.31 36.57 2.65 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.712 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -128.44 102.6 20.48 Favored Pre-proline 0 C--O 1.236 0.377 0 CA-C-N 117.067 0.433 . . . . 0.0 110.731 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.679 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 34.2 Cg_exo -71.92 114.98 4.13 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 121.777 1.651 . . . . 0.0 115.596 -177.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.732 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 12.1 p90 -128.06 168.08 15.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.574 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.525 ' CG ' ' HG2' ' A' ' 109' ' ' ARG . 27.7 mp0 -107.35 130.28 54.81 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.727 ' O ' HD12 ' A' ' 120' ' ' LEU . 4.3 pp -126.33 133.73 51.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.566 -178.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.989 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 11.5 pt-20 -93.04 123.8 36.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.629 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.939 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -116.83 134.97 54.13 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.751 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.2 m-20 -127.04 162.49 25.91 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.67 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 51.83 -136.35 33.34 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 120.293 1.406 . . . . 0.0 115.426 177.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 74.4 mt -54.84 -33.8 62.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.719 -0.741 . . . . 0.0 111.706 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.939 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.3 OUTLIER -71.47 -51.6 22.87 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.851 0.834 . . . . 0.0 109.15 179.619 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.738 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -58.82 -43.0 90.53 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.258 -1.337 . . . . 0.0 111.91 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.96 HG23 ' HG3' ' A' ' 102' ' ' ARG . 50.3 mm -67.96 -55.72 15.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.819 ' HB3' ' H91' ' A' ' 149' ' ' BB2 . 84.2 m -58.73 -50.67 73.06 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 1.053 HD11 HD11 ' A' ' 108' ' ' ILE . 20.4 tt -58.24 -43.84 86.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.13 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.776 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.4 pt20 -67.73 -37.9 82.83 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.083 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.873 ' CE1' ' H51' ' A' ' 149' ' ' BB2 . 3.8 t-160 -58.88 -47.4 85.06 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.872 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.6 mm-40 -59.61 -42.43 92.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.083 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.961 ' HA ' HD21 ' A' ' 137' ' ' LEU . 30.1 mtm -57.33 -47.48 81.44 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.832 0.825 . . . . 0.0 109.902 178.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.611 ' HB3' ' O ' ' A' ' 140' ' ' LYS . 57.8 m-20 -62.51 -47.59 83.28 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.197 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 1.025 ' HA ' HD21 ' A' ' 141' ' ' LEU . 6.2 t-80 -59.45 -52.96 63.37 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.123 0.487 . . . . 0.0 111.557 -178.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.961 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.5 pp -57.93 -31.47 66.84 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.308 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 1.004 HG23 HG13 ' A' ' 16' ' ' VAL . 14.7 p -86.86 22.78 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-O 122.356 1.074 . . . . 0.0 109.359 176.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.669 ' HA3' ' C ' ' A' ' 14' ' ' ARG . . . 53.28 38.45 56.99 Favored Glycine 0 CA--C 1.481 -2.041 0 CA-C-N 113.331 -1.759 . . . . 0.0 112.17 176.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.962 ' HG2' HG13 ' A' ' 138' ' ' VAL . 2.4 ptmt -136.13 103.55 5.37 Favored 'General case' 0 N--CA 1.42 -1.935 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.83 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 1.025 HD21 ' HA ' ' A' ' 136' ' ' HIS . 3.1 mm? -123.61 149.06 45.81 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 120.822 -1.174 . . . . 0.0 109.05 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 1.119 ' HB2' HG23 ' A' ' 100' ' ' VAL . 8.9 m-85 -60.2 -39.35 86.27 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.836 ' HA ' ' HG ' ' A' ' 146' ' ' LEU . 46.6 ttm -55.91 -25.97 45.37 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.094 0.473 . . . . 0.0 111.487 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.536 ' CG ' ' HE ' ' A' ' 14' ' ' ARG . 31.3 t70 -55.4 -25.95 38.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.335 -178.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -118.27 37.78 3.91 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 120.555 0.217 . . . . 0.0 110.905 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.836 ' HG ' ' HA ' ' A' ' 143' ' ' MET . 49.4 mt -92.39 139.12 30.92 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.667 0.27 . . . . 0.0 110.993 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 54.0 m . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.975 179.784 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' BB2 . . . . . 1.006 H113 ' HA3' ' A' ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 79.8 p . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.834 0.35 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.878 ' CG1' ' HA ' ' A' ' 37' ' ' THR . 27.1 m -84.22 133.64 28.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.388 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.98 HD11 ' HB ' ' A' ' 51' ' ' VAL . 1.1 pt? -79.68 -158.69 0.17 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.561 ' HG3' ' HB3' ' A' ' 52' ' ' ASP . 23.4 pt20 -88.66 104.43 16.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.882 0.372 . . . . 0.0 111.88 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.036 HG11 HD12 ' A' ' 91' ' ' LEU . 49.1 t -89.38 131.66 36.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-O 121.251 0.548 . . . . 0.0 111.953 -178.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.138 ' HB2' HD21 ' A' ' 13' ' ' LEU . 22.6 mt -91.08 140.11 30.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.998 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.621 ' HA ' ' CA ' ' A' ' 92' ' ' SER . 37.1 m-70 -112.53 140.6 47.15 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.083 HD13 HD12 ' A' ' 13' ' ' LEU . 37.1 mm -61.81 132.88 93.51 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.81 176.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -79.89 148.25 78.78 Favored 'Cis proline' 0 C--N 1.352 0.719 0 C-N-CA 124.795 -0.919 . . . . 0.0 111.67 -0.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 1.028 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 9.0 t0 -165.1 131.09 2.73 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.403 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 23.8 pt-20 -58.45 -45.8 87.85 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.774 0.321 . . . . 0.0 110.643 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.676 ' O ' ' HB ' ' A' ' 49' ' ' THR . 14.7 mmt85 -59.67 -26.44 65.55 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 1.138 HD21 ' HB2' ' A' ' 6' ' ' LEU . 9.9 mt -77.42 -31.43 54.02 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 120.736 1.607 . . . . 0.0 108.39 177.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.689 ' C ' ' HA3' ' A' ' 139' ' ' GLY . 25.2 mmm-85 -94.46 10.43 34.52 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.108 -1.406 . . . . 0.0 109.173 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.654 ' NZ ' ' HB2' ' A' ' 54' ' ' HIS . 64.2 tttm -84.64 141.2 30.8 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.196 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.933 HG13 ' CG2' ' A' ' 138' ' ' VAL . 61.8 t -84.22 94.95 3.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.201 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.848 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -57.71 145.12 35.54 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.887 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -104.42 134.77 19.51 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.596 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.639 ' HD3' ' HD3' ' A' ' 56' ' ' ARG . 58.8 Cg_endo -80.26 115.74 3.24 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.235 1.957 . . . . 0.0 110.384 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.759 HG12 ' H ' ' A' ' 22' ' ' GLU . 16.4 t -69.23 144.3 14.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 122.476 1.131 . . . . 0.0 113.177 -175.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -62.48 -23.59 66.99 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 113.197 -1.82 . . . . 0.0 112.57 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.759 ' H ' HG12 ' A' ' 20' ' ' VAL . 34.8 tp10 -160.03 148.0 16.82 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 121.034 -0.267 . . . . 0.0 110.744 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.868 HG21 ' HA2' ' A' ' 115' ' ' GLY . 3.0 t -82.44 105.83 12.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 1.045 ' H ' HD12 ' A' ' 27' ' ' ILE . 64.8 m-80 -89.23 157.85 18.09 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.988 -178.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.544 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -54.53 -31.48 56.38 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.509 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -71.28 -37.57 71.87 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 177.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 1.045 HD12 ' H ' ' A' ' 24' ' ' ASN . 63.4 mt -64.25 -47.15 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.143 178.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 51.0 mt-30 -57.65 -39.86 78.0 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.027 0.441 . . . . 0.0 110.733 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.544 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 38.9 mmt180 -60.99 -40.09 92.15 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.543 0.687 . . . . 0.0 109.159 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.825 ' O ' ' HG3' ' A' ' 34' ' ' MET . 4.6 mt -58.62 -49.66 81.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.879 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.819 HG21 ' CD1' ' A' ' 73' ' ' ILE . 17.9 t -68.47 -41.32 83.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.916 0.388 . . . . 0.0 111.422 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.877 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 47.8 m-20 -53.24 -46.11 69.01 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.588 0.709 . . . . 0.0 111.53 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.498 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 1.4 m-20 -74.71 -30.21 61.46 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.661 176.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 1.039 ' HG2' HG21 ' A' ' 51' ' ' VAL . 87.3 mtp -59.61 -47.0 87.29 Favored 'General case' 0 C--N 1.345 0.378 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.723 -177.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.877 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 17.4 p90 -69.54 -44.38 71.05 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.743 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 77.9 mt-10 -51.65 -42.64 62.23 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.878 ' HA ' ' CG1' ' A' ' 2' ' ' VAL . 76.8 m -69.33 -60.42 2.35 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 118.79 -1.164 . . . . 0.0 108.487 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 1.016 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 3.2 ttp -46.24 -43.33 15.38 Favored 'General case' 0 CA--C 1.463 -2.385 0 C-N-CA 123.749 0.819 . . . . 0.0 109.869 -170.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.698 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 58.9 m-85 -68.96 -42.02 77.21 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.878 178.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.55 ' HB3' ' CG1' ' A' ' 2' ' ' VAL . . . -60.14 -28.9 68.27 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.626 0.727 . . . . 0.0 109.045 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.782 ' HG2' ' CD2' ' A' ' 91' ' ' LEU . 3.2 tp10 -83.95 -10.15 58.16 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 114.392 -1.276 . . . . 0.0 108.835 177.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.436 ' H ' ' C ' ' A' ' 39' ' ' TYR . 19.2 mt-10 62.41 25.42 15.16 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.916 -176.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.866 ' HA3' H173 ' A' ' 149' ' ' BB2 . . . -79.96 140.61 22.53 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.187 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.83 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 38.5 mt -79.2 0.42 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 117.829 0.815 . . . . 0.0 111.93 -178.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.753 ' HA3' H101 ' A' ' 149' ' ' BB2 . . . -179.75 133.5 2.04 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-O 119.215 -0.77 . . . . 0.0 112.066 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.985 ' HB2' ' HG3' ' A' ' 38' ' ' MET . 9.2 tp -125.31 135.37 52.42 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-N 119.531 1.665 . . . . 0.0 111.712 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.48 ' HB1' ' HB3' ' A' ' 137' ' ' LEU . . . -101.45 130.63 47.73 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.887 ' HB1' ' CG1' ' A' ' 53' ' ' ILE . . . -29.31 -56.16 0.15 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 115.902 1.815 . . . . 0.0 115.902 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.676 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 77.2 p -53.82 -34.73 60.11 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.725 0.774 . . . . 0.0 111.378 -178.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.492 ' NE2' ' HB3' ' A' ' 90' ' ' CYS . 37.2 mt-30 -65.34 -38.52 90.34 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.168 -1.378 . . . . 0.0 109.843 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.039 HG21 ' HG2' ' A' ' 34' ' ' MET . 1.6 m -89.1 13.42 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 121.013 0.435 . . . . 0.0 111.752 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.813 ' HA ' HD11 ' A' ' 6' ' ' LEU . 38.2 t70 77.13 35.27 0.36 Allowed 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 176.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.887 ' CG1' ' HB1' ' A' ' 48' ' ' ALA . 1.2 pp -125.81 110.87 25.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 119.495 -0.882 . . . . 0.0 109.706 176.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.654 ' HB2' ' NZ ' ' A' ' 15' ' ' LYS . 23.4 p-80 -75.99 64.76 1.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 122.098 0.952 . . . . 0.0 110.145 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.813 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 89.3 mt-30 -153.97 131.83 11.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.934 -1.485 . . . . 0.0 108.146 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 1.043 ' HA ' HD22 ' A' ' 137' ' ' LEU . 60.1 mtp85 -62.81 74.55 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 -178.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.769 ' CG2' HG22 ' A' ' 31' ' ' VAL . 29.7 mm -116.56 124.2 72.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.081 HD11 ' HB2' ' A' ' 72' ' ' LEU . 1.9 pp -127.67 145.51 34.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -177.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.651 HG22 ' O ' ' A' ' 46' ' ' LEU . 33.7 m -127.44 136.33 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.123 179.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.969 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 1.3 mt -116.44 147.92 19.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.785 0.803 . . . . 0.0 110.698 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 1.016 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 33.2 t70 -136.07 30.23 3.04 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.217 -178.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.815 HG22 HG22 ' A' ' 44' ' ' ILE . 24.4 t -98.15 112.4 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.16 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.612 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 78.6 p -39.95 76.38 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -178.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.801 ' OE2' HD12 ' A' ' 126' ' ' LEU . 34.6 tp10 -75.72 -11.5 60.01 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.41 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.635 ' OD1' ' HG2' ' A' ' 66' ' ' ARG . 10.3 t-20 -164.41 -136.14 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.877 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.635 ' HG2' ' OD1' ' A' ' 65' ' ' ASN . 26.7 mmm180 -76.02 -58.78 3.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.84 0.353 . . . . 0.0 111.166 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.23 130.32 40.53 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.015 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.612 ' HG2' ' HA ' ' A' ' 63' ' ' SER . 49.8 mt-10 -86.42 121.19 28.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.871 178.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.629 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 72.9 ttt180 172.48 76.28 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.401 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.969 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 65.0 mt -104.28 133.1 49.77 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.804 ' C ' HD22 ' A' ' 72' ' ' LEU . 14.5 p -135.01 134.38 53.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.291 177.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.081 ' HB2' HD11 ' A' ' 58' ' ' ILE . 3.0 mm? -140.01 141.73 36.3 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 177.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.985 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 3.5 mm -120.43 134.32 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 121.232 0.539 . . . . 0.0 111.548 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.7 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 6.7 m120 51.36 38.68 0.54 Allowed Pre-proline 0 C--N 1.317 -0.807 0 CA-C-N 115.217 -0.902 . . . . 0.0 112.323 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.77 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 84.5 Cg_exo -54.92 149.78 40.7 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.974 2.449 . . . . 0.0 114.104 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.44 ' O ' ' HB ' ' A' ' 108' ' ' ILE . 15.7 pt-20 -135.79 142.36 44.89 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.809 HD23 ' N ' ' A' ' 78' ' ' LEU . 1.7 tt -81.79 134.21 35.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.643 0.735 . . . . 0.0 111.806 -178.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.116 HD11 ' HG3' ' A' ' 109' ' ' ARG . 6.7 mp -110.74 -37.51 5.41 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.691 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.569 ' C ' ' HE2' ' A' ' 80' ' ' LYS . 85.2 tt0 -160.28 153.71 22.19 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.186 0.517 . . . . 0.0 111.782 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.901 ' HA ' HG12 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -148.03 151.7 36.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.378 179.125 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.7 m -160.46 141.55 12.06 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.578 0.228 . . . . 0.0 110.984 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.783 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 80.35 168.33 38.0 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.235 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -146.26 113.73 6.33 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.672 0.749 . . . . 0.0 112.926 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.554 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.5 p -99.54 160.91 13.94 Favored 'General case' 0 CA--C 1.49 -1.331 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.718 ' O ' HD13 ' A' ' 86' ' ' ILE . . . -134.44 100.51 0.38 Allowed Glycine 0 C--N 1.317 -0.475 0 CA-C-N 113.064 -1.88 . . . . 0.0 111.132 178.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.718 HD13 ' O ' ' A' ' 85' ' ' GLY . 39.5 mm -143.73 135.51 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -178.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.645 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 49.0 mt-10 -72.96 143.89 47.48 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 122.389 1.09 . . . . 0.0 112.499 -178.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.67 ' HB3' H262 ' A' ' 149' ' ' BB2 . 50.4 mt-10 -154.16 166.15 34.0 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 113.619 -1.628 . . . . 0.0 109.053 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.771 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -119.87 159.61 14.89 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 119.304 -1.427 . . . . 0.0 109.623 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.855 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 69.2 m -111.71 138.83 47.76 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.552 -177.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.036 HD12 HG11 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -50.04 -32.36 15.24 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.535 0.683 . . . . 0.0 110.0 -179.636 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.792 ' HB2' HG12 ' A' ' 8' ' ' ILE . 11.4 m -77.78 -27.14 50.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.7 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.749 HG13 ' HB2' ' A' ' 90' ' ' CYS . 48.5 mt -85.96 148.3 47.76 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.617 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.722 ' HD2' ' CG2' ' A' ' 93' ' ' ILE . 59.3 Cg_endo -78.24 47.67 2.46 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.438 2.092 . . . . 0.0 114.14 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.577 ' HB2' ' O ' ' A' ' 94' ' ' PRO . 7.9 mp0 80.22 4.66 1.84 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.827 0.346 . . . . 0.0 111.653 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.61 ' HG3' ' HG2' ' A' ' 94' ' ' PRO . 84.7 mt-30 -77.97 90.02 4.15 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 1.014 HH11 H231 ' A' ' 149' ' ' BB2 . 81.1 mtm180 -84.13 133.47 34.62 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.652 0.739 . . . . 0.0 111.377 -178.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.84 148.28 49.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.874 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.682 HD23 ' N ' ' A' ' 100' ' ' VAL . 6.9 tt -75.23 135.73 40.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.208 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 1.015 HG13 ' HB2' ' A' ' 142' ' ' PHE . 55.8 t -131.97 131.49 22.61 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.173 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.896 ' HG2' ' CE2' ' A' ' 142' ' ' PHE . 74.3 Cg_endo -78.24 125.43 7.1 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.692 1.595 . . . . 0.0 113.137 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.892 ' HG2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -141.42 165.51 27.31 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.413 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.783 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -69.38 154.75 41.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.727 0.299 . . . . 0.0 110.513 -178.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -73.41 -43.33 60.68 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.243 -176.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.782 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 84.2 mttt -139.47 138.19 36.19 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.416 0.627 . . . . 0.0 109.624 176.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.901 HG12 ' HA ' ' A' ' 80' ' ' LYS . 28.3 m -144.52 140.38 23.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.991 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 1.052 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 23.6 mmtp -107.99 125.92 52.1 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 1.056 ' HA ' HD13 ' A' ' 78' ' ' LEU . 1.9 pp -132.0 161.36 41.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -177.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 1.116 ' HG3' HD11 ' A' ' 78' ' ' LEU . 92.2 mtt180 -109.58 137.53 47.28 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.782 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.73 ' HB3' HD12 ' A' ' 72' ' ' LEU . . . -155.1 166.5 33.38 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.655 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.985 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.0 pp -116.46 150.47 37.81 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.623 ' O ' HD12 ' A' ' 111' ' ' LEU . 22.0 t70 -84.0 171.33 13.06 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.579 -175.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.776 ' HD2' ' OD1' ' A' ' 32' ' ' ASP . 50.8 ttp180 -54.49 -23.43 16.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.798 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.52 -14.41 58.89 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.873 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.868 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 93.15 40.09 4.94 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.02 -1.086 . . . . 0.0 114.593 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -128.11 102.49 21.49 Favored Pre-proline 0 N--CA 1.469 0.479 0 CA-C-N 117.59 0.695 . . . . 0.0 110.389 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.668 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 32.3 Cg_exo -73.56 115.23 4.26 Favored 'Trans proline' 0 C--N 1.359 1.108 0 N-CA-C 116.249 1.596 . . . . 0.0 116.249 -177.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.64 168.95 13.01 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.739 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.667 ' HG2' ' HG2' ' A' ' 109' ' ' ARG . 36.1 mt-10 -107.6 130.03 54.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.008 0.432 . . . . 0.0 110.278 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.751 HD11 ' CD1' ' A' ' 130' ' ' ILE . 4.1 pp -126.71 134.27 50.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.804 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 1.052 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 15.5 pt-20 -96.79 124.35 40.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.004 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.739 ' O ' ' HB2' ' A' ' 127' ' ' ALA . . . -116.71 135.79 53.49 Favored 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.782 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.3 m-20 -125.99 164.71 20.24 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.737 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 45.14 -132.53 8.26 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 120.627 1.558 . . . . 0.0 116.194 177.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.678 HD12 ' H ' ' A' ' 125' ' ' LEU . 5.0 mp -54.09 -35.83 62.53 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.739 -0.731 . . . . 0.0 111.361 -178.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.801 HD12 ' OE2' ' A' ' 64' ' ' GLU . 0.6 OUTLIER -70.44 -53.02 18.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.581 0.705 . . . . 0.0 109.655 179.721 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -58.46 -41.09 84.38 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.884 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.892 HD12 ' HG2' ' A' ' 102' ' ' ARG . 51.0 mm -68.8 -54.87 18.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.522 -178.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.885 ' HB2' H112 ' A' ' 149' ' ' BB2 . 31.4 p -57.77 -50.33 73.61 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.824 HD11 HD11 ' A' ' 108' ' ' ILE . 20.6 tt -60.07 -43.9 93.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.609 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.878 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 23.3 pt20 -66.97 -37.42 84.21 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.231 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.629 ' HA ' ' OD1' ' A' ' 135' ' ' ASP . 8.5 t-160 -56.04 -47.11 78.48 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.815 ' HG2' H102 ' A' ' 149' ' ' BB2 . 3.8 mm-40 -60.68 -43.03 98.21 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.711 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.784 ' HE1' ' N ' ' A' ' 77' ' ' LEU . 76.2 mtp -61.0 -49.49 77.24 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.453 0.569 . . . . 0.0 111.66 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.708 ' OD2' HD13 ' A' ' 141' ' ' LEU . 6.6 p-10 -65.18 -45.85 83.19 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.552 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.898 ' CB ' HD11 ' A' ' 141' ' ' LEU . 18.3 t-80 -59.67 -52.34 65.93 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 121.9 -0.5 . . . . 0.0 112.035 -178.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 1.043 HD22 ' HA ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER -62.51 -29.41 70.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.656 -177.206 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.933 ' CG2' HG13 ' A' ' 16' ' ' VAL . 8.4 p -81.15 21.56 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 CA-C-O 123.067 1.413 . . . . 0.0 107.816 173.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.799 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 56.16 24.7 44.93 Favored Glycine 0 CA--C 1.487 -1.7 0 CA-C-N 111.934 -2.394 . . . . 0.0 112.587 176.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.91 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 6.2 ptmt -115.27 117.33 30.18 Favored 'General case' 0 N--CA 1.427 -1.576 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.435 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.898 HD11 ' CB ' ' A' ' 136' ' ' HIS . 3.6 mm? -135.88 147.7 48.3 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 1.015 ' HB2' HG13 ' A' ' 100' ' ' VAL . 4.1 m-85 -61.97 -32.64 73.1 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.969 ' HA ' ' HG ' ' A' ' 146' ' ' LEU . 23.5 ttt -51.92 -24.19 6.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.16 0.505 . . . . 0.0 111.697 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -48.96 -24.32 1.45 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.965 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -129.73 44.87 2.9 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 120.701 0.286 . . . . 0.0 111.034 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.969 ' HG ' ' HA ' ' A' ' 143' ' ' MET . 34.9 mt -93.79 142.39 27.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.135 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 45.5 t . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.952 179.403 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' BB2 . . . . . 1.014 H231 HH11 ' A' ' 97' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.8 t . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.876 0.37 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.7 m -84.09 138.49 19.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.771 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.968 HD23 ' HB ' ' A' ' 51' ' ' VAL . 61.5 tp -77.45 162.37 27.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.374 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -78.82 106.48 10.86 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.251 0.548 . . . . 0.0 110.282 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.677 HG22 HG12 ' A' ' 51' ' ' VAL . 33.4 t -89.93 131.69 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.788 -178.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.828 ' CD1' ' HA ' ' A' ' 52' ' ' ASP . 39.1 mt -89.49 149.35 22.95 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.135 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.582 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 1.9 m80 -124.37 149.79 46.26 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.61 HD12 ' H ' ' A' ' 8' ' ' ILE . 2.9 mp -55.81 145.54 51.71 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.835 178.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.517 ' HA ' HG23 ' A' ' 8' ' ' ILE . 71.5 Cg_endo -92.35 51.19 1.06 Allowed 'Cis proline' 0 C--N 1.355 0.916 0 C-N-CA 124.572 -1.012 . . . . 0.0 112.915 0.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.693 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 9.9 t70 -55.65 130.86 44.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.896 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -59.17 -40.13 84.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.016 0.436 . . . . 0.0 111.139 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.647 ' HB2' HD13 ' A' ' 6' ' ' LEU . 19.0 mmt-85 -57.65 -26.07 61.09 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.645 0.979 . . . . 0.0 113.645 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.792 HD21 ' HB2' ' A' ' 6' ' ' LEU . 8.8 mt -76.21 -33.24 59.26 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 120.61 1.55 . . . . 0.0 108.434 177.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.873 ' NH1' ' HB2' ' A' ' 144' ' ' ASP . 32.1 mmt180 -91.82 7.99 39.28 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.631 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.537 ' HD3' ' HB3' ' A' ' 54' ' ' HIS . 87.8 tttt -88.3 148.39 24.33 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.089 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.763 HG13 HG23 ' A' ' 138' ' ' VAL . 97.1 t -82.68 128.79 38.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.936 ' HB3' HD12 ' A' ' 137' ' ' LEU . . . -86.24 143.57 27.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.394 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.811 ' HD3' ' CD ' ' A' ' 19' ' ' PRO . 7.6 tmtt? -106.33 130.16 23.39 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.889 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 60.9 Cg_endo -78.14 116.47 3.93 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.342 2.028 . . . . 0.0 111.26 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.747 HG12 ' H ' ' A' ' 22' ' ' GLU . 19.3 t -67.08 144.7 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-O 122.803 1.287 . . . . 0.0 113.14 -175.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.96 -24.51 67.92 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 112.57 -2.105 . . . . 0.0 112.68 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.747 ' H ' HG12 ' A' ' 20' ' ' VAL . 88.6 tt0 -161.01 143.52 12.54 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.975 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.57 HG21 ' HA2' ' A' ' 115' ' ' GLY . 3.3 t -79.55 107.7 12.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 1.041 ' H ' HD12 ' A' ' 27' ' ' ILE . 57.4 m-80 -98.06 158.51 15.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.686 -178.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.73 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -55.72 -23.82 31.21 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.215 0.531 . . . . 0.0 110.678 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.513 ' HA ' ' OE1' ' A' ' 26' ' ' GLU . 4.3 mm-40 -74.05 -41.83 61.18 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 176.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 1.041 HD12 ' H ' ' A' ' 24' ' ' ASN . 69.0 mt -64.01 -48.24 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.245 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -57.15 -40.06 76.48 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.73 ' HG3' ' O ' ' A' ' 25' ' ' ALA . 99.3 mtt180 -61.76 -39.8 92.93 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.747 ' CG2' HD13 ' A' ' 53' ' ' ILE . 4.1 mt -56.91 -50.01 77.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 114.832 -1.076 . . . . 0.0 112.075 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.766 HG22 ' CG2' ' A' ' 57' ' ' ILE . 10.5 t -68.58 -42.16 83.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 120.842 0.353 . . . . 0.0 111.432 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.813 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -55.76 -39.48 71.26 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.33 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.497 ' HB3' ' HB2' ' A' ' 3' ' ' LEU . 31.6 m-20 -76.07 -30.45 58.35 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.985 175.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.98 ' HE1' HG22 ' A' ' 57' ' ' ILE . 15.2 mtm -60.58 -46.66 89.42 Favored 'General case' 0 C--N 1.347 0.465 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.44 -177.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.813 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 14.0 p90 -69.05 -46.43 67.91 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.555 ' HG2' ' O ' ' A' ' 32' ' ' ASP . 27.2 mm-40 -51.05 -38.57 52.31 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.672 HG21 ' CG2' ' A' ' 5' ' ' VAL . 57.5 m -69.83 -62.31 1.44 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 118.725 -1.19 . . . . 0.0 108.272 177.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.932 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 2.9 ttp -46.58 -44.25 17.9 Favored 'General case' 0 CA--C 1.458 -2.578 0 C-N-CA 124.016 0.926 . . . . 0.0 110.412 -170.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.713 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 70.0 m-85 -67.67 -41.73 83.24 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.794 178.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.38 -26.67 66.82 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.773 0.796 . . . . 0.0 109.038 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.965 ' HG2' HD12 ' A' ' 91' ' ' LEU . 2.6 tp10 -86.74 -10.89 52.63 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 114.361 -1.29 . . . . 0.0 109.155 177.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.445 ' H ' ' C ' ' A' ' 39' ' ' TYR . 27.7 mm-40 63.94 26.6 14.22 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.107 -176.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.979 ' HA2' H182 ' A' ' 149' ' ' BB2 . . . -80.56 144.49 25.54 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.111 178.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.857 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 46.0 mm -79.25 -3.93 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 117.631 0.715 . . . . 0.0 112.141 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.738 ' HA3' ' C11' ' A' ' 149' ' ' BB2 . . . 179.19 137.9 3.07 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-O 119.109 -0.828 . . . . 0.0 111.302 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.067 HD13 ' HG ' ' A' ' 91' ' ' LEU . 2.3 tp -124.39 135.22 53.12 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.285 1.542 . . . . 0.0 110.828 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -103.68 130.62 51.18 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 122.085 -0.384 . . . . 0.0 111.299 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.956 ' HB1' HG13 ' A' ' 53' ' ' ILE . . . -28.51 -57.99 0.13 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 116.647 2.092 . . . . 0.0 116.647 -177.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.519 ' CG2' ' HA ' ' A' ' 137' ' ' LEU . 74.9 p -53.42 -34.69 58.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 122.098 0.951 . . . . 0.0 111.478 -177.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.621 ' HG2' ' CE1' ' A' ' 136' ' ' HIS . 23.2 mt-30 -63.56 -38.47 91.26 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 113.929 -1.487 . . . . 0.0 110.686 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.968 ' HB ' HD23 ' A' ' 3' ' ' LEU . 1.5 m -92.52 19.44 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.828 ' HA ' ' CD1' ' A' ' 6' ' ' LEU . 37.5 t70 78.25 25.99 0.58 Allowed 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 176.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.956 HG13 ' HB1' ' A' ' 48' ' ' ALA . 11.9 pt -120.36 108.56 23.38 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.131 177.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.554 ' HD2' ' HE ' ' A' ' 12' ' ' ARG . 7.8 p80 -75.41 51.2 0.56 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-O 122.16 0.981 . . . . 0.0 109.905 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.546 ' O ' HG12 ' A' ' 57' ' ' ILE . 83.2 mt-30 -139.01 132.52 30.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 113.892 -1.504 . . . . 0.0 107.716 178.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.889 ' HD2' ' HD3' ' A' ' 19' ' ' PRO . 96.0 mtt180 -61.79 72.52 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -178.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.98 HG22 ' HE1' ' A' ' 34' ' ' MET . 10.3 mm -116.35 122.75 70.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.101 HD11 ' HB2' ' A' ' 72' ' ' LEU . 1.8 pp -127.0 145.4 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 -177.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.61 ' CG2' ' HB3' ' A' ' 46' ' ' LEU . 33.9 m -128.71 134.95 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.362 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.045 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 1.6 mt -116.54 145.45 22.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.504 0.669 . . . . 0.0 110.344 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.932 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 28.0 t70 -124.69 16.29 8.75 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.391 -178.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.787 HG22 ' CG2' ' A' ' 44' ' ' ILE . 29.8 t -88.05 114.04 26.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.598 178.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.547 ' N ' ' HG2' ' A' ' 68' ' ' GLU . 81.4 p -42.42 81.51 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.683 ' HB2' HD11 ' A' ' 70' ' ' LEU . 65.0 mm-40 -128.84 -17.38 4.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.47 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.603 ' O ' ' HG2' ' A' ' 66' ' ' ARG . 43.3 t30 -105.06 -35.19 7.72 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 122.015 -0.428 . . . . 0.0 110.886 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.864 ' HE ' ' HA ' ' A' ' 66' ' ' ARG . 2.4 mmp_? -161.34 -91.13 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 68' ' ' GLU . 1.4 m-20 -130.23 55.52 1.8 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.153 177.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.547 ' HG2' ' N ' ' A' ' 63' ' ' SER . 94.7 mt-10 71.78 101.38 0.07 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.997 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.552 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 35.5 ttt85 175.2 64.11 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.83 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 1.045 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 63.8 mt -102.69 135.16 44.84 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.721 ' CG2' HG11 ' A' ' 31' ' ' VAL . 12.5 p -134.74 130.5 52.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.083 178.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.101 ' HB2' HD11 ' A' ' 58' ' ' ILE . 90.6 mt -141.37 142.2 33.78 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.59 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.049 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.6 mp -121.27 134.87 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-O 120.652 0.263 . . . . 0.0 110.901 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.709 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 7.2 m120 57.02 37.56 0.38 Allowed Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.914 ' HG2' HG12 ' A' ' 58' ' ' ILE . 88.4 Cg_exo -56.59 145.72 79.48 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 122.838 2.359 . . . . 0.0 114.101 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.487 ' HG2' ' HB2' ' A' ' 109' ' ' ARG . 15.2 pt-20 -136.89 142.22 42.75 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.786 HD23 ' N ' ' A' ' 78' ' ' LEU . 1.7 tt -81.84 133.27 35.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.375 0.607 . . . . 0.0 111.753 -178.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.114 HD13 ' HA ' ' A' ' 108' ' ' ILE . 4.8 mp -108.82 -39.14 5.43 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.997 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.443 ' O ' HD21 ' A' ' 77' ' ' LEU . 42.4 tt0 -156.36 152.83 28.06 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 121.192 0.52 . . . . 0.0 111.764 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 1.056 ' HA ' HG12 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -147.28 149.81 33.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.936 179.385 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.3 p -160.07 152.94 21.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.79 0.329 . . . . 0.0 111.571 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.684 ' C ' ' HG3' ' A' ' 104' ' ' GLU . . . 73.63 146.33 0.92 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.749 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.408 ' N ' ' HG3' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -110.98 112.62 24.58 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 121.631 0.729 . . . . 0.0 111.229 -179.771 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 1.035 HG23 ' HG2' ' A' ' 104' ' ' GLU . 1.6 p -114.81 160.94 18.86 Favored 'General case' 0 CA--C 1.484 -1.595 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.801 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -155.83 123.26 1.3 Allowed Glycine 0 C--N 1.311 -0.855 0 CA-C-N 113.01 -1.904 . . . . 0.0 110.95 178.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.451 ' N ' ' HG ' ' A' ' 99' ' ' LEU . 34.4 mt -147.34 139.18 18.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-N 117.643 0.722 . . . . 0.0 111.834 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 56.1 mt-10 -71.23 135.15 47.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 123.538 1.637 . . . . 0.0 112.349 -176.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.758 ' HG2' ' O27' ' A' ' 149' ' ' BB2 . 41.0 mt-10 -154.24 166.61 32.61 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 112.132 -2.304 . . . . 0.0 111.425 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.791 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -120.73 163.3 14.32 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.847 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 65.1 m -109.64 137.42 47.49 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.865 0.364 . . . . 0.0 110.926 -177.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.067 ' HG ' HD13 ' A' ' 46' ' ' LEU . 3.1 mm? -51.53 -38.66 55.24 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.73 0.776 . . . . 0.0 109.719 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.64 ' CB ' HD13 ' A' ' 13' ' ' LEU . 22.8 m -77.12 -26.66 53.45 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.59 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.754 ' CG1' ' HB2' ' A' ' 90' ' ' CYS . 53.1 mt -85.31 149.52 52.48 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.738 ' HD2' HG23 ' A' ' 93' ' ' ILE . 66.6 Cg_endo -75.68 47.08 1.81 Allowed 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.118 1.878 . . . . 0.0 115.446 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.569 ' HB2' ' O ' ' A' ' 94' ' ' PRO . 8.3 mp0 77.26 11.54 2.28 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.607 ' HG2' ' HG2' ' A' ' 94' ' ' PRO . 9.7 mm-40 -78.69 88.99 4.57 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.791 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 18.4 mtm105 -84.86 132.13 34.43 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.852 0.834 . . . . 0.0 111.638 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 87' ' ' GLU . . . -135.15 155.55 50.51 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.273 -1.33 . . . . 0.0 109.22 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.801 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.5 tt -76.52 110.86 11.42 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.828 0.823 . . . . 0.0 111.532 -177.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.97 HG13 ' HB2' ' A' ' 142' ' ' PHE . 40.3 t -98.4 126.16 40.53 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 114.415 -1.266 . . . . 0.0 112.021 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.607 ' HG2' ' CD2' ' A' ' 142' ' ' PHE . 81.7 Cg_endo -78.84 126.55 7.31 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.318 2.012 . . . . 0.0 112.277 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.89 ' HG2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -145.03 166.77 24.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.637 179.011 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.59 154.94 40.95 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.208 0.527 . . . . 0.0 110.283 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 1.035 ' HG2' HG23 ' A' ' 84' ' ' THR . 50.0 mt-10 -73.61 -42.19 61.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.645 -176.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.797 ' NZ ' ' HB3' ' A' ' 123' ' ' ASP . 66.5 mttm -140.41 139.62 35.3 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 1.056 HG12 ' HA ' ' A' ' 80' ' ' LYS . 28.7 m -149.98 141.63 17.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.437 -178.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.697 ' CE ' ' HB3' ' A' ' 121' ' ' GLU . 0.4 OUTLIER -107.65 125.15 51.0 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.46 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 1.114 ' HA ' HD13 ' A' ' 78' ' ' LEU . 1.4 pp -135.42 151.8 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -176.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 1.042 ' HG3' HD11 ' A' ' 78' ' ' LEU . 94.2 mtt180 -100.81 138.54 37.73 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 122.214 1.007 . . . . 0.0 111.128 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.842 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -158.8 169.35 24.57 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.759 -176.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 1.049 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.9 pp -120.27 154.78 34.46 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.455 ' O ' HD12 ' A' ' 111' ' ' LEU . 25.1 t70 -88.15 164.43 15.69 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.443 0.64 . . . . 0.0 111.991 -176.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.72 ' HB2' HG11 ' A' ' 71' ' ' VAL . 24.6 ttm180 -52.62 -20.29 2.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.055 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -81.88 -22.22 37.0 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.03 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.57 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 105.11 35.86 3.06 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 119.893 -1.146 . . . . 0.0 113.857 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -128.62 102.4 20.16 Favored Pre-proline 0 C--O 1.235 0.325 0 CA-C-N 117.344 0.572 . . . . 0.0 111.185 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.676 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 36.4 Cg_exo -74.03 116.72 4.75 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 121.914 1.743 . . . . 0.0 115.715 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.427 ' N ' ' O ' ' A' ' 110' ' ' ALA . 0.5 OUTLIER -129.04 165.78 20.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.418 -179.278 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.84 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 5.8 mp0 -107.72 135.19 49.56 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.888 ' O ' HD23 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -132.39 142.26 49.22 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.679 0.752 . . . . 0.0 111.911 -179.137 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.697 ' HB3' ' CE ' ' A' ' 107' ' ' LYS . 15.2 pt-20 -94.13 123.44 37.51 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.877 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.895 ' CB ' ' HG ' ' A' ' 126' ' ' LEU . . . -115.85 134.47 54.96 Favored 'General case' 0 C--O 1.22 -0.489 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.572 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.797 ' HB3' ' NZ ' ' A' ' 105' ' ' LYS . 38.7 m-20 -127.04 162.19 26.64 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.78 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 48.42 -134.77 19.25 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 120.436 1.471 . . . . 0.0 115.491 177.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.657 HD22 ' H ' ' A' ' 125' ' ' LEU . 2.6 mm? -53.84 -35.17 61.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.052 -0.574 . . . . 0.0 111.34 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.895 ' HG ' ' CB ' ' A' ' 122' ' ' ALA . 3.7 tp -70.22 -52.34 23.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.372 0.606 . . . . 0.0 109.81 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.779 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -58.93 -42.94 90.91 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.328 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.89 HD12 ' HG2' ' A' ' 102' ' ' ARG . 47.1 mm -67.17 -56.11 14.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.987 ' HB2' H112 ' A' ' 149' ' ' BB2 . 31.4 p -56.47 -50.21 72.4 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 1.037 HD11 HD11 ' A' ' 108' ' ' ILE . 19.1 tt -58.91 -44.24 90.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.155 -178.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.876 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 23.1 pt20 -68.16 -37.77 81.38 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.071 178.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.726 ' HA ' ' OD2' ' A' ' 135' ' ' ASP . 10.9 t-160 -56.58 -50.0 73.23 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.57 0.7 . . . . 0.0 110.105 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.953 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.2 mm-40 -60.1 -42.24 94.27 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.576 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.878 ' HA ' HD21 ' A' ' 137' ' ' LEU . 74.2 mtp -57.18 -48.74 77.99 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.279 0.562 . . . . 0.0 111.059 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.726 ' OD2' ' HA ' ' A' ' 132' ' ' HIS . 3.3 p30 -66.38 -46.53 76.35 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.416 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.96 ' CE1' HD21 ' A' ' 141' ' ' LEU . 10.7 t-80 -56.12 -51.46 67.84 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.489 0.661 . . . . 0.0 110.768 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.953 HD23 ' O ' ' A' ' 133' ' ' GLU . 1.2 pp -61.35 -30.16 70.35 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.955 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.966 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 14.6 p -86.58 25.94 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-O 122.292 1.044 . . . . 0.0 109.549 176.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.614 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 59.32 15.31 30.43 Favored Glycine 0 CA--C 1.49 -1.511 0 CA-C-N 113.395 -1.73 . . . . 0.0 113.359 176.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.966 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 9.9 ptmt -110.15 119.68 40.06 Favored 'General case' 0 N--CA 1.424 -1.746 0 C-N-CA 119.617 -0.833 . . . . 0.0 108.932 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.96 HD21 ' CE1' ' A' ' 136' ' ' HIS . 9.4 mp -133.56 138.8 46.22 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.336 -0.853 . . . . 0.0 108.753 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.97 ' HB2' HG13 ' A' ' 100' ' ' VAL . 20.1 m-85 -63.81 -33.25 75.26 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 121.985 -0.447 . . . . 0.0 111.661 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 1.035 ' HA ' HD23 ' A' ' 146' ' ' LEU . 16.1 tpt -52.01 -23.88 5.82 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.336 0.589 . . . . 0.0 111.213 178.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.873 ' HB2' ' NH1' ' A' ' 14' ' ' ARG . 38.8 t70 -49.23 -25.04 2.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.681 -178.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -130.05 46.19 2.69 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.141 -177.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 1.035 HD23 ' HA ' ' A' ' 143' ' ' MET . 3.7 mm? -91.28 140.75 29.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.902 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 48.1 t . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.194 -0.908 . . . . 0.0 111.024 179.453 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' BB2 . . . . . 0.987 H112 ' HB2' ' A' ' 129' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.598 ' O ' ' HB3' ' A' ' 36' ' ' GLU . 47.4 t . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.841 0.353 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.725 HG13 ' HA ' ' A' ' 37' ' ' THR . 43.2 t -119.78 138.47 50.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.227 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 1.027 HD23 ' HB ' ' A' ' 51' ' ' VAL . 58.5 tp -77.11 165.74 24.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.404 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -78.82 107.11 11.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.084 0.469 . . . . 0.0 110.271 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.652 ' CG2' HG21 ' A' ' 37' ' ' THR . 39.0 t -89.69 131.58 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.652 -178.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.09 ' HB2' HD21 ' A' ' 13' ' ' LEU . 16.7 mt -93.52 141.33 28.59 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.497 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 35.2 m-70 -117.92 145.29 44.77 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.084 HD13 HD12 ' A' ' 13' ' ' LEU . 49.8 mm -61.0 133.56 92.58 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.229 177.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.66 145.35 69.87 Favored 'Cis proline' 0 C--N 1.353 0.779 0 C-N-CA 124.51 -1.037 . . . . 0.0 111.951 -0.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.992 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 8.8 t70 -165.04 127.1 2.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.402 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 16.1 pt-20 -58.44 -45.79 87.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.658 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.589 ' O ' ' HB ' ' A' ' 49' ' ' THR . 15.1 mmt85 -56.59 -27.97 59.21 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 1.09 HD21 ' HB2' ' A' ' 6' ' ' LEU . 10.0 mt -77.01 -35.09 57.3 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 120.585 1.539 . . . . 0.0 107.972 177.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.774 ' HB3' ' NH1' ' A' ' 14' ' ' ARG . 2.1 mmm180 -89.2 11.18 19.48 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.802 -1.545 . . . . 0.0 109.395 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.763 ' HD3' ' HB3' ' A' ' 54' ' ' HIS . 59.5 tttp -85.6 137.71 32.67 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.568 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.914 HG13 HG23 ' A' ' 138' ' ' VAL . 58.4 t -84.1 94.4 3.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.237 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.794 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -54.0 148.31 10.95 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -106.43 132.73 20.66 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.798 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.643 ' HD3' ' HD3' ' A' ' 56' ' ' ARG . 66.1 Cg_endo -78.2 114.72 3.61 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.174 1.916 . . . . 0.0 110.684 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.817 HG12 ' H ' ' A' ' 22' ' ' GLU . 17.8 t -69.14 144.4 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-O 122.521 1.153 . . . . 0.0 113.126 -175.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.47 -24.55 67.87 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 113.311 -1.768 . . . . 0.0 111.867 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.817 ' H ' HG12 ' A' ' 20' ' ' VAL . 42.4 tt0 -161.16 140.71 10.51 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.864 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.509 HG22 HD21 ' A' ' 111' ' ' LEU . 2.8 t -78.96 110.95 15.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 1.033 ' H ' HD12 ' A' ' 27' ' ' ILE . 60.8 m-80 -92.98 163.3 13.72 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.613 0.244 . . . . 0.0 110.995 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.606 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -56.04 -30.67 62.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.993 0.425 . . . . 0.0 110.819 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.723 ' O ' HD13 ' A' ' 30' ' ' ILE . 55.7 mt-10 -71.72 -40.07 69.71 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 1.033 HD12 ' H ' ' A' ' 24' ' ' ASN . 58.3 mt -62.7 -46.64 95.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.911 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.564 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 13.1 mt-30 -57.92 -39.23 77.49 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.597 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.606 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 41.0 mmt-85 -60.16 -40.98 91.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.864 0.84 . . . . 0.0 108.987 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.809 ' O ' ' HG3' ' A' ' 34' ' ' MET . 1.6 mp -58.89 -48.61 85.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 114.455 -1.248 . . . . 0.0 112.119 179.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.895 HG22 ' CG2' ' A' ' 57' ' ' ILE . 6.5 t -68.33 -41.81 83.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-O 120.845 0.355 . . . . 0.0 111.448 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.873 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -55.27 -42.36 73.48 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.526 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.545 ' HB3' ' HB2' ' A' ' 3' ' ' LEU . 56.8 m-20 -75.95 -30.18 58.58 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.632 176.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 1.063 ' HG2' HG21 ' A' ' 51' ' ' VAL . 83.7 mtp -59.86 -47.09 87.15 Favored 'General case' 0 C--N 1.347 0.473 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.531 -177.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.873 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 14.4 p90 -69.49 -44.28 71.44 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.774 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 76.6 mt-10 -51.78 -40.66 60.72 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.725 ' HA ' HG13 ' A' ' 2' ' ' VAL . 41.8 m -68.84 -61.92 1.6 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.576 -1.193 . . . . 0.0 107.864 178.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.895 ' HG3' ' HB2' ' A' ' 46' ' ' LEU . 2.8 ttp -46.11 -41.72 12.76 Favored 'General case' 0 CA--C 1.458 -2.581 0 C-N-CA 124.103 0.961 . . . . 0.0 110.21 -170.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.717 ' OH ' ' HA ' ' A' ' 69' ' ' ARG . 48.2 m-85 -69.22 -41.79 76.58 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.328 178.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.0 -27.45 68.32 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.611 0.72 . . . . 0.0 109.139 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 1.026 ' HG2' HD12 ' A' ' 91' ' ' LEU . 10.5 tp10 -85.53 -10.69 55.64 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.795 176.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.442 ' H ' ' C ' ' A' ' 39' ' ' TYR . 20.7 mt-10 62.21 28.62 17.15 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.859 0.838 . . . . 0.0 109.95 -176.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.458 ' HA2' H182 ' A' ' 149' ' ' BB2 . . . -83.43 143.41 21.76 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 114.0 -1.455 . . . . 0.0 111.122 178.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.812 ' CG2' HG22 ' A' ' 62' ' ' VAL . 47.7 mt -78.98 -2.54 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 117.709 0.754 . . . . 0.0 111.976 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.904 ' HA3' H113 ' A' ' 149' ' ' BB2 . . . 179.83 133.59 2.03 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-O 119.102 -0.832 . . . . 0.0 111.606 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.089 HD13 ' HG ' ' A' ' 91' ' ' LEU . 4.1 tp -124.56 134.55 52.94 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 119.063 1.432 . . . . 0.0 111.329 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -101.06 129.69 46.97 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.871 ' HB1' ' CD1' ' A' ' 53' ' ' ILE . . . -27.21 -56.82 0.09 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 116.099 1.889 . . . . 0.0 116.099 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.614 HG21 ' O ' ' A' ' 137' ' ' LEU . 70.1 p -53.54 -34.38 58.01 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.8 0.81 . . . . 0.0 111.727 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.691 ' OE1' HD12 ' A' ' 46' ' ' LEU . 85.1 mt-30 -64.56 -40.9 96.4 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.347 -1.297 . . . . 0.0 109.947 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.063 HG21 ' HG2' ' A' ' 34' ' ' MET . 1.0 OUTLIER -87.86 15.73 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.889 ' HA ' HD11 ' A' ' 6' ' ' LEU . 38.2 t70 77.51 33.06 0.41 Allowed 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 176.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.871 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 1.1 pp -125.93 110.45 23.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 119.155 -1.018 . . . . 0.0 110.301 177.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.763 ' HB3' ' HD3' ' A' ' 15' ' ' LYS . 0.5 OUTLIER -75.91 63.53 1.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.472 -179.109 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.726 ' C ' ' HB1' ' A' ' 17' ' ' ALA . 69.1 mt-30 -154.53 133.85 12.58 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 114.196 -1.365 . . . . 0.0 108.535 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.794 ' N ' ' HB1' ' A' ' 17' ' ' ALA . 54.3 mtp85 -64.37 72.46 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -177.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.895 ' CG2' HG22 ' A' ' 31' ' ' VAL . 7.1 mm -115.27 125.03 72.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.976 HD11 ' HB2' ' A' ' 72' ' ' LEU . 2.1 pp -131.28 147.77 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 46' ' ' LEU . 33.4 m -127.72 139.74 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.485 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.029 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 7.4 mm -115.11 151.41 16.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.692 0.758 . . . . 0.0 110.033 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.817 ' HB2' ' CE ' ' A' ' 38' ' ' MET . 10.7 t70 -138.99 39.88 2.14 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.079 -178.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.812 HG22 ' CG2' ' A' ' 44' ' ' ILE . 33.1 t -105.92 111.47 35.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.359 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.737 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 61.9 m -34.1 89.77 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -175.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 1.056 ' HG3' HD11 ' A' ' 70' ' ' LEU . 55.5 mt-10 -62.08 -26.84 68.51 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 113.987 -1.461 . . . . 0.0 111.571 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.588 ' ND2' ' HG2' ' A' ' 66' ' ' ARG . 50.6 t30 -168.16 -85.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 122.221 1.01 . . . . 0.0 109.576 177.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.588 ' HG2' ' ND2' ' A' ' 65' ' ' ASN . 26.7 mmm180 -110.37 -55.66 2.44 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 114.093 -1.412 . . . . 0.0 111.107 178.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -99.5 131.68 45.34 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.752 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.737 ' HG2' ' HA ' ' A' ' 63' ' ' SER . 47.7 mt-10 -91.38 132.26 36.32 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.072 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.717 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 72.9 ttt180 175.39 71.79 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.413 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 1.056 HD11 ' HG3' ' A' ' 64' ' ' GLU . 6.1 mp -102.47 132.54 48.44 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.825 HG21 ' HB2' ' A' ' 113' ' ' ARG . 9.6 p -133.91 131.05 56.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.367 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.976 ' HB2' HD11 ' A' ' 58' ' ' ILE . 93.5 mt -141.16 139.04 33.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.924 -0.125 . . . . 0.0 110.999 178.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.013 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.7 mp -119.53 135.71 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-O 120.595 0.236 . . . . 0.0 110.944 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.709 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 8.1 m120 55.17 34.68 0.25 Allowed Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.839 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 88.8 Cg_exo -55.91 148.02 59.46 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.649 2.233 . . . . 0.0 113.482 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -136.93 143.28 42.82 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.815 HD23 ' N ' ' A' ' 78' ' ' LEU . 1.7 tt -80.47 135.04 36.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.782 0.801 . . . . 0.0 111.544 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.046 HD13 ' HA ' ' A' ' 108' ' ' ILE . 7.3 mp -110.45 -40.2 4.7 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.335 -1.302 . . . . 0.0 112.062 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 42.2 tt0 -160.34 154.0 22.5 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.179 0.514 . . . . 0.0 111.538 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.821 ' CB ' HG12 ' A' ' 106' ' ' VAL . 9.6 ptpp? -147.83 150.63 34.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.212 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.5 t -160.58 144.65 13.9 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.548 0.213 . . . . 0.0 110.958 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.791 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 81.24 169.85 42.6 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.85 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' A' ' 102' ' ' ARG . 87.9 tt0 -147.38 113.6 5.88 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 117.788 0.794 . . . . 0.0 113.116 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.4 p -98.72 159.9 14.63 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.642 ' CA ' HD21 ' A' ' 99' ' ' LEU . . . -137.87 103.02 0.4 Allowed Glycine 0 C--N 1.317 -0.528 0 CA-C-N 113.193 -1.821 . . . . 0.0 112.1 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.734 ' HB ' ' NH2' ' A' ' 102' ' ' ARG . 21.2 mt -147.07 138.92 18.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.612 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 56.3 mt-10 -71.09 143.47 50.63 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 122.682 1.229 . . . . 0.0 112.211 -178.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.693 ' HB3' H262 ' A' ' 149' ' ' BB2 . 93.3 mt-10 -157.8 161.45 38.41 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.581 -1.645 . . . . 0.0 109.754 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.897 ' O ' ' H52' ' A' ' 149' ' ' BB2 . . . -120.24 159.11 15.24 Favored Glycine 0 CA--C 1.501 -0.809 0 C-N-CA 119.44 -1.362 . . . . 0.0 110.184 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.774 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 16.4 m -112.9 138.35 49.89 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.61 0.719 . . . . 0.0 112.207 -177.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.089 ' HG ' HD13 ' A' ' 46' ' ' LEU . 2.3 mm? -48.96 -23.37 1.1 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.375 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.882 ' CB ' HG12 ' A' ' 8' ' ' ILE . 52.7 m -83.89 -34.98 24.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.158 0.504 . . . . 0.0 110.566 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.873 HD13 ' HB ' ' A' ' 8' ' ' ILE . 45.2 mm -85.53 149.68 52.25 Favored Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.418 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.839 ' HD2' HG23 ' A' ' 93' ' ' ILE . 91.8 Cg_endo -73.32 48.93 1.6 Allowed 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.605 2.203 . . . . 0.0 114.254 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.54 ' HB2' ' O ' ' A' ' 94' ' ' PRO . 56.3 mt-10 77.05 14.68 1.95 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.7 ' HB2' HG21 ' A' ' 93' ' ' ILE . 25.8 mt-30 -78.83 87.58 4.69 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.875 ' HG2' ' HA3' ' A' ' 89' ' ' GLY . 18.2 mtm105 -85.19 133.71 34.18 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.759 0.79 . . . . 0.0 111.87 -178.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 87' ' ' GLU . . . -134.53 154.28 51.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.353 -1.294 . . . . 0.0 109.993 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.713 HD23 ' N ' ' A' ' 100' ' ' VAL . 6.5 tt -74.9 136.29 41.45 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.713 ' N ' HD23 ' A' ' 99' ' ' LEU . 21.0 t -133.46 137.9 30.07 Favored Pre-proline 0 N--CA 1.454 -0.237 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.529 -178.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.737 ' HG2' ' CE2' ' A' ' 145' ' ' TYR . 90.5 Cg_endo -85.66 125.31 2.82 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 121.704 1.603 . . . . 0.0 113.574 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.856 ' HG2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -142.05 166.29 25.11 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 113.627 -1.624 . . . . 0.0 110.684 178.643 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.791 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.47 156.05 38.7 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 120.649 0.261 . . . . 0.0 110.519 -178.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -73.2 -44.55 59.55 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.505 -176.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.806 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 81.4 mttt -139.61 138.14 35.91 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 121.658 0.742 . . . . 0.0 109.694 177.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.857 HG22 ' HB1' ' A' ' 127' ' ' ALA . 33.8 m -139.85 138.23 38.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.939 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 1.132 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 53.2 mmtt -107.5 125.72 51.62 Favored 'General case' 0 C--O 1.224 -0.27 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 1.046 ' HA ' HD13 ' A' ' 78' ' ' LEU . 1.8 pp -131.23 162.97 38.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -177.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 1.035 ' HG3' HD11 ' A' ' 78' ' ' LEU . 94.9 mtt180 -112.05 139.01 47.92 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.998 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.764 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -158.06 167.3 30.25 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 120.729 0.3 . . . . 0.0 111.095 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 1.013 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.4 pp -115.48 153.97 30.17 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 177.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.416 ' O ' HD12 ' A' ' 111' ' ' LEU . 10.3 t70 -90.77 163.27 14.52 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.581 -177.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.825 ' HB2' HG21 ' A' ' 71' ' ' VAL . 46.3 ttp180 -51.6 -19.21 1.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.101 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -78.99 -26.67 43.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.532 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.35 35.0 2.77 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.132 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.613 ' NZ ' ' HB3' ' A' ' 116' ' ' LYS . 6.6 mtpm? -128.76 102.83 19.47 Favored Pre-proline 0 C--O 1.238 0.488 0 CA-C-N 116.799 0.3 . . . . 0.0 111.167 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.652 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 34.2 Cg_exo -74.14 116.56 4.68 Favored 'Trans proline' 0 C--N 1.36 1.164 0 C-N-CA 122.009 1.806 . . . . 0.0 114.903 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.0 167.92 14.65 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.32 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.673 ' HG2' ' HG2' ' A' ' 109' ' ' ARG . 78.9 mt-10 -107.68 129.99 54.97 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.953 0.406 . . . . 0.0 109.974 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.707 ' O ' HD12 ' A' ' 120' ' ' LEU . 4.1 pp -127.19 132.91 50.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.347 0.594 . . . . 0.0 112.084 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 1.132 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 23.0 pt-20 -92.0 125.63 36.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.527 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.931 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -116.08 135.56 53.83 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.806 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.1 m-20 -126.82 163.62 23.18 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.777 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 46.92 -135.5 10.78 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-N 119.787 1.176 . . . . 0.0 115.811 177.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.637 HD23 ' H ' ' A' ' 125' ' ' LEU . 1.6 pt? -54.73 -32.57 59.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.563 -0.819 . . . . 0.0 111.674 -178.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.931 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.5 OUTLIER -70.89 -53.9 13.42 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.743 179.88 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.857 ' HB1' HG22 ' A' ' 106' ' ' VAL . . . -58.92 -42.87 90.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.492 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.856 HD12 ' HG2' ' A' ' 102' ' ' ARG . 49.7 mm -62.52 -55.05 26.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.43 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.945 ' HB2' ' H91' ' A' ' 149' ' ' BB2 . 30.4 p -60.47 -51.57 68.92 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.856 HD11 HD11 ' A' ' 108' ' ' ILE . 20.8 tt -60.08 -42.06 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 111.445 0.165 . . . . 0.0 111.445 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.69 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 20.9 pt20 -67.24 -41.68 85.23 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.617 ' CD2' ' HN1' ' A' ' 149' ' ' BB2 . 65.4 t60 -57.83 -44.8 86.7 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.672 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.855 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.8 mm-40 -60.45 -45.37 93.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 118.902 -0.57 . . . . 0.0 111.814 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.933 ' HA ' HD21 ' A' ' 137' ' ' LEU . 36.9 mtm -56.7 -47.69 79.36 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 119.06 0.845 . . . . 0.0 109.913 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.745 ' O ' HG12 ' A' ' 138' ' ' VAL . 30.9 m-20 -61.83 -49.17 77.37 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.98 178.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.44 ' CE1' ' CG ' ' A' ' 50' ' ' GLN . 12.2 t-80 -56.27 -51.81 66.79 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 121.739 -0.601 . . . . 0.0 110.908 -179.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.933 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.3 pp -60.4 -30.93 69.91 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.481 -0.782 . . . . 0.0 111.775 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.914 HG23 HG13 ' A' ' 16' ' ' VAL . 14.9 p -80.49 21.05 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 CA-C-O 123.208 1.48 . . . . 0.0 108.947 175.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.86 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 69.27 -2.37 9.98 Favored Glycine 0 CA--C 1.492 -1.377 0 CA-C-N 111.723 -2.49 . . . . 0.0 112.452 176.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.766 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 1.3 ptmt -88.68 117.14 27.45 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.617 HD12 ' C ' ' A' ' 140' ' ' LYS . 6.3 mp -113.44 168.76 9.47 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 121.827 -0.546 . . . . 0.0 110.852 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.667 ' HB2' ' CG2' ' A' ' 100' ' ' VAL . 31.3 p90 -52.93 -39.15 62.62 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.634 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 46.9 tpp -54.06 -39.25 66.08 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.246 0.546 . . . . 0.0 110.666 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -55.05 -22.65 16.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.21 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.737 ' CE2' ' HG2' ' A' ' 101' ' ' PRO . 19.9 t80 -108.85 -12.63 14.88 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.93 -178.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.9 mp -83.68 154.71 23.52 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.992 -0.442 . . . . 0.0 110.794 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 40.2 t . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.339 -0.838 . . . . 0.0 111.014 179.601 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' BB2 . . . . . 0.945 ' H91' ' HB2' ' A' ' 129' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.859 0.361 . . . . 0.0 111.216 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 1.044 HG12 ' HA ' ' A' ' 37' ' ' THR . 31.5 m -84.19 137.28 21.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.378 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 1.043 HD11 ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -79.09 -141.25 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.43 ' H ' ' HG ' ' A' ' 3' ' ' LEU . 4.0 tp-100 -112.2 106.83 15.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.953 0.406 . . . . 0.0 110.617 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.017 HG11 HD12 ' A' ' 91' ' ' LEU . 48.2 t -89.19 126.23 42.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.518 0.675 . . . . 0.0 111.47 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.028 ' HB2' HD21 ' A' ' 13' ' ' LEU . 23.1 mt -83.49 141.99 31.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.603 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.772 ' HA ' ' HB3' ' A' ' 92' ' ' SER . 1.7 m80 -111.48 145.48 38.94 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.07 HD13 HD12 ' A' ' 13' ' ' LEU . 42.5 mm -57.77 145.41 70.77 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.279 178.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.522 ' HA ' HG23 ' A' ' 8' ' ' ILE . 73.8 Cg_endo -92.14 51.68 1.02 Allowed 'Cis proline' 0 C--N 1.353 0.81 0 C-N-CA 124.442 -1.066 . . . . 0.0 112.942 0.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.881 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 9.4 t0 -52.72 134.64 36.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.951 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.404 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 12.1 pt-20 -58.62 -44.75 90.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.514 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.672 ' HB2' HD13 ' A' ' 6' ' ' LEU . 11.3 mtt85 -58.91 -24.19 62.1 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 1.07 HD12 HD13 ' A' ' 8' ' ' ILE . 11.6 mt -75.42 -33.13 60.92 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 120.205 1.366 . . . . 0.0 108.3 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.651 HH21 ' HE2' ' A' ' 143' ' ' MET . 22.8 mmt180 -92.11 8.02 39.79 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 113.841 -1.527 . . . . 0.0 109.397 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 12' ' ' ARG . 88.5 tttt -89.86 148.96 22.86 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.186 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.802 HG13 HG23 ' A' ' 138' ' ' VAL . 66.8 t -83.67 126.23 40.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.091 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.759 ' C ' ' HG3' ' A' ' 56' ' ' ARG . . . -83.53 147.8 27.57 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.297 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.741 ' HD3' ' CD ' ' A' ' 19' ' ' PRO . 5.7 tmtm? -110.48 132.31 21.61 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.776 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 63.6 Cg_endo -77.62 116.14 4.0 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.378 2.052 . . . . 0.0 111.732 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.853 HG12 ' H ' ' A' ' 22' ' ' GLU . 22.0 t -68.01 144.95 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 CA-C-O 122.869 1.319 . . . . 0.0 113.087 -175.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -63.73 -29.4 70.62 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 112.893 -1.958 . . . . 0.0 111.897 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.853 ' H ' HG12 ' A' ' 20' ' ' VAL . 88.8 tt0 -157.11 145.05 19.19 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.8 -178.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.538 HG21 ' HA2' ' A' ' 115' ' ' GLY . 3.5 t -79.41 105.18 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 1.063 ' H ' HD12 ' A' ' 27' ' ' ILE . 2.1 m120 -87.05 153.08 21.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.908 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.474 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -54.57 -30.23 53.69 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.452 0.644 . . . . 0.0 110.207 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -72.82 -37.63 67.42 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 1.063 HD12 ' H ' ' A' ' 24' ' ' ASN . 67.7 mt -67.0 -36.36 76.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.355 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -68.33 -39.49 81.92 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.372 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 40.1 mmt180 -64.09 -38.86 92.6 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.768 ' O ' ' HG3' ' A' ' 34' ' ' MET . 2.9 mt -55.7 -49.19 75.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.614 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.686 HG22 ' CG2' ' A' ' 57' ' ' ILE . 19.8 t -66.33 -40.97 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 121.135 0.493 . . . . 0.0 110.941 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.884 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 26.5 m-20 -53.84 -46.27 71.17 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.575 -178.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.501 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 1.5 m-20 -74.54 -30.11 61.63 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.907 176.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 1.011 ' HG2' HG21 ' A' ' 51' ' ' VAL . 85.2 mtp -60.21 -46.31 90.18 Favored 'General case' 0 C--N 1.345 0.408 0 C-N-CA 120.566 -0.454 . . . . 0.0 109.841 -176.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.884 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 11.9 p90 -69.79 -44.76 69.41 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.606 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 31.8 mm-40 -53.34 -39.23 63.96 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 1.044 ' HA ' HG12 ' A' ' 2' ' ' VAL . 76.9 m -70.51 -60.4 2.28 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 118.28 -1.368 . . . . 0.0 108.613 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.973 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 2.6 ttp -46.76 -41.03 14.61 Favored 'General case' 0 CA--C 1.463 -2.378 0 C-N-CA 124.101 0.96 . . . . 0.0 109.958 -172.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.708 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 60.5 m-85 -70.32 -42.06 72.43 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.312 177.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 37' ' ' THR . . . -61.07 -24.86 66.53 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.577 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.794 ' HG2' ' CD2' ' A' ' 91' ' ' LEU . 3.1 tp10 -88.94 -11.19 45.14 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 114.345 -1.298 . . . . 0.0 108.337 177.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.444 ' H ' ' C ' ' A' ' 39' ' ' TYR . 54.0 mt-10 64.11 26.68 14.0 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.7 -176.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.587 ' HA3' H173 ' A' ' 149' ' ' BB2 . . . -80.87 142.52 23.5 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 113.89 -1.504 . . . . 0.0 110.596 178.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.809 HG22 HG22 ' A' ' 62' ' ' VAL . 46.1 mm -79.52 1.2 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 117.611 0.706 . . . . 0.0 111.997 -178.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.851 ' HA3' ' C10' ' A' ' 149' ' ' BB2 . . . 176.38 137.86 2.73 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 118.838 -0.979 . . . . 0.0 111.371 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.875 ' HB2' ' HG3' ' A' ' 38' ' ' MET . 10.7 tp -126.38 134.54 51.02 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-N 119.505 1.653 . . . . 0.0 111.265 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -98.83 132.15 44.4 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.935 ' HB1' HG13 ' A' ' 53' ' ' ILE . . . -31.22 -54.88 0.23 Allowed 'General case' 0 C--N 1.343 0.285 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.579 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 80.6 p -52.86 -36.07 58.53 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.891 0.853 . . . . 0.0 111.031 -177.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.45 ' HG2' ' CE1' ' A' ' 136' ' ' HIS . 44.1 mt-30 -65.84 -40.56 91.88 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.328 -1.306 . . . . 0.0 110.202 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.043 ' HB ' HD11 ' A' ' 3' ' ' LEU . 1.0 OUTLIER -83.81 16.08 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 179.558 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.949 ' HA ' HD11 ' A' ' 6' ' ' LEU . 36.1 t70 76.93 27.67 0.7 Allowed 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 177.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.935 HG13 ' HB1' ' A' ' 48' ' ' ALA . 13.4 pt -122.26 110.94 28.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 C-N-CA 119.036 -1.066 . . . . 0.0 111.386 177.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.45 ' HB3' ' HD3' ' A' ' 15' ' ' LYS . 7.4 p80 -76.33 52.11 0.74 Allowed 'General case' 0 N--CA 1.46 0.075 0 CA-C-O 122.241 1.019 . . . . 0.0 109.767 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.496 ' C ' ' HB1' ' A' ' 17' ' ' ALA . 25.7 mt-30 -140.6 132.31 27.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 113.817 -1.538 . . . . 0.0 107.752 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.867 ' HG2' ' CD1' ' A' ' 137' ' ' LEU . 99.1 mtt180 -61.78 68.1 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -178.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.935 ' HB ' HD11 ' A' ' 53' ' ' ILE . 10.9 mm -111.88 121.65 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.136 HD11 ' HB2' ' A' ' 72' ' ' LEU . 2.2 pp -129.69 145.74 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -177.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.471 HG23 ' H ' ' A' ' 46' ' ' LEU . 32.6 m -126.0 139.88 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.293 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.056 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 11.9 mm -115.45 151.88 17.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.688 0.756 . . . . 0.0 110.154 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.973 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 34.9 t70 -141.82 37.78 1.63 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.391 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.809 HG22 HG22 ' A' ' 44' ' ' ILE . 38.8 t -99.79 108.12 22.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.378 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.746 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 79.1 p -34.08 86.87 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -175.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.469 ' OE1' HD11 ' A' ' 70' ' ' LEU . 38.3 tt0 -61.3 -22.76 65.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 113.627 -1.624 . . . . 0.0 111.899 178.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -164.75 -74.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.627 0.727 . . . . 0.0 110.02 177.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.506 HH11 ' HG2' ' A' ' 66' ' ' ARG . 39.1 mmt-85 -129.24 -48.27 1.2 Allowed 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.954 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -105.7 127.74 53.25 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.256 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.746 ' HG2' ' HA ' ' A' ' 63' ' ' SER . 48.1 mt-10 -87.17 139.93 30.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.189 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.705 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER 173.89 66.76 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.76 0.314 . . . . 0.0 111.671 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 1.056 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 4.0 mm? -103.84 132.64 49.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.937 0.399 . . . . 0.0 111.817 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.785 ' C ' HD22 ' A' ' 72' ' ' LEU . 12.3 p -134.58 134.46 54.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.226 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.136 ' HB2' HD11 ' A' ' 58' ' ' ILE . 3.0 mm? -142.14 146.55 35.47 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.531 -0.174 . . . . 0.0 110.531 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.012 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.8 mp -122.92 136.44 59.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.732 0.301 . . . . 0.0 110.595 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.716 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 6.9 m120 51.65 37.62 0.44 Allowed Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.875 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 91.1 Cg_exo -57.51 148.26 73.7 Favored 'Trans proline' 0 N--CA 1.488 1.152 0 C-N-CA 123.046 2.497 . . . . 0.0 114.302 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -137.49 142.95 41.5 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.901 HD12 ' CG2' ' A' ' 108' ' ' ILE . 10.2 tp -80.28 136.84 36.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.109 0.481 . . . . 0.0 111.015 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.16 HD21 ' HG3' ' A' ' 109' ' ' ARG . 2.7 mm? -109.94 -44.48 3.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.068 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.513 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 17.2 tp10 -153.34 144.18 22.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.05 0.452 . . . . 0.0 111.932 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 1.043 ' HA ' HG12 ' A' ' 106' ' ' VAL . 19.3 ptpt -138.14 142.53 40.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.347 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.1 p -151.75 150.49 30.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.854 0.359 . . . . 0.0 111.052 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.631 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 76.91 143.72 1.64 Allowed Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.524 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -109.87 113.8 26.84 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.81 0.814 . . . . 0.0 111.896 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.638 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.7 p -117.21 160.99 20.2 Favored 'General case' 0 CA--C 1.487 -1.447 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.824 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -154.03 124.06 1.5 Allowed Glycine 0 C--N 1.314 -0.69 0 CA-C-N 112.536 -2.12 . . . . 0.0 111.228 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.619 HD13 ' O ' ' A' ' 85' ' ' GLY . 48.8 mm -147.07 137.52 17.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 117.507 0.653 . . . . 0.0 111.46 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 56.0 mt-10 -71.38 139.78 49.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 123.21 1.481 . . . . 0.0 112.606 -176.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.764 ' HG2' ' O27' ' A' ' 149' ' ' BB2 . 40.6 mt-10 -155.78 166.25 34.05 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 112.376 -2.193 . . . . 0.0 111.901 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.741 ' N ' ' HG2' ' A' ' 97' ' ' ARG . . . -120.88 168.27 14.04 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.804 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 87.3 m -113.46 142.74 45.55 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.34 0.57 . . . . 0.0 111.041 -177.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.017 HD12 HG11 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -53.36 -15.54 1.05 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.511 -179.417 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.815 ' HB2' HG12 ' A' ' 8' ' ' ILE . 4.3 m -100.77 -33.48 10.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.2 0.524 . . . . 0.0 110.471 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.769 ' CG2' ' HD2' ' A' ' 94' ' ' PRO . 57.4 mt -85.54 150.78 54.71 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.586 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.769 ' HD2' ' CG2' ' A' ' 93' ' ' ILE . 66.0 Cg_endo -62.63 -146.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.414 2.076 . . . . 0.0 111.812 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -79.63 12.73 2.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.13 0.49 . . . . 0.0 110.986 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.572 ' HG2' ' HG2' ' A' ' 94' ' ' PRO . 10.1 mm-40 -78.95 81.85 5.19 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.127 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.761 HH11 H231 ' A' ' 149' ' ' BB2 . 84.7 mtm180 -86.44 133.33 33.77 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.142 0.496 . . . . 0.0 110.18 178.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -125.73 148.93 48.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.796 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.824 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.4 tt -76.08 113.61 13.8 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.979 0.895 . . . . 0.0 111.208 -177.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.823 HG13 ' NE ' ' A' ' 102' ' ' ARG . 14.0 p -103.7 129.21 25.77 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 114.572 -1.194 . . . . 0.0 111.575 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.638 ' HA ' ' O ' ' A' ' 84' ' ' THR . 87.8 Cg_endo -83.55 126.61 4.15 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 122.67 2.247 . . . . 0.0 113.844 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.91 ' HG2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -143.63 166.96 23.41 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.595 1.158 . . . . 0.0 109.288 179.381 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.631 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.18 155.33 39.86 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.914 0.388 . . . . 0.0 110.302 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -73.25 -40.37 64.69 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.483 -175.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.716 ' HB3' ' OD1' ' A' ' 123' ' ' ASP . 96.0 mttt -140.03 140.91 36.3 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 176.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 1.043 HG12 ' HA ' ' A' ' 80' ' ' LYS . 19.4 m -152.94 141.54 14.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.836 -1.075 . . . . 0.0 112.58 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.918 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 31.9 mmtm -107.52 127.03 53.26 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 1.079 ' HA ' HD23 ' A' ' 78' ' ' LEU . 1.8 pp -134.57 150.95 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -176.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 1.16 ' HG3' HD21 ' A' ' 78' ' ' LEU . 43.7 mtm180 -103.42 140.5 37.38 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-O 122.277 1.037 . . . . 0.0 111.602 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.757 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -160.54 168.73 24.41 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.779 -176.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 1.012 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.3 pp -116.15 151.21 36.1 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.781 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 20.5 t70 -85.53 163.84 18.15 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.742 -176.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.692 ' HB2' HG21 ' A' ' 71' ' ' VAL . 13.2 ttp-105 -52.71 -19.29 2.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.046 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -79.41 -26.12 41.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.434 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.538 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 106.77 35.99 2.68 Favored Glycine 0 C--N 1.34 0.792 0 C-N-CA 120.168 -1.015 . . . . 0.0 113.545 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -128.57 102.93 19.87 Favored Pre-proline 0 C--O 1.238 0.5 0 CA-C-N 116.859 0.33 . . . . 0.0 110.694 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.677 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 32.1 Cg_exo -72.67 115.2 4.25 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 121.307 1.338 . . . . 0.0 114.563 -177.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.781 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 10.4 p90 -127.15 168.75 14.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.551 -178.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 109' ' ' ARG . 3.0 mp0 -107.1 130.11 54.73 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.715 ' O ' HD12 ' A' ' 120' ' ' LEU . 4.3 pp -122.81 132.56 54.26 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.416 -178.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.918 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 15.3 pt-20 -92.17 123.97 35.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.789 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.937 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -118.58 133.64 55.71 Favored 'General case' 0 C--O 1.22 -0.472 0 C-N-CA 120.456 -0.498 . . . . 0.0 112.13 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.716 ' OD1' ' HB3' ' A' ' 105' ' ' LYS . 31.5 m-20 -127.38 161.54 28.43 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.576 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 55.1 -140.59 38.86 Favored Glycine 0 C--N 1.346 1.109 0 C-N-CA 118.94 -1.6 . . . . 0.0 115.145 177.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.69 HD12 ' H ' ' A' ' 125' ' ' LEU . 4.6 mp -54.9 -30.69 58.86 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.831 -0.684 . . . . 0.0 111.62 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.937 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -71.22 -51.77 22.79 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.677 0.751 . . . . 0.0 109.209 179.607 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.78 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -60.22 -47.01 87.77 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.767 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.91 HD12 ' HG2' ' A' ' 102' ' ' ARG . 46.9 mm -63.69 -55.01 25.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -177.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.947 ' HB3' ' H91' ' A' ' 149' ' ' BB2 . 81.8 m -58.19 -48.61 79.79 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.945 HD11 HD11 ' A' ' 108' ' ' ILE . 20.0 tt -59.01 -40.93 81.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.854 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.809 ' CG ' HG21 ' A' ' 106' ' ' VAL . 69.2 mt-30 -67.59 -40.76 84.81 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.493 ' HD1' ' NH2' ' A' ' 102' ' ' ARG . 79.7 t60 -57.72 -45.87 85.16 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.021 0.439 . . . . 0.0 110.026 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.903 ' O ' HD23 ' A' ' 137' ' ' LEU . 4.2 mm-40 -59.99 -42.57 94.48 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.227 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.947 ' HA ' HD21 ' A' ' 137' ' ' LEU . 3.0 mmm -56.83 -47.55 80.06 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.772 0.796 . . . . 0.0 109.999 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.766 ' O ' HG12 ' A' ' 138' ' ' VAL . 32.3 m-20 -65.4 -48.37 73.07 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.701 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.671 ' CE1' HD21 ' A' ' 141' ' ' LEU . 16.2 t-80 -57.38 -50.77 71.93 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.722 -0.611 . . . . 0.0 111.051 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.947 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.6 pp -60.7 -30.7 70.11 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.812 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.913 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 11.9 p -84.19 24.83 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-O 122.412 1.101 . . . . 0.0 109.957 177.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 66.76 3.03 19.45 Favored Glycine 0 CA--C 1.487 -1.673 0 CA-C-N 113.423 -1.717 . . . . 0.0 113.262 176.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.913 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 9.4 ptmt -95.45 133.86 38.94 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.78 HD12 ' O ' ' A' ' 140' ' ' LYS . 11.1 mp -135.99 153.03 51.51 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.809 ' HB3' ' CG2' ' A' ' 100' ' ' VAL . 8.5 p90 -53.39 -33.84 55.39 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.651 ' HE2' HH21 ' A' ' 14' ' ' ARG . 57.2 ttp -59.99 -27.32 66.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.154 0.502 . . . . 0.0 110.867 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.502 ' CB ' HH12 ' A' ' 14' ' ' ARG . 61.8 t0 -58.7 -25.29 62.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.159 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -116.43 10.29 14.59 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.654 HD13 ' O ' ' A' ' 142' ' ' PHE . 6.5 mp -91.22 143.59 26.5 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.788 0.328 . . . . 0.0 111.42 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 48.2 t . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.9 179.448 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' BB2 . . . . . 0.947 ' H91' ' HB3' ' A' ' 129' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 79.2 p . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.852 0.358 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.766 ' CG1' HG23 ' A' ' 37' ' ' THR . 37.2 t -84.24 136.21 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.833 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.825 HD11 ' CB ' ' A' ' 51' ' ' VAL . 3.4 pp -78.75 -175.97 4.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.746 0.308 . . . . 0.0 110.548 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -83.25 107.62 15.91 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.817 0.341 . . . . 0.0 110.643 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.558 ' CG2' HG21 ' A' ' 37' ' ' THR . 39.1 t -89.56 131.5 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 121.229 0.538 . . . . 0.0 112.235 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.08 ' HB2' HD21 ' A' ' 13' ' ' LEU . 14.7 mt -88.31 140.25 29.67 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.931 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.597 ' HB3' ' O ' ' A' ' 92' ' ' SER . 41.4 m-70 -116.71 144.33 44.56 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.053 HD13 HD12 ' A' ' 13' ' ' LEU . 43.5 mm -62.95 135.56 96.2 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.999 177.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -80.2 145.5 71.87 Favored 'Cis proline' 0 C--N 1.354 0.818 0 C-N-CA 124.387 -1.089 . . . . 0.0 112.006 -0.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.982 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 8.9 t70 -165.88 128.44 2.02 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.426 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.446 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 24.1 pt-20 -58.19 -46.0 86.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.592 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.622 ' HA ' ' HB2' ' A' ' 15' ' ' LYS . 20.2 mmt-85 -56.09 -28.73 58.9 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 1.08 HD21 ' HB2' ' A' ' 6' ' ' LEU . 10.1 mt -76.72 -34.27 58.13 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 120.339 1.427 . . . . 0.0 108.786 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.825 ' HB3' ' NH1' ' A' ' 14' ' ' ARG . 1.7 mmm180 -91.99 11.1 26.28 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.029 178.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.839 ' HD3' ' N ' ' A' ' 16' ' ' VAL . 11.2 tmtt? -84.3 139.37 32.36 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.482 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.891 HG13 HG23 ' A' ' 138' ' ' VAL . 46.0 t -84.29 93.93 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.79 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.799 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -53.88 147.85 11.38 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.337 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -104.25 131.24 22.1 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.746 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.547 ' HD3' ' HD3' ' A' ' 56' ' ' ARG . 69.2 Cg_endo -77.52 114.67 3.75 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.097 1.864 . . . . 0.0 110.56 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.858 HG12 ' H ' ' A' ' 22' ' ' GLU . 19.7 t -69.36 144.57 13.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 122.624 1.202 . . . . 0.0 113.313 -175.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -66.12 -24.68 66.72 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 113.266 -1.788 . . . . 0.0 111.915 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.858 ' H ' HG12 ' A' ' 20' ' ' VAL . 88.7 tt0 -160.96 141.0 10.98 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.658 0.266 . . . . 0.0 110.734 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.531 HG22 HD21 ' A' ' 111' ' ' LEU . 2.8 t -79.18 109.82 14.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 1.056 ' H ' HD12 ' A' ' 27' ' ' ILE . 60.1 m-80 -92.07 164.55 13.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.52 0.2 . . . . 0.0 110.94 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.712 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -56.22 -30.72 62.72 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.176 0.513 . . . . 0.0 110.762 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -71.52 -39.6 70.64 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 177.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 1.056 HD12 ' H ' ' A' ' 24' ' ' ASN . 59.6 mt -63.26 -47.24 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.132 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.523 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 11.5 mt-30 -57.83 -39.25 77.2 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-O 120.896 0.379 . . . . 0.0 110.701 178.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.712 ' HG3' ' O ' ' A' ' 25' ' ' ALA . 99.6 mtt180 -60.3 -39.86 88.44 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.813 ' O ' ' HG3' ' A' ' 34' ' ' MET . 3.3 mt -60.06 -48.54 87.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 114.641 -1.163 . . . . 0.0 112.108 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.88 HG22 ' CG2' ' A' ' 57' ' ' ILE . 12.5 t -68.49 -42.63 83.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-O 120.862 0.363 . . . . 0.0 111.378 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.866 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -55.17 -42.02 72.61 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.516 -179.705 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.484 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 23.4 m-20 -75.23 -30.3 60.52 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.348 175.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 1.067 ' HG2' HG21 ' A' ' 51' ' ' VAL . 86.5 mtp -60.54 -46.83 88.73 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.857 -177.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.866 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 14.1 p90 -69.38 -44.43 71.52 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.762 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 34.0 mt-10 -51.36 -42.1 61.09 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.766 HG23 ' CG1' ' A' ' 2' ' ' VAL . 73.7 m -69.3 -62.08 1.53 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.493 -1.23 . . . . 0.0 108.236 178.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 1.004 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 3.4 ttp -45.91 -42.53 12.86 Favored 'General case' 0 CA--C 1.454 -2.739 0 C-N-CA 124.183 0.993 . . . . 0.0 110.563 -170.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.681 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 50.2 m-85 -69.42 -41.58 76.18 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.569 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.8 -28.69 68.96 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.796 0.807 . . . . 0.0 109.003 178.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.994 ' HG2' HD12 ' A' ' 91' ' ' LEU . 11.0 tp10 -84.33 -10.11 57.88 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 114.248 -1.342 . . . . 0.0 108.788 177.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.444 ' H ' ' C ' ' A' ' 39' ' ' TYR . 58.9 mt-10 61.57 26.12 15.89 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 121.914 0.864 . . . . 0.0 109.987 -176.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.672 ' HA2' H182 ' A' ' 149' ' ' BB2 . . . -80.73 142.21 23.37 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 113.993 -1.458 . . . . 0.0 110.757 178.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.866 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 49.2 mt -78.57 -2.54 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 117.702 0.751 . . . . 0.0 111.925 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.884 ' HA3' ' C10' ' A' ' 149' ' ' BB2 . . . -179.28 133.33 2.04 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-O 119.114 -0.826 . . . . 0.0 111.794 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.021 HD13 ' HG ' ' A' ' 91' ' ' LEU . 5.8 tp -124.45 133.99 53.2 Favored 'General case' 0 C--N 1.351 0.632 0 CA-C-N 119.085 1.442 . . . . 0.0 111.278 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -100.44 129.27 46.38 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.218 0.207 . . . . 0.0 111.236 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.879 ' HB1' ' CG1' ' A' ' 53' ' ' ILE . . . -27.06 -55.74 0.08 Allowed 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 116.126 1.898 . . . . 0.0 116.126 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.588 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 66.2 p -53.29 -33.87 55.02 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.882 0.848 . . . . 0.0 112.032 -178.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.764 ' OE1' HD12 ' A' ' 46' ' ' LEU . 82.4 mt-30 -63.93 -42.68 97.3 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.15 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.067 HG21 ' HG2' ' A' ' 34' ' ' MET . 0.9 OUTLIER -86.9 16.2 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.876 ' HA ' HD11 ' A' ' 6' ' ' LEU . 53.6 t0 77.43 34.05 0.38 Allowed 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 176.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.879 ' CG1' ' HB1' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -125.39 109.18 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.302 177.08 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -75.74 63.34 1.61 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.206 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.74 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 88.9 mt-30 -153.96 134.0 13.19 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 114.156 -1.384 . . . . 0.0 108.425 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.799 ' N ' ' HB1' ' A' ' 17' ' ' ALA . 77.4 mtp180 -65.13 72.38 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -177.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.88 ' CG2' HG22 ' A' ' 31' ' ' VAL . 6.7 mm -114.84 124.93 71.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.065 HD11 ' HB2' ' A' ' 72' ' ' LEU . 2.2 pp -131.41 147.26 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 46' ' ' LEU . 34.1 m -128.84 138.15 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.709 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.006 HG23 H112 ' A' ' 149' ' ' BB2 . 2.2 mt -116.92 142.92 28.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.835 0.826 . . . . 0.0 110.821 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 1.004 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 11.4 t70 -124.87 25.86 7.24 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.18 -1.373 . . . . 0.0 110.294 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.793 HG22 ' CG2' ' A' ' 44' ' ' ILE . 21.9 t -95.68 116.56 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.57 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.604 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 64.1 m -34.42 85.58 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -176.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.424 ' CD ' HD21 ' A' ' 70' ' ' LEU . 42.3 tt0 -58.13 -22.15 49.78 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.176 178.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.89 ' OD1' ' HG3' ' A' ' 66' ' ' ARG . 24.9 t-20 -165.17 -79.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.49 0.662 . . . . 0.0 109.566 177.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.89 ' HG3' ' OD1' ' A' ' 65' ' ' ASN . 76.4 mtp180 -123.24 -49.76 1.92 Allowed 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.136 178.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -99.85 128.43 45.94 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.953 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.604 ' HG2' ' HA ' ' A' ' 63' ' ' SER . 96.2 mt-10 -84.12 130.07 34.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.295 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.666 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 32.8 ttm180 175.02 68.61 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.35 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.954 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 67.2 mt -100.72 132.42 46.12 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.829 HG21 ' HB2' ' A' ' 113' ' ' ARG . 9.9 p -134.38 130.09 53.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.106 178.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.065 ' HB2' HD11 ' A' ' 58' ' ' ILE . 2.8 mm? -141.07 139.54 34.07 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.505 -0.183 . . . . 0.0 110.505 178.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.042 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.7 mp -118.79 134.99 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 110.345 -0.243 . . . . 0.0 110.345 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.707 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 8.6 m120 54.04 35.56 0.29 Allowed Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.834 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 95.2 Cg_exo -55.83 150.1 47.38 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.72 2.28 . . . . 0.0 113.639 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.642 ' CD ' HH21 ' A' ' 109' ' ' ARG . 15.6 pt-20 -136.74 144.22 43.72 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.898 ' CB ' ' HE1' ' A' ' 134' ' ' MET . 1.4 tt -81.82 136.28 35.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.534 0.683 . . . . 0.0 111.215 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.863 HD11 ' HG3' ' A' ' 109' ' ' ARG . 7.5 mp -116.61 -37.81 3.62 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.308 -178.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 5.2 tp10 -155.36 146.85 22.96 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.107 0.479 . . . . 0.0 111.13 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.823 ' CB ' HG12 ' A' ' 106' ' ' VAL . 12.8 ptmt -148.4 147.38 29.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.258 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 52.8 m -160.56 145.4 14.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.675 0.274 . . . . 0.0 111.303 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.836 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 84.76 169.75 46.22 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.175 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 102' ' ' ARG . 56.7 mt-10 -146.97 113.53 6.0 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.5 p -101.94 159.87 14.98 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 115.132 1.531 . . . . 0.0 115.132 178.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.696 ' O ' HD13 ' A' ' 86' ' ' ILE . . . -137.12 102.61 0.39 Allowed Glycine 0 C--N 1.316 -0.532 0 CA-C-N 112.856 -1.974 . . . . 0.0 111.589 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.752 ' N ' ' HG ' ' A' ' 99' ' ' LEU . 39.8 mm -145.54 136.97 19.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.611 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 56.3 mt-10 -71.31 144.36 49.98 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 122.476 1.131 . . . . 0.0 111.779 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.693 ' HB3' H262 ' A' ' 149' ' ' BB2 . 55.0 mt-10 -158.06 162.06 38.06 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 113.933 -1.485 . . . . 0.0 109.618 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.908 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -119.96 158.01 15.44 Favored Glycine 0 CA--C 1.499 -0.942 0 C-N-CA 119.271 -1.442 . . . . 0.0 110.15 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.786 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 20.5 m -111.88 137.3 50.04 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.564 0.697 . . . . 0.0 111.893 -177.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.021 ' HG ' HD13 ' A' ' 46' ' ' LEU . 2.3 mm? -48.35 -23.03 0.79 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.591 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.873 ' CB ' HD13 ' A' ' 13' ' ' LEU . 48.7 m -84.25 -34.05 23.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.649 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.752 ' CG2' ' HD2' ' A' ' 94' ' ' PRO . 62.6 mt -85.6 148.85 50.14 Favored Pre-proline 0 N--CA 1.45 -0.442 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.758 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.752 ' HD2' ' CG2' ' A' ' 93' ' ' ILE . 94.7 Cg_endo -73.1 48.48 1.46 Allowed 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.573 2.182 . . . . 0.0 114.156 -178.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.55 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 37.7 tt0 78.25 14.39 1.46 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 122.671 0.388 . . . . 0.0 111.989 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.743 ' HB2' HG21 ' A' ' 93' ' ' ILE . 10.3 mm-40 -78.71 87.67 4.61 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.908 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 18.5 mtm105 -85.26 133.07 34.18 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.851 0.834 . . . . 0.0 111.903 -178.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.931 ' H ' ' HE1' ' A' ' 143' ' ' MET . . . -134.47 153.45 51.92 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.249 -1.341 . . . . 0.0 109.624 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.752 ' HG ' ' N ' ' A' ' 86' ' ' ILE . 6.8 tt -75.16 136.33 41.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.458 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.919 HG13 ' HB2' ' A' ' 142' ' ' PHE . 89.7 t -130.14 132.92 24.39 Favored Pre-proline 0 CA--C 1.53 0.177 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' A' ' 84' ' ' THR . 2.1 Cg_endo -81.3 124.1 4.67 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.693 1.595 . . . . 0.0 112.7 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.881 ' HB2' ' OE1' ' A' ' 131' ' ' GLN . 0.0 OUTLIER -142.15 166.4 24.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.765 179.112 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.836 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.67 156.22 38.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.666 0.269 . . . . 0.0 110.286 -178.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -72.82 -43.96 62.06 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.422 -176.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.716 ' HB3' ' OD1' ' A' ' 123' ' ' ASP . 56.6 mttp -139.44 138.24 36.29 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.72 0.771 . . . . 0.0 109.611 176.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.891 HG22 ' HB1' ' A' ' 127' ' ' ALA . 28.4 m -140.05 138.6 37.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.043 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 1.093 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 32.9 mmtm -107.22 125.27 50.9 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.841 HG12 ' CD1' ' A' ' 130' ' ' ILE . 2.1 pp -128.37 161.46 36.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -177.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.863 ' HG3' HD11 ' A' ' 78' ' ' LEU . 68.0 mtm180 -114.28 140.15 48.83 Favored 'General case' 0 N--CA 1.461 0.104 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.847 ' HB3' HD12 ' A' ' 72' ' ' LEU . . . -159.58 168.29 26.46 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.966 -178.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 1.042 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.5 pp -113.59 152.99 29.58 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.461 ' HB2' ' CE2' ' A' ' 118' ' ' PHE . 11.2 t70 -90.79 164.37 14.11 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 119.716 -0.793 . . . . 0.0 111.42 -177.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.829 ' HB2' HG21 ' A' ' 71' ' ' VAL . 15.1 ttm105 -51.57 -19.2 1.38 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.237 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.24 -26.56 42.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.602 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 106.81 34.63 2.98 Favored Glycine 0 C--N 1.337 0.619 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.948 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.678 ' NZ ' ' HB2' ' A' ' 116' ' ' LYS . 9.7 mtmp? -128.63 103.17 19.62 Favored Pre-proline 0 C--O 1.237 0.416 0 C-N-CA 121.228 -0.189 . . . . 0.0 111.236 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.663 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.4 Cg_exo -72.84 116.06 4.58 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 121.799 1.666 . . . . 0.0 114.802 -178.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.461 ' CE2' ' HB2' ' A' ' 112' ' ' ASP . 0.4 OUTLIER -126.45 168.62 13.97 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.372 -179.626 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.672 ' HG2' ' CG ' ' A' ' 109' ' ' ARG . 80.2 mt-10 -107.52 129.64 54.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.121 0.486 . . . . 0.0 110.16 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.71 ' O ' HD12 ' A' ' 120' ' ' LEU . 4.2 pp -123.08 129.04 50.95 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.752 -178.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 1.093 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 9.3 pm0 -92.76 124.36 36.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.27 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.937 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -116.35 137.18 52.36 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.716 ' OD1' ' HB3' ' A' ' 105' ' ' LYS . 34.3 m-20 -126.96 163.8 22.88 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.823 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 47.5 -135.47 13.62 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 119.996 1.271 . . . . 0.0 115.864 177.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.0 mt -54.66 -32.73 59.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.654 -0.773 . . . . 0.0 111.667 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.937 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -71.31 -54.01 12.29 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.842 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.891 ' HB1' HG22 ' A' ' 106' ' ' VAL . . . -58.85 -42.98 90.62 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.469 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.874 HD12 ' HG2' ' A' ' 102' ' ' ARG . 49.2 mm -62.17 -54.47 33.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.559 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.894 ' HB3' ' H91' ' A' ' 149' ' ' BB2 . 73.4 m -60.12 -50.72 72.59 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.841 ' CD1' HG12 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -58.88 -44.1 89.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 121.201 -0.199 . . . . 0.0 110.567 -179.674 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.881 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.9 pt20 -67.72 -38.35 83.48 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.738 ' HA ' ' OD2' ' A' ' 135' ' ' ASP . 68.7 t60 -59.22 -46.1 89.35 Favored 'General case' 0 C--O 1.226 -0.16 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.866 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.9 mm-40 -59.67 -45.02 93.33 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.271 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.937 ' HA ' HD21 ' A' ' 137' ' ' LEU . 72.6 mtp -56.84 -48.51 77.9 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 118.913 0.779 . . . . 0.0 110.865 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.738 ' OD2' ' HA ' ' A' ' 132' ' ' HIS . 2.4 p30 -63.35 -46.68 85.42 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.37 178.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.992 ' CE1' HD21 ' A' ' 141' ' ' LEU . 7.8 t-80 -58.03 -52.6 64.86 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.814 -0.554 . . . . 0.0 111.476 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.937 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.5 pp -59.21 -32.68 70.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.553 -177.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.925 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 10.3 p -80.09 19.02 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 CA-C-O 123.101 1.429 . . . . 0.0 108.856 175.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.826 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 61.5 20.52 59.12 Favored Glycine 0 CA--C 1.489 -1.537 0 CA-C-N 111.779 -2.464 . . . . 0.0 112.313 176.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.925 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 7.2 ptmt -111.57 115.02 28.47 Favored 'General case' 0 N--CA 1.424 -1.739 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.046 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.992 HD21 ' CE1' ' A' ' 136' ' ' HIS . 7.7 mp -127.88 132.27 49.37 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.919 ' HB2' HG13 ' A' ' 100' ' ' VAL . 9.0 m-85 -58.54 -40.09 82.03 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.931 ' HE1' ' H ' ' A' ' 98' ' ' ALA . 44.6 ttm -61.51 -27.37 68.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.288 0.566 . . . . 0.0 111.124 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.801 ' OD2' ' HD3' ' A' ' 14' ' ' ARG . 0.8 OUTLIER -55.74 -22.45 23.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.828 179.337 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -120.03 40.04 3.53 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.715 -178.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.911 HD12 ' HG3' ' A' ' 143' ' ' MET . 47.5 mt -93.11 140.84 29.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.049 179.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 57.2 m . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.991 179.648 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' BB2 . . . . . 1.006 H112 HG23 ' A' ' 60' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.3 t . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.811 0.339 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 1.004 HG12 ' HA ' ' A' ' 37' ' ' THR . 27.9 m -83.85 136.21 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.963 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.983 HD13 ' H ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -85.71 -170.15 2.97 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.595 179.88 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 70.9 tp60 -84.52 108.4 17.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.736 0.303 . . . . 0.0 110.798 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.78 HG11 HD12 ' A' ' 91' ' ' LEU . 43.0 t -89.79 131.82 36.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.25 0.548 . . . . 0.0 111.767 -179.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.089 ' HB2' HD21 ' A' ' 13' ' ' LEU . 21.5 mt -85.03 141.73 30.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.071 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.565 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 2.8 m80 -119.77 144.35 47.33 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.094 HD13 HD12 ' A' ' 13' ' ' LEU . 50.7 mm -60.71 134.28 92.02 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.29 177.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -83.02 138.88 35.56 Favored 'Cis proline' 0 C--N 1.352 0.739 0 C-N-CA 124.48 -1.05 . . . . 0.0 111.896 -0.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.629 ' CB ' ' HG ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -155.86 128.99 8.11 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.562 179.672 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 12.0 pt-20 -58.46 -44.71 89.36 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.517 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.702 ' HB2' HD13 ' A' ' 6' ' ' LEU . 24.1 mtt180 -60.5 -24.86 65.63 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 1.094 HD12 HD13 ' A' ' 8' ' ' ILE . 10.3 mt -78.41 -31.03 48.03 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 120.892 1.678 . . . . 0.0 107.617 176.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.677 HH12 ' CG ' ' A' ' 144' ' ' ASP . 15.7 mmm180 -91.8 8.77 35.59 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 113.767 -1.56 . . . . 0.0 109.12 178.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.585 ' HB2' ' HA ' ' A' ' 12' ' ' ARG . 60.2 tttp -88.19 143.5 27.01 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.08 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 1.013 HG13 HG23 ' A' ' 138' ' ' VAL . 56.4 t -83.99 100.24 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.029 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.808 ' HB3' HD12 ' A' ' 137' ' ' LEU . . . -58.74 143.78 45.85 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.944 0.402 . . . . 0.0 111.44 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.721 ' HD3' ' N ' ' A' ' 19' ' ' PRO . 1.7 tmtp? -108.94 132.47 21.16 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.183 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.919 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 56.4 Cg_endo -80.35 115.7 3.21 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.29 1.994 . . . . 0.0 111.057 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.7 HG12 ' H ' ' A' ' 22' ' ' GLU . 17.1 t -70.14 144.42 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-O 122.497 1.142 . . . . 0.0 112.665 -176.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -60.4 -22.95 63.95 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 113.29 -1.777 . . . . 0.0 112.29 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.7 ' H ' HG12 ' A' ' 20' ' ' VAL . 42.3 tt0 -161.17 140.31 10.22 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 120.801 0.334 . . . . 0.0 111.157 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.734 ' HA ' HD12 ' A' ' 27' ' ' ILE . 2.7 t -83.02 117.99 29.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.138 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.909 ' O ' ' HG3' ' A' ' 28' ' ' GLN . 9.8 p30 -105.76 -168.66 1.47 Allowed 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 122.295 -0.253 . . . . 0.0 110.353 -178.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.668 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -73.31 -25.83 60.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.779 0.323 . . . . 0.0 111.434 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.573 ' HB2' ' OD1' ' A' ' 24' ' ' ASN . 4.6 mm-40 -72.89 -40.21 65.74 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.734 HD12 ' HA ' ' A' ' 23' ' ' VAL . 50.8 mt -65.78 -46.04 89.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.166 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.909 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 45.5 mt-30 -57.09 -40.28 76.69 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.705 0.288 . . . . 0.0 110.444 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.668 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 39.4 mmt180 -61.52 -41.16 96.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.654 0.74 . . . . 0.0 109.074 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.818 ' O ' ' HG3' ' A' ' 34' ' ' MET . 4.8 mt -59.72 -50.12 81.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.742 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.898 HG22 ' CG2' ' A' ' 57' ' ' ILE . 10.8 t -67.87 -43.8 85.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-O 120.843 0.354 . . . . 0.0 111.723 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.864 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 26.0 m-20 -54.37 -41.8 69.58 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.404 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.635 ' CB ' HD12 ' A' ' 3' ' ' LEU . 55.9 m-20 -74.39 -31.17 62.25 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.077 176.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 1.01 ' HG2' HG21 ' A' ' 51' ' ' VAL . 85.1 mtp -60.3 -47.1 87.47 Favored 'General case' 0 C--N 1.346 0.453 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.869 -177.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.864 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 15.9 p90 -69.35 -44.51 71.45 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.565 ' HG2' ' O ' ' A' ' 32' ' ' ASP . 3.3 mm-40 -51.22 -43.79 61.5 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 1.004 ' HA ' HG12 ' A' ' 2' ' ' VAL . 96.6 m -70.06 -59.98 2.57 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 118.723 -1.191 . . . . 0.0 109.267 177.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.994 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 3.7 ttp -46.32 -42.5 14.81 Favored 'General case' 0 CA--C 1.461 -2.45 0 C-N-CA 123.42 0.688 . . . . 0.0 109.646 -170.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.751 ' OH ' ' HA ' ' A' ' 69' ' ' ARG . 60.4 m-85 -69.56 -42.35 74.68 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.593 178.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.494 ' CB ' HG11 ' A' ' 2' ' ' VAL . . . -59.84 -28.4 67.47 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.797 ' HG2' ' CD2' ' A' ' 91' ' ' LEU . 17.6 tp10 -84.9 -10.81 56.73 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.708 177.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.442 ' H ' ' C ' ' A' ' 39' ' ' TYR . 7.4 mm-40 63.87 24.2 13.63 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.952 -176.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.834 ' HA2' H182 ' A' ' 149' ' ' BB2 . . . -78.1 142.18 26.0 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 114.143 -1.39 . . . . 0.0 110.595 177.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.868 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 44.2 mm -78.77 -2.18 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 117.566 0.683 . . . . 0.0 112.195 -178.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.855 ' HA3' ' C10' ' A' ' 149' ' ' BB2 . . . 179.36 135.5 2.41 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-O 118.88 -0.956 . . . . 0.0 111.769 -178.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.967 ' HB2' ' HG3' ' A' ' 38' ' ' MET . 9.1 tp -125.85 135.16 51.64 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.437 1.619 . . . . 0.0 111.743 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -99.5 129.97 45.72 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.874 ' HB1' ' CD1' ' A' ' 53' ' ' ILE . . . -30.72 -54.51 0.2 Allowed 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.675 HG21 ' O ' ' A' ' 137' ' ' LEU . 66.6 p -53.53 -35.41 60.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.775 0.798 . . . . 0.0 111.364 -178.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.62 HE22 ' C3 ' ' A' ' 149' ' ' BB2 . 55.8 mt-30 -66.35 -37.36 85.16 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.078 179.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.01 HG21 ' HG2' ' A' ' 34' ' ' MET . 1.1 m -86.4 12.13 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.89 ' HA ' HD11 ' A' ' 6' ' ' LEU . 55.3 t0 78.96 32.37 0.28 Allowed 'General case' 0 C--O 1.23 0.059 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 176.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.874 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 1.2 pp -127.31 111.75 26.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.065 177.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.579 ' HB3' ' HD3' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -76.23 65.05 2.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.089 0.947 . . . . 0.0 110.466 -179.034 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.729 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 28.3 mt-30 -154.88 134.54 12.75 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 114.169 -1.378 . . . . 0.0 108.527 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.919 ' HD2' ' HD3' ' A' ' 19' ' ' PRO . 77.8 mtt-85 -63.34 70.82 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -177.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.898 ' CG2' HG22 ' A' ' 31' ' ' VAL . 8.7 mm -112.9 122.74 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.111 HD11 ' HB2' ' A' ' 72' ' ' LEU . 1.7 pp -128.61 146.03 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 119.635 -0.826 . . . . 0.0 113.177 -177.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.662 HG22 ' O ' ' A' ' 46' ' ' LEU . 33.8 m -128.05 138.75 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.96 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.984 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 12.1 mm -116.13 150.57 18.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.642 0.734 . . . . 0.0 109.859 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.994 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 28.9 t70 -132.7 21.72 4.25 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.508 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.927 HG11 HD12 ' A' ' 125' ' ' LEU . 32.6 t -94.74 114.73 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.328 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.712 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 80.0 p -38.02 83.28 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -177.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.844 ' HB2' HD11 ' A' ' 70' ' ' LEU . 4.6 tm-20 -69.4 -22.04 63.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.868 178.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.72 ' OD1' ' HG2' ' A' ' 66' ' ' ARG . 14.6 t-20 -163.87 -127.97 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.464 178.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.72 ' HG2' ' OD1' ' A' ' 65' ' ' ASN . 2.6 mmp_? -73.6 -55.13 6.69 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.653 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -97.86 130.46 44.76 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.937 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.712 ' HG2' ' HA ' ' A' ' 63' ' ' SER . 54.2 mt-10 -86.78 78.61 9.05 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.751 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 78.8 ttt180 -145.94 86.55 1.72 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -178.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.984 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 44.0 mt -104.73 133.55 49.37 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -178.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.822 ' O ' HD12 ' A' ' 72' ' ' LEU . 14.4 p -135.07 133.15 53.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.56 177.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.111 ' HB2' HD11 ' A' ' 58' ' ' ILE . 10.4 mp -138.96 139.79 38.05 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.999 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 2.6 mm -118.86 132.49 68.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.102 0.477 . . . . 0.0 111.197 -178.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.723 ' OD1' ' HA ' ' A' ' 19' ' ' PRO . 68.4 m-20 50.7 38.0 0.47 Allowed Pre-proline 0 CA--C 1.547 0.843 0 CA-C-N 115.003 -0.999 . . . . 0.0 113.075 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.784 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 96.2 Cg_exo -55.85 152.33 36.26 Favored 'Trans proline' 0 N--CA 1.487 1.135 0 C-N-CA 123.027 2.485 . . . . 0.0 114.156 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -137.14 143.25 42.37 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.829 HD23 ' N ' ' A' ' 78' ' ' LEU . 1.8 tt -81.14 135.44 35.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.711 0.767 . . . . 0.0 111.609 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.062 HD11 ' HG3' ' A' ' 109' ' ' ARG . 6.9 mp -111.99 -37.3 5.13 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.045 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 37.6 tt0 -161.0 156.09 24.23 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 121.271 0.557 . . . . 0.0 112.004 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.855 ' HA ' HG12 ' A' ' 106' ' ' VAL . 18.3 ptpt -148.07 153.14 38.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.06 178.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.6 p -159.62 146.38 16.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.852 0.358 . . . . 0.0 111.24 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.76 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 69.73 173.22 10.59 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.843 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.696 ' N ' ' HG3' ' A' ' 104' ' ' GLU . 56.1 mt-10 -146.62 113.89 6.26 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.714 HG23 ' HG2' ' A' ' 104' ' ' GLU . 1.5 p -96.03 159.89 14.73 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 178.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.699 ' O ' HD13 ' A' ' 86' ' ' ILE . . . -135.63 100.81 0.36 Allowed Glycine 0 C--N 1.319 -0.406 0 CA-C-N 113.452 -1.704 . . . . 0.0 111.878 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.699 HD13 ' O ' ' A' ' 85' ' ' GLY . 39.6 mm -145.15 136.94 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -178.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.632 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 47.6 mt-10 -73.35 143.41 46.88 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 122.845 1.307 . . . . 0.0 112.968 -177.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.708 ' HB3' H262 ' A' ' 149' ' ' BB2 . 95.2 mt-10 -154.96 166.27 34.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 113.502 -1.681 . . . . 0.0 109.515 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.803 ' HA3' ' HG2' ' A' ' 97' ' ' ARG . . . -119.86 165.31 13.5 Favored Glycine 0 CA--C 1.498 -0.993 0 C-N-CA 119.339 -1.41 . . . . 0.0 110.225 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 1.085 ' HB2' HD13 ' A' ' 93' ' ' ILE . 95.3 m -118.2 140.22 50.12 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.879 -176.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.797 ' CD2' ' HG2' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -56.9 -23.43 44.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.627 178.741 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.906 ' CB ' HD13 ' A' ' 13' ' ' LEU . 58.7 m -79.45 -38.51 34.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.407 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 1.085 HD13 ' HB2' ' A' ' 90' ' ' CYS . 2.6 mp -86.3 149.62 49.99 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.397 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.874 ' HD2' HG23 ' A' ' 93' ' ' ILE . 84.9 Cg_endo -73.66 50.12 1.97 Allowed 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.636 2.224 . . . . 0.0 114.349 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.543 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 39.4 tt0 78.03 12.34 1.8 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 178.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.731 ' HB2' HG21 ' A' ' 93' ' ' ILE . 25.9 mt-30 -78.43 88.9 4.41 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.803 ' HG2' ' HA3' ' A' ' 89' ' ' GLY . 45.8 mtm-85 -84.85 133.61 34.31 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.757 0.789 . . . . 0.0 111.437 -178.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 87' ' ' GLU . . . -134.62 153.92 51.75 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.113 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.744 HD23 ' N ' ' A' ' 100' ' ' VAL . 6.6 tt -75.13 136.95 41.07 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.912 ' HB ' ' CZ ' ' A' ' 102' ' ' ARG . 21.9 t -132.04 134.23 24.91 Favored Pre-proline 0 C--N 1.339 0.138 0 C-N-CA 120.461 -0.495 . . . . 0.0 110.986 -178.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 100' ' ' VAL . 4.1 Cg_exo -79.75 123.14 5.17 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 121.409 1.406 . . . . 0.0 112.321 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.912 ' CZ ' ' HB ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -144.08 165.75 26.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.653 178.455 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.76 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.72 154.02 42.71 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.014 0.435 . . . . 0.0 109.96 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.714 ' HG2' HG23 ' A' ' 84' ' ' THR . 46.8 mt-10 -73.95 -42.29 60.73 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.336 -176.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.642 ' HG2' ' HB3' ' A' ' 123' ' ' ASP . 93.6 mttt -139.79 137.98 35.46 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.683 0.754 . . . . 0.0 109.677 176.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.855 HG12 ' HA ' ' A' ' 80' ' ' LYS . 28.9 m -141.44 142.04 29.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.754 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 1.044 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 23.6 mmtp -108.13 125.67 51.87 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 1.033 ' HA ' HD13 ' A' ' 78' ' ' LEU . 1.9 pp -130.71 161.75 40.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -177.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 1.062 ' HG3' HD11 ' A' ' 78' ' ' LEU . 93.7 mtt180 -111.0 138.34 47.52 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.546 ' CB ' HD23 ' A' ' 72' ' ' LEU . . . -155.23 166.34 33.87 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.828 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.999 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.2 pp -117.27 152.01 35.74 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.611 ' O ' HD12 ' A' ' 111' ' ' LEU . 20.0 t70 -85.25 168.78 14.42 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 119.326 -0.95 . . . . 0.0 112.404 -176.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.669 ' HB2' HG21 ' A' ' 71' ' ' VAL . 46.5 ttp85 -54.87 -20.26 8.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.689 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -79.71 -19.4 48.96 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.523 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.607 ' HA2' HD13 ' A' ' 111' ' ' LEU . . . 98.83 39.13 3.68 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.156 -1.021 . . . . 0.0 114.141 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.673 ' NZ ' ' HB3' ' A' ' 116' ' ' LYS . 2.2 mmmp? -128.28 102.21 21.27 Favored Pre-proline 0 N--CA 1.467 0.397 0 CA-C-N 117.516 0.658 . . . . 0.0 110.82 178.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.651 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.8 Cg_exo -74.58 115.56 4.34 Favored 'Trans proline' 0 C--N 1.361 1.188 0 C-N-CA 121.733 1.622 . . . . 0.0 116.061 -177.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -125.42 168.49 13.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.043 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.705 ' HG2' ' HG2' ' A' ' 109' ' ' ARG . 35.2 mt-10 -108.09 130.63 55.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.972 0.415 . . . . 0.0 110.305 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.976 HD21 HD21 ' A' ' 72' ' ' LEU . 4.1 pp -128.48 135.72 49.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.222 0.534 . . . . 0.0 112.092 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 1.044 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 11.7 pt-20 -95.5 125.63 40.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.974 178.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.922 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -116.55 135.72 53.58 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.642 ' HB3' ' HG2' ' A' ' 105' ' ' LYS . 24.0 m-20 -125.84 165.04 19.42 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.789 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 46.81 -136.79 9.57 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 120.125 1.329 . . . . 0.0 116.261 176.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.927 HD12 HG11 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -54.76 -32.79 60.46 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.319 -0.941 . . . . 0.0 111.341 -178.387 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.922 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -71.46 -52.64 17.35 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 121.626 0.727 . . . . 0.0 109.455 179.536 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.786 ' HB2' ' C ' ' A' ' 122' ' ' ALA . . . -58.24 -40.77 82.62 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.58 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.879 HD12 ' HG2' ' A' ' 102' ' ' ARG . 49.7 mm -68.6 -54.42 21.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.437 -179.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.898 ' HB2' ' H91' ' A' ' 149' ' ' BB2 . 31.9 p -57.67 -50.92 71.6 Favored 'General case' 0 C--N 1.334 -0.089 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.763 HD11 HD11 ' A' ' 108' ' ' ILE . 20.7 tt -60.55 -44.0 95.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.41 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.844 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 21.5 pt20 -67.85 -38.33 83.03 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.226 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.753 ' HA ' ' OD2' ' A' ' 135' ' ' ASP . 7.8 t-160 -58.45 -46.93 85.57 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.89 ' O ' HD23 ' A' ' 137' ' ' LEU . 4.1 mm-40 -59.42 -44.42 92.86 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.802 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.92 ' HA ' HD21 ' A' ' 137' ' ' LEU . 75.2 mtp -57.01 -48.84 77.52 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 118.411 0.551 . . . . 0.0 110.969 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.753 ' OD2' ' HA ' ' A' ' 132' ' ' HIS . 2.6 p30 -64.24 -47.26 80.34 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.474 -0.49 . . . . 0.0 109.785 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.634 ' CD2' HD12 ' A' ' 141' ' ' LEU . 20.6 t-80 -56.47 -51.79 67.15 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 121.589 -0.694 . . . . 0.0 110.94 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.92 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.3 pp -60.6 -31.31 70.47 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 119.895 -0.722 . . . . 0.0 112.053 -177.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 1.013 HG23 HG13 ' A' ' 16' ' ' VAL . 14.7 p -80.6 23.09 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-O 122.966 1.365 . . . . 0.0 109.815 176.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.878 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 64.45 6.34 21.21 Favored Glycine 0 CA--C 1.491 -1.426 0 CA-C-N 112.482 -2.144 . . . . 0.0 112.896 176.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.822 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 4.5 ptmt -94.09 123.63 37.58 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.634 HD12 ' CD2' ' A' ' 136' ' ' HIS . 2.5 mm? -121.57 160.52 24.16 Favored 'General case' 0 N--CA 1.438 -1.06 0 O-C-N 121.474 -0.766 . . . . 0.0 110.646 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.698 ' CD2' HG21 ' A' ' 100' ' ' VAL . 13.9 p90 -60.23 -34.63 73.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.389 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.531 ' HA ' ' HB2' ' A' ' 146' ' ' LEU . 49.6 ttm -59.73 -26.09 65.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.052 0.453 . . . . 0.0 111.04 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.677 ' CG ' HH12 ' A' ' 14' ' ' ARG . 61.0 t0 -57.48 -25.37 59.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.884 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -128.02 16.0 6.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.154 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.531 ' HB2' ' HA ' ' A' ' 143' ' ' MET . 1.3 mp -90.31 141.79 28.37 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.72 0.295 . . . . 0.0 110.902 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 55.3 m . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.835 179.469 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' BB2 . . . . . 0.92 ' H72' ' HN1' ' A' ' 149' ' ' BB2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.861 0.363 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.1 m -84.01 138.6 18.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.662 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.962 HD23 ' HB ' ' A' ' 51' ' ' VAL . 58.6 tp -77.82 158.08 29.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.284 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -78.56 106.07 10.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.127 0.489 . . . . 0.0 109.946 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.044 HG11 HD12 ' A' ' 91' ' ' LEU . 37.3 t -90.51 131.98 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.668 -178.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.01 ' HB2' HD21 ' A' ' 13' ' ' LEU . 29.6 mt -83.49 140.79 32.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.951 179.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 19.5 m-70 -111.18 142.93 42.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.202 0.525 . . . . 0.0 112.33 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.931 HD13 HD12 ' A' ' 13' ' ' LEU . 49.6 mm -50.87 144.81 12.8 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.799 178.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.524 ' HA ' HG23 ' A' ' 8' ' ' ILE . 79.1 Cg_endo -98.18 55.48 1.04 Allowed 'Cis proline' 0 C--N 1.354 0.837 0 C-N-CA 124.844 -0.898 . . . . 0.0 113.159 0.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.583 ' OD2' ' HB3' ' A' ' 6' ' ' LEU . 66.8 m-20 -55.11 140.89 36.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.375 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.427 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 23.9 pt-20 -58.84 -45.54 89.81 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.656 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.79 HH21 HG22 ' A' ' 49' ' ' THR . 0.0 OUTLIER -56.8 -24.91 54.07 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 179.711 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 1.01 HD21 ' HB2' ' A' ' 6' ' ' LEU . 8.2 mt -76.77 -32.87 58.01 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 121.193 1.815 . . . . 0.0 108.509 178.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.624 ' HE ' ' CG ' ' A' ' 144' ' ' ASP . 24.3 mmt-85 -94.76 5.89 50.54 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 114.159 -1.382 . . . . 0.0 109.716 178.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.763 ' HD3' ' NH1' ' A' ' 12' ' ' ARG . 75.7 tttt -93.13 155.74 17.29 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.811 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.824 HG13 HG23 ' A' ' 138' ' ' VAL . 64.3 t -82.5 136.17 23.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.293 0.568 . . . . 0.0 111.335 -178.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.043 ' HB3' HD12 ' A' ' 137' ' ' LEU . . . -87.18 141.13 28.88 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.693 ' HD3' ' N ' ' A' ' 19' ' ' PRO . 1.9 tmtp? -102.42 127.92 29.41 Favored Pre-proline 0 C--N 1.324 -0.503 0 C-N-CA 120.717 -0.393 . . . . 0.0 109.976 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.699 ' HB3' ' HD3' ' A' ' 56' ' ' ARG . 61.9 Cg_endo -78.81 115.02 3.52 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.14 1.893 . . . . 0.0 111.151 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.791 HG12 ' H ' ' A' ' 22' ' ' GLU . 19.8 t -70.07 145.0 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 CA-C-O 122.569 1.176 . . . . 0.0 113.232 -176.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.404 ' N ' HG12 ' A' ' 20' ' ' VAL . 51.6 mt-10 -65.93 -22.59 66.5 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 113.189 -1.823 . . . . 0.0 112.636 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.791 ' H ' HG12 ' A' ' 20' ' ' VAL . 5.0 tp10 -159.55 151.38 20.45 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.199 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.896 HG21 ' HA2' ' A' ' 115' ' ' GLY . 4.4 t -80.1 101.71 5.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.944 ' CB ' HD13 ' A' ' 27' ' ' ILE . 59.9 m-80 -91.53 160.33 15.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.933 -177.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.545 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -56.39 -32.97 65.3 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.494 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -71.78 -37.45 70.45 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.944 HD13 ' CB ' ' A' ' 24' ' ' ASN . 1.7 mp -64.24 -47.93 87.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.084 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -57.94 -40.51 80.68 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.788 0.328 . . . . 0.0 111.096 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.545 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 39.3 mmt180 -61.16 -41.3 96.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.808 0.813 . . . . 0.0 109.315 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.771 ' O ' ' HG3' ' A' ' 34' ' ' MET . 6.9 mt -59.37 -50.58 79.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 114.486 -1.233 . . . . 0.0 112.322 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.932 HG22 ' CG2' ' A' ' 57' ' ' ILE . 9.4 t -67.04 -42.15 88.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-O 120.846 0.355 . . . . 0.0 111.66 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.917 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -56.24 -42.44 77.35 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.96 -179.37 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.665 ' HB3' ' HB2' ' A' ' 3' ' ' LEU . 1.4 m-20 -75.07 -30.73 61.04 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.157 176.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 1.088 ' HG2' HG21 ' A' ' 51' ' ' VAL . 79.3 mtp -60.58 -47.84 84.4 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.007 -177.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.917 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 15.9 p90 -69.02 -43.76 74.13 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.61 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 52.9 mm-40 -52.43 -41.05 62.91 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.781 HG21 ' CG2' ' A' ' 5' ' ' VAL . 31.0 m -69.98 -62.16 1.49 Allowed 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 118.792 -1.163 . . . . 0.0 108.757 177.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.89 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 1.4 ttp -46.3 -42.63 14.89 Favored 'General case' 0 CA--C 1.46 -2.496 0 C-N-CA 123.611 0.764 . . . . 0.0 110.016 -170.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.681 ' OH ' ' HA ' ' A' ' 69' ' ' ARG . 66.7 m-85 -69.29 -41.65 76.51 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.389 178.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.06 -28.49 67.83 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.8 ' HG2' ' CD2' ' A' ' 91' ' ' LEU . 3.0 tp10 -84.62 -10.38 57.41 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.977 177.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.436 ' H ' ' C ' ' A' ' 39' ' ' TYR . 51.3 mt-10 63.37 25.59 14.66 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.953 -176.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.882 ' HA3' H173 ' A' ' 149' ' ' BB2 . . . -80.43 142.73 24.15 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.856 177.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.812 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 46.1 mm -78.99 -1.71 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 117.576 0.688 . . . . 0.0 112.254 -178.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.927 ' HA3' H101 ' A' ' 149' ' ' BB2 . . . 179.12 135.94 2.5 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 118.948 -0.918 . . . . 0.0 112.024 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.878 ' HB2' ' HG3' ' A' ' 38' ' ' MET . 6.9 tp -126.82 134.54 50.52 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.359 1.58 . . . . 0.0 112.295 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.833 ' HB2' ' OE1' ' A' ' 133' ' ' GLU . . . -97.8 131.1 44.6 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 122.386 0.274 . . . . 0.0 111.39 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.911 ' HB1' ' CG1' ' A' ' 53' ' ' ILE . . . -33.73 -54.12 0.45 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -178.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.79 HG22 HH21 ' A' ' 12' ' ' ARG . 81.8 p -52.84 -35.77 57.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.722 0.772 . . . . 0.0 111.176 -178.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.595 HE22 ' C3 ' ' A' ' 149' ' ' BB2 . 53.4 mt-30 -66.85 -36.76 83.07 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.023 178.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.088 HG21 ' HG2' ' A' ' 34' ' ' MET . 1.3 m -87.21 13.49 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.843 ' HA ' HD11 ' A' ' 6' ' ' LEU . 54.5 t0 77.75 32.4 0.4 Allowed 'General case' 0 C--O 1.23 0.075 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 176.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.911 ' CG1' ' HB1' ' A' ' 48' ' ' ALA . 1.2 pp -127.11 112.76 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.201 177.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.738 ' HA ' ' NH2' ' A' ' 12' ' ' ARG . 0.4 OUTLIER -76.0 67.02 2.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.862 0.839 . . . . 0.0 110.517 -179.439 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.77 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 89.2 mt-30 -157.59 134.05 9.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.691 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.739 ' N ' ' HB1' ' A' ' 17' ' ' ALA . 52.2 mtp85 -62.84 70.69 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -178.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.932 ' CG2' HG22 ' A' ' 31' ' ' VAL . 8.5 mm -113.16 122.35 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.073 HD11 ' HB2' ' A' ' 72' ' ' LEU . 2.1 pp -129.02 146.37 34.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.877 -178.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.588 HG23 ' H ' ' A' ' 46' ' ' LEU . 33.3 m -127.82 138.6 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.652 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.079 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 12.1 mm -115.1 149.23 17.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.617 0.722 . . . . 0.0 109.301 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.89 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 57.0 t0 -134.2 30.58 3.59 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.767 -178.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.801 HG22 ' CG2' ' A' ' 44' ' ' ILE . 30.4 t -98.45 111.32 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.877 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.622 ' N ' ' HG2' ' A' ' 68' ' ' GLU . 56.0 m -35.29 89.32 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -175.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.857 ' HB2' HD21 ' A' ' 70' ' ' LEU . 37.1 tt0 -54.56 -22.1 12.22 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 114.288 -1.323 . . . . 0.0 111.554 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -165.6 -76.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.858 0.837 . . . . 0.0 109.653 177.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -120.11 -45.74 2.45 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.116 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -106.22 133.27 51.19 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.416 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.622 ' HG2' ' N ' ' A' ' 63' ' ' SER . 98.4 mt-10 -84.77 126.85 33.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.81 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.681 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 73.8 ttt180 178.23 68.83 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.135 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 1.079 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 4.0 mm? -103.89 133.11 49.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.786 0.327 . . . . 0.0 111.473 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.811 HG21 ' HB2' ' A' ' 113' ' ' ARG . 10.6 p -135.38 133.3 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.593 178.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.073 ' HB2' HD11 ' A' ' 58' ' ' ILE . 1.5 mm? -140.71 142.2 34.86 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 177.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.066 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.7 mp -121.14 135.22 62.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 117.987 0.358 . . . . 0.0 110.679 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.72 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 7.9 m120 54.46 37.07 0.38 Allowed Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.884 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 99.5 Cg_exo -56.71 148.63 64.25 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 123.058 2.505 . . . . 0.0 114.408 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.511 ' O ' ' HB ' ' A' ' 108' ' ' ILE . 15.8 pt-20 -139.61 143.04 37.07 Favored 'General case' 0 C--O 1.23 0.079 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.884 HD12 HG22 ' A' ' 108' ' ' ILE . 8.5 tp -80.07 138.02 36.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.443 0.639 . . . . 0.0 111.43 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.091 HD11 ' HG3' ' A' ' 109' ' ' ARG . 6.8 mp -113.13 -36.91 4.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.181 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.433 ' O ' ' HB ' ' A' ' 106' ' ' VAL . 41.4 tt0 -159.0 149.55 19.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.208 0.528 . . . . 0.0 111.42 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 1.077 ' HA ' HG12 ' A' ' 106' ' ' VAL . 12.5 ptmt -146.47 149.59 33.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.282 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 81.2 p -158.58 145.04 17.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.526 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.783 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 79.12 154.74 8.48 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.117 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 -127.36 113.82 16.75 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.783 0.801 . . . . 0.0 112.316 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.588 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.5 p -106.44 160.89 15.06 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 115.645 1.721 . . . . 0.0 115.645 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.739 ' CA ' HD21 ' A' ' 99' ' ' LEU . . . -140.39 105.92 0.46 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 113.046 -1.888 . . . . 0.0 111.584 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.683 ' N ' ' HG ' ' A' ' 99' ' ' LEU . 20.4 mt -144.99 135.45 19.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -178.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 52.8 mt-10 -72.73 143.28 48.07 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 122.818 1.294 . . . . 0.0 113.37 -177.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.707 ' HG2' ' O27' ' A' ' 149' ' ' BB2 . 55.6 mt-10 -156.54 168.64 26.77 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 113.301 -1.772 . . . . 0.0 109.289 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.685 ' HA3' ' HG2' ' A' ' 97' ' ' ARG . . . -120.06 165.97 13.58 Favored Glycine 0 CA--C 1.5 -0.867 0 C-N-CA 119.421 -1.371 . . . . 0.0 110.628 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.812 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 63.0 m -115.71 137.65 51.87 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.921 -177.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.044 HD12 HG11 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -50.89 -33.27 23.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.65 0.738 . . . . 0.0 109.403 179.647 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.893 ' CB ' HD13 ' A' ' 13' ' ' LEU . 60.1 m -76.92 -30.56 56.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.829 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.728 ' CG2' ' HD2' ' A' ' 94' ' ' PRO . 57.7 mt -85.91 148.36 48.04 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.728 ' HD2' ' CG2' ' A' ' 93' ' ' ILE . 68.9 Cg_endo -75.36 47.73 1.91 Allowed 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.475 2.117 . . . . 0.0 114.183 -178.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.53 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 39.7 tt0 78.77 10.78 1.67 Allowed 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 122.696 0.398 . . . . 0.0 111.988 179.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.57 ' HG3' ' HG2' ' A' ' 94' ' ' PRO . 84.9 mt-30 -78.27 88.8 4.32 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.939 -0.764 . . . . 0.0 108.939 178.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.685 ' HG2' ' HA3' ' A' ' 89' ' ' GLY . 42.9 mtm-85 -84.87 133.15 34.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.67 0.748 . . . . 0.0 111.659 -178.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.746 ' HB3' ' HE2' ' A' ' 143' ' ' MET . . . -134.2 153.94 51.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.839 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.739 HD21 ' CA ' ' A' ' 85' ' ' GLY . 6.9 tt -75.53 135.95 40.59 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.875 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.776 HG13 ' CG ' ' A' ' 142' ' ' PHE . 60.2 t -130.38 134.64 26.32 Favored Pre-proline 0 N--CA 1.454 -0.265 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.75 ' HD2' ' CD2' ' A' ' 142' ' ' PHE . 88.2 Cg_endo -82.71 124.12 3.91 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.395 1.397 . . . . 0.0 113.721 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.906 ' HG2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -141.99 164.95 28.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 113.914 -1.494 . . . . 0.0 110.22 179.204 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.783 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.86 154.85 41.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.809 0.338 . . . . 0.0 110.913 -178.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.534 ' OE1' HG21 ' A' ' 84' ' ' THR . 28.2 tp10 -72.66 -43.93 62.51 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.283 -176.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.764 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 55.8 mttm -139.13 138.36 36.94 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.463 0.649 . . . . 0.0 109.495 176.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 1.077 HG12 ' HA ' ' A' ' 80' ' ' LYS . 25.8 m -147.49 140.43 19.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.614 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.907 ' HD2' ' CB ' ' A' ' 121' ' ' GLU . 51.3 mmtt -107.41 125.37 51.13 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 1.08 ' HA ' HD13 ' A' ' 78' ' ' LEU . 1.4 pp -129.95 160.75 40.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 1.091 ' HG3' HD11 ' A' ' 78' ' ' LEU . 92.7 mtt180 -107.51 135.01 49.69 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-O 121.142 0.496 . . . . 0.0 110.326 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.904 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -155.75 167.5 30.2 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.184 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 1.066 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.3 pp -115.54 151.69 34.4 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.446 ' OD1' HG13 ' A' ' 71' ' ' VAL . 19.8 t70 -86.67 163.46 17.36 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.604 -176.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.811 ' HB2' HG21 ' A' ' 71' ' ' VAL . 14.4 ttp-105 -54.75 -16.44 2.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.77 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.37 -25.7 42.14 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.975 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.896 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 105.91 35.51 2.97 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.573 -0.822 . . . . 0.0 113.837 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -128.92 102.98 18.93 Favored Pre-proline 0 C--O 1.238 0.485 0 CA-C-N 116.967 0.383 . . . . 0.0 111.139 178.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.679 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 32.5 Cg_exo -73.23 114.76 4.12 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 121.653 1.569 . . . . 0.0 114.994 -177.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -129.6 168.93 15.69 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.908 -178.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.864 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 6.2 mp0 -106.63 130.11 54.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.91 0.386 . . . . 0.0 109.981 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.9 ' O ' HD23 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -124.45 141.78 51.82 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.881 0.848 . . . . 0.0 112.017 -178.57 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.907 ' CB ' ' HD2' ' A' ' 107' ' ' LYS . 15.3 pt-20 -94.84 123.33 38.24 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.998 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.779 ' O ' ' HB2' ' A' ' 127' ' ' ALA . . . -116.52 134.17 55.16 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.453 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.764 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.2 m-20 -126.76 163.62 23.14 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.76 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 45.89 -133.75 9.61 Favored Glycine 0 C--N 1.348 1.198 0 CA-C-N 120.832 1.651 . . . . 0.0 116.224 176.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.0 mt -53.38 -35.06 59.91 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.444 -0.878 . . . . 0.0 111.444 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.543 HD22 ' CB ' ' A' ' 122' ' ' ALA . 0.6 OUTLIER -70.68 -53.67 14.81 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.311 0.577 . . . . 0.0 110.116 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.779 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -59.0 -42.95 91.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.699 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.906 HD12 ' HG2' ' A' ' 102' ' ' ARG . 49.5 mm -64.72 -55.47 20.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.366 -178.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.797 ' HB2' ' C11' ' A' ' 149' ' ' BB2 . 28.9 p -57.76 -49.71 75.69 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -178.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.679 HD11 HD11 ' A' ' 108' ' ' ILE . 19.3 tt -59.26 -42.42 87.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.878 ' CG ' HG21 ' A' ' 106' ' ' VAL . 66.5 mt-30 -65.79 -40.57 92.07 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 178.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.689 ' HD2' ' H81' ' A' ' 149' ' ' BB2 . 74.1 t60 -56.0 -49.2 74.3 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.524 0.678 . . . . 0.0 110.219 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.89 ' CG ' H102 ' A' ' 149' ' ' BB2 . 24.0 mm-40 -60.7 -42.44 97.18 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.083 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.93 ' HA ' HD21 ' A' ' 137' ' ' LEU . 35.5 mtm -58.16 -49.62 76.36 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.351 0.978 . . . . 0.0 110.968 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.659 ' OD2' ' HA ' ' A' ' 132' ' ' HIS . 4.1 p30 -63.0 -46.09 89.31 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.681 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.981 ' CE1' HD21 ' A' ' 141' ' ' LEU . 11.7 t-80 -56.76 -51.57 68.38 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 121.78 -0.575 . . . . 0.0 111.039 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 1.043 HD12 ' HB3' ' A' ' 17' ' ' ALA . 1.2 pp -59.76 -30.72 69.05 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.799 -177.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.824 HG23 HG13 ' A' ' 16' ' ' VAL . 10.7 p -83.11 20.48 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-O 123.083 1.42 . . . . 0.0 108.22 174.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.805 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 60.36 17.49 46.99 Favored Glycine 0 CA--C 1.491 -1.455 0 CA-C-N 112.106 -2.316 . . . . 0.0 112.553 176.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.775 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -106.59 118.21 36.08 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.064 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.981 HD21 ' CE1' ' A' ' 136' ' ' HIS . 8.3 mp -132.69 144.62 50.44 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.776 ' CG ' HG13 ' A' ' 100' ' ' VAL . 7.4 m-85 -63.86 -34.24 77.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 118.226 0.466 . . . . 0.0 111.068 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.788 ' HA ' HD13 ' A' ' 146' ' ' LEU . 46.4 tpp -55.08 -26.68 39.56 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.291 0.567 . . . . 0.0 110.73 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.624 ' CG ' ' HE ' ' A' ' 14' ' ' ARG . 38.7 t70 -54.69 -25.0 24.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.895 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -128.31 40.62 3.63 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.114 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.788 HD13 ' HA ' ' A' ' 143' ' ' MET . 4.8 mp -92.35 147.01 23.25 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.722 0.296 . . . . 0.0 111.091 178.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 46.9 t . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.18 -0.914 . . . . 0.0 111.068 179.5 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' BB2 . . . . . 0.927 H101 ' HA3' ' A' ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.622 ' O ' ' HB3' ' A' ' 36' ' ' GLU . 46.9 t . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.864 0.364 . . . . 0.0 111.016 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.749 HG13 ' HA ' ' A' ' 37' ' ' THR . 42.2 t -120.18 138.7 49.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.276 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 1.074 HD23 ' HB ' ' A' ' 51' ' ' VAL . 58.4 tp -77.39 161.74 27.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.335 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 71.0 tp60 -78.44 106.67 10.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.03 0.443 . . . . 0.0 110.03 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.042 HG11 HD12 ' A' ' 91' ' ' LEU . 39.5 t -90.08 131.94 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.647 -178.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.083 ' HB2' HD21 ' A' ' 13' ' ' LEU . 25.5 mt -85.01 140.73 30.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.479 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 39.2 m-70 -115.79 141.78 47.63 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -178.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.083 HD13 HD12 ' A' ' 13' ' ' LEU . 41.4 mm -62.77 134.5 95.48 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.889 177.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.3 144.81 78.83 Favored 'Cis proline' 0 C--N 1.352 0.754 0 C-N-CA 124.615 -0.994 . . . . 0.0 111.815 -0.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.982 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.6 t70 -164.56 126.46 2.23 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.505 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.528 ' HG2' ' N ' ' A' ' 12' ' ' ARG . 10.5 pm0 -58.28 -45.49 87.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.551 -178.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.715 ' HD3' ' HE3' ' A' ' 15' ' ' LYS . 14.2 mmt-85 -58.13 -27.63 63.92 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 1.083 HD12 HD13 ' A' ' 8' ' ' ILE . 9.6 mt -77.58 -31.3 53.0 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 120.814 1.643 . . . . 0.0 108.86 177.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.627 ' C ' ' HA3' ' A' ' 139' ' ' GLY . 13.5 mmt85 -95.54 10.0 38.14 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 114.147 -1.388 . . . . 0.0 109.308 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.808 ' NZ ' ' HB2' ' A' ' 54' ' ' HIS . 20.4 ttpp -92.05 146.49 23.69 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.204 -179.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.893 ' CG1' HG23 ' A' ' 138' ' ' VAL . 44.5 t -84.15 95.26 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.535 -178.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.58 ' HB1' ' C ' ' A' ' 55' ' ' GLN . . . -54.8 148.24 13.42 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-O 121.053 0.454 . . . . 0.0 111.868 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.418 ' HB3' ' OE1' ' A' ' 55' ' ' GLN . 54.2 tttp -103.21 129.42 25.58 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.902 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.663 ' CD ' ' HD3' ' A' ' 56' ' ' ARG . 60.1 Cg_endo -79.64 116.48 3.52 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.428 2.085 . . . . 0.0 110.506 179.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.871 HG12 ' H ' ' A' ' 22' ' ' GLU . 20.9 t -71.27 144.71 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-O 122.552 1.168 . . . . 0.0 113.143 -176.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -69.15 -21.13 64.02 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 113.121 -1.854 . . . . 0.0 112.329 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.871 ' H ' HG12 ' A' ' 20' ' ' VAL . 88.7 tt0 -159.25 142.03 14.16 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 121.157 -0.217 . . . . 0.0 110.566 -179.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.596 HG21 ' CD1' ' A' ' 111' ' ' LEU . 2.8 t -80.51 106.01 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 -178.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 1.065 ' H ' HD12 ' A' ' 27' ' ' ILE . 64.5 m-80 -89.34 159.05 17.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.692 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.568 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -54.17 -30.54 49.83 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.024 0.44 . . . . 0.0 110.69 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -71.81 -39.66 69.7 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 1.065 HD12 ' H ' ' A' ' 24' ' ' ASN . 60.6 mt -63.56 -47.6 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.297 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 11.6 mt-30 -57.85 -40.34 79.87 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.77 0.319 . . . . 0.0 110.627 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 40.0 mmt-85 -59.84 -40.45 88.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.811 0.815 . . . . 0.0 108.866 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.771 ' O ' ' HG3' ' A' ' 34' ' ' MET . 4.4 mt -59.64 -49.48 83.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 114.419 -1.264 . . . . 0.0 111.846 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.9 HG22 ' CG2' ' A' ' 57' ' ' ILE . 18.7 t -66.82 -42.21 88.86 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-O 120.839 0.352 . . . . 0.0 111.395 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.878 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -55.32 -43.91 75.32 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.997 -179.321 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.648 ' HB3' ' HB2' ' A' ' 3' ' ' LEU . 31.9 m-20 -75.29 -30.83 60.5 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.355 176.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 1.004 ' HG2' HG21 ' A' ' 51' ' ' VAL . 79.2 mtp -59.55 -47.22 86.38 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.566 -177.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.878 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 13.6 p90 -69.05 -43.99 73.54 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 177.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.759 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 81.7 mt-10 -51.85 -40.31 60.35 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.749 ' HA ' HG13 ' A' ' 2' ' ' VAL . 37.2 m -69.8 -61.45 1.77 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 119.042 -1.063 . . . . 0.0 108.638 177.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.952 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 3.3 ttp -46.22 -43.81 15.72 Favored 'General case' 0 CA--C 1.459 -2.528 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.861 -170.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.711 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 70.2 m-85 -69.63 -41.62 75.41 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.635 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.23 -28.62 68.16 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.811 ' HG2' ' CD2' ' A' ' 91' ' ' LEU . 3.2 tp10 -84.72 -10.06 57.62 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 114.407 -1.269 . . . . 0.0 108.876 177.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.441 ' H ' ' C ' ' A' ' 39' ' ' TYR . 58.1 mt-10 62.01 26.05 15.68 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.824 -176.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.608 ' HA3' H173 ' A' ' 149' ' ' BB2 . . . -79.89 143.13 25.1 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.373 177.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.805 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 40.6 mt -78.99 -0.78 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 117.941 0.87 . . . . 0.0 112.008 -178.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.824 ' HA3' ' C10' ' A' ' 149' ' ' BB2 . . . 179.33 135.3 2.36 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 118.972 -0.904 . . . . 0.0 112.005 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.995 HD13 HD23 ' A' ' 91' ' ' LEU . 9.0 tp -126.51 135.43 51.31 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.535 1.667 . . . . 0.0 112.084 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -99.68 130.73 45.93 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.889 ' HB1' ' CD1' ' A' ' 53' ' ' ILE . . . -29.7 -56.15 0.16 Allowed 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.59 HG21 ' O ' ' A' ' 137' ' ' LEU . 75.7 p -53.16 -35.02 59.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.964 0.888 . . . . 0.0 111.167 -178.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.612 ' O ' HG13 ' A' ' 5' ' ' VAL . 36.6 mt-30 -66.1 -38.08 87.36 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.174 -1.375 . . . . 0.0 110.358 179.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.074 ' HB ' HD23 ' A' ' 3' ' ' LEU . 1.4 m -87.61 15.29 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.871 ' HA ' ' CD1' ' A' ' 6' ' ' LEU . 56.0 t0 76.53 32.89 0.54 Allowed 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 176.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.889 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 1.2 pp -126.91 111.12 24.77 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.404 177.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.808 ' HB2' ' NZ ' ' A' ' 15' ' ' LYS . 0.5 OUTLIER -75.6 64.89 1.73 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.942 0.877 . . . . 0.0 110.59 -179.207 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.71 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 11.8 mm100 -155.48 134.8 12.36 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 114.359 -1.291 . . . . 0.0 108.385 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.709 ' HG2' ' CD1' ' A' ' 137' ' ' LEU . 77.1 mtp180 -65.37 72.4 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -177.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.9 ' CG2' HG22 ' A' ' 31' ' ' VAL . 7.4 mm -113.52 122.99 68.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.005 HD11 ' HB2' ' A' ' 72' ' ' LEU . 1.9 pp -127.11 145.52 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -177.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 46' ' ' LEU . 32.8 m -127.48 138.41 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.369 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.053 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 13.5 mm -115.88 152.69 17.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.571 0.701 . . . . 0.0 110.58 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.952 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 36.6 t70 -146.11 34.12 1.0 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.417 -178.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.782 HG22 HG22 ' A' ' 44' ' ' ILE . 38.8 t -95.76 111.35 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.289 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.585 ' HB3' ' OE2' ' A' ' 68' ' ' GLU . 78.3 p -38.26 77.71 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -176.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 62' ' ' VAL . 87.9 tt0 -67.0 -9.73 42.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.529 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.81 ' OD1' ' HG2' ' A' ' 66' ' ' ARG . 25.1 t-20 -165.51 -84.99 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.725 0.774 . . . . 0.0 110.379 177.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.81 ' HG2' ' OD1' ' A' ' 65' ' ' ASN . 18.6 mmt85 -121.94 -48.58 2.12 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.719 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -114.62 133.63 55.69 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.458 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.585 ' OE2' ' HB3' ' A' ' 63' ' ' SER . 49.8 mp0 -84.14 132.6 34.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.905 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.605 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 76.0 ttt180 -174.92 62.1 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.152 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 1.053 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 40.8 mt -104.91 133.48 49.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.455 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.762 HG21 ' HB2' ' A' ' 113' ' ' ARG . 9.9 p -134.82 133.02 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.023 178.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.005 ' HB2' HD11 ' A' ' 58' ' ' ILE . 87.3 mt -141.85 141.95 33.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.907 -0.133 . . . . 0.0 111.252 178.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.072 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.9 mp -118.24 134.09 62.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 110.418 -0.215 . . . . 0.0 110.418 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.681 ' ND2' HG22 ' A' ' 73' ' ' ILE . 15.4 p30 46.32 40.75 0.71 Allowed Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.754 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 92.5 Cg_exo -56.79 155.43 27.26 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.987 2.458 . . . . 0.0 113.247 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -137.78 143.75 41.25 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.972 ' HB2' ' HE1' ' A' ' 134' ' ' MET . 1.8 tt -81.3 133.93 35.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.609 0.719 . . . . 0.0 111.506 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.048 HD11 ' HG3' ' A' ' 109' ' ' ARG . 6.8 mp -109.3 -38.83 5.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.541 -1.208 . . . . 0.0 111.905 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 42.7 tt0 -160.28 155.66 25.16 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.264 0.554 . . . . 0.0 112.056 -179.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.842 ' HA ' HG12 ' A' ' 106' ' ' VAL . 18.7 ptpt -148.25 151.53 35.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.451 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 53.2 m -160.08 143.46 13.94 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.679 0.276 . . . . 0.0 111.193 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.758 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 81.98 159.72 25.28 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.556 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -130.67 114.0 14.87 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.531 0.682 . . . . 0.0 112.617 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.5 p -107.76 159.31 16.59 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 179.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.71 ' O ' HD13 ' A' ' 86' ' ' ILE . . . -140.06 103.44 0.37 Allowed Glycine 0 C--N 1.318 -0.461 0 CA-C-N 113.039 -1.891 . . . . 0.0 111.63 178.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.71 HD13 ' O ' ' A' ' 85' ' ' GLY . 40.7 mm -144.67 135.86 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -178.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.639 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 48.8 mt-10 -72.27 143.68 48.66 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 122.577 1.18 . . . . 0.0 112.736 -178.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.672 ' HB3' H262 ' A' ' 149' ' ' BB2 . 50.3 mt-10 -155.61 164.16 39.0 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 113.727 -1.579 . . . . 0.0 109.482 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.781 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -118.68 163.29 13.16 Favored Glycine 0 CA--C 1.498 -1.016 0 C-N-CA 119.258 -1.449 . . . . 0.0 110.235 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.835 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 71.8 m -111.71 137.8 49.12 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.886 -177.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.042 HD12 HG11 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -50.01 -33.51 18.29 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.678 0.752 . . . . 0.0 109.891 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.853 ' CB ' HD13 ' A' ' 13' ' ' LEU . 29.2 m -77.55 -29.98 52.48 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.801 -179.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.724 ' CG2' ' HD2' ' A' ' 94' ' ' PRO . 59.9 mt -85.9 148.37 48.09 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.724 ' HD2' ' CG2' ' A' ' 93' ' ' ILE . 66.9 Cg_endo -75.51 47.7 1.94 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.522 2.148 . . . . 0.0 114.552 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.61 ' HB2' ' O ' ' A' ' 94' ' ' PRO . 0.3 OUTLIER 79.41 10.11 1.53 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 179.067 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.556 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . 98.4 mm-40 -78.16 88.88 4.25 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.966 HH11 H231 ' A' ' 149' ' ' BB2 . 77.7 mtm180 -84.52 133.23 34.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.729 0.776 . . . . 0.0 111.652 -178.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -129.63 149.68 51.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.651 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.683 HD23 ' N ' ' A' ' 100' ' ' VAL . 6.9 tt -75.07 135.39 41.22 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.685 0.279 . . . . 0.0 110.462 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.846 HG13 ' HB2' ' A' ' 142' ' ' PHE . 57.6 t -130.25 130.61 23.07 Favored Pre-proline 0 N--CA 1.453 -0.31 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 84' ' ' THR . 5.8 Cg_exo -77.95 123.85 6.47 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 121.741 1.628 . . . . 0.0 112.587 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.942 HH11 ' HB3' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -142.75 165.28 27.8 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.085 -1.416 . . . . 0.0 110.4 179.39 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.758 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.64 154.94 40.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.721 0.296 . . . . 0.0 110.656 -178.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -72.77 -43.08 63.29 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.231 -176.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.793 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 82.3 mttt -139.6 138.27 36.04 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.48 0.657 . . . . 0.0 109.621 176.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.842 HG12 ' HA ' ' A' ' 80' ' ' LYS . 27.4 m -142.51 141.49 27.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.852 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.985 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 52.8 mmtt -107.73 125.77 51.8 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 1.0 ' HA ' HD13 ' A' ' 78' ' ' LEU . 2.0 pp -130.86 160.1 42.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -177.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 1.048 ' HG3' HD11 ' A' ' 78' ' ' LEU . 95.4 mtt180 -109.84 137.8 47.12 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.862 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -156.94 167.49 30.31 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.761 -0.2 . . . . 0.0 111.108 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 1.072 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.0 pp -113.9 151.86 31.61 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.415 ' O ' HD12 ' A' ' 111' ' ' LEU . 9.4 t70 -89.06 162.7 15.86 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.503 -177.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.812 ' HD2' ' OD1' ' A' ' 32' ' ' ASP . 48.4 ttp85 -52.75 -18.6 1.92 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.235 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -79.25 -25.06 42.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.343 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.92 35.85 2.89 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.698 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -128.79 102.93 19.3 Favored Pre-proline 0 C--O 1.237 0.423 0 CA-C-N 116.986 0.393 . . . . 0.0 111.248 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.663 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.6 Cg_exo -73.54 114.84 4.14 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 121.703 1.602 . . . . 0.0 114.729 -177.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.18 168.75 13.62 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.683 -178.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.813 ' HG2' ' HG2' ' A' ' 109' ' ' ARG . 33.2 mt-10 -107.39 130.06 54.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.051 0.453 . . . . 0.0 110.132 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.939 HD21 HD11 ' A' ' 72' ' ' LEU . 4.1 pp -127.48 134.72 49.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.97 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.985 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 11.5 pt-20 -93.53 125.11 37.96 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.843 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.939 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -116.19 135.43 53.92 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.793 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.1 m-20 -126.31 164.49 20.92 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.778 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 47.16 -135.3 11.95 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 120.187 1.358 . . . . 0.0 116.302 176.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.45 ' HB3' HG11 ' A' ' 62' ' ' VAL . 87.2 mt -54.04 -33.74 58.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.493 -0.854 . . . . 0.0 111.721 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.939 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -71.26 -53.46 14.24 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.762 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.777 ' HB2' ' C ' ' A' ' 122' ' ' ALA . . . -59.3 -46.19 89.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.876 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.832 HD12 ' HG2' ' A' ' 102' ' ' ARG . 47.3 mm -61.54 -56.02 20.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.095 -178.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.911 ' HB3' ' H91' ' A' ' 149' ' ' BB2 . 73.5 m -60.0 -51.22 70.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.707 HG22 ' O ' ' A' ' 126' ' ' LEU . 20.3 tt -59.11 -42.07 85.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 121.21 -0.196 . . . . 0.0 111.004 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.864 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.4 pt20 -67.81 -37.77 82.42 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.409 ' CD2' ' O2 ' ' A' ' 149' ' ' BB2 . 72.5 t60 -59.52 -44.94 93.04 Favored 'General case' 0 CA--C 1.521 -0.146 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.871 ' O ' HD23 ' A' ' 137' ' ' LEU . 4.2 mm-40 -59.3 -44.53 92.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.173 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.972 ' HE1' ' HB2' ' A' ' 77' ' ' LEU . 74.3 mtp -57.42 -48.32 79.42 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.544 0.687 . . . . 0.0 110.28 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.518 ' O ' HG12 ' A' ' 138' ' ' VAL . 30.5 m-20 -61.32 -48.63 80.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.157 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.847 ' HA ' ' CD1' ' A' ' 141' ' ' LEU . 21.4 t-80 -59.99 -51.43 69.71 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.861 0.362 . . . . 0.0 111.65 -178.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.937 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.4 pp -58.76 -32.98 69.77 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.481 -177.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.933 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 8.2 p -82.07 20.56 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-O 123.085 1.421 . . . . 0.0 108.854 175.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.847 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 59.44 14.66 28.43 Favored Glycine 0 CA--C 1.49 -1.474 0 CA-C-N 112.178 -2.283 . . . . 0.0 112.622 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.933 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 8.5 ptmt -103.71 116.25 31.98 Favored 'General case' 0 N--CA 1.426 -1.65 0 C-N-CA 119.466 -0.893 . . . . 0.0 108.816 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.847 ' CD1' ' HA ' ' A' ' 136' ' ' HIS . 7.7 mp -128.88 141.83 51.16 Favored 'General case' 0 N--CA 1.446 -0.666 0 O-C-N 121.266 -0.896 . . . . 0.0 108.61 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.846 ' HB2' HG13 ' A' ' 100' ' ' VAL . 7.2 m-85 -63.53 -34.89 78.79 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.061 0.392 . . . . 0.0 111.509 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 1.002 ' HG2' HD12 ' A' ' 146' ' ' LEU . 15.9 tmm? -55.73 -25.39 40.21 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.508 0.67 . . . . 0.0 110.711 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -52.26 -23.83 6.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.845 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -122.0 41.64 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.732 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 1.002 HD12 ' HG2' ' A' ' 143' ' ' MET . 40.5 mt -93.57 139.85 30.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.876 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 83.2 p . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.999 179.492 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' BB2 . . . . . 0.966 H231 HH11 ' A' ' 97' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 80.2 p . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.878 0.37 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.965 HG12 ' HA ' ' A' ' 37' ' ' THR . 30.5 m -84.17 133.93 28.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.428 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.933 HD21 ' HB ' ' A' ' 51' ' ' VAL . 3.0 pp -79.63 -172.4 3.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.565 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -82.37 108.98 16.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.782 0.325 . . . . 0.0 110.454 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.528 HG22 HG21 ' A' ' 37' ' ' THR . 37.9 t -88.42 129.85 38.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.385 0.612 . . . . 0.0 112.03 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.972 ' HB2' HD21 ' A' ' 13' ' ' LEU . 23.7 mt -88.15 147.39 24.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.655 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 -128.19 146.06 50.84 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.669 HG21 ' CE ' ' A' ' 143' ' ' MET . 3.3 mp -64.22 135.23 96.24 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.205 177.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.39 140.83 58.48 Favored 'Cis proline' 0 C--N 1.352 0.741 0 C-N-CA 124.253 -1.145 . . . . 0.0 111.804 -0.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.87 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.7 t70 -160.85 125.17 3.56 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.475 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.549 ' HG2' ' N ' ' A' ' 12' ' ' ARG . 2.7 pm0 -57.8 -43.81 85.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.418 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.669 ' HE ' ' HE3' ' A' ' 15' ' ' LYS . 15.5 mmt85 -55.99 -30.05 61.2 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.972 HD21 ' HB2' ' A' ' 6' ' ' LEU . 9.8 mt -77.1 -32.7 56.79 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 120.891 1.678 . . . . 0.0 108.661 177.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.628 HH12 ' HA ' ' A' ' 144' ' ' ASP . 15.9 mmt180 -91.66 8.83 34.98 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 113.998 -1.455 . . . . 0.0 109.165 179.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.669 ' HE3' ' HE ' ' A' ' 12' ' ' ARG . 24.9 ttmm -91.26 148.05 22.62 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.05 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.546 HG13 HG23 ' A' ' 138' ' ' VAL . 85.5 t -82.78 129.83 36.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.87 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -90.45 144.31 25.92 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.384 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.766 ' HD3' ' CD ' ' A' ' 19' ' ' PRO . 2.0 tmtp? -106.35 133.14 20.37 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.766 ' CD ' ' HD3' ' A' ' 18' ' ' LYS . 45.7 Cg_endo -82.09 114.71 2.57 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 121.934 1.756 . . . . 0.0 110.73 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.745 HG12 ' H ' ' A' ' 22' ' ' GLU . 16.0 t -67.68 144.33 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 CA-C-O 122.574 1.178 . . . . 0.0 113.247 -175.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.82 -23.45 67.36 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 112.924 -1.944 . . . . 0.0 112.639 -179.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.745 ' H ' HG12 ' A' ' 20' ' ' VAL . 88.7 tt0 -158.67 144.51 16.72 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.13 -178.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.502 HG22 HD21 ' A' ' 111' ' ' LEU . 3.1 t -81.45 107.4 13.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -178.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 1.034 ' HB2' HD13 ' A' ' 27' ' ' ILE . 55.0 m-80 -95.38 157.79 15.74 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.769 -178.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.534 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -55.18 -24.22 25.73 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.282 0.563 . . . . 0.0 110.808 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.753 ' O ' HD13 ' A' ' 30' ' ' ILE . 70.8 mm-40 -74.45 -44.92 49.52 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 177.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 1.034 HD13 ' HB2' ' A' ' 24' ' ' ASN . 2.0 mp -64.72 -34.34 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 113.793 -1.548 . . . . 0.0 110.153 178.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.515 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 75.0 mt-30 -68.16 -40.59 82.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 122.297 -0.252 . . . . 0.0 110.713 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.534 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 40.3 mmt180 -61.44 -39.3 90.33 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.846 ' CG2' HD13 ' A' ' 53' ' ' ILE . 1.6 mp -57.75 -48.53 83.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.087 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.584 HG22 ' CG2' ' A' ' 57' ' ' ILE . 27.6 t -68.11 -42.26 84.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.97 0.414 . . . . 0.0 111.156 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.872 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -56.39 -42.19 77.5 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.058 -179.254 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.491 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 17.5 m-20 -75.78 -30.11 58.98 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.261 176.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 1.095 ' HG2' HG21 ' A' ' 51' ' ' VAL . 87.6 mtp -60.92 -46.27 91.33 Favored 'General case' 0 C--N 1.345 0.395 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.516 -177.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.872 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 13.5 p90 -69.59 -45.91 67.53 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.578 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 29.4 mm-40 -52.51 -38.44 59.61 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.965 ' HA ' HG12 ' A' ' 2' ' ' VAL . 61.6 m -69.9 -62.23 1.47 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.487 -1.233 . . . . 0.0 107.857 178.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.887 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 3.7 ttp -46.65 -41.85 15.43 Favored 'General case' 0 CA--C 1.461 -2.472 0 C-N-CA 124.042 0.937 . . . . 0.0 110.72 -171.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.708 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 70.9 m-85 -70.48 -42.32 71.55 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.38 178.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.457 ' CB ' HG11 ' A' ' 2' ' ' VAL . . . -61.4 -24.31 66.42 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.358 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.937 ' HG2' HD12 ' A' ' 91' ' ' LEU . 3.1 tp10 -89.05 -10.7 46.49 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 114.47 -1.241 . . . . 0.0 108.566 177.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.443 ' H ' ' C ' ' A' ' 39' ' ' TYR . 23.4 mt-10 62.96 26.7 15.65 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.818 -176.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.611 ' HA2' H182 ' A' ' 149' ' ' BB2 . . . -79.97 145.17 26.91 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.974 178.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.803 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 44.1 mm -79.3 -1.56 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 117.418 0.609 . . . . 0.0 112.028 -178.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.893 ' HA3' H113 ' A' ' 149' ' ' BB2 . . . 177.54 142.06 4.38 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -178.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.018 HD13 ' HG ' ' A' ' 91' ' ' LEU . 4.7 tp -126.21 135.63 51.85 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.528 1.664 . . . . 0.0 110.479 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -105.9 132.2 52.29 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.989 ' HB1' HG13 ' A' ' 53' ' ' ILE . . . -28.73 -56.76 0.13 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 -178.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.884 HG23 ' HA ' ' A' ' 137' ' ' LEU . 67.6 p -53.17 -34.64 57.78 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 121.953 0.883 . . . . 0.0 111.164 -178.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.856 ' OE1' HD23 ' A' ' 91' ' ' LEU . 50.3 mt-30 -63.94 -43.83 94.67 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.25 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.095 HG21 ' HG2' ' A' ' 34' ' ' MET . 1.0 OUTLIER -86.76 15.07 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.86 ' HA ' HD11 ' A' ' 6' ' ' LEU . 36.5 t70 78.29 27.87 0.5 Allowed 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 176.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 1.015 HD11 ' HB ' ' A' ' 57' ' ' ILE . 10.7 pt -119.36 109.83 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 C-N-CA 119.045 -1.062 . . . . 0.0 110.858 177.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.629 ' HB3' ' HD2' ' A' ' 15' ' ' LYS . 25.2 p-80 -75.84 49.18 0.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 122.063 0.935 . . . . 0.0 109.946 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.642 ' C ' ' HB1' ' A' ' 17' ' ' ALA . 27.9 mt-30 -136.48 130.62 32.83 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 1.085 ' HA ' HD22 ' A' ' 137' ' ' LEU . 60.3 mtp85 -62.46 75.14 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.015 ' HB ' HD11 ' A' ' 53' ' ' ILE . 15.0 mt -119.83 124.62 73.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.876 HD11 ' HG2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -131.57 148.5 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -178.069 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.589 ' CG2' ' HB3' ' A' ' 46' ' ' LEU . 32.8 m -124.34 138.85 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.046 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 6.1 mm -113.57 150.86 15.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-O 121.739 0.781 . . . . 0.0 110.137 -179.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.887 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 36.1 t70 -140.16 27.6 2.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.895 -177.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.785 HG22 ' CG2' ' A' ' 44' ' ' ILE . 41.1 t -92.5 108.86 20.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.219 178.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.523 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 63.0 m -35.95 85.4 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -175.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 62' ' ' VAL . 42.9 tt0 -48.67 -50.19 34.27 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.838 178.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -133.84 -67.1 0.61 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.123 178.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.422 HH11 ' HG2' ' A' ' 66' ' ' ARG . 69.3 mtt-85 -133.27 -42.86 0.86 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.174 0.512 . . . . 0.0 110.374 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -105.65 133.99 49.49 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.167 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.523 ' HG2' ' HA ' ' A' ' 63' ' ' SER . 92.0 mt-10 -86.75 130.6 34.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.197 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.623 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 34.3 ttp85 177.17 66.76 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.863 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 1.046 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 62.0 mt -106.79 135.43 48.34 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-O 120.692 0.282 . . . . 0.0 111.431 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.818 HG21 ' HB2' ' A' ' 113' ' ' ARG . 12.7 p -134.94 135.16 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.25 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.816 ' HB2' HD11 ' A' ' 58' ' ' ILE . 3.2 mm? -141.63 144.35 34.13 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 177.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.998 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.5 mp -124.33 135.78 62.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.9 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.715 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 6.1 m120 49.57 35.48 0.28 Allowed Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 178.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.876 ' HG2' HD11 ' A' ' 58' ' ' ILE . 80.2 Cg_exo -60.91 157.18 39.72 Favored 'Trans proline' 0 N--CA 1.485 1.02 0 C-N-CA 122.809 2.34 . . . . 0.0 114.761 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.423 ' O ' HD22 ' A' ' 78' ' ' LEU . 11.3 pt-20 -138.05 141.78 40.33 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.945 ' HA ' HG22 ' A' ' 108' ' ' ILE . 1.5 tt -80.23 131.64 35.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.151 0.5 . . . . 0.0 111.369 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.113 HD23 ' HA ' ' A' ' 108' ' ' ILE . 2.7 mm? -104.24 -39.06 6.64 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.872 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.614 ' O ' HD21 ' A' ' 77' ' ' LEU . 40.0 tp10 -152.68 152.01 31.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.138 0.495 . . . . 0.0 111.521 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 1.018 ' HA ' HG12 ' A' ' 106' ' ' VAL . 9.2 ptpp? -147.67 148.48 31.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.437 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.8 m -158.58 147.8 19.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.254 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.666 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 73.23 158.67 4.93 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.495 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -133.92 114.38 13.22 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 122.292 1.044 . . . . 0.0 113.356 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.647 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.7 p -103.73 162.11 13.36 Favored 'General case' 0 CA--C 1.488 -1.435 0 CA-C-N 113.244 -1.798 . . . . 0.0 115.232 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.8 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -148.29 117.9 0.93 Allowed Glycine 0 C--N 1.314 -0.66 0 CA-C-N 112.54 -2.118 . . . . 0.0 110.418 177.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.608 HD13 ' O ' ' A' ' 85' ' ' GLY . 48.3 mm -147.04 138.47 18.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 117.297 0.549 . . . . 0.0 111.284 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 56.3 mt-10 -72.26 139.0 47.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 123.297 1.523 . . . . 0.0 111.613 -176.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.73 ' HG2' ' O27' ' A' ' 149' ' ' BB2 . 47.2 mt-10 -155.92 161.42 40.55 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 112.693 -2.049 . . . . 0.0 111.392 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.948 ' O ' ' H52' ' A' ' 149' ' ' BB2 . . . -120.15 165.51 13.64 Favored Glycine 0 CA--C 1.496 -1.127 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.799 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 20.5 m -114.92 137.08 52.39 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.512 0.672 . . . . 0.0 112.331 -177.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.018 ' HG ' HD13 ' A' ' 46' ' ' LEU . 2.3 mm? -46.77 -40.35 13.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.453 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.691 ' CB ' HD13 ' A' ' 13' ' ' LEU . 51.0 m -78.18 -27.51 47.97 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.091 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.75 ' CG2' ' HD2' ' A' ' 94' ' ' PRO . 54.4 mt -85.54 150.39 53.82 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.75 ' HD2' ' CG2' ' A' ' 93' ' ' ILE . 94.4 Cg_endo -71.96 44.84 0.69 Allowed 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 122.18 1.92 . . . . 0.0 114.885 -178.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.562 ' HB2' ' O ' ' A' ' 94' ' ' PRO . 0.3 OUTLIER 74.53 15.59 3.35 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 178.198 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.668 ' HG3' ' HG2' ' A' ' 94' ' ' PRO . 25.9 mt-30 -78.41 89.62 4.41 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.827 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 47.9 mtm-85 -84.37 132.5 34.59 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.837 0.827 . . . . 0.0 111.892 -178.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -135.74 153.68 51.49 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.492 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.8 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.3 tt -76.34 114.23 14.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.61 0.719 . . . . 0.0 111.752 -178.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.814 HG13 ' NE ' ' A' ' 102' ' ' ARG . 13.7 p -106.56 129.66 24.11 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 114.931 -1.031 . . . . 0.0 112.181 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.647 ' HA ' ' O ' ' A' ' 84' ' ' THR . 1.1 Cg_endo -84.22 127.09 3.88 Favored 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 123.56 2.84 . . . . 0.0 113.921 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.978 ' HG2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -143.82 167.61 21.91 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.512 1.125 . . . . 0.0 109.471 179.12 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.666 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.36 155.33 40.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 118.357 0.526 . . . . 0.0 109.969 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -73.63 -41.94 62.11 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.972 -175.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.558 ' HG2' ' HB3' ' A' ' 123' ' ' ASP . 61.3 mttp -140.04 140.54 36.19 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.381 0.61 . . . . 0.0 109.573 177.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 1.018 HG12 ' HA ' ' A' ' 80' ' ' LYS . 22.5 m -151.36 140.2 14.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.598 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.988 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 52.8 mmtt -107.34 126.34 52.33 Favored 'General case' 0 CA--C 1.524 -0.026 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 1.113 ' HA ' HD23 ' A' ' 78' ' ' LEU . 1.7 pp -135.72 154.06 33.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -176.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 1.022 ' HG3' HD21 ' A' ' 78' ' ' LEU . 50.1 mtm180 -103.07 139.53 38.48 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.532 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.768 ' CB ' ' HG3' ' A' ' 75' ' ' PRO . . . -160.45 169.73 22.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.642 -176.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.998 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.3 pp -118.26 151.44 37.66 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.656 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 8.5 t70 -87.64 161.44 17.68 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.257 -176.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.818 ' HB2' HG21 ' A' ' 71' ' ' VAL . 52.0 ttp85 -52.74 -17.28 1.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.099 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.56 -29.32 46.21 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.799 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.434 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 109.2 35.58 2.29 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.45 -0.881 . . . . 0.0 113.24 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -128.79 102.99 19.26 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 121.177 -0.209 . . . . 0.0 110.972 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.686 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.3 Cg_exo -73.76 115.1 4.21 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 121.553 1.502 . . . . 0.0 114.757 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.656 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 11.0 p90 -127.38 169.01 14.05 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.442 -177.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.639 ' HG2' ' CG ' ' A' ' 109' ' ' ARG . 31.1 mt-10 -106.65 129.9 54.48 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.727 ' O ' HD12 ' A' ' 120' ' ' LEU . 4.3 pp -125.72 134.66 51.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.476 -178.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.988 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 15.3 pt-20 -92.99 123.88 36.56 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.636 178.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.917 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -117.71 134.01 55.34 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.558 ' HB3' ' HG2' ' A' ' 105' ' ' LYS . 22.9 m-20 -126.96 162.86 24.97 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.772 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 50.92 -136.68 28.97 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 120.265 1.393 . . . . 0.0 115.658 177.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.68 HD12 ' H ' ' A' ' 125' ' ' LEU . 4.7 mp -55.23 -33.24 62.94 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.684 -0.758 . . . . 0.0 111.706 -178.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.917 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -71.03 -52.12 21.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.866 0.841 . . . . 0.0 109.203 179.692 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.766 ' HB2' ' C ' ' A' ' 122' ' ' ALA . . . -59.01 -41.23 87.2 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.194 -1.366 . . . . 0.0 111.703 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.978 HD12 ' HG2' ' A' ' 102' ' ' ARG . 50.5 mm -68.43 -54.99 17.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.875 ' HB2' ' H91' ' A' ' 149' ' ' BB2 . 30.4 p -58.13 -47.73 82.39 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 1.053 HD11 HD11 ' A' ' 108' ' ' ILE . 19.5 tt -59.05 -44.03 90.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.867 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.85 ' CG ' HG21 ' A' ' 106' ' ' VAL . 69.5 mt-30 -64.72 -44.94 88.57 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 178.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.592 ' CD2' ' HN1' ' A' ' 149' ' ' BB2 . 76.0 t60 -56.44 -47.75 78.45 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.243 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.814 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 3.3 mm-40 -60.23 -38.86 84.7 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 110.552 -0.166 . . . . 0.0 110.552 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.686 ' CE ' ' HB2' ' A' ' 77' ' ' LEU . 28.4 mtm -58.77 -45.66 89.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 122.338 1.066 . . . . 0.0 109.384 177.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.813 ' O ' HG12 ' A' ' 138' ' ' VAL . 0.9 OUTLIER -66.58 -48.55 69.25 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.999 179.394 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.702 ' CE1' HD21 ' A' ' 141' ' ' LEU . 7.8 t-80 -57.15 -53.0 63.06 Favored 'General case' 0 C--N 1.32 -0.712 0 O-C-N 121.512 -0.742 . . . . 0.0 111.491 -178.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 1.085 HD22 ' HA ' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -65.17 -27.85 69.0 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 119.908 -0.717 . . . . 0.0 111.903 -179.449 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.91 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 10.9 p -81.16 23.62 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-O 122.056 0.932 . . . . 0.0 109.211 175.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 137' ' ' LEU . . . 67.94 3.67 30.44 Favored Glycine 0 CA--C 1.486 -1.752 0 CA-C-N 113.793 -1.549 . . . . 0.0 113.245 175.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.91 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 10.4 ptmt -97.95 135.03 40.25 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.882 HD12 ' O ' ' A' ' 140' ' ' LYS . 10.5 mp -139.33 149.55 44.34 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -178.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.729 ' HB3' ' CG2' ' A' ' 100' ' ' VAL . 9.6 p90 -54.36 -35.07 62.38 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.669 ' CE ' HG21 ' A' ' 8' ' ' ILE . 56.5 ttp -61.22 -28.31 69.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.158 0.504 . . . . 0.0 110.745 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.628 ' HA ' HH12 ' A' ' 14' ' ' ARG . 9.0 t70 -59.94 -25.24 65.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.919 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -121.05 14.4 11.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.413 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.432 ' HB2' ' HA ' ' A' ' 143' ' ' MET . 1.8 mp -91.15 139.43 30.76 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.672 0.272 . . . . 0.0 110.906 179.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 63.7 m . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.891 179.344 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' BB2 . . . . . 0.948 ' H52' ' O ' ' A' ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 79.7 p . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.865 0.364 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.926 HG12 ' HA ' ' A' ' 37' ' ' THR . 30.9 m -84.09 138.12 19.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.643 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.851 HD11 ' CB ' ' A' ' 51' ' ' VAL . 3.1 pp -79.03 -179.09 6.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.246 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.545 HE21 ' HA ' ' A' ' 4' ' ' GLN . 2.2 tp-100 -80.63 108.8 14.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.753 0.311 . . . . 0.0 110.883 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.888 HG11 HD12 ' A' ' 91' ' ' LEU . 46.6 t -89.21 131.64 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-O 121.216 0.531 . . . . 0.0 111.366 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.029 ' HB2' HD21 ' A' ' 13' ' ' LEU . 26.1 mt -85.21 143.22 28.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.463 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 26.0 m-70 -116.64 144.11 44.8 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.507 0.67 . . . . 0.0 112.63 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.043 HD13 HD12 ' A' ' 13' ' ' LEU . 42.8 mm -53.45 144.04 33.86 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.707 178.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.513 ' HA ' HG23 ' A' ' 8' ' ' ILE . 64.3 Cg_endo -93.49 54.12 0.94 Allowed 'Cis proline' 0 C--N 1.356 0.933 0 C-N-CA 124.727 -0.947 . . . . 0.0 113.036 0.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.93 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 9.8 t70 -55.32 134.55 50.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.037 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.477 ' CD ' ' H ' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -59.65 -42.76 93.52 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.961 0.41 . . . . 0.0 111.213 -179.495 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.705 ' HB2' HD13 ' A' ' 6' ' ' LEU . 14.0 mmt85 -59.19 -23.53 62.32 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 1.043 HD12 HD13 ' A' ' 8' ' ' ILE . 9.2 mt -76.22 -32.7 59.07 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 120.172 1.351 . . . . 0.0 107.692 177.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 16.3 mmm180 -90.86 3.17 55.23 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 113.857 -1.52 . . . . 0.0 109.554 178.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.828 ' HD3' ' HB3' ' A' ' 54' ' ' HIS . 62.3 tttp -82.09 146.88 29.4 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.671 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.507 HG13 HG23 ' A' ' 138' ' ' VAL . 96.4 t -82.14 135.4 25.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.742 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -91.4 139.68 30.48 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -103.21 130.57 23.37 Favored Pre-proline 0 C--N 1.322 -0.612 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.316 178.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.464 ' HD3' ' CD ' ' A' ' 56' ' ' ARG . 67.9 Cg_endo -77.11 114.75 3.85 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.032 1.821 . . . . 0.0 110.454 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.777 HG12 ' H ' ' A' ' 22' ' ' GLU . 17.4 t -68.98 144.51 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-O 122.426 1.108 . . . . 0.0 113.308 -176.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -63.65 -24.35 67.75 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 113.443 -1.708 . . . . 0.0 112.073 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.777 ' H ' HG12 ' A' ' 20' ' ' VAL . 88.8 tt0 -161.03 143.46 12.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.875 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.537 HG21 ' CD1' ' A' ' 111' ' ' LEU . 3.2 t -78.88 107.24 11.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.961 ' HB2' HD13 ' A' ' 27' ' ' ILE . 56.2 m-80 -91.36 159.9 15.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.317 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.599 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -56.81 -29.14 62.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.927 0.394 . . . . 0.0 110.941 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 1.03 ' HG2' HH22 ' A' ' 29' ' ' ARG . 94.7 mt-10 -71.88 -42.83 66.35 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.961 HD13 ' HB2' ' A' ' 24' ' ' ASN . 1.8 mp -62.28 -45.93 97.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.791 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.667 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 54.5 mt-30 -57.38 -40.22 77.7 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.501 178.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 1.03 HH22 ' HG2' ' A' ' 26' ' ' GLU . 75.9 mtm-85 -61.76 -38.83 89.46 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.828 HG21 HD12 ' A' ' 57' ' ' ILE . 1.6 mp -58.77 -49.12 83.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.056 178.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.935 HG22 ' CG2' ' A' ' 57' ' ' ILE . 5.3 t -65.97 -42.19 91.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.527 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.875 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 21.5 m-20 -54.43 -45.04 72.93 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.838 -179.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.485 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 54.4 m-20 -74.88 -30.72 61.39 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.64 176.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 1.007 ' HG2' HG21 ' A' ' 51' ' ' VAL . 79.7 mtp -59.88 -47.18 86.81 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.543 -177.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.875 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 14.4 p90 -69.31 -43.85 72.93 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.759 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 75.0 mt-10 -51.91 -41.89 62.34 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.926 ' HA ' HG12 ' A' ' 2' ' ' VAL . 57.2 m -68.51 -60.27 2.55 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 119.105 -1.038 . . . . 0.0 108.608 178.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.981 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 3.6 ttp -47.12 -42.42 19.16 Favored 'General case' 0 CA--C 1.466 -2.262 0 O-C-N 124.118 0.886 . . . . 0.0 109.729 -170.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.728 ' OH ' ' HA ' ' A' ' 69' ' ' ARG . 68.6 m-85 -69.32 -42.37 75.47 Favored 'General case' 0 C--N 1.285 -2.233 0 O-C-N 124.101 0.876 . . . . 0.0 110.578 178.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.486 ' CB ' HG11 ' A' ' 2' ' ' VAL . . . -60.09 -28.86 68.17 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.798 ' HG2' ' CD2' ' A' ' 91' ' ' LEU . 3.1 tp10 -84.1 -10.79 57.53 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.484 -1.234 . . . . 0.0 108.777 177.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.444 ' H ' ' C ' ' A' ' 39' ' ' TYR . 8.6 mm-40 62.8 25.1 14.92 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.74 -176.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.803 ' HA2' H182 ' A' ' 149' ' ' BB2 . . . -77.73 145.17 29.79 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 114.142 -1.39 . . . . 0.0 110.524 177.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.907 HG22 HG22 ' A' ' 62' ' ' VAL . 46.0 mm -77.96 -2.5 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 117.621 0.711 . . . . 0.0 111.687 -178.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.949 ' HA3' H101 ' A' ' 149' ' ' BB2 . . . 176.29 138.34 2.85 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-O 119.045 -0.864 . . . . 0.0 111.552 -178.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.827 ' HB2' ' HG3' ' A' ' 38' ' ' MET . 9.2 tp -125.6 135.03 51.75 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 118.821 1.311 . . . . 0.0 110.744 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -103.87 132.75 49.82 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.646 0.26 . . . . 0.0 111.553 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.881 ' HB1' ' CD1' ' A' ' 53' ' ' ILE . . . -30.72 -56.14 0.21 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -177.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.711 ' CG2' ' HA ' ' A' ' 137' ' ' LEU . 42.9 p -52.92 -35.38 58.32 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 122.168 0.985 . . . . 0.0 110.876 -178.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.563 ' HG2' ' CE1' ' A' ' 136' ' ' HIS . 15.8 mt-30 -64.58 -39.44 93.75 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.666 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.007 HG21 ' HG2' ' A' ' 34' ' ' MET . 1.7 m -88.25 14.76 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.859 ' HA ' HD11 ' A' ' 6' ' ' LEU . 37.5 t70 79.11 31.45 0.29 Allowed 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 176.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.881 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 1.2 pp -126.45 111.22 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.446 177.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.828 ' HB3' ' HD3' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -75.55 64.17 1.61 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.976 0.893 . . . . 0.0 110.518 -179.278 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.769 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 88.0 mt-30 -153.54 135.21 14.44 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.444 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.742 ' N ' ' HB1' ' A' ' 17' ' ' ALA . 75.2 mtp180 -64.66 69.04 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -178.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.935 ' CG2' HG22 ' A' ' 31' ' ' VAL . 7.2 mt -112.14 123.26 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.818 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -130.72 147.4 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-O 121.811 0.815 . . . . 0.0 112.783 -178.253 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.613 HG22 ' O ' ' A' ' 46' ' ' LEU . 34.0 m -129.08 137.96 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.44 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.926 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 1.8 mt -116.81 149.3 19.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.718 0.77 . . . . 0.0 111.262 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.981 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 33.8 t70 -136.84 31.95 2.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.449 -1.251 . . . . 0.0 110.35 -178.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.907 HG22 HG22 ' A' ' 44' ' ' ILE . 24.0 t -96.22 110.43 24.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.953 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.747 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 56.0 m -36.33 78.84 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -176.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.797 ' OE1' HD11 ' A' ' 70' ' ' LEU . 39.0 tt0 -65.76 -22.03 66.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.121 178.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.504 ' ND2' ' H ' ' A' ' 66' ' ' ARG . 52.0 t30 -167.25 -126.3 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.417 177.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.504 ' H ' ' ND2' ' A' ' 65' ' ' ASN . 99.3 mtt180 -74.2 -54.56 7.48 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.773 -178.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -106.35 133.15 51.48 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.747 ' HG2' ' HA ' ' A' ' 63' ' ' SER . 56.0 mt-10 -85.18 127.8 34.42 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.496 178.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.728 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 40.1 ttm-85 177.12 71.84 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.926 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 3.7 mm? -103.32 132.29 49.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.913 0.387 . . . . 0.0 111.872 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.843 ' O ' HD12 ' A' ' 72' ' ' LEU . 11.5 p -134.33 130.95 54.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.981 178.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.02 HD21 HD21 ' A' ' 120' ' ' LEU . 10.5 mp -139.88 140.02 36.38 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.938 -0.119 . . . . 0.0 111.019 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.01 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.6 mp -119.93 134.47 63.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.704 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 8.2 m120 54.43 35.93 0.31 Allowed Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.778 ' HG2' HG23 ' A' ' 58' ' ' ILE . 91.1 Cg_exo -55.3 148.56 50.14 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.752 2.301 . . . . 0.0 113.607 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.61 ' HG3' HD21 ' A' ' 78' ' ' LEU . 15.7 pt-20 -135.83 144.25 45.58 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.815 HD23 ' N ' ' A' ' 78' ' ' LEU . 1.8 tt -83.49 135.18 34.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.385 0.612 . . . . 0.0 111.02 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.922 ' CD2' ' HG3' ' A' ' 109' ' ' ARG . 3.3 mm? -116.76 -31.95 5.3 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.65 -178.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 36.6 tt0 -160.33 151.81 19.6 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.17 0.51 . . . . 0.0 111.854 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.895 ' HA ' HG12 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -148.39 151.78 35.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.088 178.792 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 81.0 p -160.36 145.2 14.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.73 0.3 . . . . 0.0 111.5 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.814 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 75.52 169.89 27.13 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.43 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 102' ' ' ARG . 52.3 mm-40 -146.78 114.71 6.52 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.801 0.81 . . . . 0.0 113.152 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.614 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.4 p -97.03 160.1 14.53 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 178.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.698 ' CA ' HD21 ' A' ' 99' ' ' LEU . . . -137.99 100.53 0.31 Allowed Glycine 0 CA--C 1.522 0.52 0 CA-C-N 113.186 -1.825 . . . . 0.0 111.394 178.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.808 ' N ' HH12 ' A' ' 102' ' ' ARG . 47.7 mm -147.75 141.14 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.604 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 55.4 mt-10 -72.72 143.21 48.11 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 122.359 1.076 . . . . 0.0 112.437 -177.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.749 ' HG2' ' O27' ' A' ' 149' ' ' BB2 . 54.6 mt-10 -155.77 162.78 40.45 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.157 -1.383 . . . . 0.0 109.768 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.797 ' CA ' ' HG2' ' A' ' 97' ' ' ARG . . . -120.23 160.49 14.83 Favored Glycine 0 CA--C 1.5 -0.857 0 C-N-CA 119.456 -1.355 . . . . 0.0 111.223 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.813 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 57.1 m -110.16 139.68 45.05 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.691 0.281 . . . . 0.0 110.668 -177.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.888 HD12 HG11 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -52.43 -31.25 33.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.494 0.664 . . . . 0.0 109.855 179.72 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.803 ' CB ' HD13 ' A' ' 13' ' ' LEU . 49.8 m -77.74 -29.44 51.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.711 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.725 ' CG2' ' HD2' ' A' ' 94' ' ' PRO . 58.0 mt -85.45 148.46 49.5 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.725 ' HD2' ' CG2' ' A' ' 93' ' ' ILE . 76.1 Cg_endo -74.87 48.09 1.88 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.296 1.997 . . . . 0.0 114.023 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.558 ' HB2' ' O ' ' A' ' 94' ' ' PRO . 50.9 mt-10 77.27 10.41 2.45 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 179.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.642 ' HG2' ' HG2' ' A' ' 94' ' ' PRO . 98.4 mm-40 -78.34 88.29 4.36 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.797 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 20.0 mtm105 -84.59 133.86 34.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.497 0.665 . . . . 0.0 111.384 -178.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.414 ' C ' ' HA ' ' A' ' 87' ' ' GLU . . . -133.01 150.46 52.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.133 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.735 ' HG ' ' N ' ' A' ' 86' ' ' ILE . 6.7 tt -75.43 135.57 40.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.317 -179.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.959 HG21 ' HB3' ' A' ' 142' ' ' PHE . 46.1 t -136.94 138.58 26.27 Favored Pre-proline 0 N--CA 1.464 0.243 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.684 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.953 ' HG2' ' HE2' ' A' ' 145' ' ' TYR . 3.4 Cg_exo -80.49 125.48 5.67 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.408 2.072 . . . . 0.0 113.424 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.882 ' HE ' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -143.79 166.07 25.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.066 -1.424 . . . . 0.0 109.988 177.936 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.814 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.24 153.06 44.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.962 0.346 . . . . 0.0 110.583 -178.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.416 ' OE1' ' HA ' ' A' ' 104' ' ' GLU . 5.1 tp10 -74.29 -41.97 60.33 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.638 -176.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.808 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 48.6 mttp -139.8 137.93 35.42 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.61 0.719 . . . . 0.0 109.634 177.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.895 HG12 ' HA ' ' A' ' 80' ' ' LYS . 32.0 m -142.9 143.16 25.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.046 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 1.028 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 31.8 mmtm -107.48 125.58 51.43 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.716 ' HA ' HD23 ' A' ' 78' ' ' LEU . 2.1 pp -128.79 162.09 36.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -177.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.922 ' HG3' ' CD2' ' A' ' 78' ' ' LEU . 26.6 mtt-85 -116.03 139.4 50.31 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.625 ' CB ' HD23 ' A' ' 72' ' ' LEU . . . -158.98 168.26 27.23 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.671 0.272 . . . . 0.0 111.449 -178.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 1.01 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.1 pp -113.87 152.32 30.9 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.47 ' O ' HD12 ' A' ' 111' ' ' LEU . 15.7 t70 -88.58 162.75 16.2 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.021 -0.672 . . . . 0.0 111.569 -177.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.811 ' HB2' HG21 ' A' ' 71' ' ' VAL . 46.2 ttp180 -52.67 -18.91 2.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.969 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -78.96 -25.59 43.53 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.438 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 106.44 35.61 2.83 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.518 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -128.74 102.79 19.54 Favored Pre-proline 0 C--O 1.238 0.479 0 CA-C-N 117.036 0.418 . . . . 0.0 111.178 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.667 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.9 Cg_exo -73.28 115.27 4.28 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 121.838 1.692 . . . . 0.0 114.975 -177.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -124.52 168.43 13.1 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.712 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 109' ' ' ARG . 23.0 mt-10 -107.79 131.61 54.28 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 1.02 HD21 HD21 ' A' ' 72' ' ' LEU . 3.9 pp -131.57 133.91 45.51 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 1.028 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 15.5 pt-20 -94.15 125.52 38.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.766 178.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.933 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -116.96 136.01 53.27 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.808 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.1 m-20 -126.3 164.44 21.03 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.712 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 45.55 -130.5 9.36 Favored Glycine 0 C--N 1.346 1.118 0 N-CA-C 116.431 1.332 . . . . 0.0 116.431 176.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.437 ' HB3' ' CG1' ' A' ' 62' ' ' VAL . 86.6 mt -55.18 -36.49 65.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.692 -0.754 . . . . 0.0 111.703 -178.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.933 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.3 OUTLIER -71.31 -52.9 16.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.471 0.653 . . . . 0.0 109.884 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.785 ' HB2' ' C ' ' A' ' 122' ' ' ALA . . . -58.39 -46.01 87.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.913 -1.039 . . . . 0.0 112.163 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.882 HD12 ' HE ' ' A' ' 102' ' ' ARG . 49.3 mm -63.76 -56.04 19.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.807 0.336 . . . . 0.0 111.107 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.879 ' HB3' ' C11' ' A' ' 149' ' ' BB2 . 74.6 m -60.92 -50.53 73.04 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.696 HG22 ' O ' ' A' ' 126' ' ' LEU . 20.3 tt -58.77 -43.73 88.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.328 -178.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.659 ' HG2' ' O ' ' A' ' 127' ' ' ALA . 22.9 pt20 -65.68 -37.63 87.04 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.497 ' CD2' ' CE1' ' A' ' 142' ' ' PHE . 10.3 t-160 -56.65 -48.87 76.61 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.281 179.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.915 ' CG ' H102 ' A' ' 149' ' ' BB2 . 2.8 mm-40 -60.93 -45.86 92.99 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 119.09 -0.481 . . . . 0.0 111.217 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.962 ' HA ' HD21 ' A' ' 137' ' ' LEU . 75.2 mtp -55.55 -47.78 75.8 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 118.965 0.802 . . . . 0.0 109.893 179.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.778 ' O ' HG12 ' A' ' 138' ' ' VAL . 1.1 m-20 -62.02 -48.49 80.05 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.376 178.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.563 ' CE1' ' HG2' ' A' ' 50' ' ' GLN . 10.4 t-80 -57.31 -49.99 74.34 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.294 0.569 . . . . 0.0 110.82 -178.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.962 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.5 pp -60.58 -30.51 69.86 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.032 -178.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.778 HG12 ' O ' ' A' ' 135' ' ' ASP . 12.9 p -81.78 22.18 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 CA-C-O 122.726 1.251 . . . . 0.0 109.051 175.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.603 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 70.85 -3.19 13.5 Favored Glycine 0 CA--C 1.494 -1.256 0 CA-C-N 112.629 -2.078 . . . . 0.0 113.035 176.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.752 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 1.6 ptmt -90.0 121.17 31.84 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.68 HD12 ' C ' ' A' ' 140' ' ' LYS . 6.7 mp -117.74 165.53 13.52 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 121.24 0.543 . . . . 0.0 111.469 -178.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.959 ' HB3' HG21 ' A' ' 100' ' ' VAL . 4.3 m-30 -54.93 -40.13 69.59 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.423 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 47.4 ttm -56.79 -27.29 59.49 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.306 0.574 . . . . 0.0 110.93 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.45 ' HB3' ' O ' ' A' ' 141' ' ' LEU . 8.1 t70 -57.2 -22.89 44.01 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.07 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.953 ' HE2' ' HG2' ' A' ' 101' ' ' PRO . 22.8 t80 -111.2 5.05 19.72 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -177.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 96.1 mt -92.98 149.1 21.46 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 122.169 -0.332 . . . . 0.0 110.726 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 83.5 p . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.969 179.311 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' BB2 . . . . . 0.949 H101 ' HA3' ' A' ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 79.8 p . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.821 0.343 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 1.051 HG12 ' HA ' ' A' ' 37' ' ' THR . 30.8 m -84.03 131.9 32.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.417 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 1.046 HD21 ' HB ' ' A' ' 51' ' ' VAL . 3.0 pp -79.87 -169.51 2.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.696 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.409 ' HA ' ' OE1' ' A' ' 4' ' ' GLN . 4.0 tp-100 -84.64 111.72 19.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.859 0.361 . . . . 0.0 110.053 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.642 HG22 HG21 ' A' ' 37' ' ' THR . 40.7 t -88.51 127.79 41.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.371 0.605 . . . . 0.0 111.828 -178.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.039 ' HB2' HD21 ' A' ' 13' ' ' LEU . 23.1 mt -87.14 142.69 27.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.361 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.549 ' HA ' ' HB3' ' A' ' 92' ' ' SER . 34.7 m-70 -116.16 147.06 41.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.245 0.545 . . . . 0.0 111.992 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.097 HD13 HD12 ' A' ' 13' ' ' LEU . 38.4 mm -58.27 147.0 68.91 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.358 178.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.591 ' HA ' HG23 ' A' ' 8' ' ' ILE . 78.2 Cg_endo -93.22 52.38 1.04 Allowed 'Cis proline' 0 C--N 1.354 0.854 0 C-N-CA 124.504 -1.04 . . . . 0.0 113.02 0.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.839 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.7 t70 -55.15 136.04 48.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.083 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -58.88 -44.3 91.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.377 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.584 ' HB2' ' OD2' ' A' ' 10' ' ' ASP . 14.9 mmt85 -57.44 -25.63 59.94 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 1.097 HD12 HD13 ' A' ' 8' ' ' ILE . 11.2 mt -74.82 -32.71 62.03 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 119.828 1.195 . . . . 0.0 109.025 178.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.489 ' HG3' HH11 ' A' ' 14' ' ' ARG . 13.6 mmt85 -95.23 6.94 47.66 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.227 -1.352 . . . . 0.0 109.605 178.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.715 ' HD3' ' HB3' ' A' ' 54' ' ' HIS . 88.6 tttt -82.78 147.93 28.11 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.53 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.4 t -82.48 127.89 39.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.85 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -91.36 140.53 29.69 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.218 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -105.01 136.88 19.1 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.418 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.47 ' HA ' ' ND2' ' A' ' 74' ' ' ASN . 51.8 Cg_endo -82.13 113.97 2.47 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 121.656 1.571 . . . . 0.0 110.279 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.715 HG12 ' H ' ' A' ' 22' ' ' GLU . 16.7 t -68.11 144.68 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 CA-C-O 122.852 1.31 . . . . 0.0 113.271 -175.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -60.33 -27.9 67.72 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 112.775 -2.011 . . . . 0.0 112.232 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.715 ' H ' HG12 ' A' ' 20' ' ' VAL . 39.0 tt0 -156.95 144.28 18.84 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.885 -178.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.736 HG21 ' HA2' ' A' ' 115' ' ' GLY . 3.2 t -80.11 106.51 11.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -178.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.918 ' HB2' ' CD1' ' A' ' 27' ' ' ILE . 59.4 m-80 -91.43 153.66 19.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.048 -178.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.7 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . -54.79 -25.38 27.76 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.272 0.558 . . . . 0.0 110.819 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.742 ' O ' HD13 ' A' ' 30' ' ' ILE . 55.2 mt-10 -74.28 -42.64 59.26 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 177.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.918 ' CD1' ' HB2' ' A' ' 24' ' ' ASN . 1.9 mp -66.46 -34.63 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.101 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -68.32 -39.3 82.0 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.779 -0.192 . . . . 0.0 110.549 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.7 ' HG3' ' O ' ' A' ' 25' ' ' ALA . 99.1 mtt180 -63.7 -39.12 93.53 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.832 ' O ' ' HG3' ' A' ' 34' ' ' MET . 1.6 mp -56.0 -48.47 78.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.826 178.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.964 HG22 HG21 ' A' ' 57' ' ' ILE . 15.0 t -67.14 -40.1 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.463 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.851 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 48.3 m-20 -52.85 -47.6 67.65 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.937 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.53 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 14.1 m-20 -74.44 -28.91 61.26 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.807 176.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.965 ' HG2' HG21 ' A' ' 51' ' ' VAL . 86.9 mtp -59.62 -47.04 87.16 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.169 -177.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.851 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 19.8 p90 -70.33 -46.17 64.73 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 176.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.631 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 3.8 mm-40 -52.25 -39.54 60.48 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.635 0.731 . . . . 0.0 109.182 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 1.051 ' HA ' HG12 ' A' ' 2' ' ' VAL . 76.5 m -69.14 -61.17 1.9 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.273 -1.33 . . . . 0.0 107.992 178.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.87 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 3.6 ttp -46.79 -41.1 14.87 Favored 'General case' 0 CA--C 1.46 -2.482 0 C-N-CA 124.535 1.134 . . . . 0.0 110.501 -172.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.761 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 60.3 m-85 -69.11 -42.79 75.62 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.097 178.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.56 ' CB ' HG11 ' A' ' 2' ' ' VAL . . . -61.62 -24.77 66.93 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.566 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.938 ' HG2' HD12 ' A' ' 91' ' ' LEU . 11.1 tp10 -87.97 -11.71 46.65 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.407 -1.269 . . . . 0.0 108.368 176.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.447 ' H ' ' C ' ' A' ' 39' ' ' TYR . 58.0 mt-10 63.34 27.4 15.35 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-O 122.019 0.914 . . . . 0.0 109.855 -176.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.535 ' HA2' H182 ' A' ' 149' ' ' BB2 . . . -80.02 145.31 26.97 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 113.781 -1.554 . . . . 0.0 110.799 178.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.743 ' CG1' H251 ' A' ' 149' ' ' BB2 . 45.5 mm -79.34 -0.41 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 117.497 0.648 . . . . 0.0 111.931 -178.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.959 ' HA3' H113 ' A' ' 149' ' ' BB2 . . . 175.39 140.03 3.26 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.989 HD13 ' HG ' ' A' ' 91' ' ' LEU . 3.9 tp -124.45 136.74 54.27 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.396 1.598 . . . . 0.0 110.821 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.46 ' H ' HD12 ' A' ' 46' ' ' LEU . . . -104.41 131.72 51.46 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.416 0.15 . . . . 0.0 111.165 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.848 ' HB1' ' CD1' ' A' ' 53' ' ' ILE . . . -31.06 -55.81 0.23 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 115.802 1.779 . . . . 0.0 115.802 -177.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.82 ' CG2' ' HA ' ' A' ' 137' ' ' LEU . 69.3 p -53.17 -35.39 59.75 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.665 0.745 . . . . 0.0 111.631 -177.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.726 ' OE1' HD12 ' A' ' 46' ' ' LEU . 64.6 mt-30 -64.02 -43.43 95.65 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.405 -1.271 . . . . 0.0 110.127 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.046 ' HB ' HD21 ' A' ' 3' ' ' LEU . 0.8 OUTLIER -83.16 15.49 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.883 ' HA ' HD11 ' A' ' 6' ' ' LEU . 36.9 t70 77.29 28.65 0.6 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 176.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.848 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 1.1 pp -122.73 110.78 27.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.982 177.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.715 ' HB3' ' HD3' ' A' ' 15' ' ' LYS . 21.5 p-80 -76.51 62.65 1.92 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 122.102 0.953 . . . . 0.0 110.376 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.768 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 89.4 mt-30 -151.37 133.19 14.97 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.066 -1.425 . . . . 0.0 107.468 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 1.112 ' HA ' HD22 ' A' ' 137' ' ' LEU . 98.8 mtt180 -65.02 70.99 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -177.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.964 HG21 HG22 ' A' ' 31' ' ' VAL . 30.6 mm -113.95 124.33 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.898 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -128.62 148.58 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -177.673 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 46' ' ' LEU . 30.8 m -129.29 140.35 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.71 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.093 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 9.5 mm -115.5 153.84 17.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.337 0.589 . . . . 0.0 109.882 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.87 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 38.5 t70 -145.29 39.84 1.2 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.62 -178.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.767 ' O ' ' HG3' ' A' ' 68' ' ' GLU . 57.4 t -92.85 87.26 2.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.78 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 78.0 p -55.35 74.7 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 O-C-N 124.499 1.125 . . . . 0.0 112.131 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.768 ' H ' ' HG3' ' A' ' 68' ' ' GLU . 31.9 tp10 -44.63 -26.93 0.42 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.288 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.859 ' OD1' ' HG3' ' A' ' 66' ' ' ARG . 28.2 t-20 -122.01 -72.86 0.67 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.911 0.386 . . . . 0.0 111.654 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.859 ' HG3' ' OD1' ' A' ' 65' ' ' ASN . 78.3 mtp180 -123.47 -40.19 2.38 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.862 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.624 ' HA ' ' HB3' ' A' ' 63' ' ' SER . 4.1 m-20 -161.25 116.62 2.11 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.917 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.78 ' HG2' ' HA ' ' A' ' 63' ' ' SER . 3.5 mm-40 -96.3 152.39 18.63 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.651 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -143.06 86.43 1.92 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.295 -1.321 . . . . 0.0 108.331 -179.396 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 1.093 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 3.5 mm? -108.08 139.66 42.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.076 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.72 HG21 ' HB2' ' A' ' 113' ' ' ARG . 12.9 p -133.09 135.7 56.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.583 177.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.898 ' HB2' ' CD1' ' A' ' 58' ' ' ILE . 94.7 mt -140.86 140.88 34.67 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 178.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.913 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 3.3 mm -121.79 136.57 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-O 121.233 0.54 . . . . 0.0 111.013 -179.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.7 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 7.2 m120 49.0 38.69 0.52 Allowed Pre-proline 0 C--N 1.313 -0.996 0 CA-C-N 115.096 -0.957 . . . . 0.0 112.839 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.88 ' HG2' HG23 ' A' ' 58' ' ' ILE . 99.5 Cg_exo -56.42 145.67 77.89 Favored 'Trans proline' 0 N--CA 1.484 0.943 0 C-N-CA 122.958 2.439 . . . . 0.0 114.144 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.504 ' CG ' ' HB2' ' A' ' 109' ' ' ARG . 11.7 pt-20 -133.11 143.18 49.12 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.801 HD23 ' N ' ' A' ' 78' ' ' LEU . 1.7 tt -82.95 135.71 34.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.282 0.563 . . . . 0.0 111.39 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.024 HD21 ' HG3' ' A' ' 109' ' ' ARG . 2.9 mm? -115.74 -40.59 3.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.84 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 87.4 tt0 -152.84 150.59 29.49 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.21 0.529 . . . . 0.0 111.511 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.817 ' HA ' HG12 ' A' ' 106' ' ' VAL . 9.2 ptpp? -147.18 147.4 30.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.267 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.1 t -158.22 147.99 19.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.673 0.273 . . . . 0.0 111.384 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.717 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 76.85 160.29 10.78 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.41 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -136.3 113.42 10.54 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.948 0.88 . . . . 0.0 112.736 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.831 ' HB ' HH12 ' A' ' 102' ' ' ARG . 1.7 p -105.24 161.88 13.9 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.772 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -147.45 116.86 0.87 Allowed Glycine 0 C--N 1.313 -0.701 0 CA-C-N 112.694 -2.048 . . . . 0.0 110.989 178.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.761 ' HB ' ' NH2' ' A' ' 102' ' ' ARG . 47.9 mm -147.79 139.21 18.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 117.306 0.553 . . . . 0.0 111.414 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 50.4 mt-10 -71.78 139.03 48.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 122.83 1.3 . . . . 0.0 112.019 -177.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.796 ' HB3' H262 ' A' ' 149' ' ' BB2 . 39.6 mt-10 -154.95 163.48 40.24 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 112.753 -2.021 . . . . 0.0 111.567 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.929 ' O ' ' H52' ' A' ' 149' ' ' BB2 . . . -121.49 165.62 14.44 Favored Glycine 0 CA--C 1.503 -0.714 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.782 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 13.1 m -116.21 140.76 48.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.898 0.849 . . . . 0.0 111.662 -177.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.989 ' HG ' HD13 ' A' ' 46' ' ' LEU . 2.4 mm? -48.62 -17.31 0.16 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.224 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.714 ' CB ' HD13 ' A' ' 13' ' ' LEU . 21.1 m -98.36 -34.39 10.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.255 0.55 . . . . 0.0 110.255 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.772 ' CG2' ' HD2' ' A' ' 94' ' ' PRO . 58.4 mt -85.85 151.44 55.04 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.546 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.772 ' HD2' ' CG2' ' A' ' 93' ' ' ILE . 63.1 Cg_endo -62.11 -145.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.406 2.071 . . . . 0.0 111.7 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.404 ' HA ' ' OE1' ' A' ' 95' ' ' GLU . 4.5 mm-40 -80.93 12.85 3.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.179 0.514 . . . . 0.0 110.771 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.557 ' HG2' ' HG2' ' A' ' 94' ' ' PRO . 98.7 mm-40 -78.7 82.27 4.94 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.125 -178.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.609 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 13.7 mtt85 -86.73 132.45 33.86 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.03 0.443 . . . . 0.0 109.927 178.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.2 150.52 48.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.252 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.772 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.3 tt -76.02 113.92 14.07 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.727 0.775 . . . . 0.0 110.792 -178.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.448 HG11 ' HB3' ' A' ' 142' ' ' PHE . 23.4 t -103.57 133.7 20.14 Favored Pre-proline 0 N--CA 1.469 0.492 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.991 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.554 ' HA ' ' O ' ' A' ' 84' ' ' THR . 98.6 Cg_endo -87.58 126.36 2.2 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.524 2.15 . . . . 0.0 112.675 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.889 ' HG2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -144.65 166.76 24.29 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.149 0.98 . . . . 0.0 109.764 179.438 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.717 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.41 155.3 40.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.852 0.358 . . . . 0.0 110.172 -179.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -72.67 -41.78 65.02 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.592 -175.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.749 ' HG2' ' HB3' ' A' ' 123' ' ' ASP . 95.4 mttt -140.61 140.17 35.03 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.49 0.662 . . . . 0.0 109.495 176.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.817 HG12 ' HA ' ' A' ' 80' ' ' LYS . 32.8 m -145.57 142.22 22.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.166 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.817 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 5.1 mmmt -107.43 126.22 52.22 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.974 HD11 HD11 ' A' ' 130' ' ' ILE . 1.8 pp -134.36 151.0 31.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -177.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 1.037 ' HE ' ' HG2' ' A' ' 119' ' ' GLU . 53.5 mtp180 -102.62 139.71 37.85 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.424 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.606 ' HB3' HD22 ' A' ' 72' ' ' LEU . . . -160.18 168.5 25.3 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.237 -176.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.913 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.0 pp -122.59 149.0 44.57 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.591 ' O ' HD12 ' A' ' 111' ' ' LEU . 13.5 t70 -81.67 169.11 17.4 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -175.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.804 ' HD2' ' OD1' ' A' ' 32' ' ' ASP . 43.2 ttp180 -50.93 -23.6 2.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.982 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -79.77 -21.45 44.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.158 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.752 ' HA2' HD13 ' A' ' 111' ' ' LEU . . . 101.37 38.74 3.19 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.151 -1.023 . . . . 0.0 113.983 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.936 ' HE3' ' HA ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -127.13 102.24 24.5 Favored Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 117.188 0.494 . . . . 0.0 110.184 178.532 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.662 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 32.8 Cg_exo -74.63 115.41 4.29 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 121.643 1.562 . . . . 0.0 116.107 -177.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.444 ' N ' ' O ' ' A' ' 110' ' ' ALA . 0.4 OUTLIER -125.71 168.57 13.58 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.01 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 1.037 ' HG2' ' HE ' ' A' ' 109' ' ' ARG . 21.3 mt-10 -107.41 137.11 46.06 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.74 ' O ' HD12 ' A' ' 120' ' ' LEU . 4.3 pp -135.57 133.39 38.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.081 0.467 . . . . 0.0 111.841 -178.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.817 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 0.7 OUTLIER -95.5 123.71 39.17 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.767 178.706 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.937 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -116.45 135.13 54.1 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.749 ' HB3' ' HG2' ' A' ' 105' ' ' LYS . 16.9 m-20 -126.43 163.22 23.79 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.699 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 52.89 -139.02 33.47 Favored Glycine 0 C--N 1.346 1.101 0 C-N-CA 119.344 -1.408 . . . . 0.0 115.344 177.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 78.2 mt -54.38 -32.3 56.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.601 -0.8 . . . . 0.0 111.601 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.937 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.3 OUTLIER -71.42 -51.97 21.04 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.904 0.859 . . . . 0.0 109.308 179.523 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.751 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -58.58 -41.93 86.84 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.162 -1.381 . . . . 0.0 111.648 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.889 HD12 ' HG2' ' A' ' 102' ' ' ARG . 50.8 mm -67.45 -54.83 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -178.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.957 ' HB2' ' H91' ' A' ' 149' ' ' BB2 . 32.1 p -60.7 -49.07 79.0 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.974 HD11 HD11 ' A' ' 108' ' ' ILE . 19.8 tt -59.2 -46.51 92.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.386 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.694 ' HG2' ' O ' ' A' ' 127' ' ' ALA . 21.3 pt20 -65.71 -38.19 88.52 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.337 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.596 ' HD2' ' HN1' ' A' ' 149' ' ' BB2 . 73.4 t60 -59.27 -46.4 88.63 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.549 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.804 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 3.3 mm-40 -60.81 -38.37 85.17 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.748 ' CE ' ' HB2' ' A' ' 77' ' ' LEU . 75.8 mtp -58.22 -45.18 88.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 122.271 1.034 . . . . 0.0 109.422 177.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.763 ' O ' HG12 ' A' ' 138' ' ' VAL . 0.9 OUTLIER -68.14 -47.97 66.65 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.716 179.215 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.653 ' CE1' ' HG2' ' A' ' 50' ' ' GLN . 6.5 t-80 -57.98 -52.75 64.21 Favored 'General case' 0 C--N 1.317 -0.813 0 O-C-N 121.672 -0.642 . . . . 0.0 111.483 -178.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 1.112 HD22 ' HA ' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -65.41 -28.5 69.3 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.511 -179.506 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.929 ' CG1' ' HG2' ' A' ' 140' ' ' LYS . 11.3 p -81.1 23.39 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-O 122.294 1.045 . . . . 0.0 109.218 175.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 137' ' ' LEU . . . 67.49 -0.93 7.91 Favored Glycine 0 CA--C 1.485 -1.813 0 CA-C-N 113.532 -1.667 . . . . 0.0 113.144 175.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.929 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 11.2 ptmt -90.22 138.85 31.19 Favored 'General case' 0 N--CA 1.409 -2.479 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 178.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.871 HD12 ' O ' ' A' ' 140' ' ' LYS . 10.6 mp -139.18 149.7 44.72 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -178.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.634 ' HE1' ' SG ' ' A' ' 90' ' ' CYS . 49.2 p90 -54.7 -39.49 68.23 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -178.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.494 ' HA ' ' HB2' ' A' ' 146' ' ' LEU . 1.8 tmt? -59.48 -28.52 67.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.09 0.471 . . . . 0.0 110.842 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -59.06 -24.61 63.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.625 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -118.21 6.7 11.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.376 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 143' ' ' MET . 2.3 mp -88.83 141.78 28.21 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.796 0.331 . . . . 0.0 110.999 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 48.2 t . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.831 179.592 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' BB2 . . . . . 0.959 H113 ' HA3' ' A' ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 54.6 m . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.863 0.363 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.83 HG12 ' HA ' ' A' ' 37' ' ' THR . 31.1 m -83.97 135.42 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.365 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.923 HD21 ' HB ' ' A' ' 51' ' ' VAL . 2.4 pp -79.53 -161.81 0.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.599 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.576 HE21 ' HA ' ' A' ' 4' ' ' GLN . 2.2 tp-100 -94.66 108.17 20.16 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.925 0.393 . . . . 0.0 110.446 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.537 ' CG2' HG21 ' A' ' 37' ' ' THR . 40.9 t -88.59 129.37 39.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.4 0.619 . . . . 0.0 112.067 -178.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.075 ' HB2' HD21 ' A' ' 13' ' ' LEU . 21.5 mt -87.88 143.18 27.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.021 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 51.9 m-70 -120.78 145.73 47.25 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.099 HD13 HD12 ' A' ' 13' ' ' LEU . 46.2 mm -66.05 134.41 94.93 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.676 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.8 141.36 66.57 Favored 'Cis proline' 0 C--N 1.351 0.685 0 C-N-CA 124.195 -1.169 . . . . 0.0 112.016 -0.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.989 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.7 t70 -161.24 126.28 3.6 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 12.0 pt-20 -58.21 -46.06 86.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.982 -178.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.578 ' HB2' HD13 ' A' ' 6' ' ' LEU . 25.1 mtt-85 -59.3 -26.16 64.74 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 1.099 HD12 HD13 ' A' ' 8' ' ' ILE . 10.7 mt -76.64 -33.38 58.35 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 120.284 1.402 . . . . 0.0 108.139 177.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.587 ' C ' ' HA3' ' A' ' 139' ' ' GLY . 14.1 mmt85 -94.11 11.01 31.47 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 113.854 -1.521 . . . . 0.0 109.303 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.438 ' HB2' ' HA ' ' A' ' 12' ' ' ARG . 61.8 tttp -92.76 150.67 20.5 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.283 -178.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.989 HG13 HG23 ' A' ' 138' ' ' VAL . 61.8 t -83.47 124.06 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.819 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.738 ' C ' ' HG3' ' A' ' 56' ' ' ARG . . . -80.99 147.45 30.21 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.652 ' HD3' ' N ' ' A' ' 19' ' ' PRO . 2.2 tmtp? -109.9 127.98 26.17 Favored Pre-proline 0 C--N 1.325 -0.486 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.217 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.995 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 65.6 Cg_endo -77.7 113.93 3.57 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 121.998 1.799 . . . . 0.0 110.815 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.758 HG12 ' H ' ' A' ' 22' ' ' GLU . 18.0 t -68.45 144.46 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-O 122.609 1.195 . . . . 0.0 113.29 -175.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -60.76 -27.97 68.36 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 112.97 -1.923 . . . . 0.0 111.995 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.758 ' H ' HG12 ' A' ' 20' ' ' VAL . 39.4 tt0 -157.79 143.02 16.88 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.242 -178.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.713 HG21 HD11 ' A' ' 111' ' ' LEU . 3.2 t -79.75 108.46 13.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 1.033 ' HB2' HD13 ' A' ' 27' ' ' ILE . 54.6 m-80 -93.32 173.51 7.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.813 -179.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.625 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -65.75 -28.54 69.11 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.376 0.607 . . . . 0.0 110.859 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.498 ' HA ' ' OE1' ' A' ' 26' ' ' GLU . 4.3 mm-40 -73.92 -39.72 63.61 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 1.033 HD13 ' HB2' ' A' ' 24' ' ' ASN . 1.9 mp -66.91 -37.49 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.166 178.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.823 ' HG3' ' O ' ' A' ' 24' ' ' ASN . 16.9 mt-30 -66.18 -40.46 90.48 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.233 -0.292 . . . . 0.0 110.719 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.625 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 14.0 mmp_? -63.33 -39.58 94.93 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.857 HG21 HD12 ' A' ' 57' ' ' ILE . 4.8 mt -55.34 -50.17 67.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.381 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.903 HG22 ' CG2' ' A' ' 57' ' ' ILE . 15.9 t -65.25 -41.62 91.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.072 0.463 . . . . 0.0 111.045 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.873 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 27.3 m-20 -54.97 -43.58 73.64 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.475 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.529 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 1.4 m-20 -75.81 -29.77 58.79 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.923 176.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.978 ' HE1' HG22 ' A' ' 57' ' ' ILE . 22.0 mtm -60.14 -46.69 88.82 Favored 'General case' 0 C--N 1.347 0.467 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.534 -177.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.873 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 14.9 p90 -69.87 -45.45 67.68 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.605 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 3.8 mm-40 -52.65 -39.38 61.76 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.719 0.771 . . . . 0.0 108.996 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.83 ' HA ' HG12 ' A' ' 2' ' ' VAL . 61.8 m -70.06 -61.78 1.64 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.455 -1.248 . . . . 0.0 107.642 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.879 ' HG3' ' HB2' ' A' ' 46' ' ' LEU . 1.0 OUTLIER -46.52 -41.11 13.7 Favored 'General case' 0 CA--C 1.462 -2.416 0 C-N-CA 123.958 0.903 . . . . 0.0 110.431 -170.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.701 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 58.5 m-85 -70.37 -42.43 71.79 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.281 178.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.05 -24.61 66.33 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.416 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 1.024 ' HG2' HD12 ' A' ' 91' ' ' LEU . 11.7 tp10 -88.89 -11.4 44.7 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.475 177.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.439 ' H ' ' C ' ' A' ' 39' ' ' TYR . 18.4 mt-10 65.43 23.93 11.95 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.042 -176.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.481 ' HA2' H182 ' A' ' 149' ' ' BB2 . . . -79.07 141.89 24.66 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 114.027 -1.442 . . . . 0.0 110.372 177.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.86 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 46.3 mt -81.33 1.41 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 117.648 0.724 . . . . 0.0 112.638 -178.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.849 ' HA3' ' C10' ' A' ' 149' ' ' BB2 . . . 178.73 133.78 1.98 Allowed Glycine 0 CA--C 1.528 0.867 0 CA-C-O 118.913 -0.937 . . . . 0.0 111.409 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.024 HD13 ' HG ' ' A' ' 91' ' ' LEU . 4.9 tp -126.02 134.33 51.48 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.15 1.475 . . . . 0.0 112.161 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -98.3 131.88 44.25 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.292 0.237 . . . . 0.0 111.448 178.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.894 ' HB1' ' CD1' ' A' ' 53' ' ' ILE . . . -30.01 -55.64 0.18 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.565 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 67.3 p -53.25 -36.01 60.63 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.462 0.648 . . . . 0.0 112.039 -177.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.774 ' OE1' HD12 ' A' ' 46' ' ' LEU . 85.8 mt-30 -63.83 -41.92 97.73 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.231 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.923 ' HB ' HD21 ' A' ' 3' ' ' LEU . 1.0 OUTLIER -83.74 16.49 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.447 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.933 ' HA ' HD11 ' A' ' 6' ' ' LEU . 50.5 t0 77.37 28.29 0.61 Allowed 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 176.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.894 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -122.23 110.7 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 119.204 -0.999 . . . . 0.0 111.247 177.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -76.76 63.19 2.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.493 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.735 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 94.7 mm-40 -152.96 134.33 14.31 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.237 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.995 ' HD2' ' HD3' ' A' ' 19' ' ' PRO . 98.8 mtt180 -64.5 66.72 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -177.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.978 HG22 ' HE1' ' A' ' 34' ' ' MET . 6.2 mt -111.1 123.22 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.082 HD11 ' HB2' ' A' ' 72' ' ' LEU . 1.8 pp -128.32 146.37 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 119.665 -0.814 . . . . 0.0 113.12 -177.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 46' ' ' LEU . 30.5 m -126.24 139.11 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.7 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.099 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 7.9 mm -116.16 153.39 17.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.55 0.69 . . . . 0.0 110.392 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.86 ' HB3' ' C ' ' A' ' 44' ' ' ILE . 31.3 t70 -139.46 17.85 2.55 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.363 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.776 ' H ' HG22 ' A' ' 60' ' ' ILE . 32.4 t -91.69 116.2 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.106 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.348 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.887 ' HB3' ' OE2' ' A' ' 68' ' ' GLU . 79.5 p -38.88 78.25 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -177.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.928 ' HB2' HD11 ' A' ' 70' ' ' LEU . 40.5 tt0 -68.87 -21.68 64.24 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.736 178.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.461 ' CG ' ' H ' ' A' ' 66' ' ' ARG . 0.7 OUTLIER -163.3 -138.23 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.868 178.729 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.461 ' H ' ' CG ' ' A' ' 65' ' ' ASN . 70.8 mtp180 -74.52 -56.67 4.58 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.34 120.25 23.53 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.964 178.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.887 ' OE2' ' HB3' ' A' ' 63' ' ' SER . 45.5 mt-10 -93.17 75.99 4.63 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.507 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 48.0 ttp180 -152.58 95.63 2.04 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.87 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 1.099 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 56.3 mt -111.23 138.97 47.02 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.795 HG21 ' HB2' ' A' ' 113' ' ' ARG . 11.8 p -134.82 135.29 53.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.607 177.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.082 ' HB2' HD11 ' A' ' 58' ' ' ILE . 1.8 mm? -140.4 140.77 35.55 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.061 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 3.5 mm -119.51 136.03 57.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.172 0.51 . . . . 0.0 110.952 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.716 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 8.0 m120 51.57 37.6 0.44 Allowed Pre-proline 0 C--N 1.312 -1.027 0 CA-C-N 115.349 -0.842 . . . . 0.0 112.379 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.874 ' HG2' HG12 ' A' ' 58' ' ' ILE . 77.6 Cg_exo -55.08 144.5 68.96 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 122.949 2.433 . . . . 0.0 114.102 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.5 ' CG ' ' HB2' ' A' ' 109' ' ' ARG . 11.5 pt-20 -135.45 145.43 47.19 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.817 HD22 ' NZ ' ' A' ' 80' ' ' LYS . 1.5 tt -81.2 137.69 35.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.309 0.576 . . . . 0.0 111.817 -178.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.902 HD21 ' HG3' ' A' ' 109' ' ' ARG . 2.9 mm? -118.9 -50.71 2.38 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.624 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 1.018 ' HB3' ' HD3' ' A' ' 107' ' ' LYS . 39.3 tp10 -140.5 146.51 38.26 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 120.883 0.373 . . . . 0.0 110.886 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.817 ' NZ ' HD22 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -147.32 145.66 29.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.098 179.492 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.3 t -159.07 156.58 29.47 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.787 0.327 . . . . 0.0 111.592 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.753 ' C ' ' HG3' ' A' ' 104' ' ' GLU . . . 67.53 159.62 1.17 Allowed Glycine 0 CA--C 1.506 -0.5 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.352 -179.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.734 ' N ' ' HG3' ' A' ' 104' ' ' GLU . 57.6 mt-10 -131.89 113.0 12.93 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 122.006 0.908 . . . . 0.0 113.002 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.913 HG23 ' HG2' ' A' ' 104' ' ' GLU . 1.5 p -103.54 161.36 13.95 Favored 'General case' 0 CA--C 1.486 -1.505 0 CA-C-N 113.812 -1.54 . . . . 0.0 114.733 178.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.772 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -149.84 118.34 0.93 Allowed Glycine 0 C--N 1.311 -0.828 0 CA-C-N 112.911 -1.949 . . . . 0.0 111.373 178.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.529 ' N ' ' HG ' ' A' ' 99' ' ' LEU . 32.4 mt -148.16 138.69 17.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 117.278 0.539 . . . . 0.0 111.733 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.533 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 95.3 mt-10 -70.82 137.98 49.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 123.072 1.415 . . . . 0.0 112.313 -176.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.732 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 46.8 mt-10 -156.42 160.43 39.6 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 112.652 -2.067 . . . . 0.0 111.351 -179.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.917 ' O ' ' H52' ' A' ' 149' ' ' BB2 . . . -120.57 165.0 13.89 Favored Glycine 0 CA--C 1.501 -0.783 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.745 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 18.2 m -116.09 140.81 48.9 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 117.897 0.848 . . . . 0.0 111.995 -177.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.024 ' HG ' HD13 ' A' ' 46' ' ' LEU . 2.3 mm? -47.69 -26.52 1.57 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.88 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.852 ' CB ' HD13 ' A' ' 13' ' ' LEU . 49.9 m -79.77 -38.08 33.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.871 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.77 HG23 ' HD2' ' A' ' 94' ' ' PRO . 68.9 mt -86.1 149.97 51.32 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.971 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.77 ' HD2' HG23 ' A' ' 93' ' ' ILE . 85.6 Cg_endo -70.98 49.16 0.93 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.609 2.206 . . . . 0.0 113.945 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.548 ' HB2' ' O ' ' A' ' 94' ' ' PRO . 0.3 OUTLIER 74.19 20.07 2.77 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 178.841 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.745 ' HB2' HG21 ' A' ' 93' ' ' ILE . 84.3 mt-30 -78.76 88.85 4.61 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.732 ' HA ' ' O ' ' A' ' 88' ' ' GLU . 12.9 mtt85 -85.31 132.49 34.24 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.757 0.789 . . . . 0.0 112.115 -178.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -134.19 153.34 51.9 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.792 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.772 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.5 tt -75.67 112.7 12.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.681 0.753 . . . . 0.0 110.757 -178.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.975 HG13 ' HB2' ' A' ' 142' ' ' PHE . 29.5 t -98.6 128.93 31.37 Favored Pre-proline 0 N--CA 1.468 0.434 0 CA-C-N 114.724 -1.126 . . . . 0.0 112.011 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.53 ' HD2' ' CD2' ' A' ' 142' ' ' PHE . 1.1 Cg_endo -83.4 125.69 3.99 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.726 2.284 . . . . 0.0 112.031 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.976 HH11 ' HB3' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -145.86 167.17 23.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.312 179.759 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.638 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.62 155.17 40.53 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.913 ' HG2' HG23 ' A' ' 84' ' ' THR . 95.1 mt-10 -72.88 -39.87 66.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.867 -175.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.679 ' HB3' ' OD1' ' A' ' 123' ' ' ASP . 59.1 mttp -139.73 140.56 36.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.263 0.554 . . . . 0.0 109.722 177.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.797 HG12 ' CB ' ' A' ' 80' ' ' LYS . 35.2 m -149.71 140.02 16.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.511 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 1.018 ' HD3' ' HB3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -108.09 127.75 54.07 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.874 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.89 ' HA ' HD23 ' A' ' 78' ' ' LEU . 1.5 pp -133.03 150.15 32.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -177.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.902 ' HG3' HD21 ' A' ' 78' ' ' LEU . 96.4 mtt180 -102.18 137.69 40.12 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.66 -178.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.504 ' CB ' ' HB3' ' A' ' 72' ' ' LEU . . . -161.57 169.7 21.22 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 114.746 -1.115 . . . . 0.0 111.023 -176.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 1.061 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 1.9 pp -119.35 149.12 42.35 Favored 'General case' 0 C--O 1.218 -0.59 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 176.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.624 ' O ' HD12 ' A' ' 111' ' ' LEU . 12.8 t70 -81.75 167.8 18.72 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 119.877 -0.729 . . . . 0.0 112.642 -175.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.795 ' HB2' HG21 ' A' ' 71' ' ' VAL . 51.0 ttp180 -50.28 -22.45 1.79 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.971 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -79.4 -25.07 42.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.898 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.748 ' HA2' HD13 ' A' ' 111' ' ' LEU . . . 104.83 37.91 2.65 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.189 -1.005 . . . . 0.0 113.834 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -128.36 102.73 20.6 Favored Pre-proline 0 C--O 1.235 0.342 0 CA-C-N 117.054 0.427 . . . . 0.0 110.473 178.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.709 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 36.8 Cg_exo -71.56 114.86 4.07 Favored 'Trans proline' 0 C--N 1.358 1.075 0 N-CA-C 116.409 1.657 . . . . 0.0 116.409 -176.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.524 ' CE2' ' HB2' ' A' ' 112' ' ' ASP . 0.3 OUTLIER -127.0 160.72 30.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.731 -179.227 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.628 ' HG2' ' HG2' ' A' ' 109' ' ' ARG . 21.5 mt-10 -107.42 130.69 54.79 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.909 ' O ' HD23 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -131.66 141.59 49.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.795 0.807 . . . . 0.0 111.887 -179.019 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 107' ' ' LYS . 11.4 pt-20 -97.16 125.52 41.72 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.979 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.903 ' CB ' ' HG ' ' A' ' 126' ' ' LEU . . . -115.01 135.41 54.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.839 0.352 . . . . 0.0 111.391 -179.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.679 ' OD1' ' HB3' ' A' ' 105' ' ' LYS . 31.3 m-20 -126.66 160.76 29.8 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.808 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 51.73 -138.78 28.94 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 120.645 1.566 . . . . 0.0 115.159 177.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.672 HD12 ' H ' ' A' ' 125' ' ' LEU . 4.9 mp -53.5 -32.96 52.61 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.225 -0.488 . . . . 0.0 111.309 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.903 ' HG ' ' CB ' ' A' ' 122' ' ' ALA . 4.0 tp -70.78 -52.17 22.36 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.649 0.738 . . . . 0.0 109.418 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.738 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -58.55 -42.34 87.67 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.713 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.93 HD12 ' HG2' ' A' ' 102' ' ' ARG . 44.5 mm -67.85 -54.65 21.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.875 ' HB2' ' H91' ' A' ' 149' ' ' BB2 . 30.0 p -58.19 -50.2 74.36 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -178.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.883 HD11 HD11 ' A' ' 108' ' ' ILE . 14.2 tt -59.57 -44.21 92.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.121 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.866 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.0 pt20 -68.39 -39.42 81.71 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.518 178.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.674 ' CE1' HD12 ' A' ' 141' ' ' LEU . 68.7 t60 -59.44 -47.24 86.24 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.067 0.461 . . . . 0.0 109.794 178.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.877 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.7 mm-40 -59.61 -40.41 87.47 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.586 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.946 ' HA ' HD21 ' A' ' 137' ' ' LEU . 75.5 mtp -57.52 -47.64 81.43 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.838 0.828 . . . . 0.0 109.872 178.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.572 ' O ' HG12 ' A' ' 138' ' ' VAL . 31.4 m-20 -63.38 -47.13 83.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.976 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.961 ' HA ' HD21 ' A' ' 141' ' ' LEU . 4.6 t-80 -59.07 -53.0 63.29 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 121.103 0.478 . . . . 0.0 111.593 -178.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.946 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.7 pp -58.64 -31.76 68.43 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.518 -178.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.989 HG23 HG13 ' A' ' 16' ' ' VAL . 14.9 p -86.44 23.85 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 122.329 1.061 . . . . 0.0 109.548 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.627 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 53.85 34.94 52.05 Favored Glycine 0 CA--C 1.482 -1.969 0 CA-C-N 113.388 -1.733 . . . . 0.0 112.432 176.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.968 ' HG2' HG13 ' A' ' 138' ' ' VAL . 3.6 ptmt -133.17 105.92 7.29 Favored 'General case' 0 N--CA 1.423 -1.807 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.334 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.961 HD21 ' HA ' ' A' ' 136' ' ' HIS . 3.3 mm? -122.86 151.36 41.79 Favored 'General case' 0 N--CA 1.446 -0.666 0 O-C-N 120.814 -1.179 . . . . 0.0 109.474 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.975 ' HB2' HG13 ' A' ' 100' ' ' VAL . 8.8 m-85 -64.72 -27.35 68.85 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.892 ' HA ' HD23 ' A' ' 146' ' ' LEU . 1.9 tmt? -58.83 -24.9 62.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.514 0.673 . . . . 0.0 110.183 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.449 ' CG ' ' HE ' ' A' ' 14' ' ' ARG . 67.9 m-20 -54.8 -25.63 29.48 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.314 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -122.46 36.37 4.65 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -178.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.892 HD23 ' HA ' ' A' ' 143' ' ' MET . 2.8 mm? -85.66 144.27 27.93 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.789 0.328 . . . . 0.0 111.269 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 46.7 t . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.004 179.779 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' BB2 . . . . . 0.917 ' H52' ' O ' ' A' ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.7 t . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.835 0.35 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.818 HG13 HG23 ' A' ' 37' ' ' THR . 38.2 t -84.11 128.33 38.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.619 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.964 HD21 ' HB ' ' A' ' 51' ' ' VAL . 3.1 pp -79.63 -173.39 3.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.797 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.458 ' N ' HD12 ' A' ' 3' ' ' LEU . 70.9 tp60 -83.1 106.82 15.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.026 0.441 . . . . 0.0 110.59 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.586 HG22 HG21 ' A' ' 37' ' ' THR . 40.6 t -87.65 127.95 40.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.543 0.687 . . . . 0.0 112.201 -178.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.99 ' HB2' HD21 ' A' ' 13' ' ' LEU . 35.1 mt -85.96 138.88 31.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.193 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.523 ' C ' HD11 ' A' ' 13' ' ' LEU . 28.8 m-70 -113.44 147.47 37.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.083 0.468 . . . . 0.0 112.141 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.048 HD13 HD12 ' A' ' 13' ' ' LEU . 42.9 mm -57.26 148.08 54.5 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.426 178.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.635 ' HA ' HG23 ' A' ' 8' ' ' ILE . 69.5 Cg_endo -93.49 51.84 1.1 Allowed 'Cis proline' 0 C--N 1.353 0.802 0 C-N-CA 124.707 -0.956 . . . . 0.0 112.881 0.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.886 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.7 t70 -55.66 135.78 51.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.057 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -59.37 -44.98 92.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.999 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.657 ' O ' ' HB ' ' A' ' 49' ' ' THR . 15.1 mmt85 -56.06 -25.47 45.29 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 1.048 HD12 HD13 ' A' ' 8' ' ' ILE . 10.7 mt -75.42 -33.86 60.96 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 119.46 1.027 . . . . 0.0 108.679 178.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.754 ' HD3' ' CG ' ' A' ' 144' ' ' ASP . 14.9 mmm180 -96.23 13.01 28.88 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 114.086 -1.416 . . . . 0.0 109.442 178.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.867 ' HD3' ' N ' ' A' ' 16' ' ' VAL . 1.1 tmtp? -87.01 145.38 26.51 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.918 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.94 HG13 HG23 ' A' ' 138' ' ' VAL . 49.1 t -81.86 118.95 30.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.792 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -78.16 150.84 33.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.824 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.787 ' HD3' ' O ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -114.65 133.08 22.6 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.133 178.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.763 ' HD3' ' HD2' ' A' ' 56' ' ' ARG . 61.2 Cg_endo -78.81 115.94 3.67 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.454 2.103 . . . . 0.0 111.43 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.767 HG12 ' H ' ' A' ' 22' ' ' GLU . 19.9 t -67.85 144.43 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 CA-C-O 122.618 1.199 . . . . 0.0 113.096 -175.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -61.62 -28.22 69.21 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 113.058 -1.883 . . . . 0.0 112.111 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.767 ' H ' HG12 ' A' ' 20' ' ' VAL . 38.9 tt0 -156.57 145.74 20.42 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 120.746 -0.381 . . . . 0.0 111.547 -178.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.626 HG21 ' HA2' ' A' ' 115' ' ' GLY . 3.9 t -79.15 105.87 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -178.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.91 ' HB2' HD13 ' A' ' 27' ' ' ILE . 57.4 m-80 -93.31 153.81 18.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.779 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.647 ' HB1' HH12 ' A' ' 29' ' ' ARG . . . -54.72 -24.17 20.97 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.254 0.549 . . . . 0.0 110.711 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -74.95 -41.06 60.35 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 177.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.91 HD13 ' HB2' ' A' ' 24' ' ' ASN . 1.8 mp -68.08 -33.96 63.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-N 113.846 -1.524 . . . . 0.0 110.108 178.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -69.94 -40.07 75.7 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 122.354 -0.216 . . . . 0.0 110.575 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.647 HH12 ' HB1' ' A' ' 25' ' ' ALA . 67.7 mtt85 -64.26 -38.01 89.53 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.802 ' CG2' HD13 ' A' ' 53' ' ' ILE . 4.8 mt -55.46 -50.3 66.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.302 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.785 HG22 ' CG2' ' A' ' 57' ' ' ILE . 3.8 t -67.9 -40.67 83.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.02 0.438 . . . . 0.0 110.201 178.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.83 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 12.8 m-20 -55.32 -41.38 72.35 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.73 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.485 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 52.7 m-20 -76.32 -30.21 57.6 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.158 176.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 1.092 ' HG2' HG21 ' A' ' 51' ' ' VAL . 85.4 mtp -60.31 -46.25 90.54 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.268 -177.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.83 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 11.0 p90 -69.57 -44.51 70.68 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 32' ' ' ASP . 31.2 mm-40 -53.01 -39.97 63.52 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.818 HG23 HG13 ' A' ' 2' ' ' VAL . 74.7 m -71.49 -62.6 1.35 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 118.377 -1.329 . . . . 0.0 107.886 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 1.008 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 2.0 ttp -46.91 -40.4 14.04 Favored 'General case' 0 CA--C 1.467 -2.237 0 C-N-CA 124.015 0.926 . . . . 0.0 110.145 -170.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.698 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 50.6 m-85 -70.51 -42.27 71.52 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.985 177.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 37' ' ' THR . . . -61.25 -23.23 65.5 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.566 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 1.014 ' HG2' HD12 ' A' ' 91' ' ' LEU . 11.5 tp10 -90.25 -11.38 41.07 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 114.434 -1.257 . . . . 0.0 108.273 177.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.443 ' H ' ' C ' ' A' ' 39' ' ' TYR . 21.6 mt-10 64.12 28.55 14.16 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.889 -176.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.817 ' HA2' H182 ' A' ' 149' ' ' BB2 . . . -84.48 143.66 21.02 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 113.678 -1.601 . . . . 0.0 111.207 178.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.832 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 45.7 mm -79.36 -1.44 4.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 117.323 0.561 . . . . 0.0 112.061 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.825 ' HA3' ' H92' ' A' ' 149' ' ' BB2 . . . 177.87 135.88 2.37 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-O 119.28 -0.733 . . . . 0.0 111.721 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.089 HD13 ' HG ' ' A' ' 91' ' ' LEU . 5.0 tp -125.01 133.67 52.88 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.347 1.074 . . . . 0.0 111.305 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -100.42 132.33 45.86 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.962 ' HB1' HG13 ' A' ' 53' ' ' ILE . . . -26.9 -56.5 0.09 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.657 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 70.4 p -53.34 -35.81 60.64 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.65 0.738 . . . . 0.0 111.756 -177.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.816 ' NE2' HD23 ' A' ' 91' ' ' LEU . 8.8 mt-30 -64.52 -41.57 96.31 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.59 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.092 HG21 ' HG2' ' A' ' 34' ' ' MET . 1.1 m -85.76 18.57 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.904 ' OD2' HD21 ' A' ' 6' ' ' LEU . 8.4 t0 78.43 28.09 0.48 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 176.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.962 HG13 ' HB1' ' A' ' 48' ' ' ALA . 11.1 pt -123.05 110.35 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 118.857 -1.137 . . . . 0.0 111.783 177.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.618 ' HB2' ' NZ ' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -76.82 51.74 0.79 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 121.888 0.851 . . . . 0.0 109.531 179.206 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.533 ' O ' HG12 ' A' ' 57' ' ' ILE . 26.2 mt-30 -140.52 129.94 23.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.103 -1.408 . . . . 0.0 107.501 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.792 ' N ' ' HB1' ' A' ' 17' ' ' ALA . 73.3 mtt-85 -59.83 68.34 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.936 ' HB ' HD11 ' A' ' 53' ' ' ILE . 11.1 mm -112.08 122.31 66.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.058 HD11 ' HB2' ' A' ' 72' ' ' LEU . 1.9 pp -127.82 143.46 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 119.607 -0.837 . . . . 0.0 113.174 -177.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.67 HG21 ' HB3' ' A' ' 35' ' ' PHE . 1.4 p -127.96 134.13 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.679 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.049 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 2.0 mt -114.93 151.94 16.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.445 0.64 . . . . 0.0 111.111 -177.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 1.008 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 11.4 t70 -129.65 25.73 5.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.614 -1.176 . . . . 0.0 110.83 -177.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 1.085 HG12 ' H ' ' A' ' 63' ' ' SER . 11.7 t -79.46 -161.33 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 1.085 ' H ' HG12 ' A' ' 62' ' ' VAL . 54.1 m -95.17 85.85 4.42 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.196 -0.315 . . . . 0.0 111.194 177.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.7 ' OE1' HD23 ' A' ' 70' ' ' LEU . 36.9 tt0 -61.58 -47.75 84.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.967 0.889 . . . . 0.0 109.551 178.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.762 ' ND2' ' HG3' ' A' ' 66' ' ' ARG . 53.9 t30 -165.84 -119.22 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 113.922 -1.49 . . . . 0.0 108.616 178.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.762 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 98.5 mtt180 -69.15 -46.39 67.71 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -103.17 122.67 45.19 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.596 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.736 ' HG2' ' HA ' ' A' ' 63' ' ' SER . 47.7 mt-10 -78.16 83.76 4.42 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.006 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.534 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 51.5 ttt-85 -153.85 100.44 2.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.68 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 1.049 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 48.5 mt -112.09 138.87 48.15 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -179.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.999 HG21 ' HB2' ' A' ' 113' ' ' ARG . 8.8 p -134.03 131.23 55.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.408 177.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.058 ' HB2' HD11 ' A' ' 58' ' ' ILE . 89.6 mt -142.41 143.18 32.54 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 121.31 -0.156 . . . . 0.0 110.919 177.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.054 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.6 mp -120.68 134.39 64.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.69 0.281 . . . . 0.0 110.743 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.688 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 7.4 m120 53.72 34.78 0.26 Allowed Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.846 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 84.5 Cg_exo -55.16 146.75 57.99 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.521 2.147 . . . . 0.0 113.571 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -135.99 149.23 48.77 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.959 ' HB2' ' HE1' ' A' ' 134' ' ' MET . 27.9 tp -79.63 138.3 37.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.42 0.629 . . . . 0.0 112.082 -178.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.066 HD21 ' HG3' ' A' ' 109' ' ' ARG . 2.6 mm? -114.26 -45.35 3.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.425 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.587 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 38.2 tt0 -158.06 146.82 19.16 Favored 'General case' 0 C--O 1.23 0.035 0 CA-C-O 121.114 0.483 . . . . 0.0 111.637 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.879 ' HE3' HD21 ' A' ' 77' ' ' LEU . 19.3 ptpt -143.59 146.91 33.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.045 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.4 p -159.67 150.98 19.76 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.733 0.301 . . . . 0.0 111.291 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.744 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 79.75 159.08 16.84 Favored Glycine 0 C--N 1.335 0.472 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.414 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -134.02 113.4 12.09 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.896 0.855 . . . . 0.0 112.93 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.643 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.6 p -106.97 161.53 14.64 Favored 'General case' 0 CA--C 1.486 -1.485 0 CA-C-N 113.902 -1.499 . . . . 0.0 114.936 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.746 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -146.95 115.86 0.81 Allowed Glycine 0 C--N 1.311 -0.861 0 CA-C-N 112.671 -2.059 . . . . 0.0 110.873 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.589 ' N ' ' HG ' ' A' ' 99' ' ' LEU . 34.1 mt -147.97 139.09 17.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 117.293 0.546 . . . . 0.0 111.618 -178.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 50.5 mt-10 -71.65 138.55 48.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 123.193 1.473 . . . . 0.0 112.082 -175.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.792 ' HB3' H262 ' A' ' 149' ' ' BB2 . 46.0 mt-10 -157.41 162.25 39.0 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 112.672 -2.058 . . . . 0.0 111.098 -179.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.871 ' O ' ' H52' ' A' ' 149' ' ' BB2 . . . -122.01 161.53 16.12 Favored Glycine 0 CA--C 1.501 -0.817 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.682 ' HA ' ' O4 ' ' A' ' 149' ' ' BB2 . 17.9 m -114.63 140.43 48.82 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.313 0.578 . . . . 0.0 111.344 -178.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.089 ' HG ' HD13 ' A' ' 46' ' ' LEU . 2.4 mm? -48.14 -22.8 0.69 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.333 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.863 ' CB ' HG12 ' A' ' 8' ' ' ILE . 54.0 m -83.28 -34.76 25.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.921 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.783 HG23 ' HD2' ' A' ' 94' ' ' PRO . 49.5 mm -85.43 149.41 51.89 Favored Pre-proline 0 N--CA 1.451 -0.381 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.226 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.783 ' HD2' HG23 ' A' ' 93' ' ' ILE . 92.1 Cg_endo -73.11 50.32 1.82 Allowed 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.493 2.129 . . . . 0.0 114.033 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.53 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 39.5 tt0 75.61 14.4 2.81 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.041 0.448 . . . . 0.0 111.871 178.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.703 ' HB2' HG21 ' A' ' 93' ' ' ILE . 10.0 mm-40 -78.85 88.89 4.66 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.764 ' HG2' ' CA ' ' A' ' 89' ' ' GLY . 18.5 mtm105 -85.31 132.62 34.22 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 121.637 0.732 . . . . 0.0 111.836 -178.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -135.16 155.85 50.0 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 114.539 -1.209 . . . . 0.0 109.432 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.746 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.6 tt -76.23 115.28 15.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.419 0.628 . . . . 0.0 111.773 -178.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.859 HG13 ' HB2' ' A' ' 142' ' ' PHE . 39.0 t -107.01 131.95 21.29 Favored Pre-proline 0 N--CA 1.475 0.815 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.991 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.643 ' HA ' ' O ' ' A' ' 84' ' ' THR . 85.3 Cg_endo -82.92 127.47 4.79 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.663 2.242 . . . . 0.0 112.519 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.948 ' HG3' HG23 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -144.68 167.26 22.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.224 179.351 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.744 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.79 155.48 40.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 118.34 0.518 . . . . 0.0 110.1 -179.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -73.38 -41.2 63.67 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.895 -175.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.672 ' HB3' ' OD1' ' A' ' 123' ' ' ASP . 95.4 mttt -139.64 140.23 36.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.249 0.547 . . . . 0.0 109.619 177.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.869 HG22 ' HB1' ' A' ' 127' ' ' ALA . 35.1 m -146.78 139.44 19.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.311 -178.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 1.014 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 56.1 mmtt -106.6 127.05 53.03 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 1.014 ' HA ' HD23 ' A' ' 78' ' ' LEU . 2.3 pp -133.83 146.81 31.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -176.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 1.066 ' HG3' HD21 ' A' ' 78' ' ' LEU . 68.7 mtm180 -103.6 139.32 39.06 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.68 -178.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.704 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -161.05 169.42 22.51 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.037 -176.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 1.054 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.5 pp -116.48 151.83 35.28 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.473 ' O ' HD12 ' A' ' 111' ' ' LEU . 16.8 t70 -85.24 163.61 18.56 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.231 0.539 . . . . 0.0 112.053 -177.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.999 ' HB2' HG21 ' A' ' 71' ' ' VAL . 13.1 ttp-105 -51.93 -20.11 2.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.076 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -79.4 -26.44 41.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.633 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.626 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 107.3 35.98 2.58 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.199 -1.001 . . . . 0.0 113.491 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -128.46 102.68 20.36 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.781 0.291 . . . . 0.0 110.804 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.672 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.9 Cg_exo -72.6 116.27 4.65 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 121.65 1.567 . . . . 0.0 115.663 -177.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 112' ' ' ASP . 0.4 OUTLIER -126.97 165.13 20.01 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.269 -178.655 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.545 ' HG3' ' CG ' ' A' ' 109' ' ' ARG . 5.9 mp0 -107.33 130.68 54.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.028 0.442 . . . . 0.0 109.837 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.729 HD21 ' CD1' ' A' ' 72' ' ' LEU . 4.4 pp -124.53 130.94 53.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.571 -178.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 1.014 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 15.3 pt-20 -91.5 123.79 35.18 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.917 ' CB ' HD12 ' A' ' 126' ' ' LEU . . . -116.24 135.62 53.74 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.672 ' OD1' ' HB3' ' A' ' 105' ' ' LYS . 45.4 m-20 -127.1 161.36 28.62 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.825 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 51.68 -137.88 30.3 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 120.334 1.425 . . . . 0.0 115.279 177.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 81.1 mt -54.05 -32.28 54.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.816 -0.692 . . . . 0.0 111.737 -178.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.917 HD12 ' CB ' ' A' ' 122' ' ' ALA . 0.3 OUTLIER -71.11 -52.58 18.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.663 0.744 . . . . 0.0 109.362 179.769 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.869 ' HB1' HG22 ' A' ' 106' ' ' VAL . . . -59.85 -40.9 90.16 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.569 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.948 HG23 ' HG3' ' A' ' 102' ' ' ARG . 46.4 mm -66.01 -54.31 28.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.698 -178.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.822 ' HB3' H112 ' A' ' 149' ' ' BB2 . 85.5 m -60.42 -49.39 77.76 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.768 ' CD1' HG12 ' A' ' 108' ' ' ILE . 0.1 OUTLIER -59.22 -44.72 92.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.557 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.818 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.3 pt20 -67.7 -39.14 84.42 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.683 0.278 . . . . 0.0 110.282 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.646 ' CD2' ' HN1' ' A' ' 149' ' ' BB2 . 71.3 t60 -59.86 -46.05 90.53 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.12 0.486 . . . . 0.0 109.88 178.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.885 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.5 mm-40 -60.32 -40.74 91.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.921 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.959 ' HE1' ' HB2' ' A' ' 77' ' ' LEU . 73.2 mtp -57.78 -48.07 80.75 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.751 0.786 . . . . 0.0 109.948 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.653 ' O ' HG12 ' A' ' 138' ' ' VAL . 30.6 m-20 -62.76 -46.75 86.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.811 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 1.066 ' HA ' HD21 ' A' ' 141' ' ' LEU . 4.7 t-80 -59.57 -52.72 64.35 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.206 0.527 . . . . 0.0 111.675 -178.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.927 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.5 pp -59.18 -30.38 68.15 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.315 -178.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.94 HG23 HG13 ' A' ' 16' ' ' VAL . 13.4 p -86.1 22.7 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-O 122.094 0.949 . . . . 0.0 109.356 176.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.711 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 55.88 38.75 75.54 Favored Glycine 0 CA--C 1.483 -1.966 0 CA-C-N 113.678 -1.601 . . . . 0.0 112.662 176.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.932 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 3.4 ptmt -137.66 108.81 6.79 Favored 'General case' 0 N--CA 1.426 -1.658 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.708 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 1.066 HD21 ' HA ' ' A' ' 136' ' ' HIS . 3.3 mm? -132.07 143.56 50.12 Favored 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 120.942 -1.099 . . . . 0.0 108.858 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.859 ' HB2' HG13 ' A' ' 100' ' ' VAL . 7.9 m-85 -60.28 -40.68 91.31 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 1.053 ' HA ' HD13 ' A' ' 146' ' ' LEU . 46.3 ttm -61.09 -26.73 67.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.563 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.754 ' CG ' ' HD3' ' A' ' 14' ' ' ARG . 38.8 t70 -52.47 -25.85 11.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.033 -179.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -125.58 45.87 2.51 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.536 -177.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 1.053 HD13 ' HA ' ' A' ' 143' ' ' MET . 6.0 mp -92.39 146.2 23.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.033 177.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.7 t . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.193 -0.908 . . . . 0.0 111.067 179.614 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' BB2 . . . . . 0.875 H171 HD13 ' A' ' 91' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.894 0.378 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.94 HG12 ' HA ' ' A' ' 37' ' ' THR . 31.5 m -83.98 134.99 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.481 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 1.004 HD21 ' HB ' ' A' ' 51' ' ' VAL . 3.2 pp -79.74 -165.97 0.91 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.593 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.439 ' N ' HD12 ' A' ' 3' ' ' LEU . 40.7 tt0 -89.92 109.76 20.76 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.952 0.406 . . . . 0.0 110.473 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.567 ' CG2' HG21 ' A' ' 37' ' ' THR . 43.4 t -88.66 129.84 39.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.413 0.625 . . . . 0.0 112.079 -178.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.082 ' HB2' HD21 ' A' ' 13' ' ' LEU . 15.3 mt -89.95 143.21 26.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.923 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 44.0 m-70 -121.77 147.93 45.3 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -179.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.033 HD13 HD12 ' A' ' 13' ' ' LEU . 50.3 mm -63.68 135.78 96.43 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.145 178.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -80.38 142.73 61.83 Favored 'Cis proline' 0 C--N 1.351 0.708 0 C-N-CA 124.605 -0.998 . . . . 0.0 111.746 -0.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.948 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.7 t70 -163.53 126.9 2.7 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.459 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 12' ' ' ARG . 11.9 pt-20 -58.08 -46.07 86.08 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.598 -178.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 1.024 ' HA ' ' HZ3' ' A' ' 15' ' ' LYS . 16.0 mmt85 -56.28 -29.05 60.65 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 1.082 HD21 ' HB2' ' A' ' 6' ' ' LEU . 10.0 mt -76.43 -34.28 58.77 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 120.068 1.303 . . . . 0.0 108.559 177.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.796 ' HB3' ' NH1' ' A' ' 14' ' ' ARG . 2.2 mmm180 -93.42 13.0 22.97 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 113.877 -1.51 . . . . 0.0 109.182 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 1.024 ' HZ3' ' HA ' ' A' ' 12' ' ' ARG . 4.5 ttmp? -88.66 145.65 25.54 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.207 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 1.04 HG13 HG23 ' A' ' 138' ' ' VAL . 59.5 t -82.43 121.49 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.75 ' HB1' ' N ' ' A' ' 56' ' ' ARG . . . -82.13 145.82 29.92 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.411 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -107.95 128.96 24.8 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.745 ' HA ' ' OD1' ' A' ' 74' ' ' ASN . 64.0 Cg_endo -78.97 113.54 3.26 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 121.725 1.617 . . . . 0.0 110.665 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.726 HG12 ' H ' ' A' ' 22' ' ' GLU . 16.5 t -68.97 144.43 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-O 122.469 1.128 . . . . 0.0 113.132 -175.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -60.49 -24.75 65.53 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 113.125 -1.852 . . . . 0.0 112.368 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.726 ' H ' HG12 ' A' ' 20' ' ' VAL . 42.7 tt0 -157.28 142.71 17.28 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.296 -179.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.542 HG22 HD21 ' A' ' 111' ' ' LEU . 2.9 t -80.07 108.1 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -178.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 1.038 ' H ' HD12 ' A' ' 27' ' ' ILE . 63.1 m-80 -90.85 155.36 18.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.658 -178.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.687 ' O ' ' HG2' ' A' ' 29' ' ' ARG . . . -55.29 -25.49 34.46 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.35 0.595 . . . . 0.0 110.49 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.434 ' OE2' HG12 ' A' ' 27' ' ' ILE . 0.6 OUTLIER -75.11 -38.99 60.92 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 177.745 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 1.038 HD12 ' H ' ' A' ' 24' ' ' ASN . 57.4 mt -66.06 -35.6 75.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 114.297 -1.32 . . . . 0.0 110.168 177.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -69.38 -39.21 78.15 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.254 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.687 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 38.1 mmm-85 -61.32 -39.24 89.79 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.792 ' O ' ' HG3' ' A' ' 34' ' ' MET . 3.0 mt -58.24 -48.69 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.2 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.903 HG22 ' CG2' ' A' ' 57' ' ' ILE . 8.7 t -67.9 -41.85 85.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 120.968 0.413 . . . . 0.0 111.557 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.862 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -55.8 -42.4 75.55 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.999 -179.412 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.483 ' HA ' ' HB2' ' A' ' 36' ' ' GLU . 15.5 m-20 -75.48 -29.91 59.74 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.284 176.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 1.008 ' HG2' HG21 ' A' ' 51' ' ' VAL . 83.1 mtp -60.28 -46.51 89.58 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.315 -177.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.862 ' CE2' ' HA ' ' A' ' 32' ' ' ASP . 13.4 p90 -69.7 -45.2 68.81 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.751 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 37.9 mt-10 -51.84 -40.42 60.49 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 121.762 0.791 . . . . 0.0 108.904 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.94 ' HA ' HG12 ' A' ' 2' ' ' VAL . 56.6 m -70.24 -62.23 1.47 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.33 -1.305 . . . . 0.0 108.176 178.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.955 ' HE1' ' HB2' ' A' ' 61' ' ' ASP . 2.8 ttp -46.31 -41.4 13.21 Favored 'General case' 0 CA--C 1.46 -2.485 0 C-N-CA 124.144 0.978 . . . . 0.0 110.364 -171.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.709 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 61.7 m-85 -70.55 -42.69 70.84 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.686 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.5 ' CB ' HG11 ' A' ' 2' ' ' VAL . . . -61.4 -24.27 66.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.841 0.829 . . . . 0.0 109.395 179.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 1.052 ' HG2' HD12 ' A' ' 91' ' ' LEU . 11.6 tp10 -88.74 -11.23 45.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.471 177.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.447 ' H ' ' C ' ' A' ' 39' ' ' TYR . 21.8 mt-10 64.27 25.42 13.53 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.956 -176.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.706 ' HA2' H182 ' A' ' 149' ' ' BB2 . . . -78.15 142.38 26.18 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 113.839 -1.528 . . . . 0.0 110.714 177.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.811 ' C ' ' HB3' ' A' ' 61' ' ' ASP . 44.3 mm -79.15 -2.34 5.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 117.354 0.577 . . . . 0.0 112.139 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.899 ' HA3' ' C10' ' A' ' 149' ' ' BB2 . . . 177.97 134.91 2.15 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 118.759 -1.023 . . . . 0.0 111.291 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.04 HD13 ' HG ' ' A' ' 91' ' ' LEU . 7.6 tp -124.52 134.97 52.84 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 119.29 1.545 . . . . 0.0 111.973 -179.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.451 ' H ' HE21 ' A' ' 50' ' ' GLN . . . -100.31 130.34 46.41 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.484 0.183 . . . . 0.0 111.299 178.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.872 ' HB1' ' CD1' ' A' ' 53' ' ' ILE . . . -28.61 -54.43 0.11 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -179.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.622 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 69.1 p -52.96 -35.45 58.94 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.458 0.647 . . . . 0.0 112.221 -177.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.919 ' NE2' HD23 ' A' ' 91' ' ' LEU . 34.2 mt-30 -65.22 -42.05 93.81 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.154 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.008 HG21 ' HG2' ' A' ' 34' ' ' MET . 0.8 OUTLIER -82.42 15.69 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 179.781 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.872 ' HA ' HD11 ' A' ' 6' ' ' LEU . 35.0 t70 77.46 30.07 0.52 Allowed 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 176.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.872 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 1.1 pp -123.74 111.37 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.318 177.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.679 ' HB3' ' HD2' ' A' ' 15' ' ' LYS . 6.8 p80 -76.68 61.65 1.86 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.677 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.725 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 89.0 mt-30 -151.57 134.3 15.59 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 114.495 -1.229 . . . . 0.0 107.942 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.75 ' N ' ' HB1' ' A' ' 17' ' ' ALA . 76.3 mtp180 -64.0 69.3 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -177.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.903 ' CG2' HG22 ' A' ' 31' ' ' VAL . 8.0 mm -111.27 123.47 67.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.83 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -131.43 147.39 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 121.975 0.893 . . . . 0.0 112.965 -177.779 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.588 HG22 ' O ' ' A' ' 46' ' ' LEU . 32.9 m -127.71 139.21 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.092 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.969 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 9.2 mm -114.69 150.73 16.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.646 0.736 . . . . 0.0 109.943 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.955 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 33.4 t70 -138.62 28.82 2.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.735 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.772 HG22 ' CG2' ' A' ' 44' ' ' ILE . 40.4 t -93.71 106.74 18.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.556 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.694 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 79.8 p -38.35 81.59 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -177.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 62' ' ' VAL . 17.5 tp10 -69.22 -14.47 62.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.686 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.583 ' ND2' ' H ' ' A' ' 66' ' ' ARG . 46.2 t30 -165.12 -139.98 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.583 ' H ' ' ND2' ' A' ' 65' ' ' ASN . 39.5 mmm-85 -74.07 -52.37 12.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.685 0.278 . . . . 0.0 110.416 -178.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.91 126.98 41.54 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.986 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.694 ' HG2' ' HA ' ' A' ' 63' ' ' SER . 43.5 mt-10 -89.0 132.35 34.77 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.47 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.699 ' HA ' ' OH ' ' A' ' 39' ' ' TYR . 41.7 ttm-85 173.29 72.03 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.969 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 8.5 mp -102.87 132.35 49.13 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.991 0.424 . . . . 0.0 111.908 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.93 HG21 ' HB2' ' A' ' 113' ' ' ARG . 9.6 p -133.14 134.33 57.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.06 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.83 ' HB2' ' CD1' ' A' ' 58' ' ' ILE . 90.6 mt -141.74 140.95 33.23 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 121.384 -0.126 . . . . 0.0 111.009 178.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.03 ' HB ' ' HG ' ' A' ' 111' ' ' LEU . 1.8 mp -120.2 133.65 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-O 120.838 0.351 . . . . 0.0 110.923 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.792 ' ND2' HG22 ' A' ' 73' ' ' ILE . 64.5 m-20 51.72 36.32 0.34 Allowed Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 113.863 1.061 . . . . 0.0 113.863 178.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.742 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 90.1 Cg_exo -55.65 149.5 48.86 Favored 'Trans proline' 0 N--CA 1.484 0.917 0 C-N-CA 122.708 2.272 . . . . 0.0 113.415 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.45 ' OE2' ' HD2' ' A' ' 109' ' ' ARG . 23.0 pt-20 -135.91 145.88 46.76 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.77 HD21 ' HE3' ' A' ' 80' ' ' LYS . 30.1 tp -79.71 138.38 37.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.38 0.61 . . . . 0.0 112.278 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.06 HD11 ' HG3' ' A' ' 109' ' ' ARG . 5.4 mp -112.17 -44.04 3.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.632 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.561 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 38.4 tt0 -158.79 147.79 18.74 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 121.141 0.496 . . . . 0.0 111.831 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.874 ' HA ' HG12 ' A' ' 106' ' ' VAL . 19.4 ptpt -142.3 147.46 36.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.054 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.2 t -160.03 148.02 16.83 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.702 0.287 . . . . 0.0 111.221 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.759 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . 82.97 163.93 34.89 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.515 -179.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -140.55 113.59 8.38 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.922 0.861 . . . . 0.0 113.106 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 1.6 p -106.09 161.56 14.39 Favored 'General case' 0 CA--C 1.486 -1.481 0 CA-C-N 113.999 -1.455 . . . . 0.0 114.864 178.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.702 ' HA3' HD21 ' A' ' 99' ' ' LEU . . . -145.47 114.12 0.74 Allowed Glycine 0 C--N 1.312 -0.781 0 CA-C-N 112.849 -1.978 . . . . 0.0 110.653 178.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.826 ' HB ' ' NH2' ' A' ' 102' ' ' ARG . 34.0 mt -148.67 139.56 17.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-N 117.264 0.532 . . . . 0.0 111.826 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 50.4 mt-10 -72.19 138.09 47.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 123.195 1.474 . . . . 0.0 112.581 -176.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.763 ' HB3' H262 ' A' ' 149' ' ' BB2 . 39.1 mt-10 -155.29 160.26 40.64 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 112.358 -2.201 . . . . 0.0 111.212 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.912 ' O ' ' H52' ' A' ' 149' ' ' BB2 . . . -120.12 159.56 15.04 Favored Glycine 0 CA--C 1.499 -0.911 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 1.038 ' HB2' HD13 ' A' ' 93' ' ' ILE . 21.8 m -114.27 139.91 49.03 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 117.688 0.744 . . . . 0.0 111.175 -177.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.052 HD12 ' HG2' ' A' ' 41' ' ' GLU . 2.4 mm? -49.44 -22.47 1.19 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.036 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.94 ' HB3' HD13 ' A' ' 13' ' ' LEU . 54.4 m -79.41 -38.54 34.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.277 179.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 1.038 HD13 ' HB2' ' A' ' 90' ' ' CYS . 3.2 mp -86.13 148.64 48.16 Favored Pre-proline 0 N--CA 1.448 -0.547 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.763 ' HD2' HG23 ' A' ' 93' ' ' ILE . 81.8 Cg_endo -73.88 52.41 2.58 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.439 2.093 . . . . 0.0 114.54 -178.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.537 ' HB2' ' O ' ' A' ' 94' ' ' PRO . 50.3 mt-10 78.63 12.67 1.48 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 178.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.792 ' HB2' HG21 ' A' ' 93' ' ' ILE . 25.7 mt-30 -79.0 88.42 4.77 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 178.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.889 ' NH1' H231 ' A' ' 149' ' ' BB2 . 40.2 mtt180 -85.17 132.53 34.28 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.573 0.701 . . . . 0.0 111.613 -178.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -135.35 155.46 50.55 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 114.691 -1.141 . . . . 0.0 109.716 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.702 HD21 ' HA3' ' A' ' 85' ' ' GLY . 7.3 tt -76.41 114.85 15.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.439 0.638 . . . . 0.0 111.985 -178.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.908 HG13 ' HB2' ' A' ' 142' ' ' PHE . 42.6 t -104.36 132.8 20.62 Favored Pre-proline 0 N--CA 1.47 0.573 0 CA-C-N 114.931 -1.031 . . . . 0.0 112.062 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.584 ' HA ' ' O ' ' A' ' 84' ' ' THR . 2.1 Cg_endo -84.35 125.99 3.56 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.843 2.362 . . . . 0.0 111.804 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.826 ' NH2' ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -144.61 167.51 22.36 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.56 0.744 . . . . 0.0 109.98 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.759 ' HA ' ' O ' ' A' ' 82' ' ' GLY . . . -68.79 154.86 41.22 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.836 0.351 . . . . 0.0 110.179 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -73.77 -41.16 62.81 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.146 -176.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.777 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 91.4 mttt -139.91 141.2 36.54 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.874 HG12 ' HA ' ' A' ' 80' ' ' LYS . 29.4 m -149.06 139.0 16.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.333 -179.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 1.058 ' HD2' ' HB2' ' A' ' 121' ' ' GLU . 51.0 mmtt -107.98 126.4 52.67 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 1.112 HD11 HD11 ' A' ' 130' ' ' ILE . 1.6 pp -136.1 152.76 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -176.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 1.06 ' HG3' HD11 ' A' ' 78' ' ' LEU . 93.7 mtt180 -102.68 138.78 39.12 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.93 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.605 ' HB1' ' HB3' ' A' ' 72' ' ' LEU . . . -160.04 167.82 27.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.102 -177.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 1.03 ' HG ' ' HB ' ' A' ' 73' ' ' ILE . 2.6 pp -117.12 153.25 33.11 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.609 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 10.1 t70 -88.2 162.97 16.38 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.519 -177.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.93 ' HB2' HG21 ' A' ' 71' ' ' VAL . 50.1 ttp85 -51.39 -19.04 1.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.251 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -79.1 -27.67 42.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.381 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.43 35.92 2.37 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.348 -0.93 . . . . 0.0 113.329 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -128.74 102.88 19.47 Favored Pre-proline 0 C--O 1.237 0.406 0 CA-C-N 116.815 0.308 . . . . 0.0 110.914 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.656 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 31.5 Cg_exo -73.4 116.08 4.57 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 121.766 1.644 . . . . 0.0 115.145 -177.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.609 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 10.9 p90 -126.13 166.65 16.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.312 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.706 ' HG2' ' HG2' ' A' ' 109' ' ' ARG . 30.7 mt-10 -107.5 130.51 54.84 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.817 HD11 ' CD1' ' A' ' 130' ' ' ILE . 4.3 pp -127.44 133.88 49.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.591 -178.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 1.058 ' HB2' ' HD2' ' A' ' 107' ' ' LYS . 9.1 pm0 -94.45 123.66 38.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.627 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.807 ' CB ' HD22 ' A' ' 126' ' ' LEU . . . -116.82 135.11 54.0 Favored 'General case' 0 C--O 1.222 -0.364 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.777 ' OD2' ' HD3' ' A' ' 105' ' ' LYS . 1.2 m-20 -126.66 162.35 25.97 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.728 ' O ' HG12 ' A' ' 128' ' ' ILE . . . 49.9 -134.77 26.54 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 120.418 1.463 . . . . 0.0 115.252 177.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.742 HD12 ' CG1' ' A' ' 62' ' ' VAL . 1.7 pt? -53.78 -35.46 61.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.032 -0.584 . . . . 0.0 111.462 -179.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.807 HD22 ' CB ' ' A' ' 122' ' ' ALA . 0.6 OUTLIER -70.51 -52.01 24.85 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.996 0.903 . . . . 0.0 109.281 179.563 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.713 ' HB2' ' O ' ' A' ' 122' ' ' ALA . . . -58.45 -41.5 85.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.925 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.817 HG23 ' HG3' ' A' ' 102' ' ' ARG . 50.6 mm -68.54 -54.99 17.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.827 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 29.3 p -59.03 -50.74 72.93 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 1.112 HD11 HD11 ' A' ' 108' ' ' ILE . 17.9 tt -59.65 -43.85 92.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.189 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.693 ' OE1' ' HB2' ' A' ' 102' ' ' ARG . 22.0 pt20 -67.73 -40.63 84.18 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.176 178.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.641 ' CD2' ' HN1' ' A' ' 149' ' ' BB2 . 69.9 t60 -58.5 -45.78 88.04 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.206 0.527 . . . . 0.0 109.931 178.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.878 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.2 mm-40 -59.81 -41.77 92.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.708 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.947 ' HA ' HD21 ' A' ' 137' ' ' LEU . 74.8 mtp -57.25 -47.83 80.38 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.736 0.779 . . . . 0.0 110.08 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.643 ' O ' HG12 ' A' ' 138' ' ' VAL . 1.4 m-20 -63.16 -47.12 84.0 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.951 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.983 ' CE1' HD21 ' A' ' 141' ' ' LEU . 8.7 t-80 -58.97 -53.11 62.16 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.176 0.512 . . . . 0.0 111.472 -178.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.947 HD21 ' HA ' ' A' ' 134' ' ' MET . 1.6 pp -58.65 -31.4 68.13 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.644 -178.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 1.04 HG23 HG13 ' A' ' 16' ' ' VAL . 14.5 p -85.05 24.58 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-O 122.283 1.04 . . . . 0.0 109.816 176.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.48 ' HA3' ' C ' ' A' ' 14' ' ' ARG . . . 55.84 30.81 57.49 Favored Glycine 0 CA--C 1.486 -1.757 0 CA-C-N 113.48 -1.691 . . . . 0.0 112.679 176.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.956 ' HG2' ' CG1' ' A' ' 138' ' ' VAL . 5.8 ptmt -128.5 107.88 10.08 Favored 'General case' 0 N--CA 1.425 -1.704 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.626 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.983 HD21 ' CE1' ' A' ' 136' ' ' HIS . 4.6 mp -124.17 139.35 54.01 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 120.81 -1.181 . . . . 0.0 108.125 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.908 ' HB2' HG13 ' A' ' 100' ' ' VAL . 8.9 m-85 -59.77 -40.51 88.44 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.981 -0.449 . . . . 0.0 111.874 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 1.023 ' HA ' HD13 ' A' ' 146' ' ' LEU . 45.0 ttm -60.48 -26.38 66.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.175 0.512 . . . . 0.0 111.479 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.727 ' OD1' ' HD3' ' A' ' 14' ' ' ARG . 38.7 t70 -52.39 -25.22 9.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.184 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -122.96 43.07 3.03 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 120.716 0.294 . . . . 0.0 111.062 -177.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 1.023 HD13 ' HA ' ' A' ' 143' ' ' MET . 6.0 mp -91.08 142.33 27.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.115 178.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 55.7 m . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.984 179.529 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' BB2 . . . . . 0.912 ' H52' ' O ' ' A' ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_